PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Adnan, H; Zhang, ZB; Park, HJ; Tailor, C; Che, C; Kamani, M; Spitalny, G; Binnington, B; Lingwood, C				Adnan, Humaira; Zhang, Zhenbo; Park, Hyun-Joo; Tailor, Chetankumar; Che, Clare; Kamani, Mustafa; Spitalny, George; Binnington, Beth; Lingwood, Clifford			Endoplasmic Reticulum-Targeted Subunit Toxins Provide a New Approach to Rescue Misfolded Mutant Proteins and Revert Cell Models of Genetic Diseases	PLOS ONE			English	Article							ER-ASSOCIATED DEGRADATION; ESCHERICHIA-COLI O157-H7; CHOLERA-TOXIN; RETROGRADE TRANSPORT; SHIGA TOXIN; PLASMA-MEMBRANE; UNFOLDED PROTEIN; B-SUBUNIT; IN-VITRO; CFTR	Many germ line diseases stem from a relatively minor disturbance in mutant protein endoplasmic reticulum (ER) 3D assembly. Chaperones are recruited which, on failure to correct folding, sort the mutant for retrotranslocation and cytosolic proteasomal degradation (ER-associated degradation-ERAD), to initiate/exacerbate deficiency-disease symptoms. Several bacterial (and plant) subunit toxins, retrograde transport to the ER after initial cell surface receptor binding/internalization. The A subunit has evolved to mimic a misfolded protein and hijack the ERAD membrane translocon (dislocon), to effect cytosolic access and cytopathology. We show such toxins compete for ERAD to rescue endogenous misfolded proteins. Cholera toxin or verotoxin (Shiga toxin) containing genetically inactivated (+/- an N-terminal polyleucine tail) A subunit can, within 2 -4 hrs, temporarily increase F508delCFTR protein, the major cystic fibrosis (CF) mutant (5-10x), F508delCFTR Golgi maturation (< 10x), cell surface expression (20x) and chloride transport (2x) in F508del CFTR transfected cells and patient-derived F508delCFTR bronchiolar epithelia, without apparent cytopathology. These toxoids also increase glucocerobrosidase (GCC) in N370SGCC Gaucher Disease fibroblasts (3x), another ERAD -exacerbated misfiling disease. We identify a new, potentially benign approach to the treatment of certain genetic protein misfolding diseases.	[Adnan, Humaira; Zhang, Zhenbo; Park, Hyun-Joo; Che, Clare; Kamani, Mustafa; Binnington, Beth; Lingwood, Clifford] Hosp Sick Children, Div Mol Struct & Funct, Toronto, ON, Canada; [Tailor, Chetankumar] Hosp Sick Children, Res Inst, Div Cell Biol, Toronto, ON, Canada; [Spitalny, George] ERAD Therapeut, Caledon, ON, Canada; [Lingwood, Clifford] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A1, Canada; [Lingwood, Clifford] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Lingwood, C (corresponding author), Hosp Sick Children, Div Mol Struct & Funct, Toronto, ON, Canada.; Lingwood, C (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON M5S 1A1, Canada.; Lingwood, C (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A1, Canada.	cling@sickkids.on.ca		Zhang, Zhenbo/0000-0002-2353-7869	MITACS industrial pdf fellowship awards; BREATHE program - Canadian Cystic Fibrosis Foundation; Canadian Institutes of Health Research team grant in Lysosomal Storage Disease Pharmaco-therapeutics	MITACS industrial pdf fellowship awards; BREATHE program - Canadian Cystic Fibrosis Foundation; Canadian Institutes of Health Research team grant in Lysosomal Storage Disease Pharmaco-therapeutics(Canadian Institutes of Health Research (CIHR))	The commercial affiliation provided support in the form of partial industrial support for the MITACS industrial pdf fellowship awards to H. A. and Z.Z. The company facilitated the third party cloning and purification of codon optimized CTO, and the third party using chamber chloride transport studies. The specific roles of these authors are articulated in the 'author contributions' section.; Valued discussion with Drs. C. Bear and L-J Huan at this Institute is gratefully acknowledged. We thank Dr D. Rotin for the kind supply of F508del CFTR and WT CFTR transfected HEK293 cells. This work was in part supported by a BREATHE program grant funded by the Canadian Cystic Fibrosis Foundation and a Canadian Institutes of Health Research team grant in Lysosomal Storage Disease Pharmaco-therapeutics. We acknowledge ERAD Therapeutics and the Ontario Centre for Excellence support for codon optimized CT0, FLIPR assay and the work performed at Charles River Discovery.	Amessou M, 2008, BIOCONJUGATE CHEM, V19, P532, DOI 10.1021/bc7003999; Arab S, 1999, ONCOL RES, V11, P33; Baxter DF, 2002, J BIOMOL SCREEN, V7, P79, DOI 10.1177/108705710200700110; Bendikov-Bar I, 2013, BLOOD CELL MOL DIS, V50, P141, DOI 10.1016/j.bcmd.2012.10.007; Bernardi KM, 2008, MOL BIOL CELL, V19, P877, DOI 10.1091/mbc.E07-08-0755; Bhargava A, 2012, J BIOL CHEM; Brem GJ, 2013, GYNECOL ONCOL, V128, P383, DOI 10.1016/j.ygyno.2012.10.021; Castilla J, 2015, EUR J MED CHEM, V90, P258, DOI 10.1016/j.ejmech.2014.11.002; Chen Y, 2005, HUM MOL GENET, V14, P2559, DOI 10.1093/hmg/ddi259; Chiang W.C., 2014, MOL NEUROBIOL; Chinnapen DJF, 2007, FEMS MICROBIOL LETT, V266, P129, DOI 10.1111/j.1574-6968.2006.00545.x; Chinnapen DJF, 2012, DEV CELL, V23, P573, DOI 10.1016/j.devcel.2012.08.002; Cho JA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00051; Cholon DM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008680; Dang HP, 2011, TRAFFIC, V12, P1417, DOI 10.1111/j.1600-0854.2011.01243.x; Devenica D, 2011, MED ONCOL, V28, pS675, DOI 10.1007/s12032-010-9732-8; Dixit G, 2008, EXP BIOL MED, V233, P163, DOI 10.3181/0705-RM-132; Douce G, 1997, INFECT IMMUN, V65, P2821, DOI 10.1128/IAI.65.7.2821-2828.1997; Einsele H, 2010, RECENT RESULTS CANC, V184, P173, DOI 10.1007/978-3-642-01222-8_12; Elfrink HL, 2013, MOL CELLS, V35, P291, DOI 10.1007/s10059-013-2286-9; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Eshraghi A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004295; Falguieres T, 2001, MOL BIOL CELL, V12, P2453, DOI 10.1091/mbc.12.8.2453; Fan JQ, 2008, BIOL CHEM, V389, P1, DOI 10.1515/BC.2008.009; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; Fujinaga Y, 2003, MOL BIOL CELL, V14, P4783, DOI 10.1091/mbc.E03-06-0354; Gao HY, 2010, HUM MOL GENET, V19, P16, DOI 10.1093/hmg/ddp463; Garcia-Castillo MD, 2015, J CELL SCI; GILL DM, 1978, P NATL ACAD SCI USA, V75, P3050, DOI 10.1073/pnas.75.7.3050; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Hanrahan JW, 2013, TRENDS PHARMACOL SCI, V34, P119, DOI 10.1016/j.tips.2012.11.006; Hansen GH, 2005, BIOCHEMISTRY-US, V44, P873, DOI 10.1021/bi047959+; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; Horimoto S, 2013, J BIOL CHEM, V288, P31517, DOI 10.1074/jbc.M113.476010; Ishitoya S, 2004, J UROLOGY, V171, P1309, DOI 10.1097/01.ju.0000100110.11129.85; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Kaiser ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117260; Kang JQ, 2009, J NEUROSCI, V29, P2833, DOI 10.1523/JNEUROSCI.4512-08.2009; Khan F, 2009, KIDNEY INT, V75, P1209, DOI 10.1038/ki.2009.7; Khine AA, 2004, GLYCOBIOLOGY, V14, P701, DOI 10.1093/glycob/cwh085; Kincaid MM, 2007, ANTIOXID REDOX SIGN, V9, P2373, DOI 10.1089/ars.2007.1817; Kruse KB, 2006, AUTOPHAGY, V2, P135, DOI 10.4161/auto.2.2.2388; KUROIWA T, 1991, J BIOL CHEM, V266, P9251; LaPointe P, 2005, J BIOL CHEM, V280, P23310, DOI 10.1074/JBC.m414193200; Lea N, 1999, MICROBIOL-UK, V145, P999, DOI 10.1099/13500872-145-5-999; Lencer WI, 2005, BBA-MOL CELL RES, V1746, P314, DOI 10.1016/j.bbamcr.2005.07.007; Liang GQ, 2008, HUM MOL GENET, V17, P1109, DOI 10.1093/hmg/ddm383; Loo TW, 2006, BIOCHEM J, V395, P537, DOI 10.1042/BJ20060013; Lord JM, 2003, BIOCHEM SOC T, V31, P1260; Maegawa GHB, 2009, J BIOL CHEM, V284, P23502, DOI 10.1074/jbc.M109.012393; Magadan JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000869; Maitra R, 2013, J BIOMOL SCREEN, V18, P1132, DOI 10.1177/1087057113488420; Majoul I, 2002, J CELL SCI, V115, P817; Mayor T, 2012, NAT CELL BIOL, V14, P46, DOI 10.1038/ncb2412; McHugh ML, 2011, BIOCHEM MEDICA, V21, P203; McKibbin C, 2012, BIOCHEM J, V442, P639, DOI 10.1042/BJ20111220; Merksamer PI, 2010, J CELL SCI, V123, P1003, DOI 10.1242/jcs.035832; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Moreau D, 2011, DEV CELL, V21, P231, DOI 10.1016/j.devcel.2011.06.014; Muthing J, 2009, THROMB HAEMOSTASIS, V101, P252, DOI 10.1160/TH08-05-0317; Murphy LA, 2011, CELL STRESS CHAPERON, V16, P607, DOI 10.1007/s12192-011-0270-x; Noakes KL, 1999, FEBS LETT, V453, P95, DOI 10.1016/S0014-5793(99)00609-2; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Olzmann JA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013185; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rowe SM, 2010, PULM PHARMACOL THER, V23, P268, DOI 10.1016/j.pupt.2010.02.001; Sandvig K, 2010, TOXICON, V56, P1181, DOI 10.1016/j.toxicon.2009.11.021; Sawkar AR, 2006, CELL MOL LIFE SCI, V63, P1179, DOI 10.1007/s00018-005-5437-0; Sawkar AR, 2006, ACS CHEM BIOL, V1, P235, DOI 10.1021/cb600187q; Schafer A, 2009, EMBO J, V28, P2874, DOI 10.1038/emboj.2009.231; Schmitz A, 2000, J CELL BIOL, V148, P1203, DOI 10.1083/jcb.148.6.1203; Scott DC, 2008, J CELL BIOL, V181, P1095, DOI 10.1083/jcb.200804053; Shirley RB, 2005, NEOPLASIA, V7, P1104, DOI 10.1593/neo.05520; Shun Zhenming, 2003, J Biopharm Stat, V13, P17, DOI 10.1081/BIP-120017723; Smith DC, 2002, TRAFFIC, V3, P697, DOI 10.1034/j.1600-0854.2002.31001.x; Tam P, 2008, J CELL PHYSIOL, V216, P750, DOI 10.1002/jcp.21456; Teter K, 2002, INFECT IMMUN, V70, P6166, DOI 10.1128/IAI.70.11.6166-6171.2002; Thompson H W, 1998, Nutr Neurosci, V1, P165, DOI 10.1080/1028415X.1998.11747226; Tropak MB, 2004, J BIOL CHEM, V279, P13478, DOI 10.1074/jbc.M308523200; Trzcinska-Daneluti AM, 2009, MOL CELL PROTEOMICS, V8, P780, DOI 10.1074/mcp.M800268-MCP200; Tsai Yien Che, 2010, Genes Cancer, V1, P764; Ugolino J, 2011, HUM MOL GENET, V20, P3565, DOI 10.1093/hmg/ddr274; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Varga K, 2008, BIOCHEM J, V410, P555, DOI 10.1042/BJ20071420; Veit G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008889; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; Wang BJ, 2009, LANDSLIDES, V6, P61, DOI 10.1007/s10346-008-0139-y; Wang F, 2011, J BIOL CHEM, V286, P43454, DOI 10.1074/jbc.M111.274332; Wang L, 2008, HEPATOLOGY, V48, P1558, DOI 10.1002/hep.22499; Wang QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015479; Wang XD, 2008, TRAFFIC, V9, P1878, DOI 10.1111/j.1600-0854.2008.00806.x; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Wen SX, 2006, VACCINE, V24, P1142, DOI 10.1016/j.vaccine.2005.08.094; Wesche J, 1999, J BIOL CHEM, V274, P34443, DOI 10.1074/jbc.274.48.34443; Wilke M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052070; Wolf AA, 2008, INFECT IMMUN, V76, P1476, DOI 10.1128/IAI.01286-07; Wu KL, 2005, HAEMATOLOGICA, V90, P996; Yagishita N, 2008, NAT CLIN PRACT RHEUM, V4, P91, DOI 10.1038/ncprheum0699; Yasuda Y, 1998, FEMS IMMUNOL MED MIC, V20, P311, DOI 10.1016/S0928-8244(98)00027-3; Yu M, 2005, INFECT IMMUN, V73, P2524, DOI 10.1128/IAI.73.4.2524-2532.2005	104	8	8	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166948	10.1371/journal.pone.0166948	http://dx.doi.org/10.1371/journal.pone.0166948			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935997	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100051
J	Goto, T; Tamai, N; Nakagami, G; Kitamura, A; Naito, A; Hirokawa, M; Shimokawa, C; Takahashi, K; Umemoto, J; Sanada, H				Goto, Taichi; Tamai, Nao; Nakagami, Gojiro; Kitamura, Aya; Naito, Ayumi; Hirokawa, Masayuki; Shimokawa, Chisako; Takahashi, Kazuo; Umemoto, Junichi; Sanada, Hiromi			Can Wound Exudate from Venous Leg Ulcers Measure Wound Pain Status?: A Pilot Study	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; SENSORY NEURONS; EXPRESSION; SENSITIZATION; INFLAMMATION	We investigated the associations between the self-evaluated pain status and two pain bio-marker candidates, nerve growth factor and S100A8/A9, in exudate from venous leg ulcer to finally develop an objective pain evaluation method. Patients with venous leg ulcer participated in this cross-sectional observational study conducted between April and October 2014 at two medical facilities. During routine wound care, each participant self-evaluated their pain status at each examination using the 10-point numerical rating scale (present pain intensity) and the short-form McGill Pain Questionnaire 2 (continuous pain, intermittent pain, neuropathic pain, affective descriptors, and total score). Venous leg ulcer exudate sample was collected after wound cleansing. The nerve growth factor and S100A8/A9 concentrations in the venous leg ulcer exudate were measured by enzyme-linked immunosorbent assay and standardized according to the wound area. The association between each pain status and the two standardized protein concentrations was evaluated using Spearman's correlation coefficient. In 30 sample collected from 13 participants, the standardized nerve growth factor concentration was negatively correlated with continuous pain (rho = -0.47, P = 0.01), intermittent pain (rho = -0.48, P = 0.01), neuropathic pain (rho = -0.51, P = 0.01), and total score (rho = -0.46, P = 0.01). The standardized S100A8/A9 concentration was positively correlated with present pain intensity (rho = 0.46, P = 0.03) and continuous pain (rho = 0.48, P = 0.03). Thus, these two proteins may be useful for objective evaluation of wound pain in venous leg ulcer patients.	[Goto, Taichi; Tamai, Nao; Nakagami, Gojiro; Kitamura, Aya; Naito, Ayumi; Sanada, Hiromi] Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing Wound Care Management, Bunkyo Ku, Tokyo, Japan; [Goto, Taichi] Univ Tokyo, Global Leadership Initiat Age Friendly Soc, Bunkyo Ku, Tokyo, Japan; [Goto, Taichi; Kitamura, Aya] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Naito, Ayumi; Takahashi, Kazuo; Umemoto, Junichi] Fujisawa City Hosp, Fujisawa, Kanagawa, Japan; [Hirokawa, Masayuki; Shimokawa, Chisako] Ochanomizu Vasc & Vein Clin, Chiyoda Ku, Tokyo, Japan	University of Tokyo; University of Tokyo; Japan Society for the Promotion of Science	Goto, T; Sanada, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing Wound Care Management, Bunkyo Ku, Tokyo, Japan.; Goto, T (corresponding author), Univ Tokyo, Global Leadership Initiat Age Friendly Soc, Bunkyo Ku, Tokyo, Japan.; Goto, T (corresponding author), Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan.	gottai-tky@umin.ac.jp; hsanada-tky@umin.ac.jp	Goto, Taichi/AAU-4349-2020; Nakagami, Gojiro/V-9093-2019	Goto, Taichi/0000-0001-7140-8175; Nakagami, Gojiro/0000-0002-9650-2464; Tamai, Nao/0000-0003-0170-7588	Japan Society for the Promotion of Science KAKENHI Grant [25870179]; Japanese Society of Wound, Ostomy, and Continence Management	Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Society of Wound, Ostomy, and Continence Management	This study was conducted as a part of a project funded by the Japan Society for the Promotion of Science KAKENHI Grant (Number 25870179) (https://www.jsps.go.jp/english/) and was supported by a research grant from the Japanese Society of Wound, Ostomy, and Continence Management (http://www.jwocrn.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbade LPF, 2005, INT J DERMATOL, V44, P449, DOI 10.1111/j.1365-4632.2004.02456.x; Asada M, 2012, EXP DERMATOL, V21, P118, DOI 10.1111/j.1600-0625.2011.01404.x; Briggs M, 2007, WOUND REPAIR REGEN, V15, P186, DOI 10.1111/j.1524-475X.2007.00203.x; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Cirillo G, 2010, CELL MOL NEUROBIOL, V30, P51, DOI 10.1007/s10571-009-9430-2; Closs SJ, 2008, J CLIN NURS, V17, P637, DOI 10.1111/j.1365-2702.2007.02034.x; Colangelo AM, 2008, J NEUROSCI, V28, P2698, DOI 10.1523/JNEUROSCI.5201-07.2008; Davidson S, 2014, PAIN, V155, P1861, DOI 10.1016/j.pain.2014.06.017; DRAY A, 1993, TRENDS NEUROSCI, V16, P99, DOI 10.1016/0166-2236(93)90133-7; Dworkin RH, 2009, PAIN, V144, P35, DOI 10.1016/j.pain.2009.02.007; EDGEWORTH J, 1991, J BIOL CHEM, V266, P7706; European Wound Management Association, 2002, PAIN WOUND DRESS CHA; Goto T, J JPN SOC W IN PRESS; Goto T, 2014, CHRONIC WOUND CARE M, V1, P23, DOI 10.2147/CWCMR.S67054; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Hefti FF, 2006, TRENDS PHARMACOL SCI, V27, P85, DOI 10.1016/j.tips.2005.12.001; Hopman WM, 2013, CHRON DIS INJ CAN, V33, P167; Hsu K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103629; Iizaka S, 2010, WOUND REPAIR REGEN, V18, P31, DOI 10.1111/j.1524-475X.2009.00564.x; Kannan S, 2003, CELL BIOL INT, V27, P593, DOI 10.1016/S1065-6995(03)00082-9; Kao TH, 2014, EUR SPINE J; Kawabata A, 2011, BIOL PHARM BULL, V34, P1170, DOI 10.1248/bpb.34.1170; Kessel C, 2013, CLIN IMMUNOL, V147, P229, DOI 10.1016/j.clim.2012.11.008; Khan KMF, 2002, J BIOL CHEM, V277, P2353, DOI 10.1074/jbc.M108989200; Ledowski T, 2007, ANAESTHESIA, V62, P989, DOI 10.1111/j.1365-2044.2007.05191.x; Margolis DJ, 2002, J AM ACAD DERMATOL, V46, P381, DOI 10.1067/mjd.2002.121739; Maruo T, 2014, PAIN MED, V2, P1; Maruo T, 2013, PAIN RES, V28, P43, DOI 10.11154/pain.28.43; Matsumura H, 2012, INT WOUND J, V9, P451, DOI 10.1111/j.1742-481X.2011.00911.x; McGuire L, 2006, ANN BEHAV MED, V31, P165, DOI 10.1207/s15324796abm3102_8; Miao L, 2012, INT J BIOCHEM CELL B, V44, P1919, DOI 10.1016/j.biocel.2012.06.015; Minematsu T, 2013, WOUND REPAIR REGEN, V21, P329, DOI 10.1111/wrr.12017; Mita S, 2014, FERTIL STERIL, V101, P595, DOI 10.1016/j.fertnstert.2013.10.038; Persoon A, 2004, J CLIN NURS, V13, P341, DOI 10.1046/j.1365-2702.2003.00859.x; Rukwied R, 2013, PAIN, V154, P2707, DOI 10.1016/j.pain.2013.07.054; Sanada H, 2004, J Wound Care, V13, P13; Serra R, 2013, WOUND REPAIR REGEN, V21, P395, DOI 10.1111/wrr.12035; Stucky CL, 1999, J NEUROSCI, V19, P8509; Takai Y, 2010, GERIATR GERONTOL INT, V10, P145, DOI 10.1111/j.1447-0594.2009.00568.x; Warden Victoria, 2003, J Am Med Dir Assoc, V4, P9, DOI 10.1097/00130535-200301000-00002; Wu CR, 2009, ANESTHESIOLOGY, V110, P140, DOI 10.1097/ALN.0b013e318190bc84; Zamboni P, 2005, DERMATOL SURG, V31, P644, DOI 10.1097/00042728-200506000-00005	43	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167478	10.1371/journal.pone.0167478	http://dx.doi.org/10.1371/journal.pone.0167478			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936243	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100106
J	Grattepanche, JD; McManus, GB; Katz, LA				Grattepanche, Jean-David; McManus, George B.; Katz, Laura A.			Patchiness of Ciliate Communities Sampled at Varying Spatial Scales along the New England Shelf	PLOS ONE			English	Article							PHYTOPLANKTON BLOOM; COASTAL ECOSYSTEM; PROTIST DIVERSITY; MICROZOOPLANKTON; TEMPERATE; SEA; PERFORMANCE; OLIGOTRICH; MESOSCALE; PATTERNS	Although protists (microbial eukaryotes) provide an important link between bacteria and Metazoa in food webs, we do not yet have a clear understanding of the spatial scales on which protist diversity varies. Here, we use a combination of DNA fingerprinting (denaturant gradient gel electrophoresis or DGGE) and high-throughput sequencing (HTS) to assess the ciliate community in the class Spirotrichea at varying scales of 1-3 km sampled in three locations separated by at least 25 km-offshore, midshelf and inshore-along the New England shelf. Analyses of both abundant community (DGGE) and the total community (HTS) members reveal that: 1) ciliate communities are patchily distributed inshore (i.e. the middle station of a transect is distinct from its two neighboring stations), whereas communities are more homogeneous among samples within the midshelf and offshore stations; 2) a ciliate closely related to Pelagostrobilidium paraepacrum 'blooms' inshore and; 3) environmental factors may differentially impact the distributions of individual ciliates (i.e. OTUs) rather than the community as a whole as OTUs tend to show distinct biogeographies (e.g. some OTUs are restricted to the offshore locations, some to the surface, etc.). Together, these data show the complexity underlying the spatial distributions of marine protists, and suggest that biogeography may be a property of ciliate species rather than communities.	[Grattepanche, Jean-David; Katz, Laura A.] Smith Coll, Dept Biol Sci, Northampton, MA 01063 USA; [McManus, George B.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Katz, Laura A.] Univ Massachusetts, Program Organism & Evolutionary Biol, Amherst, MA 01003 USA	Smith College; University of Connecticut; University of Massachusetts System; University of Massachusetts Amherst	Grattepanche, JD (corresponding author), Smith Coll, Dept Biol Sci, Northampton, MA 01063 USA.	jgrattepanche@smith.edu	Grattepanche, Jean-David/C-7101-2013; McManus, George/AAW-9055-2020; Katz, Laura A/AAF-4802-2019	Grattepanche, Jean-David/0000-0002-1854-3762; Katz, Laura/0000-0002-9138-4702; McManus, George/0000-0002-2768-1286	National Science Foundation [OCE-1436003, OCE-1129734, OCE-1130033, OCE-1435515]; University of Connecticut; Smith College; National Science Foundation (MRI) [DBI-0215393]; National Science Foundation (EPSCoR) [0554548, EPS-1004057]; US Department of Agriculture [2002-34438-12688, 2003-34438-13111]; University of Rhode Island; Directorate For Geosciences [1436003] Funding Source: National Science Foundation; Division Of Ocean Sciences [1435515] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Connecticut; Smith College; National Science Foundation (MRI)(National Science Foundation (NSF)); National Science Foundation (EPSCoR)(National Science Foundation (NSF)); US Department of Agriculture(United States Department of Agriculture (USDA)); University of Rhode Island; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by the National Science Foundation awards OCE-1436003 and OCE-1129734 to LAK and awards OCE-1130033 and OCE-1435515 to GBM, the University of Connecticut and Smith College. This research is based in part upon work conducted using the Rhode Island Genomics and Sequencing Center which is supported in part by the National Science Foundation (MRI Grant No. DBI-0215393 and EPSCoR Grant Nos. 0554548 & EPS-1004057), the US Department of Agriculture (Grant Nos. 2002-34438-12688 and 2003-34438-13111), and the University of Rhode Island.	Agatha S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022466; [Anonymous], 2021, LANG ENV STAT COMP; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Berger SA, 2011, SYST BIOL, V60, P291, DOI 10.1093/sysbio/syr010; Bittner L, 2013, MOL ECOL, V22, P87, DOI 10.1111/mec.12108; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Bulit C, 2003, AQUAT MICROB ECOL, V30, P185, DOI 10.3354/ame030185; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHAO A, 1984, SCAND J STAT, V11, P265; Christaki U, 2011, BIOGEOSCIENCES, V8, P1839, DOI 10.5194/bg-8-1839-2011; Christaki U, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv068; Colwell RK, 2013, COMPUTER PROGRAM EST; Costas BA, 2007, LIMNOL OCEANOGR-METH, V5, P163, DOI 10.4319/lom.2007.5.163; Countway PD, 2010, LIMNOL OCEANOGR, V55, P2381, DOI 10.4319/lo.2010.55.6.2381; de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605; Dierssen H, 2015, P NATL ACAD SCI USA, V112, P14783, DOI 10.1073/pnas.1512538112; Doherty M, 2007, AQUAT MICROB ECOL, V48, P141, DOI 10.3354/ame048141; Dolan JR, 2007, BIOGEOSCIENCES, V4, P297, DOI 10.5194/bg-4-297-2007; Dolan JR, 2002, DEEP-SEA RES PT I, V49, P1217, DOI 10.1016/S0967-0637(02)00021-3; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FENCHEL T, 1988, ANNU REV ECOL SYST, V19, P19, DOI 10.1146/annurev.es.19.110188.000315; Foissner W, 2008, BIODIVERS CONSERV, V17, P235, DOI 10.1007/s10531-007-9248-5; Forster D, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0125-5; George JA, 2015, LIMNOL OCEANOGR, V60, P110, DOI 10.1002/lno.10020; Grattepanche JD, 2016, MOL ECOL, V25, P3987, DOI 10.1111/mec.13745; Grattepanche JD, 2015, MAR ECOL PROG SER, V526, P1, DOI 10.3354/meps11256; Grattepanche JD, 2014, TRENDS MICROBIOL, V22, P432, DOI 10.1016/j.tim.2014.04.006; Grattepanche JD, 2014, AQUAT MICROB ECOL, V71, P211, DOI 10.3354/ame01675; Grattepanche JD, 2011, J PLANKTON RES, V33, P37, DOI 10.1093/plankt/fbq097; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; HOUGHTON RW, 1986, J PHYS OCEANOGR, V16, P60, DOI 10.1175/1520-0485(1986)016<0060:OOAAEN>2.0.CO;2; Hu SK, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw050; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Irigoien X, 2005, J PLANKTON RES, V27, P313, DOI 10.1093/plankt/fbi011; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Lahr DJG, 2009, BIOTECHNIQUES, V47, P857, DOI 10.2144/000113219; Li L, 2016, AM NATURALIST, V188, pE000; Logares R, 2014, CURR BIOL, V24, P813, DOI 10.1016/j.cub.2014.02.050; MacKinnon JA, 2003, J PHYS OCEANOGR, V33, P1476, DOI 10.1175/1520-0485(2003)033<1476:MOTLNE>2.0.CO;2; Mann K.H., 1982, ECOLOGY COASTAL WATE; Massana R, 2015, ENVIRON MICROBIOL, V17, P4035, DOI 10.1111/1462-2920.12955; Menden-Deuer S, 2010, MAR ECOL PROG SER, V420, P57, DOI 10.3354/meps08855; Monchy S, 2012, PLOS ONE, V7; Montagnes DJS, 1999, MAR BIOL, V134, P167, DOI 10.1007/s002270050535; Olson MB, 2013, DEEP-SEA RES PT I, V75, P28, DOI 10.1016/j.dsr.2013.01.001; PORTER KG, 1985, J PROTOZOOL, V32, P409, DOI 10.1111/j.1550-7408.1985.tb04036.x; Santoferrara LF, 2014, ENV MICROBIOLOGY; Santoferrara LF, 2016, ISME J; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Smayda TJ, 2003, J SEA RES, V49, P95, DOI 10.1016/S1385-1101(02)00219-8; SMITH WO, 1985, SCIENCE, V227, P163, DOI 10.1126/science.227.4683.163; SOURNIA A, 1987, ESTUAR COAST SHELF S, V25, P355, DOI 10.1016/0272-7714(87)90078-3; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sunda WG, 2006, J PHYCOL, V42, P963, DOI 10.1111/j.1529-8817.2006.00261.x; Tamura M, 2011, AQUAT MICROB ECOL, V64, P51, DOI 10.3354/ame01509; Uitz J, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003207; Zhang WFG, 2011, J PHYS OCEANOGR, V41, P1874, DOI 10.1175/2011JPO4604.1	59	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167659	10.1371/journal.pone.0167659	http://dx.doi.org/10.1371/journal.pone.0167659			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936137	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100142
J	Kostadinovic, M; Ignjatovic-Micic, D; Vancetovic, J; Ristic, D; Bozinovic, S; Stankovic, G; Drinic, SM				Kostadinovic, Marija; Ignjatovic-Micic, Dragana; Vancetovic, Jelena; Ristic, Danijela; Bozinovic, Sofija; Stankovic, Goran; Drinic, Snezana Mladenovic			Development of High Tryptophan Maize Near Isogenic Lines Adapted to Temperate Regions through Marker Assisted Selection Impediments and Benefits	PLOS ONE			English	Article							QUALITY PROTEIN MAIZE; MUTANT-GENE; INTROGRESSION; PERFORMANCE; GERMPLASM; LYSINE; QPM; GRAIN	Breeding program aimed at converting standard maize inbred lines to their quality protein maize (QPM) counterparts for growing in temperate climate is being conducted at Maize Research Institute (MRI). The objective of the research presented herein was to develop QPM versions of two commercial ZP inbreds through marker assisted selection (MAS) with opaque2 specific molecular markers, while maintaining their good agronomic performances and combining abilities. Donor line was a tropical QPM line CML 144. After two backcross and three selfing generations, six near isogenic lines (NILs) with 93% recovery of the recurrent parent genome were created from one cross. Average increments of 30% in tryptophan content and 36% in quality index were obtained, as well as kernels with less than 25% opaque endosperm. Grain yield was increased by 11-31% and combining abilities of the improved lines were on a par with the original line. Correlations between biochemical and agronomic parameters revealed that selection for plant height, ear length and kernel row number together with tryptophan content could be recommended for development of QPM with this material. However, several impediments emerged during selection. Major drawbacks in NIL development were small number of opaque2 recessive homozygotes (4.5% and 7.6% in BC2F2 of two crosses) and poor seed set throughout selection, which led to the loss of one cross. Moreover, in the other cross many plants in different generations had to be omitted from further selection due to the insufficient number of kernels. This phenomenon could be explained by incompatibility between pollen and style, possibly due to the exotic donor germplasm. Overall, it could be expected that the use of NILs, which are adapted to temperate climate and have high percentage of domestic germplasm, would outbalance the noted impediments and increase MAS efficiency in different breeding programs.	[Kostadinovic, Marija; Ignjatovic-Micic, Dragana; Ristic, Danijela; Drinic, Snezana Mladenovic] Maize Res Inst, Lab Mol Genet & Physiol, Belgrade, Serbia; [Vancetovic, Jelena; Bozinovic, Sofija] Maize Res Inst, Grp Breeding Early Matur Maize Hybrids Desirable, Belgrade, Serbia; [Stankovic, Goran] Maize Res Inst, Late Maize Hybrid Breeding Grp, Belgrade, Serbia		Kostadinovic, M (corresponding author), Maize Res Inst, Lab Mol Genet & Physiol, Belgrade, Serbia.	kmarija@mrizp.rs			Ministry of Education, Science and Technological Development of Republic of Serbia [TR31068, TR31028]	Ministry of Education, Science and Technological Development of Republic of Serbia	This research was supported by the Ministry of Education, Science and Technological Development of Republic of Serbia through the projects TR31068 "Improvement of maize and soybean characteristics by molecular and conventional breeding" and TR31028 "Exploitation of maize diversity to improve grain quality and drought tolerance". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal P. K., 2010, ANIMAL NUTR FEED T S, V10s, P79; Akuamoa-Boateng A., 2002, EXPT DESIGN; Ali Q, 2010, J AM OIL CHEM SOC, V87, P1179, DOI 10.1007/s11746-010-1599-5; Babu BK, 2015, PLANT CELL REP, V34, P37, DOI 10.1007/s00299-014-1685-5; Babu R, 2005, THEOR APPL GENET, V111, P888, DOI 10.1007/s00122-005-0011-6; BRESSANI R, 1991, CEREAL FOOD WORLD, V36, P806; CROSSA J, 1989, MAYDICA, V34, P53; Crow JF, 2002, GENETICS, V160, P819; Danson JW, 2006, AFR J BIOTECHNOL, V5, P2417; Denic M, 2012, GENETIKA-BELGRADE, V44, P13, DOI 10.2298/GENSR1201013D; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Doyle J. J., 1987, PHYTOCHEM B, P11; DUDLEY JW, 1982, CROP SCI, V22, P631, DOI 10.2135/cropsci1982.0011183X002200030049x; Gernah D. I., 2011, American Journal of Food Technology, V6, P404, DOI 10.3923/ajft.2011.404.412; Gimenes MA, 2000, GENET MOL BIOL, V23, P375, DOI 10.1590/S1415-47572000000200023; GOODMAN MM, 1985, IOWA STATE J RES, V59, P497; GORLA MS, 1980, THEOR APPL GENET, V57, P37, DOI 10.1007/BF00276008; Gupta HS, 2013, PLANT BREEDING, V132, P77, DOI 10.1111/pbr.12009; Hernandez H.H., 1969, CIMMYT RES B, V13; Idukut L, 2009, J ANIM VET ADV, V8, P1945; Ignjatovi-Micic D, 2009, GENETIKA-BELGRADE, V41, P81, DOI 10.2298/GENSR0901081I; Ignjatovic-Micic D, 2015, J AGR FOOD CHEM, V63, P1251, DOI 10.1021/jf504301u; Ignjatovic-Micic D, 2013, MAYDICA, V58, P311; Ignjatovic-Micic D, 2010, GENETIKA-BELGRADE, V42, P267, DOI 10.2298/GENSR1002267M; Jompuk C., 2011, Kasetsart Journal, Natural Sciences, V45, P666; Kostadinovic M, 2014, GENETIKA-BELGRADE, V46, P579, DOI 10.2298/GENSR1402579K; Krivanek AF, 2007, AFR J BIOTECHNOL, V6, P312; MA Y, 1975, CEREAL CHEM, V52, P412; Mbuya K., 2011, International Journal of Plant Breeding and Genetics, V5, P317; MCWHIRTER KS, 1971, MAIZE GENET NEWSLETT, V45, P184; MERTZ ET, 1964, SCIENCE, V145, P279, DOI 10.1126/science.145.3629.279; MSTAT Development Team, 1989, MSTAT C MICR PROGR D; NELSON OE, 1965, SCIENCE, V150, P1469, DOI 10.1126/science.150.3702.1469; Nurit E, 2009, J AGR FOOD CHEM, V57, P7233, DOI 10.1021/jf901315x; PAEZ AV, 1969, CROP SCI, V9, P251, DOI 10.2135/cropsci1969.0011183X000900020045x; Panda AK, 2010, ASIAN AUSTRAL J ANIM, V23, P1626, DOI 10.5713/ajas.2010.10036; Prakash O, 2006, NEW BOT, V33, P91; Prasanna BM, 2001, CURR SCI INDIA, V81, P1308; Reddy YR, 2013, FIELD CROP RES, V153, P63, DOI 10.1016/j.fcr.2013.06.013; Ribaut JM, 2002, CROP SCI, V42, P557, DOI 10.2135/cropsci2002.0557; Rohlf FJ, 2000, NTSYS PC NUMERICAL T; Scott MP, 2009, MAYDICA, V54, P449; Selvaraj C. I., 2011, International Journal of Plant Breeding and Genetics, V5, P209, DOI 10.3923/ijpbg.2011.209.223; Takayama S, 2005, ANNU REV PLANT BIOL, V56, P467, DOI 10.1146/annurev.arplant.56.032604.144249; VILLEGAS E, 1992, QUALITY PROTEIN MAIZE, P27; Villegas E, 1984, CHEM METHODS USED CI; Vivek B., 2008, BREEDING QUALITY PRO; Wani, 2009, J PLANT BREED CROP S, V1, P244, DOI DOI 10.5897/JPBCS.9000113; Worku M, 2008, MAYDICA, V53, P279; Worral HM, 2015, J PLANT REGIST, V9, P371, DOI 10.3198/jpr2014.11.0080crg; Zaidi PH, 2008, MAYDICA, V53, P249	51	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167635	10.1371/journal.pone.0167635	http://dx.doi.org/10.1371/journal.pone.0167635			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936171	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100137
J	Muller, F; Xu, JM; Kristensen, L; Wolters-Arts, M; de Groot, PFM; Jansma, SY; Mariani, C; Park, S; Rieu, I				Mueller, Florian; Xu, Jiemeng; Kristensen, Lieke; Wolters-Arts, Mieke; de Groot, Peter F. M.; Jansma, Stuart Y.; Mariani, Celestina; Park, Sunghun; Rieu, Ivo			High-Temperature-Induced Defects in Tomato (Solanum lycopersicum) Anther and Pollen Development Are Associated with Reduced Expression of B-Class Floral Patterning Genes	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; MADS-BOX GENES; HEAT-STRESS; MALE-STERILITY; CARBOHYDRATE CONCENTRATION; FLOWER DEVELOPMENT; STAMEN DEVELOPMENT; DROUGHT STRESS; L.; EVOLUTION	Sexual reproduction is a critical process in the life-cycle of plants and very sensitive to environmental perturbations. To better understand the effect of high temperature on plant reproduction, we cultivated tomato (Solanum lycopersicum) plants in continuous mild heat. Under this condition we observed a simultaneous reduction in pollen viability and appearance of anthers with pistil-like structures, while in a more thermotolerant genotype, both traits were improved. Ectopic expression of two pistil-specific genes, TRANSMITTING TISSUE SPECIFIC and TOMATO AGAMOUS LIKE11, in the anthers confirmed that the anthers had gained partial pistil identity. Concomitantly, expression of the B-class genes TOMATO APETALA3, TOMATO MADS BOX GENE6 (TM6) and LePISTILLATA was reduced in anthers under continuous mild heat. Plants in which TM6 was partially silenced reacted hypersensitively to temperature elevation with regard to the frequency of pistilloid anthers, pollen viability and pollen quantity. Taken together, these results suggest that high-temperature induced down-regulation of tomato B-class genes contributes to anther deformations and reduced male fertility. Improving our understanding of how temperature perturbs the molecular mechanisms of anther and pollen development will be important in the view of maintaining agricultural output under current climate changes.	[Mueller, Florian; Xu, Jiemeng; Kristensen, Lieke; Wolters-Arts, Mieke; de Groot, Peter F. M.; Jansma, Stuart Y.; Mariani, Celestina; Rieu, Ivo] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Mol Plant Physiol, Nijmegen, Netherlands; [Park, Sunghun] Kansas State Univ, Dept Hort & Human Hlth, Manhattan, KS 66506 USA	Radboud University Nijmegen; Kansas State University	Rieu, I (corresponding author), Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Mol Plant Physiol, Nijmegen, Netherlands.	i.rieu@science.ru.nl	Rieu, Ivo/B-3055-2008; Xu, Jiemeng/AAO-9278-2021; Rieu, Ivo/AAW-8656-2021; Xu, Jiemeng/Z-2085-2019; Mariani, Celestina/C-6920-2013	Rieu, Ivo/0000-0001-8575-0959; Xu, Jiemeng/0000-0001-9629-8400; Rieu, Ivo/0000-0001-8575-0959; 	European Commission (Marie Curie Initial Training Network: Solanaceae pollen thermotolerance/SPOT-ITN) [289220]; China Scholarship Council [201207565002]	European Commission (Marie Curie Initial Training Network: Solanaceae pollen thermotolerance/SPOT-ITN); China Scholarship Council(China Scholarship Council)	This research was supported by a grant from the European Commission (Marie Curie Initial Training Network: Solanaceae pollen thermotolerance/SPOT-ITN, grant number 289220) to IR and a grant from the China Scholarship Council (grant number 201207565002) to JX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko M, 2005, SEX PLANT REPROD, V18, P91, DOI 10.1007/s00497-005-0004-2; AHMED FE, 1992, AM J BOT, V79, P784, DOI 10.2307/2444945; Alghabari F, 2014, J AGRON CROP SCI, V200, P36, DOI 10.1111/jac.12038; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Becker A, 2003, MOL PHYLOGENET EVOL, V29, P464, DOI 10.1016/S1055-7903(03)00207-0; Bokszczanin KL, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00315; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; CHAPMAN GP, 1987, INT REV CYTOL, V107, P111, DOI 10.1016/S0074-7696(08)61074-8; CHEUNG AY, 1993, PLANT J, V3, P151, DOI 10.1111/j.1365-313X.1993.tb00018.x; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; de Martino G, 2006, PLANT CELL, V18, P1833, DOI 10.1105/tpc.106.042978; De Storme N, 2014, PLANT CELL ENVIRON, V37, P1, DOI 10.1111/pce.12142; Endo M, 2009, PLANT CELL PHYSIOL, V50, P1911, DOI 10.1093/pcp/pcp135; Firon N, 2006, SCI HORTIC-AMSTERDAM, V109, P212, DOI 10.1016/j.scienta.2006.03.007; Frank G, 2009, J EXP BOT, V60, P3891, DOI 10.1093/jxb/erp234; Gomez P, 1999, PLANTA, V209, P172, DOI 10.1007/s004250050619; Gourdji SM, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024041; Harsant J, 2013, J EXP BOT, V64, P2971, DOI 10.1093/jxb/ert142; Hedhly A, 2009, TRENDS PLANT SCI, V14, P30, DOI 10.1016/j.tplants.2008.11.001; Horn R, 2014, MITOCHONDRION, V19, P198, DOI 10.1016/j.mito.2014.04.004; Iwahori S., 1965, J JAPANESE SOC HORTI, V34, P33, DOI [DOI 10.2503/JJSHS.34.33, 10.2503/jjshs.34.33]; Kramer EM, 1998, GENETICS, V149, P765; Ku SJ, 2003, PLANTA, V217, P559, DOI 10.1007/s00425-003-1030-7; Lobell DB, 2012, PLANT PHYSIOL, V160, P1686, DOI 10.1104/pp.112.208298; Lozano R, 1998, PLANT PHYSIOL, V117, P91, DOI 10.1104/pp.117.1.91; Mazzucato A, 2008, PHYSIOL PLANTARUM, V132, P526, DOI 10.1111/j.1399-3054.2007.01035.x; Min L, 2013, PLANT J, V75, P823, DOI 10.1111/tpj.12245; NASH AF, 1985, HORTSCIENCE, V20, P440; Ng M, 2001, NAT REV GENET, V2, P186, DOI 10.1038/35056041; Oshino T, 2007, MOL GENET GENOMICS, V278, P31, DOI 10.1007/s00438-007-0229-x; Parish RW, 2012, FUNCT PLANT BIOL, V39, P553, DOI 10.1071/FP12090; Peet MM, 1998, PLANT CELL ENVIRON, V21, P225, DOI 10.1046/j.1365-3040.1998.00281.x; Pino-Nunes LE, 2009, ACTA HORTIC, V821, P63; Porch TG, 2001, PLANT CELL ENVIRON, V24, P723, DOI 10.1046/j.1365-3040.2001.00716.x; Pressman E, 2002, ANN BOT-LONDON, V90, P631, DOI 10.1093/aob/mcf240; Quinet M, 2014, J EXP BOT, V65, P2243, DOI 10.1093/jxb/eru089; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; SAINI HS, 1984, AUST J PLANT PHYSIOL, V11, P243, DOI 10.1071/PP9840243; Sakata T, 2000, J PLANT RES, V113, P395, DOI 10.1007/PL00013947; Sakata T, 2010, P NATL ACAD SCI USA, V107, P8569, DOI 10.1073/pnas.1000869107; Sato S, 2000, PLANT CELL ENVIRON, V23, P719, DOI 10.1046/j.1365-3040.2000.00589.x; SAWHNEY VK, 1973, AM J BOT, V60, P514, DOI 10.2307/2441374; Singh I, 2005, PLANT GROWTH REGUL, V47, P111, DOI 10.1007/s10725-005-3252-0; Song JJ, 2002, PLANT CELL PHYSIOL, V43, P619, DOI 10.1093/pcp/pcf078; Su Z, 2013, PLANT CELL, V25, P3785, DOI 10.1105/tpc.113.115428; Suzuki K, 2001, SEX PLANT REPROD, V13, P293, DOI 10.1007/s004970100071; Tang RS, 2008, PLANT GROWTH REGUL, V54, P37, DOI 10.1007/s10725-007-9225-8; Teixeira RT, 2005, PLANT J, V42, P731, DOI 10.1111/j.1365-313X.2005.02407.x; Victoria BM, 2003, PLANT MOL BIOL, V52, P801, DOI 10.1023/A:1025001402838; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; Winter CM, 2011, DEV CELL, V20, P430, DOI 10.1016/j.devcel.2011.03.019; Wu QY, 2012, PLANT BIOTECHNOL J, V10, P945, DOI 10.1111/j.1467-7652.2012.00723.x; Yu H, 2004, P NATL ACAD SCI USA, V101, P7827, DOI 10.1073/pnas.0402377101; ZHANG HQ, 1983, PLANT CELL ENVIRON, V6, P471; Zhang XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049652; Zinn KE, 2010, J EXP BOT, V61, P1959, DOI 10.1093/jxb/erq053	56	25	31	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167614	10.1371/journal.pone.0167614	http://dx.doi.org/10.1371/journal.pone.0167614			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936079	Green Published, gold			2022-12-27	WOS:000389587100130
J	Nezvalova-Henriksen, K; Wood, M; Spigset, O; Nordeng, H				Nezvalova-Henriksen, Katerina; Wood, Mollie; Spigset, Olav; Nordeng, Hedvig			Association of Prenatal Ibuprofen Exposure with Birth Weight and Gestational Age: A Population-Based Sibling Study	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; OVER-THE-COUNTER; NEONATAL COMPLICATIONS; DUCTUS-ARTERIOSUS; PREGNANT USERS; MATERNAL USE; RISK; INDOMETHACIN; MISCARRIAGE; COHORT	Objectives Three studies so far have investigated the effect of prenatal non-steroidal anti-inflammatory drug ( NSAID) exposure on birth weight and gestational age. The aim in this study was to evaluate the association of prenatal ibuprofen with birth weight and gestational age at birth, using a sibling design in an attempt to adjust for the possibility of familial confounding. Design Using data from the Norwegian Mother and Child Cohort Study (MoBa) and the Medical Birth Registry of Norway (MBRN), we identified 28 597 siblings, of whom 1080 were prenatally exposed to ibuprofen and 26 824 were not exposed to any NSAID. Random and fixed effects models with propensity score adjustment were used to evaluate the effects of ibuprofen exposure on birth weight and gestational age. Results Ibuprofen exposure during the first trimester was associated with a decrease in birth weight of 79 grams (95% confidence interval -133 to -25 grams). In contrast, second and/or third trimester exposure, and duration of exposure had no impact on the effect estimates. We found no association between ibuprofen exposure and gestational age at birth. Conclusions Our results suggest that prenatal exposure to ibuprofen during the first trimester is associated with a slight decrease in birth weight. The association does not seem to be attributable to shared genetics and family environment, and could be explained by either exposure to ibuprofen, or to non-shared confounding between pregnancies.	[Nezvalova-Henriksen, Katerina; Wood, Mollie; Nordeng, Hedvig] Univ Oslo, Sch Pharm, PharmacoEpidemiol & Drug Safety Res Grp, Oslo, Norway; [Spigset, Olav] St Olavs Univ Hosp, Dept Clin Pharmacol, Trondheim, Norway; [Spigset, Olav] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, Trondheim, Norway; [Nordeng, Hedvig] Norwegian Inst Publ Hlth, Domain Mental & Phys Hlth, Oslo, Norway	University of Oslo; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian Institute of Public Health (NIPH)	Nezvalova-Henriksen, K (corresponding author), Univ Oslo, Sch Pharm, PharmacoEpidemiol & Drug Safety Res Grp, Oslo, Norway.	katerina.nezvalova-henriksen@farmasi.uio.no		Nezvalova-Henriksen, Katerina/0000-0002-8085-4932	Norwegian Women's Public Health Association on behalf of the Norwegian ExtraFoundation for Health and Rehabilitation through EXTRA funds; Norwegian Ministry of Health; Ministry of Education and Research; National Institutes of Health/National Institute of Environmental Health Sciences [NO-ES-75558]; National Institutes of Health/National Institute of Neurological Disorders and Stroke [1 UO1 NS 047537-01]; Norwegian Research Council/Functional Genomics [151918/S10]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS047537] Funding Source: NIH RePORTER	Norwegian Women's Public Health Association on behalf of the Norwegian ExtraFoundation for Health and Rehabilitation through EXTRA funds; Norwegian Ministry of Health; Ministry of Education and Research; National Institutes of Health/National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Norwegian Research Council/Functional Genomics(Research Council of Norway); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project has been financially supported by the Norwegian Women's Public Health Association on behalf of the Norwegian ExtraFoundation for Health and Rehabilitation through EXTRA funds. The Norwegian Mother and Child Cohort Study is supported by the Norwegian Ministry of Health and the Ministry of Education and Research, National Institutes of Health/National Institute of Environmental Health Sciences (grant no. NO-ES-75558), National Institutes of Health/National Institute of Neurological Disorders and Stroke (grant no. 1 UO1 NS 047537-01), and the Norwegian Research Council/Functional Genomics (grant no.151918/S10).	Cassina M, 2010, REPROD TOXICOL, V30, P401, DOI 10.1016/j.reprotox.2010.04.010; Cleves MA, 2004, BIRTH DEFECTS RES A, V70, P107, DOI 10.1002/bdra.20005; D'Onofrio BM, 2013, AM J PUBLIC HEALTH, V103, P46, DOI 10.2105/AJPH.2013.301252; Daniel S, 2014, CAN MED ASSOC J, V186, pE177, DOI 10.1503/cmaj.130605; Daniel S, 2012, J RHEUMATOL, V39, P2163, DOI 10.3899/jrheum.120453; Doyle Nora M, 2005, J Perinatol, V25, P336, DOI 10.1038/sj.jp.7211256; Edwards DRV, 2012, OBSTET GYNECOL, V120, P113, DOI 10.1097/AOG.0b013e3182595671; Frisell T, 2012, EPIDEMIOLOGY, V23, P713, DOI 10.1097/EDE.0b013e31825fa230; Ghosh R, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/536962; Glover DD, 2003, AM J OBSTET GYNECOL, V188, P1039, DOI 10.1067/mob.2003.223; Hernandez RK, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.11.019; Jensen MS, 2010, EPIDEMIOLOGY, V21, P779, DOI 10.1097/EDE.0b013e3181f20bed; Johnston LB, 2002, ARCH DIS CHILD-FETAL, V86, pF2, DOI 10.1136/fn.86.1.F2-a; Karlsen HO, 2015, ULTRASOUND OBSTET GY; Koren G, 2006, ANN PHARMACOTHER, V40, P824, DOI 10.1345/aph.1G428; Lawlor A, 2009, FAMILY MATTERS; Li DK, 2003, BRIT MED J, V327, P368, DOI 10.1136/bmj.327.7411.368; Lupattelli A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004365; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Mando C, 2014, AM J PHYSIOL-ENDOC M, V306, pE404, DOI 10.1152/ajpendo.00426.2013; Myatt L, 2004, HISTOCHEM CELL BIOL, V122, P369, DOI 10.1007/s00418-004-0677-x; Nakhai-Pour HR, 2011, CAN MED ASSOC J, V183, P1713, DOI 10.1503/cmaj.110454; Nezvalova-Henriksen K, 2013, BJOG; Nielsen GL, 2004, BRIT MED J, V328, P109, DOI 10.1136/bmj.328.7431.109; Nielsen GL, 2001, BRIT MED J, V322, P266, DOI 10.1136/bmj.322.7281.266; Nilsen RM, 2009, PAEDIATR PERINAT EP, V23, P597, DOI 10.1111/j.1365-3016.2009.01062.x; Nohr EA, 2006, EPIDEMIOLOGY, V17, P413, DOI 10.1097/01.ede.0000220549.14177.60; Nordeng H, 2001, EUR J CLIN PHARMACOL, V57, P259, DOI 10.1007/s002280100304; NORTON ME, 1993, NEW ENGL J MED, V329, P1602, DOI 10.1056/NEJM199311253292202; Norwegian Institute of Public Health, 2013, REV PROTOCOL END ENR; Ofori B, 2006, BIRTH DEFECTS RES B, V77, P268, DOI 10.1002/bdrb.20085; Ojala R, 2000, EUR J PEDIATR, V159, P153, DOI 10.1007/s004310050040; Refuerzo JS, 2005, AM J PERINAT, V22, P321, DOI 10.1055/s-2005-873235; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Schaefer C, 2007, DRUGS DURING PREGNANCY AND LACTATION: TREATMENT OPTIONS AND RISK ASSESSMENT, 2ND EDITION, P1; Taylor RN, 2003, AM J OBSTET GYNECOL, V188, P177, DOI 10.1067/mob.2003.111; van Gelder MMHJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022174; Vermillion ST, 1997, AM J OBSTET GYNECOL, V177, P256, DOI 10.1016/S0002-9378(97)70184-4; Werler MM, 2005, AM J OBSTET GYNECOL, V193, P771, DOI 10.1016/j.ajog.2005.02.100; Wu F, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/293271; Wu W, 2015, HUM GENET, V134, P803, DOI 10.1007/s00439-015-1558-1	41	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166971	10.1371/journal.pone.0166971	http://dx.doi.org/10.1371/journal.pone.0166971			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936000	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000389587100052
J	Rajabi, M; Roxhed, N; Shafagh, RZ; Haraldson, T; Fischer, AC; van der Wijngaart, W; Stemme, G; Niklaus, F				Rajabi, Mina; Roxhed, Niclas; Shafagh, Reza Zandi; Haraldson, Tommy; Fischer, Andreas Christin; van der Wijngaart, Wouter; Stemme, Goran; Niklaus, Frank			Flexible and Stretchable Microneedle Patches with Integrated Rigid Stainless Steel Microneedles for Transdermal Biointerfacing	PLOS ONE			English	Article							POLYMER MICRONEEDLES; DRUG; SKIN; ELECTRONICS; PREDICTION; SENSORS; FORCE; PAIN	This paper demonstrates flexible and stretchable microneedle patches that combine soft and flexible base substrates with hard and sharp stainless steel microneedles. An elastomeric polymer base enables conformal contact between the microneedle patch and the complex topography and texture of the underlying skin, while robust and sharp stainless steel microneedles reliably pierce the outer layers of the skin. The flexible microneedle patches have been realized by magnetically assembling short stainless steel microneedles into a flexible polymer supporting base. In our experimental investigation, the microneedle patches were applied to human skin and an excellent adaptation of the patch to the wrinkles and deformations of the skin was verified, while at the same time the microneedles reliably penetrate the surface of the skin. The unobtrusive flexible and stretchable microneedle patches have great potential for transdermal biointerfacing in a variety of emerging applications such as transdermal drug delivery, bioelectric treatments and wearable bio-electronics for health and fitness monitoring.	[Rajabi, Mina; Roxhed, Niclas; Shafagh, Reza Zandi; Haraldson, Tommy; Fischer, Andreas Christin; van der Wijngaart, Wouter; Stemme, Goran; Niklaus, Frank] KTH Royal Inst Technol, Sch Elect Engn, Dept Micro & Nanosyst, Stockholm, Sweden; [Fischer, Andreas Christin] Karlsruhe Inst Technol, Inst Nanotechnol, Karlsruhe, Germany	Royal Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology	Rajabi, M (corresponding author), KTH Royal Inst Technol, Sch Elect Engn, Dept Micro & Nanosyst, Stockholm, Sweden.	minar@kth.s	Shafagh, Reza Zandi/AAH-4641-2020; van der Wijngaart, Wouter/O-2378-2019	Shafagh, Reza Zandi/0000-0003-4322-6192; van der Wijngaart, Wouter/0000-0001-8248-6670; Roxhed, Niclas/0000-0002-7147-6730	European Research Council (ERC) [277879 MM's, 267528 xMEMS]	European Research Council (ERC)(European Research Council (ERC))	The authors are grateful to European Research Council (ERC) for the grant agreements No. 277879 M&M's and No. 267528 xMEMS. Novo Nordisk A/S is gratefully acknowledged for kindly providing stainless steel needles.	Bandodkar AJ, 2014, BIOSENS BIOELECTRON, V54, P603, DOI 10.1016/j.bios.2013.11.039; Bleiker SJ, 2016, PROC IEEE MICR ELECT, P577, DOI 10.1109/MEMSYS.2016.7421691; Carlborg CF, 2014, J POLYM SCI POL CHEM, V52, P2604, DOI 10.1002/pola.27276; Choi S, 2016, ADV MATER, V28, P4203, DOI 10.1002/adma.201504150; Dagdeviren C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5496; Davis SP, 2004, J BIOMECH, V37, P1155, DOI 10.1016/j.jbiomech.2003.12.010; DONNELLY RF, 2010, J DRUG DELIV, V17, P187, DOI DOI 10.3109/10717541003667798; Feng X, 2011, ACS NANO, V5, P3326, DOI 10.1021/nn200477q; Fischer AC, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/10/105001; Gill HS, 2008, CLIN J PAIN, V24, P585, DOI 10.1097/AJP.0b013e31816778f9; Hattori Y, 2014, ADV HEALTHC MATER, V3, P1597, DOI 10.1002/adhm.201400073; Huang X, 2014, ADV FUNCT MATER, V24, P3846, DOI 10.1002/adfm.201303886; Huang X, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0052-8; Huang XH, 2014, SCI WORLD J, DOI 10.1155/2014/954849; Ito Y, 2012, INT J PHARMACEUT, V436, P387, DOI 10.1016/j.ijpharm.2012.06.047; Jicheng Y, 2015, PNAS, V112, P8260, DOI [10.1073/pnas.1505405112, DOI 10.1073/PNAS.1505405112]; Kaushik S, 2001, ANESTH ANALG, V92, P502, DOI 10.1213/00000539-200102000-00041; Kim DH, 2012, ANNU REV BIOMED ENG, V14, P113, DOI [10.1146/annurev-bioeng-071811-150018, 10.1146/annurev.bioeng-071811-150018]; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Kim YC, 2012, ADV DRUG DELIVER REV, V64, P1547, DOI 10.1016/j.addr.2012.04.005; Lee H, 2016, NAT NANOTECHNOL, V11, P566, DOI [10.1038/NNANO.2016.38, 10.1038/nnano.2016.38]; Lu NS, 2014, SOFT ROBOT, V1, P53, DOI 10.1089/soro.2013.0005; Miller PR, 2014, HEALTHC MATER, V3, P948, DOI DOI 10.1002/adhm.201470032; Olatunji O, 2013, J PHARM SCI-US, V102, P1209, DOI 10.1002/jps.23439; Park JH, 2007, IEEE T BIO-MED ENG, V54, P903, DOI 10.1109/TBME.2006.889173; Prausnitz MR, 2004, ADV DRUG DELIVER REV, V56, P581, DOI 10.1016/j.addr.2003.10.023; Roxhed N, 2007, J MICROELECTROMECH S, V16, P1429, DOI 10.1109/JMEMS.2007.907461; Son D, 2014, NAT NANOTECHNOL, V9, P397, DOI [10.1038/nnano.2014.38, 10.1038/NNANO.2014.38]; Tuan-Mahmood TM, 2013, EUR J PHARM SCI, V50, P623, DOI 10.1016/j.ejps.2013.05.005; Vecchione R, 2014, ADV FUNCT MATER, V24, P3515, DOI 10.1002/adfm.201303679; Xiang ZL, 2016, MICROSYST NANOENG, V2, DOI 10.1038/micronano.2016.12; Xiang ZL, 2016, ADV MATER, V28, P4472, DOI 10.1002/adma.201503423; Yang SX, 2015, ADV MATER, V27, P6423, DOI 10.1002/adma.201502386; Yung KL, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/1/015016	34	38	42	9	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166330	10.1371/journal.pone.0166330	http://dx.doi.org/10.1371/journal.pone.0166330			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935976	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100025
J	Suzuki, K; Takano, H; Kubota, Y; Inui, K; Nakamura, S; Tokita, Y; Kato, K; Asai, K; Shimizu, W				Suzuki, Keishi; Takano, Hitoshi; Kubota, Yoshiaki; Inui, Keisuke; Nakamura, Shunichi; Tokita, Yukichi; Kato, Koji; Asai, Kuniya; Shimizu, Wataru			Plaque Characteristics in Coronary Artery Disease Patients with Impaired Glucose Tolerance	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; CARDIOVASCULAR-DISEASE; FIBROUS CAP; RISK-FACTOR; PATHOPHYSIOLOGY; ATHEROSCLEROSIS; HYPERGLYCEMIA; POPULATION; THROMBOSIS; MORPHOLOGY	Background Impaired glucose tolerance (IGT) patients are known to have a high risk of cardiovascular events and their prognosis has been reported to be poor. The present study aimed to compare coronary plaque characteristics among coronary artery disease (CAD) patients with normal glucose tolerance (NGT), those with IGT, and those with diabetes mellitus (DM) by using optical coherence tomography (OCT). Methods The present study included 101 coronary artery disease patients (mean age, 67.9 +/- 10.4 years; 82.4% male). OCT was performed for target and non-target vessels during percutaneous coronary intervention. The patients were divided into the following 3 groups: the NGT, IGT, and DM groups. Results A total of 136 non-target residual plaques were found in 101 patients (27, 30, and 44 in the NGT, IGT, and DM groups, respectively). The size of the lipid core expressed as the mean angle of the lipid arc was significantly greater in the IGT and DM groups than in the NGT group (163.0 +/- 58.7 E, 170.1 +/- 59.3 E, and 130.9 +/- 37.7 E, respectively, P < 0.05). The fibrous cap covering the lipid core was significantly thinner in the IGT group than in the NGT group (77.0 +/- 23.4 mu m vs. 105.6 +/- 47.0 mu m, P = 0.040). Conclusion The coronary plaques in CAD patients are more vulnerable when having IGT compared to those with NGT, and similar to those with DM. This finding may explain the high risk of cardiovascular events in CAD patients with IGT.	[Suzuki, Keishi; Takano, Hitoshi; Kubota, Yoshiaki; Inui, Keisuke; Nakamura, Shunichi; Tokita, Yukichi; Kato, Koji; Asai, Kuniya; Shimizu, Wataru] Nippon Med Sch, Dept Cardiovasc Med, Tokyo, Japan	Nippon Medical School	Takano, H (corresponding author), Nippon Med Sch, Dept Cardiovasc Med, Tokyo, Japan.	htakano@nms.ac.jp						Ahmadi A, 2016, CIRC RES, V119, P317, DOI 10.1161/CIRCRESAHA.116.308952; Arbustini E, 1999, HEART, V82, P269, DOI 10.1136/hrt.82.3.269; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397; Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; Capaldo B, 2013, DIABETES CARE, V36, P992, DOI 10.2337/dc12-1501; Chiasson JL, 1998, DIABETES CARE, V21, P1720, DOI 10.2337/diacare.21.10.1720; de Vegt F, 1999, DIABETOLOGIA, V42, P926, DOI 10.1007/s001250051249; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Farb A, 1996, CIRCULATION, V93, P1354, DOI 10.1161/01.CIR.93.7.1354; Ferrannini E, 2011, MED CLIN N AM, V95, P327, DOI 10.1016/j.mcna.2010.11.005; Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080; Inami S, 2012, INT HEART J, V53, P261, DOI 10.1536/ihj.53.261; Jang IK, 2005, CIRCULATION, V111, P1551, DOI 10.1161/01.CIR.0000159354.43778.69; Kato K, 2012, JACC-CARDIOVASC INTE, V5, P1150, DOI 10.1016/j.jcin.2012.06.019; Kubo T, 2007, J AM COLL CARDIOL, V50, P933, DOI 10.1016/j.jacc.2007.04.082; Kuhl J, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0283-3; Kume T, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.06.030; Kurihara O, 2013, DIABETES CARE, V36, P729, DOI 10.2337/dc12-1635; Kuroda M, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0236-x; Lenzen M., 2006, J APPL INPUT OUTPUT, V11 12, P1, DOI DOI 10.1093/EURHEARTJ/EHL363; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; MacNeill BD, 2004, J AM COLL CARDIOL, V44, P972, DOI 10.1016/j.jacc.2004.05.066; Meigs JB, 2002, DIABETES CARE, V25, P1845, DOI 10.2337/diacare.25.10.1845; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Narula J, 2008, NAT CLIN PRACT CARD, V5, pS2, DOI 10.1038/ncpcardio1247; Noor R, 2007, ATHEROSCLEROSIS, V192, P92, DOI 10.1016/j.atherosclerosis.2006.06.023; Ozaki Y, 2013, CIRC J, V77, P2982, DOI 10.1253/circj.CJ-13-0512; Rodriguez BL, 1996, DIABETES CARE, V19, P587, DOI 10.2337/diacare.19.6.587; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Takano M, 2009, J AM COLL CARDIOL, V55, P26, DOI 10.1016/j.jacc.2009.08.032; Tearney GJ, 2003, CIRCULATION, V107, P113, DOI 10.1161/01.CIR.0000044384.41037.43; Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079; Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920	35	10	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167645	10.1371/journal.pone.0167645	http://dx.doi.org/10.1371/journal.pone.0167645			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936195	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100140
J	Yamamoto, T; Furuhashi, M; Sugaya, T; Oikawa, T; Matsumoto, M; Funahashi, Y; Matsukawa, Y; Gotoh, M; Miura, T				Yamamoto, Tokunori; Furuhashi, Masato; Sugaya, Takeshi; Oikawa, Tsuyoshi; Matsumoto, Megumi; Funahashi, Yasuhito; Matsukawa, Yoshihisa; Gotoh, Momokazu; Miura, Tetsuji			Transcriptome and Metabolome Analyses in Exogenous FABP4-and FABP5-Treated Adipose-Derived Stem Cells	PLOS ONE			English	Article							ACID-BINDING PROTEIN; STRESS URINARY-INCONTINENCE; PERIURETHRAL INJECTION; PLASMA FATTY-ACID-BINDING-PROTEIN-4; REGENERATIVE CELLS; APOLIPOPROTEIN-E; OBESITY; BIOMARKER; AP2; ATHEROSCLEROSIS	Adipose-derived stem cells (ADSC), which exist near adipocytes in adipose tissue, have been used as a potential tool of regenerative medicine. Lipid chaperones, fatty acid-binding protein 4 (FABP4) and 5 (FABP5), are abundantly expressed in adipocytes. FABP4 has recently been shown to be secreted from adipocytes during lipolysis in a non-classical pathway and may act as an adipokine. Here, we investigated the role of exogenous FABP4 and FABP5 in transcriptional and metabolic regulation in ADSC. FABP4 and FABP5 were little expressed in ADSC. However, both FABP4 and FABP5 were significantly induced after adipocyte differentiation of ADSC and were secreted from the differentiated adipocytes. Analysis of microarray data, including gene ontology enrichment analysis and cascade analysis of the protein-protein interaction network using a transcription factor binding site search, demonstrated that treatment of ADSC with FABP4 or FABP5 affected several kinds of genes related to inflammatory and metabolic responses and the process of cell differentiation. Notably, myogenic factors, including myocyte enhancer factors, myogenic differentiation 1 and myogenin, were modulated by treatment of ADSC with FABP4, indicating that exogenous FABP4 treatment is partially associated with myogenesis in ADSC. Metabolome analysis showed that treatment of ADSC with FABP4 and with FABP5 similarly, but differently in extent, promoted hydrolysis and/or uptake of lipids, consequentially together with enhancement of beta oxidation, inhibition of downstream of the glycolysis pathway, accumulation of amino acids, reduction of nucleic acid components and increase in the ratio of reduced and oxidized nicotinamide adenine dinucleotide phosphates (NADPH/NADP(+)), an indicator of reducing power, and the ratio of adenosine triphosphate and adenosine monophosphate (ATP/AMP), an indicator of the energy state, in ADSC. In conclusion, secreted FABP4 and FABP5 from adipocytes as adipokines differentially affect transcriptional and metabolic regulation in ADSC near adipocytes. The adiposity condition in the host of regenerative medicine may affect characteristics of ADSC by exposure of the balance of FABP4 and FABP5.	[Yamamoto, Tokunori; Funahashi, Yasuhito; Matsukawa, Yoshihisa; Gotoh, Momokazu] Nagoya Univ, Grad Sch Med, Dept Urol, Nagoya, Aichi, Japan; [Furuhashi, Masato; Matsumoto, Megumi; Miura, Tetsuji] Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Chuo Ku, Sapporo, Hokkaido, Japan; [Sugaya, Takeshi] St Marianna Univ, Sch Med, Dept Hypertens & Nephrol, Miyamae Ku, Kawasaki, Kanagawa, Japan; [Sugaya, Takeshi; Oikawa, Tsuyoshi] CIMIC Co Ltd, Bunkyo Ku, Mass Bldg Yushima, Tokyo, Japan	Nagoya University; Sapporo Medical University; Saint Marianna University	Furuhashi, M (corresponding author), Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Chuo Ku, Sapporo, Hokkaido, Japan.	furuhasi@sapmed.ac.jp	Furuhashi, Masato/AAT-5518-2021; Gotoh, Momokazu/I-7239-2014	Furuhashi, Masato/0000-0002-0145-3541; Oikawa, Tsuyoshi/0000-0002-1546-6714	Nagoya University Hospital; Health Labor Science Research Grant for Research on incurable disease and cancer from the Ministry of Health, Labor and Welfare of Japan; JSPS KAKENHI; MEXT Translational Research Network Program; Uehara Memorial Foundation; SENSHIN Medical Research Foundation; Japan Diabetes Foundation; Takeda Medical Research Foundation; Ono Medical Research Foundation; Takeda Science Foundation; Akiyama Life Science Foundation; Yamaguchi Endocrine Research Foundation; Naito Foundation Natural Science Scholarship; Suhara Memorial Foundation; Kondou Kinen Medical Foundation; CIMIC Co., Ltd.	Nagoya University Hospital; Health Labor Science Research Grant for Research on incurable disease and cancer from the Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT Translational Research Network Program; Uehara Memorial Foundation(Uehara Memorial Foundation); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Japan Diabetes Foundation; Takeda Medical Research Foundation; Ono Medical Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Akiyama Life Science Foundation; Yamaguchi Endocrine Research Foundation; Naito Foundation Natural Science Scholarship; Suhara Memorial Foundation; Kondou Kinen Medical Foundation; CIMIC Co., Ltd.	MG and TY have been supported by a grant from Nagoya University Hospital and a Health Labor Science Research Grant for Research on incurable disease and cancer from the Ministry of Health, Labor and Welfare of Japan. M.F. has been supported by grants from JSPS KAKENHI, MEXT Translational Research Network Program, Uehara Memorial Foundation, SENSHIN Medical Research Foundation, Japan Diabetes Foundation, Takeda Medical Research Foundation, Ono Medical Research Foundation, Takeda Science Foundation, Akiyama Life Science Foundation, Yamaguchi Endocrine Research Foundation, Naito Foundation Natural Science Scholarship, Suhara Memorial Foundation and Kondou Kinen Medical Foundation. CIMIC Co., Ltd. provided support in the form of salaries for TS and TO but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Al-Nbaheen M, 2013, STEM CELL REV REP, V9, P32, DOI 10.1007/s12015-012-9365-8; Aragones G, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-72; Babaev VR, 2011, ARTERIOSCL THROM VAS, V31, P1283, DOI 10.1161/ATVBAHA.111.225839; Bagheri R, 2010, AM J CARDIOL, V106, P1118, DOI 10.1016/j.amjcard.2010.06.028; Boord JB, 2004, CIRCULATION, V110, P1492, DOI 10.1161/01.CIR.0000141735.13202.B6; Burak MF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac6336; Cabre A, 2007, Atherosclerosis, V195, pe150; Cabre A, 2008, J LIPID RES, V49, P1746, DOI 10.1194/jlr.M800102-JLR200; Cabre A, 2008, CLIN CHEM, V54, P181, DOI 10.1373/clinchem.2007.094672; Cao HM, 2013, CELL METAB, V17, P768, DOI 10.1016/j.cmet.2013.04.012; Chow WS, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004176; Ertunc ME, 2015, J LIPID RES, V56, P423, DOI 10.1194/jlr.M055798; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Furuhashi M, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/642612; Furuhashi M, 2016, AM J CARDIOL, V118, P198, DOI 10.1016/j.amjcard.2016.04.037; Furuhashi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154482; Furuhashi M, 2016, ARTERIOSCL THROM VAS, V36, P825, DOI 10.1161/ATVBAHA.116.307225; Furuhashi M, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0177-8; Furuhashi M, 2015, J LIPID RES, V56, P2372, DOI 10.1194/jlr.M059469; Furuhashi M, 2015, HYPERTENS RES, V38, P252, DOI 10.1038/hr.2015.2; Furuhashi M, 2014, CLIN MED INSIGHTS-CA, V8, P23, DOI 10.4137/CMC.S17067; Furuhashi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027356; Fuseya T, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0126-7; Girona J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081914; Gotoh M, 2014, INT J UROL, V21, P294, DOI 10.1111/iju.12266; Haunerland NH, 2004, PROG LIPID RES, V43, P328, DOI 10.1016/j.plipres.2004.05.001; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Ishimura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081318; Karpisek M, 2007, EUR J CLIN INVEST, V37, P637, DOI 10.1111/j.1365-2362.2007.01835.x; Kikuchi Y, 2003, APPL ENVIRON MICROB, V69, P358, DOI 10.1128/AEM.69.1.358-366.2003; Kralisch S, 2013, INT J OBES; Lamounier-Zepter V, 2009, CIRC RES, V105, P326, DOI 10.1161/CIRCRESAHA.109.200501; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Maeda K, 2003, DIABETES, V52, P300, DOI 10.2337/diabetes.52.2.300; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Masoodi M, 2014, BIOCH BIOPHYS ACTA; Mita T, 2015, OBESITY, V23, P359, DOI 10.1002/oby.20954; Miyoshi T, 2011, HEART VESSELS, V26, P408, DOI 10.1007/s00380-010-0060-x; Ota H, 2012, AM J HYPERTENS, V25, P1124, DOI 10.1038/ajh.2012.88; Saito N, 2010, CURR OPIN MICROBIOL, V13, P358, DOI 10.1016/j.mib.2010.04.006; Schlottmann I, 2013, INT J OBES; Simpson MA, 1999, MOL CELL BIOCHEM, V192, P33, DOI 10.1023/A:1006819715146; Tso AWK, 2007, DIABETES CARE, V30, P2667, DOI 10.2337/dc07-0413; von Eynatten M, 2012, ARTERIOSCL THROM VAS, V32, P2327, DOI 10.1161/ATVBAHA.112.248609; Watanabe T, 2011, INT J UROL, V18, P659, DOI 10.1111/j.1442-2042.2011.02795.x; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Wu LE, 2014, MOL METAB, V3, P465, DOI 10.1016/j.molmet.2014.02.005; Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503; Xu AM, 2006, CLIN CHEM, V52, P405, DOI 10.1373/clinchem.2005.062463; Yamamoto T, 2012, INT J UROL, V19, P652, DOI 10.1111/j.1442-2042.2012.02999.x; Yeung DCY, 2007, ARTERIOSCL THROM VAS, V27, P1796, DOI 10.1161/ATVBAHA.107.146274; Yeung DCY, 2008, EUR HEART J, V29, P2156, DOI 10.1093/eurheartj/ehn295	55	23	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167825	10.1371/journal.pone.0167825	http://dx.doi.org/10.1371/journal.pone.0167825			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936164	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100208
J	Abou-Setta, AM; Jeyaraman, M; Attia, A; Al-Inany, HG; Ferri, M; Ansari, MT; Garritty, CM; Bond, K; Norris, SL				Abou-Setta, Ahmed M.; Jeyaraman, Maya; Attia, Abdelhamid; Al-Inany, Hesham G.; Ferri, Mauricio; Ansari, Mohammed T.; Garritty, Chantelle M.; Bond, Kenneth; Norris, Susan L.			Methods for Developing Evidence Reviews in Short Periods of Time: A Scoping Review	PLOS ONE			English	Review							SYSTEMATIC REVIEWS; PUBLICATION BIAS; RAPID REVIEWS; DECISION-MAKING; QUALITY; FULL; CONCLUSIONS; EXPLORATION; GUIDANCE; IMPACT	Introduction Rapid reviews (RR), using abbreviated systematic review (SR) methods, are becoming more popular among decision-makers. This World Health Organization commissioned study sought to summarize RR methods, identify differences, and highlight potential biases between RR and SR. Methods Review of RR methods (Key Question 1 [KQ1]), meta-epidemiologic studies comparing reliability/validity of RR and SR methods (KQ2), and their potential associated biases (KQ3). We searched Medline, EMBASE, Cochrane Library, grey literature, and checked reference lists, used personal contacts, and crowdsourcing (e.g. email listservs). Selection and data extraction was conducted by one reviewer (KQ1) or two reviewers independently (KQ2-3). Results Across all KQs, we identified 42,743 citations through the literature searches. KQ1: RR methods from 29 organizations were reviewed. There was no consensus on which aspects of the SR process to abbreviate. KQ2: Studies comparing the conclusions of RR and SR (n = 9) found them to be generally similar. Where major differences were identified, it was attributed to the inclusion of evidence from different sources (e.g. searching different databases or including different study designs). KQ3: Potential biases introduced into the review process were well-identified although not necessarily supported by empirical evidence, and focused mainly on selective outcome reporting and publication biases. Conclusion RR approaches are context and organization specific. Existing comparative evidence has found similar conclusions derived from RR and SR, but there is a lack of evidence comparing the potential of bias in both evidence synthesis approaches. Further research and decision aids are needed to help decision makers and reviewers balance the benefits of providing timely evidence with the potential for biased findings.	[Abou-Setta, Ahmed M.; Jeyaraman, Maya] Univ Manitoba, Fac Hlth Sci, George & Fay Yee Ctr Healthcare Innovat, Knowledge Synth Platform, Winnipeg, MB, Canada; [Abou-Setta, Ahmed M.] Univ Manitoba, Dept Community Hlth Sci, Coll Med, Fac Hlth Sci, Winnipeg, MB, Canada; [Attia, Abdelhamid; Al-Inany, Hesham G.] Cairo Univ, Dept Obstet & Gynecol, Fac Med, Cairo, Egypt; [Ferri, Mauricio; Norris, Susan L.] WHO, Geneva, Republic & Cant, Switzerland; [Ansari, Mohammed T.; Garritty, Chantelle M.] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Bond, Kenneth] Canadian Agcy Drugs & Technol Hlth, Ottawa, ON, Canada	University of Manitoba; University of Manitoba; Egyptian Knowledge Bank (EKB); Cairo University; World Health Organization; University of Ottawa; Ottawa Hospital Research Institute	Abou-Setta, AM (corresponding author), Univ Manitoba, Fac Hlth Sci, George & Fay Yee Ctr Healthcare Innovat, Knowledge Synth Platform, Winnipeg, MB, Canada.; Abou-Setta, AM (corresponding author), Univ Manitoba, Dept Community Hlth Sci, Coll Med, Fac Hlth Sci, Winnipeg, MB, Canada.	ahmed.abou-setta@umanitoba.ca	Garritty, Chantelle Marie/AAC-4136-2022; Attia, Abdelhamid/F-2890-2011; Al-Inany, Hesham/AAF-1089-2020; Garritty, Chantelle/ABG-7790-2020		World Health Organization	World Health Organization(World Health Organization)	This work was funded by the World Health Organization.	Akl EA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009368; Amate JM, 2010, HTAI 7 ANN M MAX VAL, P162; Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Atakpo P, 2016, J DERMATOL SCI, V82, P69, DOI 10.1016/j.jdermsci.2016.02.005; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Buchter RB, 2016, J CLIN EPIDEMIOL, V27, P27; Cairns J, 2006, HEALTH POLICY, V76, P134, DOI 10.1016/j.healthpol.2005.05.006; Cameron A, 2007, 60 ASERNIPS; Canadian Agency for Drugs and Technologies in Health, 2010, TRANSC AORT VALV IMP; Canadian Agency for Drugs and Technologies in Health, 2013, GREY MATT PRACT SEAR; Carter EC, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00823; Centre for Reviews Dissemination, SYSTEMATIC REV CRDS, V009; Dubben HH, 2005, BRIT MED J, V331, P433, DOI 10.1136/bmj.38478.497164.F7; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Featherstone RM, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0040-4; Ganann R, 2010, IMPLEMENT SCI, V5, P10, DOI 10.1186/1748-5908-5-56; Golder S, 2010, J CLIN EPIDEMIOL, V63, P1071, DOI 10.1016/j.jclinepi.2010.02.009; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Hailey D, 2009, INT J TECHNOL ASSESS, V25, P415, DOI 10.1017/S0266462309990067; Harker J, 2012, INT J EVID-BASED HEA, V10, P397, DOI 10.1111/j.1744-1609.2012.00290.x; Hartling L, 2015, EPC METHODS EXPLORAT; Hartling L, 2016, EPC METHODS AHRQ END; Hartling L, 2015, J CLIN EPIDEMIOL, V68, P1451, DOI 10.1016/j.jclinepi.2015.05.036; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hopewell S, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000001.pub2, 10.1002/14651858.MR000011.pub2]; Institute of Medicine, 2011, NATL ACAD PR; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ireland B, 2013, BMJ QUAL SAF, V22, pA21; Jayakumar KL, 2016, J HOSP MED, V11, P185, DOI 10.1002/jhm.2498; Kaltenthaler E, 2008, HEALTH POLICY, V87, P389, DOI 10.1016/j.healthpol.2008.02.007; Katikireddi SV, 2015, J EPIDEMIOL COMMUN H, V69, P189, DOI 10.1136/jech-2014-204711; Kelly SE, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0258-9; Khangura S, 2014, INT J TECHNOL ASSESS, V30, P20, DOI 10.1017/S0266462313000664; Kicinski M, 2014, PLOS ONE, V9; Kidholm K, 2009, INT J TECHNOL ASSESS, V25, P42, DOI 10.1017/S0266462309090060; Kirkham J. J., 2010, BMJ-BRIT MED J, V340, P637, DOI DOI 10.1136/BMJ.C365; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Lieb K, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010606; Lopez T, 2003, ARCH DIS CHILD, V88, P176, DOI 10.1136/adc.88.2.176-a; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; McCrae N, 2015, J EVAL CLIN PRACT, V21, P1052, DOI 10.1111/jep.12448; McDonagh MS, 2013, J CLIN EPIDEMIOL, V66, P1071, DOI 10.1016/j.jclinepi.2013.05.006; NHS Centre for Reviews and Dissemination - University of York, 2008, UND SYST REV RES EFF; Norris SL, 2014, WHO HDB GUIDELINE DE; Oakley A., 2012, INTRO SYSTEMATIC REV; Onishi A, 2014, J CLIN EPIDEMIOL, V67, P1320, DOI 10.1016/j.jclinepi.2014.07.002; Page MJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011863; Page MJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002028; Page MJ, 2015, J CLIN EPIDEMIOL, V68, P1282, DOI 10.1016/j.jclinepi.2015.02.009; Page MJ, 2014, COCHRANE DATABASE SY, V10; Papageorgiou SN, 2015, J EVID-BASED DENT PR, V15, P8, DOI 10.1016/j.jebdp.2014.09.001; Peinemann F, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-41; Peters MDJ, 2015, INT J EVID-BASED HEA, V13, P141, DOI 10.1097/XEB.0000000000000050; Polisena J, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0022-6; RELEVO R., 2012, PEER REV SEARCH STRA; Scherer RW, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000005.pub3, 10.1002/14651858.MR000005.pub4]; SCHERER RW, 1994, JAMA-J AM MED ASSOC, V272, P158, DOI 10.1001/jama.272.2.158; Schunemann HJ, 2007, LANCET INFECT DIS, V7, P21, DOI 10.1016/S1473-3099(06)70684-3; Scott NW, 2001, 17 ANN M INT SOC TEC; Song, 2000, HEALTH TECHNOL ASSES, V4, P1, DOI DOI 10.3310/HTA4100; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Tricco AC, 2008, J CLIN EPIDEMIOL, V61, P422, DOI 10.1016/j.jclinepi.2007.10.017; Tricco AC, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0465-6; Van de Velde S, 2011, PHYTOTHER RES, V25, P787, DOI 10.1002/ptr.3356; Varker T, 2015, J EVAL CLIN PRACT, V21, P1199, DOI 10.1111/jep.12405; von Elm Erik, 2003, BMC Med Res Methodol, V3, P12; Warren Virginia, 2007, J Health Serv Res Policy, V12, P142, DOI 10.1258/135581907781542996; Watt A, 2008, ANZ J SURG, V78, P1037, DOI 10.1111/j.1445-2197.2008.04730.x; Wilson MG, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0009-3; World Health Organization, 2014, PERS PROT EQ CONT FI	71	38	38	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0165903	10.1371/journal.pone.0165903	http://dx.doi.org/10.1371/journal.pone.0165903			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930662	Green Published, gold, Green Submitted			2022-12-27	WOS:000389580900007
J	Cramer, AOJ; van Borkulo, CD; Giltay, EJ; van der Maas, HLJ; Kendler, KS; Scheffer, M; Borsboom, D				Cramer, Angelique O. J.; van Borkulo, Claudia D.; Giltay, Erik J.; van der Maas, Han L. J.; Kendler, Kenneth S.; Scheffer, Marten; Borsboom, Denny			Major Depression as a Complex Dynamic System	PLOS ONE			English	Article							EARLY-WARNING SIGNALS; LIFE EVENTS; NETWORK ANALYSIS; UNITED-STATES; SLOWING-DOWN; STRESS; CONSEQUENCES; COMORBIDITY; DISORDERS; PERSPECTIVES	In this paper, we characterize major depression (MD) as a complex dynamic system in which symptoms (e.g., insomnia and fatigue) are directly connected to one another in a network structure. We hypothesize that individuals can be characterized by their own network with unique architecture and resulting dynamics. With respect to architecture, we show that individuals vulnerable to developing MD are those with strong connections between symptoms: e.g., only one night of poor sleep suffices to make a particular person feel tired. Such vulnerable networks, when pushed by forces external to the system such as stress, are more likely to end up in a depressed state; whereas networks with weaker connections tend to remain in or return to a non-depressed state. We show this with a simulation in which we model the probability of a symptom becoming 'active' as a logistic function of the activity of its neighboring symptoms. Additionally, we show that this model potentially explains some well-known empirical phenomena such as spontaneous recovery as well as accommodates existing theories about the various subtypes of MD. To our knowledge, we offer the first intra-individual, symptom-based, process model with the potential to explain the pathogenesis and maintenance of major depression.	[Cramer, Angelique O. J.; van Borkulo, Claudia D.; van der Maas, Han L. J.; Borsboom, Denny] Univ Amsterdam, Psychol Methods, Amsterdam, Netherlands; [Giltay, Erik J.] Leids Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Kendler, Kenneth S.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA; [Scheffer, Marten] Wageningen Univ, Dept Aquat Ecol, Wageningen, Netherlands	University of Amsterdam; Virginia Commonwealth University; Wageningen University & Research	Cramer, AOJ (corresponding author), Univ Amsterdam, Psychol Methods, Amsterdam, Netherlands.	aoj.cramer@gmail.com	Giltay, Erik J./AAL-9948-2021; Kendler, Kenneth/AAF-2876-2019	Borsboom, Denny/0000-0001-9720-4162; Cramer, Angelique/0000-0003-2128-0331; van der Maas, Han L. J./0000-0001-8278-319X	Netherlands Organization for Scientific Research [451-14-002]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organization for Scientific Research: http://www.nwo.nl/en, VENI grant for Angelique Cramer: 451-14-002. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON LY, 1989, PSYCHOL REV, V96, P358, DOI 10.1037/0033-295X.96.2.358; Bebbington P, 1987, Int J Soc Psychiatry, V33, P13, DOI 10.1177/002076408703300102; Beck A.T., 1987, J COGNITIVE PSYCHOTH, V1, P5; Borsboom D, 2016, PSYCHOL MED, V46, P1567, DOI 10.1017/S0033291715001944; Borsboom D, 2008, J CLIN PSYCHOL, V64, P1089, DOI 10.1002/jclp.20503; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037/0003-066X.36.2.129; BREWIN CR, 1985, PSYCHOL BULL, V98, P297, DOI 10.1037/0033-2909.98.2.297; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chen LN, 2012, SCI REP-UK, V2, DOI 10.1038/srep00342; Clark DA, 2010, TRENDS COGN SCI, V14, P418, DOI 10.1016/j.tics.2010.06.007; Clark M. S., 1982, COGNITIVE SOCIAL PSY; Cramer AOJ, 2012, EUR J PERSONALITY, V26, P414, DOI 10.1002/per.1866; Cramer AOJ, 2010, BEHAV BRAIN SCI, V33, P137, DOI 10.1017/S0140525X09991567; Cramer AOJ, 2015, EMERGING TRENDS IN T; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dakos V, 2010, THEOR ECOL-NETH, V3, P163, DOI 10.1007/s12080-009-0060-6; EHLERS CL, 1995, ARCH GEN PSYCHIAT, V52, P960; Ensel WM, 1996, J COMMUNITY PSYCHOL, V24, P66; Epskamp S, 2015, HANDBOOK OF PSYCHOME; FLAY BR, 1978, BEHAV SCI, V23, P335, DOI 10.1002/bs.3830230404; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; Fort H, 2010, J PHYS CONF SER, V246, DOI 10.1088/1742-6596/246/1/012035; Fried E. I., 2016, MOVING FORWARD CHALL; Fried EI, 2016, MENTAL DISORDERS AS; Fried EI, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00309; Gilmore R., 1981, CATASTROPHE THEORY F; Goldbeter A, 2011, PROG BIOPHYS MOL BIO, V105, P119, DOI 10.1016/j.pbiomolbio.2010.11.007; Gorban AN, 2016, J THEOR BIOL, V405, P127, DOI 10.1016/j.jtbi.2015.12.017; Gorban AN, 2010, PHYSICA A, V389, P3193, DOI 10.1016/j.physa.2010.03.035; Grasman RPPP, 2009, J STAT SOFTW, V32, P1; Greden JF, 2001, J CLIN PSYCHIAT, V62, P5; HAMMEN CL, 1978, J ABNORM PSYCHOL, V87, P322, DOI 10.1037/0021-843X.87.8.322; Harris TO, 2000, BRIT J PSYCHIAT, V177, P505, DOI 10.1192/bjp.177.6.505; Hemmeter UM, 2010, EXPERT REV NEUROTHER, V10, P1101, DOI [10.1586/ern.10.83, 10.1586/ERN.10.83]; Huber MT, 1999, BIOL PSYCHIAT, V46, P256, DOI 10.1016/S0006-3223(98)00311-4; Isvoranu A, 2016, SCHIZOPHR B; Jacobs N, 2006, ARCH GEN PSYCHIAT, V63, P989, DOI 10.1001/archpsyc.63.9.989; Kamphuis JH, 2000, BEHAV RES THER, V38, P1163, DOI 10.1016/S0005-7967(99)00147-3; Kelso JAS, 2012, PHILOS T R SOC B, V367, P906, DOI 10.1098/rstb.2011.0351; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kendler KS, 2006, GENES ENVIRONMENT AN; KESSLER RC, 1993, PSYCHOL MED, V23, P679, DOI 10.1017/S0033291700025460; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Leskela US, 2004, J NERV MENT DIS, V192, P373, DOI 10.1097/01.nmd.0000126705.15497.c9; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Malki K, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-73; MCGUFFIN P, 1988, BRIT J PSYCHIAT, V152, P775, DOI 10.1192/bjp.152.6.775; McNally RJ, 2015, CLIN PSYCHOL SCI, V3, P836, DOI 10.1177/2167702614553230; Middeldorp CM, 2008, PSYCHOL MED, V38, P1557, DOI 10.1017/S0033291708002985; MONROE SM, 1991, PSYCHOL BULL, V110, P406, DOI 10.1037/0033-2909.110.3.406; Munafo MR, 2009, BIOL PSYCHIAT, V65, P211, DOI 10.1016/j.biopsych.2008.06.009; Musmeci N, RISK DIVERSIFICATION; Pe ML, 2015, CLIN PSYCHOL SCI, V3, P292, DOI 10.1177/2167702614540645; Penninx BWJH, 2011, J AFFECT DISORDERS, V133, P76, DOI 10.1016/j.jad.2011.03.027; Prescott CA, 2000, ARCH GEN PSYCHIAT, V57, P803, DOI 10.1001/archpsyc.57.8.803; Rhemtulla M, 2016, DRUG ALCOHOL DEPEN, V161, P230, DOI 10.1016/j.drugalcdep.2016.02.005; ROBINS CJ, 1988, J PERS SOC PSYCHOL, V54, P847, DOI 10.1037/0022-3514.54.5.847; Rothbaum BO, 2002, AM J PSYCHOTHER, V56, P59, DOI 10.1176/appi.psychotherapy.2002.56.1.59; Ruzzano L, 2015, J AUTISM DEV DISORD, V45, P192, DOI 10.1007/s10803-014-2204-9; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schmittmann VD, 2013, NEW IDEAS PSYCHOL, V31, P43, DOI 10.1016/j.newideapsych.2011.02.007; TEASDALE JD, 1983, ADV BEHAV RES THER, V5, P3, DOI 10.1016/0146-6402(83)90013-9; Thom R., 2018, STRUCTURAL STABILITY; van Borkulo C, 2015, JAMA PSYCHIAT, V72, P1219, DOI 10.1001/jamapsychiatry.2015.2079; van Borkulo CD, 2014, SCI REP-UK, V4, DOI 10.1038/srep05918; van der Maas HLJ, 2006, PSYCHOL REV, V113, P842, DOI 10.1037/0033-295X.113.4.842; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; Wang J, 2007, J AFFECT DISORDERS, V103, P91, DOI 10.1016/j.jad.2007.01.010; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Wichers M, 2016, PSYCHOTHER PSYCHOSOM, V85, P114, DOI 10.1159/000441458; Wigman JTW, 2015, PSYCHOL MED, V45, P2375, DOI 10.1017/S0033291715000331; World Health Organization, 2008, THE GLOBAL BURDEN OF; Zeeman E. C., 1977, CATASTROPHE THEORY S	76	210	212	7	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167490	10.1371/journal.pone.0167490	http://dx.doi.org/10.1371/journal.pone.0167490			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4OA	27930698	Green Submitted, Green Published, gold			2022-12-27	WOS:000389580900027
J	Menasria, R; Canivet, C; Piret, J; Gosselin, J; Boivin, G				Menasria, Rafik; Canivet, Coraline; Piret, Jocelyne; Gosselin, Jean; Boivin, Guy			Both Cerebral and Hematopoietic Deficiencies in CCR2 Result in Uncontrolled Herpes Simplex Virus Infection of the Central Nervous System in Mice	PLOS ONE			English	Article							INFLAMMATORY MONOCYTES; BONE-MARROW; ALZHEIMERS-DISEASE; IMMUNE-RESPONSE; INTRAVITAL MICROSCOPY; VIRAL ENCEPHALITIS; RECRUITMENT; MICROGLIA; BRAIN; EXPRESSION	CCR2 is a chemokine receptor expressed on the surface of blood leukocytes, particularly "Ly6C(hi)" inflammatory monocytes and microglia. Signaling through this receptor is thought to influence the immune activity of microglia as well as monocytes egress from the bone marrow (BM) and their trafficking into the central nervous system (CNS) in several neurological diseases. During experimental herpes simplex virus 1 (HSV-1) encephalitis (HSE), CCR2 deficiency has been reported to exacerbate the outcome of the disease. However, the precise contribution of CCR2 expressed in cells of the CNS or peripheral monocytes in the protection against HSE remains unclear. To dissect the differential role of CCR2 during HSE, chimeric mice with receptor deficiency in the brain or blood cells were generated by transplanting wild-type (WT) C57BL/6 or CCR2(-/-) BM-derived cells in CCR2(-/-)(WT -> CCR2(-/-)) and WT (CCR2(-/-)-> WT) mice, respectively. Our results indicate that following intranasal infection with 1.2x10(6) plaque forming units of HSV-1, CCR2 deficiency in hematopoietic cells and, to a lesser extent, in CNS exacerbates the outcome of HSE. Mortality rates of CCR2(-/-) (71.4%) and CCR2(-/-)-> WT (57.1%) mice were significantly higher than that of WT (15.3%; P<0.01 and P<0.05, respectively) but the difference did not reach statistical significance for WT -> CCR2(-/-) animals (42.8%; P = 0.16). Both peripheral and CNS deficiencies in CCR2 resulted in increased infectious viral titers and wider dissemination of HSV antigens in the brain as well as an overproduction of inflammatory cytokines and chemokines including IL-1 beta, IL-6, CCL2, CCL3 and CCL5. Furthermore, CCR2 deficiency in the hematopoietic system altered monocytes egress from the BM and their recruitment to the CNS, which may contribute to the failure in HSV-1 containment. Collectively, these data suggest that CCR2 expressed on cells of CNS and especially on peripheral monocytes is important for the control of HSV-1 replication and inflammatory environment during experimental HSE.	[Menasria, Rafik; Canivet, Coraline; Piret, Jocelyne; Boivin, Guy] Univ Laval, Fac Med, Dept Microbiol Immunol & Infect Dis, Res Ctr Infect Dis,CHU Quebec Res Ctr, Quebec City, PQ, Canada; [Gosselin, Jean] Univ Laval, Dept Mol Med, CHU Quebec Res Ctr, Lab Innate Immun,Fac Med, Quebec City, PQ, Canada	Laval University; Laval University	Boivin, G (corresponding author), Univ Laval, Fac Med, Dept Microbiol Immunol & Infect Dis, Res Ctr Infect Dis,CHU Quebec Res Ctr, Quebec City, PQ, Canada.	Guy.Boivin@crchudequebec.ulaval.ca		Piret, Jocelyne/0000-0003-4102-0094; Boivin, Guy/0000-0003-3027-4662	Canadian Institutes of Health Research [MOP-133481]; Fonds de Recherche du Quebec-Sante	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This study was supported by a grant from the Canadian Institutes of Health Research (grant MOP-133481 to G.B.). G.B. is the holder of the Canada research chair on emerging viruses and antiviral resistance. R.M. has a PhD scholarship from the "Fonds de Recherche du Quebec-Sante". The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ashhurst TM, 2014, CELL IMMUNOL, V291, P49, DOI 10.1016/j.cellimm.2014.07.002; Bao Y, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-92; Boivin N, 2012, J GEN VIROL, V93, P1294, DOI 10.1099/vir.0.041046-0; Bradshaw MJ, 2016, NEUROTHERAPEUTICS TH; Cazareth J, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-132; Chen BP, 2001, J IMMUNOL, V167, P4585, DOI 10.4049/jimmunol.167.8.4585; Chu HX, 2014, J CEREBR BLOOD F MET, V34, P1425, DOI 10.1038/jcbfm.2014.120; Conrady CD, 2013, J IMMUNOL, V190, P2807, DOI 10.4049/jimmunol.1203265; Conrady CD, 2010, J NEUROIMMUNOL, V220, P1, DOI 10.1016/j.jneuroim.2009.09.013; Deng YY, 2009, GLIA, V57, P604, DOI 10.1002/glia.20790; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Hickman SE, 2010, CNS NEUROL DISORD-DR, V9, P168, DOI 10.2174/187152710791011982; Howe CL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00545; Hu SX, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-123; Iijima N, 2011, P NATL ACAD SCI USA, V108, P284, DOI 10.1073/pnas.1005201108; Inose Y, 2015, NEUROPATHOLOGY, V35, P209, DOI 10.1111/neup.12182; Jia T, 2008, J IMMUNOL, V180, P6846, DOI 10.4049/jimmunol.180.10.6846; Kaewpoowat Q, 2016, INFECTION, V44, P337, DOI 10.1007/s15010-015-0867-6; Lampron A, 2012, CELL TRANSPLANT, V21, P1149, DOI 10.3727/096368911X593154; Lim JK, 2011, J IMMUNOL, V186, P471, DOI 10.4049/jimmunol.1003003; Luhmann UFO, 2012, ADV EXP MED BIOL, V723, P17, DOI 10.1007/978-1-4614-0631-0_3; Lundberg P, 2008, J VIROL, V82, P7078, DOI 10.1128/JVI.00619-08; Marques CP, 2006, VIRUS RES, V121, P1, DOI 10.1016/j.virusres.2006.03.009; Mathur M, 2014, HAND CLINIC, V123, P149, DOI 10.1016/B978-0-444-53488-0.00006-7; McMillin M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-121; Menasria R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145773; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Naert G, 2013, J MOL CELL BIOL, V5, P284, DOI 10.1093/jmcb/mjt028; O'Connor T, 2015, ENDOCR METAB IMMUNE, V15, P105, DOI 10.2174/1871530315666150316120920; Piret J, 2015, REV MED VIROL, V25, P300, DOI 10.1002/rmv.1848; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Prinz M, 2010, J NEUROIMMUNOL, V224, P80, DOI 10.1016/j.jneuroim.2010.05.015; Raber J, 2013, BEHAV BRAIN RES, V246, P69, DOI 10.1016/j.bbr.2013.03.003; Rebenko-Moll NM, 2006, CURR OPIN IMMUNOL, V18, P683, DOI 10.1016/j.coi.2006.09.005; Riancho J, 2013, NEUROL SCI, V34, P1879, DOI 10.1007/s10072-013-1475-9; Rozenberg Flore, 2011, Infectious Disorders - Drug Targets, V11, P235; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Savarin C, 2010, J VIROL, V84, P4878, DOI 10.1128/JVI.00051-10; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Sergerie Y, 2007, J INFECT DIS, V195, P817, DOI 10.1086/511987; Sheahan T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000240; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shechter R, 2013, NAT REV IMMUNOL, V13, P206, DOI 10.1038/nri3391; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Steiner I, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0414-8; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Teixeira MM, 2010, J NEUROIMMUNOL, V224, P62, DOI 10.1016/j.jneuroim.2010.05.018; Terry RL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-270; Trujillo JA, 2013, J VIROL, V87, P2376, DOI 10.1128/JVI.03089-12; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Tuppeny M, 2013, CRIT CARE NURS CLIN, V25, P363, DOI 10.1016/j.ccell.2013.04.003; Vilela MC, 2008, NEUROSCI LETT, V445, P18, DOI 10.1016/j.neulet.2008.08.072; Vilela MC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-19; Whitley RJ, 2006, ANTIVIR RES, V71, P141, DOI 10.1016/j.antiviral.2006.04.002; Wickham S, 2005, J NEUROIMMUNOL, V162, P51, DOI 10.1016/j.jneuroim.2005.01.001; Wuest TR, 2008, FRONT BIOSCI-LANDMRK, V13, P4862, DOI 10.2741/3045; Yao Y, 2014, INT J BIOCHEM CELL B, V55, P51, DOI 10.1016/j.biocel.2014.08.002; Zhang J, 2007, J NEUROSCI, V27, P12396, DOI 10.1523/JNEUROSCI.3016-07.2007	60	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0168034	10.1371/journal.pone.0168034	http://dx.doi.org/10.1371/journal.pone.0168034			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930721	gold, Green Published, Green Submitted			2022-12-27	WOS:000389580900072
J	Patton, TG; Blamer, SL; Horak, KE				Patton, Toni G.; Blamer, Stephen L.; Horak, Katherine E.			Detecting Methemoglobinemia in Animals with a Drop of Blood	PLOS ONE			English	Article							NITRITE-INDUCED METHEMOGLOBINEMIA; ACUTE ORAL TOXICITY; P-AMINOPROPIOPHENONE; BEDSIDE TEST; HUMANE RODENTICIDES; SODIUM-NITRITE; OXYHEMOGLOBIN; INVASIONS; RAT	A major concern during pesticide development and use is the impact on non-target species, such as raptors or domestic cats and dogs. Sodium nitrite and para-aminopropiophenone (PAPP) are two toxicants currently being studied for the control of invasive species, such as starlings and feral swine. When given to an animal these compounds oxidize hemoglobin, which renders it unable to carry oxygen resulting in methemoglobinemia. This study developed a method to estimate methemoglobin levels in mammals and birds by examining the efficacy of sodium nitrite to induce the conversion of hemoglobin to methemoglobin. Varying concentrations of sodium nitrite were added to aliquots of coyote, vole, feral swine, starling, and duck blood, collected from captive animals. The blood samples were analyzed spectrophotometrically to determine percent methemoglobin and digitally to determine red color values (RCV) associated with different methemoglobin levels. The avian and mammalian blood reached 100% methemoglobin levels at 200 mM and 15 mM sodium nitrite, respectively. All animals had similar RCV for a given percent methemoglobin. In conclusion, this study developed a procedure to quickly determine methemoglobin levels in mammals and birds. Furthermore, percent methemoglobin can be estimated with one standard curve from any animal species and an image of a blood spot. The technique will be useful during field studies, in agricultural areas, or in a veterinarian's office for the rapid diagnosis of methemoglobinemia in non-target animals that have eaten toxicants/baits or baited animals.	[Patton, Toni G.; Horak, Katherine E.] USDA, Fertil Control Project 1, Natl Wildlife Res Ctr, Anim & Plant Hlth Inspect Serv, Ft Collins, CO 80524 USA; [Blamer, Stephen L.] USDA, Chem Lab Unit 2, Natl Wildlife Res Ctr, Anim & Plant Hlth Inspect Serv, Ft Collins, CO USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Horak, KE (corresponding author), USDA, Fertil Control Project 1, Natl Wildlife Res Ctr, Anim & Plant Hlth Inspect Serv, Ft Collins, CO 80524 USA.	Katherine.E.Horak@aphis.usda.gov						Ajloo D, 2002, ACTA BIOCHIM POL, V49, P459; Blackie HM, 2014, PEST MANAG SCI, V70, P345, DOI 10.1002/ps.3627; BRUNINGFANN CS, 1993, VET HUM TOXICOL, V35, P237; Conole D, 2014, BIOORGAN MED CHEM, V22, P2220, DOI 10.1016/j.bmc.2014.02.013; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; DEFEO FG, 1972, J MED CHEM, V15, P1185, DOI 10.1021/jm00281a027; Eason CT, 2010, INT J PEST MANAGE, V56, P109, DOI 10.1080/09670870903243463; Eason CT, 2002, ECOTOXICOLOGY, V11, P35, DOI 10.1023/A:1013793029831; Elliott JE, 2013, ENV MONIT ASSESS; Evelyn KA, 1938, J BIOL CHEM, V126, P655; Fisher P, 2008, J WILDLIFE DIS, V44, P655, DOI 10.7589/0090-3558-44.3.655; Fisher P, 2007, WILDLIFE RES, V34, P19, DOI 10.1071/WR06125; Fisher PM, 2005, NEW ZEAL J ZOOL, V32, P163, DOI 10.1080/03014223.2005.9518409; Hulse E, 2016, CLIN TOXICOL, V54, P826, DOI 10.1080/15563650.2016.1217421; IMAIZUMI K, 1980, INT ARCH OCC ENV HEA, V45, P97, DOI 10.1007/BF01274129; Kohn MC, 2002, DRUG METAB DISPOS, V30, P676, DOI 10.1124/dmd.30.6.676; KOSAKA H, 1979, BIOCHIM BIOPHYS ACTA, V581, P184, DOI 10.1016/0005-2795(79)90235-6; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Marks CA, 2004, ANIM WELFARE, V13, P401; Martinez-Haro M, 2008, VET J, V176, P405, DOI 10.1016/j.tvjl.2007.02.021; PAN HP, 1983, GEN PHARMACOL, V14, P465, DOI 10.1016/0306-3623(83)90032-0; Pejchar L, 2009, TRENDS ECOL EVOL, V24, P497, DOI 10.1016/j.tree.2009.03.016; Rennison D, 2013, BIOORG MED CHEM LETT, V23, P6629, DOI 10.1016/j.bmcl.2013.10.046; Shihana F, 2016, B WORLD HEALTH ORGAN, V94, P622, DOI 10.2471/BLT.15.158147; Shihana F, 2016, CLIN TOXICOL, V54, P576, DOI 10.1080/15563650.2016.1177651; Shihana F, 2010, ANN EMERG MED, V55, P184, DOI 10.1016/j.annemergmed.2009.07.022; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; SMITH RP, 1967, BIOCHEM PHARMACOL, V16, P317, DOI 10.1016/0006-2952(67)90033-0; Titov VY, 2005, BIOCHEMISTRY-MOSCOW+, V70, P473, DOI 10.1007/s10541-005-0139-7; Umbreit J, 2007, AM J HEMATOL, V82, P134, DOI 10.1002/ajh.20738; Wright RO, 1999, ANN EMERG MED, V34, P646, DOI 10.1016/S0196-0644(99)70167-8; ZIJLSTRA WG, 1994, COMP BIOCHEM PHYS B, V107, P161, DOI 10.1016/0305-0491(94)90238-0	32	5	5	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167942	10.1371/journal.pone.0167942	http://dx.doi.org/10.1371/journal.pone.0167942			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930713	Green Published, gold, Green Submitted			2022-12-27	WOS:000389580900062
J	Yamamoto, W; Asakura, K; Ando, H; Taniguchi, T; Ojima, A; Uda, T; Osada, T; Hayashi, S; Kasai, C; Miyamoto, N; Tashibu, H; Yoshinaga, T; Yamazaki, D; Sugiyama, A; Kanda, Y; Sawada, K; Sekino, Y				Yamamoto, Wataru; Asakura, Keiichi; Ando, Hiroyuki; Taniguchi, Tomohiko; Ojima, Atsuko; Uda, Takaaki; Osada, Tomoharu; Hayashi, Seiji; Kasai, Chieko; Miyamoto, Norimasa; Tashibu, Hiroyuki; Yoshinaga, Takashi; Yamazaki, Daiju; Sugiyama, Atsushi; Kanda, Yasunari; Sawada, Kohei; Sekino, Yuko			Electrophysiological Characteristics of Human iPSC-Derived Cardiomyocytes for the Assessment of Drug-Induced Proarrhythmic Potential	PLOS ONE			English	Article							QT INTERVAL; CHROMANOL 293B; DE-POINTES; PROLONGATION; HEART; REPOLARIZATION	The aims of this study were to (1) characterize basic electrophysiological elements of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) that correspond to clinical properties such as QT-RR relationship, (2) determine the applicability of QT correction and analysis methods, and (3) determine if and how these in-vitro parameters could be used in risk assessment for adverse drug-induced effects such as Torsades de pointes (TdP). Field potential recordings were obtained from commercially available hiPSC-CMs using multi-electrode array (MEA) platform with and without ion channel antagonists in the recording solution. Under control conditions, MEA-measured interspike interval and field potential duration (FPD) ranged widely from 1049 to 1635 ms and from 334 to 527 ms, respectively and provided positive linear regression coefficients similar to native QT-RR plots obtained from human electrocardiogram (ECG) analyses in the ongoing cardiovascular-based Framingham Heart Study. Similar to minimizing the effect of heart rate on the QT interval, Fridericia's and Bazett's corrections reduced the influence of beat rate on hiPSC-CM FPD. In the presence of E-4031 and cisapride, inhibitors of the rapid delayed rectifier potassium current, hiPSC-CMs showed reverse use-dependent FPD prolongation. Categorical analysis, which is usually applied to clinical QT studies, was applicable to hiPSC-CMs for evaluating torsadogenic risks with FPD and/or corrected FPD. Together, this results of this study links hiPSC-CM electrophysiological endpoints to native ECG endpoints, demonstrates the appropriateness of clinical analytical practices as applied to hiPSC-CMs, and suggests that hiPSC-CMs are a reliable models for assessing the arrhythmogenic potential of drug candidates in human.	[Yamamoto, Wataru; Asakura, Keiichi; Ando, Hiroyuki; Taniguchi, Tomohiko; Ojima, Atsuko; Uda, Takaaki; Osada, Tomoharu; Hayashi, Seiji; Kasai, Chieko; Miyamoto, Norimasa; Tashibu, Hiroyuki; Yoshinaga, Takashi; Yamazaki, Daiju; Sugiyama, Atsushi; Kanda, Yasunari; Sawada, Kohei; Sekino, Yuko] Japan iPS Cardiac Safety Assessment JiCSA, Setagaya Ku, Tokyo, Japan; [Asakura, Keiichi; Ando, Hiroyuki; Osada, Tomoharu; Hayashi, Seiji; Kasai, Chieko; Tashibu, Hiroyuki; Yoshinaga, Takashi; Sugiyama, Atsushi; Sawada, Kohei; Sekino, Yuko] Japanese Safety Pharmacol Soc, Setagaya Ku, Showa Machi, Maebashi, Gunma, Japan; [Yamamoto, Wataru] Teijin Pharma Ltd, Hino, Tokyo, Japan; [Asakura, Keiichi; Hayashi, Seiji] Nippon Shinyaku Co Ltd, Minami Ku, Nishinosho Monguchi Cho, Kyoto, Japan; [Ando, Hiroyuki; Uda, Takaaki] Ono Pharmaceut Co Ltd, Mikuni Cho, Sakai, Fukui, Japan; [Taniguchi, Tomohiko; Ojima, Atsuko; Miyamoto, Norimasa; Yoshinaga, Takashi; Sawada, Kohei] Eisai & Co Ltd, Tsukuba, Ibaraki, Japan; [Osada, Tomoharu] LSI Medience Corp, Chiyoda Ku, Uchikanda 1 Chome, Tokyo, Japan; [Kasai, Chieko] Astellas Pharma Inc, Tsukuba, Ibaraki, Japan; [Tashibu, Hiroyuki] Ina Res Inc, Ina, Nagano, Japan; [Sugiyama, Atsushi] Toho Univ, Dept Pharmacol, Fac Med, Ota Ku, Tokyo, Japan; [Yamazaki, Daiju; Kanda, Yasunari; Sekino, Yuko] Natl Inst Hlth Sci, Setagaya Ku, Tokyo, Japan	Teijin Pharma Limited; Nippon Shinyaku Co Ltd; Ono Pharmaceutical Co Ltd; Eisai Co Ltd; Astellas Pharmaceuticals; Ina Research Inc.; National Institute of Health Sciences - Japan	Yamamoto, W; Osada, T (corresponding author), Japan iPS Cardiac Safety Assessment JiCSA, Setagaya Ku, Tokyo, Japan.; Osada, T (corresponding author), Japanese Safety Pharmacol Soc, Setagaya Ku, Showa Machi, Maebashi, Gunma, Japan.; Yamamoto, W (corresponding author), Teijin Pharma Ltd, Hino, Tokyo, Japan.; Osada, T (corresponding author), LSI Medience Corp, Chiyoda Ku, Uchikanda 1 Chome, Tokyo, Japan.	w.yamamoto@teijin.co.jp; osada.tomoharu@mg.medience.co.jp	Kanda, Yasunari/AAD-7514-2019	Kanda, Yasunari/0000-0003-2527-3526	Ministry of Health Labour and Welfare (MLHW) [H24-lyaku-Shitei-030]; Research on Regulatory Harmonization and Evaluation of Pharmaceuticals, Medical Devices, Regenerative and Cellular Therapy Products, Gene Therapy Products, and Cosmetics from Japan Agency for Medical Research and development (AMED) [15mk0104053h0101, 16mk0104027j0002]; Teijin Pharma Limited; Nippon Shinyaku Co., Ltd; Ono Pharmaceutical Co., Ltd.; Eisai Co., Ltd; LSI Medience Corporation; Astellas Pharma Inc.; Ina Research Inc.	Ministry of Health Labour and Welfare (MLHW); Research on Regulatory Harmonization and Evaluation of Pharmaceuticals, Medical Devices, Regenerative and Cellular Therapy Products, Gene Therapy Products, and Cosmetics from Japan Agency for Medical Research and development (AMED)(Japan Agency for Medical Research and Development (AMED)); Teijin Pharma Limited(Teijin Pharma Limited); Nippon Shinyaku Co., Ltd(Nippon Shinyaku Co Ltd); Ono Pharmaceutical Co., Ltd.(Ono Pharmaceutical Co Ltd); Eisai Co., Ltd(Eisai Co Ltd); LSI Medience Corporation; Astellas Pharma Inc.(Astellas Pharmaceuticals); Ina Research Inc.	This research was supported by the Regulatory Science Research Grant from the Ministry of Health Labour and Welfare (MLHW) to YS (H24-lyaku-Shitei-030 from 2012 to 2014), and the Research on Regulatory Harmonization and Evaluation of Pharmaceuticals, Medical Devices, Regenerative and Cellular Therapy Products, Gene Therapy Products, and Cosmetics from Japan Agency for Medical Research and development (AMED) to YS (15mk0104053h0101 for 2015, 16mk0104027j0002 for 2016). The funding organizations (MLHW and AMED) did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Teijin Pharma Limited, Nippon Shinyaku Co., Ltd, Ono Pharmaceutical Co., Ltd., Eisai Co., Ltd, LSI Medience Corporation, Astellas Pharma Inc. and Ina Research Inc., provided support in the form of salaries for authors [Teijin Pharma Limited - WY, Nippon Shinyaku Co., Ltd - KA, SH, Ono Pharmaceutical Co., Ltd. -HA, TU, Eisai Co., Ltd - TT, AO, NM, TY, KS, LSI Medience Corporation - TO, Astellas Pharma Inc. - CK, Ina Research Inc. - HT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura K, 2015, J PHARMACOL TOX MET, V75, P17, DOI 10.1016/j.vascn.2015.04.002; Barandi L, 2010, BASIC RES CARDIOL, V105, P315, DOI 10.1007/s00395-009-0082-7; Bauer A, 2000, BASIC RES CARDIOL, V95, P324, DOI 10.1007/s003950070052; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Benatar A, 2015, ANN NONINVAS ELECTRO, V20, P119, DOI 10.1111/anec.12200; Bosch RF, 1998, CARDIOVASC RES, V38, P441, DOI 10.1016/S0008-6363(98)00021-2; Cavero I, 2014, EXPERT OPIN DRUG SAF, V13, P745, DOI 10.1517/14740338.2014.915311; Clements M, 2014, TOXICOL SCI, V140, P445, DOI 10.1093/toxsci/kfu084; Fridericia L, 1920, ACTA MED SCAND, V57, P469, DOI DOI 10.1111/J.0954-6820.1920.TB18266.X; Gilchrist KH, 2015, TOXICOL APPL PHARM, V288, P249, DOI 10.1016/j.taap.2015.07.024; Gilmour RF, 1997, J AM COLL CARDIOL, V30, P209, DOI 10.1016/S0735-1097(97)00105-8; Gintant GA, 2001, J CARDIOVASC PHARM, V37, P607, DOI 10.1097/00005344-200105000-00012; Harris K, 2013, TOXICOL SCI, V134, P412, DOI 10.1093/toxsci/kft113; ICH. International Conference on Harmonisation, 2005, FED REGISTER, V70, P61134; KARJALAINEN J, 1994, J AM COLL CARDIOL, V23, P1547, DOI 10.1016/0735-1097(94)90654-8; Kitaguchi T, 2016, J PHARMACOL TOX MET, V78, P93, DOI 10.1016/j.vascn.2015.12.002; Naitoh N, 1998, JPN HEART J, V39, P457; Nakamura Y, 2014, J PHARMACOL SCI, V124, P494, DOI 10.1254/jphs.13248FP; Okada Y, 1996, J AM COLL CARDIOL, V27, P84, DOI 10.1016/0735-1097(95)00424-6; Puisieux FL, 1996, BRIT J PHARMACOL, V117, P1377, DOI 10.1111/j.1476-5381.1996.tb15295.x; Sager PT, 2014, AM HEART J, V167, P292, DOI 10.1016/j.ahj.2013.11.004; SAGIE A, 1992, AM J CARDIOL, V70, P797, DOI 10.1016/0002-9149(92)90562-D; Sides GD, 2002, DIS MARKERS, V18, P57, DOI 10.1155/2002/482953; Spira ME, 2013, NAT NANOTECHNOL, V8, P83, DOI [10.1038/nnano.2012.265, 10.1038/NNANO.2012.265]; Sugrue A, 2015, CARDIOVASC DRUG THER, V29, P433, DOI 10.1007/s10557-015-6619-0	25	48	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2016	11	12							e0167348	10.1371/journal.pone.0167348	http://dx.doi.org/10.1371/journal.pone.0167348			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MY	27923051	Green Published, gold, Green Submitted			2022-12-27	WOS:000389577900003
J	Kohno, K; Narimatsu, H; Shiono, Y; Suzuki, I; Kato, Y; Sho, R; Otani, K; Ishizawa, K; Yamashita, H; Kubota, I; Ueno, Y; Kato, T; Fukao, A; Kayama, T				Kohno, Kei; Narimatsu, Hiroto; Shiono, Yosuke; Suzuki, Ikuko; Kato, Yuichi; Sho, Ri; Otani, Katsumi; Ishizawa, Kenichi; Yamashita, Hidetoshi; Kubota, Isao; Ueno, Yoshiyuki; Kato, Takeo; Fukao, Akira; Kayama, Takamasa			High Serum Adiponectin Level Is a Risk Factor for Anemia in Japanese Men: A Prospective Observational Study of 1,029 Japanese Subjects	PLOS ONE			English	Article							ADIPOSE-SPECIFIC PROTEIN; NATRIURETIC PEPTIDE; PLASMA ADIPONECTIN; GENE POLYMORPHISM; ASSOCIATION; HEMOGLOBIN; REGULATOR; LEUKEMIA; GROWTH; OLDER	Erythroid abnormalities including anemia and polycythemia are often observed in the general clinical setting. Because recent studies reported that adiponectin negatively affects hematopoiesis, we performed a prospective observational study to assess the relationship between anemia and adiponectin, as well as other parameters, in 1029 Japanese subjects (477 men and 552 women) 40 years of age and older. Body measurements, blood tests, and nutrition intake studies were performed at baseline, and 5 to 7 years later (follow-up). Hemoglobin (Hb) and hematocrit (Hct) levels in men with high serum adiponectin levels were lower at follow-up than at baseline. Multiple regression analysis showed that age, body mass index, adiponectin, and glutamic-pyruvic transaminase were significantly associated with erythroid-related variables (red blood cells, Hb, and Hct) in both men and women (P < 0.05). In a logistic regression analysis, adiponectin, fasting blood glucose, and beta-natriuretic peptide were significant risk factors for anemia in men, and blood urea nitrogen and amylase were significant risk factors in women. Physical features and nutrient intake were not risk factors for anemia. Our study demonstrates, both clinically and epidemiologically, that a high serum adiponectin level decreases the amounts of erythroid-related variables and is a risk factor for anemia in Japanese men.	[Kohno, Kei; Shiono, Yosuke; Suzuki, Ikuko; Kato, Yuichi; Kato, Takeo] Yamagata Univ, Sch Med, Dept Neurol Hematol Metab Endocrinol & Diabetol, Yamagata, Yamagata, Japan; [Narimatsu, Hiroto] Kanagawa Canc Ctr, Res Inst, Canc Prevent & Control Div, Yokohama, Kanagawa, Japan; [Sho, Ri; Otani, Katsumi; Fukao, Akira] Yamagata Univ, Grad Sch Med, Dept Publ Hlth, Yamagata, Yamagata, Japan; [Ishizawa, Kenichi] Yamagata Univ, Sch Med, Dept Hematol & Cell Therapy, Yamagata, Yamagata, Japan; [Yamashita, Hidetoshi] Yamagata Univ, Sch Med, Dept Ophthalmol & Visual Sci, Yamagata, Yamagata, Japan; [Kubota, Isao] Yamagata Univ, Sch Med, Dept Internal Med 1, Yamagata, Yamagata, Japan; [Ueno, Yoshiyuki] Yamagata Univ, Sch Med, Dept Internal Med 2, Yamagata, Yamagata, Japan; [Kayama, Takamasa] Yamagata Univ, Sch Med, Dept Neurosurg, Yamagata, Yamagata, Japan; [Kohno, Kei] Nagoya Univ Hosp, Dept Pathol, Nagoya, Aichi, Japan; [Kohno, Kei] Nagoya Univ Hosp, Clin Labs, Nagoya, Aichi, Japan	Yamagata University; Kanagawa Prefectural Cancer Center; Yamagata University; Yamagata University; Yamagata University; Yamagata University; Yamagata University; Yamagata University; Nagoya University; Nagoya University	Kohno, K (corresponding author), Yamagata Univ, Sch Med, Dept Neurol Hematol Metab Endocrinol & Diabetol, Yamagata, Yamagata, Japan.; Narimatsu, H (corresponding author), Kanagawa Canc Ctr, Res Inst, Canc Prevent & Control Div, Yokohama, Kanagawa, Japan.; Kohno, K (corresponding author), Nagoya Univ Hosp, Dept Pathol, Nagoya, Aichi, Japan.; Kohno, K (corresponding author), Nagoya Univ Hosp, Clin Labs, Nagoya, Aichi, Japan.	skay77jp@yahoo.co.jp; hiroto-narimatsu@umin.org	Ueno, Yoshiyuki/R-9242-2019; Narimatsu, Hiroto/ABC-9150-2021	Ueno, Yoshiyuki/0000-0001-5623-4250; Narimatsu, Hiroto/0000-0002-5302-5872	Global Center of Excellence program of the Japan Society for the Promotion of Science; Institute for Regional Innovation at Yamagata University	Global Center of Excellence program of the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Institute for Regional Innovation at Yamagata University	This work was supported by a Grant-in-Aid from the Global Center of Excellence program of the Japan Society for the Promotion of Science and by the Institute for Regional Innovation at Yamagata University.	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Atzmon G, 2008, J GERONTOL A-BIOL, V63, P447, DOI 10.1093/gerona/63.5.447; Avcu F, 2006, INT J HEMATOL, V83, P254, DOI 10.1532/IJH97.NA0411; Carmel R, 2001, BLOOD REV, V15, P9, DOI 10.1054/blre.2001.0146; Crawford LJA, 2010, J LEUKOCYTE BIOL, V88, P807, DOI 10.1189/jlb.1109723; Daimon M, 2008, BIOCHEM BIOPH RES CO, V374, P576, DOI 10.1016/j.bbrc.2008.07.065; DiMascio L, 2007, J IMMUNOL, V178, P3511, DOI 10.4049/jimmunol.178.6.3511; Guralnik JM, 2004, BLOOD, V104, P2263, DOI 10.1182/blood-2004-05-1812; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Huang MC, 2008, J RENAL NUTR, V18, P187, DOI 10.1053/j.jrn.2007.08.003; Iversen PO, 2005, CLIN CANCER RES, V11, P6793, DOI 10.1158/1078-0432.CCR-05-1033; Kajimura D, 2013, CELL METAB, V17, P901, DOI 10.1016/j.cmet.2013.04.009; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Karakas M, 2010, ATHEROSCLEROSIS, V209, P220, DOI 10.1016/j.atherosclerosis.2009.08.020; Karasawa S, 2010, ENDOCR J, V57, P293, DOI 10.1507/endocrj.K09E-305; Kawamoto R, 2013, ENDOCRINE, V43, P334, DOI 10.1007/s12020-012-9662-7; Kohno K, 2014, EUR J HAEMATOL, V92, P298, DOI 10.1111/ejh.12250; Lewerin C, 2015, J INTERN MED, V278, P68, DOI 10.1111/joim.12340; Matsubara M, 2004, THROMB HAEMOSTASIS, V91, P360, DOI 10.1160/TH03-04-0256; Milman N, 2011, ANN HEMATOL, V90, P1247, DOI 10.1007/s00277-011-1279-z; Muneyuki T, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-80; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Nybo M, 2007, CLIN CHEM, V53, P1921, DOI 10.1373/clinchem.2007.089391; Sasaki S, 1998, J Epidemiol, V8, P203; Shavit L, 2012, ARCH GERONTOL GERIAT, V54, P228, DOI 10.1016/j.archger.2011.03.007; Shi ZM, 2010, PUBLIC HEALTH NUTR, V13, P1319, DOI 10.1017/S1368980009991868; Shola OB, 2015, ANEMIA, V2015, DOI 10.1155/2015/848921; Song HJ, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-8; Sristava PM, 2006, CLIN SCI, V110, P109, DOI 10.1042/CS20050184; Ueno H, 2008, HEART VESSELS, V23, P243, DOI 10.1007/s00380-007-1034-5; Wu AHB, 2005, AM J HEMATOL, V80, P174, DOI 10.1002/ajh.20456; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; Yu LM, 2015, STEM CELLS, V33, P240, DOI 10.1002/stem.1844	33	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2016	11	12							e0165511	10.1371/journal.pone.0165511	http://dx.doi.org/10.1371/journal.pone.0165511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MR	27918575	Green Published, gold, Green Submitted			2022-12-27	WOS:000389577100001
J	Wu, RD; Tang, S; Wang, M; Xu, XD; Yao, C; Wang, SM				Wu, Ridong; Tang, Shi; Wang, Mian; Xu, Xiangdong; Yao, Chen; Wang, Shenming			MicroRNA-497 Induces Apoptosis and Suppresses Proliferation via the Bcl-2/Bax-Caspase9-Caspase3 Pathway and Cyclin D2 Protein in HUVECs	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; BREAST-CANCER; OX-LDL; ATHEROSCLEROSIS; EXPRESSION; CASPASE-3	Introduction MicroRNAs play crucial roles in various types of diseases. However, to date, no information about the role of miR-497 in the development of atherosclerosis has been reported. This study investigated the possible role of miR-497 in vascular endothelial cell injury during the early stage of atherosclerosis. Materials and Methods The expression level of miR-497 in human umbilical vein endothelial cells (HUVECs) exposed to ox-LDL was detected using qRT-PCR. To perform gain of function and loss of function analyses, miR-497 mimics were transfected into HUVECs, and miR-497 inhibitors were transfected into HUVECs stimulated with ox-LDL. Flow cytometry was used to analyze cell cycle progression and apoptosis. EdU and CCK-8 assays were employed to detect DNA synthesis and cell proliferation, respectively. After bioinformatics prediction, a dual Luciferase Reporter assay was used to analyze the direct target genes of miR-497. The mRNA and protein levels of the target genes were detected using qRT-PCR and western blot analyses, respectively. Caspase-9/3 activity was analyzed to determine the mechanism of endothelial dysfunction. Results We showed that miR-497 was significantly upregulated in HUVECs stimulated with ox-LDL. Ectopic expression of miR-497 suppressed cell proliferation, induced apoptosis and increased the activity of caspase-9/3. After verification, Bcl2 and CCND2 were shown to be direct target genes of miR-497 in HUVECs. MiR-497 significantly suppressed cell proliferation by arresting the cell cycle through the CCND2 protein and induced apoptosis through the Bcl2/Bax-caspase9-caspase3 pathway. Conclusion Overall, our study shows that miR-497 might play a role in the development of atherosclerosis by inducing apoptosis and suppressing the proliferation of vascular endothelial cells. Therefore, miR-497 could be a potential therapeutic target for the treatment of atherosclerosis.	[Wu, Ridong; Wang, Mian; Xu, Xiangdong; Yao, Chen; Wang, Shenming] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Vasc Surg, Guangzhou, Guangdong, Peoples R China; [Tang, Shi] Dongguan Maternal & Children Hlth Hosp, Dept Breast Surg, Dongguan, Peoples R China	Sun Yat Sen University	Yao, C; Wang, SM (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Vasc Surg, Guangzhou, Guangdong, Peoples R China.	skywalker_chenyao@yahoo.com.cn; shenmingwang@hotmail.com						Cain K, 2002, BIOCHIMIE, V84, P203, DOI 10.1016/S0300-9084(02)01376-7; Caporali A, 2011, CIRCULATION, V123, P282, DOI 10.1161/CIRCULATIONAHA.110.952325; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; Chen K, 2012, BIOCHEM BIOPH RES CO, V427, P138, DOI 10.1016/j.bbrc.2012.09.026; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dong Q, 2013, BRAZ J MED BIOL RES, V46, P765, DOI 10.1590/1414-431X20132733; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Fu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043204; Gui DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039824; Guo ST, 2012, ONCOGENE, DOI DOI 10.3892/ETM.2011.428; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Kaufmann SH, 2008, METHODS, V44, P262, DOI 10.1016/j.ymeth.2007.11.005; Li HY, 2013, CELL PHYSIOL BIOCHEM, V32, P1354, DOI 10.1159/000356574; Li L, 2012, LAB INVEST, V92, P571, DOI 10.1038/labinvest.2012.10; Lia D, 2010, J HYPERTENS, V28, P1646, DOI 10.1097/HJH.0b013e32833a4922; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Liuzzo G, 2001, Rays, V26, P221; Luo QF, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-95; Maiolino G, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/714653; Marsden VS, 2002, NATURE, V419, P634, DOI 10.1038/nature01101; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Menghini R, 2009, CIRCULATION, V120, P1524, DOI 10.1161/CIRCULATIONAHA.109.864629; Mermelshtein A, 2005, BRIT J CANCER, V93, P338, DOI 10.1038/sj.bjc.6602709; Mudau M, 2012, CARDIOVASC J AFR, V23, DOI 10.5830/CVJA-2011-068; Olejarz W, 2013, EUR J CLIN INVEST; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Puissant C, 2013, J MAL VASC; Qin B, 2012, MOL BIOL REP, V39, P4509, DOI 10.1007/s11033-011-1241-0; Rahman M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026390; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Samson S, 2012, CHOLESTEROL, DOI 10.1155/2012/571846; Shan Z, 2013, CHINESE MED J-PEKING, V126, P515, DOI 10.3760/cma.j.issn.0366-6999.20122289; Shen L, 2012, EXP THER MED, V3, P475, DOI 10.3892/etm.2011.428; Sun XH, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0372-2; Tu YF, 2015, SCI REP-UK, V5, DOI 10.1038/srep13827; Vasa-Nicotera M, 2011, ATHEROSCLEROSIS, V217, P326, DOI 10.1016/j.atherosclerosis.2011.03.034; Vegran F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029058; Wang M, 2011, ARTERIOSCL THROM VAS, V31, P2046, DOI 10.1161/ATVBAHA.111.229559; Westhorpe CLV, 2012, EXP MOL PATHOL, V93, P220, DOI 10.1016/j.yexmp.2012.03.014; Zhang YF, 2013, INT J MOL SCI, V14, P22708, DOI 10.3390/ijms141122708; Zhou J, 2011, P NATL ACAD SCI USA, V108, P10355, DOI 10.1073/pnas.1107052108	41	62	75	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2016	11	12							e0167052	10.1371/journal.pone.0167052	http://dx.doi.org/10.1371/journal.pone.0167052			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MR	27918592	gold, Green Submitted, Green Published			2022-12-27	WOS:000389577100007
J	Bai, X; Liu, Y				Bai, Xu; Liu, Yun			International Collaboration Patterns and Effecting Factors of Emerging Technologies	PLOS ONE			English	Article							NETWORK; VISUALIZATION; CHALLENGES; INNOVATION; COUNTRY	With the globalization of the world economy, international innovation collaboration has taken place all over the world. This study selects three emerging technologies (3D printing, big data and carbon nanotubes and graphene technology) among 20 countries as the research objects, using three patent-based indicators and network relationship analysis to reflect international collaboration patterns. Then we integrate empirical analyses to show effecting factors of international collaboration degrees by using panel data. The results indicate that while 3D printing technology is associated with a "balanced collaboration" mode, big data technology is more accurately described by a radial pattern, centered on the United States, and carbon nanotubes and graphene technology exhibits "small-world" characteristics in this respect. It also shows that the factors GDP per capita (GPC), R&D expenditure (RDE) and the export of global trade value (ETV) negatively affect the level of international collaboration. It could be useful for China and other developing countries to make international scientific and technological collaboration strategies and policies in the future.	[Bai, Xu; Liu, Yun] Beijing Inst Technol, Sch Management & Econ, Beijing, Peoples R China	Beijing Institute of Technology	Bai, X (corresponding author), Beijing Inst Technol, Sch Management & Econ, Beijing, Peoples R China.	bx0723@126.com						Axelsson R, 2013, AMBIO, V42, P215, DOI 10.1007/s13280-012-0376-0; Baccarelli E, 2016, IEEE NETWORK, V30, P54, DOI 10.1109/MNET.2016.7437025; Boekholt P, 2009, DRIVERS INT COLLABOR, V40; Boutellier R., 2008, MANAGING GLOBAL INNO; Bozeman B, 2013, J TECHNOL TRANSFER, V38, P1, DOI 10.1007/s10961-012-9281-8; Bridges DR, 2011, MED EDUC ONLINE, V16, DOI 10.3402/meo.v16i0.6035; Butun I, 2016, IEEE COMMUN MAG, V54, P47, DOI 10.1109/MCOM.2016.7452265; Castellani D, 2013, J INT BUS STUD, V44, P649, DOI 10.1057/jibs.2013.30; Chen YS, 2010, TECHNOL ANAL STRATEG, V22, P153, DOI 10.1080/09537320903498496; Cimoli M, 2009, GCG REV GLOBALIZATIO, V3; Cordeschi N, 2015, EMERGING RES CLOUD D, V122; De Prato G, 2012, INT J TECHNOL MANAGE, P2; Dunning JH, 2015, ECLECTIC PARADIGM: A FRAMEWORK FOR SYNTHESIZING AND COMPARING THEORIES OF INTERNATIONAL BUSINESS FROM DIFFERENT DISCIPLINES OR PERSPECTIVES, P111; Fernhaber SA, 2013, J BUS VENTURING, V28, P316, DOI 10.1016/j.jbusvent.2012.05.002; Freeman L C., 2012, VISUALIZING SOCIAL N; Frost TS, 2005, J INT BUS STUD, V36, P676, DOI 10.1057/palgrave.jibs.8400168; Gassler H, 2008, J TECHNOL TRANSFER, V33, P407, DOI 10.1007/s10961-007-9048-9; Gazni A, 2012, J AM SOC INF SCI TEC, V63, P323, DOI 10.1002/asi.21688; Goryawala M, 2015, BIOMED PHYS ENG EXPR, V1, DOI 10.1088/2057-1976/1/1/015001; Grieneisen ML, 2014, BIOSCIENCE, V64, P322, DOI 10.1093/biosci/biu035; Guan JC, 2016, RES POLICY, V45, P770, DOI 10.1016/j.respol.2016.01.003; Guan JC, 2013, TECHNOL FORECAST SOC, V80, P1271, DOI 10.1016/j.techfore.2012.11.013; Guellec D, 2000, ECON LETT, V69, P109, DOI 10.1016/S0165-1765(00)00265-2; Hennemann S, 2012, J INFORMETR, V6, P217, DOI 10.1016/j.joi.2011.12.002; Ito D., 2016, ASS POLICY PROMOTION, P51; Jayasinghe M, 2016, ACAD MANAGE J, V59, P658, DOI 10.5465/amj.2014.0478; Jones B., 2012, NESTA COMPENDIUM EVI; Kim YG, 2008, EXPERT SYST APPL, V34, P1804, DOI 10.1016/j.eswa.2007.01.033; Knack S, 1997, Q J ECON, V112, P1251, DOI 10.1162/003355300555475; Liu YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044459; Ma J, 2015, INT J TECHNOL MANAGE, V69, P210, DOI 10.1504/IJTM.2015.072972; Ma ZZ, 2009, TECHNOL FORECAST SOC, V76, P787, DOI 10.1016/j.techfore.2008.11.003; Mazor T, 2013, DIVERS DISTRIB, V19, P1380, DOI 10.1111/ddi.12095; Meijer I C., 2012, JOURNALISM, V8, P1; Mittal G, 2015, J IND ENG CHEM, V21, P11, DOI 10.1016/j.jiec.2014.03.022; Montobbio F, 2013, WORLD DEV, V44, P281, DOI 10.1016/j.worlddev.2012.11.017; Myers SA, 2014, WWW'14 COMPANION: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P493, DOI 10.1145/2567948.2576939; Narula R., 2014, GLOBALIZATION TECHNO; Nepelski D, 2015, TECHNOVATION, V35, P12, DOI 10.1016/j.technovation.2014.07.007; Peters B, 2011, 11002 ZEW CTR EUR EC, P11; Phaal R, 2011, TECHNOL FORECAST SOC, V78, P217, DOI 10.1016/j.techfore.2010.06.018; RAMSEY JB, 1969, J ROY STAT SOC B, V31, P350; Ruigrok W., 2013, LOGIC INT RESTRUCTUR; Santos M.E.R., 2013, INT J TECHNOLOGY MAN, V12, P89, DOI DOI 10.1386/tmsd.12.1.89_1; Schwab Klaus, 2015, 4 IND REVOLUTION WHA; Shapira P, 2015, GRAPHENE RES ENTERPR; Sun YC, 2016, IEEE ACCESS, V4, P766, DOI 10.1109/ACCESS.2016.2529723; Trench B, 2014, ROUT INT HANDB, P214; Trifilova A, 2013, CRIT PERSPECT INT BU, V9, P40, DOI 10.1108/17422041311299932; Tseng CY, 2009, TECHNOL FORECAST SOC, V76, P654, DOI 10.1016/j.techfore.2008.03.007; Vessuri H, 2013, CURR SOCIOL, P1; Wang CQ, 2012, INT BUS REV, V21, P425, DOI 10.1016/j.ibusrev.2011.05.004; Wang XF, 2014, J INFORMETR, V8, P854, DOI 10.1016/j.joi.2014.08.004; Wang YAD, 2013, INT BUS REV, V22, P1079, DOI 10.1016/j.ibusrev.2013.02.009; Wilson J, 2008, INFECT CONT HOSP EP, V29, P219, DOI 10.1086/527511; Wohlers T., 2014, 3D PRINTING ADDITIVE; Yoon B, 2010, TECHNOL ANAL STRATEG, V22, P377, DOI 10.1080/09537321003647438; Zheng J, 2014, SCIENTOMETRICS, V98, P683, DOI 10.1007/s11192-013-1081-x; Zheng J, 2012, SCIENTOMETRICS, V91, P65, DOI 10.1007/s11192-011-0529-0	59	22	23	9	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167772	10.1371/journal.pone.0167772	http://dx.doi.org/10.1371/journal.pone.0167772			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3TF	27911926	gold, Green Published, Green Submitted			2022-12-27	WOS:000389520600052
J	de Vries, S; Gerrits, WJJ; Kabel, MA; Vasanthan, T; Zijlstra, RT				de Vries, Sonja; Gerrits, Walter J. J.; Kabel, Mirjam A.; Vasanthan, Thava; Zijlstra, Ruurd T.			beta-Glucans and Resistant Starch Alter the Fermentation of Recalcitrant Fibers in Growing Pigs	PLOS ONE			English	Article							DIETARY FIBER; NONSTARCH POLYSACCHARIDES; GASTROINTESTINAL IMPLICATIONS; ENDOGENOUS NITROGEN; OAT FRACTIONS; DIGESTIBILITY; ILEAL; WHEAT; APPARENT; PROTEIN	Interactions among dietary ingredients are often assumed non-existent when evaluating the nutritive value and health effects of dietary fiber. Specific fibers can distinctly affect digestive processes; therefore, digestibility and fermentability of the complete diet may depend on fiber types present. This study aimed to evaluate the effects of readily fermentable fibers (beta-lucans and resistant starch) on the degradation of feed ingredients containing more persistent, recalcitrant, fibers. Six semi-synthetic diets with recalcitrant fibers from rapeseed meal (pectic polysaccharides, xyloglucans, and cellulose) or corn distillers dried grain with solubles (DDGS; (glucurono) arabinoxylans and cellulose) with or without inclusion of beta-glucans (6%) or retrograded tapioca (40%) substituted for corn starch were formulated. Six ileal-cannulated pigs (BW 28 +/- 1.4 kg) were assigned to the diets according to a 6x6 Latin square. beta-glucan- extract increased apparent total tract digestibility (ATTD) of non-glucosyl polysaccharides (accounting for similar to 40% of the fiber-fraction) from rapeseed meal (6%-units, P<0.001), but did not affect non-glucosyl polysaccharides from DDGS. Retrograded tapioca reduced ATTD of non-glucosyl polysaccharides from rapeseed meal and DDGS (>10%units, P<0.001), indicating that the large amount of resistant starch entering the hindgut was preferentially degraded over recalcitrant fibers from rapeseed meal and DDGS, possibly related to reduced hindgut-retention time following the increased intestinal bulk. Fermentation of fiber sources was not only dependent on fiber characteristics, but also on the presence of other fibers in the diet. Hence, interactions in the gastrointestinal tract among fibrous feed ingredients should be considered when evaluating their nutritive value.	[de Vries, Sonja; Gerrits, Walter J. J.] Wageningen Univ, Anim Nutr Grp, Wageningen, Netherlands; [Kabel, Mirjam A.] Wageningen Univ, Food Chem Lab, Wageningen, Netherlands; [Vasanthan, Thava; Zijlstra, Ruurd T.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada	Wageningen University & Research; Wageningen University & Research; University of Alberta	de Vries, S (corresponding author), Wageningen Univ, Anim Nutr Grp, Wageningen, Netherlands.	sonja.devries@wur.nl	de Vries, Sonja/M-1211-2019; Kabel, Mirjam/M-1051-2016	de Vries, Sonja/0000-0002-3842-8411; Kabel, Mirjam/0000-0002-2787-7852	European Union; European Regional Development Fund; Ministry of Economic Affairs, Agriculture and Innovation; Pieken in the Delta; Municipality of Groningen; Province of Groningen; Dutch Carbohydrate Competence Center (CCC WP7) - Agrifirm Group; Duynie Holding; Nutreco Nederland B.V.; University of Alberta; Wageningen University	European Union(European Commission); European Regional Development Fund(European Commission); Ministry of Economic Affairs, Agriculture and Innovation; Pieken in the Delta; Municipality of Groningen; Province of Groningen; Dutch Carbohydrate Competence Center (CCC WP7) - Agrifirm Group; Duynie Holding; Nutreco Nederland B.V.; University of Alberta(University of Alberta); Wageningen University(European Commission)	This work was jointly financed by the European Union (europa.eu), European Regional Development Fund (ec.europa.eu/regional_policy/en/funding/erdf/) and The Ministry of Economic Affairs, Agriculture and Innovation (https://www.rijksoverheid.nl/ministeries/ministerie-van-economische-zaken), Pieken in the Delta (www.rvo.nl/subsidies-regelingen/pieken-de-delta), the Municipality of Groningen (https://gemeentegroningen.nl), the Province of Groningen (www.provinciegroningen.nl) as well as the Dutch Carbohydrate Competence Center (CCC WP7, www.cccresearch.nl), supported by Agrifirm Group (www.agrifirm.com), Duynie Holding (www.duynie.nl), Nutreco Nederland B.V. (www.nutreco.com), University of Alberta (https://ualberta.ca), and Wageningen University (www.wageningenur.nl). Except for the University of Alberta and Wageningen University, funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, APPL ENVIRON MICROB, V60, P1897; [Anonymous], 2004, NUTR REV, V62, P105; AOAC, 2005, OFF METH AN, V18th; Appeldoorn MM, 2010, J AGR FOOD CHEM, V58, P11294, DOI 10.1021/jf102849x; Bach Knudsen KE, BR J NUTR; Bartelt J, 2002, ARCH ANIM NUTR, V56, P93, DOI 10.1080/00039420214182; Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; Buttriss JL, 2008, NUTR BULL, V33, P186, DOI 10.1111/j.1467-3010.2008.00705.x; Canibe N, 1997, ANIM FEED SCI TECH, V64, P293, DOI 10.1016/S0377-8401(96)01032-2; Chan HT, 2011, FOOD CHEM, V126, P1019, DOI 10.1016/j.foodchem.2010.11.113; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; CVB, 2011, FEED TABL; da Silva CS, 2014, ANIMAL, V8, P1917, DOI 10.1017/S1751731114001840; de Vries S, 2014, J ANIM SCI, V92, P5496, DOI 10.2527/jas.2014-7596; de Vries S, 2014, POULTRY SCI, V93, P589, DOI 10.3382/ps.2013-03476; de Vries S, 2012, ANIM FEED SCI TECH, V178, P123, DOI 10.1016/j.anifeedsci.2012.10.004; DeVries JW, 2004, J AOAC INT, V87, P682; Elia M, 2007, EUR J CLIN NUTR, V61, pS40, DOI 10.1038/sj.ejcn.1602938; ENGLYST HN, 1994, ANALYST, V119, P1497, DOI 10.1039/an9941901497; ENGLYST HN, 1984, ANALYST, V109, P937, DOI 10.1039/an9840900937; FADEL JG, 1989, J NUTR, V119, P722, DOI 10.1093/jn/119.5.722; FADEL JG, 1988, CAN J ANIM SCI, V68, P891, DOI 10.4141/cjas88-098; Fledderus J, 2007, LIVEST SCI, V109, P89, DOI 10.1016/j.livsci.2007.01.086; GRAHAM H, 1989, J ANIM SCI, V67, P1293; Grala W, 1998, J ANIM SCI, V76, P557; Heijnen MLA, 1997, J NUTR, V127, P1828, DOI 10.1093/jn/127.9.1828; Huisman MMH, 2000, CARBOHYD POLYM, V43, P269, DOI 10.1016/S0144-8617(00)00154-5; ISO, 2009, 5983 ISO; Johansen HN, 1996, BRIT J NUTR, V75, P339, DOI 10.1079/BJN19960138; Johansen HN, 1997, J SCI FOOD AGR, V73, P81, DOI 10.1002/(SICI)1097-0010(199701)73:1&lt;81::AID-JSFA695&gt;3.0.CO;2-Z; Jonathan MC, 2013, CARBOHYD POLYM, V93, P232, DOI 10.1016/j.carbpol.2012.06.057; Jorgensen H, 1996, BRIT J NUTR, V75, P365, DOI 10.1079/BJN19960140; Kil DY, 2010, J ANIM SCI, V88, P2959, DOI 10.2527/jas.2009-2216; Kim Y, 2008, BIORESOURCE TECHNOL, V99, P5165, DOI 10.1016/j.biortech.2007.09.028; Knudsen KEB, 2000, J SCI FOOD AGR, V80, P1253, DOI 10.1002/1097-0010(200006)80:8&lt;1253::AID-JSFA632&gt;3.0.CO;2-0; KNUDSEN KEB, 1991, BRIT J NUTR, V65, P233, DOI 10.1079/BJN19910083; KNUDSEN KEB, 1991, BRIT J NUTR, V65, P217, DOI 10.1079/BJN19910082; Knudsen KEB, 1997, ANIM FEED SCI TECH, V67, P319, DOI 10.1016/S0377-8401(97)00009-6; Knudsen KEB, 2001, ANIM FEED SCI TECH, V90, P3, DOI 10.1016/S0377-8401(01)00193-6; Knudsen KEB, 2007, J SCI FOOD AGR, V87, P2399, DOI 10.1002/jsfa.2893; KOHLER T, 1990, J SCI FOOD AGR, V53, P465, DOI 10.1002/jsfa.2740530405; Kotb A R, 1972, Nutr Abstr Rev, V42, P813; MANTLE M, 1981, BIOCHEM J, V195, P267, DOI 10.1042/bj1950267; Martinez-Puig D, 2003, J NUTR, V133, P134, DOI 10.1093/jn/133.1.134; McDonald DE, 2001, BRIT J NUTR, V86, P487, DOI 10.1079/BJN2001416; MERRY RJ, 1983, BRIT J NUTR, V50, P701, DOI 10.1079/BJN19830142; Metzler-Zebeli BU, 2010, LIVEST SCI, V133, P95, DOI 10.1016/j.livsci.2010.06.033; Montagne L, 2003, ANIM FEED SCI TECH, V108, P95, DOI 10.1016/S0377-8401(03)00163-9; Montoya CA, 2016, NUTR REV, V74, P517, DOI 10.1093/nutrit/nuw014; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Nindjin C, 2011, CARBOHYD POLYM, V86, P1637, DOI 10.1016/j.carbpol.2011.06.076; Nugent AP, 2005, NUTR BULL, V30, P27, DOI 10.1111/j.1467-3010.2005.00481.x; Olfert E, 1993, GUID CAR US EXP AN; Owusu-Asiedu A, 2006, J ANIM SCI, V84, P843, DOI 10.2527/2006.844843x; Pustjens AM, 2014, IND CROP PROD, V58, P271, DOI 10.1016/j.indcrop.2014.04.036; Pustjens AM, 2013, CARBOHYD POLYM, V98, P1650, DOI 10.1016/j.carbpol.2013.07.059; Pustjens AM, 2012, J AGR FOOD CHEM, V60, P8257, DOI 10.1021/jf301160m; Richards JD, 2005, CAN J ANIM SCI, V85, P421, DOI 10.4141/A05-049; Sandstrom B, 1998, BR J NUTR, V80, P457; Slavin J, 2013, NUTRIENTS, V5, P1417, DOI 10.3390/nu5041417; Theil PK, 2009, BR J NUTR, V102, P1590, DOI 10.1017/S0007114509980824; THIBAULT JF, 1979, LEBENSM WISS TECHNOL, V12, P247; Urriola PE, 2010, J ANIM SCI, V88, P2373, DOI 10.2527/jas.2009-2227; Widmer MR, 2007, J ANIM SCI, V85, P2994, DOI 10.2527/jas.2006-840; Wilfart A, 2007, BRIT J NUTR, V98, P54, DOI 10.1017/S0007114507682981; WILLIAMS CH, 1962, J AGR SCI, V59, P381, DOI 10.1017/S002185960001546X	66	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167624	10.1371/journal.pone.0167624	http://dx.doi.org/10.1371/journal.pone.0167624			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911928	Green Published, gold, Green Submitted			2022-12-27	WOS:000389520600048
J	Klein, M; Teixeira, S; Assis, J; Serrao, EA; Goncalves, EJ; Borges, R				Klein, Maria; Teixeira, Sara; Assis, Jorge; Serrao, Ester A.; Goncalves, Emanuel J.; Borges, Rita			High Interannual Variability in Connectivity and Genetic Pool of a Temperate Clingfish Matches Oceanographic Transport Predictions	PLOS ONE			English	Article							CORAL-REEF FISH; MICROSATELLITE NULL ALLELES; PELAGIC LARVAL DURATION; SELF-RECRUITMENT; POPULATION CONNECTIVITY; MARINE POPULATIONS; PARENTAGE ANALYSIS; LEPADOGASTER-LEPADOGASTER; ASSIGNMENT METHODS; TELL US	Adults of most marine benthic and demersal fish are site-attached, with the dispersal of their larval stages ensuring connectivity among populations. In this study we aimed to infer spatial and temporal variation in population connectivity and dispersal of a marine fish species, using genetic tools and comparing these with oceanographic transport. We focused on an intertidal rocky reef fish species, the shore clingfish Lepadogaster lepadogaster, along the southwest Iberian Peninsula, in 2011 and 2012. We predicted high levels of self-recruitment and distinct populations, due to short pelagic larval duration and because all its developmental stages have previously been found near adult habitats. Genetic analyses based on microsatellites countered our prediction and a biophysical dispersal model showed that oceanographic transport was a good explanation for the patterns observed. Adult sub-populations separated by up to 300 km of coastline displayed no genetic differentiation, revealing a single connected population with larvae potentially dispersing long distances over hundreds of km. Despite this, parentage analysis performed on recruits from one focal site within the Marine Park of Arrabida (Portugal), revealed self-recruitment levels of 2.5% and 7.7% in 2011 and 2012, respectively, suggesting that both long-and short-distance dispersal play an important role in the replenishment of these populations. Population differentiation and patterns of dispersal, which were highly variable between years, could be linked to the variability inherent in local oceanographic processes. Overall, our measures of connectivity based on genetic and oceanographic data highlight the relevance of long-distance dispersal in determining the degree of connectivity, even in species with short pelagic larval durations.	[Klein, Maria; Teixeira, Sara; Assis, Jorge; Serrao, Ester A.; Borges, Rita] Univ Algarve, CCMAR Ctr Marine Sci, Campus Gambelas, P-8005 ~139 Faro, Portugal; [Klein, Maria; Goncalves, Emanuel J.; Borges, Rita] ISPA Inst Univ, MARE Marine & Environm Sci Ctr, R Jardim do Tabaco 34, P-1149 ~041 Lisbon, Portugal	Universidade do Algarve; Instituto Superior Psicologia Aplicada (ISPA)	Borges, R (corresponding author), Univ Algarve, CCMAR Ctr Marine Sci, Campus Gambelas, P-8005 ~139 Faro, Portugal.; Borges, R (corresponding author), ISPA Inst Univ, MARE Marine & Environm Sci Ctr, R Jardim do Tabaco 34, P-1149 ~041 Lisbon, Portugal.	rborges@ispa.pt	Serrao, Ester A/C-6686-2012; Assis, Jorge/AAC-6524-2019; Klein, Maria/M-4170-2013	Serrao, Ester A/0000-0003-1316-658X; Assis, Jorge/0000-0002-6624-4820; Goncalves, Emanuel/0000-0002-3918-6215; Borges, Rita/0000-0001-6887-6605; Klein, Maria/0000-0003-0818-7191	Portuguese Foundation for Science and Technology (FCT) [SFRH/BD/72970/2010]; FCT project [EXPL/MAR-PRO/0933/2013, EXCL/AAG-GLO/0661/2012, SFRH/BPD/111003/2015]; FCT postdoctoral fellowship [SFRH/ BPD / 23743 / 2005]; FCT [PTDC/MAR/115226/2009, CCMAR/Multi/04326/2013, PEst-OE/MAR/U10331/2011, UID/MAR/04292/2013]; Fundação para a Ciência e a Tecnologia [EXPL/MAR-PRO/0933/2013, PTDC/MAR/115226/2009] Funding Source: FCT	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT project(Portuguese Foundation for Science and Technology); FCT postdoctoral fellowship(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	MK was supported by a PhD grant (SFRH/BD/72970/2010) from the Portuguese Foundation for Science and Technology (FCT). ST was supported by the FCT project EXPL/MAR-PRO/0933/2013. JA was supported by the FCT project EXCL/AAG-GLO/0661/2012 and a postdoctoral fellowship SFRH/BPD/111003/2015. RB was supported by a FCT postdoctoral fellowship (SFRH/ BPD / 23743 / 2005). Field and lab work were financed by the following FCT funded projects: Matrix (PTDC/MAR/115226/2009), CCMAR/Multi/04326/2013, and PEst-OE/MAR/U10331/2011 and UID/MAR/04292/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto F., 2006, STANDARICH V1 00 R P; [Anonymous], 2009, R LANG ENV STAT COMP; [Anonymous], 1996, 5000 CNRS UMR; [Anonymous], 2015, OC DAT; Assis J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128124; Assis J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068646; Beldade R, 2007, J FISH BIOL, V71, P376, DOI 10.1111/j.1095-8649.2007.01491.x; Beldade R, 2006, J MAR BIOL ASSOC UK, V86, P1221, DOI 10.1017/S0025315406014226; Beldade R, 2012, P ROY SOC B-BIOL SCI, V279, P2116, DOI 10.1098/rspb.2011.2433; Beldade R, 2006, J PLANKTON RES, V28, P1003, DOI 10.1093/plankt/fbl035; BLAXTER JHS, 1986, T AM FISH SOC, V115, P98; Borges R, 2007, MAR BIOL, V151, P1349, DOI 10.1007/s00227-006-0574-z; Borges R, 2007, ESTUAR COAST SHELF S, V71, P412, DOI 10.1016/j.ecss.2006.08.020; Botsford LW, 2009, CORAL REEFS, V28, P327, DOI 10.1007/s00338-009-0466-z; Burgess SC, 2014, ECOL APPL, V24, P257, DOI 10.1890/13-0710.1; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chassignet EP, 2007, J MARINE SYST, V65, P60, DOI 10.1016/j.jmarsys.2005.09.016; Christie MR, 2010, MOL ECOL, V19, P1042, DOI 10.1111/j.1365-294X.2010.04524.x; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Eckert GL, 2003, ECOLOGY, V84, P372, DOI 10.1890/0012-9658(2003)084[0372:EOTPPO]2.0.CO;2; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Faria AM, 2010, MAR ECOL PROG SER, V414, P237, DOI 10.3354/meps08692; Felix-Hackradt FC, 2013, MAR ENVIRON RES, V92, P23, DOI 10.1016/j.marenvres.2013.08.008; Fisher R, 2005, MAR ECOL PROG SER, V285, P223, DOI 10.3354/meps285223; Fontes J, 2009, MAR ECOL PROG SER, V387, P51, DOI 10.3354/meps08116; Fossette S, 2012, MAR ECOL PROG SER, V457, P285, DOI 10.3354/meps09581; Galarza JA, 2009, P NATL ACAD SCI USA, V106, P1473, DOI 10.1073/pnas.0806804106; Gawarkiewicz G, 2007, OCEANOGRAPHY, V20, P40, DOI 10.5670/oceanog.2007.28; Gerlach G, 2007, P NATL ACAD SCI USA, V104, P858, DOI 10.1073/pnas.0606777104; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; Goncalves DM, 1998, J FISH BIOL, V53, P447, DOI 10.1111/j.1095-8649.1998.tb00992.x; HEDGECOCK D, 1994, CAL COOP OCEAN FISH, V35, P73; Henriques M, 2002, BIOL J LINN SOC, V76, P327, DOI 10.1111/j.1095-8312.2002.tb01700.x; Hofrichter R., 1995, THESIS; Hogan JD, 2012, OECOLOGIA, V168, P61, DOI 10.1007/s00442-011-2058-1; Hogan JD, 2010, MAR ECOL PROG SER, V417, P263, DOI 10.3354/meps08793; Horne JB, 2011, MOL ECOL, V20, P2291, DOI 10.1111/j.1365-294X.2011.05097.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jenkins GP, 1999, MAR ECOL PROG SER, V184, P259, DOI 10.3354/meps184259; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; Jones DB, 2010, CORAL REEFS, V29, P455, DOI 10.1007/s00338-010-0591-8; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Keough Michael J., 2007, P19; Kingsford MJ, 2002, B MAR SCI, V70, P309; Largier JL, 2003, ECOL APPL, V13, pS71; Leis JM, 2003, MAR ECOL PROG SER, V252, P239, DOI 10.3354/meps252239; Leis JM, 2011, OCEANOGRAPHY MARINE; Lett C, 2008, ENVIRON MODELL SOFTW, V23, P1210, DOI 10.1016/j.envsoft.2008.02.005; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; MILLER TJ, 1988, CAN J FISH AQUAT SCI, V45, P1657, DOI 10.1139/f88-197; Nanninga GB, 2015, CORAL REEFS, V34, P383, DOI 10.1007/s00338-015-1266-2; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; Paris CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072808; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; Purcell JFH, 2006, P ROY SOC B-BIOL SCI, V273, P1483, DOI 10.1098/rspb.2006.3470; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Raventos N, 2001, MAR BIOL, V138, P1115; Relvas P, 2007, PROG OCEANOGR, V74, P149, DOI 10.1016/j.pocean.2007.04.021; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Saenz-Agudelo P, 2009, MOL ECOL, V18, P1765, DOI 10.1111/j.1365-294X.2009.04109.x; Saenz-Agudelo P, 2012, MOL ECOL, V21, P4695, DOI 10.1111/j.1365-294X.2012.05726.x; Schunter C, 2011, MOL ECOL, V20, P5167, DOI 10.1111/j.1365-294X.2011.05355.x; Selkoe KA, 2006, ECOLOGY, V87, P3082, DOI 10.1890/0012-9658(2006)87[3082:CSAKAE]2.0.CO;2; Selkoe KA, 2010, MOL ECOL, V19, P3708, DOI 10.1111/j.1365-294X.2010.04658.x; Shanks AL, 2009, BIOL BULL-US, V216, P373; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; Silva G, 2014, J BIOGEOGR, V41, P1171, DOI 10.1111/jbi.12275; Simpson SD, 2014, PLOS ONE, DOI [10.1371/journal.pone.0107610ER, DOI 10.1371/JOURNAL.PONE.0107610ER]; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Swearer SE, 2010, MAR ECOL PROG SER, V417, P229, DOI 10.3354/meps08801; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; Teixeira S, 2013, CONSERV GENET RESOUR, V5, P55, DOI 10.1007/s12686-012-9732-4; Thorrold SR, 2006, CAN J FISH AQUAT SCI, V63, P1193, DOI 10.1139/F06-048; Tojeira I, 2012, ENVIRON BIOL FISH, V93, P449, DOI 10.1007/s10641-011-9935-7; Underwood JN, 2012, ECOL EVOL, V2, P666, DOI 10.1002/ece3.80; Van Etten J, 2014, GDISTANCE DISTANCES; Wang JL, 2010, MOL ECOL, V19, P5061, DOI 10.1111/j.1365-294X.2010.04865.x; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Waser PM, 2011, MOL ECOL, V20, P1277, DOI 10.1111/j.1365-294X.2011.05002.x; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; WILLIAMS DM, 1984, CORAL REEFS, V3, P229, DOI 10.1007/BF00288259	93	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0165881	10.1371/journal.pone.0165881	http://dx.doi.org/10.1371/journal.pone.0165881			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911952	gold, Green Published			2022-12-27	WOS:000389520600004
J	Veiga, DF; Damasceno, CAV; Veiga, J; Paiva, LF; Fonseca, FEM; Cabral, IV; Pinto, NLL; Juliano, Y; Ferreira, LM				Veiga, Daniela Francescato; Veiga Damasceno, Carlos Americo; Veiga-Filho, Joel; Paiva, Luiz Francisley; Martins Fonseca, Fernando Elias; Cabral, Isaias Vieira; Larcher Pinto, Natalia Lana; Juliano, Yara; Ferreira, Lydia Masako			Dressing Wear Time after Breast Reconstruction: A Randomized Clinical Trial	PLOS ONE			English	Article							SURGICAL SITE INFECTIONS; PROPHYLACTIC POSTOPERATIVE ANTIBIOTICS; WOUND DRESSINGS; TISSUE EXPANDER; RISK-FACTORS; SURGERY; CARE; CHLORHEXIDINE; MASTECTOMY; PREVENTION	Background The evidence to support dressing standards for breast surgery wounds is empiric and scarce. Objective This two-arm randomized clinical trial was designed to assess the effect of dressing wear time on surgical site infection (SSI) rates, skin colonization and patient perceptions. Methods A total of 200 breast cancer patients undergoing breast reconstruction were prospectively enrolled. Patients were randomly allocated to group I (dressing removed on the first postoperative day, n = 100) or group II (dressing removed on the sixth postoperative day, n = 100). SSIs were defined and classified according to criteria from the Centers for Disease Control and Prevention. Samples collected before placing the dressing and after 1 day (group I) and 6 days (both groups) were cultured for skin colonization assessments. Patients preferences and perceptions with regard to safety, comfort and convenience were recorded and analyzed. Results A total of 186 patients completed the follow-up. The global SSI rate was 4.5%. Six patients in group I and three in group II had SSI (p = 0.497). Before dressing, the groups were similar with regard to skin colonization. At the sixth day, there was a higher colonization by coagulase-negative staphylococci in group I (p < 0.0001). Patients preferred to keep dressing for six days (p < 0.0001), and considered this a safer choice (p < 0.05). Conclusions Despite group I had a higher skin colonization by coagulase-negative staphylococci on the sixth postoperative day, there was no difference in SSI rates. Patients preferred keeping dressing for six days and considered it a safer choice.	[Veiga, Daniela Francescato; Ferreira, Lydia Masako] Univ Fed Sao Paulo, Dept Surg, Div Plast Surg, Sao Paulo, SP, Brazil; [Veiga, Daniela Francescato; Veiga-Filho, Joel; Martins Fonseca, Fernando Elias; Cabral, Isaias Vieira; Larcher Pinto, Natalia Lana] Univ Vale Sapucai, Dept Surg, Div Plast Surg, Pouso Alegre, MG, Brazil; [Veiga Damasceno, Carlos Americo; Paiva, Luiz Francisley] Univ Vale Sapucai, Dept Microbiol, Pouso Alegre, MG, Brazil; [Juliano, Yara] Univ Vale Sapucai, Dept Bioestat, Pouso Alegre, MG, Brazil; [Juliano, Yara] Univ Fed Sao Paulo, Dept Bioestat, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade do Vale do Sapucai (UNIVAS); Universidade do Vale do Sapucai (UNIVAS); Universidade do Vale do Sapucai (UNIVAS); Universidade Federal de Sao Paulo (UNIFESP)	Veiga, DF (corresponding author), Univ Fed Sao Paulo, Dept Surg, Div Plast Surg, Sao Paulo, SP, Brazil.; Veiga, DF (corresponding author), Univ Vale Sapucai, Dept Surg, Div Plast Surg, Pouso Alegre, MG, Brazil.	danielafveiga@gmail.com	Juliano, Yára/AAQ-3043-2020; Veiga, Daniela Francescato/I-9790-2014; Ferreira, Lydia Masako/B-7511-2012	, Luiz Francisley de Paiva/0000-0001-6497-7468; Veiga, Daniela Francescato/0000-0002-8713-2940; Juliano, Yara/0000-0003-2894-0208	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq, Brazil [480644/2011-0]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais-FAPEMIG, Brazil [PRI-00018-13]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais-FAPEMIG, Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq, Brazil, Grant number: 480644/2011-0, http://www.cnpq.br/web/guest/geral; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais-FAPEMIG, Brazil, Grant number: PRI-00018-13, http://www.fapemig.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Benna S, 2007, PLAST RECONSTR SURG, V119, P1634, DOI 10.1097/01.prs.0000256492.85079.2e; Alvarez JM, 2005, ANZ J SURG, V75, P179, DOI 10.1111/j.1445-2197.2005.03320.x; Anderson DJ, 2014, INFECT CONT HOSP EP, V35, P605, DOI [10.1086/676022, 10.1017/S0899823X00193869]; Anderson DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008305; Anderson DJ, 2009, INFECT DIS CLIN N AM, V23, P53, DOI 10.1016/j.idc.2008.10.004; CHRINTZ H, 1989, BRIT J SURG, V76, P204, DOI 10.1002/bjs.1800760232; Degnim AC, 2014, ANN SURG ONCOL, V21, P3240, DOI 10.1245/s10434-014-3918-9; Dustagheer S, 2009, BREAST J, V15, P214, DOI 10.1111/j.1524-4741.2009.00705.x; Edwards BL, 2014, ANN SURG ONCOL, V21, P3249, DOI 10.1245/s10434-014-3960-7; Eroglu Aydan, 2014, J Clin Med Res, V6, P30, DOI 10.4021/jocmr1642w; Grundfest-Broniatowski S, 2013, GLAND SURG, V2, P56, DOI 10.3978/j.issn.2227-684X.2013.05.01; Gulluoglu BM, 2013, ANN SURG, V257, P37, DOI 10.1097/SLA.0b013e31826d832d; Heal C, 2006, BMJ-BRIT MED J, V332, P1053, DOI 10.1136/bmj.38800.628704.AE; Holm C, 1998, EUR J SURG, V164, P179; HORAN TC, 1992, AM J INFECT CONTROL, V20, P271, DOI 10.1016/S0196-6553(05)80201-9; Janis JE, 2010, PLAST RECONSTR SURG, V125, p230E, DOI 10.1097/PRS.0b013e3181d9a0d1; Jones DJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005360.pub4; Jones Vanessa J, 2006, Int Wound J, V3, P79, DOI 10.1111/j.1742-4801.2006.00215.x; Kato H, 2013, BREAST J, V19, P618, DOI 10.1111/tbj.12175; Khansa I, 2014, PLAST RECONSTR SURG, V134, P11, DOI 10.1097/PRS.0000000000000261; Korol E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083743; Lionelli GT, 2003, SURG CLIN N AM, V83, P617, DOI 10.1016/S0039-6109(02)00192-5; Malay S, 2013, CLIN PLAST SURG, V40, P261, DOI 10.1016/j.cps.2012.10.002; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Mendes DD, 2015, TRIALS, V16, DOI 10.1186/s13063-014-0529-5; Mlodinow AS, 2013, ANN PLAS SURG, V71, P335, DOI 10.1097/SAP.0b013e3182a0df25; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Mukhtar RA, 2009, AM J SURG, V198, P529, DOI 10.1016/j.amjsurg.2009.06.006; Olsen MA, 2008, ARCH SURG-CHICAGO, V143, P53, DOI 10.1001/archsurg.2007.11; Paddle-Ledinek JE, 2006, PLAST RECONSTR SURG, V117, p110S, DOI 10.1097/01.prs.0000225439.39352.ce; Phillips BT, 2016, J AM COLL SURGEONS, V222, P1116, DOI 10.1016/j.jamcollsurg.2016.02.018; Phillips BT, 2016, PLAST RECONSTR SURG; Pittet B, 2005, LANCET INFECT DIS, V5, P94, DOI 10.1016/S1473-3099(05)01281-8; Rosenfeldt FL, 2003, ANN THORAC SURG, V75, P101, DOI 10.1016/S0003-4975(02)04121-8; Segers P, 2007, WOUND REPAIR REGEN, V15, P192, DOI 10.1111/j.1524-475X.2007.00204.x; Siegel S, 2006, NONPARAMETRIC STAT B, V2; Sircar T, 2010, ANN ROY COLL SURG, V92, P439, DOI 10.1308/003588410X12699663903719d; Sticha R S, 1998, J Foot Ankle Surg, V37, P286; Trabulsi LR, 2005, MICROBIOLOGIA, V4th; Tran CL, 2003, AM SURGEON, V69, P852; Veiga DF, 2008, PLAST RECONSTR SURG, V122, p170E, DOI 10.1097/PRS.0b013e318186cd7f; Veiga DF, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-58; Veiga DF, 2009, INFECT CONT HOSP EP, V30, P77, DOI 10.1086/592980; Veiga J, 2012, PLAST RECONSTR SURG, V129, p1E, DOI 10.1097/PRS.0b013e3182361ee9; Vilar-Compte D, 2006, INFECT CONT HOSP EP, V27, P829, DOI 10.1086/506395; Viola GM, 2014, INFECT CONT HOSP EP, V35, P75, DOI 10.1086/674390; Wynne R, 2004, CHEST, V125, P43, DOI 10.1378/chest.125.1.43; Xue DQ, 2012, EJSO-EUR J SURG ONC, V38, P375, DOI 10.1016/j.ejso.2012.02.179; Yao KH, 2013, AUST FAM PHYSICIAN, V42, P867	49	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0166356	10.1371/journal.pone.0166356	http://dx.doi.org/10.1371/journal.pone.0166356			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911904	Green Published, Green Submitted, gold			2022-12-27	WOS:000389520600006
J	Busschaert, C; Ridgers, ND; De Bourdeaudhuij, I; Cardon, G; Van Cauwenberg, J; De Cocker, K				Busschaert, Cedric; Ridgers, Nicola D.; De Bourdeaudhuij, Ilse; Cardon, Greet; Van Cauwenberg, Jelle; De Cocker, Katrien			Socio-Demographic, Social-Cognitive, Health-Related and Physical Environmental Variables Associated with Context-Specific Sitting Time in Belgian Adolescents: A One-Year Follow-Up Study	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; SCREEN TIME; HOME-ENVIRONMENT; LMS METHOD; YOUTH; DEPRESSION; ADULTHOOD; REDUCE; DETERMINANTS; PREDICTORS	Introduction More knowledge is warranted about multilevel ecological variables associated with contextspecific sitting time among adolescents. The present study explored cross-sectional and longitudinal associations of ecological domains of sedentary behaviour, including sociodemo graphic, social-cognitive, health-related and physical-environmental variables with sitting during TV viewing, computer use, electronic gaming and motorized transport among adolescents. Methods For this longitudinal study, a sample of Belgian adolescents completed questionnaires at school on context-specific sitting time and associated ecological variables. At baseline, complete data were gathered from 513 adolescents (15.0 +/- 1.7 years). At one-year follow-up, complete data of 340 participants were available (retention rate: 66.3%). Multilevel linear regression analyses were conducted to explore cross-sectional correlates (baseline variables) and longitudinal predictors (change scores variables) of context-specific sitting time. Results Social-cognitive correlates/ predictors were most frequently associated with context-specific sitting time. Longitudinal analyses revealed that increases over time in considering it pleasant to watch TV (p < .001), in perceiving TV watching as a way to relax (p < .05), in TV time of parents/care givers (p < .01) and in TV time of siblings (p < .001) were associated with more sitting during TV viewing at follow-up. Increases over time in considering it pleasant to use a computer in leisure time (p < .01) and in the computer time of siblings (p < .001) were associated with more sitting during computer use at follow-up. None of the changes in potential predictors were significantly related to changes in sitting during motorized transport or during electronic gaming. Conclusions Future intervention studies aiming to decrease TV viewing and computer use should acknowledge the importance of the behaviour of siblings and the pleasure adolescents experience during these screen-related behaviours. In addition, more time parents or care givers spent sitting may lead to more sitting during TV viewing of the adolescents, so that a family-based approach may be preferable for interventions. Experimental study designs are warranted to confirm the present findings.	[Busschaert, Cedric; De Bourdeaudhuij, Ilse; Cardon, Greet; De Cocker, Katrien] Univ Ghent, Dept Movement & Sport Sci, Ghent, Belgium; [Busschaert, Cedric; Van Cauwenberg, Jelle; De Cocker, Katrien] Res Fdn Flanders FWO, Brussels, Belgium; [Ridgers, Nicola D.] Deakin Univ, Ctr Phys Act & Nutr Res, Burwood Melbourne, Australia; [Van Cauwenberg, Jelle] Univ Ghent, Dept Publ Hlth, Ghent, Belgium; [Van Cauwenberg, Jelle] Vrije Univ Brussel, Dept Human Biometry & Biomech, Brussels, Belgium	Ghent University; Deakin University; Ghent University; Vrije Universiteit Brussel	De Bourdeaudhuij, I (corresponding author), Univ Ghent, Dept Movement & Sport Sci, Ghent, Belgium.	Ilse.Debourdeaudhuij@UGent.be	De Cocker, Katrien/AEV-4609-2022; Ridgers, Nicola/AGN-1339-2022; De+Bourdeaudhuij, Ilse/AAC-5528-2019; De Cocker, Katrien/AAA-5783-2020; Ridgers, Nicola/B-2092-2013	De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; De Cocker, Katrien/0000-0001-7510-4419; Ridgers, Nicola/0000-0001-5713-3515; Cardon, Greet/0000-0003-4983-6557	Research Foundation Flanders [B/12530/01]	Research Foundation Flanders(FWO)	This study was supported by the Research Foundation Flanders (no. B/12530/01): CB IDB.	Babey SH, 2013, J ADOLESCENT HEALTH, V52, P70, DOI 10.1016/j.jadohealth.2012.05.001; Babic MJ, 2015, CONTEMP CLIN TRIALS, V40, P150, DOI 10.1016/j.cct.2014.12.001; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Borner I, 2010, CLIN PEDIATR, V49, P947, DOI 10.1177/0009922810370203; Busschaert C, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0277-2; Busschaert C, 2015, J ADOLESCENT HEALTH, V56, P440, DOI 10.1016/j.jadohealth.2014.11.016; Chastin SFM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082313; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Coll C.V.N., 2014, INT J BEHAV NUTR PHY, V54, P209; De Bourdeaudhuij I, 2005, OBES RES, V13, P1097, DOI 10.1038/oby.2005.128; De Bourdeaudhuij I, 2002, PREV MED, V34, P279, DOI 10.1006/pmed.2001.0979; Dowd KP, 2014, MED SCI SPORT EXER, V46, P2295, DOI 10.1249/MSS.0000000000000357; Esteban-Cornejo I, 2015, PREV MED, V77, P106, DOI 10.1016/j.ypmed.2015.05.013; Ghasemi A, 2012, INT J ENDOCRINOL MET, V10, P486, DOI 10.5812/ijem.3505; Granich J, 2010, HEALTH EDUC RES, V25, P199, DOI 10.1093/her/cyn025; Grontved A, 2015, PREV MED, V81, P108, DOI 10.1016/j.ypmed.2015.08.009; Hamar P, 2010, EUR J PUBLIC HEALTH, V20, P85, DOI 10.1093/eurpub/ckp100; Cillero IH, 2011, EUR J PEDIATR, V170, P93, DOI 10.1007/s00431-010-1276-6; Ivuskans A, 2015, J BONE MINER METAB, V33, P85, DOI 10.1007/s00774-013-0556-4; Lee PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110732; de Rezende LFM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105620; McManus AM, 2015, EXP PHYSIOL, V100, P1379, DOI 10.1113/EP085355; Minges KE, 2015, HEALTH PSYCHOL, V34, P381, DOI 10.1037/hea0000172; Owen N, 2014, BRIT J SPORT MED, V48, P174, DOI 10.1136/bjsports-2013-093107; Owen N, 2011, AM J PREV MED, V41, P189, DOI 10.1016/j.amepre.2011.05.013; Philippaerts RM, 2006, INT J SPORTS MED, V27, P131, DOI 10.1055/s-2005-837619; Plewis I, 2003, BRIT J EDUC STUD, V51, P408, DOI 10.1046/j.1467-8527.2003.00246.x; Richardson LP, 2010, PEDIATRICS, V125, pE1097, DOI 10.1542/peds.2009-2712; Rideout VJ, 2010, GENERATIONM SUPERSCR; Ridgers ND, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056838; Roelants M., 2004, GROEICURVEN 2 20 JAA; Salmon J, 2010, J PHYS ACT HEALTH, V7, pS299, DOI 10.1123/jpah.7.s3.s299; Saunders TJ, 2014, CAN J DIABETES, V38, P53, DOI 10.1016/j.jcjd.2013.08.266; Saunders TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079143; Sebire SJ, 2011, PREV MED, V53, P303, DOI 10.1016/j.ypmed.2011.08.019; Simons D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-323; Stierlin AS, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0291-4; Tandon PS, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-88; Van Dyck D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-668; Wennberg P, 2014, J EPIDEMIOL COMMUN H, V68, P928, DOI 10.1136/jech-2013-203504	41	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167553	10.1371/journal.pone.0167553	http://dx.doi.org/10.1371/journal.pone.0167553			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936073	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000389587100123
J	Chien, TL; Wang, JH; Kee, KM; Chen, CH; Hung, CH; Lu, SN				Chien, Tai-Long; Wang, Jing-Houng; Kee, Kwong-Ming; Chen, Chien-Hung; Hung, Chao-Hung; Lu, Sheng-Nan			Factors Predicting HBsAg Seroclearance and Alanine Transaminase Elevation in HBeAg-Negative Hepatitis B Virus-Infected Patients with Persistently Normal Liver Function	PLOS ONE			English	Article							SURFACE-ANTIGEN; NATURAL-HISTORY; DISEASE PROGRESSION; CLINICAL-COURSE; SERUM-LEVELS; LEVELS HELP; NORMAL ALT; CARRIERS; DNA	Background A certain proportion of hepatitis B virus (HBV)-infected patients with persistently normal alanine transaminase (ALT) levels have significant fibrosis. Using liver stiffness measurements (Fibroscan (R)) and laboratory data, including serum ALT, quantitative HBsAg (qHBsAg), and HBV DNA, we attempted to predict the natural histories of these patients. Methods Non-cirrhotic HBeAg-negative chronic hepatitis B patients with persistently normal ALT were followed up prospectively with the end points of HBsAg seroclearance and ALT elevation above the upper limit of normal. The factors that were predictive of the end points were identified. Results A total of 235 patients with an average age of 48.1 +/- 10.7 years were followed up for 7 years. Eight patients (3.4%) lost HBsAg, and 15 patients (6.4%) experienced ALT elevation. The overall cumulative HBsAg seroclearances were 0.4%, 1.3% and 2.3% at years 1, 3 and 5, respectively. Regarding HBsAg seroclearance, the qHBsAg (< 30 IU/ml) cutoff resulted in a hazard ratio (HR) of 19.6 with a 95% confidence interval (CI) of 2.2-166.7 (P = 0.008). The baseline ALT level (odd ratio (OR) 1.075, 95% CI 1.020-1.132, P = 0.006) and a qHBsAg above 1000 IU/ml (3.7, 1.1-12.4, P = 0.032) were associated with ALT elevation. Limited to men, the baseline liver stiffness (1.6, 1.0-2.5, P = 0.031) and a qHBsAg above 1000 IU/ml (10.4, 2.1-52.4, P = 0.004) were factors that were independently associated with ALT elevation. Conclusion A low qHBsAg level predicted HBsAg clearance. Baseline ALT and a qHBsAg above 1000 IU/ml were independent predictive factors for ALT elevation. Among the men, the independent predictive factors for ALT elevation were qHBsAg and liver stiffness.	[Chien, Tai-Long] Antai Med Care Cooperat Antai Tian Sheng Mem Hosp, Div Hepatogastroenterol, Dept Internal Med, Donggang Township, Pingtung County, Taiwan; [Wang, Jing-Houng; Kee, Kwong-Ming; Chen, Chien-Hung; Hung, Chao-Hung; Lu, Sheng-Nan] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan; [Wang, Jing-Houng; Kee, Kwong-Ming; Chen, Chien-Hung; Hung, Chao-Hung; Lu, Sheng-Nan] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Lu, SN (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan.; Lu, SN (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.	juten@ms17.hinet.net			Chang Gung Memorial Hospital, Taiwan [CMRPG 880881-2]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This study was supported in part by contract grant (CMRPG 880881-2) from Chang Gung Memorial Hospital, Taiwan, to Dr. Sheng-Nan Lu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank our colleagues Shu-Fen Hung from the research department and Chin-Yun Lin from Biostatistics and Bioinformatics Center, Kaohsiung Chang Gung Memorial Hospital who provided insight and expertise regarding the statistical analyses. This study was supported in part by contract grant (CMRPG 880881-2) from Chang Gung Memorial Hospital, Taiwan to Dr. Sheng-Nan Lu.	Andreani T, 2007, CLIN GASTROENTEROL H, V5, P636, DOI 10.1016/j.cgh.2007.01.005; Arena U, 2008, HEPATOLOGY, V47, P380, DOI 10.1002/hep.22007; Brunetto MR, 2010, GASTROENTEROLOGY, V139, P483, DOI 10.1053/j.gastro.2010.04.052; Chan HLY, 2007, CLIN GASTROENTEROL H, V5, P1462, DOI 10.1016/j.cgh.2007.09.005; Chan HLY, 2010, HEPATOLOGY, V52, P1232, DOI 10.1002/hep.23803; Chen CH, 2004, EUR J GASTROEN HEPAT, V16, P1213, DOI 10.1097/00042737-200411000-00021; Chen CJ, 2011, J GASTROEN HEPATOL, V26, P628, DOI 10.1111/j.1440-1746.2011.06695.x; Chen YC, 2002, GASTROENTEROLOGY, V123, P1084, DOI 10.1053/gast.2002.36026; Chu CM, 2007, HEPATOLOGY, V45, P1187, DOI 10.1002/hep.21612; Feld JJ, 2007, HEPATOLOGY, V46, P1057, DOI 10.1002/hep.21811; Fung J, 2010, HEPATOL INT, V4, P716, DOI 10.1007/s12072-010-9189-z; Hui CK, 2007, HEPATOLOGY, V46, P395, DOI 10.1002/hep.21724; Kumar M, 2008, J GASTROENTEROL, V134, P1376; Kumar M, 2009, GASTROENTEROLOGY, V136, P1272, DOI 10.1053/j.gastro.2009.01.011; Kuo YH, 2015, KAOHSIUNG J MED SCI, V31, P102, DOI 10.1016/j.kjms.2014.11.002; Kwak MS, 2011, DIGESTION, V84, P23, DOI 10.1159/000333211; Lai M, 2007, J HEPATOL, V47, P760, DOI 10.1016/j.jhep.2007.07.022; Liu J, 2010, GASTROENTEROLOGY, V139, P474, DOI 10.1053/j.gastro.2010.04.048; Maimone S, 2016, LIVER INT; Martinot-Peignoux M, 2013, J CLIN VIROL, V58, P401, DOI 10.1016/j.jcv.2013.08.010; McMahon BJ, 2001, ANN INTERN MED, V135, P759, DOI 10.7326/0003-4819-135-9-200111060-00006; Nguyen K, 2015, J VIRAL HEPATITIS, V22, P809, DOI 10.1111/jvh.12388; Park H, 2012, LIVER INT, V32, P796, DOI 10.1111/j.1478-3231.2011.02693.x; Tseng TC, 2013, HEPATOLOGY, V57, P441, DOI 10.1002/hep.26041; Tseng TC, 2012, GASTROENTEROLOGY, V142, P1140, DOI 10.1053/j.gastro.2012.02.007; Tseng TC, 2011, GASTROENTEROLOGY, V141, P517, DOI 10.1053/j.gastro.2011.04.046; Wang JH, 2009, J GASTROENTEROL, V44, P439, DOI 10.1007/s00535-009-0017-y; Xu XR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/623509	28	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166543	10.1371/journal.pone.0166543	http://dx.doi.org/10.1371/journal.pone.0166543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935953	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100033
J	Delussu, G; Lianas, L; Frexia, F; Zanetti, G				Delussu, Giovanni; Lianas, Luca; Frexia, Francesca; Zanetti, Gianluigi			A Scalable Data Access Layer to Manage Structured Heterogeneous Biomedical Data	PLOS ONE			English	Article							HEALTH-CARE; SYSTEM; DIAGNOSIS; GENOMICS	This work presents a scalable data access layer, called PyEHR, designed to support the implementation of data management systems for secondary use of structured heterogeneous biomedical and clinical data. PyEHR adopts the openEHR's formalisms to guarantee the decoupling of data descriptions from implementation details and exploits structure indexing to accelerate searches. Data persistence is guaranteed by a driver layer with a common driver interface. Interfaces for two NoSQL Database Management Systems are already implemented: MongoDB and Elasticsearch. We evaluated the scalability of PyEHR experimentally through two types of tests, called "Constant Load" and "Constant Number of Records", with queries of increasing complexity on synthetic datasets of ten million records each, containing very complex openEHR archetype structures, distributed on up to ten computing nodes.	[Delussu, Giovanni; Lianas, Luca; Frexia, Francesca; Zanetti, Gianluigi] Data Intens Comp Grp, CRS4, Pula, Italy		Delussu, G (corresponding author), Data Intens Comp Grp, CRS4, Pula, Italy.	surfer@crs4.it	PAN, ZEQIANG/X-6341-2018	Frexia, Francesca/0000-0003-1007-1286; Lianas, Luca/0000-0002-7123-6948; Zanetti, Gianluigi/0000-0003-1683-7350; delussu, giovanni/0000-0002-1023-2257				Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], 2015, P OP RES COMP ALG SO; Atzeni P, 2014, INFORM SYST, V43, P117, DOI 10.1016/j.is.2013.05.002; Auffray C, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0323-y; Austin T, 2015, J HEALTHC ENG, V6, P325, DOI 10.1260/2040-2295.6.3.325; Baccarelli E, 2016, CHALLENGES CASE STUD, V30, DOI [10.1109/MNET.2016.7437025, DOI 10.1109/MNET.2016.7437025]; BaseX, THE XML DAT; Beale T., 2002, P OOPSLA 2002 WORKSH, V105, P1, DOI 10.1.1.147.8835; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Brass A, 2010, STUD HEALTH TECHNOL, V155, P212, DOI 10.3233/978-1-60750-563-1-212; Butun I, 2016, IEEE COMMUNICATIONS, V54; Barca CC, 2014, 2014 IEEE-EMBS INTERNATIONAL CONFERENCE ON BIOMEDICAL AND HEALTH INFORMATICS (BHI), P89, DOI 10.1109/BHI.2014.6864311; Chen HW, 2014, TOXICOL APPL PHARM, V280, P1, DOI 10.1016/j.taap.2014.07.024; Chute CG, 2013, GENET MED, V15, P802, DOI 10.1038/gim.2013.121; Cordeschi N, 2015, ENERGY SAVING QOS RE, DOI [10.4018/978-1-4666-8213-9.ch004, DOI 10.4018/978-1-4666-8213-9.CH004]; Cuccuru G, 2014, 2014 INTERNATIONAL CONFERENCE ON HIGH PERFORMANCE COMPUTING & SIMULATION (HPCS), P600, DOI 10.1109/HPCSim.2014.6903742; Dinu V, 2007, INT J MED INFORM, V76, P769, DOI 10.1016/j.ijmedinf.2006.09.023; Du QH, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0506-5; Dull T., 2015, MARKETERS ASK ISNT D; Eberius M, 2009, BIOINFORMATICS: TOOLS AND APPLICATIONS, P259, DOI 10.1007/978-0-387-92738-1_13; Frade S, 2013, COMP MED SY, P303, DOI 10.1109/CBMS.2013.6627806; Francalacci P, 2013, SCIENCE, V341, P565, DOI 10.1126/science.1237947; Freire SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150069; Hassanalieragh M, 2015, 2015 IEEE 12TH INTERNATIONAL CONFERENCE ON SERVICES COMPUTING (SCC 2015), P285, DOI 10.1109/SCC.2015.47; Houbing Song CB., 2016, CYBER PHYS SYSTEMS F; Jiang Y, 2016, DATA CTR RUNTIME VER, DOI [10.1109/TII.2016.2573762, DOI 10.1109/TII.2016.2573762]; Lee KKY, 2013, COMPUT METH PROG BIO, V110, P99, DOI 10.1016/j.cmpb.2012.10.018; Leopold G, HLTH CARE EMERGES HA; Luo J, 2016, BIOMED INFORM INSIGH, V8, P1, DOI 10.4137/BII.S31559; Ma CL, 2007, STUD HEALTH TECHNOL, V129, P397; Marx V, 2013, NATURE, V496, P253, DOI 10.1038/498255a; Med D, 2010, MED E TEL; Millard BL, 2011, NAT METHODS, V8, P487, DOI [10.1038/NMETH.1600, 10.1038/nmeth.1600]; Miranda S., 2012, SCAND C HLTH INF SWE, P51; Mudunuri US, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080503; Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041; Pareek CS, 2011, J APPL GENET, V52, P413, DOI 10.1007/s13353-011-0057-x; Plebani M, 2016, CLIN CHEM LAB MED, V54, P1117, DOI 10.1515/cclm-2016-0217; Psiuk-Maksymowicz K, 2016, COMM COM INF SC, V613, P449, DOI 10.1007/978-3-319-34099-9_34; Radovic M, 2015, TECHNOL HEALTH CARE, V23, P757, DOI 10.3233/THC-151034; Raghupathi W, 2014, HEALTH INF SCI SYST, V2, DOI 10.1186/2047-2501-2-3; Rongfang Bie, 2016, HOLTER NEUROCOMPUTIN, DOI [10.1016/j.neucom.2016.06.074, DOI 10.1016/J.NEUCOM.2016.06.074]; Saqi M, 2016, METHODS MOL BIOL, V1386, P43, DOI 10.1007/978-1-4939-3283-2_3; Schilsky RL, 2016, ONCOLOGY INFORM, P3, DOI [10.1016/B978-0-12-802115-6.00001-X, DOI 10.1016/B978-0-12-802115-6.00001-X]; Schmitt O., 2012, 9 INT C INF SYST CRI, P1; Simon R, 2013, NAT REV DRUG DISCOV, V12, P359, DOI 10.1038/nrd3979; Soon WW, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.61; Sun YC, 2016, IEEE ACCESS, V4, P766, DOI 10.1109/ACCESS.2016.2529723; Sundvall E, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-57; Terrizzano I. G., 2015, 7 BIENN C INN DAT SY; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Yao Q, 2015, J MED SYST, V39, DOI 10.1007/s10916-015-0220-8; Zhang Y, 2015, NEW MEDIA SOC, V17, P1007, DOI 10.1177/1461444813520477	53	1	1	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168004	10.1371/journal.pone.0168004	http://dx.doi.org/10.1371/journal.pone.0168004			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936191	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100248
J	McDonald, CR; Darling, AM; Liu, EJ; Tran, V; Cabrera, A; Aboud, S; Urassa, W; Kain, KC; Fawzi, WW				McDonald, Chloe R.; Darling, Anne M.; Liu, Enju; Tran, Vanessa; Cabrera, Ana; Aboud, Said; Urassa, Willy; Kain, Kevin C.; Fawzi, Wafaie W.			Angiogenic proteins, placental weight and perinatal outcomes among pregnant women in Tanzania	PLOS ONE			English	Article							HUMAN FETOPLACENTAL VASCULOGENESIS; FETAL-GROWTH; GESTATIONAL-AGE; BIRTH-WEIGHT; RISK	Introduction Placental vascular development, and ultimately placental weight, is essential to healthy fetal development. Here, we examined placental weight in a cohort of Tanzanian women in association with angiogenic proteins known to regulate placental vascular development and perinatal outcomes. Methods A total of n = 6579 women with recorded placental weight were included in this study. The relative risk of adverse perinatal outcomes (Apgar score, death, asphyxia, respiratory distress, seizures, pneumonia and sepsis) was compared between placental weight in the bottom and top 10 th percentiles. We quantified angiogenic mediators (Ang-1, Ang-2, VEGF, PGF and sFlt-1) in plasma samples (n = 901) collected between 12 to 27 weeks of pregnancy using ELISA and assessed the relative risk of placental weight in the bottom and top 10 th percentiles by protein levels in quartiles. Results Women with Ang-2 levels in the highest quartile had an increased relative risk of placental weight in the bottom 10 th percentile (RR = 1.45 (1.10, 1.91), p = 0.01). Women with VEGF-A (RR = 0.73 (0.56, 0.96), p = 0.05) and PGF (RR = 0.58 (0.44, 0.72), p = 0.002) in the highest quartile had a reduced relative risk of placental weight in the bottom 10 th percentile. Low placental weight (in bottom 10 th percentile) was associated with an increased relative risk of Apgar score of < 7 at 1 minute (RR = 2.31 (1.70, 3.13), p = 0.001), at 5 minutes (RR = 3.53 (2.34, 5.33), p = 0.001), neonatal death (RR = 5.02 (3.61, 7.00), p = 0.001), respiratory distress (RR = 4.80(1.71, 13.45), p = 0.001), and seizures (RR = 4.18 (1.16, 15.02), p = 0.03). Discussion The association between low placental weight and risk of adverse perinatal outcomes in this cohort suggests that placental weight could serve as a useful indicator, providing additional insight into high-risk pregnancies and identifying neonates that may require additional monitoring and follow-up.	[McDonald, Chloe R.; Darling, Anne M.; Fawzi, Wafaie W.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [McDonald, Chloe R.; Tran, Vanessa; Cabrera, Ana; Kain, Kevin C.] Univ Toronto, Univ Hlth Network, Toronto Gen Hosp, SAR Labs,Sandra Rotman Ctr Global Hlth, Toronto, ON, Canada; [Darling, Anne M.; Liu, Enju; Fawzi, Wafaie W.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Liu, Enju; Fawzi, Wafaie W.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Aboud, Said; Urassa, Willy] Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania; [Kain, Kevin C.] Univ Toronto, Dept Med, Div Infect Dis, Trop Dis Unit, Toronto, ON, Canada	Harvard University; Harvard T.H. Chan School of Public Health; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Muhimbili University of Health & Allied Sciences; University of Toronto	McDonald, CR (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.; McDonald, CR (corresponding author), Univ Toronto, Univ Hlth Network, Toronto Gen Hosp, SAR Labs,Sandra Rotman Ctr Global Hlth, Toronto, ON, Canada.	cmcdonald@hsph.harvard.edu	Cabrera, Ana/AES-5002-2022	Cabrera, Ana/0000-0003-2246-3471; Kain, Kevin/0000-0001-6068-1272	National Institute of Child Health and Human Development [NICHD R01 37701]; Global Alliance to Prevent Prematurity and Stillbirth and Grand Challenges in Global Health: Preventing Preterm Birth Initiative [12003]; Canadian Institutes of Health Research [MOP-115160, 13721]; Canadian Institutes of Health Research; Canada Research Chair	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Global Alliance to Prevent Prematurity and Stillbirth and Grand Challenges in Global Health: Preventing Preterm Birth Initiative; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by the National Institute of Child Health and Human Development (NICHD R01 37701 [WF]), the Global Alliance to Prevent Prematurity and Stillbirth and Grand Challenges in Global Health: Preventing Preterm Birth Initiative Grant No. 12003 [KK]; the Canadian Institutes of Health Research MOP-115160 and 13721 [KK], Canadian Institutes of Health Research Fellowship [CM] and Canada Research Chair [KK].	BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Benton SJ, 2016, PLACENTA, V42, P1, DOI 10.1016/j.placenta.2016.03.010; Burton GJ, 2009, REPRODUCTION, V138, P895, DOI 10.1530/REP-09-0092; Bush PG, 2000, PLACENTA, V21, P824, DOI 10.1053/plac.2000.0571; Charnock-Jones DS, 2004, PLACENTA, V25, P103, DOI 10.1016/j.placenta.2003.10.004; Chisholm KM, 2016, PLACENTA, V39, P61, DOI 10.1016/j.placenta.2016.01.012; Conroy AL, 2013, CELL HOST MICROBE, V13, P215, DOI 10.1016/j.chom.2013.01.010; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Demir R, 2004, PLACENTA, V25, P560, DOI 10.1016/j.placenta.2003.11.011; Fawzi WW, 2007, NEW ENGL J MED, V356, P1423, DOI 10.1056/NEJMoa064868; Frankel S, 1996, LANCET, V348, P1478, DOI 10.1016/S0140-6736(96)03482-4; Geva E, 2002, J CLIN ENDOCR METAB, V87, P4213, DOI 10.1210/jc.2002-020195; Hutcheon JA, 2012, OBSTET GYNECOL, V119, P1251, DOI 10.1097/AOG.0b013e318253d3df; Jones HN, 2007, PLACENTA, V28, P763, DOI 10.1016/j.placenta.2007.05.002; Karimu AL, 1995, REPROD FERT DEVELOP, V7, P1269, DOI 10.1071/RD9951269; Kaufmann P, 2004, PLACENTA, V25, P114, DOI 10.1016/j.placenta.2003.10.009; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kingdom J, 2000, EUR J OBSTET GYN R B, V92, P35, DOI 10.1016/S0301-2115(00)00423-1; Krauss T, 2004, HYPERTENS PREGNANCY, V23, P101, DOI 10.1081/PRG-120028286; Leach L, 2002, J ANAT, V200, P599, DOI 10.1046/j.1469-7580.2002.00062.x; Macdonald EM, 2014, PLACENTA, V35, P582, DOI 10.1016/j.placenta.2014.04.019; Mayhew TM, 2004, PLACENTA, V25, P127, DOI 10.1016/j.placenta.2003.10.010; McNamara H, 2014, PAEDIATR PERINAT EP, V28, P97, DOI 10.1111/ppe.12104; NYONGO AD, 1991, E AFR MED J, V68, P239; Ogunyemi D, 2003, J Matern Fetal Neonatal Med, V13, P102, DOI 10.1080/jmf.13.2.102.109; POSTON L, 1995, PHARMACOL THERAPEUT, V65, P215, DOI 10.1016/0163-7258(94)00064-A; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Risnes KR, 2009, AM J EPIDEMIOL, V170, P622, DOI 10.1093/aje/kwp182; Salafia CM, 2006, CLIN OBSTET GYNECOL, V49, P236, DOI 10.1097/00003081-200606000-00007; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Thame M, 2004, EUR J CLIN NUTR, V58, P894, DOI 10.1038/sj.ejcn.1601909; Triunfo S, 2014, PLACENTA, V35, P398, DOI 10.1016/j.placenta.2014.03.021; Umbers AJ, 2011, TRENDS PARASITOL, V27, P168, DOI 10.1016/j.pt.2011.01.007; Wang Y, 2010, VASCULAR BIOL PLACEN	35	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167716	10.1371/journal.pone.0167716	http://dx.doi.org/10.1371/journal.pone.0167716			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936130	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100162
J	Mukherjee, N; Bartelli, D; Patra, C; Chauhan, BV; Dowd, SE; Banerjee, P				Mukherjee, Nabanita; Bartelli, Debra; Patra, Cyril; Chauhan, Bhavin V.; Dowd, Scot E.; Banerjee, Pratik			Microbial Diversity of Source and Point-of-Use Water in Rural Haiti - A Pyrosequencing-Based Metagenomic Survey	PLOS ONE			English	Article							TOXIGENIC VIBRIO-CHOLERAE; BIOFILM FORMATION; DRINKING-WATER; KLEBSIELLA-PNEUMONIAE; BACTERIAL COMMUNITIES; RISK-ASSESSMENT; SURFACE WATERS; TAP WATER; AEROMONAS; IDENTIFICATION	Haiti endures the poorest water and sanitation infrastructure in the Western Hemisphere, where waterborne diseases cause significant morbidity and mortality. Most of these diseases are reported to be caused by waterborne pathogens. In this study, we examined the overall bacterial diversity of selected source and point-of-use water from rural areas in Central Plateau, Haiti using pyrosequencing of 16s rRNA genes. Taxonomic composition of water samples revealed an abundance of Firmicutes phyla, followed by Proteobacteria and Bacteroidetes. A total of 38 bacterial families and 60 genera were identified. The presence of several Klebsiella spp. (tentatively, K. pneumoniae, K. variicola and other Klebsiella spp.) was detected in most water samples. Several other human pathogens such as Aeromonas, Bacillus, Clostridium, and Yersinia constituted significantly higher proportion of bacterial communities in the point-of-use water samples compared to source water. Bacterial genera traditionally associated with biofilm formation, such as Chryseobacterium, Fusobacterium, Prevotella, Pseudomonas were found in the point-of-use waters obtained from water filters or domestic water storage containers. Although the pyrosequencing method utilized in this study did not reveal the viability status of these pathogens, the abundance of genetic footprints of the pathogens in water samples indicate the probable risk of bacterial transmission to humans. Therefore, the importance of appropriate handling, purification, and treatment of the source water needed to be clearly communicated to the communities in rural Haiti to ensure the water is safe for their daily use and intake.	[Mukherjee, Nabanita; Bartelli, Debra; Patra, Cyril; Chauhan, Bhavin V.; Banerjee, Pratik] Univ Memphis, Sch Publ Hlth, Div Epidemiol Biostat & Environm Hlth, Desoto Ave, Memphis, TN 38152 USA; [Dowd, Scot E.] Mol Res LP MR DNA, Shallowater, TX USA	University of Memphis	Banerjee, P (corresponding author), Univ Memphis, Sch Publ Hlth, Div Epidemiol Biostat & Environm Hlth, Desoto Ave, Memphis, TN 38152 USA.	pbnerjee@memphis.edu	Banerjee, Pratik/H-9521-2012; Dowd, Scot E/M-5386-2017	Banerjee, Pratik/0000-0001-5553-5350; Dowd, Scot E/0000-0002-6296-1427	University of Memphis; Memphis Research Consortium; U.S. Food & Drug Administration [1U54FD004330-01]; MR DNA Molecular Research; FOOD AND DRUG ADMINISTRATION [U54FD004330] Funding Source: NIH RePORTER	University of Memphis; Memphis Research Consortium; U.S. Food & Drug Administration; MR DNA Molecular Research; FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services)	This research was partly supported by start-up funds from University of Memphis (PB, DB), Memphis Research Consortium (PB, DB), and a grant from the U.S. Food & Drug Administration (1U54FD004330-01) to PB. MR DNA Molecular Research provided support in the form of salaries for author [SD]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Anderson M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00045; Bai YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061011; Bain R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001644; Balleste E, 2010, APPL ENVIRON MICROB, V76, P7608, DOI 10.1128/AEM.00883-10; Bao K, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0258-7; Be NA, 2015, MICROB ECOL, V69, P346, DOI 10.1007/s00248-014-0517-z; Berger T, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.32.20877; Bhotmange DU, 2015, J APPL MICROBIOL, V119, P1046, DOI 10.1111/jam.12914; Cangelosi GA, 2014, APPL ENVIRON MICROB, V80, P5884, DOI 10.1128/AEM.01763-14; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Dunn G, 2014, SCI TOTAL ENVIRON, V468, P544, DOI 10.1016/j.scitotenv.2013.08.004; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eren AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026732; Fang MX, 2012, INT J SYST EVOL MICR, V62, P3018, DOI 10.1099/ijs.0.034660-0; Fernandez N, 2009, WATER SCI TECHNOL, V59, P1227, DOI 10.2166/wst.2009.092; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Heyland DK, 1999, AM J RESP CRIT CARE, V159, P1249, DOI 10.1164/ajrccm.159.4.9807050; Hill VR, 2011, EMERG INFECT DIS, V17, P2147, DOI 10.3201/eid1711.110748; Hwang G, 2014, BIOFOULING, V30, P1079, DOI 10.1080/08927014.2014.969249; Hwang HG, 2014, INT J ENV RES PUB HE, V11, P2033, DOI 10.3390/ijerph110202033; Isozaki A, 2010, J INFECT CHEMOTHER, V16, P436, DOI 10.1007/s10156-010-0067-3; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Kahler AM, 2015, AM J TROP MED HYG, V92, P118, DOI 10.4269/ajtmh.13-0601; Kivanc M, 2011, BRAZ J MICROBIOL, V42, P126, DOI 10.1590/S1517-83822011000100016; KLIPSTEIN FA, 1976, GASTROENTEROLOGY, V70, P1035; Kotiranta A, 2000, MICROBES INFECT, V2, P189, DOI 10.1016/S1286-4579(00)00269-0; Kupferschmidt K, 2012, SCIENCE, V336, P1493, DOI 10.1126/science.336.6088.1493; Limbago BM, 2011, J CLIN MICROBIOL, V49, P4239, DOI 10.1128/JCM.05297-11; Lin WH, 2014, EUR J CLIN MICROBIOL, V33, P1533, DOI 10.1007/s10096-014-2100-4; Lo HH, 2014, DIAGN MICR INFEC DIS, V79, P298, DOI 10.1016/j.diagmicrobio.2014.01.027; Mathers AJ, 2015, CLIN MICROBIOL REV, V28, P565, DOI 10.1128/CMR.00116-14; Mehrshad M, 2016, APPL ENVIRON MICROB, V82, P1599, DOI 10.1128/AEM.03381-15; Mukherjee N, 2014, INT J ENV RES PUB HE, V11, P12544, DOI 10.3390/ijerph111212544; Nathisuwan S, 2001, PHARMACOTHERAPY, V21, P920, DOI 10.1592/phco.21.11.920.34529; Nelson WC, 2016, APPL ENVIRON MICROB, V82, P255, DOI 10.1128/AEM.02274-15; Nicholson WL, 2002, CELL MOL LIFE SCI, V59, P410, DOI 10.1007/s00018-002-8433-7; PALUMBO SA, 1989, J CLIN MICROBIOL, V27, P854, DOI 10.1128/JCM.27.5.854-859.1989; Passariello C, 2013, EUR J PAEDIATR DENT, V14, P199; Patrick M, 2013, AM J TROP MED HYG, V89, P647, DOI 10.4269/ajtmh.13-0308; Podschun R, 2001, APPL ENVIRON MICROB, V67, P3325, DOI 10.1128/AEM.67.7.3325-3327.2001; Rahimian J, 2004, CLIN INFECT DIS, V39, P1654, DOI 10.1086/425616; Revell PA, 2001, FEMS MICROBIOL LETT, V205, P159, DOI [10.1111/j.1574-6968.2001.tb10941.x, 10.1016/S0378-1097(01)00476-1]; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Rudi K, 2010, LETT APPL MICROBIOL, V50, P1, DOI 10.1111/j.1472-765X.2009.02743.x; Shaheed A, 2014, B WORLD HEALTH ORGAN, V92, P283, DOI 10.2471/BLT.13.119594; Swanson KS, 2011, ISME J, V5, P639, DOI 10.1038/ismej.2010.162; TDR, 2020, JOINT MON PROGR WAT; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; Thomson AA, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4677-1; Torre D, 2005, SCAND J INFECT DIS, V37, P375, DOI 10.1080/00365540410021180-1; Turska-Szewczuk A, 2010, CARBOHYD RES, V345, P680, DOI 10.1016/j.carres.2009.12.030; USAID, WAT SAN HYG SECT TRE; Wampler PJ, 2011, ENVIRON EARTH SCI, V62, P1619, DOI 10.1007/s12665-010-0645-9; Wang J, 1998, MAIZE SCI, V6, P26; WHO-UNICEF, 2015, WHO UNICEF JOINT MON; Widmer JM, 2014, AM J TROP MED HYG, V91, P790, DOI 10.4269/ajtmh.14-0165; World Health Organization, 2015, PROGR SAN DRINK WAT; World-Bank-Group, 2016, WORLD DEV IND HAIT; Wu HT, 2015, APPL MICROBIOL BIOT, V99, P1947, DOI 10.1007/s00253-014-6095-7; Zhang DY, 2011, BIOMED ENVIRON SCI, V24, P122, DOI 10.3967/0895-3988.2011.02.006; Zhou JZ, 2015, MBIO, V6, DOI 10.1128/mBio.02288-14; Zilm PS, 2007, ANAEROBE, V13, P146, DOI 10.1016/j.anaerobe.2007.04.005	65	18	19	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167353	10.1371/journal.pone.0167353	http://dx.doi.org/10.1371/journal.pone.0167353			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936055	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100088
J	Munisi, DZ; Buza, J; Mpolya, EA; Kinung'hi, SM				Munisi, David Zadock; Buza, Joram; Mpolya, Emmanuel A.; Kinung'hi, Safari M.			Schistosoma mansoni Infections, Undernutrition and Anaemia among Primary Schoolchildren in Two Onshore Villages in Rorya District, North-Western Tanzania	PLOS ONE			English	Article							CHILDREN; PREVALENCE; GROWTH	Background Undernutrition and anaemia remains to be a major public health problem in many developing countries, where they mostly affect children. Intestinal parasitic infections are known to affect both growth and haemoglobin levels. Much has been reported on the impact of geohelminths on anaemia and undernutrition, leaving that of Schistosoma mansoni not well studied. Therefore this study intended to determine the association between S. mansoni infections, anaemia and undernutrition among schoolchildren in Rorya district, Northwestern Tanzania. Methodology A cross-sectional study was carried among schoolchildren in two onshore villages namely Busanga and Kibuyi in Rorya district. Single stool specimens were collected from 513 randomly selected schoolchildren and processed for microscopic examination using the KatoKatz method. Nutritional status was determined by anthropometry. Blood samples were also collected and examined for malaria parasites and haemoglobin levels using the Giemsa stain and HaemoCue methods, respectively. A pretested questionnaire was used to collect socio-demographic data and associated factors. Results The prevalence of S. mansoni infection and malaria was 84.02% and 9.16%, respectively. Other parasites found were Ascaris lumbricoides (1.36%) and Hookworm (1.36%). The prevalence of stunting and wasting was 38.21% and 14.42%, respectively. The prevalence of anaemia was 29.43%, whereby 0.58% had severe anaemia. S. mansoni infection was not found to be associated with undernutrition or anaemia (p>0.05). The risk of stunting and wasting increased with increasing age (p<0.001). Anaemia was associated with age, sex and village of residence ( p<0.05). Conclusions S. mansoni, undernutrition and anaemia are highly prevalent in the study area. The observed rates of undernutrition and anaemia were seen not to be associated with S. mansoni infection suggesting possibly being a result of poor dietary nutrients. This study suggests that policy makers should consider Rorya district for inclusion into national schistosomiasis control and school feeding programmes.	[Munisi, David Zadock; Buza, Joram; Mpolya, Emmanuel A.] Nelson Mandela African Inst Sci & Technol, Sch Life Sci & Bioengn, Dept Global Hlth & Biomed Sci, Arusha, Tanzania; [Munisi, David Zadock] Univ Dodoma, Sch Med & Dent, Dept Biomed Sci, Coll Hlth Sci, Dodoma, Tanzania; [Kinung'hi, Safari M.] Mwanza Res Ctr, NIMR, Isamilo Rd, Mwanza, Tanzania	Nelson Mandela African Institution of Science & Technology; National Institute of Medical Research	Munisi, DZ (corresponding author), Nelson Mandela African Inst Sci & Technol, Sch Life Sci & Bioengn, Dept Global Hlth & Biomed Sci, Arusha, Tanzania.; Munisi, DZ (corresponding author), Univ Dodoma, Sch Med & Dent, Dept Biomed Sci, Coll Hlth Sci, Dodoma, Tanzania.	munisid@nm-aist.ac.tz	Munisi, David Zadock/S-5765-2017	Munisi, David Zadock/0000-0001-8437-7988; Mpolya, Emmanuel/0000-0002-6210-9445	Government of Tanzania through the Nelson Mandela African Institution of Science and Technology	Government of Tanzania through the Nelson Mandela African Institution of Science and Technology	This study received financial support from the Government of Tanzania through the Nelson Mandela African Institution of Science and Technology and formed part of the PhD training programme for DZM.	Abdel-Rasoul GM, 2015, MENOUFIA MED J, V28, P663; Andrade C, 2001, MEM I OSWALDO CRUZ, V96, P1075, DOI 10.1590/S0074-02762001000800008; Bailey KV, 1995, B WORLD HEALTH ORGAN, V73, P673; Bartelt LA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002125; Best C, 2010, FOOD NUTR BULL, V31, P400, DOI 10.1177/156482651003100303; Cabada MM, 2015, REV PANAM SALUD PUBL, V37, P69; Chami GF, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004193; Cheesbrough M, 1987, MED LAB MANUAL TROPI, VI; de Onis M, 1997, WHO GLOBAL DATABASE, P52; De Stefano GF, 2009, COLLEGIUM ANTROPOL, V33, P729; Degarege A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1490-2; Degarege D, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1714-5; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; Gurarie D, 2011, AM J TROP MED HYG, V84, P773, DOI 10.4269/ajtmh.2011.10-0642; Gutierrez EJ, 2014, AM J TROP MED HYG, V91, P267, DOI 10.4269/ajtmh.13-0438; Herrador Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105880; Hussein A, 2007, TANZANIA MED J, V19, P32; Iannotti LL, 2015, AM J TROP MED HYG, V93, P1092, DOI 10.4269/ajtmh.15-0073; Jari M., 2014, Journal of Isfahan Medical School, V31, P2209; Kabatereine NB, 2003, T ROY SOC TROP MED H, V97, P599, DOI 10.1016/S0035-9203(03)80044-5; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Kinung'hi SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086510; Kirkwood BR, 2003, ESSENTIAL MED STAT, P413; Leach V., 2009, I ANAL NUTR TANZANIA; Lwambo NJS, 1999, T ROY SOC TROP MED H, V93, P497, DOI 10.1016/S0035-9203(99)90349-8; Mazigo H, 2010, TANZANIA J HLTH RES, V12, P121; Mboera LE, 2015, BMC PUBLIC HEALTH, V15, P1; Mekonnen Zeleke, 2014, BMC Res Notes, V7, P763, DOI 10.1186/1756-0500-7-763; Munisi DZ, 2014, IMTU MED J, V5, P15; Musgrove P, 1993, Bull Pan Am Health Organ, V27, P284; Nokes C, 1998, EFFECTS IRON DEFICIE, P1; Parraga IM, 1996, GENDER DIFFERENCES G, P150; Punyawardena BVR, 2012, IMPACT CLIMATE CHANG; Ricci JA, 1996, AM J CLIN NUTR, V63, P966, DOI 10.1093/ajcn/63.6.966; Saathoff E, 2004, BMC INFECT DIS, V4, P1, DOI DOI 10.HTTPS://D0I.0RG/10.1186/1471-2334-4-40; Schellenberg D, 2003, B WORLD HEALTH ORGAN, V81, P581; Schmied D., 1993, Geojournal, V30, P153, DOI 10.1007/BF00808133; Shubair Mohammad E., 2000, Journal of the Egyptian Society of Parasitology, V30, P365; Simbauranga RH, 2015, BMC HEMATOLOGY, V15, P1; Tatala S, 2009, TANZANIA J HLTH RES, V10, P189; TDHS, 2005, TANZ DEM HLTH SURV 2, P176; TDS, 2013, MAR REG PROF, P110; Tesha H, 2016, 3 DISTRICTS KNJARO F, P40; Tsuyuoka R, 1999, Cad Saude Publica, V15, P413, DOI 10.1590/S0102-311X1999000200026; Uneke J, 2009, INTERNET J HLTH, V9, P1; VONSCHENCK H, 1986, CLIN CHEM, V32, P526; Webber GC, 2014, HEALTH CARE WOMEN IN, V35, P758, DOI 10.1080/07399332.2014.915843; WHO, 2007, WHO ANTHROPLUS SOFTW; WHO, 2001, IR DEF AN ASS PREV C, P17; WHO, 2008, WORLD HLTH REPORT 20; World Health Organization, 2002, WHO TRADITIONAL MED, P1; World Health Organization, 1991, BAS LAB METH MED PAR, P25	52	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167122	10.1371/journal.pone.0167122	http://dx.doi.org/10.1371/journal.pone.0167122			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936031	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100063
J	Olsson, LE; Hockings, PD				Olsson, Lars E.; Hockings, Paul D.			In Vivo Measurements of T2 Relaxation Time of Mouse Lungs during Inspiration and Expiration	PLOS ONE			English	Article							T-2 RELAXATION; TRANSVERSE RELAXATION; SKELETAL-MUSCLE; MRI; TISSUE; SIGNAL; T-2-ASTERISK; INFLATION; SMOKERS; BLOOD	Purpose The interest in measurements of magnetic resonance imaging relaxation times, T1, T2, T2*, with intention to characterize healthy and diseased lungs has increased recently. Animal studies play an important role in this context providing models for understanding and linking the measured relaxation time changes to the underlying physiology or disease. The aim of this work was to study how the measured transversal relaxation time (T2) in healthy lungs is affected by normal respiration in mouse. Method T2 of lung was measured in anaesthetized freely breathing mice. Image acquisition was performed on a 4.7 T, Bruker BioSpec with a multi spin-echo sequence (Car-Purcell-MeiboomGill) in both end-expiration and end-inspiration. The echo trains consisted of ten echoes of inter echo time 3.5 ms or 4.0 ms. The proton density, T2 and noise floor were fitted to the measured signals of the lung parenchyma with a Levenberg-Marquardt least-squares three-parameter fit. Results T2 in the lungs was longer (p< 0.01) at end-expiration (9.7 +/- 0.7 ms) than at end-inspiration (9.0 +/- 0.8 ms) measured with inter-echo time 3.5 ms. The corresponding relative proton density (lung/muscle tissue) was higher (p< 0.001) during end-expiration, (0.61 +/- 0.06) than during end-inspiration (0.48 +/- 0.05). The ratio of relative proton density at end-inspiration to that at end-expiration was 0.78 +/- 0.09. Similar results were found for inter-echo time 4.0 ms and there was no significant difference between the T2 values or proton densities acquired with different interecho times. The T2 value increased linearly (p< 0.001) with proton density. Conclusion The measured T2 in-vivo is affected by diffusion across internal magnetic susceptibility gradients. In the lungs these gradients are modulated by respiration, as verified by calculations. In conclusion the measured T2 was found to be dependent on the size of the alveoli.	[Olsson, Lars E.] Lund Univ, Dept Med Radiat Phys, Translat Med, Malmo, Sweden; [Hockings, Paul D.] BioVenture Hub, Antaros Med, Molndal, Sweden; [Hockings, Paul D.] Chalmers Univ Technol, Medtech West, Gothenburg, Sweden	Lund University; Chalmers University of Technology	Olsson, LE (corresponding author), Lund Univ, Dept Med Radiat Phys, Translat Med, Malmo, Sweden.	lars_e.olsson@med.lu.se	Hockings, Paul D/AAM-7950-2020	Hockings, Paul D/0000-0002-7154-9047; Olsson, Lars E./0000-0001-6090-6697	AstraZeneca; Allmanna sjukhusets i Malmo stiftelse for bekampande av cancer; AstraZenenca, Molndal	AstraZeneca(AstraZeneca); Allmanna sjukhusets i Malmo stiftelse for bekampande av cancer; AstraZenenca, Molndal	This work was supported by AstraZeneca and Allmanna sjukhusets i Malmo stiftelse for bekampande av cancer. The funders provided support in form of salaries for LEO and PDH, but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; The authors wish to express their gratitude to AstraZenenca, Molndal for supporting the study and to Ms M. Palmer for her excellent technical assistance.	Alamidi DF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149760; Araujo ECA, 2014, BIOPHYS J, V106, P2267, DOI 10.1016/j.bpj.2014.04.010; Beckmann N, 2011, SMALL ANIMAL IMAGING: BASICS AND PRACTICAL GUIDE, P47, DOI 10.1007/978-3-642-12945-2_4; Buzan MTA, 2015, EUR RADIOL, V25, P3167, DOI 10.1007/s00330-015-3751-y; Callot V, 2003, MAGN RESON MED, V50, P531, DOI 10.1002/mrm.10568; Carinci F, 2015, SOC MAGN RES IM, P3975; Cutillo AG, 1998, MAGNET RESON MED, V39, P190, DOI 10.1002/mrm.1910390205; Cutillo AG., 1996, APPL MAGNETIC RESONA; Estilaei M, 1999, JMRI-J MAGN RESON IM, V9, P699, DOI 10.1002/(SICI)1522-2586(199905)9:5<699::AID-JMRI12>3.0.CO;2-H; Ganesan K, 1988, SOC MAGN RES IM, P577; Ganesan KAD, 1996, APPL MAGNETIC RESONA, P115; Haacke EM, 1999, MAGNETIC RESONANCE I, P624; Hajari AJ, 2012, J APPL PHYSIOL, V112, P937, DOI 10.1152/japplphysiol.00768.2011; HUBER DJ, 1985, INVEST RADIOL, V20, P460, DOI 10.1097/00004424-198508000-00004; Kindvall SSI, 2016, J MAGN RESON IMAGING, V43, P1250, DOI 10.1002/jmri.25085; Kolem H, 1989, P ANN M SOC MAGN RES, P783; Kurz FT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141894; Mulkern R, 2014, CONCEPT MAGN RESON A, V43, P29, DOI 10.1002/cmr.a.21297; Noseworthy MD, 1999, JMRI-J MAGN RESON IM, V9, P814, DOI 10.1002/(SICI)1522-2586(199906)9:6<814::AID-JMRI8>3.0.CO;2-5; Ohno Y, 2014, J MAGN RESON IMAGING, V39, P988, DOI 10.1002/jmri.24232; Olsson LE, 2007, J MAGN RESON IMAGING, V25, P488, DOI 10.1002/jmri.20840; Pracht ED, 2005, MAGNET RESON MED, V53, P1193, DOI 10.1002/mrm.20448; PURVES MJ, 1966, RESP PHYSIOL, V1, P281, DOI 10.1016/0034-5687(66)90047-8; Segars WP, 2004, MOL IMAGING BIOL, V6, P149, DOI 10.1016/j.mibio.2004.03.002; Shioya S, 1997, RADIAT RES, V148, P359, DOI 10.2307/3579521; Shioya S, 1990, SOC MAGN RES MED, P581; Shioya S, 2000, J MAGNETIC RESONANCE; Shioya S, 1996, APPL MAGNETIC RESONA, P227; Shioya S, 1990, SOC MAGN RES IM, P591; Spees WM, 2001, MAGN RESON MED, V45, P533, DOI 10.1002/mrm.1072; Stadler A, 2005, J MAGN RESON IMAGING, V21, P759, DOI 10.1002/jmri.20319; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Tadamura E, 1997, J MAGN RESON IMAGING, V7, P220, DOI 10.1002/jmri.1880070134; Takahashi M, 2010, J MAGN RESON IMAGING, V32, P326, DOI 10.1002/jmri.22267; Theilmann RJ, 2009, J MAGN RESON IMAGING, V30, P527, DOI 10.1002/jmri.21866; Wild JM, 2012, INSIGHTS IMAGING, V3, P345, DOI 10.1007/s13244-012-0176-x; Yung KT, 2003, MAGN RESON IMAGING, V21, P451, DOI 10.1016/S0730-725X(02)00640-9	37	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166879	10.1371/journal.pone.0166879	http://dx.doi.org/10.1371/journal.pone.0166879			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936061	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100046
J	Weng, QN; Liu, ZQ; Li, BJ; Liu, KQ; Wu, WJ; Liu, HL				Weng, Qiannan; Liu, Zequn; Li, Bojiang; Liu, Kaiqing; Wu, Wangjun; Liu, Honglin			Oxidative Stress Induces Mouse Follicular Granulosa Cells Apoptosis via JNK/FoxO1 Pathway	PLOS ONE			English	Article							IN-VITRO MATURATION; DEVELOPMENTAL COMPETENCE; TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION; JNK ACTIVATION; SURVIVAL; INVOLVEMENT; CANCER; INHIBITION; EXPRESSION	The c-Jun N-terminal protein kinase (JNK) plays an important role in the regulation of cell apoptosis. Forkhead box O (FoxO) transcription factors are involved in diverse biological processes, including cellular metabolism, cell apoptosis, and cell cycle. However, the JNK/FoxO1 pathway involved in the process of apoptosis induced by oxidative stress remains to be elucidated. Here, we demonstrated that the JNK activity significantly increased in response to oxidative stress in mouse follicular granulosa cells (MGCs). SP600125, a selective JNK inhibitor, attenuated the oxidative stress-induced MGCs apoptosis. Oxidative stress enhanced the FoxO1 nuclear translocation by activating the JNK activity. Moreover, JNK mediated the dissociation of FoxO1 from 14-3-3 proteins in MGCs after the treatment with H2O2. Finally, oxidative stress up-regulated the expression of FoxO1 via JNK mediation of FoxO1 self-regulation in MGCs. Taken together, our findings suggest that JNK/FoxO1 is involved in the regulation of oxidative stress-induced cell apoptosis in MGCs.	[Weng, Qiannan; Liu, Zequn; Li, Bojiang; Liu, Kaiqing; Wu, Wangjun; Liu, Honglin] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Liu, Zequn] Liaoning Prov Anim Product Safety Supervis, Shenyang, Peoples R China	Nanjing Agricultural University	Liu, HL (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	liuhonglin@njau.edu.cn	liu, honglin/HDN-0409-2022; Wu, Wangjun/AAA-9684-2019	liu, honglin/0000-0002-1254-3163; 	973 Program [2014CB138502]; National Natural Science Foundation of China [31472073, 31630072, 31501920]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This project was supported by the 973 Program (2014CB138502), the National Natural Science Foundation of China (31472073), the State Key Program of National Natural Science Foundation of China (31630072), the National Natural Science Foundation of China (31501920), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Aghazadeh Y, 2016, DRUG DISCOV TODAY, V21, P278, DOI 10.1016/j.drudis.2015.09.012; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering B, 2008, ONCOGENE, V27, P2258, DOI 10.1038/onc.2008.29; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Cao JL, 2015, AQUAT TOXICOL, V167, P180, DOI 10.1016/j.aquatox.2015.08.004; Chae HD, 2011, STEM CELLS DEV, V20, P1277, DOI 10.1089/scd.2010.0465; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cui W, 2012, PLOS ONE, V7; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Diebold I, 2011, MOL BIOL CELL, V22, P4424, DOI 10.1091/mbc.E10-12-0971; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Fontani F, 2015, CALCIFIED TISSUE INT, V96, P335, DOI 10.1007/s00223-015-9961-0; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Huang F., 2016, INT J MOL SCI, V17; Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200; Jiao GZ, 2016, CELL REPROGRAM, V18, P17, DOI 10.1089/cell.2015.0055; Jiao GZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058018; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Lin YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079299; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Liu Z. H., 2015, HIGHWAY, V2015, P1, DOI DOI 10.1016/J.FUPR0C.2015.01.025; Lu XH, 1997, J BIOL CHEM, V272, P24751, DOI 10.1074/jbc.272.40.24751; Matsuda F, 2012, J REPROD DEVELOP, V58, P44, DOI 10.1262/jrd.2011-012; Ou XH, 2010, CELL CYCLE, V9, P4130, DOI 10.4161/cc.9.20.13389; Paul M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127558; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Shen M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.400; Shen M, 2012, J BIOL CHEM, V287, P25727, DOI 10.1074/jbc.M112.349902; Shukla S, 2016, TOXICOL APPL PHARM, V291, P70, DOI 10.1016/j.taap.2015.12.006; Sun QY, 1999, REPROD FERT DEVELOP, V11, P443, DOI 10.1071/RD00014; Sun W, 2016, FREE RADICAL BIO MED, V92, P61, DOI 10.1016/j.freeradbiomed.2016.01.014; Sunayama J, 2005, J CELL BIOL, V170, P295, DOI 10.1083/jcb.200409117; Tang HB, 2011, FASEB J, V25, P2921, DOI 10.1096/fj.11-183798; Wang HL, 2011, CELL REPROGRAM, V13, P225, DOI 10.1089/cell.2010.0101; Wang TY, 2014, MOL HUM REPROD, V20, P318, DOI 10.1093/molehr/gat088; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Yoon JD, 2015, THERIOGENOLOGY, V83, P294, DOI 10.1016/j.theriogenology.2014.09.025; Yuan ZQ, 2009, J BIOL CHEM, V284, P11285, DOI 10.1074/jbc.M900461200; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang XY, 2015, SCI REP-UK, V5, DOI [10.1038/srep09940, 10.1038/srep09803]; Zhou JY, 2012, AUTOPHAGY, V8, P1712, DOI 10.4161/auto.21830; Zhou P, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095281	48	44	49	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167869	10.1371/journal.pone.0167869	http://dx.doi.org/10.1371/journal.pone.0167869			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936150	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100222
J	Fayad, SM; Guzick, AG; Reid, AM; Mason, DM; Bertone, A; Foote, KD; Okun, MS; Goodman, WK; Ward, HE				Fayad, Sarah M.; Guzick, Andrew G.; Reid, Adam M.; Mason, Dana M.; Bertone, Agustina; Foote, Kelly D.; Okun, Michael S.; Goodman, Wayne K.; Ward, Herbert E.			Six-Nine Year Follow-Up of Deep Brain Stimulation for Obsessive-Compulsive Disorder	PLOS ONE			English	Article							LONGITUDINAL DATA; RATING-SCALE; DEPRESSION; PSYCHOTHERAPY; EPIDEMIOLOGY	Objective Deep brain stimulation (DBS) of the ventral capsule/ventral striatum (VC/VS) region has shown promise as a neurosurgical intervention for adults with severe treatment-refractory obsessive-compulsive disorder (OCD). Pilot studies have revealed improvement in obsessive-compulsive symptoms and secondary outcomes following DBS. We sought to establish the long-term safety and effectiveness of DBS of the VC/VS for adults with OCD. Materials and Methods A long term follow-up study (73-112 months) was conducted on the six patients who were enrolled in the original National Institute of Mental Health pilot study of DBS for OCD. Qualitative and quantitative data were collected. Results Reduction in OCD symptoms mirrored the one-year follow-up data. The same four participants who were treatment responders after one year of treatment showed a consistent OCD response (greater than 35% reduction in Yale Brown Obsessive Compulsive Scale (YBOCS)). Another subject, classified as a non-responder, achieved a 26% reduction in YBOCS score at long term follow-up. The only patient who did not achieve a 25% or greater reduction in YBOCS was no longer receiving active DBS treatment. Secondary outcomes generally matched the one-year follow-up with the exception of depressive symptoms, which significantly increased over the follow-up period. Qualitative feedback indicated that DBS was well tolerated by the subjects. Discussion These data indicate that DBS was safe and conferred a long-term benefit in reduction of obsessive-compulsive symptoms. DBS of the VC/VS region did not reveal a sustained response for comorbid depressive symptoms in patients with a primary diagnosis of OCD.	[Fayad, Sarah M.; Guzick, Andrew G.; Reid, Adam M.; Mason, Dana M.; Bertone, Agustina; Ward, Herbert E.] Univ Florida, Coll Med, Dept Psychiat, Gainesville, FL 32611 USA; [Guzick, Andrew G.; Reid, Adam M.] Univ Florida, Dept Clin & Hlth Psychol, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Reid, Adam M.] Harvard Med Sch, Dept Psychiat, Boston, MA USA; [Foote, Kelly D.] Univ Florida, Coll Med, Dept Neurosurg, Gainesville, FL USA; [Okun, Michael S.] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA; [Goodman, Wayne K.] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Harvard University; Harvard Medical School; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Icahn School of Medicine at Mount Sinai	Ward, HE (corresponding author), Univ Florida, Coll Med, Dept Psychiat, Gainesville, FL 32611 USA.	hward@ufl.edu		Foote, Kelly/0000-0002-2436-4138	National Institutes of Health [R21MH064161]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The follow-up study was unfunded; the initial pilot study was supported by the following grant: National Institutes of Health (R21MH064161); ClinicalTrials.gov Identifier: NCT00057603.	ABRAMOWITZ JS, 2005, UNDERSTANDING TREATI; Bloch MH, 2010, MOL PSYCHIATR, V15, P850, DOI 10.1038/mp.2009.50; Bobes J, 2001, EUR PSYCHIAT, V16, P239, DOI 10.1016/S0924-9338(01)00571-5; Fins JJ, 2011, HEALTH AFFAIR, V30, P302, DOI 10.1377/hlthaff.2010.0157; Gallop R, 2009, PSYCHOTHER RES, V19, P438, DOI 10.1080/10503300902849475; Goodman WK, 2010, BIOL PSYCHIAT, V67, P535, DOI 10.1016/j.biopsych.2009.11.028; Goodman WK, 2000, LEA SER PER CLIN PSY, P333; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Greenberg BD, 2006, NEUROPSYCHOPHARMACOL, V31, P2384, DOI 10.1038/sj.npp.1301165; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Horwath E, 2000, PSYCHIAT CLIN N AM, V23, P493, DOI 10.1016/S0193-953X(05)70176-3; Kahn JH, 2013, J CLIN PSYCHOL, V69, P543, DOI 10.1002/jclp.21964; KARNO M, 1988, ARCH GEN PSYCHIAT, V45, P1094, DOI 10.1001/archpsyc.1988.01800360042006; Maas C.J.M., 2005, METHODOLOGY, V1, P86, DOI [10.1027/1614-2241.1.3.86, DOI 10.1027/1614-2241.1.3.86]; Malone DA, 2009, BIOL PSYCHIAT, V65, P267, DOI 10.1016/j.biopsych.2008.08.029; Monroe SM, 2011, PSYCHOL REV, V118, P655, DOI 10.1037/a0025190; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nuttin B, 1999, LANCET, V354, P1526, DOI 10.1016/S0140-6736(99)02376-4; Nuttin BJ, 2003, NEUROSURGERY, V52, P1263, DOI 10.1227/01.NEU.0000064565.49299.9A; Ooms P, 2014, J NEUROL NEUROSUR PS, V85, P153, DOI 10.1136/jnnp-2012-302550; Pine DS, 1998, ARCH GEN PSYCHIAT, V55, P56, DOI 10.1001/archpsyc.55.1.56; Rosa-Alcazar AI, 2008, CLIN PSYCHOL REV, V28, P1310, DOI 10.1016/j.cpr.2008.07.001; Rufer M, 2005, J AFFECT DISORDERS, V88, P99, DOI 10.1016/j.jad.2005.06.003; Ruscio AM, 2010, MOL PSYCHIATR, V15, P53, DOI 10.1038/mp.2008.94; Snijders T., 1999, MULTILEVEL MODELING; Tasca GA, 2009, PSYCHOTHER RES, V19, P429, DOI 10.1080/10503300802641444; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Zimmerman M, 2013, J AFFECT DISORDERS, V150, P384, DOI 10.1016/j.jad.2013.04.028	28	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167875	10.1371/journal.pone.0167875	http://dx.doi.org/10.1371/journal.pone.0167875			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4OA	27930748	gold, Green Submitted, Green Published			2022-12-27	WOS:000389580900054
J	Grove, E; Eckardt, S; McLaughlin, KJ				Grove, Erin; Eckardt, Sigrid; McLaughlin, K. John			High-Speed Mouse Backcrossing Through the Female Germ Line	PLOS ONE			English	Article							GENE-EXPRESSION; SUPEROVULATION; MICE; STRAINS; PERTURBATIONS; METHYLATION; STRATEGIES; MODEL; DNA	Transferring mouse mutations into specific mouse strain backgrounds can be critical for appropriate analysis of phenotypic effects of targeted genomic alterations and quantitative trait loci. Speed congenic breeding strategies incorporating marker-assisted selection of progeny with the highest percentage target background as breeders for the next generation can produce congenic strains within approximately 5 generations. When mating selected donor males to target strain females, this may require more than 1 year, with each generation lasting 10 to 11 weeks including 3 weeks of gestation and 7 to 8 weeks until the males reach sexual maturity. Because ovulation can be induced in female mice as early as 3 weeks of age, superovulation-aided backcrossing of marker-selected females could accelerate the production of congenic animals by approximately 4 weeks per generation, reducing time and cost. Using this approach, we transferred a transgenic strain of undefined genetic background to >99% C57BL/6J within 10 months, with most generations lasting 7 weeks. This involved less than 60 mice in total, with 9 to 18 animals per generation. Our data demonstrate that high-speed backcrossing through the female germline is feasible and practical with small mouse numbers.	[Grove, Erin; Eckardt, Sigrid; McLaughlin, K. John] Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, Columbus, OH 43205 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	McLaughlin, KJ (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, Columbus, OH 43205 USA.	John.McLaughlin@nationwidechildrens.org			Research Institute at Nationwide Children's Hospital	Research Institute at Nationwide Children's Hospital(Ohio State University)	This study was funded by The Research Institute at Nationwide Children's Hospital, and there was no additional external funding received for this study.	Ackert-Bicknell CL, 2016, J BONE MINER RES, V31, P270, DOI 10.1002/jbmr.2772; Almind K, 2003, DIABETES, V52, P1535, DOI 10.2337/diabetes.52.6.1535; Armstrong NJ, 2006, MAMM GENOME, V17, P273, DOI 10.1007/s00335-005-0123-y; Behringer R, 1998, NAT GENET, V18, P108, DOI 10.1038/ng0298-108; Behringer RR, 2014, MANIPULATING THE MOU; de Waal E, 2015, HUM MOL GENET, V24, P6975, DOI 10.1093/hmg/ddv400; Denomme MM, 2011, FERTIL STERIL, V96, P734, DOI 10.1016/j.fertnstert.2011.06.055; Fortier AL, 2014, MOL CELL ENDOCRINOL, V388, P51, DOI 10.1016/j.mce.2014.03.003; Gao Z, 2014, J ASSIST REPROD GEN, V31, P1243, DOI 10.1007/s10815-014-0295-z; Huffman SR, 2015, MOL REPROD DEV, V82, P207, DOI 10.1002/mrd.22463; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Landa V, 2010, METHODS MOL BIOL, V597, P267, DOI 10.1007/978-1-60327-389-3_18; Linder CC, 2006, ILAR J, V47, P132, DOI 10.1093/ilar.47.2.132; Luo C, 2011, J AM ASSOC LAB ANIM, V50, P471; Lusis AJ, 2007, ARTERIOSCL THROM VAS, V27, P2100, DOI 10.1161/ATVBAHA.107.147918; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; Market-Velker BA, 2010, BIOL REPROD, V83, P938, DOI 10.1095/biolreprod.110.085480; Market-Velker BA, 2010, HUM MOL GENET, V19, P36, DOI 10.1093/hmg/ddp465; Ogonuki N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004943; Rivera J, 2008, IMMUNITY, V28, P1, DOI 10.1016/j.immuni.2007.12.008; Singh P, 2015, GENETICS, V199, P1, DOI 10.1534/genetics.114.169771; Takeo T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128330; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Vanden Berghe T, 2015, IMMUNITY, V43, P200, DOI 10.1016/j.immuni.2015.06.011; Wei ZT, 2014, J ASSIST REPROD GEN, V31, P555, DOI 10.1007/s10815-014-0191-6; Yoshiki A, 2006, ILAR J, V47, P94, DOI 10.1093/ilar.47.2.94	26	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2016	11	12							e0166822	10.1371/journal.pone.0166822	http://dx.doi.org/10.1371/journal.pone.0166822			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4NG	27926922	Green Published, Green Submitted, gold			2022-12-27	WOS:000389578800007
J	Jonkergouw, N; Prins, MR; Buis, AWP; van der Wurff, P				Jonkergouw, Niels; Prins, Maarten R.; Buis, Arjan W. P.; van der Wurff, Peter			The Effect of Alignment Changes on Unilateral Transtibial Amputee's Gait: A Systematic Review	PLOS ONE			English	Article							SOCKET REACTION MOMENTS; BELOW-KNEE AMPUTEES; DIFFERENT PROSTHETIC COMPONENTS; INTACT LIMB; AMPUTATION; WALKING; INDIVIDUALS; ADAPTATIONS; INITIATION; ASYMMETRY	Introduction Prosthetic alignment, positioning of a prosthetic foot relative to a socket, is an iterative process in which an amputee's gait is optimized through repetitive optical gait observation and induction of alignment adjustments when deviations are detected in spatiotemporal and kinematic gait parameters. An important limitation of the current prosthetic alignment approach is the subjectivity and the lack of standardized quantifiable baseline values. The purpose of this systematic review is to investigate if an optimal alignment criterion can be derived from published articles. Moreover, we investigated the effect of alignment changes on spatiotemporal, kinematic and kinetic gait parameters. Results A total of 11 studies were included, two controlled before-and-after studies and nine-interrupted time series studies. Discussion The results demonstrate that alignment changes have a predictable influence on the included kinetic parameters. However, the effect of alignment changes on spatio-temporal and kinematic gait parameters are generally unpredictable. These findings suggest that it is imperative to include kinetics in the process of dynamic prosthetic alignment. Partially this can be established by communication with the prosthetic user in terms of perceived socket comfort, but the use of measurement tools should also be considered. While current literature is not conclusive about an optimal alignment, future alignment research should focus on alignment optimisation based on kinetic outcomes.	[Jonkergouw, Niels] Mil Rehabil Ctr Aardenburg, Dept Orthopaed Technol, Doorn, Netherlands; [Jonkergouw, Niels; Buis, Arjan W. P.] Univ Strathclyde, Dept Biomed Engn, Glasgow, Lanark, Scotland; [Jonkergouw, Niels; Prins, Maarten R.; van der Wurff, Peter] Mil Rehabil Ctr Aardenburg, Dept Res & Dev, Doorn, Netherlands; [Prins, Maarten R.] Vrije Univ Amsterdam, Fac Human Movement Sci, Res Inst MOVE, Amsterdam, Netherlands; [Prins, Maarten R.; van der Wurff, Peter] HU Univ Appl Sci Utrecht, Dept Phys Therapy, Utrecht, Netherlands	University of Strathclyde; Vrije Universiteit Amsterdam	Jonkergouw, N (corresponding author), Mil Rehabil Ctr Aardenburg, Dept Orthopaed Technol, Doorn, Netherlands.; Jonkergouw, N (corresponding author), Univ Strathclyde, Dept Biomed Engn, Glasgow, Lanark, Scotland.; Jonkergouw, N (corresponding author), Mil Rehabil Ctr Aardenburg, Dept Res & Dev, Doorn, Netherlands.	n.jonkergouw@mrcdoorn.nl	Prins, Maarten/E-7963-2018	Prins, Maarten/0000-0003-3593-202X; Jonkergouw, Niels/0000-0001-6449-6656; Buis, Arjan/0000-0003-3947-293X				ANDRES RO, 1990, CLIN BIOMECH, V5, P88, DOI 10.1016/0268-0033(90)90043-6; Bartels B, 2013, PHYS THER, V93, P529, DOI 10.2522/ptj.20120210; BATENI H, 2002, J PROSTHET ORTHOT, V14, P2; Beyaert C, 2008, GAIT POSTURE, V28, P278, DOI 10.1016/j.gaitpost.2007.12.073; Blumentritt S, 1997, PROSTHET ORTHOT INT, V21, P107; Boone D.A, 2005, INVESITAGTION SOCKET; Boone DA, 2013, GAIT POSTURE, V37, P620, DOI 10.1016/j.gaitpost.2012.10.002; Chow DHK, 2006, PROSTHET ORTHOT INT, V30, P114, DOI 10.1080/03093640600568617; Fiedler G, 2014, PROSTHET ORTHOT INT, P1; Fridman A, 2003, PROSTHET ORTHOT INT, V27, P17; Grumillier C, 2008, J BIOMECH, V41, P2926, DOI 10.1016/j.jbiomech.2008.07.018; Hak L, 2014, PHYS THER, V94, P1480, DOI 10.2522/ptj.20130431; ISAKOV E, 1994, CLIN BIOMECH, V9, P258, DOI 10.1016/0268-0033(94)90008-6; Isakov E, 2000, PROSTHET ORTHOT INT, V24, P216, DOI 10.1080/03093640008726550; Jia Xiaohong, 2008, Tsinghua Science and Technology, V13, P581, DOI 10.1016/S1007-0214(08)70092-0; Kobayashi T, 2014, 2014 26 INT TEL C IT, P1; Kobayashi T, 2014, CLIN BIOMECH, V29, P590, DOI 10.1016/j.clinbiomech.2014.04.002; Kobayashi T, 2014, J BIOMECH, V47, P1315, DOI 10.1016/j.jbiomech.2014.02.012; Kobayashi T, 2014, CLIN BIOMECH, V29, P47, DOI 10.1016/j.clinbiomech.2013.11.005; Kobayashi T, 2013, J BIOMECH, V46, P1343, DOI 10.1016/j.jbiomech.2013.01.026; Kobayashi T, 2012, J BIOMECH, V45, P2603, DOI 10.1016/j.jbiomech.2012.08.014; Kolarova B, 2013, ARCH PHYS MED REHAB, V94, P2234, DOI 10.1016/j.apmr.2013.05.019; Major MJ, 2012, PROSTHET ORTHOT INT, V36, P231, DOI 10.1177/0309364611435996; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Pinzur MS, 1995, J REHABIL RES DEV, V32, P373; Roerdink M, 2012, GAIT POSTURE, V35, P446, DOI 10.1016/j.gaitpost.2011.11.005; ROSSI SA, 1995, J REHABIL RES DEV, V32, P120; Sadeghi H, 2001, AM J PHYS MED REHAB, V80, P25, DOI 10.1097/00002060-200101000-00007; Sanderson DJ, 1997, GAIT POSTURE, V6, P126, DOI 10.1016/S0966-6362(97)01112-0; Schmalz T, 2002, GAIT POSTURE, V16, P255, DOI 10.1016/S0966-6362(02)00008-5; Tokuno CD, 2003, GAIT POSTURE, V18, P158, DOI 10.1016/S0966-6362(03)00004-3; van der Linde H, 2004, J REHABIL RES DEV, V41, P555, DOI 10.1682/JRRD.2003.06.0102; vanTulder MW, 1997, SPINE, V22, P2323, DOI 10.1097/00007632-199710150-00001; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; WINTER DA, 1988, J BIOMECH, V21, P361, DOI 10.1016/0021-9290(88)90142-X; Zahedi M S, 1986, J Rehabil Res Dev, V23, P2	36	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2016	11	12							e0167466	10.1371/journal.pone.0167466	http://dx.doi.org/10.1371/journal.pone.0167466			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4MY	27923050	gold, Green Published, Green Accepted			2022-12-27	WOS:000389577900005
J	Garge, SS; Nerurkar, AS				Garge, Sneha S.; Nerurkar, Anuradha S.			Attenuation of Quorum Sensing Regulated Virulence of Pectobacterium carotovorum subsp carotovorum through an AHL Lactonase Produced by Lysinibacillus sp Gs50	PLOS ONE			English	Article							N-ACYLHOMOSERINE LACTONASE; SP STRAIN; BACTERIA; ENZYME; GROWTH; SIGNAL; IDENTIFICATION; COMMUNICATION; RHIZOSPHERE; SPECIFICITY	Quorum sensing (QS) is a mechanism in which Gram negative bacterial pathogens sense their population density through acyl homoserine lactones (AHLs) and regulate the expression of virulence factors. Enzymatic degradation of AHLs by lactonases, known as quorum quenching (QQ), is thus a potential strategy for attenuating QS regulated bacterial infections. We characterised the QQ activity of soil isolate Lysinibacillus sp. Gs50 and explored its potential for controlling bacterial soft rot of crop plants. Lysinibacillus sp. Gs50 inactivated AHL, which could be restored upon acidification, suggested that inactivation was due to the lactone ring hydrolysis of AHL. Heterologous expression of cloned gene for putative hydro lase (792 bp) designated adeH from Lysinibacillus sp. Gs50 produced a-29 kDa protein which degraded AHLs of varying chain length. Mass spectrometry analysis of AdeH enzymatic reaction product revealed that AdeH hydrolyses the lactone ring of AHL and hence is an AHL lactonase. Multiple sequence alignment of the amino acid sequence of AdeH showed that it belongs to the metallo-13-lactamase superfamily, has a conserved "HXHXDH" motif typical of AHL lactonases. KM for AdeH for C6HSL was found to be 3.089 mu M and the specific activity was 0.8 picomol min(-1) mu g(-1). AdeH has not so far been reported from any Lysinibacillus sp. and has less than 40% identity with known AHL lactonases. Finally we found that Lysinibacillus sp. Gs50 can degrade AHL produced by Pectobacterium carotovorum subsp. carotovorum (Pcc), a common cause of soft rot. This QQ activity causes a decrease in production of plant cell wall degrading enzymes of Pcc and attenuates symptoms of soft rot in experimental infection of potato, carrot and cucumber. Our results demonstrate the potential of Lysinibacillus sp. Gs50 as a preventive and curative biocontrol agent.	[Nerurkar, Anuradha S.] Maharaja Sayajirao Univ Baroda, Dept Microbiol, Vadodara, Gujarat, India; Maharaja Sayajirao Univ Baroda, Fac Sci, Ctr Biotechnol, Vadodara, Gujarat, India	Maharaja Sayajirao University Baroda; Maharaja Sayajirao University Baroda	Nerurkar, AS (corresponding author), Maharaja Sayajirao Univ Baroda, Dept Microbiol, Vadodara, Gujarat, India.	anuner26@yahoo.com	Nerurkar, Anuradha/AAA-4099-2019		Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India [BT/PR3474/AGR/05/559/2011]	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	ASN acknowledges Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India (BT/PR3474/AGR/05/559/2011), for funding, and SSG for the fellowship in this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2007, INT J SYST EVOL MICR, V57, P1117, DOI 10.1099/ijs.0.63867-0; Amara N, 2011, CHEM REV, V111, P195, DOI 10.1021/cr100101c; Augustine N, 2010, ARCH MICROBIOL, V192, P1019, DOI 10.1007/s00203-010-0633-1; Barnard AML, 2007, ANAL BIOANAL CHEM, V387, P415, DOI 10.1007/s00216-006-0701-1; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; Carlier A, 2003, APPL ENVIRON MICROB, V69, P4989, DOI 10.1128/AEM.69.8.4989-4993.2003; Cirou A, 2007, ENVIRON MICROBIOL, V9, P1511, DOI 10.1111/j.1462-2920.2007.01270.x; Czajkowski R, 2009, ACTA BIOCHIM POL, V56, P1; d'Angelo-Picard C, 2005, ENVIRON MICROBIOL, V7, P1796, DOI 10.1111/j.1462-2920.2005.00886.x; Dong YH, 2005, J MICROBIOL, V43, P101; Dong YH, 2004, APPL ENVIRON MICROB, V70, P954, DOI 10.1128/AEM.70.2.954-960.2004; Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897; Dong YH, 2002, APPL ENVIRON MICROB, V68, P1754, DOI 10.1128/AEM.68.4.1754-1759.2002; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; Faure D, 2007, EUR J PLANT PATHOL, V119, P353, DOI 10.1007/s10658-007-9149-1; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; Gantner S, 2006, FEMS MICROBIOL ECOL, V56, P188, DOI 10.1111/j.1574-6941.2005.00037.x; Gao A, 2013, ACTA CRYSTALLOGR D, V69, P82, DOI 10.1107/S0907444912042369; Hirakawa H, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00114; Huang JJ, 2003, APPL ENVIRON MICROB, V69, P5941, DOI 10.1128/AEM.69.10.5941-5949.2003; Jafra S, 2006, CAN J MICROBIOL, V52, P1006, DOI 10.1139/W06-062; Kalia VC, 2011, OPEN MICROBIOL J, V5; Kim MH, 2005, BBA-PROTEINS PROTEOM, V1750, P5, DOI 10.1016/j.bbapap.2005.04.004; Leadbetter JR, 2000, J BACTERIOL, V182, P6921, DOI 10.1128/JB.182.24.6921-6926.2000; Lee SJ, 2002, APPL ENVIRON MICROB, V68, P3919, DOI 10.1128/AEM.68.8.3919-3924.2002; Lin YH, 2003, MOL MICROBIOL, V47, P849, DOI 10.1046/j.1365-2958.2003.03351.x; Liu DL, 2007, BIOCHEMISTRY-US, V46, P11789, DOI 10.1021/bi7012849; Liu DL, 2005, P NATL ACAD SCI USA, V102, P11882, DOI 10.1073/pnas.0505255102; Liu H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000093; Maisuria VB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138034; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; Mei GY, 2010, APPL ENVIRON MICROB, V76, P4933, DOI 10.1128/AEM.00477-10; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Molina L, 2003, FEMS MICROBIOL ECOL, V45, P71, DOI 10.1016/S0168-6496(03)00125-9; Nedjma M, 2001, ANAL BIOCHEM, V291, P290, DOI 10.1006/abio.2001.5032; Pana J, 2008, MICROBIOL RES, V163, P711, DOI 10.1016/j.micres.2007.12.002; Park SY, 2006, FEMS MICROBIOL LETT, V261, P102, DOI 10.1111/j.1574-6968.2006.00336.x; Park SY, 2005, APPL ENVIRON MICROB, V71, P2632, DOI 10.1128/AEM.71.5.2632-2641.2005; Park SY, 2003, MICROBIOL-SGM, V149, P1541, DOI 10.1099/mic.0.26269-0; Seo MJ, 2011, BIOSCI BIOTECH BIOCH, V75, P1789, DOI 10.1271/bbb.110322; Tang KH, 2015, APPL ENVIRON MICROB, V81, P774, DOI 10.1128/AEM.02805-14; Uroz S, 2003, MICROBIOL-SGM, V149, P1981, DOI 10.1099/mic.0.26375-0; Uroz S, 2008, APPL ENVIRON MICROB, V74, P1357, DOI 10.1128/AEM.02014-07; Uroz S, 2007, ARCH MICROBIOL, V187, P249, DOI 10.1007/s00203-006-0186-5; Uroz S, 2009, CHEMBIOCHEM, V10, P205, DOI 10.1002/cbic.200800521; von Bodman SB, 2003, ANNU REV PHYTOPATHOL, V41, P455, DOI 10.1146/annurev.phyto.41.052002.095652; Wang LH, 2004, J BIOL CHEM, V279, P13645, DOI 10.1074/jbc.M311194200; Wang W-Z, 2010, APPL ENVIRON MICROB, V78, P7985; Wang WZ, 2010, APPL ENVIRON MICROB, V76, P2524, DOI 10.1128/AEM.02738-09; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x; Yates EA, 2002, INFECT IMMUN, V70, P5635, DOI 10.1128/IAI.70.10.5635-5646.2002; Yin XT, 2010, WORLD J MICROB BIOT, V26, P1361, DOI 10.1007/s11274-010-0308-8; Zhang H, 2007, CURR PROTOC MICROBIO	53	24	27	10	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167344	10.1371/journal.pone.0167344	http://dx.doi.org/10.1371/journal.pone.0167344			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911925	gold, Green Published, Green Submitted			2022-12-27	WOS:000389520600030
J	Lee, DK; Kim, HJ; Lee, DH				Lee, Do-Kyung; Kim, Hyun-Jung; Lee, Dae-Hee			Incidence of Deep Vein Thrombosis and Venous Thromboembolism following TKA in Rheumatoid Arthritis versus Osteoarthritis: A Meta-Analysis	PLOS ONE			English	Article							TOTAL KNEE ARTHROPLASTY; SILENT PULMONARY-EMBOLISM; TOTAL JOINT ARTHROPLASTY; RISK; COMPLICATIONS; INFLAMMATION; COAGULATION	This meta-analysis was designed to compare the incidence of deep vein thrombosis (DVT) and venous thromboembolism (VTE) following total knee arthroplasty (TKA) in patients with rheumatoid arthritis (RA) and osteoarthritis (OA). All studies directly comparing the post-TKA incidence of DVT and/or VTE in patients with RA and OA were included. For all comparisons, odds ratios and 95% confidence intervals (CI) were calculated for binary outcomes. Six studies were included in the meta-analysis. The pooled data showed that the combined rates of asymptomatic and symptomatic DVT did not differ significantly in the RA and OA groups (1065/222,714 [0.5%] vs. 35,983/6,959,157 [0.5%]; OR 0.77, 95% CI: 0.57 to 1.02; P = 0.07). The combined rates of asymptomatic and symptomatic DVT and pulmonary embolism (PE) after TKA were significantly lower in the RA than in the OA group (1831/225,406 [0.8%] vs. 63,953/7,018,721 [0.9%]; OR 0.76, 95% CI: 0.62 to 0.93; P = 0.008). Conclusiviely, the DVT rates after primary TKA were similar in RA and OA patients. In contrast, the incidence of VTE (DVT plus PE) after primary TKA was lower in RA than in OA patients, despite patients with RA being at theoretically higher risk of thrombi due to chronic inflammation.	[Lee, Do-Kyung; Lee, Dae-Hee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Orthopaed Surg, Seoul, South Korea; [Kim, Hyun-Jung] Korea Univ, Dept Prevent Med, Coll Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Korea University; Korea University Medicine (KU Medicine)	Lee, DH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Orthopaed Surg, Seoul, South Korea.	eoak22@empal.com	lee, dae hee/I-9390-2017	Lee, Do kyung/0000-0001-6596-1222				Borensztajn KS, 2011, CURR PHARM DESIGN, V17, P9; Choi HK, 2013, ANN RHEUM DIS, V72, P1182, DOI 10.1136/annrheumdis-2012-201669; Chung WS, 2014, ANN RHEUM DIS, V73, P1774, DOI 10.1136/annrheumdis-2013-203380; Hansson GK, 2015, J INTERN MED, V278, P483, DOI 10.1111/joim.12406; Hughes MJ, 2014, THROMB RES, V134, P1182, DOI 10.1016/j.thromres.2014.09.036; Izumi M, 2015, J RHEUMATOL, V42, P928, DOI 10.3899/jrheum.140768; Jauregui JJ, 2016, CLIN RHEUMATOL, V35, P595, DOI 10.1007/s10067-015-3037-4; Kim Jun-Young, 2012, Knee Surg Relat Res, V24, P221, DOI 10.5792/ksrr.2012.24.4.221; Kim SC, 2013, ARTHRIT CARE RES, V65, P1600, DOI 10.1002/acr.22039; Kory PD, 2011, CHEST, V139, P538, DOI 10.1378/chest.10-1479; Kwak JY, 2012, CLIN ORTHOP SURG, V4, P256, DOI 10.4055/cios.2012.4.4.256; Lee DH, 2010, KNEE SURG SPORT TR A, V18, P381, DOI 10.1007/s00167-009-0983-x; Lee Jin Kyu, 2012, Knee Surg Relat Res, V24, P1, DOI 10.5792/ksrr.2012.24.1.1; Lee WS, 2013, CLIN ORTHOP RELAT R, V471, P1523, DOI 10.1007/s11999-012-2758-9; Li FH, 2014, PHLEBOLOGY, V29, P442, DOI 10.1177/0268355513487331; LoVerde ZJ, 2015, J RHEUMATOL, V42, P1123, DOI 10.3899/jrheum.141251; Matta F, 2009, THROMB HAEMOSTASIS, V101, P134, DOI 10.1160/TH08-08-0551; Mukubo Yukiko, 2004, J Anesth, V18, P62, DOI 10.1007/s00540-003-0206-4; Niki Y, 2010, J ORTHOP SCI, V15, P57, DOI 10.1007/s00776-009-1410-3; Porfidia A, 2016, INTERN EMERG MED; Ravi B, 2014, ARTHRITIS RHEUMATOL, V66, P254, DOI 10.1002/art.38231; Ravi B, 2012, ARTHRITIS RHEUM-US, V64, P3839, DOI 10.1002/art.37690; Schnaser EA, 2015, J ARTHROPLASTY, V30, P76, DOI 10.1016/j.arth.2014.12.040; Stundner O, 2014, J ARTHROPLASTY, V29, P308, DOI 10.1016/j.arth.2013.05.008; Xu J, 2010, HAMOSTASEOLOGIE, V30, P5	25	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0166844	10.1371/journal.pone.0166844	http://dx.doi.org/10.1371/journal.pone.0166844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911916	gold, Green Submitted, Green Published			2022-12-27	WOS:000389520600015
J	Ayuso, M; Fernandez, A; Nunez, Y; Benitez, R; Isabel, B; Fernandez, AI; Rey, AI; Gonzalez-Bulnes, A; Medrano, JF; Canovas, A; Lopez-Bote, CJ; Ovilo, C				Ayuso, Miriam; Fernandez, Almudena; Nunez, Yolanda; Benitez, Rita; Isabel, Beatriz; Fernandez, Ana I.; Rey, Ana I.; Gonzalez-Bulnes, Antonio; Medrano, Juan F.; Canovas, Angela; Lopez-Bote, Clemente J.; Ovilo, Cristina			Developmental Stage, Muscle and Genetic Type Modify Muscle Transcriptome in Pigs: Effects on Gene Expression and Regulatory Factors Involved in Growth and Metabolism	PLOS ONE			English	Article							MEAT QUALITY TRAITS; FATTY-ACID PROFILE; TERMINAL SIRE LINE; IBERIAN PIGS; DIFFERENTIAL EXPRESSION; CARCASS CHARACTERISTICS; LIPID-COMPOSITION; BODY-COMPOSITION; ADIPOSE-TISSUE; ADVANCED ONSET	Iberian pig production includes purebred (IB) and Duroc-crossbred (IBxDU) pigs, which show important differences in growth, fattening and tissue composition. This experiment was conducted to investigate the effects of genetic type and muscle (Longissimus dorsi (LD) vs Biceps femoris (BF)) on gene expression and transcriptional regulation at two developmental stages. Nine IB and 10 IBxDU piglets were slaughtered at birth, and seven IB and 10 IBxDU at four months of age (growing period). Carcass traits and LD intramuscular fat (IMF) content were measured. Muscle transcriptome was analyzed on LD samples with RNA-Seq technology. Carcasses were smaller in IB than in IBxDU neonates (p < 0.001), while growing IB pigs showed greater IMF content (p < 0.05). Gene expression was affected (p < 0.01 and Fold change > 1.5) by the developmental stage (5,812 genes), muscle type (135 genes), and genetic type (261 genes at birth and 113 at growth). Newborns transcriptome reflected a highly proliferative developmental stage, while older pigs showed upregulation of catabolic and muscle functioning processes. Regarding the genetic type effect, IBxDU newborns showed enrichment of gene pathways involved in muscle growth, in agreement with the higher prenatal growth observed in these pigs. However, IB growing pigs showed enrichment of pathways involved in protein deposition and cellular growth, supporting the compensatory gain experienced by IB pigs during this period. Moreover, newborn and growing IB pigs showed more active glucose and lipid metabolism than IBxDU pigs. Moreover, LD muscle seems to have more active muscular and cell growth, while BF points towards lipid metabolism and fat deposition. Several regulators controlling transcriptome changes in both genotypes were identified across muscles and ages (SIM1, PVALB, MEFs, TCF7L2 or FOXO1), being strong candidate genes to drive expression and thus, phenotypic differences between IB and IBxDU pigs. Many of the identified regulators were known to be involved in muscle and adipose tissues development, but others not previously associated with pig muscle growth were also identified, as PVALB, KLF1 or IRF2. The present study discloses potential molecular mechanisms underlying phenotypic differences observed between IB and IBxDU pigs and highlights candidate genes implicated in these molecular mechanisms.	[Ayuso, Miriam; Isabel, Beatriz; Rey, Ana I.; Lopez-Bote, Clemente J.] Univ Complutense Madrid, Dept Anim Prod, Fac Vet, Madrid, Spain; [Fernandez, Almudena; Nunez, Yolanda; Benitez, Rita; Fernandez, Ana I.; Ovilo, Cristina] INIA, Dept Mejora Genet Anim, Madrid, Spain; [Gonzalez-Bulnes, Antonio] SGIT INIA, Comparat Physiol Grp, Madrid, Spain; [Canovas, Angela] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Ayuso, Miriam] Univ Antwerp, Dept Vet Sci, Fac Biomed Pharmaceut & Vet Sci, Antwerp, Belgium; [Canovas, Angela] Univ Guelph, Dept Anim & Poultry Sci, Ctr Genet Improvement Livestock, Guelph, ON, Canada	Complutense University of Madrid; University of California System; University of California Davis; University of Antwerp; University of Guelph	Ovilo, C (corresponding author), INIA, Dept Mejora Genet Anim, Madrid, Spain.	ovilo@inia.es	Gonzalez-Bulnes, Antonio/K-7691-2015; ayuso, miriam/GPX-8386-2022; Lopez-Bote, Clemente/F-5103-2014; Cánovas, Angela/AAG-6282-2020; Hernando, Miriam Ayuso/AAY-3751-2020; Muñoz, Almudena Fernández/AAB-4608-2019; MUÑOZ, ANA ISABEL REY/G-9894-2016; bote, clemente lopez/AAQ-6503-2021; Benítez, Rita/AAL-6381-2020; Ovilo, Cristina/N-9931-2014	Gonzalez-Bulnes, Antonio/0000-0002-0917-4475; ayuso, miriam/0000-0001-6045-394X; Lopez-Bote, Clemente/0000-0002-6839-8057; Muñoz, Almudena Fernández/0000-0002-4495-9366; MUÑOZ, ANA ISABEL REY/0000-0003-4403-9225; Ovilo, Cristina/0000-0002-5738-8435; BENITEZ, RITA/0000-0001-7459-2836	Spanish Ministry of Science and Innovation [AGL2010-21991-C03]; Ministry of Economy and Competitiveness [AGL2013-48121-C3]; FEDER; Ministry of Science and Innovation [BES-2011-045136]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of Economy and Competitiveness; FEDER(European Commission); Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The experimental work was supported by funds from the Spanish Ministry of Science and Innovation (project AGL2010-21991-C03) and the Ministry of Economy and Competitiveness (project AGL2013-48121-C3), co-funded by FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Miriam Ayuso was granted by the Ministry of Science and Innovation (BES-2011-045136).	Aagaard-Tillery KM, 2008, J MOL ENDOCRINOL, V41, P91, DOI 10.1677/JME-08-0025; Abdesselem H, 2015, J BIOL CHEM; Alexander DL, 1998, J CELL SCI, V111, P3311; Allen DL, 2007, AM J PHYSIOL-CELL PH, V292, pC188, DOI 10.1152/ajpcell.00542.2005; Almudevar Anthony, 2006, NeuroRx, V3, P384, DOI 10.1016/j.nurx.2006.05.037; Andres AI, 2001, MEAT SCI, V59, P39, DOI 10.1016/S0309-1740(01)00050-X; Angelini C, 2016, BBA-MOL BASIS DIS, V1862, P1367, DOI 10.1016/j.bbadis.2016.04.008; ASHMORE CR, 1973, J ANIM SCI, V36, P1088, DOI 10.2527/jas1973.3661088x; Astiz S, 2014, EXP PHYSIOL, V99, P1241, DOI 10.1113/expphysiol.2014.081455; Ayuso M, 2015, J ANIM SCI, V93, P2730, DOI 10.2527/jas.2014-8573; Ayuso M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145162; Bachar-Dahan L, 2006, MOL BIOL CELL, V17, P2572, DOI 10.1091/mbc.E06-01-0052; Bonet ML, 2003, CELL MOL LIFE SCI, V60, P1311, DOI 10.1007/s00018-003-2290-x; Bonnefond A, 2013, J CLIN INVEST, V123, P3037, DOI 10.1172/JCI68035; Brandebourg TD, 2005, J ANIM SCI, V83, P98; Brun PJ, 2013, BIOFACTORS, V39, P151, DOI 10.1002/biof.1056; Canovas A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05297; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Casas-Diaz E, 2015, VET CLIN PATHOLOGY; Cepica S, 2012, ANIM GENET, V43, P333, DOI 10.1111/j.1365-2052.2011.02252.x; Chang KC, 2003, MEAT SCI, V64, P93, DOI 10.1016/S0309-1740(02)00208-5; Chauhan SS, 2014, J ANIM SCI, V92, P4897, DOI 10.2527/jas.2014-8047; Cho OH, 2015, DEV DYNAM, V244, P43, DOI 10.1002/dvdy.24217; D'Andrea M, 2011, ANIM GENET, V42, P501, DOI 10.1111/j.1365-2052.2010.02164.x; Daza A, 2007, ANIM FEED SCI TECH, V139, P81, DOI 10.1016/j.anifeedsci.2007.01.003; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Dunn JR, 2006, BRIT J CANCER, V94, P1186, DOI 10.1038/sj.bjc.6603006; EDMONDSON DG, 1992, MOL CELL BIOL, V12, P3665, DOI 10.1128/MCB.12.9.3665; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Fonken LK, 2014, ENDOCR REV, V35, P648, DOI 10.1210/er.2013-1051; Franks PW, 2014, DIABETOLOGIA, V57, P485, DOI 10.1007/s00125-013-3133-4; Gonzalez-Anover P, 2010, REPROD DOMEST ANIM, V45, P1003, DOI 10.1111/j.1439-0531.2009.01476.x; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Gupta D, 2013, J BIOL CHEM, V288, P25440, DOI 10.1074/jbc.M113.486852; Hakuno F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025655; He QH, 2012, J NUTR BIOCHEM, V23, P133, DOI 10.1016/j.jnutbio.2010.11.007; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herault F, 2014, LONGISSIMUS SEMIMEMB; Hirata M, 2011, DIABETES, V60, P1926, DOI 10.2337/db10-1500; Holder JL, 2004, AM J PHYSIOL-ENDOC M, V287, pE105, DOI 10.1152/ajpendo.00446.2003; Hsiao SP, 2009, BIOCHEM J, V422, P343, DOI 10.1042/BJ20090072; Hudson NJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-356; Jaitovich A, 2015, J BIOL CHEM, V290, P9183, DOI 10.1074/jbc.M114.625715; Jang SM, 2013, J CELL SCI, V126, P5178, DOI 10.1242/jcs.131581; Jesse TL, 1998, J CELL BIOL, V140, P1265, DOI 10.1083/jcb.140.5.1265; Kabir SM, 2014, ADIPOCYTE, V3, P97, DOI 10.4161/adip.28110; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; KARLSSON A, 1993, J ANIM SCI, V71, P930, DOI 10.2527/1993.714930x; Kayan A, 2011, MEAT SCI, V89, P76, DOI 10.1016/j.meatsci.2011.04.001; Kim JH, 2008, ASIAN AUSTRAL J ANIM, V21, P138, DOI 10.5713/ajas.2008.70208; Klem TB, 2010, VET CLIN PATH, V39, P221, DOI 10.1111/j.1939-165X.2009.00199.x; Latorre MA, 2003, ANIM SCI, V77, P33, DOI 10.1017/S1357729800053625; Lebret B, 2001, ANIM SCI, V72, P87, DOI 10.1017/S1357729800055582; Lee K, 1996, MOL CELL BIOCHEM, V155, P31, DOI 10.1007/BF00714330; Lei HQ, 2013, AM J PHYSIOL-CELL PH, V305, pC529, DOI 10.1152/ajpcell.00051.2013; LESEIGNEURMEYNIER A, 1991, MEAT SCI, V29, P229, DOI 10.1016/0309-1740(91)90052-R; Li WZ, 2012, RES VET SCI, V93, P1190, DOI 10.1016/j.rvsc.2012.06.006; Liu JW, 2013, MOLECULES, V18, P14470, DOI 10.3390/molecules181214470; Londhe P, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004633; Lopez-Bote CJ, 1998, MEAT SCI, V49, pS17, DOI 10.1016/S0309-1740(98)00072-2; LopezBote C, 1997, ANIM SCI, V64, P177, DOI 10.1017/S1357729800015691; Lujan R, 2005, NEUROSCIENCE, V130, P567, DOI 10.1016/j.neuroscience.2004.09.042; Marion V, 2013, HEPATIC ADAPTATION C; Miller MR, 2010, OBESITY, V18, P555, DOI 10.1038/oby.2009.303; Miron M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-333; Mizugishi K, 2004, BIOCHEM BIOPH RES CO, V320, P233, DOI 10.1016/j.bbrc.2004.05.158; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Munoz G, 2009, J ANIM SCI, V87, P459, DOI 10.2527/jas.2008-1127; Munoz J, 2006, DIABETES, V55, P3630, DOI 10.2337/db06-0574; Muriel E, 2004, MEAT SCI, V67, P299, DOI 10.1016/j.meatsci.2003.11.002; Neal JW, 2003, J BIOL CHEM, V278, P17246, DOI 10.1074/jbc.M300528200; Ovilo C, 2005, GENET RES, V85, P57, DOI 10.1017/S0016672305007330; Ovilo C, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-413, 10.1186/s12863-014-0148-x]; Pan H, 2011, DEV BIOL, V351, P120, DOI 10.1016/j.ydbio.2010.12.037; Peckett AJ, 2011, METABOLISM, V60, P1500, DOI 10.1016/j.metabol.2011.06.012; Perez-Enciso M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-89; Picard B, 2002, REPROD NUTR DEV, V42, P415, DOI 10.1051/rnd:2002035; Ponsuksili S, 2011, J LIPID RES, V52, P668, DOI 10.1194/jlr.M013342; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Potokar M, 1998, ANN ZOOTECH; Villafan-Bernal JR, 2011, INT J MOL MED, V28, P283, DOI 10.3892/ijmm.2011.706; Ramachandrappa S, 2013, J CLIN INVEST, V123, P3042, DOI 10.1172/JCI68016; Ren W, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/406909; Reverter A, 2010, BIOINFORMATICS, V26, P896, DOI 10.1093/bioinformatics/btq051; Rivera-Ferre MG, 2005, J NUTR, V135, P469, DOI 10.1093/jn/135.3.469; Robina A, 2013, SPAN J AGRIC RES, V11, P1057, DOI 10.5424/sjar/2013114-4637; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez-Sanchez JA, 2010, ANIMAL, V4, P289, DOI 10.1017/S1751731109991029; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Saito Y, 2011, ANTIOXID REDOX SIGN, V15, P2109, DOI 10.1089/ars.2010.3714; Segura J, 2014, FOOD CHEM, V145, P821, DOI 10.1016/j.foodchem.2013.08.131; Sepe A, 2011, GERONTOLOGY, V57, P66, DOI 10.1159/000279755; Serrano MP, 2008, MEAT SCI, V78, P420, DOI 10.1016/j.meatsci.2007.07.006; Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866; SHARMA N, 1987, MEAT SCI, V19, P121, DOI 10.1016/0309-1740(87)90017-9; Simopoulos AP, 2004, FOOD REV INT, V20, P77, DOI 10.1081/FRI-120028831; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Sobol M, 2015, J ANIM FEED SCI, V24, P31, DOI 10.22358/jafs/65650/2015; Swarbrick MM, 2011, OBESITY, V19, P2394, DOI 10.1038/oby.2011.79; Te Pas MF, 2011, J LIFE SCI, V5, P598; Tolson KP, 2014, ENDOCRINOLOGY, V155, P2436, DOI 10.1210/en.2013-2125; Torres-Rovira L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066728; Torres-Rovira L, 2011, REPROD BIOL, V11, P165, DOI 10.1016/S1642-431X(12)60053-9; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Unruh JA, 1996, J ANIM SCI, V74, P1274; Ventanas S, 2006, MEAT SCI, V73, P651, DOI 10.1016/j.meatsci.2006.03.009; Voillet V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-797; Walters ZS, 2014, ONCOGENE, V33, P1148, DOI 10.1038/onc.2013.46; Wang YZ, 2011, INT J MOL MED, V28, P617, DOI 10.3892/ijmm.2011.711; WHO, 2003, WHO TECHN REP SER, V916, P54; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Wu XX, 2011, J APPL PHYSIOL, V110, P746, DOI 10.1152/japplphysiol.00293.2010; Xia SF, 2015, METABOLISM, V64, P566, DOI 10.1016/j.metabol.2014.12.010; Yamamoto M, 2003, DEV GROWTH DIFFER, V45, P485; Yang X, 2015, PLOS ONE, V10; Yasuhara K, 2011, J APPL PHYSIOL, V111, P1142, DOI 10.1152/japplphysiol.00471.2011; Yu KF, 2014, FEBS J, V281, P2399, DOI 10.1111/febs.12792; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhao X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019774, 10.1371/journal.pone.0021739]; Zhao YQ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1580-7	122	39	40	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167858	10.1371/journal.pone.0167858	http://dx.doi.org/10.1371/journal.pone.0167858			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936208	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100218
J	Barnhart, PR; Gillam, EH				Barnhart, Paul R.; Gillam, Erin H.			Understanding Peripheral Bat Populations Using Maximum-Entropy Suitability Modeling	PLOS ONE			English	Article							BIG-EARED BAT; HABITAT USE; SPECIES DISTRIBUTIONS; SAMPLE-SIZE; RANGE SIZE; CONSERVATION; MYOTIS; PERFORMANCE; SELECTION; PATTERNS	Individuals along the periphery of a species distribution regularly encounter more challenging environmental and climatic conditions than conspecifics near the center of the distribution. Due to these potential constraints, individuals in peripheral margins are expected to change their habitat and behavioral characteristics. Managers typically rely on species distribution maps when developing adequate management practices. However, these range maps are often too simplistic and do not provide adequate information as to what fine-scale biotic and abiotic factors are driving a species occurrence. In the last decade, habitat suitability modelling has become widely used as a substitute for simplistic distribution mapping which allows regional managers the ability to fine-tune management resources. The objectives of this study were to use maximum-entropy modeling to produce habitat suitability models for seven species that have a peripheral margin intersecting the state of North Dakota, according to current IUCN distributions, and determine the vegetative and climatic characteristics driving these models. Mistnetting resulted in the documentation of five species outside the IUCN distribution in North Dakota, indicating that current range maps for North Dakota, and potentially the northern Great Plains, are in need of update. Maximum-entropy modeling showed that temperature and not precipitation were the variables most important for model production. This fine-scale result highlights the importance of habitat suitability modelling as this information cannot be extracted from distribution maps. Our results provide baseline information needed for future research about how and why individuals residing in the peripheral margins of a species' distribution may show marked differences in habitat use as a result of urban expansion, habitat loss, and climate change compared to more centralized populations.	[Barnhart, Paul R.] Dickinson State Univ, Dickinson, ND 58601 USA; [Gillam, Erin H.] North Dakota State Univ, Fargo, ND 58105 USA	North Dakota State University Fargo	Barnhart, PR (corresponding author), Dickinson State Univ, Dickinson, ND 58601 USA.	Paul.Barnhart@dickinsonstate.edu			North Dakota Game and Fish Department under their State Wildlife Grant program [T-2-5-R-1]	North Dakota Game and Fish Department under their State Wildlife Grant program	Funding was provided by the North Dakota Game and Fish Department under their State Wildlife Grant program (Grant number:T-2-5-R-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the North Dakota Game and Fish Department for funding this research through a State Wildlife Grant. We would like to thank J.J. Nelson for his assistance with data collection in the field and Liam McGuire for guidance and objective input during manuscript development.	ADAM MD, 1994, J WILDLIFE MANAGE, V58, P462, DOI 10.2307/3809317; [Anonymous], 1988, CONSERVATION EUROPEA; Baker MD, 2006, J WILDLIFE MANAGE, V70, P207, DOI 10.2193/0022-541X(2006)70[207:DHOFLM]2.0.CO;2; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; BRUSSARD PF, 1984, ANNU REV ECOL SYST, V15, P25, DOI 10.1146/annurev.es.15.110184.000325; BURLEY TM, 1961, PROF GEOGR, V13, P18, DOI 10.1111/j.0033-0124.1961.136_18.x; Caceres M.C., 2000, MAMMAL SPECIES, V634, P1; Carvalho SB, 2011, BIOL CONSERV, V144, P2020, DOI 10.1016/j.biocon.2011.04.024; Chruszcz BJ, 2002, FUNCT ECOL, V16, P18, DOI 10.1046/j.0269-8463.2001.00602.x; Dodd LE, 2008, FOREST ECOL MANAG, V255, P3866, DOI 10.1016/j.foreco.2008.03.034; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elmore LW, 2004, FOREST ECOL MANAG, V199, P11, DOI 10.1016/j.foreco.2004.03.045; Farrow LJ, 2011, MAMM BIOL, V76, P172, DOI 10.1016/j.mambio.2010.04.004; Fellers GM, 2002, J MAMMAL, V83, P167, DOI 10.1644/1545-1542(2002)083<0167:HUAFBO>2.0.CO;2; Foster RW, 1999, J MAMMAL, V80, P659, DOI 10.2307/1383310; Franklin J, 2009, MAPPING SPECIES DIST; Fry J, 2011, PHOTOGRAMM ENG REMOT, V77, P858; Garner TWJ, 2004, MOL ECOL, V13, P1047, DOI 10.1111/j.1365-294X.2004.02119.x; Genoways H, 1972, MAMMALS SW N DAKOTA; Genoways H. H., 1966, Transactions of the Kansas Academy of Science, V69, P355, DOI 10.2307/3627432; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holloway Gillian L., 2001, Mammalian Species, V670, P1, DOI 10.1644/1545-1410(2001)670<0001:MC>2.0.CO;2; Jones B, 2001, BIOL CONSERV, V101, P147, DOI 10.1016/S0006-3207(01)00055-6; Jones Jr JK, 1962, J MAMMAL, V43, P263; Kennedy JP, 2014, ACTA CHIROPTEROL, V16, P53, DOI 10.3161/150811014X683264; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; Kluth C, 2005, J ECOL, V93, P584, DOI 10.1111/j.1365-2745.2005.00997.x; Knox Jones J., 1966, Transactions of the Kansas Academy of Science, V69, P88; Knox Jones J. Jr, 1978, Prairie Naturalist, V10, P49; Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096; Krusic RA, 1996, J WILDLIFE MANAGE, V60, P625, DOI 10.2307/3802081; Kuenzi AJ, 1998, WILDLIFE SOC B, V26, P307; Lenard S, 2010, SUMMARY 2009 BAT SUR; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Loeb SC, 2006, J WILDLIFE MANAGE, V70, P1210, DOI 10.2193/0022-541X(2006)70[1210:HUBFBI]2.0.CO;2; Mackie LJ, 2007, BIOL CONSERV, V140, P70, DOI 10.1016/j.biocon.2007.07.031; Martin RA., 1982, MAMMAL SPECIES, V175, P1; Owen SF, 2003, AM MIDL NAT, V150, P352, DOI 10.1674/0003-0031(2003)150[0352:HSAHUB]2.0.CO;2; Peterman WE, 2013, BIOL CONSERV, V158, P351, DOI 10.1016/j.biocon.2012.07.028; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; POTTER LD, 1961, ECOLOGY, V42, P468, DOI 10.2307/1932232; Razgour O, 2011, BIOL CONSERV, V144, P2922, DOI 10.1016/j.biocon.2011.08.010; Russo D, 2002, BIOL CONSERV, V107, P71, DOI 10.1016/S0006-3207(02)00047-2; SEABLOOM RW, 1978, VERTEBRATES SW N DAK; Tigner J., 2006, BAT SURVEYS 2006 LIT; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Young N., 2011, MAXENT MODEL V3 3 3E, DOI DOI 10.1145/1015330.1015412; Zhang ZH, 2008, AQUAT BOT, V89, P57, DOI 10.1016/j.aquabot.2008.03.002	53	1	1	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0152508	10.1371/journal.pone.0152508	http://dx.doi.org/10.1371/journal.pone.0152508			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935936	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100002
J	Bonafiglia, JT; Rotundo, MP; Whittall, JP; Scribbans, TD; Graham, RB; Gurd, BJ				Bonafiglia, Jacob T.; Rotundo, Mario P.; Whittall, Jonathan P.; Scribbans, Trisha D.; Graham, Ryan B.; Gurd, Brendon J.			Inter-Individual Variability in the Adaptive Responses to Endurance and Sprint Interval Training: A Randomized Crossover Study	PLOS ONE			English	Article							EXERCISE PERFORMANCE; LACTATE THRESHOLD; SKELETAL-MUSCLE; INDIVIDUAL PATTERNS; AEROBIC CAPACITY; HERITAGE FAMILY; ADAPTATIONS; VO2MAX; FITNESS; NONRESPONSE	The current study examined the adaptive response to both endurance (END) and sprint interval training (SIT) in a group of twenty-one recreationally active adults. All participants completed three weeks (four days/week) of both END (30 minutes at similar to 65% VO(2)peak work rate (WR) and SIT (eight, 20-second intervals at similar to 170% VO(2)peak WR separated by 10 seconds of active rest) following a randomized crossover study design with a three-month washout period between training interventions. While a main effect of training was observed for VO(2)peak, lactate threshold, and submaximal heart rate (HR), considerable variability was observed in the individual responses to both END and SIT. No significant positive relationships were observed between END and SIT for individual changes in any variable. Nonresponses were determined using two times the typical error (TE) of measurement for VO(2)peak (0.107 L/min), lactate threshold (15.7 W), and submaximal HR (10.7bpm). Nonresponders in VO(2)peak, lactate threshold, and submaximal HR were observed following both END and SIT, however, the individual patterns of response differed following END and SIT. Interestingly, all individuals responded in at least one variable when exposed to both END and SIT. These results suggest that the individual response to exercise training is highly variable following different training protocols and that the incidence of non-response to exercise training may be reduced by changing the training stimulus for non-responders to three weeks of END or SIT.	[Bonafiglia, Jacob T.; Rotundo, Mario P.; Whittall, Jonathan P.; Scribbans, Trisha D.; Gurd, Brendon J.] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada; [Graham, Ryan B.] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada	Queens University - Canada; University of Ottawa	Gurd, BJ (corresponding author), Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada.	gurdb@queensu.ca	Bonafiglia, Jacob T./AAA-1768-2019		Natural Sciences and Engineering Council of Canada [402635]; Canadian Foundation for Innovation [25476]	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation)	Funding was provided by the Natural Sciences and Engineering Council of Canada (grant number: 402635; http://www.nserc-crsng.gc.ca/index_eng.asp) and the Canadian Foundation for Innovation (grant number: 25476;https://www.innovation.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, OPEN J MOL INTEGR PH, V03, P202, DOI [10.4236/ojmip.2013.34027, DOI 10.4236/OJMIP.2013.34027]; Astorino TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097638; Atkinson G, 2015, EXP PHYSIOL, V6, P1; Bacon AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073182; Bentley DJ, 2007, SPORTS MED, V37, P575, DOI 10.2165/00007256-200737070-00002; Bishop D, 1998, MED SCI SPORT EXER, V30, P1270, DOI 10.1097/00005768-199808000-00014; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bouchard C, 1999, J APPL PHYSIOL, V87, P1003, DOI 10.1152/jappl.1999.87.3.1003; Bouchard C, 2001, MED SCI SPORT EXER, V33, pS446, DOI 10.1097/00005768-200106001-00013; Bouchard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037887; Bouchard C, 2011, J APPL PHYSIOL, V110, P1160, DOI 10.1152/japplphysiol.00973.2010; Buford TW, 2013, SPORTS MED, V43, P157, DOI 10.1007/s40279-013-0018-0; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Edgett BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071623; Esfarjani F, 2007, J SCI MED SPORT, V10, P27, DOI 10.1016/j.jsams.2006.05.014; Faude O, 2009, SPORTS MED, V39, P469, DOI 10.2165/00007256-200939060-00003; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Gist NH, 2014, SPORTS MED, V44, P269, DOI 10.1007/s40279-013-0115-0; Granata C, 2015, FASEB J; Gurd BJ, 2016, APPL PHYSIOL NUTR ME, V41, P229, DOI 10.1139/apnm-2015-0449; Hautala AJ, 2006, EUR J APPL PHYSIOL, V96, P535, DOI 10.1007/s00421-005-0116-2; He Z, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.042945; HECK H, 1985, INT J SPORTS MED, V6, P117, DOI 10.1055/s-2008-1025824; Hecksteden A, 2015, J APPL PHYSIOL, V118, P1450, DOI 10.1152/japplphysiol.00714.2014; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hopkins WG, 2015, J APPL PHYSIOL, V118, P1444, DOI 10.1152/japplphysiol.00098.2015; Jacobs RA, 2013, J APPL PHYSIOL, V115, P785, DOI 10.1152/japplphysiol.00445.2013; Jones AM, 2000, SPORTS MED, V29, P373, DOI 10.2165/00007256-200029060-00001; Karavirta L, 2011, MED SCI SPORT EXER, V43, P484, DOI 10.1249/MSS.0b013e3181f1bf0d; KOHRT WM, 1991, J APPL PHYSIOL, V71, P2004, DOI 10.1152/jappl.1991.71.5.2004; Macpherson REK, 2011, MED SCI SPORT EXER, V43, P115, DOI 10.1249/MSS.0b013e3181e5eacd; Matsuo T, 2014, MED SCI SPORT EXER, V46, P42, DOI 10.1249/MSS.0b013e3182a38da8; McPhee JS, 2011, EXP PHYSIOL, V96, P699, DOI 10.1113/expphysiol.2011.057729; Montero D, 2015, J PHYSIOL-LONDON, V593, P4677, DOI 10.1113/JP270250; Ross R, 2015, MAYO CLIN PROC, V90, P1506, DOI 10.1016/j.mayocp.2015.07.024; Scharhag-Rosenberger F, 2012, SCAND J MED SCI SPOR, V22, P113, DOI 10.1111/j.1600-0838.2010.01139.x; Scribbans TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098119; Sisson SB, 2009, MED SCI SPORT EXER, V41, P539, DOI 10.1249/MSS.0b013e3181896c4e; Skinner JS, 2001, J APPL PHYSIOL, V90, P1770, DOI 10.1152/jappl.2001.90.5.1770; Sloth M, 2013, SCAND J MED SCI SPOR, V23, pE341, DOI 10.1111/sms.12092; Svedahl K, 2003, CAN J APPL PHYSIOL, V28, P299, DOI 10.1139/h03-023; Timmons JA, 2012, J APPL PHYSL; Vollaard NBJ, 2009, J APPL PHYSIOL, V106, P1479, DOI 10.1152/japplphysiol.91453.2008; Wellek S, 2012, DTSCH ARZTEBL INT, V109, P276, DOI 10.3238/arztebl.2012.0276; Wolpern AE, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0011-z; Zelt JGE, 2014, EUR J APPL PHYSL	46	101	101	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167790	10.1371/journal.pone.0167790	http://dx.doi.org/10.1371/journal.pone.0167790			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936084	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100191
J	Joo, SY; Goo, YK; Ryu, JS; Lee, SE; Lee, WK; Chung, DI; Hong, Y				Joo, So-Young; Goo, Youn-Kyoung; Ryu, Jae-Sook; Lee, Sang-Eun; Lee, Won Kee; Chung, Dong-Il; Hong, Yeonchul			Epidemiology of Trichomoniasis in South Korea and Increasing Trend in Incidence, Health Insurance Review and Assessment 2009-2014	PLOS ONE			English	Review							TRANSCRIPTION-MEDIATED AMPLIFICATION; VAGINALIS INFECTION; REPRODUCTIVE-AGE; HIGH PREVALENCE; UNITED-STATES; WOMEN; MEN; DIAGNOSIS; HIV-1; DISEASE	Trichomoniasis, which is caused by Trichomonas vaginalis, is one of the most common non-viral sexually transmitted infections; however, limited population-based data are available that describe patterns and trends of the disease. We summarized insurance claims of trichomoniasis cases reported during 2009-2014 to South Korea Health Insurance Review and Assessment Service. The average annual incidence in South Korea was 276.8 persons per 100,000 population, and a substantial sex-associated variation was observed. The incidence rate among female subjects trended upward over 6 years, that is, it increased from 501 in 2009 to 625.8 in 2014 per 100,000 female population, which indicates a 25% overall increase. This trend was sharpest in the >= 60 years group of female population. However, a 66% decrease in incidence rates was observed among male subjects (23.7 in 2009 to 15.7 in 2014 per 100,000 male population). Further, substantial decrease was observed in the >= 40 years groups of male population. The incidence of trichomoniasis varied across regions and was the highest in Jeju province of South Korea. Overall, as the incidence of trichomoniasis appears to have increased in South Korea during 2009-2014, the disease burden is increasing; hence, there is a need to better understand the disease transmission.	[Joo, So-Young; Goo, Youn-Kyoung; Chung, Dong-Il; Hong, Yeonchul] Kyungpook Natl Univ, Sch Med, Dept Parasitol & Trop Med, Daegu, South Korea; [Ryu, Jae-Sook] Hanyang Univ, Coll Med, Dept Environm Biol & Med Parasitol, Seoul, South Korea; [Lee, Sang-Eun] Korea Ctr Dis Control & Prevent, Korea Natl Inst Hlth, Div Malaria & Parasit Dis, Osong, South Korea; [Lee, Won Kee] Kyungpook Natl Univ, Sch Med, KNUH, Med Res Collaborat Ctr, Daegu, South Korea	Kyungpook National University; Hanyang University; Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Disease Prevention; Korea National Institute of Health (KNIH); Kyungpook National University	Hong, Y (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Parasitol & Trop Med, Daegu, South Korea.	ychong@knu.ac.kr						[Anonymous], 2011, PREVALENCE INCIDENCE; [Anonymous], 2004, INT CLASS DIS; [Anonymous], 2004, INT CLASS DIS; Cotch MF, 1997, SEX TRANSM DIS, V24, P353, DOI 10.1097/00007435-199707000-00008; Fang XQ, 2007, JPN J INFECT DIS, V60, P257; Fichorova RN, 2009, J REPROD IMMUNOL, V83, P185, DOI 10.1016/j.jri.2009.08.007; GARDNER WA, 1986, ARCH PATHOL LAB MED, V110, P430; Gerbase AC, 1998, SEX TRANSM INFECT, V74, pS12; Ginocchio CC, 2012, J CLIN MICROBIOL, V50, P2601, DOI 10.1128/JCM.00748-12; Goo YK, 2016, KOREAN J PARASITOL, V54, P75, DOI 10.3347/kjp.2016.54.1.75; Guenthner PC, 2005, INFECT IMMUN, V73, P4155, DOI 10.1128/IAI.73.7.4155-4160.2005; Hobbs MM, 2013, SEX TRANSM INFECT, V89, P434, DOI 10.1136/sextrans-2013-051057; Huppert JS, 2007, CLIN INFECT DIS, V45, P194, DOI 10.1086/518851; Kigozi GG, 2003, AM J OBSTET GYNECOL, V189, P1398, DOI 10.1067/S0002-9378(03)00777-4; Kissinger P, 2009, SEX TRANSM DIS, V36, P11, DOI 10.1097/OLQ.0b013e318186decf; KRIEGER JN, 1995, SEX TRANSM DIS, V22, P83, DOI 10.1097/00007435-199503000-00003; Kurth A, 2004, J CLIN MICROBIOL, V42, P2940, DOI 10.1128/JCM.42.7.2940-2943.2004; Kwon S, 2009, HEALTH POLICY PLANN, V24, P63, DOI 10.1093/heapol/czn037; Lan PT, 2008, SEX TRANSM INFECT, V84, P126, DOI 10.1136/sti.2007.027821; Lewis DA, 2013, SEX TRANSM INFECT, V89, P523, DOI 10.1136/sextrans-2013-051049; Meites E, 2013, SEX TRANSM DIS, V40, P865, DOI 10.1097/OLQ.0000000000000038; Miller WC, 2005, SEX TRANSM DIS, V32, P593, DOI 10.1097/01.olq.0000179874.76360.ad; Mitteregger D, 2012, MED MICROBIOL IMMUN, V201, P113, DOI 10.1007/s00430-011-0205-2; Moodley P, 2002, CLIN INFECT DIS, V34, P519, DOI 10.1086/338399; Munson E, 2012, J CLIN MICROBIOL, V50, P3927, DOI 10.1128/JCM.02078-12; Munson KL, 2013, J CLIN MICROBIOL, V51, P101, DOI 10.1128/JCM.02526-12; Muzny CA, 2014, CLIN INFECT DIS, V59, P834, DOI 10.1093/cid/ciu446; Nye MB, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.005; Radonjic IV, 2006, EUR J OBSTET GYN R B, V126, P116, DOI 10.1016/j.ejogrb.2005.07.033; Rendon-Maldonado J, 2003, J EUKARYOT MICROBIOL, V50, P43, DOI 10.1111/j.1550-7408.2003.tb00104.x; Rowley J, 2012, GLOBAL INCIDENCE PRE; Ryu Jae-Sook, 2006, Korean Journal of Parasitology, V44, P101, DOI 10.3347/kjp.2006.44.2.101; Seo HJ, 2016, J CLIN EPIDEMIOL, V70, P200, DOI 10.1016/j.jclinepi.2015.09.013; Song Y.J., 2009, JAPAN MED ASS J, V52, P206, DOI 10.3345/kjp.2009.52.7.752; Soper D, 2004, AM J OBSTET GYNECOL, V190, P281, DOI 10.1016/j.ajog.2003.08.023; Sutton M, 2007, CLIN INFECT DIS, V45, P1319, DOI 10.1086/522532; Weinstock H, 2004, PERSPECT SEX REPRO H, V36, P6, DOI 10.1111/j.1931-2393.2004.tb00002.x; Wendel KA, 2003, SEX TRANSM INFECT, V79, P151, DOI 10.1136/sti.79.2.151; WHO World Health Organisation STD Statistics, 2001, GLOB PREV INC SEL CU	39	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167938	10.1371/journal.pone.0167938	http://dx.doi.org/10.1371/journal.pone.0167938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936227	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100235
J	Li, P; Quan, W; Lu, D; Wang, Y; Zhang, HH; Liu, SA; Jiang, RC; Zhou, YY				Li, Pan; Quan, Wei; Lu, Da; Wang, Yan; Zhang, Hui-Hong; Liu, Shuai; Jiang, Rong-Cai; Zhou, Yu-Ying			Association between Metabolic Syndrome and Cognitive Impairment after Acute Ischemic Stroke: A Cross-Sectional Study in a Chinese Population	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; VASCULAR DEMENTIA; ELDERLY-PEOPLE; OLDER-ADULTS; RISK; VERSION; AGE; INFLAMMATION; RELIABILITY; PERFORMANCE	Background and Objectives Metabolic syndrome (MetS), a risk factor for many vascular conditions, is associated with vascular cognitive disorders. The objective of the present study was to explore the associations of MetS and its individual components with the risks of cognitive impairment and neurological dysfunction in patients after acute stroke. Methods This cross-sectional study enrolled 840 patients ranging in age from 53 to 89 years from the Tianjin area of North China. Cognitive function was evaluated using the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination. Neuropsychiatric behavior was assessed using the Neuropsychiatric Inventory Questionnaire. Emotional state was examined according to the Hamilton Depression Rating Scale, and neuromotor function was evaluated using the National Institutes of Health Stroke Scale, Barthel index, and the Activity of Daily Living test. After overnight fasting, blood samples were obtained to measure biochemistry indicators. Results MetS and its individual components were closely correlated with MoCA score. MetS patients had high levels of inflammation and a 3.542-fold increased odds ratio (OR) for cognitive impairment [95% confidence interval (CI): 1.972-6.361]. Of the individual MetS components, central obesity (OR 3.039; 95% CI: 1.839-5.023), high fasting plasma glucose (OR 1.915; 95% CI: 1.016-3.607), and type 2 diabetes (OR 2.241; 95% CI: 1.630-3.081) were associated with an increased incidence of cognitive impairment. Consistent and significant worsening in different neurological domains was observed with greater numbers of MetS components. Conclusions MetS was associated with worse cognitive function, neuromotor dysfunction, and neuropsychological symptoms among Chinese acute stroke patients.	[Li, Pan; Lu, Da; Wang, Yan; Zhang, Hui-Hong; Liu, Shuai; Zhou, Yu-Ying] Tianjin Huanhu Hosp, Dept Neurol, Tianjin, Peoples R China; [Li, Pan; Lu, Da; Wang, Yan; Zhang, Hui-Hong; Liu, Shuai; Zhou, Yu-Ying] Tianjin Huanhu Hosp, Tianjin Neurosurg Inst, Tianjin Key Lab of Cerebral Vasc & Neurodegenerat, Tianjin, Peoples R China; [Quan, Wei; Jiang, Rong-Cai] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Quan, Wei; Jiang, Rong-Cai] Gen Hosp, Minist Educ, Tianjin Neurol Inst, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin, Peoples R China; [Quan, Wei; Jiang, Rong-Cai] Gen Hosp, Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin, Peoples R China	Tianjin Medical University	Li, P; Zhou, YY (corresponding author), Tianjin Huanhu Hosp, Dept Neurol, Tianjin, Peoples R China.; Li, P; Zhou, YY (corresponding author), Tianjin Huanhu Hosp, Tianjin Neurosurg Inst, Tianjin Key Lab of Cerebral Vasc & Neurodegenerat, Tianjin, Peoples R China.	doc_panpan@163.com; professor_yyzhou@163.com			Science and Technology Project of the Tianjin Municipal Health Bureau [2013KG121]; Tianjin Science and Technology Plan Foundation [13ZCZDSY01600]; National Clinical and Medical Research [L2014071]; National Nature Science Foundation of China [81301629]	Science and Technology Project of the Tianjin Municipal Health Bureau; Tianjin Science and Technology Plan Foundation; National Clinical and Medical Research; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Science and Technology Project of the Tianjin Municipal Health Bureau (http://www.tjwsj.gov.cn/html/WSJn/portal/index/index.htm) (2013KG121), the Tianjin Science and Technology Plan Foundation (http://www.tstc.gov.cn/) (grant no. 13ZCZDSY01600), the Special Fund of National Clinical and Medical Research (http://www.nsfc.gov.cn/) (grant no. L2014071), the Youth fund of National Nature Science Foundation of China (http://www.nsfc.gov.cn/) (grant no. 81301629). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Azizi Gholamreza, 2015, Sultan Qaboos Univ Med J, V15, pe305, DOI 10.18295/squmj.2015.15.03.002; Cervellati C, 2014, J NEUROL SCI, V337, P156, DOI 10.1016/j.jns.2013.11.041; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Crichton GE, 2012, J ALZHEIMERS DIS, V30, pS77, DOI 10.3233/JAD-2011-111022; Forti P, 2010, J AM GERIATR SOC, V58, P487, DOI 10.1111/j.1532-5415.2010.02731.x; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hachinski V, 2012, ARCH NEUROL-CHICAGO, V69, P169, DOI 10.1001/archneurol.2011.1698; Ho RCM, 2008, AM J GERIAT PSYCHIAT, V16, P519, DOI 10.1097/JGP.0b013e31816b7841; Hu JB, 2013, ARCH GERONTOL GERIAT, V56, P38, DOI 10.1016/j.archger.2012.05.008; Jung WB, 2014, PSYCHIAT CLIN NEUROS, V68, P821, DOI 10.1111/pcn.12196; Kalmijn S, 2000, ARTERIOSCL THROM VAS, V20, P2255, DOI 10.1161/01.ATV.20.10.2255; KATZMAN R, 1988, J CLIN EPIDEMIOL, V41, P971, DOI 10.1016/0895-4356(88)90034-0; Kester MI, 2014, JAMA NEUROL, V71, P855, DOI 10.1001/jamaneurol.2014.754; Kim B, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.3; Kwon HM, 2006, STROKE, V37, P466, DOI 10.1161/01.STR.0000199081.17935.81; Liu CY, 2009, EUR J NEUROL, V16, P1022, DOI 10.1111/j.1468-1331.2009.02640.x; Liu M, 2015, CLIN ENDOCRINOL, V82, P844, DOI 10.1111/cen.12734; Luchsinger JA, 2007, ARCH NEUROL-CHICAGO, V64, P392, DOI 10.1001/archneur.64.3.392; Misiak B, 2012, BRAIN RES BULL, V89, P144, DOI 10.1016/j.brainresbull.2012.08.003; Muller M, 2007, DEMENT GERIATR COGN, V24, P185, DOI 10.1159/000105927; Pan YS, 2014, J STROKE CEREBROVASC, V23, P2335, DOI 10.1016/j.jstrokecerebrovasdis.2014.04.031; Prins ND, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.10; Raffaitin C, 2009, DIABETES CARE, V32, P169, DOI 10.2337/dc08-0272; Rao M., 2007, CHINA GUIDELINE CERE; Razay G, 2007, ARCH NEUROL-CHICAGO, V64, P93, DOI 10.1001/archneur.64.1.93; Roberts RO, 2010, ALZ DIS ASSOC DIS, V24, P11, DOI 10.1097/WAD.0b013e3181a4485c; Roriz-Cruz M, 2007, NEUROBIOL AGING, V28, P1723, DOI 10.1016/j.neurobiolaging.2006.07.013; Sachdev P, 2014, ALZ DIS ASSOC DIS, V28, P206, DOI 10.1097/WAD.0000000000000034; Skoog I, 2000, J NEURAL TRANSM-SUPP, P37; Solfrizzi V, 2010, J NEUROL NEUROSUR PS, V81, P433, DOI 10.1136/jnnp.2009.181743; Spielman L. J., 2014, IMMUNOENDOCRINOLOGY, V1, P1, DOI [10.14800/Immunoendocrinology.391, DOI 10.1016/J.JNEUR0IM.2014.06.004]; Vanhanen M, 2006, NEUROLOGY, V67, P843, DOI 10.1212/01.wnl.0000234037.91185.99; Wang Dewen, 2009, Environmental Health and Preventive Medicine, V14, P128, DOI 10.1007/s12199-008-0072-7; Wang J, 2008, STROKE, V39, P1078, DOI 10.1161/STROKEAHA.107.499830; Wang T, 2012, INT J GERIATR PSYCH, V27, P539, DOI 10.1002/gps.2757; Wotton CJ, 2014, POSTGRAD MED J, V90, P547, DOI 10.1136/postgradmedj-2014-132571; Zhang JL, 2015, SPINAL CORD, V53, P679, DOI 10.1038/sc.2014.206; ZHENG YP, 1988, BRIT J PSYCHIAT, V152, P660, DOI 10.1192/bjp.152.5.660	39	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167327	10.1371/journal.pone.0167327	http://dx.doi.org/10.1371/journal.pone.0167327			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936074	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100086
J	Olguin-Alor, R; de la Fuente-Granada, M; Bonifaz, LC; Antonio-Herrera, L; Garcia-Zepeda, EA; Soldevila, G				Olguin-Alor, Roxana; de la Fuente-Granada, Marisol; Bonifaz, Laura C.; Antonio-Herrera, Laura; Garcia-Zepeda, Eduardo A.; Soldevila, Gloria			A Key Role for Inhibins in Dendritic Cell Maturation and Function	PLOS ONE			English	Article							MOUSE PERITONEAL-MACROPHAGES; REGULATORY T-CELLS; ACTIVIN-A; BONE-MARROW; THYMOCYTE DEVELOPMENT; SEMI-MATURE; IN-VITRO; MICE; SKIN; CYTOKINE	Inhibins are members of the TGF beta superfamily, which regulate many cellular processes including differentiation, proliferation, survival and apoptosis. Although initially described as hormones regulating the hypothalamus-pituitary-gonadal axis, based on their ability to antagonize Activins, our group has recently reported that they play a role in thymocyte differentiation and survival, as well as in thymic stromal cell maturation and nTreg generation. Here, we used Inhibin knock out mice (Inh alpha(-/-)) to investigate the role of Inhibins in peripheral dendritic cell maturation and function. We first demonstrated that LPS treated Inh alpha(+/+) bone marrow derived dendritic cells (BMDC) were capable to produce significant levels of Inhibin A. Interestingly, Inh alpha(-/-) BMDC showed reduced MHCII and CD86 upregulation and increased PD-L1 expression in response to LPS compared to Inh alpha(+/+), which correlated with reduced ability to induce proliferation of allogeneic T cells. The "semi-mature" phenotype displayed by Inh alpha(-/-) mBMDC correlated with increased levels of IL-10 and slightly decreased IL-6 production after LPS stimulation. In addition, Inh alpha(-/-) mBMDC showed impaired migration towards CCL19 and CCL21, assessed by in vitro chemotaxis and in vivo competitive homing experiments, despite their normal CCR7 expression. Furthermore, in vivo LPS-induced DC maturation was also diminished in Inh alpha(-/-) mice, specially within the LC (CD207+ CD11b+ CD103-) subpopulation. Finally, analysis of delayed type hypersensitivity responses in Inh alpha(-/-) mice, showed reduced ear swelling as a result of reduced cellular infiltration in the skin, correlating with impaired homing of CD207+ DCs to the draining lymph nodes. In summary, our data demonstrate for the first time that Inhibins play a key role in peripheral DC maturation and function, regulating the balance between immunity and tolerance.	[Olguin-Alor, Roxana; de la Fuente-Granada, Marisol; Garcia-Zepeda, Eduardo A.; Soldevila, Gloria] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City, DF, Mexico; [Bonifaz, Laura C.; Antonio-Herrera, Laura] Inst Mexicano Seguro Social, Ctr Med Nacl Siglo 21, Unidad Invest Med Inmunoquim, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Mexicano del Seguro Social	Soldevila, G (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City, DF, Mexico.	soldevi@servidor.unam.mx	De La Fuente-Granada, Marisol/F-3745-2019	De La Fuente-Granada, Marisol/0000-0002-6878-4265; Soldevila, Gloria/0000-0003-1539-2548; Olguin-Alor, Roxana/0000-0003-2976-3370	Direccion General de Asuntos del Personal Academico (DGAPA) UNAM, Mexico [IN209615]; Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico [339203, 344606]	Direccion General de Asuntos del Personal Academico (DGAPA) UNAM, Mexico(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The study was funded by Direccion General de Asuntos del Personal Academico (DGAPA) UNAM, Mexico;http://dgapa.unam.mx; Grant # IN209615.ROA was a student in the Ph.D program "Programa de Doctorado en Ciencias Bioquimicas, Universidad Nacional Autonoma de Mexico". ROA and MFG were recipients of pre-doctoral fellowships from Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico; http;///www.conacyt.gob.mx, ROA # 339203; MFG # 344606. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman-Muench G R, 2011, IMMUNOLOGY CELL BIOL; Ambriz-Pena X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088014; Borkowski TA, 1996, J EXP MED, V184, P2417, DOI 10.1084/jem.184.6.2417; Burns S, 2004, CELL MOTIL CYTOSKEL, V57, P118, DOI 10.1002/cm.10163; Carbajal-Franco E, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/837859; Clausen BE, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00534; Dai SY, 2014, CELL IMMUNOL, V290, P72, DOI 10.1016/j.cellimm.2014.05.006; De Nardo D, 2015, CYTOKINE, V74, P181, DOI 10.1016/j.cyto.2015.02.025; Dudek AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00438; Garcia-Zepeda EA, 2007, IMMUNOLOGY, V122, P247, DOI 10.1111/j.1365-2567.2007.02634.x; Gross M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00254; Idoyaga J, 2013, J CLIN INVEST, V123, P844, DOI 10.1172/JCI65260; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kushwah R, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-20; Licona P, 2006, DEV DYNAM, V235, P1124, DOI 10.1002/dvdy.20707; Licona-Limon P, 2007, IMMUNOL LETT, V109, P1, DOI 10.1016/j.imlet.2006.12.010; Licona-Limon P, 2009, BIOCHEM BIOPH RES CO, V381, P229, DOI 10.1016/j.bbrc.2009.02.029; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Makanji Y, 2014, ENDOCR REV, V35, P747, DOI 10.1210/er.2014-1003; Maldonado RA, 2010, ADV IMMUNOL, V108, P111, DOI [10.1016/B978-0-12-380995-7.00004-5, 10.1016/S0065-2776(10)08004_1]; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; MATZUK MM, 1994, P NATL ACAD SCI USA, V91, P8817, DOI 10.1073/pnas.91.19.8817; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Munz B, 1999, EMBO J, V18, P5205, DOI 10.1093/emboj/18.19.5205; Musso T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003271; Nusing RM, 1999, BRIT J PHARMACOL, V127, P919, DOI 10.1038/sj.bjp.0702626; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Phillips DJ, 2004, GROWTH FACTORS, V22, P13, DOI 10.1080/08977190410001688687; Ramos RN, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/806025; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rivas-Caicedo A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007066; Robson NC, 2008, BLOOD, V111, P2733, DOI 10.1182/blood-2007-03-080994; Rutella S, 2006, BLOOD, V108, P1435, DOI 10.1182/blood-2006-03-006403; Sanin DE, 2015, J IMMUNOL, V195, P1218, DOI 10.4049/jimmunol.1500146; Seeger P, 2015, CYTOKINE GROWTH FACT; Segerer SE, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-17; Stenvers KL, 2010, TRENDS ENDOCRIN MET, V21, P174, DOI 10.1016/j.tem.2009.11.009; Xiao WH, 2004, CANCER BIOL THER, V3, P1007, DOI 10.4161/cbt.3.10.1141; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Zhang XJ, 2005, CELL MOL IMMUNOL, V2, P63; Zhou J, 2009, CELL IMMUNOL, V255, P69, DOI 10.1016/j.cellimm.2008.11.001	43	9	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167813	10.1371/journal.pone.0167813	http://dx.doi.org/10.1371/journal.pone.0167813			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936218	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100203
J	Santiago, MD; Fonseca, BDFE; Marques, CDD; da Silva, ED; Bertho, AL; Nogueira, ACMD				Santiago, Marta de Almeida; Fonseca e Fonseca, Bruna de Paula; da Silva Marques, Christiane de Fatima; da Silva, Edimilson Domingos; Bertho, Alvaro Luiz; Martins de Almeida Nogueira, Ana Cristina			Flow Cytometry as a Tool for Quality Control of Fluorescent Conjugates Used in Immunoassays	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; PERFORMANCE EVALUATION; PHYCOERYTHRIN; CALIBRATION; PLATFORMS; INTENSITY; STANDARDIZATION; ERYTHROPOIETIN; QUANTITATION; EXPRESSION	The use of antibodies in immunodiagnostic kits generally implies the conjugation of these proteins with other molecules such as chromophores or fluorochromes. The development of more sensitive quality control procedures than spectrophotometry is essential to assure the use of better fluorescent conjugates since the fluorescent conjugates are critical reagents for a variety of immunodiagnostic kits. In this article, we demonstrate a new flow cytometric protocol to evaluate conjugates by molecules of equivalent soluble fluorochromes (MESF) and by traditional flow cytometric analysis. We have coupled microspheres with anti-IgG-PE and anti-HBSAg-PE conjugates from distinct manufactures and/or different lots and evaluated by flow cytometry. Their fluorescence intensities were followed for a period of 18 months. Our results showed that there was a great difference in the fluorescence intensities between the conjugates studied. The differences were observed between manufactures and lots from both anti-IgG-PE and anti-HBSAg-PE conjugates. Coefficients of variation (CVs) showed that this parameter can be used to determine better coupling conditions, such as homogenous coupling. The MESF analysis, as well as geometric mean evaluation by traditional flow cytometry, showed a decrease in the values for all conjugates during the study and were indispensable tools to validate the results of stability tests. Our data demonstrated the feasibility of the flow cytometric method as a standard quality control of immunoassay kits.	[Santiago, Marta de Almeida; Fonseca e Fonseca, Bruna de Paula; da Silva Marques, Christiane de Fatima; da Silva, Edimilson Domingos] Fiocruz MS, Immunobiol Technol Inst, Lab Diagnost Technol, Rio De Janeiro, RJ, Brazil; [Bertho, Alvaro Luiz] Fiocruz MS, Inst Oswaldo Cruz, Lab Immunoparasitol, Rio De Janeiro, RJ, Brazil; [Bertho, Alvaro Luiz] Fiocruz MS, Inst Oswaldo Cruz, Flow Cytometry Core Facil, Rio De Janeiro, RJ, Brazil; [Martins de Almeida Nogueira, Ana Cristina] Fiocruz MS, Inst Oswaldo Cruz, Clin Immunol Lab, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Bertho, AL (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Immunoparasitol, Rio De Janeiro, RJ, Brazil.; Bertho, AL (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Flow Cytometry Core Facil, Rio De Janeiro, RJ, Brazil.; Nogueira, ACMD (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Clin Immunol Lab, Rio De Janeiro, RJ, Brazil.	alvaro.bertho@hotmail.com; ana.martins@ioc.fiocruz.br	Nogueira, Ana Cristina M A/C-2200-2013					Barth T, 2008, J AOAC INT, V91, P285; Bertho AL, 2013, CITOMETRIA FLUXO APL, P3; Carey JL, 2007, CLIN LAB MED, V27, P687, DOI 10.1016/j.cll.2007.05.010; Chan Huai En Huang, 2007, Methods Mol Biol, V378, P65, DOI 10.1007/978-1-59745-323-3_5; Comas-Riu J, 2009, J IND MICROBIOL BIOT, V36, P999, DOI 10.1007/s10295-009-0608-x; de Oliveira ERA, 2012, J IMMUNOL METHODS, V375, P271, DOI 10.1016/j.jim.2011.11.005; dos Santos R.V., 2006, REV BRAS ALERG IMUNO, V29, P77; Ellington AA, 2010, CLIN CHEM, V56, P186, DOI 10.1373/clinchem.2009.127514; Elshal MF, 2006, METHODS, V38, P317, DOI 10.1016/j.ymeth.2005.11.010; Fonseca BPF, 2011, CLIN VACCINE IMMUNOL, V18, P802, DOI 10.1128/CVI.00265-10; Gratama JW, 1998, CYTOMETRY, V33, P166, DOI 10.1002/(SICI)1097-0320(19981001)33:2<166::AID-CYTO11>3.0.CO;2-S; Guryev O, 2011, ANAL CHEM, V83, P7109, DOI 10.1021/ac2014146; Hayashi-Takanaka Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106271; Henderson LO, 1998, CYTOMETRY, V33, P97, DOI 10.1002/(SICI)1097-0320(19981001)33:2<97::AID-CYTO3>3.0.CO;2-H; Hsu HY, 2009, ELECTROPHORESIS, V30, P4008, DOI 10.1002/elps.200900211; Ishida H, 2011, TRANSPL INT, V24, P150, DOI 10.1111/j.1432-2277.2010.01166.x; Jani IV, 2002, LANCET INFECT DIS, V2, P243, DOI 10.1016/S1473-3099(02)00242-6; Jung KM, 2010, TOXICOL LETT, V192, P229, DOI 10.1016/j.toxlet.2009.10.024; Kay S, 2006, CYTOM PART B-CLIN CY, V70B, P218, DOI 10.1002/cyto.b.20078; Kellar KL, 2002, EXP HEMATOL, V30, P1227, DOI 10.1016/S0301-472X(02)00922-0; Li F, 2010, MABS-AUSTIN, V2, P466, DOI 10.4161/mabs.2.5.12720; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Lysak D, 2010, INT J LAB HEMATOL, V32, pE229, DOI 10.1111/j.1751-553X.2010.01244.x; Mahmoudian J, 2011, CELL J, V13, P169; Mittag A, 2009, J BIOPHOTONICS, V2, P470, DOI 10.1002/jbio.200910033; Mobarrez F, 2010, THROMB RES, V125, pE110, DOI 10.1016/j.thromres.2009.10.006; Munier M, 2014, FOOD CHEM, V150, P400, DOI 10.1016/j.foodchem.2013.10.113; Pannu KK, 2001, CYTOMETRY, V45, P250, DOI 10.1002/1097-0320(20011201)45:4<250::AID-CYTO10021>3.0.CO;2-T; Patsenker L, 2008, ANN NY ACAD SCI, V1130, P179, DOI 10.1196/annals.1430.035; Randlev B, 2010, BIOLOGICALS, V38, P249, DOI 10.1016/j.biologicals.2009.12.001; Reilly JT, 1996, CLIN LAB HAEMATOL, V18, P1; Rigato PO, 2013, CITOMETRIA FLUXO APL, P35; Rossmann ED, 2007, CYTOM PART B-CLIN CY, V72B, P450, DOI 10.1002/cyto.b.20359; SCHMIDT C, 1989, J BIOTECHNOL, V11, P235, DOI 10.1016/0168-1656(89)90120-X; Schwartz A, 2002, J RES NATL INST STAN, V107, P83, DOI 10.6028/jres.107.009; Shapiro HM, 2003, PRACTICAL FLOW CYTOM; Shukla AA, 2007, J CHROMATOGR B, V848, P28, DOI 10.1016/j.jchromb.2006.09.026; Sousa S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002371; Tighe P, 2013, METHODS, V61, P23, DOI 10.1016/j.ymeth.2013.01.003; Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6; Vogt RF, 2000, METHODS, V21, P289, DOI 10.1006/meth.2000.1009; Voskuil JLA., 2014, F1000 RES; Wang L, 2008, CYTOM PART A, V73A, P279, DOI 10.1002/cyto.a.20507; Wang LL, 2006, CYTOM PART B-CLIN CY, V70B, P410, DOI 10.1002/cyto.b.20140; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Wiczling P, 2009, CYTOM PART A, V75A, P584, DOI 10.1002/cyto.a.20736	46	1	1	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167669	10.1371/journal.pone.0167669	http://dx.doi.org/10.1371/journal.pone.0167669			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936034	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100145
J	Skrivanova, E; Van Immerseel, F; Hovorkova, P; Kokoska, L				Skrivanova, Eva; Van Immerseel, Filip; Hovorkova, Petra; Kokoska, Ladislav			In Vitro Selective Growth-Inhibitory Effect of 8-Hydroxyquinoline on Clostridium perfringens versus Bifidobacteria in a Medium Containing Chicken Ileal Digesta	PLOS ONE			English	Article							NECROTIC ENTERITIS; BROILER-CHICKENS; ANTIMICROBIAL ACTIVITY; ESSENTIAL OILS; MICROBIOTA; ACID; 8-QUINOLINOL; PATHOGENESIS; ANTIBIOTICS; CLIOQUINOL	Clostridium perfringens-induced necrotic enteritis is generally controlled by antibiotics. However, because of increasing antibiotic resistance, other antibacterial agents are required, preferably ones that do not affect the beneficial intestinal microbiota of the host. This study evaluated the in vitro selective growth-inhibitory effect of 8-hydroxyquinoline (8HQ) on C. perfringens vs. bifidobacteria in a medium containing chicken ileal digesta. Prior to the experiments, the minimum inhibitory concentrations of 8HQ and penicillin G were determined by broth microdilution assay. The minimum inhibitory concentration values of 8HQ for C. perfringens were 16-32 times lower than the values for bifidobacteria. Treatment of autoclaved and non-autoclaved chicken ileal digesta with 8HQ showed a selective anticlostridial effect. After incubation of C. perfringens with autoclaved ileal digesta for 3 h, all 8HQ concentrations tested (32-2048 mu g/mL) significantly reduced C. perfringens bacterial count. In contrast, the same treatment had no or only a slight effect on bifidobacteria counts. Unlike 8HQ, penicillin G did not exhibit any selectivity. Similar results were obtained after incubation for 24 h. In non-autoclaved ileal digesta, all 8HQ concentrations tested significantly reduced C. perfringens bacterial counts after incubation for 30 min and 3 h, while no effect was observed on bifidobacteria. These results suggest that 8HQ may serve as a prospective veterinary compound for use against necrotic enteritis in poultry.	[Skrivanova, Eva; Hovorkova, Petra] Inst Anim Sci, Dept Physiol Nutr & Qual Anim Prod, Prague, Czech Republic; [Skrivanova, Eva; Hovorkova, Petra] Czech Univ Life Sci, Fac Agrobiol Food & Nat Resources, Dept Microbiol Nutr & Dietet, Prague, Czech Republic; [Van Immerseel, Filip] Univ Ghent, Dept Pathol Bacteriol & Poultry Dis, Merelbeke, Belgium; [Kokoska, Ladislav] Czech Univ Life Sci, Fac Trop AgriSci, Dept Crop Sci & Agroforestry, Prague, Czech Republic	Czech Research Institute of Animal Science; Czech University of Life Sciences Prague; Ghent University; Czech University of Life Sciences Prague	Kokoska, L (corresponding author), Czech Univ Life Sci, Fac Trop AgriSci, Dept Crop Sci & Agroforestry, Prague, Czech Republic.	kokoska@ftz.czu.cz	Van Immerseel, Filip/K-3701-2014; Kokoska, Ladislav/AAH-9857-2019; Skrivanova, Eva/V-6389-2019	Van Immerseel, Filip/0000-0003-0455-3350; Skrivanova, Eva/0000-0001-9336-5436; Kokoska, Ladislav/0000-0002-5677-692X	Ministry of Agriculture of the Czech Republic [MZERO0716]	Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	The study was supported by the Ministry of Agriculture of the Czech Republic (project No. MZERO0716).; This study was supported by the Ministry of Agriculture of the Czech Republic (project No. MZERO0716).	Agunos A, 2012, CAN VET J, V53, P1289; Baumans V, 2004, GENE THER, V11, pS64, DOI 10.1038/sj.gt.3302371; Butaye P, 2003, CLIN MICROBIOL REV, V16, P175, DOI 10.1128/CMR.16.2.175-188.2003; Chen C, 2014, BIOORG MED CHEM LETT, V24, P595, DOI 10.1016/j.bmcl.2013.12.015; Cheng GY, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00217; Chobot V, 2011, NAT PROD COMMUN, V6, P597; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Collier CT, 2008, VET IMMUNOL IMMUNOP, V122, P104, DOI 10.1016/j.vetimm.2007.10.014; Cos P, 2006, J ETHNOPHARMACOL, V106, P290, DOI 10.1016/j.jep.2006.04.003; Duarte MC, 2016, VET PARASITOL, V217, P81, DOI 10.1016/j.vetpar.2016.01.002; FOX LK, 1994, J DAIRY SCI, V77, P2281, DOI 10.3168/jds.S0022-0302(94)77171-X; FRASER RSS, 1975, BIOCHEM J, V147, P401, DOI 10.1042/bj1470401; Fuller R., 2001, POULTRY SCI, V38, P189, DOI [10.2141/jpsa. 38. 189, DOI 10.2141/JPSA.38.189]; Gadbois P, 2008, AVIAN DIS, V52, P407, DOI 10.1637/8114-091807-Reg; Gosselin RE, 1984, CLIN TOXICOLOGY COMM, pII; Hecht DW., 1999, MANUAL CLIN MICROBIO, V7th ed, P1555; Jeon JH, 2009, J KOREAN SOC APPL BI, V52, P202, DOI 10.3839/jksabc.2009.037; Jung WJ, 2008, J MICROBIOL BIOTECHN, V18, P1836, DOI 10.4014/jmb.0800.120; Kanakaraj R, 1998, VET MICROBIOL, V63, P29, DOI 10.1016/S0378-1135(98)00229-6; Kim YM, 2006, FOOD SCI BIOTECHNOL, V15, P817; Lee KW, 2011, POULTRY SCI, V90, P1381, DOI 10.3382/ps.2010-01319; Magyar K, 1989, U.S. Patent, Patent No. [4,871,722, 4871722]; Namkung H, 2011, POULTRY SCI, V90, P2217, DOI 10.3382/ps.2011-01498; Novakova J, 2016, LETT APPL MICROBIOL, V62, P330, DOI 10.1111/lam.12552; Novakova J, 2014, J MED MICROBIOL, V63, P1663, DOI 10.1099/jmm.0.080796-0; Novakova J, 2013, ANAEROBE, V22, P134, DOI 10.1016/j.anaerobe.2013.05.008; Pang Y, 2009, POULTRY SCI, V88, P586, DOI 10.3382/ps.2008-00243; Park SS, 2008, AVIAN DIS, V52, P14, DOI 10.1637/7997-041707-Reg; Prachayasittikul V, 2013, DRUG DES DEV THER, V7, P1157, DOI 10.2147/DDDT.S49763; Rada V, 2000, J MICROBIOL METH, V43, P127, DOI 10.1016/S0167-7012(00)00205-0; SAS Institute, 2001, SAS SYST WIND REL 8; SAWADA Y, CHEM PHARM B, V26, P1357; Shojadoost B, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-74; Si W, 2009, J APPL MICROBIOL, V106, P213, DOI 10.1111/j.1365-2672.2008.03994.x; Si W, 2007, APPL ENVIRON MICROB, V73, P7110, DOI 10.1128/AEM.01108-07; Tateishi J, 2000, NEUROPATHOLOGY, V20, pS20; Timbermont L, 2011, AVIAN PATHOL, V40, P341, DOI 10.1080/03079457.2011.590967; Timbermont L, 2010, AVIAN PATHOL, V39, P117, DOI 10.1080/03079451003610586; Ubeda C, 2012, TRENDS IMMUNOL, V33, P459, DOI 10.1016/j.it.2012.05.003; Vasudevan P, 2005, J APPL POULTRY RES, V14, P122, DOI 10.1093/japr/14.1.122; Wise MG, 2005, APPL ENVIRON MICROB, V71, P3911, DOI 10.1128/AEM.71.7.3911-3916.2005; Yoshinari K, 2011, TOXICOL LETT, V206, P229, DOI 10.1016/j.toxlet.2011.07.023	42	10	10	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167638	10.1371/journal.pone.0167638	http://dx.doi.org/10.1371/journal.pone.0167638			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936245	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100138
J	Yang, WW; Wang, AN; Zhao, CL; Li, QH; Pan, ZF; Han, XF; Zhang, CJ; Wang, GH; Ji, C; Wang, GL; Jia, GT; Ju, JY; Gao, W; Yu, WJ; Liu, XY; Chen, X; Feng, WG; Gao, ZQ; Li, J; Ren, CN				Yang, Weiwei; Wang, Anning; Zhao, Chunling; Li, Qinghua; Pan, Zhifang; Han, Xuefu; Zhang, Cuijuan; Wang, Guohui; Ji, Chao; Wang, Guili; Jia, Guangtao; Ju, Jiyu; Gao, Wei; Yu, Wenjing; Liu, Xiaoying; Chen, Xi; Feng, Weiguo; Gao, Zhiqin; Li, Jie; Ren, Chune			miR-125b Enhances IL-8 Production in Early-Onset Severe Preeclampsia by Targeting Sphingosine-1-Phosphate Lyase 1	PLOS ONE			English	Article							MICRORNA FUNCTIONS; INVASION; INTERLEUKIN-8; PATHOGENESIS; PLASMA; GROWTH; DIFFERENTIATION; PROLIFERATION; ANGIOGENESIS; MIGRATION	Preeclampsia (PE) is one of the leading causes of maternal and perinatal mortality and morbidity. One of the main hallmarks observed in PE is impaired inflammation state. In the current study, we found that miR-125b was deregulated in placental tissues and plasma derived from PE patients, which suggest a potential association between this miRNA and the pathogenesis of PE. Overexpression of miR-125b significantly reduced SGPL1 expression, and luciferase assays confirmed that SGPL1 is a direct target of miR-125b. We also found that miR-125b enhanced IL-8 production by directly targeting sphingosine-1-phosphate lyase 1 (SGPL1), and this effect could be reversed by SGPL1 overexpression. In placentas derived from PE patients, a negative correlation of miR-125b and SGPL1 was observed, and IL-8 was validated to be increased in the circulation of PE patients. Our data demonstrated a critical role of miR-125b in IL-8 production and the development of PE.	[Yang, Weiwei; Zhao, Chunling; Pan, Zhifang; Wang, Guohui; Ji, Chao; Jia, Guangtao; Ju, Jiyu; Gao, Wei; Yu, Wenjing; Liu, Xiaoying; Feng, Weiguo; Gao, Zhiqin] Weifang Med Univ, Sch Biol Sci, Weifang, Peoples R China; [Wang, Anning] Weifang Peoples Hosp, Dept Cardiol, Weifang, Peoples R China; [Li, Qinghua] Weifang Med Univ, Coll Publ Hlth, Weifang, Peoples R China; [Han, Xuefu] Weifang Peoples Hosp, Dept Cardiol, Weifang, Peoples R China; [Zhang, Cuijuan; Li, Jie] Weifang Med Univ, Dept Obstet, Affiliated Hosp, Weifang, Peoples R China; [Wang, Guili; Ren, Chune] Weifang Med Univ, Ctr Reprod Med, Affiliated Hosp, Weifang, Peoples R China; [Chen, Xi] Weifang Matern & Child Care Hosp, Dept Dent, Weifang, Peoples R China; [Yang, Weiwei; Zhao, Chunling; Gao, Zhiqin] Weifang Med Univ, Biopharmaceut Lab Hlth & Family Planning Commiss, Weifang, Peoples R China	Weifang Medical University; Weifang Medical University; Weifang Medical University; Weifang Medical University; Weifang Medical University	Gao, ZQ (corresponding author), Weifang Med Univ, Sch Biol Sci, Weifang, Peoples R China.; Gao, ZQ (corresponding author), Weifang Med Univ, Biopharmaceut Lab Hlth & Family Planning Commiss, Weifang, Peoples R China.	zhiqingao2013@163.com			Natural Science Foundation of China [81601318, 31671208, 81572578, 81274093]; Natural Science Foundation of Shandong Province [ZR2015HL021, ZR2014AQ025, ZR2013CM032]; Shandong Province Higher Educational Science and Technology Program [J16LM06]; Shandong Outstanding Youth Scientists [BS2013YY063]; Weifang Medical University [K1302021]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Shandong Province Higher Educational Science and Technology Program; Shandong Outstanding Youth Scientists; Weifang Medical University	This work was supported by grants from the Natural Science Foundation of China (81601318, 31671208, 81572578, 81274093), Natural Science Foundation of Shandong Province (ZR2015HL021, ZR2014AQ025, ZR2013CM032), Shandong Province Higher Educational Science and Technology Program (J16LM06), Shandong Outstanding Youth Scientists (BS2013YY063), Weifang Medical University (No. K1302021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende ML, 2011, J BIOL CHEM, V286, P7348, DOI 10.1074/jbc.M110.171819; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bektas M, 2010, J BIOL CHEM, V285, P10880, DOI 10.1074/jbc.M109.081489; Brosens I A, 1972, Obstet Gynecol Annu, V1, P177; Chen DB, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.107805; Chen SW, 2015, FEBS LETT, V589, P710, DOI 10.1016/j.febslet.2015.01.038; Conrad KP, 1997, AM J REPROD IMMUNOL, V37, P240; Dai Y, 2012, PLACENTA, V33, P824, DOI 10.1016/j.placenta.2012.07.012; Dekker GA, 1998, AM J OBSTET GYNECOL, V179, P1359, DOI 10.1016/S0002-9378(98)70160-7; Feliciano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076247; Fu GD, 2013, HYPERTENSION, V61, P864, DOI 10.1161/HYPERTENSIONAHA.111.203489; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Gu Y, 2013, AM J PHYSIOL-ENDOC M, V304, pE836, DOI 10.1152/ajpendo.00660.2012; Gupta AK, 2005, HUM IMMUNOL, V66, P1146, DOI 10.1016/j.humimm.2005.11.003; Hod T, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023473; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Kappelmann M, 2013, ONCOGENE, V32, P2984, DOI 10.1038/onc.2012.307; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; Kauma S, 2002, OBSTET GYNECOL, V100, P706, DOI 10.1016/S0029-7844(02)02169-5; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Lalevee S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.368; Laresgoiti-Servitje E, 2010, HUM REPROD UPDATE, V16, P510, DOI 10.1093/humupd/dmq007; Li DS, 2014, INT J DISTRIB SENS N, DOI 10.1155/2014/827130; Li JYZ, 2014, HYPERTENS PREGNANCY, V33, P102, DOI 10.3109/10641955.2013.832772; Li PF, 2013, CLIN SCI, V124, P27, DOI 10.1042/CS20120121; Liu J, 2009, MOL ENDOCRINOL, V23, P1014, DOI 10.1210/me.2008-0451; Luo LL, 2012, J CELL SCI, V125, P3124, DOI 10.1242/jcs.096412; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Morales-Prieto DM, 2014, PLACENTA, V35, pS39, DOI 10.1016/j.placenta.2013.11.017; Nadeem U, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119065; Pineles BL, 2007, AM J OBSTET GYNECOL, V196, P261, DOI 10.1016/j.ajog.2007.01.008; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; So AY-L, 2014, BLOOD; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Sun YM, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-6; Szarka A, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-59; Taub DD, 1996, J CLIN INVEST, V97, P1931, DOI 10.1172/JCI118625; Tili E, 2013, IMMUNOL REV, V253, P167, DOI 10.1111/imr.12050; Tosun M, 2010, J MATERN-FETAL NEO M, V23, P880, DOI 10.3109/14767051003774942; Wang A, 2009, PHYSIOLOGY, V24, P147, DOI 10.1152/physiol.00043.2008; Wang H, 2012, PLOS ONE, V7, P34210, DOI DOI 10.1371/J0URNAL.P0NE.0034210; Wang XW, 2006, NUCLEIC ACIDS RES, V34, P1646, DOI 10.1093/nar/gkl068; Wu L, 2012, REPRODUCTION, V143, P389, DOI 10.1530/REP-11-0304; Xu P, 2014, HYPERTENSION, V63, P1276, DOI 10.1161/HYPERTENSIONAHA.113.02647; Yang Q, 2014, ONCOTARGET; Zhang C, 2015, PLACENTA, V36, P250, DOI 10.1016/j.placenta.2014.11.020; Zhang L, 2014, GENE DEV, V28, P2532, DOI 10.1101/gad.248377.114; Zhao X, 2015, ANIM BIOL, V65, P1, DOI 10.1163/15707563-00002455; Zhou S, 2014, BURNS J INT SOC BURN; Zhu XM, 2009, AM J OBSTET GYNECOL, V200, P661, DOI [DOI 10.1016/J.AJ0G.2008.12.045, DOI 10.1016/J.AJOG.2008.12.045]	51	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166940	10.1371/journal.pone.0166940	http://dx.doi.org/10.1371/journal.pone.0166940			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935985	gold, Green Submitted, Green Published			2022-12-27	WOS:000389587100049
J	Yu, MZ; Yang, CW				Yu, Manzhu; Yang, Chaowei			Improving the Non-Hydrostatic Numerical Dust Model by Integrating Soil Moisture and Greenness Vegetation Fraction Data with Different Spatiotemporal Resolutions	PLOS ONE			English	Article							AEROSOL OPTICAL-THICKNESS; PREDICTION; AERONET; SUN	Dust storms are devastating natural disasters that cost billions of dollars and many human lives every year. Using the Non-Hydrostatic Mesoscale Dust Model (NMM-dust), this research studies how different spatiotemporal resolutions of two input parameters (soil moisture and greenness vegetation fraction) impact the sensitivity and accuracy of a dust model. Experiments are conducted by simulating dust concentration during July 1-7, 2014, for the target area covering part of Arizona and California (31, 37, -118, -112), with a resolution of similar to 3 km. Using ground-based and satellite observations, this research validates the temporal evolution and spatial distribution of dust storm output from the NMM-dust, and quantifies model error using measurements of four evaluation metrics (mean bias error, root mean square error, correlation coefficient and fractional gross error). Results showed that the default configuration of NMM-dust (with a low spatiotemporal resolution of both input parameters) generates an overestimation of Aerosol Optical Depth (AOD). Although it is able to qualitatively reproduce the temporal trend of the dust event, the default configuration of NMM-dust cannot fully capture its actual spatial distribution. Adjusting the spatiotemporal resolution of soil moisture and vegetation cover datasets showed that the model is sensitive to both parameters. Increasing the spatiotemporal resolution of soil moisture effectively reduces model's overestimation of AOD, while increasing the spatiotemporal resolution of vegetation cover changes the spatial distribution of reproduced dust storm. The adjustment of both parameters enables NMM-dust to capture the spatial distribution of dust storms, as well as reproducing more accurate dust concentration.	[Yang, Chaowei] George Mason Univ, NSF Spatiotemporal Innovat Ctr, Fairfax, VA 22030 USA; George Mason Univ, Dept Geog & Geoinformat Sci, Fairfax, VA 22030 USA	George Mason University; George Mason University	Yang, CW (corresponding author), George Mason Univ, NSF Spatiotemporal Innovat Ctr, Fairfax, VA 22030 USA.	cyang3@gmu.edu	Yang, Chaowei/A-9881-2017; Yu, Manzhu/J-6953-2019	Yang, Chaowei/0000-0001-7768-4066; Yu, Manzhu/0000-0001-6769-7517	NSF [PLR-1349259, IIP-1338925, CNS-1117300]; NASA [NNX15AM85G, NNG16PU001, NNG14HH38I]	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	This work was supported by NSF (PLR-1349259, IIP-1338925, CNS-1117300) and NASA (NNX15AM85G, NNG16PU001, NNG14HH38I).	Ament F, 2006, BOUND-LAY METEOROL, V121, P153, DOI 10.1007/s10546-006-9066-4; Arizona Department of Environmental Quality, 2014, STAT AR EXC EV DOC J, P49; Bagnold R.A., 1941, PHYS BLOWN SAND DESE, V265; Broxton PD, 2014, J APPL METEOROL CLIM, V53, P1996, DOI 10.1175/JAMC-D-13-0356.1; Case JL, 2011, P 15 INT OBS ASS SYS; Cesnulyte V, 2014, ATMOS CHEM PHYS, V14, P593, DOI 10.5194/acp-14-593-2014; Cheng T, 2008, ATMOS CHEM PHYS, V8, P1105, DOI 10.5194/acp-8-1105-2008; Chin M, 2002, J ATMOS SCI, V59, P461, DOI 10.1175/1520-0469(2002)059<0461:TAOTFT>2.0.CO;2; Dubovik O, 2000, J GEOPHYS RES-ATMOS, V105, P20673, DOI 10.1029/2000JD900282; Fecan F, 1998, ANN GEOPHYS; Gesch D.B., 1999, EOS T AM GEOPHYS UN, V80, P69, DOI [10.1029/99EO00050, DOI 10.1029/99EO00050]; Gong SL, 2008, ATMOS CHEM PHYS, V8, P2333, DOI 10.5194/acp-8-2333-2008; Govaerts A, 2010, QUANT GEO G, V16, P219, DOI 10.1007/978-90-481-2322-3_20; Gui Z, 2016, PLOS ONE IN PRESS; Gutman G, 1998, INT J REMOTE SENS, V19, P1533, DOI 10.1080/014311698215333; Hain CR, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015633; Hansen MC, 2000, INT J REMOTE SENS, V21, P1331, DOI 10.1080/014311600210209; Hengl T, 2007, COMPUT GEOSCI-UK, V33, P1301, DOI 10.1016/j.cageo.2007.05.001; Holben BN, 1998, REMOTE SENS ENVIRON, V66, P1, DOI 10.1016/S0034-4257(98)00031-5; Hong SB, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011249; Hsu NC, 2004, IEEE T GEOSCI REMOTE, V42, P557, DOI 10.1109/TGRS.2004.824067; Huang QY, 2013, INT J GEOGR INF SCI, V27, P765, DOI 10.1080/13658816.2012.715650; Janjic Z, 2005, UNIFIED MODEL APPROA; Janjic Z, 2011, MON WEATHER REV, V139, P1556, DOI 10.1175/2010MWR3448.1; Jiang L, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013204; Kinne S, 2006, ATMOS CHEM PHYS, V6, P1815, DOI 10.5194/acp-6-1815-2006; Kumar SV, 2012, WATER RESOURCES RES, V48; Laurent B, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033654; Lee YH, 2010, ATMOS CHEM PHYS, V10, P2129, DOI 10.5194/acp-10-2129-2010; Lingli Wang, 2009, Frontiers of Earth Science in China, V3, P237, DOI 10.1007/s11707-009-0023-7; Menut L, 2009, J GEOPHYS RES ATMOSP; Menut L, 2013, J GEOPHYS RES-ATMOS, V118, P6505, DOI 10.1002/jgrd.50313; Nickovic S, 2001, J GEOPHYS RES-ATMOS, V106, P18113, DOI 10.1029/2000JD900794; Perez C, 2011, ATMOS CHEM PHYS, V11, P13001, DOI 10.5194/acp-11-13001-2011; Shao YP, 1997, J GEOPHYS RES-ATMOS, V102, P30091, DOI 10.1029/97JD02298; Takemura T, 2000, J GEOPHYS RES-ATMOS, V105, P17853, DOI 10.1029/2000JD900265; Tegen I, 1996, J GEOPHYS RES-ATMOS, V101, P19237, DOI 10.1029/95JD03610; Tegen I, 2002, ATMOSPHERES, V107, P2156; Terradellas E, 2016, MODEL INTER COMPARIS; Todd MC, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010476; Valari M, 2008, J ATMOS OCEAN TECH, V25, P1955, DOI 10.1175/2008JTECHA1123.1; WHITE BR, 1979, J GEOPHYS RES, V84, P4643, DOI 10.1029/JB084iB09p04643; Xia Y., 2012, J GEOPHYS RES ATMOSP, V117; Xie JB, 2010, COMPUT ENVIRON URBAN, V34, P278, DOI 10.1016/j.compenvurbsys.2009.08.002; Yang C., 2016, INT J DIGITAL EARTH; Yang C, 2016, COMPUTERS ENV URBAN; Yang CW, 2011, P NATL ACAD SCI USA, V108, P5498, DOI 10.1073/pnas.0909315108; Yu M, 2016, LECT NOTES COMPUT SC, V9864, P3, DOI 10.1007/978-3-319-45940-0_1; Zender C.S., 2003, J GEOPHYS RES ATMOSP, V108	49	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0165616	10.1371/journal.pone.0165616	http://dx.doi.org/10.1371/journal.pone.0165616			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936136	Green Submitted, gold, Green Published			2022-12-27	WOS:000389587100012
J	Anwar, T; Gourinath, S				Anwar, Tamanna; Gourinath, Samudrala			Deep Insight into the Phosphatomes of Parasitic Protozoa and a Web Resource ProtozPhosDB	PLOS ONE			English	Article							EUKARYOTIC PROTEIN-KINASES; TRYPANOSOMA-BRUCEI; ACID-PHOSPHATASE; LEISHMANIA-AMAZONENSIS; PLASMODIUM-FALCIPARUM; TYROSINE PHOSPHATASES; ENTAMOEBA-HISTOLYTICA; SURFACE-MEMBRANE; PROCYCLIC FORMS; CELL-SURFACE	Phosphorylation dynamically regulates the function of proteins by maintaining a balance between protein kinase and phosphatase activity. A comprehensive understanding of the role phosphatases in cellular signaling is lacking in case of protozoans of medical and veterinary importance worldwide. The drugs used to treat protozoal diseases have many undesired effects and the development of resistance, highlights the need for new effective and safer antiprotozoal agents. In the present study we have analyzed phosphatomes of 15 protozoans of medical significance. We identified similar to 2000 phosphatases, out of which 21% are uncharacterized proteins. A significant positive correlation between phosphatome and proteome size was observed except for E. histolytica, having highest density of phosphatases irrespective of its proteome size. A difference in the number of phosphatases among different genera shows the variation in the signaling pathways they are involved in. The phosphatome of parasites is dominated by ser/thr phosphatases contrary to the vertebrate host dominated by tyrosine phosphatases. Phosphatases were widely distributed throughout the cell suggesting physiological adaptation of the parasite to regulate its host. 20% to 45% phosphatome of different protozoa consists of ectophosphatases, i.e. crucial for the survival of parasites. A database and a webserver "ProtozPhosDB" can be used to explore the phosphatomes of protozoans of medical significance.	[Anwar, Tamanna; Gourinath, Samudrala] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi, India	Jawaharlal Nehru University, New Delhi	Gourinath, S (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi, India.	sgourinath@mail.jnu.ac.in			University Grants Commission (Government of India) [F.4-2/2006(BSR)/13-739/2012(BSR)]	University Grants Commission (Government of India)(University Grants Commission, India)	The authors are thankful to University Grants Commission (Government of India) for providing the funds for this project under Dr. D. S. Kothari postdoctoral fellowship scheme. Grant No. F.4-2/2006(BSR)/13-739/2012(BSR).	Pinheiro AAD, 2007, EXP PARASITOL, V115, P352, DOI 10.1016/j.exppara.2006.09.019; Aguirre-Garcia MM, 2003, PARASITOLOGY, V126, P195, DOI 10.1017/S0031182002002767; Amazonas JN, 2009, EXP PARASITOL, V121, P15, DOI 10.1016/j.exppara.2008.09.010; Andrade LO, 2005, NAT REV MICROBIOL, V3, P819, DOI 10.1038/nrmicro1249; Andreeva AV, 2008, INT J PARASITOL, V38, P1279, DOI 10.1016/j.ijpara.2008.04.003; Andrews KT, 2014, INT J PARASITOL-DRUG, V4, P95, DOI 10.1016/j.ijpddr.2014.02.002; Andrews PD, 2000, J CELL SCI, V113, P2685; Anwar T, 2016, IJBRA138978; Anwar T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078714; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Bakalara N, 2000, J BIOL CHEM, V275, P8863, DOI 10.1074/jbc.275.12.8863; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Cosentino-Gomes D, 2011, J BIOENERG BIOMEMBR, V43, P89, DOI 10.1007/s10863-011-9334-y; de Almeida-Amaral EE, 2006, EXP PARASITOL, V114, P334, DOI 10.1016/j.exppara.2006.04.011; de Jesus JB, 2002, PARASITOL RES, V88, P991, DOI 10.1007/s00436-001-0583-2; De Jesus JB, 2006, PARASITOL INT, V55, P285, DOI 10.1016/j.parint.2006.08.002; DELL KR, 1994, MOL BIOCHEM PARASIT, V64, P283, DOI 10.1016/0166-6851(94)00030-1; DICK CF, 2011, ENZYME RES, V2011, DOI DOI 10.4061/2011/103980; Doerig C, 2002, TRENDS PARASITOL, V18, P366, DOI 10.1016/S1471-4922(02)02321-8; Dutra PML, 2006, ACTA TROP, V100, P88, DOI 10.1016/j.actatropica.2006.05.014; Fernandes ACS, 2013, FEMS MICROBIOL LETT, V340, P117, DOI 10.1111/1574-6968.12080; Fernandes EC, 1997, Z NATURFORSCH C, V52, P351; Fernandes EC, 2003, FEMS MICROBIOL LETT, V220, P197, DOI 10.1016/S0378-1097(03)00091-0; Fernandes EC, 2003, VET PARASITOL, V118, P19, DOI 10.1016/j.vetpar.2003.09.012; Furuya T, 1998, MOL BIOCHEM PARASIT, V92, P339, DOI 10.1016/S0166-6851(97)00246-6; Gomes Marta T., 2011, Journal of Parasitology Research, P479146, DOI 10.1155/2011/479146; Gomes SAO, 2006, EXP PARASITOL, V112, P253, DOI 10.1016/j.exppara.2005.11.015; GOTTLIEB M, 1981, SCIENCE, V212, P939, DOI 10.1126/science.7233189; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Herrera L, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00259; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kellosalo J, 2012, SCIENCE, V337, P473, DOI 10.1126/science.1222505; Kutuzov MA, 2008, MOL BIOCHEM PARASIT, V161, P81, DOI 10.1016/j.molbiopara.2008.06.008; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liberti S, 2013, FEBS J, V280, P379, DOI 10.1111/j.1742-4658.2012.08712.x; Manning G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r66; Martin DMA, 2009, NUCLEIC ACIDS RES, V37, pD244, DOI 10.1093/nar/gkn834; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; Meyer-Fernandes JR, 1999, Z NATURFORSCH C, V54, P977; Meyer-Fernandes JR, 2002, PARASITOL INT, V51, P299, DOI 10.1016/S1383-5769(02)00017-X; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Miranda-Saavedra D, 2007, PROTEINS, V68, P893, DOI 10.1002/prot.21444; Neves RFC, 2014, PARASITOL RES, V113, P2961, DOI 10.1007/s00436-014-3958-x; Pandey R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1024; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; PARSONS M, 1991, MOL BIOCHEM PARASIT, V45, P241, DOI 10.1016/0166-6851(91)90091-J; Shakarian AM, 2002, J BIOL CHEM, V277, P17994, DOI 10.1074/jbc.M200114200; Stefani M, 1995, LIFE CHEM REPORTS, V12, P271; Szoor B, 2010, MOL BIOCHEM PARASIT, V173, P53, DOI 10.1016/j.molbiopara.2010.05.017; Veeramani S, 2009, TRENDS BIOCHEM SCI, V34, P273, DOI 10.1016/j.tibs.2009.03.002; Wilkes JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-412; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604	54	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167594	10.1371/journal.pone.0167594	http://dx.doi.org/10.1371/journal.pone.0167594			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930683	Green Submitted, Green Published, gold			2022-12-27	WOS:000389580900029
J	Guido, NJ; Handerson, S; Joseph, EM; Leake, D; Kung, LA				Guido, Nicholas J.; Handerson, Steven; Joseph, Elaine M.; Leake, Devin; Kung, Li A.			Determination of a Screening Metric for High Diversity DNA Libraries	PLOS ONE			English	Article							GENE SYNTHESIS; ERROR-CORRECTION; SEQUENCES; ALIGNMENT; GAP	The fields of antibody engineering, enzyme optimization and pathway construction rely increasingly on screening complex variant DNA libraries. These highly diverse libraries allow researchers to sample a maximized sequence space; and therefore, more rapidly identify proteins with significantly improved activity. The current state of the art in synthetic biology allows for libraries with billions of variants, pushing the limits of researchers' ability to qualify libraries for screening by measuring the traditional quality metrics of fidelity and diversity of variants. Instead, when screening variant libraries, researchers typically use a generic, and often insufficient, oversampling rate based on a common rule-of-thumb. We have developed methods to calculate a library-specific oversampling metric, based on fidelity, diversity, and representation of variants, which informs researchers, prior to screening the library, of the amount of oversampling required to ensure that the desired fraction of variant molecules will be sampled. To derive this oversampling metric, we developed a novel alignment tool to efficiently measure frequency counts of individual nucleotide variant positions using next-generation sequencing data. Next, we apply a method based on the "coupon collector" probability theory to construct a curve of upper bound estimates of the sampling size required for any desired variant coverage. The calculated oversampling metric will guide researchers to maximize their efficiency in using highly variant libraries.	[Guido, Nicholas J.; Handerson, Steven; Joseph, Elaine M.; Leake, Devin; Kung, Li A.] Gen9 Inc, Cambridge, MA 02139 USA		Guido, NJ (corresponding author), Gen9 Inc, Cambridge, MA 02139 USA.	nguido@gen9bio.com		Joseph, Elaine/0000-0002-9632-4207	Gen9	Gen9	Gen9 provided support in the form of salaries for authors NJG, SH, EMJ, DL, LAK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALTSCHUL SF, 1986, B MATH BIOL, V48, P603, DOI 10.1016/S0092-8240(86)90010-8; Arndt KM, 2007, PROTEIN ENG PROTOCOL, pxi; Boneh A, 1996, COMMUNICATIONS STA C, V13, P39; Bradley LH, 2014, METHODS MOL BIOL, V1216, P117, DOI 10.1007/978-1-4939-1486-9_6; Carr PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh160; Davis PJ, 1975, METHODS NUMERICAL IN, pxii; Ferragina P, 2000, ANN IEEE SYMP FOUND, P390, DOI 10.1109/SFCS.2000.892127; Ferrante M, 2014, MAT MATEMATICS, V2, P1; FLAJOLET P, 1992, DISCRETE APPL MATH, V39, P207, DOI 10.1016/0166-218X(92)90177-C; Gan R., 2016, BIOTECHNOL BIOENG; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; Hoebenreich S, 2015, ACS SYNTH BIOL, V4, P317, DOI 10.1021/sb5002399; Kosuri S, 2013, P NATL ACAD SCI USA, V110, P14024, DOI 10.1073/pnas.1301301110; Kosuri S, 2010, NAT BIOTECHNOL, V28, P1295, DOI 10.1038/nbt.1716; Langmead B., BOWTIE 2 MANUAL 2016; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LeProust EM, 2010, NUCLEIC ACIDS RES, V38, P2522, DOI 10.1093/nar/gkq163; Ma SY, 2012, TRENDS BIOTECHNOL, V30, P147, DOI 10.1016/j.tibtech.2011.10.002; Motwani R, 1995, RANDOMIZED ALGORITHM, pxiv; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Poust S, 2014, CURR OPIN BIOTECH, V30, P32, DOI 10.1016/j.copbio.2014.04.011; Quan JY, 2011, NAT BIOTECHNOL, V29, P449, DOI 10.1038/nbt.1847; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Townsend S, 2015, P NATL ACAD SCI USA, V112, P15354, DOI 10.1073/pnas.1510944112; Vidal E, 2005, IEEE T PATTERN ANAL, V27, P1013, DOI 10.1109/TPAMI.2005.147	25	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167088	10.1371/journal.pone.0167088	http://dx.doi.org/10.1371/journal.pone.0167088			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930689	Green Submitted, Green Published, gold			2022-12-27	WOS:000389580900020
J	Larson, CL; Reed, SE; Merenlender, AM; Crooks, KR				Larson, Courtney L.; Reed, Sarah E.; Merenlender, Adina M.; Crooks, Kevin R.			Effects of Recreation on Animals Revealed as Widespread through a Global Systematic Review	PLOS ONE			English	Review							REPEATED HUMAN INTRUSION; BEHAVIORAL-RESPONSES; PROTECTED AREAS; HABITAT USE; NONCONSUMPTIVE RECREATION; VISITOR MANAGEMENT; STRESS-RESPONSE; DISTURBANCE; CONSERVATION; TOURISM	Outdoor recreation is typically assumed to be compatible with biodiversity conservation and is permitted in most protected areas worldwide. However, increasing numbers of studies are discovering negative effects of recreation on animals. We conducted a systematic review of the scientific literature and analyzed 274 articles on the effects of non-consumptive recreation on animals, across all geographic areas, taxonomic groups, and recreation activities. We quantified trends in publication rates and outlets, identified knowledge gaps, and assessed evidence for effects of recreation. Although publication rates are low and knowledge gaps remain, the evidence was clear with over 93% of reviewed articles documenting at least one effect of recreation on animals, the majority of which (59%) were classified as negative effects. Most articles focused on mammals (42% of articles) or birds (37%), locations in North America (37.7%) or Europe (26.6%), and individual-level responses (49%). Meanwhile, studies of amphibians, reptiles, and fish, locations in South America, Asia, and Africa, and responses at the population and community levels are lacking. Although responses are likely to be species-specific in many cases, some taxonomic groups (e.g., raptors, shorebirds, ungulates, and corals) had greater evidence for an effect of recreation. Counter to public perception, non-motorized activities had more evidence for a negative effect of recreation than motorized activities, with effects observed 1.2 times more frequently. Snow-based activities had more evidence for an effect than other types of recreation, with effects observed 1.3 times more frequently. Protecting biodiversity from potentially harmful effects of recreation is a primary concern for conservation planners and land managers who face increases in park visitation rates; accordingly, there is demand for science-based information to help solve these dilemmas.	[Larson, Courtney L.; Reed, Sarah E.; Crooks, Kevin R.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Reed, Sarah E.] Wildlife Conservat Soc, North Amer Program, Bozeman, MT USA; [Merenlender, Adina M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	Colorado State University; Wildlife Conservation Society; University of California System; University of California Berkeley	Larson, CL (corresponding author), Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA.	courtney.larson@colostate.edu		MERENLENDER, Adina/0000-0002-0681-8642	California Department of Fish and Game [P1182112]	California Department of Fish and Game	This study was funded by the California Department of Fish and Game (Local Assistance Grant P1182112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Gutierrez A, 2011, CONSERV BIOL, V25, P623, DOI 10.1111/j.1523-1739.2010.01611.x; Arlettaz R, 2007, P R SOC B, V274, P1219, DOI 10.1098/rspb.2006.0434; Balmford A, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002074; Balmford A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000144; Banks PB, 2007, BIOLOGY LETT, V3, P611, DOI 10.1098/rsbl.2007.0374; Barros A, 2015, AMBIO, V44, P82, DOI 10.1007/s13280-014-0550-7; Barto EK, 2012, OIKOS, V121, P228, DOI 10.1111/j.1600-0706.2011.19401.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baudains TP, 2007, ANIM CONSERV, V10, P400, DOI 10.1111/j.1469-1795.2007.00126.x; Beale CM, 2005, CONSERV BIOL, V19, P2015, DOI 10.1111/j.1523-1739.2005.00256.x; Becken S, 2014, J SUSTAIN TOUR, V22, P507, DOI 10.1080/09669582.2013.877913; Bejder L, 1999, MAR MAMMAL SCI, V15, P738, DOI 10.1111/j.1748-7692.1999.tb00840.x; Bejder L, 2006, ANIM BEHAV, V72, P1149, DOI 10.1016/j.anbehav.2006.04.003; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; BILLINGS WD, 1973, BIOSCIENCE, V23, P697, DOI 10.2307/1296827; BOYLE SA, 1985, WILDLIFE SOC B, V13, P110; Bushell R., 2007, Tourism and protected areas: benefits beyond boundaries. The Vth IUCN World Parks Congress, P1, DOI 10.1079/9780851990224.0001; Cassini MH, 2004, J ETHOL, V22, P127, DOI 10.1007/s10164-003-0112-0; Christ C, 2003, TOURISM BIODIVERSITY; Christensen RHB, 2015, ORDINAL REGRESSIONS; Clark JA, 2002, SCIENCE, V297, P191; Cook CN, 2013, CONSERV BIOL, V27, P902, DOI 10.1111/cobi.12114; Cooper CA, 2008, NORTHEAST NAT, V15, P619, DOI 10.1656/1092-6194-15.4.619; Cordell H.K., 2012, RES BRIEF IRIS SERIE; DUFFUS DA, 1990, BIOL CONSERV, V53, P213, DOI 10.1016/0006-3207(90)90087-6; Eagles P. F., 2002, SUSTAINABLE TOURISM; Finney SK, 2005, BIOL CONSERV, V121, P53, DOI 10.1016/j.biocon.2004.04.009; Frid A, 2002, CONSERV ECOL, V6; Gallagher AJ, 2015, BIOL CONSERV, V184, P365, DOI 10.1016/j.biocon.2015.02.007; George SL, 2006, BIOL CONSERV, V133, P107, DOI 10.1016/j.biocon.2006.05.024; Gill JA, 2001, J APPL ECOL, V38, P846, DOI 10.1046/j.1365-2664.2001.00643.x; Griffin SC, 2007, CONSERV BIOL, V21, P1070, DOI 10.1111/j.1523-1739.2007.00688.x; Guillemain M, 2007, BIODIVERS CONSERV, V16, P3633, DOI 10.1007/s10531-007-9160-z; Gutzwiller KJ, 2002, J WILDLIFE MANAGE, V66, P372, DOI 10.2307/3803170; Hawkins JP, 1999, CONSERV BIOL, V13, P888, DOI 10.1046/j.1523-1739.1999.97447.x; Heil L, 2007, BIODIVERS CONSERV, V16, P1009, DOI 10.1007/s10531-006-9040-y; Ikuta LA, 2003, BIOL CONSERV, V112, P447, DOI 10.1016/S0006-3207(02)00324-5; IUCN (International Union for Conservation of Nature), 2021, THE IUCN RED LIST TH, DOI [10.2305/IUCN.UK.2015-2.RLTS.T2446A22156678.en, DOI 10.2305/IUCN.UK.2015-2.RLTS.T2446A22156678.EN]; IUCN & UNEP-WCMC, 2014, WORLD DAT PROT AR WD; Jennions MD., 2013, HDB META ANAL ECOLOG, P207, DOI [10.23943/princeton/9780691137285.003.0014, DOI 10.23943/PRINCETON/9780691137285.003.0014, DOI 10.1515/9781400846184-016]; Jimenez G, 2011, BIOL CONSERV, V144, P1702, DOI 10.1016/j.biocon.2011.03.003; Kangas K, 2010, ECOL APPL, V20, P1775, DOI 10.1890/09-0399.1; KELLER VE, 1991, BIOL CONSERV, V58, P213, DOI 10.1016/0006-3207(91)90120-X; Knight Richard L., 1995, P51; Koricheva J., 2013, HDB METAANALYSIS ECO, P195, DOI DOI 10.23943/PRINCETON/9780691137285.001.0001; Krebs J, 2007, J WILDLIFE MANAGE, V71, P2180, DOI 10.2193/2007-099; Leighton PA, 2010, BIOL CONSERV, V143, P2156, DOI 10.1016/j.biocon.2010.05.028; Lenth R., 2015, ISMEANS LEAST SQAURE; Lortie CJ, 2007, OIKOS, V116, P1247, DOI 10.1111/j.0030-1299.2007.15686.x; LOSOS E, 1995, BIOSCIENCE, V45, P446, DOI 10.2307/1312788; Louv R., 2008, Last child in the woods: saving our children from nature-deficit disorder; MAININI B, 1993, BIOL CONSERV, V64, P161, DOI 10.1016/0006-3207(93)90653-I; Malo JE, 2011, BIODIVERS CONSERV, V20, P3477, DOI 10.1007/s10531-011-0136-7; Martinez-Abrain A, 2010, BASIC APPL ECOL, V11, P312, DOI 10.1016/j.baae.2009.12.011; Marzano M, 2012, BIODIVERS CONSERV, V21, P2967, DOI 10.1007/s10531-012-0350-y; Marzluff JM, 2006, BIOL CONSERV, V130, P301, DOI 10.1016/j.biocon.2005.12.026; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; McCurdy LE, 2010, CURR PROB PEDIATR AD, V40, P102, DOI 10.1016/j.cppeds.2010.02.003; Medio D, 1997, BIOL CONSERV, V79, P91, DOI 10.1016/S0006-3207(96)00074-2; Monz CA, 2013, FRONT ECOL ENVIRON, V11, P441, DOI 10.1890/120358; Mullner A, 2004, BIOL CONSERV, V118, P549, DOI 10.1016/j.biocon.2003.10.003; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Naylor LM, 2009, J WILDLIFE MANAGE, V73, P328, DOI 10.2193/2008-102; Neumann W, 2010, EUR J WILDLIFE RES, V56, P513, DOI 10.1007/s10344-009-0340-x; Newsome D, 2004, ENV IMPACTS ASS RECR; O'Connor S., 2009, Whale watching worldwide: tourism numbers, expenditures and expanding economic benefits. A special report from the International Fund for Animal Welfare; Orams MB, 2002, TOURISM MANAGE, V23, P281, DOI 10.1016/S0261-5177(01)00080-2; Parsons C.M., 2012, J MAR BIOL, V5, DOI DOI 10.1155/2012/807294; Pfeiffer S, 2004, POLAR REC, V40, P345, DOI 10.1017/S0032247404003845; POMERANTZ GA, 1988, WILDLIFE SOC B, V16, P58; Pullin AS, 2009, BIOL CONSERV, V142, P931, DOI 10.1016/j.biocon.2009.01.010; Pullin AS, 2006, CONSERV BIOL, V20, P1647, DOI 10.1111/j.1523-1739.2006.00485.x; R Core Team, 2021, R LANGUAGE ENV STAT; Reed SE, 2008, CONSERV LETT, V1, P146, DOI 10.1111/j.1755-263X.2008.00019.x; Riffell SK, 1996, ECOL APPL, V6, P492, DOI 10.2307/2269386; Rogala JK, 2011, ECOL SOC, V16, DOI 10.5751/ES-04251-160316; Sato CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064282; Semeniuk CAD, 2008, MAR ECOL PROG SER, V357, P271, DOI 10.3354/meps07299; Semeniuk CAD, 2009, BIOL CONSERV, V142, P1818, DOI 10.1016/j.biocon.2009.03.022; Showler DA, 2010, CEE REV; Stankowich T, 2008, BIOL CONSERV, V141, P2159, DOI 10.1016/j.biocon.2008.06.026; Steidl RJ, 2000, ECOL APPL, V10, P258, DOI 10.1890/1051-0761(2000)010[0258:EEOHAB]2.0.CO;2; STEINER AJ, 1981, BIOL CONSERV, V20, P111, DOI 10.1016/0006-3207(81)90022-7; Steven R, 2013, BIODIVERS CONSERV, V22, P1063, DOI 10.1007/s10531-013-0470-z; Steven R, 2011, J ENVIRON MANAGE, V92, P2287, DOI 10.1016/j.jenvman.2011.05.005; Storch I, 2003, WILDLIFE BIOL, V9, P301, DOI 10.2981/wlb.2003.018; Thiel D, 2008, J APPL ECOL, V45, P845, DOI 10.1111/j.1365-2664.2008.01465.x; Trip NV, 2015, NAT AREA J, V35, P266, DOI 10.3375/043.035.0207; UNWTO, 2018, UNWTO TOUR HIGHL 201, Vxxx; Wade AA, 2010, CONSERV BIOL, V24, P151, DOI 10.1111/j.1523-1739.2009.01296.x; Welsh HH, 1998, ECOL APPL, V8, P1118; Wildermuth RP, 2013, CONSERV LETT, V6, P86, DOI 10.1111/j.1755-263X.2012.00298.x; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900; Wolfe SA, 2000, POLAR RES, V19, P63, DOI 10.1111/j.1751-8369.2000.tb00329.x; Zakai D, 2002, BIOL CONSERV, V105, P179, DOI 10.1016/S0006-3207(01)00181-1; Zaradic PA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007367; Zhong LS, 2015, BIOL CONSERV, V181, P219, DOI 10.1016/j.biocon.2014.11.007	98	119	125	7	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167259	10.1371/journal.pone.0167259	http://dx.doi.org/10.1371/journal.pone.0167259			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4OA	27930730	Green Published, gold			2022-12-27	WOS:000389580900022
J	Leonard, SR; Mammel, MK; Lacher, DW; Elkins, CA				Leonard, Susan R.; Mammel, Mark K.; Lacher, David W.; Elkins, Christopher A.			Strain-Level Discrimination of Shiga Toxin-Producing Escherichia coli in Spinach Using Metagenomic Sequencing	PLOS ONE			English	Article							FLAGELLIN GENES; OUTBREAK; INFECTIONS; O157-H7	Consumption of fresh bagged spinach contaminated with Shiga toxin-producing Escherichia coli (STEC) has led to severe illness and death; however current culture-based methods to detect foodborne STEC are time consuming. Since not all STEC strains are considered pathogenic to humans, it is crucial to incorporate virulence characterization of STEC in the detection method. In this study, we assess the comprehensiveness of utilizing a shotgun metagenomics approach for detection and strain-level identification by spiking spinach with a variety of genomically disparate STEC strains at a low contamination level of 0.1 CFU/g. Molecular serotyping, virulence gene characterization, microbial community analysis, and E. coli core gene single nucleotide polymorphism (SNP) analysis were performed on metagenomic sequence data from enriched samples. It was determined from bacterial community analysis that E. coli, which was classified at the phylogroup level, was a major component of the population in most samples. However, in over half the samples, molecular serotyping revealed the presence of indigenous E. coli which also contributed to the percent abundance of E. coli. Despite the presence of additional E. coli strains, the serotype and virulence genes of the spiked STEC, including correct Shiga toxin subtype, were detected in 94% of the samples with a total number of reads per sample averaging 2.4 million. Variation in STEC abundance and/or detection was observed in replicate spiked samples, indicating an effect from the indigenous microbiota during enrichment. SNP analysis of the metagenomic data correctly placed the spiked STEC in a phylogeny of related strains in cases where the indigenous E. coli did not predominate in the enriched sample. Also, for these samples, our analysis demonstrates that strain-level phylogenetic resolution is possible using shotgun metagenomic data for determining the genomic relatedness of a contaminating STEC strain to other closely related E. coli.	[Leonard, Susan R.; Mammel, Mark K.; Lacher, David W.; Elkins, Christopher A.] US FDA, Div Mol Biol, Ctr Food Safety & Appl Nutr, Laurel, MD 20708 USA	US Food & Drug Administration (FDA)	Leonard, SR (corresponding author), US FDA, Div Mol Biol, Ctr Food Safety & Appl Nutr, Laurel, MD 20708 USA.	Susan.Leonard@fda.hhs.gov		Elkins, Christopher/0000-0002-6029-9812	Oak Ridge Institute for Science and Education	Oak Ridge Institute for Science and Education(General Electric)	SRL was supported by a fellowship appointment administered by Oak Ridge Institute for Science and Education.	Baylis CL, 2008, J APPL MICROBIOL, V105, P1259, DOI 10.1111/j.1365-2672.2008.03859.x; Bielaszewska M, 2014, EMBO MOL MED, V6, P347, DOI 10.1002/emmm.201303133; Doyle MP, 2008, J APPL MICROBIOL, V105, P317, DOI 10.1111/j.1365-2672.2008.03746.x; Feng P., 2013, BACTERIOLOGICAL ANAL; Feng P, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0010-2013; Feng PCH, 2013, APPL ENVIRON MICROB, V79, P6917, DOI 10.1128/AEM.02455-13; Gould LH, 2013, FOODBORNE PATHOG DIS, V10, P453, DOI 10.1089/fpd.2012.1401; Herman KM, 2015, EPIDEMIOL INFECT, P1; Iguchi A, 2015, DNA RES, V22, P101, DOI 10.1093/dnares/dsu043; Ilic S, 2008, J FOOD PROTECT, V71, P2398, DOI 10.4315/0362-028X-71.12.2398; Jackson BR, 2016, CLIN INFECT DIS, V63, P380, DOI 10.1093/cid/ciw242; Jarvis KG, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0497-2; Jensen AK, 2016, CLIN INFECT DIS, V63, P64, DOI 10.1093/cid/ciw192; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leonard SR, 2016, APPL ENVIRON MICROB, V82, P4309, DOI 10.1128/AEM.01129-16; Leonard SR, 2015, APPL ENVIRON MICROB, V81, P8183, DOI 10.1128/AEM.02601-15; Mariani-Kurkdjian P, 2014, New Microbes New Infect, V2, P127, DOI 10.1002/nmi2.49; Melton-Celsa AR, 2014, MICROBIOLOGY SPECTRU, V2; Ottesen AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073079; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Ratiner YA, 2010, ARCH MICROBIOL, V192, P267, DOI 10.1007/s00203-010-0556-x; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Taylor AJ, 2015, J CLIN MICROBIOL, V53, P3334, DOI 10.1128/JCM.01280-15; Teunis PFM, 2008, EPIDEMIOL INFECT, V136, P761, DOI 10.1017/S0950268807008771; Tilden J, 1996, AM J PUBLIC HEALTH, V86, P1142, DOI 10.2105/AJPH.86.8_Pt_1.1142; Tominaga A, 2004, GENES GENET SYST, V79, P1, DOI 10.1266/ggs.79.1; Tominaga A, 2007, GENES GENET SYST, V82, P1, DOI 10.1266/ggs.82.1; Tuttle J, 1999, EPIDEMIOL INFECT, V122, P185, DOI 10.1017/S0950268898001976; Valentin-Bon I, 2008, APPL ENVIRON MICROB, V74, P1240, DOI 10.1128/AEM.02258-07; Wang F, 2013, FOODBORNE PATHOG DIS, V10, P665, DOI 10.1089/fpd.2012.1448; Wang L, 2003, J BACTERIOL, V185, P2936, DOI 10.1128/JB.185.9.2936-2943.2003; Wang W, 2007, MICROBIOL-SGM, V153, P2159, DOI 10.1099/mic.0.2007/004192-0; Wilson MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146929	35	44	44	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167870	10.1371/journal.pone.0167870	http://dx.doi.org/10.1371/journal.pone.0167870			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930729	Green Submitted, gold, Green Published			2022-12-27	WOS:000389580900053
J	Oren, DA; Wei, Y; Skrabanek, L; Chow, BKC; Mommsen, T; Mojsov, S				Oren, Deena A.; Wei, Yang; Skrabanek, Luce; Chow, Billy K. C.; Mommsen, Thomas; Mojsov, Svetlana			Structural Mapping and Functional Characterization of Zebrafish Class B G-Protein Coupled Receptor (GPCR) with Dual Ligand Selectivity towards GLP-1 and Glucagon	PLOS ONE			English	Article							TERMINAL EXTRACELLULAR DOMAIN; TISSUE-SPECIFIC EXPRESSION; AMINO-ACID-SEQUENCES; PEPTIDE-I; CRYSTAL-STRUCTURE; RAT-LIVER; BIOLOGICAL-ACTIVITY; BINDING; PANCREAS; RESIDUES	GLP-1 and glucagon regulate glucose metabolism through a network of metabolic pathways initiated upon binding to their specific receptors that belong to class B G-protein coupled receptors (GPCRs). The therapeutic potential of glucagon is currently being evaluated, while GLP-1 is already used in the treatment of type 2 diabetes and obesity. Development of a second generation of GLP-1 based therapeutics depends on a molecular and structural understanding of the interactions between the GLP-1 receptor (GLP-1R) and its ligand GLP-1. There is considerable sequence conservation between GLP-1 and glucagon and between the hGLP-1R and human glucagon receptor (hGCGR), yet each receptor recognizes only its own specific ligand. Glucagon receptors in fish and frogs also exhibit ligand selectivity only towards glucagon and not GLP-1. Based on competitive binding experiments and assays of increase in intracellular cAMP, we demonstrate here that a GPCR in zebrafish (Danio rerio) exhibits dual ligand selectivity towards GLP-1 and glucagon, a characteristic not found in mammals. Further, many structural features found in hGLP-1R and hGCGR are also found in this zebrafish GPCR (zfGPCR). We show this by mapping of its sequence and structural features onto the hGLP-1R and hGCGR based on their partial and complementary crystal structures. Thus, we propose that zfGPCR represents a dual GLP-1R/GCGR. The main differences between the three receptors are in their stalk regions that connect their N-terminal extracellular domains (NECDs) with their transmembrane domains and the absence of loop 3 in the NECD in zfGLP-1R/GCGR. These observations suggest that the interactions between GLP-1 and glucagon with loop 3 and the stalk regions may induce different conformational changes in hGLP-1R and hGCGR upon ligand binding and activation that lead to selective recognition of their native ligands.	[Oren, Deena A.; Wei, Yang; Mojsov, Svetlana] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA; [Skrabanek, Luce] Weill Cornell Med Coll, Appl Bioinformat Core, New York, NY USA; [Chow, Billy K. C.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Mommsen, Thomas] Univ Victoria, Dept Biochem, Victoria, BC, Canada; [Wei, Yang] Regeneron Pharmaceut, Tarrytown, NY USA	Rockefeller University; Cornell University; University of Hong Kong; University of Victoria; Regeneron	Mojsov, S (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	mojsov@rockefeller.edu	Chow, Billy/D-3064-2009	Chow, Billy/0000-0003-3390-0307	National Science Foundation (NSF) [IBN-9904506]	National Science Foundation (NSF)(National Science Foundation (NSF))	Support was provided by the National Science Foundation (NSF) Grant No. IBN-9904506 to SM.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BROMER WW, 1976, METABOLISM, V25, P1315, DOI 10.1016/S0026-0495(76)80130-8; Chen QA, 2010, J BIOL CHEM, V285, P24508, DOI 10.1074/jbc.M110.135749; Chen Q, 2009, J BIOL CHEM, V284, P34135, DOI 10.1074/jbc.M109.038109; Chow BKC, 2004, ENDOCRINOLOGY, V145, P3273, DOI 10.1210/en.2003-0597; Coin I, 2013, CELL, V155, P1258, DOI 10.1016/j.cell.2013.11.008; Cooke RM, 2015, DRUG DISCOV TODAY, V20, P1355, DOI 10.1016/j.drudis.2015.08.003; Coopman K, 2011, MOL ENDOCRINOL, V25, P1804, DOI 10.1210/me.2011-1160; Delano W.L, 2002, PYMOL USERS MANUAL; ENG J, 1992, J BIOL CHEM, V267, P7402; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; GARRISON JC, 1973, J BIOL CHEM, V248, P5333; GEFEL D, 1990, ENDOCRINOLOGY, V126, P2164, DOI 10.1210/endo-126-4-2164; GOKE R, 1993, J BIOL CHEM, V268, P19650; HARMAR T, 1994, TRENDS PHARMACOL SCI, V15, P97, DOI 10.1016/0165-6147(94)90042-6; HEINRICH G, 1984, ENDOCRINOLOGY, V115, P2176, DOI 10.1210/endo-115-6-2176; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Hollenstein K, 2014, TRENDS PHARMACOL SCI, V35, P12, DOI 10.1016/j.tips.2013.11.001; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Irwin DM, 2014, GEN COMP ENDOCR, V209, P50, DOI 10.1016/j.ygcen.2014.03.002; JELINEK LJ, 1993, SCIENCE, V259, P1614, DOI 10.1126/science.8384375; Kirkpatrick A, 2012, P NATL ACAD SCI USA, V109, P19988, DOI [10.1073/pnas.1218051109, 10.1073/pnas.12180511091]; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Kumar S., 2011, J PHARM ALLIED HLTH, V1, P1, DOI [10.3923/jpahs.2011.1.15, DOI 10.3923/JPAHS.2011.1.15]; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li MY, 2015, J ENDOCRINOL, V227, P93, DOI 10.1530/JOE-15-0284; LOK S, 1994, GENE, V140, P203, DOI 10.1016/0378-1119(94)90545-2; MACNEIL DJ, 1994, BIOCHEM BIOPH RES CO, V198, P328, DOI 10.1006/bbrc.1994.1046; Miller JR, 2003, GRAPHPAD PRISM STEP; Miller LJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217901; Mojsov S, 2000, AM ZOOL, V40, P246, DOI 10.1668/0003-1569(2000)040[0246:GLPGAT]2.0.CO;2; MOJSOV S, 1986, J BIOL CHEM, V261, P1880; MOJSOV S, 1987, J CLIN INVEST, V79, P616, DOI 10.1172/JCI112855; MOJSOV S, 1992, INT J PEPT PROT RES, V40, P333; MOMMSEN TP, 1987, FEBS LETT, V219, P227, DOI 10.1016/0014-5793(87)81222-X; MOMMSEN TP, 1990, J ENDOCRINOL, V126, P109, DOI 10.1677/joe.0.1260109; Moon MJ, 2015, J BIOL CHEM, V290, P5696, DOI 10.1074/jbc.M114.612606; MOTULSKI HJ, 2003, FITTING MODELS BIOL; Ngan ESW, 1999, FEBS LETT, V457, P499, DOI 10.1016/S0014-5793(99)01112-6; ORSKOV C, 1986, ENDOCRINOLOGY, V119, P1467, DOI 10.1210/endo-119-4-1467; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Patterson JT, 2013, MOL METAB, V2, P86, DOI 10.1016/j.molmet.2013.01.003; Perrin MH, 1999, ANN NY ACAD SCI, V885, P312, DOI 10.1111/j.1749-6632.1999.tb08687.x; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Plisetskaya EM, 1996, INT REV CYTOL, V168, P187, DOI 10.1016/S0074-7696(08)60885-2; Poudyal H, 2016, ACTA PHYSIOL, V216, P277, DOI 10.1111/apha.12604; Roch GJ, 2009, GEN COMP ENDOCR, V161, P3, DOI 10.1016/j.ygcen.2008.10.017; RODBELL M, 1971, J BIOL CHEM, V246, P1861; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Skrabanek L, 2003, NUCLEIC ACIDS RES, V31, P3856, DOI 10.1093/nar/gkg552; SONNE O, 1978, J BIOL CHEM, V253, P3203; Stalmans W., 1983, GLUCAGON LIVER GLYCO; ter Haar E, 2010, STRUCTURE, V18, P1083, DOI 10.1016/j.str.2010.05.014; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; VanEyll B, 1996, PEPTIDES, V17, P565, DOI 10.1016/0196-9781(96)00019-8; WAGLE SR, 1973, BIOCHEM BIOPH RES CO, V52, P125, DOI 10.1016/0006-291X(73)90963-7; Wei Y, 1996, J NEUROENDOCRINOL, V8, P811, DOI 10.1046/j.1365-2826.1996.05191.x; WEI Y, 1995, FEBS LETT, V358, P219, DOI 10.1016/0014-5793(94)01430-9; Wei Y, 1998, ANN NY ACAD SCI; Wilmen A, 1997, PEPTIDES, V18, P301, DOI 10.1016/S0196-9781(96)00321-X; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Zhou L, 2004, COMP BIOCHEM PHYS B, V137, P255, DOI 10.1016/j.cbpc.2003.11.009; Zidovetzki R, 2003, BIOPHYS CHEM, V100, P555, DOI 10.1016/S0301-4622(02)00306-X	68	9	9	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167718	10.1371/journal.pone.0167718	http://dx.doi.org/10.1371/journal.pone.0167718			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930690	Green Submitted, gold, Green Published			2022-12-27	WOS:000389580900040
J	Sardarinia, M; Akbarpour, S; Lotfaliany, M; Bagherzadeh-Khiabani, F; Bozorgmanesh, M; Sheikholeslami, F; Azizi, F; Hadaegh, F				Sardarinia, Mahsa; Akbarpour, Samaneh; Lotfaliany, Mojtaba; Bagherzadeh-Khiabani, Farideh; Bozorgmanesh, Mohammadreza; Sheikholeslami, Farhad; Azizi, Fereidoun; Hadaegh, Farzad			Risk Factors for Incidence of Cardiovascular Diseases and All-Cause Mortality in a Middle Eastern Population over a Decade Follow-up: Tehran Lipid and Glucose Study	PLOS ONE			English	Article							BODY-MASS INDEX; CHRONIC KIDNEY-DISEASE; WAIST CIRCUMFERENCE; MYOCARDIAL-INFARCTION; DIABETES-MELLITUS; OBESITY PARADOX; POOLED ANALYSIS; 52 COUNTRIES; HYPERTENSION; PREVALENCE	Background To examine the association between potentially modifiable risk factors with cardiovascular disease (CVD) and all-cause mortality and to quantify their population attributable fractions (PAFs) among a sample of Tehran residents. Methods Overall, 8108 participants (3686 men) aged >= 30 years, were investigated. To examine the association between risk factors and outcomes, multivariate sex-adjusted Cox proportional hazard regression analysis were conducted, using age as time-scale in two models including general/central adiposity: 1) adjusted for different independent variables including smoking, education, family history of CVD and sex for both outcomes and additionally adjusted for prevalent CVD for all-cause mortality 2) further adjusted for obesity mediators (hypertension, diabetes, lipid profile and chronic kidney disease). Separate models were used including either general or central adiposity. Results During median follow-up of >10 years, 827 first CVD events and 551 deaths occurred. Both being overweight (hazard ratio (HR), 95% CI: 1.41, 1.18-1.66, PAF 13.66) and obese (1.51, 1.24-1.84, PAF 9.79) played significant roles for incident CVD in the absence of obesity mediators. Predicting CVD, in the presence of general adiposity and its mediators, significant positive associations were found for hypercholesterolemia (1.59, 1.36-1.85, PAF 16.69), low HDL-C (1.21, 1.03-1.41, PAF 12.32), diabetes (1.86, 1.57-2.27, PAF 13.87), hypertension (1.79, 1.46-2.19, PAF 21.62) and current smoking (1.61, 1.34-1.94, PAF 7.57). Central adiposity remained a significant positive predictor, even after controlling for mediators (1.17, 1.01-1.35, PAF 7.55). For all-cause mortality, general/central obesity did not have any risk even in the absence of obesity mediators. Predictors including diabetes (2.56, 2.08-3.16, PAF 24.37), hypertension (1.43, 1.11-1.84, PAF 17.13), current smoking (1.75, 1.38-2.22, PAF 7.71), and low education level (1.59, 1.01-2.51, PAF 27.08) were associated with higher risk, however, hypertriglyceridemia (0.83, 0.68-1.01) and being overweight (0.71, 0.58-0.87) were associated with lower risk. Conclusions Modifiable risk factors account for more than 70% risk for both CVD and mortality events.	[Sardarinia, Mahsa; Akbarpour, Samaneh; Lotfaliany, Mojtaba; Bagherzadeh-Khiabani, Farideh; Bozorgmanesh, Mohammadreza; Sheikholeslami, Farhad; Hadaegh, Farzad] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran; [Akbarpour, Samaneh] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Lotfaliany, Mojtaba] Univ Melbourne, Sch Populat & Global Hlth, Noncommunicable Dis Control, Melbourne, Vic, Australia; [Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran	Shahid Beheshti University Medical Sciences; Tehran University of Medical Sciences; University of Melbourne; Shahid Beheshti University Medical Sciences	Hadaegh, F (corresponding author), Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran.	fzhadaegh@endocrine.ac.ir	Lotfaliany, Mojtaba/ABB-6325-2020; bozorgmanesh, mohammadreza/AAE-1001-2022; Azizi, Fereidoun/ABD-4136-2021; hadaegh, farzad/K-2460-2017	Azizi, Fereidoun/0000-0002-6470-2517; Hajsheikholeslami, Farhad/0000-0001-6016-1867; hadaegh, farzad/0000-0002-0352-8666; Lotfaliany Abrand Abadi, Mojtaba/0000-0001-6594-9004; Hadaegh, Farzad/0000-0002-8935-2744	National Research Council of the Islamic Republic of Iran [121]	National Research Council of the Islamic Republic of Iran	This study was supported by Grant No.121 from the National Research Council of the Islamic Republic of Iran. Funding source had no role in design, in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.	Akbarpour S, 2015, IRANIAN J EPIDEMIOLO, V11, P23; Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; American Diabetes Association, 2015, Clin Diabetes, V33, P97, DOI 10.2337/diaclin.33.2.97; Azizi F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-5; Balkau B, 2007, CIRCULATION, V116, P1942, DOI 10.1161/CIRCULATIONAHA.106.676379; Barr ELM, 2007, CIRCULATION, V116, P151, DOI 10.1161/CIRCULATIONAHA.106.685628; Boshtam M, 2005, PAK J CARDIOL, V16, P23; Bozorgmanesh M, 2012, ACTA DIABETOL, V49, P341, DOI 10.1007/s00592-011-0298-5; Bucholz EM, 2012, AM J MED, V125, P796, DOI 10.1016/j.amjmed.2012.01.018; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Carl J., 2012, J GLYCOMICS LIPIDOMI; Cerhan JR, 2014, MAYO CLIN PROC, V89, P335, DOI 10.1016/j.mayocp.2013.11.011; Chang Y, 2016, ANN INTERN MED, V164, P305, DOI 10.7326/M15-1323; Cvetkovic Z, 2009, J BUON, V14, P501; Derakhshan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102563; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Foster MC, 2008, AM J KIDNEY DIS, V52, P39, DOI 10.1053/j.ajkd.2008.03.003; Gellert C, 2012, ARCH INTERN MED, V172, P837, DOI 10.1001/archinternmed.2012.1397; Ghasemzadeh Z, 2016, NUTR METAB, V13, P1; Gray L, 2011, J AM COLL CARDIOL, V58, P2396, DOI 10.1016/j.jacc.2011.07.045; GREENLAND S, 1988, AM J EPIDEMIOL, V128, P1185, DOI 10.1093/oxfordjournals.aje.a115073; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hadaegh F, 2009, INT J OBESITY, V33, P1437, DOI 10.1038/ijo.2009.180; Hadaegh F, 2015, DIABETIC MED; Hadaegh F, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-176; Hadaegh F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139412; Hadaegh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076304; Hadaegh F, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-84; Hainer V, 2013, DIABETES CARE, V36, pS276, DOI 10.2337/dcS13-2023; Hastie CE, 2010, EUR HEART J, V31, P222, DOI 10.1093/eurheartj/ehp317; Hong YL, 2009, CLIN CHEM, V55, P1450, DOI 10.1373/clinchem.2009.125369; Jackson C, 2004, ARCH PEDIAT ADOL MED, V158, P1050, DOI 10.1001/archpedi.158.11.1050; Jahangiri-Noudeh Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112639; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Karimy M, 2013, IRAN RED CRESCENT ME, V15, P187, DOI 10.5812/ircmj.3378; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kheirandish M, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-20; Kutner M., 2005, APPL LINEAR STAT MOD; Levey A, 2000, SIMPLIFIED EQUATION; Liu J, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-159; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lotfaliany M, 2015, J HYPERTENS, V33, P1153, DOI 10.1097/HJH.0000000000000540; Lu Y, 2015, EPIDEMIOLOGY, V26, P153, DOI 10.1097/EDE.0000000000000234; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; McMahon K, 1998, SEMINARS ONCOLOGY; Moghaddam MM, 2014, ANN SAUDI MED, V34, P134, DOI 10.5144/0256-4947.2014.134; Morgan CL, 2000, DIABETES CARE, V23, P1103, DOI 10.2337/diacare.23.8.1103; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Norman K, 2008, CLIN NUTR, V27, P5, DOI 10.1016/j.clnu.2007.10.007; Organization WH, 2010, MORT BURD DIS EST WH; Organization WH, 2009, GLOB HLTH RISKS MORT; Parikh NI, 2008, AM J CARDIOL, V102, P47, DOI 10.1016/j.amjcard.2008.02.095; Pednekar MS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-567; Pencina MJ, 2007, STAT MED, V26, P1343, DOI 10.1002/sim.2699; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Samadi S, 2013, INT J CARDIOL, V165, P260, DOI 10.1016/j.ijcard.2011.08.049; Schulze MB, 2006, DIABETES CARE, V29, P1921, DOI 10.2337/dc06-0895; Shankar A, 2007, ATHEROSCLEROSIS, V192, P177, DOI 10.1016/j.atherosclerosis.2006.04.029; Smith DG, 2007, AM J MANAG CARE, V13, pS68; Staiano AE, 2012, INT J OBESITY, V36, P1450, DOI 10.1038/ijo.2011.268; Taylor KS, 2013, DIABETES CARE, V36, P2366, DOI 10.2337/dc12-1513; Thorogood M, 2003, J EPIDEMIOL COMMUN H, V57, P130, DOI 10.1136/jech.57.2.130; van Buuren S, 2011, J STAT SOFTW, V45, P1; Visscher TLS, 2001, INT J OBESITY, V25, P1730, DOI 10.1038/sj.ijo.0801787; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	72	54	55	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167623	10.1371/journal.pone.0167623	http://dx.doi.org/10.1371/journal.pone.0167623			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930696	gold, Green Published, Green Submitted			2022-12-27	WOS:000389580900031
J	Hu, C; Li, Z; Zhou, T; Zhu, AJ; Xu, CP				Hu, Cong; Li, Zhi; Zhou, Tian; Zhu, Aijun; Xu, Chuanpei			A Multi-Verse Optimizer with Levy Flights for Numerical Optimization and Its Application in Test Scheduling for Network-on-Chip	PLOS ONE			English	Article							GLOBAL OPTIMIZATION; PARTICLE SWARM; TEST ACCESS; ALGORITHM; SEARCH	We propose a new meta-heuristic algorithm named Levy flights multi-verse optimizer (LFMVO), which incorporates Levy flights into multi-verse optimizer (MVO) algorithm to solve numerical and engineering optimization problems. The Original MVO easily falls into stagnation when wormholes stochastically re-span a number of universes (solutions) around the best universe achieved over the course of iterations. Since Levy flights are superior in exploring unknown, large-scale search space, they are integrated into the previous best universe to force MVO out of stagnation. We test this method on three sets of 23 well-known benchmark test functions and an NP complete problem of test scheduling for Network-on-Chip (NoC). Experimental results prove that the proposed LFMVO is more competitive than its peers in both the quality of the resulting solutions and convergence speed.	[Hu, Cong; Li, Zhi] Xidian Univ, Sch Mechanoelect Engn, Xian, Shaanxi, Peoples R China; [Hu, Cong; Zhou, Tian; Zhu, Aijun; Xu, Chuanpei] Guilin Univ Elect Technol, Sch Elect Engn & Automat, Guilin, Guangxi, Peoples R China; [Li, Zhi] Guilin Univ Aerosp Technol, Guilin, Guangxi, Peoples R China	Xidian University; Guilin University of Electronic Technology; Guilin University of Aerospace Technology	Xu, CP (corresponding author), Guilin Univ Elect Technol, Sch Elect Engn & Automat, Guilin, Guangxi, Peoples R China.	mataaedu@outlook.com	Zhu, Aijun/AGO-3276-2022	Zhu, Aijun/0000-0003-3112-4172	National Natural Science Foundation of China [61561012]; Guangxi Natural Science Foundation of China [2014GXNSFAA118393]; Guangxi Key Laboratory of Automatic Detecting Technology and Instruments [YQ16106]; Science and Technology Research Project of Guangxi Department of Education [KY2015Y13110]; National Natural Science Foundation of China [61561012]; Guangxi Natural Science Foundation of China [2014GXNSFAA118393]; Guangxi Key Laboratory of Automatic Detecting Technology and Instruments [YQ16106]; Science and Technology Research Project of Guangxi Department of Education [KY2015Y13110]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation of China; Guangxi Key Laboratory of Automatic Detecting Technology and Instruments; Science and Technology Research Project of Guangxi Department of Education; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation of China; Guangxi Key Laboratory of Automatic Detecting Technology and Instruments; Science and Technology Research Project of Guangxi Department of Education	This work is supported by the National Natural Science Foundation of China (Grant No. 61561012), the Guangxi Natural Science Foundation of China (Grant No. 2014GXNSFAA118393), the Guangxi Key Laboratory of Automatic Detecting Technology and Instruments (Grant No. YQ16106), and the Science and Technology Research Project of Guangxi Department of Education (Grant No. KY2015Y13110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdechiri M, 2013, APPL SOFT COMPUT, V13, P2932, DOI 10.1016/j.asoc.2012.03.068; Ahmed SH, 2016, IEEE T VEH TECHNOL, V65, P3954, DOI 10.1109/TVT.2016.2558650; Al-Temeemy AA, 2010, 2010 IEEE INT C IM S; Butun I, 2016, IEEE COMMUN MAG, V54, P47, DOI 10.1109/MCOM.2016.7452265; Candela R, 2010, LECT NOTES ARTIF INT, V6097, P288, DOI 10.1007/978-3-642-13025-0_31; Chen Y, 2010, J OCCUPATIONAL SAFET, V18, P1, DOI DOI 10.1109/GE0INF0RMATICS.2010.5; Cheng MY, 2014, COMPUT STRUCT, V139, P98, DOI 10.1016/j.compstruc.2014.03.007; Clerc M, 2002, IEEE T EVOLUT COMPUT, V6, P58, DOI 10.1109/4235.985692; COLORNI A, 1992, FROM ANIM ANIMAT, P134; Cordeschi N, 2015, J SUPERCOMPUT, V71, P448, DOI 10.1007/s11227-014-1305-8; Cordeschi N, 2013, COMPUT NETW, V57, P3479, DOI 10.1016/j.comnet.2013.08.002; Gandomi AH, 2014, J COMPUT SCI-NETH, V5, P224, DOI 10.1016/j.jocs.2013.10.002; Geem ZW, 2001, SIMULATION, V76, P60, DOI 10.1177/003754970107600201; Hakli H, 2014, APPL SOFT COMPUT, V23, P333, DOI 10.1016/j.asoc.2014.06.034; Holland J.H., 1975, ADAPTATION NATURAL A; Houbing Song CB., 2016, CYBER PHYS SYSTEMS F; Hu C, 2016, J ELECTRON TEST, V32, P31, DOI 10.1007/s10836-016-5565-5; Iyengar V, 2002, J ELECTRON TEST, V18, P213, DOI 10.1023/A:1014916913577; Jordehi AR, 2014, NEURAL COMPUT APPL, V25, P1329, DOI 10.1007/s00521-014-1613-1; Karaboga D, 2007, J GLOBAL OPTIM, V39, P459, DOI 10.1007/s10898-007-9149-x; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; Lee CY, 2001, IEEE C EVOL COMPUTAT, P568, DOI 10.1109/CEC.2001.934442; Li W, 2016, FUTURE GENE IN PRESS; Liu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097822; Liu CS, 2006, IEEE VLSI TEST SYMP, P46; Lo Ai A., 2016, 2016 IEEE 1 INT C CO; Lv ZH, 2016, IEEE INTERNET THINGS, V3, P1015, DOI 10.1109/JIOT.2016.2546307; MANTEGNA RN, 1994, PHYS REV E, V49, P4677, DOI 10.1103/PhysRevE.49.4677; Marinissen EJ, 2002, INT TEST CONF P, P519, DOI 10.1109/TEST.2002.1041802; Mirjalili S, 2015, KNOWL-BASED SYST, V89, P228, DOI 10.1016/j.knosys.2015.07.006; Mirjalili S, 2016, NEURAL COMPUT APPL, V27, P495, DOI 10.1007/s00521-015-1870-7; Nurzaman SG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016168; Pan WT, 2012, KNOWL-BASED SYST, V26, P69, DOI 10.1016/j.knosys.2011.07.001; Rashedi E, 2009, INFORM SCIENCES, V179, P2232, DOI 10.1016/j.ins.2009.03.004; Richter M, 2014, IEEE T COMPUT, V63, P691, DOI 10.1109/TC.2013.82; Saadi Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144371; Shojafar M, 2019, IEEE T CLOUD COMPUT, V7, P196, DOI 10.1109/TCC.2016.2551747; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Tegmark M., 2004, SCI ULTIMATE REALITY, P459; Wei W, 2018, IEEE T SERV COMPUT, V11, P78, DOI 10.1109/TSC.2016.2528246; Yang XS, 2009, WOR CONG NAT BIOL, P210, DOI 10.1109/nabic.2009.5393690; Yang XS, 2013, COMPUT OPER RES, V40, P1616, DOI 10.1016/j.cor.2011.09.026; Yang XS, 2010, RESEARCH AND DEVELOPMENT IN INTELLIGENT SYSTEMS XXVI, P209, DOI 10.1007/978-1-84882-983-1_15; Zhang YY, 2015, 2015 INTERNATIONAL CONFERENCE ON IDENTIFICATION, INFORMATION, AND KNOWLEDGE IN THE INTERNET OF THINGS (IIKI), P197, DOI 10.1109/IIKI.2015.49	44	24	24	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2016	11	12							e0167341	10.1371/journal.pone.0167341	http://dx.doi.org/10.1371/journal.pone.0167341			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4NG	27926946	Green Submitted, Green Published, gold			2022-12-27	WOS:000389578800010
J	Mountain, D; Keijzers, G; Chu, K; Joseph, A; Read, C; Blecher, G; Furyk, J; Bharat, C; Velusamy, K; Munro, A; Baker, K; Kinnear, F; Mukherjee, A; Watkins, G; Buntine, P; Livesay, G; Fatovich, D				Mountain, David; Keijzers, Gerben; Chu, Kevin; Joseph, Anthony; Read, Catherine; Blecher, Gabriel; Furyk, Jeremy; Bharat, Chrianna; Velusamy, Karthik; Munro, Andrew; Baker, Kylie; Kinnear, Frances; Mukherjee, Ahses; Watkins, Gina; Buntine, Paul; Livesay, Georgia; Fatovich, Daniel			RESPECT-ED: Rates of Pulmonary Emboli ( PE) and Sub-Segmental PE with Modern Computed Tomographic Pulmonary Angiograms in Emergency Departments: A Multi-Center Observational Study Finds Significant Yield Variation, Uncorrelated with Use or Small PE Rates	PLOS ONE			English	Article							CT ANGIOGRAPHY; RULE; DIAGNOSIS; PREVALENCE; MANAGEMENT; PHYSICIANS; NEED; TOO	Introduction Overuse of CT Pulmonary Angiograms (CTPA) for diagnosing pulmonary embolism (PE), particularly in Emergency Departments (ED), is considered problematic. Marked variations in positive CTPA rates are reported, with American 4-10% yields driving most concerns. Higher resolution CTPA may increase sub-segmental PE (SSPE) diagnoses, which may be up to 40% false positive. Excessive use and false positives could increase harm vs. benefit. These issues have not been systematically examined outside America. Aims To describe current yield variation and CTPA utilisation in Australasian ED, exploring potential factors correlated with variation. Methods A retrospective multi-centre review of consecutive ED-ordered CTPA using standard radiology reports. ED CTPA report data were inputted onto preformatted data-sheets. The primary outcome was site level yield, analysed both intra-site and against a nominated 15.3% yield. Factors potentially associated with yield were assessed for correlation. Results Fourteen radiology departments (15 ED) provided 7077 CTPA data (94% >= 64-slice CT); PE were reported in 1028 (yield 14.6% (95% CI 13.8-15.4%; range 9.3-25.3%; site variation p < 0.0001) with four sites significantly below and one above the 15.3% target. Admissions, CTPA usage, PE diagnosis rates and size of PE were uncorrelated with yield. Large PE (>= lobar) were 55% (CI: 52.1-58.2%) and SSPE 8.8% (CI: 7.1-10.5%) of positive scans. CTPA usage (0.2-1.5% adult attendances) was correlated (p<0.006) with PE diagnosis but not SSPE: large PE proportions. Discussion/Conclusions We found significant intra-site CTPA yield variation within Australasia. Yield was not clearly correlated with CTPA usage or increased small PE rates. Both SSPE and large PE rates were similar to higher yield historical cohorts. CTPA use was considerably below USA 2.5- 3% rates. Higher CTPA utilisation was positively correlated with PE diagnoses, but without evidence of increased proportions of small PE. This suggests that increased diagnoses seem to be of clinically relevant sized PE.	[Mountain, David] Univ Western Australia, Sch Primary Aboriginal & Rural Hlth Care, Discipline Emergency Med, Perth, WA, Australia; [Mountain, David] Sir Charles Gairdner Hosp, Emergency Dept, Perth, WA, Australia; [Keijzers, Gerben] Gold Coast Univ Hosp, Dept Emergency Med, Southport, Qld, Australia; [Chu, Kevin] Royal Brisbane & Womens Hosp, Dept Emergency Med, Brisbane, Qld, Australia; [Chu, Kevin] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Joseph, Anthony] Royal North Shore Hosp, Emergency Med, Sydney, NSW, Australia; [Read, Catherine] Inst Resp Hlth, Pleural Med Unit, Perth, WA, Australia; [Read, Catherine] Univ Western Australia, Ctr Resp Hlth, Sch Med & Pharmacol, Perth, WA, Australia; [Read, Catherine] Sir Charles Gairdner Hosp, Resp Med Unit Res Pleural Dis, Perth, WA, Australia; [Blecher, Gabriel] Monash Hlth, Emergency Med, Melbourne, Vic, Australia; [Blecher, Gabriel] Monash Univ, Dept Med, Melbourne, Vic, Australia; [Furyk, Jeremy; Velusamy, Karthik] Townsville Hosp, Emergency Dept, Townsville, Qld, Australia; [Bharat, Chrianna] Sir Charles Gairdner Hosp, Dept Res, Stat Support, Perth, WA, Australia; [Bharat, Chrianna] Univ Western Australia, Ctr Appl Stat, Perth, WA, Australia; [Munro, Andrew] Nelson Hosp, Emergency Dept, Nelson, New Zealand; [Baker, Kylie] Ipswich Hosp, Emergency Med, Ipswich, Qld, Australia; [Kinnear, Frances] Prince Charles Hosp, Emergency Med, Brisbane, Qld, Australia; [Mukherjee, Ahses] Armadale Gen Hosp, Emergency Med, Perth, WA, Australia; [Watkins, Gina] Sutherland Hosp & Community Hlth Ctr, Emergency Med, Caringbah, Australia; [Buntine, Paul] Box Hill Hosp, Emergency Dept, Melbourne, Vic, Australia; [Livesay, Georgia] Princess Alexandra Hosp, Emergency Med Res, Brisbane, Qld, Australia; [Fatovich, Daniel] Univ Western Australia, Ctr Clin Res Emergency Med, Harry Perkins Inst Med Res, Perth, WA, Australia; [Fatovich, Daniel] Royal Perth Hosp, Emergency Dept, Perth, WA, Australia	University of Western Australia; University of Western Australia; Gold Coast University Hospital; Royal Brisbane & Women's Hospital; University of Queensland; Royal North Shore Hospital; University of Western Australia; Monash University; University of Western Australia; Prince Charles Hospital; Box Hill Hospital; Harry Perkins Institute of Medical Research; University of Western Australia; Royal Perth Hospital; University of Western Australia	Mountain, D (corresponding author), Univ Western Australia, Sch Primary Aboriginal & Rural Hlth Care, Discipline Emergency Med, Perth, WA, Australia.; Mountain, D (corresponding author), Sir Charles Gairdner Hosp, Emergency Dept, Perth, WA, Australia.	dmount63@gmail.com	Joseph, Anthony/AAA-3774-2019; buntine, paul/AAS-6409-2020; Livesay, Georgia J/C-2537-2014; Bharat, Chrianna I/S-6776-2017; Mountain, David/ABB-5672-2021; Kinnear, Fran/AFW-1146-2022; Livesay, Georgia/AFU-9023-2022; Fatovich, Daniel/J-5510-2013	Livesay, Georgia J/0000-0002-6213-3349; Bharat, Chrianna I/0000-0002-9778-0386; Mountain, David/0000-0002-6552-4855; Munro, Andrew/0000-0002-3668-0111; Blecher, Gabriel/0000-0001-8537-2011; buntine, paul/0000-0003-4329-3117; Read, Catherine/0000-0002-6201-4366; Fatovich, Daniel/0000-0001-9414-6905				Bozarth AL, 2015, AM J EMERG MED, V33, P483, DOI 10.1016/j.ajem.2013.10.010; Carrier M, 2010, J THROMB HAEMOST, V8, P1716, DOI 10.1111/j.1538-7836.2010.03938.x; Cervini P, 2008, ACAD RADIOL, V15, P556, DOI 10.1016/j.acra.2007.12.007; Chandra S, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-9; Chen YA, 2015, EMERG RADIOL, V22, P221, DOI 10.1007/s10140-014-1265-6; Corwin MT, 2009, AM J ROENTGENOL, V192, P1319, DOI 10.2214/AJR.08.1346; Costa AF, 2014, EMERG RADIOL, V21, P133, DOI 10.1007/s10140-013-1169-x; Costantino MM, 2008, AM J ROENTGENOL, V191, P471, DOI 10.2214/AJR.07.2552; Cronin P, 2011, ACAD RADIOL, V18, P1087, DOI 10.1016/j.acra.2011.04.011; Hall WB, 2009, ARCH INTERN MED, V169, P1961, DOI 10.1001/archinternmed.2009.360; Hutchinson BD, 2015, AM J ROENTGENOL, V205, P271, DOI 10.2214/AJR.14.13938; Kanaan Y, 2013, ACAD RADIOL, V20, P1107, DOI 10.1016/j.acra.2013.05.005; Kim B, 2013, THE USE OF COMPUTED, V2013; Kindermann DR, 2014, J EMERG MED, V46, P791, DOI 10.1016/j.jemermed.2013.12.002; Kline JA, 2008, J THROMB HAEMOST, V6, P772, DOI 10.1111/j.1538-7836.2008.02944.x; Kline JA, 2004, ANN EMERG MED, V44, P490, DOI 10.1016/j.annemergmed.2004.03.018; Laporte S, 2008, CIRCULATION, V117, P1711, DOI 10.1161/CIRCULATIONAHA.107.726232; Mamlouk MD, 2010, RADIOLOGY, V256, P625, DOI 10.1148/radiol.10091624; Miller WT, 2015, ANN AM THORAC SOC, V12, P1022, DOI 10.1513/AnnalsATS.201502-105OC; Mitchell AM, 2012, ACAD EMERG MED, V19, P618, DOI 10.1111/j.1553-2712.2012.01374.x; Mongan J, 2015, EMERG MED J, V32, P840, DOI 10.1136/emermed-2014-204531; Morley NCD, 2015, CLIN RADIOL, V70, P1370, DOI 10.1016/j.crad.2015.07.010; Newman DH, 2011, ANN EMERG MED, V57, P622, DOI 10.1016/j.annemergmed.2011.04.014; Ong CW, 2013, INTERN MED J, V43, P169, DOI 10.1111/j.1445-5994.2012.02926.x; Pollack CV, 2011, J AM COLL CARDIOL, V57, P700, DOI 10.1016/j.jacc.2010.05.071; R Core Team, 2021, R LANGUAGE ENV STAT; Righini M, 2008, LANCET, V371, P1343, DOI 10.1016/S0140-6736(08)60594-2; Rohacek M, 2012, INTENS CARE MED, V38, P1345, DOI 10.1007/s00134-012-2595-z; Schissler AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065669; Segard T, 2013, MED J AUSTRALIA, V198; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; Stein PD, 1997, CHEST, V111, P1246, DOI 10.1378/chest.111.5.1246; Sud R, 2013, INTERN MED J, V43, P1231, DOI 10.1111/imj.12225; Wang RC, 2015, ANN EMERG MED; Wiener RS, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3368; Woo JKH, 2012, AM J ROENTGENOL, V198, P1332, DOI 10.2214/AJR.10.6329; Zompatori M, 2013, RADIOL MED, V118, P901, DOI 10.1007/s11547-013-0966-3	37	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2016	11	12							e0166483	10.1371/journal.pone.0166483	http://dx.doi.org/10.1371/journal.pone.0166483			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MR	27918576	gold, Green Published, Green Submitted			2022-12-27	WOS:000389577100002
J	Jiang, FM; Huang, WW; Wang, Y; Tian, PW; Chen, XR; Liang, ZA				Jiang, Faming; Huang, Weiwei; Wang, Ye; Tian, Panwen; Chen, Xuerong; Liang, Zongan			Nucleic Acid Amplification Testing and Sequencing Combined with Acid-Fast Staining in Needle Biopsy Lung Tissues for the Diagnosis of Smear-Negative Pulmonary Tuberculosis	PLOS ONE			English	Article							PARAFFIN-EMBEDDED TISSUES; MYCOBACTERIUM-TUBERCULOSIS; NONTUBERCULOUS MYCOBACTERIA; RAPID DIAGNOSIS; PCR; PREVALENCE; SECTIONS; ONTARIO; DISEASE; DNA	Background Smear-negative pulmonary tuberculosis (PTB) is common and difficult to diagnose. In this study, we investigated the diagnostic value of nucleic acid amplification testing and sequencing combined with acid-fast bacteria (AFB) staining of needle biopsy lung tissues for patients with suspected smear-negative PTB. Methods Patients with suspected smear-negative PTB who underwent percutaneous transthoracic needle biopsy between May 1, 2012, and June 30, 2015, were enrolled in this retrospective study. Patients with AFB in sputum smears were excluded. All lung biopsy specimens were fixed in formalin, embedded in paraffin, and subjected to acid-fast staining and tuberculous polymerase chain reaction (TB-PCR). For patients with positive AFB and negative TB-PCR results in lung tissues, probe assays and 16S rRNA sequencing were used for identification of nontuberculous mycobacteria (NTM). The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy of PCR and AFB staining were calculated separately and in combination. Results Among the 220 eligible patients, 133 were diagnosed with TB (men/women: 76/57; age range: 17-80 years, confirmed TB: 9, probable TB: 124). Forty-eight patients who were diagnosed with other specific diseases were assigned as negative controls, and 39 patients with indeterminate final diagnosis were excluded from statistical analysis. The sensitivity, specificity, PPV, NPV, and accuracy of histological AFB (HAFB) for the diagnosis of smear-negative were 61.7% (82/133), 100% (48/48), 100% (82/82), 48.5% (48/181), and 71.8% (130/181), respectively. The sensitivity, specificity, PPV, and NPV of histological PCR were 89.5% (119/133), 95.8% (46/48), 98.3% (119/121), and 76.7% (46/60), respectively, demonstrating that histological PCR had significantly higher accuracy (91.2% [165/181]) than histological acid-fast staining (71.8% [130/181]), P < 0.001. Parallel testing of histological AFB staining and PCR showed the sensitivity, specificity, PPV, NPV, and accuracy to be 94.0% (125/133), 95.8% (46/48), 98.4% (125/127), 85.2% (46/54), and 94.5% (171/181), respectively. Among patients with positive AFB and negative PCR results in lung tissue specimens, two were diagnosed with NTM infections (Mycobacterium avium-intracellulare complex and Mycobacterium kansasil). Conclusion Nucleic acid amplification testing combined with acid-fast staining in lung biopsy tissues can lead to early and accurate diagnosis in patients with smear-negative pulmonary tuberculosis. For patients with positive histological AFB and negative tuberculous PCR results in lung tissue, NTM infection should be suspected and could be identified by specific probe assays or 16S rRNA sequencing.	[Liang, Zongan] Sichuan Univ, West China Med Sch, Dept Resp & Crit Care Med, Chengdu, Sichuan, Peoples R China; Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Liang, ZA (corresponding author), Sichuan Univ, West China Med Sch, Dept Resp & Crit Care Med, Chengdu, Sichuan, Peoples R China.	liangza@scu.edu.cn						Adjemian J, 2012, AM J RESP CRIT CARE, V185, P881, DOI 10.1164/rccm.201111-2016OC; Al Houqani M, 2011, CAN RESPIR J, V18, P19, DOI 10.1155/2011/865831; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P7; [Anonymous], 2015 GLOB TUB REP; Azov AG, 2005, APMIS, V113, P586, DOI 10.1111/j.1600-0463.2005.apm_234.x; BEIGE J, 1995, J CLIN MICROBIOL, V33, P90, DOI 10.1128/JCM.33.1.90-95.1995; BRISSONNOEL A, 1989, LANCET, V2, P1069; Chien JY, 2014, EMERG INFECT DIS, V20, P1382, DOI 10.3201/eid2008.131673; EISENACH KD, 1991, AM REV RESPIR DIS, V144, P1160, DOI 10.1164/ajrccm/144.5.1160; Fukunaga H, 2002, AM J RESP CRIT CARE, V166, P994, DOI 10.1164/rccm.2111028; Hofman V, 2003, ANN PATHOL, V23, P206; Kim JK, 2013, TUBERC RESPIR DIS, V74, P215, DOI 10.4046/trd.2013.74.5.215; Li JYW, 2000, DIAGN MOL PATHOL, V9, P67, DOI 10.1097/00019606-200006000-00001; LONGO MC, 1990, GENE, V93, P125, DOI 10.1016/0378-1119(90)90145-H; Marras TK, 2013, EMERG INFECT DIS, V19, P1889, DOI 10.3201/eid1911.130737; Maurya AK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/465403; Montenegro S, 2014, REV CHIL INFECTOL, V31, P676, DOI 10.4067/S0716-10182014000600006; Moore DF, 2005, DIAGN MICR INFEC DIS, V52, P247, DOI 10.1016/j.diagmicrobio.2005.02.014; Morcillo Nora, 2008, Infect Drug Resist, V1, P21; Park JS, 2010, EUR RESPIR J, V35, P851, DOI 10.1183/09031936.00067209; PENEAU A, 1992, EUR J CLIN MICROBIOL, V11, P270, DOI 10.1007/BF02098099; PEROSIO PM, 1993, AM J CLIN PATHOL, V100, P643, DOI 10.1093/ajcp/100.6.643; Salian NV, 1998, AM J RESP CRIT CARE, V158, P1150, DOI 10.1164/ajrccm.158.4.9802034; Shao Y, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003623; Shingadia D, 2012, PEDIATR INFECT DIS J, V31, P302, DOI 10.1097/INF.0b013e318249f26d; Shinnick Thomas M., 2005, Morbidity and Mortality Weekly Report, V54, P1; Taegtmeyer M, 2008, THORAX, V63, P317, DOI 10.1136/thx.2007.083816; Technical Guidance Group of the Fifth National TB Epi-demiological Survey; The Office of the Fifth National TB Epidemiological Survey, 2012, CHIN J ANTITUBERC, V34; Vago L, 1998, AM J CLIN PATHOL, V109, P411; Wang Y, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004460; World Health Organization, IMPL TUB DIAGN POL F; World Health Organization, TREATM TUB GUID, V4th; Wu J., 2014, PLOS ONE, V9	33	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167342	10.1371/journal.pone.0167342	http://dx.doi.org/10.1371/journal.pone.0167342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911922	Green Published, Green Submitted, gold			2022-12-27	WOS:000389520600029
J	Sengupta, S; Roebroeck, A; Kemper, VG; Poser, BA; Zimmermann, J; Goebel, R; Adriany, G				Sengupta, Shubharthi; Roebroeck, Alard; Kemper, Valentin G.; Poser, Benedikt A.; Zimmermann, Jan; Goebel, Rainer; Adriany, Gregor			A Specialized Multi-Transmit Head Coil for High Resolution fMRI of the Human Visual Cortex at 7T	PLOS ONE			English	Article							TO-NOISE RATIO; PHASED-ARRAY; HUMAN BRAIN; FAST MRI; DESIGN; TESLA; SENSE; FIELD; NMR	Purpose To design, construct and validate radiofrequency (RF) transmit and receive phased array coils for high-resolution visual cortex imaging at 7 Tesla. Methods A 4 channel transmit and 16 channel receive array was constructed on a conformal polycarbonate former. Transmit field efficiency and homogeneity were simulated and validated, along with the Specific Absorption Rate, using B-1(+) mapping techniques and electromagnetic simulations. Receiver signal-to-noise ratio (SNR), temporal SNR (tSNR) across EPI time series, g-factors for accelerated imaging and noise correlations were evaluated and compared with a commercial 32 channel whole head coil. The performance of the coil was further evaluated with human subjects through functional MRI (fMRI) studies at standard and submillimeter resolutions of upto 0.8mm isotropic. Results The transmit and receive sections were characterized using bench tests and showed good interelement decoupling, preamplifier decoupling and sample loading. SNR for the 16 channel coil was similar to 1.5 times that of the commercial coil in the human occipital lobe, and showed better g-factor values for accelerated imaging. fMRI tests conducted showed better response to Blood Oxygen Level Dependent (BOLD) activation, at resolutions of 1.2mm and 0.8mm isotropic. Conclusion The 4 channel phased array transmit coil provides homogeneous excitation across the visual cortex, which, in combination with the dual row 16 channel receive array, makes for a valuable research tool for high resolution anatomical and functional imaging of the visual cortex at 7T.	[Sengupta, Shubharthi; Roebroeck, Alard; Kemper, Valentin G.; Poser, Benedikt A.; Goebel, Rainer] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [Sengupta, Shubharthi; Roebroeck, Alard; Kemper, Valentin G.; Poser, Benedikt A.; Goebel, Rainer] Maastricht Univ, Fac Psychol & Neurosci, Maastricht Brain Imaging Ctr, Maastricht, Netherlands; [Adriany, Gregor] Univ Minnesota, Sch Med, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA; [Zimmermann, Jan] NYU, Ctr Neural Sci, New York, NY 10003 USA	Maastricht University; Maastricht University; University of Minnesota System; University of Minnesota Twin Cities; New York University	Sengupta, S (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands.; Sengupta, S (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Maastricht Brain Imaging Ctr, Maastricht, Netherlands.	shubharthi.sengupta@maastrichtuniversity.nl	Sengupta, Shubharthi/AAZ-2649-2020; Adriany, Gregor/AAK-1323-2020; Poser, Benedikt A/F-4992-2010	Sengupta, Shubharthi/0000-0001-5033-0110; Zimmermann, Jan/0000-0003-3345-6074; Poser, Benedikt A/0000-0001-8190-4367; Goebel, Rainer/0000-0003-1780-2467	NWO Middelgroot Grant [36020201N]; ERC Starting Grant (MULTICONNECT) [639938]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R41MH111541] Funding Source: NIH RePORTER	NWO Middelgroot Grant; ERC Starting Grant (MULTICONNECT); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the NWO Middelgroot Grant (#36020201N) to RG [http://www.nwo.ni/en]. AR was supported by an ERC Starting Grant (MULTICONNECT, #639938) [https://erc.europa.eu/projects-and-results/erc-funded-projects/multiconnect]. The funders had no role in study design, data collection and analysis,; We would like to thank Christopher J. Wiggins for his help with the project. This work was supported by the NWO Middelgroot Grant (#36020201N). Alard Roebroeck was supported by an ERC Starting Grant (MULTICONNECT, #639938).	Adriany G, 2005, MAGN RESON MED, V53, P434, DOI 10.1002/mrm.20321; Adriany G., 2012, INT SOC MAGN RESON M, V20, P429; Avdievich NI, 2015, P 23 ISMRM ANN M TOR, P3177; de Zwart JA, 2002, MAGNET RESON MED, V47, P1218, DOI 10.1002/mrm.10169; GLOVER GH, 1985, J MAGN RESON, V64, P255, DOI 10.1016/0022-2364(85)90349-X; Hoult DI, 2000, CONCEPT MAGNETIC RES, V12, P173, DOI 10.1002/1099-0534(2000)12:4<173::AID-CMR1>3.0.CO;2-Q; Keil B, 2011, MAGN RESON MED, V66, P1777, DOI 10.1002/mrm.22961; KELTNER JR, 1991, MAGNET RESON MED, V22, P467, DOI 10.1002/mrm.1910220254; Kozlov M, 2009, J MAGN RESON, V200, P147, DOI 10.1016/j.jmr.2009.06.005; Lattanzi R, 2012, MAGN RESON MED, V68, P286, DOI 10.1002/mrm.23198; Ledden PJ., 2007, P INT SOC MAGN RESON, P242; Moeller S., 2008, P INT SOC MAG RESON, V16, P2366; Oezerdem C., 2015, MAGN RESON MED; Orzada S, 2010, MED PHYS, V37, P2225, DOI 10.1118/1.3378478; Petridou N, 2013, NMR BIOMED, V26, P65, DOI 10.1002/nbm.2820; Possanzini C, 2008, P 16 ANN M INT SOC M, V16, P1123; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; REYKOWSKI A, 1995, MAGNET RESON MED, V33, P848, DOI 10.1002/mrm.1910330617; Robson PM, 2008, MAGN RESON MED, V60, P895, DOI 10.1002/mrm.21728; ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203; Sengupta S, 2015, P 23 ISMRM ANN M TOR, P1777; Shajan G, 2016, MAGN RESON MED, V75, P906, DOI 10.1002/mrm.25666; Shajan G, 2014, MAGN RESON MED, V71, P870, DOI 10.1002/mrm.24726; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Van de Moortele P-F, 2007, P 15 ANN M ISMRM BER, P1676; Vaughan JT, 2001, MAGN RESON MED, V46, P24, DOI 10.1002/mrm.1156; WALD LL, 1995, MAGNET RESON MED, V34, P433, DOI 10.1002/mrm.1910340321; Walsh DO, 2000, MAGNET RESON MED, V43, P682, DOI 10.1002/(SICI)1522-2594(200005)43:5<682::AID-MRM10>3.0.CO;2-G; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Wiggins G., 2009, P 17 ISMRM ANN M HON, P394; Wiggins GC, 2006, MAGN RESON MED, V56, P216, DOI 10.1002/mrm.20925; Wiggins GC, 2009, MAGN RESON MED, V62, P754, DOI 10.1002/mrm.22028; Wright SM, 1997, NMR BIOMED, V10, P394, DOI 10.1002/(SICI)1099-1492(199712)10:8<394::AID-NBM494>3.0.CO;2-0; Yarnykh VL, 2007, MAGN RESON MED, V57, P192, DOI 10.1002/mrm.21120	34	18	18	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0165418	10.1371/journal.pone.0165418	http://dx.doi.org/10.1371/journal.pone.0165418			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911950	Green Published, gold, Green Submitted			2022-12-27	WOS:000389520600003
J	Watanabe, K; Kobayashi, T; Wada, T				Watanabe, Kenji; Kobayashi, Takumi; Wada, Toshikazu			Semi-Supervised Feature Transformation for Tissue Image Classification	PLOS ONE			English	Article							RECOGNITION	Various systems have been proposed to support biological image analysis, with the intent of decreasing false annotations and reducing the heavy burden on biologists. These systems generally comprise a feature extraction method and a classification method. Task-oriented methods for feature extraction leverage characteristic images for each problem, and they are very effective at improving the classification accuracy. However, it is difficult to utilize such feature extraction methods for versatile task in practice, because few biologists specialize in Computer Vision and/or Pattern Recognition to design the task-oriented methods. Thus, in order to improve the usability of these supporting systems, it will be useful to develop a method that can automatically transform the image features of general propose into the effective form toward the task of their interest. In this paper, we propose a semi-supervised feature transformation method, which is formulated as a natural coupling of principal component analysis (PCA) and linear discriminant analysis (LDA) in the framework of graph-embedding. Compared with other feature transformation methods, our method showed favorable classification performance in biological image analysis.	[Watanabe, Kenji; Kobayashi, Takumi] Natl Inst Adv Ind Sci & Technol, Dept Informat Technol & Human Factors, Tsukuba, Ibaraki, Japan; [Wada, Toshikazu] Wakayama Univ, Dept Comp & Commun Sci, Wakayama, Wakayama, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Wakayama University	Watanabe, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Dept Informat Technol & Human Factors, Tsukuba, Ibaraki, Japan.	kenji.watanabe@aist.go.jp	Kobayashi, Takumi/M-4913-2016; Watanabe, Kenji/M-4826-2016	Kobayashi, Takumi/0000-0002-9244-317X; Watanabe, Kenji/0000-0002-7765-9749	JSPS KAKENHI Grant [26330194]; Grants-in-Aid for Scientific Research [26330194] Funding Source: KAKEN	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 26330194 (https://www.isps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awate SP, 2006, MED IMAGE ANAL, V10, P726, DOI 10.1016/j.media.2006.07.002; Bache Kevin, 2013, UCI MACHINE LEARNING; Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; Bianconi F, 2014, PATTERN RECOGN LETT, V45, P33, DOI 10.1016/j.patrec.2014.02.017; Boland MV, 2001, BIOINFORMATICS, V17, P1213, DOI 10.1093/bioinformatics/17.12.1213; Cai D., 2007, IEEE C COMP VIS ICCV, P1, DOI DOI 10.1109/ICCV.2007.4408856; Cocosco CA, 2003, MED IMAGE ANAL, V7, P513, DOI 10.1016/S1361-8415(03)00037-9; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Dosovitskiy A, 2014, P C ADV NEUR INF PRO; Douze M., 2009, CIVR 09; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Gurevich I. B., 2006, Pattern Recognition and Image Analysis, V16, P265, DOI 10.1134/S1054661806030023; He X, 2003, NIPS; He XF, 2005, IEEE T PATTERN ANAL, V27, P328, DOI 10.1109/TPAMI.2005.55; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Krizhevsky A., 2012, P ADV NEUR INF PROC, V25, P1090; Marcialis GL, 2002, LNCS, P30; Martinez AM, 2001, IEEE T PATTERN ANAL, V23, P228, DOI 10.1109/34.908974; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Orlov N, 2008, PATTERN RECOGN LETT, V29, P1684, DOI 10.1016/j.patrec.2008.04.013; Ranzato M, 2007, PATTERN RECOGN LETT, V28, P31, DOI 10.1016/j.patrec.2006.06.010; Razavian AS, 2014, IEEE COMPUT SOC CONF, P512, DOI 10.1109/CVPRW.2014.131; Shamir L, 2008, MED BIOL ENG COMPUT, V46, P943, DOI 10.1007/s11517-008-0380-5; Shie CK, 2015, IEEE ENG MED BIO, P711, DOI 10.1109/EMBC.2015.7318461; Watanabe K, 2015, IEEE SYS MAN CYBERN, P3011, DOI 10.1109/SMC.2015.524; Watanabe S., 1965, P 4 PRAG C INF THEOR, P635; Yan SC, 2007, IEEE T PATTERN ANAL, V29, P40, DOI 10.1109/TPAMI.2007.250598	27	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0166413	10.1371/journal.pone.0166413	http://dx.doi.org/10.1371/journal.pone.0166413			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911905	Green Submitted, gold, Green Published			2022-12-27	WOS:000389520600007
J	Weyandt, JD; Carney, JM; Pavlisko, EN; Xu, MM; Counter, CM				Weyandt, Jamie D.; Carney, John M.; Pavlisko, Elizabeth N.; Xu, MengMeng; Counter, Christopher M.			Isoform-Specific Effects of Wild-Type Ras Genes on Carcinogen-Induced Lung Tumorigenesis in Mice	PLOS ONE			English	Article							N-RAS; H-RAS; ACTIVATION; PROTOONCOGENE; ONCOGENES; TUMORS; MOUSE	The gene KRAS is commonly mutated in lung cancer to encode a constitutively active and oncogenic protein that is well established to initiate and maintain lung tumorigenesis. However, the remaining wild-type KRAS protein, or the other family members HRAS and NRAS, can still be activated in the presence of oncogenic KRAS. Moreover, loss of any one of these three genes has been shown to increase the sensitivity of mice to the carcinogen urethane, which induces Kras mutation-positive early lung lesions. To determine the contribution of progressively disrupting Hras and Nras genes on urethane lung tumorigenesis, mice with different combinations of wild-type and null alleles of Hras and Nras were exposed with urethane and tumor burden was assessed. As previously reported, loss of one allele of Hras increased the sensitivity of mice to this carcinogen, and this effect was further exacerbated by the loss of the second Hras allele. However, loss of one or both alleles of Nras failed to alter tumor burden, either in the absence or presence of Hras, after exposure to urethane. Additionally, no obvious difference between lung lesions in mice with wild-type versus null alleles was detected, suggesting that wild-type Ras proteins may exert a tumor suppressive effects at the time of initiation, although other interpretations are certainly possible. In summary, these data suggest that in some genetic backgrounds inactivation of different wild type Ras genes can have different effects on urethane-induced lung tumorigenesis.	[Weyandt, Jamie D.; Xu, MengMeng; Counter, Christopher M.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Carney, John M.; Pavlisko, Elizabeth N.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Counter, Christopher M.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Counter, CM (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.; Counter, CM (corresponding author), Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27708 USA.	count004@mc.duke.edu		Counter, Christopher M/0000-0003-0748-3079	National Cancer Institute [R01CA123031]; NATIONAL CANCER INSTITUTE [R01CA123031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Cancer Institute, Grant Number: R01CA123031. Grant Recipient: Christopher M. Counter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviel-Ronen S, 2006, CLIN LUNG CANCER, V8, P30, DOI 10.3816/CLC.2006.n.030; Brambilla E, 2016, J CLIN ONCOL, V34, P1223, DOI 10.1200/JCO.2015.63.0970; Castellano E, 2007, ONCOGENE, V26, P917, DOI 10.1038/sj.onc.1209845; Diaz R, 2002, CANCER RES, V62, P4514; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; Grabocka E, 2014, CANCER CELL, V25, P243, DOI 10.1016/j.ccr.2014.01.005; Huang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123918; Iborra S, 2011, BLOOD, V117, P5102, DOI 10.1182/blood-2010-10-315770; Jeng HH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2173; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; Manenti G, 2008, ONCOGENE, V27, P5753, DOI 10.1038/onc.2008.194; Miller Mark Steven, 2012, Frontiers in Genetics, V2, P100, DOI 10.3389/fgene.2011.00100; Pershing NLK, 2015, J CLIN INVEST, V125, P222, DOI 10.1172/JCI77627; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; To MD, 2013, ONCOGENE, V32, P4028, DOI 10.1038/onc.2012.404; Weyandt JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140253; YOU M, 1989, P NATL ACAD SCI USA, V86, P3070, DOI 10.1073/pnas.86.9.3070; Young A, 2013, CANCER DISCOV, V3, P112, DOI 10.1158/2159-8290.CD-12-0231; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721	21	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167205	10.1371/journal.pone.0167205	http://dx.doi.org/10.1371/journal.pone.0167205			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911940	Green Submitted, Green Published, gold			2022-12-27	WOS:000389520600026
J	Cadogan, A; McNair, PJ; Laslett, M; Hing, WA				Cadogan, Angela; McNair, Peter J.; Laslett, Mark; Hing, Wayne A.			Diagnostic Accuracy of Clinical Examination and Imaging Findings for Identifying Subacromial Pain	PLOS ONE			English	Article							PHYSICAL-EXAMINATION TESTS; ROTATOR CUFF DISEASE; ACROMIOCLAVICULAR JOINT; CALCIFYING TENDINITIS; IMPINGEMENT SYNDROME; SHOULDER DISORDERS; PREVALENCE; MANAGEMENT; TEARS; METAANALYSIS	Background The diagnosis of subacromial pathology is limited by the poor accuracy of clinical tests for specific pathologies. The aim of this study was to estimate the diagnostic accuracy of clinical examination and imaging features for identifying subacromial pain (SAP) defined by a positive response to diagnostic injection, and to evaluate the influence of imaging findings on the clinical diagnosis of SAP. Methods and Findings In a prospective, diagnostic accuracy design, 208 consecutive patients presenting to their primary healthcare practitioner for the first time with a new episode of shoulder pain were recruited. All participants underwent a standardized clinical examination, shoulder x-ray series and diagnostic ultrasound scan. Results were compared with the response to a diagnostic block of xylocaine (TM) injected into the SAB under ultrasound guidance using >= 80% post-injection reduction in pain intensity as the positive anaesthetic response (PAR) criterion. Diagnostic accuracy statistics were calculated for combinations of clinical and imaging variables demonstrating the highest likelihood of a PAR. A PAR was reported by 34% of participants. In participants with no loss of passive external rotation, combinations of three clinical variables (anterior shoulder pain, strain injury, absence of symptoms at end-range external rotation (in abduction)) demonstrated 100% specificity for a PAR when all three were positive (LR+ infinity; 95% CI 2.9, infinity). A full-thickness supraspinatus tear on ultrasound increased the likelihood of a PAR irrespective of age (specificity 98% (95% CI 94, 100); LR+ 6.2; 95% CI 1.5, 25.7)). Imaging did not improve the ability to rule-out a PAR. Conclusion Combinations of clinical examination findings and a full-thickness supraspinatus tear on ultrasound scan can help confirm, but not exclude, the presence of subacromial pain. Other imaging findings were of limited value for diagnosing SAP.	[Cadogan, Angela; McNair, Peter J.; Laslett, Mark] AUT Univ, Hlth & Rehabil Res Inst, Auckland, New Zealand; [Hing, Wayne A.] Bond Univ, Fac Hlth Sci & Med, Robina, Qld, Australia	Auckland University of Technology; Bond University	Cadogan, A (corresponding author), AUT Univ, Hlth & Rehabil Res Inst, Auckland, New Zealand.	acadogan@vodafone.co.nz		Hing, Wayne/0000-0002-5507-9778; Cadogan, Angela/0000-0002-7972-5463	Health Research Council of New Zealand; New Zealand Manipulative Physiotherapists Association; Physiotherapy New Zealand	Health Research Council of New Zealand(Health Research Council of New Zealand); New Zealand Manipulative Physiotherapists Association; Physiotherapy New Zealand	This work was supported by the Health Research Council of New Zealand, Clinical Research Training Fellowship to AC, New Zealand Manipulative Physiotherapists Association to AC, and Physiotherapy New Zealand to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts M, 2009, THE EVIDENCE BASE OF; Anderson J, 1998, ATLAS IMAGING SPORTS, V1, P96; Awerbuch MS, 2008, MED J AUSTRALIA, V188, P50, DOI 10.5694/j.1326-5377.2008.tb01507.x; Backhaus M, 2001, ANN RHEUM DIS, V60, P641, DOI 10.1136/ard.60.7.641; Baring T, 2007, BEST PRACT RES CL RH, V21, P279, DOI 10.1016/j.berh.2006.12.001; berg B, 2012, BMJ, V344; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BOGDUK N, 2004, PRACTICE GUIDELINES; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Bryant TN, 2000, STATISTICS WITH CONF; Buchbinder R., 2003, COCHRANE DB SYST REV, V2003, pCD004016, DOI [DOI 10.1002/14651858.CD004016, 10.1002/14651858.CD004016]; Cadogan A, 2012, J REHABIL MED, V44, P877, DOI 10.2340/16501977-1049; Cadogan A, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-119; Cadogan A, 2011, MANUAL THER, V16, P97, DOI 10.1016/j.math.2010.05.005; Calis M, 2000, ANN RHEUM DIS, V59, P44, DOI 10.1136/ard.59.1.44; Chronopoulos E, 2004, AM J SPORT MED, V32, P655, DOI 10.1177/0363546503261723; Codman EA, 1934, RUPTURE SUPRASPINATU, P123; de Jesus JO, 2009, AM J ROENTGENOL, V192, P1701, DOI 10.2214/AJR.08.1241; Dong W, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000510; Dreyfuss P, 1996, SPINE, V21, P2594, DOI 10.1097/00007632-199611150-00009; Eubank BH, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0165-8; Feleus A, 2008, MANUAL THER, V13, P426, DOI 10.1016/j.math.2007.05.010; Flahault A, 2005, J CLIN EPIDEMIOL, V58, P859, DOI 10.1016/j.jclinepi.2004.12.009; GARTNER J, 1995, ORTHOPADE, V24, P284; Greving K, 2012, SCAND J RHEUMATOL, V41, P150, DOI 10.3109/03009742.2011.605390; Haik MN, 2016, BRIT J SPORT MED, V50, P1124, DOI 10.1136/bjsports-2015-095771; Hanchard NCA, 2008, COCHRANE DB SYST REV; Hancock MJ, 2007, EUR SPINE J, V16, P1539, DOI 10.1007/s00586-007-0391-1; HAWKINS RJ, 1980, AM J SPORT MED, V8, P151, DOI 10.1177/036354658000800302; Hegedus EJ, 2008, BRIT J SPORT MED, V42, P80, DOI 10.1136/bjsm.2007.038406; Hegedus EJ, 2012, BRIT J SPORT MED, V46, P964, DOI 10.1136/bjsports-2012-091066; Hertel R, 1996, J Shoulder Elbow Surg, V5, P307, DOI 10.1016/S1058-2746(96)80058-9; IBM Corp, 2013, SPSS WINDOWS; International Spine Intervention Society [ISIS], 2004, PRACTICE GUIDELINES, P61; Itoi E, 1999, AM J SPORT MED, V27, P65, DOI 10.1177/03635465990270011901; Jobe F W, 1989, Orthop Rev, V18, P963; JOBE FW, 1982, AM J SPORT MED, V10, P336, DOI 10.1177/036354658201000602; Johol P, 2008, AUST FAM PHYSICIAN, V37, P263; Kim SH, 2005, AM J SPORT MED, V33, P1188, DOI 10.1177/0363546504272687; Lam F, 2006, CURR ORTHOPAED, V20, P446, DOI 10.1016/j.cuor.2006.09.005; Laslett Mark, 2006, Spine J, V6, P370, DOI 10.1016/j.spinee.2006.01.004; LEROUX JL, 1995, REV RHUM, V62, P423; Louwerens JKG, 2014, J SHOULDER ELB SURG, V23, P1240, DOI 10.1016/j.jse.2014.02.002; Luime JJ, 2004, SCAND J RHEUMATOL, V33, P73, DOI 10.1080/03009740310004667; MacDonald PB, 2000, J SHOULDER ELB SURG, V9, P299, DOI 10.1067/mse.2000.106918; Magarey ME, 2016, BRIT J SPORT MED, V50, P1151, DOI 10.1136/bjsports-2014-094339; MILGROM C, 1995, J BONE JOINT SURG BR, V77B, P296, DOI 10.1302/0301-620X.77B2.7706351; Moosmayer S, 2009, J BONE JOINT SURG BR, V91B, P196, DOI 10.1302/0301-620X.91B2.21069; Morgan CD, 1998, ARTHROSCOPY, V14, P553, DOI 10.1016/S0749-8063(98)70049-0; NEER CS, 1983, CLIN ORTHOP RELAT R, P70; O'Brien SJ, 1998, AM J SPORT MED, V26, P610, DOI 10.1177/03635465980260050201; Ombregt L, 2003, SYSTEM OF ORTHOPAEDI, P291; Ostor AJK, 2005, RHEUMATOLOGY, V44, P800, DOI 10.1093/rheumatology/keh598; Parentis MA, 2006, AM J SPORT MED, V34, P265, DOI 10.1177/0363546505279911; Park HB, 2005, J BONE JOINT SURG AM, V87A, P1446, DOI 10.2106/JBJS.D.02335; Ruotolo C, 2002, ARTHROSCOPY, V18, P527, DOI 10.1053/jars.2002.31707; SHER JS, 1995, J BONE JOINT SURG AM, V77A, P10, DOI 10.2106/00004623-199501000-00002; Stein BES, 2006, J SHOULDER ELB SURG, V15, P56, DOI 10.1016/j.jse.2005.05.013; Steyerberg EW, 1999, J CLIN EPIDEMIOL, V52, P935, DOI 10.1016/S0895-4356(99)00103-1; Stoller DW, 2007, MAGNETIC RESONANCE I, V2, P1131; Strobel K, 2003, AM J ROENTGENOL, V181, P755, DOI 10.2214/ajr.181.3.1810755; Tallia AF, 2003, AM FAM PHYSICIAN, V67, P1271; Tempelhof S, 1999, J SHOULDER ELB SURG, V8, P296, DOI 10.1016/S1058-2746(99)90148-9; VANDERWINDT DAWM, 1995, ANN RHEUM DIS, V54, P959, DOI 10.1136/ard.54.12.959; Virta L, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-17; Walch G, 1998, J BONE JOINT SURG BR, V80B, P624, DOI 10.1302/0301-620X.80B4.8651; Whiting P, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8250; Wittich CM, 2009, MAYO CLIN PROC, V84, P831, DOI 10.1016/S0025-6196(11)60493-X; Yoo Wonsuk, 2014, Int J Appl Sci Technol, V4, P9; [No title captured]	70	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167738	10.1371/journal.pone.0167738	http://dx.doi.org/10.1371/journal.pone.0167738			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936246	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100170
J	Fung, FKC; Law, BYK; Lo, ACY				Fung, Frederic K. C.; Law, Betty Y. K.; Lo, Amy C. Y.			Lutein Attenuates Both Apoptosis and Autophagy upon Cobalt (II) Chloride-Induced Hypoxia in Rat Muller Cells	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; RETINAL GANGLION-CELLS; MACULAR DEGENERATION; OXIDATIVE STRESS; PROTECTS; ZEAXANTHIN; PATHWAY; PIGMENT; ISCHEMIA/REPERFUSION; RETINOPATHY	Retinal ischemia/reperfusion injury is a common feature of various retinal diseases such as glaucoma and diabetic retinopathy. Lutein, a potent anti-oxidant, is used to improve visual function in patients with age-related macular degeneration (AMD). Lutein attenuates apoptosis, oxidative stress and inflammation in animal models of acute retinal ischemia/hypoxia. Here, we further show that lutein improved Muller cell viability and enhanced cell survival upon hypoxia-induced cell death through regulation of intrinsic apoptotic pathway. Moreover, autophagy was activated upon treatment of cobalt (II) chloride, indicating that hypoxic injury not only triggered apoptosis but also autophagy in our in vitro model. Most importantly, we report for the first time that lutein treatment suppressed autophagosome formation after hypoxic insult and lutein administration could inhibit autophagic event after activation of autophagy by a pharmacological approach (rapamycin). Taken together, lutein may have a beneficial role in enhancing glial cell survival after hypoxic injury through regulating both apoptosis and autophagy.	[Fung, Frederic K. C.; Lo, Amy C. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Ophthalmol, Hong Kong, Hong Kong, Peoples R China; [Law, Betty Y. K.] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Lo, Amy C. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Macau University of Science & Technology; University of Hong Kong	Lo, ACY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Ophthalmol, Hong Kong, Hong Kong, Peoples R China.; Lo, ACY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China.	amylo@hku.hk	Lo, Amy C. Y./C-1195-2009	Lo, Amy C. Y./0000-0003-4239-6851	Hong Kong Research Grants Council (GRF) [HKU773210M]; FDCT grant from the Science and Technology Development Fund of Macao [090/2013/A3]	Hong Kong Research Grants Council (GRF)(Hong Kong Research Grants Council); FDCT grant from the Science and Technology Development Fund of Macao	Support was provided by Hong Kong Research Grants Council (GRF#HKU773210M) and an FDCT grant from the Science and Technology Development Fund of Macao (Project code: 090/2013/A3). Both funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Barber AJ, 2011, INVEST OPHTH VIS SCI, V52, P1156, DOI 10.1167/iovs.10-6293; Beatty S, 1999, BRIT J OPHTHALMOL, V83, P867, DOI 10.1136/bjo.83.7.867; Bian QN, 2012, ADV EXP MED BIOL, V723, P43, DOI 10.1007/978-1-4614-0631-0_7; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Chang CL, 2013, J DENT SCI, V8, P8, DOI 10.1016/j.jds.2012.09.006; Chucair AJ, 2007, INVEST OPHTH VIS SCI, V48, P5168, DOI 10.1167/iovs.07-0037; Gallo S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.155; Gao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046092; Garcia M, 2003, ROLE MULLER GLIA NEU; Guo L, 2005, INVEST OPHTH VIS SCI, V46, P175, DOI 10.1167/iovs.04-0832; Jin XH, 2006, INVEST OPHTH VIS SCI, V47, P2562, DOI 10.1167/iovs.05-1429; Jung JY, 2008, BRAIN RES BULL, V76, P579, DOI 10.1016/j.brainresbull.2008.04.006; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kawasaki A, 2000, INVEST OPHTH VIS SCI, V41, P3444; Khan SA, 2006, J MOL CELL CARDIOL, V41, P256, DOI 10.1016/j.yjmcc.2006.04.014; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Koh PO, 2008, NEUROSCI LETT, V444, P74, DOI 10.1016/j.neulet.2008.08.024; Krinsky NI, 2003, ANNU REV NUTR, V23, P171, DOI 10.1146/annurev.nutr.23.011702.073307; Krishnaswamy R, 2010, FREE RADICAL BIO MED, V49, P50, DOI 10.1016/j.freeradbiomed.2010.03.016; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Li HF, 2015, NEUROSCI LETT, V588, P178, DOI 10.1016/j.neulet.2015.01.007; Li L, 2013, INFLAMM RES, V62, P387, DOI 10.1007/s00011-013-0590-7; Li SJ, 2012, APPL MATH COMPUT, V218, P6874, DOI 10.1016/j.amc.2011.12.064; Li SY, 2012, INVEST OPHTH VIS SCI, V53, P5976, DOI 10.1167/iovs.12-10007; Li SY, 2010, INT J MOL SCI, V11, P2109, DOI 10.3390/ijms11052109; Li SY, 2009, INVEST OPHTH VIS SCI, V50, P836, DOI 10.1167/iovs.08-2310; MANGELS AR, 1993, J AM DIET ASSOC, V93, P284, DOI 10.1016/0002-8223(93)91553-3; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Nataraj J, 2015, NUTR NEUROSCIENCE; OJIMA F, 1993, FREE RADICAL BIO MED, V15, P377, DOI 10.1016/0891-5849(93)90037-U; Ozawa Y, 2012, CURR PHARM DESIGN, V18, P51, DOI 10.2174/138161212798919101; Peng PH, 2008, EXP EYE RES, V86, P637, DOI 10.1016/j.exer.2008.01.008; Piras A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022514; Produit-Zengaffinen N, 2014, AUTOPHAGY INDUCTION, P677; Qin L, 2014, INVESTIGATIVE OPHTHA; Ribaya-Mereado JD, 2004, J AM COLL NUTR, V23, p567S, DOI 10.1080/07315724.2004.10719427; Sapieha P, 2010, J CLIN INVEST, V120, P3022, DOI 10.1172/JCI42142; Sarthy VP, 1998, INVEST OPHTH VIS SCI, V39, P212; Sasaki M, 2010, DIABETOLOGIA, V53, P971, DOI 10.1007/s00125-009-1655-6; Sasaki M, 2012, J NUTR BIOCHEM, V23, P423, DOI 10.1016/j.jnutbio.2011.01.006; Sasaki M, 2009, INVEST OPHTH VIS SCI, V50, P1433, DOI 10.1167/iovs.08-2493; Shi GD, 2011, BIOCHEM BIOPH RES CO, V404, P941, DOI 10.1016/j.bbrc.2010.12.085; Shinjo SK, 2007, CLIN RHEUMATOL, V26, P1248, DOI 10.1007/s10067-006-0478-9; Sommerburg O, 1998, BRIT J OPHTHALMOL, V82, P907, DOI 10.1136/bjo.82.8.907; Song H, 2015, LIFE SCI, V126, P69, DOI 10.1016/j.lfs.2015.02.004; Song ZC, 2012, CELL PROLIFERAT, V45, P239, DOI 10.1111/j.1365-2184.2012.00810.x; Tian H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116453; Wang AL, 2009, AUTOPHAGY, V5, P563, DOI 10.4161/auto.5.4.8163; Wang M., 2015, MATH PROBL ENG, V2015, P1, DOI DOI 10.1155/2015/892549; Wang X, 2014, OPHTHALMIC RES, V52, P198, DOI 10.1159/000363327; Wei T, 2015, EXP THER MED, V9, P476, DOI 10.3892/etm.2014.2084; Willcox JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090864; Woo TTY, 2013, GRAEF ARCH CLIN EXP, V251, P41, DOI 10.1007/s00417-012-2128-z; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Xu HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063232; Yang L, 2012, CELL MOL NEUROBIOL, V32, P1275, DOI 10.1007/s10571-012-9852-0; Yao J, 2014, CELL PHYSIOL BIOCHEM, V33, P107, DOI 10.1159/000356654; Zheng YQ, 2014, J PHARMACOL SCI, V124, P354, DOI 10.1254/jphs.13220FP	60	33	34	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167828	10.1371/journal.pone.0167828	http://dx.doi.org/10.1371/journal.pone.0167828			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936094	gold, Green Submitted, Green Published			2022-12-27	WOS:000389587100209
J	Jaakkola, J; Mustonen, P; Kiviniemi, T; Hartikainen, JEK; Palomaki, A; Hartikainen, P; Nuotio, I; Ylitalo, A; Airaksinen, KEJ				Jaakkola, Jussi; Mustonen, Pirjo; Kiviniemi, Tuomas; Hartikainen, Juha E. K.; Palomaki, Antti; Hartikainen, Palvi; Nuotio, Ilpo; Ylitalo, Antti; Airaksinen, K. E. Juhani			Stroke as the First Manifestation of Atrial Fibrillation	PLOS ONE			English	Article							THROMBOEMBOLIC COMPLICATIONS; CARDIOVERSION; THERAPY; ARRHYTHMIAS; POPULATION; MANAGEMENT; MECHANISMS; FIBSTROKE; QUALITY; TIME	Atrial fibrillation may remain undiagnosed until an ischemic stroke occurs. In this retrospective cohort study we assessed the prevalence of ischemic stroke or transient ischemic attack as the first manifestation of atrial fibrillation in 3,623 patients treated for their first ever stroke or transient ischemic attack during 2003-2012. Two groups were formed: patients with a history of atrial fibrillation and patients with new atrial fibrillation diagnosed during hospitalization for stroke or transient ischemic attack. A control group of 781 patients with intracranial hemorrhage was compiled similarly to explore causality between new atrial fibrillation and stroke. The median age of the patients was 78.3 [13.0] years and 2,009 (55.5%) were women. New atrial fibrillation was diagnosed in 753 (20.8%) patients with stroke or transient ischemic attack, compared to 15 (1.9%) with intracranial hemorrhage. Younger age and no history of coronary artery disease or other vascular diseases, heart failure, or hypertension were the independent predictors of new atrial fibrillation detected concomitantly with an ischemic event. Thus, ischemic stroke was the first clinical manifestation of atrial fibrillation in 37% of younger (<75 years) patients with no history of cardiovascular diseases. In conclusion, atrial fibrillation is too often diagnosed only after an ischemic stroke has occurred, especially in middle-aged healthy individuals. New atrial fibrillation seems to be predominantly the cause of the ischemic stroke and not triggered by the acute cerebrovascular event.	[Jaakkola, Jussi; Kiviniemi, Tuomas; Palomaki, Antti; Airaksinen, K. E. Juhani] Turku Univ Hosp, Ctr Heart, Turku, Finland; [Jaakkola, Jussi; Kiviniemi, Tuomas; Palomaki, Antti; Airaksinen, K. E. Juhani] Univ Turku, Turku, Finland; [Mustonen, Pirjo] Keski Suomi Cent Hosp, Dept Med, Jyvaskyla, Finland; [Hartikainen, Juha E. K.] Kuopio Univ Hosp, Ctr Heart, Kuopio, Finland; [Hartikainen, Palvi] Kuopio Univ Hosp, Neuroctr, Neurol, Kuopio, Finland; [Nuotio, Ilpo] Turku Univ Hosp, Div Med, Dept Acute Internal Med, Turku, Finland; [Ylitalo, Antti] Satakunta Cent Hosp, Ctr Heart, Pori, Finland	University of Turku; University of Turku; Central Finland Central Hospital; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Turku; Satakunta Central Hospital	Airaksinen, KEJ (corresponding author), Turku Univ Hosp, Ctr Heart, Turku, Finland.; Airaksinen, KEJ (corresponding author), Univ Turku, Turku, Finland.	juhani.airaksinen@tyks.fi	Kiviniemi, Tuomas/A-1107-2016; Airaksinen, Juhani/AAC-7857-2021	Kiviniemi, Tuomas/0000-0002-0908-3741; Airaksinen, Juhani/0000-0002-0193-568X; Palomaki, Antti/0000-0002-8835-8116	Finnish Foundation for Cardiovascular Research (Helsinki, Finland); Clinical Research Fund (EVO) of Turku University Hospital (Turku, Finland)	Finnish Foundation for Cardiovascular Research (Helsinki, Finland); Clinical Research Fund (EVO) of Turku University Hospital (Turku, Finland)	This study was funded by the Finnish Foundation for Cardiovascular Research (Helsinki, Finland [http://www.sydantutkimussaatio.fi/en/foundation], and the Clinical Research Fund (EVO) of Turku University Hospital (Turku, Finland [http://www.vsshp.fl/en/tutkijoille/rahoitus/Pages/default.aspx]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen KEJ, 2013, J AM COLL CARDIOL, V62, P1187, DOI 10.1016/j.jacc.2013.04.089; Boriani G, 2015, AM J MED, V128, P509, DOI 10.1016/j.amjmed.2014.11.026; Brambatti M, 2014, CIRCULATION, V129, P2094, DOI 10.1161/CIRCULATIONAHA.113.007825; Chen PS, 2014, CIRC RES, V114, P1500, DOI 10.1161/CIRCRESAHA.114.303772; Chung MK, 2001, CIRCULATION, V104, P2886, DOI 10.1161/hc4901.101760; Engdahl J, 2013, CIRCULATION, V127, P930, DOI 10.1161/CIRCULATIONAHA.112.126656; Gladstone DJ, 2014, NEW ENGL J MED, V370, P2467, DOI 10.1056/NEJMoa1311376; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575; Kamel H, 2016, STROKE, V47, P895, DOI 10.1161/STROKEAHA.115.012004; Kiviniemi T, 2015, INT J CARDIOL, V183, P105, DOI 10.1016/j.ijcard.2015.01.056; Kolominsky-Rabas PL, 2001, STROKE, V32, P2735, DOI 10.1161/hs1201.100209; LIN HJ, 1995, STROKE, V26, P1527, DOI 10.1161/01.STR.26.9.1527; Nuotio I, 2014, JAMA-J AM MED ASSOC, V312, P647, DOI 10.1001/jama.2014.3824; PAGE RL, 1994, CIRCULATION, V89, P224, DOI 10.1161/01.CIR.89.1.224; Palomaki A, 2016, EUR J NEUROL, V23, P133, DOI 10.1111/ene.12820; Palomaki A, 2016, INT J CARDIOL, V203, P269, DOI 10.1016/j.ijcard.2015.10.168; Roche FDR, 2002, PACE, V25, P1587, DOI 10.1046/j.1460-9592.2002.01587.x; Savelieva I, 2000, J INTERV CARD ELECTR, V4, P369, DOI 10.1023/A:1009823001707; Sund R, 2012, SCAND J PUBLIC HEALT, V40, P505, DOI 10.1177/1403494812456637; Toledo ME Gonzalez, 2013, STROKE CEREBROVASC D, V22, pe486; VINGERHOETS F, 1993, STROKE, V24, P26, DOI 10.1161/01.STR.24.1.26; Virtanen R, 2014, EUR J PREV CARDIOL, V21, P1437, DOI 10.1177/2047487313494041; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	24	44	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168010	10.1371/journal.pone.0168010	http://dx.doi.org/10.1371/journal.pone.0168010			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936187	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100251
J	Kolu, P; Raitanen, J; Puhkala, J; Tuominen, P; Husu, P; Luoto, R				Kolu, Paivi; Raitanen, Jani; Puhkala, Jatta; Tuominen, Pipsa; Husu, Pauliina; Luoto, Riitta			Effectiveness and Cost-Effectiveness of a Cluster-Randomized Prenatal Lifestyle Counseling Trial: A Seven-Year Follow-Up	PLOS ONE			English	Article							GESTATIONAL WEIGHT-GAIN; PREGNANCY; OBESITY	There is a link between the pregnancy and its long-term influence on health and susceptibility to future chronic disease both in mother and offspring. The objective was to determine whether individual counseling on physical activity and diet and weight gain at five antenatal visits can prevent type 2 diabetes mellitus (T2DM) and overweight or improve glycemic parameters, among all at-risk-mothers and their children. Another objective was to evaluate whether gestational lifestyle intervention was cost-effective as measured with mother's sickness absence and quality-adjusted life years (QALY). This study was a seven-year follow-up study for women, who were enrolled to the antenatal cluster-randomized controlled trial (RCT). Analysis of the outcome included all women whose outcome was available, in addition with subgroup analysis including women adherent to all lifestyle aims. A total of 173 women with their children participated to the study, representing 43% (173/399) of the women who finished the original RCT. Main outcome measures were: T2DM based on medication use or fasting blood glucose or oral glucose tolerance test (OGTT), body mass index (BMI), glycosylated hemoglobin (HbA1c). None of the women were diagnosed to have T2DM. HbA1c or fasting blood glucose differences were not found among mothers or children. Differences in BMI were non-significant among mothers (Intervention 27.3, Usual care 28.1 kg/m(2), p = 0.33) and children (I 21.3 vs U 22.5 kg/m(2), p = 0.07). Children's BMI was significantly lower among adherent group (I 20.5 vs U 22.5, p = 0.04). The mean total cost per person was 30.6% lower in the intervention group than in the usual care group (I sic2,944 vs. U sic4,243; p = 0.74). Intervention was cost-effective in terms of sickness absence but not in QALY gained i.e. if society is willing to pay additional sic100 per one avoided sickness absence day; there is a 90% probability of the intervention arm to be cost-effective. Longterm effectiveness of antenatal lifestyle counseling was not shown, in spite of possible effect on children's BMI. Cost-effectiveness of the intervention in terms of sickness absence may have larger societal impact.	[Kolu, Paivi; Raitanen, Jani; Puhkala, Jatta; Tuominen, Pipsa; Husu, Pauliina] UKK Inst Hlth Promot, Tampere, Finland; [Raitanen, Jani; Luoto, Riitta] Univ Tampere, Sch Hlth Sci, Tampere, Finland	UKK Institute; Tampere University	Kolu, P (corresponding author), UKK Inst Hlth Promot, Tampere, Finland.	paivi.kolu@uta.fi	Vähä-Ypyä, Henri/GSO-2044-2022; Raitanen, Jani/AAW-9233-2021	Raitanen, Jani/0000-0001-7674-0978; Husu, Pauliina/0000-0003-1502-7428	Pirkanmaa hospital district [9R030, 9S034, 9M053]; Academy of Finland [277079]; Ministry of Education; Ministry of Social Affairs and Health	Pirkanmaa hospital district; Academy of Finland(Academy of Finland); Ministry of Education; Ministry of Social Affairs and Health	The main sources of funding in this follow-up study are Competitive research funding from Pirkanmaa hospital district (grants 9R030, 9S034, 9M053), Academy of Finland (3-year grant nr 277079). The trial was also founded from the Juho Vainio Foundation, the Yrjb Jahnsson Foundation and the Finnish Cultural Foundation. Earlier grants from Ministry of Education and Ministry of Social Affairs and Health have enabled the collection of the basic data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095132; Aittasalo M, 2008, BMC WOMENS HEALTH, P14, DOI DOI 10.1186/1472-6874-8-14; [Anonymous], 2006, MED SCI SPORTS EXERC; Bain E, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010443.pub2; Barber JA, 2000, STAT MED, V19, P3219, DOI 10.1002/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Flynn AC, 2016, NUTR REV, V74, P312, DOI 10.1093/nutrit/nuw005; Gaillard R, 2015, EUR J EPIDEMIOL, V30, P1141, DOI 10.1007/s10654-015-0085-7; Gilmore LA, 2015, SEMIN PERINATOL, V39, P296, DOI 10.1053/j.semperi.2015.05.009; Han SS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009021.pub2; Kapiainen S, 2014, TERVEYDEN JA SOSIAAL; Kinnunen Tarja I, 2008, BMC Pregnancy Childbirth, V8, P37, DOI 10.1186/1471-2393-8-37; Kinnunen TI, 2014, MATERN CHILD NUTR, V10, P184, DOI 10.1111/j.1740-8709.2012.00426.x; Kolu P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056392; Lau EY, 2014, J OBES, V2014, DOI 10.1155/2014/524939; Ludwig DS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001521; Luoto R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001036; Luoto RM, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-39; Mamun AA, 2014, OBES REV, V15, P338, DOI 10.1111/obr.12132; Mooney CZ, 1993, BOOTSTRAPPING NONPAR, DOI DOI 10.4135/9781412983532; Muktabhant B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007145.pub3; Nehring I, 2011, AM J CLIN NUTR, V94, P1225, DOI 10.3945/ajcn.111.015289; Oostdam N, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-64; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Rasmussen CDN, 2015, J OCCUP ENVIRON MED, V57, P526, DOI 10.1097/JOM.0000000000000395; Saari A, 2011, ANN MED, V43, P235, DOI 10.3109/07853890.2010.515603; SINTONEN H, 1993, QUALITY OF LIFE ASSESSMENT : KEY ISSUES IN THE 1990S, P185; Sintonen H., 2012, INSTRUCTIONS REPLACI; Thangaratinam S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2088; Vaha-Ypya H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134813; Vaha-Ypya H, 2015, CLIN PHYSIOL FUNCT I, V35, P64, DOI 10.1111/cpf.12127; WHO, 2015, OV; WHO, 2015, IN	33	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167759	10.1371/journal.pone.0167759	http://dx.doi.org/10.1371/journal.pone.0167759			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936083	Green Published, gold			2022-12-27	WOS:000389587100177
J	Rodolfo, C; Rocco, M; Cattaneo, L; Tartaglia, M; Sassi, M; Aducci, P; Scaloni, A; Camoni, L; Marra, M				Rodolfo, Carlo; Rocco, Mariapina; Cattaneo, Lucia; Tartaglia, Maria; Sassi, Mauro; Aducci, Patrizia; Scaloni, Andrea; Camoni, Lorenzo; Marra, Mauro			Ophiobolin A Induces Autophagy and Activates the Mitochondrial Pathway of Apoptosis in Human Melanoma Cells	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; GLYCOLYTIC-ENZYMES; MCF-7 CELLS; CANCER; IDENTIFICATION; DEATH; EXPRESSION; CARCINOMA; STATHMIN; INACTIVATION	Ophiobolin A, a fungal toxin from Bipolaris species known to affect different cellular processes in plants, has recently been shown to have anti-cancer activity in mammalian cells. In the present study, we investigated the anti-proliferative effect of Ophiobolin A on human melanoma A375 and CHL-1 cell lines. This cellular model was chosen because of the incidence of melanoma malignant tumor on human population and its resistance to chemical treatments. Ophyobolin A strongly reduced cell viability of melanoma cells by affecting mitochondrial functionality. The toxin induced depolarization of mitochondrial membrane potential, reactive oxygen species production and mitochondrial network fragmentation, leading to autophagy induction and ultimately resulting in cell death by activation of the mitochondrial pathway of apoptosis. Finally, a comparative proteomic investigation on A375 cells allowed to identify several Ophiobolin A down-regulated proteins, which are involved in fundamental processes for cell homeostasis and viability.	[Rodolfo, Carlo; Cattaneo, Lucia; Aducci, Patrizia; Camoni, Lorenzo; Marra, Mauro] Univ Roma Tor Vergata, Dept Biol, Rome, Italy; [Rocco, Mariapina; Tartaglia, Maria] Univ Sannio, Dept Sci & Technol, Benevento, Italy; [Sassi, Mauro; Scaloni, Andrea] CNR, ISPAAM, Prote & Mass Spectrometry Lab, Naples, Italy	University of Rome Tor Vergata; University of Sannio; Consiglio Nazionale delle Ricerche (CNR); Istituto Per Il Sistema Produzione Animale In Ambiente Mediterraneo (ISPAAM-CNR)	Camoni, L (corresponding author), Univ Roma Tor Vergata, Dept Biol, Rome, Italy.	camoni@uniroma2.it	Tartaglia, Maria/AAS-9004-2021; Rodolfo, Carlo/H-8953-2019	Tartaglia, Maria/0000-0002-3797-9377; Rodolfo, Carlo/0000-0001-7087-545X; CAMONI, LORENZO/0000-0001-9020-0812; ROCCO, Mariapina/0000-0002-5869-029X; Scaloni, Andrea/0000-0001-9362-8515	Italian Ministry of Economy and Finance [191/2009]; Regione Campania for the Project BenTeN - Nuovi Processi e Prodotti per la Nutraceutica, la Cosmeceutica e la Nutrizione umana" (P.O.R.)	Italian Ministry of Economy and Finance; Regione Campania for the Project BenTeN - Nuovi Processi e Prodotti per la Nutraceutica, la Cosmeceutica e la Nutrizione umana" (P.O.R.)	This work was supported by funds from the Italian Ministry of Economy and Finance to the National Research Council for the project "Innovazione e sviluppo del Mezzogiorno - Conoscenze Integrate per Sostenibilita ed Innovazione del Made in Italy Agroalimentare" - Legge n.191/2009, and from Regione Campania for the Project BenTeN - Nuovi Processi e Prodotti per la Nutraceutica, la Cosmeceutica e la Nutrizione umana" (P.O.R. 2007/2013, objectives 2.1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaiya AA, 1997, INT J CANCER, V73, P678, DOI 10.1002/(SICI)1097-0215(19971127)73:5<678::AID-IJC11>3.0.CO;2-2; Alldinger I, 2005, PANCREATOLOGY, V5, P370, DOI 10.1159/000086537; Ashkenazi A, 2014, ANNU REV CELL DEV BI, V30, P337, DOI 10.1146/annurev-cellbio-100913-013226; Atallah Ehab, 2005, Curr Treat Options Oncol, V6, P185; Au TK, 2000, LIFE SCI, V67, P733, DOI 10.1016/S0024-3205(00)00668-8; Au TK, 2000, INT J BIOCHEM CELL B, V32, P1173, DOI 10.1016/S1357-2725(00)00058-3; Benbrook D. M., 2012, Experimental Oncology, V34, P286; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bury M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.85; Bury M, 2013, INT J ONCOL, V43, P575, DOI 10.3892/ijo.2013.1979; Chaerkady R, 2008, J PROTEOME RES, V7, P4289, DOI 10.1021/pr800197z; Chan THM, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/369384; Chen GA, 2002, CLIN CANCER RES, V8, P2298; Collins C, 2001, GENOME RES, V11, P1034, DOI 10.1101/gr.GR1743R; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; Fujiwara Hironori, 2000, Pharmacy and Pharmacology Communications, V6, P427; GlassMarmor L, 1997, EUR J PHARMACOL, V328, P241, DOI 10.1016/S0014-2999(97)83051-8; Honore B, 2000, FEBS LETT, V466, P11, DOI 10.1016/S0014-5793(99)01780-9; Kajita E, 2001, MECH DEVELOP, V102, P283, DOI 10.1016/S0925-4773(01)00324-0; Ko JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086569; Kuang XY, 2015, ONCOTARGET, V6, P22227, DOI 10.18632/oncotarget.4276; Lee WH, 2010, TOXICOLOGY, V278, P224, DOI 10.1016/j.tox.2010.02.005; Li D, 2015, CHIN J NAT MEDICINES, V13, P41, DOI 10.1016/S1875-5364(15)60005-X; Li ZY, 2013, CANCER CHEMOTH PHARM, V72, P1001, DOI 10.1007/s00280-013-2285-8; Lianos GD, 2015, CANCER LETT, V360, P114, DOI 10.1016/j.canlet.2015.02.026; Lincet H, 2015, ONCOGENE, V34, P3751, DOI 10.1038/onc.2014.320; Liu HS, 2005, INT J FOOD ENG, V1, DOI 10.2202/1556-3758.1004; Lopez V, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-182; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lv CT, 2015, MAR DRUGS, V13, P431, DOI 10.3390/md13010431; Machado-Neto JA, 2014, BMB REP, V47, P660, DOI 10.5483/BMBRep.2014.47.12.020; Marugame T, 2010, JPN J CLIN ONCOL, V40, P710, DOI 10.1093/jjco/hyq107; McCommis KS, 2012, BBA-BIOMEMBRANES, V1818, P1444, DOI 10.1016/j.bbamem.2011.10.025; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; Myung Jae-Kyung, 2004, Proteome Sci, V2, P8, DOI 10.1186/1477-5956-2-8; Obama K, 2006, CLIN CANCER RES, V12, P70, DOI 10.1158/1078-0432.CCR-05-0588; Ostergaard M, 2006, PROTEOMICS, V6, P3509, DOI 10.1002/pmic.200500686; Ostrov DA, 2007, TISSUE ANTIGENS, V69, P181, DOI 10.1111/j.1399-0039.2006.00730.x; Parcellier A, 2003, BIOCHEM BIOPH RES CO, V304, P505, DOI 10.1016/S0006-291X(03)00623-5; Pastorino JG, 2008, J BIOENERG BIOMEMBR, V40, P171, DOI 10.1007/s10863-008-9148-8; PFLEIDERER G, 1975, BEITR PATHOL, V156, P266; Poschmann G, 2009, MOL CELL PROTEOMICS, V8, P1105, DOI 10.1074/mcp.M800422-MCP200; RAMAGLI LS, 1985, ELECTROPHORESIS, V6, P559, DOI 10.1002/elps.1150061109; Rho JH, 2009, PROTEIN J, V28, P148, DOI 10.1007/s10930-009-9177-0; Scippa GS, 2010, ELECTROPHORESIS, V31, P497, DOI 10.1002/elps.200900459; Stankiewicz M, 2010, FEBS J, V277, P3353, DOI 10.1111/j.1742-4658.2010.07737.x; SUGAWARA F, 1987, P NATL ACAD SCI USA, V84, P3081, DOI 10.1073/pnas.84.10.3081; Sun W, 2001, Curr Treat Options Oncol, V2, P193, DOI 10.1007/s11864-001-0033-5; Takahashi M, 2007, ANTIVIR RES, V75, P152, DOI 10.1016/j.antiviral.2007.02.002; Talamo F, 2003, PROTEOMICS, V3, P440, DOI 10.1002/pmic.200390059; Tanaka M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096785; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Tawbi Hussein A, 2010, Clin Adv Hematol Oncol, V8, P259; Tuynder M, 2002, P NATL ACAD SCI USA, V99, P14976, DOI 10.1073/pnas.222470799; Unwin RD, 2003, PROTEOMICS, V3, P1620, DOI 10.1002/pmic.200300464; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Yang TT, 2012, BIOORG MED CHEM LETT, V22, P579, DOI 10.1016/j.bmcl.2011.10.079; Ying LS, 2013, ONCOL LETT, V5, P1315, DOI 10.3892/ol.2013.1144	58	25	25	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167672	10.1371/journal.pone.0167672	http://dx.doi.org/10.1371/journal.pone.0167672			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936075	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100146
J	Wu, DC; He, DM; Gu, HL; Wu, PP; Yi, X; Wang, WJ; Shi, HF; Wu, DX; Sun, GL				Wu, De-Chuan; He, Deng-Min; Gu, Hai-Lan; Wu, Pan-Pan; Yi, Xu; Wang, Wei-Jie; Shi, Han-Feng; Wu, De-Xiang; Sun, Genlou			Origin and Evolution of Allopolyploid Wheatgrass Elymus fibrosus (Schrenk) Tzvelev (Poaceae: Triticeae) Reveals the Effect of Its Origination on Genetic Diversity	PLOS ONE			English	Article							NORTH-AMERICAN ELYMUS; GENOME CONSTITUTION; BRASSICA-NAPUS; H-GENOME; MOLECULAR PHYLOGENY; RPB2 GENE; POPULATIONS; DIFFERENTIATION; CANINUS; RECOMBINATION	Origin and evolution of tetraploid Elymus fibrosus (Schrenk) Tzvelev were characterized using low-copy nuclear gene Rpb2 (the second largest subunit of RNA polymerase II), and chloroplast region trnL-trnF (spacer between the tRNA Leu (UAA) gene and the tRNA-Phe (GAA) gene). Ten accessions of E. fibrosus along with 19 Elymus species with StH genomic constitution and diploid species in the tribe Triticeae were analyzed. Chloroplast trnL-trnF sequence data suggested that Pseudoroegneria (St genome) was the maternal donor of E. fibrosus. Rpb2 data confirmed the presence of StH genomes in E. fibrosus, and suggested that St and H genomes in E. fibrosus each is more likely originated from single gene pool. Single origin of E. fibrosus might be one of the reasons causing genetic diversity in E. fibrosus lower than those in E. caninus and E. trachycaulus, which have similar ecological preferences and breeding systems with E. fibrosus, and each was originated from multiple sources. Convergent evolution of St and H copy Rpb2 sequences in some accessions of E. fibrosus might have occurred during the evolutionary history of this allotetraploid.	[Wu, De-Chuan; He, Deng-Min; Gu, Hai-Lan; Wu, Pan-Pan; Yi, Xu; Wang, Wei-Jie; Shi, Han-Feng; Wu, De-Xiang; Sun, Genlou] Anhui Agr Univ, Coll Agron, Hefei, Anhui, Peoples R China; [Sun, Genlou] St Marys Univ, Dept Biol, Halifax, NS, Canada	Anhui Agricultural University; Saint Marys University - Canada	Wu, DX; Sun, GL (corresponding author), Anhui Agr Univ, Coll Agron, Hefei, Anhui, Peoples R China.; Sun, GL (corresponding author), St Marys Univ, Dept Biol, Halifax, NS, Canada.	dexiangwu198@163.com; genlou.sun@smu.ca			Research Foundation for Talented Scholars from Anhui Agricultural University; introduced leading talent research team for Universities in Anhui Province; Natural Sciences and Engineering Research Council of Canada [DDG-2015-00039]	Research Foundation for Talented Scholars from Anhui Agricultural University; introduced leading talent research team for Universities in Anhui Province; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This project was supported in part by a Research Foundation for Talented Scholars from Anhui Agricultural University and the introduced leading talent research team for Universities in Anhui Province, a discovery development grants DDG-2015-00039 from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clegg MT, 1997, P NATL ACAD SCI USA, V94, P7791, DOI 10.1073/pnas.94.15.7791; Dewey D.R., 1984, GENE MANIPULATION PL, P209, DOI DOI 10.1007/978-1-4613-2429-4_9; Diaz O, 2000, GENET RESOUR CROP EV, V47, P11, DOI 10.1023/A:1008719119756; Diaz O, 1999, THEOR APPL GENET, V99, P210, DOI 10.1007/s001220051227; Diaz O, 1999, HEREDITAS, V131, P63, DOI 10.1111/j.1601-5223.1999.00063.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frankel O.H., 1995, CONSERVATION PLANT B; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Gaudett M, 2005, PLANT SYST EVOL, V250, P81, DOI 10.1007/s00606-004-0199-y; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huelsenbeck JP, 2005, STAT BIOL HEALTH, P183, DOI 10.1007/0-387-27733-1_7; Jakobsson M, 2006, MOL BIOL EVOL, V23, P1217, DOI 10.1093/molbev/msk006; JENSEN KB, 1995, INT J PLANT SCI, V156, P731, DOI 10.1086/297295; JUNGHANS H, 1990, BIOTECHNIQUES, V8, P176; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Leflon M, 2006, THEOR APPL GENET, V113, P1467, DOI 10.1007/s00122-006-0393-0; Liu QL, 2006, NEW PHYTOL, V170, P411, DOI 10.1111/j.1469-8137.2006.01665.x; Love A., 1984, Feddes Repertorium, V95, P425; Mahelka V, 2007, ANN BOT-LONDON, V100, P249, DOI 10.1093/aob/mcm093; Mahelka V, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-127; Mason-Gamer RJ, 2002, GENOME, V45, P991, DOI [10.1139/g02-065, 10.1139/G02-065]; Mason-Gamer RJ, 2001, SYST BOT, V26, P757; Mason-Gamer RJ, 1995, METHODS OF GENOME AN; Mason-Gamer RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010989; Mason-Gamer Roberta J., 2007, Aliso, V23, P372; McMillan E, 2004, THEOR APPL GENET, V108, P535, DOI 10.1007/s00122-003-1453-3; Ni Y, 2011, BIOL PLANTARUM, V55, P68, DOI 10.1007/s10535-011-0009-7; Redinbaugh MG, 2000, GENOME, V43, P846, DOI 10.1139/gen-43-5-846; Small RL, 2004, AUST SYST BOT, V17, P145, DOI 10.1071/SB03015; Sun G, 2005, PLANT SYST EVOL, V256, P179, DOI 10.1007/s00606-005-0368-7; Sun G, 2003, GENOME, V46, P729, DOI [10.1139/g03-052, 10.1139/G03-052]; Sun GL, 2008, MOL PHYLOGENET EVOL, V46, P897, DOI 10.1016/j.ympev.2007.12.024; Sun GL, 2007, PLANT MOL BIOL, V64, P645, DOI 10.1007/s11103-007-9183-6; Sun GL, 2014, J SYST EVOL, V52, P706, DOI 10.1111/jse.12080; Sun GL, 2011, GENOME, V54, P655, DOI [10.1139/G11-036, 10.1139/g11-036]; Sun G, 2010, MOL PHYLOGENET EVOL, V56, P727, DOI 10.1016/j.ympev.2010.03.037; Sun GL, 2002, PLANT SYST EVOL, V234, P101, DOI 10.1007/s00606-002-0211-3; Sun GL, 1999, GENOME, V42, P420, DOI 10.1139/gen-42-3-420; Sun GL, 1998, HEREDITAS, V129, P275, DOI 10.1111/j.1601-5223.1998.00275.x; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Symonds VV, 2010, EVOLUTION, V64, P1984, DOI [10.1111/j.1558-5646.2010.00978-x, 10.1111/j.1558-5646.2010.00978.x]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TORABINEJAD J, 1993, GENOME, V36, P147, DOI 10.1139/g93-018; TZVELEV NN, 1989, BOT REV, V55, P141, DOI 10.1007/BF02858328; Udall JA, 2005, GENETICS, V169, P967, DOI 10.1534/genetics.104.033209; Wang R.R.-C., 1994, P 2 INT TRIT S LOG U, P20; Xu DH, 2004, THEOR APPL GENET, V108, P1443, DOI 10.1007/s00122-004-1588-x; Yan C, 2012, MOL PHYLOGENET EVOL, V64, P441, DOI 10.1016/j.ympev.2012.04.017; Zhang C, 2009, BIOL PLANTARUM, V53, P759, DOI 10.1007/s10535-009-0139-3; Zhang XQ, 2002, GENET RESOUR CROP EV, V49, P397; Zou HW, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]	51	2	2	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167795	10.1371/journal.pone.0167795	http://dx.doi.org/10.1371/journal.pone.0167795			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936163	Green Submitted, gold, Green Published			2022-12-27	WOS:000389587100194
J	Yamaguchi, S; Hirata, K; Toyonaga, T; Kobayashi, K; Ishi, Y; Motegi, H; Kobayashi, H; Shiga, T; Tamaki, N; Terasaka, S; Houkin, K				Yamaguchi, Shigeru; Hirata, Kenji; Toyonaga, Takuya; Kobayashi, Kentaro; Ishi, Yukitomo; Motegi, Hiroaki; Kobayashi, Hiroyuki; Shiga, Tohru; Tamaki, Nagara; Terasaka, Shunsuke; Houkin, Kiyohiro			Change in F-18-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; NEWLY-DIAGNOSED GLIOBLASTOMA; ANTIANGIOGENIC TREATMENT; F-18 FLUOROMISONIDAZOLE; MALIGNANT GLIOMA; RESPONSE ASSESSMENT; BLOOD PERFUSION; PHASE-II; HYPOXIA; SURVIVAL	Background Bevacizumab (BEV), a humanized monoclonal antibody, become a currently important chemotherapeutic option for the patients with recurrent glioma. The aim of this retrospective study is to investigate whether 18 F-Fluoromisonidazole (FMISO) PET have the potential to detect BEV-resistant gliomas in the early-stage. Methods We reviewed the FMISO PET and MRI appearances before and 3 to 4 courses after BEV treatment on 18 recurrent glioma patients. FMISO accumulation was assessed by visual inspection and semi-quantitative values which were tumor-to-normal (T/N) ratio and hypoxic volume. MRI responses were evaluated based on RANO (Response Assessment in Neuro-Oncology) criteria. The prognostic analysis was performed in relation to the response assessment by FMISO PET and MRI using overall survival (OS) after BEV application. Results After BEV application, MRI revealed partial response in 14 of 18 patients (78%), of which 9 patients also demonstrated decreased FMISO accumulation. These 9 patients (50%) were classified as "MRI-FMISO double responder". As for the other 5 patients (28%), FMISO accumulation volumes increased or remained stable after BEV treatment although partial responses were achieved on MRI. Therefore, these cases were classified as "MRI-only responder". The remaining 4 patients (22%) did not show treatment response on FMISO PET or MRI ("non-responder"). MRI-FMISO double responders showed significantly longer OS than that in other groups (median 12.4 vs 5.7 months; P < 0.001), whereas there were no overall survival difference between MRI-only responders and non-responders (median OS, 5.7 and 4.8 months; P = 0.58). Among the pre-treatment clinical factors, high FMISO T/N ratio was a significant prognostic factor of overall survival in these patients under the assessment of Cox proportional hazard model. Conclusions Recurrent gliomas with decreasing FMISO accumulation after short-term BEV application could derive a survival benefit from BEV treatment. Change in FMISO PET appearance can identify BEV-resistant gliomas in early-stage regardless of MRI findings in a comprehensible way.	[Yamaguchi, Shigeru; Ishi, Yukitomo; Motegi, Hiroaki; Kobayashi, Hiroyuki; Terasaka, Shunsuke; Houkin, Kiyohiro] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Sapporo, Hokkaido, Japan; [Yamaguchi, Shigeru; Hirata, Kenji; Toyonaga, Takuya; Kobayashi, Kentaro; Shiga, Tohru; Tamaki, Nagara] Hokkaido Univ, Grad Sch Med, Dept Nucl Med, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Terasaka, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Sapporo, Hokkaido, Japan.	terasas@med.hokudai.ac.jp	Toyonaga, Takuya/ABE-1742-2021; Yamaguchi, Shigeru/G-5419-2012	Toyonaga, Takuya/0000-0002-0369-8294; Yamaguchi, Shigeru/0000-0003-3710-5888; Ishi, Yukitomo/0000-0003-4834-2619; mao mu, yang huang/0000-0001-6153-5461	Japan Society for the Promotion of Science [24700999]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The research was partly supported by a Grant-in-Aid for General Scientific Research from the Japan Society for the Promotion of Science (#24700999). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Barajas Ramon F Jr, 2015, Case Rep Radiol, V2015, P731361, DOI 10.1155/2015/731361; Batchelor TT, 2013, P NATL ACAD SCI USA, V110, P19059, DOI 10.1073/pnas.1318022110; Bell C, 2015, SEMIN NUCL MED, V45, P136, DOI 10.1053/j.semnuclmed.2014.10.001; Boxerman JL, 2013, NEURO-ONCOLOGY, V15, P945, DOI 10.1093/neuonc/not049; Bruehlmeier M, 2004, J NUCL MED, V45, P1851; Cher LM, 2006, J NUCL MED, V47, P410; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Ellingson BM, 2011, NEURO-ONCOLOGY, V13, P401, DOI 10.1093/neuonc/noq206; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Fueger BJ, 2010, J NUCL MED, V51, P1532, DOI 10.2967/jnumed.110.078592; Galldiks N, 2013, EUR J NUCL MED MOL I, V40, P22, DOI 10.1007/s00259-012-2251-4; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Hirata K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105682; Hirata K, 2012, EUR J NUCL MED MOL I, V39, P760, DOI 10.1007/s00259-011-2037-0; Hu YL, 2012, CANCER RES, V72, P1773, DOI 10.1158/0008-5472.CAN-11-3831; Huang RY, 2013, CANCER-AM CANCER SOC, V119, P3479, DOI 10.1002/cncr.28210; Hutterer M, 2015, NEURO-ONCOLOGY, V17, P784, DOI 10.1093/neuonc/nou322; Hutterer M, 2011, J NUCL MED, V52, P856, DOI 10.2967/jnumed.110.086645; Kargiotis O, 2006, J NEURO-ONCOL, V78, P281, DOI 10.1007/s11060-005-9097-6; Kawai N, 2011, EUR J NUCL MED MOL I, V38, P441, DOI 10.1007/s00259-010-1645-4; Koch CJ, 2003, ADV EXP MED BIOL, V510, P285; KOH WJ, 1992, INT J RADIAT ONCOL, V22, P199, DOI 10.1016/0360-3016(92)91001-4; Kreisl TN, 2009, J CLIN ONCOL, V27, P740, DOI 10.1200/JCO.2008.16.3055; Liang BC, 1996, J NEURO-ONCOL, V29, P149; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Narita T, 2012, JPN J CLIN ONCOL, V42, P120, DOI 10.1093/jjco/hyr181; Norden AD, 2008, NEUROLOGY, V70, P779, DOI 10.1212/01.wnl.0000304121.57857.38; Nowosielski M, 2014, NEUROLOGY, V82, P1684, DOI 10.1212/WNL.0000000000000402; Pauleit D, 2005, BRAIN, V128, P678, DOI 10.1093/brain/awh399; Piert M, 1999, EUR J NUCL MED, V26, P95, DOI 10.1007/s002590050365; RASEY JS, 1990, RADIAT RES, V122, P301, DOI 10.2307/3577760; Schaub C, 2013, ONCOLOGY-BASEL, V85, P191, DOI 10.1159/000354692; Schwarzenberg J, 2014, CLIN CANCER RES, V20, P3550, DOI 10.1158/1078-0432.CCR-13-1440; Sorensen AG, 2012, CANCER RES, V72, P402, DOI 10.1158/0008-5472.CAN-11-2464; Spence AM, 2008, CLIN CANCER RES, V14, P2623, DOI 10.1158/1078-0432.CCR-07-4995; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Swanson KR, 2009, J NUCL MED, V50, P36, DOI 10.2967/jnumed.108.055467; Thomas AA, 2014, CURR TREAT OPTION ON, V15, P551, DOI 10.1007/s11864-014-0308-2; Valable S, 2011, NUCL MED BIOL, V38, P781, DOI 10.1016/j.nucmedbio.2011.01.010; Weathers SP, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0443-y; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wick A, 2011, ANN NEUROL, V69, P586, DOI 10.1002/ana.22336	42	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167917	10.1371/journal.pone.0167917	http://dx.doi.org/10.1371/journal.pone.0167917			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936194	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100230
J	Jha, JK; Chattoraj, DK				Jha, Jyoti K.; Chattoraj, Dhruba K.			Inactivation of Individual SeqA Binding Sites of the E. coli Origin Reveals Robustness of Replication Initiation Synchrony	PLOS ONE			English	Article							ESCHERICHIA-COLI; DNA-REPLICATION; GATC SITES; COORDINATED REPLICATION; CHROMOSOME-REPLICATION; STRANDED-DNA; PROTEIN; SEQUESTRATION; RESTRICTION; SEQUENCES	The Escherichia coli origin of replication, oriC, comprises mostly binding sites of two proteins: DnaA, a positive regulator, and SeqA, a negative regulator. SeqA, although not essential, is required for timely initiation, and during rapid growth, synchronous initiation from multiple origins. Unlike DnaA, details of SeqA binding to oriC are limited. Here we have determined that SeqA binds to all its sites tested (9/11) and with variable efficiency. Titration of DnaA alters SeqA binding to two sites, both of which have overlapping DnaA sites. The altered SeqA binding, however, does not affect initiation synchrony. Synchrony is also unaffected when individual SeqA sites are mutated. An apparent exception was one mutant where the mutation also changed an overlapping DnaA site. In this mutant, the observed asynchrony could be from altered DnaA binding, as selectively mutating this SeqA site did not cause asynchrony. These results reveal robust initiation synchrony against alterations of individual SeqA binding sites. The redundancy apparently ensures SeqA function in controlling replication in E. coli.	[Jha, Jyoti K.; Chattoraj, Dhruba K.] NCI, Lab Biochem & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chattoraj, DK (corresponding author), NCI, Lab Biochem & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	chattoraj@nih.gov			Intramural Research Program of the Center for Cancer Research, NCI, NIH; NATIONAL CANCER INSTITUTE [ZIABC010277] Funding Source: NIH RePORTER	Intramural Research Program of the Center for Cancer Research, NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the Intramural Research Program of the Center for Cancer Research, NCI, NIH.	Bach T, 2005, J MOL BIOL, V350, P7, DOI 10.1016/j.jmb.2005.04.055; Bach T, 2004, MOL MICROBIOL, V51, P1589, DOI 10.1111/j.1365-2958.2003.03943.x; Bach MT, 2008, J MOL BIOL, V384, P1076, DOI 10.1016/j.jmb.2008.09.042; Boye E, 1996, P NATL ACAD SCI USA, V93, P12206, DOI 10.1073/pnas.93.22.12206; Brendler T, 1999, EMBO J, V18, P2304, DOI 10.1093/emboj/18.8.2304; CAMPBELL JL, 1990, CELL, V62, P967, DOI 10.1016/0092-8674(90)90271-F; CHATTORAJ DK, 1977, VIROLOGY, V81, P460, DOI 10.1016/0042-6822(77)90161-1; Court DL, 2003, GENE, V315, P63, DOI 10.1016/S0378-1119(03)00728-5; Duderstadt KE, 2013, CURR OPIN STRUC BIOL, V23, P144, DOI 10.1016/j.sbi.2012.11.012; Han JS, 2004, J BIOL CHEM, V279, P30236, DOI 10.1074/jbc.M402612200; Jha JK, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00062; Kasho K, 2013, P NATL ACAD SCI USA, V110, P936, DOI 10.1073/pnas.1212070110; Kim MS, 2005, J BACTERIOL, V187, P6998, DOI 10.1128/JB.187.20.6998-7008.2005; KOHIYAMA M, 1966, ANN I PASTEUR PARIS, V110, P465; Kurokawa K, 1999, EMBO J, V18, P6642, DOI 10.1093/emboj/18.23.6642; Langer U, 1996, MOL MICROBIOL, V21, P301, DOI 10.1046/j.1365-2958.1996.6481362.x; Leonard AC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010116; LOBNEROLESEN A, 1989, CELL, V57, P881, DOI 10.1016/0092-8674(89)90802-7; LU M, 1994, CELL, V77, P413, DOI 10.1016/0092-8674(94)90156-2; McGarry KC, 2004, P NATL ACAD SCI USA, V101, P2811, DOI 10.1073/pnas.0400340101; Morigen, 2003, MOL MICROBIOL, V50, P349, DOI 10.1046/j.1365-2958.2003.03695.x; Nievera C, 2006, MOL CELL, V24, P581, DOI 10.1016/j.molcel.2006.09.016; Ozaki S, 2012, NUCLEIC ACIDS RES, V40, P1648, DOI 10.1093/nar/gkr832; PRITCHARD R H, 1969, Symposium of the Society for General Microbiology, V19, P263; Riber L, 2005, J BACTERIOL, V187, P5605, DOI 10.1128/JB.187.16.5605-5613.2005; Riber L, 2009, MOL MICROBIOL, V71, P107, DOI 10.1111/j.1365-2958.2008.06516.x; Rozgaja TA, 2011, MOL MICROBIOL, V82, P475, DOI 10.1111/j.1365-2958.2011.07827.x; Sanchez-Romero MA, 2010, MBIO, V1, DOI 10.1128/mBio.00012-10; SKARSTAD K, 1988, J BACTERIOL, V170, P852, DOI 10.1128/jb.170.2.852-858.1988; SKARSTAD K, 1986, EMBO J, V5, P1711, DOI 10.1002/j.1460-2075.1986.tb04415.x; Skarstad K, 2003, EMBO J, V22, P140, DOI 10.1093/emboj/cdg003; Skarstad K, 2001, BIOCHIMIE, V83, P49, DOI 10.1016/S0300-9084(00)01207-4; Skarstad K, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012922; SLATER S, 1995, CELL, V82, P927, DOI 10.1016/0092-8674(95)90272-4; SMITH DW, 1985, EMBO J, V4, P1319, DOI 10.1002/j.1460-2075.1985.tb03779.x; Speck C, 2001, EMBO J, V20, P1469, DOI 10.1093/emboj/20.6.1469; Srivastava P, 2006, J BACTERIOL, V188, P1060, DOI 10.1128/JB.188.3.1060-1070.2006; Stepankiw N, 2009, MOL MICROBIOL, V74, P467, DOI 10.1111/j.1365-2958.2009.06877.x; THOMAS M, 1975, J MOL BIOL, V91, P315, DOI 10.1016/0022-2836(75)90383-6; Torheim NK, 1999, EMBO J, V18, P4882, DOI 10.1093/emboj/18.17.4882; VONFREIESLEBEN U, 1994, MOL MICROBIOL, V14, P763; Weigel C, 2001, MOL MICROBIOL, V40, P498, DOI 10.1046/j.1365-2958.2001.02409.x; Wilkinson TG, 2006, J BACTERIOL, V188, P4573, DOI 10.1128/JB.00089-06; Wold S, 1998, EMBO J, V17, P4158, DOI 10.1093/emboj/17.14.4158; ZYSKIND JW, 1986, CELL, V46, P489, DOI 10.1016/0092-8674(86)90873-1	45	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0166722	10.1371/journal.pone.0166722	http://dx.doi.org/10.1371/journal.pone.0166722			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930658	gold, Green Published			2022-12-27	WOS:000389580900014
J	Pang, KP; Du, LQ; Zhang, K; Dai, CY; Ju, CQ; Zhu, J; Wu, XY				Pang, Kunpeng; Du, Liqun; Zhang, Kai; Dai, Chenyang; Ju, Chengqun; Zhu, Jing; Wu, Xinyi			Three-Dimensional Construction of a Rabbit Anterior Corneal Replacement for Lamellar Keratoplasty	PLOS ONE			English	Article							DISEASE TRANSMISSION; STEM-CELLS; MATRIX; EXPRESSION; MORPHOLOGY; RECONSTRUCTION; REGENERATION; KERATOCYTES; SUBSTITUTE; SURGERY	The aim of this study was to construct a rabbit anterior corneal replacement for transplantation using acellular porcine corneal matrix (APCM) and rabbit epithelial or stromal cells. APCM was prepared from fresh porcine cornea treated with 0.5% (wt./vol.) sodium dodecyl sulfate (SDS) solution. The expanded stromal cells were first injected into APCM parallel to its surface and were cultured in a shaking culture system for 7 days to obtain the stromal construct. Next, corneal epithelial cells were cultured on the stromal construct surface for another 7 days to obtain rabbit anterior corneal lamella. The construct had a phenotype similar to that of normal cornea, with high expression of cytokeratin 3 in the epithelial cell layer and vimentin in the stromal cells. More importantly, the construct integrated well with the implanted host corneal tissue, and the implant cornea maintained transparency in the 6-month follow-up, although there was a slight haze in the central corneal area. The endothelium in the surgery cornea had a similar cell density and mosaic pattern with normal cornea as shown by confocal laser corneal microscopy, and the regenerated corneal epithelial cells on the implant surface showed a similar morphology to that of natural epithelial cells. These results demonstrate that the constructed anterior corneal replacement exhibits an excellent biological property for lamellar keratoplasty and might be a possible alternative to human corneal tissue in the future.	[Pang, Kunpeng; Du, Liqun; Dai, Chenyang; Ju, Chengqun; Zhu, Jing; Wu, Xinyi] Shandong Univ, Qilu Hosp, Dept Ophthalmol, Jinan, Shandong, Peoples R China; [Pang, Kunpeng] Shandong Univ, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Qilu Hosp, Jinan, Shandong, Peoples R China; [Pang, Kunpeng] Shandong Univ, Chinese Minist Hlth, Qilu Hosp, Jinan, Shandong, Peoples R China; [Zhang, Kai] Shandong Univ, Prov Hosp, Dept Ophthalmol, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University	Wu, XY (corresponding author), Shandong Univ, Qilu Hosp, Dept Ophthalmol, Jinan, Shandong, Peoples R China.	xywu8868@163.com	Pang, Kunpeng/B-6084-2008	Pang, Kunpeng/0000-0003-4421-6359	National Natural Science Foundation of China [81271716, 81400377]; Key research and development program of Shandong Province [2015GSF118018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key research and development program of Shandong Province	This study was supported by National Natural Science Foundation of China (No.81271716; No.81400377; http://www. nsfc.gov.cn/) and Key research and development program of Shandong Province (No. 2015GSF118018; http://www.sdstc.gov.cn/). The corresponding author XYW received funding of No.81271716 and No. 2015GSF118018. The first author KPP received funding of No.81400377. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidin FZ, 2015, ORGANOGENESIS, V11, P122, DOI 10.1080/15476278.2015.1093267; Alaminos M, 2006, INVEST OPHTH VIS SCI, V47, P3311, DOI 10.1167/iovs.05-1647; Armitage WJ, 2009, EYE, V23, P1926, DOI 10.1038/eye.2008.381; Arnalich-Montiel F, 2016, EYE VISION, V3, DOI 10.1186/s40662-016-0033-y; Boote C, 2003, INVEST OPHTH VIS SCI, V44, P2941, DOI 10.1167/iovs.03-0131; Carlsson David J, 2003, Curr Opin Ophthalmol, V14, P192, DOI 10.1097/00055735-200308000-00004; Chen CC, 2002, INVEST OPHTH VIS SCI, V43, P2593; Couture C, 2016, BIOMATERIALS, V78, P86, DOI 10.1016/j.biomaterials.2015.11.006; de Araujo AL, 2015, WORLD J STEM CELLS, V7, P806, DOI 10.4252/wjsc.v7.i5.806; DelMonte DW, 2011, J CATARACT REFR SURG, V37, P588, DOI 10.1016/j.jcrs.2010.12.037; Du LQ, 2011, BRIT J OPHTHALMOL, V95, P410, DOI 10.1136/bjo.2008.142539; Dubord PJ, 2013, CORNEA, V32, P1155, DOI 10.1097/ICO.0b013e31828f9d64; Duignan ES, 2015, BR J OPHTHALMOL; Espana EM, 2003, INVEST OPHTH VIS SCI, V44, P5136, DOI 10.1167/iovs.03-0484; Fagerholm P, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001022; Freegard TJ, 1997, EYE, V11, P465, DOI 10.1038/eye.1997.127; Goweida MBB, 2015, CORNEA, V34, P621, DOI 10.1097/ICO.0000000000000407; Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169; Hogan RN, 1999, CORNEA, V18, P2, DOI 10.1097/00003226-199901000-00002; Jester JV, 2005, INVEST OPHTH VIS SCI, V46, P2369, DOI 10.1167/iovs.04-1225; Ju CQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042378; Ju CQ, 2012, INDIAN J MED RES, V135, P887; Kim DK, 2016, ACS APPL MATER INTER, V8, P15160, DOI 10.1021/acsami.6b04901; Lagali N, 2008, INVEST OPHTH VIS SCI, V49, P3895, DOI 10.1167/iovs.07-1354; Liu YW, 2006, INVEST OPHTH VIS SCI, V47, P1869, DOI 10.1167/iovs.05-1339; Matthaei M., 2016, TRANSPLANTATION; McLaughlin CR, 2008, CORNEA, V27, P580, DOI 10.1097/ICO.0b013e3181658408; Meller D, 1997, CELL TISSUE RES, V288, P111, DOI 10.1007/s004410050798; MINAMI Y, 1993, INVEST OPHTH VIS SCI, V34, P2316; Nishida K, 2003, CORNEA, V22, pS28, DOI 10.1097/00003226-200310001-00005; Pang KP, 2010, BIOMATERIALS, V31, P7257, DOI 10.1016/j.biomaterials.2010.05.066; Marquez SP, 2009, ACTA BIOMATER, V5, P1839, DOI 10.1016/j.actbio.2009.02.011; Rafat M, 2016, BIOMATERIALS, V83, P142, DOI 10.1016/j.biomaterials.2016.01.004; Razmjoo Hasan, 2016, Adv Biomed Res, V5, P39, DOI 10.4103/2277-9175.178784; Reichl S, 2003, INT J PHARM, V250, P191, DOI 10.1016/S0378-5173(02)00541-0; Salvador-Culla B, 2016, JOURNAL OF FUNCTIONA, V7; SANCHEZQUEVEDO MC, 1994, HISTOL HISTOPATHOL, V9, P149; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Terry MA, 2000, CORNEA, V19, P611, DOI 10.1097/00003226-200009000-00006; Watson SL, 2004, OPHTHALMOLOGY, V111, P1676, DOI 10.1016/j.ophtha.2004.02.010; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; YOSHINO K, 1995, EXP CELL RES, V220, P138, DOI 10.1006/excr.1995.1300; Zavala J, 2013, EYE, V27, P579, DOI 10.1038/eye.2013.15; Zhu J, 2013, TISSUE ENG PT A, V19, P2412, DOI [10.1089/ten.tea.2013.0097, 10.1089/ten.TEA.2013.0097]	44	4	4	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0168084	10.1371/journal.pone.0168084	http://dx.doi.org/10.1371/journal.pone.0168084			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930708	Green Submitted, Green Published, gold			2022-12-27	WOS:000389580900079
J	Santos, VC; Sierra, APR; Oliveira, R; Cacula, KG; Momesso, CM; Sato, FT; Silva, MBB; Oliveira, HH; Passos, MEP; de Souza, DR; Gondim, OS; Benetti, M; Levada-Pires, AC; Ghorayeb, N; Kiss, MAPD; Gorjao, R; Pithon-Curi, TC; Cury-Boaventura, MF				Santos, Vinicius Coneglian; Renno Sierra, Ana Paula; Oliveira, Rodrigo; Cacula, Kim Guimaraes; Momesso, Cesar Miguel; Sato, Fabio Takeo; Barros Silva, Maysa Braga; Oliveira, Heloisa Helena; Pereira Passos, Maria Elizabeth; de Souza, Diego Ribeiro; Gondim, Olivia Santos; Benetti, Marino; Levada-Pires, Adriana Cristina; Ghorayeb, Nabil; Peduti Dal Molin Kiss, Maria Augusta; Gorjao, Renata; Pithon-Curi, Tania Cristina; Cury-Boaventura, Maria Fernanda			Marathon Race Affects Neutrophil Surface Molecules: Role of Inflammatory Mediators	PLOS ONE			English	Article							INDUCED MUSCLE DAMAGE; ENDURANCE EXERCISE; SKELETAL-MUSCLE; IMMUNE FUNCTION; CELL DEATH; CYTOKINE; PERFORMANCE; APOPTOSIS; RESPONSES; RUNNERS	The fatigue induced by marathon races was observed in terms of inflammatory and immunological outcomes. Neutrophil survival and activation are essential for inflammation resolution and contributes directly to the pathogenesis of many infectious and inflammatory conditions. The aim of this study was to investigate the effect of marathon races on surface molecules related to neutrophil adhesion and extrinsic apoptosis pathway and its association with inflammatory markers. We evaluated 23 trained male runners at the Sao Paulo International Marathon 2013. The following components were measured: hematological and inflammatory mediators, muscle damage markers, and neutrophil function. The marathon race induced an increased leukocyte and neutrophil counts; creatine kinase (CK), lactate dehydrogenase (LDH), CK-MB, interleukin (IL)-6, IL-10, and IL-8 levels. C-reactive protein (CRP), IL-12, and tumor necrosis factor (TNF)-alpha plasma concentrations were significantly higher 24 h and 72 h after the marathon race. Hemoglobin and hematocrit levels decreased 72 h after the marathon race. We also observed an increased intercellular adhesion molecule-1 (ICAM-1) expression and decreasedTNF receptor-1 (TNFR1) expression immediately after and 24 h after the marathon race. We observed an increased DNA fragmentation and L-selectin and Fas receptor expressions in the recovery period, indicating a possible slow rolling phase and delayed neutrophil activation and apoptosis. Marathon racing affects neutrophils adhesion and survival in the course of inflammation, supporting the "open-window" post-exercise hypothesis.	[Santos, Vinicius Coneglian; Sato, Fabio Takeo; Pithon-Curi, Tania Cristina] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, SP, Brazil; [Santos, Vinicius Coneglian; Oliveira, Rodrigo; Cacula, Kim Guimaraes; Momesso, Cesar Miguel; Barros Silva, Maysa Braga; Oliveira, Heloisa Helena; Pereira Passos, Maria Elizabeth; de Souza, Diego Ribeiro; Gondim, Olivia Santos; Levada-Pires, Adriana Cristina; Gorjao, Renata; Pithon-Curi, Tania Cristina; Cury-Boaventura, Maria Fernanda] Univ Cruzeiro Sul, Inst Phys Act & Sports Sci, Sao Paulo, SP, Brazil; [Renno Sierra, Ana Paula; Benetti, Marino; Peduti Dal Molin Kiss, Maria Augusta] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, SP, Brazil; [Renno Sierra, Ana Paula; Ghorayeb, Nabil] Dante Pazzanese Inst Cardiol, Sports Cardiol Dept, Sao Paulo, SP, Brazil; [Renno Sierra, Ana Paula] Nove de Julho Univ, Dept Med, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade Cruzeiro do Sul; Universidade de Sao Paulo; Instituto Dante Pazzanese de Cardiologia; Universidade Nove de Julho	Cury-Boaventura, MF (corresponding author), Univ Cruzeiro Sul, Inst Phys Act & Sports Sci, Sao Paulo, SP, Brazil.; Sierra, APR (corresponding author), Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, SP, Brazil.; Sierra, APR (corresponding author), Dante Pazzanese Inst Cardiol, Sports Cardiol Dept, Sao Paulo, SP, Brazil.; Sierra, APR (corresponding author), Nove de Julho Univ, Dept Med, Sao Paulo, SP, Brazil.	anasierra@usp.br; maria.boaventura@cruzeirodosul.edu.br	Pires, Adriana Cristina Levada/AAC-9783-2021; Gorjão, Renata/D-4130-2013; Ghorayeb, Nabil/G-4333-2015; Momesso, Cesar Miguel/D-3281-2012; Cury-Boaventura, Maria Fernanda MF/B-3945-2012; Nabil Ghorayeb, Instituto Dante Pazzanese de Cardiologia/AAA-7193-2019; Sierra, Ana Paula R/G-3449-2012; Pithon-Curi, Tania Cristina/AAB-9436-2021; de Souza, Diego Ribeiro/ABE-4442-2020; Sato, Fabio Takeo/AAS-6614-2020	Ghorayeb, Nabil/0000-0002-7056-7593; Momesso, Cesar Miguel/0000-0001-6448-6028; Cury-Boaventura, Maria Fernanda MF/0000-0002-1596-0624; Nabil Ghorayeb, Instituto Dante Pazzanese de Cardiologia/0000-0002-7056-7593; Sierra, Ana Paula R/0000-0002-8547-7195; Gorjao, Renata/0000-0002-9655-1477; de Oliveira Alves, Heloisa Helena/0000-0002-5378-4510; Braga Barros Silva, Maysa/0000-0001-9253-4066; PITHON-CURI, TANIA CRISTINA/0000-0002-9714-9105; Ribeiro de Souza, Diego/0000-0003-2088-9356; Sato, Fabio Takeo/0000-0002-9863-4364				Akimoto T, 2000, EUR J APPL PHYSIOL, V81, P510, DOI 10.1007/s004210050076; Arizono S, 2014, RESP CARE, V59, P1108, DOI 10.4187/respcare.02674; Bonsignore MR, 2001, AM J PHYSIOL-LUNG C, V281, pL668, DOI 10.1152/ajplung.2001.281.3.L668; Burt DG, 2011, J STRENGTH COND RES, V25, P2185, DOI 10.1519/JSC.0b013e3181e86148; Cabrini M, 2010, CURR OPIN HEMATOL, V17, P31, DOI 10.1097/MOH.0b013e3283333b29; Chandra J, 2001, DIABETES, V50, pS44, DOI 10.2337/diabetes.50.2007.S44; Chazaud B, 2016, IMMUNOL CELL BIOL, V94, P140, DOI 10.1038/icb.2015.97; Chinda D, 2003, LUMINESCENCE, V18, P324, DOI 10.1002/bio.744; Diment BC, 2015, MED SCI SPORT EXER, V47, P1390, DOI 10.1249/MSS.0000000000000562; Dimitriou L, 2015, J INT SOC SPORT NUTR, V12, DOI 10.1186/s12970-015-0085-8; Futosi K, 2013, INT IMMUNOPHARMACOL, V17, P1185, DOI 10.1016/j.intimp.2013.11.010; Gleeson M, 2012, SCAND J MED SCI SPOR, V22, P410, DOI 10.1111/j.1600-0838.2010.01272.x; Gleeson M, 2016, IMMUNOL CELL BIOL, V94, P124, DOI 10.1038/icb.2015.100; Guadalupe-Grau A, 2010, EUR J APPL PHYSIOL, V110, P635, DOI 10.1007/s00421-010-1550-3; Hellard P, 2015, MED SCI SPORT EXER, V47, P698, DOI 10.1249/MSS.0000000000000461; Jee H, 2012, J SPORT SCI MED, V11, P719; Kim YB, 1999, BIOCHEM BIOPH RES CO, V254, P720, DOI 10.1006/bbrc.1998.9940; Kuvibidila S, 2004, CYTOKINE, V26, P73, DOI 10.1016/j.cyto.2003.12.010; Lippi G, 2010, INT J LAB HEMATOL, V32, P117, DOI 10.1111/j.1751-553X.2008.01133.x; Marcora SM, 2007, SCAND J MED SCI SPOR, V17, P662, DOI 10.1111/j.1600-0838.2006.00627.x; McCracken Jenna M, 2014, J Cell Death, V7, P15, DOI 10.4137/JCD.S11038; Mooren FC, 2012, J APPL PHYSIOL, V113, P1082, DOI 10.1152/japplphysiol.00797.2012; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Nielsen HG, 2004, MED SCI SPORT EXER, V36, P68, DOI 10.1249/01.MSS.0000106168.12113.95; Nieman DC, 2001, J APPL PHYSIOL, V91, P109, DOI 10.1152/jappl.2001.91.1.109; Pal M, 2014, IMMUNOL CELL BIOL, V92, P331, DOI 10.1038/icb.2014.16; Peake J, 2005, EXERC IMMUNOL REV, V11, P64; Peake JM, 2005, MED SCI SPORT EXER, V37, P737, DOI 10.1249/01.MSS.0000161804.05399.3B; Reid SA, 2004, CLIN J SPORT MED, V14, P344, DOI 10.1097/00042752-200411000-00004; Robson-Ansley P, 2012, MED SCI SPORT EXER, V44, P999, DOI 10.1249/MSS.0b013e318243253d; Santos VC, 2013, INT J SPORT NUTR EXE, V23, P161, DOI 10.1123/ijsnem.23.2.161; Schumacher YO, 2002, MED SCI SPORT EXER, V34, P869; Shaashua L, 2012, BRAIN BEHAV IMMUN, V26, P996, DOI 10.1016/j.bbi.2012.05.012; Shin YO, 2013, CYTOKINE, V61, P364, DOI 10.1016/j.cyto.2012.11.019; Sugama K, 2013, EXERC IMMUNOL REV, V19, P29; Suzuki K, 2003, MED SCI SPORT EXER, V35, P348, DOI 10.1249/01.MSS.0000048861.57899.04; Tauler P, 2013, MED SCI SPORT EXER, V45, P1269, DOI 10.1249/MSS.0b013e3182857c8a; van de Vyver M, 2015, SCANDINAVIAN J MED S; Walsh NP, 2016, IMMUNOL CELL BIOL, V94, P132, DOI 10.1038/icb.2015.99; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P6; Wang Q, 2015, MED SCI SPORT EXER, V47, P1362, DOI 10.1249/MSS.0000000000000563	41	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0166687	10.1371/journal.pone.0166687	http://dx.doi.org/10.1371/journal.pone.0166687			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911915	Green Submitted, Green Published, gold			2022-12-27	WOS:000389520600010
J	Arffa, ML; Zapf, MA; Kothari, AN; Chang, V; Gupta, GN; Ding, X; Al-Gayyar, MM; Syn, W; Elsherbiny, NM; Kuo, PC; Mi, Z				Arffa, M. L.; Zapf, M. A.; Kothari, A. N.; Chang, V.; Gupta, G. N.; Ding, X.; Al-Gayyar, M. M.; Syn, W.; Elsherbiny, N. M.; Kuo, P. C.; Mi, Z.			Epigallocatechin-3-Gallate Upregulates miR-221 to Inhibit Osteopontin-Dependent Hepatic Fibrosis	PLOS ONE			English	Article							GREEN TEA CATECHINS; FATTY LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA; NONALCOHOLIC STEATOHEPATITIS; OXIDATIVE STRESS; EXPRESSION; GALLATE; RNA; CELLS; MODEL	Osteopontin (OPN) promotes hepatic fibrosis, and developing therapies targeting OPN expression in settings of hepatic injury holds promise. The polyphenol epigallocatechin-3-gallate (EGCG), found in high concentrations in green tea, downregulates OPN expression through OPN mRNA degradation, but the mechanism is unknown. Previous work has shown that microRNAs can decrease OPN mRNA levels, and other studies have shown that EGCG modulates the expression of multiple microRNAs. In our study, we first demonstrated that OPN induces hepatic stellate cells to transform into an activated state. We then identified three microRNAs which target OPN mRNA: miR-181a, miR-10b, and miR-221. In vitro results show that EGCG upregulates all three microRNAs, and all three microRNAs are capable of down regulating OPN mRNA when administered alone. Interestingly, only miR-221 is necessary for EGCG-mediated OPN mRNA degradation and miR-221 inhibition reduces the effects of EGCG on cell function. In vivo experiments show that thioacetamide (TAA)-induced cell cytotoxicity upregulates OPN expression; treatment with EGCG blocks the effects of TAA. Furthermore, chronic treatment of EGCG in vivo upregulates all three microRNAs equally, suggesting that in more chronic treatment all three microRNAs are involved in modulating OPN expression. We conclude that in in vitro and in vivo models of TAA-induced hepatic fibrosis, EGCG inhibits OPN-dependent injury and fibrosis. EGCG works primarily by upregulating miR-221 to accelerate OPN degradation. EGCG may therefore have utility as a protective agent in settings of liver injury.	[Arffa, M. L.; Zapf, M. A.; Kothari, A. N.; Chang, V.; Gupta, G. N.; Ding, X.; Kuo, P. C.; Mi, Z.] Loyola Univ, Med Ctr, Dept Surg, Maywood, IL 60153 USA; [Al-Gayyar, M. M.; Elsherbiny, N. M.] Mansoura Univ, Dept Biochem, Fac Pharm, Mansoura, Egypt; [Syn, W.] Med Univ South Carolina, Div Gastroenterol & Hepatol, Charleston, SC 29425 USA; [Syn, W.] Ralph H Johnson Vet Affairs Med Ctr, Gastroenterol Sect, Charleston, SC USA; [Al-Gayyar, M. M.] Univ Tabuk, Dept Pharmaceut Chem, Tabuk, Saudi Arabia	Loyola University Chicago; Egyptian Knowledge Bank (EKB); Mansoura University; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; University of Tabuk	Kuo, PC (corresponding author), Loyola Univ, Med Ctr, Dept Surg, Maywood, IL 60153 USA.	pkuo@lumc.edu	elsherbiny, nehal N/M-5006-2018; Syn, Wing-Kin/AAB-8406-2020; Zapf, Matthew/GRS-0086-2022; Elsherbiny, Nehal/AAF-9206-2019; Al-Gayyar, Mohammed M H/E-8250-2014	elsherbiny, nehal N/0000-0001-5167-3377; Elsherbiny, Nehal/0000-0001-5167-3377; Al-Gayyar, Mohammed M H/0000-0003-4777-3919; Zapf, Matthew/0000-0001-5544-8900; Arffa, Matthew/0000-0002-9539-9100				Ahn JI, 2010, MOL CELL TOXICOL, V6, P169, DOI 10.1007/s13273-010-0024-3; Arola-Arnal A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025982; Arriazu E., 2016, GUT; Baselga-Escudero L, 2014, NUCLEIC ACIDS RES, V42, P882, DOI 10.1093/nar/gkt1011; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bhattacharya SD, 2010, SURGERY, V148, P291, DOI 10.1016/j.surg.2010.05.007; Broderick JA, 2011, GENE THER, V18, P1104, DOI 10.1038/gt.2011.50; Callegari E, 2012, HEPATOLOGY, V56, P1025, DOI 10.1002/hep.25747; Chow HHS, 2005, CLIN CANCER RES, V11, P4627, DOI 10.1158/1078-0432.CCR-04-2549; Coombes JD, 2015, GUT, V64, P1120, DOI 10.1136/gutjnl-2013-306484; Coombes JD, 2015, BIOCH BIOPHYS ACTA; Darweish MM, 2014, J PHARM PHARMACOL, V66, P1032, DOI 10.1111/jphp.12229; Ding Y, 2015, EUR J PHARMACOL, V761, P405, DOI 10.1016/j.ejphar.2015.05.005; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Gines P, 2004, NEW ENGL J MED, V350, P1646, DOI 10.1056/NEJMra035021; Huang WB, 2010, CLIN CHIM ACTA, V411, P675, DOI 10.1016/j.cca.2010.01.029; Hung GD, 2012, J FORMOS MED ASSOC, V111, P550, DOI 10.1016/j.jfma.2011.06.026; John K, 2014, HEPATOLOGY, V60, P1346, DOI 10.1002/hep.27250; Kim HK, 2009, WORLD J GASTROENTERO, V15, P5200, DOI 10.3748/wjg.15.5200; Koelz M, 2011, INT J ONCOL, V38, P503, DOI 10.3892/ijo.2010.857; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kuzuhara T, 2007, MOL CARCINOGEN, V46, P640, DOI 10.1002/mc.20332; Kuzuhara T, 2006, J BIOL CHEM, V281, P17446, DOI 10.1074/jbc.M601196200; Leung TM, 2013, LAB INVEST, V93, P1082, DOI 10.1038/labinvest.2013.104; Lim YS, 2008, CLIN LIVER DIS, V12, P733, DOI 10.1016/j.cld.2008.07.007; Matsue Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118744; Mi ZY, 2009, MOL THER, V17, P153, DOI 10.1038/mt.2008.235; Milenkovic D, 2012, PLOS ONE, V7, P156, DOI 10.1371/journal.pone.0029837; Oh K, 2015, IMMUNE NETW, V15, P142, DOI 10.4110/in.2015.15.3.142; Patouraux S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035612; Safer AM, 2015, EXP THER MED, V9, P787, DOI 10.3892/etm.2014.2158; Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG264, DOI 10.1152/ajpgi.00002.2004; Santamarina AB, 2015, J NUTR BIOCHEM, V26, P1348, DOI 10.1016/j.jnutbio.2015.07.002; Sharma AD, 2011, HEPATOLOGY, V53, P1651, DOI 10.1002/hep.24243; Shen CJ, 2014, BIOMED RES INT, V2014; Simao A, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0307-1; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Sriram N, 2015, CLIN EXP PHARMACOL P, V42, P849, DOI 10.1111/1440-1681.12428; Strazzabosco M, 2014, GUT, V63, P1693, DOI 10.1136/gutjnl-2014-307712; Suzuki Y, 2012, P JPN ACAD B-PHYS, V88, P88, DOI 10.2183/pjab.88.88; Tan TK, 2013, LAB INVEST, V93, P434, DOI 10.1038/labinvest.2013.3; Tian RQ, 2011, J BIOL CHEM, V286, P25556, DOI 10.1074/jbc.M111.221564; Torres AG, 2011, RNA, V17, P933, DOI 10.1261/rna.2533811; Tsang WP, 2010, J NUTR BIOCHEM, V21, P140, DOI 10.1016/j.jnutbio.2008.12.003; Ui A, 2009, CANCER CAUSE CONTROL, V20, P1939, DOI 10.1007/s10552-009-9388-x; Ullmann U, 2003, J INT MED RES, V31, P88, DOI 10.1177/147323000303100205; Wang XD, 2014, GUT, V63, P1805, DOI 10.1136/gutjnl-2013-306373; Xiao J, 2014, EUR J NUTR, V53, P187, DOI 10.1007/s00394-013-0516-8; Yamada S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19225; Yang JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114533; Yin XR, 2015, INT J CLIN EXP MED, V8, P8339; Yuan JM, 2013, AM J CLIN NUTR, V98, p1676S, DOI 10.3945/ajcn.113.058271; Yuan QG, 2013, HEPATOLOGY, V57, P299, DOI 10.1002/hep.25984; Zapf MAC, 2015, SURGERY, V158, P1039, DOI 10.1016/j.surg.2015.06.011; Zheng C, 2012, MED ONCOL, V29, P815, DOI 10.1007/s12032-011-9934-8; Zhong Z, 2003, AM J PHYSIOL-GASTR L, V285, pG1004, DOI 10.1152/ajpgi.00008.2003	57	27	27	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167435	10.1371/journal.pone.0167435	http://dx.doi.org/10.1371/journal.pone.0167435			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935974	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100097
J	Colard, T; Falgayrac, G; Bertrand, B; Naji, S; Devos, O; Balsack, C; Delannoy, Y; Penel, G				Colard, Thomas; Falgayrac, Guillaume; Bertrand, Benoit; Naji, Stephan; Devos, Olivier; Balsack, Clara; Delannoy, Yann; Penel, Guillaume			New Insights on the Composition and the Structure of the Acellular Extrinsic Fiber Cementum by Raman Analysis	PLOS ONE			English	Article							COLLAGEN FIBRILS; MECHANICAL-PROPERTIES; CHEMICAL-COMPOSITION; DENTAL CEMENTUM; AGE ESTIMATION; BONE; ORIENTATION; ANNULATION; ULTRASTRUCTURE; ARCHITECTURE	Acellular extrinsic fiber cementum is a mineralized tissue that covers the cervical half of the tooth root surface. It contains mainly extrinsic or Sharpey's fibers that run perpendicular to the root surface to anchor the tooth via the periodontal ligament. Acellular cementum is continuously and slowly produced throughout life and exhibits an alternating bright and dark pattern under light microscopy. However, although a better understanding of the structural background of acellular cementum is relevant to many fields, such as cementochronology, periodontology and tissue engineering, acellular cementum remains rarely studied and poorly understood. In this work, we studied the acellular cementum at the incremental line scale of five human mandibular canines using polarized Raman spectroscopy. We provided Raman imaging analysis and polarized acquisitions as a function of the angular orientation of the sample. The results showed that mineral crystals were always parallel to collagen fibrils, and at a larger scale, we proposed an organizational model in which we found radial collagen fibers, "orthogonal" to the cementum surface, and "non-orthogonal" fibers, which consist of branching and bending radial fibers. Concerning the alternating pattern, we observed that the dark lines corresponded to smaller, more mineralized and probably more organized bands, which is consistent with the zoological assumption that incremental lines are produced during a winter rest period of acellular cementum growth.	[Colard, Thomas; Bertrand, Benoit; Balsack, Clara; Delannoy, Yann] Univ Lille, CHU Lille, UTML, EA 7367, Lille, France; [Falgayrac, Guillaume; Penel, Guillaume] Univ Lille, PMOI, EA 4490, Lille, France; [Naji, Stephan] NYU, CIRHUS, New York, NY USA; [Devos, Olivier] Univ Lille, CNRS, LASIR Lab Spectrochim & Raman, UMR 8516, Lille, France	Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; New York University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Lille - ISITE; Universite de Lille	Colard, T (corresponding author), Univ Lille, CHU Lille, UTML, EA 7367, Lille, France.	thomas.colard@univ-lille2.fr	, Falgayrac/O-2917-2013; Devos, Olivier/B-3974-2009; naji, Stephan/AAF-6478-2019	, Falgayrac/0000-0003-1806-1509; Devos, Olivier/0000-0002-3354-0420; naji, Stephan/0000-0003-1396-3204; Bertrand, Benoit/0000-0001-7640-6929; Colard, Thomas/0000-0002-2235-6759				Aboulfadl H, 2015, J STRUCT BIOL, V192, P67, DOI 10.1016/j.jsb.2015.08.011; Bertrand B, 2015, INT J PALEO IN PRESS; Bosshardt DD, 1997, PERIODONTOL 2000, V13, P41, DOI 10.1111/j.1600-0757.1997.tb00095.x; Cape AT, 1930, J AM DENT ASSOC, V17, P193, DOI [10.14219/JADA.ARCHIVE.1930.0047, DOI 10.14219/JADA.ARCHIVE.1930.0047]; Catros S, 2008, J PERIODONTOL, V79, P1095, DOI [10.1902/jop.2008.070482, 10.1902/jop.2008.070482 ]; Cho MI, 2000, PERIODONTOL 2000, V24, P9, DOI 10.1034/j.1600-0757.2000.2240102.x; Colard T, 2018, INT J LEGAL MED, V132, P1117, DOI 10.1007/s00414-015-1172-8; Cool SM, 2002, BONE, V30, P386, DOI 10.1016/S8756-3282(01)00686-X; Falgayrac G, 2012, ANAL CHEM, V84, P9116, DOI 10.1021/ac301758y; Falgayrac G, 2010, APPL SPECTROSC, V64, P775, DOI 10.1366/000370210791666255; Foster BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038393; FURSETH R, 1968, ARCH ORAL BIOL, V13, P1197, DOI 10.1016/0003-9969(68)90075-7; Galvis L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063518; Gamsjaeger S, 2010, BONE, V47, P392, DOI 10.1016/j.bone.2010.04.608; Gauthier J, 2013, HOMO, V64, P42, DOI 10.1016/j.jchb.2012.11.001; Gebhardt FS., 1905, ROUX ARCH, V20, P187; GIRAUDGUILLE MM, 1988, CALCIFIED TISSUE INT, V42, P167, DOI 10.1007/BF02556330; HALS E, 1977, CARIES RES, V11, P62, DOI 10.1159/000260250; Ho SP, 2007, BIOMATERIALS, V28, P5238, DOI 10.1016/j.biomaterials.2007.08.031; Ho SP, 2009, DENT MATER, V25, P1195, DOI 10.1016/j.dental.2009.04.005; Ho SP, 2009, ACTA BIOMATER, V5, P707, DOI 10.1016/j.actbio.2008.08.013; Jones SJ, 1981, DENT ANATOMY EMBRYOL; Kazanci M, 2006, J STRUCT BIOL, V156, P489, DOI 10.1016/j.jsb.2006.06.011; LAWS RM, 1952, NATURE, V169, P972, DOI 10.1038/169972b0; LIEBERMAN DE, 1994, J ARCHAEOL SCI, V21, P525, DOI 10.1006/jasc.1994.1052; Maat GJR, 2006, FORENSIC SCI INT, V159, pS95, DOI 10.1016/j.forsciint.2006.02.038; Mandair GS, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2014.115; MAROTTI G, 1993, CALCIFIED TISSUE INT, V53, pS47, DOI 10.1007/BF01673402; Masic A, 2011, BIOMACROMOLECULES, V12, P3989, DOI 10.1021/bm201008b; Naji S, 2015, INT J PALEO IN PRESS; Raspanti M, 2000, ARCH ORAL BIOL, V45, P185, DOI 10.1016/S0003-9969(99)00145-4; Renz H, 1997, Adv Dent Res, V11, P472; Reznikov N, 2014, ACTA BIOMATER, V10, P3815, DOI 10.1016/j.actbio.2014.05.024; Reznikov N, 2013, BONE, V52, P676, DOI 10.1016/j.bone.2012.10.034; Ritz C, 2008, USE R, P1; Saygin NE, 2000, PERIODONTOL 2000, V24, P73, DOI 10.1034/j.1600-0757.2000.2240105.x; Schroeder H.E., 1986, HDB MICROSCOPIC ANAT, VV/5, P246; Schrof S, 2014, J STRUCT BIOL, V187, P266, DOI 10.1016/j.jsb.2014.07.001; Schug GR, 2012, HOMO, V63, P94, DOI 10.1016/j.jchb.2012.01.002; SELVIG KA, 1977, J PERIODONTAL RES, V12, P419, DOI 10.1111/j.1600-0765.1977.tb00137.x; SMITH KG, 1994, J MAMMAL, V75, P406, DOI 10.2307/1382560; SONI NN, 1962, J PERIODONTOL, V33, P372, DOI 10.1902/jop.1962.33.4.372; STOTT GG, 1982, J DENT RES, V61, P814, DOI 10.1177/00220345820610063401; Team RC, 2014, R LANG ENV STAT COMP; Wagermaier W, 2006, BIOINTERPHASES, V1, P1, DOI 10.1116/1.2178386; Wittwer-Backofen U, 2004, AM J PHYS ANTHROPOL, V123, P119, DOI 10.1002/ajpa.10303; Yamamoto H, 2009, J HARD TISSUE BIOL, V18, P41; Yamamoto T, 1997, ANAT EMBRYOL, V196, P115, DOI 10.1007/s004290050084; Yamamoto T, 2012, J ELECTRON MICROSC, V61, P113, DOI 10.1093/jmicro/dfs033; Yamamoto T, 2010, ODONTOLOGY, V98, P102, DOI 10.1007/s10266-010-0134-3	50	19	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167316	10.1371/journal.pone.0167316	http://dx.doi.org/10.1371/journal.pone.0167316			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936010	gold, Green Published			2022-12-27	WOS:000389587100083
J	Dipnall, JF; Pasco, JA; Berk, M; Williams, LJ; Dodd, S; Jacka, FN; Meyer, D				Dipnall, Joanna F.; Pasco, Julie A.; Berk, Michael; Williams, Lana J.; Dodd, Seetal; Jacka, Felice N.; Meyer, Denny			Into the Bowels of Depression: Unravelling Medical Symptoms Associated with Depression by Applying Machine-Learning Techniques to a Community Based Population Sample	PLOS ONE			English	Article							LOGISTIC-REGRESSION; DIETARY PATTERNS; GUT; MICROBIOME; MECHANISMS; DISORDERS; HEALTH; IMPACT	Background Depression is commonly comorbid with many other somatic diseases and symptoms. Identification of individuals in clusters with comorbid symptoms may reveal new pathophysiological mechanisms and treatment targets. The aim of this research was to combine machine-learning (ML) algorithms with traditional regression techniques by utilising self-reported medical symptoms to identify and describe clusters of individuals with increased rates of depression from a large cross-sectional community based population epidemiological study. Methods A multi-staged methodology utilising ML and traditional statistical techniques was performed using the community based population National Health and Nutrition Examination Study (2009 - 2010) (N = 3,922). A Self-organised Mapping (SOM) ML algorithm, combined with hierarchical clustering, was performed to create participant clusters based on 68 medical symptoms. Binary logistic regression, controlling for sociodemographic confounders, was used to then identify the key clusters of participants with higher levels of depression (PHQ-9 >= 10, n = 377). Finally, a Multiple Additive Regression Tree boosted ML algorithm was run to identify the important medical symptoms for each key cluster within 17 broad categories: heart, liver, thyroid, respiratory, diabetes, arthritis, fractures and osteoporosis, skeletal pain, blood pressure, blood transfusion, cholesterol, vision, hearing, psoriasis, weight, bowels and urinary. Results Five clusters of participants, based on medical symptoms, were identified to have significantly increased rates of depression compared to the cluster with the lowest rate: odds ratios ranged from 2.24 ( 95% CI 1.56, 3.24) to 6.33 ( 95% CI 1.67, 24.02). The ML boosted regression algorithm identified three key medical condition categories as being significantly more common in these clusters: bowel, pain and urinary symptoms. Bowel- related symptoms was found to dominate the relative importance of symptoms within the five key clusters. Conclusion This methodology shows promise for the identification of conditions in general populations and supports the current focus on the potential importance of bowel symptoms and the gut in mental health research.	[Dipnall, Joanna F.; Pasco, Julie A.; Berk, Michael; Williams, Lana J.; Dodd, Seetal; Jacka, Felice N.] Deakin Univ, Sch Med, IMPACT Strateg Res Ctr, Geelong, Vic, Australia; [Dipnall, Joanna F.; Meyer, Denny] Swinburne Univ Technol, Dept Stat, Data Sci & Epidemiol, Melbourne, Vic, Australia; [Pasco, Julie A.] Univ Melbourne, Melbourne Clin School, Western Campus, St Albans, Vic, Australia; [Pasco, Julie A.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Pasco, Julie A.; Berk, Michael; Williams, Lana J.; Dodd, Seetal] Univ Hosp Geelong, Geelong, Vic, Australia; [Berk, Michael; Dodd, Seetal; Jacka, Felice N.] Univ Melbourne, Dept Psychiat, Parkville, Vic, Australia; [Berk, Michael] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Berk, Michael; Dodd, Seetal] Natl Ctr Excellence Youth Mental Hlth, Orygen, Parkville, Vic, Australia; [Jacka, Felice N.] Murdoch Childrens Res Inst, Ctr Adolescent Hlth, Melbourne, Vic, Australia; [Jacka, Felice N.] Black Dog Inst, Sydney, NSW, Australia	Deakin University; Swinburne University of Technology; University of Melbourne; Monash University; Geelong Hospital; University of Melbourne; Florey Institute of Neuroscience & Mental Health; Orygen, The National Centre of Excellence in Youth Mental Health; Murdoch Children's Research Institute; Black Dog Institute	Dipnall, JF (corresponding author), Deakin Univ, Sch Med, IMPACT Strateg Res Ctr, Geelong, Vic, Australia.; Dipnall, JF (corresponding author), Swinburne Univ Technol, Dept Stat, Data Sci & Epidemiol, Melbourne, Vic, Australia.	jdipnall@deakin.edu.au	Jacka, Felice N/ABE-6322-2020; Berk, Michael/M-7891-2013; Jacka, Felice N/D-9424-2012; Berk, Michael/M-3585-2019	Jacka, Felice N/0000-0002-9825-0328; Berk, Michael/0000-0002-5554-6946; Jacka, Felice N/0000-0002-9825-0328; Berk, Michael/0000-0002-5554-6946; Dipnall, Joanna/0000-0001-7543-0687; Williams, Lana/0000-0002-1377-1272	NHMRC [1059660, 1064272, 1108125, GNT1064272]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	MB is supported by a NHMRC Senior Principal Research Fellowship 1059660. LJW is supported by a NHMRC Career Development Fellowship 1064272. FNJ is supported by an NHMRC Career Development Fellowship 1108125. The author(s) received no specific funding for this work.; LJW is supported by a NHMRC Career Development Fellowship (GNT1064272).	Abu Abbas O, 2008, INT ARAB J INF TECHN, V5, P320; Albenberg LG, 2014, GASTROENTEROLOGY, V146, P1564, DOI 10.1053/j.gastro.2014.01.058; [Anonymous], 2009, NAT HLTH NUTR EX SUR; Archer KJ, 2006, STATA J, V6, P97, DOI 10.1177/1536867X0600600106; Arnrich B, 2010, MACHINE LEARNING ASS, V45; Berry M.J.A., 2011, DATA MINING TECHNIQU; Black MM, 2004, PEDIATRICS, V114, P169, DOI 10.1542/peds.114.1.169; Bureau U.S.C., 2008, CURRENT POPULATION S; Centers for Disease Control and Prevention, 2013, NAT HLTH NUTR EX SUR; Chaovalitwongse W, 2010, SPRINGER SER OPTIM A, V38, P1, DOI 10.1007/978-0-387-88630-5; Chekroud AM, 2016, LANCET PSYCHIAT; Crofts DJ, 1999, ACTA PAEDIATR, V88, P969, DOI 10.1080/08035259950168478; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Dash S, 2015, CURR OPIN PSYCHIATR, V28, P1, DOI 10.1097/YCO.0000000000000117; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dipnall J, 2017, EUR PSYCHIAT, V39, P40; Dipnall JF, 2014, DATA INTEGRATION PRO; Dipnall JF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148195; Dipnall JF, 2015, J AFFECT DISORDERS, V174, P215, DOI 10.1016/j.jad.2014.11.030; Eshghi A., 2011, J DATA SCI, V9, P271, DOI [10.6339/JDS.201104_09(2).0009, DOI 10.6339/JDS.201104_09(2).0009]; Fernandes BS, 2016, DRUG AGING, V33, P21, DOI 10.1007/s40266-015-0323-4; Fond G, 2014, EUR ARCH PSY CLIN N, V264, P651, DOI 10.1007/s00406-014-0502-z; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Freund Y., 1999, JAPANESE SOC ART INT, V14, P1612; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Friedman J, 2001, SPRINGER SERIES STAT, V10; Gabor AJ, 1996, ELECTROEN CLIN NEURO, V99, P257, DOI 10.1016/0013-4694(96)96001-0; Hagenaars J., 2002, APPL LATENT CLASS AN, DOI DOI 10.1017/CBO9780511499531; HARRIS B, 1992, BMJ-BRIT MED J, V305, P152, DOI 10.1136/bmj.305.6846.152; Hastie T, 2009, ELEMENTS STAT LEARNI, P33, DOI 10.1007/978-0-387-84858-7; Jacka FN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087657; Joanna F, 2016, EUR PSYCHIAT; Kapfhammer Hans-Peter, 2006, Dialogues Clin Neurosci, V8, P227; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Kohenen T., 1997, LECT NOTES INFORM SC, V30; Kohn H.F., 2014, WILEY STATSREF STAT, P1, DOI [10.1002/9781118445112.stat02449, DOI 10.1002/9781118445112.STAT02449]; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Kohonen T., 2001, SELF ORG MAPS, P501; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kronish IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052771; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Maes M, 2012, J AFFECT DISORDERS, V141, P55, DOI 10.1016/j.jad.2012.02.023; Magdolen J, 1997, PSYCHIAT RES-NEUROIM, V68, P171; Massie Mary Jane, 2004, J Natl Cancer Inst Monogr, P57; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Mitchell TM, 1997, MACH LEARN, P45; Monteith S, 2016, INT J BIPOLAR DISORD, V4, DOI 10.1186/s40345-016-0051-7; Mykletun A, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-88; Natekin A, 2013, FRONT NEUROROBOTICS, V7, DOI 10.3389/fnbot.2013.00021; Olver JS, 2013, MED J AUSTRALIA, V199, P9, DOI 10.5694/mjao12.10597; Passos IC, 2015, LANCET PSYCHIAT, V2, P1002, DOI 10.1016/S2215-0366(15)00309-0; Penninx BWJH, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-129; Persoons P, 2005, ALIMENT PHARM THER, V22, P101, DOI 10.1111/j.1365-2036.2005.02535.x; Poulin C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085733; Sanna L, 2014, J AFFECT DISORDERS, V155, P261, DOI 10.1016/j.jad.2013.11.009; Sanna L, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-194; Sanna L, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-110; Schonlau M, 2005, STATA J, V5, P330, DOI 10.1177/1536867X0500500304; Seref O, 2007, DATA MINING SYSTEMS; Shim L, 2013, SCAND J GASTROENTERO, V48, P295, DOI 10.3109/00365521.2012.758767; Shim RS, 2011, J AM BOARD FAM MED, V24, P33, DOI 10.3122/jabfm.2011.01.100121; Simon GE, 1999, NEW ENGL J MED, V341, P1329, DOI 10.1056/NEJM199910283411801; Tran T, 2015, KNOWL INF SYST, V43, P555, DOI 10.1007/s10115-014-0740-4; Van Hulle MM, 2012, SELF ORGANIZING MAPS, P585; Vesanto J, 2000, IEEE T NEURAL NETWOR, V11, P586, DOI 10.1109/72.846731; Wehrens R, 2007, J STAT SOFTW, V21, P1; Whitehead WE, 2002, GASTROENTEROLOGY, V122, P1140, DOI 10.1053/gast.2002.32392; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344	70	11	13	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167055	10.1371/journal.pone.0167055	http://dx.doi.org/10.1371/journal.pone.0167055			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27935995	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100056
J	Fullen, DJ; Murray, B; Mori, J; Catchpole, A; Borley, DW; Murray, EJ; Balaratnam, G; Gilbert, A; Mann, A; Hughes, F; Lambkin-Williams, R				Fullen, Daniel J.; Murray, Bryan; Mori, Julie; Catchpole, Andrew; Borley, Daryl W.; Murray, Edward J.; Balaratnam, Ganesh; Gilbert, Anthony; Mann, Alex; Hughes, Fiona; Lambkin-Williams, Rob			A Tool for Investigating Asthma and COPD Exacerbations: A Newly Manufactured and Well Characterised GMP Wild-Type Human Rhinovirus for Use in the Human Viral Challenge Model	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; LOWER RESPIRATORY-TRACT; INFECTION; ADULTS; VIRUS; SEVERITY; COLDS	Background Human Rhinovirus infection is an important precursor to asthma and chronic obstructive pulmonary disease exacerbations and the Human Viral Challenge model may provide a powerful tool in studying these and other chronic respiratory diseases. In this study we have reported the production and human characterisation of a new Wild-Type HRV-16 challenge virus produced specifically for this purpose. Methods and Stock Development A HRV-16 isolate from an 18 year old experimentally infected healthy female volunteer (University of Virginia Children's Hospital, USA) was obtained with appropriate medical history and consent. We manufactured a new HRV-16 stock by minimal passage in a WI-38 cell line under Good Manufacturing Practice conditions. Having first subjected the stock to rigorous adventitious agent testing and determining the virus suitability for human use, we conducted an initial safety and pathogenicity clinical study in adult volunteers in our dedicated clinical quarantine facility in London. Human Challenge and Conclusions In this study we have demonstrated the new Wild-Type HRV-16 Challenge Virus to be both safe and pathogenic, causing an appropriate level of disease in experimentally inoculated healthy adult volunteers. Furthermore, by inoculating volunteers with a range of different inoculum titres, we have established the minimum inoculum titre required to achieve reproducible disease. We have demonstrated that although inoculation titres as low as 1 TCID50 can produce relatively high infection rates, the optimal titre for progression with future HRV challenge model development with this virus stock was 10 TCID50. Studies currently under-way are evaluating the use of this virus as a challenge agent in asthmatics.	[Fullen, Daniel J.; Murray, Bryan; Mori, Julie; Catchpole, Andrew; Borley, Daryl W.; Murray, Edward J.; Balaratnam, Ganesh; Gilbert, Anthony; Mann, Alex; Hughes, Fiona; Lambkin-Williams, Rob] hVIVO Grp PLC, Queen Mary BioEnterprises Innovat Ctr, London, England		Lambkin-Williams, R (corresponding author), hVIVO Grp PLC, Queen Mary BioEnterprises Innovat Ctr, London, England.	RLW@hvivo.com	Lambkin-Williams, Rob/L-2397-2019	Lambkin-Williams, Rob/0000-0003-2107-0174; Mann, Alexander/0000-0002-3744-4604; Fullen, Daniel/0000-0002-8562-7157	hVIVO Services Limited	hVIVO Services Limited	The study was funded by hVIVO Services Limited. hVIVO Services Limited provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adura PT, 2014, EUR RESPIR J, V43, P1186, DOI 10.1183/09031936.00141713; Bardin PG, 2000, EUR RESPIR J, V16, P980, DOI 10.1183/09031936.00.16598000; Bousquet J, 2010, J ALLERGY CLIN IMMUN, V126, P926, DOI 10.1016/j.jaci.2010.07.019; DeVincenzo JP, 2010, AM J RESP CRIT CARE, V182, P1305, DOI 10.1164/rccm.201002-0221OC; FRAENKEL DJ, 1994, AM J RESP CRIT CARE, V150, P1130, DOI 10.1164/ajrccm.150.4.7921447; Fullen DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145902; Gamble J, 2009, AM J RESP CRIT CARE, V180, P817, DOI 10.1164/rccm.200902-0166OC; Greenberg SB, 2003, ARCH INTERN MED, V163, P278, DOI 10.1001/archinte.163.3.278; Gunawardana N, 2014, ANTIVIR RES, V102, P95, DOI 10.1016/j.antiviral.2013.12.006; HALPERIN SA, 1985, AM REV RESPIR DIS, V132, P976; Hayden FG, 2004, REV MED VIROL, V14, P17, DOI 10.1002/rmv.406; HENDLEY JO, 1972, J INFECT DIS, V125, P243, DOI 10.1093/infdis/125.3.243; Johnston SL, 2003, AM J RESP CRIT CARE, V168, P1145, DOI 10.1164/rccm.2309004; JOHNSTON SL, 1995, AM J RESP CRIT CARE, V152, pS46, DOI 10.1164/ajrccm/152.4_Pt_2.S46; Kling S, 2005, CLIN EXP ALLERGY, V35, P672, DOI 10.1111/j.1365-2222.2005.02244.x; Mallia P, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-116; Mallia P, 2014, RESP MED, V108, P78, DOI 10.1016/j.rmed.2013.09.010; Mallia P, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-72; Mallia P, 2011, AM J RESP CRIT CARE, V183, P734, DOI 10.1164/rccm.201006-0833OC; NICHOLSON KG, 1993, BRIT MED J, V307, P982, DOI 10.1136/bmj.307.6910.982; Rohde G, 2014, CLIN EXP ALLERGY, V44, P930, DOI 10.1111/cea.12313; THOMAS LH, 1994, J ALLERGY CLIN IMMUN, V94, P1255, DOI 10.1016/0091-6749(94)90340-9; TREANOR JJ, 1990, J CLIN MICROBIOL, V28, P596, DOI 10.1128/JCM.28.3.596-599.1990; TYRRELL DAJ, 1993, EPIDEMIOL INFECT, V111, P143, DOI 10.1017/S0950268800056764; Watson JM, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0240-5; Wright AKA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002622; Zhu J, 2014, CHEST, V145, P1219, DOI 10.1378/chest.13-1567	27	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166113	10.1371/journal.pone.0166113	http://dx.doi.org/10.1371/journal.pone.0166113			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936016	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100018
J	Hamad, HA; Thurston, J; Teague, T; Ackad, E; Yousef, MS				Hamad, Hamzah A.; Thurston, Jeremy; Teague, Thomas; Ackad, Edward; Yousef, Mohammad S.			The NS4A Cofactor Dependent Enhancement of HCV NS3 Protease Activity Correlates with a 4D Geometrical Measure of the Catalytic Triad Region	PLOS ONE			English	Article							HEPATITIS-C VIRUS; MOLECULAR-DYNAMICS SIMULATIONS; SWISS-MODEL; PEGYLATED INTERFERON; COMPLEX-FORMATION; IN-VITRO; INHIBITORS; PROTEINASE; RESISTANCE; ACTIVATION	We are developing a 4D computational methodology, based on 3D structure modeling and molecular dynamics simulation, to analyze the active site of HCV NS3 proteases, in relation to their catalytic activity. In our previous work, the 4D analyses of the interactions between the catalytic triad residues (His57, Asp81, and Ser139) yielded divergent, gradual and genotype -dependent, 4D conformational instability measures, which strongly correlate with the known disparate catalytic activities among genotypes. Here, the correlation of our 4D geometrical measure is extended to intra-genotypic alterations in NS3 protease activity, due to sequence variations in the NS4A activating cofactor. The correlation between the 4D measure and the enzymatic activity is qualitatively evident, which further validates our methodology, leading to the development of an accurate quantitative metric to predict protease activity in silico. The results suggest plausible "communication" pathways for conformational propagation from the activation subunit (the NS4A cofactor binding site) to the catalytic subunit (the catalytic triad). The results also strongly suggest that the well-sampled (via convergence quantification) structural dynamics are more connected to the divergent catalytic activity observed in HCV NS3 proteases than to rigid structures. The method could also be applicable to predict patients' responses to interferon therapy and better understand the innate interferon activation pathway.	[Hamad, Hamzah A.; Thurston, Jeremy; Teague, Thomas; Ackad, Edward; Yousef, Mohammad S.] Southern Illinois Univ Edwardsville, Coll Arts & Sci, Dept Phys, Edwardsville, IL 62026 USA; [Yousef, Mohammad S.] Cairo Univ, Dept Biophys, Fac Sci, Giza, Egypt	Southern Illinois University System; Southern Illinois University Edwardsville; Egyptian Knowledge Bank (EKB); Cairo University	Yousef, MS (corresponding author), Southern Illinois Univ Edwardsville, Coll Arts & Sci, Dept Phys, Edwardsville, IL 62026 USA.; Yousef, MS (corresponding author), Cairo Univ, Dept Biophys, Fac Sci, Giza, Egypt.	myousef@siue.edu	Ackad, Edward/AAD-1947-2021	Yousef, Mohammad/0000-0003-0492-7658	SIUE's URCA program; AFOSR [FA9550-14-1-0247]	SIUE's URCA program; AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	T. Teague, H. Hamad and J. Thurston were supported by SIUE's URCA program. E. Ackad is supported by AFOSR award No FA9550-14-1-0247.	Anjum S, 2013, J INFECT DIS, V208, P1888, DOI 10.1093/infdis/jit376; Anwar MI, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-351; Aparicio E, 2011, J VIROL, V85, P5961, DOI 10.1128/JVI.00308-11; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barbato G, 2000, EMBO J, V19, P1195, DOI 10.1093/emboj/19.6.1195; Barbato G, 1999, J MOL BIOL, V289, P371, DOI 10.1006/jmbi.1999.2745; BARTENSCHLAGER R, 1995, J VIROL, V69, P7519, DOI 10.1128/JVI.69.12.7519-7528.1995; Butkiewicz NJ, 1996, VIROLOGY, V225, P328, DOI 10.1006/viro.1996.0607; Cento V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039652; Cerny A, 1999, HEPATOLOGY, V30, P595, DOI 10.1002/hep.510300312; Chatel-Chaix L, 2010, VIRUSES-BASEL, V2, P1752, DOI 10.3390/v2081752; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Du GX, 2002, WORLD J GASTROENTERO, V8, P1088, DOI 10.3748/wjg.v8.i6.1088; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; FAILLA C, 1994, J VIROL, V68, P3753, DOI 10.1128/JVI.68.6.3753-3760.1994; Foster DV, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.010101; Franco S, 2008, VIRUS RES, V131, P260, DOI 10.1016/j.virusres.2007.10.003; Fried MW, 2013, HEPATOLOGY, V58, P1918, DOI 10.1002/hep.26641; Gottwein JM, 2011, GASTROENTEROLOGY, V141, P1067, DOI 10.1053/j.gastro.2011.06.004; Guan Y, 2015, MOL BIOSYST, V11, P2568, DOI 10.1039/c5mb00394f; Guan Y, 2014, ANTIVIR RES, V103, P60, DOI 10.1016/j.antiviral.2014.01.010; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Heintges T, 2001, J MED VIROL, V65, P671, DOI 10.1002/jmv.2089; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hospital A, 2012, BIOINFORMATICS, V28, P1278, DOI 10.1093/bioinformatics/bts139; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Imhof I, 2011, HEPATOLOGY, V53, P1090, DOI 10.1002/hep.24172; Khattab MA, 2011, J HEPATOL, V54, P1250, DOI 10.1016/j.jhep.2010.11.016; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Koch JO, 1996, VIROLOGY, V221, P54, DOI 10.1006/viro.1996.0352; Koukos PI, 2014, J CHEM INF MODEL, V54, P209, DOI 10.1021/ci4005817; Koukos PI, 2013, J COMPUT CHEM, V34, P2310, DOI 10.1002/jcc.23381; Kramer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104425; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Kwo PY, 2011, GUT LIVER, V5, P406, DOI 10.5009/gnl.2011.5.4.406; Lange OF, 2006, PROTEINS, V62, P1053, DOI 10.1002/prot.20784; Large MK, 1999, J IMMUNOL, V162, P931; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lauletta G, 2012, CLIN DEV IMMUNOL, V2012, P11; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; LIN C, 1994, J VIROL, V68, P8147, DOI 10.1128/JVI.68.12.8147-8157.1994; Lin C., 2006, HEPATITIS C VIRUSES; Lin C, 1995, J VIROL, P69; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Manos MM, 2012, J MED VIROL, V84, P1744, DOI 10.1002/jmv.23399; McCoy MA, 2001, J MOL BIOL, V305, P1099, DOI 10.1006/jmbi.2000.4365; Meeprasert A, 2014, J CHEM INF MODEL, V54, P1208, DOI 10.1021/ci400605a; Meller J, 2001, PROTEINS, V45, P241, DOI 10.1002/prot.1145; Miller FD, 2010, P NATL ACAD SCI USA, V107, P14757, DOI 10.1073/pnas.1008877107; Nagpal N, 2015, GENE, V570, P115, DOI 10.1016/j.gene.2015.06.008; Nevot M, 2014, J VIRAL HEPATITIS, V21, pE19, DOI 10.1111/jvh.12254; Nguyen Mindie H, 2005, Clin Liver Dis, V9, P411, DOI 10.1016/j.cld.2005.05.010; Nishiya AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086413; Ozen A, 2013, J CHEM THEORY COMPUT, V9, P5693, DOI 10.1021/ct400603p; Pearlman BL, 2012, LANCET INFECT DIS, V12, P717, DOI 10.1016/S1473-3099(12)70060-9; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Polavarapu P. L., 1998, VIBRATIONAL SPECTRA; Pontius J, 1996, J MOL BIOL, V264, P121, DOI 10.1006/jmbi.1996.0628; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rennebaum S, 2012, PROTEINS, V80, P1998, DOI 10.1002/prot.24088; Rimmert B, 2014, J BIOMOL STRUCT DYN, V32, P950, DOI 10.1080/07391102.2013.800001; Rong X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052467; Saleha Shamim, 2014, Hepat Res Treat, V2014, P165826, DOI 10.1155/2014/165826; SATOH S, 1995, J VIROL, V69, P4255, DOI 10.1128/JVI.69.7.4255-4260.1995; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shimizu Y, 1996, J VIROL, V70, P127, DOI 10.1128/JVI.70.1.127-132.1996; Soumana DI, 2016, ACS CHEM BIOL, V11, P900, DOI 10.1021/acschembio.5b00647; Steinkuhler C, 1996, J VIROL, V70, P6694; Tamori A, 2016, MEDIAT INFLAMM, V2016, P11; TANJI Y, 1995, J VIROL, V69, P1575, DOI 10.1128/JVI.69.3.1575-1581.1995; Tomei L, 1996, J GEN VIROL, V77, P1065, DOI 10.1099/0022-1317-77-5-1065; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wong MT, 2016, CELL MOL IMMUNOL, V13, P11, DOI 10.1038/cmi.2014.127; Yan YW, 1998, PROTEIN SCI, V7, P837	78	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168002	10.1371/journal.pone.0168002	http://dx.doi.org/10.1371/journal.pone.0168002			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936126	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100247
J	Kuriyama, A; Umakoshi, N; Fujinaga, J; Kaihara, T; Urushidani, S; Kuninaga, N; Ichikawa, M; Ienaga, S; Sasaki, A; Ikegami, T				Kuriyama, Akira; Umakoshi, Noriyuki; Fujinaga, Jun; Kaihara, Toshie; Urushidani, Seigo; Kuninaga, Naoki; Ichikawa, Motohiro; Ienaga, Shinichiro; Sasaki, Akira; Ikegami, Tetsunori			Impact of Attending Physicians' Comments on Residents' Workloads in the Emergency Department: Results from Two J PAN Randomized Controlled Trials	PLOS ONE			English	Article							FULL-MOON; FRIDAY; 13TH	Objective To examine whether peppy comments from attending physicians increased the workload of residents working in the emergency department (ED). Methods We conducted two parallel-group, assessor-blinded, randomized trials at the ED in a tertiary care hospital in western Japan. Twenty-five residents who examined either ambulatory (J (<^>o<^>) PAN-1 Trial) or transferred patients (J(<^>o<^>) PAN-2 Trial) in the ED on weekdays. Participants were randomly assigned to groups that either received a peppy message such as "Hope you have a quiet day!" (intervention group) or did not (control group) from the attending physicians. Both trials were conducted from June 2014 through March 2015. For each trial, residents rated the number of patients examined during and the busyness and difficulty of their shifts on a 5-point Likert scale. Results A total of 169 randomizations (intervention group, 81; control group, 88) were performed for the J(<^>o<^>) PAN-1 Trial, and 178 (intervention group, 85; control group, 93) for the J(<^>o<^>) PAN-2 Trial. In the J(<^>o<^>) PAN-1 trial, no differences were observed in the number of ambulatory patients examined during their shifts (5.5 and 5.7, respectively, p = 0.48), the busyness of their shifts (2.8 vs 2.8; p = 0.58), or the difficulty of their shifts (3.1 vs 3.1, p = 0.94). However, in the J(<^>o<^>) PAN-2 trial, although busyness (2.8 vs 2.7; p = 0.40) and difficulty (3.1 vs 3.2; p = 0.75) were similar between groups, the intervention group examined more transferred patients than the control group (4.4 vs 3.9; p = 0.01). Conclusions Peppy comments from attending physicians had a minimal jinxing effect on the workload of residents working in the ED.	[Kuriyama, Akira; Kuninaga, Naoki; Sasaki, Akira] Kurashiki Cent Hosp, Dept Gen Med, Kurashiki, Okayama, Japan; [Umakoshi, Noriyuki; Fujinaga, Jun; Kaihara, Toshie; Urushidani, Seigo; Ichikawa, Motohiro; Ienaga, Shinichiro; Ikegami, Tetsunori] Kurashiki Cent Hosp, Dept Emergency Med, Kurashiki, Okayama, Japan	Kurashiki Central Hospital; Kurashiki Central Hospital	Kuriyama, A (corresponding author), Kurashiki Cent Hosp, Dept Gen Med, Kurashiki, Okayama, Japan.	akira.kuriyama.jpn@gmail.com		Fujinaga, Jun/0000-0001-6222-7292				Ackermann Hans-W, 2012, Bacteriophage, V2, P122; Ahn A, 2002, AM J MED, V112, P504, DOI 10.1016/S0002-9343(01)01128-7; Berry Steve, 2012, JEMS, V37, P72; Chiang HY, 2010, NURS OUTLOOK, V58, P17, DOI 10.1016/j.outlook.2009.06.001; Exadaktylos AK, 2001, AM J EMERG MED, V19, P319, DOI 10.1053/ajem.2001.24488; Fujita S, 2013, BMC HLTH SERVICES RE, V13, P1472; Kim J, 2007, WESTERN J NURS RES, V29, P827, DOI 10.1177/0193945906297370; Lo BM, 2012, AM J EMERG MED, V30, P886, DOI 10.1016/j.ajem.2011.06.008; SCANLON TJ, 1993, BRIT MED J, V307, P1584, DOI 10.1136/bmj.307.6919.1584; Schuld J, 2011, WORLD J SURG, V35, P1945, DOI 10.1007/s00268-011-1166-8; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Tan MH, 2008, ANN ACAD MED SINGAP, V37, P255; TANZ RR, 1993, AM J DIS CHILD, V147, P579, DOI 10.1001/archpedi.1993.02160290085032; Thompson DA, 1996, AM J EMERG MED, V14, P161, DOI 10.1016/S0735-6757(96)90124-2; Walling HW, 2004, ANN INTERN MED, V140, P847, DOI 10.7326/0003-4819-140-10-200405180-00031	15	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167480	10.1371/journal.pone.0167480	http://dx.doi.org/10.1371/journal.pone.0167480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936189	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100107
J	Navas, J; Fernandez-Martinez, M; Salas, C; Cano, ME; Martinez-Martinez, L				Navas, Jesus; Fernandez-Martinez, Marta; Salas, Carlos; Cano, Maria Eliecer; Martinez-Martinez, Luis			Susceptibility to Aminoglycosides and Distribution of aph and aac(3)-XI Genes among Corynebacterium striatum Clinical Isolates	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; NOSOCOMIAL PATHOGEN; LIFE-STYLE; BACTERIA; STRAINS; PATIENT; SAMPLES	Corynebacterium striatum is an opportunistic pathogen, often multidrug-resistant, which has been associated with serious infections in humans. Aminoglycosides are second-line or complementary antibiotics used for the treatment of Corynebacterium infections. We investigated the susceptibility to six aminoglycosides and the molecular mechanisms involved in aminoglycoside resistance in a collection of 64 Corynebacterium striatum isolated in our laboratory during the period 2005-2009. Antimicrobial susceptibility was determined using E-test. The mechanisms of aminoglycoside resistance were investigated by PCR and sequencing. The 64 C. striatum were assessed for the possibility of clonal spreading by Pulsed-field Gel Electrophoresis (PFGE). Netilmicin and amikacin were active against the 64 C. striatum isolates (MICs90 = 0.38 and 0.5 mg/L, respectively). Twenty-seven of the 64 C. striatum strains showed a MIC90 for kanamycin > 256 mg/L, and 26 out the 27 were positive for the aph(3')-Ic gene. Thirty-six out of our 64 C. striatum were streptomycin resistant, and 23 out of the 36 carried both the aph(3 '')-Ib and aph(6)-Id genes. The gene aac(3)-XI encoding a new aminoglycoside 3-N acetyl transferase from C. striatum was present in 44 out of the 64 isolates, all of them showing MICs of gentamicin and tobramycin > 1 mg/L. CS4933, a C. striatum showing very low susceptibility to kanamycin and streptomycin, contains an aminoglycoside resistance region that includes the aph(3')-Ic gene, and the tandem of genes aph(3 '')-Ib and aph(6)-Id. Forty-six major PFGE types were identified among the 64 C. striatum isolates, indicating that they were mainly not clonal. Our results showed that the 64 clinical C. striatum were highly resistant to aminoglycosides and mostly unrelated.	[Navas, Jesus; Martinez-Martinez, Luis] Univ Cantabria, Dept Mol Biol, Fac Med, Herrera Oria S-N, Santander, Spain; [Fernandez-Martinez, Marta; Salas, Carlos; Cano, Maria Eliecer; Martinez-Martinez, Luis] Hosp Univ Marques Valdecilla IDIVAL, Microbiol Serv, Avda Valdecilla S-N, Santander, Spain	Universidad de Cantabria; Hospital Universitario Marques de Valdecilla (HUMV)	Navas, J (corresponding author), Univ Cantabria, Dept Mol Biol, Fac Med, Herrera Oria S-N, Santander, Spain.	navasj@unican.es	Martínez, Luis Martínez/U-1801-2017	Martínez, Luis Martínez/0000-0002-6091-4045; FERNANDEZ-MARTINEZ, MARTA/0000-0002-1748-4481	Ministerio de Economia y Competitividad, Institute de Salud Carlos III; European Development Regional Fund "A way to achieve Europe"; Spanish Network for the Research in Infectious Diseases [REIPI RD12/0015]; BBSRC [BBS/E/D/20310000] Funding Source: UKRI	Ministerio de Economia y Competitividad, Institute de Salud Carlos III; European Development Regional Fund "A way to achieve Europe"; Spanish Network for the Research in Infectious Diseases; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Support was provided by the Ministerio de Economia y Competitividad, Institute de Salud Carlos III (co-financed by European Development Regional Fund "A way to achieve Europe") and the Spanish Network for the Research in Infectious Diseases (REIPI RD12/0015).	Bernard K, 2012, J CLIN MICROBIOL, V50, P3152, DOI 10.1128/JCM.00796-12; Brandenburg AH, 1996, J CLIN MICROBIOL, V34, P2089, DOI 10.1128/JCM.34.9.2089-2094.1996; Campanile F, 2009, EMERG INFECT DIS, V15, P75, DOI 10.3201/eid1501.080804; Clinical and Laboratoy Standars Institute, 2015, M45ED3 CLIN LAB STAN; European Committee on Antimicrobial Susceptibility Testing, 2016, BREAKP TABL INT MICS; Guerrero MLF, 2013, J HEART VALVE DIS, V22, P428; Galimand M, 2015, ANTIMICROB AGENTS CH, V59, P5647, DOI 10.1128/AAC.01203-15; Gomez-Garces JL, 2007, INT J ANTIMICROB AG, V29, P688, DOI 10.1016/j.ijantimicag.2006.11.032; Lee PP, 2005, J INFECTION, V50, P338, DOI 10.1016/j.jinf.2004.05.005; LEONARD RB, 1994, J CLIN MICROBIOL, V32, P164, DOI 10.1128/JCM.32.1.164-169.1994; Martinez-Martinez L., 1997, Clin Microbiol Infect, V3, P634, DOI 10.1111/j.1469-0691.1997.tb00470.x; MARTINEZMARTINEZ L, 1995, J CLIN MICROBIOL, V33, P2458; Marull J, 2008, CASES J, V1, P388; Otsuka Y, 2006, DIAGN MICR INFEC DIS, V54, P109, DOI 10.1016/j.diagmicrobio.2005.08.005; Ramirez MS, 2010, DRUG RESIST UPDATE, V13, P151, DOI 10.1016/j.drup.2010.08.003; RUFAEL DW, 1994, CLIN INFECT DIS, V19, P1054, DOI 10.1093/clinids/19.6.1054; Schroder J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-141; Tauch A, 2000, MOL GEN GENET, V263, P1, DOI 10.1007/PL00008668; Tauch A, 2008, J BIOTECHNOL, V136, P11, DOI 10.1016/j.jbiotec.2008.02.009	19	15	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167856	10.1371/journal.pone.0167856	http://dx.doi.org/10.1371/journal.pone.0167856			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936101	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100217
J	Pimenta, AFR; Serro, AP; Paradiso, P; Saramago, B; Colaco, R				Pimenta, Andreia F. R.; Serro, Ana Paula; Paradiso, Patrizia; Saramago, Benilde; Colaco, Rogerio			Diffusion-Based Design of Multi-Layered Ophthalmic Lenses for Controlled Drug Release	PLOS ONE			English	Article							HYDROGEL CONTACT-LENSES; IN-VITRO; HEMA HYDROGEL; DELIVERY; CIPROFLOXACIN; FORMULATIONS; PERFORMANCE	The study of ocular drug delivery systems has been one of the most covered topics in drug delivery research. One potential drug carrier solution is the use of materials that are already commercially available in ophthalmic lenses for the correction of refractive errors. In this study, we present a diffusion-based mathematical model in which the parameters can be adjusted based on experimental results obtained under controlled conditions. The model allows for the design of multi-layered therapeutic ophthalmic lenses for controlled drug delivery. We show that the proper combination of materials with adequate drug diffusion coefficients, thicknesses and interfacial transport characteristics allows for the control of the delivery of drugs from multi-layered ophthalmic lenses, such that drug bursts can be minimized, and the release time can be maximized. As far as we know, this combination of a mathematical modelling approach with experimental validation of non-constant activity source lamellar structures, made of layers of different materials, accounting for the interface resistance to the drug diffusion, is a novel approach to the design of drug loaded multi-layered contact lenses.	[Pimenta, Andreia F. R.; Paradiso, Patrizia; Colaco, Rogerio] Univ Lisbon, Inst Super Tecn, Dept Mech Engn, Lisbon, Portugal; [Pimenta, Andreia F. R.; Paradiso, Patrizia; Colaco, Rogerio] Univ Lisbon, Inst Super Tecn, IDMEC, Lisbon, Portugal; [Pimenta, Andreia F. R.; Serro, Ana Paula; Paradiso, Patrizia; Saramago, Benilde] Univ Lisbon, Inst Super Tecn, Ctr Qum Estrutural, Lisbon, Portugal; [Serro, Ana Paula] Inst Super Ciencias Saude Egas Moniz, CIIEM, Caparica, Portugal	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico; Instituto Superior de Ciencias da Saude Egas Moniz	Colaco, R (corresponding author), Univ Lisbon, Inst Super Tecn, Dept Mech Engn, Lisbon, Portugal.; Colaco, R (corresponding author), Univ Lisbon, Inst Super Tecn, IDMEC, Lisbon, Portugal.	rogerio.colaco@tecnico.ulisboa.pt	Paradiso, Patrizia/L-7231-2019; Saramago, Benilde/A-4882-2012; Colaco, Rogerio/B-5432-2013; Serro, Ana/H-7797-2012	Paradiso, Patrizia/0000-0003-2531-8499; Saramago, Benilde/0000-0002-8968-4781; Colaco, Rogerio/0000-0001-7374-6741; Pimenta, Andreia/0000-0002-9990-4581; Colaco, Rogerio/0000-0002-5529-1621; Serro, Ana/0000-0002-6179-9296	Fundacao para a Ciencia e a Tecnologia [SFRH/BD/52334/2013, SFRH/BD/71990/2010, PEstOE/QUI/UI0100/2013, M-ERA.NET/0005/2012]; Fundação para a Ciência e a Tecnologia [M-ERA.NET/0005/2012, PEst-OE/QUI/UI0100/2013] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This study was supported by Fundacao para a Ciencia e a Tecnologia for A. Pimenta and P. Paradiso PhD grants (SFRH/BD/52334/2013 and SFRH/BD/71990/2010) and for funding through the projects PEstOE/QUI/UI0100/2013 and M-ERA.NET/0005/2012.	Ali M, 2008, EXPERT REV CLIN PHAR, V1, P145, DOI 10.1586/17512433.1.1.145; Ali M, 2007, J CONTROL RELEASE, V124, P154, DOI 10.1016/j.jconrel.2007.09.006; Anderson EM, 2009, BIOMATERIALS, V30, P5675, DOI 10.1016/j.biomaterials.2009.06.047; Ciolino JB, 2014, BIOMATERIALS, V35, P432, DOI 10.1016/j.biomaterials.2013.09.032; Ciolino JB, 2009, INVEST OPHTH VIS SCI, V50, P3346, DOI 10.1167/iovs.08-2826; Galante R, 2015, J BIOMAT SCI-POLYM E, V26, P235, DOI 10.1080/09205063.2014.994948; Goel M, 2010, OPEN OPHTHALMOL J, V4, P52, DOI 10.2174/1874364101004010052; Gulsen D, 2005, INT J PHARMACEUT, V292, P95, DOI 10.1016/j.ijpharm.2004.11.033; Hiratani H, 2004, BIOMATERIALS, V25, P1105, DOI 10.1016/S0142-9612(03)00622-7; Hui A, 2014, INVEST OPHTH VIS SCI, V55, P4896, DOI 10.1167/iovs.14-14855; Karlgard CCS, 2003, INT J PHARM, V257, P141, DOI 10.1016/S0378-5173(03)00124-8; Kleinmann G, 2006, J CATARACT REFR SURG, V32, P1717, DOI 10.1016/j.jcrs.2006.04.033; Kowalski RP, 2003, AM J OPHTHALMOL, V136, P500, DOI 10.1016/S0002-9394(03)00294-0; Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004; Packer M, 2011, J CATARACT REFR SURG, V37, P1699, DOI 10.1016/j.jcrs.2011.06.018; Paradiso P, 2014, J BIOMED MATER RES B, V102, P1170, DOI 10.1002/jbm.b.33099; Paradiso P, 2014, J BIOMED MATER RES B, V2010, P1; Peng CC, 2010, BIOMATERIALS, V31, P4032, DOI 10.1016/j.biomaterials.2010.01.113; PEPPAS NA, 1993, ADV DRUG DELIVER REV, V11, P1, DOI 10.1016/0169-409X(93)90025-Y; Siepmann J, 2012, J CONTROL RELEASE, V161, P351, DOI 10.1016/j.jconrel.2011.10.006; Urtti A, 2006, ADV DRUG DELIVER REV, V58, P1131, DOI 10.1016/j.addr.2006.07.027; Xinming Li, 2008, Cont Lens Anterior Eye, V31, P57, DOI 10.1016/j.clae.2007.09.002	22	9	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167728	10.1371/journal.pone.0167728	http://dx.doi.org/10.1371/journal.pone.0167728			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936138	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100165
J	Rantala, AK; Mehtonen, IT; Jaakkola, MS; Nayha, S; Hugg, TT; Jaakkola, JJK				Rantala, Aino K.; Mehtonen, Ilkka T.; Jaakkola, Maritta S.; Nayha, Simo; Hugg, Timo T.; Jaakkola, Jouni J. K.			Early Respiratory Infections and Dental Caries in the First 27 Years of Life: A Population-Based Cohort Study	PLOS ONE			English	Article							HOSPITAL DISCHARGE REGISTER; RISK-FACTORS; PREVALENCE; ENAMEL; ASTHMA; DETERMINANTS; ASSOCIATION; OPACITIES; VALIDITY; DEFECTS	Early-life respiratory tract infections (RTIs) and dental caries are among the most common infectious diseases worldwide. The relations between early RTIs and development of caries in permanent teeth have not been studied earlier. We assessed childhood RTIs as potential predictors of caries in young adulthood in a 20-year prospective population-based cohort study (The Espoo Cohort Study). Information on lower respiratory tract infections (LRTIs) that had required hospitalization was retrieved from the National Hospital Discharge Registry (n = 1623). Additional information on LRTIs and upper RTIs (URTIs) was assessed based on the questionnaire reports that covered the preceding 12 months. Caries was measured as the number of teeth with fillings (i.e. filled teeth, FT) reported in the 20-year follow-up questionnaire. The absolute and relative excess numbers of FT were estimated applying negative binomial regression. The mean number of FT in young adulthood was 1.4 greater among subjects who had experienced LRTIs requiring hospitalization before the age of 2 years (SD 4.8) compared to those without any such infections (SD 3.4), and the adjusted relative excess number of FT was 1.5 (95% CI 1.0-2.2). LRTIs up to 7 years were associated with an absolute increase of 0.9 in the mean FT number, the adjusted relative excess being 1.3 (1.0-1.8). Also the questionnaire- based LRTIs (adjusted relative excess 1.3; 95% CI 0.9-1.8) and URTIs (adjusted relative excess 1.4, 1.0-1.8) before the age of 2 years predicted higher occurrence of FT. Findings suggest that early RTIs have a role in the development of dental caries in permanent teeth.	[Jaakkola, Jouni J. K.] Univ Oulu, Ctr Environm & Resp Hlth Res, Oulu, Finland; Med Res Ctr Oulu, Oulu, Finland	University of Oulu	Jaakkola, JJK (corresponding author), Univ Oulu, Ctr Environm & Resp Hlth Res, Oulu, Finland.	jouni.jaakkola@oulu.fi	Hugg, Timo/P-5531-2018; Jaakkola, Jouni J.K./G-4314-2012; Rantala, Aino/AAZ-7578-2020	Rantala, Aino/0000-0002-4845-076X; Jaakkola, Jouni/0000-0003-4168-4683; Hugg, Timo/0000-0003-2558-1780; Jaakkola, Maritta S./0000-0003-1373-7784	Academy of Finland [129419, 138691, 266314]; Finnish Lung Health Association	Academy of Finland(Academy of Finland); Finnish Lung Health Association	This study was funded by the Academy of Finland [grant number 129419 of Responding to Public Health Challenges (SALVE) research program and grant numbers 138691 and 266314], and the Finnish Lung Health Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaki SM, 2008, PEDIATR DENT, V30, P105; Alavaikko S, 2011, AM J EPIDEMIOL, V174, P631, DOI 10.1093/aje/kwr129; Alm A, 2012, COMMUNITY DENT ORAL, V40, P125, DOI 10.1111/j.1600-0528.2011.00647.x; American Dental Association, CAR RISK ASS MAN; Arnadottir IB, 2005, COMMUNITY DENT HLTH, V22, P279; Arrow P, 2009, COMMUNITY DENT ORAL, V37, P405, DOI 10.1111/j.1600-0528.2009.00480.x; Balakrishnan M, 2000, AUST DENT J, V45, P235, DOI 10.1111/j.1834-7819.2000.tb00257.x; Chonmaitree T, 2008, CLIN INFECT DIS, V46, P815, DOI 10.1086/528685; Clark MB, 2014, PEDIATRICS, V134, P626, DOI 10.1542/peds.2014-1699; Ditmyer M, 2010, BMC ORAL HEALTH, V10, DOI 10.1186/1472-6831-10-24; Dye Bruce A, 2015, NCHS Data Brief, P1; Jaakkola JJK, 2005, ENVIRON HEALTH PERSP, V113, P357, DOI 10.1289/ehp.7242; JAAKKOLA JJK, 1993, J EXPO ANAL ENV EPID, V3, P129; Jaakkola JJK, 2010, AM J EPIDEMIOL, V172, P451, DOI 10.1093/aje/kwq110; Jalevik B, 2000, Int J Paediatr Dent, V10, P278, DOI 10.1046/j.1365-263x.2000.00210.x; Jalevik B, 2001, EUR J ORAL SCI, V109, P230, DOI 10.1034/j.1600-0722.2001.00047.x; Koskinen S, 2012, 682012 NAT I HLTH WE; Kumar S, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-41; Laisi S, 2009, J DENT RES, V88, P132, DOI 10.1177/0022034508328334; LOUHIALA PJ, 1995, AM J PUBLIC HEALTH, V85, P1109, DOI 10.2105/AJPH.85.8_Pt_1.1109; Mahonen M, 1997, EUR J EPIDEMIOL, V13, P403, DOI 10.1023/A:1007306110822; Metwalli KH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003616; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Nelson Suchitra, 2005, Oral Health Prev Dent, V3, P165; Ollila P, 1997, ACTA ODONTOL SCAND, V55, P9, DOI 10.3109/00016359709091933; Pajunen P, 2005, EUR J CARDIOV PREV R, V12, P132, DOI 10.1097/00149831-200504000-00007; PARVINEN T, 1981, J DENT RES, V60, P1929, DOI 10.1177/00220345810600120201; Phipps Kathy R, 2010, J Evid Based Dent Pract, V10, P112, DOI 10.1016/j.jebdp.2010.02.015; Pitiphat W, 2002, J PUBLIC HEALTH DENT, V62, P122, DOI 10.1111/j.1752-7325.2002.tb03432.x; Rantala AK, 2015, AM J EPIDEMIOL, V182, P615, DOI 10.1093/aje/kwv093; Rothman K., 2012, EPIDEMIOLOGY INTRO; Saraiva MCD, 2007, COMMUNITY DENT ORAL, V35, P364, DOI 10.1111/j.1600-0528.2006.00345.x; Schwendicke F, 2015, J DENT RES, V94, P10, DOI 10.1177/0022034514557546; Simonsen RJ, 2011, AUST DENT J, V56, P45, DOI 10.1111/j.1834-7819.2010.01295.x; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; Tanner T, 2013, ACTA ODONTOL SCAND, V71, P1436, DOI 10.3109/00016357.2013.767932; Tanzer J M, 2001, J Dent Educ, V65, P1028; Vargas-Ferreira F, 2015, J DENT, V43, P619, DOI 10.1016/j.jdent.2015.03.011; William V, 2006, PEDIATR DENT, V28, P224	39	2	2	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168141	10.1371/journal.pone.0168141	http://dx.doi.org/10.1371/journal.pone.0168141			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936203	gold, Green Submitted, Green Published			2022-12-27	WOS:000389587100275
J	Shatrova, AN; Mityushova, EV; Vassilieva, IO; Aksenov, ND; Zenin, VV; Nikolsky, NN; Marakhova, II				Shatrova, Alla N.; Mityushova, Elena V.; Vassilieva, Irina O.; Aksenov, Nikolay D.; Zenin, Valery V.; Nikolsky, Nikolay N.; Marakhova, Irina I.			Time-Dependent Regulation of IL-2R alpha-Chain (CD25) Expression by TCR Signal Strength and IL-2-Induced STAT5 Signaling in Activated Human Blood T Lymphocytes	PLOS ONE			English	Article							CELL ANTIGEN RECEPTOR; JANUS KINASE 3; CYTOPLASMIC DOMAINS; BETA-CHAIN; INTERLEUKIN-2; PROGRESSION; INHIBITORS; INDUCTION; GAMMA(C); COMPLEX	The expression of the IL-2R alpha-chain (IL-2R alpha) is regulated at the transcriptional level via TCR- and IL-2R-signaling. The question is how to precede in time the activation signals to induce the IL-2R alpha expression in native primary T cells. By comparing the effects of selective drugs on the dynamics of CD25 expression during the mitogen stimulation of human peripheral blood lymphocytes, we identified distinct Src- and JAK-dependent stages of IL-2R alpha upregulation. PP2, a selective inhibitor of TCR-associated Src kinase, prevents CD25 expression at initial stages of T cell activation, prior to the cell growth. This early IL-2R alpha upregulation underlies the T cell competence and the IL-2 responsiveness. We found that the activated with "weak" mitogen, the population of blood lymphocytes has some pool of competent CD25+ cells bearing a high affinity IL-2R. A distinct pattern of IL-2R signaling in resting and competent T lymphocytes has been shown. Based on the inhibitory effect of WHI-P131, a selective drug of JAK3 kinase activity, we concluded that in quiescent primary T lymphocytes, the constitutive STAT3 and the IL-2-induced prolonged STAT5 activity (assayed by tyrosine phosphorylation) is mostly JAK3-independent. In competent T cells, in the presence of IL-2 JAK3/STAT5 pathway is switched to maintain the higher and sustained IL-2R alpha expression as well as cell growth and proliferation. We believe that understanding the temporal coordination of antigen-and cytokine-evoked signals in primary T cells may be useful for improving immunotherapeutic strategies.	[Shatrova, Alla N.; Mityushova, Elena V.; Vassilieva, Irina O.; Aksenov, Nikolay D.; Zenin, Valery V.; Nikolsky, Nikolay N.; Marakhova, Irina I.] Russian Acad Sci, Inst Cytol, Dept Intracellular Signaling & Transport, St Petersburg, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Marakhova, II (corresponding author), Russian Acad Sci, Inst Cytol, Dept Intracellular Signaling & Transport, St Petersburg, Russia.	iim@incras.ru	Shatrova, Alla/R-8042-2016; Vassilieva, Irina/F-3011-2017; Zenin, Valery/AAE-9303-2021; Aksenov, Nikolay D/F-1679-2017; Nikolsky, Nikolay/AAB-5657-2021	Vassilieva, Irina/0000-0002-0423-8118; Nikolsky, Nikolay/0000-0001-9914-874X	Molecular and Cell Biology Program of the Russian Academy of Sciences; Russian Science Foundation; Federal Agency of Scientific Organizations (Russia) [14-50-00068]	Molecular and Cell Biology Program of the Russian Academy of Sciences(Russian Academy of Sciences); Russian Science Foundation(Russian Science Foundation (RSF)); Federal Agency of Scientific Organizations (Russia)	This work was supported by the Molecular and Cell Biology Program of the Russian Academy of Sciences, NNN; the Russian Science Foundation with the financial support from the Federal Agency of Scientific Organizations (Russia),(project n. 14-50-00068, NNN.	Bani L, 1997, INT IMMUNOL, V9, P573, DOI 10.1093/intimm/9.4.573; Berridge MJ, 1997, CRIT REV IMMUNOL, V17, P155, DOI 10.1615/CritRevImmunol.v17.i2.30; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chueh FY, 2012, BIOCHEM BIOPH RES CO, V426, P242, DOI 10.1016/j.bbrc.2012.08.074; Ellery JM, 2002, IMMUNOL CELL BIOL, V80, P351, DOI 10.1046/j.1440-1711.2002.01097.x; Ellery JM, 2002, CYTOKINE GROWTH F R, V13, P27, DOI 10.1016/S1359-6101(01)00023-5; Ellery JM, 2000, CELL SIGNAL, V12, P367, DOI 10.1016/S0898-6568(00)00085-1; Frank DA., 2012, JAK STAT, V1, P1; Gorentla Balachandra K, 2012, J Clin Cell Immunol, V2012, P5; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hilbrands R, 2013, IMMUNOTHERAPY-UK, V5, P717, DOI 10.2217/imt.13.69; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Imbert V, 2002, EUR CYTOKINE NETW, V13, P331; Imbert V, 1999, EUR CYTOKINE NETW, V10, P71; Karitskaya I, 2010, PFLUG ARCH EUR J PHY, V460, P777, DOI 10.1007/s00424-010-0843-z; Kim HP, 2002, EMBO J, V21, P3051, DOI 10.1093/emboj/cdf321; KIM HPJ, 2006, CYTOKINE GROWTH F R, V17, P350; KUMAGAI N, 1988, J CELL PHYSIOL, V137, P329, DOI 10.1002/jcp.1041370217; Leonard WJ, 2000, J ALLERGY CLIN IMMUN, V105, P877, DOI 10.1067/mai.2000.106899; Leonard WJ, 1996, ANNU REV MED, V47, P229; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; Leonard WJ, 2001, INT J HEMATOL, V73, P271, DOI 10.1007/BF02981951; Leonard WJ, 1999, COLD SPRING HARB SYM, V64, P417, DOI 10.1101/sqb.1999.64.417; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Marakhova I, 2005, FEBS LETT, V579, P2773, DOI 10.1016/j.febslet.2005.03.096; Marakhova II, 1998, BBA-BIOMEMBRANES, V1368, P61, DOI 10.1016/S0005-2736(97)00164-8; Mayack SR, 2006, J IMMUNOL, V176, P2059, DOI 10.4049/jimmunol.176.4.2059; Moriggl R, 1999, IMMUNITY, V11, P225, DOI 10.1016/S1074-7613(00)80097-7; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Nakajima H, 1997, IMMUNITY, V7, P691, DOI 10.1016/S1074-7613(00)80389-1; NAKAMURA Y, 1994, NATURE, V369, P330, DOI 10.1038/369330a0; Nel AE, 2002, J ALLERGY CLIN IMMUN, V109, P758, DOI 10.1067/mai.2002.124259; NELSON BH, 1994, NATURE, V369, P333, DOI 10.1038/369333a0; PROUST JJ, 1991, EUR J IMMUNOL, V21, P335, DOI 10.1002/eji.1830210214; Rapecki S, 2002, J PHARMACOL EXP THER, V303, P1325, DOI 10.1124/jpet.102.038380; ROBB RJ, 1987, P NATL ACAD SCI USA, V84, P2002, DOI 10.1073/pnas.84.7.2002; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Shatrova A N, 2011, Tsitologiia, V53, P652; Shi M, 2009, J IMMUNOL, V183, P4493, DOI 10.4049/jimmunol.0804339; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sudbeck EA, 1999, CLIN CANCER RES, V5, P1569; Suzuki K, 2000, INT IMMUNOL, V12, P123, DOI 10.1093/intimm/12.2.123; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; WEISS A, 1986, ANNU REV IMMUNOL, V4, P593, DOI 10.1146/annurev.iy.04.040186.003113; Zenin V V, 2011, Tsitologiia, V53, P645	48	31	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167215	10.1371/journal.pone.0167215	http://dx.doi.org/10.1371/journal.pone.0167215			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936140	gold, Green Submitted, Green Published			2022-12-27	WOS:000389587100073
J	Yin, HD; Han, BM; Li, DW; Wu, JJ; Sun, HJ				Yin, Haodong; Han, Baoming; Li, Dewei; Wu, Jianjun; Sun, Huijun			Modeling and Simulating Passenger Behavior for a Station Closure in a Rail Transit Network	PLOS ONE			English	Article							DESIGN PROBLEM; DISRUPTIONS; MANAGEMENT; RECOVERY	A station closure is an abnormal operational situation in which the entrances or exits of a rail transit station have to be closed for some time due to an unexpected incident. A novel approach is developed to estimate the impacts of the alternative station closure scenarios on both passenger behavioral choices at the individual level and passenger demand at the disaggregate level in a rail transit network. Therefore, the contributions of this study are twofold: (1) A basic passenger behavior optimization model is mathematically constructed based on 0-1 integer programming to describe passengers' responses to alternative origin station closure scenarios and destination station closure scenarios; this model also considers the availability of multi-mode transportation and the uncertain duration of the station closure; (2) An integrated solution algorithm based on the passenger simulation is developed to solve the proposed model and to estimate the effects of a station closure on passenger demand in a rail transit network. Furthermore, 13 groups of numerical experiments based on the Beijing rail transit network are performed as case studies with 2,074,267 records of smart card data. The comparisons of the model outputs and the manual survey show that the accuracy of our proposed behavior optimization model is approximately 80%. The results also show that our model can be used to capture the passenger behavior and to quantitatively estimate the effects of alternative closure scenarios on passenger flow demand for the rail transit network. Moreover, the closure duration and its overestimation greatly influence the individual behavioral choices of the affected passengers and the passenger demand. Furthermore, if the rail transit operator can more accurately estimate the closure duration (namely, as g approaches 1), the impact of the closure can be somewhat mitigated.	[Yin, Haodong; Han, Baoming; Wu, Jianjun; Sun, Huijun] Beijing Jiaotong Univ, State Key Lab Rail Traff Control & Safety, Beijing, Peoples R China; [Yin, Haodong; Han, Baoming; Li, Dewei] Beijing Jiaotong Univ, Sch Traff & Transportat, Beijing, Peoples R China	Beijing Jiaotong University; Beijing Jiaotong University	Li, DW (corresponding author), Beijing Jiaotong Univ, Sch Traff & Transportat, Beijing, Peoples R China.	dwli.bjtu@163.com		Yin, Haodong/0000-0001-6653-6789	National Natural Science Foundation of China [U1434207]; China National Funds for Distinguished Young Scientists [71525002]; Beijing Municipal Natural Science Foundation [8162033]; NSFC [71621001]; Research Foundation of State Key Laboratory of Rail Traffic Control and Safety [RCS2016ZT001]; Fundamental Research Funds for the Central Universities [2016JBM030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National Funds for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); NSFC(National Natural Science Foundation of China (NSFC)); Research Foundation of State Key Laboratory of Rail Traffic Control and Safety; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China (U1434207, http://www.nsfc.gov.cn/), BH; China National Funds for Distinguished Young Scientists (71525002, http://www.nsfc.gov.cn/), JW; and Beijing Municipal Natural Science Foundation (8162033, http://www.bjnsf.org/), BH.; This work was supported by the "China National Funds for Distinguished Young Scientists" (71525002), NSFC (71621001), "Research Foundation of State Key Laboratory of Rail Traffic Control and Safety" (RCS2016ZT001), the "Beijing Municipal Natural Science Foundation" (8162033), and the "Fundamental Research Funds for the Central Universities" (2016JBM030).	Ahmed SH, 2016, IEEE T VEH TECHNOL, V65, P3954, DOI 10.1109/TVT.2016.2558650; Batty M, 2001, ENVIRON PLANN B, V28, P321, DOI 10.1068/b2803ed; Bin Othman N, 2015, J COMPUT SCI-NETH, V10, P338, DOI 10.1016/j.jocs.2015.03.006; Blanco J.I., 2014, SIMULATION TECHNOLOG, P547; Bouman P, 2012, ATT2012, P113; Bouman P, 2013, IEEE INT C INTELL TR, P1047, DOI 10.1109/ITSC.2013.6728370; Cadarso L, 2014, PROCD SOC BEHV, V111, P528, DOI 10.1016/j.sbspro.2014.01.086; Cadarso L, 2013, TRANSPORT RES E-LOG, V53, P15, DOI 10.1016/j.tre.2013.01.013; Cats O., 2011, THESIS; Cats O, 2012, TRANSPORT RES REC, P100, DOI 10.3141/2274-11; Cats O, 2010, TRANSPORT RES REC, P9, DOI 10.3141/2188-02; Houbing Song CB., 2016, CYBER PHYS SYSTEMS F; Huang L, 2016, EURASIP J BIOINFORM, DOI 10.1186/s13637-016-0040-2; Kusakabe T, 2014, TRANSPORT RES C-EMER, V46, P179, DOI 10.1016/j.trc.2014.05.012; Li WJ, 2016, IEEE T INTELL TRANSP, V17, P960, DOI 10.1109/TITS.2015.2494017; Lin Y., 2006, IEEE PERVAS COMPUT, V4, P65; Liu HX, 2015, TRANSPORT RES B-METH, V72, P20, DOI 10.1016/j.trb.2014.10.009; Mehmood A, 2015, AD HOC SENS WIREL NE, V28, P1; NIELSEN LE, 2011, THESIS; Nuzzolo A, 2012, TRANSPORT RES C-EMER, V20, P16, DOI 10.1016/j.trc.2011.02.007; Passenger Focus, 2011, INF RAIL PASS NEEDS; Pelletier MP, 2011, TRANSPORT RES C-EMER, V19, P557, DOI 10.1016/j.trc.2010.12.003; Shojafar Mohammad, 2013, Journal of Computing Science and Engineering, V7, P44, DOI 10.5626/JCSE.2013.7.1.44; Shojafar M, 2019, IEEE T CLOUD COMPUT, V7, P196, DOI 10.1109/TCC.2016.2551747; Silva R, 2015, P NATL ACAD SCI USA, V112, P5643, DOI 10.1073/pnas.1412908112; Song H, 2009, TRANSP RES BOARD 88; Song H, 2006, DEV CALIBRATION ANIS; Tsuchiya R, 2006, WIT TRANS BUILT ENV, V88, P189, DOI 10.2495/CR060191; van der Hurk E., 2015, PASSENGERS INFORM DI; Wang DZW, 2015, TRANSPORT RES E-LOG, V79, P213, DOI 10.1016/j.tre.2015.04.005; Yin HD, 2011, ADV INTEL SOFT COMPU, V124, P689; Zhao W., 2013, THESIS; Zhou WT, 2014, APPL MECH MATER, V505-506, P689, DOI 10.4028/www.scientific.net/AMM.505-506.689; Zong F, 2009, J TRANSP SYST ENG IN, P114	34	5	6	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167126	10.1371/journal.pone.0167126	http://dx.doi.org/10.1371/journal.pone.0167126			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935963	gold, Green Published			2022-12-27	WOS:000389587100065
J	Zhang, XG; Ding, FS; Li, HN; Zhao, WF; Jing, H; Yan, YG; Chen, YP				Zhang, Xuguang; Ding, Fengshu; Li, Huaining; Zhao, Wenfeng; Jing, Hong; Yan, Yageng; Chen, Yanping			Low Serum Levels of Vitamins A, D, and E Are Associated with Recurrent Respiratory Tract Infections in Children Living in Northern China: A Case Control Study	PLOS ONE			English	Article							RETINOIC ACID; EXPRESSION; IMMUNITY; MUCIN	Background This study aimed to investigate the association of serum concentrations of vitamin A, D, and E with recurrent respiratory tract infections (RRTIs). Methods A total of 1200 children aged at 0.5-14 years were selected via a face-to-face survey in Harbin, China. Among the participants, 600 children with RRTIs comprised the symptomatic group (RRTI group), whereas 600 healthy children were used as controls (control group). Blood samples were collected to measure serum levels of vitamins A and E by HPLC; the serum level of 25-hydroxycholecalciferol (25(OH) D), was measured by HPLC-MS/MS. Results Serum levels of vitamins A and E, as well as 25(OH) D, were significantly lower in the RRTI group than the control group. The conditional logistic regression model and the receiver-operating characteristic curve showed that the insufficiency or deficiency of vitamins A, D, and E was positively correlated with RRTI occurrence (p < 0.05). Conclusions Low serum concentrations of vitamins A, D, and E were associated with RRTIs in children from northern China.	[Zhang, Xuguang; Ding, Fengshu; Li, Huaining; Jing, Hong; Chen, Yanping] Harbin Childrens Hosp, Dept Clin Nutr, Harbin, Peoples R China; [Zhao, Wenfeng] Harbin Childrens Hosp, Dept Clin Lab, Harbin, Peoples R China; [Yan, Yageng] Harbin Med Univ, Dept Clin Nutr, Affiliated Clin Hosp 1, Harbin, Peoples R China	Harbin Medical University	Chen, YP (corresponding author), Harbin Childrens Hosp, Dept Clin Nutr, Harbin, Peoples R China.	heyypchen@163.com			Development Center for Medical Science and Technology National Health and Family Planning Commission of the People's Republic of China [W2015EAE007]	Development Center for Medical Science and Technology National Health and Family Planning Commission of the People's Republic of China	This work was supported in part by grants from The Development Center for Medical Science and Technology National Health and Family Planning Commission of the People's Republic of China (no. W2015EAE007) to FSD, http://www.dcmst.org.cn/.	Abrams SA, 2011, PEDIATRICS, V127, P566, DOI 10.1542/peds.2010-3576; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; CLEMENS TL, 1982, LANCET, V1, P74; COQUETTE A, 1986, ARCH INT PHYSIOL BIO, V94, pS29; Diez-Domingo J, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0544-x; Dong F, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1062-8; Drewel BT, 2006, J NUTR BIOCHEM, V17, P132, DOI 10.1016/j.jnutbio.2005.06.003; Esposito S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-194; Fares S, 2011, PUBLIC HEALTH NUTR, V14, P255, DOI 10.1017/S1368980010001631; FRIEDMAN A, 1989, BRIT J NUTR, V62, P439, DOI 10.1079/BJN19890044; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hardelid P, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1191; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Kim KC, 1997, EUR RESPIR J, V10, P2644, DOI 10.1183/09031936.97.10112644; Kim SW, 2007, MOL CELL BIOL, V27, P6933, DOI 10.1128/MCB.02385-06; Maciel BLL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107564; Liu H, 2015, INT J DISTRIB SENS N, V2015, P12, DOI DOI 10.1088/1741-2560/12/5/056008; Long KZ, 2006, AM J CLIN NUTR, V83, P693, DOI 10.1093/ajcn.83.3.693; Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41; Meydani SN, 2004, JAMA-J AM MED ASSOC, V292, P828, DOI 10.1001/jama.292.7.828; Misra M, 2008, PEDIATRICS, V122, P398, DOI 10.1542/peds.2007-1894; Mora JR, 2009, SEMIN IMMUNOL, V21, P28, DOI 10.1016/j.smim.2008.08.002; Moreira A, 2014, J STRENGTH COND RES, V28, P467, DOI 10.1519/JSC.0b013e31829b5512; Mustacich DJ, 2007, VITAM HORM, V76, P1, DOI 10.1016/S0083-6729(07)76001-6; Najada AS, 2004, J TROP PEDIATRICS, V50, P364, DOI 10.1093/tropej/50.6.364; Norman AW, 2008, AM J CLIN NUTR, V88, p491S, DOI 10.1093/ajcn/88.2.491S; Organization WH, 2009, EN NUTR PUBL MICR VI; Raniszewska A, 2015, CENT EUR J IMMUNOL, V40, P167, DOI 10.5114/ceji.2015.52830; Singh Meenu, 1999, Indian Journal of Pediatrics, V66, P887, DOI 10.1007/BF02723862; SOMMER A, 1983, LANCET, V2, P585; Underwood MA, 2010, PEDIATRICS, V125, P1237, DOI 10.1542/peds.2009-3289; Wang CW, 2013, J EXP MED, V210, P475, DOI 10.1084/jem.20121088; Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6; Wu DY, 2014, ENDOCR METAB IMMUNE, V14, P283, DOI 10.2174/1871530314666140922143950; Yang C, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0170-0; Young IS, 2001, J CLIN PATHOL, V54, P176, DOI 10.1136/jcp.54.3.176	36	14	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167689	10.1371/journal.pone.0167689	http://dx.doi.org/10.1371/journal.pone.0167689			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936124	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100152
J	Zou, L; Chen, YX; Penttinen, P; Lan, Q; Wang, K; Liu, M; Peng, D; Zhang, XP; Chen, Q; Zhao, K; Zeng, XZ; Xu, KW				Zou, Lan; Chen, Yuan Xue; Penttinen, Petri; Lan, Qin; Wang, Ke; Liu, Ming; Peng, Dan; Zhang, Xiaoping; Chen, Qiang; Zhao, Ke; Zeng, Xiangzhong; Xu, Kai Wei			Genetic Diversity and Symbiotic Efficiency of Nodulating Rhizobia Isolated from Root Nodules of Faba Bean in One Field	PLOS ONE			English	Article							VICIA-FABA; PHASEOLUS-VULGARIS; SP NOV.; LEGUMINOSARUM; PHYLOGENY; STRAINS; L.; RECOMBINATION; REGIONS; SICHUAN	Thirty-one nodulating rhizobium strains were collected from root nodules of spring and winter type faba bean cultivars grown in micro ecoarea, i.e. the same field in Chengdu plain, China. The symbiotic efficiency and phylogeny of these strains were studied. Effectively nitrogen fixing strains were isolated from both winter type and spring type cultivars. Based on phylogenetic analysis of 16S rRNA gene and concatenated sequence of atpD, glnII and recA genes, the isolates were assigned as Rhizobium anhuiense and a potential new Rhizobium species. The isolates were diverse on symbiosis related gene level, carrying five, four and three variants of nifH, nodC and nodD, respectively. Strains carrying similar gene combinations were trapped by both winter and spring cultivars, disagreeing with the specificity of symbiotic genotypes to reported earlier faba bean ecotypes.	[Zou, Lan; Chen, Yuan Xue; Lan, Qin; Wang, Ke; Liu, Ming; Peng, Dan; Zhang, Xiaoping; Chen, Qiang; Zhao, Ke; Xu, Kai Wei] Sichuan Agr Univ, Coll Resources, Dept Microbiol, Chengdu, Peoples R China; [Penttinen, Petri] Univ Helsinki, Dept Environm Sci, Helsinki, Finland; [Zeng, Xiangzhong] Sichuan Acad Agr Sci, Soil & Fertilizer Inst, Chengdu, Peoples R China	Sichuan Agricultural University; University of Helsinki; Sichuan Academy of Agricultural Sciences (SAAS)	Chen, YX; Xu, KW (corresponding author), Sichuan Agr Univ, Coll Resources, Dept Microbiol, Chengdu, Peoples R China.	cyxue11889@163.com; xkwei@sicau.edu.cn	Penttinen, Petri/AAJ-2143-2020; chen, qiang/HGU-5418-2022; Penttinen, Petri/CAJ-0885-2022	Penttinen, Petri/0000-0002-9203-9484	National Key Research and Development Program of China [2016YFD0300300]; Special Fund for Agro-scientific Research in the Public Interest of China [201103005]	National Key Research and Development Program of China; Special Fund for Agro-scientific Research in the Public Interest of China	This work was supported by National Key Research and Development Program of China (2016YFD0300300) YXC, the Special Fund for Agro-scientific Research in the Public Interest of China (No.201103005) XZZ.	Cao Y, 2014, SOIL BIOL BIOCHEM, V78, P128, DOI 10.1016/j.soilbio.2014.07.026; Cardoso JD, 2012, APPL MICROBIOL BIOT, V93, P2035, DOI 10.1007/s00253-011-3708-2; Chen YX, 2015, BIOL FERT SOILS, V51, P707, DOI 10.1007/s00374-015-1019-y; Duc G, 2010, FIELD CROP RES, V115, P270, DOI 10.1016/j.fcr.2008.10.003; Flores F, 2012, AGRON SUSTAIN DEV, V32, P727, DOI 10.1007/s13593-012-0082-0; Gurkanli CT, 2014, ANN MICROBIOL, V64, P99, DOI 10.1007/s13213-013-0638-5; Herridge DF, 2008, PLANT SOIL, V311, P1, DOI 10.1007/s11104-008-9668-3; Kopke U, 2010, FIELD CROP RES, V115, P217, DOI 10.1016/j.fcr.2009.10.012; Laguerre G, 2003, APPL ENVIRON MICROB, V69, P2276, DOI 10.1128/AEM.69.4.2276-2283.2003; Laguerre G, 1996, APPL ENVIRON MICROB, V62, P2029, DOI 10.1128/AEM.62.6.2029-2036.1996; Lindstrom K, 2010, RES MICROBIOL, V161, P453, DOI 10.1016/j.resmic.2010.05.005; Little MC, 1991, [No title captured], Patent No. [5,075,430, 5075430]; Luyten E, 2000, EUR J SOIL BIOL, V36, P1, DOI 10.1016/S1164-5563(00)00134-5; Mousavi SA, 2015, SYST APPL MICROBIOL, V38, P84, DOI 10.1016/j.syapm.2014.12.003; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; Ribeiro RA, 2013, RES MICROBIOL, V164, P740, DOI 10.1016/j.resmic.2013.05.002; ROHLF FJ, 1993, NTSYS PC NUMERICAL T; Saidi S, 2014, INT J SYST EVOL MICR, V64, P242, DOI 10.1099/ijs.0.052191-0; Santillana N, 2008, ARCH MICROBIOL, V189, P239, DOI 10.1007/s00203-007-0313-y; Sarita S, 2005, FEMS MICROBIOL ECOL, V54, P1, DOI 10.1016/j.femsec.2005.02.015; SULLIVAN JT, 1995, P NATL ACAD SCI USA, V92, P8985, DOI 10.1073/pnas.92.19.8985; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tian CF, 2007, ARCH MICROBIOL, V188, P273, DOI 10.1007/s00203-007-0245-6; Tian CF, 2010, FEMS MICROBIOL ECOL, V73, P563, DOI 10.1111/j.1574-6941.2010.00909.x; Tian CF, 2008, INT J SYST EVOL MICR, V58, P2871, DOI 10.1099/ijs.0.2008/000703-0; VANBERKUM P, 1995, APPL ENVIRON MICROB, V61, P2649, DOI 10.1128/AEM.61.7.2649-2653.1995; VINCENT J. M., 1970, A Manual for the Practical Study of the Root- Bacteria.; Vinuesa P, 2005, MOL PHYLOGENET EVOL, V34, P29, DOI 10.1016/j.ympev.2004.08.020; Wernegreen JJ, 1999, MOL BIOL EVOL, V16, P98, DOI 10.1093/oxfordjournals.molbev.a026041; Xu KW, 2015, SYST APPL MICROBIOL, V38, P515, DOI 10.1016/j.syapm.2015.06.009; Xu KW, 2013, APPL MICROBIOL BIOT, V97, P783, DOI 10.1007/s00253-012-4246-2; Xu KW, 2013, WORLD J MICROBIOL BI, V29; Ye Y, 2003, GSET; Youseif SH, 2014, SYST APPL MICROBIOL, V37, P560, DOI 10.1016/j.syapm.2014.10.001; Zhang YJ, 2015, INT J SYST EVOL MICR, V65, P2960, DOI 10.1099/ijs.0.000365	35	3	6	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167804	10.1371/journal.pone.0167804	http://dx.doi.org/10.1371/journal.pone.0167804			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936180	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100199
J	Hayat, SA; Luben, R; Dalzell, N; Moore, S; Anuj, S; Matthews, FE; Wareham, N; Brayne, C; Khaw, KT				Hayat, Shabina A.; Luben, Robert; Dalzell, Nichola; Moore, Stephanie; Anuj, Serena; Matthews, Fiona E.; Wareham, Nick; Brayne, Carol; Khaw, Kay-Tee			Cross Sectional Associations between Socio-Demographic Factors and Cognitive Performance in an Older British Population: The European Investigation of Cancer in Norfolk (EPIC-Norfolk) Study	PLOS ONE			English	Article							SOCIAL-CLASS; AGE; DEMENTIA; EDUCATION; INTELLIGENCE; IMPAIRMENT; PREVALENCE; DOMAINS; DECLINE; MEMORY	Background Cognition covers a range of abilities, such as memory, response time and language, with tests assessing either specific or generic aspects. However differences between measures may be observed within the same individuals. Objective To investigate the cross-sectional association of cognitive performance and socio-demographic factors using different assessment tools across a range of abilities in a British cohort study. Methods Participants of the European Prospective Investigation of Cancer (EPIC) in Norfolk Study, aged 48-92 years, underwent a cognitive assessment between 2006 and 2011 (piloted between 2004 and 2006) and were investigated over a different domains using a range of cognitive tests. Results Cognitive measures were available on 8584 men and women. Though age, sex, education and social class were all independently associated with cognitive performance in multivariable analysis, different associations were observed for different cognitive tests. Increasing age was associated with increased risk of a poor performance score in all of the tests, except for the National Adult Reading Test (NART), an assessment of crystallized intelligence. Compared to women, men were more likely to have had poor performance for verbal episodic memory, Odds Ratio, OR = 1.99 (95% Confidence Interval, 95% CI 1.72, 2.31), attention OR = 1.62, (95% CI 1.39, 1.88) and prospective memory OR = 1.46, (95% CI 1.29, 1.64); however, no sex difference was observed for global cognition, OR = 1.07 (95% CI 0.93, 1.24). The association with education was strongest for NART, and weakest for processing speed. Conclusion Age, sex, education and social class were all independently associated with performance on cognitive tests assessing a range of different domains. However, the magnitude of associations of these factors with different cognitive tests differed. The varying relationships seen across different tests may help explain discrepancies in results reported in the current literature, and provides insights into influences on cognitive performance in later life.	[Hayat, Shabina A.; Luben, Robert; Dalzell, Nichola; Moore, Stephanie; Anuj, Serena; Brayne, Carol; Khaw, Kay-Tee] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; [Matthews, Fiona E.] Cambridge Inst Publ Hlth, Cambridge Biomed Campus, MRC Biostat Unit, Cambridge, England; [Wareham, Nick] Univ Cambridge, Sch Clin Med, MRC Epidemiol Unit, Cambridge, England	University of Cambridge; MRC Biostatistics Unit; University of Cambridge; University of Cambridge	Hayat, SA (corresponding author), Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England.	Sah63@medschl.cam.ac.uk	Matthews, Fiona/O-6932-2015; Khaw, Kay-Tee/AAZ-3209-2021; Brayne, Carol/AAA-4285-2020; Luben, Robert N/H-5519-2015	Matthews, Fiona/0000-0002-1728-2388; Brayne, Carol/0000-0001-5307-663X; Luben, Robert N/0000-0002-5088-6343	Medical Research Council, UK [G0401527]; Cancer Research UK (CRUK) [C864/A8257]; Age UK [262]; MRC [G9502233, U105292687]; CRUK [C864/A2883]; Medical Research Council [MR/N003284/1, MC_PC_13048, MC_UU_12015/1, MC_U106179471, MC_UU_00002/12, G1000143, MC_U105292687, G0401527] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10135, NF-SI-0611-10084, NF-SI-0512-10114] Funding Source: researchfish; MRC [MR/N003284/1, MC_UU_00002/12, MC_U105292687, MC_UU_12015/1] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK (CRUK)(Cancer Research UK); Age UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CRUK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The infrastructure for this study was supported by the Medical Research Council, UK http://www.mrc.ac.uk/ (Ref: G0401527) and Cancer Research UK http:/www.cancerresearch.uk.org/ (CRUK, Ref: C864/A8257). The clinic for EPIC-Norfolk 3 was funded by Research into Ageing, now known as Age UK http://www.ageuk.org.uk/ (Grant Ref: 262). The pilot phase was supported by MRC (Ref: G9502233) and CRUK (Ref: C864/A2883). KK received the above funding. FEM Is supported by MRC (Ref: U105292687). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal NT, 2005, J NEUROL NEUROSUR PS, V76, P1479, DOI 10.1136/jnnp.2004.053561; Backman L, 2004, J INTERN MED, V256, P195, DOI 10.1111/j.1365-2796.2004.01386.x; Bamford SM, 2012, MATURITAS, V73, P121, DOI 10.1016/j.maturitas.2012.06.013; Bandelow S, 2008, P INT C ADV COMP INT; BEARDSALL L, 1990, BRIT J CLIN PSYCHOL, V29, P83, DOI 10.1111/j.2044-8260.1990.tb00851.x; Brandt J., 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; BRAYNE C, 1990, BRIT J CLIN PSYCHOL, V29, P217, DOI 10.1111/j.2044-8260.1990.tb00872.x; Brayne C, 1998, PSYCHOL MED, V28, P319; Cargin JW, 2008, J CLIN EXP NEUROPSYC, V30, P245, DOI 10.1080/13803390701377829; CRAWFORD JR, 1988, BRIT J CLIN PSYCHOL, V27, P181, DOI 10.1111/j.2044-8260.1988.tb00770.x; Cullen B, 2007, J NEUROL NEUROSUR PS, V78, P790, DOI 10.1136/jnnp.2006.095414; Cullum S, 2000, INT J GERIATR PSYCH, V15, P853, DOI 10.1002/1099-1166(200009)15:9<853::AID-GPS211>3.0.CO;2-T; Dangour AD, 2013, AM J CLIN NUTR, V97, P909, DOI 10.3945/ajcn.113.061168; Day N, 1999, BRIT J CANCER, V80, P95; de Jager CA, 2009, AGE AGEING, V38, P455, DOI 10.1093/ageing/afp068; Deary IJ, 2007, J EPIDEMIOL COMMUN H, V61, P378, DOI 10.1136/jech.2005.039206; Deary IJ, 2010, INT J EPIDEMIOL, V39, P1362, DOI 10.1093/ije/dyq072; Der G, 2009, PSYCHOL AGING, V24, P229, DOI 10.1037/a0015515; Fowler KS, 2002, J INT NEUROPSYCH SOC, V8, P58, DOI 10.1017/S1355617701020069; Fowler KS, 2002, J INT NEUROPSYCH SOC, V3, P139; Gallacher JEJ, 1999, EUR J EPIDEMIOL, V15, P161, DOI 10.1023/A:1007576324313; Gerstorf D, 2006, J GERONTOL B-PSYCHOL, V61, pP245, DOI 10.1093/geronb/61.4.P245; Hayat SA, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-142; Hayat SA, 2014, INT J EPIDEMIOL, V43, P1063, DOI 10.1093/ije/dyt086; HOFMAN A, 1991, INT J EPIDEMIOL, V20, P736, DOI 10.1093/ije/20.3.736; Hogervorst E, 2008, MED SCI SPORT EXER, V40, P1841, DOI 10.1249/MSS.0b013e31817bb8b7; Huppert FA, 2000, APPL COGNITIVE PSYCH, V14, pS63, DOI 10.1002/acp.771; Huppert Felicia A, 2005, BMC Geriatr, V5, P7, DOI 10.1186/1471-2318-5-7; Mcfadden E, 2009, DIFFERENT MEASURES S, P231; Meinz EJ, 1998, PSYCHON B REV, V5, P56, DOI 10.3758/BF03209457; NELSON HE, 1975, BRIT J SOC CLIN PSYC, V14, P259, DOI 10.1111/j.2044-8260.1975.tb00178.x; Richards M, 1999, NEUROLOGY, V53, P308, DOI 10.1212/WNL.53.2.308; Ruitenberg A, 2001, NEUROBIOL AGING, V22, P575, DOI 10.1016/S0197-4580(01)00231-7; SAHAKIAN BJ, 1988, BRAIN, V111, P695, DOI 10.1093/brain/111.3.695; Salthouse TA, 2004, CURR DIR PSYCHOL SCI, V13, P140, DOI 10.1111/j.0963-7214.2004.00293.x; Salthouse TA, 2003, PSYCHOL AGING, V18, P91, DOI 10.1037/0882-7974.18.1.91; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Shohaimi S, 2004, J EPIDEMIOL COMMUN H, V58, P686, DOI 10.1136/jech.2003.008490; Singh-Manoux A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d7622; Sliwinski M, 1999, PSYCHOL AGING, V14, P18, DOI 10.1037/0882-7974.14.1.18; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; Tucker-Drob EM, 2011, DEV PSYCHOL, V47, P331, DOI 10.1037/a0021361; Williams JG, 2003, INT J GERIATR PSYCH, V18, P631, DOI 10.1002/gps.886; Wilson RS, 2002, PSYCHOL AGING, V17, P179, DOI 10.1037/0882-7974.17.2.179	45	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0166779	10.1371/journal.pone.0166779	http://dx.doi.org/10.1371/journal.pone.0166779			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4OA	27930656	Green Published, gold			2022-12-27	WOS:000389580900015
J	Leong, KH; Abdul-Rahman, H; Wang, C; Onn, CC; Loo, SC				Leong, Kah Huo; Abdul-Rahman, Hamzah; Wang, Chen; Onn, Chiu Chuen; Loo, Siaw-Chuing			Bee Inspired Novel Optimization Algorithm and Mathematical Model for Effective and Efficient Route Planning in Railway System	PLOS ONE			English	Article							TRANSIT NETWORK DESIGN; COLONY OPTIMIZATION	Railway and metro transport systems (RS) are becoming one of the popular choices of transportation among people, especially those who live in urban cities. Urbanization and increasing population due to rapid development of economy in many cities are leading to a bigger demand for urban rail transit. Despite being a popular variant of Traveling Salesman Problem (TSP), it appears that the universal formula or techniques to solve the problem are yet to be found. This paper aims to develop an optimization algorithm for optimum route selection to multiple destinations in RS before returning to the starting point. Bee foraging behaviour is examined to generate a reliable algorithm in railway TSP. The algorithm is then verified by comparing the results with the exact solutions in 10 test cases, and a numerical case study is designed to demonstrate the application with large size sample. It is tested to be efficient and effective in railway route planning as the tour can be completed within a certain period of time by using minimal resources. The findings further support the reliability of the algorithm and capability to solve the problems with different complexity. This algorithm can be used as a method to assist business practitioners making better decision in route planning.	[Leong, Kah Huo; Abdul-Rahman, Hamzah] Int Univ Malaya Wales, Fac Sci Technol Engn & Math STEM, Kuala Lumpur, Malaysia; [Wang, Chen] Huaqiao Univ, Coll Civil Engn, Xiamen 361021, Peoples R China; [Onn, Chiu Chuen; Loo, Siaw-Chuing] Univ Malaya, Fac Engn, Dept Civil Engn, Kuala Lumpur, Malaysia; Univ Malaya, Fac Built Environm, Ctr Bldg Construct & Trop Architecture, Kuala Lumpur, Malaysia	Universiti Malaya; Huaqiao University; Universiti Malaya; Universiti Malaya	Loo, SC (corresponding author), Univ Malaya, Fac Engn, Dept Civil Engn, Kuala Lumpur, Malaysia.	siawchuing@um.edu.my	wang, chen/GWM-9481-2022; Loo, Siaw-Chuing/AAT-3921-2020; ABDUL RAHMAN, HAMZAH/B-8583-2010; ONN, CHIU CHUEN/B-9460-2010; Loo, Siaw-Chuing/B-3958-2009; Wang, Chen/F-1586-2010; Leong, Kah Huo/R-3769-2017	Loo, Siaw-Chuing/0000-0003-2528-1817; ONN, CHIU CHUEN/0000-0002-5093-5651; Loo, Siaw-Chuing/0000-0003-2528-1817; Wang, Chen/0000-0001-7892-3575; Leong, Kah Huo/0000-0001-7266-631X	University of Malaya; Center of Building, Construction AMP; Tropical Architecture of the Faculty of Built Environment, Center of Transport Research, Department of Civil Engineering, Faculty of Engineering, and University of Malaya (UM), Malaysia;  [LL026-16SUS]	University of Malaya(Universiti Malaya); Center of Building, Construction AMP; Tropical Architecture of the Faculty of Built Environment, Center of Transport Research, Department of Civil Engineering, Faculty of Engineering, and University of Malaya (UM), Malaysia; 	This research was supported by the University of Malaya. We thank the reviewers and associate editor for their comments that greatly improved the manuscript.r The authors wish to thank the Center of Building, Construction & Tropical Architecture of the Faculty of Built Environment, Center of Transport Research, Department of Civil Engineering, Faculty of Engineering, and University of Malaya (UM), Malaysia for their financial support to carry out this research project. The project was funded under the project LL026-16SUS.	Aghazadeh F., 2011, INT C INF INT COMP, P115; Awuni K., 2014, DYNAMIC PROGRAMMING; Baykasoglu A, 2007, SWARM INTELLIGENCE F, P113; Bellizzi C, 2015, ANIM COGN, V18, P1207, DOI 10.1007/s10071-015-0890-0; Beni G, 1993, ROBOTS BIOL SYSTEMS, V102, P703, DOI [DOI 10.1007/978-3-642-58069-7_38, 10.1007/978-3-642-58069-7, DOI 10.1007/978-3-642-58069-7]; Bonabeau E DdRDF, 1999, SWARM INTELLIGENCE N; Ch'ng B., 2014, STAR; Chauhan J. R., 2013, J INFORM KNOWLEDGE R, V2, P616; Cook W. J., 2012, PURSUIT TRAVELING SA; Gandomi AH, 2011, INFORM SCIENCES, V181, P5227, DOI 10.1016/j.ins.2011.07.026; Kennedy J., 1995, P ICNN 95 INT C NEUR, P1942; LAPORTE G, 1992, EUR J OPER RES, V59, P345, DOI 10.1016/0377-2217(92)90192-C; Li R., 2013, MATH PROBLEMS ENG, V2013; MAGNANTI TL, 1984, TRANSPORT SCI, V18, P1, DOI 10.1287/trsc.18.1.1; Matai R., 2010, TRAVELING SALESMAN P; Mittal S., 2014, J ADV COMPUTING COMM, V2; Moghaddam B. F., 2010, INT J RES REV APPL S, V2, P108; Nikolic M, 2014, EXPERT SYST APPL, V41, P7200, DOI 10.1016/j.eswa.2014.05.034; Nikolic M, 2013, EXPERT SYST APPL, V40, P5945, DOI 10.1016/j.eswa.2013.05.002; Nikolic M, 2013, EXPERT SYST APPL, V40, P4609, DOI 10.1016/j.eswa.2013.01.063; Orr J. L., TRAVELING SALESMAN P; Osaba E, 2016, ENG APPL ARTIF INTEL, V48, P59, DOI 10.1016/j.engappai.2015.10.006; Quak C., 2003, THESIS; Sahalot Antima, 2014, INT J RES ENG TECHNO, V2, P59; Sathya N., 2015, INDIAN J SCI TECHNOL, V8, P1; Teodorovic D., 2011, ACM T COMPUT LOG, V1529, P3785; Teodorovic D, 2009, STUD COMPUT INTELL, V248, P39; Todorovic N, 2013, IEEE T SYST MAN CY-S, V43, P467, DOI 10.1109/TSMCA.2012.2210404; Yang XS, 2014, APPL MATH INFORM SCI, V8, P977, DOI 10.12785/amis/080306; Yuce Baris, 2013, Insects, V4, P646, DOI 10.3390/insects4040646	31	3	3	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0166064	10.1371/journal.pone.0166064	http://dx.doi.org/10.1371/journal.pone.0166064			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930659	gold, Green Published, Green Submitted			2022-12-27	WOS:000389580900008
J	Ma, XF; Huang, XL; Ge, Y; Hu, YM; Chen, W; Liu, AL; Liu, HX; Chen, Y; Li, B; Ning, XB				Ma, Xiaofei; Huang, Xiaolin; Ge, Yun; Hu, Yueming; Chen, Wei; Liu, Aili; Liu, Hongxing; Chen, Ying; Li, Bin; Ning, Xinbao			Brain Connectivity Variation Topography Associated with Working Memory	PLOS ONE			English	Article							SYNCHRONIZATION; CORTEX; NETWORKS; PATHWAYS; GAMMA; STATE	Brain connectivity analysis plays an essential role in the research of working memory that involves complex coordination of various brain regions. In this research, we present a comprehensive view of trans-states brain connectivity variation based on continuous scalp EEG, extending beyond traditional stimuli-lock averaging or restriction to short time scales of hundreds of milliseconds after stimulus onset. The scalp EEG was collected under three conditions: quiet, memory, and control. The only difference between the memory and control conditions was that in the memory condition, subjects made an effort to retain information. We started our investigation with calibrations of Pearson correlation in EEG analysis and then derived two indices, link strength and node connectivity, to make comparisons between different states. Finally, we constructed and studied trans-state brain connectivity variation topography. Comparing memory and control states with quiet state, we found that the beta topography highlights links between T5/T6 and O1/O2, which represents the visual ventral stream, and the gamma topography conveys strengthening of inter-hemisphere links and weakening of intra-hemisphere frontal-posterior links, implying parallel inter-hemisphere coordination combined with sequential intra-hemisphere coordination when subjects are confronted with visual stimuli and a motor task. For comparison between memory and control states, we also found that the node connectivity of T6 stands out in gamma topography, which provides strong proof from scalp EEG for the information binding or relational processing function of the temporal lobe in memory formation. To our knowledge, this is the first time for any method to effectively capture brain connectivity variation associated with working memory from a relatively large scale both in time (from a second to a minute) and in space (from the scalp). The method can track brain activity continuously with minimal manual interruptions; therefore, it has promising potential in applications such as brain computer interfaces and brain training.	[Ma, Xiaofei; Huang, Xiaolin; Ge, Yun; Hu, Yueming; Chen, Wei; Liu, Aili; Liu, Hongxing; Chen, Ying; Ning, Xinbao] Nanjing Univ, Sch Elect Sci & Engn, Nanjing, Jiangsu, Peoples R China; [Li, Bin] Nanjing Univ, Sch Life Sci, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Huang, XL (corresponding author), Nanjing Univ, Sch Elect Sci & Engn, Nanjing, Jiangsu, Peoples R China.	xlhuang@nju.edu.cn			Forward-looking Project on the Integration of Industry, Education and Research of Jiangsu Province [BY2015069-06]; Social Development Program of Primary Research & Development Plan in Jiangsu Province [BE2016733]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Forward-looking Project on the Integration of Industry, Education and Research of Jiangsu Province; Social Development Program of Primary Research & Development Plan in Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions	This research was supported by Forward-looking Project on the Integration of Industry, Education and Research of Jiangsu Province (BY2015069-06), the Social Development Program of Primary Research & Development Plan in Jiangsu Province (BE2016733) and the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Uriguen JA, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/3/031001; Antony AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077916; Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Barlow JS, 1997, INT J PSYCHOPHYSIOL, V26, P443, DOI 10.1016/S0167-8760(97)00781-2; Bonita JD, 2014, COGN NEURODYNAMICS, V8, P1, DOI 10.1007/s11571-013-9267-8; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Charlton RA, 2010, CORTEX, V46, P474, DOI 10.1016/j.cortex.2009.07.005; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; Eriksson J, 2015, NEURON, V88, P33, DOI 10.1016/j.neuron.2015.09.020; Fadlallah B, 2012, IEEE T BIO-MED ENG, V59, P2773, DOI 10.1109/TBME.2012.2210283; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Gazzaley Adam, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P580, DOI 10.3758/CABN.4.4.580; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Holz EM, 2010, NEUROIMAGE, V52, P326, DOI 10.1016/j.neuroimage.2010.04.003; Kilicarslan A, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/2/026013; Lee TG, 2013, J NEUROSCI, V33, P13233, DOI 10.1523/JNEUROSCI.5652-12.2013; Ma WJ, 2014, NAT NEUROSCI, V17, P347, DOI 10.1038/nn.3655; Palva JM, 2010, P NATL ACAD SCI USA, V107, P7580, DOI 10.1073/pnas.0913113107; Plume A., 2014, SCI ENG ETHICS, V38, P16, DOI DOI 10.1016/J.TICS.2013.10.010; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salazar RF, 2012, SCIENCE, V338, P1097, DOI 10.1126/science.1224000; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Schall JD, 2004, VISION RES, V44, P1453, DOI 10.1016/j.visres.2003.10.025; Schubert T, 2014, PSYCHOL RES-PSYCH FO, V78, P749, DOI 10.1007/s00426-014-0619-8; Tesche CD, 2000, P NATL ACAD SCI USA, V97, P919, DOI 10.1073/pnas.97.2.919	27	9	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0165168	10.1371/journal.pone.0165168	http://dx.doi.org/10.1371/journal.pone.0165168			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930672	Green Published, gold, Green Submitted			2022-12-27	WOS:000389580900003
J	Castro-Izaguirre, N; Chi, XL; Baruffol, M; Tang, ZY; Ma, KP; Schmid, B; Niklaus, PA				Castro-Izaguirre, Nadia; Chi, Xiulian; Baruffol, Martin; Tang, Zhiyao; Ma, Keping; Schmid, Bernhard; Niklaus, Pascal A.			Tree Diversity Enhances Stand Carbon Storage but Not Leaf Area in a Subtropical Forest	PLOS ONE			English	Article							NET PRIMARY PRODUCTION; SPECIES RICHNESS; STRUCTURAL COMPLEXITY; PRODUCTIVITY; BIODIVERSITY; INCREASES; GROWTH; ROOT	Research about biodiversity-productivity relationships has focused on herbaceous ecosystems, with results from tree field studies only recently beginning to emerge. Also, the latter are concentrated largely in the temperate zone. Tree species diversity generally is much higher in subtropical and tropical than in temperate or boreal forests, with reasons not fully understood. Niche overlap and thus complementarity in the use of resources that support productivity may be lower in forests than in herbaceous ecosystems, suggesting weaker productivity responses to diversity change in forests. We studied stand basal area, vertical structure, leaf area, and their relationship with tree species richness in a subtropical forest in south-east China. Permanent forest plots of 30 x 30 m were selected to span largely independent gradients in tree species richness and secondary successional age. Plots with higher tree species richness had a higher stand basal area. Also, stand basal area increases over a 4-year census interval were larger at high than at low diversity. These effects translated into increased carbon stocks in aboveground phytomass (estimated using allometric equations). A higher variability in tree height in more diverse plots suggested that these effects were facilitated by denser canopy packing due to architectural complementarity between species. In contrast, leaf area was not or even negatively affected by tree diversity, indicating a decoupling of carbon accumulation from leaf area. Alternatively, the same community leaf area might have assimilated more C per time interval in more than in less diverse plots because of differences in leaf turnover and productivity or because of differences in the display of leaves in vertical and horizontal space. Overall, our study suggests that in species-rich forests niche-based processes support a positive diversity-productivity relationship and that this translates into increased carbon storage in long-lived woody structures. Given the high growth rates of these forests during secondary succession, our results further indicate that a forest management promoting tree diversity after disturbance may accelerate CO2 sequestration from the atmosphere and thus be relevant in a climate-change context.	[Castro-Izaguirre, Nadia; Baruffol, Martin; Schmid, Bernhard; Niklaus, Pascal A.] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Chi, Xiulian; Tang, Zhiyao] Peking Univ, Coll Urban & Environm Sci, Dept Ecol, Beijing, Peoples R China; [Chi, Xiulian; Tang, Zhiyao] Peking Univ, Key Lab Earth Surface Proc, Minist Educ, Beijing, Peoples R China; [Ma, Keping] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China	University of Zurich; Peking University; Peking University; Chinese Academy of Sciences; Institute of Botany, CAS	Castro-Izaguirre, N; Niklaus, PA (corresponding author), Univ Zurich, Dept Evolutionary Biol & Environm Studies, Zurich, Switzerland.	nadia.castro@ieu.uzh.ch; pascal.niklaus@ieu.uzh.ch	Niklaus, Pascal A/G-5786-2010; Tang, Zhiyao/B-8795-2008; Schmid, Bernhard/C-8625-2009; Baruffol, Martin/A-2406-2014	Niklaus, Pascal A/0000-0002-2360-1357; Schmid, Bernhard/0000-0002-8430-3214; Baruffol, Martin/0000-0001-9358-5885	German Science Foundation [DFG FOR-891]; Swiss National Science Foundation [130720]; University of Zurich; National Natural Science Foundation of China [30710103907, 31470486, 31321061]	German Science Foundation(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by a German Science Foundation grant to PAN (DFG FOR-891 TP1), a Swiss National Science Foundation grant to BS (130720), the University of Zurich, and National Natural Science Foundation of China grants to KPM (30710103907) and ZT (31470486, 31321061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the staff of the Gutianshan National Nature Reserve and the BEF-China team for their logistic support. This project was funded a German research foundation grant to PAN (DFG FOR 891 TP1) and the University of Zurich.	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barrufol M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081246; Binkley D, 2013, FOREST ECOL MANAG, V288, P5, DOI 10.1016/j.foreco.2011.11.002; Brassard BW, 2011, FUNCT ECOL, V25, P238, DOI 10.1111/j.1365-2435.2010.01769.x; Brokaw N, 2000, TRENDS ECOL EVOL, V15, P183, DOI 10.1016/S0169-5347(00)01822-X; Bruelheide H, 2011, ECOL MONOGR, V81, P25, DOI 10.1890/09-2172.1; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Chisholm RA, 2013, J ECOL, P101; Churkina G, 1998, ECOSYSTEMS, V1, P206, DOI 10.1007/s100219900016; Clark JS, 2003, ECOLOGY, V84, P17, DOI 10.1890/0012-9658(2003)084[0017:CHTITT]2.0.CO;2; Ewel JJ, 2015, BIOTROPICA, V47, P162, DOI 10.1111/btp.12190; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Farrior CE, 2016, SCIENCE, V351, P155, DOI 10.1126/science.aad0592; Gamfeldt L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2328; Geissler C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049618; Hardiman BS, 2013, FOREST ECOL MANAG, V298, P111, DOI 10.1016/j.foreco.2013.02.031; Hardiman BS, 2011, ECOLOGY, V92, P1818, DOI 10.1890/10-2192.1; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huang Y, 2017, J PLANT ECOLOGY; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Hubbell SP, 2006, ECOLOGY, V87, P1387, DOI 10.1890/0012-9658(2006)87[1387:NTATEO]2.0.CO;2; Jacob M, 2010, ANN FOREST SCI, V67, DOI [10.1051/forest/2009094, DOI 10.1051/FOREST/2009094]; Johnson DJ, 2012, SCIENCE, V336, P904, DOI 10.1126/science.1220269; Jucker T, 2015, FUNCT ECOL, V29, P1078, DOI 10.1111/1365-2435.12428; Korner C, 2015, CURR OPIN PLANT BIOL, V25, P107, DOI 10.1016/j.pbi.2015.05.003; Lin DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048244; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Lou LuHuan, 2000, Journal of Beijing Forestry University, V22, P33; McElhinny C, 2005, FOREST ECOL MANAG, V218, P1, DOI 10.1016/j.foreco.2005.08.034; Meinen C, 2009, ECOSYSTEMS, V12, P1103, DOI 10.1007/s10021-009-9271-3; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Morin X, 2011, ECOL LETT, V14, P1211, DOI 10.1111/j.1461-0248.2011.01691.x; Norby RJ, 2011, ANNU REV ECOL EVOL S, V42, P181, DOI 10.1146/annurev-ecolsys-102209-144647; Norby RJ, 2010, P NATL ACAD SCI USA, V107, P19368, DOI 10.1073/pnas.1006463107; Palacio S, 2014, NEW PHYTOL, V201, P1096, DOI 10.1111/nph.12602; Paquette A, 2011, GLOBAL ECOL BIOGEOGR, V20, P170, DOI 10.1111/j.1466-8238.2010.00592.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Piotto D, 2008, FOREST ECOL MANAG, V255, P781, DOI 10.1016/j.foreco.2007.09.065; Poorter L, 2015, GLOBAL ECOL BIOGEOGR, V24, P1314, DOI 10.1111/geb.12364; Potvin C, 2008, ECOL LETT, V11, P217, DOI 10.1111/j.1461-0248.2007.01148.x; Ruesch A., 2008, NEW IPCC TIER 1 GLOB; Ruiz-Benito P, 2014, GLOBAL ECOL BIOGEOGR, V23, P311, DOI 10.1111/geb.12126; Scharlemann JPW, 2014, CARBON MANAG, V5, P81, DOI 10.4155/CMT.13.77; Schleppi P, 2007, AGR FOREST METEOROL, V144, P236, DOI 10.1016/j.agrformet.2007.02.004; Schmid B, 2002, TRENDS ECOL EVOL, V17, P113, DOI 10.1016/S0169-5347(01)02422-3; Seidel D, 2013, FOREST ECOL MANAG, V310, P366, DOI 10.1016/j.foreco.2013.08.058; Shi L, 2011, PLOS ONE, V6; Vila M, 2007, ECOL LETT, V10, P241, DOI 10.1111/j.1461-0248.2007.01016.x; Vila M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053530; Wang LC, 2014, ADV INTEL SYS RES, V109, P9, DOI 10.1371/journal.pone.0085683; WANG Y, 2011, BIOGEOSCIENCES, V8, P2099, DOI DOI 10.5194/bg-8-2099-2011; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Zhang Y, 2012, J ECOL, V100, P742, DOI 10.1111/j.1365-2745.2011.01944.x	53	20	20	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167771	10.1371/journal.pone.0167771	http://dx.doi.org/10.1371/journal.pone.0167771			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936198	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000389587100182
J	Gibellini, L; De Biasi, S; Bianchini, E; Bartolomeo, R; Fabiano, A; Manfredini, M; Ferrari, F; Albertini, G; Trenti, T; Nasi, M; Pinti, M; Iannone, A; Salvarani, C; Cossarizza, A; Pellacani, G				Gibellini, Lara; De Biasi, Sara; Bianchini, Elena; Bartolomeo, Regina; Fabiano, Antonella; Manfredini, Marco; Ferrari, Federica; Albertini, Giuseppe; Trenti, Tommaso; Nasi, Milena; Pinti, Marcello; Iannone, Anna; Salvarani, Carlo; Cossarizza, Andrea; Pellacani, Giovanni			Anti-TNF-alpha Drugs Differently Affect the TNF alpha-sTNFR System and Monocyte Subsets in Patients with Psoriasis	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; NECROSIS-FACTOR-ALPHA; DENDRITIC CELLS; PHASE-III; RHEUMATOID-ARTHRITIS; GENE POLYMORPHISMS; THERAPY; INFLIXIMAB; ETANERCEPT; DISEASE	TNF-alpha has a central role in the development and maintenance of psoriatic plaques, and its serum levels correlate with disease activity. Anti-TNF-alpha drugs are, however, ineffective in a relevant percentage of patients for reasons that are currently unknown. To understand whether the response to anti-TNF-alpha drugs is influenced by the production of anti-drug antibodies or by the modulation of the TNF alpha-TNF alpha receptor system, and to identify changes in monocyte phenotype and activity, we analysed 119 psoriatic patients who either responded or did not respond to different anti-TNF-alpha therapies (adalimumab, etanercept or infliximab), and measured plasma levels of TNF-alpha, TNF-alpha soluble receptors, drug and anti-drug antibodies. Moreover, we analyzed the production of TNF-alpha and TNF-alpha soluble receptors by peripheral blood mononuclear cells (PBMCs), and characterized different monocyte populations. We found that: i) the drug levels varied between responders and non-responders; ii) anti-infliximab antibodies were present in 15% of infliximab-treated patients, while anti-etanercept or anti-adalimumab antibodies were never detected; iii) plasma TNF-alpha levels were higher in patients treated with etanercept compared to patients treated with adalimumab or infliximab; iv) PBMCs from patients responding to adalimumab and etanercept produced more TNF-alpha and sTNFRII in vitro than patients responding to infliximab; v) PBMCs from patients not responding to infliximab produce higher levels of TNF-alpha and sTNFRII than patients responding to infliximab; vi) anti-TNF-alpha drugs significantly altered monocyte subsets. A complex remodelling of the TNF alpha-TNF alpha receptor system thus takes place in patients treated with anti-TNF-alpha drugs, that involves either the production of anti-drug antibodies or the modulation of monocyte phenotype or inflammatory activity.	[Gibellini, Lara; De Biasi, Sara; Bartolomeo, Regina; Fabiano, Antonella; Manfredini, Marco; Ferrari, Federica; Nasi, Milena; Salvarani, Carlo; Pellacani, Giovanni] Univ Modena & Reggio Emilia, Dept Surg Med Dent & Morphol Sci, Modena, Italy; [Bianchini, Elena; Pinti, Marcello] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy; [Albertini, Giuseppe] IRCCS Santa Maria Nuova Hosp, Dermatol Unit, Reggio Emilia, Italy; [Trenti, Tommaso] NOCSAE Baggiovara, Dept Clin Pathol, Modena, Italy; [Iannone, Anna] Univ Modena & Reggio Emilia, Dept Diagnost Clin & Publ Hlth Med, Modena, Italy; [Salvarani, Carlo] IRCCS Santa Maria Nuova Hosp, Reumatol Unit, Reggio Emilia, Italy; [Cossarizza, Andrea] Univ Modena & Reggio Emilia, Dept Med & Surg Sci Children & Adults, Modena, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; IRCCS Arcispedale S. Maria Nuova; Universita di Modena e Reggio Emilia; IRCCS Arcispedale S. Maria Nuova; Universita di Modena e Reggio Emilia	Cossarizza, A (corresponding author), Univ Modena & Reggio Emilia, Dept Med & Surg Sci Children & Adults, Modena, Italy.	andrea.cossarizza@unimore.it	Iannone, Anna/A-8872-2017; pellacani, giovanni/E-8573-2011; Salvarani, Carlo/K-2431-2018; De Biasi, Sara/AAB-7520-2019; Trenti, Tommaso/K-8457-2016; Pinti, Marcello/C-9351-2015	Iannone, Anna/0000-0002-6151-7818; pellacani, giovanni/0000-0002-7222-2951; De Biasi, Sara/0000-0002-3217-9821; Trenti, Tommaso/0000-0001-8093-4011; Pinti, Marcello/0000-0001-9118-1262; Manfredini, Marco/0000-0003-3601-655X; Cossarizza, Andrea/0000-0002-5381-1558	Pfizer [WI128634]; Fondazione Cassa di Risparmio di Vignola	Pfizer(Pfizer); Fondazione Cassa di Risparmio di Vignola	This work was supported by an unrestricted grant from Pfizer (number: WI128634) to GP, and by Fondazione Cassa di Risparmio di Vignola to GP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardigo M, 2015, J EUR ACAD DERMATOL, V29, P2363, DOI 10.1111/jdv.13235; Atzeni F, 2013, AUTOIMMUN REV, V12, P703, DOI 10.1016/j.autrev.2012.10.021; Atzeni F, 2008, EXPERT REV CLIN IMMU, V4, P275, DOI 10.1586/1744666X.4.2.275; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Baeten D, 2000, ARTHRITIS RHEUM, V43, P1233, DOI 10.1002/1529-0131(200006)43:6<1233::AID-ANR6>3.0.CO;2-9; Bonifati C, 1999, INT J DERMATOL, V38, P241, DOI 10.1046/j.1365-4362.1999.00622.x; Cassinotti A, 2009, INFLAMM BOWEL DIS, V15, P1264, DOI 10.1002/ibd.20899; Chara L, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3928; Chomarat P, 2003, J IMMUNOL, V171, P2262, DOI 10.4049/jimmunol.171.5.2262; Cossarizza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050728; De Biasi S, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0515-0; De Simone C, 2015, J EUR ACAD DERMATOL, V29, P1786, DOI 10.1111/jdv.13024; Fantuzzi F, 2008, EXPERT OPIN THER TAR, V12, P1085, DOI 10.1517/14728222.12.9.1085 ; Fry L, 2007, CLIN DERMATOL, V25, P606, DOI 10.1016/j.clindermatol.2007.08.015; Gallo E, 2013, BRIT J DERMATOL, V169, P819, DOI 10.1111/bjd.12425; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; Haider AS, 2008, J INVEST DERMATOL, V128, P655, DOI 10.1038/sj.jid.5701064; Haider AS, 2007, J INVEST DERM SYMP P, V12, P9, DOI 10.1038/sj.jidsymp.5650032; Hanai H, 2008, AM J GASTROENTEROL, V103, P1210, DOI 10.1111/j.1572-0241.2007.01714.x; Hsu L, 2014, BRIT J DERMATOL, V170, P261, DOI 10.1111/bjd.12654; Hunter HJA, 2013, BRIT J DERMATOL, V169, P965, DOI 10.1111/bjd.12478; Jankovic S, 2009, ACTA DERM-VENEREOL, V89, P364, DOI 10.2340/00015555-0669; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Lugli E, 2010, CYTOM PART A, V77A, P705, DOI 10.1002/cyto.a.20901; Mascia F, 2003, AM J PATHOL, V163, P303, DOI 10.1016/S0002-9440(10)63654-1; Menter A, 2008, J AM ACAD DERMATOL, V58, P106, DOI 10.1016/j.jaad.2007.09.010; Mizutani H, 1997, J DERMATOL SCI, V14, P145, DOI 10.1016/S0923-1811(96)00562-2; Mukherjee R, 2015, SCI REP-UK, V5, DOI 10.1038/srep13886; Naldi L, 2014, BRIT J DERMATOL, V170, P634, DOI 10.1111/bjd.12735; Nazareth N, 2014, CLIN EXP IMMUNOL, V177, P703, DOI 10.1111/cei.12375; Paolisso G, 1998, AM J PHYSIOL-ENDOC M, V275, pE294, DOI 10.1152/ajpendo.1998.275.2.E294; Papp KA, 2005, BRIT J DERMATOL, V152, P1304, DOI 10.1111/j.1365-2133.2005.06688.x; Prajapati R, 2011, PHARMACOGENOMICS, V12, P1571, DOI [10.2217/PGS.11.114, 10.2217/pgs.11.114]; Reich K, 2005, LANCET, V366, P1367, DOI 10.1016/S0140-6736(05)67566-6; Romani J, 2013, ARCH DERMATOL RES, V305, P105, DOI 10.1007/s00403-012-1306-5; Shen C, 2005, ALIMENT PHARM THER, V21, P251, DOI 10.1111/j.1365-2036.2005.02309.x; Stansfield BK, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-014-0040-3; Vasilopoulos Y, 2012, MOL DIAGN THER, V16, P29, DOI 10.2165/11594660-000000000-00000; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	40	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167757	10.1371/journal.pone.0167757	http://dx.doi.org/10.1371/journal.pone.0167757			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936119	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100176
J	Guihard, PJ; Yao, JY; Blazquez-Medela, AM; Iruela-Arispe, L; Bostrom, KI; Yao, YC				Guihard, Pierre J.; Yao, Jiayi; Blazquez-Medela, Ana M.; Iruela-Arispe, Luisa; Bostrom, Kristina I.; Yao, Yucheng			Endothelial-Mesenchymal Transition in Vascular Calcification of Ins2(Akita/+) Mice	PLOS ONE			English	Article							MATRIX GLA PROTEIN; BONE MORPHOGENETIC PROTEIN-4; TISSUE KALLIKREIN; DIABETIC-NEPHROPATHY; ATHEROSCLEROSIS PROGRESSION; TRANSENDOTHELIAL MIGRATION; CELLS; MOUSE; ANGIOGENESIS; DEFICIENCY	Endothelial-mesenchymal transition (EndMT) drives endothelium to contribute to normal development and disease processes. Here, we report that EndMTs occur in the diabetic endothelium of Ins(2Akita/wt) mouse, and show that induction of sex determining region Y-box 2 (Sox2) is a mediator of excess BMP signaling that results in activation of EndMTs and increased vascular calcification. We also find an induction of a complex of serine proteases in the diabetic endothelium, required for the up-regulation of Sox2. Our results suggest that EndMTs contribute to vascular calcification in diabetic arteries.	[Guihard, Pierre J.; Yao, Jiayi; Blazquez-Medela, Ana M.; Bostrom, Kristina I.; Yao, Yucheng] Univ Calif Los Angeles, David Geffen Sch Med, Div Cardiol, Los Angeles, CA 90095 USA; [Iruela-Arispe, Luisa; Bostrom, Kristina I.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Iruela-Arispe, Luisa; Yao, Yucheng] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Bostrom, KI; Yao, YC (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Cardiol, Los Angeles, CA 90095 USA.; Bostrom, KI (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA.; Yao, YC (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA.	yyao@mednet.ucla.edu; kbostrom@mednet.ucla.edu	Guihard, Pierre J/S-1157-2018; Blázquez-Medela, Ana/ABC-1517-2021; Guihard, Pierre/AAT-3571-2020; Iruela-Arispe, M. Luisa/AAJ-1297-2020; Blazquez-Medela, Ana/K-3142-2014	Guihard, Pierre J/0000-0001-5824-0160; Guihard, Pierre/0000-0001-5824-0160; Iruela-Arispe, M. Luisa/0000-0002-3050-4168; Blazquez-Medela, Ana/0000-0003-3829-6997; Yao, Jiayi/0000-0001-9235-2406	National Institute Health grants [NS79353, HL30568, HL81397, HL112839]; American Heart Association (Western Affiliate); NIH [NS79353, HL30568, HL81397, HL112839]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568, R01HL081397, R01HL112839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079353] Funding Source: NIH RePORTER	National Institute Health grants; American Heart Association (Western Affiliate)(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this work was provided in part by National Institute Health grants NS79353, HL30568, HL81397 and HL112839, and the American Heart Association (Western Affiliate). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this work was provided in part by NIH grants NS79353, HL30568, HL81397 and HL112839, and the American Heart Association (Western Affiliate).	Abu El-Asrar AM, 2015, EXP EYE RES, V132, P179, DOI 10.1016/j.exer.2015.01.023; Aimes RT, 2003, THROMB HAEMOSTASIS, V89, P561, DOI 10.1055/s-0037-1613388; Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Antonicelli F, 2007, CURR TOP DEV BIOL, V79, P99, DOI 10.1016/S0070-2153(06)79005-6; Azizi M, 2005, J CLIN INVEST, V115, P780, DOI 10.1172/JCI200523669; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Bieth Joseph G., 2001, Journal de la Societe de Biologie, V195, P173; Bostrom KI, 2012, STEM CELLS, V30, P386, DOI 10.1002/stem.1027; Bostrom KI, 2011, CIRC RES, V108, P446, DOI 10.1161/CIRCRESAHA.110.236596; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Bostrom K, 2004, J BIOL CHEM, V279, P52904, DOI 10.1074/jbc.M406868200; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Campbell DJ, 2010, DIABETOLOGIA, V53, P779, DOI 10.1007/s00125-009-1645-8; Cepinskas G, 1999, J CELL SCI, V112, P1937; Chen PY, 2015, J CLIN INVEST, V125, P4514, DOI 10.1172/JCI82719; Emami N, 2007, CLIN CHIM ACTA, V381, P78, DOI 10.1016/j.cca.2007.02.023; Emanueli C, 2001, CIRCULATION, V103, P125; Feng B, 2016, DIABETES, V65, P768, DOI 10.2337/db15-1033; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Gu HF, 2009, GENDER MED, V6, P555, DOI 10.1016/j.genm.2009.11.001; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Khavandgar Z, 2013, J BONE MINER RES; Kovacic JC, 2012, CIRCULATION, V125, P1795, DOI 10.1161/CIRCULATIONAHA.111.040352; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Lin T, 2012, INT J DEV NEUROSCI, V30, P113, DOI 10.1016/j.ijdevneu.2011.12.004; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Maurice P, 2013, TRENDS CARDIOVAS MED, V23, P211, DOI 10.1016/j.tcm.2012.12.004; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Nagai T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/696475; Patschan D, 2014, AM J PHYSIOL-RENAL, V307, pF686, DOI 10.1152/ajprenal.00650.2013; Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658; Ranchoux B, 2015, CIRCULATION, V131, P1006, DOI 10.1161/CIRCULATIONAHA.114.008750; Rao RM, 2004, J EXP MED, V200, P713, DOI 10.1084/jem.20040499; Sage AP, 2010, NAT REV CARDIOL, V7, P528, DOI 10.1038/nrcardio.2010.115; Shaham O, 2009, DEVELOPMENT, V136, P2567, DOI 10.1242/dev.032888; Sinha A, 2013, DIABETES VASC DIS RE, V10, P410, DOI 10.1177/1479164113485101; Spinetti G, 2011, CIRC RES, V108, P284, DOI 10.1161/CIRCRESAHA.110.236786; Stoller JK, 2005, LANCET, V365, P2225, DOI 10.1016/S0140-6736(05)66781-5; Stone OA, 2009, ARTERIOSCL THROM VAS, V29, P657, DOI 10.1161/ATVBAHA.108.182139; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Towler DA, 2015, CIRC RES, V117, P744, DOI 10.1161/CIRCRESAHA.115.307407; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Welch-Reardon KM, 2015, ARTERIOSCL THROM VAS, V35, P303, DOI 10.1161/ATVBAHA.114.303220; Yao JY, 2015, CIRC RES, V117, P758, DOI 10.1161/CIRCRESAHA.115.306751; Yao YC, 2008, CIRC RES, V102, P1065, DOI 10.1161/CIRCRESAHA.107.166124; Yao Y, 2007, J BIOL CHEM, V282, P30131, DOI 10.1074/jbc.M704297200; Yao YC, 2006, J BIOL CHEM, V281, P33921, DOI 10.1074/jbc.M604239200; Yao YC, 2013, CIRC RES, V113, P495, DOI 10.1161/CIRCRESAHA.113.301792; Yao YC, 2011, J CLIN INVEST, V121, P2993, DOI 10.1172/JCI57567; Yao YC, 2010, CIRC RES, V107, P485, DOI 10.1161/CIRCRESAHA.110.219071; Yayama K, 2003, BBA-MOL CELL RES, V1593, P231, DOI 10.1016/S0167-4889(02)00393-2	51	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167936	10.1371/journal.pone.0167936	http://dx.doi.org/10.1371/journal.pone.0167936			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936229	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100233
J	Ibrahim, N; Moy, FM; Awalludin, IAN; Ali, ZM; Ismail, IS				Ibrahim, Norliza; Moy, Foong Ming; Awalludin, Intan Attikah Nur; Ali, Zainudin Mohd; Ismail, Ikram Shah			Effects of a Community-Based Healthy Lifestyle Intervention Program (Co-HELP) among Adults with Prediabetes in a Developing Country: A Quasi-Experimental Study	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; DIABETES PREVENTION PROGRAM; PHYSICAL-ACTIVITY; RISK-FACTORS; REAL-WORLD; EXERCISE; DIET; IMPACT; POPULATION; MELLITUS	Background The prevalence of type 2 diabetes among Malaysian adults has increased by more than two folds over the past two decades. Strategies to collaborate with the existing community partners may become a promising channel for wide-scale dissemination of diabetes prevention in the country. The objectives of this study were to determine the effects of community-based lifestyle interventions delivered to adults with prediabetes and their health-related quality of life as compared to the usual care group. Methods This was a quasi-experimental study conducted in two sub-urban communities in Seremban, Malaysia. A total of 268 participants with prediabetes aged between 18 to 65 years old were assigned to either the community-based lifestyle intervention (Co-HELP) (n=122) or the usual care (n=146) groups. The Co-HELP program was delivered in partnership with the existing community volunteers to incorporate diet, physical activity, and behaviour modification strategies. Participants in the Co-HELP group received twelve group-based sessions and two individual counselling to reinforce behavioural change. Participants in the usual care group received standard health education from primary health providers in the clinic setting. Primary outcomes were fasting blood glucose, 2-hour plasma glucose, and HbA1C. Secondary outcomes included weight, BMI, waist circumference, total cholesterol, triglyceride, LDL cholesterol, HDL cholesterol, systolic and diastolic blood pressure, physical activity, diet, and health-related quality of life (HRQOL). Results An intention-to-treat analysis of between-groups at 12-month (mean difference, 95% CI) revealed that the Co-HELP participants' mean fasting plasma glucose reduced by -0.40 mmol/l (-0.51 to -0.28, p< 0.001), 2-hour post glucose by -0.58 mmol/l (-0.91 to -0.24, p< 0.001), HbA1C by -0.24% (-0.34 to -0.15, p< 0.001), diastolic blood pressure by -2.63 mmHg (-3.79 to -1.48, p< 0.01), and waist circumference by -2.44 cm (-4.75 to -0.12, p< 0.05) whereas HDL cholesterol increased by 0.12 mmol/l (0.05 to 0.13, p< 0.01), compared to the usual care group. Significant improvements were also found in HRQOL for both physical component (PCS) by 6.51 points (5.21 to 7.80, p< 0.001) and mental component (MCS) by 7.79 points (6.44 to 9.14, p< 0.001). Greater proportion of participants from the Co-HELP group met the clinical recommended target of 5% or more weight loss from the initial weight (24.6% vs 3.4%, p< 0.001) and physical activity of > 600 METS/min/wk (60.7% vs 32.2%, p< 0.001) compared to the usual care group. Conclusions This study provides evidence that a culturally adapted diabetes prevention program can be implemented in the community setting, with reduction of several diabetes risk factors and improvement of HRQOL. Collaboration with existing community partners demonstrated a promising channel for the wide-scale dissemination of diabetes prevention at the community level. Further studies are required to determine whether similar outcomes could be achieved in communities with different socioeconomic backgrounds and geographical areas.	[Ibrahim, Norliza] Univ Malaya, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Moy, Foong Ming] Univ Malaya, Dept Social & Prevent Med, Julius Ctr, Kuala Lumpur, Malaysia; [Awalludin, Intan Attikah Nur] Hosp Taiping, Dept Dietet, Perak, Malaysia; [Ali, Zainudin Mohd] State Hlth Dept Negeri Sembilan, Seremban, Negeri Sembilan, Malaysia; [Ismail, Ikram Shah] Univ Malaya, Med Ctr, Dept Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Ibrahim, N (corresponding author), Univ Malaya, Dept Social & Prevent Med, Kuala Lumpur, Malaysia.	drliza72@gmail.com	ISMAIL, IKRAM SHAH/B-8651-2010; Moy, Foong Ming/B-7899-2010; Ismail, Ikram Shah/A-6329-2009	ISMAIL, IKRAM SHAH/0000-0001-8796-1936; Moy, Foong Ming/0000-0002-0306-4419; 	University of Malaya [PV 065/2011A]; National Health Promotion Board; Ministry of Health Malaysia [(4) LPKM/04/061/06/07]; Ministry of Education-High Impact Research (MOE-HIR) Grant, Malaysia [H-20001-00-E00069]	University of Malaya(Universiti Malaya); National Health Promotion Board; Ministry of Health Malaysia; Ministry of Education-High Impact Research (MOE-HIR) Grant, Malaysia	University of Malaya (Post Graduate Research Grant, ref no: PV 065/2011A), the National Health Promotion Board, Ministry of Health Malaysia (ref no: (4) LPKM/04/061/06/07) and Ministry of Education-High Impact Research (MOE-HIR) Grant, Malaysia (ref no: H-20001-00-E00069. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absetz P, 2007, DIABETES CARE, V30, P2465, DOI 10.2337/dc07-0171; Ackermann RT, 2006, DIABETES CARE, V29, P1237, DOI 10.2337/dc05-1709; Ackermann RT, 2008, AM J PREV MED, V35, P357, DOI 10.1016/j.amepre.2008.06.035; Al-Haddad MA, 2009, J CLIN DIAGN RES, V3, P1633; Ali MK, 2012, HEALTH AFFAIR, V31, P67, DOI 10.1377/hlthaff.2011.1009; ALI O, 1993, DIABETES CARE, V16, P68, DOI 10.2337/diacare.16.1.68; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS55, DOI 10.2337/dc08-S055; Armstrong R, 2008, J PUBLIC HEALTH-UK, V30, P103, DOI 10.1093/pubmed/fdm082; Azman A B, 2003, Med J Malaysia, V58, P694; Boltri JM, 2008, J PUBLIC HEALTH MAN, V14, P29; Chan S.P., 1999, 10 C AS FED END SOC; Cohen J.E., 1988, STAT POWER ANAL BEHA; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; de Vegt F, 2001, JAMA-J AM MED ASSOC, V285, P2109, DOI 10.1001/jama.285.16.2109; DeHaven MJ, 2011, CONTEMP CLIN TRIALS, V32, P630, DOI 10.1016/j.cct.2011.05.017; Department of Statistics Malaysia, 2011, POPULATION DISTRIBUT; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Duncan GE, 2003, DIABETES CARE, V26, P557, DOI 10.2337/diacare.26.3.557; Dunkley AJ, 2014, DIABETES CARE, V37, P922, DOI 10.2337/dc13-2195; Eriksson KM, 2006, SCAND J PUBLIC HEALT, V34, P453, DOI 10.1080/14034940500489826; ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196; Faridi Z, 2010, HEALTH EDUC RES, V25, P306, DOI 10.1093/her/cyp005; Forouhi NG, 2007, DIABETIC MED, V24, P200, DOI 10.1111/j.1464-5491.2007.02068.x; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Institute of Public Health, 2006, 3 NAT HLTH MORB SURV, V2; International Diabetes Federation, GLOB BURD IDF DIAB A; International Diabetes Federation, 2009, GLOB EST PREV DIAB 2; IPAQ, 2005, GUIDELINES DATA PROC; Ismail IS, 2004, MANAGEMENT OBESITY, V1, P1; Jaber LA, 2011, DIABETES RES CLIN PR, V91, P307, DOI 10.1016/j.diabres.2010.11.032; Katula JA, 2011, DIABETES CARE, V34, P1451, DOI 10.2337/dc10-2115; Kementerian Kesihatan Malaysia, 2018, CLIN PRACTICE GUIDEL, V5th Edition; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kulzer B, 2009, DIABETES CARE, V32, P1143, DOI 10.2337/dc08-2141; Levitzky YS, 2008, J AM COLL CARDIOL, V51, P264, DOI 10.1016/j.jacc.2007.09.038; LiChia-Li, 2008, ARCH GERONT IN PRESS; Malaysian Dietitians' Association, 2005, MED NUTR THER TYP 2; Malaysian Dietitians' Association, 2013, MED NUTR THER GUID T; Ministry of Health Malaysia, 2009, MAN TYP 2 DIAB MELL; Nanri A, 2012, J OCCUP HEALTH, V54, P215, DOI 10.1539/joh.11-0238-OA; Norlaili, 2011, DIABETES CARE, P1; Norma S, 2013, J NURSING HLTH SCI I, V2, P14; Oka R, 2009, DIABETES RES CLIN PR, V83, P100, DOI 10.1016/j.diabres.2008.10.001; Oldroyd JC, 2006, DIABETES RES CLIN PR, V72, P117, DOI 10.1016/j.diabres.2005.09.018; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Rampal L, 2008, PUBLIC HEALTH, V122, P11, DOI 10.1016/j.puhe.2007.05.008; Rampal S, 2009, ASIA PACIFIC J PUBLI, V22; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Sararaks S, 2005, Med J Malaysia, V60, P163; Seppala T, 2013, PRIM CARE DIABETES, P1; Shaharudin Idrus, 2010, MALAYSIAN J ENV MANA, V11; State Health Department of Negeri Sembilan and Ministry of Health Malaysia, 2009, INT ED MOD NONC DIS; Tapp RJ, 2006, DIABETES RES CLIN PR, V74, P154, DOI 10.1016/j.diabres.2006.03.012; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WHO, 2004, LANCET, V363, P902; Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62; Yeboah J, 2011, J AM COLL CARDIOL, V58, P140, DOI 10.1016/j.jacc.2011.03.025; Zaini A, 2000, DIABETES RES CLIN PR, V50, pS23, DOI 10.1016/S0168-8227(00)00175-3	62	26	25	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167123	10.1371/journal.pone.0167123	http://dx.doi.org/10.1371/journal.pone.0167123			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27935988	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100064
J	Jia, CL; Kong, XY; Koltes, JE; Gou, X; Yang, SL; Yan, DW; Lu, SX; Wei, ZH				Jia, Cunling; Kong, Xiaoyan; Koltes, James E.; Gou, Xiao; Yang, Shuli; Yan, Dawei; Lu, Shaoxiong; Wei, Zehui			Gene Co-Expression Network Analysis Unraveling Transcriptional Regulation of High Altitude Adaptation of Tibetan Pig	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; REVEALS ADAPTATION; HEMOGLOBIN CONCENTRATION; HYPOXIA; GENOME; EXPRESSION; SELECTION; PATTERNS; PROTEIN; DOMAIN	Tibetan pigs have survived at high altitude for millennia and they have a suite of adaptive features to tolerate the hypoxic environment. However, the molecular mechanisms underlying the regulation of hypoxia-adaptive phenotypes have not been completely elucidated. In this study, we analyzed differentially expressed genes (DEGs), biological pathways and constructed co-expression regulation networks using whole-transcriptome microarrays from lung tissues of Tibetan and Duroc pigs both at high and low altitude. A total of 3,066 DEGs were identified and this list was over-represented for the ontology terms including metabolic process, catalytic activity, and KEGG pathway including metabolic pathway and PI3K-Akt signaling pathway. The regulatory (RIF) and phenotypic (PIF) impact factor analysis identified several known and several potentially novel regulators of hypoxia adaption, including: IKBKG, KLF6 and RBPJ(RIF1), SF3B1, EFEMP1, HOXB6 and ATF6(RIF2). These findings provide new details of the regulatory architecture of hypoxia-adaptive genes and also insight into which genes may undergo epigenetic modification for further study in the high altitude adaptation.	[Jia, Cunling; Wei, Zehui] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Kong, Xiaoyan; Gou, Xiao; Yang, Shuli; Yan, Dawei; Lu, Shaoxiong] Yunnan Agr Univ, Coll Anim Sci & Technol, Kunming, Yunnan, Peoples R China; [Koltes, James E.] Univ Arkansas, Dept Anim Sci, Fayetteville, AR 72701 USA	Northwest A&F University - China; Yunnan Agricultural University; University of Arkansas System; University of Arkansas Fayetteville	Wei, ZH (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.; Lu, SX (corresponding author), Yunnan Agr Univ, Coll Anim Sci & Technol, Kunming, Yunnan, Peoples R China.	shxl@126.com; weizehui7848@163.com		Jia, Cunling/0000-0002-2753-2352	National High Technology Research and Development Program 863 [2013AA102503]; National Natural Science Foundation of China [U1036604, 31260542]	National High Technology Research and Development Program 863(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National High Technology Research and Development Program 863 (http://program.most.gov.cn/) Grant # 2013AA102503, to XG; National Natural Science Foundation of China (http://www.nsfc.gov.cn) Grant # U1036604, to ZHW and National Natural Science Foundation of China (http://www.nsfc.gov.cn) Grant # 31260542 to DWY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-834; Bastian FB, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav043; Beall CM, 2006, INTEGR COMP BIOL, V46, P18, DOI 10.1093/icb/icj004; Beall CM, 2000, HUM BIOL, V72, P201; Beall CM, 1998, AM J PHYS ANTHROPOL, V106, P385, DOI 10.1002/(SICI)1096-8644(199807)106:3<385::AID-AJPA10>3.3.CO;2-6; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Bigham AW, 2014, GENE DEV, V28, P2189, DOI 10.1101/gad.250167.114; Blanchon L, 2001, MECH DEVELOP, V105, P185, DOI 10.1016/S0925-4773(01)00391-4; Borggrefe T, 2016, BBA-MOL CELL RES, V1863, P303, DOI 10.1016/j.bbamcr.2015.11.020; Bracken CP, 2005, J BIOL CHEM, V280, P14240, DOI 10.1074/jbc.M409987200; Chen JJ, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/768756; Cheviron ZA, 2012, HEREDITY, V108, P354, DOI 10.1038/hdy.2011.85; Clerici C, 2009, AM J PHYSIOL-LUNG C, V296, pL267, DOI 10.1152/ajplung.90528.2008; Dolatshad H, 2015, LEUKEMIA, V29, P1798, DOI 10.1038/leu.2015.178; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gallagher WM, 2005, TRENDS MOL MED, V11, P336, DOI 10.1016/j.molmed.2005.06.001; Ge RL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2860; Gou X, 2014, GENOME RES, V24, P1308, DOI 10.1101/gr.171876.113; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; Hudson NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007249; Hudson NJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000382; Johnson AB, 2008, MUTAT RES-FUND MOL M, V640, P174, DOI 10.1016/j.mrfmmm.2008.01.001; Koesterke L., 2013, P C EXTR SCI ENG DIS; Li MZ, 2013, NAT GENET, V45, P1431, DOI 10.1038/ng.2811; Liu L, 2013, AM J PATHOL, V182, P1412, DOI 10.1016/j.ajpath.2012.12.020; Lorenzo FR, 2014, NAT GENET, V46, P951, DOI 10.1038/ng.3067; MacInnis MJ, 2010, HIGH ALT MED BIOL, V11, P349, DOI 10.1089/ham.2010.1030; Magli MC, 1997, J CELL PHYSIOL, V173, P168, DOI 10.1002/(SICI)1097-4652(199711)173:2<168::AID-JCP16>3.0.CO;2-C; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mirtschink P, 2016, BBA-MOL CELL RES, V1863, P1822, DOI 10.1016/j.bbamcr.2016.02.011; Moore LG, 2001, HIGH ALT MED BIOL, V2, P257, DOI 10.1089/152702901750265341; Pavlidis P, 2003, METHODS, V31, P282, DOI 10.1016/S1046-2023(03)00157-9; Peng Y, 2011, MOL BIOL EVOL, V28, P1075, DOI 10.1093/molbev/msq290; Perez-Perri JI, 2011, INT J MOL SCI, V12, P4705, DOI 10.3390/ijms12074705; Petousi N, 2014, J APPL PHYSIOL, V116, P875, DOI 10.1152/japplphysiol.00605.2013; Qiu Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10283; Qiu Q, 2012, NAT GENET, V44, P946, DOI 10.1038/ng.2343; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; Reverter A, 2010, BIOINFORMATICS, V26, P896, DOI 10.1093/bioinformatics/btq051; Roach RC, 2013, HYPOXIA GENES BEDSID; Sakai A, 2003, JPN J PHYSIOL, V53, P377, DOI 10.2170/jjphysiol.53.377; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shifera AS, 2010, J CELL MOL MED, V14, P2404, DOI 10.1111/j.1582-4934.2010.01054.x; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Singh RS, 2015, GENOME, V58, P55, DOI 10.1139/gen-2015-0012; Sit B, 2013, UNIVERSITY OF TORONT, V7; Song S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2449-0; Stepanek J, 1998, WILD ENVIRON MED, V9, P8, DOI 10.1580/1080-6032(1998)009[0008:TPAAAM]2.3.CO;2; STREETER RG, 1975, J APPL PHYSIOL, V38, P309, DOI 10.1152/jappl.1975.38.2.309; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Wang L, 2009, HEPATOLOGY, V49, P268, DOI 10.1002/hep.22579; Warke VG, 2003, J BIOL CHEM, V278, P14812, DOI 10.1074/jbc.M300787200; Watson JA, 2010, EPIGENETICS-US, V5, P293, DOI 10.4161/epi.5.4.11684; Wei CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep26770; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wu MZ, 2011, MOL CELL, V43, P811, DOI 10.1016/j.molcel.2011.07.012; Wu TY, 2005, J APPL PHYSIOL, V98, P598, DOI 10.1152/japplphysiol.01034.2002; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Yu YH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00584; Zhang FX, 2015, INT J CLIN EXP PATHO, V8, P5189; Zhang Q, 2016, GENOME BIOL EVOL, V8, P765, DOI 10.1093/gbe/evw032; Zhang W. T., 2014, CHINESE TEA, V10, P10, DOI DOI 10.1371/J0URNAL.PPAT.1004244; Zimmermann F, 1997, BLOOD, V89, P2723, DOI 10.1182/blood.V89.8.2723	68	18	23	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168161	10.1371/journal.pone.0168161	http://dx.doi.org/10.1371/journal.pone.0168161			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936142	gold, Green Submitted, Green Published			2022-12-27	WOS:000389587100276
J	Ratajczak, J; Hilkens, P; Gervois, P; Wolfs, E; Jacobs, R; Lambrichts, I; Bronckaers, A				Ratajczak, Jessica; Hilkens, Petra; Gervois, Pascal; Wolfs, Esther; Jacobs, Reinhilde; Lambrichts, Ivo; Bronckaers, Annelies			Angiogenic Capacity of Periodontal Ligament Stem Cells Pretreated with Deferoxamine and/or Fibroblast Growth Factor-2	PLOS ONE			English	Article							HYDROXYLASE INHIBITORS INCREASE; REGENERATIVE MEDICINE; FACTOR EXPRESSION; STROMAL CELLS; DIFFERENTIATION; CULTURE; VEGF	Periodontal ligament stem cells (PDLSCs) represent a good source of multipotent cells for cell-based therapies in regenerative medicine. The success rate of these treatments is severely dependent on the establishment of adequate vasculature in order to provide oxygen and nutrients to the transplanted cells. Pharmacological preconditioning of stem cells has been proposed as a promising method to augment their therapeutic efficacy. In this study, the aim was to improve the intrinsic angiogenic properties of PDLSCs by in vitro pretreatment with deferoxamine (DFX; 100 mu M), fibroblast growth factor-2 (FGF-2; 10ng/mL) or both substances combined. An antibody array revealed the differential expression of several proteins, including vascular endothelial growth factor (VEGF) and placental growth factor (PlGF). ELISA data confirmed a 1.5 to 1.8-fold increase in VEGF for all tested conditions. Moreover, 48 hours after the removal of DFX, VEGF levels remained elevated (1.8-fold) compared to control conditions. FGF-2 and combination treatment resulted in a 5.4 to 13.1-fold increase in PlGF secretion, whereas DFX treatment had no effect. Furthermore, both PDLSCs as pretreated PDLSCs induced endothelial migration. Despite the significant elevated VEGF levels of pretreated PDLSCs, the induced endothelial migration was not higher by pretreated PDLSCs. We find that the observed induced endothelial cell motility was not dependent on VEGF, since blocking the VEGFR1-3 with Axitinib (0.5nM) did not inhibit endothelial motility towards PDLSCs. Taken together, this study provides evidence that preconditioning with DFX and/or FGF-2 significantly improves the angiogenic secretome of PDLSCs, in particular VEGF and PlGF secretion. However, our data suggest that VEGF is not the only player when it comes to influencing endothelial behavior by the PDLSCs.	[Ratajczak, Jessica; Hilkens, Petra; Gervois, Pascal; Wolfs, Esther; Lambrichts, Ivo; Bronckaers, Annelies] Hasselt Univ, Biomed Res Inst, Morphol Res Grp, Diepenbeek, Belgium; [Jacobs, Reinhilde] Univ Leuven, Fac Med, Dept Imaging & Pathol, OMFS IMPATH Res Grp,Oral Imaging Ctr, Leuven, Belgium	Hasselt University; KU Leuven	Bronckaers, A (corresponding author), Hasselt Univ, Biomed Res Inst, Morphol Res Grp, Diepenbeek, Belgium.	annelies.bronckaers@uhasselt.be	Lambrichts, Ivo/CAJ-1727-2022; Wolfs, Esther/H-1862-2017; Gervois, Pascal/AAC-4624-2022; Hilkens, Petra/ABE-4972-2020	Wolfs, Esther/0000-0001-9277-6524; Bronckaers, Annelies/0000-0001-8969-873X; jacobs, reinhilde/0000-0002-3461-0363; Lambrichts, Ivo/0000-0001-7520-0021; Gervois, Pascal/0000-0002-8320-1320	Research Foundation-Flanders ('Fonds Wetenschappelijk onderzoek Vlaanderen-FWO') [G089213N]	Research Foundation-Flanders ('Fonds Wetenschappelijk onderzoek Vlaanderen-FWO')(FWO)	This research was supported by grants to Ivo Lambrichts, Reinhilde Jacobs and Jessica Ratajczak from the Research Foundation-Flanders ('Fonds Wetenschappelijk onderzoek Vlaanderen-FWO', grant no G089213N). Annelies Bronckaers and Petra Hilkens are postdoctoral fellows of the FWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Agis H, 2012, J PERIODONTAL RES, V47, P165, DOI 10.1111/j.1600-0765.2011.01415.x; Bando Y, 2009, J PERIODONTAL RES, V44, P395, DOI 10.1111/j.1600-0765.2008.01118.x; Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chimote G, 2014, DRUG DES DEV THER, V8, P1107, DOI 10.2147/DDDT.S55621; Distler JHW, 2003, Q J NUCL MED, V47, P149; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Gerwins P, 2000, CRIT REV ONCOL HEMAT, V34, P185, DOI 10.1016/S1040-8428(00)00062-7; Hilkens P, 2014, STEM CELL RES, V12, P778, DOI 10.1016/j.scr.2014.03.008; Hilkens P, 2013, CELL TISSUE RES, V353, P65, DOI 10.1007/s00441-013-1630-x; Kubo M, 2008, AM J PHYSIOL-HEART C, V294, pH590, DOI 10.1152/ajpheart.00856.2007; Lee MJ, 2010, BIOCHEM BIOPH RES CO, V396, P370, DOI 10.1016/j.bbrc.2010.04.099; Liu GS, 2016, J TISSUE ENG REGEN M, V10, pE167, DOI 10.1002/term.1796; Liu LQ, 2013, CELL BIOL INT, V37, P551, DOI 10.1002/cbin.10097; Muller HD, 2012, J ENDODONT, V38, P1498, DOI 10.1016/j.joen.2012.08.003; Muscari C, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-63; Nakamura S, 2008, BIO-MED MATER ENG, V18, P129, DOI 10.3233/BME-2008-0516; Nokhbehsaim M, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/796565; Osathanon T, 2015, ARCH ORAL BIOL, V60, P29, DOI 10.1016/j.archoralbio.2014.08.018; Oyama T, 2000, J PERIODONTOL, V71, P1546, DOI 10.1902/jop.2000.71.10.1546; Potier E, 2008, J TISSUE ENG REGEN M, V2, P272, DOI 10.1002/term.92; Potier E, 2007, BONE, V40, P1078, DOI 10.1016/j.bone.2006.11.024; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Yanagita M, 2014, J DENT RES, V93, P89, DOI 10.1177/0022034513511640; Yeasmin S, 2014, TISSUE ENG PT A, V20, P1188, DOI [10.1089/ten.TEA.2013.0512, 10.1089/ten.tea.2013.0512]	28	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167807	10.1371/journal.pone.0167807	http://dx.doi.org/10.1371/journal.pone.0167807			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936076	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100200
J	Reese, AT; Ames, GM; Wright, JP				Reese, Aspen T.; Ames, Gregory M.; Wright, Justin P.			Variation in Plant Response to Herbivory Underscored by Functional Traits	PLOS ONE			English	Article							LATITUDINAL VARIATION; SIMULATED HERBIVORY; HABITAT SPECIALIZATION; RESOURCE AVAILABILITY; TOLERANCE; RESISTANCE; EVOLUTION; PATTERNS; ECOLOGY; GROWTH	The effects of herbivory can shape plant communities and evolution. However, the many forms of herbivory costs and the wide variation in herbivory pressure, including across latitudinal gradients, can make predicting the effects of herbivory on different plant species difficult. Functional trait approaches may aid in contextualizing and standardizing the assessment of herbivory impacts. Here we assessed the response of 26 old-field plant species to simulated defoliation in a greenhouse setting by measuring whole plant and leaf level traits in control and treated individuals. Simulated defoliation had no significant effects on any plant traits measured. However, the baseline leaf level traits of healthy plants consistently predicted the log response ratio for these species whole plant response to defoliation. The latitudinal mid-point of species' distributions was also significantly correlated with aboveground biomass and total leaf area responses, with plants with a more northern distribution being more negatively impacted by treatment. These results indicate that even in the absence of significant overall impacts, functional traits may aid in predicting variability in plant responses to defoliation and in identifying the underlying limitations driving those responses.	[Reese, Aspen T.; Ames, Gregory M.; Wright, Justin P.] Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University	Reese, AT (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	aspen.reese@duke.edu	Wright, Justin/AAG-6461-2019	Wright, Justin/0000-0002-9102-5347; Ames, Gregory/0000-0003-4893-5318	National Science Foundation [DGE 1106401, DEB-1119715]; Division Of Environmental Biology [1119715] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	ATR was supported by National Science Foundation Graduate Research Fellowship Program under Grant No. DGE 1106401. JPW was supported by National Science Foundation grant DEB-1119715. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala-Roberts L, 2016, J ECOL, V104, P580, DOI 10.1111/1365-2745.12512; Agrawal AA, 2006, ECOLOGY, V87, pS132, DOI 10.1890/0012-9658(2006)87[132:PDS]2.0.CO;2; Ames GM, 2016, FUNCT ECOL, V30, P789, DOI 10.1111/1365-2435.12536; Anstett DN, 2015, ECOL LETT, V18, P1376, DOI 10.1111/ele.12532; Ashton IW, 2008, DIVERS DISTRIB, V14, P169, DOI 10.1111/j.1472-4642.2007.00425.x; BALDWIN IT, 1988, OECOLOGIA, V77, P378, DOI 10.1007/BF00378046; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bergman M, 2002, OIKOS, V96, P164, DOI 10.1034/j.1600-0706.2002.960118.x; Bossdorf O, 2004, AM J BOT, V91, P856, DOI 10.3732/ajb.91.6.856; BROWN VK, 1989, OIKOS, V54, P67, DOI 10.2307/3565898; Cadenasso ML, 2002, J TORREY BOT SOC, V129, P228, DOI 10.2307/3088773; Carmona D, 2011, FUNCT ECOL, V25, P358, DOI 10.1111/j.1365-2435.2010.01794.x; Carson WP, 1999, OECOLOGIA, V121, P260, DOI 10.1007/s004420050928; CHOONG MF, 1992, NEW PHYTOL, V121, P597, DOI 10.1111/j.1469-8137.1992.tb01131.x; Cingolani AM, 2005, J APPL ECOL, V42, P50, DOI 10.1111/j.1365-2664.2004.00978.x; Clissold FJ, 2009, ECOLOGY, V90, P3393, DOI 10.1890/09-0130.1; Coley P.D., 1991, PLANT ANIMAL INTERAC, P25; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; COLEY PD, 1988, OECOLOGIA, V74, P531, DOI 10.1007/BF00380050; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Crawley M. J., 1983, Herbivory. The dynamics of animal--plant interactions.; Diaz A, 2000, AGR ECOSYST ENVIRON, V78, P249, DOI 10.1016/S0167-8809(99)00131-0; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; Endara MJ, 2011, FUNCT ECOL, V25, P389, DOI 10.1111/j.1365-2435.2010.01803.x; Escarre J, 1996, OECOLOGIA, V105, P501, DOI 10.1007/BF00330013; Fine PVA, 2004, SCIENCE, V305, P663, DOI 10.1126/science.1098982; Fornoni J, 2011, FUNCT ECOL, V25, P399, DOI 10.1111/j.1365-2435.2010.01805.x; Gruner DS, 2008, ECOL LETT, V11, P740, DOI 10.1111/j.1461-0248.2008.01192.x; Hanley ME, 2007, PERSPECT PLANT ECOL, V8, P157, DOI 10.1016/j.ppees.2007.01.001; Hillebrand H, 2007, P NATL ACAD SCI USA, V104, P10904, DOI 10.1073/pnas.0701918104; Hjalten J, 2004, ECOL STU AN, V173, P243; HJALTEN J, 1993, ECOLOGY, V74, P1136, DOI 10.2307/1940483; Hjalten J, 1999, ECOSCIENCE, V6, P62; Houle G, 1996, OECOLOGIA, V107, P373, DOI 10.1007/BF00328454; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kursar TA, 2003, BIOCHEM SYST ECOL, V31, P929, DOI 10.1016/S0305-1978(03)00087-5; Lamarre GPA, 2012, ECOLOGY, V93, pS195, DOI 10.1890/11-0397.1; Lehtila K, 2004, ECOL STU AN, V173, P257; Lim JY, 2015, GLOBAL ECOL BIOGEOGR, V24, P1106, DOI 10.1111/geb.12336; Long WX, 2011, OECOLOGIA, V167, P1103, DOI 10.1007/s00442-011-2050-9; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Moles AT, 2011, NEW PHYTOL, V191, P777, DOI 10.1111/j.1469-8137.2011.03732.x; Moles AT, 2011, FUNCT ECOL, V25, P380, DOI 10.1111/j.1365-2435.2010.01814.x; Moreira X, 2014, ECOL LETT, V17, P537, DOI 10.1111/ele.12253; Nabity PD, 2009, ANN BOT-LONDON, V103, P655, DOI 10.1093/aob/mcn127; Novotny V, 2006, SCIENCE, V313, P1115, DOI 10.1126/science.1129237; Nunez-Farfan J, 2007, ANNU REV ECOL EVOL S, V38, P541, DOI 10.1146/annurev.ecolsys.38.091206.095822; Pearse IS, 2012, EVOLUTION, V66, P2272, DOI 10.1111/j.1558-5646.2012.01591.x; Pennings SC, 2009, ECOLOGY, V90, P183, DOI 10.1890/08-0222.1; QUESADA M, 1995, ECOLOGY, V76, P437, DOI 10.2307/1941202; Rasmann S, 2011, ECOL LETT, V14, P476, DOI 10.1111/j.1461-0248.2011.01609.x; Reich PB, 2003, INT J PLANT SCI, V164, pS143, DOI 10.1086/374368; Restif O, 2004, AM NAT, V164, pE90, DOI 10.1086/423713; ROOT RB, 1992, ECOL MONOGR, V62, P393, DOI 10.2307/2937117; Salazar D, 2012, P NATL ACAD SCI USA, V109, P12616, DOI 10.1073/pnas.1202907109; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Siefert A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111189; Stowe KA, 2000, ANNU REV ECOL SYST, V31, P565, DOI 10.1146/annurev.ecolsys.31.1.565; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Strickland MS, 2013, P NATL ACAD SCI USA, V110, P11035, DOI 10.1073/pnas.1305191110; Tiffin P, 2000, EVOLUTION, V54, P1024, DOI 10.1111/j.0014-3820.2000.tb00101.x; Tiffin P, 2000, AM NAT, V155, P128, DOI 10.1086/303301; TURNER IM, 1994, FUNCT ECOL, V8, P669, DOI 10.2307/2390225; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Westbrook JW, 2011, AM NAT, V177, P800, DOI 10.1086/659963; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; Wieski K, 2014, ECOGRAPHY, V37, P763, DOI 10.1111/ecog.00498; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P411, DOI 10.1111/j.1466-822x.2005.00172.x; Wright JP, 2010, J BIOGEOGR, V37, P1584, DOI 10.1111/j.1365-2699.2010.02298.x; Zanne AE, 2014, NATURE, V506, P89, DOI 10.1038/nature12872	71	13	14	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166714	10.1371/journal.pone.0166714	http://dx.doi.org/10.1371/journal.pone.0166714			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936155	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100043
J	Sato, S; Chiba, T				Sato, Shin'ichi; Chiba, Tomoki			Structural Changes in Molluscan Community over a 15-Year Period before and after the 2011 Great East Japan Earthquake and Subsequent Tsunami around Matsushima Bay, Miyagi Prefecture, Northeastern Japan	PLOS ONE			English	Article							GASTROPODA NATICIDAE; SENDAI BAY; RECOVERY; IMPACTS; SEA; POPULATIONS; VEGETATION; RESPONSES; INVASION; PREDATOR	We examined structural changes in the molluscan community for ten years (2001-2010) before and five years (2011-2015) after the 2011 Great East Japan Earthquake and subsequent tsunami around Matsushima Bay, Miyagi Prefecture, northeastern Japan. Before the earthquake and tsunami, Ruditapes philippinarum, Macoma incongrua, Pillucina pisidium, and Batillaria cumingii were dominant, and an alien predator Laguncula pulchella appeared in 2002 and increased in number. After the tsunami, R. philippinarum and M. incongrua populations quickly recovered in 2012, but P. pisidium and B. cumingii populations did not recover until 2015. By contrast, Musculista senhousia, Mya arenaria, Retusa sp., and Solen strictus were found in low densities before the tsunami, but they rapidly increased in abundance/number over five years after the tsunami. These results suggest that the molluscan community on the Tona Coast was drastically changed by the earthquake and tsunami, and some species mainly inhabiting the intertidal-subtidal zone may have increased in number because of land subsidence. We also emphasize that the seawall delayed recovery of the intertidal community after the earthquake and tsunami.	[Sato, Shin'ichi] Shizuoka Univ, Inst Geosci, Shizuoka, Japan	Shizuoka University	Sato, S (corresponding author), Shizuoka Univ, Inst Geosci, Shizuoka, Japan.	sato.shinichi.c@shizuoka.ac.jp			Tohoku Ecosystem-Associated Marine Science (TEAMS) from the Ministry of Education, Culture, Sports, Science and Technology, Japan	Tohoku Ecosystem-Associated Marine Science (TEAMS) from the Ministry of Education, Culture, Sports, Science and Technology, Japan	This study was supported in part by the research fund from Tohoku Ecosystem-Associated Marine Science (TEAMS), from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balthis WL, 2006, ENVIRON MONIT ASSESS, V119, P367, DOI 10.1007/s10661-005-9031-6; Beukema JJ, 1999, J SEA RES, V42, P235, DOI 10.1016/S1385-1101(99)00027-1; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Borja A, 2010, ESTUAR COAST, V33, P1249, DOI 10.1007/s12237-010-9347-5; Chiba T, 2014, LETHAIA, V47, P4, DOI 10.1111/let.12033; Chiba T, 2013, BIOL INVASIONS, V15, P587, DOI 10.1007/s10530-012-0310-1; Chiba T, 2012, J MOLLUS STUD, V78, P205, DOI 10.1093/mollus/eys002; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; El uber M., 2015, COMPENDIUM BIVALVES, V2; Furota Toshio, 2002, Venus (Tokyo), V61, P15; Geospatial Information Authority of Japan, LAND SUBS CAUS 2011; Geospatial Information Authority of Japan, 5 YEARS 2011 TOH EAR; Hayasaka D, 2012, ECOL ENG, V44, P227, DOI 10.1016/j.ecoleng.2012.03.014; Huber M., 2010, COMPENDIUM BIVALVES; Japanese Association of Benthology, 2012, THREATENED ANIMALS J; Jaramillo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035348; Kanaya G., 2014, GLOB ENVIRON RES, V18, P35; Kanaya G, 2008, ESTUAR COAST SHELF S, V78, P674, DOI 10.1016/j.ecss.2008.02.005; Kanaya G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135125; Kanaya Gen, 2012, Japanese Journal of Benthology, V67, P20; Kortsch S, 2012, P NATL ACAD SCI USA, V109, P14052, DOI 10.1073/pnas.1207509109; Kroeker KJ, 2013, NAT CLIM CHANGE, V3, P156, DOI [10.1038/NCLIMATE1680, 10.1038/nclimate1680]; Lomovasky BJ, 2011, J SEA RES, V65, P205, DOI 10.1016/j.seares.2010.10.002; MATSUSHIMA Y, 1984, B KANAGAWA PREF MUS, V15, P37; Miura O, 2012, J MOLLUS STUD, V78, P377, DOI 10.1093/mollus/eys025; Newell RC, 1998, OCEANOGR MAR BIOL<D>, V36, P127; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Okutani T., 2017, MARINE MOLLUSKS JAPA; PETERSON CH, 1985, PALEOBIOLOGY, V11, P139; R Core Team, 2020, R LANG ENV STAT COMP; RHOADS DC, 1970, J MAR RES, V28, P150; Sato Shin'Ichi, 2006, Plankton & Benthos Research, V1, P123; Sato S, 2016, ECOL RES MONOGR, P179, DOI 10.1007/978-4-431-56448-5_13; Sato S, 2012, FISHERIES SCI, V78, P589, DOI 10.1007/s12562-012-0491-7; Schlacher TA, 2011, ESTUAR COAST, V34, P937, DOI 10.1007/s12237-010-9354-6; Seike K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065417; Suzuki T., 2011, J JAPAN SOC WATER EN, V34, P395; Takami H, 2013, FISH OCEANOGR, V22, P113, DOI 10.1111/fog.12008; The 2011 Tohoku Earthquake Tsunami Joint Survey (TTJS) Group, 2011 OFF PAC COAST T; Urabe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062779; Van Colen C, 2008, MAR ECOL PROG SER, V372, P31, DOI 10.3354/meps07640; Whanpetch N, 2010, ESTUAR COAST SHELF S, V87, P246, DOI 10.1016/j.ecss.2010.01.001	42	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168206	10.1371/journal.pone.0168206	http://dx.doi.org/10.1371/journal.pone.0168206			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936182	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100277
J	Tamaki, FK; Souza, DP; Souza, VP; Ikegami, CM; Farah, CS; Marana, SR				Tamaki, Fabio K.; Souza, Diorge P.; Souza, Valquiria P.; Ikegami, Cecilia M.; Farah, Chuck S.; Marana, Sandro R.			Using the Amino Acid Network to Modulate the Hydrolytic Activity of beta-Glycosidases	PLOS ONE			English	Article							SUBSTRATE-SPECIFICITY; STRUCTURE VALIDATION; TRICHODERMA-REESEI; MIDGUT CELLS; GLUCOSIDASE; RESIDUES; SITE; PURIFICATION; MUTAGENESIS; RESOLUTION	The active site residues in GH1 beta-glycosidases are compartmentalized into 3 functional regions, involved in catalysis or binding of glycone and aglycone motifs from substrate. However, it still remains unclear how residues outside the active site modulate the enzymatic activity. To tackle this question, we solved the crystal structure of the GH1 beta-glycosidase from Spodoptera frugiperda (Sf beta gly) to systematically map its residue contact network and correlate effects of mutations within and outside the active site. External mutations neighbouring the functional residues involved in catalysis and glycone-binding are deleterious, whereas mutations neighbouring the aglycone-binding site are less detrimental or even beneficial. The large dataset of new and previously characterized Sfpgly mutants supports that external perturbations are coherently transmitted to active site residues possibly through contacts and specifically disturb functional regions they interact to, reproducing the effects observed for direct mutations of functional residues. This allowed us to suggest that positions related to the aglycone-binding site are preferential targets for introduction of mutations aiming to further improve the hydrolytic activity of beta-glycosidases.	[Tamaki, Fabio K.; Souza, Diorge P.; Souza, Valquiria P.; Ikegami, Cecilia M.; Farah, Chuck S.; Marana, Sandro R.] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil; [Tamaki, Fabio K.] Inst Med Sci, Foresterhill, Aberdeen, Scotland	Universidade de Sao Paulo	Tamaki, FK (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil.; Tamaki, FK (corresponding author), Inst Med Sci, Foresterhill, Aberdeen, Scotland.	fktamaki@gmail.com	Marana, Sandro/D-3867-2012; Tamaki, Fabio K./L-6024-2013; Farah, Chuck Shaker/G-5565-2012; Souza, Valquiria/F-8726-2015	Marana, Sandro/0000-0002-5117-1921; Tamaki, Fabio K./0000-0003-2515-8202; Farah, Chuck Shaker/0000-0003-3110-6302; Souza, Valquiria/0000-0002-3052-2112; Souza, Diorge/0000-0003-1303-1765	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [08/55914-9, 14/19439-5]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); Instituto Nacional de Ciencias e Tecnologia para o Bioetanol [08/57908-1, 574002/2008-1]; FAPESP; CAPES/PNPD post-doctoral fellowship; Capes	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencias e Tecnologia para o Bioetanol; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES/PNPD post-doctoral fellowship; Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This project was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Grants 08/55914-9 and 14/19439-5), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and "Instituto Nacional de Ciencias e Tecnologia para o Bioetanol" (Grants: 08/57908-1 and 574002/2008-1). S.R.M and C.S.F are research fellows of CNPq. F.K.T. and D.P.S were supported by post-doctoral scholarships from FAPESP. D.P.S. and F.K.T. acknowledge a CAPES/PNPD post-doctoral fellowship. F.K.T. is a CNPq "Science Without Borders" fellow. C.M.I is a graduate student supported by Capes and V.P.S is a graduate student supported by FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer MW, 1996, J BIOL CHEM, V271, P23749, DOI 10.1074/jbc.271.39.23749; Cairns JRK, 2010, CELL MOL LIFE SCI, V67, P3389, DOI 10.1007/s00018-010-0399-2; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chuenchor W, 2008, J MOL BIOL, V377, P1200, DOI 10.1016/j.jmb.2008.01.076; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Daily MD, 2008, PROTEINS, V71, P455, DOI 10.1002/prot.21800; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Desai MM, 2007, GENETICS, V176, P1759, DOI 10.1534/genetics.106.067678; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERREIRA C, 1983, BIOCHEM J, V213, P43, DOI 10.1042/bj2130043; Frutuoso MA, 2013, PROTEIN PEPTIDE LETT, V20, P102, DOI 10.2174/092986613804096757; Galbe M, 2002, APPL MICROBIOL BIOT, V59, P618, DOI 10.1007/s00253-002-1058-9; Goldsmith M, 2013, METHOD ENZYMOL, V523, P257, DOI 10.1016/B978-0-12-394292-0.00012-6; Greene LH, 2003, J MOL BIOL, V334, P781, DOI 10.1016/j.jmb.2003.08.061; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Husebye H, 2005, INSECT BIOCHEM MOLEC, V35, P1311, DOI 10.1016/j.ibmb.2005.07.004; Jeng WY, 2012, ACTA CRYSTALLOGR D, V68, P829, DOI 10.1107/S0907444912013224; Jeng WY, 2011, J STRUCT BIOL, V173, P46, DOI 10.1016/j.jsb.2010.07.008; Khan S, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-11; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee HL, 2012, PROTEIN ENG DES SEL, V25, P733, DOI 10.1093/protein/gzs073; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Marana SR, 2006, IUBMB LIFE, V58, P63, DOI 10.1080/15216540600617156; Marana SR, 2004, EUR J BIOCHEM, V271, P4169, DOI 10.1111/j.1432-1033.2004.04354.x; Marana SR, 2003, EUR J BIOCHEM, V270, P4866, DOI 10.1046/j.1432-1033.2003.03887.x; Marana SR, 2002, EUR J BIOCHEM, V269, P3705, DOI 10.1046/j.1432-1033.2002.03061.x; Marana SR, 2001, BBA-PROTEIN STRUCT M, V1545, P41, DOI 10.1016/S0167-4838(00)00260-0; Marana SR, 2000, INSECT BIOCHEM MOLEC, V30, P1139, DOI 10.1016/S0965-1748(00)00090-4; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mendonca LMF, 2008, FEBS J, V275, P2536, DOI 10.1111/j.1742-4658.2008.06402.x; Mendonca LMF, 2011, BBA-PROTEINS PROTEOM, V1814, P1616, DOI 10.1016/j.bbapap.2011.08.012; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001; Resa P, 2011, ANAL BIOCHEM, V415, P1, DOI 10.1016/j.ab.2011.03.003; Seshadri S, 2009, PLANT PHYSIOL, V151, P47, DOI 10.1104/pp.109.139436; Souza VP, 2016, FEBS J, V283, P1124, DOI 10.1111/febs.13659; Stiffler MA, 2015, CELL, V160, P882, DOI 10.1016/j.cell.2015.01.035; Tamaki Fabio K, 2016, Biochem Biophys Rep, V7, P52, DOI 10.1016/j.bbrep.2016.05.014; Tamaki FK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096627; Tomassi MH, 2010, BRAZ J MED BIOL RES, V43, P8, DOI 10.1590/S0100-879X2009007500033	46	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167978	10.1371/journal.pone.0167978	http://dx.doi.org/10.1371/journal.pone.0167978			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936116	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100244
J	Vilchez-Lopez, S; Saez-Castillo, AJ; Olmo-Jimenez, MJ				Vilchez-Lopez, Silverio; Jose Saez-Castillo, Antonio; Jose Olmo-Jimenez, Maria			GWRM: An R Package for Identifying Sources of Variation in Overdispersed Count Data	PLOS ONE			English	Article							MODEL	Understanding why a random variable is actually random has been in the core of Statistics from its beginnings. The generalized Waring regression model for count data explains that inherent variability is given by three possible sources: randomness, liability and proneness. The model extends the negative binomial regression model and it is not included in the family of generalized linear models. In order to avoid that shortcoming, we developed the GWRM R package for fitting, describing and validating the model. The version we introduce in this communication provides a new design of the modelling function as well as new methods operating on the associated fitted model objects, so that the new software integrates easily into the computational toolbox for modelling count data in R. The release of a plug-in in order to use the package from the interface R Commander tries to contribute to the spreading of the model among non-advanced users. We illustrate the usage and the possibilities of the software with two examples from the fields of health and sport.	[Vilchez-Lopez, Silverio] IES Las Fuentezuelas, Jaen, Spain; [Jose Saez-Castillo, Antonio; Jose Olmo-Jimenez, Maria] Univ Jaen, Dept Stat & Operat Res, Jaen, Spain	Universidad de Jaen	Olmo-Jimenez, MJ (corresponding author), Univ Jaen, Dept Stat & Operat Res, Jaen, Spain.	mjolmo@ujaen.es	Saez-Castillo, Antonio Jose/B-5948-2015; , Olmo-Jimenez, M.J./E-1282-2015	Saez-Castillo, Antonio Jose/0000-0001-9795-9610; , Olmo-Jimenez, M.J./0000-0003-3527-3239				Ariza-Lopez FJ, 2015, INT J GEOGR INF SCI, V29, P1394, DOI 10.1080/13658816.2015.1010536; Atkinson A. C., 1985, TRANSFORMATIONS REGR; Baccini A, 2014, SCIENTOMETRICS, V101, P2035, DOI 10.1007/s11192-014-1395-3; Cameron A. C., 2013, REGRESSION ANAL COUN, V53, DOI [10.1017/CBO9781139013567, DOI 10.1017/CBO9781139013567]; Faddy MJ, 2011, J APPL STAT, V38, P2683, DOI 10.1080/02664763.2011.567250; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; Greenwood, 1920, J R STAT SOC, V83, P255; IRWIN JO, 1968, J R STAT SOC SER A-G, V131, P205, DOI 10.2307/2343842; Karlis D, 2005, INT STAT REV, V73, P35; Peng YC, 2014, ACCIDENT ANAL PREV, V73, P20, DOI 10.1016/j.aap.2014.07.031; Poisson S., 1837, PROBABILITE JUGEMENT; R Core Team, 2013, R LANG ENV STAT COMP; Rodriguez-Avi J, 2009, COMPUT STAT DATA AN, V53, P3717, DOI 10.1016/j.csda.2009.03.013; Castillo AS, 2013, EUR J SPORT SCI, V13, P127, DOI 10.1080/17461391.2011.589473; Saez-Castillo AJ, 2016, GWRM GEN WARING REGR; Saez-Castillo AJ, 2016, RCMDRPLUGIN GWRM R C; Vieira AMC, 2000, J APPL STAT, V27, P373, DOI 10.1080/02664760021673; XEKALAKI E, 1986, COMMUN STAT THEORY, V15, P1047, DOI 10.1080/03610928608829168	18	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167570	10.1371/journal.pone.0167570	http://dx.doi.org/10.1371/journal.pone.0167570			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936064	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100126
J	Zhang, I; Alizadeh, D; Liang, JL; Zhang, LY; Gao, H; Song, YY; Ren, H; Ouyang, M; Wu, XW; D'Apuzzo, M; Badie, B				Zhang, Ian; Alizadeh, Darya; Liang, Junling; Zhang, Leying; Gao, Hang; Song, Yanyan; Ren, Hui; Ouyang, Mao; Wu, Xiwei; D'Apuzzo, Massimo; Badie, Behnam			Characterization of Arginase Expression in Glioma-Associated Microglia and Macrophages	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; SUPPRESSOR-CELLS; MYELOID CELLS; PROMOTES; THERAPY; GROWTH; PROGRESSION; INVASION	Microglia (MG) and macrophages (MPs) represent a significant component of the inflammatory response to gliomas. When activated, MG/MP release a variety of pro-inflammatory cytokines, however, they also secrete anti-inflammatory factors that limit their cytotoxic function. The balance between pro and anti-inflammatory functions dictates their antitumor activity. To evaluate potential variations in MG and MP function in gliomas, we isolated these cells (and other Gr1(+) cells) from intracranial GL261 murine gliomas by FACS and evaluated their gene expression profiles by microarray analysis. As expected, arginase 1 (Arg1, M2 marker) was highly expressed by tumor-associated Gr1(+), MG and MP. However, in contrast to MP and Gr1(+) cells that expressed Arg1 shortly after tumor trafficking, Arg1 expression in MG was delayed and occurred in larger tumors. Interestingly, depletion of MPs in tumors did not prevent MG polarization, suggesting direct influence of tumor-specific factors on MG Arg1 upregulation. Finally, Arg1 expression was confirmed in human GBM samples, but most Arg1(+) cells were neutrophils and not MPs. These findings confirm variations in tumor MG and MP polarization states and its dependency on tumor microenvironmental factors.	[Zhang, Ian; Alizadeh, Darya; Zhang, Leying; Badie, Behnam] City Hope Natl Med Ctr, Beckman Res Inst, Div Neurosurg, Duarte, CA 91010 USA; [Liang, Junling] Zhejiang Univ, Coll Life Sci, Res Ctr Siyuan Nat Pharm & Biotoxicol, Hangzhou, Zhejiang, Peoples R China; [Gao, Hang] Jilin Univ, Hosp 1, Dept Bone & Joint Surg, Changchun, Jilin Province, Peoples R China; [Song, Yanyan] Jilin Univ, Hosp 2, Dept Nephrol, Changchun, Jilin Province, Peoples R China; [Ren, Hui] Jilin Univ, Hosp 2, Dept Gen Surg, Changchun, Jilin Province, Peoples R China; [Ouyang, Mao] Cent S Univ, Xiangya Hosp 3, Dept Cardiol, Changsha, Hunan, Peoples R China; [Wu, Xiwei] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol & Cellular Biol, Duarte, CA USA; [D'Apuzzo, Massimo] City Hope Natl Med Ctr, Beckman Res Inst, Dept Pathol, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; Zhejiang University; Jilin University; Jilin University; Jilin University; Central South University; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Badie, B (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Div Neurosurg, Duarte, CA 91010 USA.	bbadie@coh.org			National Cancer Institute and National Institute of Neurological Disorders [R01CA1 55769, R21NS081594, R21CA1 89223]; National Cancer Institute of the National Institutes of Health [P30CA33572]	National Cancer Institute and National Institute of Neurological Disorders; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the National Cancer Institute and National Institute of Neurological Disorders (R01CA1 55769, R21NS081594, R21CA1 89223), and the Flow Cytometry Core supported by the National Cancer Institute of the National Institutes of Health under award number (P30CA33572). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh D, 2010, CLIN CANCER RES, V16, P3399, DOI 10.1158/1078-0432.CCR-09-3087; Badie B, 2000, NEUROSURGERY, V46, P957, DOI 10.1097/00006123-200004000-00035; Chen XB, 2014, CANCER RES, V74, P7285, DOI 10.1158/0008-5472.CAN-14-1240; Coniglio SJ, 2012, MOL MED, V18, P519, DOI 10.2119/molmed.2011.00217; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrusiewicz K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023902; Galarneau H, 2007, CANCER RES, V67, P8874, DOI 10.1158/0008-5472.CAN-07-0177; Kohanbash G, 2013, CANCER RES, V73, P6413, DOI 10.1158/0008-5472.CAN-12-4124; Krause MS, 2011, J ENDOCRINOL, V211, P87, DOI 10.1530/JOE-11-0236; Kushchayev SV, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2012.11.059; Li W, 2012, NEURO-ONCOLOGY, V14, P958, DOI 10.1093/neuonc/nos116; Markovic DS, 2009, P NATL ACAD SCI USA, V106, P12530, DOI 10.1073/pnas.0804273106; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; Nagaraj S, 2010, CANCER J, V16, P348, DOI 10.1097/PPO.0b013e3181eb3358; Piao YJ, 2012, NEURO-ONCOLOGY, V14, P1379, DOI 10.1093/neuonc/nos158; Sarkar S, 2014, NAT NEUROSCI, V17, P46, DOI 10.1038/nn.3597; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Sippel TR, 2011, CLIN CANCER RES, V17, P6992, DOI 10.1158/1078-0432.CCR-11-1107; Terada K, 2006, GENE THER, V13, P705, DOI 10.1038/sj.gt.3302717; Tripathi P, 2007, INDIAN J BIOCHEM BIO, V44, P310; Umemura N, 2008, J LEUKOCYTE BIOL, V83, P1136, DOI 10.1189/jlb.0907611; Van Overmeire E, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27561; Wang HQ, 2013, CLIN CANCER RES, V19, P3764, DOI 10.1158/1078-0432.CCR-12-3725; Ye XZ, 2012, J IMMUNOL, V189, P444, DOI 10.4049/jimmunol.1103248	25	32	32	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0165118	10.1371/journal.pone.0165118	http://dx.doi.org/10.1371/journal.pone.0165118			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936099	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100009
J	Chen, H; Zhu, WJ; Lu, J; Fan, JQ; Sun, LN; Feng, XK; Liu, H; Zhang, ZH; Wang, YQ				Chen, Huan; Zhu, Weijian; Lu, Jing; Fan, Jinqing; Sun, Luning; Feng, Xiaoke; Liu, Hao; Zhang, Zhaohui; Wang, Yongqing			The Effects of Auricular Electro-Acupuncture on Ameliorating the Dysfunction of Interstitial Cells of Cajal Networks and nNOSmRNA Expression in Antrum of STZ-Induced Diabetic Rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; AUTONOMIC NEUROPATHY; ACUPUNCTURE; MECHANISMS; MOTILITY; MUSCLE; GASTROPARESIS; LOCALIZATION; PATHWAY	Backgroud Interstitial cells of Cajal (ICCs) and nNOS play a crucial role in diabetic gastrointestinal dysmotility(DGD). Our previous study found that electro-acupuncture(EA) on ear point 'stomach' could repair the gastric dysrhythmias in rats induced by rectal distention(RD) after meal. However, little were known about the possible effect of auricular electro-acupuncture (AEA) on diabetic rats. Thus, we designed this study to investigate the effect of AEA on streptozotocin(STZ)-induced diabetic rats. Method Forty male Sprague_Dawley (SD) rats were injected with STZ, at the end of 8th week after injection, animals were randomly divided into four groups and received 2 weeks-treatment (10 times) respectively: control group(CON, n = 10, no stimulation), sham auricular electro-acupuncture group(SEA, n = 10, low frequency EA on earlobes), auricular eletro-acupuncture group(AEA, n = 10, low frequency EA on ear point 'stomach'), and ST-36 group(ST-36, n = 10, low frequency EA on ST-36). Gastrointestinal (GI) motility was measured by GI transit rate. ICCs(c-kit+ expression) in antrum were analyzed by Immunohistochemistry and western blotting. NO level in blood serum were detected by Griess Reagent, and nNOSmRNA expression in antrum were determined by Real-time PCR. Results GI transit rate and ICCs(c-kit+ expression) in antrum of AEA group have the tendency to increase compared with CON group, but had no statistics difference (P>0.05). nNOSmRNA expression in antrum of AEA group was dramatically increased compared with CON group (P = 0.037). Conclusions Low frequency EA on ear 'stomach' point could significantly up-regulate nNOS mRNA expression and ameliorate the ICCs networks partly in gastric antrum of STZ -induced diabetic rats, which may has benefits on regulating the GI motility.	[Chen, Huan; Zhu, Weijian; Lu, Jing; Fan, Jinqing; Zhang, Zhaohui] Nanjing Med Univ, Dept Acupuncture, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Sun, Luning; Wang, Yongqing] Nanjing Med Univ, Dept Pharm, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Feng, Xiaoke; Liu, Hao] Nanjing Med Univ, Dept Tradit Chinese Med, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Zhang, ZH (corresponding author), Nanjing Med Univ, Dept Acupuncture, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.; Wang, YQ (corresponding author), Nanjing Med Univ, Dept Pharm, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	Z1356@126.com; wyqjsph@163.com	zhang, zh/GWV-4677-2022		Project of Jiangsu Province Bureau of Traditional Chinese Medicine [LZ13214 ZZ]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) [JX10231801]; National Natural Sciences Foundation of China [81503160, 8150150393]	Project of Jiangsu Province Bureau of Traditional Chinese Medicine; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support was received from the the Project of Jiangsu Province Bureau of Traditional Chinese Medicine (LZ13214 ZZ http://www.jstcm.gov.cn/), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) (JX10231801 http://202.119.175.131/pages/xkmd.aspx?onetype=2), and the National Natural Sciences Foundation of China (81503160 LS & 8150150393 HC http://www.nsfc.gov.cn/).	AIMI Y, 1993, NEUROSCIENCE, V53, P553, DOI 10.1016/0306-4522(93)90220-A; Al-Sajee Dhuha, 2012, Sultan Qaboos Univ Med J, V12, P411; Al-Shboul OA, 2013, SAUDI J GASTROENTERO, V19, P3, DOI 10.4103/1319-3767.105909; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Cellek S, 2003, DIABETES, V52, P2353, DOI 10.2337/diabetes.52.9.2353; Chen Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083904; Chen Y, 2013, AM J CHINESE MED, V41, P1233, DOI 10.1142/S0192415X13500833; Chrasekharan B., 2008, NEUROGASTROENT MOTIL, V19, P951; Deli G, 2013, NEUROENDOCRINOLOGY, V98, P267, DOI 10.1159/000358728; Du F, 2015, AM J PHYSIOL-REG I, V309, pR109, DOI 10.1152/ajpregu.00396.2014; Edwards JL, 2008, PHARMACOL THERAPEUT, V120, P1, DOI 10.1016/j.pharmthera.2008.05.005; Gangula PRR, 2011, DIGEST DIS SCI, V56, P2520, DOI 10.1007/s10620-011-1735-6; Gangula P. R. R., 2010, NEUROGASTROENT MOTIL, V22, P351; Gori L, 2007, EVID-BASED COMPL ALT, V4, P13, DOI 10.1093/ecam/nem106; Han LT, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/517931; He W, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/786839; Henry TR, 2002, NEUROLOGY, V59, pS3, DOI 10.1212/WNL.59.6_suppl_4.S3; Hou PW, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/495684; Joel P., 2007, AJP GASTROINTESTINAL, V292, P718; Kito Yoshihiko, 2011, Journal of Smooth Muscle Research, V47, P47; Kluppel M, 1998, DEV DYNAM, V211, P60; Komuro T, 1999, MICROSC RES TECHNIQ, V47, P267, DOI 10.1002/(SICI)1097-0029(19991115)47:4<267::AID-JEMT5>3.0.CO;2-O; Li G., 2015, ACUPUNCTURE MED J BR, V33; Li H, 2013, ACUPUNCT MED, V31, P57, DOI 10.1136/acupmed-2012-010173; Li H, 2015, WORLD J GASTROENTERO, V21, P8304, DOI 10.3748/wjg.v21.i27.8304; Li MK, 2010, J ALTERN COMPLEM MED, V16, P435, DOI 10.1089/acm.2009.0348; Li YQ, 2007, WORLD J GASTROENTERO, V13, P709, DOI 10.3748/wjg.v13.i5.709; Lu HL, 2014, WORLD J GASTROENTERO, V20, P4626, DOI 10.3748/wjg.v20.i16.4626; Mostafa RM, 2010, WORLD J GASTROENTERO, V16, P3239, DOI 10.3748/wjg.v16.i26.3239; Noguchi E, 2010, AUTON NEUROSCI-BASIC, V156, P15, DOI 10.1016/j.autneu.2010.06.010; O'Grady G, 2015, GASTROENTEROL CLIN N, V44, P169, DOI 10.1016/j.gtc.2014.11.013; Ordog T, 2008, NEUROGASTROENT MOTIL, V20, P8, DOI 10.1111/j.1365-2982.2007.01056.x; Oh JH, 2013, J NEUROGASTROENTEROL, V19, P18, DOI 10.5056/jnm.2013.19.1.18; Ordog T, 2000, DIABETES, V49, P1731, DOI 10.2337/diabetes.49.10.1731; Pop-Busui R, 2010, DIABETES CARE, V33, P434, DOI 10.2337/dc09-1294; Powley TL, 2012, NEUROGASTROENT MOTIL, V24, pe526, DOI 10.1111/nmo.12003; Powley TL, 2011, NEUROSCIENCE, V186, P188, DOI 10.1016/j.neuroscience.2011.04.036; Powley TL, 2016, J COMP NEUROL, V524, P713, DOI 10.1002/cne.23892; SATO A, 1993, NEUROSCI RES, V18, P53, DOI 10.1016/0168-0102(93)90105-Y; SCHMIDT RE, 1983, LAB INVEST, V49, P538; Spallone V, 2011, NUTR METAB CARDIOVAS, V21, P69, DOI 10.1016/j.numecd.2010.07.005; Takahashi T, 2003, J GASTROENTEROL, V38, P421, DOI 10.1007/s00535-003-1094-y; Tan YY, 2014, INT J CLIN EXP MED, V7, P4099; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Ueshima S, 2014, BIOMED RES-TOKYO, V35, P251, DOI 10.2220/biomedres.35.251; Wang XY, 2009, NEUROGASTROENT MOTIL, V21, DOI 10.1111/j.1365-2982.2009.01336.x; Wang YG, 2007, CHINESE ACUPUNCTURE, V27; Wrzos HF, 1997, DIGEST DIS SCI, V42, P2106, DOI 10.1023/A:1018830820537; Yang ZK, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/276320; Yin JY, 2010, AM J PHYSIOL-GASTR L, V298, pG563, DOI 10.1152/ajpgi.00252.2009; Zhaohui Z., 2015, PLOS ONE, V10	53	2	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0166638	10.1371/journal.pone.0166638	http://dx.doi.org/10.1371/journal.pone.0166638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930657	Green Published, gold, Green Submitted			2022-12-27	WOS:000389580900013
J	Fisher, A; Bassett, K; Goel, G; Stanely, D; Brookhart, MA; Freeman, HR; Wright, JM; Dormuth, CR				Fisher, Anat; Bassett, Ken; Goel, Gautam; Stanely, Dana; Brookhart, M. Alan; Freeman, Hugh R.; Wright, James M.; Dormuth, Colin R.			Heterogeneity in Comparisons of Discontinuation of Tumor Necrosis Factor Antagonists in Rheumatoid Arthritis - A Meta-Analysis	PLOS ONE			English	Article							DRUG SURVIVAL RATES; 1ST ANTI-TNF; RETENTION RATES; CONCOMITANT METHOTREXATE; PATIENT CHARACTERISTICS; CLINICAL-PRACTICE; FACTOR INHIBITORS; FACTOR THERAPIES; ETANERCEPT; INFLIXIMAB	Objective We did a systematic review of studies comparing discontinuation of tumor necrosis factor alpha (TNF) antagonists in rheumatoid arthritis (RA) patients, pooled hazard ratios and assessed clinical and methodological heterogeneity. Methods We searched MEDLINE and EMBASE until June 2015 for pairwise hazard ratios for discontinuing infliximab, etanercept, and adalimumab from cohorts of RA patients. Hazard ratios were pooled using inverse variance weighting and random effects estimates of the combined hazard ratio were obtained. Clinical and methodological heterogeneity was assessed using the between-subgroup I-square statistics and meta-regression. Results Twenty-four unique studies were eligible and large heterogeneity (I-square statistics >50%) was observed in all comparisons. Type of data, location, and order of treatment (first or second line) modified the magnitude and direction of discontinuation comparing infliximab with either adalimumab or etanercept; however, some heterogeneity remained. No effect modifier was identified when adalimumab and etanercept were compared. Conclusion Heterogeneity in studies comparing discontinuation of TNF antagonists in RA is partially explained by type of data, location, and order of treatment. Pooling hazard ratios for discontinuing TNF antagonists is inappropriate because largely unexplained heterogeneity was demonstrated when random effect estimates were calculated.	[Fisher, Anat; Bassett, Ken; Stanely, Dana; Wright, James M.; Dormuth, Colin R.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC, Canada; [Bassett, Ken] Univ British Columbia, Dept Family Practice, Vancouver, BC, Canada; [Goel, Gautam] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Brookhart, M. Alan] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Freeman, Hugh R.; Wright, James M.] Univ British Columbia, Dept Med, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of Toronto; University of North Carolina; University of North Carolina Chapel Hill; University of British Columbia	Fisher, A (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC, Canada.	anat.fisher@ti.ubc.ca		Fisher, Anat/0000-0001-9730-5107	University of British Columbia Graduate Fellowship	University of British Columbia Graduate Fellowship	The study was supported by the University of British Columbia Graduate Fellowship.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Arora A, 2013, INT J RHEUMATOL, V2013, DOI 10.1155/2013/764518; Berthelot JM, 2010, JOINT BONE SPINE, V77, P564, DOI 10.1016/j.jbspin.2010.05.011; Blum MA, 2011, CLIN THER, V33, P901, DOI 10.1016/j.clinthera.2011.06.001; Bolge SC, 2015, PATIENT PREFER ADHER, V9, P121, DOI 10.2147/PPA.S70834; Borah BJ, 2009, CURR MED RES OPIN, V25, P1365, DOI 10.1185/03007990902896386; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Caporali R, 2013, ANNALS OF THE RHEUMA, V71; Chen HH, 2013, ARTHRITIS RHEUM-US, V65, pS452; Cho SK, 2012, RHEUMATOL INT, V32, P3851, DOI 10.1007/s00296-011-2312-1; Curtis JR, 2010, SEMIN ARTHRITIS RHEU, V40, P2, DOI 10.1016/j.semarthrit.2010.03.003; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dezii C M, 2001, Manag Care, V10, P42; Du Pan SM, 2009, ARTHRIT RHEUM-ARTHR, V61, P560, DOI 10.1002/art.24463; Fafa BP, 2015, CLIN RHEUMATOL, V34, P921, DOI 10.1007/s10067-015-2929-7; Favalli EG, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/831603; Fernandez-Nebro A, 2007, J RHEUMATOL, V34, P2334; Fisher A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105193; Flouri I, 2014, SEMIN ARTHRITIS RHEU, V43, P447, DOI 10.1016/j.semarthrit.2013.07.011; Frazier-Mironer A, 2013, ANN RHEUM DIS, V72, P221; Frazier-Mironer A, 2014, JOINT BONE SPINE, V81, P352, DOI 10.1016/j.jbspin.2014.02.014; Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1; Gomez-Reino JJ, 2012, ANN RHEUM DIS, V71, P382, DOI 10.1136/annrheumdis-2011-200302; Greenberg JD, 2014, ANN RHEUM DIS, V73, P241, DOI 10.1136/annrheumdis-2014-eular.1836; Greenberg JD, 2012, ANN RHEUM DIS, V71, P1134, DOI 10.1136/annrheumdis-2011-150573; Hetland ML, 2010, ARTHRITIS RHEUM-US, V62, P22, DOI 10.1002/art.27227; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hishitani Y, 2013, SCAND J RHEUMATOL, V42, P253, DOI 10.3109/03009742.2012.762037; Hyrich KL, 2011, RHEUMATOLOGY, V50, P117, DOI 10.1093/rheumatology/keq209; Johnston S, 2014, ARTHRITIS RHEUMATOL, V66, pS40; Johnston S, 2013, ANN RHEUM DIS 2013, V72; Johnston SS, 2015, RHEUMATOL THER, V2, P59, DOI 10.1007/s40744-014-0006-3; Kang JH, 2014, J KOREAN MED SCI, V29, P1205, DOI 10.3346/jkms.2014.29.9.1205; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Kievit W, 2007, ANN RHEUM DIS, V66, P1473, DOI 10.1136/ard.2007.072447; Koncz T, 2010, EXPERT OPIN BIOL TH, V10, P1367, DOI 10.1517/14712598.2010.510508; Kristensen LE, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2084; Kristensen LE, 2006, ARTHRITIS RHEUM, V54, P600, DOI 10.1002/art.21570; Lee J, 2014, PHARMACOEPIDEM DR S, V23, P471; Lee SS, 2013, ANN RHEUM DIS, V72, P875; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Marchesoni A, 2009, ANN NY ACAD SCI, V1173, P837, DOI 10.1111/j.1749-6632.2009.04621.x; Markenson JA, 2011, J RHEUMATOL, V38, P1273, DOI 10.3899/jrheum.101142; Martinez-Santana V, 2013, PATIENT PREFER ADHER, V7, P719, DOI 10.2147/PPA.S47453; Navarro-Millan I, 2013, CLIN THER, V35, P1850, DOI 10.1016/j.clinthera.2013.09.015; Neovius M, 2015, ANN RHEUM DIS, V74, P354, DOI 10.1136/annrheumdis-2013-204128; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Scire CA, 2013, CLIN EXP RHEUMATOL, V31, P857; Senabre Gallego JM, 2012, REVISTA DE LA SVR SO, V4, P5; Senabre-Gallego JM, 2013, ANNALS OF THE RHEUMA, V71; Soderlin MK, 2012, SCAND J RHEUMATOL, V41, P1, DOI 10.3109/03009742.2011.599073; Sokka T, 2003, ARTHRITIS RHEUM-US, V48, P313, DOI 10.1002/art.10817; Souto A, 2016, RHEUMATOLOGY, V55, P523, DOI 10.1093/rheumatology/kev374; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; von Elm E, 2007, EPIDEMIOLOGY, V18, P800, DOI 10.1097/EDE.0b013e3181577654; Wells GA, 2013, THE NEWCASTLE OTTAWA; WOLFE F, 1995, BAILLIERE CLIN RHEUM, V9, P619, DOI 10.1016/S0950-3579(05)80305-X; Zhang J, 2015, ARTHRIT CARE RES, V67, P624, DOI 10.1002/acr.22510; Zink A, 2006, ARTHRITIS RHEUM-US, V54, P3399, DOI 10.1002/art.22193	59	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0168005	10.1371/journal.pone.0168005	http://dx.doi.org/10.1371/journal.pone.0168005			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930739	Green Published, Green Submitted, gold			2022-12-27	WOS:000389580900069
J	Nagpal, BN; Gupta, SK; Shamim, A; Vikram, K; Srivastava, A; Tuli, NR; Saxena, R; Singh, H; Singh, VP; Bhagat, VN; Yadav, NK; Valecha, N				Nagpal, B. N.; Gupta, Sanjeev Kumar; Shamim, Arshad; Vikram, Kumar; Srivastava, Aruna; Tuli, N. R.; Saxena, Rekha; Singh, Himmat; Singh, V. P.; Bhagat, V. N.; Yadav, N. K.; Valecha, Neena			Control of Aedes aegypti Breeding: A Novel Intervention for Prevention and Control of Dengue in an Endemic Zone of Delhi, India	PLOS ONE			English	Article							SOLID-WASTE MANAGEMENT; HEMORRHAGIC-FEVER; VECTORS; INDEXES; CITIES	Background and objective The study is based on hypothesis that whether continuous entomological surveillance of Ae. aegypti and simultaneous appropriate interventions in key containers during non-transmission (December -May) months would have any impact on breeding of Aedes and dengue cases during the following transmission months (June -November). The impact of the surveillance and intervention measures undertaken during non-transmission months were assessed by entomological indicators namely container index (CI), house index (HI), pupal index (PI) and breteau index (BI). Methods A total of 28 localities of West Zone of Delhi with persistent dengue endemicity were selected for the study. Out of these localities, 20 were included in study group while other 8 localities were in control group. IEC and various Aedes breeding control activities were carried out in study group in both non-transmission and transmission season whereas control group did not have any such interventions during non-transmission months as per guidelines of MCD. These activities were undertaken by a team of investigators from NIMR and SDMC, Delhi. In control group, investigators from NIMR carried out surveillance activity to monitor the breeding of Aedes mosquito in localities. Results Comparison of baseline data revealed that all indices in control and study group of localities were comparable and statistically non-significant (p>0.05). In both study and control groups, indices were calculated after pooling data on seasonal basis, i.e., transmission and non-transmission months for both years. The test of significance conducted on all the four indices, i.e., HI, PI, CI, and BI, revealed a significant difference (p<0.05) between the study group and control group during transmission and non-transmission months except in HI. Due to consistent intervention measures undertaken in non-transmission months in study group, reduction in CI, HI, BI and PI was observed 63%, 62%, 64% and 99% respectively during transmission months as compared to control group where increase of 59%, 102%, 73% and 71% respectively. As a result of reduction in larval indices, no dengue case (except one NS1) was observed in study group, whereas 38 dengue cases were observed in control group. Conclusion Through this pilot study, it is concluded that proper intervention in non-transmission season reduces vector density and subsequently dengue cases in transmission season-	[Nagpal, B. N.; Gupta, Sanjeev Kumar; Shamim, Arshad; Vikram, Kumar; Srivastava, Aruna; Saxena, Rekha; Singh, Himmat; Valecha, Neena] Natl Inst Malaria Res, New Delhi, India; [Tuli, N. R.; Bhagat, V. N.; Yadav, N. K.] Municipal Corp Delhi, Delhi, India; [Singh, V. P.] Minist Hlth & Family Welf, Dept Hlth Res, Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR)	Nagpal, BN (corresponding author), Natl Inst Malaria Res, New Delhi, India.	b_n_nagpal@hotmail.com	Singh, Himmat/J-3579-2014; Singh, Himmat/GWZ-4925-2022	Singh, Himmat/0000-0001-7682-651X; Gupta, Sanjeev/0000-0002-2014-5333	Indian Council of Medical Research (Vector Science Forum); Indian Council of Medical Research	Indian Council of Medical Research (Vector Science Forum); Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	Indian Council of Medical Research (Vector Science Forum).; Authors are thankful to vector science forum of Indian Council of Medical Research for funding of study. We are also thankful to MCD for assisting in study sites selection and also in conducting control activities. We thank the entire field staff for their constant support in surveillance, control and providing health education to community. Acknowledgment is also due to Mr. Mrityunjay Prasad and Ms Ashoo Sharma for data management. Institute Publication Committee is acknowledged for giving consent for publication of manuscript vide Approval No. 003/2016.	Balakrishnan N, 2006, J Commun Dis, V38, P164; Bhoyar RV., 1996, J IAEM, V23, P53; Centers for Disease Control and Prevention, 2012, DENG AED ALB MOSQ; Chang FS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004043; Chareonviriyaphap Theeraphap, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P529; Dutta P, 1999, J ENVIRON BIOL, V20, P343; Edillo FE, 2012, SE ASIAN J TROP MED, V43, P1365; Erica RW, 2009, PRENSA MED ARGENT, V96, P185; Focks D.A., 2004, REV ENTOMOLOGICAL SA; Hartjes Laurie B, 2011, Nurse Pract, V36, P45, DOI 10.1097/01.NPR.0000397912.05693.20; Kumar VA, 2010, TROP BIOMED, V27, P330; Kumar S, 2009, WASTE MANAGE, V29, P883, DOI 10.1016/j.wasman.2008.04.011; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Maciel-de-Freitas R, 2011, TROP MED INT HEALTH, V16, P965, DOI 10.1111/j.1365-3156.2011.02797.x; Mandagere N, 2003, BUFFER OPERATIONS GI; Mondal R, 2014, MODERN PARASITOLOGY, V28, P255; Montgomery BL, 2002, AM J TROP MED HYG, V67, P244, DOI 10.4269/ajtmh.2002.67.244; Nagpal BN, 2015, DENGUE B IN PRESS, V39; Nandi J., 2014, Dengue Bulletin, V38, P1; PANDYA G, 1982, DEFENCE SCI J, V32, P359; Salamat MSS, 2013, ACTA MED PHILIPP, V47, P63; Sanchez L, 2006, EMERG INFECT DIS, V12, P800; Sarkar P, 2003, P 3 INT C ENV HLTH C, P451; Sharholy M, 2008, WASTE MANAGE, V28, P459, DOI 10.1016/j.wasman.2007.02.008; Sinh Vu N., 2013, BEST PRACTICES DENGU, P51; Sulaiman S, 1996, J AM MOSQUITO CONTR, V12, P494; Thammapalo S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000263; Vikram Kumar, 2015, International Journal of Mosquito Research, V2, P83; World Health Organization, 2015, DENG PREV CONTR; World Health Organization ROfS-EA, 2011, COMPR GUID PREV CONT	30	12	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2016	11	12							e0166768	10.1371/journal.pone.0166768	http://dx.doi.org/10.1371/journal.pone.0166768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MR	27918577	Green Submitted, Green Published, gold			2022-12-27	WOS:000389577100004
J	Li, XY; Deng, YP; Yang, K; Gan, WX; Zeng, RK; Deng, LJ; Song, ZB				Li, Xiaoyan; Deng, Yuanping; Yang, Kun; Gan, Weixiong; Zeng, Rukui; Deng, Longjun; Song, Zhaobin			Genetic Diversity and Structure Analysis of Percocypris pingi (Cypriniformes: Cyprinidae): Implications for Conservation and Hatchery Release in the Yalong River	PLOS ONE			English	Article							MICROSATELLITE DNA ANALYSIS; POPULATION-STRUCTURE; FRESH-WATER; CONTROL REGION; STATISTICAL TESTS; FISH ASSEMBLAGES; YANGTZE-RIVER; MANAGEMENT; SEQUENCE; CHINA	Percocypris pingi is a near threatened cyprinid species, which has suffered a dramatic decline due to anthropogenic factors. As one response to this decline, hatchery release for P. pingi has been conducted in the lower reaches of the Yalong River since 2012. To understand the conservation status of this species and the potential impact of the release of hatchery-reared fish, we studied the genetic diversity and population structure of wild and hatchery populations of P. pingi. Two hatchery populations (Jinping [JPH] and Ya'an [YAH]) and two wild populations (Muli [MLW] and Woluo [WLW]) of P. pingi were analyzed based on microsatellite markers and the mitochondrial DNA control region. The results showed that P. pingi possesses moderate levels of genetic diversity, with observed heterozygosities ranging from 0.657 to 0.770 and nucleotide diversities ranging from 0.00212 to 0.00491. Our results also suggested WLW harbors considerable proportions of genetic diversity in this species and serves as a refuge for P. pingi during anthropogenic disturbance, thus playing an important role for the conservation of P. pingi populations. Microsatellite and mitochondrial markers both indicated close genetic relationships between YAH and MLW, JPH and WLW, respectively. The results to some extent reflected the geographical provenances for original broodstocks of the two hatchery populations, which provide some practical guidance for hatchery release of P. pingi. The existence of remarkable genetic divergence distributed along limited geographical range (approximately 10 kilometers) suggests the two wild populations should be regarded at least as two distinct evolutionary significant units (ESUs) and management units (MUs). Considering reduced intra-population genetic variation in hatchery population for release and significant genetic compositions of the two hatchery populations, some appropriate breeding strategies were proposed to benefit conservation of P. pingi.	[Li, Xiaoyan; Deng, Yuanping; Yang, Kun; Song, Zhaobin] Sichuan Univ, Coll Life Sci, Sichuan Key Lab Conservat Biol Endangered Wildlif, Chengdu, Peoples R China; [Gan, Weixiong; Zeng, Rukui; Deng, Longjun] Yalong River Hydropower Dev Co Ltd, Chengdu, Peoples R China; [Song, Zhaobin] Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu, Peoples R China	Sichuan University; Sichuan University	Song, ZB (corresponding author), Sichuan Univ, Coll Life Sci, Sichuan Key Lab Conservat Biol Endangered Wildlif, Chengdu, Peoples R China.; Song, ZB (corresponding author), Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu, Peoples R China.	zbsong@scu.edu.cn		Yang, Kun/0000-0003-4409-6836	Yalong River Hydropower Development Company, Ltd. [12H0856]; Program for New Century Excellent Talents in University [NCET-11-0347]	Yalong River Hydropower Development Company, Ltd.; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	Yalong River Hydropower Development Company, Ltd. (No. 12H0856) and Program for New Century Excellent Talents in University (No. NCET-11-0347). Yalong River Hydropower Development Company, Ltd. provided financial support for field studies and relevant expenditure (e.g., field sampling and purchasing artificial propagated samples); Program for New Century Excellent Talents in University provided financial support for laboratory experiments and relevant expenditure (e.g., DNA extraction, genotyping and sequencing). Weixiong Gan, Rukui Zeng and Longjun Deng are employed by Yalong River Hydropower Development Company, Ltd. Yalong River Hydropower Development Company, Ltd. provided support in the form of salaries for authors WG, RZ and LD and played a role in data collection, contributed reagents and analysis tools. The specific roles of these authors are articulated in the 'author contributions' section.	Abdolhay HA, 2011, REV FISH BIOL FISHER, V21, P247, DOI 10.1007/s11160-010-9163-9; ALLENDORF FW, 1980, T AM FISH SOC, V109, P537, DOI 10.1577/1548-8659(1980)109&lt;537:LOGVIA&gt;2.0.CO;2; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Beaumont M, 2000, README 2MOD; BROWN JR, 1993, MOL BIOL EVOL, V10, P326; Chen XH, 2006, FRESHWATER FISHERIES, V36; Cheng F, 2011, FISHERIES SCI, V77, P765, DOI 10.1007/s12562-011-0383-2; Cornuet JM, 1996, GENETICS, V144, P2001; Dadswell MJ, 1996, REMOVAL EDWARDS DAM, V1-3, P92; Deng YP, 2015, ISOLATION MICROSATEL, P13; Deng YP, 2015, CONSERV GENET RESOUR, V7, P99, DOI 10.1007/s12686-014-0302-9; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1111/j.1095-8649.2000.tb00748.x; Ding RH, 1994, FISHES SICHUAN, P219; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Dong Xinpei, 2014, Journal of Hebei University Natural Science Edition, V34, P201; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Ferreira D, 2015, CONSERV GENET, V16, P151, DOI 10.1007/s10592-014-0648-2; Fu YX, 1997, GENETICS, V147, P915; Gilk SE, 2004, OUTBREEDING DEPRESSI, P287; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Thanh HN, 2015, BIOCHEM SYST ECOL, V59, P144, DOI 10.1016/j.bse.2014.12.023; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Huang F, 2011, ENVIRON BIOL FISH, V92, P569, DOI 10.1007/s10641-011-9880-5; Hughes JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040546; Jiang Hong, 2007, Acta Hydrobiologica Sinica, V31, P532; Jiang Zhigang, 2016, Biodiversity Science, V24, P500, DOI 10.17520/biods.2016076; Koizumi I, 2006, MOL ECOL, V15, P3175, DOI 10.1111/j.1365-294X.2006.03019.x; Kotus A, 2016, AQUAT LIVING RESOUR, V29, P103; Kubota H, 2003, ICHTHYOL RES, V50, P123, DOI 10.1007/s10228-002-0146-2; Kumar S, 2016, MOL BIOL EVOL, V33, P2628; Laikre L, 2005, AMBIO, V34, P111, DOI 10.1639/0044-7447(2005)034[0111:GPSOFI]2.0.CO;2; LEBER KM, 1995, AM FISH S S, V15, P376; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu HZ, 2002, CAN J ZOOL, V80, P569, DOI 10.1139/Z02-035; Lorenzen K, 2012, BIOL REV, V87, P639, DOI 10.1111/j.1469-185X.2011.00215.x; Loukovitis D, 2015, MEDITERR MAR SCI, V16, P197; McNeely JA, 1990, CONSERVING THE WORLD; [孟玮 Meng Wei], 2012, [水生生物学报, Acta Hydrobiologica Sinica], V36, P851; Paiva SR, 2006, HYDROBIOLOGIA, V560, P393, DOI 10.1007/s10750-005-9415-1; Paz-Vinas I, 2013, MOL ECOL, V22, P3279, DOI 10.1111/mec.12321; Philipp DP, 2002, AM FISH S S, V31, P349; Piorski NM, 2008, BRAZ J BIOL, V68, P1039, DOI 10.1590/S1519-69842008000500011; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A., 2014, TRACER V1 6; Ramstad KM, 2004, MOL ECOL, V13, P277, DOI 10.1046/j.1365-294X.2003.2062.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; RYMAN N, 1991, CONSERV BIOL, V5, P325, DOI 10.1111/j.1523-1739.1991.tb00144.x; Sato T, 2014, FISHERIES SCI, V80, P493, DOI 10.1007/s12562-014-0730-1; Sekino M, 2002, AQUACULTURE, V213, P101, DOI 10.1016/S0044-8486(01)00885-7; Shaw PW, 1999, HEREDITY, V83, P490, DOI 10.1038/sj.hdy.6885860; Song J, 2014, BIOCHEM SYST ECOL, V55, P1, DOI 10.1016/j.bse.2014.02.008; Song Xiao, 2009, Acta Hydrobiologica Sinica, V33, P709, DOI 10.3724/SP.J.1035.2009.40709; Swenson NG, 2005, AM NAT, V166, P581, DOI 10.1086/491688; TAJIMA F, 1989, GENETICS, V123, P585; THOMPSON D, 1985, AQUACULTURE, V46, P341, DOI 10.1016/0044-8486(85)90112-7; Van de Putte AP, 2012, MAR GENOM, V8, P23, DOI 10.1016/j.margen.2012.05.002; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vogiatzi E, 2014, BIOL J LINN SOC, V111, P334, DOI 10.1111/bij.12206; Wang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061827; Wang YM, 2013, SICHUAN J ZOOLOGY, V32, P012; Wright JM, 1995, MOL GENETICS FISHERI, P230; Wright S., 1978, EVOLUTION GENETICS P; Wu XW, 1977, CYPRINID FISHES CHIN, P266; Yan L, 2008, ENVIRON BIOL FISH, V82, P35, DOI 10.1007/s10641-007-9248-z; [易建华 Yi Jianhua], 2013, [西南师范大学学报. 自然科学版, Journal of Southwest China Normal University. Natural Science Edition], V38, P62; [岳兴建 Yue Xingjian], 2015, [淡水渔业, Freshwater Fisheries], V45, P14; Zhang CG, 2016, SPECIES DIVERSITY DI, P94; Zhang X, 2015, ENVIRON BIOL FISH, V98, P261, DOI 10.1007/s10641-014-0257-4; Zhao H, 2012, IUCN 2012 IUCN RED L	73	10	11	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0166769	10.1371/journal.pone.0166769	http://dx.doi.org/10.1371/journal.pone.0166769			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911911	gold, Green Published, Green Submitted			2022-12-27	WOS:000389520600012
J	Alibardi, L; Holthaus, KB; Sukseree, S; Hermann, M; Tschachler, E; Eckhart, L				Alibardi, Lorenzo; Holthaus, Karin Brigit; Sukseree, Supawadee; Hermann, Marcela; Tschachler, Erwin; Eckhart, Leopold			Immunolocalization of a Histidine-Rich Epidermal Differentiation Protein in the Chicken Supports the Hypothesis of an Evolutionary Developmental Link between the Embryonic Subperiderm and Feather Barbs and Barbules	PLOS ONE			English	Article							BETA BETA KERATINS; MOLECULAR EVOLUTION; CELL-DEATH; ORIGIN; SKIN; GENES; DIVERSIFICATION; CORNIFICATION; EXPRESSION; FILAGGRIN	The morphogenesis of feathers is a complex process that depends on a tight spatiotemporal regulation of gene expression and assembly of the protein components of mature feathers. Recent comparative genomics and gene transcription studies have indicated that genes within the epidermal differentiation complex (EDC) encode numerous structural proteins of cornifying skin cells in amniotes including birds. Here, we determined the localization of one of these proteins, termed EDMTFH (Epidermal Differentiation Protein starting with a MTF motif and rich in Histidine), which belongs to a group of EDC-encoded proteins rich in aromatic amino acid residues. We raised an antibody against an EDMTFH-specific epitope and performed immunohistochemical investigations by light microscopy and immunogold labeling by electron microscopy of chicken embryos at days 14-18 of development. EDMTFH was specifically present in the subperiderm, a transient layer of the embryonic epidermis, and in barbs and barbules of feathers. In the latter, it partially localized to bundles of socalled feather beta-keratins (corneous beta-proteins, CBPs). Cells of the embryonic periderm, the epidermis proper, and the feather sheath were immunonegative for EDMTFH. The results of this study indicate that EDMTFH may contribute to the unique mechanical properties of feathers and define EDMTFH as a common marker of the subperiderm and the feather barbules. This expression pattern of EDMTFH resembles that of epidermal differentiation cysteine-rich protein (EDCRP) and feather CBPs and is in accordance with the hypothesis that a major part of the cyclically regenerating feather follicle is topologically, developmentally and evolutionarily related to the embryonic subperiderm.	[Alibardi, Lorenzo; Holthaus, Karin Brigit] Univ Bologna, Comparat Histolab, Bologna, Italy; [Alibardi, Lorenzo; Holthaus, Karin Brigit] Univ Bologna, Dipartimento Sci Biol Geol & Ambientali BiGeA, Bologna, Italy; [Holthaus, Karin Brigit; Sukseree, Supawadee; Tschachler, Erwin; Eckhart, Leopold] Med Univ Vienna, Dept Dermatol, Res Div Biol & Pathobiol Skin, Vienna, Austria; [Hermann, Marcela] Med Univ Vienna, Dept Med Biochem, Vienna, Austria	University of Bologna; University of Bologna; Medical University of Vienna; Medical University of Vienna	Eckhart, L (corresponding author), Med Univ Vienna, Dept Dermatol, Res Div Biol & Pathobiol Skin, Vienna, Austria.	leopold.eckhart@meduniwien.ac.at	Sukseree, Supawadee/AAT-6545-2020	Sukseree, Supawadee/0000-0002-7011-9352; Eckhart, Leopold/0000-0002-5645-2036	Austrian Science Fund (FWF) [P23801, P28004]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The study was supported by the Austrian Science Fund (FWF): P23801 (LE) and Austrian Science Fund (FWF): P28004 (LE) (https://www.fwf.ac.at/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibardi L., 2006, Journal of Submicroscopic Cytology and Pathology, V38, P175; Alibardi L., 2006, Journal of Submicroscopic Cytology and Pathology, V38, P51; Alibardi L, 2006, CELLS TISSUES ORGANS, V182, P35, DOI 10.1159/000091717; Alibardi L, 2015, ANAT REC, V298, P479, DOI 10.1002/ar.23039; Alibardi L, 2013, ANN ANAT, V195, P189, DOI 10.1016/j.aanat.2012.08.005; Alibardi L, 2003, J EXP ZOOL PART B, V298B, P12, DOI 10.1002/jez.b.00024; Alibardi L, 2002, J MORPHOL, V251, P294, DOI 10.1002/jmor.1090; Alibardi L., 2016, REV CORNIFICATION MO; Alibardi L, 2007, EXP DERMATOL, V16, P961, DOI 10.1111/j.1600-0625.2007.00609.x; Alibardi L, 2016, J EXP ZOOL PART B, V326, P338, DOI 10.1002/jez.b.22689; BARNES GL, 1995, J EXP ZOOL, V271, P307, DOI 10.1002/jez.1402710408; Barresi C, 2011, J INVEST DERMATOL, V131, P188, DOI 10.1038/jid.2010.231; Calvaresi M, 2016, J STRUCT BIOL, V194, P282, DOI 10.1016/j.jsb.2016.03.004; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Eckhart L, 2013, BBA-MOL CELL RES, V1833, P3471, DOI 10.1016/j.bbamcr.2013.06.010; Eckhart L, 2008, P NATL ACAD SCI USA, V105, P18419, DOI 10.1073/pnas.0805154105; Fischer H, 2005, DIFFERENTIATION, V73, P406, DOI 10.1111/j.1432-0436.2005.00046.x; Fraser RDB, 2008, J STRUCT BIOL, V162, P1, DOI 10.1016/j.jsb.2008.01.011; Greenwold MJ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0249-1; Greenwold MJ, 2013, J EXP ZOOL PART B, V320, P393, DOI 10.1002/jez.b.22514; Greenwold MJ, 2011, J EXP ZOOL PART B, V316B, P609, DOI 10.1002/jez.b.21436; Greenwold MJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-148; Henry J, 2012, FRONT BIOSCI-LANDMRK, V17, P1517, DOI 10.2741/4001; Holthaus KB, 2016, MOL BIOL EVOL, V33, P726, DOI 10.1093/molbev/msv265; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Lopes RJ, 2016, CURR BIOL, V26, P1427, DOI 10.1016/j.cub.2016.03.076; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Mildner M, 2010, J INVEST DERMATOL, V130, P2286, DOI 10.1038/jid.2010.115; Mlitz V, 2014, J INVEST DERMATOL, V134, P2685, DOI 10.1038/jid.2014.204; Ng CS, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1966-6; Pendaries V, 2014, J INVEST DERMATOL, V134, P2938, DOI 10.1038/jid.2014.259; POWELL BC, 1979, NUCLEIC ACIDS RES, V7, P2165, DOI 10.1093/nar/7.8.2165; PRESLAND RB, 1989, J MOL BIOL, V209, P549, DOI 10.1016/0022-2836(89)90593-7; RAMSDEN M, 1983, DIFFERENTIATION, V23, P243; Rice RH, 2013, J PROTEOME RES, V12, P771, DOI 10.1021/pr301036k; ROGERS GE, 1985, ANN NY ACAD SCI, V455, P403, DOI 10.1111/j.1749-6632.1985.tb50425.x; Rogers MA, 2002, J BIOL CHEM, V277, P48993, DOI 10.1074/jbc.M206422200; Rogers MA, 2001, J BIOL CHEM, V276, P19440, DOI 10.1074/jbc.M100657200; Sawyer R.H., 1986, P194; Sawyer RH, 2005, DEV DYNAM, V232, P256, DOI 10.1002/dvdy.20291; Sawyer RH, 2003, J EXP ZOOL PART B, V298B, P57, DOI 10.1002/jez.b.26; Sawyer RH, 2003, J EXP ZOOL PART B, V295B, P12, DOI 10.1002/jez.b.00005; Sawyer RH, 2000, AM ZOOL, V40, P530, DOI 10.1668/0003-1569(2000)040[0530:TEOBKI]2.0.CO;2; SAWYER RH, 1974, J EXP ZOOL, V190, P57, DOI 10.1002/jez.1401900105; SCALA C, 1992, J HISTOCHEM CYTOCHEM, V40, P1799, DOI 10.1177/40.11.1431065; Strasser B, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0360-y; Strasser B, 2014, MOL BIOL EVOL, V31, P3194, DOI 10.1093/molbev/msu251; WALKER ID, 1976, EUR J BIOCHEM, V69, P329, DOI 10.1111/j.1432-1033.1976.tb10917.x; Waters ML, 2002, CURR OPIN CHEM BIOL, V6, P736, DOI 10.1016/S1367-5931(02)00359-9; Widelitz RB, 2003, J EXP ZOOL PART B, V298B, P109, DOI 10.1002/jez.b.00029; Wu P, 2015, P NATL ACAD SCI USA, V112, pE6770, DOI 10.1073/pnas.1520566112; Yu MK, 2002, NATURE, V420, P308, DOI 10.1038/nature01196	52	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167789	10.1371/journal.pone.0167789	http://dx.doi.org/10.1371/journal.pone.0167789			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936131	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100190
J	Angelini, V; Klijs, B; Smidt, N; Mierau, JO				Angelini, Viola; Klijs, Bart; Smidt, Nynke; Mierau, Jochen O.			Associations between Childhood Parental Mental Health Difficulties and Depressive Symptoms in Late Adulthood: The Influence of Life-Course Socioeconomic, Health and Lifestyle Factors	PLOS ONE			English	Article							14 EUROPEAN CENTERS; RISK-FACTORS; D SCALE; TRANSMISSION; PREVALENCE; DISORDERS; MOTHERS; MODEL; AGE	Background Depression among older adults (i.e., the 50+) is a major health concern. The objective of this study is to investigate whether growing up with a parent suffering from mental health problems is associated with depressive symptoms in late-adulthood and how this association is influenced by life-course socio-economic, health and lifestyle factors in childhood and late adulthood. Methods We used life-history data from the SHARE survey, consisting of 21,127 participants living in 13 European countries. Symptoms of depression were assessed using the EURO-D scale. Parental mental health was assessed by asking respondents to report whether any of their parents had mental health problems during the respondents' childhood. Logistic regression models were used to assess the association between parental mental health status and depression. Variables on childhood and late-life socio-economic, health and lifestyle factors were sequentially added to the model to assess the extent to which this association is influenced by life-course circumstances. Results Individuals who were exposed during childhood to a parent with mental health problems suffered from depressive symptoms more often in late adulthood than those who were not (OR 1.76, 95% CI: 1.43-2.17). Adjustment for life-course socio-economic, health and lifestyle factors in childhood and late adulthood diminished this association to an OR of 1.54 (95% CI: 1.24-1.90) and OR of 1.45 (95% CI: 1.16-1.82), respectively. Conclusion Our results indicate a substantial association between parental mental health problems in childhood and depression in late adulthood and that this association is partly explained by childhood as well as late adulthood socio-economic, health and lifestyle factors.	[Angelini, Viola; Mierau, Jochen O.] Univ Groningen, Dept Econ Econometr & Finance, Groningen, Netherlands; [Klijs, Bart] Stat Netherlands, The Hague, Netherlands; [Smidt, Nynke] Univ Groningen, Univ Med Ctr Groningen, Dept Geriatr, Dept Epidemiol, Groningen, Netherlands; [Smidt, Nynke] Univ Groningen, Univ Med Ctr Groningen, Dept Geriatr, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Angelini, V (corresponding author), Univ Groningen, Dept Econ Econometr & Finance, Groningen, Netherlands.	v.angelini@rug.nl	Angelini, Viola/AAF-6679-2021	Angelini, Viola/0000-0002-5177-3447; Mierau, Jochen/0000-0002-9968-8807	European Commission [QLK6-CT-2001-00360, RII-CT-2006-062193, CIT5- CT-2005-028857, CIT4-CT-2006-028812, 211909, 227822, 261982]; U.S. National Institute on Aging [U01 AG09740-13S2, P01 AG005842, P01 AG08291, P30 AG12815, R21 AG025169, Y1-AG-4553-01, IAG BSR06-11, OGHA 04-064]; German Ministry of Education and Research; NATIONAL INSTITUTE ON AGING [R21AG025169, P01AG008291, P30AG012815, U01AG009740, P01AG005842] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); U.S. National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank two anonymous referees, the editor (Therese van Amelsvoort) as well as Annabeth Groenman for helpful comments and discussion. This paper uses data from SHARE wave 1 and 2 release 2.6.0, as of November 29 2013 (DOI: 10.6103/SHARE.w1.260 and 10.6103/SHARE.w2.260) and SHARELIFE release 1, as of November 24th 2010 (DOI: 10.6103/SHARE.w3.100). The SHARE data collection has been primarily funded by the European Commission through the 5th Framework Programme (project QLK6-CT-2001-00360 in the thematic programme Quality of Life), through the 6th Framework Programme (projects SHARE-I3, RII-CT-2006-062193, COMPARE, CIT5- CT-2005-028857, and SHARELIFE, CIT4-CT-2006-028812) and through the 7th Framework Programme (SHARE-PREP, No 211909, SHARE-LEAP, No 227822 and SHARE M4, No 261982). Additional funding from the U.S. National Institute on Aging (U01 AG09740-13S2, P01 AG005842, P01 AG08291, P30 AG12815, R21 AG025169, Y1-AG-4553-01, IAG BSR06-11 and OGHA 04-064) and the German Ministry of Education and Research as well as from various national sources is gratefully acknowledged (see www.share-project.org for a full list of funding institutions).	Alexapoulos GS, 2005, LANCET, V365, P1961, DOI 10.1016/S0140-6736(05)66665-2; Aro A R, 2005, HLTH AGEING RETIREME; Beardslee WR, 2012, MED J AUST S, V199, pS23; Belli RF, 1998, MEMORY, V6, P383, DOI 10.1080/741942610; Blane DB, 1996, SOC SCI MED, V42, P751, DOI 10.1016/0277-9536(95)00340-1; Blazer DG, 2003, J GERONTOL A-BIOL, V58, P249; Borsch-Supan A, 2013, INT J EPIDEMIOL, V42, P992, DOI 10.1093/ije/dyt088; Borsch-Supan A., 2008, 1 RESULTS SURVEY HLT; BorschSupan A, 2011, INDIVIDUAL AND THE WELFARE STATE: LIFE HISTORIES IN EUROPE, P1; Chapman D.P., 2008, PREVENTING CHRONIC D, V5, P1; Chatterji P, 2007, HEALTH ECON, V16, P1069, DOI 10.1002/hec.1210; Collishaw S, 2016, LANCET PSYCHIAT, V3, P49, DOI 10.1016/S2215-0366(15)00358-2; Copeland John R M, 2004, World Psychiatry, V3, P45; Dewey ME, 2005, HLTH AGEING RETIREME; Djernes JK, 2006, ACTA PSYCHIAT SCAND, V113, P372, DOI 10.1111/j.1600-0447.2006.00770.x; Doesum KT, 2009, AUSTR E J ADV MENTAL, V8; Goodman SH, 1999, PSYCHOL REV, V106, P458, DOI 10.1037/0033-295X.106.3.458; Goodman SH, 2007, ANNU REV CLIN PSYCHO, V3, P107, DOI 10.1146/annurev.clinpsy.3.022806.091401; Gopfert M., 2004, PARENTAL PSYCHIAT DI; Hammen C, 2004, J CONSULT CLIN PSYCH, V72, P511, DOI 10.1037/0022-006X.72.3.511; Hancock KJ, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-299; Havari E, 2015, EUR J POPUL, V31, P233, DOI 10.1007/s10680-014-9332-y; Heun R, 2005, EUR PSYCHIAT, V20, P199, DOI 10.1016/j.eurpsy.2004.09.036; Hosman C., 2009, AUSTR E J ADV MENTAL, V8; Institute for Health Metrics and Evaluation, PERC CHANG TOT DALYS; Johnston DW, 2013, J HEALTH ECON, V32, P1077, DOI 10.1016/j.jhealeco.2013.09.001; KATZ S, 1983, J AM GERIATR SOC, V31, P721, DOI 10.1111/j.1532-5415.1983.tb03391.x; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Luppa M, 2012, INT J GERIATR PSYCH, V27, P286, DOI 10.1002/gps.2718; OECD, 2014, MAKING MENTAL HEALTH; Prince MJ, 1999, BRIT J PSYCHIAT, V174, P339, DOI 10.1192/bjp.174.4.339; Prince MJ, 1999, BRIT J PSYCHIAT, V174, P330, DOI 10.1192/bjp.174.4.330; Reupert A, 2015, PARENTAL PSYCHIAT DI, VThird; Reupert A, 2016, CHILD YOUTH SERV, V37, P98, DOI 10.1080/0145935X.2016.1104037; Rutter M., 2006, GENES BEHAV; Schroder M, 2011, RETROSPECTIVE DATA C; Vink D, 2008, J AFFECT DISORDERS, V106, P29, DOI 10.1016/j.jad.2007.06.005; World Health Organization, 2012, DEPRESSION GLOBAL PU	39	19	19	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167703	10.1371/journal.pone.0167703	http://dx.doi.org/10.1371/journal.pone.0167703			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936078	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100159
J	Govey, PM; Zhang, Y; Donahue, HJ				Govey, Peter M.; Zhang, Yue; Donahue, Henry J.			Mechanical Loading Attenuates Radiation-Induced Bone Loss in Bone Marrow Transplanted Mice	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; LONG-TERM SURVIVORS; IN-VIVO; CORTICAL BONE; TRABECULAR BONE; PHYSICAL-EXERCISE; RANDOMIZED-TRIAL; FRACTURE REPAIR; MOUSE MODEL; FEMALE	Exposure of bone to ionizing radiation, as occurs during radiotherapy for some localized malignancies and blood or bone marrow cancers, as well as during space travel, incites dose-dependent bone morbidity and increased fracture risk. Rapid trabecular and endosteal bone loss reflects acutely increased osteoclastic resorption as well as decreased bone formation due to depletion of osteoprogenitors. Because of this dysregulation of bone turnover, bone's capacity to respond to a mechanical loading stimulus in the aftermath of irradiation is unknown. We employed a mouse model of total body irradiation and bone marrow transplantation simulating treatment of hematologic cancers, hypothesizing that compression loading would attenuate bone loss. Furthermore, we hypothesized that loading would upregulate donor cell presence in loaded tibias due to increased engraftment and proliferation. We lethally irradiated 16 female C57Bl/6J mice at age 16 wks with 10.75 Gy, then IVinjected 20 million GFP(+) total bone marrow cells. That same day, we initiated 3 wks compression loading (1200 cycles 5x/wk, 10 N) in the right tibia of 10 of these mice while 6 mice were irradiated, non-mechanically-loaded controls. As anticipated, before-and-after microCT scans demonstrated loss of trabecular bone (-48.2% Tb.BV/TV) and cortical thickness (-8.3%) at 3 wks following irradiation. However, loaded bones lost 31% less Tb.BV/TV and 8% less cortical thickness (both p<0.001). Loaded bones also had significant increases in trabecular thickness and tissue mineral densities from baseline. Mechanical loading did not affect donor cell engraftment. Importantly, these results demonstrate that both cortical and trabecular bone exposed to high-dose therapeutic radiation remain capable of an anabolic response to mechanical loading. These findings inform our management of bone health in cases of radiation exposure.	[Govey, Peter M.; Zhang, Yue; Donahue, Henry J.] Penn State Coll Med, Dept Orthopaed & Rehabil, Div Musculoskeletal Sci, Hershey, PA 17033 USA; [Govey, Peter M.; Donahue, Henry J.] Penn State Coll Engn, Dept Biomed Engn, University Pk, PA 16802 USA; [Donahue, Henry J.] Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Zhang, Yue; Donahue, Henry J.] Virginia Commonwealth Coll Engn, Dept Biomed Engn, Richmond, VA 23220 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Donahue, HJ (corresponding author), Penn State Coll Med, Dept Orthopaed & Rehabil, Div Musculoskeletal Sci, Hershey, PA 17033 USA.; Donahue, HJ (corresponding author), Penn State Coll Engn, Dept Biomed Engn, University Pk, PA 16802 USA.; Donahue, HJ (corresponding author), Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA.; Donahue, HJ (corresponding author), Virginia Commonwealth Coll Engn, Dept Biomed Engn, Richmond, VA 23220 USA.	hjdonahue@vcu.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases [7 R01 AR068132 17]	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (Grant number 7 R01 AR068132 17). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An NF, 2013, JOVE-J VIS EXP, DOI 10.3791/50193; Vazquez MA, 2015, J BONE MINER RES, V30, P1790, DOI 10.1002/jbmr.2519; Arrington SA, 2010, CALCIFIED TISSUE INT, V87, P263, DOI 10.1007/s00223-010-9390-z; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brodt MD, 1999, J BONE MINER RES, V14, P2159, DOI 10.1359/jbmr.1999.14.12.2159; Calvi LM, 2015, BLOOD, V126, P2443, DOI 10.1182/blood-2015-07-533588; Calvi LM, 2013, BEST PRACT RES CL HA, V26, P249, DOI 10.1016/j.beha.2013.10.004; Chandra A, 2015, J BIOL CHEM, V290, P157, DOI 10.1074/jbc.M114.608158; Chandra A, 2014, BONE, V67, P33, DOI 10.1016/j.bone.2014.06.030; Chandra A, 2013, BONE, V55, P449, DOI 10.1016/j.bone.2013.02.023; Clines GA, 2010, CURR OPIN ORGAN TRAN, V15, P73, DOI 10.1097/MOT.0b013e328333d52c; De Lisio M, 2013, EXP HEMATOL, V41, P143, DOI 10.1016/j.exphem.2012.10.003; De Souza RL, 2005, BONE, V37, P810, DOI 10.1016/j.bone.2005.07.022; Dumas A, 2009, OSTEOPOROSIS INT, V20, P435, DOI 10.1007/s00198-008-0658-3; Duran-Struuck R, 2009, J AM ASSOC LAB ANIM, V48, P11; Fiuza-Luces C, 2013, MED SCI SPORT EXER, V45, P1703, DOI 10.1249/MSS.0b013e31828fa004; Frisch BJ, 2012, BLOOD, V119, P540, DOI 10.1182/blood-2011-04-348151; Fritton JC, 2005, BONE, V36, P1030, DOI 10.1016/j.bone.2005.02.013; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Gong B, 2013, BONE, V57, P252, DOI 10.1016/j.bone.2013.08.014; Gonzalez-Nieto D, 2012, BLOOD; Granero-Molto F, 2009, STEM CELLS, V27, P1887, DOI 10.1002/stem.103; Green DE, 2014, BONE, V63, P87, DOI 10.1016/j.bone.2014.02.018; Green DE, 2012, J BONE MINER RES, V27, P749, DOI 10.1002/jbmr.1505; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Grimston SK, 2011, J BONE MINER RES, V26, P2151, DOI 10.1002/jbmr.425; Hartman A, 2009, PEDIATR BLOOD CANCER, V53, P64, DOI 10.1002/pbc.21942; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Hoggatt J, 2009, BLOOD, V113, P5444, DOI 10.1182/blood-2009-01-201335; Keenawinna L, 2013, RADIAT RES, V180, P89, DOI 10.1667/RR3200.1; Kfoury Y, 2015, CELL STEM CELL, V16, P239, DOI 10.1016/j.stem.2015.02.019; Kitase Y, 2014, J DENT RES, V93, P1108, DOI 10.1177/0022034514553008; Kitase Y, 2010, J BONE MINER RES, V25, P2381, DOI 10.1002/jbmr.168; Klinck RJ, 2008, MED ENG PHYS, V30, P888, DOI 10.1016/j.medengphy.2007.11.004; Leucht P, 2013, J ORTHOP RES, V31, P1828, DOI 10.1002/jor.22440; Li F, 2010, BONE, V47, P546, DOI 10.1016/j.bone.2010.05.040; Li S, 2008, J CELL PHYSIOL, V215, P204, DOI 10.1002/jcp.21302; Lloyd SA, 2012, J BONE MINER RES, V27, P2359, DOI 10.1002/jbmr.1687; Main RP, 2014, J EXP BIOL, V217, P1775, DOI 10.1242/jeb.085522; Main RP, 2010, J BIOMECH, V43, P2689, DOI 10.1016/j.jbiomech.2010.06.019; Melville KM, 2015, METHODS MOL BIOL, V1226, P99, DOI 10.1007/978-1-4939-1619-1_9; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mostoufi-Moab S, 2015, J BONE MINER RES, V30, P1657, DOI 10.1002/jbmr.2512; Mostoufi-Moab S, 2012, J BONE MINER RES, V27, P760, DOI 10.1002/jbmr.1499; Nicolay NH, 2013, INT J RADIAT ONCOL, V87, P1171, DOI 10.1016/j.ijrobp.2013.09.003; Oest ME, 2015, J ORTHOP RES, V33, P334, DOI 10.1002/jor.22761; Oh JY, 2012, MOL THER, V20, P2143, DOI 10.1038/mt.2012.165; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Park D, 2014, JOVE-J VIS EXP, DOI 10.3791/51289; Persoon S, 2013, CANCER TREAT REV, V39, P682, DOI 10.1016/j.ctrv.2013.01.001; Plotkin LI, 2014, CURR OSTEOPOROS REP, V12, P121, DOI 10.1007/s11914-014-0194-3; Porter RL, 2013, STEM CELLS, V31, P372, DOI 10.1002/stem.1286; Rapp AE, 2015, EUR CELLS MATER, V29, P22, DOI 10.22203/eCM.v029a02; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Roddy GW, 2011, STEM CELLS, V29, P1572, DOI 10.1002/stem.708; Sample SJ, 2010, J BONE MINER RES, V25, P2016, DOI 10.1002/jbmr.101; Sato AY, 2015, BONE, V73, P60, DOI 10.1016/j.bone.2014.12.012; Schmitz KH, 2010, MED SCI SPORT EXER, V42, P1409, DOI 10.1249/MSS.0b013e3181e0c112; Shirazi-Fard Y, 2015, BONE, V81, P260, DOI 10.1016/j.bone.2015.07.019; Spiegelberg L, 2015, J CRANIO MAXILL SURG, V43, P214, DOI 10.1016/j.jcms.2014.11.008; Sugiyama T, 2010, BONE, V46, P314, DOI 10.1016/j.bone.2009.08.054; Thorsen K, 1996, J CLIN INVEST, V98, P2446, DOI 10.1172/JCI119061; Wang XJ, 2006, STEM CELLS, V24, P1869, DOI 10.1634/stemcells.2005-0430; Wernle JD, 2010, J BIOMECH, V43, P2738, DOI 10.1016/j.jbiomech.2010.06.017; Willey JS, 2010, BONE, V46, P101, DOI 10.1016/j.bone.2009.09.002; Willie BM, 2013, BONE, V55, P335, DOI 10.1016/j.bone.2013.04.023; Wiskemann J, 2008, BONE MARROW TRANSPL, V41, P321, DOI 10.1038/sj.bmt.1705917; Wiskemann J, 2015, INT J CANCER, V137, P2749, DOI 10.1002/ijc.29633; Wiskemann J, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1631-0; Wright LE, 2015, J BONE MINER RES OFF; Yamamori T, 2012, FREE RADICAL BIO MED, V53, P260, DOI 10.1016/j.freeradbiomed.2012.04.033; Yang GC, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/162410; Yardeni T, 2011, LAB ANIMAL, V40, P155, DOI 10.1038/laban0511-155; Zhang Y, 2000, J BIOL CHEM, V275, P32628, DOI 10.1074/jbc.M002594200; Zhang YY, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2340	75	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167673	10.1371/journal.pone.0167673	http://dx.doi.org/10.1371/journal.pone.0167673			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936104	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100147
J	Hanon, O; Chaussade, E; Gueranger, P; Gruson, E; Bonan, S; Gay, A				Hanon, Olivier; Chaussade, Edouard; Gueranger, Pierre; Gruson, Elise; Bonan, Sabrina; Gay, Alain			Patient-Reported Treatment Satisfaction with Rivaroxaban for Stroke Prevention in Atrial Fibrillation. A French Observational Study, the SAFARI Study	PLOS ONE			English	Article							PULMONARY-EMBOLISM; ORAL RIVAROXABAN; STANDARD THERAPY; WARFARIN; ADHERENCE; DABIGATRAN; ASSOCIATION; MANAGEMENT; RISK	Background For antithrombotic treatments, Patient Reported Outcomes (PRO) and patient satisfaction with treatment are essential data for physicians because of the strong relationship between patient satisfaction and adherence to treatment. The impact of rivaroxaban on patient satisfaction and quality of life was not sufficiently documented in phase III studies. There is a need for further data in this field especially in real life conditions. Methods The SAFARI study is composed of patients with non-valvular atrial fibrillation (AF), previously treated with vitamin K antagonist (VKA) and switched to rivaroxaban. Patient satisfaction with anticoagulant therapy was measured by the Anti-Clot Treatment Scale (ACTS), a validated 15-item patient-reported scale including a 12-item ACTS Burdens scale and a 3-item ACTS Benefits scale. Satisfaction of medication was compared between baseline and 1, 3 and 6 months. Results Study population was composed of 405 patients. Mean age was 74.8 (standard deviation = 9.0) years and 63.0% were male. Mean CHA(2)DS(2)-VASc score was 3.4 (1.5) and mean HAS-BLED score was 2.9 (1.0). After 3 months of treatment with rivaroxaban, patient satisfaction improved compared with VKA: mean ACTS burdens scores significantly increased by 8.3 (8.9) points (p<0.0001) and ACTS benefits scale by 0.4 (2.9) (p<0.001). Compared with baseline, the improvement in ACTS burdens and benefits became apparent at 1 month (46.5 vs. 53.6 p<0.001 and 10.4 vs. 10.7, p<0.05 respectively) and persisted at 6 months (46.5 vs. 54.76 p<0.001 and 10.4 vs. 10.8 p = 0.02 respectively). Rivaroxaban persistence was 88.7% at 6 months. Conclusions SAFARI data support a good risk-benefit balance for rivaroxaban, with a good safety profile and encourage PRO design studies. The switch from VKA to rivaroxaban improved patient satisfaction at 1, 3 and 6 months after rivaroxaban initiation among patients with AF, particularly in reducing patient-reported anticoagulation burden.	[Hanon, Olivier; Chaussade, Edouard] Hop Broca, AP HP, Serv Geriatrie, Paris, France; [Hanon, Olivier; Chaussade, Edouard] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Gueranger, Pierre] CH La Chartreuse, Serv Cardiol, Villefranche De Rouergue, France; [Gruson, Elise; Gay, Alain] Bayer Healthcare SAS, Loos, France; [Bonan, Sabrina] ICTA Project Management, Fontaine Les Dijon, France; [Gay, Alain] Bayer Pharma Aktiengesell Cardio Pulmono & Infect, Berlin, Germany	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Broca - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals	Hanon, O (corresponding author), Hop Broca, AP HP, Serv Geriatrie, Paris, France.; Hanon, O (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.	olivier.hanon@aphp.fr	Hanon, Olivier/GWR-0220-2022	Hanon, Olivier/0000-0002-4697-122X	ICTA; Bayer HealthCare SAS	ICTA; Bayer HealthCare SAS	SAFARI study was supported by Bayer HealthCare SAS. Bayer HealthCare SAS provided support in the form of salaries for EG and AG, but did not have any additional role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The specific roles of EG and AG are articulated in the 'author contributions' section. Bayer HealthCare SAS also provided unrestricted support to ICTA for data collection and analysis. ICTA provided support in the form of salaries for SB, but did not have any additional role in the study design, decision to publish, and preparation of the manuscript. The specific role of SB is articulated in the 'author contributions' section.	Andrade JG, 2016, CAN J CARDIOL, V32, P747, DOI 10.1016/j.cjca.2015.09.023; Bamber L, 2013, THROMB HAEMOSTASIS, V110, P732, DOI 10.1160/TH13-03-0243; Beyer-Westendorf J, 2015, EUROPACE, V17, P530, DOI 10.1093/europace/euu319; Camm AJ, 2016, EUR HEART J, V37, P1145, DOI 10.1093/eurheartj/ehv466; Camm AJ, 2012, EUR HEART J, V33; Cano SJ, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-120; Carrothers AD, 2014, J ARTHROPLASTY, V29, P1463, DOI 10.1016/j.arth.2013.02.001; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Cohen J., 1988, STATISTICAL POWER AN, DOI DOI 10.1234/12345678; Connolly SJ, 2009, N ENGL J MED, V361, P1139, DOI [10.1056/NEJMoa0905561, DOI 10.1056/NEJM0A0905561]; Engelberger RP, 2015, EUR J INTERN MED, V26, P508, DOI 10.1016/j.ejim.2015.04.014; Essers BAB, 2010, CURR OPIN PULM MED, V16, P437, DOI 10.1097/MCP.0b013e32833bde2b; Fang MC, 2010, CIRC-CARDIOVASC QUAL, V3, P624, DOI 10.1161/CIRCOUTCOMES.110.937680; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; January CT, 2014, J AM COLL CARDIOL, V64, P2304, DOI 10.1016/j.jacc.2014.04.004; KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015; Le Heuzey JY, 2014, THROMB HAEMOSTASIS, V111, P833, DOI 10.1160/TH13-12-1007; Le Heuzey JY, 2004, AM HEART J, V147, P121, DOI 10.1016/S0002-8703(03)00524-6; Lip GYH, 2011, EUROPACE, V13, P723, DOI 10.1093/europace/eur126; Martinez C, 2016, THROMB HAEMOSTASIS, V115, P31, DOI 10.1160/TH15-04-0350; Monz BU, 2013, INT J CARDIOL, V168, P2540, DOI 10.1016/j.ijcard.2013.03.059; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Prins MH, 2015, THROMB RES, V135, P281, DOI 10.1016/j.thromres.2014.11.008; Shore S, 2014, AM HEART J, V167, P810, DOI 10.1016/j.ahj.2014.03.023; Tilson HH, 2004, ANN PHARMACOTHER, V38, P161, DOI 10.1345/aph.1D207; Wang Y, 2014, THROMB RES, V133, P550, DOI 10.1016/j.thromres.2014.01.002	29	23	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166218	10.1371/journal.pone.0166218	http://dx.doi.org/10.1371/journal.pone.0166218			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935987	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100021
J	Kuroda, K; Nobu, MK; Mei, R; Narihiro, T; Bocher, BTW; Yamaguchi, T; Liu, WT				Kuroda, Kyohei; Nobu, Masaru K.; Mei, Ran; Narihiro, Takashi; Bocher, Benjamin T. W.; Yamaguchi, Takashi; Liu, Wen-Tso			A Single-Granule-Level Approach Reveals Ecological Heterogeneity in an Upflow Anaerobic Sludge Blanket Reactor	PLOS ONE			English	Article							WASTE-WATER TREATMENT; SYNTROPHIC ASSOCIATION; SOFTWARE ENVIRONMENT; SP. NOV.; COMMUNITY; BACTERIA; LOCALIZATION; DIVERSITY; DIGESTION; CONSORTIA	Upflow anaerobic sludge blanket (UASB) reactor has served as an effective process to treat industrial wastewater such as purified terephthalic acid (PTA) wastewater. For optimal UASB performance, balanced ecological interactions between syntrophs, methanogens, and fermenters are critical. However, much of the interactions remain unclear because UASB have been studied at a "macro"-level perspective of the reactor ecosystem. In reality, such reactors are composed of a suite of granules, each forming individual micro-ecosystems treating wastewater. Thus, typical approaches may be oversimplifying the complexity of the microbial ecology and granular development. To identify critical microbial interactions at both macro-and micro-level ecosystem ecology, we perform community and network analyses on 300 PTA-degrading granules from a lab-scale UASB reactor and two full-scale reactors. Based on MiSeq-based 16S rRNA gene sequencing of individual granules, different granule-types co-exist in both full-scale reactors regardless of granule size and reactor sampling depth, suggesting that distinct microbial interactions occur in different granules throughout the reactor. In addition, we identify novel networks of syntrophic metabolic interactions in different granules, perhaps caused by distinct thermodynamic conditions. Moreover, unseen methanogenic relationships (e.g. "Candidatus Aminicenantes" and Methanosaeta) are observed in UASB reactors. In total, we discover unexpected microbial interactions in granular micro-ecosystems supporting UASB ecology and treatment through a unique single-granule level approach.	[Kuroda, Kyohei; Nobu, Masaru K.; Mei, Ran; Narihiro, Takashi; Liu, Wen-Tso] Univ Illinois, Dept Civil & Environm Engn, North Mathews Ave, Urbana, IL 61801 USA; [Kuroda, Kyohei; Yamaguchi, Takashi] Nagaoka Univ Technol, Dept Environm Syst Engn, Nagaoka, Niigata, Japan; [Narihiro, Takashi] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan; [Bocher, Benjamin T. W.] BP Amer, Petrochem Technol, Naperville, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; Nagaoka University of Technology; National Institute of Advanced Industrial Science & Technology (AIST); BP	Liu, WT (corresponding author), Univ Illinois, Dept Civil & Environm Engn, North Mathews Ave, Urbana, IL 61801 USA.	wtliu@illinois.edu	Liu, Wen-Tso/C-8788-2011; Narihiro, Takashi/L-8617-2016; Kuroda, Kyohei/AAQ-4452-2020	Liu, Wen-Tso/0000-0002-8700-9803; Narihiro, Takashi/0000-0003-2936-7204; Kuroda, Kyohei/0000-0002-3681-1265; Mei, Ran/0000-0002-6464-6519	Energy Bioscience Institute at UIUC; Petrochemicals Technology, BP America; Energy Bioscience Institute at University of Illinois at Urbana-Champaign	Energy Bioscience Institute at UIUC; Petrochemicals Technology, BP America; Energy Bioscience Institute at University of Illinois at Urbana-Champaign	This work was supported by a grant from Energy Bioscience Institute at UIUC. Petrochemicals Technology, BP America provided support in the form of salaries for author BTWB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; This study was supported by a grant from Energy Bioscience Institute at University of Illinois at Urbana-Champaign to WTL. MKN, TN, BTWB, and WTL designed the experiments, KK, MKN, TN, and BTWB performed the experiments, and all authors participated in results discussion and manuscript preparation. The authors declare no conflict of interest.	Abbasi T, 2012, RENEW SUST ENERG REV, V16, P1696, DOI 10.1016/j.rser.2011.11.017; American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chouari R, 2005, APPL ENVIRON MICROB, V71, P2145, DOI 10.1128/AEM.71.4.2145-2153.2005; Del Nery V, 2008, BIORESOURCE TECHNOL, V99, P2018, DOI 10.1016/j.biortech.2007.03.019; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fang HHP, 2006, WATER RES, V40, P427, DOI 10.1016/j.watres.2005.11.025; Farag IF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092139; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Jackson BE, 1999, ARCH MICROBIOL, V171, P107, DOI 10.1007/s002030050685; Kim JY, 2012, WATER RES, V46, P2805, DOI 10.1016/j.watres.2012.02.042; Kleerebezem R, 2003, CHEM ENG-NEW YORK, V110, P56; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kuroda K, 2015, BIORESOURCE TECHNOL, V196, P225, DOI 10.1016/j.biortech.2015.07.070; Kuroda K, 2015, MICROB ECOL, V69, P586, DOI 10.1007/s00248-014-0525-z; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lykidis A, 2011, ISME J, V5, P122, DOI 10.1038/ismej.2010.125; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McInerney MJ, 2009, CURR OPIN BIOTECH, V20, P623, DOI 10.1016/j.copbio.2009.10.001; Narihiro T, 2015, ENVIRON MICROBIOL, V17, P1707, DOI 10.1111/1462-2920.12616; Narihiro T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119131; Nobu MK, 2015, ISME J, V9, P1710, DOI 10.1038/ismej.2014.256; Nobu MK, 2015, ENVIRON MICROBIOL, V17, P4861, DOI 10.1111/1462-2920.12444; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Perkins SD, 2011, WATER SCI TECHNOL, V64, P1406, DOI 10.2166/wst.2011.552; Pol LWH, 2004, WATER RES, V38, P1376, DOI 10.1016/j.watres.2003.12.002; Qiu YL, 2008, APPL ENVIRON MICROB, V74, P2051, DOI 10.1128/AEM.02378-07; Qiu YL, 2006, ARCH MICROBIOL, V185, P172, DOI 10.1007/s00203-005-0081-5; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Schmidt JE, 1996, BIOTECHNOL BIOENG, V49, P229, DOI [10.1002/(SICI)1097-0290(19960205)49:3<229::AID-BIT1>3.0.CO;2-M, 10.1002/(SICI)1097-0290(19960205)49:3&lt;229::AID-BIT1&gt;3.0.CO;2-M]; Sekiguchi Y, 1999, APPL ENVIRON MICROB, V65, P1280; Sekiguchi Y, 1998, MICROBIOL-UK, V144, P2655, DOI 10.1099/00221287-144-9-2655; SEKIGUCHI Y, 2006, MICROBES ENVIRON, V21, P1, DOI DOI 10.1264/JSME2.21.1; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tamaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025263; Wu JH, 2013, APPL ENVIRON MICROB, V79, P105, DOI 10.1128/AEM.02327-12; Wu JH, 2001, MICROBIOL-UK, V147, P373, DOI 10.1099/00221287-147-2-373; Yamada T, 2005, APPL ENVIRON MICROB, V71, P7493, DOI 10.1128/AEM.71.11.7493-7503.2005; Yan YG, 1997, WATER RES, V31, P1573, DOI 10.1016/S0043-1354(96)00354-5	43	25	25	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167788	10.1371/journal.pone.0167788	http://dx.doi.org/10.1371/journal.pone.0167788			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936088	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100189
J	Pivot, D; Debouverie, M; Grzebyk, M; Brassat, D; Clanet, M; Clavelou, P; Confavreux, C; Edan, G; Leray, E; Moreau, T; Vukusic, S; Hedelin, G; Guillemin, F				Pivot, Diane; Debouverie, Marc; Grzebyk, Michel; Brassat, David; Clanet, Michel; Clavelou, Pierre; Confavreux, Christian; Edan, Gilles; Leray, Emmanuelle; Moreau, Thibault; Vukusic, Sandra; Hedelin, Guy; Guillemin, Francis			Geographical Heterogeneity of Multiple Sclerosis Prevalence in France	PLOS ONE			English	Article							ENVIRONMENTAL RISK-FACTORS; EPIDEMIOLOGY; METAANALYSIS	Introduction Geographical variation in the prevalence of multiple sclerosis (MS) is controversial. Heterogeneity is important to acknowledge to adapt the provision of care within the healthcare system. We aimed to investigate differences in prevalence of MS in departments in the French territory. Methods We estimated MS prevalence on October 31, 2004 in 21 administrative departments in France (22% of the metropolitan departments) by using multiple data sources: the main French health insurance systems, neurologist networks devoted to MS and the Technical Information Agency of Hospitalization. We used a spatial Bayesian approach based on estimating the number of MS cases from 2005 and 2008 capture-recapture studies to analyze differences in prevalence. Results The age-and sex-standardized prevalence of MS per 100,000 inhabitants ranged from 68.1 (95% credible interval 54.6, 84.4) in Hautes-Pyrenees (southwest France) to 296.5 (258.8, 338.9) in Moselle (northeast France). The greatest prevalence was in the northeast departments, and the other departments showed great variability. Discussion By combining multiple data sources into a spatial Bayesian model, we found heterogeneity in MS prevalence among the 21 departments of France, some with higher prevalence than anticipated from previous publications. No clear explanation related to health insurance coverage and hospital facilities can be advanced. Population migration, socioeconomic status of the population studied and environmental effects are suspected.	[Pivot, Diane; Guillemin, Francis] Nancy Univ Hosp, Clin & Evaluat Dept, Vandoeuvre Les Nancy, France; [Debouverie, Marc] Paris Descartes Univ, Lorraine Univ, EA Apemac 4360, Nancy, France; [Debouverie, Marc] Nancy Univ Hosp, Dept Neurol, Nancy, France; [Grzebyk, Michel; Hedelin, Guy] Natl Inst Occupat Safety & Hlth, Vandoeuvre Les Nancy, France; [Brassat, David; Clanet, Michel] Toulouse Univ Hosp, Dept Neurol, Toulouse, France; [Clavelou, Pierre] Clermont Ferrand Univ Hosp, Dept Neurol, Clermont Ferrand, France; [Confavreux, Christian; Vukusic, Sandra] Pierre Wertheimer Univ Hosp, Lyon Hosp Civils, Dept Neurol, Lyon, France; [Edan, Gilles] Rennes Univ Hosp, Dept Neurol, Rennes, France; [Leray, Emmanuelle] Ecoles Hautes Etud Sante Publ, Rennes, France; [Moreau, Thibault] Dijon Univ Hosp, Dept Neurol, Dijon, France; [Guillemin, Francis] INSERM, CIC EC, Nancy, France	CHU de Nancy; UDICE-French Research Universities; Universite Paris Cite; Universite de Lorraine; CHU de Nancy; CHU de Toulouse; CHU Clermont Ferrand; CHU Lyon; CHU Rennes; Universite de Rennes; CHU Dijon Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm)	Guillemin, F (corresponding author), Nancy Univ Hosp, Clin & Evaluat Dept, Vandoeuvre Les Nancy, France.; Guillemin, F (corresponding author), INSERM, CIC EC, Nancy, France.	francis.guillemin@chu-nancy.fr	Leray, Emmanuelle/ABH-4374-2020; Grzebyk, Michel/A-1574-2008; Edan, Gilles/AAI-5944-2020	Leray, Emmanuelle/0000-0001-8424-4499; Grzebyk, Michel/0000-0001-6522-7554; Clavelou, Pierre/0000-0003-2363-9352; pivot, diane/0000-0002-8225-9248	French State and handled by the "Agence Nationale de la Recherche," within the framework of the "Investments for the Future" programme [ANR-10-COHO-002]; Eugene Devic EDMUS Foundation	French State and handled by the "Agence Nationale de la Recherche," within the framework of the "Investments for the Future" programme(French National Research Agency (ANR)); Eugene Devic EDMUS Foundation	This work has been realized with the help of the Observatoire Francais de la Sclerose en Plaques (OFSEP), which is supported by a grant provided by the , under the referenceFrench State and handled by the "Agence Nationale de la Recherche," within the framework of the "Investments for the Future" programme ANR-10-COHO-002, and the Eugene Devic EDMUS Foundation against multiple sclerosis.	Alonso A, 2008, NEUROLOGY, V71, P129, DOI 10.1212/01.wnl.0000316802.35974.34; Ascherio A, 2007, ANN NEUROL, V61, P504, DOI 10.1002/ana.21141; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Beale L, 2008, ENVIRON HEALTH PERSP, V116, P1105, DOI 10.1289/ehp.10816; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; CONFAVREUX C, 1992, J NEUROL NEUROSUR PS, V55, P671, DOI 10.1136/jnnp.55.8.671; Cressie NA., 1996, FAC INFORM PAP ARCH, P159; De Pedro-Cuesta J, 2009, BMC NEUROL, V13, P58, DOI DOI 10.1186/1471-2377-13-58; Debouverie M, 2007, REV NEUROL-FRANCE, V163, P637, DOI 10.1016/S0035-3787(07)90472-5; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; El Adssi H, 2012, MULT SCLER J, V18, P1244, DOI 10.1177/1352458512437811; Fromont A, 2010, BRAIN, V133, P1889, DOI 10.1093/brain/awq134; Ha-Vinh Philippe, 2016, Mult Scler J Exp Transl Clin, V2, p2055217316631762, DOI 10.1177/2055217316631762; HAMMOND SR, 1988, BRAIN, V111, P1, DOI 10.1093/brain/111.1.1; Horakova D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053996; Koch-Henriksen N, 2011, J NEUROL SCI, V311, P58, DOI 10.1016/j.jns.2011.09.003; Koch-Henriksen N, 2010, LANCET NEUROL, V9, P520, DOI 10.1016/S1474-4422(10)70064-8; KUROIWA Y, 1982, JPN J MED, V21, P135; Kurtzke JF, 1997, NEUROLOGY, V48, P204, DOI 10.1212/WNL.48.1.204; Orton SM, 2011, NEUROLOGY, V76, P425, DOI 10.1212/WNL.0b013e31820a0a9f; Pugliatti M, 2006, EUR J NEUROL, V13, P700, DOI 10.1111/j.1468-1331.2006.01342.x; Rosati G, 2001, NEUROL SCI, V22, P117, DOI 10.1007/s100720170011; Sagnes-Raffy C, 2010, REV EPIDEMIOL SANTE, V58, P23, DOI 10.1016/j.respe.2009.08.012; Simpson S, 2011, J NEUROL NEUROSUR PS, V82, P1132, DOI 10.1136/jnnp.2011.240432; Vukusic S, 2007, J NEUROL NEUROSUR PS, V78, P707, DOI 10.1136/jnnp.2006.101196; Zivadinov R, 2003, NEUROEPIDEMIOLOGY, V22, P65, DOI 10.1159/000067107	26	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167556	10.1371/journal.pone.0167556	http://dx.doi.org/10.1371/journal.pone.0167556			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936086	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100124
J	Tang, JS; Ning, RH; Zeng, B; Li, Y				Tang, Jingsi; Ning, Ruihong; Zeng, Bo; Li, Ying			Molecular Evolution of PTEN Pseudogenes in Mammals	PLOS ONE			English	Article							CANCER RESISTANCE; RNA; PATHWAY; CERNA	Phosphatase and tensin homolog (PTEN) is a tumor-suppressor gene. PTEN pseudogene (PTENp) acts as an endogenous RNA, which regulates its parental gene by competitively binding to the 3' UTR of PTEN gene in the human. Despite the importance of this pseudogene, little is known about the molecular evolution of PTENp in mammals. In this study, we identified 37 pseudogenes from 65 mammalian genomes. Among them, 32 were from rodents or primates. Phylogenetic analyse showed a complex evolutionary history of this gene family. Some PTENps were shared both in primates and rodents. However, some PTENps were shown to be species-specific, such as the tasmanian devil PTENp1, nine banded armadillo PTENp1 and gibbon PTENp1. Most interestingly, the naked mole rat (NMR), an anticancer model organism, possessed 17 copies of PTENps, which were classified into four clades based on the phylogenetic analyses. Furthermore, we found that all the 3' UTR of PTEN and PTENps shared common microRNA (MicroRNA) binding sites in NMR, based on our prediction of specific MicroRNA binding sites. Our findings suggested that multiple gene duplications have occurred in the formation of PTEN/PTENp gene family during the evolution of mammals. Some PTENps were relatively ancient and were shared by primates and rodents; others were newly originated through species-specific gene duplications. PTENps in NMR may function as competitive endogenous RNAs (ceRNAs) to regulate their counterpart genes by competing for common MicroRNAs, which may be one of the interpretations for the cancer resistance in NMR.	[Tang, Jingsi; Ning, Ruihong; Zeng, Bo; Li, Ying] Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Peoples R China	Sichuan Agricultural University	Li, Y (corresponding author), Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Peoples R China.	yingli@sicau.edu.cn		Zeng, Bo/0000-0001-7482-7340	"1000-Talent Program" in Sichuan; University of Sichuan Bureau of Education	"1000-Talent Program" in Sichuan; University of Sichuan Bureau of Education	This work was supported by the "1000-Talent Program" in Sichuan and the Innovative Research Team in University of Sichuan Bureau of Education to Ying Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegglen LM, 2015, JAMA-J AM MED ASSOC, V314, P1850, DOI 10.1001/jama.2015.13134; Esposito F, 2014, ONCOTARGET, V5, P8341, DOI 10.18632/oncotarget.2202; Fang X, 2014, NAT COMMUN, V5; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; JACQ C, 1977, CELL, V12, P109, DOI 10.1016/0092-8674(77)90189-1; Jansson MD, 2015, ONCOGENE, V34, P1908, DOI 10.1038/onc.2014.130; Johnsson P, 2013, NAT STRUCT MOL BIOL, V20, P440, DOI 10.1038/nsmb.2516; Karreth FA, 2015, CELL, V161, P319, DOI 10.1016/j.cell.2015.02.043; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kimura M., 1980, SIMPLE METHOD ESTIMA, DOI [10.1038/ng2135, DOI 10.1038/NG2135]; Kozomara A, 2014, MIRBASE ANNOTATING H; Nei M., 2000, MOL EVOLUTION PHYLOG; Piontkivska H, 2003, MOL BIOL EVOL, V20, P601, DOI 10.1093/molbev/msg064; Poliseno L, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002858; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Rutnam ZJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3914; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Tian X, 2013, NATURE, V499, P346, DOI 10.1038/nature12234; Xing MZ, 2010, THYROID, V20, P697, DOI 10.1089/thy.2010.1646; Zheng LF, 2015, BREAST CANCER RES TR, V150, P105, DOI 10.1007/s10549-015-3298-2	23	17	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167851	10.1371/journal.pone.0167851	http://dx.doi.org/10.1371/journal.pone.0167851			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936183	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100216
J	Yang, QQ; Xue, WZ; Zou, RX; Xu, Y; Du, Y; Wang, S; Xu, L; Chen, YZ; Wang, HL; Chen, XT				Yang, Qian-Qian; Xue, Wei-Zhen; Zou, Rong-Xin; Xu, Yi; Du, Yang; Wang, Shuang; Xu, Lai; Chen, Yuan-Zhi; Wang, Hui-Li; Chen, Xiang-Tao			beta-Asarone Rescues Pb-Induced Impairments of Spatial Memory and Synaptogenesis in Rats	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ACORI-GRAMINEI-RHIZOMA; CHONG-MYUNG-TANG; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; DENDRITIC SPINES; DENTATE GYRUS; IN-VIVO; HIPPOCAMPAL NEUROGENESIS; NEURONAL APOPTOSIS	Chronic lead (Pb) exposure causes cognitive deficits. This study aimed to explore the neuroprotective effect and mechanism of beta-asarone, an active component from Chinese Herbs Acorus tatarinowii Schott, to alleviate impairments of spatial memory and synaptogenesis in Pb-exposed rats. Both Sprague-Dawley developmental rat pups and adult rats were used in the study. Developmental rat pups were exposed to Pb throughout the lactation period and beta-asarone (10, 40mg kg(-1), respectively) was given intraperitoneally from postnatal day 14 to 21. Also, the adult rats were exposed to Pb from embryo stage to 11 weeks old and beta-asarone (2.5, 10, 40mg kg(-1), respectively) was given from 9 to 11 weeks old. The level of beta-asarone in brain tissue was measured by High Performance Liquid Chromatography. The Morris water maze test and Golgi-Cox staining method were used to assess spatial memory ability and synaptogenesis. The protein expression of NR2B subunit of NMDA receptor, Activity-regulated cytoskeleton-associated protein (Arc/Arg3.1) and Wnt family member 7A (Wnt7a) in hippocampus, as well as mRNA expression of Arc/Arg3.1 and Wnt7a, was also explored. We found that beta-asarone could pass through the blood brain barrier quickly. And beta-asarone effectively attenuated Pb-induced reduction of spine density in hippocampal CA1 and dentate gyrus areas in a dose-dependent manner both in developmental and adult rats, meanwhile the Pb-induced impairments of learning and memory were partially rescued. In addition, beta-asarone effectively up-regulated the protein expression of NR2B, Arc and Wnt7a, as well as the mRNA levels of Arc/Arg3.1 and Wnt7a, which had been suppressed by Pb exposure. The results suggest the neuroprotective properties of beta-asarone against Pb-induced memory impairments, and the effect is possibly through the regulation of synaptogenesis, which is mediated via Arc/Arg3.1 and Wnt pathway.	[Yang, Qian-Qian; Xue, Wei-Zhen; Zou, Rong-Xin; Xu, Yi; Du, Yang; Wang, Shuang; Wang, Hui-Li] Hefei Univ Technol, Sch Food Sci & Engn, Hefei, Anhui, Peoples R China; [Xu, Lai; Chen, Yuan-Zhi; Chen, Xiang-Tao] Anhui Med Univ, Sch Pharm, Hefei, Anhui, Peoples R China	Hefei University of Technology; Anhui Medical University	Chen, XT (corresponding author), Anhui Med Univ, Sch Pharm, Hefei, Anhui, Peoples R China.	chenxt@ustc.edu.cn	wang, hui/GRS-4730-2022	Wang, Hui-Li/0000-0001-6852-8002	National Key Basic Research Program of China [2012CB525003]; National Science Foundation of China [31200851, 31401671, 81673624]; Program for New Century Excellent Talents in University [NCET-12-0835]; Key Laboratory of Xin'an Medicine [2015sbgj005]; Huangshan Young Scholar Fund of Hefei University of Technology [407-037030]; Training Program of Innovation and Entrepreneurship for Undergraduates of Anhui Medical University [201510366121]	National Key Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Key Laboratory of Xin'an Medicine; Huangshan Young Scholar Fund of Hefei University of Technology; Training Program of Innovation and Entrepreneurship for Undergraduates of Anhui Medical University	This work was supported by the National Key Basic Research Program of China (No. 2012CB525003, www.973.gov.cn), the National Science Foundation of China (No.31200851, 31401671, 81673624, www.nsfc.gov.cn), the Program for New Century Excellent Talents in University (NCET-12-0835, www.dost.moe.edu.cn), The Open Project of Key Laboratory of Xin'an Medicine (No. 2015sbgj005), the Huangshan Young Scholar Fund of Hefei University of Technology (No. 407-037030) and the Training Program of Innovation and Entrepreneurship for Undergraduates of Anhui Medical University (No.201510366121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Bamji SX, 2006, J CELL BIOL, V174, P289, DOI 10.1083/jcb.200601087; Bloomer WAC, 2008, J BIOL CHEM, V283, P582, DOI 10.1074/jbc.M702451200; Cerpa W, 2008, J BIOL CHEM, V283, P5918, DOI 10.1074/jbc.M705943200; Chen BY, 2013, J NEUROSCI RES, V91, P30, DOI 10.1002/jnr.23138; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Chen WH, 2007, NEUROSCIENCE, V147, P853, DOI 10.1016/j.neuroscience.2007.04.042; Cho J, 2002, LIFE SCI, V71, P591, DOI 10.1016/S0024-3205(02)01729-0; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; David MD, 2008, J CELL SCI, V121, P2718, DOI 10.1242/jcs.029660; Dong HY, 2014, MOLECULES, V19, P5634, DOI 10.3390/molecules19055634; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Falsafi SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032082; Fang YQ, 2012, PHARMAZIE, V67, P120, DOI 10.1691/ph.2012.1100; Geng YT, 2010, BIOL PHARM BULL, V33, P836, DOI 10.1248/bpb.33.836; Gortazar AR, 2013, J BIOL CHEM, V288, P8168, DOI 10.1074/jbc.M112.437921; Grandjean P, 2014, LANCET NEUROL, V13, P330, DOI 10.1016/S1474-4422(13)70278-3; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Hiester BG, 2013, MOL CELL NEUROSCI, V56, P115, DOI 10.1016/j.mcn.2013.04.006; Hu F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101894; Inestrosa NC, 2014, J MOL CELL BIOL, V6, P64, DOI 10.1093/jmcb/mjt051; Inestrosa NC, 2012, J NEUROIMMUNE PHARM, V7, P788, DOI 10.1007/s11481-012-9417-5; Jeon SH, 2007, J BIOL CHEM, V282, P14482, DOI 10.1074/jbc.M611129200; Kim JH, 2009, EVID-BASED COMPL ALT, V6, P457, DOI 10.1093/ecam/nem158; Lee BB, 2003, LIFE SCI, V74, P435, DOI 10.1016/j.lfs.2003.06.034; Lee MR, 2010, J ETHNOPHARMACOL, V132, P70, DOI 10.1016/j.jep.2010.07.041; Li ZQ, 2012, J ETHNOPHARMACOL, V144, P305, DOI 10.1016/j.jep.2012.09.013; Lidsky TI, 2006, ENVIRON RES, V100, P284, DOI 10.1016/j.envres.2005.03.002; Lim H. S., 2014, SCI REP, V4, P1, DOI DOI 10.1016/J.FCT; Liu L, 2014, BIOSCI BIOTECH BIOCH, V78, P1710, DOI 10.1080/09168451.2014.930319; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Mao JX, 2015, AGING CELL, V14, P784, DOI 10.1111/acel.12356; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Neal AP, 2011, NEUROTOXICOLOGY, V32, P281, DOI 10.1016/j.neuro.2010.12.013; Nihei MK, 2001, NEUROTOXICOLOGY, V22, P635, DOI 10.1016/S0161-813X(01)00035-3; Pina-Crespo JC, 2002, J PHYSIOL-LONDON, V541, P41, DOI 10.1113/jphysiol.2001.014001; Rajput SB, 2014, PHYTOMEDICINE, V21, P268, DOI 10.1016/j.phymed.2013.09.020; Rana TS, 2013, PHYSIOL MOL BIOL PLA, V19, P231, DOI 10.1007/s12298-013-0164-8; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Rochefort NL, 2012, EMBO REP, V13, P699, DOI 10.1038/embor.2012.102; Satyal P, 2013, NAT PROD COMMUN, V8, P1179; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Toscano CD, 2002, DEV BRAIN RES, V139, P217, DOI 10.1016/S0165-3806(02)00569-2; Tzingounis AV, 2006, NEURON, V52, P403, DOI 10.1016/j.neuron.2006.10.016; Unger Pascal, 2012, Sci Pharm, V80, P663; Wang HL, 2006, EUR J NEUROSCI, V23, P1111, DOI 10.1111/j.1460-9568.2006.04645.x; Wei G, 2013, J ALZHEIMERS DIS, V33, P863, DOI 10.3233/JAD-2012-120865; Yan L, 2015, J ETHNOPHARMACOL, V162, P155, DOI 10.1016/j.jep.2014.12.049; Yun MS, 2005, J CELL SCI, V118, P313, DOI 10.1242/jcs.01601; Zhang H, 2007, J PHARM PHARMACOL, V59, P301, DOI 10.1211/jpp.59.2.0016; Zhu KY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/731385; Zhu XQ, 2016, CEREB CORTEX, V26, P334, DOI 10.1093/cercor/bhu258	56	16	19	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167401	10.1371/journal.pone.0167401	http://dx.doi.org/10.1371/journal.pone.0167401			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936013	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100091
J	Ghane, E; Ranaivoson, AZ; Feyereisen, GW; Rosen, CJ; Moncrief, JF				Ghane, Ehsan; Ranaivoson, Andry Z.; Feyereisen, Gary W.; Rosen, Carl J.; Moncrief, John F.			Comparison of Contaminant Transport in Agricultural Drainage Water and Urban Stormwater Runoff	PLOS ONE			English	Article							TILE DRAINAGE; SUBSURFACE DRAINAGE; MANURE APPLICATIONS; PHOSPHORUS EXPORT; UNITED-STATES; NITROGEN; NITRATE; SURFACE; DYNAMICS; YIELD	Transport of nitrogen and phosphorus from agricultural and urban landscapes to surface water bodies can cause adverse environmental impacts. The main objective of this long-term study was to quantify and compare contaminant transport in agricultural drainage water and urban stormwater runoff. We measured flow rate and contaminant concentration in stormwater runoff from Willmar, Minnesota, USA, and in drainage water from subsurface-drained fields with surface inlets, namely, Unfertilized and Fertilized Fields. Commercial fertilizer and turkey litter manure were applied to the Fertilized Field based on agronomic requirements. Results showed that the City Stormwater transported significantly higher loads per unit area of ammonium, total suspended solids (TSS), and total phosphorus (TP) than the Fertilized Field, but nitrate load was significantly lower. Nitrate load transport in drainage water from the Unfertilized Field was 58% of that from the Fertilized Field. Linear regression analysis indicated that a 1% increase in flow depth resulted in a 1.05% increase of TSS load from the City Stormwater, a 1.07% increase in nitrate load from the Fertilized Field, and a 1.11% increase in TP load from the Fertilized Field. This indicates an increase in concentration with a rise in flow depth, revealing that concentration variation was a significant factor influencing the dynamics of load transport. Further regression analysis showed the importance of targeting high flows to reduce contaminant transport. In conclusion, for watersheds similar to this one, management practices should be directed to load reduction of ammonium and TSS from urban areas, and nitrate from cropland while TP should be a target for both.	[Ghane, Ehsan; Ranaivoson, Andry Z.; Rosen, Carl J.; Moncrief, John F.] Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA; [Feyereisen, Gary W.] ARS, USDA, Soil & Water Management Res Unit, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA)	Ghane, E (corresponding author), Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA.	ehsan.ghane@outlook.com	Ghane, Ehsan/AAI-4950-2021	Ghane, Ehsan/0000-0002-3337-5015	Minnesota Soybean Research and Promotion Council; Minnesota Corn Research and Promotion Council; Minnesota Agricultural Water Resource Center [CON000000050126]; Minnesota Turkey Research and Promotion Council; ARS [ARS-0422678] Funding Source: Federal RePORTER	Minnesota Soybean Research and Promotion Council; Minnesota Corn Research and Promotion Council; Minnesota Agricultural Water Resource Center; Minnesota Turkey Research and Promotion Council; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding of this research was provided in part by Minnesota Soybean Research and Promotion Council; Minnesota Corn Research and Promotion Council; Minnesota Agricultural Water Resource Center (CON000000050126), and Minnesota Turkey Research and Promotion Council. The funding sources were not involved in the study design, collection, analysis, interpretation of data, decision to publish and preparation of the manuscript.	Alexander RB, 1996, BIOGEOCHEMISTRY, V33, P149, DOI 10.1007/BF02181070; Bechmann M, 2014, AGR ECOSYST ENVIRON, V198, P13, DOI 10.1016/j.agee.2014.05.010; Bernhardt ES, 2008, ANN NY ACAD SCI, V1134, P61, DOI 10.1196/annals.1439.014; Brezonik PL, 2002, WATER RES, V36, P1743, DOI 10.1016/S0043-1354(01)00375-X; Coelho BB, 2012, AGR WATER MANAGE, V104, P40, DOI 10.1016/j.agwat.2011.11.014; Collins KA, 2010, ECOL ENG, V36, P1507, DOI 10.1016/j.ecoleng.2010.03.015; Duan SW, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001782; FAUSEY NR, 1995, J IRRIG DRAIN E-ASCE, V121, P283, DOI 10.1061/(ASCE)0733-9437(1995)121:4(283); Feyereisen GW, 2015, J ENVIRON QUAL, V44, P594, DOI 10.2134/jeq2014.05.0219; Fissore C, 2012, URBAN ECOSYST, V15, P1, DOI 10.1007/s11252-011-0189-0; Gall HE, 2015, WATER RES, V72, P162, DOI 10.1016/j.watres.2014.08.041; Ghane E, 2012, J SOIL WATER CONSERV, V67, P465, DOI 10.2489/jswc.67.6.465; Ghane E, 2015, WATER RES, V71, P294, DOI 10.1016/j.watres.2014.10.039; Ginting D, 2000, J ENVIRON QUAL, V29, P551, DOI 10.2134/jeq2000.00472425002900020024x; Groh TA, 2015, J ENVIRON QUAL, V44, P1001, DOI 10.2134/jeq2014.10.0415; Gunn KM, 2015, AGR WATER MANAGE, V149, P131, DOI 10.1016/j.agwat.2014.10.014; Heeb NV, 2006, ATMOS ENVIRON, V40, P3750, DOI 10.1016/j.atmosenv.2006.03.002; Heiskary S, 2014, LAKE RESERV MANAGE, V30, P268, DOI 10.1080/10402381.2014.917347; Hernandez-Ramirez G, 2011, J ENVIRON QUAL, V40, P1229, DOI 10.2134/jeq2010.0195; Hodgkinson RA, 2002, AGR WATER MANAGE, V57, P155, DOI 10.1016/S0378-3774(02)00057-4; Hofmann BS, 2004, ECOL ENG, V23, P251, DOI 10.1016/j.ecoleng.2004.09.008; Homer C, 2015, PHOTOGRAMM ENG REM S, V81, P345, DOI 10.14358/PERS.81.5.345; Janke BD, 2014, BIOGEOCHEMISTRY, V121, P209, DOI 10.1007/s10533-013-9926-1; Kadlec R.H., 2008, TREATMENT WETLANDS, DOI [10.1201/9781420012514, DOI 10.1201/9781420012514]; Kalita PK, 2006, AGR ECOSYST ENVIRON, V115, P183, DOI 10.1016/j.agee.2006.01.006; Kaushal SS, 2011, ENVIRON SCI TECHNOL, V45, P8225, DOI 10.1021/es200779e; Kayhanian M, 2012, WATER RES, V46, P6609, DOI 10.1016/j.watres.2012.07.026; King KW, 2015, J ENVIRON QUAL, V44, P486, DOI 10.2134/jeq2014.04.0149; Lee JY, 2015, J ENVIRON MANAGE, V152, P171, DOI 10.1016/j.jenvman.2015.01.028; LeFevre GH, 2015, J ENVIRON ENG, V141, DOI 10.1061/(ASCE)EE.1943-7870.0000876; Macrae ML, 2007, AGR WATER MANAGE, V92, P171, DOI 10.1016/j.agwat.2007.05.015; Madison AM, 2014, J HYDROL, V519, P892, DOI 10.1016/j.jhydrol.2014.08.016; Maestre A., 2005, COMPILATION ANAL NPD; Milne I, 2000, ENVIRON TOXICOL CHEM, V19, P2929, DOI 10.1002/etc.5620191213; Montgomery D. C., 2015, INTRO TIME SERIES AN; MPCA, 2005, LAK WAK KAND DITCH W; Nguyen HQ, 2013, T ASABE, V56, P91; Passeport E, 2009, J HYDROL ENG, V14, P352, DOI 10.1061/(ASCE)1084-0699(2009)14:4(352); Perri KA, 2015, J GREAT LAKES RES, V41, P326, DOI 10.1016/j.jglr.2015.03.022; RAMSEY F, 2013, STAT SLEUTH COURSE M; Randall GW, 2008, NITROGEN IN THE ENVIRONMENT: SOURCES, PROBLEMS, AND MANAGEMENT, 2ND EDITION, P145, DOI 10.1016/B978-0-12-374347-3.00006-8; Rice EW, 2012, STANDARD METHODS EXA; Rosen C. J., 2005, International Turfgrass Society Research Journal, V10, P130; Skaggs RW, 2016, 2016 10 INT DRAIN S, P18; Smith DR, 2015, J ENVIRON QUAL, V44, P495, DOI 10.2134/jeq2014.04.0176; Smith EL, 2011, J ENVIRON MANAGE, V92, P2892, DOI 10.1016/j.jenvman.2011.06.043; Spokes LJ, 2005, CONT SHELF RES, V25, P2022, DOI 10.1016/j.csr.2005.07.004; Steffen MM, 2014, HARMFUL ALGAE, V33, P12, DOI 10.1016/j.hal.2013.12.008; Sudduth KA, 2007, AGRON J, V99, P1471, DOI 10.2134/agronj2006.0326; Taebi A, 2004, SCI TOTAL ENVIRON, V327, P175, DOI 10.1016/j.scitotenv.2003.11.015; Tiemeyer B, 2006, AGR WATER MANAGE, V85, P47, DOI 10.1016/j.agwat.2006.03.016; Tomer MD, 2003, J ENVIRON QUAL, V32, P642, DOI 10.2134/jeq2003.0642; Ulen B, 2014, AGR WATER MANAGE, V146, P208, DOI 10.1016/j.agwat.2014.08.012; Ulen B, 2012, AGR ECOSYST ENVIRON, V151, P61, DOI 10.1016/j.agee.2012.02.005; USDA-NASS, 2013, TURK NUMB RAIS STAT; USEPA, 2013, REASS 2013 ASS PROGR; USGS (US Geological Survey), 1999, QUAL OUR NAT WAT NUT; Vidon P, 2011, AGR WATER MANAGE, V98, P532, DOI 10.1016/j.agwat.2010.09.010; Zhang L, 2012, ATMOS CHEM PHYS, V12, P4539, DOI 10.5194/acp-12-4539-2012	59	36	36	7	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167834	10.1371/journal.pone.0167834	http://dx.doi.org/10.1371/journal.pone.0167834			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930684	Green Submitted, Green Published, gold			2022-12-27	WOS:000389580900049
J	Su, W; Liu, J; Miles, BA; Genden, EM; Misiukiewicz, KJ; Posner, M; Gupta, V; Bakst, RL				Su, William; Liu, Jerry; Miles, Brett A.; Genden, Eric M.; Misiukiewicz, Krzysztof J.; Posner, Marshall; Gupta, Vishal; Bakst, Richard L.			Adjuvant Radiation Therapy Alone for HPV Related Oropharyngeal Cancers with High Risk Features	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; LOCALLY ADVANCED HEAD; HUMAN-PAPILLOMAVIRUS; NECK-CANCER; CHEMORADIOTHERAPY; CHEMORADIATION; SURGERY; CHEMOTHERAPY; RADIOTHERAPY; TOXICITY	Background Current standard of care for oropharyngeal cancers with positive surgical margins and/or extracapsular extension is adjuvant chemoradiotherapy. It is unknown whether HPV+ oropharyngeal cancer benefits from this treatment intensification. Objective To investigate the outcomes of HPV+ patients treated with adjuvant radiotherapy alone when chemoradiotherapy was indicated based on high risk pathological features. They were compared with high risk HPV+ patients treated with adjuvant chemoradiotherapy. Methods All high risk HPV+ oropharyngeal cancer patients (9) who received radiotherapy alone were identified. We also identified 17 patients who received chemoradiotherapy as a comparison group. Median follow up time was 37.3 months. Results No local failures developed in adjuvant radiotherapy group. There was 1 distant recurrence in this cohort and 3 in CRT cohort. Regarding toxicity, 8 (47.1%) chemoradiotherapy patients had >10 lb. weight loss (p = 0.013), despite 75% of them having a percutaneous endoscopic gastrostomy tube placed. No individuals in radiotherapy group experienced a >10 lb. weight loss and none required a gastrostomy tube. Conclusions This series provides preliminary evidence suggesting that the omission of concurrent chemotherapy to adjuvant radiotherapy may offer comparative local control rates with a lower toxicity profile in the setting of HPV+ patients with traditional high risk features.	[Su, William] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Liu, Jerry] Mt Sinai Beth Israel, Dept Radiat Oncol, New York, NY USA; [Miles, Brett A.; Genden, Eric M.] Icahn Sch Med Mt Sinai, Dept Otolaryngol Head & Neck Surg, New York, NY 10029 USA; [Misiukiewicz, Krzysztof J.; Posner, Marshall] Icahn Sch Med Mt Sinai, Dept Med Oncol, New York, NY 10029 USA; [Gupta, Vishal; Bakst, Richard L.] Icahn Sch Med Mt Sinai, Dept Radiat Oncol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Bakst, RL (corresponding author), Icahn Sch Med Mt Sinai, Dept Radiat Oncol, New York, NY 10029 USA.	Richard.Bakst@mountsinai.org	Liu, Jerry/AAO-1599-2021	Su, William/0000-0002-5198-2054; Liu, Jerry/0000-0002-4743-6675				Adelstein DJ, 2003, J CLIN ONCOL, V21, P92, DOI 10.1200/JCO.2003.01.008; [Anonymous], 2016, SIN ROB SURG TRIAL H; Bernier J, 2004, NEW ENGL J MED, V350, P1945, DOI 10.1056/NEJMoa032641; Broglie MA, 2015, EUR ARCH OTO-RHINO-L, V272, P1755, DOI 10.1007/s00405-014-3099-y; Carpenter TJ, 2014, ANN OTO RHINOL LARYN, V123, P791, DOI 10.1177/0003489414535560; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Habbous S, 2014, HEAD NECK-J SCI SPEC, V36, P802, DOI 10.1002/hed.23360; Hanasoge S, 2016, HEAD NECK-J SCI SPEC, V38, P846, DOI 10.1002/hed.24073; Henk J M, 1997, Clin Oncol (R Coll Radiol), V9, P308, DOI 10.1016/S0936-6555(05)80064-0; Kaczmar JM, 2016, HEAD NECK-J SCI SPEC, V38, P59, DOI 10.1002/hed.23850; Kann BH, 2014, HEAD NECK-J SCI SPEC, V36, P1689, DOI 10.1002/hed.23512; Lawrence TS, 2003, SEMIN RADIAT ONCOL, V13, P13, DOI 10.1053/srao.2003.50002; Machtay M, 2008, J CLIN ONCOL, V26, P3582, DOI 10.1200/JCO.2007.14.8841; Moore EJ, 2013, INT J RADIAT ONCOL, V85, P1163, DOI 10.1016/j.ijrobp.2012.08.033; O'Sullivan B, 2013, J CLIN ONCOL, V31, P543, DOI 10.1200/JCO.2012.44.0164; Pederson AW, 2010, HEAD NECK-J SCI SPEC, V32, P1519, DOI 10.1002/hed.21360; Sedaghat AR, 2009, LARYNGOSCOPE, V119, P1542, DOI 10.1002/lary.20533; Shaw RJ, 2010, HEAD NECK-J SCI SPEC, V32, P714, DOI 10.1002/hed.21244; Sinha P, 2015, CANCER-AM CANCER SOC, V121, P1747, DOI 10.1002/cncr.29242; Ward MC, 2016, HEAD NECK-J SCI SPEC, V38, pE1054, DOI 10.1002/hed.24157; Ward MJ, 2015, HEAD NECK-J SCI SPEC, V37, P1002, DOI 10.1002/hed.23697; Yokota T, 2014, INT J CLIN ONCOL, V19, P38, DOI 10.1007/s10147-013-0532-y	23	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0168061	10.1371/journal.pone.0168061	http://dx.doi.org/10.1371/journal.pone.0168061			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930732	Green Published, gold, Green Submitted			2022-12-27	WOS:000389580900076
J	Li, Y; Tian, X; Xiong, ZY; Liao, JL; Hao, L; Liu, GL; Ren, YP; Wang, Q; Duan, LP; Zheng, ZX; Quan, WX; Dong, J				Li, Yi; Tian, Xue; Xiong, Zu-Ying; Liao, Jin-Lan; Hao, Li; Liu, Gui-Ling; Ren, Ye-Ping; Wang, Qin; Duan, Li-Ping; Zheng, Zhao-Xia; Quan, Wen-Xiang; Dong, Jie			Performance of the Modified Mini-Mental State Examination (3MS) in Assessing Specific Cognitive Function in Patients Undergoing Peritoneal Dialysis	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RISK-FACTORS; CARDIOVASCULAR-DISEASE; IMPAIRMENT; DEMENTIA; PREVALENCE; DECLINE	Purpose While Cognitive impairment (CI) has been identified as an independent risk factors for mortality in patients undergoing peritoneal dialysis (PD), it is inadequately assessed. We evaluated the applicability of the Modified Mini-Mental State Examination (3MS) in assessing specific cognitive function and compared it to a detailed neuropsychological test battery as the reference standard. Methods In this multicentric cross-sectional study, we enrolled 445 clinically stable patients from five PD units, who were undergoing PD for at least 3 months. The 3MS was evaluated for general cognitive function. A detailed neuropsychological battery including domains of immediate memory, delayed memory, executive function, language, and visuospatial ability were evaluated as reference standards. Sensitivity and specificity of the 3MS was determined by using receiver operating characteristic (ROC) analysis. Results The CI prevalence evaluated by 3MS was 23.6%. PD patients with CI performed worse in all cognitive domains. The 3MS correlated well with specific cognitive domains. However, 18.5%, 57.4%, 12.6%, 8.8%, and 41.2% of patients whom were idendified as normal by 3MS still showed executive dysfunction, immediate memory impairment, delayed memory impairment, and language-ability and visuospatial-ability impairment, respectively. The 3MS identified patients having specific cognitive dysfunction with varied extent of diagnostic value, with 0.50, 0.42, 0.35, 0.34, and 0.26 of Youden index in executive function, delayed memory, language ability, immediate memory, and visuospatial ability, respectively. Conclusions The 3MS is not a comprehensive instrument for major cognitive domains in PD patients. It could, however, be used for executive dysfunction and delayed memory impairment screening.	[Li, Yi; Tian, Xue; Dong, Jie] Peking Univ, Hosp 1, Dept Med, Div Renal, Beijing, Peoples R China; [Xiong, Zu-Ying; Liao, Jin-Lan] Peking Univ, Shenzhen Hosp, Div Renal, Shenzhen, Peoples R China; [Hao, Li; Liu, Gui-Ling] Anhui Med Univ, Hosp 2, Div Renal, Hefei, Anhui, Peoples R China; [Ren, Ye-Ping; Wang, Qin] Harbin Med Univ, Affiliated Hosp 2, Div Renal, Harbin, Heilongjiang, Peoples R China; [Duan, Li-Ping; Zheng, Zhao-Xia] Handan Cent Hosp, Div Renal, Handan, Hebei, Peoples R China; [Quan, Wen-Xiang] Peking Univ, Hosp 6, Inst Mental Hlth, Key Lab Mental Hlth,Minist Hlth, Beijing, Peoples R China	Peking University; Peking University; Anhui Medical University; Harbin Medical University; Peking University	Dong, J (corresponding author), Peking Univ, Hosp 1, Dept Med, Div Renal, Beijing, Peoples R China.	jie.dong@bjmu.edu.cn	LIAO, JINLAN/M-7953-2019; Dong, Jie/AFM-0048-2022		New Century Excellent Talents from Education Department of China; ISN Research Award from ISN GO RP Committee	New Century Excellent Talents from Education Department of China(Program for New Century Excellent Talents in University (NCET)); ISN Research Award from ISN GO RP Committee	This work was in part supported by the New Century Excellent Talents from Education Department of China, and the ISN Research Award from ISN GO R&P Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to express their appreciation to the patients, doctors, and nursing staff of the Peritoneal Dialysis Centers of Peking University First Hospital, Peking University Shenzhen Hospital, the Second Hospital of Anhui Medical University, the Second Affiliated Hospital of Harbin Medical University, and Handan Central Hospital, who participated in this study. This work was in part supported by the New Century Excellent Talents from Education Department of China, and the ISN Research Award from ISN GO R&P Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, C R RBANS MAN REP BA; Asimakopoulou K., 2002, DIABETES SPECTR, V15, P116, DOI [10.2337/diaspect.15.2.116, DOI 10.2337/DIASPECT.15.2.116]; Bland RC, 2001, CAN J PSYCHIAT, V46, P506, DOI 10.1177/070674370104600604; Cheng Y, 2011, ARCH MED SCI, V7, P850, DOI 10.5114/aoms.2011.25561; Costa AS, 2014, AM J KIDNEY DIS, V64, P434, DOI 10.1053/j.ajkd.2014.02.012; D'Elia L.F., 1996, COLOR TRAILS TEST; Dong J, 2016, AM J KIDNEY DIS, V67, P111, DOI 10.1053/j.ajkd.2015.06.025; Drew DA, 2015, AM J KIDNEY DIS, V65, P303, DOI 10.1053/j.ajkd.2014.07.009; Fadili W, 2014, AGING MENT HEALTH, V18, P207, DOI 10.1080/13607863.2013.823375; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Griva K, 2010, AM J KIDNEY DIS, V56, P693, DOI 10.1053/j.ajkd.2010.07.003; Helmer C, 2011, NEUROLOGY, V77, P2043, DOI 10.1212/WNL.0b013e31823b4765; Kalirao P, 2011, AM J KIDNEY DIS, V57, P612, DOI 10.1053/j.ajkd.2010.11.026; Kurella M, 2005, J AM SOC NEPHROL, V16, P2127, DOI 10.1681/ASN.2005010005; Kurella M, 2004, J AM GERIATR SOC, V52, P1863, DOI 10.1111/j.1532-5415.2004.52508.x; Kurella M, 2006, NEPHROL DIAL TRANSPL, V21, P2543, DOI 10.1093/ndt/gfl275; Lin FR, 2013, JAMA INTERN MED, V173, P293, DOI 10.1001/jamainternmed.2013.1868; Lux S, 2010, KIDNEY INT, V78, P794, DOI 10.1038/ki.2010.253; McDowell I, 1997, J CLIN EPIDEMIOL, V50, P377, DOI 10.1016/S0895-4356(97)00060-7; Murray AM, 2006, NEUROLOGY, V67, P216, DOI 10.1212/01.wnl.0000225182.15532.40; Obi Y, 2016, AM J KIDNEY DIS OFFI; Oliver MJ, 2007, KIDNEY INT, V71, P673, DOI 10.1038/sj.ki.5002107; Roy M, 2013, CAN GERIATR J, V16, P120, DOI 10.5770/cgj.16.76; Sarnak MJ, 2013, NEUROLOGY, V80, P471, DOI 10.1212/WNL.0b013e31827f0f7f; Sehgal AR, 1997, AM J KIDNEY DIS, V30, P41, DOI 10.1016/S0272-6386(97)90563-1; Seidel UK, 2014, KIDNEY INT, V85, P693, DOI 10.1038/ki.2013.366; Shavit L, 2014, CLIN NEPHROL, V82, P313, DOI 10.5414/CN108335; Smith SC, 2004, CIRCULATION, V109, P3112, DOI 10.1161/01.CIR.0000133427.35111.67; Tamura MK, 2011, CLIN J AM SOC NEPHRO, V6, P248, DOI 10.2215/CJN.02660310; Tamura MK, 2011, KIDNEY INT, V79, P14, DOI 10.1038/ki.2010.336; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Weiner DE, 2011, AM J KIDNEY DIS, V58, P773, DOI 10.1053/j.ajkd.2011.03.034; World Health Organization, 1987, CLIN DESCR DIAGN GUI; Xu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050766; Yaffe K, 2003, NEUROLOGY, V61, P76, DOI 10.1212/01.WNL.0000073620.42047.D7; YEUDALL LT, 1987, J CLIN PSYCHOL, V43, P346, DOI 10.1002/1097-4679(198705)43:3<346::AID-JCLP2270430308>3.0.CO;2-Q	36	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0166470	10.1371/journal.pone.0166470	http://dx.doi.org/10.1371/journal.pone.0166470			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3TF	27911914	Green Submitted, gold, Green Published			2022-12-27	WOS:000389520600008
J	MacIvor, JS; Packer, L				MacIvor, J. Scott; Packer, Laurence			The Bees among Us: Modelling Occupancy of Solitary Bees	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; LAND-USE; DETECTION PROBABILITY; SPECIES OCCURRENCE; FORAGING RANGES; INTRODUCED BEES; WILD BEES; HYMENOPTERA; POLLINATION; CITY	Occupancy modelling has received increasing attention as a tool for differentiating between true absence and non-detection in biodiversity data. This is thought to be particularly useful when a species of interest is spread out over a large area and sampling is constrained. We used occupancy modelling to estimate the probability of three phylogenetically independent pairs of native-introduced species [Megachile campanulae (Robertson)-Megachile rotundata (Fab.), Megachile pugnata Say-Megachile centuncularis (L.), Osmia pumila Cresson-Osmia caerulescens (L.)] (Apoidea: Megachilidae) being present when repeated sampling did not always find them. Our study occurred along a gradient of urbanization and used nest boxes (bee hotels) set up over three consecutive years. Occupancy modelling discovered different patterns to those obtained by species detection and abundance-based data alone. For example, it predicted that the species that was ranked 4th in terms of detection actually had the greatest occupancy among all six species. The native M. pugnata had decreased occupancy with increasing building footprint and a similar but not significant pattern was found for the native O. pumila. Two introduced bees (M. rotundata and M. centuncularis), and one native (M. campanulae) had modelled occupancy values that increased with increasing urbanization. Occupancy probability differed among urban green space types for three of six bee species, with values for two native species (M. campanulae and O. pumila) being highest in home gardens and that for the exotic O. caerulescens being highest in community gardens. The combination of occupancy modelling with analysis of habitat variables as an augmentation to detection and abundance-based sampling is suggested to be the best way to ensure that urban habitat management results in the desired outcomes.	[MacIvor, J. Scott] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON, Canada; [MacIvor, J. Scott; Packer, Laurence] York Univ, Dept Biol, Toronto, ON, Canada	University of Toronto; University Toronto Scarborough; York University - Canada	MacIvor, JS (corresponding author), Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON, Canada.; MacIvor, JS (corresponding author), York Univ, Dept Biol, Toronto, ON, Canada.	scott.macivor@utoronto.ca			Canadian National Science and Engineering Council [CGS D 408565]; NSERC discovery grant; Natural Sciences and Engineering Research Council of Canada [CGS D 408565]	Canadian National Science and Engineering Council; NSERC discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The first author was funded by a scholarship awarded by the Canadian National Science and Engineering Council (CGS D 408565) and an NSERC discovery grant funding awarded to the second author.; We thank the participants of the study that permitted access to their properties to monitor nest boxes and the bees therein. Thanks to Dr. Alana Pindar, three anonymous reviewers and the editor for comments on the manuscript. As well, to Baharak Salehi, Jen Albert, Jennifer Cabral, Veronica Ladico, and Armando Ponte for help organizing, sorting, and rearing nest box contents and to the PCYU team for discussion. The first author was funded by a scholarship awarded by the Natural Sciences and Engineering Research Council of Canada (CGS D 408565) and both were supported by an NSERC discovery grant awarded to the second author.	Ahrne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005574; Aizen MA, 2008, PLOS BIOL, V6, P396, DOI 10.1371/journal.pbio.0060031; Bailey LL, 2004, ECOL APPL, V14, P692, DOI 10.1890/03-5012; Baldock KCR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2849; Banaszak-Cibicka W, 2012, J INSECT CONSERV, V16, P331, DOI 10.1007/s10841-011-9419-2; Barthell JF, 1998, ENVIRON ENTOMOL, V27, P240, DOI 10.1093/ee/27.2.240; Bartomeus I, 2013, P NATL ACAD SCI USA, V110, P4656, DOI 10.1073/pnas.1218503110; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; BOHART GE, 1972, ANNU REV ENTOMOL, V17, P287, DOI 10.1146/annurev.en.17.010172.001443; Bradford DF, 2003, ECOLOGY, V84, P1012, DOI 10.1890/0012-9658(2003)084[1012:HPOBTB]2.0.CO;2; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cane James H., 2003, P113; Cane JH, 2006, ECOL APPL, V16, P632, DOI 10.1890/1051-0761(2006)016[0632:CRWADB]2.0.CO;2; Colding J, 2007, LANDSCAPE URBAN PLAN, V81, P46, DOI 10.1016/j.landurbplan.2006.10.016; Colla SR, 2008, BIODIVERS CONSERV, V17, P1379, DOI 10.1007/s10531-008-9340-5; Davies Richard G., 2008, Urban Ecosystems, V11, P269, DOI 10.1007/s11252-008-0062-y; Dunnett N., 2010, PLANTING GREEN ROOFS; Fetridge ED, 2008, ANN ENTOMOL SOC AM, V101, P1067, DOI 10.1603/0013-8746-101.6.1067; Field SA, 2005, J WILDLIFE MANAGE, V69, P473, DOI 10.2193/0022-541X(2005)069[0473:OAOMEU]2.0.CO;2; Fortel L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104679; Francis RA, 2012, APPL GEOGR, V32, P514, DOI 10.1016/j.apgeog.2011.06.013; Frankie GW, 2009, CALIF AGR, V63, P113, DOI 10.3733/ca.v063n03p113; Frankie GW, 1998, ENVIRON ENTOMOL, V27, P1137, DOI 10.1093/ee/27.5.1137; Garbuzov M, 2014, BIOSCIENCE, V64, P1019, DOI 10.1093/biosci/biu150; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gibb H, 2002, BIOL CONSERV, V106, P91, DOI 10.1016/S0006-3207(01)00232-4; Gilbert O.L., 1989, ECOLOGY URBAN HABITA; Giles V, 2006, J HYMENOPT RES, V15, P208; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Gonzalez V. H., 2008, THESIS; Goodell K, 2003, OECOLOGIA, V134, P518, DOI 10.1007/s00442-002-1159-2; Goulson D, 2003, ANNU REV ECOL EVOL S, V34, P1, DOI 10.1146/annurev.ecolsys.34.011802.132355; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Grixti JC, 2006, CAN ENTOMOL, V138, P147; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Guillera-Arroita G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099571; Guillera-Arroita G, 2010, METHODS ECOL EVOL, V1, P131, DOI 10.1111/j.2041-210X.2010.00017.x; Hernandez JL, 2009, CITIES ENV, V2, P1, DOI DOI 10.15365/cate.2132009; Hudewenz A, 2013, J INSECT CONSERV, V17, P1275, DOI 10.1007/s10841-013-9609-1; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Kawanishi K, 2004, BIOL CONSERV, V120, P329, DOI 10.1016/j.biocon.2004.03.005; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Kennedy CM, 2013, ECOL LETT, V16, P584, DOI 10.1111/ele.12082; Kerr JT, 2015, SCIENCE, V349, P177, DOI 10.1126/science.aaa7031; Klatt BK, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2440; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Leonhardt SD, 2013, BASIC APPL ECOL, V14, P461, DOI 10.1016/j.baae.2013.06.003; Lizee MH, 2011, ECOL INDIC, V11, P353, DOI 10.1016/j.ecolind.2010.06.003; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Lowenstein DM, 2014, BIODIVERS CONSERV, V23, P2857, DOI 10.1007/s10531-014-0752-0; MacIvor JS, 2017, APIDOLOGIE, V48, P311, DOI 10.1007/s13592-016-0477-z; MacIvor JS, 2015, URBAN ECOSYST, V18, P419, DOI 10.1007/s11252-014-0408-6; MacIvor JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122126; Macivor JS, 2014, ENVIRON ENTOMOL, V43, P1027, DOI 10.1603/EN13241; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2009, ECOLOGY, V90, P823, DOI 10.1890/08-0141.1; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Madjidian JA, 2008, OECOLOGIA, V156, P835, DOI 10.1007/s00442-008-1039-5; Mangum WA, 2003, J KANSAS ENTOMOL SOC, V76, P658; Matteson K.C., 2009, CITIES ENV, V2, P1, DOI [10.15365/cate.2152009, DOI 10.15365/CATE.2152009]; Matteson KC, 2008, ANN ENTOMOL SOC AM, V101, P140, DOI 10.1603/0013-8746(2008)101[140:BRAAIN]2.0.CO;2; Matteson Kevin C., 2010, Urban Ecosystems, V13, P333, DOI 10.1007/s11252-010-0122-y; McDonnell Mark J., 1997, Urban Ecosystems, V1, P21, DOI 10.1023/A:1014359024275; McFrederick QS, 2006, BIOL CONSERV, V129, P372, DOI 10.1016/j.biocon.2005.11.004; McIntyre NE, 2001, BASIC APPL ECOL, V2, P209, DOI 10.1078/1439-1791-00051; Morales CL, 2013, FRONT ECOL ENVIRON, V11, P529, DOI 10.1890/120321; Morales Carolina L., 2002, Biological Invasions, V4, P87, DOI 10.1023/A:1020513012689; Oertli S, 2005, EUR J ENTOMOL, V102, P53, DOI 10.14411/eje.2005.008; Olea PP, 2011, DIVERS DISTRIB, V17, P714, DOI 10.1111/j.1472-4642.2011.00777.x; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Osborne JL, 2008, J APPL ECOL, V45, P784, DOI 10.1111/j.1365-2664.2007.01359.x; Pardee GL, 2014, URBAN ECOSYST, V17, P641, DOI 10.1007/s11252-014-0349-0; Pitts-Singer TL, 2011, ANNU REV ENTOMOL, V56, P221, DOI 10.1146/annurev-ento-120709-144836; Plummer M., 2013, RJAGS BAYESIAN GRAPH; Pollock KH, 2002, ENVIRONMETRICS, V13, P105, DOI 10.1002/env.514; Potter A, 2015, URBAN ECOSYST, V18, P885, DOI 10.1007/s11252-015-0435-y; R Core Team, 2021, R LANGUAGE ENV STAT; Roulston T, 2012, J KANSAS ENTOMOL SOC, V85, P387, DOI 10.2317/0022-8567-85.4.387; Salisbury A, 2015, J APPL ECOL, V52, P1156, DOI 10.1111/1365-2664.12499; Sheffield CS, 2013, APIDOLOGIE, V44, P501, DOI 10.1007/s13592-013-0200-2; Stephen WP, 2003, NONNATIVE CROPS WHEN; Stout JC, 2002, BIOL CONSERV, V106, P425, DOI 10.1016/S0006-3207(02)00046-0; Studds CE, 2005, ECOLOGY, V86, P2380, DOI 10.1890/04-1145; Suarez AV, 1998, ECOLOGY, V79, P2041, DOI 10.1890/0012-9658(1998)079[2041:EOFAIO]2.0.CO;2; Tanadini LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028244; Torrance S, 2013, CITY TORONTO GUIDELI; Tscharntke T, 1998, J APPL ECOL, V35, P708, DOI 10.1046/j.1365-2664.1998.355343.x; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Welsh AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052015; Westphal C, 2008, ECOL MONOGR, V78, P653, DOI 10.1890/07-1292.1; WHITNEY GG, 1985, URBAN ECOL, V9, P143, DOI 10.1016/0304-4009(85)90003-8; Williams NM, 2010, BIOL CONSERV, V143, P2280, DOI 10.1016/j.biocon.2010.03.024; Williams NM, 2001, CONSERV ECOL, V5; Zurbuchen A, 2010, BIOL CONSERV, V143, P669, DOI 10.1016/j.biocon.2009.12.003	97	8	8	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0164764	10.1371/journal.pone.0164764	http://dx.doi.org/10.1371/journal.pone.0164764			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911954	gold, Green Published, Green Submitted			2022-12-27	WOS:000389520600001
J	Audiffren, J; Bargiotas, I; Vayatis, N; Vidal, PP; Ricard, D				Audiffren, Julien; Bargiotas, Ioannis; Vayatis, Nicolas; Vidal, Pierre-Paul; Ricard, Damien			A Non Linear Scoring Approach for Evaluating Balance: Classification of Elderly as Fallers and Non-Fallers	PLOS ONE			English	Article							DWELLING OLDER-ADULTS; POSTURAL SWAY; DENSITY; TOOLS; TASK	Almost one third of population 65 years-old and older faces at least one fall per year. An accurate evaluation of the risk of fall through simple and easy-to-use measurements is an important issue in current clinic. A common way to evaluate balance in posturography is through the recording of the centre-of-pressure (CoP) displacement (statokinesigram) with force platforms. A variety of indices have been proposed to differentiate fallers from non fallers. However, no agreement has been reached whether these analyses alone can explain sufficiently the complex synergies of postural control. In this work, we study the statokinesigrams of 84 elderly subjects (80.3+-6.4 years old), which had no impairment related to balance control. Each subject was recorded 25 seconds with eyes open and 25 seconds with eyes closed and information pertaining to the presence of problems of balance, such as fall, in the last six months, was collected. Five descriptors of the statokinesigrams were computed for each record, and a Ranking Forest algorithm was used to combine those features in order to evaluate each subject's balance with a score. A classical train-test split approach was used to evaluate the performance of the method through ROC analysis. ROC analysis showed that the performance of each descriptor separately was close to a random classifier (AUC between 0.49 and 0.54). On the other hand, the score obtained by our method reached an AUC of 0.75 on the test set, consistent over multiple train-test split. This non linear multi-dimensional approach seems appropriate in evaluating complex postural control.	[Audiffren, Julien; Bargiotas, Ioannis; Vayatis, Nicolas] Univ Paris Saclay, CNRS, ENS Cachan, CMLA, Cachan, France; [Audiffren, Julien; Bargiotas, Ioannis; Vayatis, Nicolas; Vidal, Pierre-Paul; Ricard, Damien] Univ Paris 05, CNRS, SSA, COGNAG G,UMR 8257, Paris, France; [Ricard, Damien] Serv Sante Armees, HIA Percy, Serv Neurol, Clamart, France; [Ricard, Damien] Ecole Val de Grace, Serv Sante Armees, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Audiffren, J (corresponding author), Univ Paris Saclay, CNRS, ENS Cachan, CMLA, Cachan, France.; Audiffren, J (corresponding author), Univ Paris 05, CNRS, SSA, COGNAG G,UMR 8257, Paris, France.	julien.audiffren@cmla.ens-cachan.fr		Audiffren, Julien/0000-0003-4321-2575; BARGIOTAS, IOANNIS/0000-0002-1069-1293	specific grant for the SmartCheck project	specific grant for the SmartCheck project	This work was funded by specific grant for the SmartCheck project thanks to the Societe d'Acceleration de Transfert Technologique (http://www.idfinnov.com/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audiffren J, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16081208; Baratto L, 2002, MOTOR CONTROL, V6, P246, DOI 10.1123/mcj.6.3.246; Barry E, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-14; Bigelow KE, 2010, J GERONTOL A-BIOL; Black Alex, 2005, Clin Exp Optom, V88, P212; Blaszczyk JW, 2007, EXP BRAIN RES, V183, P107, DOI 10.1007/s00221-007-1024-y; Blum L, 2008, PHYS THER, V88, P559, DOI 10.2522/ptj.20070205; Breiman L., 2001, MACH LEARN, V45, P5; Castelli L, 2015, J NEUROL SCI, V359, P440, DOI 10.1016/j.jns.2015.10.016; Chagdes JR, 2009, EXP BRAIN RES, V197, P297, DOI 10.1007/s00221-009-1915-1; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Clemencon S, 2013, J MACH LEARN RES, V14, P39; Marrega LHG, 2014, 2014 IEEE INTERNATIONAL CONFERENCE ON DATA MINING WORKSHOP (ICDMW), P111, DOI 10.1109/ICDMW.2014.127; Jacono M, 2004, MOTOR CONTROL, V8, P292, DOI 10.1123/mcj.8.3.292; KANTNER RM, 1991, AM J OTOLARYNG, V12, P196, DOI 10.1016/0196-0709(91)90120-5; Leach JM, 2014, SENSORS-BASEL, V14, P18244, DOI 10.3390/s141018244; Liu CL, 2010, EXPERT SYST APPL, V37, P7174, DOI 10.1016/j.eswa.2010.04.014; Mancini M, 2010, EUR J PHYS REHAB MED, V46, P239; Mancini M, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-59; Melzer I, 2004, AGE AGEING, V33, P602, DOI 10.1093/ageing/afh218; Muir JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070566; Pagnacco Guido, 2011, Biomed Sci Instrum, V47, P12; Perell KL, 2001, J GERONTOL A-BIOL, V56, pM761, DOI 10.1093/gerona/56.12.M761; PETERKA RJ, 1995, EXP BRAIN RES, V105, P101; Piirtola M, 2006, GERONTOLOGY, V52, P1, DOI 10.1159/000089820; Rocchi L, 2006, NEUROSCI LETT, V394, P140, DOI 10.1016/j.neulet.2005.10.020; Rocchi L, 2002, J NEUROL NEUROSUR PS, V73, P267, DOI 10.1136/jnnp.73.3.267; Ruhe A, 2010, GAIT POSTURE, V32, P436, DOI 10.1016/j.gaitpost.2010.09.012; Schoneburg B, 2013, MOVEMENT DISORD, V28, P1474, DOI 10.1002/mds.25613; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Swanenburg J, 2010, GAIT POSTURE, V31, P317, DOI 10.1016/j.gaitpost.2009.11.013; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Yamamoto T, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12329; Yelnik A, 2008, NEUROPHYSIOL CLIN, V38, P439, DOI 10.1016/j.neucli.2008.09.008; Young W, 2011, GAIT POSTURE, V33, P303, DOI 10.1016/j.gaitpost.2010.10.089; Zecevic AA, 2006, GERONTOLOGIST, V46, P367, DOI 10.1093/geront/46.3.367	37	19	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167456	10.1371/journal.pone.0167456	http://dx.doi.org/10.1371/journal.pone.0167456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936060	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100101
J	Goring, SJ; Mladenoff, DJ; Cogbill, CV; Record, S; Paciorek, CJ; Jackson, ST; Dietze, MC; Dawson, A; Matthes, JH; McLachlan, JS; Williams, JW				Goring, Simon J.; Mladenoff, David J.; Cogbill, Charles V.; Record, Sydne; Paciorek, Christopher J.; Jackson, Stephen T.; Dietze, Michael C.; Dawson, Andria; Matthes, Jaclyn Hatala; McLachlan, Jason S.; Williams, John W.			Novel and Lost Forests in the Upper Midwestern United States, from New Estimates of Settlement-Era Composition, Stem Density, and Biomass	PLOS ONE			English	Article							HISTORICAL LAND-USE; GREAT-LAKES FORESTS; LANDSCAPE-SCALE; ANCIENT FORESTS; CLIMATE-CHANGE; VEGETATION CHANGE; BIG WOODS; PRESETTLEMENT; DISTURBANCE; WISCONSIN	Background EuroAmerican land-use and its legacies have transformed forest structure and composition across the United States (US). More accurate reconstructions of historical states are critical to understanding the processes governing past, current, and future forest dynamics. Here we present new gridded (8x8km) reconstructions of pre-settlement (1800s) forest composition and structure from the upper Midwestern US (Minnesota, Wisconsin, and most of Michigan), using 19th Century Public Land Survey System (PLSS), with estimates of relative composition, above-ground biomass, stem density, and basal area for 28 tree types. This mapping is more robust than past efforts, using spatially varying correction factors to accommodate sampling design, azimuthal censoring, and biases in tree selection. Changes in Forest Structure We compare pre-settlement to modern forests using US Forest Service Forest Inventory and Analysis (FIA) data to show the prevalence of lost forests (pre-settlement forests with no current analog), and novel forests (modern forests with no past analogs). Differences between pre-settlement and modern forests are spatially structured owing to differences in land-use impacts and accompanying ecological responses. Modern forests are more homogeneous, and ecotonal gradients are more diffuse today than in the past. Novel forest assemblages represent 28% of all FIA cells, and 28% of pre-settlement forests no longer exist in a modern context. Lost forests include tamarack forests in northeastern Minnesota, hemlock and cedar dominated forests in north-central Wisconsin and along the Upper Peninsula of Michigan, and elm, oak, basswood and ironwood forests along the forest-prairie boundary in south central Minnesota and eastern Wisconsin. Novel FIA forest assemblages are distributed evenly across the region, but novelty shows a strong relationship to spatial distance from remnant forests in the upper Midwest, with novelty predicted at between 20 to 60km from remnants, depending on historical forest type. The spatial relationships between remnant and novel forests, shifts in ecotone structure and the loss of historic forest types point to significant challenges for land managers if landscape restoration is a priority. The spatial signals of novelty and ecological change also point to potential challenges in using modern spatial distributions of species and communities and their relationship to underlying geophysical and climatic attributes in understanding potential responses to changing climate. The signal of human settlement on modern forests is broad, spatially varying and acts to homogenize modern forests relative to their historic counterparts, with significant implications for future management.	[Goring, Simon J.] Univ Wisconsin, Dept Geog, Madison, WI 53706 USA; [Mladenoff, David J.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI USA; [Cogbill, Charles V.; Record, Sydne] Harvard Univ, Harvard Forest, Petersham, MA USA; [Record, Sydne] Bryn Mawr Coll, Dept Biol, Bryn Mawr, PA 19010 USA; [Paciorek, Christopher J.; Dawson, Andria] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Jackson, Stephen T.] US Geol Survey, Dept Interior Southwest Climate Sci Ctr, Tucson, AZ USA; [Jackson, Stephen T.] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ USA; [Jackson, Stephen T.] Univ Arizona, Dept Geosci, Tucson, AZ USA; [Dietze, Michael C.] Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA; [Matthes, Jaclyn Hatala] Dartmouth Coll, Dept Geog, Hanover, NH 03755 USA; [McLachlan, Jason S.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Williams, John W.] Univ Wisconsin, Dept Geog, Madison, WI 53706 USA; [Williams, John W.] Univ Wisconsin, Ctr Climat Res, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Bryn Mawr College; University of California System; University of California Berkeley; United States Department of the Interior; United States Geological Survey; University of Arizona; University of Arizona; Boston University; Dartmouth College; University of Notre Dame; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Goring, SJ (corresponding author), Univ Wisconsin, Dept Geog, Madison, WI 53706 USA.	goring@wisc.edu	Dietze, Michael/A-5834-2009	Dietze, Michael/0000-0002-2324-2518; Record, Sydne/0000-0001-7293-2155; Goring, Simon/0000-0002-2700-4605; Jackson, Stephen/0000-0002-1487-4652; Matthes, Jaclyn/0000-0001-8999-8062	National Science Foundation PaIEON MacroSystems Biology [DEB-1065702, DEB-1065656, DEB-1065848, DEB-1065732]	National Science Foundation PaIEON MacroSystems Biology	This material is based upon work supported by the National Science Foundation PaIEON MacroSystems Biology under grant nos. DEB-1065702 (JSM, CJP, AD), DEB-1065656 (SJG, JWW), DEB-1065848 (MCD, JHM), DEB-1065732 (STJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMENDINGER J. C., 1996, MINNESOTAS BEARING T; Andersen BJ, 2005, MICH BOT, V44, P127; ANDERSON R C, 1975, Castanea, V40, P345; [Anonymous], 2014, R LANG ENV STAT COMP; Auguie B, 2012, GRIDEXTRA FUNCTIONS; Bellemare J, 2002, J BIOGEOGR, V29, P1401, DOI 10.1046/j.1365-2699.2002.00762.x; Birks HJB., 2010, OPEN ECOL J, V3, P68, DOI [10.2174/1874213001003020068, DOI 10.2174/1874213001003020068, https://doi.org/10.1016/j.quaint.2012.07.228, DOI 10.1016/J.QUAINT.2012.07.228]; Bivand R., 2014, RGEOS INTERFACE GEOM; Bivand R, 2014, RGDAL BINDINGS GEOSP; BIVAND R., 2014, SPDEP SPATIAL DEPEND; Bivand R., 2013, APPL SPATIAL DATA AN, V2nd; Bolliger J, 2004, RESTOR ECOL, V12, P124, DOI 10.1111/j.1526-100X.2004.00285.x; Booth RK, 2012, ECOLOGY, V93, P219, DOI 10.1890/11-1068.1; Bouldin J, 2008, J BIOGEOGR, V35, P2000, DOI 10.1111/j.1365-2699.2008.01940.x; BOURDO EA, 1956, ECOLOGY, V37, P754, DOI 10.2307/1933067; BRUGAM RB, 1978, QUATERNARY RES, V9, P349, DOI 10.1016/0033-5894(78)90038-8; Cogbill CV, 2002, J BIOGEOGR, V29, P1279, DOI 10.1046/j.1365-2699.2002.00757.x; Cogbill CV, ESTIMATION ROBUST CO; COTTAM G, 1956, ECOLOGY, V37, P451, DOI 10.2307/1930167; Cramer VA, 2008, TRENDS ECOL EVOL, V23, P104, DOI 10.1016/j.tree.2007.10.005; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Curtis JT, 1959, VEGETATION WISCONSIN; Dawson A, 2016, QUATERNARY SCI REV, V137, P156, DOI 10.1016/j.quascirev.2016.01.012; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Deines JM, AM MIDLAND IN PRESS; DUNN CP, 1983, CAN J BOT, V61, P211, DOI 10.1139/b83-023; Dupouey JL, 2002, ECOLOGY, V83, P2978, DOI 10.1890/0012-9658(2002)083[2978:IIOPLU]2.0.CO;2; Duren OC, 2012, NORTHWEST SCI, V86, P310, DOI 10.3955/046.086.0407; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Etienne D, 2013, HOLOCENE, V23, P678, DOI 10.1177/0959683612470173; Ewing HA, 2002, ECOLOGY, V83, P2766, DOI 10.1890/0012-9658(2002)083[2766:TIOSOV]2.0.CO;2; Fahey RT, 2012, LANDSCAPE ECOL, V27, P999, DOI 10.1007/s10980-012-9754-z; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Foster D, 2003, BIOSCIENCE, V53, P77, DOI 10.1641/0006-3568(2003)053[0077:TIOLUL]2.0.CO;2; Foster DR, 1998, ECOSYSTEMS, V1, P96, DOI 10.1007/s100219900008; Friedman SK, 2005, ECOL APPL, V15, P726, DOI 10.1890/04-0748; Fritschle JA, 2008, ANN ASSOC AM GEOGR, V98, P24, DOI 10.1080/00045600701734018; Fuller TL, 1998, ECOSYSTEMS, V1, P76; Gimmi U, 2013, ENVIRON MANAGE, V52, P481, DOI 10.1007/s00267-013-0102-0; Goring S, 2009, J BIOGEOGR, V36, P626, DOI 10.1111/j.1365-2699.2008.02021.x; Gray AN, 2012, VEG DATABASES 21 CEN, P255; GRIMM EC, 1984, ECOL MONOGR, V54, P291, DOI 10.2307/1942499; Groffman PM, 2012, BIOSCIENCE, V62, P1056, DOI 10.1525/bio.2012.62.12.7; Grossmann EB, 2008, FOREST ECOL MANAG, V256, P827, DOI 10.1016/j.foreco.2008.05.048; Hamburg SP, 1986, B ECOL SOC AM, V67, P169; Hanberry BB, 2014, ECOSYSTEMS, V17, P66, DOI 10.1007/s10021-013-9707-7; Hanberry BB, 2012, LANDSCAPE ECOL, V27, P1495, DOI 10.1007/s10980-012-9805-5; Hanberry BB, 2012, AM MIDL NAT, V167, P285, DOI 10.1674/0003-0031-167.2.285; Hanberry BB, 2011, LANDSCAPE ECOL, V26, P59, DOI 10.1007/s10980-010-9533-7; Hartig F, 2012, J BIOGEOGR, V39, P2240, DOI 10.1111/j.1365-2699.2012.02745.x; He HS, 1999, ECOSYSTEMS, V2, P308, DOI 10.1007/s100219900082; Heffernan JB, 2014, FRONT ECOL ENVIRON, V12, P5, DOI 10.1890/130017; Higgs E., 2012, SUSTAINABILITY SCI, P383, DOI [10.1007/978-1-4614-3188-6_18, DOI 10.1007/978-1-4614-3188-6_18]; Hijmans R.J., 2019, GEOGRAPHIC DATA ANAL; Hobbs RJ, 2014, FRONT ECOL ENVIRON, V12, P557, DOI 10.1890/130300; Hobbs RJ, 2014, TRENDS ECOL EVOL, V29, P645, DOI 10.1016/j.tree.2014.09.006; Hotchkiss SC, 2007, LANDSCAPE ECOL, V22, P25, DOI 10.1007/s10980-007-9133-3; Iverson LR, 2013, LANDSCAPE ECOL, V28, P879, DOI 10.1007/s10980-013-9885-x; Iverson LR, 1998, ECOL MONOGR, V68, P465, DOI 10.1890/0012-9615(1998)068[0465:PAOTSF]2.0.CO;2; Jenkins J.C., 2004, COMPREHENSIVE DATABA; Johnson WC, 1988, LANDSCAPE ECOL, V1, P175, DOI 10.1007/BF00162743; Knoot TG, 2010, ECOL SOC, V15; Kronenfeld BJ, 2007, CAN J FOREST RES, V37, P2365, DOI 10.1139/X07-068; Kronenfeld BJ, 2010, PROF GEOGR, V62, P182, DOI 10.1080/00330120903546759; Kronenfeld BJ, 2014, ECOGRAPHY; Leahy MJ, 2003, AM MIDL NAT, V149, P71, DOI 10.1674/0003-0031(2003)149[0071:ACOPAP]2.0.CO;2; Li D-J, 2014, ECOLOGY; Liu F, 2011, ECOL MONOGR, V81, P259, DOI 10.1890/10-0232.1; Lynch EA, 2014, CAN J FOREST RES, V44, P1331, DOI 10.1139/cjfr-2014-0107; Maechler M, 2014, CLUSTER CLUSTER ANAL; Manies KL, 2000, LANDSCAPE ECOL, V15, P741, DOI 10.1023/A:1008115200471; Manies KL, 2001, CAN J FOREST RES, V31, P1719, DOI 10.1139/cjfr-31-10-1719; Martinuzzi S, 2015, ECOSYSTEMS, V18, P1332, DOI 10.1007/s10021-015-9901-x; Matthes JH, 2016, J GEOPHYS RES-BIOGEO, V121, P523, DOI 10.1002/2015JG003175; McAndrews JH, 1988, VEGETATION HIST, P673; Menz MHM, 2013, SCIENCE, V339, P526, DOI 10.1126/science.1228334; Mladenoff DJ, 2002, ECOSYSTEMS, V5, P539, DOI 10.1007/s10021-002-0167-8; MORISHITA. MASAAKI, 1957, PHYSIOL AND ECOL [JAPAN], V7, P134; Morisita M., 1954, MEMOIRS FACULTY SCI, V1, P187; Munoz SE, 2014, J BIOGEOGR, V41, P2195, DOI 10.1111/jbi.12386; Murcia C, 2014, TRENDS ECOL EVOL, V29, P548, DOI 10.1016/j.tree.2014.07.006; Nyamai PA, 2014, FOREST ECOL MANAG, V322, P37, DOI 10.1016/j.foreco.2014.03.027; Oksanen J., 2014, VEGAN COMMUNITY ECOL; Paciorek CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150087; Paciorek CJ, 2009, J AM STAT ASSOC, V104, P608, DOI 10.1198/jasa.2009.0026; Pebesma E.I., 2005, CLASSES METHODS SPAT, V5; Pederson N, 2014, ECOL MONOGR, V84, P599, DOI 10.1890/13-1025.1; Persson O, 1971, STAT ECOLOGY SAMPLIN; Radeloff VC, 2000, RESTOR ECOL, V8, P119, DOI 10.1046/j.1526-100x.2000.80018.x; Radeloff VC, 2015, ECOL APPL, V25, P2051, DOI 10.1890/14-1781.1; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; Ratajczak Z, 2012, ECOLOGY, V93, P697, DOI 10.1890/11-1199.1; Rayburn AP, 2009, NAT AREA J, V29, P4, DOI 10.3375/043.029.0102; Record S, 2013, GLOBAL ECOL BIOGEOGR, V22, P760, DOI 10.1111/geb.12017; Rhemtulla JM, 2009, ECOL APPL, V19, P1061, DOI 10.1890/08-1453.1; Rhemtulla JM, 2009, P NATL ACAD SCI USA, V106, P6082, DOI 10.1073/pnas.0810076106; Schulte LA, 2005, ECOLOGY, V86, P431, DOI 10.1890/03-4065; Schulte LA, 2005, ECOSYSTEMS, V8, P73, DOI 10.1007/s10021-004-0052-8; Schulte LA, 2002, CAN J FOREST RES, V32, P1616, DOI 10.1139/X02-082; Schulte LA, 2001, J FOREST, V99, P5; Schulte LA, 2007, LANDSCAPE ECOL, V22, P1089, DOI 10.1007/s10980-007-9095-5; Seddon PJ, 2010, RESTOR ECOL, V18, P796, DOI 10.1111/j.1526-100X.2010.00724.x; Smyth G, 2016, STATMOD STAT MODELIN; St Jacques JM, 2008, J BIOGEOGR, V35, P306, DOI 10.1111/j.1365-2699.2007.01785.x; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; Stewart LO, 1935, PUBLIC LAND SURVEYS, P202; Terrail R, 2014, J VEG SCI, V25, P691, DOI 10.1111/jvs.12142; Thompson JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072540; Umbanhowar CE, 2004, HOLOCENE, V14, P661, DOI 10.1191/0959683604hl745rp; Umbanhowar CE, 2006, QUATERNARY RES, V66, P53, DOI 10.1016/j.yqres.2006.03.005; White CA., 1983, HIST RECTANGULAR SUR, P774; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wickham H, 2007, J STAT SOFTW, V21, P1; Williams MA, 2011, ECOL MONOGR, V81, P63, DOI 10.1890/10-0256.1; Wolkovich EM, 2014, ECOL LETT, V17, P1365, DOI 10.1111/ele.12353; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Woudenberg, 2010, FOREST INVENTORY ANA, DOI 10.2737/RMRS-GTR-245	118	34	35	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0151935	10.1371/journal.pone.0151935	http://dx.doi.org/10.1371/journal.pone.0151935			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935944	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100001
J	Gu, XF; He, J; Tang, YW; Zheng, YX				Gu, Xinfeng; He, Jie; Tang, Yiwen; Zheng, Yuxin			Comparison of Polyethylene Wear before and after Hip Revision with Liner Exchange Fixed with the Original Locking Mechanism	PLOS ONE			English	Article							CROSS-LINKED POLYETHYLENE; CONVENTIONAL POLYETHYLENE; RADIOSTEREOMETRIC ANALYSIS; ACETABULAR COMPONENT; FOLLOW-UP; ARTHROPLASTY; REPLACEMENTS; RADIOGRAPHS; OSTEOLYSIS; ACCURACY	Objective To compare the wear of conventional ultra-high molecular weight polyethylene (CUHMWPE) and highly cross-linked polyethylene (HCLPE) in hip revision with liner exchange fixed with original locking mechanism using analysis of history medical data. Methods From Jan. 1, 2000, to Dec. 31, 2007, 26 patients (with 29 involved hips) underwent liner exchange revision fixed with the original locking mechanism due to wear of CUHMWPE and/or osteolysis. The mean age was 53 +/- 9 years at the time of the primary total hip arthroplasty (THA) and 64 +/- 9 years at the revision. The exchanged liners (Marathon, Depuy) were made of HCLPE. Annual X-rays were used to measure linear wear and osteolysis. The annual linear penetration was measured using PolyWare software (Draftware Inc.). Annual Harris Hip Scores(HSS) were recorded. Results The mean follow-up time between the primary and revision THAs was 11 +/- 2 years and 8 +/- 2 years after revision. The mean Harris Hip Score(HHS) before primary THA, 1 year after primary THA, before revision and 1 year after revision was 43 +/- 5, 85 +/- 5, 71 +/- 6, 83 +/- 7 individually. The mean penetration of the CUHMWPE and HCLPE liners occurring in the first year were 0.44 +/- 0.28 mm and 0.38 +/- 0.14 mm, respectively (p = 0.211). The mean annual linear penetration of CUHMWPE and HCLPE from the second year onward were 0.29 +/- 0.09 mm and 0.08 +/- 0.03 mm respectively (p <0.01). All THAs with CUHMWPE showed osteolysis on ace tabular and/or femoral side before revision. No HCLPE liner showed osteolysis at the last follow-up. Conclusion: The CUHMWPE liner had a significantly higher wear rate than did the HCLPE liner. The HCLPE liner showed a satisfactory liner penetration rate after revision with isolated liner exchange fixed with the original locking mechanism.	[Gu, Xinfeng; He, Jie; Tang, Yiwen; Zheng, Yuxin] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Orthoped & Traumatol, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine	Zheng, YX (corresponding author), Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Orthoped & Traumatol, Shanghai, Peoples R China.	arthroscopy@163.com						Adelani MA, 2014, J BONE JOINT SURG AM, V96A, P1015, DOI 10.2106/JBJS.L.01177; Beaule PE, 2004, J BONE JOINT SURG AM, V86A, P929, DOI 10.2106/00004623-200405000-00007; Berry DJ, 2012, SURG HIP ELSEVIER HE; Blumenfeld TJ, 2011, J ARTHROPLASTY, V26, DOI DOI 10.1016/J.ARTH.2010.07.009; Callaghan JJ, 2012, CLIN ORTHOP RELAT R, V470, P3142, DOI 10.1007/s11999-012-2380-x; CHARNLEY J, 1973, CLIN ORTHOP RELAT R, P9; CHARNLEY J, 1975, CLIN ORTHOP RELAT R, P170; Christie MJ, 1999, J BONE JOINT SURG AM, V81A, P1707, DOI 10.2106/00004623-199912000-00008; DEVANE PA, 1995, CLIN ORTHOP RELAT R, P303; DEVANE PA, 1995, CLIN ORTHOP RELAT R, P317; Duffy GP., 2009, J ARTHROPLASTY, V158, DOI [10.1016/j.arth.2007.12.020, DOI 10.1016/J.ARTH.2007.12.020]; Ebramzadeh E, 2003, J BONE JOINT SURG AM, V85A, P2378, DOI 10.2106/00004623-200312000-00016; Furmanski J, 2009, BIOMATERIALS, V30, P5572, DOI 10.1016/j.biomaterials.2009.07.013; Gaffey JL, 2004, J BONE JOINT SURG AM, V86A, P257, DOI 10.2106/00004623-200402000-00007; Garcia-Rey E, 2010, HIP INT, V20, pS86, DOI 10.5301/HIP.2010.34; Hanna SA, 2016, BONE JOINT J, V98B, P28, DOI 10.1302/0301-620X.98B1.36527; HARDINGE K, 1991, J BONE JOINT SURG BR, V73, P724, DOI 10.1302/0301-620X.73B5.1894658; HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012; ILCHMANN T, 1995, J ARTHROPLASTY, V10, P636, DOI 10.1016/S0883-5403(05)80208-6; Johanson PE, 2012, CLIN ORTHOP RELAT R, V470, P3083, DOI 10.1007/s11999-012-2400-x; Kuzyk PRT, 2011, J BONE JOINT SURG BR, V93B, P593, DOI 10.1302/0301-620X.93B5.25908; Lim SJ, 2014, J ARTHROPLASTY, V29, P634, DOI 10.1016/j.arth.2013.07.042; LIVERMORE J, 1990, J BONE JOINT SURG AM, V72A, P518, DOI 10.2106/00004623-199072040-00008; Lombardi AV, 2008, J AM ACAD ORTHOP SUR, V16, P243, DOI 10.5435/00124635-200805000-00002; Martell JM, 1997, J BONE JOINT SURG AM, V79A, P1635, DOI 10.2106/00004623-199711000-00004; McCalden RW, 2005, J BONE JOINT SURG AM, V87A, P2323, DOI 10.2106/JBJS.E.00223; Naudie DDR, 2004, J ARTHROPLASTY, V19, P124, DOI 10.1016/j.arth.2004.02.019; Nebergall AK, 2016, J ARTHROPLASTY, V31, P1251, DOI 10.1016/j.arth.2015.12.023; Orishimo KF, 2003, J BONE JOINT SURG AM, V85A, P1095, DOI 10.2106/00004623-200306000-00018; Park MS, 2015, HIP INT, V25, P61, DOI 10.5301/hipint.5000191; Paxton E, 2014, J BONE JOINT SURG AM, V96A, P19, DOI 10.2106/JBJS.N.00460; Stilling M, 2010, ACTA ORTHOP, V81, P570, DOI 10.3109/17453674.2010.506632; Thomas GER, 2011, J BONE JOINT SURG AM, V93A, P716, DOI 10.2106/JBJS.J.00287	33	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167607	10.1371/journal.pone.0167607	http://dx.doi.org/10.1371/journal.pone.0167607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935994	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100129
J	Li, B; Zhao, LN; Chen, HJ; Sun, DW; Deng, BX; Li, JW; Liu, YF; Wang, F				Li, Bo; Zhao, Lina; Chen, Hongjian; Sun, Dewei; Deng, Boxin; Li, Jinwei; Liu, Yuanfa; Wang, Fei			Inactivation of Lipase and Lipoxygenase of Wheat Germ with Temperature-Controlled Short Wave Infrared Radiation and Its Effect on Storage Stability and Quality of Wheat Germ Oil	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; RICE BRAN; MOISTURE; STABILIZATION; OXIDATION; NUTRACEUTICALS; PURIFICATION; RANCIDITY	Wheat germ (WG) is quite susceptible to deterioration due to the presence of lipase (LA) and lipoxygenase (LOX). Therefore it is indispensable to adopt a stabilization step to decrease the activity of LA and LOX while retaining a maximum level of nutrients. But over-drying can make foodstuffs more susceptible to autoxidation. So a stabilization protocol for inactivating LA and LOX of WG with a temperature-controlled short wave infrared (SIR) radiation system was adopted to retard its rancidity and retain a maximum level of fat-soluble nutrients. Meanwhile, the critical storage water activity (Aw) of WG for inhibiting both hydrolytic and oxidative rancidity was appraised. Results indicate that WG irradiated at 90 degrees C for 20 min acquired the optimal stabilization effect, and its residual LA and LOX activity were 18.02% and 19.21%, respectively. At this condition, the free fatty acids (FFA) content and peroxide value (PV) increment of WG oil at 40 degrees C remained below 5% and 2.24 meq O-2/kg for 60 days, respectively. The residual Aw of this WG sample was 0.13, and it is near the Aw corresponding to its monolayer. No significant decrease of fatty acids was observed during SIR processing, while about 96.42% of its original tocopherols still retained inWG treated at 90 degrees C for 20 min.	[Li, Bo; Chen, Hongjian; Sun, Dewei; Deng, Boxin; Li, Jinwei; Liu, Yuanfa] Jiangnan Univ, Sch Food Sci & Technol, Synerget Innovat Ctr Food Safety & Nutr, State Key Lab Food Sci & Technol, Lihu Ave, Wuxi, Jiangsu, Peoples R China; [Zhao, Lina] Jiangsu Univ, Sch Food & Biol Engn, Zhenjiang, Jiangsu, Peoples R China; [Wang, Fei] Jiangsu Berkgen Biopharmaceut Co Ltd, Yangzhou, Jiangsu, Peoples R China	Jiangnan University; Jiangsu University	Liu, YF (corresponding author), Jiangnan Univ, Sch Food Sci & Technol, Synerget Innovat Ctr Food Safety & Nutr, State Key Lab Food Sci & Technol, Lihu Ave, Wuxi, Jiangsu, Peoples R China.; Wang, F (corresponding author), Jiangsu Berkgen Biopharmaceut Co Ltd, Yangzhou, Jiangsu, Peoples R China.	yfliu@jiangnan.edu.cn; wangfei@berkgen.com			National Natural Science Foundation of China [31571878, 31171703]; Public sector research special food [201313011-7-3]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public sector research special food	This study was funded by National Natural Science Foundation of China (31571878 and 31171703), the Public sector research special food (201313011-7-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, WATER ACTIVITY FOODS; Barden L, 2013, CRIT REV FOOD SCI NU; Barnes P., 1991, Lipid Technology, V3, P23; Baysal T, 2007, ENZYME MICROB TECH, V40, P491, DOI 10.1016/j.enzmictec.2006.11.025; Brandolini A, 2012, INT J FOOD SCI NUTR, V63, P71, DOI 10.3109/09637486.2011.633898; Cao RG, 2012, FOOD BIOPROCESS TECH, V5, P1853, DOI 10.1007/s11947-011-0551-5; de Vasconcelos MCBM, 2013, IND CROP PROD, V42, P292, DOI 10.1016/j.indcrop.2012.06.007; Duckworth RB, 1963, RECENT ADV FOOD SCI, P230; Dunford NT, 2003, FOOD RES INT, V36, P905, DOI 10.1016/S0963-9969(03)00099-1; El Amrani F, 2003, SCI ALIMENT, V23, P209, DOI 10.3166/sda.23.209-221; Furmaniak S, 2009, FOOD RES INT, V42, P1203, DOI 10.1016/j.foodres.2009.06.004; GALLIARD T, 1986, J CEREAL SCI, V4, P179, DOI 10.1016/S0733-5210(86)80020-0; Ge YQ, 2001, EUR FOOD RES TECHNOL, V212, P344, DOI 10.1007/s002170000253; GREENSPAN L, 1977, J RES NBS A PHYS CH, V81, P89, DOI 10.6028/jres.081A.011; Jacques N, 1982, J SCI FOOD AGR, V33, P365; Kapranchikov VS, 2004, APPL BIOCHEM MICRO+, V40, P84, DOI 10.1023/B:ABIM.0000010360.46824.56; Kathiravan K., 2007, COMPR REV FOOD SCI F, V7, P2; Kim JY, 2014, FOOD CHEM, V146, P134, DOI 10.1016/j.foodchem.2013.09.025; Kumar GS, 2015, J FOOD SCI TECH MYS, V52, P1145, DOI 10.1007/s13197-013-1119-3; Kumar GS, 2014, INT J FOOD SCI NUTR, V65, P327, DOI 10.3109/09637486.2013.866640; Labuza T. P., 1971, CRC Critic. Rev. Fd Technol., V2, P355, DOI 10.1080/10408397109527127; LABUZA TP, 1971, J AM OIL CHEM SOC, V48, P86, DOI 10.1007/BF02635692; Li B, 2016, RSC ADV, V6, P37265, DOI 10.1039/c5ra23335f; LOEB JR, 1949, J AM OIL CHEM SOC, V26, P738, DOI 10.1007/BF02903184; MALONEY JF, 1966, J FOOD SCI, V31, P878, DOI 10.1111/j.1365-2621.1966.tb03264.x; Moreira R, 2010, IND CROP PROD, V32, P252, DOI 10.1016/j.indcrop.2010.04.021; Ng Lean-Teik, 2013, J AGR FOOD CHEM, V61, P12604; Ozcan MM, 2015, QUAL ASSUR SAF CROP, V7, P517, DOI 10.3920/QAS2014.0457; Piras A, 2009, MOLECULES, V14, P2573, DOI 10.3390/molecules14072573; QUAST DG, 1972, J FOOD SCI, V37, P584, DOI 10.1111/j.1365-2621.1972.tb02698.x; RAO PH, 1980, LEBENSM WISS TECHNOL, V13, P302; Rizzello CG, 2010, FOOD CHEM, V119, P1079, DOI 10.1016/j.foodchem.2009.08.016; Romani S, 2016, FOOD CHEM, V195, P97, DOI 10.1016/j.foodchem.2015.06.114; Rose DJ, 2006, J AM OIL CHEM SOC, V83, P415, DOI 10.1007/s11746-006-1220-0; SALWIN H, 1959, FOOD TECHNOL-CHICAGO, V13, P594; SHIIBA K, 1991, CEREAL CHEM, V68, P115; Shin TS, 1996, J AGR FOOD CHEM, V44, P567, DOI 10.1021/jf950386a; Sjovall O, 2000, J AGR FOOD CHEM, V48, P3522, DOI 10.1021/jf981309t; Srivastava AK, 2007, EUR FOOD RES TECHNOL, V224, P365, DOI 10.1007/s00217-006-0317-x; WEST AUGUSTUS P., 1933, PHILIPPINE JOYX SCI, V52, P1; Xu B, 2012, QUAL ASSUR SAF CROP, V4, P26, DOI 10.1111/j.1757-837X.2011.00120.x; Xu B, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/437950; Yalcin S, 2015, FOOD CHEM, V169, P203, DOI 10.1016/j.foodchem.2014.07.114; Yilmaz N, 2016, FOOD CHEM, V190, P179, DOI 10.1016/j.foodchem.2015.05.094; Yilmaz N, 2014, J SCI FOOD AGR, V94, P1568, DOI 10.1002/jsfa.6459; Yondem-Makascioglu F, 2005, J SCI FOOD AGR, V85, P1329, DOI 10.1002/jsfa.2102; Yoshida H, 1999, J AM OIL CHEM SOC, V76, P915, DOI 10.1007/s11746-999-0106-3	47	41	43	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167330	10.1371/journal.pone.0167330	http://dx.doi.org/10.1371/journal.pone.0167330			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936025	Green Submitted, gold, Green Published			2022-12-27	WOS:000389587100087
J	Liu, YH; Zhang, B; Lu, GM; Zhang, D				Liu, Yahui; Zhang, Bob; Lu, Guangming; Zhang, David			Online 3D Ear Recognition by Combining Global and Local Features	PLOS ONE			English	Article							FIELD	The three-dimensional shape of the ear has been proven to be a stable candidate for biometric authentication because of its desirable properties such as universality, uniqueness, and permanence. In this paper, a special laser scanner designed for online three- dimensional ear acquisition was described. Based on the dataset collected by our scanner, two novel feature classes were defined from a three-dimensional ear image: the global feature class (empty centers and angles) and local feature class (points, lines, and areas). These features are extracted and combined in an optimal way for three- dimensional ear recognition. Using a large dataset consisting of 2,000 samples, the experimental results illustrate the effectiveness of fusing global and local features, obtaining an equal error rate of 2.2%.	[Liu, Yahui; Lu, Guangming; Zhang, David] Harbin Inst Technol, Shenzhen Grad Sch, Dept Comp Sci & Technol, Shenzhen, Peoples R China; [Zhang, Bob] Univ Macau, Dept Comp & Informat Sci, Macau, Peoples R China	Harbin Institute of Technology; University Town of Shenzhen; University of Macau	Zhang, D (corresponding author), Harbin Inst Technol, Shenzhen Grad Sch, Dept Comp Sci & Technol, Shenzhen, Peoples R China.	cvpro1024@gmail.com	Zhang, Bob/ABD-5926-2021; Zhang, Hao/HHM-1940-2022; Zhang, David D/O-9396-2016; Zhang, Bob/HIR-3656-2022	Zhang, Bob/0000-0003-2497-9519; Zhang, David D/0000-0002-5027-5286; liu, yahui/0000-0002-8764-0769; LIU, Yahui/0000-0002-4632-2369	GRF fund from the HKSAR Government; central fund from Hong Kong Polytechnic University; NSFC fund [61332011, 61272292, 61271344]; Shenzhen Fundamental Research fund [JCYJ20150403161923528]; Key Laboratory of Network Oriented Intelligent Computation, Shenzhen, China	GRF fund from the HKSAR Government; central fund from Hong Kong Polytechnic University; NSFC fund(National Natural Science Foundation of China (NSFC)); Shenzhen Fundamental Research fund; Key Laboratory of Network Oriented Intelligent Computation, Shenzhen, China	The work is partially supported by the GRF fund from the HKSAR Government, the central fund from Hong Kong Polytechnic University, the NSFC fund (61332011, 61272292, 61271344), Shenzhen Fundamental Research fund (JCYJ20150403161923528), and Key Laboratory of Network Oriented Intelligent Computation, Shenzhen, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaza A., 2010, BIOM THEOR APPL SYST, P1; Abaza A, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2431211.2431221; Burge M, 2000, INT C PATT RECOG, P822, DOI 10.1109/ICPR.2000.906202; Chen H, 2009, IEEE T PATTERN ANAL, V31, P172, DOI 10.1109/TPAMI.2008.176; Chen H, 2007, IEEE T PATTERN ANAL, V29, P718, DOI 10.1109/TPAMI.2007.1005; Chen L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129505; Ear M., 2005, ELCVIA ELECT LETT CO, V5, P84; Huang C, 2009, ICCIT: 2009 FOURTH INTERNATIONAL CONFERENCE ON COMPUTER SCIENCES AND CONVERGENCE INFORMATION TECHNOLOGY, VOLS 1 AND 2, P511, DOI 10.1109/ICCIT.2009.56; Hurley DJ, 2005, COMPUT VIS IMAGE UND, V98, P491, DOI 10.1016/j.cviu.2004.11.001; Iannarelli A., 1989, FORENSIC IDENTIFICAT; Islam SMS, 2012, ACM COMPUT SURV, V44, DOI 10.1145/2187671.2187676; Islam SMS, 2011, INT J COMPUT VISION, V95, P52, DOI 10.1007/s11263-011-0436-0; JAIN AK, 1999, BIOMETRICS PERSONAL; Kakadiaris IA, 2007, IEEE T PATTERN ANAL, V29, P640, DOI 10.1109/TPAMI.2007.1017; Li W, 2012, IEEE T SYST MAN CY A, V42, P443, DOI 10.1109/TSMCA.2011.2164066; Liu Y., 2014, PATTERN RECOGN, V53, P9; Liu Y., 2015, J GEOSCI ENV PROT, V3, P10, DOI [10.4236/gep.2015.32002, DOI 10.1371/J0URNAL.P0NE.0129439]; Mian AS, 2008, INT J COMPUT VISION, V79, P1, DOI 10.1007/s11263-007-0085-5; Pang YW, 2011, SIGNAL PROCESS, V91, P773, DOI 10.1016/j.sigpro.2010.08.010; Pang YW, 2010, IEEE T CIRC SYST VID, V20, P172, DOI 10.1109/TCSVT.2009.2020337; Pang YW, 2010, INT J COMPUT MATH, V87, P956, DOI 10.1080/00207160802044118; Purkait R, 2008, FORENSIC SCI INT, V178, P112, DOI 10.1016/j.forsciint.2008.02.009; Yan P, 2007, IEEE T PATTERN ANAL, V29, P1297, DOI 10.1109/TPAMI.2007.1067; Zhang D, 2003, IEEE T PATTERN ANAL, V25, P1041, DOI 10.1109/TPAMI.2003.1227981; Zhang D., 2013, AUTOMATED BIOMETRICS, V7; Zhang D, 2010, PATTERN RECOGN, V43, P358, DOI 10.1016/j.patcog.2009.04.026; Zhang D, 2009, IEEE T SYST MAN CY C, V39, P505, DOI 10.1109/TSMCC.2009.2020790; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095506; Zhang YB, 2007, LECT NOTES COMPUT SC, V4781, P154; Zhou JD, 2012, IEEE T INF FOREN SEC, V7, P978, DOI 10.1109/TIFS.2012.2189005	31	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166204	10.1371/journal.pone.0166204	http://dx.doi.org/10.1371/journal.pone.0166204			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935955	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100020
J	Wu, ZJ; Liu, Y; Li, XL; Li, XH				Wu, Zijing; Liu, Ye; Li, Xuelian; Li, Xiaohan			Resilience and Associated Factors among Mainland Chinese Women Newly Diagnosed with Breast Cancer	PLOS ONE			English	Article							PSYCHOLOGICAL DISTRESS; PSYCHOSOCIAL CARE; HOPE; TRAJECTORIES; CHEMOTHERAPY; ADOLESCENTS; PREDICTORS; DEPRESSION; SURVIVORS; CHILDREN	Purpose Resilience is the individual's ability to bounce back from trauma. It has been studied for some time in the U.S., but few studies in China have addressed this important construct. In mainland China, relatively little is known about the resilience of patients in clinical settings, especially among patients with breast cancer. In this study, we aimed to evaluate the level of resilience and identify predictors of resilience among mainland Chinese women newly diagnosed with breast cancer. Methods A cross-sectional descriptive study was conducted with 213 mainland Chinese women newly diagnosed with breast cancer between November 2014 and June 2015. Participants were assessed with the Connor-Davidson Resilience Scale (CD-RISC), Social Support Rating Scale (SSRS), Medical Coping Modes Questionnaire (MCMQ, including 3 subscales: confrontation, avoidance, and acceptance-resignation), Herth Hope Index (HHI), and demographic and disease-related information. Descriptive statistics, bivariate analyses and multiple stepwise regression were conducted to explore predictors for resilience. Results The average score for CD-RISC was 60.97, ranging from 37 to 69. Resilience was positively associated with educational level, family income, time span after diagnosis, social support, confrontation, avoidance, and hope. However, resilience was negatively associated with age, body mass index (BMI), and acceptance-resignation. Multiple stepwise regression analysis indicated that hope (beta = 0.343, P<0.001), educational level of junior college or above (beta = 0.272, P<0.001), educational level of high school (beta = 0.235, P<0.001), avoidance (beta = 0.220, P<0.001), confrontation (beta = 0.187, P = 0.001), and age (beta =-0.108, P = 0.037) significantly affected resilience and explained 50.1% of the total variance in resilience. Conclusions Women with newly diagnosed breast cancer from mainland China demonstrated particularly low resilience level, which was predicted by hope educational level, avoidance, confrontation, and age.	[Wu, Zijing; Li, Xiaohan] China Med Univ, Sch Nursing, Shenyang, Liaoning, Peoples R China; [Liu, Ye] China Med Univ, Dept Surg Oncol & Breast Surg, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China; [Li, Xuelian] China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University	Li, XH (corresponding author), China Med Univ, Sch Nursing, Shenyang, Liaoning, Peoples R China.	xhli@cmu.edu.cn			China Medical Board (CMB) Young Nursing Faculty Research Grant [13-168-201413]	China Medical Board (CMB) Young Nursing Faculty Research Grant	This study was supported by China Medical Board (CMB) Young Nursing Faculty Research Grant (grant number: 13-168-201413). No individuals employed or contracted by the funders played any role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburn G, 2016, J ADV NURS, V72, P980, DOI 10.1111/jan.12888; Casellas-Grau A, 2014, PSYCHO-ONCOLOGY, V23, P9, DOI 10.1002/pon.3353; Clayton JM, 2005, CANCER-AM CANCER SOC, V103, P1965, DOI 10.1002/cncr.21011; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Solano JPC, 2016, BMC PALLIAT CARE, V15, DOI 10.1186/s12904-016-0139-y; Del Mastro L, 2002, EUR J CANCER, V38, P359, DOI 10.1016/S0959-8049(01)00380-X; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Deshields T, 2006, PSYCHO-ONCOLOGY, V15, P398, DOI 10.1002/pon.962; Edward KL, 2009, J ADV NURS, V65, P587, DOI 10.1111/j.1365-2648.2008.04912.x; Eicher M, 2015, ONCOL NURS FORUM, V42, pE3, DOI 10.1188/15.ONF.E3-E16; Fan L, 2014, LANCET ONCOL, V15, pE279, DOI 10.1016/S1470-2045(13)70567-9; Fann JR, 2012, J CLIN ONCOL, V30, P1178, DOI 10.1200/JCO.2011.39.7398; FEIFEL H, 1987, PSYCHOSOM MED, V49, P616, DOI 10.1097/00006842-198711000-00007; Fu MR, 2008, J ADV NURS, V63, P155, DOI 10.1111/j.1365-2648.2008.04647.x; Haase Joan E, 2004, J Pediatr Oncol Nurs, V21, P289, DOI 10.1177/1043454204267922; Haase JE, 2014, CANCER NURS, V37, pE1, DOI 10.1097/NCC.0b013e31828941bb; Helgeson VS, 2004, HEALTH PSYCHOL, V23, P3, DOI 10.1037/0278-6133.23.1.3; HERTH K, 1992, J ADV NURS, V17, P1251, DOI 10.1111/j.1365-2648.1992.tb01843.x; Herth K, 2000, J ADV NURS, V32, P1431, DOI 10.1046/j.1365-2648.2000.01619.x; Ho SMY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-279; Hou WK, 2010, HEALTH PSYCHOL, V29, P484, DOI 10.1037/a0020809; Howard A Fuchsia, 2007, Cancer Nurs, V30, pE27, DOI 10.1097/01.NCC.0000281737.33232.3c; Jacobsen PB, 2012, J CLIN ONCOL, V30, P1154, DOI 10.1200/JCO.2011.39.5046; Kim DH, 2010, J PAEDIATR CHILD H, V46, P431, DOI 10.1111/j.1440-1754.2010.01749.x; Lam WWT, 2010, PSYCHO-ONCOLOGY, V19, P1044, DOI 10.1002/pon.1658; Lee Sunmin, 2013, N Am J Med Sci (Boston), V6, P1; Llewellyn CD, 2013, PSYCHO-ONCOLOGY, V22, P97, DOI 10.1002/pon.2065; Lopez-Tarruella S, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2226; Loprinzi CE, 2011, CLIN BREAST CANCER, V11, P364, DOI 10.1016/j.clbc.2011.06.008; Manne SL, 2015, CANCER NURS, V38, P375, DOI 10.1097/NCC.0000000000000215; Markovitz SE, 2015, PSYCHO-ONCOLOGY, DOI [10.1188/14.CJON.93-101, DOI 10.1188/14.CJON.93-101]; Masera Giuseppe, 2013, Epidemiol Prev, V37, P278; Molina Y, 2014, CLIN J ONCOL NURS, V18, P93, DOI 10.1188/14.CJON.93-101; Pandey Manoj, 2006, World J Surg Oncol, V4, P68, DOI 10.1186/1477-7819-4-68; Philip EJ, 2013, PSYCHO-ONCOLOGY, V22, P987, DOI 10.1002/pon.3088; Richardson GE, 2002, J CLIN PSYCHOL, V58, P307, DOI 10.1002/jclp.10020; Rosenberg AR, 2015, CANCER; Rowland JH, 2005, CANCER-AM CANCER SOC, V104, P2543, DOI 10.1002/cncr.21487; Ryan L., 2009, ASIAN SOCIAL SCI, V5, P39, DOI [10.5539/ass.v5n11p39, DOI 10.5539/ASS.V5N11P39]; Schumacher A, 2014, SUPPORT CARE CANCER, V22, P487, DOI 10.1007/s00520-013-2001-6; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Simpson P, 2005, PSYCHO-ONCOLOGY, V14, P671, DOI 10.1002/pon.893; Southwick SM, 2012, SCIENCE, V338, P79, DOI 10.1126/science.1222942; Strauss B, 2007, J CANCER RES CLIN, V133, P511, DOI 10.1007/s00432-007-0195-z; Wang P, 2014, PROCD SOC BEHV, V116, P3259, DOI 10.1016/j.sbspro.2014.01.744; Wang Y., 2010, CHINESE NURSING RES, V24, P20, DOI [DOI 10.3969/J.ISSN.1009-6493.2010.01.008, 10.3969/j.issn.1009-6493.2010.01.008]; Wu LM, 2013, J ADV NURS, V69, P158, DOI 10.1111/j.1365-2648.2012.06003.x; Xiao S., 1994, J CLIN PSYCHIAT, V4, P98, DOI DOI 10.1186/S12913-016-1423-5; Ye ZJ, 2015, CANCER NURS, V38, P466, DOI 10.1097/NCC.0000000000000220; Yu XN, 2007, SOC BEHAV PERSONAL, V35, P19, DOI 10.2224/sbp.2007.35.1.19	50	38	43	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167976	10.1371/journal.pone.0167976	http://dx.doi.org/10.1371/journal.pone.0167976			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936196	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100243
J	Luo, T; Liu, H; Kim, JK				Luo, Tao; Liu, Han; Kim, Jin Kyung			Estrogen Protects the Female Heart from Ischemia/Reperfusion Injury through Manganese Superoxide Dismutase Phosphorylation by Mitochondrial p38 beta at Threonine 79 and Serine 106	PLOS ONE			English	Article							P38 MAP KINASES; PREVENTS CARDIOMYOCYTE APOPTOSIS; ACUTE MYOCARDIAL PROTECTION; CARDIAC MYOCYTES; RECEPTOR-BETA; NULL MICE; ACTIVATION; STRESS; ALPHA; 17-BETA-ESTRADIOL	A collective body of evidence indicates that estrogen protects the heart from myocardial ischemia/reperfusion (I/R) injury, but the underlying mechanism remains incompletely understood. We have previously delineated a novel mechanism of how 17 beta-estradiol (E2) protects cultured neonatal rat cardiomyocytes from hypoxia/reoxygenation (H/R) by identifying a functionally active mitochondrial pool of p38 beta and E2-driven upregulation of manganese superoxide dismutase (MnSOD) activity via p38 beta, leading to the suppression of reactive oxygen species (ROS) and apoptosis. Here we investigate these cytoprotective actions of E2 in vivo. Left coronary artery ligation and reperfusion was used to produce I/R injury in ovariectomized (OVX) female mice and in estrogen receptor (ER) null female mice. E2 treatment in OVX mice reduced the left ventricular infarct size accompanied by increased activity of mitochondrial p38 beta and MnSOD. I/R-induced infarct size in ER alpha knockout (ERKO), ER beta knockout (BERKO) and ER alpha and beta double knockout (DERKO) female mice was larger than that in wild type (WT) mice, with little difference among ERKO, BERKO, and DERKO. Loss of both ER alpha and ER beta led to reduced activity of mitochondrial p38 beta and MnSOD at baseline and after I/R. The physical interaction between mitochondrial p38 beta and MnSOD in the heart was detected by co-immunoprecipitation (co-IP). Threonine 79 (T79) and serine 106 (S106) of MnSOD were identified to be phosphorylated by p38 beta in kinase assays. Overexpression of WT MnSOD in cardiomyocytes reduced ROS generation during H/R, while point mutation of T79 and S106 of MnSOD to alanine abolished its antioxidative function. We conclude that the protective effects of E2 and ER against cardiac I/R injury involve the regulation of MnSOD via posttranslational modification of the dismutase by p38 beta.	[Luo, Tao; Liu, Han; Kim, Jin Kyung] Univ Calif Irvine, Sch Med, Dept Med, Div Cardiol, Irvine, CA 92717 USA	University of California System; University of California Irvine	Kim, JK (corresponding author), Univ Calif Irvine, Sch Med, Dept Med, Div Cardiol, Irvine, CA 92717 USA.	jkim13@uci.edu	LUO, TAO/G-5064-2018	LUO, TAO/0000-0002-4144-4500	National Heart, Lung, and Blood Institute [R01 HL111180]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by The National Heart, Lung, and Blood Institute; grand number: R01 HL111180; URL: http://www.nhlbi.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Loza PA, 2007, HYPERTENSION, V50, P432, DOI 10.1161/HYPERTENSIONAHA.106.084798; Beenstock J, 2016, MOL CELL BIOL, V36, P1540, DOI 10.1128/MCB.01105-15; Beenstock J, 2014, J BIOL CHEM, V289, P23546, DOI 10.1074/jbc.M114.578237; Booth EA, 2003, J PHARMACOL EXP THER, V307, P395, DOI 10.1124/jpet.103.054205; Borras C, 2006, FASEB J, V20, P2136, DOI 10.1096/fj.05-5522fje; Candas D, 2013, J MOL CELL BIOL, V5, P166, DOI 10.1093/jmcb/mjs062; Ceravolo GS, 2013, STEROIDS, V78, P341, DOI 10.1016/j.steroids.2012.11.018; Costa TJ, 2015, AM J PHYSIOL-HEART C, V308, pH723, DOI 10.1152/ajpheart.00681.2014; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Cross HR, 2009, ACTA PHYSIOL HUNG, V96, P307, DOI 10.1556/APhysiol.96.2009.3.5; Barrantes IDB, 2011, P NATL ACAD SCI USA, V108, P12764, DOI 10.1073/pnas.1015013108; Gabel Scott A, 2005, J Mol Cell Cardiol, V38, P289, DOI 10.1016/j.yjmcc.2004.11.013; Gottipati S, 2008, MOL VIS, V14, P898; Grohe C, 1997, FEBS LETT, V416, P107, DOI 10.1016/S0014-5793(97)01179-4; Hsia J, 2006, ARCH INTERN MED, V166, P357, DOI 10.1001/archinte.166.3.357; Jazbutyte V, 2009, BIOCHEM BIOPH RES CO, V384, P450, DOI 10.1016/j.bbrc.2009.04.139; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Jin CH, 2015, FREE RADICAL BIO MED, V81, P77, DOI 10.1016/j.freeradbiomed.2014.12.026; Jovanovic S, 2000, J AM COLL CARDIOL, V36, P948, DOI 10.1016/S0735-1097(00)00798-1; Kim JK, 2006, J BIOL CHEM, V281, P6760, DOI 10.1074/jbc.M511024200; Kim YD, 1996, CIRCULATION, V94, P2901, DOI 10.1161/01.CIR.94.11.2901; Kurian GA, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1656450; Lan XL, 2009, NUCL MED BIOL, V36, P207, DOI 10.1016/j.nucmedbio.2008.10.016; Li QX, 2008, J BIOL CHEM, V283, P11014, DOI 10.1074/jbc.M709682200; Liu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085272; Liu H, 2011, CARDIOVASC RES, V89, P119, DOI 10.1093/cvr/cvq265; Luo T, 2016, CAN J CARDIOL, V32, P1017, DOI 10.1016/j.cjca.2015.10.021; Luo T, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0342-4; Manson JE, 2007, NEW ENGL J MED, V356, P2591, DOI 10.1056/NEJMoa071513; New L, 2003, MOL BIOL CELL, V14, P2603, DOI 10.1091/mbc.E02-08-0538; Nuedling S, 1999, CARDIOVASC RES, V43, P666, DOI 10.1016/S0008-6363(99)00093-0; Rattanasopa C, 2015, J STEROID BIOCHEM, V147, P1, DOI 10.1016/j.jsbmb.2014.11.009; Satoh M, 2007, CIRCULATION, V115, P3197, DOI 10.1161/CIRCULATIONAHA.106.657981; Schierbeck LL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6409; Strehlow K, 2003, CIRC RES, V93, P170, DOI 10.1161/01.RES.0000082334.17947.11; Sugden PH, 1998, CIRC RES, V83, P345, DOI 10.1161/01.RES.83.4.345; Wang MJ, 2008, SURGERY, V144, P233, DOI 10.1016/j.surg.2008.03.009; Wang MJ, 2006, AM J PHYSIOL-HEART C, V290, pH2204, DOI 10.1152/ajpheart.01219.2005; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Xin HB, 2002, NATURE, V416, P334, DOI 10.1038/416334a; Yamakura F, 2010, BBA-PROTEINS PROTEOM, V1804, P318, DOI 10.1016/j.bbapap.2009.10.010; Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101; Yokota T, 2016, GENE, V575, P369, DOI 10.1016/j.gene.2015.09.030	43	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167761	10.1371/journal.pone.0167761	http://dx.doi.org/10.1371/journal.pone.0167761			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930699	Green Published, gold, Green Submitted			2022-12-27	WOS:000389580900044
J	Mueller, KAL; Heck, C; Heinzmann, D; Schwille, J; Klingel, K; Kandolf, R; Kramer, U; Gramlich, M; Geisler, T; Gawaz, MP; Schreieck, J; Seizer, P				Mueller, Karin A. L.; Heck, Christian; Heinzmann, David; Schwille, Johannes; Klingel, Karin; Kandolf, Reinhard; Kramer, Ulrich; Gramlich, Michael; Geisler, Tobias; Gawaz, Meinrad P.; Schreieck, Juergen; Seizer, Peter			Comparison of Ventricular Inducibility with Late Gadolinium Enhancement and Myocardial Inflammation in Endomyocardial Biopsy in Patients with Dilated Cardiomyopathy	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; MAGNETIC-RESONANCE ASSESSMENT; AMERICAN-HEART-ASSOCIATION; NONISCHEMIC CARDIOMYOPATHY; SCIENTIFIC STATEMENT; PROGNOSTIC VALUE; DISEASE; STIMULATION; FAILURE	Background Risk stratification of patients with non-ischemic dilated cardiomyopathy remains a matter of debate in the era of device implantation. Objective We investigated associations between histopathological findings, contrast-enhanced cardiac MRI and the inducibility of ventricular tachycardia (VT) or fibrillation (VF) in programmed ventricular stimulation. Methods 56 patients with impaired left ventricular ejection fraction (LVEF <= 50%, mean 36.6 +/- 10.5%) due to non-ischemic dilated cardiomyopathy underwent cardiac MRI, programmed ventricular stimulation, and endomyocardial biopsy and were retrospectively investigated. Inducibility was defined as sustained mono-or polymorphic VT or unstable VT/VF requiring cardioversion/defibrillation. Primary study endpoint was defined as the occurrence of hemodynamically relevant VT/VF and/or adequate ICD-therapy during follow-up. Results Endomyocardial biopsy detected cardiac fibrosis in 18 (32.1%) patients. Cardiac MRI revealed 35 (62.5%) patients with positive late gadolinium enhancement. VT/VF was induced in ten (17.9%) patients during programmed ventricular stimulation. Monomorphic VT was inducible in 70%, while 20% of patients showed polymorphic VT. One patient (10%) presented with VF. Inducibility correlated significantly with the presence of positive late gadolinium enhancement in cardiac MRI (p<0.01). We could not find a significant association between inducibility and the degree of cardiac inflammation and fibrosis in non-site directed routine right ventricular endomyocardial biopsy. During a mean follow-up of 2.6 years, nine (16.1%) patients reached the primary endpoint. Monomorphic VTs were found in 66.7% patients and were terminated by antitachycardia pacing therapy. One patient with polymorphic VT and two patients with VF received adequate therapy by an ICD-shock. However, inducibility did not correlate with the occurrence of endpoints. Conclusion Inducibilty during programmed ventricular stimulation is associated with positive late gadolinium enhancement in cardiac MRI of patients with non-ischemic dilated cardiomyopathy. The presence of myocardial fibrosis or inflammation in undirected endomyocardial biopsy does not seem to be sufficient to predict future ventricular arrhythmias.	[Mueller, Karin A. L.; Heck, Christian; Heinzmann, David; Schwille, Johannes; Gramlich, Michael; Geisler, Tobias; Gawaz, Meinrad P.; Schreieck, Juergen; Seizer, Peter] Eberhard Karls Univ Tubingen, Univ Klinikum, Med Klin Kardiol & Kreislauferkrankungen 3, Tubingen, Germany; [Klingel, Karin; Kandolf, Reinhard] Eberhard Karls Univ Tubingen, Univ Klinikum, Abt Mol Pathol, Tubingen, Germany; [Kramer, Ulrich] Eberhard Karls Univ Tubingen, Univ Klinikum, Inst Radiol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Seizer, P (corresponding author), Eberhard Karls Univ Tubingen, Univ Klinikum, Med Klin Kardiol & Kreislauferkrankungen 3, Tubingen, Germany.	peter.seizer@med.uni-tuebingen.de	Geisler, Tobias/AAO-4472-2020		Deutsche Forschungsgemeinschaft (Transregio "Inflammatory Cardiomyopathy") [SFB TR19, BO 3786/1-1]; Klinische Forschergruppe "Platelets-Molecular Mechanisms and Translational Implications" [KFO 274]; Tuebingen Platelet Investigative Consortium (TuePIC); TUFF Frauenforderungsprogramm [2241-0-0]; Deutsche Forschungsgemeinschaft; University of Tubingen	Deutsche Forschungsgemeinschaft (Transregio "Inflammatory Cardiomyopathy"); Klinische Forschergruppe "Platelets-Molecular Mechanisms and Translational Implications"; Tuebingen Platelet Investigative Consortium (TuePIC); TUFF Frauenforderungsprogramm; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Tubingen	This study was supported by the Deutsche Forschungsgemeinschaft (Transregio SFB TR19 "Inflammatory Cardiomyopathy"; BO 3786/1-1), the Klinische Forschergruppe "Platelets-Molecular Mechanisms and Translational Implications" (KFO 274), the Tuebingen Platelet Investigative Consortium (TuePIC), the TUFF Frauenforderungsprogramm (Karin Mueller, 2241-0-0), and by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basso C, 2013, HEART FAIL REV, V18, P673, DOI 10.1007/s10741-012-9355-6; Brignole M, 2009, EUROPACE, V11, P1129, DOI 10.1093/europace/eup174; Brilakis ES, 2001, PACE, V24, P1623, DOI 10.1046/j.1460-9592.2001.01623.x; CHEN X, 1994, EUR HEART J, V15, P76, DOI 10.1093/oxfordjournals.eurheartj.a060383; Cooper LT, 2007, CIRCULATION, V116, P2216, DOI 10.1161/CIRCULATIONAHA.107.186093; Daubert JP, 2006, J AM COLL CARDIOL, V47, P98, DOI 10.1016/j.jacc.2005.08.049; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Fishman GI, 2010, CIRCULATION, V122, P2335, DOI 10.1161/CIRCULATIONAHA.110.976092; Gatzoulis KA, 2014, INT J CARDIOL, V176, P1449, DOI 10.1016/j.ijcard.2014.08.068; Goldberger JJ, 2014, CIRC-ARRHYTHMIA ELEC, V7, P1006, DOI 10.1161/CIRCEP.114.002395; Grimm W, 1998, J AM COLL CARDIOL, V32, P739, DOI 10.1016/S0735-1097(98)00306-4; Gulati A, 2013, JAMA-J AM MED ASSOC, V309, P896, DOI 10.1001/jama.2013.1363; Iles L, 2011, J AM COLL CARDIOL, V57, P821, DOI 10.1016/j.jacc.2010.06.062; Kallianos K, 2015, MAGN RESON IMAGING C, V23, P89, DOI 10.1016/j.mric.2014.09.004; Katritsis DG, 2012, EUROPACE, V14, P787, DOI 10.1093/europace/eus001; Kindermann I, 2008, CIRCULATION, V118, P639, DOI 10.1161/CIRCULATIONAHA.108.769489; Klingel K, 1996, J VIROL, V70, P8888, DOI 10.1128/JVI.70.12.8888-8895.1996; Leone O, 2012, CARDIOVASC PATHOL, V21, P245, DOI 10.1016/j.carpath.2011.10.001; Mahrholdt H, 2004, CIRCULATION, V109, P1250, DOI 10.1161/01.CIR.0000118493.13323.81; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Muller K, 2010, ATHEROSCLEROSIS, V213, P256, DOI 10.1016/j.atherosclerosis.2010.07.023; Mueller KAL, 2013, J CARD FAIL, V19, P678, DOI 10.1016/j.cardfail.2013.09.001; Muller KAL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057077; Nazarian S, 2005, CIRCULATION, V112, P2821, DOI 10.1161/CIRCULATIONAHA.105.549659; Nichol G, 2004, ANN INTERN MED, V141, P343, DOI 10.7326/0003-4819-141-5-200409070-00102; Piers SRD, 2013, CIRC-ARRHYTHMIA ELEC, V6, P875, DOI 10.1161/CIRCEP.113.000537; Priori SG, 2015, ESG GUIDELINES MANAG; Scott PA, 2013, EUR J HEART FAIL, V15, P1019, DOI 10.1093/eurjhf/hft053; Seizer P, 2011, INT J CARDIOLOGY; Seizer P, 2013, INT J CARDIOL, V168, P3113, DOI 10.1016/j.ijcard.2013.04.068; Seizer P, 2013, INT J CARDIOL, V167, P1070, DOI 10.1016/j.ijcard.2012.10.065	31	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167616	10.1371/journal.pone.0167616	http://dx.doi.org/10.1371/journal.pone.0167616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930686	Green Published, gold, Green Submitted			2022-12-27	WOS:000389580900030
J	Murphy, N; Falk, RT; Messinger, DB; Pollak, M; Xue, XN; Lin, J; Sgueglia, R; Strickler, HD; Gaudet, MM; Gunter, MJ				Murphy, Neil; Falk, Roni T.; Messinger, Diana B.; Pollak, Michael; Xue, Xiaonan; Lin, Juan; Sgueglia, Robin; Strickler, Howard D.; Gaudet, Mia M.; Gunter, Marc J.			Influence of Fasting Status and Sample Preparation on Metabolic Biomarker Measurements in Postmenopausal Women	PLOS ONE			English	Article							GROWTH-FACTOR-I; SERUM C-PEPTIDE; COLORECTAL-CANCER; BREAST-CANCER; PLASMA ADIPONECTIN; DIABETES-MELLITUS; HEALTHY-SUBJECTS; BINDING-PROTEIN; RISK; INSULIN	Background Epidemiologic data linking metabolic markers-such as insulin, insulin-like growth factors (IGFs)-and adipose tissue-derived factors with cancer are inconsistent. Between-study differences in blood collection protocols, in particular participant's fasting status, may influence measurements. Methods We investigated the impact of fasting status and blood sample processing time on components of the insulin/IGF axis and in adipokines in a controlled feeding study of 45 healthy postmenopausal-women aged 50-75 years. Fasting blood samples were drawn (T0), after which subjects ate a standardized breakfast; subsequent blood draws were made at 1 hour (T1), 3 hours (T3), and 6 hours (T6) after breakfast. Serum samples were assayed for insulin, C-peptide, total-and free-IGF-I, IGF-binding protein [BP]-1 and -3, total and high molecular weight (HMW)-adiponectin, retinol binding protein-4, plasminogen activator inhibitor (PAI)-1, and resistin. Results Insulin and C-peptide levels followed similar postprandial trajectories; intra-class correlation coefficients [ICC] for insulin = 0.75, (95% CI: 0.64-0.97) and C-peptide (ICC = 0.66, 95% CI: 0.54-0.77) were similarly correlated in fasting (Spearman correlation, r = 0.78, 95% CI: 0.64-0.88) and postprandial states (T1, r = 0.77 (95% CI: 0.62-0.87); T3, r = 0.78 (95% CI: 0.63-0.87); T6, r = 0.77 (95% CI: 0.61-0.87)). Free-IGF-I and IGFBP-1 levels were also affected by fasting status, whereas total-IGF-I and IGFBP-3 levels remained unchanged. Levels of adipokines were largely insensitive to fasting status and blood sample processing delays. Conclusion Several components of the insulin/IGF axis were significantly impacted by fasting state and in particular, C-peptide levels were substantially altered postprandially and in a similar manner to insulin.	[Murphy, Neil] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Murphy, Neil; Gunter, Marc J.] Int Agcy Res Canc, Lyon, France; [Falk, Roni T.] NCI, Div Canc Epidemiol & Genet, Hormonal & Reprod Epidemiol Branch, Bethesda, MD 20892 USA; [Messinger, Diana B.] Rockefeller Univ Hosp, 1230 York Ave, New York, NY 10021 USA; [Pollak, Michael] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Xue, Xiaonan; Lin, Juan; Sgueglia, Robin; Strickler, Howard D.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Gaudet, Mia M.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA USA	Imperial College London; World Health Organization; International Agency for Research on Cancer (IARC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rockefeller University; McGill University; Yeshiva University; Albert Einstein College of Medicine; American Cancer Society	Murphy, N (corresponding author), Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England.; Murphy, N (corresponding author), Int Agcy Res Canc, Lyon, France.	murphyn@iarc.fr	Murphy, Neil/E-1189-2017; Gunter, Marc/AAP-8621-2020	Murphy, Neil/0000-0003-3347-8249; Gunter, Marc/0000-0001-5472-6761; Pollak, Michael/0000-0003-3047-0604	National Center for Advancing Translational Sciences (NCATS), National Institutes of Health [UL1RR024143]; National Cancer Institute [R03CA143956-01]; ICTR Einstein-Montefiore CTSA [UL1TR001073]; Diabetes Research Center [DK020541];  [8 UL1 TR000043]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences (NCATS), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ICTR Einstein-Montefiore CTSA; Diabetes Research Center; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study population were recruited at the Center for Clinical and Translational Science (CCTS) at the Rockefeller University Hospital (New York, NY) using funds Grant # 8 UL1 TR000043. Supported in part by grant # UL1RR024143 from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health. The funds for the measurement of adipokines were obtained from the National Cancer Institute (R03CA143956-01). Robin Sgueglia is supported by the ICTR Einstein-Montefiore CTSA (UL1TR001073) and the Diabetes Research Center (DK020541).	Aleksandrova K, 2012, CARCINOGENESIS, V33, P1211, DOI 10.1093/carcin/bgs133; BONSER AM, 1984, CRC CR REV CL LAB SC, V19, P297, DOI 10.3109/10408368409165766; COTTERILL AM, 1993, CLIN ENDOCRINOL, V39, P357, DOI 10.1111/j.1365-2265.1993.tb02377.x; Esposito K, 2003, AM J CLIN NUTR, V78, P1135, DOI 10.1093/ajcn/78.6.1135; Esposito K, 2012, DIABETES CARE, V35, P2402, DOI 10.2337/dc12-0336; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Gunter MJ, 2009, JNCI-J NATL CANCER I, V101, P48, DOI 10.1093/jnci/djn415; Harris TG, 2006, GROWTH HORM IGF RES, V16, P86, DOI 10.1016/j.ghir.2006.01.002; HOLLY JMP, 1988, CLIN ENDOCRINOL, V29, P667, DOI 10.1111/j.1365-2265.1988.tb03715.x; Imbeault P, 2004, CLIN ENDOCRINOL, V60, P429, DOI 10.1111/j.1365-2265.2004.01997.x; Jellema A, 2004, EUR J CLIN INVEST, V34, P766, DOI 10.1111/j.1365-2362.2004.01414.x; Jenab M, 2007, INT J CANCER, V121, P368, DOI 10.1002/ijc.22697; Karlsson FA, 2004, OBES RES, V12, P1031, DOI 10.1038/oby.2004.126; Keinan-Boker L, 2003, INT J CANCER, V106, P90, DOI 10.1002/ijc.11193; Lewandowski KC, 2005, MOL GENET METAB, V85, P61, DOI 10.1016/j.ymgme.2004.12.014; Lukanova A, 2006, CANCER EPIDEM BIOMAR, V15, P401, DOI 10.1158/1055-9965.EPI-05-0836; Ma J, 2004, JNCI-J NATL CANCER I, V96, P546, DOI 10.1093/jnci/djh082; Peake PW, 2003, INT J OBESITY, V27, P657, DOI 10.1038/sj.ijo.0802289; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Sanders TAB, 2001, AM J CLIN NUTR, V73, P715; Shea SA, 2005, J CLIN ENDOCR METAB, V90, P2537, DOI 10.1210/jc.2004-2232; Verheus M, 2006, INT J CANCER, V119, P659, DOI 10.1002/ijc.21861; Wei EK, 2005, JNCI-J NATL CANCER I, V97, P1688, DOI 10.1093/jnci/dji376	23	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167832	10.1371/journal.pone.0167832	http://dx.doi.org/10.1371/journal.pone.0167832			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930694	Green Published, gold, Green Submitted			2022-12-27	WOS:000389580900048
J	Sprenger, JU; Bork, NI; Herting, J; Fischer, TH; Nikolaev, VO				Sprenger, Julia U.; Bork, Nadja I.; Herting, Jonas; Fischer, Thomas H.; Nikolaev, Viacheslav O.			Interactions of Calcium Fluctuations during Cardiomyocyte Contraction with Real-Time cAMP Dynamics Detected by FRET	PLOS ONE			English	Article							CARDIAC MYOCYTES; ADENYLYL-CYCLASE; CYCLIC-AMP; IN-VIVO; PHOSPHODIESTERASE; HEART; COMPARTMENTATION; SIGNALS; KINASE	Calcium (Ca2+) and 3',5'-cyclic adenosine monophosphate (cAMP) play a critical role for cardiac excitation-contraction-coupling. Both second messengers are known to interact with each other, for example via Ca2+-dependent modulation of phosphodiesterase 1 (PDE1) and adenylyl cyclase 5/6 (AC 5/6) activities, which is supposed to occur especially at the local level in distinct subcellular microdomains. Currently, many studies analyze global and local cAMP signaling and its regulation in resting cardiomyocytes devoid of electrical stimulation. For example, Forster resonance energy transfer (FRET) microscopy is a popular approach for visualization of real time cAMP dynamics performed in resting cardiomyocytes to avoid potential contractility-related movement artifacts. However, it is unknown whether such data are comparable with the cell behavior under more physiologically relevant conditions during contraction. Here, we directly compare the cAMP-FRET responses to AC stimulation and PDE inhibition in resting vs. paced adult mouse ventricular cardiomyocytes for both cytosolic and subsarcolemmal microdomains. Interestingly, no significant differences in cAMP dynamics could be detected after beta-adrenergic (isoproterenol) stimulation, suggesting low impact of rapidly changing contractile Ca2+ concentrations on cytosolic cAMP levels associated with AC activation. However, the contribution of the calcium-dependent PDE1, but not of the Ca2+-insensitive PDE4, to the regulation of cAMP levels after forskolin stimulation was significantly increased. This increase could be mimicked by pretreatment of resting cells with Ca2+ elevating agents. Ca2+ imaging demonstrated significantly higher amplitudes of Ca2+ transients in forskolin than in isoproterenol stimulated cells, suggesting that forskolin stimulation might lead to stronger activation of PDE1. In conclusion, changes in intracellular Ca2+ during cardiomyocyte contraction dynamically interact with cAMP levels, especially after strong AC stimulation. The use of resting cells for FRET-based measurements of cAMP can be justified under beta-adrenergic stimulation, while the reliable analysis of PDE1 effects may require electric field stimulation.	[Sprenger, Julia U.; Bork, Nadja I.; Nikolaev, Viacheslav O.] Univ Med Ctr Hamburg Eppendorf, Inst Expt Cardiovasc Res, Hamburg, Germany; [Sprenger, Julia U.; Herting, Jonas; Fischer, Thomas H.] Univ Med Ctr Gottingen, Heart Res Ctr Gottingen, Clin Cardiol & Pulmonol, Gottingen, Germany; [Bork, Nadja I.; Nikolaev, Viacheslav O.] DZHK German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, Berlin, Germany; [Herting, Jonas; Fischer, Thomas H.] DZHK German Ctr Cardiovasc Res, Partner Site Gottingen, Berlin, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Gottingen; German Centre for Cardiovascular Research; German Centre for Cardiovascular Research	Nikolaev, VO (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Expt Cardiovasc Res, Hamburg, Germany.; Nikolaev, VO (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, Berlin, Germany.	v.nikolaev@uke.de	Nikolaev, Vyacheslav/AAT-7746-2020		"Deutsche Forschungsgemeinschaft" (DFG, German Research Council) [NI 1301/1, NI 1301/2, SFB 1002]; Gertraud and Heinz-Rose Stiftung	"Deutsche Forschungsgemeinschaft" (DFG, German Research Council)(German Research Foundation (DFG)); Gertraud and Heinz-Rose Stiftung	Support was provided by the "Deutsche Forschungsgemeinschaft" (DFG, German Research Council) grants NI 1301/1, NI 1301/2, SFB 1002) and the Gertraud and Heinz-Rose Stiftung [www.dfg.de].	Agarwal SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095835; Agarwal SR, 2011, J MOL CELL CARDIOL, V50, P500, DOI 10.1016/j.yjmcc.2010.11.015; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Borner S, 2011, NAT PROTOC, V6, P427, DOI 10.1038/nprot.2010.198; Brooker G, 1979, Adv Cyclic Nucleotide Res, V10, P1; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; De Arcangelis V, 2010, MOL PHARMACOL, V78, P340, DOI 10.1124/mol.110.064444; Despa S, 2014, CIRC RES, V115, P339, DOI 10.1161/CIRCRESAHA.115.303582; Fischmeister R, 2006, CIRC RES, V99, P816, DOI 10.1161/01.RES.0000246118.98832.04; KATSUSHIKA S, 1992, P NATL ACAD SCI USA, V89, P8774, DOI 10.1073/pnas.89.18.8774; Leroy J, 2008, CIRC RES, V102, P1091, DOI 10.1161/CIRCRESAHA.107.167817; Lompre AM, 2010, CIRCULATION, V121, P822, DOI 10.1161/CIRCULATIONAHA.109.890954; Miller CL, 2009, CIRC RES, V105, P956, DOI 10.1161/CIRCRESAHA.109.198515; Molina CE, 2012, J AM COLL CARDIOL, V59, P2182, DOI 10.1016/j.jacc.2012.01.060; Nikolaev VO, 2006, CIRC RES, V99, P1084, DOI 10.1161/01.RES.0000250046.69918.d5; Perera RK, 2013, ACTA PHYSIOL, V207, P650, DOI 10.1111/apha.12077; Perera RK, 2015, CIRC RES, V116, P1304, DOI 10.1161/CIRCRESAHA.116.306082; Richter W, 2008, EMBO J, V27, P384, DOI 10.1038/sj.emboj.7601968; Richter W, 2013, EMBO REP, V14, P276, DOI 10.1038/embor.2013.4; Rochais F, 2004, J BIOL CHEM, V279, P52095, DOI 10.1074/jbc.M405697200; Sprenger JU, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7965; Stangherlin A, 2011, CIRC RES, V108, P929, DOI 10.1161/CIRCRESAHA.110.230698; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; Zaccolo M, 2009, BRIT J PHARMACOL, V158, P50, DOI 10.1111/j.1476-5381.2009.00185.x	26	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167974	10.1371/journal.pone.0167974	http://dx.doi.org/10.1371/journal.pone.0167974			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930744	Green Published, gold, Green Submitted			2022-12-27	WOS:000389580900066
J	Hubel, TY; Shotton, J; Wilshin, SD; Horgan, J; Klein, R; McKenna, R; Wilson, AM				Hubel, Tatjana Y.; Shotton, Justine; Wilshin, Simon D.; Horgan, Jane; Klein, Rebecca; McKenna, Rick; Wilson, Alan M.			Cheetah Reunion - The Challenge of Finding Your Friends Again	PLOS ONE			English	Article							HABITAT SELECTION; PLAYBACK EXPERIMENTS; ACINONYX-JUBATUS; RANGE USE; PREDATORS; BEHAVIOR; LIONS; MECHANISMS; NAVIGATION; AVOIDANCE	Animals navigate their environment using a variety of senses and strategies. This multiplicity enables them to respond to different navigational requirements resulting from habitat, scale and purpose. One of the challenges social animals face is how to reunite after periods of separation. We explore a variety of possible mechanisms used to reunite the members of a cheetah coalition dispersed within a large area after prolonged separation. Using GPS data from three cheetahs reuniting after weeks of separation, we determined that 1) the likelihood of purely coincidental reunion is miniscule 2) the reunion occurred in an area not normally frequented 3) with very little time spent in the region in advance of the reunion. We therefore propose that timely encounter of scent markings where paths cross is the most likely mechanism used to aid the reunion.	[Hubel, Tatjana Y.; Shotton, Justine; Wilshin, Simon D.; Wilson, Alan M.] Royal Vet Coll, Struct & Motion Lab, Hatfield, Herts, England; [Horgan, Jane; Klein, Rebecca; McKenna, Rick] Cheetah Conservat Botswana, Kgale Siding Pk,Plot 1069 KO, Gaborone, Botswana	University of London; University of London Royal Veterinary College	Hubel, TY (corresponding author), Royal Vet Coll, Struct & Motion Lab, Hatfield, Herts, England.	thubel@rvc.ac.uk		Wilson, Alan/0000-0001-9914-3455; Hubel, Tatjana/0000-0002-6749-6747	Engineering and Physical Sciences Research Council [EP/H013016/1]; Biotechnology and Biological Sciences Research Council [BB/J018007/1]; European Research Council [323041]; BBSRC [BB/J018007/1] Funding Source: UKRI; EPSRC [EP/H013016/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Engineering and Physical Sciences Research Council (EP/H013016/1), https://www.epsrc.ac.uk/; Biotechnology and Biological Sciences Research Council (BB/J018007/1), http://www.bbsrc.ac.uk/; European Research Council, (323041), https://erc.europa.eu/.	Akesson S, 2005, J NAVIGATION, V58, P365, DOI 10.1017/S0373463305003401; [Anonymous], 2010, WOLVES BEHAV ECOLOGY; [Anonymous], 2014, PHEROMONES ANIMAL BE; Boinski S., 2000, MOVE WHY ANIMALS TRA; Caro T., 1994, CHEETAHS SERENGETI P; Dacke M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0036; Dittman AH, 1996, J EXP BIOL, V199, P83; Durant SM, 2000, BEHAV ECOL, V11, P624, DOI 10.1093/beheco/11.6.624; Eaton R.L., 1974, CHEETAH BIOL ECOLOGY; EMLEN ST, 1970, SCIENCE, V170, P1198, DOI 10.1126/science.170.3963.1198; ESTES RD, 1991, BEHAV GUIDE AFRICAN; Etienne AS, 1996, J EXP BIOL, V199, P201; Foo P, 2005, J EXP PSYCHOL LEARN, V31, P195, DOI 10.1037/0278-7393.31.2.195; GREGORY RS, 1993, CAN J FISH AQUAT SCI, V50, P241, DOI 10.1139/f93-027; Grinnell J, 1996, BEHAV ECOL, V7, P55, DOI 10.1093/beheco/7.1.55; Grinnell J, 2001, ANIM BEHAV, V62, P93, DOI 10.1006/anbe.2001.1735; Heithaus MR, 2001, OIKOS, V92, P542, DOI 10.1034/j.1600-0706.2001.920315.x; Houser A, 2009, S AFR J WILDL RES, V39, P11, DOI 10.3957/056.039.0102; HUGIE DM, 1994, J FISH BIOL, V45, P151, DOI 10.1111/j.1095-8649.1994.tb01090.x; Hunter L, 2005, CATS OF AFRICA; Justus KA, 2005, J NEUROPHYSIOL, V93, P2233, DOI 10.1152/jn.00888.2004; Lamm N., 2013, WHAT DO CATS SEE; LAURENSON MK, 1993, ZOO BIOL, V12, P31, DOI 10.1002/zoo.1430120106; Lohmann Kenneth J., 2008, Navigation. Journal of the Institute of Navigation, V55, P115; Luschi P, 1998, P ROY SOC B-BIOL SCI, V265, P2279, DOI 10.1098/rspb.1998.0571; Marker LL, 2008, J ZOOL, V274, P226, DOI 10.1111/j.1469-7998.2007.00375.x; Marnewick K, 2006, S AFR J WILDL RES, V36, P147; Mauck B, 2008, ANIM COGN, V11, P715, DOI 10.1007/s10071-008-0156-1; MCCRACKEN GF, 1991, ETHOLOGY, V89, P305; MULLER M, 1988, P NATL ACAD SCI USA, V85, P5287, DOI 10.1073/pnas.85.14.5287; Rosenheim JA, 2004, ISRAEL J ZOOL, V50, P129, DOI 10.1560/K796-DMB2-546Q-Y4AQ; Ruiz-Miranda CR, 1998, ZOO BIOL, V17, P1, DOI 10.1002/(SICI)1098-2361(1998)17:1<1::AID-ZOO1>3.0.CO;2-D; Schaller G. B., 1972, SERENGETI LION STUDY; Schulz S, 2005, CHEM PHEROMONES OTHE, VII; Sih Andrew, 1998, P221; Sunquist ME, 2002, WILD CATS WORLD; Vanak AT, 2013, ECOLOGY, V94, P2619, DOI 10.1890/13-0217.1; von Saint Paul U., 1982, P298; Webster H, 2012, ETHOLOGY, V118, P147, DOI 10.1111/j.1439-0310.2011.01992.x; Webster H, 2010, ETHOLOGY, V116, P233, DOI 10.1111/j.1439-0310.2009.01729.x; Wehner R, 1996, J EXP BIOL, V199, P129; Wilson AM, 2013, NATURE, V498, P185, DOI 10.1038/nature12295; WILTSCHKO W, 1980, TRENDS NEUROSCI, V3, P140, DOI 10.1016/0166-2236(80)90052-1; Wright HWY, 2006, ANIM BEHAV, V71, P503, DOI 10.1016/j.anbehav.2005.03.043	44	3	3	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2016	11	12							e0166864	10.1371/journal.pone.0166864	http://dx.doi.org/10.1371/journal.pone.0166864			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4NG	27926915	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000389578800008
J	Freyler, K; Krause, A; Gollhofer, A; Ritzmann, R				Freyler, Kathrin; Krause, Anne; Gollhofer, Albert; Ritzmann, Ramona			Specific Stimuli Induce Specific Adaptations: Sensorimotor Training vs. Reactive Balance Training	PLOS ONE			English	Article							DUAL-TASK CONDITIONS; OLDER-ADULTS; POSTURAL CONTROL; CORTICAL CONTROL; MUSCLE COACTIVATION; EXERCISE PROGRAM; IMPROVE BALANCE; PERFORMANCE; STABILITY; ANKLE	Typically, balance training has been used as an intervention paradigm either as static or as reactive balance training. Possible differences in functional outcomes between the two modalities have not been profoundly studied. The objective of the study was to investigate the specificity of neuromuscular adaptations in response to two balance intervention modalities within test and intervention paradigms containing characteristics of both profiles: classical sensorimotor training (SMT) referring to a static ledger pivoting around the ankle joint vs. reactive balance training (RBT) using externally applied perturbations to deteriorate body equilibrium. Thirty-eight subjects were assigned to either SMT or RBT. Before and after four weeks of intervention training, postural sway and electromyographic activities of shank and thigh muscles were recorded and co-contraction indices (CCI) were calculated. We argue that specificity of training interventions could be transferred into corresponding test settings containing properties of SMT and RBT, respectively. The results revealed that i) postural sway was reduced in both intervention groups in all test paradigms; magnitude of changes and effect sizes differed dependent on the paradigm: when training and paradigm coincided most, effects were augmented (P<0.05). ii) These specificities were accompanied by segmental modulations in the amount of CCI, with a greater reduction within the CCI of thigh muscles after RBT compared to the shank muscles after SMT (P<0.05). The results clearly indicate the relationship between test and intervention specificity in balance performance. Hence, specific training modalities of postural control cause multi-segmental and context-specific adaptations, depending upon the characteristics of the trained postural strategy. In relation to fall prevention, perturbation training could serve as an extension to SMT to include the proximal segment, and thus the control of structures near to the body's centre of mass, into training.	[Freyler, Kathrin; Krause, Anne; Gollhofer, Albert; Ritzmann, Ramona] Albert Ludwigs Univ Freiburg, Dept Sport & Sport Sci, Freiburg, Germany	University of Freiburg	Freyler, K (corresponding author), Albert Ludwigs Univ Freiburg, Dept Sport & Sport Sci, Freiburg, Germany.	kathrin.freyler@sport.uni-freiburg.de	Gollhofer, Albert/ABF-5766-2020; Albert, Gollhofer/V-3291-2019	Krause, Anne/0000-0002-3692-2846	German Aerospace Center [DLR 50WB1120]; open access publication fund of the Albert-Ludwigs-University Freiburg	German Aerospace Center(Helmholtz AssociationGerman Aerospace Centre (DLR)); open access publication fund of the Albert-Ludwigs-University Freiburg	This study was funded by the German Aerospace Center (DLR 50WB1120). The article processing charge was funded by the open access publication fund of the Albert-Ludwigs-University Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Allum JHJ, 2002, J PHYSIOL-LONDON, V542, P643, DOI 10.1113/jphysiol.2001.015644; Beauchet Olivier, 2005, J Neuroeng Rehabil, V2, P26, DOI 10.1186/1743-0003-2-26; Bieryla KA, 2011, ARCH PHYS MED REHAB, V92, P841, DOI 10.1016/j.apmr.2010.12.004; Bobrova E. V., 2009, Biophysics, V54, P648, DOI 10.1134/S0006350909050169; Boeer J, 2010, SPORTVERLETZ SPORTSC, V24, P40, DOI 10.1055/s-0029-1245184; Boeer J, 2010, J GERIATR PHYS THER, V33, P10, DOI 10.1097/JPT.0b013e3181d0720e; Boyas S, 2011, GAIT POSTURE, V34, P254, DOI 10.1016/j.gaitpost.2011.05.009; Brauer SG, 2004, HUM MOVEMENT SCI, V23, P489, DOI 10.1016/j.humov.2004.08.020; Bruhn S, 2004, INT J SPORTS MED, V25, P56; Buchanan JJ, 1999, J NEUROPHYSIOL, V81, P2325, DOI 10.1152/jn.1999.81.5.2325; Chen CL, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-50; Cohen J.E., 1988, STAT POWER ANAL BEHA; DIETZ V, 1993, EXP BRAIN RES, V93, P352; DIETZ V, 1988, NEUROSCI LETT, V94, P82, DOI 10.1016/0304-3940(88)90274-1; Emery CA, 2005, CAN MED ASSOC J, V172, P749, DOI 10.1503/cmaj.1040805; Ferber R, 2002, GAIT POSTURE, V16, P238, DOI 10.1016/S0966-6362(02)00010-3; Freyler K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144529; Gage WH, 2004, GAIT POSTURE, V19, P124, DOI 10.1016/S0966-6362(03)00037-7; Gatev P, 1999, J PHYSIOL-LONDON, V514, P915, DOI 10.1111/j.1469-7793.1999.915ad.x; Giboin LS, 2015, HUM MOVEMENT SCI, V44, P22, DOI 10.1016/j.humov.2015.08.012; GOLLHOFER A, 1989, NEUROSCI LETT, V105, P73, DOI 10.1016/0304-3940(89)90014-1; GOTTLIEB GL, 1981, J NEUROPHYSIOL, V46, P179, DOI 10.1152/jn.1981.46.1.179; Granacher U, 2010, INT J SPORTS MED, V31, P353, DOI 10.1055/s-0030-1248322; Granacher Urs, 2012, J Aging Res, V2012, P708905, DOI 10.1155/2012/708905; Granacher U, 2011, GERONTOLOGY, V57, P304, DOI 10.1159/000320250; Granacher U, 2011, GERONTOLOGY, V57, P424, DOI 10.1159/000322149; Granacher U, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-56; Gruber M, 2007, J STRENGTH COND RES, V21, P274, DOI 10.1519/00124278-200702000-00049; Gruneberg C, 2004, EXP BRAIN RES, V157, P472, DOI 10.1007/s00221-004-1861-x; Gschwind YJ, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-105; Halvarsson A, 2015, CLIN REHABIL, V29, P365, DOI 10.1177/0269215514544983; Henry SM, 1998, J NEUROPHYSIOL, V80, P1939, DOI 10.1152/jn.1998.80.4.1939; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; HOFFMAN M, 1995, J ORTHOP SPORT PHYS, V21, P90, DOI 10.2519/jospt.1995.21.2.90; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Horak FB, 1996, HDB PHYSL; HORSTMANN GA, 1990, ELECTROEN CLIN NEURO, V76, P165, DOI 10.1016/0013-4694(90)90214-5; HUGHES MA, 1995, CLIN BIOMECH, V10, P318, DOI 10.1016/0268-0033(94)00001-N; Jacobs JV, 2007, J NEURAL TRANSM, V114, P1339, DOI 10.1007/s00702-007-0657-0; Jacobs JV, 2014, PARKINSONISM RELAT D, V20, P779, DOI 10.1016/j.parkreldis.2014.04.001; Keck ME, 1998, ELECTROMYOGR MOTOR C, V109, P215, DOI 10.1016/S0924-980X(98)00009-5; Kuo A.D., 1993, PROG BRAIN RES, V97, P349, DOI 10.1016/s0079-6123(08)62294-3; LAVOIE BA, 1995, EXP BRAIN RES, V103, P97; Lesinski M, 2015, SPORTS MED, V45, P557, DOI 10.1007/s40279-014-0284-5; Lewek MD, 2004, OSTEOARTHR CARTILAGE, V12, P745, DOI 10.1016/j.joca.2004.05.005; Lord SR, 1999, J AM GERIATR SOC, V47, P1077, DOI 10.1111/j.1532-5415.1999.tb05230.x; Madureira MM, 2007, OSTEOPOROSIS INT, V18, P419, DOI 10.1007/s00198-006-0252-5; Maki BE, 2007, J NEURAL TRANSM, V114, P1279, DOI 10.1007/s00702-007-0764-y; Mansfield A, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0347-8; Mansfield A, 2009, J BIOMECH, V42, P1023, DOI 10.1016/j.jbiomech.2009.02.007; Maurer C, 2005, J NEUROPHYSIOL, V93, P189, DOI 10.1152/jn.00221.2004; Maurer C, 2006, EXP BRAIN RES, V171, P231, DOI 10.1007/s00221-005-0256-y; MCCOLLUM G, 1989, J MOTOR BEHAV, V21, P225; McIlroy WE, 1996, J GERONTOL A-BIOL, V51, pM289, DOI 10.1093/gerona/51A.6.M289; McKeon PO, 2008, J ATHL TRAINING, V43, P305, DOI 10.4085/1062-6050-43.3.305; Melzer I, 2013, CLIN REHABIL, V27, P195, DOI 10.1177/0269215512450295; Muehlbauer T, 2012, GERONTOLOGY, V58, P504, DOI 10.1159/000341614; Muller O, 2004, BIOMED TECH, V49, P56, DOI 10.1515/BMT.2004.011; Nagai K, 2013, ARCH GERONTOL GERIAT, V56, P129, DOI 10.1016/j.archger.2012.08.009; Nagai K, 2012, J GERONTOL A-BIOL, V67, P882, DOI 10.1093/gerona/glr252; Nagai K, 2011, ARCH GERONTOL GERIAT, V53, P338, DOI 10.1016/j.archger.2011.01.003; NASHNER LM, 1985, BEHAV BRAIN SCI, V8, P135, DOI 10.1017/S0140525X00020008; NASHNER LM, 1976, EXP BRAIN RES, V26, P59; Overstall PW, 1999, REV CLIN GERONTOL, V13, P153; Pai YC, 1997, J BIOMECH, V30, P347, DOI 10.1016/S0021-9290(96)00165-0; Pan X, 2014, Int J Nurs Sci, V1, P441, DOI 10.1016/j.ijnss.2014.09.001; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Rankin JK, 2000, J GERONTOL A-BIOL, V55, pM112, DOI 10.1093/gerona/55.3.M112; Resch JE, 2011, J ATHL TRAINING, V46, P170, DOI 10.4085/1062-6050-46.2.170; Rhe CK, 2012, GAIT POSTURE, V36, P332, DOI 10.1016/j.gaitpost.2012.03.014; Roelants M, 2006, J STRENGTH COND RES, V20, P124, DOI 10.1519/R-16674.1; Rozzi SL, 1999, J ORTHOP SPORT PHYS, V29, P478, DOI 10.2519/jospt.1999.29.8.478; Shumway-Cook A, 2003, DEV MED CHILD NEUROL, V45, P591, DOI 10.1017/S0012162203001099; Silsupadol P, 2006, PHYS THER, V86, P269, DOI 10.1093/ptj/86.2.269; Silva P, 2015, J BODYW MOV THER, V19, P453, DOI 10.1016/j.jbmt.2014.11.002; Solopova IA, 2003, NEUROSCI LETT, V337, P25, DOI 10.1016/S0304-3940(02)01297-1; Swartz EE, 2011, ATHLETIC TRAINIG SPO, V3, P171, DOI DOI 10.3928/19425864-20110629-05; Taube W, 2008, ACTA PHYSIOL, V193, P101, DOI 10.1111/j.1748-1716.2008.01850.x; Taube W, 2007, INT J SPORTS MED, V28, P999, DOI 10.1055/s-2007-964996; Taube W, 2007, ACTA PHYSIOL, V189, P347, DOI 10.1111/j.1748-1716.2007.01665.x; Taube W, 2006, J APPL PHYSIOL, V101, P420, DOI 10.1152/japplphysiol.01447.2005; Tucker MG, 2008, HUM MOVEMENT SCI, V27, P728, DOI 10.1016/j.humov.2008.03.002; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; Winter DA, 2003, J ELECTROMYOGR KINES, V13, P49, DOI 10.1016/S1050-6411(02)00085-8; Wu G, 1998, CLIN BIOMECH, V13, P300, DOI 10.1016/S0268-0033(98)00068-0; Yao WX, 2012, EUR J PHYS REHAB MED, V48, P209	87	27	27	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167557	10.1371/journal.pone.0167557	http://dx.doi.org/10.1371/journal.pone.0167557			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3TF	27911944	Green Published, Green Submitted, gold			2022-12-27	WOS:000389520600042
J	Iwasa, YI; Nishio, SY; Usami, SI				Iwasa, Yoh-ichiro; Nishio, Shin-ya; Usami, Shin-ichi			Comprehensive Genetic Analysis of Japanese Autosomal Dominant Sensorineural Hearing Loss Patients	PLOS ONE			English	Article							WFS1 GENE; MUTATION; DEAFNESS; VARIANTS; IMPAIRMENT; FREQUENCY; DFNA28	Background In general, autosomal dominant inherited hearing loss does not have a founder mutation, with the causative mutation different in each family. For this reason, there has been a strong need for efficient diagnosis methods for autosomal dominant sensorineural hearing loss (ADSNHL) patients. This study sought to verify the effectiveness of our analysis algorithm for the screening of ADSNHL patients as well as the usefulness of the massively parallel DNA sequencing (MPS). Subjects and Methods Seventy-five Japanese ADSNHL patients from 53 ENT departments nationwide participated in this study. We conducted genetic analysis of 75 ADSNHL patients using the Invader assay, TaqMan genotyping assay and MPS-based genetic screening. Results A total of 46 (61.3%) ADSNHL patients were found to have at least one candidate gene variant. Conclusion We were able to achieve a high mutation detection rate through the combination of the Invader assay, TaqMan genotyping assay and MPS. MPS could be used to successfully identify mutations in rare deafness genes.	[Iwasa, Yoh-ichiro; Nishio, Shin-ya; Usami, Shin-ichi] Shinshu Univ, Sch Med, Dept Otorhinolaryngol, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan	Shinshu University	Usami, SI (corresponding author), Shinshu Univ, Sch Med, Dept Otorhinolaryngol, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	usami@shinshu-u.ac.jp		Iwasa, Yoh-ichiro/0000-0001-8989-9021; Nishio, Shin-ya/0000-0001-6640-2297	Health, Labour and Welfare of Japan Scientific Research Grant [H25-Kankaku-Ippan-002]; Japan Agency for Medical Research and Development [15dk0310011h0003]; Ministry of Education, Science and Culture of Japan [15H02565]	Health, Labour and Welfare of Japan Scientific Research Grant; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was grant aided by a Health, Labour and Welfare of Japan Scientific Research Grant (H25-Kankaku-Ippan-002), Japan Agency for Medical Research and Development (15dk0310011h0003), and a Grant-in-Aid for Scientific Research (A) (15H02565) from the Ministry of Education, Science and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2007, GENET TEST, V11, P333, DOI 10.1089/gte.2007.0002; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Chang X, 2012, J MED GENET, V49, P433, DOI 10.1136/jmedgenet-2012-100918; Eiberg H, 2006, J MED GENET, V43, P435, DOI 10.1136/jmg.2005.034892; Fujikawa T, 2010, LARYNGOSCOPE, V120, P166, DOI 10.1002/lary.20691; Fukuoka H, 2007, J HUM GENET, V52, P510, DOI 10.1007/s10038-007-0144-3; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Iwasa Y, 2015, ANN OTO RHINOL LARYN, V124, p111S, DOI 10.1177/0003489415575044; Kim YR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119443; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; Miyagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075793; Miyagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071381; Modamio-Hoybjor S, 2007, AM J HUM GENET, V80, P1076, DOI 10.1086/518311; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Naito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063231; Narahara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100924; Nishio S, 2015, ANN OTO RHINOL LARYN, V124, p49S, DOI 10.1177/0003489415575059; Nishio SY, 2015, GENET TEST MOL BIOMA, V19, P209, DOI 10.1089/gtmb.2014.0252; Peters LM, 2002, HUM MOL GENET, V11, P2877, DOI 10.1093/hmg/11.23.2877; Sanggaard KM, 2008, AM J MED GENET A, V146A, P1017, DOI 10.1002/ajmg.a.32174; Shearer AE, 2014, AM J HUM GENET, V95, P445, DOI 10.1016/j.ajhg.2014.09.001; Shearer AE, 2010, P NATL ACAD SCI USA, V107, P21104, DOI 10.1073/pnas.1012989107; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; Sun Y, 2011, J HUM GENET, V56, P64, DOI 10.1038/jhg.2010.147; Tsukada K, 2015, ANN OTO RHINOL LARYN, V124, p100S, DOI 10.1177/0003489415573074; Usami S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031276; Vona B, 2013, AM J MED GENET A, V161, P2060, DOI 10.1002/ajmg.a.36017; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wu CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057369; Yang T, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-85; Yoshimura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090688; Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286	32	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0166781	10.1371/journal.pone.0166781	http://dx.doi.org/10.1371/journal.pone.0166781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911912	Green Published, Green Submitted, gold			2022-12-27	WOS:000389520600013
J	Pfankuche, VM; Sayed-Ahmed, M; Contioso, VB; Spitzbarth, I; Rohn, K; Ulrich, R; Deschl, U; Kalkuhl, A; Baumgartner, W; Puff, C				Pfankuche, Vanessa Maria; Sayed-Ahmed, Mohamed; Contioso, Vanessa Bono; Spitzbarth, Ingo; Rohn, Karl; Ulrich, Reiner; Deschl, Ulrich; Kalkuhl, Arno; Baumgaertner, Wolfgang; Puff, Christina			Persistent Morbillivirus Infection Leads to Altered Cortactin Distribution in Histiocytic Sarcoma Cells with Decreased Cellular Migration Capacity	PLOS ONE			English	Article							CANINE-DISTEMPER VIRUS; MATRIX-METALLOPROTEINASE; EPITHELIAL TRANSITION; CONTACT INHIBITION; INVADOPODIA; CANCER; EXPRESSION; MEASLES; INVASION; ROLES	Histiocytic sarcomas represent rare but fatal neoplasms in humans. Based on the absence of a commercially available human histiocytic sarcoma cell line the frequently affected dog displays a suitable translational model. Canine distemper virus, closely related to measles virus, is a highly promising candidate for oncolytic virotherapy. Therapeutic failures in patients are mostly associated with tumour invasion and metastasis often induced by misdirected cytoskeletal protein activities. Thus, the impact of persistent canine distemper virus infection on the cytoskeletal protein cortactin, which is frequently overexpressed in human cancers with poor prognosis, was investigated in vitro in a canine histiocytic sarcoma cell line (DH82). Though phagocytic activity, proliferation and apoptotic rate were unaltered, a significantly reduced migration activity compared to controls (6 hours and 1 day after seeding) accompanied by a decreased number of cortactin mRNA transcripts (1 day) was detected. Furthermore, persistently canine distemper virus infected DH82 cells showed a predominant diffuse intracytoplasmic cortactin distribution at 6 hours and 1 day compared to controls with a prominent membranous expression pattern (p <= 0.05). Summarized, persistent canine distemper virus infection induces reduced tumour cell migration associated with an altered intracellular cortactin distribution, indicating cytoskeletal changes as one of the major pathways of virus-associated inhibition of tumour spread.	[Pfankuche, Vanessa Maria; Sayed-Ahmed, Mohamed; Contioso, Vanessa Bono; Spitzbarth, Ingo; Ulrich, Reiner; Baumgaertner, Wolfgang; Puff, Christina] Univ Vet Med Hannover, Dept Pathol, Hannover, Germany; [Rohn, Karl] Univ Vet Med Hannover, Inst Biometry Epidemiol & Informat Proc, Hannover, Germany; [Deschl, Ulrich; Kalkuhl, Arno] Boehringer Ingelheim Pharma GmbH & Co KG, Dept Nonclin Drug Safety, Biberach, Riss, Germany; [Pfankuche, Vanessa Maria; Spitzbarth, Ingo; Ulrich, Reiner; Baumgaertner, Wolfgang] Univ Vet Med Hannover, Ctr Syst Neurosci, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; Boehringer Ingelheim; University of Veterinary Medicine Hannover, Foundation	Baumgartner, W (corresponding author), Univ Vet Med Hannover, Dept Pathol, Hannover, Germany.; Baumgartner, W (corresponding author), Univ Vet Med Hannover, Ctr Syst Neurosci, Hannover, Germany.	wolfgang.baumgaertner@tiho-hannover.de	Sayed-Ahmed, Mohamed Zakaria/ABF-6616-2020	Sayed-Ahmed, Mohamed Zakaria/0000-0003-0777-8256	Akademie fur Tiergesundheit e. V. (Bonn, Germany); Ministry of Higher Education (Cairo, Egypt); German Research Foundation (Researcher's group) [1103, BA815/10-2, UL421/1-2]; Gesellschaft zur Forderung Kynologischer Forschung e.V (GkF, Bonn, Germany)	Akademie fur Tiergesundheit e. V. (Bonn, Germany); Ministry of Higher Education (Cairo, Egypt)(Ministry of Higher Education & Scientific Research (MHESR)); German Research Foundation (Researcher's group); Gesellschaft zur Forderung Kynologischer Forschung e.V (GkF, Bonn, Germany)	VMP was financially supported by the Akademie fur Tiergesundheit e. V. (Bonn, Germany; http://www.aft-onlinemet/home/die-akademie/). MSA received financial support from the Ministry of Higher Education (Cairo, Egypt). WBA and RU: This study was in part supported by the German Research Foundation (Researcher's group 1103; grants BA815/10-2 and UL421/1-2 (http:/www.dfg.de/). WBA: This study was in part supported by the Gesellschaft zur Forderung Kynologischer Forschung e.V (GkF, Bonn, Germany; https://www.gkl-berndeiindex.php/startate.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VJ, 2010, J SMALL ANIM PRACT, V51, P512, DOI 10.1111/j.1748-5827.2010.00974.x; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Banon-Rodriguez I, 2011, EUR J CELL BIOL, V90, P213, DOI 10.1016/j.ejcb.2010.09.001; BARKALOW K, 1995, CURR BIOL, V5, P1000, DOI 10.1016/S0960-9822(95)00200-4; Batson J, 2013, J MICROSC-OXFORD, V251, P232, DOI 10.1111/jmi.12024; BAUMGARTNER W, 1988, AM J VET RES, V49, P477; Beineke A, 2009, VET IMMUNOL IMMUNOP, V127, P1, DOI 10.1016/j.vetimm.2008.09.023; Bergman A, 2014, CELL ADHES MIGR, V8, P273, DOI 10.4161/cam.28349; Bowden ET, 1999, ONCOGENE, V18, P4440, DOI 10.1038/sj.onc.1202827; Bozzuto G, 2010, ANN I SUPER SANITA, V46, P66, DOI 10.4415/ANN_10_01_09; Buday L, 2007, BBA-REV CANCER, V1775, P263, DOI 10.1016/j.bbcan.2006.12.002; Cai JH, 2010, J GASTROINTEST SURG, V14, P1248, DOI 10.1007/s11605-010-1247-2; CARTER RL, 1978, INVEST CELL PATHOL, V1, P275; Clark ES, 2008, EUR J CELL BIOL, V87, P581, DOI 10.1016/j.ejcb.2008.01.008; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; Eckert MA, 2011, ONCOTARGET, V2, P562; Fidel J, 2006, VET COMP ONCOL, V4, P63, DOI 10.1111/j.1476-5810.2006.00090.x; Gibcus JH, 2008, BRIT J CANCER, V98, P950, DOI 10.1038/sj.bjc.6604246; Grone A, 2002, VIRAL IMMUNOL, V15, P493, DOI 10.1089/088282402760312368; Grote D, 2001, BLOOD, V97, P3746, DOI 10.1182/blood.V97.12.3746; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hedan B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-201; Hernandez-Sanchez M, 2015, ONCOTARGET, V6, P17479, DOI 10.18632/oncotarget.4127; Hornick JL, 2004, AM J SURG PATHOL, V28, P1133, DOI 10.1097/01.pas.0000131541.95394.23; HOWARD JM, 1983, J GEN VIROL, V64, P2379, DOI 10.1099/0022-1317-64-11-2379; ITO M, 1979, CELL IMMUNOL, V46, P48, DOI 10.1016/0008-8749(79)90244-2; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Katayama H, 2004, J VET MED SCI, V66, P409, DOI 10.1292/jvms.66.409; Kirkbride KC, 2011, CELL ADHES MIGR, V5, P187, DOI 10.4161/cam.5.2.14773; Klauschies F, 2010, ARCH VIROL, V155, P1503, DOI 10.1007/s00705-010-0737-6; Lapp S, 2014, VIRUSES-BASEL, V6, P2340, DOI 10.3390/v6062340; Linder S, 2009, J CELL SCI, V122, P3009, DOI 10.1242/jcs.032631; Lu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088918; Mayor R, 2010, TRENDS CELL BIOL, V20, P319, DOI 10.1016/j.tcb.2010.03.005; Msaouel P, 2012, CURR PHARM BIOTECHNO, V13, P1732, DOI 10.2174/138920112800958896; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Palosaari H, 2003, J VIROL, V77, P7635, DOI 10.1128/JVI.77.13.7635-7644.2003; Patil SS, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-3; Pringproa K, 2010, BRAIN RES, V1327, P24, DOI 10.1016/j.brainres.2010.02.068; Puff C, 2009, VET J, V182, P100, DOI 10.1016/j.tvjl.2008.03.026; Qeska V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096121; Raddatz BBR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086643; Revach OY, 2014, CELL ADHES MIGR, V8, P215, DOI 10.4161/cam.27842; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; Rozen S, 2000, Methods Mol Biol, V132, P365; Saito T, 2006, HUM PATHOL, V37, P689, DOI 10.1016/j.humpath.2006.01.017; Saitoh Y, 2009, INT J ONCOL, V35, P1277, DOI 10.3892/ijo_00000445; Schiffman JD, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0231; Schlick K, 2012, ONKOLOGIE, V35, P447, DOI 10.1159/000340066; Schwens C, 2011, TIERAERZTL PRAX K H, V39, P176; Seehusen F, 2007, ACTA NEUROPATHOL, V114, P597, DOI 10.1007/s00401-007-0307-5; Seeliger FA, 2007, VET PATHOL, V44, P621, DOI 10.1354/vp.44-5-621; Small JV, 1999, MICROSC RES TECHNIQ, V47, P3; Somarelli JA, 2016, MOL CELL BIOL, V36, P2503, DOI 10.1128/MCB.00373-16; Stoletov K, 2015, EXPERT REV ANTICANC, V15, P733, DOI 10.1586/14737140.2015.1058711; Stylli SS, 2008, J CLIN NEUROSCI, V15, P725, DOI 10.1016/j.jocn.2008.03.003; Suter SE, 2005, CLIN CANCER RES, V11, P1579, DOI 10.1158/1078-0432.CCR-04-1944; Takada M, 2014, CANCER RES, V74, DOI 10.1158/1538-7445.AM2014-3931; Tang H, 2016, ONCOTARGET; Techangamsuwan S, 2009, J NEUROSCI METH, V176, P112, DOI 10.1016/j.jneumeth.2008.08.030; Trepat X, 2012, COMPR PHYSIOL, V2, P2369, DOI 10.1002/cphy.c110012; Tsai WC, 2013, APMIS, V121, P171, DOI 10.1111/j.1600-0463.2012.02952.x; Vos JA, 2005, MODERN PATHOL, V18, P693, DOI 10.1038/modpathol.3800346; Walker A, 2014, INT J ONCOL, V45, P1699, DOI 10.3892/ijo.2014.2549; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; WELLMAN ML, 1988, IN VITRO CELL DEV B, V24, P223, DOI 10.1007/BF02623551; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Yamaguchi H, 2012, EUR J CELL BIOL, V91, P902, DOI 10.1016/j.ejcb.2012.04.005; Yang JL, 2014, EUR J CANCER, V50, P593, DOI 10.1016/j.ejca.2013.11.006; Yang JL, 2010, MOL CELL PROTEOMICS, V9, P2405, DOI 10.1074/mcp.M110.000240	72	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167517	10.1371/journal.pone.0167517	http://dx.doi.org/10.1371/journal.pone.0167517			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911942	Green Published, Green Submitted, gold			2022-12-27	WOS:000389520600040
J	Blanco-Reina, E; Garcia-Merino, MR; Ocana-Riola, R; Aguilar-Cano, L; Valdellos, J; Bellido-Estevez, I; Ariza-Zafra, G				Blanco-Reina, Encarnacion; Garcia-Merino, Maria Rosa; Ocana-Riola, Ricardo; Aguilar-Cano, Lorena; Valdellos, Jennifer; Bellido-Estevez, Inmaculada; Ariza-Zafra, Gabriel			Assessing Potentially Inappropriate Prescribing in Community-Dwelling Older Patients Using the Updated Version of STOPP-START Criteria: A Comparison of Profiles and Prevalences with Respect to the Original Version	PLOS ONE			English	Article							STOPP/START CRITERIA; SCREENING TOOL; PRIMARY-CARE; PRESCRIPTIONS/SCREENING TOOL; HOSPITALIZED-PATIENTS; ALERT DOCTORS; COST OUTCOMES; PEOPLE; POPULATION; ADULTS	Emerging and changing evidence made it necessary to update STOPP-START criteria, and version 2 was published recently. In this study the objectives were to determine the prevalence of potentially inappropriate medication prescribing (PIM) in primary care using STOPP versions 1 (v1) and 2 (v2), as well as 2012 AGS Beers criteria, and analyze the factors associated with inappropriate prescribing according to STOPP/START v2. A cross-sectional study was carried out including community-dwelling older adults over the age of 65. Socio-demographic, clinical, functional and comprehensive drug therapy data were collected. The primary endpoint was the percentage of patients receiving at least one PIM. This variable was measured using three tools: STOPP v1, 2012 AGS Beers criteria and STOPP v2. Similarly, the percentage of patients receiving at least one potential prescribing omission (PPO) was calculated using START versions 1 and 2. A total of 1,615 prescriptions were reviewed. The median number of medications per patient was 7.1 drugs (+/- 3.8). The prevalence of elderly people exposed to polypharmacy (>= 5 medications) was 72.9%, whereas 28.4% of the participants took >= 10 drugs regularly. PIM were present in 18.7%, 37.3% and 40.4% of participants, according to the STOPP v1, 2012 Beers criteria and STOPP v2, respectively. According to STOPP v2, the number of medications taken (OR: 1.14, 1.06-1.25), the presence of a psychological disorder (OR: 2.22, 1.13-4.37) and insomnia (OR: 3.35, 1.80-6.32) were risk factors for taking a PIM. The prevalence of PPOs was 34.7% and 21.8% according to version 1 and 2, respectively. In conclusion, STOPP-START criteria have been remarkably modified, which is evidenced by the different prevalence rates detected using version 2, as compared to version 1. In fact, the level of agreement between version 1 and the updated version is only moderate. Special attention should be paid on benzodiazepines, which keep being the most frequent PIM.	[Blanco-Reina, Encarnacion; Bellido-Estevez, Inmaculada] Univ Malaga, Malaga Biomed Inst IBIMA, Sch Med, Dept Pharmacol & Therapeut, Malaga, Spain; [Garcia-Merino, Maria Rosa] Hlth Dist Cordoba Sur, Cordoba, Spain; [Ocana-Riola, Ricardo] Andalusian Sch Publ Hlth, Dept Stat, Granada, Spain; [Aguilar-Cano, Lorena] Hlth Dist Malaga, Malaga, Spain; [Valdellos, Jennifer] Hlth Area Malaga Norte, Malaga, Spain; [Ariza-Zafra, Gabriel] Univ Hosp Albacete, Dept Geriatr, Albacete, Spain	Universidad de Malaga; Escuela Andaluza de Salud Publica	Blanco-Reina, E (corresponding author), Univ Malaga, Malaga Biomed Inst IBIMA, Sch Med, Dept Pharmacol & Therapeut, Malaga, Spain.	eblanco@uma.es	Estevez, Inmaculada Bellido/AAU-9222-2021; Ocaña-Riola, Ricardo/F-1576-2011	Ocaña-Riola, Ricardo/0000-0002-8965-0418; Bellido, Inmaculada/0000-0002-9362-8635; Valdellos Cabello, Jenifer/0000-0002-1034-5649; Blanco Reina, Encarnacion/0000-0001-5892-5450; Ariza-Zafra, Gabriel/0000-0001-9171-5535	Fundacion Publica Andaluza Progreso y Salud, Consejena de Salud, Junta de Andalucia [PI 0234/14]	Fundacion Publica Andaluza Progreso y Salud, Consejena de Salud, Junta de Andalucia	This research has been supported by public grant funding provided by the Fundacion Publica Andaluza Progreso y Salud, Consejena de Salud, Junta de Andalucia (grant number PI 0234/14). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahat G, 2016, GERIATR GERONTOL INT; Blanco-Reina E, 2015, EUR J CLIN PHARMACOL, V71, P199, DOI 10.1007/s00228-014-1780-0; Blanco-Reina E, 2014, J AM GERIATR SOC, V62, P1217, DOI 10.1111/jgs.12891; Bradley MC, 2012, EUR J CLIN PHARMACOL, V68, P1425, DOI 10.1007/s00228-012-1249-y; Cahir C, 2014, BRIT J CLIN PHARMACO, V77, P201, DOI 10.1111/bcp.12161; Cahir C, 2010, BRIT J CLIN PHARMACO, V69, P543, DOI 10.1111/j.1365-2125.2010.03628.x; Di Giorgio C, 2016, INT J CLIN PHARM-NET, V38, P462, DOI 10.1007/s11096-016-0284-7; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Gallagher P, 2008, INT J CLIN PHARM TH, V46, P72; Gallagher P, 2011, EUR J CLIN PHARMACOL, V67, P1175, DOI 10.1007/s00228-011-1061-0; Galvin R, 2014, EUR J CLIN PHARMACOL, V70, P599, DOI 10.1007/s00228-014-1651-8; Hamilton H, 2011, ARCH INTERN MED, V171, P1013, DOI 10.1001/archinternmed.2011.215; Hedna K, 2015, EUR J CLIN PHARMACOL, V71, P1525, DOI 10.1007/s00228-015-1950-8; Hill-Taylor B, 2016, J CLIN PHARM THER, V41, P158, DOI 10.1111/jcpt.12372; Hill-Taylor B, 2013, J CLIN PHARM THER, V38, P360, DOI 10.1111/jcpt.12059; Khong TP, 2012, CALCIFIED TISSUE INT, V91, P24, DOI 10.1007/s00223-012-9603-8; Kovacevic SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095536; Lozano-Montoya I, 2015, AGE AGEING, V44, P861, DOI 10.1093/ageing/afv079; Martinez-Almazan E, 2013, J AM GERIATR SOC, V61, P1622, DOI 10.1111/jgs.12432; Moriarty F, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008656; Moriarty F, 2015, EUR J CLIN PHARMACOL, V71, P473, DOI 10.1007/s00228-015-1815-1; O'Mahony D, 2015, AGE AGEING, V44, P213, DOI 10.1093/ageing/afu145; O'Sullivan DP, 2013, DRUG AGING, V30, P39, DOI 10.1007/s40266-012-0039-7; Lopez NP, 2014, ATEN PRIM, V46, P290, DOI 10.1016/j.aprim.2013.12.007; Projovic I, 2016, EUR J CLIN PHARMACOL, V72, P93, DOI 10.1007/s00228-015-1957-1; Ryan C, 2013, INT J CLIN PHARM-NET, V35, P230, DOI 10.1007/s11096-012-9733-0; Ryan C, 2009, BRIT J CLIN PHARMACO, V68, P936, DOI 10.1111/j.1365-2125.2009.03531.x; Tommelein E, 2015, EUR J CLIN PHARMACOL, V71, P1415, DOI 10.1007/s00228-015-1954-4; Tosato M, 2014, AGE AGEING, V43, P767, DOI 10.1093/ageing/afu029; Verdoorn S, 2015, EUR J CLIN PHARMACOL, V71, P1255, DOI 10.1007/s00228-015-1908-x	30	28	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167586	10.1371/journal.pone.0167586	http://dx.doi.org/10.1371/journal.pone.0167586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27907210	gold, Green Submitted, Green Published			2022-12-27	WOS:000389482700204
J	Vignesh, S; Dahms, HU; Muthukumar, K; Vignesh, G; James, RA				Vignesh, Sivanandham; Dahms, Hans-Uwe; Muthukumar, Krishnan; Vignesh, Gopalaswamy; James, Rathinam Arthur			Biomonitoring along the Tropical Southern Indian Coast with Multiple Biomarkers	PLOS ONE			English	Article							HEAVY-METALS; PATHOGENIC BACTERIA; POLLUTION INDICATOR; ESCHERICHIA-COLI; TRACE-ELEMENTS; WATER-QUALITY; SEDIMENTS; CONTAMINATION; SALMONELLA; PARAMETERS	We assessed the spatial and temporal variations of pollution indicators and geochemical and trace metal parameters (23 in total) from water and sediment (144 samples) of three different eco-niches (beach, fishing harbor, and estuary) in larger coastal cities of southern India (Cuddalore and Pondicherry) for one year. A total of 120 marine Pseudomonas isolates were challenged against different concentrations of copper solutions and 10 different antibiotics in heavy metal and antibiotic resistance approaches, respectively. The study shows that 4.16% of the isolates could survive in 250 mM of copper; 70% were resistant to minimum concentrations. Strains were resistant (98.4%) to at least one antibiotic in Cuddalore compared to the Pondicherry (78.4%) region. Pollution index (PI) (0-14.55) and antibiotic resistance index (ARI) (0.05-0.10) ratio indicated that high bacterial and antibiotic loads were released into the coastal environment. The degree of trace metal contamination in sediments were calculated by enrichment factor (EF), contamination factor (CF), pollution load index (PLI), and geo-accumulation index (Igeo). Statistical parameters like two-way analysis of variance (ANOVA), correlation, factor analysis and scatter matrix tools were employed between the 23 parameters in order to find sources, pathways, disparities and interactions of environmental pollutants. It indicates that geochemical and biological parameters were not strongly associated with each other (except a few) and were affected by different sources. Factor analysis elucidated, 'microbe-metal' interaction (Factor 1-48.86%), 'anthropogenic' factor (Factor 2-13.23%) and 'Pseudomonas-Cadmium' factor (Factor 3-11.74%), respectively.	[Vignesh, Sivanandham; Muthukumar, Krishnan; James, Rathinam Arthur] Bharathidasan Univ, Dept Marine Sci, Tiruchirappalli, Tamil Nadu, India; [Dahms, Hans-Uwe; James, Rathinam Arthur] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, 70 Lienhai Rd, Kaohsiung, Taiwan; [Vignesh, Gopalaswamy] Bharathidasan Univ, Dept Chem, Tiruchirappalli, Tamil Nadu, India; [Dahms, Hans-Uwe] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, 100 Shin Chuan 1st Rd, Kaohsiung, Taiwan	Bharathidasan University; National Sun Yat Sen University; Bharathidasan University; Kaohsiung Medical University	James, RA (corresponding author), Bharathidasan Univ, Dept Marine Sci, Tiruchirappalli, Tamil Nadu, India.; Dahms, HU; James, RA (corresponding author), Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, 70 Lienhai Rd, Kaohsiung, Taiwan.; Dahms, HU (corresponding author), Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, 100 Shin Chuan 1st Rd, Kaohsiung, Taiwan.	hansd@kmu.edu.tw; james.msbdu@gmail.com		Muthukumar, Krishnan/0000-0001-7826-8179	Department of Biotechnology (DBT), India [BT/PR 121814/2009]; MOST [MOST 104-2621-M-037-001]	Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); MOST	The authors would like to thank the Department of Biotechnology (DBT), India for finan-cial assistance (BT/PR 121814/2009) in carrying out this research. A grant from MOST to HUD is gratefully acknowledged (MOST 104-2621-M-037-001 to T.H. Shih). We also thank the Asia Pacific Ocean Research Center of the Department of Oceanography [No. 76211194] in the frame of KMU/NSYSU cooperation. The funders had no role in study design, data collection and analysis,	Abdelzaher AM, 2010, APPL ENVIRON MICROB, V76, P724, DOI 10.1128/AEM.02127-09; Ahlf W, 2001, J SOIL SEDIMENT, V1, P1; Alm EW, 2003, WATER RES, V37, P3978, DOI 10.1016/S0043-1354(03)00301-4; American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; [Anonymous], 1996, HLTH CRIT OTH SUPP I; ARAUJO RM, 1989, J APPL BACTERIOL, V67, P213, DOI 10.1111/j.1365-2672.1989.tb03398.x; Ashbolt N, WATER SCI TECHNOLOGY, V27, P449; BIS, 2009, 2009252047C BIS FAD, V25, P1; Bricker SB, 2008, HARMFUL ALGAE, V8, P21, DOI 10.1016/j.hal.2008.08.028; BROOKS RR, 1967, TALANTA, V14, P809, DOI 10.1016/0039-9140(67)80102-4; Chapman PM, 2001, ENVIRON TOXICOL CHEM, V20, P3, DOI [10.1002/etc.5620200102, 10.1897/1551-5028(2001)020&lt;0003:ASCIE&gt;2.0.CO;2]; Clark A, 2003, ECOTOX ENVIRON SAFE, V56, P390, DOI 10.1016/S0147-6513(03)00098-8; Clark RB, 1992, MARINE POLLUTION; Dell'Anno A, 2003, WORLD J MICROB BIOT, V19, P93, DOI 10.1023/A:1022581632116; DeSanto RS, 1991, INORGANIC CONTAMINAN; FABIANO M, 1994, MAR POLLUT BULL, V28, P18, DOI 10.1016/0025-326X(94)90181-3; Fatoki OS, 2002, WATER S AFRICA, V2, P2; Finstein MS, POLLUTION MICROBIOLO, P127; George I, 2001, ESTUARIES, V24, P994, DOI 10.2307/1353012; Grande JA, 2003, MAR POLLUT BULL, V46, P475, DOI 10.1016/S0025-326X(02)00452-6; Harakeh S, 2006, ENVIRON POLLUT, V143, P269, DOI 10.1016/j.envpol.2005.11.027; Hassen A, 1998, BIORESOURCE TECHNOL, V64, P7, DOI 10.1016/S0960-8524(97)00161-2; HINTON M, 1985, J APPL BACTERIOL, V58, P27, DOI 10.1111/j.1365-2672.1985.tb01426.x; HOLMBERG SD, 1984, SCIENCE, V225, P833, DOI 10.1126/science.6382605; Kennish M.J., 1994, PRACTICAL HDB MARINE; Koukal B, 2004, ENVIRON POLLUT, V131, P163, DOI 10.1016/j.envpol.2004.01.014; Kumarasamy P., 2009, Research Journal of Microbiology, V4, P540; Langergraber G, 2005, ENVIRON INT, V31, P433, DOI 10.1016/j.envint.2004.08.006; Mandal P, 2012, ENVIRON MONIT ASSESS, V170, P661; Mazel D, 1999, CELL MOL LIFE SCI, V56, P742, DOI 10.1007/s000180050021; McLellan SL, 2001, APPL ENVIRON MICROB, V67, P4934, DOI 10.1128/AEM.67.10.4934-4938.2001; Mohandass C, 2010, ENVIRON MONIT ASSESS, V169, P639, DOI 10.1007/s10661-009-1203-3; Mustapha A, 2012, POL J ENVIRON STUD, V21, P1359; Nagvenkar GS, 2009, ENVIRON MONIT ASSESS, V155, P245, DOI 10.1007/s10661-008-0432-1; NAKAHARA H, 1977, NATURE, V266, P165, DOI 10.1038/266165a0; *NCCLS, 1998, M100S8 NCCLS; Ow D., 1993, DEV BIOL, V29, P213; Ramaiah N, 2004, CURR SCI INDIA, V87, P435; Salah E. A. M., 2012, Journal of Water Resource and Protection, V4, P1009, DOI 10.4236/jwarp.2012.412117; Santhiya G, 2011, MICROCHEM J, V99, P197, DOI 10.1016/j.microc.2011.05.004; STARZECKA A, 1993, ARCH HYDROBIOL, P71; Thuy HTT, 2000, ENVIRON GEOL, V39, P733, DOI 10.1007/s002540050487; TNPCB, 2000, REV, V2, P1; TOMLINSON DL, 1980, HELGOLANDER MEERESUN, V33, P566, DOI 10.1007/BF02414780; TUREKIAN KK, 1961, GEOL SOC AM BULL, V72, P175, DOI 10.1130/0016-7606(1961)72[175:DOTEIS]2.0.CO;2; Vignesh S., 2013, SUSTAINABLE FUTURE E, P363, DOI [DOI 10.1007/978-3-642-32917-3-20, 10.1007/978-3-642-32917-3_20, DOI 10.1007/978-3-642-32917-3_20]; Vignesh S, 2015, ENVIRON PROCESS, V2, P125, DOI 10.1007/s40710-015-0058-6; Vignesh S, 2014, ENVIRON MONIT ASSESS, V186, P1875, DOI 10.1007/s10661-013-3501-z; Vignesh S, 2012, MAR POLLUT BULL, V64, P790, DOI 10.1016/j.marpolbul.2012.01.015; WHO, 1998, GUID DRINK WAT QUAL, V1; WHO, 2011, GUID DRINK WAT QUAL; World Health Organization (WHO), 2006, GUID SAF US WAST EXC, P182	52	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0154105	10.1371/journal.pone.0154105	http://dx.doi.org/10.1371/journal.pone.0154105			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941969	gold, Green Published, Green Submitted			2022-12-27	WOS:000392745600001
J	Al-Subari, K; Al-Baddai, S; Tome, AM; Volberg, G; Ludwig, B; Lang, EW				Al-Subari, Karema; Al-Baddai, Saad; Tome, Ana Maria; Volberg, Gregor; Ludwig, Bernd; Lang, Elmar W.			Combined EMD-sLORETA Analysis of EEG Data Collected during a Contour Integration Task	PLOS ONE			English	Article							EMPIRICAL MODE DECOMPOSITION; SOURCE LOCALIZATION; RESOLUTION; BRAIN; NOISE; DENSITY; SYSTEMS; NUMBER	Lately, Ensemble Empirical Mode Decomposition (EEMD) techniques receive growing interest in biomedical data analysis. Event-Related Modes (ERMs) represent features extracted by an EEMD from electroencephalographic (EEG) recordings. We present a new approach for source localization of EEG data based on combining ERMs with inverse models. As the first step, 64 channel EEG recordings are pooled according to six brain areas and decomposed, by applying an EEMD, into their underlying ERMs. Then, based upon the problem at hand, the most closely related ERM, in terms of frequency and amplitude, is combined with inverse modeling techniques for source localization. More specifically, the standardized low resolution brain electromagnetic tomography (sLORETA) procedure is employed in this work. Accuracy and robustness of the results indicate that this approach deems highly promising in source localization techniques for EEG data.	[Al-Subari, Karema; Al-Baddai, Saad; Lang, Elmar W.] Univ Regensburg, Inst Biophys, Dept Biol, Regensburg, Germany; [Al-Subari, Karema; Al-Baddai, Saad; Ludwig, Bernd] Univ Regensburg, Inst Informat Sci, Dept Linguist Literature & Culture, Regensburg, Germany; [Tome, Ana Maria] Univ Aveiro, Inst Elect Engn & Elect, Dept Elect Engn Telecommun & Informat, Aveiro, Portugal; [Volberg, Gregor] Univ Regensburg, Inst Expt Psychol, Dept Psychol Pedag & Sport, Regensburg, Germany	University of Regensburg; University of Regensburg; Universidade de Aveiro; University of Regensburg	Al-Baddai, S (corresponding author), Univ Regensburg, Inst Biophys, Dept Biol, Regensburg, Germany.; Al-Baddai, S (corresponding author), Univ Regensburg, Inst Informat Sci, Dept Linguist Literature & Culture, Regensburg, Germany.	saad.al-baddai@ur.de		Lang, Elmar W./0000-0001-7440-0224; Volberg, Gregor/0000-0002-4427-2409; Tome, Ana Maria/0000-0002-1210-0266				Al-Baddai S, 2014, BIOMED SIGNAL PROCES, V13, P218, DOI 10.1016/j.bspc.2014.04.011; Al-Baddai S, 2015, BMVA, V2015, P1; Al-Baddai S, 2016, THESIS; Al-Baddai S, 2016, INFORM SCIENCES, V348, P305, DOI 10.1016/j.ins.2016.01.089; Al-Subari K, 2015, J NEUROSCI METH, V253, P193, DOI 10.1016/j.jneumeth.2015.06.020; Al-Subari K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119489; Aydin U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093154; Baillet S, 1997, IEEE T BIO-MED ENG, V44, P374, DOI 10.1109/10.568913; Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275; Belardinelli P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051985; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Cho JH, 2015, NEUROIMAGE, V110, P60, DOI 10.1016/j.neuroimage.2015.01.043; Comon P, 2010, HANDBOOK OF BLIND SOURCE SEPARATION: INDEPENDENT COMPONENT ANALYSIS AND APPLICATIONS, P1; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Durka PJ, 2005, J NEUROSCI METH, V148, P49, DOI 10.1016/j.jneumeth.2005.04.001; Edelman BJ, 2015, ENGINEERING-PRC, V1, P292, DOI [10.15302/J-ENG-2015078, 10.15302/j-eng-2015078]; FENDER DH, 1991, J CLIN NEUROPHYSIOL, V8, P381, DOI 10.1097/00004691-199110000-00003; Fender DH, 1987, METHODS ANAL BRAIN E; Flandrin P, 2004, IEEE SIGNAL PROC LET, V11, P112, DOI 10.1109/LSP.2003.821662; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; Goetz T, 2016, J NEURAL EN IN PRESS; Gordon SM, 2015, J NEUROSCI METH, V256, P41, DOI 10.1016/j.jneumeth.2015.08.019; Grech R, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-25; Hallez H, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-46; He B, 2002, CLIN NEUROPHYSIOL, V113, P227, DOI 10.1016/S1388-2457(01)00740-4; He B, 2013, ELECTROPHYSIOLOGICAL, P499; He B, 2011, IEEE T BIO-MED ENG, V58, P1918, DOI 10.1109/TBME.2011.2139210; Huang N.E., 1998, P ROYAL SOC LONDON S, V454, P903, DOI DOI 10.1098/RSPA.1998.0193; Hyvarinen A, 2001, NEURAL COMPUT, V13, P1527, DOI 10.1162/089976601750264992; Ikkai A, 2010, J NEUROPHYSIOL, V103, P1963, DOI 10.1152/jn.00978.2009; Jatoi MA, 2014, BIOMED SIGNAL PROCES, V11, P42, DOI 10.1016/j.bspc.2014.01.009; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Koles ZJ, 1998, ELECTROEN CLIN NEURO, V106, P127, DOI 10.1016/S0013-4694(97)00115-6; Lu W, 2003, NEUROCOMPUTING, V50, P271, DOI 10.1016/S0925-2312(01)00710-X; Luu P, 2001, J CLIN NEUROPHYSIOL, V18, P302, DOI 10.1097/00004691-200107000-00002; Malony A, 2011, P MED MEETS VIRT REA; Menendez RGD, 2004, NEUROIMAGE, V21, P527, DOI 10.1016/j.neuroimage.2003.09.051; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pascual-Marqui RD, 1999, PSYCHIAT RES-NEUROIM, V90, P169, DOI 10.1016/S0925-4927(99)00013-X; Pascual-Marqui RD., 2007, ARXIV 07103341 MATH; Pascual-Marqui RD, 2011, PHILOS T R SOC A, V369, P3768, DOI 10.1098/rsta.2011.0081; Rey RR, 2010, NEUROELECTROMAGNETIC, V38, P127; Roelfsema PR, 2006, ANNU REV NEUROSCI, V29, P203, DOI 10.1146/annurev.neuro.29.051605.112939; Ryynanen ORM, 2004, IEEE T BIO-MED ENG, V51, P1547, DOI 10.1109/TBME.2004.828036; Ryynanen ORM, 2006, IEEE T BIO-MED ENG, V53, P1851, DOI 10.1109/TBME.2006.873744; SARVAS J, 1987, PHYS MED BIOL, V32, P11, DOI 10.1088/0031-9155/32/1/004; Sekihara K, 2001, IEEE T BIO-MED ENG, V48, P760, DOI 10.1109/10.930901; Sohrabpour A, 2015, CLIN NEUROPHYSIOL, V126, P472, DOI 10.1016/j.clinph.2014.05.038; Song J., 2013, FUNCT NEUROL REHABIL, V3, P275; Song J, 2015, J NEUROSCI METH, V256, P9, DOI 10.1016/j.jneumeth.2015.08.015; Staudigl T, 2013, CURR BIOL, V23, P1101, DOI 10.1016/j.cub.2013.04.074; Tadel F, COMPUTATIONAL INTELL; Tarantola A, 2005, INVERSE PROBLEM THEO, DOI DOI 10.1137/1.9780898717921; Vitali P, 2015, FUNCT NEUROL, V30, P9; Volberg G, 2016, VISUAL WORKING MEMOR; Volberg G, 2014, EXP PSYCHOL, V61, P331, DOI 10.1027/1618-3169/a000252; Volberg G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00264; Vorwerk J, BIOMED TECH; Wagner M, 2007, P 15 INT C BIOM VANC, P1300; Wang G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/459346; Wendel Katrina, 2009, Comput Intell Neurosci, P656092, DOI 10.1155/2009/656092; Wu ZH, 2004, P ROY SOC A-MATH PHY, V460, P1597, DOI 10.1098/rspa.2003.1221; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; Yang L, 2011, NEUROIMAGE, V56, P1908, DOI 10.1016/j.neuroimage.2011.03.043; Yu K, 2016, IEEE T BIO-MED ENG, V63, P1787, DOI 10.1109/TBME.2016.2591924	67	7	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167957	10.1371/journal.pone.0167957	http://dx.doi.org/10.1371/journal.pone.0167957			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936219	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100238
J	Bieler, S; Waltenberger, H; Barrett, MP; McCulloch, R; Mottram, JC; Carrington, M; Schwaeble, W; McKerrow, J; Phillips, MA; Michels, PA; Buscher, P; Sanchez, JC; Bishop, R; Robinson, DR; Bangs, J; Ferguson, M; Nerima, B; Albertini, A; Michel, G; Radwanska, M; Ndung'u, JM				Bieler, Sylvain; Waltenberger, Harald; Barrett, Michael P.; McCulloch, Richard; Mottram, Jeremy C.; Carrington, Mark; Schwaeble, Wilhelm; McKerrow, James; Phillips, Margaret A.; Michels, Paul A.; Buscher, Philippe; Sanchez, Jean-Charles; Bishop, Richard; Robinson, Derrick R.; Bangs, James; Ferguson, Michael; Nerima, Barbara; Albertini, Audrey; Michel, Gerd; Radwanska, Magdalena; Ndung'u, Joseph Mathu			Evaluation of Antigens for Development of a Serological Test for Human African Trypanosomiasis	PLOS ONE			English	Article							VARIANT SURFACE GLYCOPROTEINS; RAPID DIAGNOSTIC-TEST; BRUCEI-GAMBIENSE; SLEEPING SICKNESS; AGGLUTINATION-TEST; TRYPTECT CIATT(R); PROTEIN; GENE; RHODESIENSE; SERUM	Background Control and elimination of human African trypanosomiasis (HAT) can be accelerated through the use of diagnostic tests that are more accurate and easier to deploy. The goal of this work was to evaluate the immuno-reactivity of antigens and identify candidates to be considered for development of a simple serological test for the detection of Trypanosoma brucei gambiense or T. b. rhodesiense infections, ideally both. Methodology/Principal Findings The reactivity of 35 antigens was independently evaluated by slot blot and ELISA against sera from both T. b. gambiense and T. b. rhodesiense infected patients and controls. The antigens that were most reactive by both tests to T. b. gambiense sera were the membrane proteins VSG LiTat 1.3, VSG LiTat 1.5 and ISG64. Reactivity to T. b. rhodesiense sera was highest with VSG LiTat 1.3, VSG LiTat 1.5 and SRA, although much lower than with T. b. gambiense samples. The reactivity of all possible combinations of antigens was also calculated. When the slot blot results of 2 antigens were paired, a VSG LiTat 1.3-ISG75 combination performed best on T. b. gambiense sera, while a VSG LiTat 1.3-VSG LiTat 1.5 combination was the most reactive using ELISA. A combination of SRA and either VSG LiTat 1.3 or VSG LiTat 1.5 had the highest reactivity on T. b. rhodesiense sera according to slot blot, while in ELISA, pairing SRA with either GM6 or VSG LiTat 1.3 yielded the best results. Conclusions This study identified antigens that were highly reactive to T. b. gambiense sera, which could be considered for developing a serological test for gambiense HAT, either individually or in combination. Antigens with potential for inclusion in a test for T. b. rhodesiense HAT were also identified, but because their reactivity was comparatively lower, a search for additional antigens would be required before developing a test for this form of the disease.	[Bieler, Sylvain; Albertini, Audrey; Michel, Gerd; Radwanska, Magdalena; Ndung'u, Joseph Mathu] FIND, Geneva, Switzerland; [Waltenberger, Harald] Microcoat Biotechnol GmbH, Bernried, Germany; [Barrett, Michael P.; McCulloch, Richard; Mottram, Jeremy C.] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Glasgow, Lanark, Scotland; [Carrington, Mark] Univ Cambridge, Cambridge, England; [Schwaeble, Wilhelm] Univ Leicester, Leicester, Leics, England; [McKerrow, James] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Phillips, Margaret A.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Michels, Paul A.] Christian Duve Inst, Brussels, Belgium; [Buscher, Philippe] Inst Trop Med, Antwerp, Belgium; [Sanchez, Jean-Charles] Univ Geneva, Biomed Prote Res Grp, Geneva, Switzerland; [Bishop, Richard] Int Livestock Res Inst, Nairobi, Kenya; [Robinson, Derrick R.] Univ Bordeaux, CNRS, UMR 5234, Bordeaux, France; [Bangs, James] Univ Wisconsin Madison, Madison, WI USA; [Ferguson, Michael] Univ Dundee, Dundee, Scotland; [Nerima, Barbara] Univ Bern, Bern, Switzerland; [Nerima, Barbara] Makerere Univ, Kampala, Uganda; [McKerrow, James] Univ Calif San Diego, San Diego, CA 92103 USA; [Bangs, James] SUNY Buffalo, Buffalo, NY USA; [Radwanska, Magdalena] Univ Ghent, Global Campus, Inchon, South Korea	Foundation For Innovative New Diagnostics; University of Glasgow; University of Cambridge; University of Leicester; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas; Institute of Tropical Medicine (ITM); University of Geneva; CGIAR; International Livestock Research Institute (ILRI); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; University of Wisconsin System; University of Wisconsin Madison; University of Dundee; University of Bern; Makerere University; University of California System; University of California San Diego; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Ghent University	Bieler, S (corresponding author), FIND, Geneva, Switzerland.	sylvain.bieler@finddx.org	Carrington, Mark/N-3653-2019; Radwanska, Magdalena/Q-4279-2018; Michels, Paul A/A-5637-2009; Büscher, Philippe/B-9956-2012; Carrington, Mark/N-4892-2018	Carrington, Mark/0000-0002-6435-7266; Radwanska, Magdalena/0000-0002-0797-6001; Michels, Paul A/0000-0003-3726-6104; Büscher, Philippe/0000-0002-1926-7472; Carrington, Mark/0000-0002-6435-7266; Ferguson, Michael/0000-0003-1321-8714; Mottram, Jeremy/0000-0001-5574-3766; Schwaeble, Wilhelm/0000-0001-8927-0864	Bill & Melinda Gates Foundation [39524]; National Institutes of Health [2R37AI034432]; National Institute of Allergy and Infectious Diseases [AI035739, AI056866]; Wellcome Trust [101842]; Sandler Foundation; Agence nationale de la recherche [ANR-11-LABX-0024]; Wellcome Trust Centre for Molecular Parasitology [104111/Z/14/Z]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035739, R37AI034432, R01AI056866] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome Trust); Sandler Foundation; Agence nationale de la recherche(French National Research Agency (ANR)); Wellcome Trust Centre for Molecular Parasitology(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support was provided by Bill & Melinda Gates Foundation (http://www.gatesfoundation.org/), grant 39524 (JMN); National Institutes of Health (https://www.nih.gov/), grant 2R37AI034432 (MAP); National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov/), grants AI035739 and AI056866 (JB); Wellcome Trust (https://wellcome.ac.uk/), grant 101842 (MF); The Sandler Foundation to University of California (JMK); Agence nationale de la recherche (http://www.agence-nationale-recherche.fr/), grant ANR-11-LABX-0024 (DRR); Wellcome Trust Centre for Molecular Parasitology (http://www.gla.ac.uk/researchinstitutes/iii/wtcmp/), grant 104111/Z/14/Z (MPB, RMC and JCM). The funders provided support in the form of salaries for authors JMN, SB, AA, GM, MR, MAP, JB, MF, JMK, DRR, MPB, RMC and JCM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. HW is an employee of MicroCoat Biotechnologie GmbH. This company was contracted by FIND to evaluate the reactivity of the antigens by slot blot and ELISA against sera. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakaki TL, 2008, MOL MICROBIOL, V68, P37, DOI 10.1111/j.1365-2958.2008.06131.x; Asonganyi T, 1998, ANN TROP MED PARASIT, V92, P837, DOI 10.1080/00034989858871; Bakker BM, 1999, J BIOL CHEM, V274, P14551, DOI 10.1074/jbc.274.21.14551; Bart JM, 2015, CELL MICROBIOL, V17, P1523, DOI 10.1111/cmi.12454; Berberof M, 2001, MOL BIOCHEM PARASIT, V113, P127, DOI 10.1016/S0166-6851(01)00208-0; Bisser S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004608; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Buscher P, 2015, EXPERT REV MOL DIAGN, V15, P607, DOI 10.1586/14737159.2015.1027195; Buscher P, 2014, LANCET GLOB HEALTH, V2, pE359, DOI 10.1016/S2214-109X(14)70203-7; Buscher P, 2013, NEW ENGL J MED, V368, P1069, DOI 10.1056/NEJMc1210373; Buza J, 1999, VET IMMUNOL IMMUNOP, V69, P1, DOI 10.1016/S0165-2427(99)00033-1; Capewell P, 2015, PARASITOLOGY, V142, pS108, DOI 10.1017/S0031182014000602; Capewell P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003686; Chappuis F, 2005, CLIN MICROBIOL REV, V18, P133, DOI 10.1128/CMR.18.1.133-146.2005; Cordeiro AT, 2009, BIOORGAN MED CHEM, V17, P2483, DOI 10.1016/j.bmc.2009.01.068; DEGREEF C, 1994, MOL BIOCHEM PARASIT, V68, P277, DOI 10.1016/0166-6851(94)90172-4; DEGREEF C, 1989, MOL BIOCHEM PARASIT, V36, P169, DOI 10.1016/0166-6851(89)90189-8; DIFFLEY P, 1983, J IMMUNOL, V131, P1983; Dobson R, 2011, MOL MICROBIOL, V81, P434, DOI 10.1111/j.1365-2958.2011.07703.x; DUKES P, 1992, ACTA TROP, V51, P123, DOI 10.1016/0001-706X(92)90054-2; EISENHART C, 1972, ANN MATH STAT, V43, P1035, DOI 10.1214/aoms/1177692458; Eyford BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071463; Franco JR, 2014, PARASITOLOGY, V141, P748, DOI 10.1017/S0031182013002102; Fyfe J, 2016, ACTA TROP; Gualdron-Lopez M, 2013, BBA-MOL CELL RES, V1833, P3076, DOI 10.1016/j.bbamcr.2013.08.008; Haanstra JR, 2008, J BIOL CHEM, V283, P2495, DOI 10.1074/jbc.M705782200; Huynh TT, 2003, J BIOL CHEM, V278, P39794, DOI 10.1074/jbc.M306306200; Jamonneau V, 2000, ACTA TROP, V76, P175, DOI 10.1016/S0001-706X(00)00095-4; Jamonneau V, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003480; Caceres AJ, 2010, MOL BIOCHEM PARASIT, V169, P50, DOI 10.1016/j.molbiopara.2009.09.001; Lynch NJ, 2002, INT IMMUNOPHARMACOL, V2, P415, DOI 10.1016/S1567-5769(01)00165-5; Mackey ZB, 2004, J BIOL CHEM, V279, P48426, DOI 10.1074/jbc.M402470200; MAGNUS E, 1978, ANN SOC BELG MED TR, V58, P169; Malabanan MM, 2011, BIOCHEMISTRY-US, V50, P5767, DOI 10.1021/bi2005416; Malvy D, 2011, CLIN MICROBIOL INFEC, V17, P986, DOI 10.1111/j.1469-0691.2011.03536.x; McDowell MA, 1998, BIOCHEM J, V335, P681, DOI 10.1042/bj3350681; Mcnae IW, 2009, J MOL BIOL, V385, P1519, DOI 10.1016/j.jmb.2008.11.047; Mercaldi GF, 2012, FEBS J, V279, P2012, DOI 10.1111/j.1742-4658.2012.08586.x; Milne KG, 2001, MOL BIOCHEM PARASIT, V112, P301, DOI 10.1016/S0166-6851(00)00369-8; MULLER N, 1992, PARASITOLOGY, V104, P111, DOI 10.1017/S0031182000060856; MULLER N, 1993, PARASITOLOGY, V107, P411, DOI 10.1017/S0031182000067767; Nantulya VM, 1997, T ROY SOC TROP MED H, V91, P551, DOI 10.1016/S0035-9203(97)90023-7; Navarro MVDS, 2007, FEBS J, V274, P5077, DOI 10.1111/j.1742-4658.2007.06027.x; Nzou SM, 2016, PARASITOL INT, V65, P121, DOI 10.1016/j.parint.2015.10.008; OKA M, 1988, MICROBIOL IMMUNOL, V32, P1175, DOI 10.1111/j.1348-0421.1988.tb01481.x; Peck RF, 2008, MOL MICROBIOL, V68, P933, DOI 10.1111/j.1365-2958.2008.06195.x; Radwanska M, 2000, INFECT IMMUN, V68, P848, DOI 10.1128/IAI.68.2.848-860.2000; Roge S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003006; Rooney B, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004271; Ruda GF, 2010, BIOORGAN MED CHEM, V18, P5056, DOI 10.1016/j.bmc.2010.05.077; Rudd SG, 2013, MOL CELL, V52, P554, DOI 10.1016/j.molcel.2013.10.034; Sanderson SJ, 2003, FEBS LETT, V542, P12, DOI 10.1016/S0014-5793(03)00327-2; SCHLAEPPI K, 1989, J CELL BIOL, V109, P1695, DOI 10.1083/jcb.109.4.1695; Schnekenburger M, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00170; Schwede A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005259; Simarro PP, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-57; Simarro PP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001859; Sistrom M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147660; Sistrom M, 2014, GENOME BIOL EVOL, V6, P2811, DOI 10.1093/gbe/evu222; Sullivan L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002087; Van Nieuwenhove L, 2013, TROP MED INT HEALTH, V18, P461, DOI 10.1111/tmi.12058; Van Nieuwenhove L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001682; Van Nieuwenhove LC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001189; VanMeirvenne N, 1995, ACTA TROP, V60, P189, DOI 10.1016/0001-706X(95)00127-Z; Whitley E, 2002, CRIT CARE, V6, P143; Willert EK, 2007, P NATL ACAD SCI USA, V104, P8275, DOI 10.1073/pnas.0701111104	66	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168074	10.1371/journal.pone.0168074	http://dx.doi.org/10.1371/journal.pone.0168074			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936225	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000389587100269
J	Dong, CJ; Chen, L; Feng, JY; Xu, J; Mahboob, S; Al-Ghanim, K; Li, XJ; Xu, P				Dong, Chuanju; Chen, Lin; Feng, Jingyan; Xu, Jian; Mahboob, Shahid; Al-Ghanim, Khalid; Li, Xuejun; Xu, Peng			Genome Wide Identification, Phylogeny, and Expression of Aquaporin Genes in Common Carp (Cyprinus carpio)	PLOS ONE			English	Article							LINKAGE MAP; DUPLICATION; EVOLUTION; DIVERSITY; CDNA; L.	Background Aquaporins (Aqps) are integral membrane proteins that facilitate the transport of water and small solutes across cell membranes. Among vertebrate species, Aqps are highly conserved in both gene structure and amino acid sequence. These proteins are vital for maintaining water homeostasis in living organisms, especially for aquatic animals such as teleost fish. Studies on teleost Aqps are mainly limited to several model species with diploid genomes. Common carp, which has a tetraploidized genome, is one of the most common aquaculture species being adapted to a wide range of aquatic environments. The complete common carp genome has recently been released, providing us the possibility for gene evolution of aqp gene family after whole genome duplication. Results In this study, we identified a total of 37 aqp genes from common carp genome. Phylogenetic analysis revealed that most of aqps are highly conserved. Comparative analysis was performed across five typical vertebrate genomes. We found that almost all of the aqp genes in common carp were duplicated in the evolution of the gene family. We postulated that the expansion of the aqp gene family in common carp was the result of an additional whole genome duplication event and that the aqp gene family in other teleosts has been lost in their evolution history with the reason that the functions of genes are redundant and conservation. Expression patterns were assessed in various tissues, including brain, heart, spleen, liver, intestine, gill, muscle, and skin, which demonstrated the comprehensive expression profiles of aqp genes in the tetraploidized genome. Significant gene expression divergences have been observed, revealing substantial expression divergences or functional divergences in those duplicated aqp genes post the latest WGD event. Conclusions To some extent, the gene families are also considered as a unique source for evolutionary studies. Moreover, the whole set of common carp aqp gene family provides an essential genomic resource for future biochemical, toxicological, physiological, and evolutionary studies in common carp.	[Dong, Chuanju; Chen, Lin; Li, Xuejun] Henan Normal Univ, Coll Fishery, Xinxiang, Henan, Peoples R China; [Dong, Chuanju; Feng, Jingyan] Shanghai Ocean Univ, Coll Life Sci, Shanghai, Peoples R China; [Chen, Lin; Xu, Peng] Xiamen Univ, Coll Ocean & Earth Sci, Fujian Collaborat Innovat Ctr Exploitat & Utiliza, Xiamen, Peoples R China; [Feng, Jingyan; Xu, Jian; Xu, Peng] Chinese Acad Fishery Sci, Key Lab Aquat Genom, Beijing, Peoples R China; [Feng, Jingyan; Xu, Jian; Xu, Peng] Chinese Acad Fishery Sci, Beijing Key Lab Fishery Biotechnol, Ctr Appl Aquat Genom, Beijing, Peoples R China; [Mahboob, Shahid] King Saud Univ, Coll Sci, Dept Zool, Riyadh, Saudi Arabia; [Mahboob, Shahid] GC Univ, Dept Zool, Faisalabad, Pakistan	Henan Normal University; Shanghai Ocean University; Xiamen University; Chinese Academy of Fishery Sciences; Chinese Academy of Fishery Sciences; King Saud University; Government College University Faisalabad	Xu, P (corresponding author), Xiamen Univ, Coll Ocean & Earth Sci, Fujian Collaborat Innovat Ctr Exploitat & Utiliza, Xiamen, Peoples R China.; Xu, P (corresponding author), Chinese Acad Fishery Sci, Key Lab Aquat Genom, Beijing, Peoples R China.; Xu, P (corresponding author), Chinese Acad Fishery Sci, Beijing Key Lab Fishery Biotechnol, Ctr Appl Aquat Genom, Beijing, Peoples R China.	xupeng77@xmu.edu.cn	Xu, Jian/H-5349-2019; Xu, Peng/J-4018-2012; Rana, Shahid Mahboob/P-1131-2014	Xu, Jian/0000-0003-0274-4268; Xu, Peng/0000-0002-1531-5078; Rana, Shahid Mahboob/0000-0003-4969-5387	National Natural Science Foundation of China [31422057]; National High Technology Research and Development Program of China (863 program) [2011AA100401]; Special Scientific Research Funds for Central Nonprofit Institutes of Chinese Academy of Fishery Sciences [2014A03YQ01, 2016GH02]; Deanship of Scientific Research at King Saud University [RG 1435-012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); Special Scientific Research Funds for Central Nonprofit Institutes of Chinese Academy of Fishery Sciences; Deanship of Scientific Research at King Saud University(King Saud University)	This research was supported by grants from the National Natural Science Foundation of China (No. 31422057), the National High Technology Research and Development Program of China (863 program; 2011AA100401), and the Special Scientific Research Funds for Central Nonprofit Institutes of Chinese Academy of Fishery Sciences (2014A03YQ01 and 2016GH02). The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for funding this research (No. RG 1435-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2014, BBA-GEN SUBJECTS, V1840, P1468, DOI 10.1016/j.bbagen.2013.12.001; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Aparicio S, 2000, TRENDS GENET, V16, P54, DOI 10.1016/S0168-9525(99)01934-4; Campbell EM, 2008, J COMP PHYSIOL B, V178, P935, DOI 10.1007/s00360-008-0288-2; Christoffels A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S2; Conrad B, 2007, ANNU REV GENOM HUM G, V8, P17, DOI 10.1146/annurev.genom.8.021307.110233; David L, 2003, MOL BIOL EVOL, V20, P1425, DOI 10.1093/molbev/msg173; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; DENKER BM, 1988, J BIOL CHEM, V263, P15634; Dong C, 2015, PLOS ONE, V10; Edger PP, 2009, CHROMOSOME RES, V17, P699, DOI 10.1007/s10577-009-9055-9; Finn RN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113686; Finn RN, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00044; Gates MA, 1999, GENOME RES, V9, P334; Gomes D, 2009, BBA-BIOMEMBRANES, V1788, P1213, DOI 10.1016/j.bbamem.2009.03.009; Gong Z, 1998, NAT GENET, V18, P303; Ji PF, 2012, INT J MOL SCI, V13, P9798, DOI 10.3390/ijms13089798; Jiang LM, 2015, ACTA MATER, V90, P344, DOI 10.1016/j.actamat.2015.02.039; KIMURA M, 1979, SCI AM, V241, P98, DOI 10.1038/scientificamerican1179-98; Kondrashov FA, 2012, P ROYAL SOC LONDON B; Kumar S., 2016, MOL BIOL EVOLUTION; Li Y, 2011, MAR BIOTECHNOL, V13, P1183, DOI 10.1007/s10126-011-9404-5; Liu S. -R, 2013, PLOS ONE, V8; Loh YH, 2004, GENOME RES, V14, P1248, DOI 10.1101/gr.2400004; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; Moens LN, 2007, J BIOCHEM MOL TOXIC, V21, P299, DOI 10.1002/jbt.20190; Park JS, 2006, CANCER RES, V57, P3606; PRESTON GM, 1991, P NATL ACAD SCI USA, V88, P11110, DOI 10.1073/pnas.88.24.11110; Soukup S. W, 1974, TERATOLOGY, V9, P250, DOI DOI 10.1002/TERA.1420090224; Staniscuaski F, 2013, J INSECT PHYSIOL, V59, P1140, DOI 10.1016/j.jinsphys.2013.08.013; Sun XW, 2004, AQUACULTURE, V238, P165, DOI 10.1016/S0044-8486(03)00445-9; Tingaud-Sequeira A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-38; Tingaudsequeira A, 2010, BMC EVOLUTIONARY BIO, V10, P91; Wang D, 2007, AQUACULTURE, V271, P558, DOI 10.1016/j.aquaculture.2007.06.001; Wang JT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-96; Wang JY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-273; Xu J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-307; Xu J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048140, 10.1371/journal.pone.0029552]; Xu P, 2011, BMC GENOMICS, V12; Xu P, 2014, NAT GENET, V46, P1212, DOI 10.1038/ng.3098; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhang XF, 2013, MAR BIOTECHNOL, V15, P275, DOI 10.1007/s10126-012-9485-9; Zhao L, 2013, ABSTR APPL ANAL, V2013, P8, DOI [DOI 10.1371/J0URNAL.P0NE.0063928, DOI 10.1155/2013/812143]; Zhao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063928	44	19	22	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166160	10.1371/journal.pone.0166160	http://dx.doi.org/10.1371/journal.pone.0166160			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935978	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100019
J	Gladkikh, OL; Romanenko, SA; Lemskaya, NA; Serdyukova, NA; O'Brien, PCM; Kovalskaya, JM; Smorkatcheva, AV; Golenishchev, FN; Perelman, PL; Trifonov, VA; Ferguson-Smith, MA; Yang, FT; Graphodatsky, AS				Gladkikh, Olga L.; Romanenko, Svetlana A.; Lemskaya, Natalya A.; Serdyukova, Natalya A.; O'Brien, Patricia C. M.; Kovalskaya, Julia M.; Smorkatcheva, Antonina V.; Golenishchev, Feodor N.; Perelman, Polina L.; Trifonov, Vladimir A.; Ferguson-Smith, Malcolm A.; Yang, Fengtang; Graphodatsky, Alexander S.			Rapid Karyotype Evolution in Lasiopodomys Involved at Least Two Autosome - Sex Chromosome Translocations	PLOS ONE			English	Article							MICROTUS-MANDARINUS-MANDARINUS; ARVICOLINAE CRICETIDAE; GENOME HOMOLOGY; FIELD VOLE; RODENTIA; GENE; HETEROCHROMATIN; DIVERSITY; GREGALIS; ORIGIN	The generic status of Lasiopodomys and its division into subgenera Lasiopodomys (L. mandarinus, L. brandtii) and Stenocranius (L. gregalis, L. raddei) are not generally accepted because of contradictions between the morphological and molecular data. To obtain cytogenetic evidence for the Lasiopodomys genus and its subgenera and to test the autosome to sex chromosome translocation hypothesis of sex chromosome complex origin in L. mandarinus proposed previously, we hybridized chromosome painting probes from the field vole (Microtus agrestis, MAG) and the Arctic lemming (Dicrostonyx torquatus, DTO) onto the metaphases of a female Mandarin vole (L. mandarinus, 2n = 47) and a male Brandt's vole (L. brandtii, 2n = 34). In addition, we hybridized Arctic lemming painting probes onto chromosomes of a female narrow-headed vole (L. gregalis, 2n = 36). Cross-species painting revealed three cytogenetic signatures (MAG12/18, 17a/19, and 22/24) that could validate the genus Lasiopodomys and indicate the evolutionary affinity of L. gregalis to the genus. Moreover, all three species retained the associations MAG1bc/17b and 2/8a detected previously in karyotypes of all arvicolins studied. The associations MAG2a/8a/19b, 8b/21, 9b/23, 11/13b, 12b/18, 17a/19a ,and 5 fissions of ancestral segments appear to be characteristic for the subgenus Lasiopodomys. We also validated the autosome to sex chromosome translocation hypothesis on the origin of complex sex chromosomes in L. mandarinus. Two translocations of autosomes onto the ancestral X chromosome in L. mandarinus led to a complex of neo-X-1, neo-X-2, and neo-X-3 elements. Our results demonstrate that genus Lasiopodomys represents a striking example of rapid chromosome evolution involving both autosomes and sex chromosomes. Multiple reshuffling events including Robertsonian fusions, chromosomal fissions, inversions and heterochromatin expansion have led to the formation of modern species karyotypes in a very short time, about 2.4 MY.	[Gladkikh, Olga L.; Romanenko, Svetlana A.; Lemskaya, Natalya A.; Serdyukova, Natalya A.; Perelman, Polina L.; Trifonov, Vladimir A.; Graphodatsky, Alexander S.] Russian Acad Sci, Siberian Branch, Inst Mol & Cellular Biol, Novosibirsk, Russia; [Romanenko, Svetlana A.; Perelman, Polina L.; Trifonov, Vladimir A.; Graphodatsky, Alexander S.] Novosibirsk State Univ, Novosibirsk, Russia; [O'Brien, Patricia C. M.; Ferguson-Smith, Malcolm A.] Univ Cambridge, Dept Vet Med, Cambridge Resource Ctr Comparat Genom, Cambridge, England; [Kovalskaya, Julia M.] Russian Acad Sci, Severtzov Inst Ecol & Evolut, Moscow, Russia; [Smorkatcheva, Antonina V.] St Petersburg State Univ, Dept Vertebrate Zool, St Petersburg, Russia; [Golenishchev, Feodor N.] Russian Acad Sci, Inst Zool, St Petersburg, Russia; [Yang, Fengtang] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge, England	Russian Academy of Sciences; Novosibirsk State University; University of Cambridge; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution; Saint Petersburg State University; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; Wellcome Trust Sanger Institute	Romanenko, SA (corresponding author), Russian Acad Sci, Siberian Branch, Inst Mol & Cellular Biol, Novosibirsk, Russia.; Romanenko, SA (corresponding author), Novosibirsk State Univ, Novosibirsk, Russia.	rosa@mcb.nsc.ru	Golenishchev, Fedor/HDO-4568-2022; Graphodatsky, Alexander/B-4922-2010; Romanenko, Svetlana/N-2500-2015; Trifonov, Vladimir/E-4907-2012; Perelman, Polina/AAD-9030-2019; Serdyukova, Natalia/AAU-6393-2021; Perelman, Polina/N-8088-2015; Yang, Fan/GYU-4249-2022; Lemskaya, Natalya A./N-5609-2015	Graphodatsky, Alexander/0000-0002-8282-1085; Romanenko, Svetlana/0000-0002-0951-5209; Trifonov, Vladimir/0000-0003-0454-8359; Perelman, Polina/0000-0002-0982-5100; Serdyukova, Natalia/0000-0002-0409-1371; Perelman, Polina/0000-0002-0982-5100; Lemskaya, Natalya/0000-0002-3682-6125; Yang, Fengtang/0000-0002-3573-2354	Russian Science Foundation (RSF) [16-14-10009]; Federal Agency for Scientific Organizations (FASO Russia) [01201351185, 0310-2016-0002]; Russian Foundation for Basic Research (RFBR) [14-04-00451, 15-04-00962, 15-29-02384, 16-04-00983-a]; Russian Science Foundation [16-14-10009] Funding Source: Russian Science Foundation	Russian Science Foundation (RSF)(Russian Science Foundation (RSF)); Federal Agency for Scientific Organizations (FASO Russia); Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	The study was funded by the by the Russian Science Foundation (RSF, http://rscf.ru/) under project No. 16-14-10009 to ASG. This work was partially supported by the Programs of the Federal Agency for Scientific Organizations (FASO Russia, http://fano.gov.ru/) No. 01201351185 to FNG for the animals collection and No. 0310-2016-0002 for cell culture collection to ASG. Significant funding was also provided by the Russian Foundation for Basic Research (RFBR, http://www.rfbr.ru/) grants No. 14-04-00451 to SAR, No. 15-04-00962 and No. 15-29-02384 both to ASG, No. 16-04-00983-a to FNG for the animals and tissue cell collections.	Abramson N, 2011, NARROW HEADED VOLE L, P1; Abramson N, 2010, MOL PHYLOGENETICS, P18; Abramson N I, 2009, Dokl Biol Sci, V428, P458; Borodin PM, 2012, CHROMOSOME RES, V20, P259, DOI 10.1007/s10577-011-9261-0; Chen YQ, 2008, MAMM GENOME, V19, P61, DOI 10.1007/s00335-007-9076-7; Chen YQ, 2011, HEREDITAS, V148, P93, DOI 10.1111/j.1601-5223.2011.02207.x; Dupal TA, 2010, ZOOL ZH, V89, P850; Dupal TA, 2000, ZOOL ZH, V79, P851; Golenishchev F, 2002, THERILOGICHESKIE ISS, P17; Gornung E, 2011, CYTOGENET GENOME RES, V132, P144, DOI 10.1159/000321572; Graphodatsky A, 2001, CYTOGENET CELL GENET, V92, P243, DOI 10.1159/000056911; Graphodatsky A, 1981, GENETIKA, P1498; Graphodatsky AS, 2000, CYTOGENET CELL GENET, V88, P296, DOI 10.1159/000015513; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; Graves JAM, 1998, HUM MOL GENET, V7, P1991, DOI 10.1093/hmg/7.13.1991; IJDO JW, 1991, NUCLEIC ACIDS RES, V19, P4780, DOI 10.1093/nar/19.17.4780; KOVALSKAYA YM, 1974, TSITOLOGIYA+, V16, P497; Lemskaya NA, 2010, CHROMOSOME RES, V18, P459, DOI 10.1007/s10577-010-9124-0; Lissovsky Andrey A., 2013, Russian Journal of Theriology, V12, P83; Liu H, 2010, NEUROGASTROENT MOTIL, V22, P1232, DOI 10.1111/j.1365-2982.2010.01586.x; Liu SY, 2012, SCI WORLD J, DOI 10.1100/2012/614263; MADEN BEH, 1987, BIOCHEM J, V246, P519, DOI 10.1042/bj2460519; MEZHZHERIN SV, 1993, GENETIKA+, V29, P28; Musser GG, 2005, MAMMAL SPECIES WORLD, P926; Nguyen P, 2013, P NATL ACAD SCI USA, V110, P6931, DOI 10.1073/pnas.1220372110; Ohno S., 1967, BIOSCIENCE, P331; Pala I, 2012, HEREDITY, V108, P264, DOI 10.1038/hdy.2011.70; Pavlinov I.Y., 2012, MAMMALS RUSSIA TAXON; Petrova TV, 2015, J ZOOL SYST EVOL RES, V53, P97, DOI 10.1111/jzs.12082; Petrova TV, 2016, ZOOL SCR; Petrova TV, 2015, STRUCTURE MAMMALIAN, P64; Romanenko SA, 2012, CYTOGENET GENOME RES, V137, P233, DOI 10.1159/000339294; Romanenko SA, 2007, CHROMOSOME RES, V15, P891, DOI 10.1007/s10577-007-1171-9; Romanenko SA, 2016, CHROMOSOME RES, V24, P145, DOI 10.1007/s10577-015-9504-6; Romanenko SA, 2015, MOL CYTOGENET, V8, DOI 10.1186/s13039-015-0194-8; Schibler L, 1998, GENOME RES, V8, P901, DOI 10.1101/gr.8.9.901; SEABRIGH.M, 1971, LANCET, V2, P971; Sitnikova NA, 2007, CHROMOSOME RES, V15, P447, DOI 10.1007/s10577-007-1137-y; STANYON R, 1991, B ZOOL, V58, P81, DOI 10.1080/11250009109355732; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; TELENIUS H, 1992, GENE CHROMOSOME CANC, V4, P257, DOI 10.1002/gcc.2870040311; Toder R, 1997, MAMM GENOME, V8, P418, DOI 10.1007/s003359900459; Veyrunes F, 2006, P ROY SOC B-BIOL SCI, V273, P2925, DOI 10.1098/rspb.2006.3670; Wang JY, 2014, CELL MOL LIFE SCI, V71, P4841, DOI 10.1007/s00018-014-1725-x; Wang JX, 2003, HEREDITAS, V138, P47, DOI 10.1034/j.1601-5223.2003.01615.x; Yang F, 1999, GENOMICS, V62, P189, DOI 10.1006/geno.1999.5989; YANG F, 1995, CHROMOSOMA, V103, P642, DOI 10.1007/BF00357691; Zhou Q, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r98; Zhu B, 2003, HEREDITAS, V139, P90, DOI 10.1111/j.1601-5223.2003.01756.x; Zhu B, 1993, ACTA GENET SIN, P135; Zhu BC, 2006, HEREDITAS, V143, P130, DOI 10.1111/j.2006.0018-0661.01950.x	51	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167653	10.1371/journal.pone.0167653	http://dx.doi.org/10.1371/journal.pone.0167653			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936177	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100141
J	Jandova, Z; Musilek, M; Vackova, Z; Kozakova, J; Krizova, P				Jandova, Zuzana; Musilek, Martin; Vackova, Zuzana; Kozakova, Jana; Krizova, Pavla			Serogroup and Clonal Characterization of Czech Invasive Neisseria meningitidis Strains Isolated from 1971 to 2015	PLOS ONE			English	Article							MENINGOCOCCAL DISEASE; CHANGING EPIDEMIOLOGY; ENGLAND; VACCINE; POPULATIONS; EMERGENCE; WALES; W135	Background This study presents antigenic and genetic characteristics of Neisseria meningitidis strains recovered from invasive meningococcal disease (IMD) in the Czech Republic in 1971-2015. Material and Methods A total of 1970 isolates from IMD, referred to the National Reference Laboratory for Meningococcal Infections in 1971-2015, were studied. All isolates were identified and characterized by conventional biochemical and serological tests. Most isolates (82.5%) were characterized by multilocus sequence typing method. Results In the study period 1971-2015, the leading serogroup was B (52.4%), most often assigned to clonal complexes cc32, cc41/44, cc18, and cc269. A significant percentage of strains were of serogroup C (41.4%), with high clonal homogeneity due to hyperinvasive complex cc11, which played an important role in IMD in the Czech Republic in the mid-1990s. Serogroup Y isolates, mostly assigned to cc23, and isolates of clonally homogeneous serogroup Whave also been recovered more often over the last years. Conclusion The incidence of IMD and distribution of serogroups and clonal complexes of N. meningitidis in the Czech Republic varied over time, as can be seen from the long-term monitoring, including molecular surveillance data. Data from the conventional and molecular IMD surveillance are helpful in refining the antimeningococcal vaccination strategy in the Czech Republic.	[Jandova, Zuzana; Musilek, Martin; Vackova, Zuzana; Kozakova, Jana; Krizova, Pavla] Natl Inst Publ Hlth, Natl Reference Lab Meningococcal Infect, Prague, Czech Republic	National Institute of Public Health (SZU) - Czech Republic	Krizova, P (corresponding author), Natl Inst Publ Hlth, Natl Reference Lab Meningococcal Infect, Prague, Czech Republic.	pavla.krizova@szu.cz	Krizova, Pavla/M-6120-2015		Ministry of Health of the Czech Republic [15-34887A]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	This study was supported by the Ministry of Health of the Czech Republic, grant no. 15-34887A.; This study was supported by the Ministry of Health of the Czech Republic, grant no. 15-34887A. All rights reserved.	Brehony C, 2007, FEMS MICROBIOL REV, V31, P15, DOI 10.1111/j.1574-6976.2006.00056.x; Campbell H, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.28.21188; Caugant DA, 2008, INFECT GENET EVOL, V8, P558, DOI 10.1016/j.meegid.2008.04.002; Caugant DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046019; Frosch M, 2006, HDB MENINGOCOCCAL DI; Halperin SA, 2012, VACCINE, V30, pB26, DOI 10.1016/j.vaccine.2011.12.032; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Ibarz-Pavon AB, 2011, J INFECT DIS, V204, P1046, DOI 10.1093/infdis/jir466; Jandova Z, 2015, EPIDEMIOL MIKROBI IM, V64, P147; Krauland MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035699; Kristiansen PA, 2013, CLIN INFECT DIS, V56, P354, DOI 10.1093/cid/cis892; Kriz P, 2011, EXPERT REV VACCINES, V10, P1477, DOI [10.1586/ERV.11.117, 10.1586/erv.11.117]; Krizova P, 2014, EPIDEMIOL MIKROBI IM, V63, P61; Ladhani SN, 2015, CLIN INFECT DIS, V60, P578, DOI 10.1093/cid/ciu881; Ladhani SN, 2012, VACCINE, V30, P3710, DOI 10.1016/j.vaccine.2012.03.011; Ladhani SN, 2012, EMERG INFECT DIS, V18, P63, DOI 10.3201/eid1801.110901; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Mustapha MM, 2016, VACCINE, V34, P1515, DOI 10.1016/j.vaccine.2016.02.014; Neri A, 2012, J PREV MED HYG, V53, P109; Nicolas P, 2001, EMERG INFECT DIS, V7, P849; Pollard AJ, 2004, EMERG INFECT DIS, V10, P1812, DOI 10.3201/eid1010.040335; Pollard Andrew J, 2004, Pediatr Infect Dis J, V23, pS274; Racloz VN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-175; Rosenstein NE, 1999, J INFECT DIS, V180, P1894, DOI 10.1086/315158; Skoczynska A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071943; Teyssou R, 2007, VACCINE, V25, pA3, DOI 10.1016/j.vaccine.2007.04.032; Toros B, 2014, EUROSURVEILLANCE, V19, P25; Toros B, 2015, J CLIN MICROBIOL, V53, P2154, DOI 10.1128/JCM.03524-14; Trotter CL, 2007, FEMS MICROBIOL REV, V31, P27, DOI 10.1111/j.1574-6976.2006.00060.x; Vackova Z, 2015, EPIDEMIOL MIKROBI IM, V64, P222; Vogel U, 1999, MOL MICROBIOL, V32, P1133, DOI 10.1046/j.1365-2958.1999.01469.x; Vogel U, 2003, FRONT BIOSCI-LANDMRK, V8, pE14, DOI 10.2741/920; Watkins ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045349; Wilder-Smith A, 2003, CLIN INFECT DIS, V36, P679, DOI 10.1086/367858; Yazdankhah SP, 2004, J CLIN MICROBIOL, V42, P5146, DOI 10.1128/JCM.42.11.5146-5153.2004	36	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167762	10.1371/journal.pone.0167762	http://dx.doi.org/10.1371/journal.pone.0167762			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936105	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100178
J	Jumar, A; Harazny, JM; Ott, C; Friedrich, S; Kistner, I; Striepe, K; Schmieder, RE				Jumar, Agnes; Harazny, Joanna M.; Ott, Christian; Friedrich, Stefanie; Kistner, Iris; Striepe, Kristina; Schmieder, Roland E.			Retinal Capillary Rarefaction in Patients with Type 2 Diabetes Mellitus	PLOS ONE			English	Article							TO-LUMEN RATIO; NITRIC-OXIDE; HYPERTENSION; DENSITY; SKIN; WALL; ANGIOGENESIS; ARTERIOLES; PERFUSION; MICROCIRCULATION	Purpose In diabetes mellitus type 2, capillary rarefaction plays a pivotal role in the pathogenesis of end-organ damage. We investigated retinal capillary density in patients with early disease. Methods This cross-sectional study compares retinal capillary rarefaction determined by intercapillary distance (ICD) and capillary area (CapA), measured non-invasively and in vivo by scanning laser Doppler flowmetry, in 73 patients with type 2 diabetes, 55 healthy controls and 134 individuals with hypertension stage 1 or 2. Results In diabetic patients, ICD was greater (23.2 +/- 5.5 vs 20.2 +/- 4.2, p = 0.013) and CapA smaller (1592 +/- 595 vs 1821 +/- 652, p = 0.019) than in healthy controls after adjustment for differences in cardiovascular risk factors between the groups. Compared to hypertensive patients, diabetic individuals showed no difference in ICD (23.1 +/- 5.8, p = 0.781) and CapA (1556 +/- 649, p = 0.768). Conclusion In the early stage of diabetes type 2, patients showed capillary rarefaction compared to healthy individuals.	[Jumar, Agnes; Harazny, Joanna M.; Ott, Christian; Friedrich, Stefanie; Kistner, Iris; Striepe, Kristina; Schmieder, Roland E.] Friedrich Alexander Univ Erlangen Eurnberg FAU, Dept Hypertens & Nephrol, Erlangen, Germany; [Harazny, Joanna M.] Univ Warmia & Mazury, Dept Pathophysiol, Olsztyn, Poland	University of Erlangen Nuremberg; University of Warmia & Mazury	Schmieder, RE (corresponding author), Friedrich Alexander Univ Erlangen Eurnberg FAU, Dept Hypertens & Nephrol, Erlangen, Germany.	roland.schmieder@uk-erlangen.de	Harazna, Joanna/AAV-1502-2021	Harazna, Joanna/0000-0003-0124-0543	AstraZeneca/Bristol-Myers Squibb; Novartis Pharma GmbH	AstraZeneca/Bristol-Myers Squibb(Bristol-Myers SquibbAstraZeneca); Novartis Pharma GmbH	The clinical trials were financially supported by grants from AstraZeneca/Bristol-Myers Squibb and Novartis Pharma GmbH. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abaci A, 1999, CIRCULATION, V99, P2239, DOI 10.1161/01.CIR.99.17.2239; Aellen J, 2012, MICROCIRCULATION, V19, P554, DOI 10.1111/j.1549-8719.2012.00188.x; Battegay EJ, 2007, CURR OPIN PHARMACOL, V7, P151, DOI 10.1016/j.coph.2006.09.007; Cheng Cynthia, 2008, Ther Adv Cardiovasc Dis, V2, P79, DOI 10.1177/1753944708089696; Cheng C, 2008, CTS-CLIN TRANSL SCI, V1, P75, DOI 10.1111/j.1752-8062.2008.00016.x; Clark Michael G, 2002, Semin Vasc Med, V2, P21, DOI 10.1055/s-2002-23506; Debbabi H, 2006, AM J HYPERTENS, V19, P477, DOI 10.1016/j.amjhyper.2005.10.021; Delles C, 2004, STROKE, V35, P1289, DOI 10.1161/01.STR.0000126597.11534.3b; Estato V, 2013, MICROVASC RES, V87, P41, DOI 10.1016/j.mvr.2013.02.007; Feihl F, 2006, HYPERTENSION, V48, P1012, DOI 10.1161/01.HYP.0000249510.20326.72; FENTON BM, 1979, MICROVASC RES, V18, P153, DOI 10.1016/0026-2862(79)90025-6; Frisbee JC, 2003, AM J PHYSIOL-HEART C, V285, pH104, DOI 10.1152/ajpheart.00118.2003; Goligorsky MS, 2010, ORGANOGENESIS, V6, P1, DOI 10.4161/org.6.1.10427; Harazny JM, 2007, HYPERTENSION, V50, P623, DOI 10.1161/HYPERTENSIONAHA.107.090779; Harazny JM, 2011, J HYPERTENS, V29, P777, DOI 10.1097/HJH.0b013e328343c27a; Humar R, 2009, J HUM HYPERTENS, V23, P773, DOI 10.1038/jhh.2009.63; JAAP AJ, 1994, DIABETOLOGIA, V37, P214, DOI 10.1007/s001250050096; Jaap AJ, 1996, DIABETIC MED, V13, P160, DOI 10.1002/(SICI)1096-9136(199602)13:2<160::AID-DIA36>3.3.CO;2-Z; Jumar A, 2016, MICROCIRCULATION; Jumar A, 2016, J CLIN HYPERTENSION; Kaiser SE, 2013, MICROCIRCULATION, V20, P703, DOI 10.1111/micc.12067; Kida Y, 2014, PEDIATR NEPHROL, V29, P333, DOI 10.1007/s00467-013-2430-y; Kivela R, 2006, FASEB J, V20, P1570, DOI 10.1096/fj.05-4780fje; Larger E, 2004, DIABETES, V53, P752, DOI 10.2337/diabetes.53.3.752; LASH JM, 1989, DIABETES, V38, P854, DOI 10.2337/diabetes.38.7.854; Lorenzi M, 2001, DIABETOLOGIA, V44, P791, DOI 10.1007/s001250100544; Lynch FM, 2012, J HYPERTENS, V30, P384, DOI 10.1097/HJH.0b013e32834e38a0; Michelson G, 1998, BRIT J OPHTHALMOL, V82, P1294, DOI 10.1136/bjo.82.11.1294; Muiesan ML, 2013, HYPERTENS RES, V36, P485, DOI 10.1038/hr.2013.30; Parenti A, 1998, J BIOL CHEM, V273, P4220, DOI 10.1074/jbc.273.7.4220; PIEPER GM, 1995, J CARDIOVASC PHARM, V25, P397, DOI 10.1097/00005344-199503000-00008; Ritt M, 2008, J HYPERTENS, V26, P1427, DOI 10.1097/HJH.0b013e3282ffdc66; Ritt M, 2012, MICROVASC RES, V83, P111, DOI 10.1016/j.mvr.2011.10.002; Ritt M, 2009, HYPERTENSION, V54, P384, DOI 10.1161/HYPERTENSIONAHA.109.133025; Rivard A, 1999, AM J PATHOL, V154, P355, DOI 10.1016/S0002-9440(10)65282-0; Rizzoni D, 2012, J HYPERTENS, V30, P1169, DOI 10.1097/HJH.0b013e328352f81d; SANDEMAN DD, 1991, BRIT MED J, V302, P1122, DOI 10.1136/bmj.302.6785.1122; Serne EH, 2001, HYPERTENSION, V38, P238, DOI 10.1161/01.HYP.38.2.238; TESFAMARIAM B, 1990, J CLIN INVEST, V85, P929, DOI 10.1172/JCI114521; Tomassoni D, 2002, CLIN EXP HYPERTENS, V24, P741, DOI 10.1081/CEH-120015349; Triantafyllou A, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0543-3; Weltermann B, 2013, Z EVIDENZ FORTBILD Q, V107, P403, DOI 10.1016/j.zefq.2012.11.019	42	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0162608	10.1371/journal.pone.0162608	http://dx.doi.org/10.1371/journal.pone.0162608			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935938	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100004
J	Kim, BH; Shin, HY; Goto, JJ; Carp, RI; Choi, EK; Kim, YS				Kim, Boe-Hyun; Shin, Hae-Young; Goto, Joy J.; Carp, Richard I.; Choi, Eun-Kyoung; Kim, Yong-Sun			Cellular Prion Protein Combined with Galectin-3 and-6 Affects the Infectivity Titer of an Endogenous Retrovirus Assayed in Hippocampal Neuronal Cells	PLOS ONE			English	Article							MURINE LEUKEMIA-VIRUS; NUCLEOCAPSID PROTEIN; SENESCENCE-PRONE; SCRAPIE; MICE; LINE; PRPC; INTERACTS; BINDING; HIV-1	Prion diseases are infectious and fatal neurodegenerative diseases which require the cellular prion protein, PrPC, for development of diseases. The current study shows that the PrPC augments infectivity and plaque formation of a mouse endogenous retrovirus, MuLV. We have established four neuronal cell lines expressing mouse PrPC, PrP+/+; two express wild type PrPC (MoPrPwild) and the other two express mutant PrPC (MoPrPmut). Infection of neuronal cells from various PrP+/+ and PrP-/- (MoPrPKO) lines with MuLV yielded at least three times as many plaques in PrP+/+ than in PrP-/-. Furthermore, among the four PrP+/+ lines, one mutant line, P101L, had at least 2.5 times as many plaques as the other three PrP+/+ lines. Plaques in P101L were four times larger than those in other PrP+/+ lines. Colocalization of PrP and CAgag was seen in MuLV-infected PrP+/+ cells. In the PrP-MuLV interaction, the involvement of galectin-3 and -6 was observed by immunoprecipitation with antibody to PrPC. These results suggest that PrPC combined with galectin-3 and -6 can act as a receptor for MuLV. P101L, the disease form of mutant PrPC results suggest the genetic mutant form of PrPC may be more susceptible to viral infection.	[Kim, Boe-Hyun] Icahn Sch Med Mt Sinai, Div Infect Dis, Dept Med, New York, NY 10029 USA; [Shin, Hae-Young; Choi, Eun-Kyoung; Kim, Yong-Sun] Hallym Univ, Ilsong Inst Life Sci, Anyang, Gyeonggi Do, South Korea; [Goto, Joy J.] Calif State Univ Fresno, Dept Chem, Fresno, CA USA; [Carp, Richard I.] New York State Inst Basic Res Dev Disabil, Staten Isl, NY USA	Icahn School of Medicine at Mount Sinai; Hallym University; California State University System; California State University Fresno; Institute for Basic Research in Developmental Disabilities	Choi, EK; Kim, YS (corresponding author), Hallym Univ, Ilsong Inst Life Sci, Anyang, Gyeonggi Do, South Korea.	ekchoi@hallym.ac.kr; yskim@hallym.ac.kr		Kim, Boe-Hyun/0000-0003-2821-0467	National Research Foundation of Korea - Korean Government [NRF-2011K3A1A1003362, 2016R1A2B4013052]; Hallym University Specialization Fund [HRF-S-51]; Korea Healthcare technology R&D Project, the Korea Health Industry Development Institute [A090960]	National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government); Hallym University Specialization Fund; Korea Healthcare technology R&D Project, the Korea Health Industry Development Institute	This research was supported by the National Research Foundation of Korea Grant Funded by the Korean Government (NRF-2011K3A1A1003362), Hallym University Specialization Fund (HRF-S-51), and the National Research Foundation of Korea Grant Funded by the Korean Government (2016R1A2B4013052) and a grant of the Korea Healthcare technology R&D Project, the Korea Health Industry Development Institute (A090960).	Alais S, 2012, CELL MOL LIFE SCI, V69, P1331, DOI 10.1007/s00018-011-0879-z; Almkvist J, 2002, GLYCOCONJUGATE J, V19, P575, DOI 10.1023/B:GLYC.0000014088.21242.e0; ANDERSEN KB, 1994, J VIROL, V68, P3175, DOI 10.1128/JVI.68.5.3175-3182.1994; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Carp RI, 1998, J GEN VIROL, V79, P2863, DOI 10.1099/0022-1317-79-11-2863; Carp RI, 1999, J GEN VIROL, V80, P5, DOI 10.1099/0022-1317-80-1-5; Carp RI, 2002, MECH AGEING DEV, V123, P575, DOI 10.1016/S0047-6374(01)00377-3; Chiariotti L, 2002, GLYCOCONJUGATE J, V19, P441, DOI 10.1023/B:GLYC.0000014073.23096.3a; Choi JK, 2006, HYBRIDOMA, V25, P271, DOI 10.1089/hyb.2006.25.271; Cooper DNW, 2002, BBA-GEN SUBJECTS, V1572, P209, DOI 10.1016/S0304-4165(02)00310-0; Derrington E, 2002, CR BIOL, V325, P17, DOI 10.1016/S1631-0691(02)01388-4; Edenhofer F, 1996, J VIROL, V70, P4724, DOI 10.1128/JVI.70.7.4724-4728.1996; Ferrer I, 2011, TRANSL NEUROSCI, V2, P23, DOI 10.2478/s13380-011-0001-x; Gabus C, 2001, J BIOL CHEM, V276, P19301, DOI 10.1074/jbc.M009754200; Gabus C, 2001, J MOL BIOL, V307, P1011, DOI 10.1006/jmbi.2001.4544; GAJDUSEK DC, 1977, SCIENCE, V197, P943, DOI 10.1126/science.142303; Jin JK, 2007, NEUROSCI LETT, V420, P138, DOI 10.1016/j.neulet.2007.04.069; Kim BH, 2005, NEUROREPORT, V16, P425, DOI 10.1097/00001756-200504040-00002; Kim BH, 2004, MOL BRAIN RES, V124, P40, DOI 10.1016/j.molbrainres.2004.02.005; Kim BH, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-104; KURSCHNER C, 1995, MOL BRAIN RES, V30, P165, DOI 10.1016/0169-328X(95)00013-I; Kurschner C, 1996, MOL BRAIN RES, V37, P249, DOI 10.1016/0169-328X(95)00323-K; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Lasmezas CI, 2003, BRIT MED BULL, V66, P61, DOI 10.1093/bmb/66.1.61; Leblanc P, 2004, J MOL BIOL, V337, P1035, DOI 10.1016/j.jmb.2004.02.007; Lee B, 2007, ANN NY ACAD SCI, V1102, P51, DOI 10.1196/annals.1408.004; Lee KH, 2006, BIOCHEM BIOPH RES CO, V349, P122, DOI 10.1016/j.bbrc.2006.08.016; LEHMANN S, 1995, J BIOL CHEM, V270, P24589, DOI 10.1074/jbc.270.41.24589; Lotscher M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001158; Marriott DR, 1995, NEURAL CELL CULTURE, P85; Meeker HC, 1997, NEUROBIOL AGING, V18, P543, DOI 10.1016/S0197-4580(97)00041-9; Oh JM, 2008, MOL CELL NEUROSCI, V39, P238, DOI 10.1016/j.mcn.2008.07.003; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, BRAIN PATHOL, V8, P499; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Sakudo A, 2003, BIOCHEM BIOPH RES CO, V308, P660, DOI 10.1016/S0006-291X(03)01459-1; Sato S, 2002, GLYCOCONJUGATE J, V19, P583, DOI 10.1023/B:GLYC.0000014089.17121.cc; Spielhaupter C, 2001, J BIOL CHEM, V276, P44604, DOI 10.1074/jbc.M103289200; Stanton JB, 2008, J VIROL, V82, P9839, DOI 10.1128/JVI.01137-08; Tranchant C, 1997, J NEUROL NEUROSUR PS, V63, P240, DOI 10.1136/jnnp.63.2.240; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Viles JH, 1999, P NATL ACAD SCI USA, V96, P2042, DOI 10.1073/pnas.96.5.2042; Wang XH, 2006, J BIOL CHEM, V281, P13559, DOI 10.1074/jbc.M512306200; Yano S, 2003, J HISTOCHEM CYTOCHEM, V51, P199, DOI 10.1177/002215540305100208	49	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167293	10.1371/journal.pone.0167293	http://dx.doi.org/10.1371/journal.pone.0167293			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936017	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100080
J	Kutty, RG; Xin, G; Schauder, DM; Cossette, SM; Bordas, M; Cui, WG; Ramchandran, R				Kutty, Raman G.; Xin, Gang; Schauder, David M.; Cossette, Stephanie M.; Bordas, Michelle; Cui, Weiguo; Ramchandran, Ramani			Dual Specificity Phosphatase 5 Is Essential for T Cell Survival	PLOS ONE			English	Article							NUCLEAR ERK ACTIVITY; GENE-FUNCTION; MEMORY; DUSP5; HYPERTROPHY; RESPONSES; RESOURCE	The mitogen-activated protein kinase (MAPK) pathway regulates many key cellular processes such as differentiation, apoptosis, and survival. The final proteins in this pathway, ERK1/2, are regulated by dual specificity phosphatase 5 (DUSP5). DUSP5 is a nuclear, inducible phosphatase with high affinity and fidelity for ERK1/2. By regulating the final step in the MAPK signaling cascade, DUSP5 exerts strong regulatory control over a central cellular pathway. Like other DUSPs, DUSP5 plays an important role in immune function. In this study, we have utilized new knockout mouse reagents to explore its function further. We demonstrate that global loss of DUSP5 does not result in any gross phenotypic changes. However, loss of DUSP5 affects memory/effector CD8(+) T cell populations in response to acute viral infection. Specifically, Dusp5(-/-) mice have decreased proportions of short-lived effector cells (SLECs) and increased proportions of memory precursor effector cells (MPECs) in response to infection. Further, we show that this phenotype is T cell intrinsic; a bone marrow chimera model restricting loss of DUSP5 to the CD8(+) T cell compartment displays a similar phenotype. Dusp5(-/-) T cells also display increased proliferation, increased apoptosis, and altered metabolic profiles, suggesting that DUSP5 is a pro-survival protein in T cells.	[Kutty, Raman G.; Cossette, Stephanie M.; Bordas, Michelle; Ramchandran, Ramani] Med Coll Wisconsin, Dept Pediat, Dev Vasc Biol Program, Dept Obstet & Gynecol,Div Neonatol,Childrens Res, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Kutty, Raman G.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Xin, Gang; Schauder, David M.; Cui, Weiguo] BloodCtr Wisconsin, Blood Res Inst, 8727 Watertown Plank Rd, Milwaukee, WI USA; [Schauder, David M.; Cui, Weiguo] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Versiti Blood Center of Wisconsin; Medical College of Wisconsin	Ramchandran, R (corresponding author), Med Coll Wisconsin, Dept Pediat, Dev Vasc Biol Program, Dept Obstet & Gynecol,Div Neonatol,Childrens Res, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	rramchan@mcw.edu	Xin, Gang/N-5788-2018; Xin, Gang/AAX-7651-2020		National Institutes of Health, National Heart, Lung, and Blood Institute [HL090712, HL102745, HL112639]; American Cancer Society [6-004-26]; T32 training grant - National Institutes of Health, National Institute of General Medical Sciences [T32-GM080202]; Children's Hospital of Wisconsin; Department of Pediatrics grant; MCW; NIH [Al125741]; Elizabeth Elser Doolittle Postdoctoral Fellowship; NIGMS [T32-GM080202]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125741] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Cancer Society(American Cancer Society); T32 training grant - National Institutes of Health, National Institute of General Medical Sciences; Children's Hospital of Wisconsin; Department of Pediatrics grant; MCW; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elizabeth Elser Doolittle Postdoctoral Fellowship; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support was provided by: National Institutes of Health, National Heart, Lung, and Blood Institute, HL090712, [http://www.nhlbi.nih.gov] to RR; National Institutes of Health, National Heart, Lung, and Blood Institute, HL102745, [http/www.nhlbi.nih.gov] to RR; National Institutes of Health, National Heart, Lung, and Blood Institute, HL112639, [http.//www.nhlbi.nih.gov] to RR; American Cancer Society, 86-004-26, [http.www.cancer.org] to WC; Supported by T32 training grant - National Institutes of Health, National Institute of General Medical Sciences, T32-GM080202, [https://www.nigms.nih.gov/Pages/default.aspx] to RR; RK - Children's Hospital of Wisconsin; and Department of Pediatrics grant, MCW to RK. WC is supported by NIH grant Al125741. GX is supported by The Elizabeth Elser Doolittle Postdoctoral Fellowship. DMS is a member of the Medical Scientist Training Program at MCW, which is partially supported by a training grant from NIGMS T32-GM080202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsen D, 2013, CROSSROADS INNATE AD, VIV, P107; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Bradley A, 2012, MAMM GENOME, V23, P580, DOI 10.1007/s00335-012-9422-2; Chen YB, 2011, J CELL BIOL, V195, P263, DOI 10.1083/jcb.201108059; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Chowdhury FZ, 2011, BLOOD, V118, P3890, DOI 10.1182/blood-2011-05-357111; Fan F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112878; Ferguson BS, 2013, P NATL ACAD SCI USA, V110, P9806, DOI 10.1073/pnas.1301509110; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Fu Q, 2006, FASEB J, V20, P2127, DOI 10.1096/fj.06-6179fje; Holmes DA, 2014, EMBO J; ISHIBASHI T, 1994, J BIOL CHEM, V269, P29897; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Jeong DG, 2007, PROTEINS, V66, P253, DOI 10.1002/prot.21224; Kovanen PE, 2008, J BIOL CHEM, V283, P17362, DOI 10.1074/jbc.M709887200; Kovanen PE, 2003, J BIOL CHEM, V278, P5205, DOI 10.1074/jbc.M209015200; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Mandl M, 2005, MOL CELL BIOL, V25, P1830, DOI 10.1128/MCB.25.5.1830-1845.2005; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pillai VB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7656; Pramanik K, 2009, BLOOD, V113, P1184, DOI 10.1182/blood-2008-06-162180; Rushworth LK, 2014, P NATL ACAD SCI USA, V111, P18267, DOI 10.1073/pnas.1420159112; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Tanzola MB, 2006, MOL IMMUNOL, V43, P754, DOI 10.1016/j.molimm.2005.03.006; Ueda K, 2003, ONCOGENE, V22, P5586, DOI 10.1038/sj.onc.1206845; van der Windt GJW, 2012, IMMUNOL REV, V249, P27, DOI 10.1111/j.1600-065X.2012.01150.x; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007	29	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167246	10.1371/journal.pone.0167246	http://dx.doi.org/10.1371/journal.pone.0167246			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936095	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100078
J	Lill, Y; Jordan, LD; Smallwood, CR; Newton, SM; Lill, MA; Klebba, PE; Ritchie, K				Lill, Yoriko; Jordan, Lorne D.; Smallwood, Chuck R.; Newton, Salete M.; Lill, Markus A.; Klebba, Phillip E.; Ritchie, Ken			Confined Mobility of TonB and FepA in Escherichia coli Membranes	PLOS ONE			English	Article							SINGLE-MOLECULE TRACKING; FERRIC ENTEROBACTIN TRANSPORT; BACTERIAL OUTER-MEMBRANE; GRAM-NEGATIVE BACTERIA; CRYSTAL-STRUCTURE; SPATIAL-DISTRIBUTION; ENERGY TRANSDUCTION; INNER MEMBRANE; PROTEIN; EXBD	The important process of nutrient uptake in Escherichia coli, in many cases, involves transit of the nutrient through a class of beta-barrel proteins in the outer membrane known as TonB-dependent transporters (TBDTs) and requires interaction with the inner membrane protein TonB. Here we have imaged the mobility of the ferric enterobactin transporter FepA and TonB by tracking them in the membranes of live E. coli with single-molecule resolution at time-scales ranging from milliseconds to seconds. We employed simple simulations to model/analyze the lateral diffusion in the membranes of E. coli, to take into account both the highly curved geometry of the cell and artifactual effects expected due to finite exposure time imaging. We find that both molecules perform confined lateral diffusion in their respective membranes in the absence of ligand with FepA confined to a region 0.180(-0.007)(+0.006) mu m in radius in the outer membrane and TonB confined to a region 0.266(0.009)(+0.007) mu m in radius in the inner membrane. The diffusion coefficient of these molecules on millisecond time-scales was estimated to be 21(-5)(+9) mu m(2)/s and 5.4(-0.8)(+1.5) mu m(2)/s for FepA and TonB, respectively, implying that each molecule is free to diffuse within its domain. Disruption of the inner membrane potential, deletion of ExbB/D from the inner membrane, presence of ligand or antibody to FepA and disruption of the MreB cytoskeleton was all found to further restrict the mobility of both molecules. Results are analyzed in terms of changes in confinement size and interactions between the two proteins.	[Lill, Yoriko; Ritchie, Ken] Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA; [Jordan, Lorne D.; Newton, Salete M.; Klebba, Phillip E.] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA; [Smallwood, Chuck R.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; [Lill, Markus A.] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Smallwood, Chuck R.] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Kansas State University; University of Oklahoma System; University of Oklahoma - Norman; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California Berkeley	Ritchie, K (corresponding author), Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA.; Klebba, PE (corresponding author), Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA.	peklebba@ksu.edu; kpritchie@purdue.edu	Lill, Markus A/E-5118-2017; Smallwood, Chuck/P-5421-2017	Lill, Markus A/0000-0003-3023-5188; Smallwood, Chuck/0000-0003-2221-5726	National Science Foundation [MCB09522999]; National Institutes of Health [GM53836]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were supported by grant MCB09522999 from the National Science Foundation (P.E.K., S.M.N., and K.R.) and GM53836 from the National Institutes of Health (P.E.K. and S.M.N.).	Bakshi S, 2011, BIOPHYS J, V101, P2535, DOI 10.1016/j.bpj.2011.10.013; Bean GJ, 2009, BIOCHEMISTRY-US, V48, P4852, DOI 10.1021/bi900014d; BRADBEER C, 1993, J BACTERIOL, V175, P3146, DOI 10.1128/JB.175.10.3146-3150.1993; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Cao ZH, 2003, J BIOL CHEM, V278, P1022, DOI 10.1074/jbc.M210360200; Chang CS, 2001, J BIOL CHEM, V276, P27535, DOI 10.1074/jbc.M102778200; Deich J, 2004, P NATL ACAD SCI USA, V101, P15921, DOI 10.1073/pnas.0404200101; English BP, 2011, P NATL ACAD SCI USA, V108, pE365, DOI 10.1073/pnas.1102255108; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; Gibbs KA, 2004, MOL MICROBIOL, V53, P1771, DOI 10.1111/j.1365-2958.2004.04242.x; Gresock MG, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00206; Haas BL, 2015, MOL MICROBIOL, V96, P4, DOI 10.1111/mmi.12834; HASHIMOTOGOTOH T, 1981, GENE, V16, P227, DOI 10.1016/0378-1119(81)90079-2; Higgs PI, 2002, MOL MICROBIOL, V44, P271, DOI 10.1046/j.1365-2958.2002.02880.x; Jordan LD, 2013, P NATL ACAD SCI USA, V110, P11553, DOI 10.1073/pnas.1304243110; KAMPFENKEL K, 1992, J BACTERIOL, V174, P5485, DOI 10.1128/JB.174.16.5485-5487.1992; Kaserer WA, 2008, J BACTERIOL, V190, P4001, DOI 10.1128/JB.00135-08; KLEBBA PE, 1982, J BACTERIOL, V149, P880, DOI 10.1128/JB.149.3.880-888.1982; Kodding J, 2005, J BIOL CHEM, V280, P3022, DOI 10.1074/jbc.M411155200; Kohler SD, 2010, PROTEIN SCI, V19, P625, DOI 10.1002/pro.345; Kojima S, 2001, BIOCHEMISTRY-US, V40, P13041, DOI 10.1021/bi011263o; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Lill Y, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.021907; Ma L, 2007, J BIOL CHEM, V282, P397, DOI 10.1074/jbc.M605333200; MURPHY CK, 1990, J BACTERIOL, V172, P2736, DOI 10.1128/jb.172.5.2736-2746.1990; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Newton SM, 2010, J BIOL CHEM, V285, P17488, DOI 10.1074/jbc.M109.100206; Newton SMC, 1999, MOL MICROBIOL, V32, P1153, DOI 10.1046/j.1365-2958.1999.01424.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Oddershede L, 2002, BIOPHYS J, V83, P3152, DOI 10.1016/S0006-3495(02)75318-6; Oh D, 2014, BIOPHYS J, V106, P145, DOI 10.1016/j.bpj.2013.09.059; Ollis AA, 2012, J BACTERIOL, V194, P3069, DOI 10.1128/JB.00015-12; Ollis AA, 2009, MOL MICROBIOL, V73, P466, DOI 10.1111/j.1365-2958.2009.06785.x; Pawelek PD, 2006, SCIENCE, V312, P1399, DOI 10.1126/science.1128057; Peacock RS, 2006, BIOMETALS, V19, P127, DOI 10.1007/s10534-005-5420-0; Postle K, 2007, BIOMETALS, V20, P453, DOI 10.1007/s10534-006-9071-6; Rassam P, 2015, NATURE, V523, P333, DOI 10.1038/nature14461; Ritchie K, 2005, BIOPHYS J, V88, P2266, DOI 10.1529/biophysj.104.054106; Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012; Scott DC, 2001, J BIOL CHEM, V276, P13025, DOI 10.1074/jbc.M011282200; Shultis DD, 2006, SCIENCE, V312, P1396, DOI 10.1126/science.1127694; Smallwood CR, 2014, J GEN PHYSIOL, V144, P69, DOI 10.1085/jgp.201311159; Smallwood CR, 2009, MOL MICROBIOL, V72, P1171, DOI 10.1111/j.1365-2958.2009.06715.x; Sverzhinsky A, 2014, STRUCTURE, V22, P791, DOI 10.1016/j.str.2014.02.010; WAYNE R, 1976, J BACTERIOL, V126, P7, DOI 10.1128/JB.126.1.7-12.1976; Young KD, 2010, ANNU REV MICROBIOL, V64, P223, DOI 10.1146/annurev.micro.112408.134102	50	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0160862	10.1371/journal.pone.0160862	http://dx.doi.org/10.1371/journal.pone.0160862			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935943	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100003
J	Lim, JY; Kim, CM; Rhee, JH; Kim, YR				Lim, Ju Young; Kim, Choon-Mee; Rhee, Joon Haeng; Kim, Young Ran			Effects of Pyrogallol on Growth and Cytotoxicity of Wild-Type and katG Mutant Strains of Vibrio vulnificus	PLOS ONE			English	Article							INFECTIONS; RESISTANCE; PATHOGEN; BACTERIA; REVEALS; DEATH; CELLS	Vibrio vulnificus is a causative agent of fatal septicemia and necrotic wound infection and the pathogen infection became an important public health problem in many counties. Vibrio vulnificus causes RtxA1 toxin-induced acute cell death. We tried to identify natural products that inhibit the acute cytotoxicity of V. vulnificus using a lactate hydrogenase assay. A polyphenol pyrogallol protected HeLa cells from V. vulnificus-induced cytotoxicity. Pyrogallol also decreased the growth of V. vulnificus; this inhibitory effect was more significant during log phase than stationary phase. To further elucidate the inhibitory mechanism, pyrogallol-induced toxicity was compared between a V. vulnificus catalase-peroxidase mutant (katG(-)) and the isogenic wild-type MO6-24/O strains. No growth was observed for the katG(-) mutant in the presence of pyrogallol (50 mu g/mL) even after 24 h, whereas the wild-type strain demonstrated growth recovery following a prolonged lag phase. Pyrogallol-mediated growth inhibition of the katG(-) mutant strain was partially rescued by exogenous catalase treatment. These results indicate that the mechanism by which pyrogallol inhibits the growth and cytotoxicity of V. vulnificus likely involves polyphenol-induced prooxidant damage. Taken together, these results suggest that pyrogallol has potential for development as a new paradigm drug to treat infectious diseases.	[Lim, Ju Young; Kim, Young Ran] Chonnam Natl Univ, Coll Pharm, Gwangju, South Korea; [Lim, Ju Young; Kim, Young Ran] Chonnam Natl Univ, Res Inst Drug Dev, Gwangju, South Korea; [Kim, Choon-Mee] Chosun Univ, Sch Med, Premed Sci, Gwangju, South Korea; [Rhee, Joon Haeng] Chonnam Natl Univ, Dept Microbiol, Clin Vaccine Res & Dev Ctr, Sch Med, Gwangju, South Korea	Chonnam National University; Chonnam National University; Chosun University; Chonnam National University	Kim, YR (corresponding author), Chonnam Natl Univ, Coll Pharm, Gwangju, South Korea.; Kim, YR (corresponding author), Chonnam Natl Univ, Res Inst Drug Dev, Gwangju, South Korea.	kimyr@chonnam.ac.kr			Basic Science Research Program - Ministry of Education, Science, and Technology of South Korea [NRF-2015R1A2A2A01002919]	Basic Science Research Program - Ministry of Education, Science, and Technology of South Korea	This work was supported by the Basic Science Research Program (grant NRF-2015R1A2A2A01002919) that is funded by the Ministry of Education, Science, and Technology of South Korea, http://www.nrf.re.kr.	Baker-Austin C, 2009, MICROB ECOL, V57, P151, DOI 10.1007/s00248-008-9413-8; Baruah K, 2015, FREE RADICAL BIO MED, V89, P593, DOI 10.1016/j.freeradbiomed.2015.10.397; Chen CH, 2007, MOL NUTR FOOD RES, V51, P962, DOI 10.1002/mnfr.200600230; Kim BA, 2016, J INFECT DIS, V213, P131, DOI 10.1093/infdis/jiv362; Kim JR, 2010, EUR J PHARMACOL, V642, P163, DOI 10.1016/j.ejphar.2010.05.037; Kim YR, 2008, CELL MICROBIOL, V10, P848, DOI 10.1111/j.1462-5822.2007.01088.x; Kim YR, 2013, J INFECT DIS, V207, P1406, DOI 10.1093/infdis/jis746; Kim YR, 2003, INFECT IMMUN, V71, P5461, DOI 10.1128/IAI.71.10.5461-5471.2003; Na HS, 2011, FEMS IMMUNOL MED MIC, V63, P355, DOI 10.1111/j.1574-695X.2011.00855.x; Ni NT, 2008, BIOORG MED CHEM LETT, V18, P1567, DOI 10.1016/j.bmcl.2008.01.081; Oliver JD, 2013, MICROB ECOL, V65, P793, DOI 10.1007/s00248-012-0140-9; Oliver JD, 2005, EPIDEMIOL INFECT, V133, P383, DOI 10.1017/S0950268805003894; Park JH, 2011, J BACTERIOL, V193, P2062, DOI 10.1128/JB.00110-11; Radu S, 1998, FEMS MICROBIOL LETT, V165, P139, DOI 10.1016/S0378-1097(98)00266-3; Rao NV, 2014, WORLD J MICROB BIOT, V30, P2205, DOI 10.1007/s11274-014-1640-1; REDDY GP, 1992, J BACTERIOL, V174, P2620, DOI 10.1128/JB.174.8.2620-2630.1992; Reyrat JM, 1998, INFECT IMMUN, V66, P4011; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; TACKET CO, 1984, J INFECT DIS, V149, P558, DOI 10.1093/infdis/149.4.558; Taguri T, 2006, BIOL PHARM BULL, V29, P2226, DOI 10.1248/bpb.29.2226; Vezzulli L, 2013, MICROB ECOL, V65, P817, DOI 10.1007/s00248-012-0163-2	21	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167699	10.1371/journal.pone.0167699	http://dx.doi.org/10.1371/journal.pone.0167699			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936080	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100157
J	Ng, DHL; Wong, JGX; Thein, TL; Leo, YS; Lye, DC				Ng, Deborah H. L.; Wong, Joshua G. X.; Thein, Tun-Linn; Leo, Yee-Sin; Lye, David C.			The Significance of Prolonged and Saddleback Fever in Hospitalised Adult Dengue	PLOS ONE			English	Article							SHOCK SYNDROME; VIREMIA; INFECTION; SEVERITY; PATTERN; RISK	Dengue fever is gaining importance in Singapore with an increase in the number of cases and mortality in recent years. Although prolonged and saddleback fever have been reported in dengue fever, there are no specific studies on their significance in dengue. This study aims to examine the prevalence of prolonged and saddleback fever in dengue as well as their associations with dengue severity. A total of 2843 polymerase-chain reaction (PCR) confirmed dengue patients admitted to Tan Tock Seng Hospital from 2004 to 2008 were included in the study. Sixty-nine percent of them were male with a median age of 34 years. Prolonged fever (fever > 7 days duration) was present in 572 (20.1%) of patients. Dengue hemorrhagic fever (DHF), dengue shock syndrome (DSS) and severe dengue (SD) were significantly more likely to occur in patients with prolonged fever. Mucosal bleeding, anorexia, diarrhea, abdominal pain, nausea or vomiting, lethargy, rash, clinical fluid accumulation, hepatomegaly, nosocomial infection, leukopenia, higher neutrophil count, higher hematocrit, higher alanine transaminase (ALT) and aspartate transaminase (AST), higher creatinine, lower protein and prolonged activated partial thromboplastin time (APTT) were significantly associated with prolonged fever but not platelet count or prothrombin time (PT). Saddleback fever was present in 165 (5.8%). Although DHF and SD were more likely to occur in patients in those with saddleback fever, DSS was not. Compared with prolonged fever, saddleback fever did not show many significant associations except for diarrhea, abdominal pain, clinical fluid accumulation, hematocrit and platelet change, and lower systolic blood pressure. This study demonstrates that prolonged fever may be associated with various warning signs and more severe forms of dengue (SD, DSS, DHF), while saddleback fever showed associations with DHF and SD but not DSS. The presence of prolonged or saddleback fever in dengue patients should therefore prompt detailed evaluation for complications of dengue, as well as early investigation to evaluate for development of nosocomial infection.	[Ng, Deborah H. L.; Wong, Joshua G. X.; Thein, Tun-Linn; Leo, Yee-Sin; Lye, David C.] Inst Infect Dis & Epidemiol, Communicable Dis Ctr, Singapore, Singapore; [Leo, Yee-Sin; Lye, David C.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Leo, Yee-Sin; Lye, David C.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Leo, Yee-Sin] Saw Swee Hock Sch Publ Hlth, Singapore, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Ng, DHL (corresponding author), Inst Infect Dis & Epidemiol, Communicable Dis Ctr, Singapore, Singapore.	deborah.ng@mohh.com.sg	Thein, Tun-Linn/Y-9520-2018; Thein, Tun-Linn/K-5281-2019; Lye, David/ABF-4402-2021	Thein, Tun-Linn/0000-0002-5254-032X; Thein, Tun-Linn/0000-0002-5254-032X; Lye, David/0000-0003-0324-0205; Wong, Joshua/0000-0001-8268-5610; Ng, Deborah/0000-0002-5169-2401				Barkham TM, 2006, T ROY SOC TROP MED H, V100, P142, DOI 10.1016/j.trstmh.2005.05.015; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Ghosh Sanat Kumar, 2011, J Indian Med Assoc, V109, P790; GUBLER DJ, 1981, B WORLD HEALTH ORGAN, V59, P623; Lahiri M, 2008, T ROY SOC TROP MED H, V102, P1011, DOI 10.1016/j.trstmh.2008.06.005; Lee IK, 2005, AM J TROP MED HYG, V72, P221, DOI 10.4269/ajtmh.2005.72.221; Lee LK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001676; Lee TH, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004576; Leo YS, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-123; Lum LCS, 2003, J PEDIATR-US, V143, P682, DOI 10.1067/S0022-3476(03)00503-1; Ministry of Health Singapore, 2005, COMM DIS SURV SING 2; Huy NT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002412; Ratageri Vinod H., 2005, Indian Journal of Pediatrics, V72, P705, DOI 10.1007/BF02724083; Rowe EK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002777; Sideridis K, 2003, HEART LUNG, V32, P414, DOI 10.1016/S0147-9563(03)00105-5; Trayers FJ, 2008, MIL MED, V173, P1188, DOI 10.7205/MILMED.173.12.1188; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Vaughn DW, 1997, J INFECT DIS, V176, P322, DOI 10.1086/514048; World Health Organisation Special Programme for Research and Training in Tropical Diseases, 2000, WHO SPEC PORGR RES T; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 1997, DENG HEM FEV DIAGN T, V2nd	22	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167025	10.1371/journal.pone.0167025	http://dx.doi.org/10.1371/journal.pone.0167025			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936002	Green Published, gold			2022-12-27	WOS:000389587100055
J	Sammer, D; Krause, K; Gube, M; Wagner, K; Kothe, E				Sammer, Dominik; Krause, Katrin; Gube, Matthias; Wagner, Katharina; Kothe, Erika			Hydrophobins in the Life Cycle of the Ectomycorrhizal Basidiomycete Tricholoma vaccinum	PLOS ONE			English	Article							FUNGUS PAXILLUS-INVOLUTUS; SCHIZOPHYLLUM-COMMUNE; PISOLITHUS-TINCTORIUS; RESOLUTION STRUCTURE; AERIAL HYPHAE; ORGANIC-ACIDS; RODLET LAYER; GENES; EXPRESSION; SEQUENCE	Hydrophobins-secreted small cysteine-rich, amphipathic proteins-foster interactions of fungal hyphae with hydrophobic surfaces, and are involved in the formation of aerial hyphae. Phylogenetic analyses of Tricholoma vaccinum hydrophobins showed a grouping with hydrophobins of other ectomycorrhizal fungi, which might be a result of co-evolution. Further analyses indicate angiosperms as likely host trees for the last common ancestor of the genus Tricholoma. The nine hydrophobin genes in the T. vaccinum genome were investigated to infer their individual roles in different stages of the life cycle, host interaction, asexual and sexual development, and with respect to different stresses. In aerial mycelium, hyd8 was up-regulated. In silico analysis predicted three packing arrangements, i.e., ring-like, plus-like and sheet-like structure for Hyd8; the first two may assemble to rodlets of hydrophobin covering aerial hyphae, whereas the third is expected to be involved in forming a two-dimensional network of hydrophobins. Metal stress induced hydrophobin gene hyd5. In early steps of mycorrhization, induction of hyd4 and hyd5 by plant root exudates and root volatiles could be shown, followed by hyd5 up-regulation during formation of mantle, Hartig' net, and rhizomorphs with concomitant repression of hyd8 and hyd9. During fruiting body formation, mainly hyd3, but also hyd8 were induced. Host preference between the compatible host Picea abies and the low compatibility host Pinus sylvestris could be linked to a stronger induction of hyd4 and hyd5 by the preferred host and a stronger repression of hyd8, whereas the repression of hyd9 was comparable between the two hosts.	[Sammer, Dominik; Krause, Katrin; Gube, Matthias; Wagner, Katharina; Kothe, Erika] Friedrich Schiller Univ Jena, Inst Microbiol, Jena, Germany; [Sammer, Dominik] Food GmbH Jena, Analyt & Consulting, Jena, Germany; [Gube, Matthias] Univ Gottingen, Dept Soil Sci Temperate Ecosyst, Gottingen, Germany; [Wagner, Katharina] Wacker Biotech GmbH, Jena, Germany	Friedrich Schiller University of Jena; University of Gottingen; Wacker Chemie	Krause, K (corresponding author), Friedrich Schiller Univ Jena, Inst Microbiol, Jena, Germany.	Katrin.Krause@uni-jena.de		Gube, Matthias/0000-0001-5101-3096	International Leibnitz and Research School, Max Planck Society, Germany; German Research Foundation	International Leibnitz and Research School, Max Planck Society, Germany; German Research Foundation(German Research Foundation (DFG))	This research was supported by the International Leibnitz and Research School, Max Planck Society, Germany, and by the German Research Foundation with Graduate School 214 (www.dfg.de).	Ahonen-Jonnarth U, 2000, NEW PHYTOL, V146, P557, DOI 10.1046/j.1469-8137.2000.00653.x; [Anonymous], 2012, PCR PROTOCOLS GUIDE; Asiimwe T, 2012, MYCORRHIZA, V22, P471, DOI 10.1007/s00572-011-0424-9; Bailey TL, 2015, MEME SUITE; Bailey TL, 2009, MEME SUITE TOOLS MOT; BEEVER RE, 1979, J BACTERIOL, V140, P1063, DOI 10.1128/JB.140.3.1063-1070.1979; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; Chauhan JS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067008, 10.1371/journal.pone.0080000]; Chuang HW, 2009, FEMS MICROBIOL LETT, V293, P205, DOI 10.1111/j.1574-6968.2009.01533.x; Creevey C, CRANN SOFTWARE; de Vocht ML, 1998, BIOPHYS J, V74, P2059, DOI 10.1016/S0006-3495(98)77912-3; Ditengou FA, 2015, NAT COMMUN, V6279, P1; Dominguez C, 2003, HADDOCK PROTEIN PROT, DOI [10.1021/ja026939x, DOI 10.1021/JA026939X]; Erdmann S, 2012, EUKARYOT CELL, V11, P571, DOI 10.1128/EC.05214-11; Gasteiger E, PROTEIN IDENTIFICATI, DOI [10.1016/j.jmb.2004.05.028, DOI 10.1016/J.JMB.2004.05.028]; Hakanpaa J, 2006, ACTA CRYSTALLOGR D, V62, P356, DOI 10.1107/S0907444906000862; Hakanpaa J, 2004, J BIOL CHEM, V279, P534, DOI 10.1074/jbc.M309650200; Hektor HJ, 2005, CURR OPIN BIOTECH, V16, P434, DOI 10.1016/j.copbio.2005.05.004; Henke C, 2015, ENVIRON EXP BOT, V110, P56, DOI 10.1016/j.envexpbot.2014.09.009; Hibbett DS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-13; Hibbett DS, 2000, NATURE, V407, P506, DOI 10.1038/35035065; HONEGGER R, 1991, ANNU REV PLANT PHYS, V42, P553, DOI 10.1146/annurev.arplant.42.1.553; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jacob C, 2004, FEBS LETT, V576, P423, DOI 10.1016/j.febslet.2004.09.028; Jarosz-Wilkolazka A, 2002, CELL BIOL INT, V26, P605, DOI 10.1006/cbir.2002.0887; Jentschke G, 2000, PHYSIOL PLANTARUM, V109, P107, DOI 10.1034/j.1399-3054.2000.100201.x; Kallio JM, 2007, J BIOL CHEM, V282, P28733, DOI 10.1074/jbc.M704238200; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kawabata T., 2003, MATRAS PROGRAM PROTE; Kothe E., 2013, AGR APPL, V2nd, P295, DOI [10.1007/978-3-642-36821-9_11, DOI 10.1007/978-3-642-36821-9_11]; Kottke I, 1987, TREES-STRUCT FUNCT, V1, P191, DOI 10.1007/BF00193562; Krause K, 2015, APPL ENVIRON MICROB, V81, P7003, DOI 10.1128/AEM.01991-15; Krause K, 2006, J BASIC MICROB, V46, P387, DOI 10.1002/jobm.200610153; Kriegelsteiner GJ, 2001, GROSSPILZE BADEN WUR, V3; Kwan AHY, 2006, P NATL ACAD SCI USA, V103, P3621, DOI 10.1073/pnas.0505704103; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Linder MB, 2009, CURR OPIN COLLOID IN, V14, P356, DOI 10.1016/j.cocis.2009.04.001; Macindoe I, 2012, P NATL ACAD SCI USA, V109, pE804, DOI 10.1073/pnas.1114052109; Mankel A, 1999, MICROBIOL RES, V153, P377, DOI 10.1016/S0944-5013(99)80053-6; Mankel A, 2002, APPL ENVIRON MICROB, V68, P1408, DOI 10.1128/AEM.68.3.1408-1413.2002; Mankel A, 2000, J APPL BOT-ANGEW BOT, V74, P95; Meade A, 2014, BAYES TRAITS V2; Mgbeahuruike AC, 2013, MYCOLOGIA, V105, P1471, DOI 10.3852/13-077; Morris VK, 2013, J MOL BIOL, V425, P244, DOI 10.1016/j.jmb.2012.10.021; Moser M., 1958, Forstwissenschaftliches Zentralblatt, V77, P32, DOI 10.1007/BF01827194; Moser M., 1960, GATTUNG PHLEGMACIUM, V4, P440; Neumann G, 2007, RHIZOSPHERE BIOCH OR; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Pachlewski R, 1974, STUDIES SYMBIOTIC PR, V1, P228; Pfaffl MW, 2004, BIOSPEKTRUM, V01, P92; Plett JM, 2012, FUNGAL GENET BIOL, V49, P199, DOI 10.1016/j.fgb.2012.01.002; Rajashekar B, 2007, NEW PHYTOL, V174, P399, DOI 10.1111/j.1469-8137.2007.02022.x; Rambaut A, 2009, FIGTREE V1 3 1; Rambaut A, 2009, TRACER V1 5; Raudaskoski M, 2015, MYCORRHIZA, V25, P243, DOI 10.1007/s00572-014-0607-2; RIGOU L, 1995, NEW PHYTOL, V130, P141, DOI 10.1111/j.1469-8137.1995.tb01824.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sandnes A, 2005, SOIL BIOL BIOCHEM, V37, P259, DOI 10.1016/j.soilbio.2004.07.036; Tagu D, 1996, GENE, V168, P93, DOI 10.1016/0378-1119(95)00725-3; TAGU D, 1995, MOL PLANT MICROBE IN, V8, P781; van Wetter MA, 2000, MOL MICROBIOL, V36, P201, DOI 10.1046/j.1365-2958.2000.01848.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; vanWetter MA, 1996, FEMS MICROBIOL LETT, V140, P265, DOI 10.1016/0378-1097(96)00192-9; Wadhwa K, 2012, J BASIC MICROB, V52, P613, DOI 10.1002/jobm.201100407; Wagner K, 2016, ENDOCYT CELL RES, V27, P47; Wagner K, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv120; Wang ZF, 2010, LANGMUIR, V26, P8491, DOI 10.1021/la101240e; WESSELS JGH, 1991, PLANT CELL, V3, P793; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wiemken V, 2002, CURR OPIN PLANT BIOL, V5, P355, DOI 10.1016/S1369-5266(02)00269-8; WOSTEN HAB, 1993, PLANT CELL, V5, P1567; Wosten HAB, 2001, ANNU REV MICROBIOL, V55, P625, DOI 10.1146/annurev.micro.55.1.625; Yang J, 2015, I TASSER SUITE PROTE; Yu L, 2008, MICROBIOL-SGM, V154, P1677, DOI 10.1099/mic.0.2007/015263-0	75	24	24	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167773	10.1371/journal.pone.0167773	http://dx.doi.org/10.1371/journal.pone.0167773			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936063	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100183
J	Silva, FH; Claudino, MA; Calmasini, FB; Alexandre, EC; Franco-Penteado, C; Burnett, AL; Antunes, E; Costa, FF				Silva, Fabio H.; Claudino, Mario A.; Calmasini, Fabiano B.; Alexandre, Eduardo C.; Franco-Penteado, Carla; Burnett, Arthur L.; Antunes, Edson; Costa, Fernando F.			Sympathetic Hyperactivity, Increased Tyrosine Hydroxylase and Exaggerated Corpus Cavernosum Relaxations Associated with Oxidative Stress Plays a Major Role in the Penis Dysfunction in Townes Sickle Cell Mouse	PLOS ONE			English	Article							SOLUBLE GUANYLYL CYCLASE; ERECTILE DYSFUNCTION; SIGNALING PATHWAY; PRIAPISM; DISEASE; MICE; MECHANISM; RESPONSES; THERAPY; TISSUE	Background Sickle cell disease patients display priapism that may progress to erectile dysfunction. However, little is known about the pathophysiological alterations of corpus cavernosum in sickle cell disease. Objective Thus, this study aimed to evaluate the functional and molecular alterations of sympathetic machinery and nitric oxide-cyclic guanosine monophosphate signaling pathway in Townes transgenic sickle cell disease mice. Methods Concentration-response curves to contractile (phenylephrine) and relaxant agents (acetylcholine and sodium nitroprusside) were obtained in corpus cavernosum strips from sickle and C57BL/6 (control) mice. Neurogenic contractions and nitrergic relaxations were obtained using electrical-field stimulation. Measurements of endothelial nitric oxide synthase (eNOS), neuronal nitric oxide synthase (nNOS), phosphodiesterase-5 (PDE5) and a alpha(1A)-, alpha(1B)-and alpha(1D)-adrenoceptor mRNA expressions and reactive-oxygen species were performed. Tyrosine hydroxylase phosphorylated at Ser-31 and total tyrosine hydroxylase protein expressions in cavernosal tissues were also measured. Results The neurogenic contractions were higher in the sickle cell disease group, in association with elevated tyrosine hydroxylase phosphorylated at Ser-31 and total tyrosine hydroxylase protein expression, as well as increased tyrosine hydroxylase mRNA expression. Likewise, phenylephrine-induced contractions were greater in the sickle mice, whereas a alpha(1A)-, alpha(1B)-and alpha(1D)-adrenoceptor mRNA expression remained unchanged. Cavernosal relaxations to acetylcholine, sodium nitroprusside and EFS were higher in sickle mice, accompanied by decreased eNOS and nNOS, along with lower PDE5 mRNA expression. An increase of about 40% in reactive-oxygen species generation in corpus cavernosum from sickle mice was also detected. Conclusion Our study shows that decreased nitric oxide bioavailability in erectile tissue due to increased oxidative stress leads to both sympathetic hyperactivity and dysregulation of nitric oxide signaling in corpus cavernosum from Townes sickle mice.	[Silva, Fabio H.; Franco-Penteado, Carla; Costa, Fernando F.] Univ Estadual Campinas, Fac Med Sci, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil; [Claudino, Mario A.] Univ Sao Francisco, Lab Multidisciplinary Res, Sch Med, Braganca Paulista, SP, Brazil; [Calmasini, Fabiano B.; Alexandre, Eduardo C.; Antunes, Edson] Univ Estadual Campinas, Fac Med Sci, Dept Pharmacol, Campinas, SP, Brazil; [Burnett, Arthur L.] James Buchanan Brady Urol Inst, Baltimore, MD USA; [Burnett, Arthur L.] Johns Hopkins Sch Med, Dept Urol, Baltimore, MD USA	Universidade Estadual de Campinas; Universidade Sao Francisco; Universidade Estadual de Campinas; Johns Hopkins University; Johns Hopkins Medicine	Silva, FH (corresponding author), Univ Estadual Campinas, Fac Med Sci, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil.	fabiohsilva87@gmail.com	Costa, Fernando F/D-1566-2012; Claudino, Mário A/D-5367-2014; SILVA, FABIO HENRIQUE/AAZ-8140-2020; Silva, Fábio/D-5412-2013; Calmasini, Fabiano/S-9691-2019; ANTUNES, EDSON/F-6731-2012	Costa, Fernando F/0000-0002-4632-572X; Silva, Fábio/0000-0003-3374-5570; Calmasini, Fabiano/0000-0002-7790-2550; Claudino, Mario Angelo/0000-0002-3590-9607; ANTUNES, EDSON/0000-0003-2201-8247	Sao Paulo Research Foundation (FAPESP) [2013/19781-2, 2014/00984-3]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The work was supported by Sao Paulo Research Foundation (FAPESP) (www.fapesp.br), grant number: 2013/19781-2 and 2014/00984-3.; Fabio H. Silva and Fernando F. Costa thank Sao Paulo Research Foundation (FAPESP) for financial support (2013/19781-2, 2014/00984-3).	Andersson KE, 2011, PHARMACOL REV, V63, P811, DOI 10.1124/pr.111.004515; Azadzoi KM, 2010, BJU INT, V105, P404, DOI 10.1111/j.1464-410X.2009.08717.x; Bonaventura D, 2008, NITRIC OXIDE-BIOL CH, V18, P287, DOI 10.1016/j.niox.2008.02.004; Burnett AL, 2005, CURR PHARM DESIGN, V11, P3987, DOI 10.2174/138161205774913381; Carson CC, 2005, BJU INT, V96, P257, DOI 10.1111/j.1464-410X.2005.05614.x; Cellek S, 1997, P NATL ACAD SCI USA, V94, P8226, DOI 10.1073/pnas.94.15.8226; Champion HC, 2005, P NATL ACAD SCI USA, V102, P1661, DOI 10.1073/pnas.0407183102; Claudino MA, 2009, J SEX MED, V6, P2187, DOI 10.1111/j.1743-6109.2009.01337.x; Hedlund F, 2000, J UROLOGY, V164, P868, DOI 10.1016/S0022-5347(05)67329-6; Kheirandish P, 2011, BJU INT, V108, P1068, DOI 10.1111/j.1464-410X.2011.10367.x; Kolo LL, 2004, AM J PHYSIOL-HEART C, V286, pH296, DOI 10.1152/ajpheart.00668.2003; Lagoda G, 2013, J UROLOGY, V189, P762, DOI 10.1016/j.juro.2012.08.198; Lin CS, 2002, INT J IMPOT RES, V14, P15, DOI 10.1038/sj.ijir.3900802; Lue TF, 2000, NEW ENGL J MED, V342, P1802, DOI 10.1056/NEJM200006153422407; Macarthur H, 2011, ACTA PHYSIOL, V203, P37, DOI 10.1111/j.1748-1716.2010.02242.x; Morrison JFB, 2007, MOL CELL BIOCHEM, V295, P53, DOI 10.1007/s11010-006-9271-y; Moy LY, 2004, J BIOL CHEM, V279, P54487, DOI 10.1074/jbc.M406636200; Muniz JJ, 2015, LIFE SCI, V141, P44, DOI 10.1016/j.lfs.2015.09.017; Nakashima A, 2009, J NEURAL TRANSM, V116, P1355, DOI 10.1007/s00702-009-0227-8; Nangle MR, 2004, PFLUG ARCH EUR J PHY, V448, P139, DOI 10.1007/s00424-003-1232-7; Ning C, 2014, FASEB J, V28, P2725, DOI 10.1096/fj.13-247833; Nur E, 2011, AM J HEMATOL, V86, P484, DOI 10.1002/ajh.22012; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Salonia A, 2014, EUR UROL, V65, P480, DOI 10.1016/j.eururo.2013.11.008; SCHWARZ P, 1995, CIRC RES, V77, P841, DOI 10.1161/01.RES.77.4.841; Silva FH, 2014, AM J PHYSIOL-HEART C, V307, pH1393, DOI 10.1152/ajpheart.00708.2013; Silva FH, 2014, J SEX MED, V11, P2661, DOI 10.1111/jsm.12682; TAMURA M, 1995, J UROLOGY, V153, P530, DOI 10.1097/00005392-199502000-00077; Toque HA, 2011, BJU INT, V107, P1628, DOI 10.1111/j.1464-410X.2010.09704.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wu LC, 2006, BLOOD, V108, P1183, DOI 10.1182/blood-2006-02-004812	32	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166291	10.1371/journal.pone.0166291	http://dx.doi.org/10.1371/journal.pone.0166291			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935981	gold, Green Submitted, Green Published			2022-12-27	WOS:000389587100023
J	Stockman, VB; Ghamsari, L; Lasso, G; Honig, B; Shapira, SD; Wang, HH				Stockman, Victoria B.; Ghamsari, Lila; Lasso, Gorka; Honig, Barry; Shapira, Sagi D.; Wang, Harris H.			A High-Throughput Strategy for Dissecting Mammalian Genetic Interactions	PLOS ONE			English	Article							HUMAN-CELLS; RNA; CRISPR-CAS9; CAS9; NETWORKS; COMPLEX; VECTOR; SYSTEM; YEAST	Comprehensive delineation of complex cellular networks requires high -throughput interrogation of genetic interactions. To address this challenge, we describe the development of a multiplex combinatorial strategy to assess pairwise genetic interactions using CRISPR-Cas9 genome editing and next-generation sequencing. We characterize the performance of combinatorial genome editing and analysis using different promoter and gRNA designs and identified regions of the chimeric RNA that are compatible with next-generation sequencing preparation and quantification. This approach is an important step towards elucidating genetic networks relevant to human diseases and the development of more efficient Cas9based therapeutics.	[Stockman, Victoria B.; Ghamsari, Lila; Lasso, Gorka; Honig, Barry; Shapira, Sagi D.; Wang, Harris H.] Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY 10027 USA; [Ghamsari, Lila; Shapira, Sagi D.] Columbia Univ, Dept Microbiol & Immunol, Med Ctr, New York, NY 10027 USA; [Lasso, Gorka; Honig, Barry] Columbia Univ, Dept Biochem, Med Ctr, New York, NY USA; [Wang, Harris H.] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; Columbia University	Shapira, SD; Wang, HH (corresponding author), Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY 10027 USA.; Shapira, SD (corresponding author), Columbia Univ, Dept Microbiol & Immunol, Med Ctr, New York, NY 10027 USA.; Wang, HH (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY 10027 USA.	ss4197@columbia.edu; hw2429@columbia.edu	Lasso, Gorka/GYV-3393-2022; Cabrera, Gorka Lasso/ABD-1962-2020	Cabrera, Gorka Lasso/0000-0001-5355-323X; Honig, Barry/0000-0002-1835-1031; Wang, Harris/0000-0003-2164-4318	NIH [1DP5OD009172-02, 1U01GM110714-01A1]; NSF [MCB-1453219]; Sloan Foundation [FR-2015-65795]; DARPA [W911NF-15-2-0065]; ONR [N00014-15-1-2704]; NIH R01 [GM109018-04]; NIH U54 [CA21852-07]; NATIONAL CANCER INSTITUTE [U54CA121852, U54CA209997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM110714, R01GM109018, R01GM030518] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021764, DP5OD009172, S10OD012351] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Sloan Foundation(Alfred P. Sloan Foundation); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); ONR(Office of Naval Research); NIH R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH U54(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHW acknowledges funding from NIH (1DP5OD009172-02, 1U01GM110714-01A1), NSF (MCB-1453219), Sloan Foundation (FR-2015-65795), DARPA (W911NF-15-2-0065), and ONR (N00014-15-1-2704). SDS acknowledges funding from NIH R01 (GM109018-04) and NIH U54 (CA21852-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; H.H.W. acknowledges funding from NIH (1DP5OD009172-02, 1U01GM110714-01A1), NSF (MCB-1453219), Sloan Foundation (FR-2015-65795), DARPA (W911NF-15-2-0065), and ONR (N00014-15-1-2704). S.S. acknowledges funding from NIH R01 (GM109018-04) and NIH U54 (CA121852-07). We thank Beatrice Leitao, Nathan Johns and Jacky Cheung for technical assistance and members of the Shapira and Wang labs for helpful discussions. We additionally thank Michael Metzger and Stephen Goff for providing reagents including an eGFP cell line.	Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wong ASL, 2016, P NATL ACAD SCI USA, V113, P2544, DOI 10.1073/pnas.1517883113; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	24	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167617	10.1371/journal.pone.0167617	http://dx.doi.org/10.1371/journal.pone.0167617			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936040	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100131
J	Xiang, Y; Wang, XZ; He, LH; Wang, WY; Moran, W				Xiang, Yu; Wang, Xuezhi; He, Lihua; Wang, Wenyong; Moran, William			Spatial-Temporal Analysis of Environmental Data of North Beijing District Using Hilbert-HuangTransform	PLOS ONE			English	Article							EMPIRICAL MODE DECOMPOSITION; VARIABILITY; TEMPERATURE	Temperature, solar radiation and water are major important variables in ecosystem models which are measurable via wireless sensor networks (WSN). Effective data analysis is necessary to extract significant spatial and temporal information. In this work, information regarding the long term variation of seasonal field environment conditions is explored using Hilbert-Huang transform (HHT) based analysis on the wireless sensor network data collection. The data collection network, consisting of 36 wireless nodes, covers an area of 100 square kilometres in Yanqing, the northwest of Beijing CBD, in China and data collection involves environmental parameter observations taken over a period of three months in 2011. The analysis used the empirical mode decomposition (EMD/EEMD) to break a time sequence of data down to a finite set of intrinsic mode functions (IMFs). Both spatial and temporal properties of data explored by HHT analysis are demonstrated. Our research shows potential for better understanding the spatial-temporal relationships among environmental parameters using WSN and HHT.	[Xiang, Yu; He, Lihua; Wang, Wenyong] Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Chengdu, Sichuan, Peoples R China; [Wang, Xuezhi; Moran, William] RMIT Univ, Sch Elect & Comp Engn, Melbourne, Vic, Australia; [He, Lihua] Guilin Univ Aerosp Technol, Sch Comp Sci & Engn, Guilin, Guangxi, Peoples R China	University of Electronic Science & Technology of China; Royal Melbourne Institute of Technology (RMIT); Guilin University of Aerospace Technology	Xiang, Y (corresponding author), Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Chengdu, Sichuan, Peoples R China.	jcxiang@uestc.edu.cn	Xiang, Yu/P-5005-2016	Xiang, Yu/0000-0001-9622-7661				[Anonymous], 2004, P 2 INT C EMB NETW S, DOI DOI 10.1145/1031495.1031560; Barnhart BL, 2011, J ATMOS SOL-TERR PHY, V73, P1771, DOI 10.1016/j.jastp.2011.04.012; Biswas A, 2013, GEODERMA, V209, P57, DOI 10.1016/j.geoderma.2013.06.003; Bogena HR, 2010, VADOSE ZONE J, V9, P1002, DOI 10.2136/vzj2009.0173; Feng HH, 2015, REMOTE SENS-BASEL, V7, P5398, DOI 10.3390/rs70505398; Houbing Song CB., 2016, CYBER PHYS SYSTEMS F; Hu B, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007965; Hu W, 2014, CATENA, V113, P377, DOI 10.1016/j.catena.2013.08.024; Huang NE, 2005, INTERD MATH SCI, V5, P1; Huang NE, 2009, ADV DATA SCI ADAPT, V1, P177, DOI 10.1142/S1793536909000096; Jiang DD, 2016, IEEE ACCESS, V4, P3046, DOI 10.1109/ACCESS.2016.2573264; Langendoen K., 2006, P 20 IEEE INT PAR DI, P155; Li SN, 2016, IEEE ACCESS, V4, P4484, DOI 10.1109/ACCESS.2016.2600623; Lin Y., 2006, IEEE PERVAS COMPUT, V4, P65; Mandic DP, 2013, IEEE SIGNAL PROC MAG, V30, P74, DOI 10.1109/MSP.2013.2267931; Massei N, 2012, J HYDROL, V448, P119, DOI 10.1016/j.jhydrol.2012.04.052; Miralles DG, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053703; Morais R., 2005, P 5 EUR FED INF TECH, P845; Othman MF, 2012, PROCEDIA ENGINEER, V41, P1204, DOI 10.1016/j.proeng.2012.07.302; Ouyang ZT, 2014, ECOL COMPLEX, V19, P46, DOI 10.1016/j.ecocom.2014.04.005; Seneviratne SI, 2010, EARTH-SCI REV, V99, P125, DOI 10.1016/j.earscirev.2010.02.004; Urbanski S, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000293; van Dijk Albert IJM, 2005, GLOBAL BIOGEOCHEMICA, V19; Wang ZH, 2015, IEEE COMMUN MAG, V53, P216, DOI 10.1109/MCOM.2015.7105668; Western AW, 1998, J HYDROL, V205, P20, DOI 10.1016/S0022-1694(97)00142-X; Wu ZH, 2007, P NATL ACAD SCI USA, V104, P14889, DOI 10.1073/pnas.0701020104; Wu ZH, 2010, ADV DATA SCI ADAPT, V2, P397, DOI 10.1142/S1793536910000604; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; Xiao XM, 2004, REMOTE SENS ENVIRON, V91, P256, DOI 10.1016/j.rse.2004.03.010; Yang T, 2015, APPL RES CO IN PRESS; Yao XM, 2009, 2009 WRI INTERNATIONAL CONFERENCE ON COMMUNICATIONS AND MOBILE COMPUTING: CMC 2009, VOL 2, P9, DOI 10.1109/CMC.2009.111; Zhou QP, 2014, SCI TOTAL ENVIRON, V496, P264, DOI 10.1016/j.scitotenv.2014.07.051; Zhu XD, 2010, J GEOGR SCI, V20, P803, DOI 10.1007/s11442-010-0812-7	33	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167662	10.1371/journal.pone.0167662	http://dx.doi.org/10.1371/journal.pone.0167662			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936056	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100143
J	Yang, XL; Zhao, L; Li, SQ; Ma, SC; Yang, AN; Ning, D; Li, N; Jia, YX; Yang, XM; Li, GZ; Jiang, YD				Yang Xiaoling; Zhao Li; Li ShuQiang; Ma Shengchao; Yang Anning; Ding Ning; Li Nan; Jia Yuexia; Yang Xiaoming; Li Guizhong; Jiang Yideng			Hyperhomocysteinemia in ApoE-/- Mice Leads to Overexpression of Enhancer of Zeste Homolog 2 via miR-92a Regulation	PLOS ONE			English	Article							ARGININE METHYLATION; DNA METHYLATION; HISTONE; PROTEIN; LYSINE; HYPOMETHYLATION; ATHEROSCLEROSIS; TRIMETHYLATION; HOMOCYSTEINE; EPIGENETICS	Hyperhomocysteinemia (HHcy) is an independent risk factor for cardiovascular diseases, such as atherosclerosis. HHcy promotes atherogenesis by modifying the histone methylation patterns and miRNA regulation. In this study, we investigated the effects of homocysteine (Hcy) on the expression of enhancer of zeste homolog 2 (EZH2), and tested our hypothesis that Hcy-induced atherosclerosis is mediated by increased EZH2 expression, which is regulated by miR-92a. The levels of EZH2 and H3K27me3 were increased in the aorta of ApoE-/- mice fed a high-methionine diet for 16 weeks, whereas miR-92a expression was decreased. Over-expression of EZH2 increased H3K27me3 level and the accumulation of total cholesterol and triglycerides in the foam cells. Furthermore, upregulation of miR-92a reduced EZH2 expression in the foam cells. These data suggested that EZH2 plays a key role in Hcy-mediated lipid metabolism disorders, and that miR-92a may be a novel therapeutic target in Hcy-related atherosclerosis.	[Yang Xiaoling; Zhao Li; Li ShuQiang; Ma Shengchao; Yang Anning; Ding Ning; Li Nan; Jia Yuexia; Yang Xiaoming; Li Guizhong; Jiang Yideng] Ningxia Med Univ, Basic Med Sch, Key Lab Cardiocerebro Vasc Dis, Ningxia, Peoples R China; [Yang Xiaoling] Inst Med Sci Ningxia, Ningxia, Peoples R China	Ningxia Medical University	Jiang, YD (corresponding author), Ningxia Med Univ, Basic Med Sch, Key Lab Cardiocerebro Vasc Dis, Ningxia, Peoples R China.	yangxl@nxmu.edu.cn	Jiang, Yideng/Q-1329-2019		National Natural Science Foundation of China [81360027, 81360052, 81360053, 81460080]; Provincial Natural Science Foundation of Ningxia [NZ15209]; Education Department Foundation of Ningxia [NGY2015092, NGY2015084]; Ningxia Medical University Foundation [XY201505]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Natural Science Foundation of Ningxia; Education Department Foundation of Ningxia; Ningxia Medical University Foundation	This work was supported in part by grants from the National Natural Science Foundation of China (81360027, 81360052, 81360053, 81460080), the Provincial Natural Science Foundation of Ningxia (NZ15209), the Education Department Foundation of Ningxia (NGY2015092, NGY2015084) and the Ningxia Medical University Foundation (XY201505). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araldi E, 2015, CURR VASC PHARMACOL, V13, P291, DOI 10.2174/15701611113119990012; Boros J, 2014, MOL CELL BIOL, V34, P3662, DOI 10.1128/MCB.00205-14; Byrne K, 2014, ANIM GENET, V45, P427, DOI 10.1111/age.12145; Cao Y, 2014, EUR REV MED PHARMACO, V18, P3097; Chen KC, 2011, FASEB J, V25, P1718, DOI 10.1096/fj.10-174904; Esse R, 2014, FASEB J, V28, P2686, DOI 10.1096/fj.13-246579; Esse R, 2013, BBA-MOL BASIS DIS, V1832, P1708, DOI 10.1016/j.bbadis.2013.05.013; Fang Y, 2012, ARTERIOSCL THROM VAS, V32, P979, DOI 10.1161/ATVBAHA.111.244053; Gatti M, 2012, CELL CYCLE, V11, P2538, DOI 10.4161/cc.20919; Gurok U, 2007, EUR J NEUROSCI, V26, P1079, DOI 10.1111/j.1460-9568.2007.05734.x; He QY, 2015, CELL STEM CELL, V17, P273, DOI 10.1016/j.stem.2015.07.022; Inoue S, 2015, NUTRITION, V31, P366, DOI 10.1016/j.nut.2014.07.017; Jiao LY, 2015, SCIENCE, V350, DOI 10.1126/science.aac4383; Kalani A, 2013, MOL NEUROBIOL, V48, P157, DOI 10.1007/s12035-013-8421-y; Liang Y, 2014, SOC INDIC RES, V116, P307, DOI 10.1007/s11205-013-0280-4; Lillico R, 2016, J PROTEOMICS, V133, P125, DOI 10.1016/j.jprot.2015.12.018; Liu FH, 2015, INT J CLIN EXP PATHO, V8, P4972; Liu T, 2011, GENOME RES, V21, P227, DOI 10.1101/gr.115519.110; Luan Y, 2015, ORGANIC BIOMOLECULAR, V14, P631; Mishra PK, 2009, CELL BIOCHEM BIOPHYS, V55, P153, DOI 10.1007/s12013-009-9063-6; Pommier AJC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003483; Reynolds LM, 2015, CIRC-CARDIOVASC GENE, V8, P707, DOI 10.1161/CIRCGENETICS.115.001097; Tikoo K, 2015, BIOCHEM PHARMACOL, V93, P343, DOI 10.1016/j.bcp.2014.11.013; Watanabe K, 2015, CANCER MED-US, V4, P1573, DOI 10.1002/cam4.505; Wierda RJ, 2015, LIFE SCI, V129, P3, DOI 10.1016/j.lfs.2014.10.010; Yang XW, 2014, ADV MATER SCI ENG, V2014, DOI 10.1155/2014/697170; Zhao Li, 2015, Shengli Xuebao, V67, P207; Zhou XX, 2016, J AM SOC NEPHROL, V27, P2092, DOI 10.1681/ASN.2015040457	28	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167744	10.1371/journal.pone.0167744	http://dx.doi.org/10.1371/journal.pone.0167744			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936205	Green Submitted, gold, Green Published			2022-12-27	WOS:000389587100172
J	Kilpelainen, M; Theeuwes, J				Kilpelainen, Markku; Theeuwes, Jan			Efficient Avoidance of the Penalty Zone in Human Eye Movements	PLOS ONE			English	Article							SACCADES; REWARD; INTEGRATION; INFORMATION; DISTRACTOR; SELECTION; CAPTURE; TARGET	People use eye movements extremely effectively to find objects of interest in a cluttered visual scene. Distracting, task-irrelevant attention capturing regions in the visual field should be avoided as they jeopardize the efficiency of search. In the current study, we used eye tracking to determine whether people are able to avoid making saccades to a predetermined visual area associated with a financial penalty, while making fast and accurate saccades towards stimuli placed near the penalty area. We found that in comparison to the same task without a penalty area, the introduction of a penalty area immediately affected eye movement behaviour: the proportion of saccades to the penalty area was immediately reduced. Also, saccadic latencies increased, but quite modestly, and mainly for saccades towards stimuli near the penalty area. We conclude that eye movement behaviour is under efficient cognitive control and thus quite flexible: it can immediately be adapted to changing environmental conditions to improve reward outcome.	[Kilpelainen, Markku] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Theeuwes, Jan] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands	University of Helsinki; Vrije Universiteit Amsterdam	Kilpelainen, M (corresponding author), Univ Helsinki, Inst Behav Sci, Helsinki, Finland.	markku.kilpelainen@helsinki.fi	Theeuwes, Jan/ABF-3771-2020; Kilpeläinen, Markku/AAF-3420-2021; Kilpeläinen, Markku/C-7613-2011	Kilpeläinen, Markku/0000-0002-4112-7548; Kilpeläinen, Markku/0000-0002-4112-7548; Theeuwes, Jan/0000-0002-5849-7721	Academy of Finland [266007]; ERC [ERC-2012-AdG - 323413]	Academy of Finland(Academy of Finland); ERC(European Research Council (ERC)European Commission)	This work was supported by Academy of Finland grant (266007) to MK and ERC advanced grant (ERC-2012-AdG - 323413) to JT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews TJ, 1999, VISION RES, V39, P2947, DOI 10.1016/S0042-6989(99)00019-X; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Blaukopf CL, 2006, EXP BRAIN RES, V174, P786, DOI 10.1007/s00221-006-0685-2; Bucker B, 2015, VISION RES, V108, P103, DOI 10.1016/j.visres.2015.01.020; Carpenter RHS, 2000, CURR BIOL, V10, pR291, DOI 10.1016/S0960-9822(00)00430-9; Chelazzi L, 2014, J NEUROSCI, V34, P8594, DOI 10.1523/JNEUROSCI.0277-14.2014; Chou IH, 1999, VISION RES, V39, P4200, DOI 10.1016/S0042-6989(99)00133-9; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; DEJONG R, 1995, J EXP PSYCHOL HUMAN, V21, P498, DOI 10.1037/0096-1523.21.3.498; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Deubel H., 1984, THEORETICAL APPL ASP, P55, DOI DOI 10.1016/S0166-4115(08)61818-X; Godijn R, 2003, J EXP PSYCHOL HUMAN, V29, P882, DOI 10.1037/0096-1523.29.5.882; Godijn R, 2002, J EXP PSYCHOL HUMAN, V28, P1039, DOI 10.1037//0096-1523.28.5.1039; GUITTON D, 1985, EXP BRAIN RES, V58, P455; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Kilpelainen M, 2013, J VISION, V13, DOI 10.1167/13.6.5; Kleiner M, 2007, PERCEPTION, V36, P14; Ludwig CJH, 2002, J EXP PSYCHOL HUMAN, V28, P902, DOI 10.1037//0096-1523.28.4.902; Munneke J, 2008, ACTA PSYCHOL, V129, P101, DOI 10.1016/j.actpsy.2008.05.004; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; OTTES FP, 1985, VISION RES, V25, P849, DOI 10.1016/0042-6989(85)90193-2; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Ross M, 2011, NEUROSCIENCE, V196, P168, DOI 10.1016/j.neuroscience.2011.08.006; Ruff CC, 2006, J COGNITIVE NEUROSCI, V18, P522, DOI 10.1162/jocn.2006.18.4.522; Schiller PH, 2001, PROG BRAIN RES, V134, P127; Schutz AC, 2012, P NATL ACAD SCI USA, V109, P7547, DOI 10.1073/pnas.1115638109; Schutz AC, 2011, J VIS, V11; Tatler BW, 2011, J VISION, V11, DOI 10.1167/11.5.5; Theeuwes J, 1998, PSYCHOL SCI, V9, P379, DOI 10.1111/1467-9280.00071; Theeuwes J, 1999, J EXP PSYCHOL HUMAN, V25, P1595, DOI 10.1037/0096-1523.25.6.1595; Van der Stigchel S, 2006, NEUROSCI BIOBEHAV R, V30, P666, DOI 10.1016/j.neubiorev.2005.12.001; Van der Stigchel S, 2011, J EYE MOVEMENT RES, V4; Verbruggen F, 2008, TRENDS COGN SCI, V12, P418, DOI 10.1016/j.tics.2008.07.005	33	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167956	10.1371/journal.pone.0167956	http://dx.doi.org/10.1371/journal.pone.0167956			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4OA	27930724	Green Published, Green Submitted, gold			2022-12-27	WOS:000389580900063
J	Lankarani, KB; Malek-Hosseini, SA; Nikeghbalian, S; Dehghani, M; Pourhashemi, M; Kazemi, K; Janghorban, P; Akbari, M; Ghahramani, S; Eghtesad, B; Moini, M; Jaberi, AR; Shamsaifar, A; Gholami, S; Rahmanian, F; Geramizadeh, B				Lankarani, Kamran B.; Malek-Hosseini, Seyed Ali; Nikeghbalian, Saman; Dehghani, Mohsen; Pourhashemi, Mohammad; Kazemi, Kourosh; Janghorban, Parisa; Akbari, Maryam; Ghahramani, Sulmaz; Eghtesad, Bijan; Moini, Maryam; Jaberi, Abbas Rahmi; Shamsaifar, Alireza; Gholami, Siavosh; Rahmanian, Fatemeh; Geramizadeh, Bita			Fourteen Years of Experience of Liver Transplantation for Wilson's Disease; a Report on 107 Cases from Shiraz, Iran	PLOS ONE			English	Article							OUTCOMES; DIAGNOSIS	Background and Aim Liver transplantation is a potential cure for liver damage from Wilson's disease but the course of neuropsychiatric manifestations after transplantation remains undetermined. Material and methods In this study, data on all patients who'd received a liver transplant for Wilson's disease at the Shiraz Organ Transplantation Center between December 2000 and March 2014 were reviewed and compared to data on a control group who'd received a liver transplant over the same period but due to other causes. Results Out of 2198 patients who'd received a liver transplant in the period; 107 patients were diagnosed with Wilson's disease (21 with fulminant hepatic failure); age of patient ranged from 5 to 59 years; 56.07% of patients in this series had some type of neuropsychiatric manifestation before transplantation, of which 66.67% showed improvement after the procedure. 18 patients had aggravation of neuropsychiatric symptoms after transplantation. These neuropsychiatric symptoms were mostly for anxiety, tremor and depression but there were four cases of new onset dysarthria, rigidity and ataxia in various combinations. Survival rates of 1-month, 1-year, and 5-years for patients with Wilson's disease were 88%, 86%, 82%, respectively, evaluations were not statistically different from that of the control group. Conclusions Liver transplantation showed good long-term results in patients with Wilson's disease, even in those presenting fulminant hepatic failure. Neuropsychiatric manifestations normally show improvement after transplantation but in some cases new onset of manifestations occurred after successful liver transplantation.	[Lankarani, Kamran B.; Pourhashemi, Mohammad; Akbari, Maryam; Ghahramani, Sulmaz] Shiraz Univ Med Sci, Ctr Hlth Policy Res, Shiraz, Iran; [Malek-Hosseini, Seyed Ali; Nikeghbalian, Saman; Kazemi, Kourosh; Janghorban, Parisa; Shamsaifar, Alireza; Gholami, Siavosh; Geramizadeh, Bita] Shiraz Univ Med Sci, Shiraz Transplant Res Ctr, Shiraz, Iran; [Dehghani, Mohsen] Shiraz Univ Med Sci, Pediat Gastroenterol & Hepatol Dept, Shiraz, Iran; [Eghtesad, Bijan] Cleveland Clin, Transplant Ctr, Cleveland, OH 44106 USA; [Moini, Maryam; Rahmanian, Fatemeh] Shiraz Univ Med Sci, Gastroenterohepatol Res Ctr, Shiraz, Iran; [Jaberi, Abbas Rahmi] Shiraz Univ Med Sci, Shiraz Neurol Res Ctr, Shiraz, Iran	Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science; Cleveland Clinic Foundation; Shiraz University of Medical Science; Shiraz University of Medical Science	Lankarani, KB (corresponding author), Shiraz Univ Med Sci, Ctr Hlth Policy Res, Shiraz, Iran.	lankaran@sums.ac.ir	Ghahramani, Sulmaz/S-3942-2019; Geramizadeh, Bita/AAA-9497-2021; Shamsaeefar, Alireza/Z-5309-2019; Kazemi, Kourosh/AAW-9184-2020; Malek-Hosseini, Seyed Ali/AAQ-9080-2021; Lankarani, Kamran B/P-5336-2019; Ghahramani, Sulmaz/S-7384-2017; Nikeghbalian, Saman/T-6992-2019; Rahmanian, Fatemeh/L-9036-2016; lankarani, kamran b/D-5901-2012; Moini, Maryam/C-5213-2018; Lankarani, Kamran Bagheri/P-2066-2017; Dehghani, Seyed Mohsen/A-9226-2018	Ghahramani, Sulmaz/0000-0002-4161-5146; Geramizadeh, Bita/0000-0002-4867-5686; Shamsaeefar, Alireza/0000-0003-3798-6064; Kazemi, Kourosh/0000-0003-4477-7121; Malek-Hosseini, Seyed Ali/0000-0002-0853-9938; Lankarani, Kamran B/0000-0002-7524-9017; Ghahramani, Sulmaz/0000-0002-4161-5146; Nikeghbalian, Saman/0000-0003-4530-8829; Rahmanian, Fatemeh/0000-0003-4270-5554; Moini, Maryam/0000-0001-9619-4206; Lankarani, Kamran Bagheri/0000-0002-7524-9017; Dehghani, Seyed Mohsen/0000-0001-5930-0110; Rahimi jaberi, Abbas/0000-0002-3402-6060	Shiraz University of Medical Sciences	Shiraz University of Medical Sciences	This work was funded by Shiraz University of Medical Sciences for access to data and software costs but the authors received no specific funding for this work.	Ala A, 2007, LANCET, V369, P397, DOI 10.1016/S0140-6736(07)60196-2; Annema C, 2015, LIVER TRANSPLANT, V21, P524, DOI 10.1002/lt.24075; BELLARY S, 1995, J HEPATOL, V23, P373, DOI 10.1016/0168-8278(95)80194-4; Borhani-Haghighi A, 2005, TRANSPL P, V37, P3197, DOI 10.1016/j.transproceed.2005.08.025; Catana AM, 2012, WORLD J HEPATOL, V4, P5, DOI 10.4254/wjh.v4.i1.5; Coffey AJ, 2013, BRAIN, V136, P1476, DOI 10.1093/brain/awt035; Dalvi A, 2014, DM-DIS MON, V60, P450, DOI 10.1016/j.disamonth.2014.07.002; Dare AJ, 2014, LIVER TRANSPLANT, V20, P281, DOI 10.1002/lt.23818; DUBOIS RS, 1971, LANCET, V1, P505; Eghtesad B, 1999, LIVER TRANSPLANT SUR, V5, P467, DOI 10.1002/lt.500050614; Emre S, 2001, TRANSPLANTATION, V72, P1232, DOI 10.1097/00007890-200110150-00008; Ferenci P, 2003, LIVER INT, V23, P139, DOI 10.1034/j.1600-0676.2003.00824.x; Geissler I, 2003, TRANSPLANTATION P; Gollan John L., 1998, Journal of Hepatology, V28, P28, DOI 10.1016/S0168-8278(98)80373-5; Guillaud O, 2014, J HEPATOL, V60, P579, DOI 10.1016/j.jhep.2013.10.025; Haseli N, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.10257; Lankarani KB, 2013, ARCH IRAN MED, V16, P64, DOI 013162/AIM.003; Malek-Hosseini S-A, 2002, ARCH IRAN MED, V5, P213; Martinez-Camacho A, 2009, J HEPATOL, V50, pS23, DOI 10.1016/S0168-8278(09)60055-6; ODER W, 1991, J NEUROL, V238, P281; Peedikayil MC, 2013, WORLD J HEPATOL, V5, P127, DOI 10.4254/wjh.v5.i3.127; Roberts EA, 2003, HEPATOLOGY, V37, P1475, DOI 10.1053/jhep.2003.50252; Saberifiroozi Mehdi, 2006, Indian J Gastroenterol, V25, P11; SCHILSKY ML, 1994, HEPATOLOGY, V19, P583, DOI 10.1002/hep.1840190307; Semis S, 2008, TRANSPL P, V40, P228, DOI 10.1016/j.transproceed.2007.11.007; STARZL TE, 1971, TRANSPLANT P, V3, P308; Taly AB, 2007, MEDICINE, V86, P112, DOI 10.1097/MD.0b013e318045a00e; Wadhwa S, 2013, CANCER LETT, V337, P8, DOI 10.1016/j.canlet.2013.05.027; Weiss KH, 2013, CLIN TRANSPLANT, V27, P914, DOI 10.1111/ctr.12259	29	10	10	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167890	10.1371/journal.pone.0167890	http://dx.doi.org/10.1371/journal.pone.0167890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930723	gold, Green Published, Green Submitted			2022-12-27	WOS:000389580900056
J	Patel, RC; Odoyo, J; Anand, K; Stanford-Moore, G; Wakhungu, I; Bukusi, EA; Baeten, JM; Brown, JM				Patel, Rena C.; Odoyo, Josephine; Anand, Keerthana; Stanford-Moore, Gaelen; Wakhungu, Imeldah; Bukusi, Elizabeth A.; Baeten, Jared M.; Brown, Joelle M.			Facilitators and Barriers of Antiretroviral Therapy Initiation among HIV Discordant Couples in Kenya: Qualitative Insights from a Pre-Exposure Prophylaxis Implementation Study	PLOS ONE			English	Article							TEST-AND-TREAT; ADHERENCE; CARE; INTERVENTIONS; STRATEGIES; ENGAGEMENT; RETENTION; ATTITUDES; REASONS; ACCESS	Introduction The World Health Organization now recommends antiretroviral therapy (ART) initiation for all HIV-infected individuals regardless of CD4 cell count or disease status. Understanding the facilitators and barriers to initiation of and adherence to ART is essential to successful scale-up of "universal" ART. Methods To investigate facilitators and barriers to ART initiation, we conducted 44 in-depth individual or couple interviews with 63 participants (33 participants with HIV and 30 without HIV) already enrolled in a prospective implementation study of oral antiretroviral-based prevention in Kisumu, Kenya between August and September 2014. A semi-structured interview guided discussions on: 1) perceived advantages and disadvantages of ART; 2) reasons for accepting or declining ART initiation; and 3) influence of prevention of transmission to partner or infant influencing ART use. Transcripts from the interviews were iteratively analyzed using inductive content analysis. Results HIV-infected participants indicated that living a healthier life, preventing HIV transmission to others, and appearing "normal" or "healthy" again facilitated their initiation of ART. While appearing "normal" allowed these individuals to interact with their communities without stigmatization, they also perceived community opposition to their initiating ART, because appearing "normal" again prevented community members from easily identifying infected individuals in their community. Denial of diagnosis, disclosure stigma, perceived side-effects, and challenges in obtaining refills were additional barriers to ART initiation. Conclusions Community perceptions play an important role in both facilitating and inhibiting ART initiation. Perceived stigma, including perceived community opposition to widespread ART use, is an important barrier to ART initiation. Addressing such barriers, while capitalizing on facilitators, to ART initiation should be central to universal ART scale-up efforts.	[Patel, Rena C.] Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA; [Odoyo, Josephine; Wakhungu, Imeldah; Bukusi, Elizabeth A.] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Kisumu, Kenya; [Anand, Keerthana] Northwestern Univ, Chicago, IL 60611 USA; [Stanford-Moore, Gaelen] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; [Bukusi, Elizabeth A.] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Bukusi, Elizabeth A.; Baeten, Jared M.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Baeten, Jared M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Baeten, Jared M.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Brown, Joelle M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Brown, Joelle M.] Univ Calif San Francisco, Dept Obstet, San Francisco, CA 94143 USA; [Brown, Joelle M.] Univ Calif San Francisco, Dept Gynecol, San Francisco, CA 94143 USA; [Brown, Joelle M.] Univ Calif San Francisco, Dept Reprod Sci, San Francisco, CA 94143 USA	University of Washington; University of Washington Seattle; Kenya Medical Research Institute; Northwestern University; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Patel, RC (corresponding author), Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA.	rcpatel@uw.edu			U.S. National Institute of Health (NIH) National Institute of Mental Health [K01MH100994]; Kenya Medical Research Institute (KEMRI); NIH Biology of Infectious Diseases Training Program [T32AI007641]; NIH National Institute of Allergy and Infectious Diseases [K23AI120855]; University of California, San Francisco School of Medicine by the Pathways Explore Summer Fellowship; University of California, San Francisco-Clinical and Translational Science Institute [KL2TR000143]; National Institute of Mental Health of the US National Institutes of Health [R01 MH095507]; Bill & Melinda Gates Foundation [OPP1056051]; US Agency for International Development [AID-OAA-A-12-00023]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI120855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095507, K01MH100994] Funding Source: NIH RePORTER	U.S. National Institute of Health (NIH) National Institute of Mental Health; Kenya Medical Research Institute (KEMRI); NIH Biology of Infectious Diseases Training Program; NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of California, San Francisco School of Medicine by the Pathways Explore Summer Fellowship; University of California, San Francisco-Clinical and Translational Science Institute(University of California System); National Institute of Mental Health of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); US Agency for International Development(United States Agency for International Development (USAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was funded by the U.S. National Institute of Health (NIH) National Institute of Mental Health (K01MH100994) and Kenya Medical Research Institute (KEMRI). Dr. Patel was supported by the NIH Biology of Infectious Diseases Training Program (T32AI007641) and NIH National Institute of Allergy and Infectious Diseases (K23AI120855). Ms. Gaelen Stanford-Moore was supported by the University of California, San Francisco School of Medicine by the Pathways Explore Summer Fellowship. Dr. Brown received support from the University of California, San Francisco-Clinical and Translational Science Institute (KL2TR000143). The Partners Demonstration Project was funded by the National Institute of Mental Health of the US National Institutes of Health (R01 MH095507), the Bill & Melinda Gates Foundation (OPP1056051), and through the generous support of the American people through the US Agency for International Development (AID-OAA-A-12-00023). Gilead Sciences donated the PrEP medication but had no role in data collection or analysis. The study results are solely the responsibility of the authors and do not necessarily represent the official views of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; [Anonymous], NVIVO QUAL DAT AN SO; [Anonymous], 2011, GUID ANT THER KEN; Baeten JM, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002099; Brubaker SG, 2011, HIV MED, V12, P316, DOI 10.1111/j.1468-1293.2010.00884.x; Cambiano V, 2011, CURR OPIN INFECT DIS, V24, P19, DOI 10.1097/QCO.0b013e3283422c8c; Connell R., 1987, GENDER POWER SOC PER, pxvii; Curran K, 2014, AIDS, V28, P227, DOI 10.1097/QAD.0000000000000025; da Silva M, 2015, AIDS BEHAV, V19, P666, DOI 10.1007/s10461-014-0874-0; El-Khatib Z, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-88; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Govindasamy D, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19032; Guthrie BL, 2011, JAIDS-J ACQ IMM DEF, V58, pE87, DOI 10.1097/QAI.0b013e31822f064e; Hodgson I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111421; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Johnson MO, 2009, J GEN INTERN MED, V24, P247, DOI 10.1007/s11606-008-0854-z; Kahn TR, 2013, AIDS CARE, V25, P265, DOI 10.1080/09540121.2012.712660; Kaiser R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017842; Kurth AE, 2012, JAIDS-J ACQ IMM DEF, V61, pE65, DOI [10.1097/QAI.0b013e31826a184c., 10.1097/QAI.0b013e31826a184c]; Lyimo RA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-716; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Munro S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-104; Nabukeera-Barungi N, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1265-5; NASCOP N., 2014, KEN HIV EST; Organization) WWH, 2015, GUID START ANT THER; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Patel RC, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21134; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Scanlon ML, 2013, HIV AIDS-RES PALLIAT, V5, P1, DOI 10.2147/HIV.S28912; Sutcliffe CG, 2016, PEDIATR INFECT DIS J, V35, pE107, DOI 10.1097/INF.0000000000001021; Tabatabai J, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24795; Vittinghoff E, 1999, J INFECT DIS, V179, P717, DOI 10.1086/314623; Wouters E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163963; Wouters E, 2012, SOC THEOR HEALTH, V10, P368, DOI 10.1057/sth.2012.12	35	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0168057	10.1371/journal.pone.0168057	http://dx.doi.org/10.1371/journal.pone.0168057			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930740	Green Published, gold, Green Submitted			2022-12-27	WOS:000389580900075
J	Brisola, GMP; Artioli, GG; Papoti, M; Zagatto, AM				Pinheiro Brisola, Gabriel Motta; Artioli, Guilherme Giannini; Papoti, Marcelo; Zagatto, Alessandro Moura			Effects of Four Weeks of beta-Alanine Supplementation on Repeated Sprint Ability in Water Polo Players	PLOS ONE			English	Article							MUSCLE CARNOSINE; SODIUM-BICARBONATE; SARCOPLASMIC-RETICULUM; EXERCISE PERFORMANCE; CA2+; RELIABILITY; RECOVERY; TIME	The purpose of this study was to investigate the effect of four weeks of beta-alanine supplementation on repeated sprint ability in water polo players. Twenty-two male water polo players participated in the study, divided randomly into two homogeneous groups (placebo and beta-alanine groups). The study design was double-blind, parallel and placebo controlled. Before and after the supplementation period (28 days), the athletes performed two specific repeated sprint ability tests interspaced by a 30-minute swimming test. Participants received 4.8g.day(-1) of the supplement (dextrose or beta-alanine) on the first 10 days and 6.4g.day(-1) on the final 18 days. There was no significant group-time interaction for any variable. The qualitative inference for substantial changes demonstrated a likely beneficial effect in the beta-alanine group (beta-alanine vs placebo) for mean time (6.6 +/- 0.4s vs 6.7 +/- 0.4s; 81% likely beneficial), worst time (6.9 +/- 0.5s vs 7.1 +/- 0.5s; 78% likely beneficial) and total time (39.3 +/- 2.5s vs 40.4 +/- 2.5s; 81% likely beneficial) in the first repeated sprint ability set and for worst time (7.2 +/- 0.6s vs 7.5 +/- 0.6s; 57% possible beneficial) in the second repeated sprint ability set. Further, was found substantial change for total time for both repeated sprint ability tests (80.8 +/- 5.7s vs 83.4 +/- 5.6s; 52% possible beneficial). To conclude, four weeks of beta-alanine supplementation had a likely beneficial effect in the first set of repeated sprint ability tests and a possible beneficial effect for worst time in the second set performed in a specific protocol in water polo players.	[Pinheiro Brisola, Gabriel Motta] Sao Paulo State Univ, UNESP, Postgrad Program Movement Sci, Inst Biosci, Rio Claro, SP, Brazil; [Pinheiro Brisola, Gabriel Motta; Zagatto, Alessandro Moura] Sao Paulo State Univ, UNESP, Lab Physiol & Sport Performance LAFIDE, Dept Phys Educ,Sch Sci, Bauru, SP, Brazil; [Artioli, Guilherme Giannini] Nottingham Trent Univ, Sch Sci & Technol, Dept Sport Sci, Nottingham, England; [Papoti, Marcelo] Univ Sao Paulo, Sch Phys Educ & Sport Ribeirao Preto, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Nottingham Trent University; Universidade de Sao Paulo	Zagatto, AM (corresponding author), Sao Paulo State Univ, UNESP, Lab Physiol & Sport Performance LAFIDE, Dept Phys Educ,Sch Sci, Bauru, SP, Brazil.	azagatto@yahoo.com.br	Artioli, Guilherme Giannini/K-5925-2013; Papoti, Marcelo MP/D-1725-2012; Zagatto, Alessandro M/F-9969-2012; Papoti, Marcelo/AAM-6394-2021	Artioli, Guilherme Giannini/0000-0001-8463-2213; Papoti, Marcelo MP/0000-0002-3702-7149; Zagatto, Alessandro M/0000-0003-1065-4158; 	National Council of Technological and Scientific Development (CNPq) [475699/2013-0]; Sao Paulo Research Foundation (FAPESP) [2014/02186-7]	National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors would like to thank the National Council of Technological and Scientific Development (CNPq), process number 475699/2013-0, for financing the study and the Sao Paulo Research Foundation (FAPESP), process number 2014/02186-7 for a scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artioli GG, 2010, MED SCI SPORT EXER, V42, P1162, DOI 10.1249/MSS.0b013e3181c74e38; Balsalobre-Fernandez C, 2014, J STRENGTH COND RES, V28, P528, DOI 10.1519/JSC.0b013e318299a52e; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Bellinger PM, 2014, J STRENGTH COND RES, V28, P1751, DOI 10.1519/JSC.0000000000000327; Bex T, 2014, J APPL PHYSIOL, V116, P204, DOI 10.1152/japplphysiol.01033.2013; Bishop D, 2004, MED SCI SPORT EXER, V36, P807, DOI 10.1249/01.MSS.0000126392.20025.17; Bishop D, 2003, J SCI MED SPORT, V6, P199, DOI 10.1016/S1440-2440(03)80255-4; Cohen J.E., 1988, STAT POWER ANAL BEHA; Danaher J, 2014, EUR J APPL PHYSIOL, V114, P1715, DOI 10.1007/s00421-014-2895-9; Decombaz J, 2012, AMINO ACIDS, V43, P67, DOI 10.1007/s00726-011-1169-7; Ducker KJ, 2013, INT J SPORT NUTR EXE, V23, P554, DOI 10.1123/ijsnem.23.6.554; Ducker KJ, 2013, J STRENGTH COND RES, V27, P3450, DOI 10.1519/JSC.0b013e31828fd310; Dutka TL, 2012, J APPL PHYSIOL, V112, P728, DOI 10.1152/japplphysiol.01331.2011; FABIATO A, 1978, J PHYSIOL-LONDON, V276, P233, DOI 10.1113/jphysiol.1978.sp012231; Fitzsimons M., 1993, AUST J SCI MED SPORT, V25, P82; Foster C, 1998, MED SCI SPORT EXER, V30, P1164, DOI 10.1097/00005768-199807000-00023; Franchini E, J SCI MED S IN PRESS; Harris RC, 2006, AMINO ACIDS, V30, P279, DOI 10.1007/s00726-006-0299-9; HARRIS RC, 1976, PFLUG ARCH EUR J PHY, V367, P137, DOI 10.1007/BF00585149; Hill CA, 2007, AMINO ACIDS, V32, P225, DOI 10.1007/s00726-006-0364-4; Hobson RM, 2012, AMINO ACIDS, V43, P25, DOI 10.1007/s00726-011-1200-z; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Kern BD, 2011, J STRENGTH COND RES, V25, P1804, DOI 10.1519/JSC.0b013e3181e741cf; Melchiorri G, 2010, J STRENGTH COND RES, V24, P2647, DOI 10.1519/JSC.0b013e3181e3486b; OLBRECHT J, 1985, INT J SPORTS MED, V6, P74, DOI 10.1055/s-2008-1025816; Painelli VD, 2013, APPL PHYSIOL NUTR ME, V38, P525, DOI 10.1139/apnm-2012-0286; Parolin ML, 1999, AM J PHYSIOL-ENDOC M, V277, pE890, DOI 10.1152/ajpendo.1999.277.5.E890; Platanou T., 2009, SERB J SPORTS SCI, V3, P85; Saunders B, 2014, INT J SPORT NUTR EXE, V24, P196, DOI 10.1123/ijsnem.2013-0102; Smith ECB, 1938, J PHYSIOL-LONDON, V92, P336, DOI 10.1113/jphysiol.1938.sp003605; Smith HK, 1998, SPORTS MED, V26, P317, DOI 10.2165/00007256-199826050-00003; Spencer M, 2005, SPORTS MED, V35, P1025, DOI 10.2165/00007256-200535120-00003; SPRIET LL, 1989, J APPL PHYSIOL, V66, P8, DOI 10.1152/jappl.1989.66.1.8; Sweeney KM, 2010, J STRENGTH COND RES, V24, P79, DOI 10.1519/JSC.0b013e3181c63bd5; Swietach P, 2014, J PHYSIOL-LONDON, V592, P3179, DOI 10.1113/jphysiol.2013.265959; Swietach P, 2013, P NATL ACAD SCI USA, V110, pE2064, DOI 10.1073/pnas.1222433110; Tan F, 2009, J SPORT SCI, V27, P1095, DOI 10.1080/02640410903207416; Tan FHY, 2010, INTJ SPORT PHYSIOL, V5, P117, DOI 10.1123/ijspp.5.1.117; Tomlin DL, 2001, SPORTS MED, V31, P1, DOI 10.2165/00007256-200131010-00001; Womack CJ, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-7	40	10	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167968	10.1371/journal.pone.0167968	http://dx.doi.org/10.1371/journal.pone.0167968			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930743	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000389580900065
J	Mason, MJ; Cornwall, HL; Smith, ES				Mason, Matthew J.; Cornwall, Hannah L.; Smith, Ewan St J.			Ear Structures of the Naked Mole-Rat, Heterocephalus glaber, and Its Relatives (Rodentia: Bathyergidae)	PLOS ONE			English	Article							MIDDLE-EAR; SPALAX-EHRENBERGI; FUNCTIONAL-MORPHOLOGY; ACOUSTIC COMMUNICATION; CRYPTOMYS-HOTTENTOTUS; CONDUCTING APPARATUS; VOCAL COMMUNICATION; SUBTERRANEAN RODENT; SOUND LOCALIZATION; FREQUENCY HEARING	Although increasingly popular as a laboratory species, very little is known about the peripheral auditory system of the naked mole-rat, Heterocephalus glaber. In this study, middle and inner ears of naked mole-rats of a range of ages were examined using micro-computed tomography and dissection. The ears of five other bathyergid species (Bathyergus suillus, Cryptomys hottentotus, Fukomys micklemi, Georychus capensis and Heliophobius argenteocinereus) were examined for comparative purposes. The middle ears of bathyergids show features commonly found in other members of the Ctenohystrica rodent clade, including a fused malleus and incus, a synovial stapedio-vestibular articulation and the loss of the stapedius muscle. Heterocephalus deviates morphologically from the other bathyergids examined in that it has a more complex mastoid cavity structure, poorly-ossified processes of the malleus and incus, a 'columelliform' stapes and fewer cochlear turns. Bathyergids have semicircular canals with unusually wide diameters relative to their radii of curvature. How the lateral semicircular canal reaches the vestibule differs between species. Heterocephalus has much more limited high-frequency hearing than would be predicted from its small ear structures. The spongy bone forming its ossicular processes, the weak incudo-stapedial articulation, the columelliform stapes and (compared to other bathyergids) reduced cochlear coiling are all potentially degenerate features which might reflect a lack of selective pressure on its peripheral auditory system. Substantial intraspecific differences were found in certain middle and inner ear structures, which might also result from relaxed selective pressures. However, such interpretations must be treated with caution in the absence of experimental evidence.	[Mason, Matthew J.; Cornwall, Hannah L.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Smith, Ewan St J.] Univ Cambridge, Dept Pharmacol, Cambridge, England	University of Cambridge; University of Cambridge	Mason, MJ (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	mjm68@hermes.cam.ac.uk	St. John Smith, Ewan/G-1776-2011; Mason, Matthew James/AAX-9783-2021	St. John Smith, Ewan/0000-0002-2699-1979; Mason, Matthew James/0000-0001-7845-0720; Cornwall, Hannah/0000-0001-7647-9503	John Ray Trust Summer Research Grant; Royal Society Research Grant [RG130110]	John Ray Trust Summer Research Grant; Royal Society Research Grant(Royal Society of London)	Support was provided by a John Ray Trust Summer Research Grant (2015) to HLC [http://johnraytrust.com/] and a Royal Society Research Grant (RG130110) to ESS [https://royalsociety.org/grants-schemes-awards/grants/?gclid=CObSzoidrc8CFeQp0wodk4QENg]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors would like to record their immense gratitude to Phil Cox for sending us specimens and CT scans, and to Dominique Adriaens, Paul van Daele, Nigel Bennett and Radim umbera for originally providing the specimens concerned. Matt Lowe and Robert Asher at the University Museum of Zoology, Cambridge, kindly allowed access to that collection. We thank Mrs. Anita Shelley for making the histological slides, members of the Smith lab for help with specimen preparation, the Cambridge Biotomography Centre for the use of their scanner and the two reviewers for commenting on this paper. This work was supported by a John Ray Trust Summer Research Grant to H.L.C. and a Royal Society Research Grant (RG130110) to E.S.J.S.	Argyle EC, 2008, J MAMMAL, V89, P1447, DOI 10.1644/07-MAMM-A-401.1; Begall S, 2006, J MORPHOL, V267, P382, DOI 10.1002/jmor.10411; Begall S, 2004, J COMP PHYSIOL A, V190, P963, DOI 10.1007/s00359-004-0552-1; Bruckmann G, 1997, J COMP PHYSIOL A, V181, P83, DOI 10.1007/s003590050095; BRUNS V, 1988, HEARING RES, V33, P1, DOI 10.1016/0378-5955(88)90017-2; Buffenstein R, 2005, J GERONTOL A-BIOL, V60, P1369, DOI 10.1093/gerona/60.11.1369; BURDA H, 1990, Zoologische Jahrbuecher Abteilung fuer Systematik Oekologie und Geographie der Tiere, V117, P369; BURDA H, 1992, J MORPHOL, V214, P49, DOI 10.1002/jmor.1052140104; BURDA H, 1989, HEARING RES, V39, P225, DOI 10.1016/0378-5955(89)90042-7; Burda H, 2006, ANIM BIOL, V56, P475, DOI 10.1163/157075606778967847; COHEN YE, 1992, HEARING RES, V62, P187, DOI 10.1016/0378-5955(92)90185-P; Credner S, 1997, J COMP PHYSIOL A, V180, P245, DOI 10.1007/s003590050045; Crumpton N, 2015, J MORPHOL, V276, P900, DOI 10.1002/jmor.20391; Ekdale EG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066624; Ekdale EG, 2010, ANAT REC, V293, P1896, DOI 10.1002/ar.21234; Fabre PH, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-88; FLEISCHER G, 1973, Saeugetierkundliche Mitteilungen, V21, P131; Fleischer G., 1978, Advances in Anatomy Embryology and Cell Biology, V55, P1; Gessele N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146428; HEFFNER RS, 1993, J COMP NEUROL, V331, P418, DOI 10.1002/cne.903310311; Heffner RS, 2001, HEARING RES, V157, P138, DOI 10.1016/S0378-5955(01)00298-2; HEFFNER RS, 1990, HEARING RES, V46, P239, DOI 10.1016/0378-5955(90)90005-A; HEFFNER RS, 1992, HEARING RES, V62, P206, DOI 10.1016/0378-5955(92)90188-S; HEMILA S, 1995, HEARING RES, V85, P31, DOI 10.1016/0378-5955(95)00031-X; HETH G, 1986, EXPERIENTIA, V42, P1287, DOI 10.1007/BF01946426; Hetling JR, 2005, J COMP PHYSIOL A, V191, P317, DOI 10.1007/s00359-004-0584-6; HOYTE DA, 1961, AM J ANAT, V108, P1, DOI 10.1002/aja.1001080102; Huang GT, 2002, J COMP PHYSIOL A, V188, P663, DOI 10.1007/s00359-002-0332-8; HUANGFU M, 1983, J MORPHOL, V176, P249, DOI 10.1002/jmor.1051760302; Huttenbrink KB, 1996, LARYNGO RHINO OTOL, V75, P123, DOI 10.1055/s-2007-997549; Ingram CM, 2004, MOL PHYLOGENET EVOL, V31, P997, DOI 10.1016/j.ympev.2003.11.004; Jarvis Jennifer U.M., 2002, Mammalian Species, V706, P1, DOI 10.1644/1545-1410(2002)706<0001:HG>2.0.CO;2; Knotkova E, 2009, BIOACOUSTICS, V18, P241, DOI 10.1080/09524622.2009.9753604; Kossl M, 1996, J COMP PHYSIOL A, V178, P427; Kott O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011810; Lange S, 2005, AFRICAN BIODIVERSITY: MOLECULES, ORGANISMS, ECOSYSTEMS, P329, DOI 10.1007/0-387-24320-8_33; Lange S, 2007, NATURWISSENSCHAFTEN, V94, P134, DOI 10.1007/s00114-006-0168-0; Lange S, 2005, BELG J ZOOL, V135, P5; Laube B, 1990, VERH DTSCH ZOOL GES, V83, P415; LAY DOUGLAS, 1972, J MORPHOL, V138, P41, DOI 10.1002/jmor.1051380103; LINDENLAUB T, 1994, ANAT RECORD, V240, P286, DOI 10.1002/ar.1092400217; LINDENLAUB T, 1995, J MORPHOL, V224, P303, DOI 10.1002/jmor.1052240305; LINDENLAUB T, 1993, ANAT EMBRYOL, V188, P159; Manoussaki D, 2008, P NATL ACAD SCI USA, V105, P6162, DOI 10.1073/pnas.0710037105; Mason MJ, 2013, J LARYNGOL OTOL, V127, P2, DOI 10.1017/S0022215112002496; Mason MJ, 2016, J ANAT, V228, P300, DOI 10.1111/joa.12316; Mason MJ, 2016, J ANAT, V228, P284, DOI 10.1111/joa.12313; Mason MJ, 2013, HEARING RES, V301, P4, DOI 10.1016/j.heares.2012.10.004; Mason MJ, 2010, J MORPHOL, V271, P462, DOI 10.1002/jmor.10810; Mason MJ, 2006, J MORPHOL, V267, P678, DOI 10.1002/jmor.10430; Mason MJ, 2004, J MAMMAL, V85, P797, DOI 10.1644/BEL-102; Mason MJ, 2003, J ZOOL, V260, P391, DOI 10.1017/S095283690300387X; Mason MJ, 2001, J ZOOL, V255, P467; Mason MJ, 1999, FUNCTIONAL ANATOMY M; Mason MJ, 2015, CAMBRIDGE STUDIES MO, P373; Mason MJ, 2010, USE VIBRATIONS COMMU, P121; Mennecart B, 2016, J ANAT, V229, P422, DOI 10.1111/joa.12487; MULLER M, 1989, NATURWISSENSCHAFTEN, V76, P134, DOI 10.1007/BF00366611; MULLER M, 1992, J COMP PHYSIOL A, V171, P469; Oaks ECJ., 1967, STRUCTURE FUNCTION I; OMAN CM, 1987, ACTA OTO-LARYNGOL, V103, P1, DOI 10.3109/00016488709134691; Parent J.P., 1980, Memoires et Travaux de l'Institut de Montpellier de l'Ecole Pratique des Hautes Etudes, P1; PARENT JP, 1976, CR ACAD SCI D NAT, V283, P243; PEAKE WT, 1992, HEARING RES, V57, P245, DOI 10.1016/0378-5955(92)90155-G; Pepper J.W., 1991, P243; Potapova E.G., 2001, TRAKYA U J SCI RES, V2, P159; Prochel J, 2014, ACTA ZOOL-STOCKHOLM, V95, P220, DOI 10.1111/azo.12022; PYE A, 1977, J ZOOL, V182, P309; Pye A, 1972, SOUND, V6, P14; RADO R, 1989, HEARING RES, V41, P23, DOI 10.1016/0378-5955(89)90175-5; RAVICZ ME, 1992, J ACOUST SOC AM, V92, P157, DOI 10.1121/1.404280; Rosowski JJ, 2006, J COMP PHYSIOL A, V192, P1287, DOI 10.1007/s00359-006-0159-9; Schleich CE, 2004, J MAMMAL, V85, P290, DOI 10.1644/1545-1542(2004)085<0290:FMOTME>2.0.CO;2; Schumacher L, 2015, OPEN ACCESS ANIM PHY, V7, P137, DOI [DOI 10.2147/OAAP.S50376, 10.2147/OAAP.S50376, 10.2147/oaap.s50376]; SEGALL W, 1973, ACTA ANAT, V86, P96; SILVA M, 1995, CRC HDB MAMMALIAN BO; STEPHENS CB, 1972, ACTA OTO-LARYNGOL, P1; Van Daele PAAG, 2009, PHYSIOL BIOCHEM ZOOL, V82, P40, DOI 10.1086/594379; Vanden Hole C, 2014, BIOACOUSTICS, V23, P143, DOI 10.1080/09524622.2013.841085; VRETTAKOS PA, 1988, AM J OTOLARYNG, V9, P58, DOI 10.1016/S0196-0709(88)80009-7; Walton AH, 2000, MOL PHYLOGENET EVOL, V16, P467, DOI 10.1006/mpev.2000.0808; WEBSTER DB, 1975, J MORPHOL, V146, P343, DOI 10.1002/jmor.1051460304; WEBSTER DB, 1975, J MORPHOL, V146, P377, DOI 10.1002/jmor.1051460305; WEST CD, 1985, J ACOUST SOC AM, V77, P1091, DOI 10.1121/1.392227; ZIMMER WM, 1994, ANAT REC, V239, P475, DOI 10.1002/ar.1092390413; [No title captured]	86	36	36	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2016	11	12							e0167079	10.1371/journal.pone.0167079	http://dx.doi.org/10.1371/journal.pone.0167079			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4NG	27926945	gold, Green Published, Green Submitted			2022-12-27	WOS:000389578800009
J	Cisneros-Montemayor, AM; Pauly, D; Weatherdon, LV; Ota, Y				Cisneros-Montemayor, Andreas M.; Pauly, Daniel; Weatherdon, Lauren V.; Ota, Yoshitaka			A Global Estimate of Seafood Consumption by Coastal Indigenous Peoples	PLOS ONE			English	Article							CLIMATE-CHANGE IMPACTS; FISHERIES; FOOD; METAANALYSIS; RIGHTS; FRAMEWORK; BENEFITS; MERCURY; LOSSES; RISKS	Coastal Indigenous peoples rely on ocean resources and are highly vulnerable to ecosystem and economic change. Their challenges have been observed and recognized at local and regional scales, yet there are no global-scale analyses to inform international policies. We compile available data for over 1,900 coastal Indigenous communities around the world representing 27 million people across 87 countries. Based on available data at local and regional levels, we estimate a total global yearly seafood consumption of 2.1 million (1.5 million -2.8 million) metric tonnes by coastal Indigenous peoples, equal to around 2% of global yearly commercial fisheries catch. Results reflect the crucial role of seafood for these communities; on average, consumption per capita is 15 times higher than non-Indigenous country populations. These findings contribute to an urgently needed sense of scale to coastal Indigenous issues, and will hopefully prompt increased recognition and directed research regarding the marine knowledge and resource needs of Indigenous peoples. Marine resources are crucial to the continued existence of coastal Indigenous peoples, and their needs must be explicitly incorporated into management policies.	[Cisneros-Montemayor, Andreas M.; Ota, Yoshitaka] Univ British Columbia, Inst Oceans & Fisheries, NEREUS Program, Vancouver, BC, Canada; [Pauly, Daniel] Univ British Columbia, Sea Us Project, Inst Oceans & Fisheries, Vancouver, BC, Canada; [Weatherdon, Lauren V.] UNEP World Conservat Monitoring Ctr, Cambridge, England	University of British Columbia; University of British Columbia	Cisneros-Montemayor, AM; Ota, Y (corresponding author), Univ British Columbia, Inst Oceans & Fisheries, NEREUS Program, Vancouver, BC, Canada.	a.cisneros@oceans.ubc.ca; y.ota@oceans.ubc.ca	Pauly, Daniel Marc/AAY-2316-2021	Weatherdon, Lauren V./0000-0002-3989-027X; Cisneros-Montemayor, Andres M./0000-0002-4132-5317; Pauly, Daniel/0000-0003-3756-4793	Nippon Foundation Nereus Program; Sea Around US project; UN World Conservation Monitoring Centre	Nippon Foundation Nereus Program; Sea Around US project; UN World Conservation Monitoring Centre	The authors are supported by The Nippon Foundation Nereus Program (http://www.nereusprogram.org/), the Sea Around US project (http://www.seaaroundus.org/), and the UN World Conservation Monitoring Centre (http://www.unep-wcmc.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson JM, 2011, INT J COMMONS, V5, P319; Adger WN, 2009, FRONT ECOL ENVIRON, V7, P150, DOI 10.1890/070148; Alfred GT, 2009, INT J INDIG HEALTH, V5, P42; [Anonymous], [No title captured]; Anticamara JA, 2011, FISH RES, V107, P131, DOI 10.1016/j.fishres.2010.10.016; Australian Bureau of Statistics, 2015, COMMUNITY PROFILES; Bailar JC, 1997, NEW ENGL J MED, V337, P559, DOI 10.1056/NEJM199708213370810; Berkes F, 2000, ECOL APPL, V10, P1251, DOI 10.1890/1051-0761(2000)010[1251:ROTEKA]2.0.CO;2; Berkes F, 2006, ECOL SOC, V11; Brashares JS, 2014, SCIENCE, V345, P376, DOI 10.1126/science.1256734; Cantor-Graae E, 2014, AM J PSYCHIAT; Capistrano RCG, 2012, OCEAN COAST MANAGE, V69, P200, DOI 10.1016/j.ocecoaman.2012.08.011; Castro-Gonzalez MI, 2008, ENVIRON TOXICOL PHAR, V26, P263, DOI 10.1016/j.etap.2008.06.001; Cheung WWL, 2013, NATURE, V497, P365, DOI 10.1038/nature12156; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Cinner JE, 2012, P NATL ACAD SCI USA, V109, P5219, DOI 10.1073/pnas.1121215109; Cisneros-Montemayor A. M., 2010, J BIOECONOMICS, V12, P245, DOI DOI 10.1007/S10818-010-9092-7; Clark CW, 2005, J ENVIRON ECON MANAG, V50, P47, DOI 10.1016/j.jeem.2004.11.002; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; CROWLEY PH, 1992, ANNU REV ECOL SYST, V23, P405, DOI 10.1146/annurev.es.23.110192.002201; Crystal D., 2000, LANGUAGE DEATH; Cunneen C., 2006, CURRENT ISSUES CRIMI, V17, P329, DOI DOI 10.1080/10345329.2006.12036363; DAA, 2014, ABORIGINAL COMMUNITI; Davis A, 2001, MAR POLICY, V25, P223, DOI 10.1016/S0308-597X(01)00014-8; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FAO, 2015, FOOD BALANCE SHEET O; FAO, 2014, STATE OF WORLD FISHE; FAO, 2015, CWP HANDBOOK OF FISH; FAO (Food and Agriculture Organization of the United Nations), 2015, VOLUNTARY GUIDELINES; Gillett R., 2009, FISHERIES EC PACIFIC, P521; Government of Canada, 2015, FIRST NATION PROFILE; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; anazaki Natalia, 2007, Ambient. soc., V10, P121, DOI 10.1590/S1414-753X2007000100008; Howard BV, 1999, CIRCULATION, V99, P2389, DOI 10.1161/01.CIR.99.18.2389; Hsiang SM, 2013, SCIENCE, V341, P1212, DOI 10.1126/science.1235367; Human Relations Area Files, 2015, EHRAF WORLD CULTURES; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jentoft S, 2015, MARE PUBL SER, V13, P727, DOI 10.1007/978-3-319-17034-3_37; Johannes RE., 1992, MARINE RESOURCE EC, V7, P249, DOI [10.1086/mre.7.4.42629038, DOI 10.1086/MRE.7.4.42629038]; Kirk JL, 2012, ENVIRON RES, V119, P64, DOI 10.1016/j.envres.2012.08.012; Kleisner K, 2015, REPORT NO 2015 02; Kuhnlein HV, 2007, J NUTR, V137, P1110, DOI 10.1093/jn/137.4.1110; Laird BD, 2013, J NUTR, V143, P923, DOI 10.3945/jn.112.173351; Lam VWY, 2012, AFR J MAR SCI, V34, P103, DOI 10.2989/1814232X.2012.673294; Martinez Cobo JR, 1983, REPORT NO E CN 4 SUB; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; McGoodwin JR, 1990, CRISIS IN THE WORLD; McNiven IJ, 2003, WORLD ARCHAEOL, V35, P329, DOI 10.1080/0043824042000185757; Meur C., 2001, PEOPLES AFRICA ETHNO; Minority Rights Group International, 2005, WORLD DIRECTORY OF M; Office of the High Commissioner for Human Rights Asia Pacific Forum of National Human Rights Institutions, 2013, THE UNITED NATIONS D; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pauly D., 2006, MAR STUD MAST, V4, P7, DOI DOI 10.1126/SCIENCE.279.5352.860.PMID:9452385; Pauly D, 1950, GLOBAL FISHERIES CAT; Pauly D, 2014, FISH FISH, V15, P474, DOI 10.1111/faf.12032; Poe MR, 2015, ECOL ECON, V116, P241, DOI 10.1016/j.ecolecon.2015.05.003; Rosenberger RS, 2006, ECOL ECON, V60, P372, DOI 10.1016/j.ecolecon.2006.03.018; Rosenthal R, 2001, ANNU REV PSYCHOL, V52, P59, DOI 10.1146/annurev.psych.52.1.59; Rouja PM, 1998, FISHING FOR CULTURE; Russian Federal State Statistics Service, 2010, LANGUAGES OF INDIGEN, V4; Sanders D.E., 1999, INT J CULT PROP, V8, P4, DOI [DOI 10.1017/S0940739199770591, 10.1017/S0940739199770591]; Sidhu KS, 2003, REGUL TOXICOL PHARM, V38, P336, DOI 10.1016/j.yrtph.2003.07.002; Smith LC, 2013, P NATL ACAD SCI USA, V110, pE1191, DOI 10.1073/pnas.1214212110; Srinivasan UT, 2012, MAR POLICY, V36, P544, DOI 10.1016/j.marpol.2011.10.001; Stuck AE, 1998, BRIT MED J, V316, P469, DOI 10.1136/bmj.316.7129.469; Sumaila UR, 2011, NAT CLIM CHANGE, V1, P449, DOI 10.1038/NCLIMATE1301; Taylor LE, 2014, VACCINE, V32, P3623, DOI 10.1016/j.vaccine.2014.04.085; The Fund for Peace, 2015, FRAGILE STATES INDEX; Thorson JT, 2015, FISH FISH, V16, P342, DOI 10.1111/faf.12061; UN, 2008, UN EXP GROUP M POP D, P1; UN, 2015, WORKING GROUP ON IND; UN, 2015, COMPOSITION OF MACRO; UN-DESA, 2009, STATE OF THE WORLDS; United Nations, 2015, SUSTAINABLE DEV GOAL, DOI DOI 10.1163/157180910X12665776638740; US Census Bureau, 2010, 2010 AMERICAN INDIAN; Weatherdon LV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145285; Witter R, 2014, CONSERV BIOL, V28, P1394, DOI 10.1111/cobi.12283; Wittman H, 2011, ENVIRON SOC, V2, P87, DOI 10.3167/ares.2011.020106; World Bank, 2009, THE SUNKEN BILLIONS, P130; YOUNG TK, 1992, INT J EPIDEMIOL, V21, P730, DOI 10.1093/ije/21.4.730; Zeller D, 2011, POLAR BIOL, V34, P955, DOI 10.1007/s00300-010-0952-3	82	98	99	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2016	11	12							e0166681	10.1371/journal.pone.0166681	http://dx.doi.org/10.1371/journal.pone.0166681			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4MR	27918581	Green Published, gold, Green Submitted			2022-12-27	WOS:000389577100003
J	Carslake, D; Pinger, PR; Romundstad, P; Smith, GD				Carslake, David; Pinger, Pia R.; Romundstad, Pal; Smith, George Davey			Early-Onset Paternal Smoking and Offspring Adiposity: Further Investigation of a Potential Intergenerational Effect Using the HUNT Study	PLOS ONE			English	Article							WEIGHT-GAIN; CHILDHOOD; CESSATION; NUTRITION	Recently it has been suggested that rearing conditions during preadolescence in one generation may affect health outcomes in subsequent generations. Such parental effects, potentially induced by epigenetic modifications in the germ line, have attracted considerable attention because of their implications for public health and social policies. Yet, to date, evidence in humans has been rare due to data limitations and much further investigation in large studies is required. The aim of this paper is to reproduce and extend a recent study which found that paternal smoking before age 11 was associated with elevated body mass index (BMI) among male offspring in the Avon Longitudinal Study of Parents and Children (ALSPAC). Using the Nord-Trondelag Health (HUNT) Study, we find that paternal smoking during pre-adolescence (< age 11) is not reliably or strongly associated with BMI among sons, with an estimated association close to zero (mean difference in kg m(-2) (95% CI) was -0.18 (-1.75, 1.39) for sons aged 12-19 and 0.22 (-0.53, 0.97) for all ages). Among daughters, early-onset paternal smoking was imprecisely associated with an elevated BMI (mean difference was 1.50 (0.00, 3.00) for daughters aged 12-19 and 0.97 (0.06, 1.87) for all ages). Our results do not support a son-specific association of the magnitude reported in the ALSPAC study and we consider it improbable that early onset paternal smoking should influence specifically sons' BMI in one population and daughters' BMI in another. However, despite our considerable sample size (> 45,000 offspring), we cannot rule out a weaker association, perhaps common to sons and daughters, which would be consistent with the ALSPAC study. Alternatively, we discuss whether confounding, chance in parallel tests, or sample selection effects might explain the observed associations of early paternal smoking with offspring BMI.	[Carslake, David; Smith, George Davey] Univ Bristol, MRC, Integrat Epidemiol Unit, Bristol, Avon, England; [Carslake, David; Smith, George Davey] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Pinger, Pia R.] Univ Bonn, Dept Econ, Bonn, Germany; [Romundstad, Pal] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, Trondheim, Norway	University of Bristol; University of Bristol; University of Bonn; Norwegian University of Science & Technology (NTNU)	Carslake, D (corresponding author), Univ Bristol, MRC, Integrat Epidemiol Unit, Bristol, Avon, England.; Carslake, D (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.; Pinger, PR (corresponding author), Univ Bonn, Dept Econ, Bonn, Germany.	David.Carslake@bristol.ac.uk; pinger@uni-bonn.de	Davey Smith, George/A-7407-2013; Pinger, Pia/AAA-1212-2022	Davey Smith, George/0000-0002-1407-8314; s, hema/0000-0002-3440-9475; Carslake, David/0000-0003-2916-4546; Venkatasubramanian, Siddharth/0000-0002-5860-0768	UK Medical Research Council [MC_UU_12013/1, MC_UU_12013/9]; Medical Research Council [MC_UU_12013/9, MC_UU_12013/1] Funding Source: researchfish; MRC [MC_UU_12013/1, MC_UU_12013/9] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	David Carslake and George Davey Smith work in a unit that receives funds from the UK Medical Research Council (grant numbers MC_UU_12013/1 and MC_UU_12013/9, http://www.mrc.ac.uk). Pia Pinger and Pal Romundstad received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Belinsky SA, 2002, CANCER RES, V62, P2370; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Bygren LO, 2001, ACTA BIOTHEOR, V49, P53, DOI 10.1023/A:1010241825519; Cooney CA, 2006, P NATL ACAD SCI USA, V103, P17071, DOI 10.1073/pnas.0608653103; Dunn GA, 2011, ENDOCRINOLOGY, V152, P2228, DOI 10.1210/en.2010-1461; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Freathy RM, 2011, INT J EPIDEMIOL; Grossniklaus U, 2013, NAT REV GENET, V14, P228, DOI 10.1038/nrg3435; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Harrell FE, 2013, SPRINGER SCI BUSINES; HOLMEN J, 1990, Tidsskrift for den Norske Laegeforening, V110, P1973; Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI DOI 10.1093/eurheartj/eht019; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Klesges RC, 1997, J CONSULT CLIN PSYCH, V65, P286, DOI 10.1037/0022-006X.65.2.286; Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095; Northstone K, 2014, EUROPEAN J HUMAN GEN, P1; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Rubin Donald B, 1987, MULTIPLE IMPUTATION; Soubry A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-29; Sparen P, 2004, BRIT MED J, V328, P11, DOI 10.1136/bmj.37942.603970.9A; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Stouder C, 2011, REPRODUCTION, V141, P207, DOI 10.1530/REP-10-0400; Stouder C, 2010, REPRODUCTION, V139, P373, DOI 10.1530/REP-09-0340; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353; van den Berg GJ, 2016, ECON HUM BIOL, V23, P103, DOI 10.1016/j.ehb.2016.07.001; van den Berg GJ, 2014, J EUR ECON ASSOC, V12, P1521, DOI 10.1111/jeea.12112; Whitelaw NC, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r111; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106; Youngson NA, 2013, PHILOS T R SOC B, V1, P368	31	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0166952	10.1371/journal.pone.0166952	http://dx.doi.org/10.1371/journal.pone.0166952			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911909	Green Submitted, Green Published, gold			2022-12-27	WOS:000389520600018
J	Bregante, M; Carpaneto, A; Piazza, V; Sbrana, F; Vassalli, M; Faimali, M; Gambale, F				Bregante, Monica; Carpaneto, Armando; Piazza, Veronica; Sbrana, Francesca; Vassalli, Massimo; Faimali, Marco; Gambale, Franco			Osmoregulated Chloride Currents in Hemocytes from Mytilus galloprovincialis	PLOS ONE			English	Article							POTASSIUM CHANNELS; ESSENTIAL COMPONENT; VOLUME REGULATION; ION CHANNELS; MUSSEL; TRANSMISSION; TRANSPORTERS; IMMUNOCYTE; ACTIVATION; VACUOLES	We investigated the biophysical properties of the transport mediated by ion channels in hemocytes from the hemolymph of the bivalve Mytilus galloprovincialis. Besides other transporters, mytilus hemocytes possess a specialized channel sensitive to the osmotic pressure with functional properties similar to those of other transport proteins present in vertebrates. As chloride fluxes may play an important role in the regulation of cell volume in case of modifications of the ionic composition of the external medium, we focused our attention on an inwardly-rectifying voltage-dependent, chloride-selective channel activated by negative membrane potentials and potentiated by the low osmolality of the external solution. The chloride channel was slightly inhibited by micromolar concentrations of zinc chloride in the bath solution, while the antifouling agent zinc pyrithione did not affect the channel conductance at all. This is the first direct electrophysiological characterization of a functional ion channel in ancestral immunocytes of mytilus, which may bring a contribution to the understanding of the response of bivalves to salt and contaminant stresses.	[Bregante, Monica; Carpaneto, Armando; Sbrana, Francesca; Vassalli, Massimo; Gambale, Franco] Natl Res Council Italy IBF, Inst Biophys, Genoa, Italy; [Piazza, Veronica; Faimali, Marco] Natl Res Council Italy ISMAR, Inst Marine Sci, Genoa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Gambale, F (corresponding author), Natl Res Council Italy IBF, Inst Biophys, Genoa, Italy.	gambale@ge.ibf.cnr.it	Faimali, Marco/AAK-5723-2021; Vassalli, Massimo/F-6762-2011; Faimali, Marco/B-7191-2008	Faimali, Marco/0000-0001-5558-3555; Vassalli, Massimo/0000-0002-3063-4376; Carpaneto, Armando/0000-0002-5060-3657; PIAZZA, VERONICA/0000-0003-0142-6057; Sbrana, Francesca/0000-0001-7500-7774	Italian "Progetti di Ricerca di Interesse Nazionale" [PRIN2010CSJX4F, PRIN 2015795S5W_003]; Compagnia di San Paolo Research Foundation [ROL 291]; RITMARE (Ricerca Italiana peril MARE) Flagship Project; National Research Programme - Italian Ministry of University and Research (MIUR)	Italian "Progetti di Ricerca di Interesse Nazionale"(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Compagnia di San Paolo Research Foundation(Compagnia di San Paolo); RITMARE (Ricerca Italiana peril MARE) Flagship Project; National Research Programme - Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	AC was supported by the Italian "Progetti di Ricerca di Interesse Nazionale" (PRIN2010CSJX4F and PRIN 2015795S5W_003), as well as the Compagnia di San Paolo Research Foundation (ROL 291). MF was supported by RITMARE (Ricerca Italiana peril MARE) Flagship Project, a National Research Programme funded by the Italian Ministry of University and Research (MIUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A. C. was supported by the Italian "Progetti di Ricerca di Interesse Nazionale" (PRIN2010CSJX4F and PRIN 201579555W_003) as well as by Compagnia di San Paolo Research Foundation (ROL 291). M.F. was supported by RITMARE (Ricerca Habana peril MARE) Flagship Project, a National Research Programme funded by the Italian Ministry of University and Research (MIUR).	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Astuya A, 2015, INT J MOL SCI, V16, P15235, DOI 10.3390/ijms160715235; Barber BJ, 2004, AQUAT LIVING RESOUR, V17, P449, DOI 10.1051/alr:2004052; Bose T, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.23; Bott T.R., 1995, FOULING HEAT EXCHANG; Bregante M, 1997, EUR BIOPHYS J BIOPHY, V26, P381, DOI 10.1007/s002490050092; CAJARAVILLE MP, 1995, CELL STRUCT FUNCT, V20, P355, DOI 10.1247/csf.20.355; Calisi A, 2008, ENVIRON TOXICOL CHEM, V27, P1435, DOI 10.1897/07-396; Cao GZ, 2011, J MEMBRANE BIOL, V240, P111, DOI 10.1007/s00232-011-9349-7; Carpaneto A, 2003, J BIOCHEM BIOPH METH, V55, P179, DOI 10.1016/S0165-022X(02)00184-7; Carpaneto A, 1999, EXP BRAIN RES, V124, P193, DOI 10.1007/s002210050614; Carpaneto A, 2001, PLANTA, V213, P457, DOI 10.1007/s004250100519; Carpaneto A, 1999, FEBS LETT, V442, P129, DOI 10.1016/S0014-5793(98)01642-1; CHANDY KG, 1984, J EXP MED, V160, P369, DOI 10.1084/jem.160.2.369; Clark S, 1998, J PHYSIOL-LONDON, V506, P665, DOI 10.1111/j.1469-7793.1998.665bv.x; Curtis TM, 1999, COMP BIOCHEM PHYS A, V124, P231, DOI 10.1016/S1095-6433(99)00118-X; Dash D., 2012, ISRN CHEM ENG, V2012, P1, DOI 10.5402/2012/730154; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; De Jesus-Perez JJ, 2016, J GEN PHYSIOL, V147, P25, DOI 10.1085/jgp.201511424; ERMOLAYEVA E, 1995, APPL ENVIRON MICROB, V61, P3385, DOI 10.1128/AEM.61.9.3385-3390.1995; Feske S, 2015, ANNU REV IMMUNOL, V33, P291, DOI 10.1146/annurev-immunol-032414-112212; FIORICAHOWELLS E, 1990, J PHARMACOL EXP THER, V252, P610; Gambale F, 1996, J MEMBRANE BIOL, V154, P69, DOI 10.1007/s002329900133; Hamer W. J., 1972, J PHYS CHEM REF DATA, V1, P1047, DOI DOI 10.1063/1.3253108; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hansen Lars Koch, 2014, Dan Med J, V61, pB4946; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Jentsch TJ, 2016, NAT REV MOL CELL BIO, V17, P293, DOI 10.1038/nrm.2016.29; Kodirov SA, 2011, COMP BIOCHEM PHYS A, V160, P102, DOI 10.1016/j.cbpa.2011.06.014; Kurbannazarova RS, 2011, INT J MOL SCI, V12, P9125, DOI 10.3390/ijms12129125; Le Foll F, 2010, FISH SHELLFISH IMMUN, V28, P372, DOI 10.1016/j.fsi.2009.11.011; LEWIS RS, 1988, SCIENCE, V239, P771, DOI 10.1126/science.2448877; LEWIS RS, 1993, J GEN PHYSIOL, V101, P801, DOI 10.1085/jgp.101.6.801; Lockwood BL, 2011, MOL ECOL, V20, P517, DOI 10.1111/j.1365-294X.2010.04973.x; Lofts H, 2009, C03634 CEH; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Lowe S., 2000, ALIENS; Malagoli D, 2006, CELL BIOL INT, V30, P721, DOI 10.1016/j.cellbi.2006.05.003; Marcheselli M, 2011, AQUAT TOXICOL, V102, P39, DOI 10.1016/j.aquatox.2010.12.015; Marcheselli M, 2010, ENVIRON TOXICOL CHEM, V29, P2583, DOI 10.1002/etc.316; Metzger MJ, 2016, NATURE, V534, P705, DOI 10.1038/nature18599; Metzger MJ, 2015, CELL, V161, P255, DOI 10.1016/j.cell.2015.02.042; Murchison EP, 2016, NATURE, V534, P628, DOI 10.1038/nature18455; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Ottaviani E, 2011, ISJ-INVERT SURVIV J, V8, P1; Ottaviani E, 1998, ITAL J ZOOL, V65, P349, DOI 10.1080/11250009809386772; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; Rajagopal S, 2003, WATER RES, V37, P329, DOI 10.1016/S0043-1354(02)00270-1; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Robinson R.A., 1959, ELECTROLYTE SOLUTION, DOI DOI 10.1073?PNAS.0305836101; SILVA AL, 1994, J EXP BIOL, V194, P47; Staley K, 1996, NEURON, V17, P543, DOI 10.1016/S0896-6273(00)80186-5; Stauber T, 2012, COMPR PHYSIOL, V2, P1701, DOI 10.1002/cphy.c110038; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0; THOROED SM, 1994, J EXP BIOL, V186, P245; Torre A, 2013, TOXICOL IN VITRO, V27, P1260, DOI 10.1016/j.tiv.2013.02.017; Torre A, 2013, CELL BIOCHEM FUNCT, V31, P489, DOI 10.1002/cbf.2925; Turner A, 2010, MAR POLLUT BULL, V60, P159, DOI 10.1016/j.marpolbul.2009.12.004; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Wickenden AD, 2009, CURR PHARM DESIGN, V15, P1773, DOI 10.2174/138161209788186326; Xiong QJ, 2007, NAT CHEM BIOL, V3, P287, DOI 10.1038/nchembio874; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	63	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167972	10.1371/journal.pone.0167972	http://dx.doi.org/10.1371/journal.pone.0167972			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936151	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000389587100242
J	Endow, JK; Agostinho, GRA; Baldwin, AJ; Roston, RL; Yamaguchi, T; Kamikubo, H; Inoue, K				Endow, Joshua K.; Rocha, Agostinho Gomes; Baldwin, Amy J.; Roston, Rebecca L.; Yamaguchi, Toshio; Kamikubo, Hironari; Inoue, Kentaro			Polyglycine Acts as a Rejection Signal for Protein Transport at the Chloroplast Envelope	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; BETA-BARREL PROTEINS; INNER ENVELOPE; OUTER ENVELOPE; TRANSIT PEPTIDE; TRANSMEMBRANE DOMAIN; INTERMEMBRANE SPACE; MEMBRANE-PROTEINS; IMPORT APPARATUS; CHANNEL TOC75	PolyGly is present in many proteins in various organisms. One example is found in a transmembrane a-barrel protein, translocon at the outer-envelope-membrane of chloroplasts 75 (Toc75). Toc75 requires its N-terminal extension (t75) for proper localization. t75 comprises signals for chloroplast import (n75) and envelope sorting (c75) in tandem. n75 and c75 are removed by stromal processing peptidase and plastidic type I signal peptidase 1, respectively. PolyGly is present within c75 and its deletion or substitution causes mistargeting of Toc75 to the stroma. Here we have examined the properties of polyGly-dependent protein targeting using two soluble passenger proteins, the mature portion of the small subunit of ribulose-1,5-bisphosphate carboxylase/oxygenase (mSS) and enhanced green fluorescent protein (EGFP). Both t75-mSS and t75-EGFP were imported into isolated chloroplasts and their n75 removed. Resultant c75-mSS was associated with the envelope at the intermembrane space, whereas c75-EGFP was partially exposed outside the envelope. Deletion of polyGly or substitution of tri-Ala for the critical tri-Gly segment within polyGly caused each passenger to be targeted to the stroma. Transient expression of t75-EGFP in Nicotiana benthamiana resulted in accumulation of c75-EGFP exposed at the surface of the chloroplast, but the majority of the EGFP passenger was found free in the cytosol with most of its c75 attachment removed. Results of circular dichroism analyses suggest that polyGly within c75 may form an extended conformation, which is disrupted by tri-Ala substitution. These data suggest that polyGly is distinct from a canonical stop-transfer sequence and acts as a rejection signal at the chloroplast inner envelope.	[Endow, Joshua K.; Rocha, Agostinho Gomes; Baldwin, Amy J.; Roston, Rebecca L.; Yamaguchi, Toshio; Inoue, Kentaro] Univ Calif Davis, Dept Plant Sci, One Shields Ave, Davis, CA 95616 USA; [Kamikubo, Hironari] Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara, Japan; [Rocha, Agostinho Gomes] Washington Univ, Sch Med, Dept Internal Med, Ctr Pharmacogenom, St Louis, MO 63110 USA; [Baldwin, Amy J.] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales; [Roston, Rebecca L.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Yamaguchi, Toshio] Niigata Univ Pharm & Appl Life Sci, Dept Microbiol, Fac Pharm, Niigata, Japan	University of California System; University of California Davis; Nara Institute of Science & Technology; Washington University (WUSTL); Cardiff University; University of Nebraska System; University of Nebraska Lincoln; Niigata University	Endow, JK (corresponding author), Univ Calif Davis, Dept Plant Sci, One Shields Ave, Davis, CA 95616 USA.	jkendow@ucdavis.edu	Roston, Rebecca/AAQ-5309-2020	Endow-Monteiro, Joshua/0000-0002-5845-0077; Roston, Rebecca/0000-0002-3063-5002; Baldwin, Amy/0000-0002-2162-3771; G Rocha, PhD, Agostinho/0000-0001-7134-7376	National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service [2003-02860]; Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the US Department of Energy [DE-FG02-08ER15963]; Division of Molecular and Cellular Biosciences at the US National Science Foundation [1050602]	National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); Division of Molecular and Cellular Biosciences at the US National Science Foundation	The initial phase of this work involving preparation of some DNA constructs was supported by the National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service (grant no. 2003-02860) to KI. The assay using recombinant Plsp1 was supported by the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the US Department of Energy (grant no. DE-FG02-08ER15963) to KI. Performance of all other experiments and data analysis was supported by the Division of Molecular and Cellular Biosciences at the US National Science Foundation (grant no. 1050602) to KI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2005, PLANT CELL, V17, P1233, DOI 10.1105/tpc.104.030452; Bae W, 2008, NAT CELL BIOL, V10, P220, DOI 10.1038/ncb1683; Baldwin AJ, 2006, FEBS J, V273, P1547, DOI 10.1111/j.1742-4658.2006.05175.x; Blaby-Haas CE, 2014, P NATL ACAD SCI USA, V111, pE5480, DOI 10.1073/pnas.1421545111; Bolter B, 2011, CHEMBIOCHEM, V12, P1655, DOI 10.1002/cbic.201100118; Breuers FKH, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00097; Brito M, 2005, CARCINOGENESIS, V26, P2046, DOI 10.1093/carcin/bgi168; Brockschmidt FF, 2007, J MOL ENDOCRINOL, V39, P1, DOI 10.1677/JME-06-0072; Celedon JM, 2013, BBA-MOL CELL RES, V1833, P341, DOI 10.1016/j.bbamcr.2012.06.028; Chiang CF, 2001, ARCH BIOCHEM BIOPHYS, V394, P229, DOI 10.1006/abbi.2001.2537; Chiu CC, 2008, PLANT J, V56, P793, DOI 10.1111/j.1365-313X.2008.03638.x; CLINE K, 1984, PLANT PHYSIOL, V75, P675, DOI 10.1104/pp.75.3.675; Dopf J, 1996, GENE, V173, P39, DOI 10.1016/0378-1119(95)00692-3; Faux N, 2012, ADV EXP MED BIOL, V769, P26; Froehlich JE, 2001, J BIOL CHEM, V276, P31806, DOI 10.1074/jbc.M104652200; Froehlich JE, 2011, PLANT J, V68, P844, DOI 10.1111/j.1365-313X.2011.04735.x; Gutierrez-Carbonell E, 2014, J PROTEOME RES, V13, P2941, DOI 10.1021/pr500106s; Harvey CG, 2007, AM J MED GENET B, V144B, P355, DOI 10.1002/ajmg.b.30425; Hewitt VL, 2014, BBA-GEN SUBJECTS, V1840, P1246, DOI 10.1016/j.bbagen.2013.08.013; Hinnah SC, 1997, EMBO J, V16, P7351, DOI 10.1093/emboj/16.24.7351; Hinnah SC, 2002, BIOPHYS J, V83, P899, DOI 10.1016/S0006-3495(02)75216-8; Hsu SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027258; Hsu SC, 2009, BIOSCI TRENDS, V3, P168; Inoue K, 2005, J CELL BIOL, V171, P425, DOI 10.1083/jcb.200506171; Inoue K, 2004, PLANT J, V39, P354, DOI 10.1111/j.1365-313X.2004.02135.x; Inoue K, 2003, PLANT J, V34, P661, DOI 10.1046/j.1365-313X.2003.01755.x; Inoue K, 2001, EUR J BIOCHEM, V268, P4036, DOI 10.1046/j.1432-1327.2001.02316.x; Inoue K, 2006, PHYSIOL PLANTARUM, V127, P561, DOI 10.1111/j.1399-3054.2006.00690.x; Inoue K, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00278; Inoue K, 2014, ADVAN PL BIO, V5, P305, DOI 10.1007/978-1-4939-1136-3_12; Inoue K, 2011, TRENDS PLANT SCI, V16, P550, DOI 10.1016/j.tplants.2011.06.005; Jackson DT, 1998, J BIOL CHEM, V273, P16583, DOI 10.1074/jbc.273.26.16583; Kim DH, 2014, DEV CELL, V30, P598, DOI 10.1016/j.devcel.2014.07.026; Kim DH, 2013, TRAFFIC, V14, P613, DOI 10.1111/tra.12043; Kim HK, 1998, BRAIN RES BULL, V47, P35, DOI 10.1016/S0361-9230(98)00020-3; Klasek L, 2016, INT REV CEL MOL BIO, V323, P231, DOI 10.1016/bs.ircmb.2015.12.008; Kouranov A, 1998, J CELL BIOL, V143, P991, DOI 10.1083/jcb.143.4.991; Kouranov A, 1999, J BIOL CHEM, V274, P25181, DOI 10.1074/jbc.274.35.25181; Lamppa G, 2004, CHLOROPLAST STROMAL; Lee J, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00173; Li M, 2006, J CELL BIOL, V175, P249, DOI 10.1083/jcb.200605162; Li XQ, 1997, J BIOL CHEM, V272, P28545, DOI 10.1074/jbc.272.45.28545; Lubeck J, 1997, J CELL BIOL, V137, P1279, DOI 10.1083/jcb.137.6.1279; Macintyre G, 2010, SCHIZOPHR RES, V120, P143, DOI 10.1016/j.schres.2010.04.002; Marques JP, 2003, MOL GENET GENOMICS, V269, P381, DOI 10.1007/s00438-003-0846-y; Midorikawa T, 2014, PLANT J, V80, P592, DOI 10.1111/tpj.12655; Miras S, 2002, J BIOL CHEM, V277, P47770, DOI 10.1074/jbc.M207477200; Miras S, 2007, J BIOL CHEM, V282, P29482, DOI 10.1074/jbc.M611112200; Muthan B, 2013, PLANT PHYSIOL, V163, P61, DOI 10.1104/pp.113.222513; Nada A, 2004, J CELL SCI, V117, P3975, DOI 10.1242/jcs.01265; Nakachi Y, 1997, MOL BIOL EVOL, V14, P1042, DOI 10.1093/oxfordjournals.molbev.a025710; Ohnishi S, 2006, J AM CHEM SOC, V128, P16338, DOI 10.1021/ja066008b; Paila YD, 2015, J MOL BIOL, V427, P1038, DOI 10.1016/j.jmb.2014.08.016; Pogson BJ, 2015, BBA-BIOENERGETICS, V1847, P1017, DOI 10.1016/j.bbabio.2015.02.003; Rolland N., 2009, V13, P41, DOI 10.1007/7089_2008_33; Shipman RL, 2009, FEBS LETT, V583, P938, DOI 10.1016/j.febslet.2009.02.016; Shipman-Roston RL, 2010, PLANT PHYSIOL, V152, P1297, DOI 10.1104/pp.109.151977; Simm S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00011; Spreitzer RJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P141, DOI 10.1016/S0003-9861(03)00171-1; Tranel PJ, 1996, PLANT CELL, V8, P2093, DOI 10.1105/tpc.8.11.2093; TRANEL PJ, 1995, EMBO J, V14, P2436, DOI 10.1002/j.1460-2075.1995.tb07241.x; Tripp J, 2007, PLANT J, V52, P824, DOI 10.1111/j.1365-313X.2007.03279.x; Tu SL, 2004, PLANT CELL, V16, P2078, DOI 10.1105/tpc.104.023952; Ulrich T, 2015, INT J MED MICROBIOL, V305, P259, DOI 10.1016/j.ijmm.2014.12.009; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Viana AAB, 2010, J BIOL CHEM, V285, P12948, DOI 10.1074/jbc.M110.109744; WARD WW, 2005, BIOCH PHYS PROPERTIE, P39; Woody RW, 2009, J AM CHEM SOC, V131, P8234, DOI 10.1021/ja901218m; Zhang LD, 2006, GENOME, V49, P900, DOI 10.1139/G06-054	69	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167802	10.1371/journal.pone.0167802	http://dx.doi.org/10.1371/journal.pone.0167802			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936133	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000389587100198
J	Gernaat, SAM; Isgum, I; de Vos, BD; Takx, RAP; Young-Afat, DA; Rijnberg, N; Grobbee, DE; van der Graaf, Y; de Jong, PA; Leiner, T; van den Bongard, DHJ; Pignol, JP; Verkooijen, HM				Gernaat, Sofie A. M.; Isgum, Ivana; de Vos, Bob D.; Takx, Richard A. P.; Young-Afat, Danny A.; Rijnberg, Noor; Grobbee, Diederick E.; van der Graaf, Yolanda; de Jong, Pim A.; Leiner, Tim; van den Bongard, Desiree H. J.; Pignol, Jean-Philippe; Verkooijen, Helena M.			Automatic Coronary Artery Calcium Scoring on Radiotherapy Planning CT Scans of Breast Cancer Patients: Reproducibility and Association with Traditional Cardiovascular Risk Factors	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; VALVE CALCIFICATIONS; PROGNOSTIC VALUE; HEART-DISEASE; EVENTS; PROGRESSION; PREDICTION; AGREEMENT; MDCT	Objectives Coronary artery calcium (CAC) is a strong and independent predictor of cardiovascular disease (CVD) risk. This study assesses reproducibility of automatic CAC scoring on radiotherapy planning computed tomography (CT) scans of breast cancer patients, and examines its association with traditional cardiovascular risk factors. Methods This study included 561 breast cancer patients undergoing radiotherapy between 2013 and 2015. CAC was automatically scored with an algorithm using supervised pattern recognition, expressed as Agatston scores and categorized into five categories (0, 1-10, 11-100, 101-400, >400). Reproducibility between automatic and manual expert scoring was assessed in 79 patients with automatically determined CAC above zero and 84 randomly selected patients without automatically determined CAC. Interscan reproducibility of automatic scoring was assessed in 294 patients having received two scans (82% on the same day). Association between CAC and CVD risk factors was assessed in 36 patients with CAC scores >100, 72 randomly selected patients with scores 1-100, and 72 randomly selected patients without CAC. Reliability was assessed with linearly weighted kappa and agreement with proportional agreement. Results 134 out of 561 (24%) patients had a CAC score above zero. Reliability of CVD risk categorization between automatic and manual scoring was 0.80 (95% Confidence Interval (CI): 0.74-0.87), and slightly higher for scans with breath-hold. Agreement was 0.79 (95% CI: 0.72-0.85). Interscan reliability was 0.61 (95% CI: 0.50-0.72) with an agreement of 0.84 (95% CI: 0.80-0.89). Ten out of 36 (27.8%) patients with CAC scores above 100 did not have other cardiovascular risk factors. Conclusions Automatic CAC scoring on radiotherapy planning CT scans is a reliable method to assess CVD risk based on Agatston scores. One in four breast cancer patients planned for radiotherapy have elevated CAC score. One in three patients with high CAC scores don't have other CVD risk factors and wouldn't have been identified as high risk.	[Gernaat, Sofie A. M.; Young-Afat, Danny A.; Grobbee, Diederick E.; van der Graaf, Yolanda] Univ Med Ctr Utrecht, Dept Epidemiol, Julius Ctr, Utrecht, Netherlands; [Isgum, Ivana; de Vos, Bob D.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Takx, Richard A. P.; de Jong, Pim A.; Leiner, Tim] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Rijnberg, Noor] Acad Med Ctr, Devis Internal Med, Amsterdam, Netherlands; [van den Bongard, Desiree H. J.] Univ Med Ctr Utrecht, Dept Radiat Oncol, Utrecht, Netherlands; [Pignol, Jean-Philippe] Erasmus MC, Dept Radiat Oncol, Rotterdam, Netherlands; [Verkooijen, Helena M.] Univ Med Ctr Utrecht, Imaging Div, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center	Gernaat, SAM (corresponding author), Univ Med Ctr Utrecht, Dept Epidemiol, Julius Ctr, Utrecht, Netherlands.	S.A.M.Gernaat@umcutrecht.nl	Takx, Richard/T-2852-2019	Takx, Richard/0000-0003-2252-3040; Pignol, Jean-Philippe/0000-0002-0253-8520; van den Bongard, Desiree/0000-0002-5549-324X; Gernaat, Sofie/0000-0001-7828-1138				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Bird BRJH, 2008, CLIN CANCER RES, V14, P14, DOI 10.1158/1078-0432.CCR-07-1033; Blaha MJ, 2011, LANCET, V378, P684, DOI 10.1016/S0140-6736(11)60784-8; Borger JH, 2007, INT J RADIAT ONCOL, V69, P1131, DOI 10.1016/j.ijrobp.2007.04.042; Brenner H, 1996, EPIDEMIOLOGY, V7, P199, DOI 10.1097/00001648-199603000-00016; Brunner G, 2010, INT J CARDIOVAS IMAG, V26, P829, DOI 10.1007/s10554-010-9608-1; Budoff MJ, 2007, J AM COLL CARDIOL, V49, P1860, DOI 10.1016/j.jacc.2006.10.079; Budoff MJ, 2011, J CARDIOVASC COMPUT, V5, P12, DOI 10.1016/j.jcct.2010.11.004; Budoff MJ, 2011, J CARDIOVASC COMPUT, V5, P113, DOI 10.1016/j.jcct.2010.11.002; Chiles C, 2015, RADIOLOGY, V276, P82, DOI 10.1148/radiol.15142062; Cutter D, 2011, CANCER RES, V71, DOI 10.1158/0008-5472.SABCS11-P3-13-06; Gepner AD, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.002262; Isgum I, 2012, IEEE T MED IMAGING, V31, P2322, DOI 10.1109/TMI.2012.2216889; Jacobs PC, 2012, AM J ROENTGENOL, V198, P505, DOI 10.2214/AJR.10.5577; Jairam PM, 2014, RADIOLOGY, V272, P700, DOI 10.1148/radiol.14132211; Kim SM, 2008, AM J ROENTGENOL, V190, P917, DOI 10.2214/AJR.07.2979; Kronmal RA, 2007, CIRCULATION, V115, P2722, DOI 10.1161/CIRCULATIONAHA.106.674143; Kurkure U, 2010, INT J CARDIOVAS IMAG, V26, P817, DOI 10.1007/s10554-010-9607-2; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee YC, 2015, BREAST CANC RES TREA; Lehmann N, 2014, ATHEROSCLEROSIS, V232, P339, DOI 10.1016/j.atherosclerosis.2013.11.045; Maher JE, 1999, MAYO CLIN PROC, V74, P347, DOI 10.4065/74.4.347; McGale P, 2011, RADIOTHER ONCOL, V100, P167, DOI 10.1016/j.radonc.2011.06.016; Mets OM, 2013, JACC-CARDIOVASC IMAG, V6, P899, DOI 10.1016/j.jcmg.2013.02.008; Nasir K, 2012, CIRC-CARDIOVASC IMAG, V5, P467, DOI 10.1161/CIRCIMAGING.111.964528; Pinder MC, 2007, J CLIN ONCOL, V25, P3808, DOI 10.1200/JCO.2006.10.4976; Raggi P, 2001, AM J CARDIOL, V87, p27A; RUMBERGER JA, 1995, CIRCULATION, V92, P2157, DOI 10.1161/01.CIR.92.8.2157; Shahzad R, 2013, ACAD RADIOL, V20, P1, DOI 10.1016/j.acra.2012.07.018; Shaw LJ, 2006, EUR HEART J, V27, P968, DOI 10.1093/eurheartj/ehi750; Sobin L, 2009, TNM CLASSIFICATION M; Takx RAP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091239; Taunk NK, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00039; Taylor CW, 2015, CLIN ONCOL R COLL RA; Toutouzas K, 2013, NEW ENGL J MED, V368, P2524, DOI 10.1056/NEJMc1304601; van Hamersvelt RW, 2014, EUR RADIOL, V24, P1557, DOI 10.1007/s00330-014-3191-0; Vossen LM, 2015, NUTRIENTS, V7, P8905, DOI 10.3390/nu7115443; Willemink MJ, 2015, INT J CARDIOVAS IMAG, V31, P1243, DOI 10.1007/s10554-015-0664-4; Wolterink JM, 2015, IEEE T MED IMAGING, V34, P1867, DOI 10.1109/TMI.2015.2412651; Wu MT, 2008, AM J ROENTGENOL, V190, P923, DOI 10.2214/AJR.07.2974; Xie Y., 2014, SPIE INT S MED IM 20, V9035	41	26	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167925	10.1371/journal.pone.0167925	http://dx.doi.org/10.1371/journal.pone.0167925			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936125	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100232
J	Li, TX; Zhang, MJ; Lu, ZM; Herman, U; Mumbengegwi, D; Crittenden, J				Li, Tianxin; Zhang, Minjie; Lu, Zhongming; Herman, Uwizeyimana; Mumbengegwi, Dzivaidzo; Crittenden, John			Effects of Heavy Metals from Soil and Dust Source on DNA Damage of the Leymus chinensis Leaves in Coal-Mining Area in Northwest China	PLOS ONE			English	Article							CONTAMINATION; SEDIMENTS; PLANTS	Air and soil pollution from mining activities has been considered as a critical issue to the health of living organisms. However, few efforts have been made in distinguishing the main pathway of organism genetic damage by heavy metals related to mining activities. Therefore, we investigated the genetic damage of Leymus chinensis leaf cells, the air particulate matter (PM) contents, and concentrations of the main heavy metals (Pb, Cd, Cr, Hg) in soil and foliar dust samples collected from seven experiment points at the core mining area and one control point 20 kilometers away from the core mining area in Inner Mongolia in 2013. Comet assay was used to test the genetic damage of the Leymus chinensis leaf cells; the Tail DNA% and Tail Moment were used to characterize the genetic damage degree of the plant cells. The comet assay results showed that the cell genetic damage ratio was up to 77.0% in experiment points but was only 35.0% in control point. The control point also had the slight Tail DNA% and Tail Moment values than other experiment groups. The cell damage degree of the control group was 0.935 and experiment groups were 1.299-1.815. The geo-accumulation index and comperehensive pollution index(CPI) were used to characterize heavy metal pollution in foliar dust samples, and single factor pollution index and CPI were used to characterize the heavy metal pollution in soil samples. The CPIfoliar dust of control group was 0.36 and experiment groups were 1.45-2.57; the CPIsoil of control group was 0.04 and experiment groups were 0.07-0.12. The results of correlation analyze showed that Air Quality Index (AQI)-CPIfoliar dust(r = 0.955**)>Damage degree-CPIfoliar dust(r = 0.923**) >Damage degree-AQI(r = 0.908**)> Damage degree-CPIsoil (r = 0.824*). The present research proved that mining activity had a high level of positive correlation with organism genetic damage caused by heavy metals through comparing with the control point; soil and atmosphere were both the important action pathway for heavy metal induced genetic damage in mining area. Furthermore, heavy metal contents in foliar dust showed a higher positive correlation with genetic damage than when compared with soil. This means the heavy metal contents that L. chinensis absorbed through respiration from the atmosphere could make more serious genetic damage than when absorbed by root systems from soil in the mining area. This study can provide theoretical support for research on plant genetic damage mechanisms and exposure pathways induced by environmental pollution.	[Li, Tianxin; Zhang, Minjie; Herman, Uwizeyimana; Mumbengegwi, Dzivaidzo] Univ Sci & Technol Beijing, Sch Civil & Environm Engn, Beijing, Peoples R China; [Lu, Zhongming; Crittenden, John] Georgia Inst Technol, Brook Byers Inst Sustainable Syst, Atlanta, GA 30332 USA; [Herman, Uwizeyimana] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China; [Lu, Zhongming; Crittenden, John] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA	University of Science & Technology Beijing; University System of Georgia; Georgia Institute of Technology; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); University System of Georgia; Georgia Institute of Technology	Li, TX (corresponding author), Univ Sci & Technol Beijing, Sch Civil & Environm Engn, Beijing, Peoples R China.	tianxinli@ustb.edu.cn	Lu, Zhongming/M-8292-2018; Lu, Zhongming/S-2757-2019	Lu, Zhongming/0000-0002-4151-5065; Lu, Zhongming/0000-0002-4151-5065	National Basic Research Fund of the Chinese Ministry of Education [FRF-SD-12-008A]; Brook Byers Institute for Sustainable Systems; Hightower Chair; Georgia Research Alliance at the Georgia Institute of Technology; Emerging Frontiers & Multidisciplinary Activities [1441208] Funding Source: National Science Foundation	National Basic Research Fund of the Chinese Ministry of Education; Brook Byers Institute for Sustainable Systems; Hightower Chair; Georgia Research Alliance at the Georgia Institute of Technology; Emerging Frontiers & Multidisciplinary Activities(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project is supported by the National Basic Research Fund of the Chinese Ministry of Education (No. FRF-SD-12-008A). The authors also appreciate support from the Brook Byers Institute for Sustainable Systems and the Hightower Chair and Georgia Research Alliance at the Georgia Institute of Technology.	Azqueta A, 2013, ARCH TOXICOL, V87, P949, DOI 10.1007/s00204-013-1070-0; Bian Z, 2010, MIN SCI TECHNOL, V20, P215, DOI DOI 10.1016/S1674-5264(09)60187-3; Clark MW, 2001, ENVIRON GEOL, V40, P655, DOI 10.1007/s002549900073; Cook AG, 2005, BIOL TRACE ELEM RES, V103, P1, DOI 10.1385/BTER:103:1:001; Deng HG, 2010, ENVIRON EARTH SCI, V60, P57, DOI 10.1007/s12665-009-0169-3; Escarre J, 2011, WATER AIR SOIL POLL, V216, P485, DOI 10.1007/s11270-010-0547-1; Feng JF, 2011, J ENVIRON SCI-CHINA, V23, P1158, DOI 10.1016/S1001-0742(10)60529-3; Gao Y, 2010, J ENVIRON SCI-CHINA, V22, P1040, DOI 10.1016/S1001-0742(09)60215-1; Ghrefat HA, 2011, ENVIRON MONIT ASSESS, V178, P95, DOI 10.1007/s10661-010-1675-1; Gjorgieva D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/276417; Guerrero-Castilla A, 2014, MUTAT RES-GEN TOX EN, V762, P24, DOI 10.1016/j.mrgentox.2013.12.005; Khorasanipour M, 2011, APPL GEOCHEM, V26, P714, DOI 10.1016/j.apgeochem.2011.01.030; Li KX, 2015, J GEOGR SCI, V25, P1439, DOI 10.1007/s11442-015-1244-1; Li TX, 2015, INT J ENV RES PUB HE, V12, P12475, DOI 10.3390/ijerph121012475; [林健 Lin Jian], 2002, [环境与健康杂志, Journal of Environment and Health], V19, P119; Loska K, 2004, ENVIRON INT, V30, P159, DOI 10.1016/S0160-4120(03)00157-0; Lu XW, 2009, ATMOS ENVIRON, V43, P2489, DOI 10.1016/j.atmosenv.2009.01.048; Manta DS, 2002, SCI TOTAL ENVIRON, V300, P229, DOI 10.1016/S0048-9697(02)00273-5; Miler M, 2012, J GEOCHEM EXPLOR, V112, P152, DOI 10.1016/j.gexplo.2011.08.012; Monterroso C, 2014, APPL GEOCHEM, V44, P3, DOI 10.1016/j.apgeochem.2013.09.001; Ogunkunle CO, 2013, POL J ENVIRON STUD, V22, P487; Pan Luqing, 2011, Journal of Ocean University of China, V10, P177, DOI 10.1007/s11802-011-1809-2; Shi G, 2010, ENVIRON POLLUT, V158, P694, DOI 10.1016/j.envpol.2009.10.020; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Song SJ, 2012, ENVIRON POLLUT, V161, P215, DOI 10.1016/j.envpol.2011.10.014; Weimin C, 2012, APPL MECH MAT, V246-247, P608; [杨利民 Yang Limin], 2007, [生态学报, Acta Ecologica Sinica], V27, P16; Yin RJ, 2013, J ENVIRON QUAL, V42, P1724, DOI 10.2134/jeq2013.04.0150; Yiru Y, 2009, J PLANT RESOURCES EN	29	9	9	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166522	10.1371/journal.pone.0166522	http://dx.doi.org/10.1371/journal.pone.0166522			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935969	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100032
J	McAuley, EM; Bertram, SM				McAuley, Emily M.; Bertram, Susan M.			Field Crickets Compensate for Unattractive Static Long-Distance Call Components by Increasing Dynamic Signalling Effort	PLOS ONE			English	Article							SEXUAL-SELECTION; CONDITION DEPENDENCE; FEMALE PREFERENCE; ORNAMENTS; BEHAVIOR; TEMPERATURE; EVOLUTION; TRAITS; AGE; COMMUNICATION	The evolution of multiple sexual signals presents a dilemma since individuals selecting a mate should pay attention to the most honest signal and ignore the rest; however, multiple signals may evolve if, together, they provide more information to the receiver than either one would alone. Static and dynamic signals, for instance, can act as multiple messages, providing information on different aspects of signaller quality that reflect condition at different time scales. While the nature of static signals makes them difficult or impossible for individuals to augment, dynamic signals are much more susceptible to temporary fluctuations in effort. We investigated whether male Texas field crickets, Gryllus texensis, that produce unattractive static signals compensate by dynamically increasing their calling effort. Our findings lend partial support to the compensation hypothesis, as males that called at unattractive carrier frequencies (a static trait) spent more time calling each night (a dynamic trait). Interestingly, this finding was most pronounced in males that called with attractive pulse characteristics (static traits) but did not occur in males that called with unattractive pulse characteristics. Males that signalled with unattractive pulse characteristics (duration and pause) spent less time calling through the night. Our correlative findings on wild caught males suggest that only males that signal with attractive pulse characteristics may be able to afford to pay the costs of both trait exaggeration and increased calling effort to compensate for poor carrier frequencies.	[McAuley, Emily M.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC, Canada; [Bertram, Susan M.] Carleton Univ, Dept Biol, Ottawa, ON, Canada	Simon Fraser University; Carleton University	Bertram, SM (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON, Canada.	sue.bertram@carleton.ca		Bertram, Susan/0000-0002-1822-3208	Natural Science and Engineering Research Council (NSERC) of Canada; NSERC	Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by an Natural Science and Engineering Research Council (NSERC) of Canada Discovery Grant to SB. NSERC also provided a Canada Graduate Scholarship to EM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RICHARD D., 1961, BEHAVIOUR, V17, P130, DOI 10.1163/156853961X00042; Andersson Malte, 1994; Bailey WJ, 1998, J ZOOL, V244, P505, DOI 10.1111/j.1469-7998.1998.tb00056.x; Bailey WJ, 2001, J EXP BIOL, V204, P2827; Bennet-Clark HC, 1999, J EXP BIOL, V202, P3347; Berglund A, 1996, BIOL J LINN SOC, V58, P385, DOI 10.1111/j.1095-8312.1996.tb01442.x; Bertram SM, 2004, TECHNICAL ACOUSTICS, P1; Bertram SM, 2007, EVOL ECOL RES, V9, P975; Bertram SM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0074938, 10.1371/journal.pone.0069247]; Bertram SM, 2012, ECOL EVOL, V2, P181, DOI 10.1002/ece3.76; Blankers T, 2015, J EVOLUTION BIOL, V28, P1656, DOI 10.1111/jeb.12686; Blankers T, 2015, J EVOLUTION BIOL, V28, P630, DOI 10.1111/jeb.12599; CADE W, 1975, SCIENCE, V190, P1312, DOI 10.1126/science.190.4221.1312; CADE WH, 1992, ANIM BEHAV, V43, P49, DOI 10.1016/S0003-3472(05)80070-3; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Candolin U, 1999, ANIM BEHAV, V58, P1261, DOI 10.1006/anbe.1999.1259; CICERAN M, 1994, CAN J ZOOL, V72, P38, DOI 10.1139/z94-006; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; Copeland EK, 2012, P ROY SOC B-BIOL SCI, V279, P4740, DOI 10.1098/rspb.2012.1914; Cotton S, 2004, P ROY SOC B-BIOL SCI, V271, P771, DOI 10.1098/rspb.2004.2688; Crnokrak P, 1995, ANIM BEHAV, V50, P1475, DOI 10.1016/0003-3472(95)80004-2; Doucet SM, 2003, BEHAV ECOL, V14, P503, DOI 10.1093/beheco/arg035; Eshel I, 2000, EVOL ECOL RES, V2, P509; GERHARDT HC, 1991, ANIM BEHAV, V42, P615, DOI 10.1016/S0003-3472(05)80245-3; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Gray DA, 2001, ANIM BEHAV, V62, P871, DOI 10.1006/anbe.2001.1825; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Hedrick A, 2005, ANIM BEHAV, V70, P1121, DOI 10.1016/j.anbehav.2005.02.011; Hedrick AV, 2000, P ROY SOC B-BIOL SCI, V267, P671, DOI 10.1098/rspb.2000.1054; HEDRICK AV, 1986, BEHAV ECOL SOCIOBIOL, V19, P73, DOI 10.1007/BF00303845; HEDRICK AV, 1988, AM NAT, V132, P267, DOI 10.1086/284849; Higgins LA, 2004, ANIM BEHAV, V68, P1139, DOI 10.1016/j.anbehav.2003.10.035; HILL KG, 1974, J COMP PHYSIOL, V93, P7, DOI 10.1007/BF00608756; Hoglund J, 1998, OIKOS, V83, P478, DOI 10.2307/3546675; Holzer B, 2003, BEHAV ECOL, V14, P353, DOI 10.1093/beheco/14.3.353; Hunt J, 2004, NATURE, V432, P1024, DOI 10.1038/nature03084; IWASA Y, 1994, EVOLUTION, V48, P853, DOI 10.1111/j.1558-5646.1994.tb01367.x; Johnstone RA, 1996, PHILOS T R SOC B, V351, P329, DOI 10.1098/rstb.1996.0026; Judge KA, 2008, EVOLUTION, V62, P868, DOI 10.1111/j.1558-5646.2008.00318.x; Kelly CD, 2015, PEERJ, V3, DOI 10.7717/peerj.1501; KODRICBROWN A, 1984, AM NAT, V124, P309, DOI 10.1086/284275; Kokko H, 2002, P ROY SOC B-BIOL SCI, V269, P1331, DOI 10.1098/rspb.2002.2020; Kokko H, 1997, BEHAV ECOL SOCIOBIOL, V41, P99, DOI 10.1007/s002650050369; Kostarakos Konstantinos, 2009, Frontiers in Zoology, V6, P1; Martin SD, 2000, CAN J ZOOL, V78, P706, DOI 10.1139/cjz-78-5-706; MOLLER AP, 1993, BEHAV ECOL SOCIOBIOL, V32, P167; NUR N, 1984, J THEOR BIOL, V110, P275, DOI 10.1016/S0022-5193(84)80059-4; PFAU HK, 1994, J EXP BIOL, V195, P147; Polkki M, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1002; Pomiankowski A.N., 1988, Oxford Surveys in Evolutionary Biology, V5, P136; PRESTWICH KN, 1994, AM ZOOL, V34, P625, DOI 10.1093/icb/34.6.625; PRESTWICH KN, 1981, J COMP PHYSIOL, V143, P199; ROBERT D, 1992, SCIENCE, V258, P1135, DOI 10.1126/science.1439820; Rowe C, 1999, ANIM BEHAV, V58, P921, DOI 10.1006/anbe.1999.1242; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Scheuber H, 2003, P ROY SOC B-BIOL SCI, V270, P1779, DOI 10.1098/rspb.2003.2449; Scheuber H, 2004, P ROY SOC B-BIOL SCI, V271, P2453, DOI 10.1098/rspb.2004.2907; Scheuber H, 2003, ANIM BEHAV, V65, P721, DOI 10.1006/anbe.2003.2083; SCHLUTER D, 1993, P ROY SOC B-BIOL SCI, V253, P117, DOI 10.1098/rspb.1993.0089; Simmons LW, 1996, P ROY SOC B-BIOL SCI, V263, P1305, DOI 10.1098/rspb.1996.0191; SMITH JM, 1988, PHILOS T ROY SOC B, V319, P557, DOI 10.1098/rstb.1988.0065; Thomson IR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090409; VANWYK JW, 1995, J INSECT PHYSIOL, V41, P837, DOI 10.1016/0022-1910(95)00055-Y; Wagner WE, 1999, ANIM BEHAV, V57, P89, DOI 10.1006/anbe.1998.0964; WALKER TJ, 1993, J INSECT BEHAV, V6, P389, DOI 10.1007/BF01048119; Whattam EM, 2011, ANIM BEHAV, V81, P135, DOI 10.1016/j.anbehav.2010.09.024; Zahavi A., 1977, P253; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; ZEH DW, 1988, AM NAT, V132, P454, DOI 10.1086/284863	70	6	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167311	10.1371/journal.pone.0167311	http://dx.doi.org/10.1371/journal.pone.0167311			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936045	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100082
J	Song, ZC; Miao, H; Zhang, S; Wang, Y; Zhang, SP; Gu, XF				Song, Zi-Chao; Miao, Han; Zhang, Song; Wang, Ye; Zhang, Sheng-Ping; Gu, Xing-Fang			Genetic Analysis and QTL Mapping of Fruit Peduncle Length in Cucumber (Cucumis sativus L.)	PLOS ONE			English	Article							TRAITS; FAMILY; IDENTIFICATION; RESISTANCE; GENOME; ROBOT	Mechanized harvesting of cucumbers offers significant advantages compared to manual labor as both shortages and costs of labor increase. However the efficient use of machines depends on breeding plants with longer peduncles, but the genetic and molecular basis of fruit peduncle development in cucumber is not well understood. In this study, F-2 populations were developed from a cross between two inbred lines, 1101 with a long peduncle and 1694 with a short peduncle. These were grown at two field sites, Hainan, with a tropical marine climate, in December 2014, and Beijing, with a warm temperate climate, in May 2015. Electron microscope examination of the pith cells in the peduncles of the two parental lines showed that line 1101 had significantly greater numbers of smaller cells compared to line 1694. The inheritance of cucumber fruit peduncle length (FPL) was investigated by the mixed major gene and polygene inheritance model. Genetic analysis indicated that FPL in cucumber is quantitatively inherited and controlled by one additive major gene and additive-dominant polygenes (D-2 model). A total of 1460 pairs of SSR (simple sequence repeat) primers were analyzed to identify quantitative trait loci (QTLs). Two similar genetic maps with 78 SSR markers which covered 720.6 cM in seven linkage groups were constructed based on two F2 populations. QTL analysis from the data collected at the two field sites showed that there are two minor QTLs on chromosome 1, named qfpl1.1 and qfpl1.2, and one major QTL on chromosome 6, named qfpl6.1. The marker UW021226, which was the closest one to qfpl6.1, had an accuracy rate of 79.0% when tested against plants selected from populations of the two parents. The results from this study provide insights into the inheritance and molecular mechanism of the variation of FPL in cucumber, and further research will be carried out to fine map qfpl6.1 to develop more accurate markers for MAS breeding.	[Song, Zi-Chao; Miao, Han; Zhang, Song; Wang, Ye; Zhang, Sheng-Ping; Gu, Xing-Fang] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS	Zhang, SP; Gu, XF (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing, Peoples R China.	zhangshengping@caas.cn; guxingfang@caas.cn		Song, Zichao/0000-0002-2143-9501	earmarked fund for Modern Agro-industry Technology Research System [CARS-25]; Science and Technology Innovation Program of the Chinese Academy of Agricultural Science (CAAS-ASTIP-IVFCAAS); Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, the People's Republic of China	earmarked fund for Modern Agro-industry Technology Research System; Science and Technology Innovation Program of the Chinese Academy of Agricultural Science (CAAS-ASTIP-IVFCAAS); Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, the People's Republic of China	This study was supported by the earmarked fund for Modern Agro-industry Technology Research System (CARS-25), the Science and Technology Innovation Program of the Chinese Academy of Agricultural Science (CAAS-ASTIP-IVFCAAS), and the Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bac CW, 2013, COMPUT ELECTRON AGR, V96, P148, DOI 10.1016/j.compag.2013.05.004; Cavagnaro PF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-569; Chen F.Z.., 2011, J ANHUI AGR SCI, V39, P6988, DOI [10.13989/j.cnki.0517-6611.2011.12.359, DOI 10.13989/J.CNKI.0517-6611.2011.12.359]; Chen Xue-jun, 2012, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V32, P246; [崔竣杰 Cui Junjie], 2014, [广东农业科学, Guangdong Agricultural Sciences], V41, P52; Gai J., 2003, GENETIC SYSTEM QUANT; Gan DF, 2013, J GENET, V92, P513, DOI 10.1007/s12041-013-0306-3; Hayashi S., 2003, Journal of Society of High Technology in Agriculture, V15, P211, DOI 10.2525/jshita.15.211; Hayashi S, 2010, BIOSYST ENG, V105, P160, DOI 10.1016/j.biosystemseng.2009.09.011; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Junyi G, 2006, FRONT BIOL CHINA, V1, P85, DOI [10.1007/s11515-005-0001-8, DOI 10.1007/S11515-005-0001-8]; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Li Z, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-540; Lin TingTing, 2014, Acta Agronomica Sinica, V40, P1733; Ling P, 2004, 043088 ASAE; Lu HW, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0263-z; MENG XL, 1993, BIOMETRIKA, V80, P267, DOI 10.2307/2337198; Miao Han, 2011, Scientia Agricultura Sinica, V44, P5031; Miao H, 2011, EUPHYTICA, V182, P167, DOI 10.1007/s10681-011-0410-5; Plebe A, 2001, MACH VISION APPL, V13, P70, DOI 10.1007/PL00013271; Ren Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005795; Song J, 2007, NEW ZEAL J AGR RES, V50, P959; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Tian GL, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0279-4; Van Henten EJ, 2009, COMPUT ELECTRON AGR, V65, P247, DOI 10.1016/j.compag.2008.11.004; van Henten EJ, 2002, AUTON ROBOT, V13, P241, DOI 10.1023/A:1020568125418; Van Ooijen JW., 2006, JOINMAP4 0 SOFTWARE; van Ooijen JW, 2000, MAPQTL VERSION 4 0 S; VANOOIJEN JW, 1992, THEOR APPL GENET, V84, P803, DOI 10.1007/BF00227388; Wang H., 2006, HEILONGJIANG AGR SCI, V5, P124; Wang H, 2008, PLANT GROWTH REGUL, V56, P225, DOI 10.1007/s10725-008-9313-4; Yang XQ, 2014, EUPHYTICA, V196, P341, DOI 10.1007/s10681-013-1037-5; Yang XQ, 2014, MOL BREEDING, V33, P15, DOI 10.1007/s11032-013-9927-8; Yuan XJ, 2008, EUPHYTICA, V164, P473, DOI 10.1007/s10681-008-9722-5; Yuan XJ, 2008, PLANT BREEDING, V127, P180, DOI 10.1111/j.1439-0523.2007.01426.x; Zhang SP, 2013, PLANT DIS, V97, P245, DOI 10.1094/PDIS-11-11-0941-RE; Zhang SB, 2016, SCI REP-UK, V6, DOI 10.1038/srep23173; Zhang WW, 2010, THEOR APPL GENET, V120, P645, DOI 10.1007/s00122-009-1182-3; Zhao DA, 2011, BIOSYST ENG, V110, P112, DOI 10.1016/j.biosystemseng.2011.07.005	39	11	11	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167845	10.1371/journal.pone.0167845	http://dx.doi.org/10.1371/journal.pone.0167845			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936210	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100214
J	Sun, LW; Johnson, RD; Williams, V; Summerfelt, P; Dubra, A; Weinberg, DV; Stepien, KE; Fishman, GA; Carroll, J				Sun, Lynn W.; Johnson, Ryan D.; Williams, Vesper; Summerfelt, Phyllis; Dubra, Alfredo; Weinberg, David V.; Stepien, Kimberly E.; Fishman, Gerald A.; Carroll, Joseph			Multimodal Imaging of Photoreceptor Structure in Choroideremia	PLOS ONE			English	Article							OPTICAL-COHERENCE-TOMOGRAPHY; OUTER RETINAL TUBULATION; ADAPTIVE OPTICS; RETINITIS-PIGMENTOSA; GENE; DISRUPTION; MORPHOLOGY; MUTATION; METRICS; CLONING	Purpose Choroideremia is a progressive X-linked recessive dystrophy, characterized by degeneration of the retinal pigment epithelium (RPE), choroid, choriocapillaris, and photoreceptors. We examined photoreceptor structure in a series of subjects with choroideremia with particular attention to areas bordering atrophic lesions. Methods Twelve males with clinically-diagnosed choroideremia and confirmed hemizygous mutations in the CHM gene were examined. High-resolution images of the retina were obtained using spectral domain optical coherence tomography (SD-OCT) and both confocal and non-confocal split-detector adaptive optics scanning light ophthalmoscope (AOSLO) techniques. Results Eleven CHM gene mutations (3 novel) were identified; three subjects had the same mutation and one subject had two mutations. SD-OCT findings included interdigitation zone (IZ) attenuation or loss in 10/12 subjects, often in areas with intact ellipsoid zones; RPE thinning in all subjects; interlaminar bridges in the imaged areas of 10/12 subjects; and outer retinal tubulations (ORTs) in 10/12 subjects. Only split-detector AOSLO could reliably resolve cones near lesion borders, and such cones were abnormally heterogeneous in morphology, diameter and density. On split-detector imaging, the cone mosaic terminated sharply at lesion borders in 5/5 cases examined. Split-detector imaging detected remnant cone inner segments within ORTs, which were generally contiguous with a central patch of preserved retina. Conclusions Early IZ dropout and RPE thinning on SD-OCT are consistent with previously published results. Evidence of remnant cone inner segments within ORTs and the continuity of the ORTs with preserved retina suggests that these may represent an intermediate state of retinal degeneration prior to complete atrophy. Taken together, these results supports a model of choroideremia in which the RPE degenerates before photoreceptors.	[Sun, Lynn W.; Johnson, Ryan D.; Williams, Vesper; Summerfelt, Phyllis; Dubra, Alfredo; Weinberg, David V.; Stepien, Kimberly E.; Carroll, Joseph] Med Coll Wisconsin, Dept Ophthalmol & Visual Sci, Milwaukee, WI 53226 USA; [Dubra, Alfredo; Fishman, Gerald A.] Marquette Univ, Dept Biomed Engn, Milwaukee, WI 53233 USA; [Dubra, Alfredo; Carroll, Joseph] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Dubra, Alfredo; Carroll, Joseph] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Carroll, Joseph] Chicago Lighthouse, Chicago, IL 60608 USA; [Dubra, Alfredo] Stanford Univ, Dept Ophthalmol, Stanford, CA 94305 USA; [Stepien, Kimberly E.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI USA	Medical College of Wisconsin; Marquette University; Medical College of Wisconsin; Medical College of Wisconsin; Stanford University; University of Wisconsin System; University of Wisconsin Madison	Carroll, J (corresponding author), Med Coll Wisconsin, Dept Ophthalmol & Visual Sci, Milwaukee, WI 53226 USA.; Carroll, J (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.; Carroll, J (corresponding author), Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA.; Carroll, J (corresponding author), Chicago Lighthouse, Chicago, IL 60608 USA.	jcarroll@mcw.edu		Dubra, Alfredo/0000-0002-6506-9020	National Eye Institute of the National Institutes of Health [P30EY001931, R01EY017607]; Richard O. Schultz, MD / Ruth Works Professorship; Edward N. & Della L. Thome Memorial Foundation; Foundation Fighting Blindness; Thomas M. Aaberg Sr. Retina Research Fund; Gene and Ruth Posner Foundation; R.D. and Linda Peters Foundation; Research Facilities Improvement Program; National Center for Research Resources, NIH [C06RR016511]; NATIONAL EYE INSTITUTE [R01EY017607, P30EY001931] Funding Source: NIH RePORTER	National Eye Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Richard O. Schultz, MD / Ruth Works Professorship; Edward N. & Della L. Thome Memorial Foundation; Foundation Fighting Blindness(European Commission); Thomas M. Aaberg Sr. Retina Research Fund; Gene and Ruth Posner Foundation; R.D. and Linda Peters Foundation; Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Research reported in this publication was supported by the National Eye Institute of the National Institutes of Health under Award Numbers P30EY001931 & R01EY017607. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Additional support comes from the Richard O. Schultz, MD / Ruth Works Professorship, The Edward N. & Della L. Thome Memorial Foundation, Foundation Fighting Blindness, the Thomas M. Aaberg Sr. Retina Research Fund, the Gene and Ruth Posner Foundation, and the R.D. and Linda Peters Foundation. This investigation was conducted in part in a facility constructed with support from the Research Facilities Improvement Program; grant number C06RR016511 from the National Center for Research Resources, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carroll J, 2009, P NATL ACAD SCI USA, V106, P20948, DOI 10.1073/pnas.0910128106; Chen YM, 2011, INVEST OPHTH VIS SCI, V52, P3281, DOI 10.1167/iovs.10-6538; Cooper RE, 2016, INVEST OPHTH VIS SCI, V57, P2992, DOI 10.1167/iovs.16-19072; Cooper RF, 2011, BIOMED OPT EXPRESS, V2, P2577, DOI 10.1364/BOE.2.002577; Coussa RG, 2012, OPHTHALMIC GENET, V33, P57, DOI 10.3109/13816810.2011.620056; CREMERS FPM, 1990, NATURE, V347, P674, DOI 10.1038/347674a0; DeLuca AM, 2013, INVEST OPHTHALMOL VI, V54, P3382; Dubis AM, 2014, INVEST OPHTH VIS SCI, V55, P7303, DOI 10.1167/iovs.14-14225; Dubra A, 2011, BIOMED OPT EXPRESS, V2, P1864, DOI 10.1364/BOE.2.001864; Dubra A, 2011, BIOMED OPT EXPRESS, V2, P1757, DOI 10.1364/BOE.2.001757; Dubra A, 2010, LECT NOTES COMPUT SC, V6204, P60, DOI 10.1007/978-3-642-14366-3_6; Duncan JL, 2007, INVEST OPHTH VIS SCI, V48, P3283, DOI 10.1167/iovs.06-1422; Duncan JL, 2011, INVEST OPHTH VIS SCI, V52, P1557, DOI 10.1167/iovs.10-6549; Edwards TL, 2016, NEW ENGL J MED, V374, P1996, DOI 10.1056/NEJMc1509501; FLANNERY JG, 1990, INVEST OPHTH VIS SCI, V31, P229; Flatter JA, 2014, RETINA-J RET VIT DIS, V34, P2133, DOI 10.1097/IAE.0000000000000169; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Garrioch R, 2012, OPTOMETRY VISION SCI, V89, P632, DOI 10.1097/OPX.0b013e3182540562; Genead MA, 2011, INVEST OPHTH VIS SCI, V52, P7298, DOI 10.1167/iovs.11-7762; Godara P, 2010, ARCH OPHTHALMOL-CHIC, V128, P253, DOI 10.1001/archophthalmol.2009.383; Heon E, 2016, INVEST OPHTH VIS SCI, V57, pOCT377, DOI 10.1167/iovs.15-18421; Huang YJ, 1998, INVEST OPHTH VIS SCI, V39, P2405; Jacobson SG, 2006, INVEST OPHTH VIS SCI, V47, P4113, DOI 10.1167/iovs.06-0424; Lazow MA, 2011, INVEST OPHTH VIS SCI, V52, P9581, DOI 10.1167/iovs.11-8554; Litts KM, 2016, INVEST OPHTH VIS SCI, V57, P2647, DOI 10.1167/iovs.16-19262; Litts KM, 2016, RETINA; Lujan BJ, 2015, RETINA-J RET VIT DIS, V35, P1511, DOI 10.1097/IAE.0000000000000527; MacDonald IM, 2009, SURV OPHTHALMOL, V54, P401, DOI 10.1016/j.survophthal.2009.02.008; MacLaren RE, 2014, LANCET, V383, P1129, DOI 10.1016/S0140-6736(13)62117-0; McAllister JT, 2010, VISION RES, V50, P810, DOI 10.1016/j.visres.2010.02.003; McTaggart KE, 2002, HUM MUTAT, V20, P189, DOI 10.1002/humu.10114; Michaelides M, 2011, INVEST OPHTH VIS SCI, V52, P4757, DOI 10.1167/iovs.10-6659; Morgan JIW, 2014, INVEST OPHTH VIS SCI, V55, P6381, DOI 10.1167/iovs.13-13454; Packer O., 2003, SCI COLOR, P41, DOI 10.1016/B978-044451251-2/50003-9; Razeen MM, 2016, TRANSL VIS SCI TECHN, V5, DOI 10.1167/tvst.5.2.6; RODRIGUES MM, 1984, OPHTHALMOLOGY, V91, P873; Rossi EA, 2011, EYE, V25, P301, DOI 10.1038/eye.2010.221; Scoles D, 2016, RETINA; Scoles D, 2016, RETINA-J RET VIT DIS, V36, P91, DOI 10.1097/IAE.0000000000000618; Scoles D, 2014, INVEST OPHTH VIS SCI, V55, P4244, DOI 10.1167/iovs.14-14542; SORSBY A, 1952, BRIT J OPHTHALMOL, V36, P547, DOI 10.1136/bjo.36.10.547; Stepien KE, 2012, ARCH OPHTHALMOL-CHIC, V130, P400, DOI 10.1001/archopthalmol.2011.1490; Sun LW, 2016, INVEST OPHTH VIS SCI, V57, P2428, DOI 10.1167/iovs.15-18246; Syed N, 2001, OPHTHALMOLOGY, V108, P711, DOI 10.1016/S0161-6420(00)00643-6; Syed R, 2013, INVEST OPHTH VIS SCI, V54, P950, DOI 10.1167/iovs.12-10707; Talcott KE, 2011, INVEST OPHTH VIS SCI, V52, P2219, DOI 10.1167/iovs.10-6479; Tanna H, 2010, BRIT J OPHTHALMOL, V94, P372, DOI 10.1136/bjo.2009.163501; Tuten WS, 2012, OPTOMETRY VISION SCI, V89, P563, DOI 10.1097/OPX.0b013e3182512b98; van den Hurk JAJM, 2003, HUM GENET, V113, P268, DOI 10.1007/s00439-003-0970-0; VANBOKHOVEN H, 1994, HUM MOL GENET, V3, P1041, DOI 10.1093/hmg/3.7.1041; Wilk MA, 2014, INVEST OPHTH VIS SCI, V55, P4186, DOI 10.1167/iovs.13-13217; Zweifel SA, 2009, ARCH OPHTHALMOL-CHIC, V127, P1596, DOI 10.1001/archophthalmol.2009.326	52	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167526	10.1371/journal.pone.0167526	http://dx.doi.org/10.1371/journal.pone.0167526			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936069	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100115
J	Baumgartner, T; Saulin, A; Hein, G; Knoch, D				Baumgartner, Thomas; Saulin, Anne; Hein, Grit; Knoch, Daria			Structural Differences in Insular Cortex Reflect Vicarious Injustice Sensitivity	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; JUSTICE SENSITIVITY; INDIVIDUAL-DIFFERENCES; BRAIN STRUCTURE; SEGMENTATION; THICKNESS; BEHAVIOR; EMPATHY; SHAPES; GAME	Sensitivity to injustice inflicted on others is a strong motivator of human social behavior. There are, however, enormous individual differences in vicarious injustice sensitivity. Some people are strongly affected when witnessing injustice, while others barely notice it, but the factors behind this heterogeneity are poorly understood. Here we examine the neuroanatomical basis of these differences using voxel-based morphometry and Freesurfer image analysis suite. Whole brain corrected analyses show that a person's propensity to be vicariously affected by injustice to others is reflected by the gray matter volume and thickness of the bilateral mid insular cortex. The larger a person's gray matter volume and thickness of the mid insula, the higher that person's sensitivity to injustice experienced by others. These findings show that the individual neuroanatomy of the mid insular cortex captures a person's predisposition to be vicariously affected by injustice, and thus adds a novel aspect to previous functional work that has linked this region to the processing of transient vicarious states.	[Baumgartner, Thomas; Saulin, Anne; Hein, Grit; Knoch, Daria] Univ Bern, Inst Psychol, Dept Social Psychol & Social Neurosci, Bern, Switzerland	University of Bern	Baumgartner, T; Knoch, D (corresponding author), Univ Bern, Inst Psychol, Dept Social Psychol & Social Neurosci, Bern, Switzerland.	thomas.baumgartner@psy.unibe.ch; daria.knoch@psy.unibe.ch	Hein, Grit/AAF-7964-2019	Baumgartner, Thomas/0000-0001-5966-7377	Swiss National Science Foundation [PP00P1_146317]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This project was supported by a grant to D.K. by the Swiss National Science Foundation (PP00P1_146317). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2014, SOC COGN AFFECT NEUR, V9, P1223, DOI 10.1093/scan/nst104; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Baumert A., 2016, HDB SOCIAL JUSTICE T, P161, DOI DOI 10.1007/978-1-4939-3216-0_9; Baumgartner T, 2013, NEUROIMAGE, V81, P317, DOI 10.1016/j.neuroimage.2013.05.047; Bickart KC, 2011, NAT NEUROSCI, V14, P163, DOI 10.1038/nn.2724; Corradi-Dell'Acqua C, 2016, NAT COMMUN, V7, P1; Corradi-Dell'Acqua C, 2013, SOC COGN AFFECT NEUR, V8, P424, DOI 10.1093/scan/nss014; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Critchley HD, 2013, NEURON, V77, P624, DOI 10.1016/j.neuron.2013.02.008; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davidson RJ, 2012, NAT NEUROSCI, V15, P689, DOI 10.1038/nn.3093; Decety Jean, 2015, AJOB Neurosci, V6, P3; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; Edele A, 2013, LEARN INDIVID DIFFER, V24, P96, DOI 10.1016/j.lindif.2012.12.020; Fetchenhauer D, 2004, PERS INDIV DIFFER, V36, P1015, DOI 10.1016/S0191-8869(03)00197-1; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Frye RE, 2010, CEREB CORTEX, V20, P2625, DOI 10.1093/cercor/bhq010; Gollwitzer M, 2009, J RES PERS, V43, P999, DOI 10.1016/j.jrp.2009.07.003; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Hein G, 2016, P NATL ACAD SCI USA, V113, P80, DOI 10.1073/pnas.1514539112; Hoffman Martin L., 2011, EMPATHY PHILOS PSYCH, P230; Im K, 2008, CEREB CORTEX, V18, P2181, DOI 10.1093/cercor/bhm244; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Klimecki O, 2013, CAMBRIDGE HDB HUMAN, P533; Klimecki OM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151028; Klimecki OM, 2014, SOC COGN AFFECT NEUR, V9, P873, DOI 10.1093/scan/nst060; KRACH S, 2011, PLOS ONE, V6; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Lotz S, 2011, NEGOT CONFL MANAG R, V4, P297, DOI 10.1111/j.1750-4716.2011.00084.x/abstract; Lu F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097743; Masten CL, 2010, SOC NEUROSCI-UK, V5, P496, DOI 10.1080/17470919.2010.490673; Morishima Y, 2012, NEURON, V75, P73, DOI 10.1016/j.neuron.2012.05.021; Muller-Pinzler L, 2015, SOC COGN AFFECT NEUR, P1; Nash K, 2015, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00458; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Reese G, 2014, ANAL SOC ISS PUB POL, V14, P217, DOI 10.1111/asap.12032; Schmid M, 2005, AIP CONF PROC, V786, P202, DOI 10.1063/1.2103852; Schmitt M, 2005, EUR J PSYCHOL ASSESS, V21, P202, DOI 10.1027/1015-5759.21.3.202; Schmitt M, 2010, SOC JUSTICE RES, V23, P211, DOI 10.1007/s11211-010-0115-2; Silk TJ, 2011, J DEV BEHAV PEDIATR, V32, P158, DOI 10.1097/DBP.0b013e318206d58f; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Steinbeis N, 2012, NEURON, V73, P1040, DOI 10.1016/j.neuron.2011.12.027; Tanaka S, 2013, PLOS ONE, V8, P4, DOI DOI 10.1371/J0URNAL.P0NE.0066998; Uddin LQ, 2015, NAT REV NEUROSCI, V16, P55, DOI 10.1038/nrn3857; Wesselmann ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00153; Yoder KJ, 2014, J NEUROSCI, V34, P4161, DOI 10.1523/JNEUROSCI.4648-13.2014	50	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167538	10.1371/journal.pone.0167538	http://dx.doi.org/10.1371/journal.pone.0167538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4OA	27930678	Green Published, gold, Green Submitted			2022-12-27	WOS:000389580900028
J	Cong, L; Liao, Y; Yang, ST; Yang, RY				Cong, Lin; Liao, Yong; Yang, Suteng; Yang, Rongya			In Vitro Antifungal Activity of Sertraline and Synergistic Effects in Combination with Antifungal Drugs against Planktonic Forms and Biofilms of Clinical Trichosporon asahii Isolates	PLOS ONE			English	Article							AMPHOTERICIN-B; CRYPTOCOCCUS-NEOFORMANS; SUSCEPTIBILITY; CASPOFUNGIN; INFECTIONS; RESISTANCE; FUNGEMIA	Trichosporon asahii (T. asahii) is the major pathogen of invasive trichosporonosis which occurred mostly in immunocompromised patients. The biofilms formation ability of T. asahii may account for resistance to antifungal drugs and results a high mortality rate. Sertraline, a commonly prescribed antidepressant, has been demonstrated to show in vitro and in vivo antifungal activities against many kinds of pathogenic fungi, especially Cryptococcus species. In the present study, the in vitro activities of sertraline alone or combined with fluconazole, voriconazole, itraconazole, caspofungin and amphotericin B against planktonic forms and biofilms of 21 clinical T. asahii isolates were evaluated using broth microdilution checker-board method and XTT reduction assay, respectively. The fractional inhibitory concentration index (FICI) was used to interpret drug interactions. Sertraline alone exhibited antifungal activities against both T. asahii planktonic cells (MICs, 4-8 mu g/ml) and T. asahii biofilms (SMICs, 16-32 mu g/ml). Furthermore, SRT exhibited synergistic effects against T. asahii planktonic cells in combination with amphotericin B, caspofungin or fluconazole (FICI <= 0.5) and exhibited synergistic effects against T. asahii biofilms in combination with amphotericin B (FICI <= 0.5). SRT exhibited mostly indifferent interactions against T. asahii biofilms in combination with three azoles in this study. Sertraline-amphotericin B combination showed the highest percentage of synergistic effects against both T. asahii planktonic cells (90.5%) and T. asahii biofilms (81.0%). No antagonistic interaction was observed. Our study suggests the therapeutic potential of sertraline against invasive T. asahii infection, especially catheter-related T. asahii infection. Further in vivo studies are needed to validate our findings.	[Cong, Lin] Third Mil Med Univ, Grad Sch, Chongqing, Peoples R China; [Cong, Lin; Liao, Yong; Yang, Suteng; Yang, Rongya] PLA Army Gen Hosp, Dept Dermatol, Beijing, Peoples R China	Army Medical University	Yang, RY (corresponding author), PLA Army Gen Hosp, Dept Dermatol, Beijing, Peoples R China.	yangrya_l@sina.com		Yang, Rongya/0000-0002-4490-4007	National Natural Science Foundation of China [81301410]; Beijing Natural Science Foundation [7163225]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the National Natural Science Foundation of China (No. 81301410) (http://www.nsfc.gov.cn/) and Beijing Natural Science Foundation (NO. 7163225). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antachopoulos C, 2005, J PEDIAT HEMATOL ONC, V27, P283, DOI 10.1097/01.mph.0000164865.70522.d7; Arendrup MC, 2014, CLIN MICROBIOL INFEC, V20, P76, DOI 10.1111/1469-0691.12360; Bassetti M, 2004, J ANTIMICROB CHEMOTH, V54, P575, DOI 10.1093/jac/dkh337; Bayramoglu G, 2008, INFECTION, V36, P68, DOI 10.1007/s15010-007-6278-6; Bujdakova H, 2016, FUTURE MICROBIOL, V11, P235, DOI 10.2217/fmb.15.139; Colombo AL, 2011, CLIN MICROBIOL REV, V24, P682, DOI 10.1128/CMR.00003-11; DeVane CL, 2002, CLIN PHARMACOKINET, V41, P1247, DOI 10.2165/00003088-200241150-00002; Di Bonaventura G, 2006, ANTIMICROB AGENTS CH, V50, P3269, DOI 10.1128/AAC.00556-06; Hawser SP, 1998, J CLIN MICROBIOL, V36, P1450, DOI 10.1128/JCM.36.5.1450-1452.1998; Heller I, 2004, INT J ANTIMICROB AG, V24, P401, DOI 10.1016/j.ijantimicag.2004.03.021; Iturrieta-Gonzalez IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109553; Lass-Florl C, 2001, J ANTIMICROB CHEMOTH, V48, P775, DOI 10.1093/jac/48.6.775; Lass-Florl C, 2001, CLIN INFECT DIS, V33, P135, DOI 10.1086/324589; Lewis RJ, 2013, J ANAL TOXICOL, V37, P208, DOI 10.1093/jat/bkt014; Li HM, 2010, INT J ANTIMICROB AG, V35, P550, DOI 10.1016/j.ijantimicag.2010.01.013; Liao Y, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv141; Liao Y, 2015, MED MYCOL, V53, P396, DOI 10.1093/mmy/myv006; Liu SY, 2014, INT J ANTIMICROB AG, V43, P395, DOI 10.1016/j.ijantimicag.2013.12.009; Naranjo CA, 1999, INT CLIN PSYCHOPHARM, V14, pS35; Nayak R., 2010, Mycology - An International Journal on Fungal Biology, V1, P99, DOI 10.1080/21501203.2010.487054; Nett JE, 2011, EUKARYOT CELL, V10, P1660, DOI 10.1128/EC.05126-11; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Oliveira dos Santos C, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1477-3; Pierce CG, 2008, NAT PROTOC, V3, P1494, DOI 10.1038/nprot.2008.141; Rainey MM, 2010, GENETICS, V185, P1221, DOI 10.1534/genetics.110.117846; Rex JH, 2008, REFERENCE METHOD BRO, P1; Rhein J, 2016, LANCET INFECT DIS, V16, P809, DOI 10.1016/S1473-3099(16)00074-8; Rossato L, 2016, FOLIA MICROBIOL, P1; Smith KD, 2015, ANTIMICROB AGENTS CH, V59, P7197, DOI 10.1128/AAC.01299-15; Spitzer M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.31; Sun W, 2012, J MED MICROBIOL, V61, P1750, DOI 10.1099/jmm.0.049817-0; TREMAINE LM, 1989, DRUG METAB DISPOS, V17, P542; Trevino-Rangel RD, 2016, MED MYCOL, V54, P280, DOI 10.1093/mmy/myv109; Walker LA, 2010, FUNGAL GENET BIOL, V47, P117, DOI 10.1016/j.fgb.2009.09.003; Walraven CJ, 2013, ANTIMICROB AGENTS CH, V57, P1, DOI 10.1128/AAC.01351-12; Wolf DG, 2001, J CLIN MICROBIOL, V39, P4420, DOI 10.1128/JCM.39.12.4420-4425.2001; Yang ST, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157047; Zhai B, 2012, ANTIMICROB AGENTS CH, V56, P3758, DOI 10.1128/AAC.00212-12	38	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167903	10.1371/journal.pone.0167903	http://dx.doi.org/10.1371/journal.pone.0167903			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930704	Green Submitted, Green Published, gold			2022-12-27	WOS:000389580900057
J	Cottrell, KA; Djuranovic, S				Cottrell, Kyle A.; Djuranovic, Sergej			Urb-RIP - An Adaptable and Efficient Approach for Immunoprecipitation of RNAs and Associated RNAs/Proteins	PLOS ONE			English	Article							AFFINITY PURIFICATION; POLY(A)-BINDING PROTEIN; BINDING PROTEIN; BC200 RNA; IDENTIFICATION; COMPLEXES; MICRORNAS; INTERACT; SEQUENCE; PLATFORM	Post-transcriptional regulation of gene expression is an important process that is mediated by interactions between mRNAs and RNA binding proteins (RBP), non-coding RNAs (ncRNA) or ribonucleoproteins (RNP). Key to the study of post-transcriptional regulation of mRNAs and the function of ncRNAs such as long non-coding RNAs (lncRNAs) is an understanding of what factors are interacting with these transcripts. While several techniques exist for the enrichment of a transcript whether it is an mRNA or an ncRNA, many of these techniques are cumbersome or limited in their application. Here we present a novel method for the immunoprecipitation of mRNAs and ncRNAs, Urb-RNA immunoprecipitation (Urb-RIP). This method employs the RRM1 domain of the "resurrected" snRNA-binding protein Urb to enrich messages containing a stem-loop tag. Unlike techniques which employ the MS2 protein, which require large repeats of the MS2 binding element, Urb-RIP requires only one stem-loop. This method routinely provides over similar to 100-fold enrichment of tagged messages. Using this technique we have shown enrichment of tagged mRNAs and lncRNAs as well as miRNAs and RNA-binding proteins bound to those messages. We have confirmed, using Urb-RIP, interaction between RNA PolIII transcribed lncRNA BC200 and polyA binding protein.	[Cottrell, Kyle A.; Djuranovic, Sergej] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Djuranovic, S (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	sergej.djuranovic@wustl.edu		Djuranovic, Sergej/0000-0002-9417-0822; Cottrell, Kyle/0000-0003-1779-4292	NIH [T32 GM007067, RO1 GM112824]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067, R01GM112824] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NIH training grant T32 GM007067 to KAC and NIH Grant RO1 GM112824 to SD.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Braun J, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku127; Chang TH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S4; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chu C, 2012, JOVE-J VIS EXP, DOI 10.3791/3912; Chu L, 2012, J CLIN INVEST, V122, P2793, DOI 10.1172/JCI63051; Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069; Darnell RB, 2010, WIRES RNA, V1, P266, DOI 10.1002/wrna.31; Davis CP, 2015, METHODS MOL BIOL, V1262, P167, DOI 10.1007/978-1-4939-2253-6_10; Delaney KJ, 2014, RNA, V20, P1035, DOI 10.1261/rna.044255.114; Dong YC, 2015, INT J MOL SCI, V16, P22456, DOI 10.3390/ijms160922456; Engreitz J, 2015, METHODS MOL BIOL, V1262, P183, DOI 10.1007/978-1-4939-2253-6_11; Fukaya T, 2012, MOL CELL, V48, P825, DOI 10.1016/j.molcel.2012.09.024; Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088; Gong CG, 2015, METHODS MOL BIOL, V1206, P81, DOI 10.1007/978-1-4939-1369-5_7; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hamzeiy H, 2014, METHODS MOL BIOL, V1107, P207, DOI 10.1007/978-1-62703-748-8_12; Hershey JW, 2012, COLD SPRING HARB PER, V4; Hogg JR, 2007, RNA, V13, P868, DOI 10.1261/rna.565207; Iioka H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1316; Khanam Tasneem, 2006, RNA Biol, V3, P170; Kondrashov AV, 2005, J MOL BIOL, V353, P88, DOI 10.1016/j.jmb.2005.07.049; Law MJ, 2006, RNA, V12, P1168, DOI 10.1261/rna.75206; Lechertier T, 2009, EXP CELL RES, V315, P928, DOI 10.1016/j.yexcr.2009.01.016; LECUYER KA, 1995, BIOCHEMISTRY-US, V34, P10600, DOI 10.1021/bi00033a035; Lee HY, 2013, P NATL ACAD SCI USA, V110, P5416, DOI 10.1073/pnas.1302807110; Leppek K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt956; Liu S, 2015, APPL BIOCH BIOTECHNO; Marin-Bejar O, 2015, METHODS MOL BIOL, V1206, P87, DOI 10.1007/978-1-4939-1369-5_8; MARTIGNETTI JA, 1993, P NATL ACAD SCI USA, V90, P11563, DOI 10.1073/pnas.90.24.11563; Muddashetty RS, 2002, J MOL BIOL, V321, P433, DOI 10.1016/S0022-2836(02)00655-1; Mullin C, 2004, FEBS LETT, V576, P437, DOI 10.1016/j.febslet.2004.09.054; Muppirala UK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-489; Olanich ME, 2011, ONCOGENE, V30, P77, DOI 10.1038/onc.2010.404; PICKETT GG, 1993, NUCLEIC ACIDS RES, V21, P4621, DOI 10.1093/nar/21.19.4621; Said N, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp719; Slobodin B, 2010, RNA, V16, P2277, DOI 10.1261/rna.2091710; Suresh V, 2015, NUCLEIC ACIDS RES, V43, P1370, DOI 10.1093/nar/gkv020; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wang XW, 2009, RNA, V15, P716, DOI 10.1261/rna.1460509; Wei K, 2014, INT J MOL SCI, V15, P14753, DOI 10.3390/ijms150814753; Williams SG, 2013, J MOL BIOL, V425, P3846, DOI 10.1016/j.jmb.2013.05.031; Yoon JH, 2012, METHODS, V58, P81, DOI 10.1016/j.ymeth.2012.07.004; Yue D, 2009, CURR GENOMICS, V10, P478, DOI 10.2174/138920209789208219	46	6	6	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167877	10.1371/journal.pone.0167877	http://dx.doi.org/10.1371/journal.pone.0167877			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930710	Green Published, gold, Green Submitted			2022-12-27	WOS:000389580900055
J	He, S; Zhao, TC; Guo, H; Meng, YZ; Qin, GJ; Goukassian, DA; Han, JH; Gao, XM; Zhu, Y				He, Shuang; Zhao, Tiechan; Guo, Hao; Meng, Yanzhi; Qin, Gangjian; Goukassian, David A.; Han, Jihong; Gao, Xuimei; Zhu, Yan			Coordinated Activation of VEGF/VEGFR-2 and PPARd Pathways by a Multi-Component Chinese Medicine DHI Accelerated Recovery from Peripheral Arterial Disease in Type 2 Diabetic Mice	PLOS ONE			English	Article							ISCHEMIA-INDUCED NEOVASCULARIZATION; DANHONG INJECTION; HYDROXYSAFFLOR YELLOW; SALVIA-MILTIORRHIZA; RECEPTOR-DELTA; RAT MODEL; IN-VIVO; ANGIOGENESIS; DANSHENSU; PROMOTES	Diabetic mellitus (DM) patients are at an increased risk of developing peripheral arterial disease (PAD). Danhong injection (DHI) is a Chinese patent medicine widely used for several cardiovascular indications but the mechanism of action is not well-understood. We investigated the therapeutic potential of DHI on experimental PAD in mice with chemically induced as well as genetic (KKAy) type 2 DM and the overlapping signaling pathways regulating both therapeutic angiogenesis and glucose homeostasis. Compared with normal genetic background wild type (WT) mice, both DM mice showed impaired perfusion recovery in hind-limb ischemia (HLI) model. DHI treatment significantly accelerated perfusion recovery, lowered blood glucose and improved glucose tolerance in both DM models. Bioluminescent imaging demonstrated a continuous ischemia-induced vascular endothelial growth factor receptor 2 (VEGFR-2) gene expressions with a peak time coincident with the maximal DHI stimulation. Flow cytometry analysis showed a DHI-mediated increase in endothelial progenitor cell (EPC) mobilization from bone marrow to circulating peripheral blood. DHI administration upregulated the expression of vascular endothelial growth factor A (VEGF-A) and VEGF receptor-2 (VEGFR-2) in ischemic muscle. A cross talk between ischemia-induced angiogenesis and glucose tolerance pathways was analyzed by Ingenuity Pathway Analysis (IPA) which suggested an interaction of VEGF-A/VEGFR-2 and peroxisome proliferator-activated receptor delta (PPAR delta)/peroxisome proliferator-activated receptor gamma (PPAR gamma) genes. We confirmed that upregulation of VEGF-A/VEGFR-2 by DHI promoted PPAR delta gene expression in both type 2 diabetic mice. Our findings demonstrated that a multi-component Chinese medicine DHI effectively increased blood flow recovery after tissue ischemia in diabetic mice by promoting angiogenesis and improving glucose tolerance through a concomitant activation of VEGF-A/VEGFR-2 and PPAR delta signaling pathways.	[He, Shuang; Zhao, Tiechan; Guo, Hao; Meng, Yanzhi; Qin, Gangjian; Gao, Xuimei; Zhu, Yan] Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China; [He, Shuang; Zhao, Tiechan; Guo, Hao; Meng, Yanzhi; Zhu, Yan] Tianjin Int Joint Acad Biotechnol & Med, Res & Dev Ctr TCM, Tianjin, Peoples R China; [Zhu, Yan] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA USA; [Zhu, Yan] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Qin, Gangjian] Northwestern Univ, Feinberg Sch Med, Dept Med Cardiol, Chicago, IL 60611 USA; [Qin, Gangjian] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Goukassian, David A.] Tufts Univ, Sch Med, Ctr Biomed Res, Boston, MA 02111 USA; [Han, Jihong] Nankai Univ, State Key Lab Med Chem Biol, Tianjin, Peoples R China; [Han, Jihong] Nankai Univ, Collaborat Innovat Ctr Biotherapy, Tianjin, Peoples R China	Tianjin University of Traditional Chinese Medicine; Tianjin International Joint Academy of Biomedicine; Tufts Medical Center; Tufts University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Tufts University; Nankai University; Nankai University	Zhu, Y (corresponding author), Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China.; Zhu, Y (corresponding author), Tianjin Int Joint Acad Biotechnol & Med, Res & Dev Ctr TCM, Tianjin, Peoples R China.; Zhu, Y (corresponding author), Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA USA.; Zhu, Y (corresponding author), Tufts Univ, Sch Med, Boston, MA 02111 USA.	yanzhu.harvard@iCloud.com	Zhu, Yan/A-1548-2017	Zhu, Yan/0000-0002-3197-7936; Goukassian, David/0000-0001-5270-5270	National Key Basic Research Program of China [2012CB723504]; National Major New Drug Discovery Grant [2013ZX09201020]; National Science Foundation of China [NSFC 81274128]; Program for Tianjin Innovative Research Team in University [TD12-5031]	National Key Basic Research Program of China(National Basic Research Program of China); National Major New Drug Discovery Grant; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Tianjin Innovative Research Team in University	This study was supported by grants from the National Key Basic Research Program of China (2012CB723504), the National Major New Drug Discovery Grant (2013ZX09201020), the National Science Foundation of China (NSFC 81274128); and the Program for Tianjin Innovative Research Team in University (TD12-5031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop-Bailey D, 2011, BIOCHEM SOC T, V39, P1601, DOI 10.1042/BST20110643; Bojic LA, 2014, J LIPID RES, V55, P1254, DOI 10.1194/jlr.M046037; Boucher JM, 2014, NAT MED, V20, P1383, DOI 10.1038/nm.3767; Chen HX, 2014, SCI REP-UK, V4, DOI 10.1038/srep06222; Clark N, 2003, DIABETES CARE, V26, P3333; Dokun AO, 2014, CARDIOVASC RES, V101, P364, DOI 10.1093/cvr/cvt342; Ehrenborg E, 2013, ATHEROSCLEROSIS, V231, P95, DOI 10.1016/j.atherosclerosis.2013.08.027; Freudenberg U, 2015, J CONTROL RELEASE, V220, P79, DOI 10.1016/j.jconrel.2015.10.028; Guo H, 2014, NEUROCHEM RES, V39, P1817, DOI 10.1007/s11064-014-1384-1; He HB, 2008, J PHARM PHARMACOL, V60, P115, DOI 10.1211/jpp.60.1.0015; He Y, 2012, J ETHNOPHARMACOL, V144, P387, DOI 10.1016/j.jep.2012.09.025; Herkenne S, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa2403; Huang PH, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-99; Huang PH, 2012, ANGIOGENESIS, V15, P377, DOI 10.1007/s10456-012-9267-z; Huang PH, 2010, ATHEROSCLEROSIS, V212, P426, DOI 10.1016/j.atherosclerosis.2010.06.034; Huang PH, 2009, ARTERIOSCL THROM VAS, V29, P1179, DOI 10.1161/ATVBAHA.109.189175; Ishikawa Y, 2012, EXP DIABETES RES, DOI 10.1155/2012/702948; Jiang MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105412; Jiang XQ, 2015, J ETHNOPHARMACOL, V174, P270, DOI 10.1016/j.jep.2015.08.026; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Li YG, 2015, CHEM-BIOL INTERACT, V225, P70, DOI 10.1016/j.cbi.2014.11.003; Li YJ, 2014, J ETHNOPHARMACOL, V151, P218, DOI 10.1016/j.jep.2013.10.019; Liao P, 2015, EVID-BASED COMPL ALT, V2015, DOI [10.1155/2015/646530, DOI 10.1155/2015646530]; Liu HT, 2013, BIOMED CHROMATOGR, V27, P655, DOI 10.1002/bmc.2842; Liu MY, 2015, SCI REP-UK, V5, DOI 10.1038/srep11219; Lu HY, 2014, BIOL PHARM BULL, V37, P961, DOI 10.1248/bpb.b13-00921; Mao HP, 2016, J ETHNOPHARMACOL, V186, P20, DOI 10.1016/j.jep.2016.03.015; Nie PH, 2012, J ETHNOPHARMACOL, V139, P746, DOI 10.1016/j.jep.2011.11.054; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Petznick Allison M, 2010, Osteopath Med Prim Care, V4, P5, DOI 10.1186/1750-4732-4-5; Qin GJ, 2006, P NATL ACAD SCI USA, V103, P11015, DOI 10.1073/pnas.0509533103; Rao XQ, 2011, CIRCULATION, V123, P2964, DOI 10.1161/CIRCULATIONAHA.110.966408; Selvin E, 2006, DIABETES CARE, V29, P877, DOI 10.2337/diacare.29.04.06.dc05-2018; Sun K, 2014, PAK J PHARM SCI, V27, P1699; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vazquez-Carrera M, 2016, TRENDS ENDOCRIN MET, V27, P319, DOI 10.1016/j.tem.2016.02.008; Wang DD, 2013, J CARDIOVASC PHARM, V62, P457, DOI 10.1097/FJC.0b013e3182a29657; Yang MZ, 2016, BRAIN RES, V1642, P516, DOI 10.1016/j.brainres.2016.04.046; Yang RX, 2010, ACTA PHARMACOL SIN, V31, P1395, DOI 10.1038/aps.2010.167; Yoon JW, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0131785, DOI 10.1371/JOURNALPONE0131785]; Youngblood RC, 2014, INT J MED SCI, V11, P545, DOI 10.7150/ijms.6994; Yu JW, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0408-3; Yu JM, 2015, MOL MED REP, V12, P6718, DOI 10.3892/mmr.2015.4307; Zhang Hao, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P44, DOI 10.3969/j.issn.1672-7347.2011.01.007; Zhang QQ, 2016, CHIN J NAT MEDICINES, V14, P147, DOI 10.1016/S1875-5364(16)60008-0; Zhao BL, 1996, BIOCHEM MOL BIOL INT, V38, P1171; Zhao DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071472; Zhao GR, 2008, FOOD CHEM TOXICOL, V46, P73, DOI 10.1016/j.fct.2007.06.034; Zhou XL, 2012, PHYTOMEDICINE, V19, P1263, DOI 10.1016/j.phymed.2012.08.011	51	25	27	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167305	10.1371/journal.pone.0167305	http://dx.doi.org/10.1371/journal.pone.0167305			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930695	Green Submitted, Green Published, gold			2022-12-27	WOS:000389580900024
J	Kolivand, H; Billinghurst, M; Sunar, MS				Kolivand, Hoshang; Billinghurst, Mark; Sunar, Mohd Shahrizal			LivePhantom: Retrieving Virtual World Light Data to Real Environments	PLOS ONE			English	Article							OUTDOOR; ILLUMINATION; GENERATION	To achieve realistic Augmented Reality (AR), shadows play an important role in creating a 3D impression of a scene. Casting virtual shadows on real and virtual objects is one of the topics of research being conducted in this area. In this paper, we propose a new method for creating complex AR indoor scenes using real time depth detection to exert virtual shadows on virtual and real environments. A Kinect camera was used to produce a depth map for the physical scene mixing into a single real-time transparent tacit surface. Once this is created, the camera's position can be tracked from the reconstructed 3D scene. Real objects are represented by virtual object phantoms in the AR scene enabling users holding a webcam and a standard Kinect camera to capture and reconstruct environments simultaneously. The tracking capability of the algorithm is shown and the findings are assessed drawing upon qualitative and quantitative methods making comparisons with previous AR phantom generation applications. The results demonstrate the robustness of the technique for realistic indoor rendering in AR systems.	[Kolivand, Hoshang; Sunar, Mohd Shahrizal] Univ Teknol Malaysia, UTM IRDA Digital Media Ctr, MaGIC X Media & Games Innovat Ctr Excellence, Skudai 81310, Johor, Malaysia; [Billinghurst, Mark] Univ South Australia, Sch Informat Technol & Math Sci, Adelaide, SA 5001, Australia	Universiti Teknologi Malaysia; University of South Australia	Kolivand, H (corresponding author), Univ Teknol Malaysia, UTM IRDA Digital Media Ctr, MaGIC X Media & Games Innovat Ctr Excellence, Skudai 81310, Johor, Malaysia.	hoshang@utm.my	Sunar, Mohd Shahrizal/AFQ-7366-2022; Billinghurst, Mark/AAJ-4236-2020; Kolivand, Hoshang/B-2501-2016	Sunar, Mohd Shahrizal/0000-0002-0244-1622; Billinghurst, Mark/0000-0003-4172-6759; Kolivand, Hoshang/0000-0001-5460-5679	PDRU grant at MaGICX UTM-IRDA Universiti Teknologi Malaysia [Q.J130000.21A2.03E19]	PDRU grant at MaGICX UTM-IRDA Universiti Teknologi Malaysia	This paper is supported by PDRU grant vote: Q.J130000.21A2.03E19 at MaGICX UTM-IRDA Universiti Teknologi Malaysia.	Aittala M, 2010, VISUAL COMPUT, V26, P669, DOI 10.1007/s00371-010-0501-7; Annen T, 2008, ACM T GRAPHIC, V27, DOI 10.1145/1360612.1360633; [Anonymous], 2013, P SIGCHI C HUM FACT, DOI [10.1145/2468356.2468527, DOI 10.1145/2468356.2468527]; Azuma RT, 1997, PRESENCE-VIRTUAL AUG, V6, P355, DOI 10.1162/pres.1997.6.4.355; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Chai ML, 2012, ACM T GRAPHIC, V31, DOI 10.1145/2185520.2185612; Corbett-Davies S, 2013, P IEEE VIRT REAL ANN, P19, DOI 10.1109/VR.2013.6549351; Cui Y, 2010, PROC CVPR IEEE, P1173, DOI 10.1109/CVPR.2010.5540082; de Castro T. K., 2012, 2012 14th Symposium on Virtual and Augmented Reality (SVR), P36, DOI 10.1109/SVR.2012.9; Dimitrov R, 2007, TECHNICAL REPORT; Dollner J., 2006, P 25 INT S URBAN DAT; Donnelly W., 2006, P 2006 S INT 3D GRAP, P161, DOI DOI 10.1145/1111411.1111440; FAUGERAS OD, 1986, INT J ROBOT RES, V5, P27, DOI 10.1177/027836498600500302; Grasset R, 2012, INT SYM MIX AUGMENT, P177, DOI 10.1109/ISMAR.2012.6402555; Haller M., 2003, P ACM S VIRT REAL SO, P56, DOI DOI 10.1145/1008653.1008665; Hartley R., 2000, MULTIPLE VIEW GEOMET, V2; Hensley J, 2005, COMPUT GRAPH FORUM, V24, P547, DOI 10.1111/j.1467-8659.2005.00880.x; HORN BKP, 1987, J OPT SOC AM A, V4, P629, DOI 10.1364/JOSAA.4.000629; Izadi Shahram, 2011, UIST, DOI [10.1145/2047196.2047270, DOI 10.1145/2047196.2047270]; Jensen B, 2009, SIMPLIFYING REAL TIM; Kan P, 2013, INT SYM MIX AUGMENT, P133, DOI 10.1109/ISMAR.2013.6671773; Kanbara M, 2004, INT C PATT RECOG, P911, DOI 10.1109/ICPR.2004.1334407; Keller M, 2013, 2013 INTERNATIONAL CONFERENCE ON 3D VISION (3DV 2013), P1, DOI 10.1109/3DV.2013.9; Khoshelham K, 2012, SENSORS-BASEL, V12, P1437, DOI 10.3390/s120201437; Knecht M., 2010, 2010 9th IEEE International Symposium on Mixed and Augmented Reality (ISMAR). Science & Technology Papers, P99, DOI 10.1109/ISMAR.2010.5643556; Knecht M., 2011, FRAMEWORK PERCEPTUAL; Knecht M, 2012, COMPUT GRAPH-UK, V36, P846, DOI 10.1016/j.cag.2012.04.013; Kolivand H, 2015, LECT N BIOENG, P169, DOI 10.1007/978-981-287-540-2_8; Kolivand H, 2015, MULTIMED TOOLS APPL, V74, P7461, DOI 10.1007/s11042-014-1987-1; Kolivand H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108334; Kolivand H, 2014, MULTIMED TOOLS APPL, V72, P2143, DOI 10.1007/s11042-013-1494-9; Kolivand H, 2013, IETE TECH REV, V30, P38, DOI 10.4103/0256-4602.107338; Kolivand H, 2012, INT J INNOV COMPUT I, V8, P7169; Lensing P, 2012, INT SYM MIX AUGMENT, P109, DOI 10.1109/ISMAR.2012.6402547; Levoy M, 2000, COMP GRAPH, P131, DOI 10.1145/344779.344849; Lv ZH, 2016, IEEE ACCESS, V4, P407, DOI 10.1109/ACCESS.2016.2517076; Lv ZH, 2015, PERS UBIQUIT COMPUT, V19, P551, DOI 10.1007/s00779-015-0844-1; Lv Z, 2014, ACM T MULTIM COMPUT, V11, DOI 10.1145/2645860; Lv ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057990; Madsen BC, 2011, OUTDOOR ILLUMINATION, P129; Madsen C, 2003, P 6 ANN INT WORKSH P; Madsen CB, 2013, COMPUTER VISION IMAG, P33; Madsen CB, 2007, GRAPP 2007: PROCEEDINGS OF THE SECOND INTERNATIONAL CONFERENCE ON COMPUTER GRAPHICS THEORY AND APPLICATIONS, VOL GM/R, P252; Newcombe RA, 2011, INT SYM MIX AUGMENT, P127, DOI 10.1109/ISMAR.2011.6092378; Newell ME, 1977, P ACM NATL C, P444; Nowrouzezahrai D., 2011, 2011 IEEE International Symposium on Mixed and Augmented Reality, P173, DOI 10.1109/ISMAR.2011.6092384; Reeves W, 1987, P SIGGRAPH 87, V21, P557; Roth H, 2012, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2012, DOI 10.5244/C.26.112; Song HB, 2012, J LIGHTWAVE TECHNOL, V30, P713, DOI 10.1109/JLT.2011.2180360; Su TY, 2016, ADV ENG SOFTW, V95, P7, DOI 10.1016/j.advengsoft.2016.01.009; Sugano N, 2003, SECOND IEEE AND ACM INTERNATIONAL SYMPOSIUM ON MIXED AND AUGMENTED REALITY, PROCEEDINGS, P76, DOI 10.1109/ISMAR.2003.1240690; Sun YC, 2016, IEEE ACCESS, V4, P766, DOI 10.1109/ACCESS.2016.2529723; Supan P, 2004, INT J VIRTUAL REALIT, V5, P1; Williams L., 1978, ACM SIGGRAPH COMPUTE, V12, P270, DOI DOI 10.1145/800248.807402; Xing GY, 2012, COMPUT GRAPH-UK, V36, P857, DOI 10.1016/j.cag.2012.07.005; Yan F, 2008, CISP 2008: FIRST INTERNATIONAL CONGRESS ON IMAGE AND SIGNAL PROCESSING, VOL 3, PROCEEDINGS, P771, DOI 10.1109/CISP.2008.87; Zhang XL, 2016, J VIS COMMUN IMAGE R, V40, P779, DOI 10.1016/j.jvcir.2016.07.011	57	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0166424	10.1371/journal.pone.0166424	http://dx.doi.org/10.1371/journal.pone.0166424			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930663	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000389580900009
J	Marmamula, S; Khanna, RC; Shekhar, K; Rao, GN				Marmamula, Srinivas; Khanna, Rohit C.; Shekhar, Konegari; Rao, Gullapalli N.			Outcomes of Cataract Surgery in Urban and Rural Population in the South Indian State of Andhra Pradesh: Rapid Assessment of Visual Impairment (RAVI) Project	PLOS ONE			English	Article							AVOIDABLE BLINDNESS; EYE SURVEY; SATKHIRA DISTRICT; OLDER ADULTS; PREVALENCE; BANGLADESH; NUMBER; NEPAL	Objective To assess the visual outcomes after cataract surgery among urban and rural population aged >= 40 years in the South India state of Andhra Pradesh. Methods A population based cross-sectional study was conducted in which 7800 subjects were sampled from two rural and one urban location. Visual Acuity was assessed and eye examination were performed by trained personnel. A questionnaire was used to collect personal and demographic information, and history of cataract surgery. Blindness and moderate Visual Impairment (MVI) was defined as presenting VA <6/60 and <6/18 to 6/60 in the better eye respectively. Results In total, 7378 (94.6%) were examined. Of these, 1228 eyes of 870 individuals were operated for cataract. The mean age of operated subjects was 63.7 years (SD: 10.7 years). Overall, 56.3% of those operated were women, 76% were illiterate and 42% of them were using spectacles after cataract surgery. Even after surgery, 12.2% of the operated eyes had MVI and blindness was seen in 14.7% of the eyes. A significantly higher proportion of subjects in urban area had good outcome as compared to those in the rural area (p = 0.01). Uncorrected refractive error (58.7%) was the leading cause of MVI, and posterior segment disease (34.3%) was the leading cause of blindness. On applying multiple logistic regression, risk factors for poor outcomes were age >= 70 years (OR: 1.9, 95% CI: 1.3-2.8), rural residence (OR: 1.3, 95% CI: 1.0-1.8) and presence of aphakia (OR: 8.9, 95% CI: 5.7-13.8). Conclusions Post cataract surgery, refractive errors remain an important correctable cause of MVI, in the south Indian state of Andhra Pradesh. The correction of refractive errors is required to provide good visual recovery and achieve the benefit of cataract surgery.	[Marmamula, Srinivas; Khanna, Rohit C.; Shekhar, Konegari; Rao, Gullapalli N.] LV Prasad Eye Inst, Allen Foster Community Eye Hlth Res Ctr, Gullapalli Pratibha Rao Int Ctr Adv Rural Eye Car, Hyderabad, Andhra Pradesh, India; [Marmamula, Srinivas; Khanna, Rohit C.; Rao, Gullapalli N.] LV Prasad Eye Inst, Brien Holden Inst Optometry & Vis Sci, Hyderabad, Andhra Pradesh, India; [Marmamula, Srinivas] LV Prasad Eye Inst, Wellcome Trust Dept Biotechnol India Alliance, Hyderabad, Andhra Pradesh, India	L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; Wellcome Trust DBT India Alliance	Khanna, RC (corresponding author), LV Prasad Eye Inst, Allen Foster Community Eye Hlth Res Ctr, Gullapalli Pratibha Rao Int Ctr Adv Rural Eye Car, Hyderabad, Andhra Pradesh, India.; Khanna, RC (corresponding author), LV Prasad Eye Inst, Brien Holden Inst Optometry & Vis Sci, Hyderabad, Andhra Pradesh, India.	rohit@lvpei.org			Hyderabad Eye Research Foundation	Hyderabad Eye Research Foundation	This study was funded by the Hyderabad Eye Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dandona L, 2003, CLIN EXP OPHTHALMOL, V31, P23, DOI 10.1046/j.1442-9071.2003.00595.x; Dandona L, 1999, AM J OPHTHALMOL, V127, P650, DOI 10.1016/S0002-9394(99)00044-6; Finger RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044268; Garms R C, 1998, Community Eye Health, V11, P56; Haider S, 2003, OPHTHALMIC EPIDEMIOL, V10, P249, DOI 10.1076/opep.10.4.249.15907; Huang WY, 2011, INVEST OPHTH VIS SCI, V52, P16, DOI 10.1167/iovs.10-5382; Kalua K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019226; Kandel RP, 2010, OPHTHAL EPIDEMIOL, V17, P276, DOI 10.3109/09286586.2010.508355; Khairallah M, 2015, INVEST OPHTH VIS SCI, V56, P6762, DOI 10.1167/iovs.15-17201; Khanna RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035701; Lamoureux EL, 2011, CURR OPIN OPHTHALMOL, V22, P19, DOI 10.1097/ICU.0b013e3283414284; Lepcha NT, 2013, OPHTHAL EPIDEMIOL, V20, P212, DOI 10.3109/09286586.2013.794902; Limburg H, 1996, BRIT J OPHTHALMOL, V80, P951, DOI 10.1136/bjo.80.11.951; Limburg H, 1999, B WORLD HEALTH ORGAN, V77, P455; Lindfield R, 2008, EYE, V22, P1054, DOI 10.1038/sj.eye.6702836; Marmamula S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005125; Marmamula S, 2014, CLIN EXP OPHTHALMOL, V42, P227, DOI 10.1111/ceo.12160; Marmamula S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070120; Mathenge W, 2007, PLOS MED, V4, P1187, DOI 10.1371/journal.pmed.0040217; Murthy GVS, 2009, OPHTHAL EPIDEMIOL, V16, P400, DOI 10.3109/09286580903315809; Murthy GVS, 1996, ACTA OPHTHALMOL SCAN, V74, P60; Murthy GVS, 2001, OPHTHALMOLOGY, V108, P686, DOI 10.1016/S0161-6420(00)00578-9; Nirmalan PK, 2002, BRIT J OPHTHALMOL, V86, P505, DOI 10.1136/bjo.86.5.505; Polack S, 2012, OPHTHALMOLOGY, V119, P1033, DOI 10.1016/j.ophtha.2011.11.002; Sapkota YD, 2010, OPHTHAL EPIDEMIOL, V17, P82, DOI 10.3109/09286581003624947; StataCorp, 2011, STAT STAT SOFTW REL, P173; Stevens GA, 2013, OPHTHALMOLOGY, V120, P2377, DOI 10.1016/j.ophtha.2013.05.025; Thulasiraj RD, 2002, OPHTHALMIC EPIDEMIOL, V9, P313, DOI 10.1076/opep.9.5.313.10339; Vijaya L, 2010, INDIAN J OPHTHALMOL, V58, P223, DOI 10.4103/0301-4738.62648; Wadud Z, 2006, BRIT J OPHTHALMOL, V90, P1225, DOI 10.1136/bjo.2006.101287; Wu M, 2008, OPHTHALMOLOGY, V115, P969, DOI 10.1016/j.ophtha.2007.08.002	31	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2016	11	12							e0167708	10.1371/journal.pone.0167708	http://dx.doi.org/10.1371/journal.pone.0167708			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MR	27918589	Green Submitted, Green Published, gold			2022-12-27	WOS:000389577100016
J	Kotwinski, P; Smith, G; Cooper, J; Sanders, J; Ma, L; Teis, A; Kotwinski, D; Mythen, M; Pennell, DJ; Jones, A; Montgomery, H				Kotwinski, Paul; Smith, Gillian; Cooper, Jackie; Sanders, Julie; Ma, Louise; Teis, Albert; Kotwinski, David; Mythen, Michael; Pennell, Dudley J.; Jones, Alison; Montgomery, Hugh		Breast Canc Early Dis Toxicity	Body Surface Area and Baseline Blood Pressure Predict Subclinical Anthracycline Cardiotoxicity in Women Treated for Early Breast Cancer	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; VENTRICULAR SYSTOLIC DYSFUNCTION; HEART-FAILURE; ADULT SURVIVORS; EJECTION FRACTION; AMERICAN SOCIETY; CARDIAC TOXICITY; RISK; CHEMOTHERAPY; DOXORUBICIN	Background and Aims Anthracyclines are highly effective chemotherapeutic agents which may cause long-term cardiac damage (chronic anthracycline cardiotoxicity) and heart failure. The pathogenesis of anthracycline cardiotoxicity remains incompletely understood and individual susceptibility difficult to predict. We sought clinical features which might contribute to improved risk assessment. Methods Subjects were women with early breast cancer, free of pre-existing cardiac disease. Left ventricular ejection fraction was measured using cardiovascular magnetic resonance before and >12 months after anthracycline-based chemotherapy (>3 months post-Trastuzumab). Variables associated with subclinical cardiotoxicity (defined as a fall in left ventricular ejection fraction of >= 5%) were identified by logistic regression. Results One hundred and sixty-five women (mean age 48.3 years at enrollment) completed the study 21.7 months [IQR 18.0-26.8] after starting chemotherapy. All received anthracyclines (98.8% epirubicin, cumulative dose 400 [300-450] mg/m(2)); 18% Trastuzumab. Baseline blood pressure was elevated (>= 140/90mmHg, mean 147.3/86.1mmHg) in 18 subjects. Thirty-four subjects (20.7%) were identified with subclinical cardiotoxicity, independent predictors of which were the number of anthracycline cycles (odds ratio, OR 1.64 [1.17-2.30] per cycle), blood pressure >= 140/90mmHg (OR 5.36 [1.73-17.61]), body surface area (OR 2.08 [1.36-3.20] per standard deviation (0.16m(2)) increase), and Trastuzumab therapy (OR 3.35 [1.18-9.51]). The resultant predictive-model had an area under the receiver operating characteristics curve of 0.78 [0.70-0.86]. Conclusions We found subclinical cardiotoxicity to be common even within this low risk cohort. Risk of cardiotoxicity was associated with modestly elevated baseline blood pressure-indicating that close attention should be paid to blood pressure in patients considered for anthracycline based chemotherapy. The association with higher body surface area suggests that indexing of anthracycline doses to surface area may not be appropriate for all, and points to the need for additional research in this area.	[Kotwinski, Paul] North & East Hertfordshire NHS Trust, Dept Cardiol, Stevenage, Herts, England; [Kotwinski, Paul; Sanders, Julie; Ma, Louise; Kotwinski, David; Montgomery, Hugh] UCL, Inst Human Hlth & Performance, London, England; [Kotwinski, Paul; Smith, Gillian; Pennell, Dudley J.] Royal Brompton Hosp, NIHR Cardiovasc Biomed Res Unit, London, England; [Kotwinski, Paul; Smith, Gillian; Pennell, Dudley J.] Imperial Coll, London, England; [Cooper, Jackie] UCL, Ctr Cardiovasc Genet, London, England; [Sanders, Julie] Barts Hlth NHS Trust, St Bartholemews Hosp, Barts Heart Ctr, London, England; [Teis, Albert] Germans Trias & Pujol Univ Hosp, Dept Cardiol, Cardiovasc Imaging Unit, Barcelona, Spain; [Kotwinski, David] Derriford Hosp, Dept Anaesthet, Plymouth, Devon, England; [Mythen, Michael] Univ Coll London Hosp, Dept Anaesthesia & Crit Care, London, England; [Jones, Alison] LOC, London, England; [Mythen, Michael] UCL Inst Cardiovasc Sci, London, England; [Mythen, Michael] Univ Coll London Hosp, Biomed Res Ctr, NIHR, London, England	University of London; University College London; Royal Brompton Hospital; Imperial College London; University of London; University College London; Barts Health NHS Trust; Derriford Hospital; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; King's College London; University College London	Kotwinski, P (corresponding author), North & East Hertfordshire NHS Trust, Dept Cardiol, Stevenage, Herts, England.; Kotwinski, P (corresponding author), UCL, Inst Human Hlth & Performance, London, England.; Kotwinski, P (corresponding author), Royal Brompton Hosp, NIHR Cardiovasc Biomed Res Unit, London, England.; Kotwinski, P (corresponding author), Imperial Coll, London, England.	p.kotwinski@nhs.net	, Albert Teis/GOJ-7595-2022; Montgomery, Hugh/L-1229-2019; Montgomery, Hugh/C-2592-2008	, Albert Teis/0000-0002-4820-0736; Sanders, Julie/0000-0002-7335-2803; Pennell, Dudley/0000-0001-5523-1314; Coombes, Raoul Charles/0000-0002-4811-1100; Montgomery, Hugh/0000-0001-8797-5019	United Kingdom Department of Health [PHGX23A]; National Institute for Health Research (NIHR), through the NCRN [1516]; NIHR's University College London Hospitals (UCLH) Biomedical Research Centre	United Kingdom Department of Health; National Institute for Health Research (NIHR), through the NCRN(National Institute for Health Research (NIHR)); NIHR's University College London Hospitals (UCLH) Biomedical Research Centre	This work was supported by the United Kingdom Department of Health under the Pharmacogenetics Research programme (grant number PHGX23A). DISCLAIMER: The views expressed in this publication are those of the author(s) and not necessarily those of the National Health Service or the Department of Health. The funder provided support in the form of salaries for authors (PK, JS, DK, LM) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The BETTER-CARE research team acknowledges the support of the National Institute for Health Research (NIHR), through the NCRN (trial ID 1516). HM is supported by the NIHR's University College London Hospitals (UCLH) Biomedical Research Centre. We are indebted to Dr J Lyddiard of the NCRN, and the research staff at the recruiting centres. Also to the study coordinators (M Mutch, K Bvabek and J Crause). We thank Professor D Goldstein (Columbia University) for is assistance as a grant co-author. We acknowledge and thank Professor S Humphries (UCL) for his advice and for acting as chairman of the study steering committee. We thank Dr R Roylance (UCLH) for her assistance with manuscript preparation. The co-investigators of the BETTER-CARE study group (participants enrolled/scanned in parenthesis) are: From London, Dr A Jones, The Royal Free (39) and Whittington (25) Hospitals; Dr S Cleator, St Mary's Hospital (28); Dr R Stein, UCLH (25); Dr P Riddle, The West Middlesex University Hospital (18); Dr M Harries, St Thomas' Hospital, (17); The C Gallagher, St Bartholemew's Hospital (14); Prof C Coombes and Dr C Lowdell, Charing Cross Hospital (11); Dr C Cottrill, Whipp's Cross Hospital (10); Dr J Newby, North Middlesex Hospital, (3). Hertfordshire: Prof J Mansi, Mount Vernon Hospital (MVH) (3). Glasgow: Dr P Canney, The Beatson Centre (3). The CMR Units: Professor D Pennell, RBH, London (190); Mr J Stirling, The Paul Strickland Scanner Centre, MVH (3); Prof H Dargie, Glasgow Royal Infirmary (3).	Akpek M, 2015, EUR J HEART FAIL, V17, P81, DOI 10.1002/ejhf.196; Armstrong GT, 2014, PROG PEDIATR CARDIOL, V36, P19, DOI 10.1016/j.ppedcard.2014.09.003; Barpe DR, 2010, EUR J PHARM SCI, V41, P458, DOI 10.1016/j.ejps.2010.07.015; Barrett-Lee PJ, 2009, ANN ONCOL, V20, P816, DOI 10.1093/annonc/mdn728; Bellenger NG, 2000, J CARDIOV MAGN RESON, V2, P271, DOI 10.3109/10976640009148691; Bellenger NG, 2000, EUR HEART J, V21, P1387, DOI 10.1053/euhj.2000.2011; Bernaba BN, 2010, CARDIOVASC PATHOL, V19, P308, DOI 10.1016/j.carpath.2009.07.004; Bosch X, 2013, J AM COLL CARDIOL, V61, P2355, DOI 10.1016/j.jacc.2013.02.072; Britton KA, 2009, EUR J HEART FAIL, V11, P1129, DOI 10.1093/eurjhf/hfp141; Cardinale D, 2015, CIRCULATION, V131, P1981, DOI 10.1161/CIRCULATIONAHA.114.013777; Cheng S, 2009, CIRC-CARDIOVASC IMAG, V2, P191, DOI 10.1161/CIRCIMAGING.108.819938; Curigliano G, 2012, ANN ONCOL, V23, P155, DOI 10.1093/annonc/mds293; Dranitsaris G, 2008, BREAST CANCER RES TR, V107, P443, DOI 10.1007/s10549-007-9803-5; Eschenhagen T, 2011, EUR J HEART FAIL, V13, P1, DOI 10.1093/eurjhf/hfq213; Ewer MS, 2008, J CLIN ONCOL, V26, P1201, DOI 10.1200/JCO.2007.14.8742; Ewer MS, 2010, NAT REV CARDIOL, V7, P564, DOI 10.1038/nrcardio.2010.121; Ezaz G, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000472; Fatima N, 2011, NUCL MED COMMUN, V32, P381, DOI 10.1097/MNM.0b013e328343ceb9; Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694; Griggs JJ, 2012, J CLIN ONCOL, V30, P1553, DOI 10.1200/JCO.2011.39.9436; Grothues F, 2002, AM J CARDIOL, V90, P29, DOI 10.1016/S0002-9149(02)02381-0; Guenancia C, 2016, J CLIN ONCOLOGY OFFI; Hequet O, 2004, J CLIN ONCOL, V22, P1864, DOI 10.1200/JCO.2004.06.033; Hershman DL, 2008, JNCI-J NATL CANCER I, V100, P1046, DOI 10.1093/jnci/djn241; Hershman DL, 2008, J CLIN ONCOL, V26, P3159, DOI 10.1200/JCO.2007.14.1242; Jones LW, 2007, J AM COLL CARDIOL, V50, P1435, DOI 10.1016/j.jacc.2007.06.037; Kenchaiah S, 2009, CIRCULATION, V119, P44, DOI 10.1161/CIRCULATIONAHA.108.807289; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lipshultz SE, 2016, CANCER-AM CANCER SOC, V122, P946, DOI 10.1002/cncr.29872; Lipshultz SE, 2015, ANNU REV MED, V66, P161, DOI 10.1146/annurev-med-070213-054849; Maceira AM, 2006, J CARDIOVASC MAGN R, V8, P417, DOI 10.1080/10976640600572889; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; McCrohon A, 2003, CIRCULATION, V108, P54, DOI 10.1161/01.CIR.0000078641.19365.4C; MINOW RA, 1977, CANCER, V39, P1397, DOI 10.1002/1097-0142(197704)39:4<1397::AID-CNCR2820390407>3.0.CO;2-U; Montgomery H, 2003, EUR J CLIN INVEST, V33, P635, DOI 10.1046/j.1365-2362.2003.01205.x; Mulrooney DA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4606; Piegari E, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0334-4; Pinder MC, 2007, J CLIN ONCOL, V25, P3808, DOI 10.1200/JCO.2006.10.4976; Plana JC, 2014, EUR HEART J-CARD IMG, V15, P1063, DOI 10.1093/ehjci/jeu192; Prado CMM, 2011, CANCER CHEMOTH PHARM, V67, P93, DOI 10.1007/s00280-010-1288-y; Ryberg M, 2008, JNCI-J NATL CANCER I, V100, P1058, DOI 10.1093/jnci/djn206; Salz T, 2015, EUR J CANCER, V51, P758, DOI 10.1016/j.ejca.2015.02.002; Szmit S, 2014, J AM SOC HYPERTENS, V8, P791, DOI 10.1016/j.jash.2014.08.009; Tham EB, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-48; Yancy C, 2013, CIRCULATION, V2013, P6, DOI DOI 10.1016/J.JACC.2013.05.020	46	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0165262	10.1371/journal.pone.0165262	http://dx.doi.org/10.1371/journal.pone.0165262			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911951	Green Published, gold			2022-12-27	WOS:000389520600002
J	Shu, CC; Yeh, CC; Jhang, WS; Lo, SC				Shu, Che-Chi; Yeh, Chen-Chao; Jhang, Wun-Sin; Lo, Shih-Chiang			Driving Cells to the Desired State in a Bimodal Distribution through Manipulation of Internal Noise with Biologically Practicable Approaches	PLOS ONE			English	Article							GENETIC TOGGLE SWITCH; REGULATORY NETWORKS; LINEAGE-COMMITMENT; POSITIVE FEEDBACK; ESCHERICHIA-COLI; EXPRESSION; PU.1; CONSEQUENCES; BISTABILITY; DYNAMICS	The stochastic nature of gene regulatory networks described by Chemical Master Equation (CME) leads to the distribution of proteins. A deterministic bistability is usually reflected as a bimodal distribution in stochastic simulations. Within a certain range of the parameter space, a bistable system exhibits two stable steady states, one at the low end and the other at the high end. Consequently, it appears to have a bimodal distribution with one sub-population (mode) around the low end and the other around the high end. In most cases, only one mode is favorable, and guiding cells to the desired state is valuable. Traditionally, the population was redistributed simply by adjusting the concentration of the inducer or the stimulator. However, this method has limitations; for example, the addition of stimulator cannot drive cells to the desired state in a common bistable system studied in this work. In fact, it pushes cells only to the undesired state. In addition, it causes a position shift of the modes, and this shift could be as large as the value of the mode itself. Such a side effect might damage coordination, and this problem can be avoided by applying a new method presented in this work. We illustrated how to manipulate the intensity of internal noise by using biologically practicable methods and utilized it to prompt the population to the desired mode. As we kept the deterministic behavior untouched, the aforementioned drawback was overcome. Remarkably, more than 96% of cells has been driven to the desired state. This method is genetically applicable to biological systems exhibiting a bimodal distribution resulting from bistability. Moreover, the reaction network studied in this work can easily be extended and applied to many other systems.	[Shu, Che-Chi; Yeh, Chen-Chao; Jhang, Wun-Sin; Lo, Shih-Chiang] Natl Taipei Univ Technol, Dept Chem Engn & Biotechnol, Taipei, Taiwan	National Taipei University of Technology	Shu, CC (corresponding author), Natl Taipei Univ Technol, Dept Chem Engn & Biotechnol, Taipei, Taiwan.	cshu@ntut.edu.tw		Shu, Che-Chi/0000-0002-6930-1050	Ministry of Science and Technology, R.O.C [MOST 104-2221-E-027-100, MOST 105-2221-E-027-116]	Ministry of Science and Technology, R.O.C	This work was supported by the grant (MOST 104-2221-E-027-100 -) and the grant (MOST 105-2221-E-027-116 -) from the Ministry of Science and Technology, R.O.C to C.-C. Shu (https://www.most.gov.Mte/en/public). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. decision to publish, or preparation of the manuscript.; This work was supported by the grant (MOST 104-2221-E-027-100 -) and the grant (MOST 105-2221-E-027-116 -) from the Ministry of Science and Technology, R.O.C.	Andrecut M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019358; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Chatterjee A, 2013, P NATL ACAD SCI USA, V110, P7086, DOI 10.1073/pnas.1212256110; Chatterjee A, 2011, P NATL ACAD SCI USA, V108, P9721, DOI 10.1073/pnas.1101569108; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; Dar RD, 2014, SCIENCE, V344, P1392, DOI 10.1126/science.1250220; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Hill AD, 2008, BIOINFORMATICS, V24, P2551, DOI 10.1093/bioinformatics/btn468; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Mehra S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002724; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Paulsson J, 2000, P NATL ACAD SCI USA, V97, P7148, DOI 10.1073/pnas.110057697; Ptashne M, 1992, PHAGE LAMBDA HIGHER; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Reddy VA, 2002, BLOOD, V100, P483, DOI 10.1182/blood.V100.2.483; Shu CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079196; Shu CC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002140; Singh A, 2009, CURR OPIN MICROBIOL, V12, P460, DOI 10.1016/j.mib.2009.06.016; Song HS, 2013, PROCESSES, V1, P263, DOI 10.3390/pr1030263; Tian TH, 2006, P NATL ACAD SCI USA, V103, P8372, DOI 10.1073/pnas.0507818103; Xu Y, 2014, PHYSICA A, V416, P461, DOI 10.1016/j.physa.2014.08.042; Yildirim N, 2003, BIOPHYS J, V84, P2841, DOI 10.1016/S0006-3495(03)70013-7; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	32	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167563	10.1371/journal.pone.0167563	http://dx.doi.org/10.1371/journal.pone.0167563			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911933	gold, Green Published, Green Submitted			2022-12-27	WOS:000389520600043
J	Alam, AHMK; Hossain, ASMS; Khan, MA; Kabir, SR; Abu Reza, M; Rahman, MM; Islam, MS; Rahman, MAA; Rashid, M; Sadik, MG				Alam, A. H. M. Khurshid; Hossain, A. S. M. Sakhawat; Khan, Muhammad Ali; Kabir, Syed Rashel; Abu Reza, Md; Rahman, Md Mahbubur; Islam, Mohammad Saiful; Rahman, Md Aziz Abdur; Rashid, Mamunur; Sadik, Md Golam			The Antioxidative Fraction of White Mulberry Induces Apoptosis through Regulation of p53 and NF kappa B in EAC Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; GROWTH-INHIBITION; PHASE ARREST; CYCLE ARREST; CANCER; EXTRACTS; TEA; CHEMILUMINESCENCE; INDUCTION; INSIGHTS	In this study, the antioxidative fraction of white mulberry (Morus alba) was found to have an apotogenic effect on Ehrlich's ascites carcinoma cell-induced mice (EAC mice) that correlate with upregulated p53 and downregulated NF kappa B signaling. The antioxidant activities and polyphenolic contents of various mulberry fractions were evaluated by spectrophotometry and the ethyl acetate fraction (EAF) was selected for further analysis. Strikingly, the EAF caused 70.20% tumor growth inhibition with S-phase cell cycle arrest, normalized blood parameters including red/white blood cell counts and suppressed the tumor weight of EAC mice compared with untreated controls. Fluorescence microscopy analysis of EAF-treated EAC cells revealed DNA fragmentation, cell shrinkage, and plasma membrane blebbing. These characteristic morphological features of apoptosis influenced us to further investigate pro-and anti-apoptotic signals in EAF-treated EAC mice. Interestingly, apoptosis correlated with the upregulation of p53 and its target genes PARP-1 and Bax, and also with the down-regulation of NF.B and its target genes Bcl-2 and Bcl-xL. Our results suggest that the tumor-suppressive effect of the antioxidative fraction of white mulberry is likely due to apoptosis mediated by p53 and NF kappa B signaling.	[Alam, A. H. M. Khurshid; Hossain, A. S. M. Sakhawat; Rahman, Md Mahbubur; Islam, Mohammad Saiful; Rahman, Md Aziz Abdur; Rashid, Mamunur; Sadik, Md Golam] Rajshahi Univ, Dept Pharm, Rajshahi, Bangladesh; [Khan, Muhammad Ali] Bangabandhu Sheikh Mujibur Rahman Sci & Technol U, Dept Pharm, Gopalganj, Bangladesh; [Kabir, Syed Rashel] Rajshahi Univ, Dept Biochem & Mol Biol, Rajshahi, Bangladesh; [Abu Reza, Md] Rajshahi Univ, Dept Genet Engn & Biotechnol, Rajshahi, Bangladesh	University of Rajshahi; Bangabandhu Sheikh Mujibur Rahman Science & Technology University; University of Rajshahi; University of Rajshahi	Alam, AHMK (corresponding author), Rajshahi Univ, Dept Pharm, Rajshahi, Bangladesh.	khurshid.jaist@gmail.com	Abu Reza/ABE-6824-2020; Abu Reza, M./P-6725-2019; Khan, Muhammad Ali/ABA-9088-2021; Sadik, Md. Golam/ABA-9831-2021; Kabir, Syed Rashel/I-6247-2015; Hossain, ABm Sharif/C-2446-2019	Khan, Muhammad Ali/0000-0002-6980-6112; Kabir, Syed Rashel/0000-0002-5708-014X; Hossain, ABm Sharif/0000-0002-6437-3864; Alam, AHM Khurshid/0000-0003-2690-6559	Department of Pharmacy, University of Rajshahi, Bangladesh	Department of Pharmacy, University of Rajshahi, Bangladesh	The authors acknowledge the Dean and Department of Pharmacy, University of Rajshahi, Bangladesh for financial support. We further acknowledge Ms. Jenelle Hyunji Lee and Mr. John Vaughen for comments on the manuscript. We acknowledge ICDDR'B, Bangladesh for FAGS analysis. We also thank Dr. AHM Mahabubur Rahman, Associate Professor,	AHMED H, 1988, J BIOSCIENCE, V13, P419, DOI 10.1007/BF02703454; Alam AHMK, 2010, CELL BIOL INT, V34, P631, DOI 10.1042/CBI20090332; [Anonymous], 2011, INT J PHARM PHARM SC; Arfan M, 2012, INT J MOL SCI, V13, P2472, DOI 10.3390/ijms13022472; Balasubramanian A, 2004, IRANIAN J PHARM THER, V4, P13; Bhattacharyya A, 2003, CARCINOGENESIS, V24, P75, DOI 10.1093/carcin/24.1.75; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; BLOT WJ, 1993, JNCI-J NATL CANCER I, V85, P1483, DOI 10.1093/jnci/85.18.1483; Borner C, 2003, MOL IMMUNOL, V39, P615, DOI 10.1016/S0161-5890(02)00252-3; Bruchlausen F.V, 1979, N-S ARCH PHARMACOL, V308, P27; Chinni SR, 2001, ONCOGENE, V20, P2927, DOI 10.1038/sj.onc.1204365; Choi HY, 2000, PHYTOTHER RES, V14, P250, DOI 10.1002/1099-1573(200006)14:4&lt;250::AID-PTR587&gt;3.0.CO;2-J; Chon SU, 2009, EUR FOOD RES TECHNOL, V230, P231, DOI 10.1007/s00217-009-1165-2; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Deepa M, 2013, NUTR CANCER, V65, P305, DOI 10.1080/01635581.2013.748924; Duan XW, 2007, MOLECULES, V12, P759, DOI 10.3390/12040759; Durackova Z, 2010, PHYSIOL RES, V59, P459, DOI 10.33549/physiolres.931844; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Garg A, 2002, LEUKEMIA, V16, P1053, DOI 10.1038/sj.leu.2402482; Giannakakou P, 2001, ONCOGENE, V20, P3806, DOI 10.1038/sj.onc.1204487; Gomes A, 2011, TOXICON, V58, P85, DOI 10.1016/j.toxicon.2011.05.008; Halliwell B, 2007, BIOCHEM J, V401, P1, DOI 10.1042/BJ20061131; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hussein MSh, 2010, J AM SCI, V6, P762; Islam S, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-142; Jaganathan SK, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/989163; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Kabir SR, 2013, PHYTOMEDICINE, V20, P1288, DOI 10.1016/j.phymed.2013.06.010; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Khalid N, 2011, PAK J BOT, V43, P91; Khan Muhammad Ali, 2013, BMC Res Notes, V6, P24, DOI 10.1186/1756-0500-6-24; Khanam JA, 2010, J NATL SCI FOUND SRI, V38, P225, DOI 10.4038/jnsfsr.v38i4.2649; Klaunig JE, 1998, ENVIRON HEALTH PERSP, V106, P289, DOI 10.2307/3433929; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; Kumaran A, 2007, LWT-FOOD SCI TECHNOL, V40, P344, DOI 10.1016/j.lwt.2005.09.011; Kumari SR, 1998, CANCER RES, V58, P5075; Kwon HK, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-392; Landete JM, 2013, CRIT REV FOOD SCI, V53, P706, DOI 10.1080/10408398.2011.555018; Li H, 2009, FOOD CHEM, V112, P454, DOI 10.1016/j.foodchem.2008.05.111; Liu F, 2000, LIFE SCI, V66, P725, DOI 10.1016/S0024-3205(99)00643-8; Lopez-Lazaro M, 2010, MOL MED, V16, P144, DOI 10.2119/molmed.2009.00162; Nagai T, 2005, FOOD CHEM, V91, P389, DOI 10.1016/j.foodchem.2004.04.016; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Naowaratwattana W, 2010, J MED FOOD, V13, P1045, DOI 10.1089/jmf.2010.1021; Nomura M, 2000, CARCINOGENESIS, V21, P1885, DOI 10.1093/carcin/21.10.1885; Oktay M, 2003, LEBENSM-WISS TECHNOL, V36, P263, DOI 10.1016/S0023-6438(02)00226-8; Ordonez AAL, 2006, FOOD CHEM, V97, P452, DOI 10.1016/j.foodchem.2005.05.024; Prieto P, 1999, ANAL BIOCHEM, V269, P337, DOI 10.1006/abio.1999.4019; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; Saxena A, 2010, CHEM-BIOL INTERACT, V188, P580, DOI 10.1016/j.cbi.2010.09.029; Scully C, 1993, Dent Update, V20, P95; Srivastava S, 2016, SCI REP-UK, V6, DOI 10.1038/srep24049; Sun JS, 1998, BURNS, V24, P225, DOI 10.1016/S0305-4179(97)00115-0; SUR P, 1994, PLANTA MED, V60, P106, DOI 10.1055/s-2006-959427; Visconti R, 2009, CURR OPIN DRUG DISC, V12, P240; Wang YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071144; Wolfe K, 2003, J AGR FOOD CHEM, V51, P609, DOI 10.1021/jf020782a; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Zhang YX, 2000, CANCER RES, V60, P2025	63	28	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167536	10.1371/journal.pone.0167536	http://dx.doi.org/10.1371/journal.pone.0167536			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936037	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100117
J	Cai, XL; Yang, WJ; Gao, XY; Zhou, LL; Han, XY; Ji, LN				Cai, Xiaoling; Yang, Wenjia; Gao, Xueying; Zhou, Lingli; Han, Xueyao; Ji, Linong			Baseline Body Mass Index and the Efficacy of Hypoglycemic Treatment in Type 2 Diabetes: A Meta-Analysis	PLOS ONE			English	Article							DIPEPTIDYL PEPTIDASE-4 INHIBITORS; NON-ASIANS; ROSIGLITAZONE; SITAGLIPTIN; PREDICTORS; METFORMIN; SAFETY	Aim The aim of this study is to compare the effects of hypoglycemic treatments in groups of patients categorized according to the mean baseline body mass indexes (BMIs). Methods Studies were identified by a literature search and all the studies were double blind, placebo-controlled randomized trials in type 2 diabetes patients; study length of >= 12 weeks with the efficacy evaluated by changes in HbA1c from baseline in groups. The electronic search was first conducted in January 2015 and repeated in June 2015. Results 227 studies were included. Treatment with sulfonylureas was compared with placebo in overweight patients and resulted in a significantly greater change in the HbA1c levels (weighted mean difference (WMD), -1.39%) compared to obese patients (WMD, -0.77%)(p<0.05). Treatment with metformin in overweight patients resulted in a comparable change in the HbA1c levels (WMD, -0.99%) compared to obese patients (WMD, -1.06%)(p>0.05). Treatment with alpha glucosidase inhibitors in normal weight patients was associated with a HbA1c change (WMD, -0.94%) that was comparable that in overweight (WMD, -0.72%) and obese patients (WMD, -0.56%)(p>0.05). Treatment with thiazolidinediones in normal weight patients was associated with a HbA1c change (WMD, -1.04%) that was comparable with that in overweight (WMD, -1.02%) and obese patients (WMD, -0.88%)(p>0.05). Treatment with DPP-4 inhibitors in normal weight patients was associated with a HbA1c change (WMD, -0.93%) that was comparable with that in overweight (WMD, -0.66%) and obese patients (WMD, -0.61%)(p>0.05). In total, of the seven hypoglycemic agents, regression analysis indicated that the mean baseline BMI was not associated with the mean HbA1c changes from baseline. Conclusion In each kind of hypoglycemic therapy in type 2 diabetes, the baseline BMI was not associated with the efficacy of HbA1c changes from baseline.	[Cai, Xiaoling; Yang, Wenjia; Gao, Xueying; Zhou, Lingli; Han, Xueyao; Ji, Linong] Peking Univ, Peoples Hosp, Endocrine & Metab Dept, Beijing, Peoples R China	Peking University	Ji, LN (corresponding author), Peking Univ, Peoples Hosp, Endocrine & Metab Dept, Beijing, Peoples R China.	jiln@bjmu.edu.cn	Linong, Ji/AAB-6543-2020	Cai, Xiaoling/0000-0002-7881-0543	National High-technology Research and Development Program of China (863 Program) [2012AA02A509]; National Natural Science Foundation of China (NSFC) [81000334]; Merck China Ltd.	National High-technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Merck China Ltd.	This meta-analysis was supported by the National High-technology Research and Development Program of China (863 Program 2012AA02A509) and National Natural Science Foundation of China (NSFC) (81000334). We also received financial support for this study from Merck China Ltd. The funding agencies had no role in the study design, data collection or analysis, decision to publish or preparation of the manuscript.	Cai XL, 2015, J DIABETES, V7, P347, DOI 10.1111/1753-0407.12196; Gavin L A, 2000, Endocr Pract, V6, P305; Grarup N, 2014, DIABETOLOGIA, V57, P1528, DOI 10.1007/s00125-014-3270-4; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Huang Z., 2014, CHINESE J POPULATION, V2, P2, DOI DOI 10.1155/2014/273692; Ji LN, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063404, 10.1371/journal.pone.0057222]; Jones TA, 2003, DIABETES OBES METAB, V5, P163, DOI 10.1046/j.1463-1326.2003.00258.x; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kim SA, 2011, DIABETES METAB J, V35, P159, DOI 10.4093/dmj.2011.35.2.159; Kim YG, 2014, DIABETES OBES METAB, V16, P900, DOI 10.1111/dom.12293; Kim YG, 2013, DIABETOLOGIA, V56, P696, DOI 10.1007/s00125-012-2827-3; Kim YM, 2005, DIABETES RES CLIN PR, V67, P43, DOI 10.1016/j.diabres.2004.05.001; Lapolla A, 2015, CLIN THER, V24; Liberati A, 2009, PLOS MED, V6, DOI DOI 10.1186/s13643-016-0384-4; Maeda H, 2012, DIABETES RES CLIN PR, V95, pE20, DOI 10.1016/j.diabres.2011.10.011; Monami M, 2011, DIABETES-METAB RES, V27, P362, DOI 10.1002/dmrr.1184; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pencek R, 2012, POSTGRAD MED, V124, P21, DOI 10.3810/pgm.2012.07.2567; Schweizer Anja, 2012, Diabetes Ther, V3, P8, DOI 10.1007/s13300-012-0008-5; Toyoda M, 2014, DIABETES RES CLIN PR, V106, P451, DOI 10.1016/j.diabres.2014.09.052; Yagi S, 2015, DIABETES METAB J, V39, P342, DOI 10.4093/dmj.2015.39.4.342; Zoungas S, 2010, DIABETES RES CLIN PR, V89, P126, DOI 10.1016/j.diabres.2010.05.012	22	16	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166625	10.1371/journal.pone.0166625	http://dx.doi.org/10.1371/journal.pone.0166625			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935975	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100038
J	Gil-Cayuela, C; Rosello-LLeti, E; Ortega, A; Tarazon, E; Trivino, JC; Martinez-Dolz, L; Gonzalez-Juanatey, JR; Lago, F; Portoles, M; Rivera, M				Gil-Cayuela, Carolina; Rosello-LLeti, Esther; Ortega, Ana; Tarazon, Estefania; Carlos Trivino, Juan; Martinez-Dolz, Luis; Ramon Gonzalez-Juanatey, Jose; Lago, Francisca; Portoles, Manuel; Rivera, Miguel			New Altered Non-Fibrillar Collagens in Human Dilated Cardiomyopathy: Role in the Remodeling Process	PLOS ONE			English	Article							VIII COLLAGEN; MOLECULAR-MECHANISMS; ARTERIAL INJURY; HEART-FAILURE; ATHEROSCLEROSIS; HYPERTROPHY; GUIDELINES; CELLS	Background In dilated cardiomyopathy (DCM), cardiac failure is accompanied by profound alterations of extracellular matrix associated with the progression of cardiac dilation and left ventricular (LV) dysfunction. Recently, we reported alterations of non-fibrillar collagen expression in ischemic cardiomyopathy linked to fibrosis and cardiac remodeling. We suspect that expression changes in genes coding for non-fibrillar collagens may have a potential role in DCM development. Objectives This study sought to analyze changes in the expression profile of non-fibrillar collagen genes in patients with DCM and to examine relationships between cardiac remodeling parameters and the expression levels of these genes. Methods and Results Twenty-three human left ventricle tissue samples were obtained from DCM patients (n = 13) undergoing heart transplantation and control donors (n = 10) for RNA sequencing analysis. We found increased mRNA levels of six non-fibrillar collagen genes, such as COL4A5, COL9A1, COL21A1, and COL23A1 (P < 0.05 for all), not previously described in DCM. Protein levels of COL8A1 and COL16A1 (P < 0.05 for both), were correspondingly increased. We also identified TGF-beta 1 significantly upregulated and related to both COL8A1 and COL16A1. Interestingly, we found a significant relationship between LV mass index and the gene expression level of COL8A1 (r = 0.653, P < 0.05). Conclusions In our research, we identified new non-fibrillar collagens with altered expression in DCM, being COL8A1 overexpression directly related to LV mass index, suggesting that they may be involved in the progression of cardiac dilation and remodeling.	[Gil-Cayuela, Carolina; Rosello-LLeti, Esther; Ortega, Ana; Tarazon, Estefania; Portoles, Manuel; Rivera, Miguel] La Fe Univ Hosp IIS La Fe, Hlth Inst, Cardiocirculatory Unit, Valencia, Spain; [Carlos Trivino, Juan] Genom Syst, Paterna, Valencia, Spain; [Martinez-Dolz, Luis] La Fe Univ Hosp, Dept Cardiol, Heart Failure & Transplantat Unit, Valencia, Spain; [Ramon Gonzalez-Juanatey, Jose; Lago, Francisca] Univ Clin Hosp, Cellular & Mol Cardiol Res Unit, Dept Cardiol, Santiago De Compostela, Spain; [Ramon Gonzalez-Juanatey, Jose; Lago, Francisca] Univ Clin Hosp, Inst Biomed Res, Santiago De Compostela, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Portoles, M; Rivera, M (corresponding author), La Fe Univ Hosp IIS La Fe, Hlth Inst, Cardiocirculatory Unit, Valencia, Spain.	portoles_man@gva.es; miguelrivera492@gmail.com	PORTOLES, MANUEL/B-4789-2009; Tarazón, Estefanía/D-6950-2017; Dolz, Luis Martinez/X-4627-2018; Ortega, Ana AO/D-3027-2017; Roselló Lletí, Esther/ABG-8503-2020; Roselló-Lletí, Esther/B-2695-2017; Gil-Cayuela, Carolina/D-6996-2017; Ortega, Ana/AAG-5941-2020	PORTOLES, MANUEL/0000-0002-4415-7160; Tarazón, Estefanía/0000-0003-3466-2558; Dolz, Luis Martinez/0000-0001-5145-8191; Ortega, Ana AO/0000-0002-9763-0505; Roselló Lletí, Esther/0000-0003-2627-6104; Roselló-Lletí, Esther/0000-0003-2627-6104; Gil-Cayuela, Carolina/0000-0002-1106-7935; Ortega, Ana/0000-0002-9763-0505; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388	National Institute of Health "Fondo de Investigaciones Sanitarias del Institute de Salud Carlos III" Madrid, Spain [PI13/00100, PI14/01506]; European Regional Development Fund (FEDER); RETICS, Madrid, Spain [12/0042/0003]	National Institute of Health "Fondo de Investigaciones Sanitarias del Institute de Salud Carlos III" Madrid, Spain; European Regional Development Fund (FEDER)(European Commission); RETICS, Madrid, Spain	This work was supported by the National Institute of Health "Fondo de Investigaciones Sanitarias del Institute de Salud Carlos III" Madrid, Spain [PI13/00100, PI14/01506]; European Regional Development Fund (FEDER); and RETICS, Madrid, Spain [12/0042/0003]. The funders provided support in the form of salaries for authors CGC, ERL, AO, and ET, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section and also included in this letter.	Barnes MJ, 1999, EXP GERONTOL, V34, P513, DOI 10.1016/S0531-5565(99)00038-8; Basbaum CB, 1996, CURR OPIN CELL BIOL, V8, P731, DOI 10.1016/S0955-0674(96)80116-5; Brower GL, 2001, AM J PHYSIOL-HEART C, V280, pH674, DOI 10.1152/ajpheart.2001.280.2.H674; CAMPBELL GR, 1990, ANN NY ACAD SCI, V598, P143, DOI 10.1111/j.1749-6632.1990.tb42286.x; CARVER W, 1991, CIRC RES, V69, P116, DOI 10.1161/01.RES.69.1.116; Dray S., 2007, R NEWS, V7, P47; Fitzgerald J, 2001, FEBS LETT, V505, P275, DOI 10.1016/S0014-5793(01)02754-5; Gil-Cayuela C, 2015, J AM COLL CARDIOL, V65, P1265, DOI 10.1016/j.jacc.2015.01.029; GunjaSmith Z, 1996, AM J PATHOL, V148, P1639; Hou GP, 2000, AM J PATHOL, V156, P467, DOI 10.1016/S0002-9440(10)64751-7; Johnson C, 2004, ARTERIOSCL THROM VAS, V24, P54, DOI 10.1161/01.ATV.0000100402.69997.C3; Kapelko V I, 2001, Exp Clin Cardiol, V6, P41; Kuzuya M, 2006, ARTERIOSCL THROM VAS, V26, P1120, DOI 10.1161/01.ATV.0000218496.60097.e0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeffler I, 2011, J AM SOC NEPHROL, V22, P649, DOI 10.1681/ASN.2010010098; Lopes J, 2013, AM J PATHOL, V182, P2241, DOI 10.1016/j.ajpath.2013.02.011; Macrae Duncan J, 2007, Proc Am Thorac Soc, V4, P176, DOI 10.1513/pats.200701-011GC; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; MEDUGORAC I, 1982, BASIC RES CARDIOL, V77, P589, DOI 10.1007/BF01908312; Monkawa T, 2002, J AM SOC NEPHROL, V13, P1172, DOI 10.1097/01.ASN.0000013162.29833.45; Orr AW, 2009, ARTERIOSCL THROM VAS, V29, P225, DOI 10.1161/ATVBAHA.108.178749; Plenz GAM, 2003, ATHEROSCLEROSIS, V166, P1, DOI 10.1016/S0021-9150(01)00766-3; Ratzinger S, 2010, MATRIX BIOL, V29, P177, DOI 10.1016/j.matbio.2009.11.004; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Shamhart PE, 2010, J MOL CELL CARDIOL, V48, P530, DOI 10.1016/j.yjmcc.2009.06.017; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Sibinga NES, 1997, CIRC RES, V80, P532, DOI 10.1161/01.RES.80.4.532; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Tarazon E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090157; Towbin JA, 2006, JAMA-J AM MED ASSOC, V296, P1867, DOI 10.1001/jama.296.15.1867; Veit G, 2007, J BIOL CHEM, V282, P27424, DOI 10.1074/jbc.M703425200; Watanabe T, 1998, JPN HEART J, V39, P753; WEBER KT, 1995, HERZ, V20, P81; Winters AL, 2005, ANAL BIOCHEM, V346, P43, DOI 10.1016/j.ab.2005.07.041; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x; Wolf G, 2001, AM J PATHOL, V158, P1091, DOI 10.1016/S0002-9440(10)64056-4; Xu R, 2001, BIOCHEM BIOPH RES CO, V289, P264, DOI 10.1006/bbrc.2001.5970	39	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168130	10.1371/journal.pone.0168130	http://dx.doi.org/10.1371/journal.pone.0168130			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936202	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100274
J	Griggio, M; Fracasso, G; Mahr, K; Hoi, H				Griggio, Matteo; Fracasso, Gerardo; Mahr, Katharina; Hoi, Herbert			Olfactory Assessment of Competitors to the Nest Site: An Experiment on a Passerine Species	PLOS ONE			English	Article							ODOR RECOGNITION; PROCELLARIIFORM SEABIRDS; KIN RECOGNITION; BIRDS; PREDATORS; SONGBIRD; SCENT; PREFERENCE; AVOIDANCE; NAVIGATION	Since most avian species have been considered anosmic or microsmatic, olfaction and associated behavioural patterns have hardly been investigated. Most importantly, empirical data on avian olfaction is not equally distributed among species. Initial investigations focused on species with relatively big olfactory bulbs because they were thought to have better olfactory capabilities. Hence, in this study we tested the ability of house sparrows (Passer domesticus) to use chemical cues as parameters to estimate nest features. House sparrows are a commonly used model species, but their olfactory capabilities have not been studied so far. We offered two different odours to males and females, namely the scent of mouse urine (Mus musculus domesticus), representing a possible competitor and a threat to eggs and hatchlings, and the odour of hay, representing a familiar and innocuous odour. The experiment was performed at the sunset to simulate a first inspection to new possible roosting or nesting sites. Interestingly, males but not females preferred to spend significantly more time in front of the hay odour, than in front of the scent of mouse urine. Our results strengthen the hypothesis that oscines can not only perceive odours but also use olfaction to assess the environment and estimate nest site quality.	[Griggio, Matteo; Fracasso, Gerardo] Univ Padua, Dipartimento Biol, Via U Bassi, Padua, Italy; [Mahr, Katharina; Hoi, Herbert] Univ Vet Med Vienna, Dept Integrat Biol & Evolut, Konrad Lorenz Inst Ethol, Vienna, Austria	University of Padua; University of Veterinary Medicine Vienna	Griggio, M (corresponding author), Univ Padua, Dipartimento Biol, Via U Bassi, Padua, Italy.	matteo.griggio@unipd.it	Fracasso, Gerardo/G-4082-2018	Fracasso, Gerardo/0000-0003-3384-4472; Griggio, Matteo/0000-0002-3298-2905				Amo L, 2008, FUNCT ECOL, V22, P289, DOI 10.1111/j.1365-2435.2007.01361.x; Amo L, 2013, ECOL LETT, V16, P1348, DOI 10.1111/ele.12177; Amo L, 2012, ANIM BEHAV, V84, P1483, DOI 10.1016/j.anbehav.2012.09.021; Amo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027576; Amo L, 2011, ARDEA, V99, P177, DOI 10.5253/078.099.0207; [Anonymous], 1963, THE HOUSE SPARROW; BANG BG, 1968, AUK, V85, P55; BANG BG, 1960, NATURE, V188, P547, DOI 10.1038/188547a0; Blight LK, 1999, CONDOR, V101, P871, DOI 10.2307/1370079; Bonadonna F, 2003, J EXP BIOL, V206, P3719, DOI 10.1242/jeb.00610; Bonadonna F, 2003, BEHAV ECOL SOCIOBIOL, V54, P174, DOI 10.1007/s00265-003-0610-7; Bonadonna F, 2002, J EXP BIOL, V205, P2519; Bonadonna F, 2004, SCIENCE, V306, P835, DOI 10.1126/science.1103001; Bonadonna F, 2012, ANIM BEHAV, V84, P509, DOI 10.1016/j.anbehav.2012.06.014; Bradley JE, 2003, AUK, V120, P1180, DOI 10.1642/0004-8038(2003)120[1180:RANPIO]2.0.CO;2; CLARK L, 1988, OECOLOGIA, V77, P174, DOI 10.1007/BF00379183; Clark L, 1991, BIRD PARASITE INTERA, P204; Corfield JR, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00102; Corfield JR, 2012, BRAIN BEHAV EVOLUT, V80, P181, DOI 10.1159/000339828; CRAMP S, 1992, BIRDS W PALEARCTIC, V8; Degraaf RM, 1999, WILSON BULL, V111, P236; Dell'Ariccia G, 2013, J EXP BIOL, V216, P1430, DOI 10.1242/jeb.082826; Forstmeier W, 2004, ANIM BEHAV, V68, P1017, DOI 10.1016/j.anbehav.2004.02.007; Gagliardo A, 2013, J EXP BIOL, V216, P2165, DOI 10.1242/jeb.070250; Godard RD, 2007, J AVIAN BIOL, V38, P128, DOI 10.1111/j.2007.0908-8857.03788.x; Griggio M, 2016, ECOL EVOL, V6, P493, DOI 10.1002/ece3.1903; Griggio M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-44; Griggio M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-261; GRUBB TC, 1974, ANIM BEHAV, V22, P192, DOI 10.1016/S0003-3472(74)80069-2; Gwinner H, 2008, ANIM BEHAV, V75, P971, DOI 10.1016/j.anbehav.2007.08.008; Haahr M., 1998, TRUE RANDOM NUMBER S; Hagelin JC, 2003, P ROY SOC B-BIOL SCI, V270, P1323, DOI 10.1098/rspb.2003.2379; HUTCHISON LV, 1980, CONDOR, V82, P314, DOI 10.2307/1367400; Johnson LS, 2011, J FIELD ORNITHOL, V82, P150, DOI 10.1111/j.1557-9263.2011.00317.x; Krause ET, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036615; Krause ET, 2012, BIOL LETTERS, V8, P327, DOI 10.1098/rsbl.2011.1093; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Mehlhorn J, 2010, BRAIN BEHAV EVOLUT, V75, P63, DOI 10.1159/000295151; Nevitt GA, 2000, BIOL BULL-US, V198, P245, DOI 10.2307/1542527; Nevitt GA, 2008, J EXP BIOL, V211, P1706, DOI 10.1242/jeb.015412; Petit C, 2002, ECOL LETT, V5, P585, DOI 10.1046/j.1461-0248.2002.00361.x; PICMAN J, 1994, WILSON BULL, V106, P456; Roth TC, 2008, ANIM BEHAV, V76, P2021, DOI 10.1016/j.anbehav.2008.08.022; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Thompson FR, 1999, AUK, V116, P259, DOI 10.2307/4089477; WIMBERGER PH, 1984, AUK, V101, P615, DOI 10.1093/auk/101.3.615; Zidar J, 2012, ANIM BEHAV, V84, P547, DOI 10.1016/j.anbehav.2012.06.006	47	8	8	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167905	10.1371/journal.pone.0167905	http://dx.doi.org/10.1371/journal.pone.0167905			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936093	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100228
J	Huckstepp, RTR; Llaudet, E; Gourine, AV				Huckstepp, Robert T. R.; Llaudet, Enrique; Gourine, Alexander V.			CO2-Induced ATP-Dependent Release of Acetylcholine on the Ventral Surface of the Medulla Oblongata	PLOS ONE			English	Article							BRAIN-STEM; CO2 CHEMOSENSITIVITY; VENTILATORY RESPONSE; MAMMALIAN BRAIN; ASTROCYTES; SENSITIVITY; NEURONS; CHEMORECEPTORS; INHIBITION; MECHANISMS	Complex mechanisms that detect changes in brainstem parenchymal PCO2/[H+] and trigger adaptive changes in lung ventilation are responsible for central respiratory CO2 chemosensitivity. Previous studies of chemosensory signalling pathways suggest that at the level of the ventral surface of the medulla oblongata (VMS), CO2-induced changes in ventilation are (at least in part) mediated by the release and actions of ATP and/or acetylcholine (ACh). Here we performed simultaneous real-time biosensor recordings of CO2-induced ATP and ACh release from the VMS in vivo and in vitro, to test the hypothesis that central respiratory CO2 chemosensory transduction involves simultaneous recruitment of purinergic and cholinergic signalling pathways. In anaesthetised and artificially ventilated rats, an increase in inspired CO2 triggered ACh release on the VMS with a peak amplitude of similar to 5 mu M. Release of ACh was only detected after the onset of CO2-induced activation of the respiratory activity and was markedly reduced (by similar to 70%) by ATP receptor blockade. In horizontal slices of the VMS, CO2-induced release of ATP was reliably detected, whereas CO2 or bath application of ATP (100 mu M) failed to trigger release of ACh. These results suggest that during hypercapnia locally produced ATP induces or potentiates the release of ACh (likely from the medullary projections of distal groups of cholinergic neurones), which may also contribute to the development and/or maintenance of the ventilatory response to CO2.	[Huckstepp, Robert T. R.; Gourine, Alexander V.] UCL, Ctr Cardiovasc & Metab Neurosci, Neurosci Physiol & Pharmacol, London, England; [Huckstepp, Robert T. R.; Llaudet, Enrique] Univ Warwick, Sch Life Sci, Coventry, W Midlands, England	University of London; University College London; University of Warwick	Huckstepp, RTR (corresponding author), UCL, Ctr Cardiovasc & Metab Neurosci, Neurosci Physiol & Pharmacol, London, England.; Huckstepp, RTR (corresponding author), Univ Warwick, Sch Life Sci, Coventry, W Midlands, England.	R.Huckstepp@warwick.ac.uk	Huckstepp, Robert/L-2387-2018	Huckstepp, Robert/0000-0003-4410-3397; Llaudet, Enrique/0000-0003-1136-0602	Wellcome trust	Wellcome trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome trust awarded to AVG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballantyne D, 2000, J PHYSIOL-LONDON, V525, P567, DOI 10.1111/j.1469-7793.2000.00567.x; Daly M. D. B., 1997, MONOGRAPH PHYSL SOC; DEV NB, 1979, PFLUG ARCH EUR J PHY, V379, P19, DOI 10.1007/BF00622900; Dubreuil V, 2008, P NATL ACAD SCI USA, V105, P1067, DOI 10.1073/pnas.0709115105; FUKUDA Y, 1979, PFLUG ARCH EUR J PHY, V379, P125, DOI 10.1007/BF00586938; Garg SK, 2015, J APPL PHYSIOL, V119, P670, DOI 10.1152/japplphysiol.00411.2015; GONZALEZ C, 1994, PHYSIOL REV, V74, P829, DOI 10.1152/physrev.1994.74.4.829; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Gourine AV, 2009, TRENDS NEUROSCI, V32, P241, DOI 10.1016/j.tins.2009.03.002; Gourine AV, 2005, J PHYSIOL-LONDON, V568, P715, DOI 10.1113/jphysiol.2005.095968; Gourine AV, 2005, NATURE, V436, P108, DOI 10.1038/nature03690; Gourine AV, 2005, J NEUROSCI, V25, P1211, DOI 10.1523/JNEUROSCI.3763-04.2005; Gourine AV, 2003, J PHYSIOL-LONDON, V552, P197, DOI 10.1113/jphysiol.2003.045294; Guyenet PG, 2016, J PHYSIOL-LONDON, V594, P1529, DOI 10.1113/JP271480; Hawkins V, 2014, FASEB J S, V28; HEERINGA J, 1979, RESP PHYSIOL, V37, P365, DOI 10.1016/0034-5687(79)90082-3; Huckstepp RTR, 2015, J NEUROSCI, V35, P1052, DOI 10.1523/JNEUROSCI.2953-14.2015; Huckstepp RTR, 2011, J PHYSIOL-LONDON, V589, P5561, DOI 10.1113/jphysiol.2011.214759; Huckstepp RTR, 2010, J PHYSIOL-LONDON, V588, P3901, DOI 10.1113/jphysiol.2010.192088; Huckstepp RTR, 2010, J PHYSIOL-LONDON, V588, P3921, DOI 10.1113/jphysiol.2010.192096; Kasymov V, 2013, J NEUROSCI, V33, P435, DOI 10.1523/JNEUROSCI.2813-12.2013; Kumar NN, 2015, SCIENCE, V348, P1255, DOI 10.1126/science.aaa0922; Llaudet E, 2005, ANAL CHEM, V77, P3267, DOI 10.1021/ac048106q; Llaudet E, 2003, BIOSENS BIOELECTRON, V18, P43, DOI 10.1016/S0956-5663(02)00106-9; LOESCHCKE HH, 1982, J PHYSIOL-LONDON, V332, P1; Marina N, 2010, J NEUROSCI, V30, P12466, DOI 10.1523/JNEUROSCI.3141-10.2010; Meigh L, 2013, ELIFE, V2, DOI 10.7554/eLife.01213; NATTIE EE, 1994, RESP PHYSIOL, V97, P63, DOI 10.1016/0034-5687(94)90012-4; Nattie E, 2011, J APPL PHYSIOL, V110, P1, DOI 10.1152/japplphysiol.01061.2010; Ramanantsoa N, 2011, J NEUROSCI, V31, P12880, DOI 10.1523/JNEUROSCI.1721-11.2011; Sobrinho CR, 2016, J PHYSIOL-LONDON, V594, P407, DOI 10.1113/JP271761; Spyer KM, 2009, PHILOS T R SOC B, V364, P2603, DOI 10.1098/rstb.2009.0082; Stornetta RL, 2013, BRAIN STRUCT FUNCT, V218, P455, DOI 10.1007/s00429-012-0408-3; Thomas T, 2000, J PHYSIOL-LONDON, V523, P441, DOI 10.1111/j.1469-7793.2000.00441.x; Thomas T, 1999, J PHYSIOL-LONDON, V517, P899, DOI 10.1111/j.1469-7793.1999.00899.x; Turovsky E, 2016, J NEUROSCI, V36, P10750, DOI 10.1523/JNEUROSCI.1281-16.2016; Turovsky E, 2015, J PHYSIOL-LONDON, V593, P3159, DOI 10.1113/JP270369; Wenker IC, 2012, J PHYSIOL-LONDON, V590, P2137, DOI 10.1113/jphysiol.2012.229666; Wenker IC, 2010, J NEUROPHYSIOL, V104, P3042, DOI 10.1152/jn.00544.2010; WOOLF NJ, 1989, BRAIN RES BULL, V23, P519, DOI 10.1016/0361-9230(89)90197-4; WOOLF NJ, 1991, PROG NEUROBIOL, V37, P475, DOI 10.1016/0301-0082(91)90006-M; Zhang M, 2000, J PHYSIOL-LONDON, V525, P143, DOI 10.1111/j.1469-7793.2000.t01-1-00143.x	42	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167861	10.1371/journal.pone.0167861	http://dx.doi.org/10.1371/journal.pone.0167861			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936179	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100219
J	Kim, YB; Park, N; Zhang, Q; Kim, JG; Kang, SJ; Kim, CH				Kim, Young Bin; Park, Nuri; Zhang, Qimeng; Kim, Jun Gi; Kang, Shin Jin; Kim, Chang Hun			Predicting Virtual World User Population Fluctuations with Deep Learning	PLOS ONE			English	Article							GAME; NETWORKS; FORECASTS; PATTERNS; BEHAVIOR; LIFE	This paper proposes a system for predicting increases in virtual world user actions. The virtual world user population is a very important aspect of these worlds; however, methods for predicting fluctuations in these populations have not been well documented. Therefore, we attempt to predict changes in virtual world user populations with deep learning, using easily accessible online data, including formal datasets from Google Trends, Wikipedia, and online communities, as well as informal datasets collected from online forums. We use the proposed system to analyze the user population of EVE Online, one of the largest virtual worlds.	[Kim, Young Bin; Zhang, Qimeng] Korea Univ, Interdisciplinary Program Visual Informat Proc, Seoul, South Korea; [Park, Nuri; Kim, Chang Hun] Korea Univ, Dept Comp & Radio Commun Engn, Seoul, South Korea; [Kim, Jun Gi; Kang, Shin Jin] Hongik Univ, Sch Games, Seoul, South Korea	Korea University; Korea University; Hongik University	Kim, CH (corresponding author), Korea Univ, Dept Comp & Radio Commun Engn, Seoul, South Korea.	chkim@korea.ac.kr		Kim, YoungBin/0000-0002-2114-0120; Zhang, Qimeng/0000-0003-4679-7919	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science, ICT and future Planning [NRF-2014R1A2A2A01007143, NRF-2015R1A2A1A16074940, NRF-2015R1A1A1A05001196]; ICT R&D program of MSIP/IITP [R-20160404-003511]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, ICT and future Planning; ICT R&D program of MSIP/IITP(Institute for Information & Communication Technology Planning & Evaluation (IITP), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science, ICT and future Planning (NRF-2014R1A2A2A01007143, NRF-2015R1A2A1A16074940, and NRF-2015R1A1A1A05001196) and the ICT R&D program of MSIP/IITP (R-20160404-003511, High performance computing (HPC) based rendering solution development). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi M., 2016, TENSORFLOW LARGE SCA; Bainbridge WS, 2007, SCIENCE, V317, P472, DOI 10.1126/science.1146930; Benesty J, 2009, NOISE REDUCTION SPEE, P1; Bergstrom K, 2013, P DIGRA 2013 DEFRAGG; BRASS W, 1974, J R STAT SOC A STAT, V137, P532, DOI 10.2307/2344713; Chi GQ, 2011, POPUL SPACE PLACE, V17, P505, DOI 10.1002/psp.617; Chi GQ, 2009, DEMOGRAPHY, V46, P405, DOI 10.1353/dem.0.0059; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Ciresan D, 2012, NEURAL NETWORKS, V32, P333, DOI 10.1016/j.neunet.2012.02.023; Corominas-Murtra B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112606; Daniel P, 2007, 6 ACM SIGCOMM WORKSH; De Lucia A, 2009, COMPUT EDUC, V52, P220, DOI 10.1016/j.compedu.2008.08.001; Deng L, 2013, 2013 IEEE INTERNATIO; Fuchs B, 2014, ARXIV14033228; Fuchs B, 2014, PLOS ONE, V9; Goldberg Y., 2014, ARXIV14023722; Gursimsek RA, 2012, CONVERGENCE-US, V18, P112, DOI 10.1177/1354856511419923; Hau YS, 2011, COMPUT HUM BEHAV, V27, P956, DOI 10.1016/j.chb.2010.11.022; Hutto C., 2014, 8 INT C WEBL SOC MED, P1, DOI DOI 10.1093/A0BPLA/PLV053; Jarmon L, 2009, COMPUT EDUC, V53, P169, DOI 10.1016/j.compedu.2009.01.010; Jiang ZQ, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/48007; Kang MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079823; Kang SJ, 2013, MULTIMED TOOLS APPL, V66, P383, DOI 10.1007/s11042-012-1052-x; Kang SJ, 2010, VISUAL COMPUT, V26, P467, DOI 10.1007/s00371-010-0457-7; Kim MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159528; Kim YB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132944; Klimek P, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/6/063008; Kong JSL, 2012, INFORM MANAGE-AMSTER, V49, P1, DOI 10.1016/j.im.2011.10.004; Kristoufek L, 2013, SCI REP UK, V3; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Le Q., 2014, 31 INT C MACH LEARN, P1188; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Messinger PR, 2009, DECIS SUPPORT SYST, V47, P204, DOI 10.1016/j.dss.2009.02.014; Mestyan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071226; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; Moat HS, 2013, SCI REP UK, V3; Mryglod O, 2015, PHYSICA A, V419, P681, DOI 10.1016/j.physa.2014.09.056; O'Donnell C, 2012, TECHNOL CULT, V53, P196, DOI 10.1353/tech.2012.0007; Panzarasa P, 2009, J AM SOC INF SCI TEC, V60, P911, DOI 10.1002/asi.21015; Pena J, 2013, J COMMUN, V63, P703, DOI 10.1111/jcom.12043; Preis T, 2013, SCI REP UK, V3; Ratan RA, 2010, J COMPUT-MEDIAT COMM, V16, DOI 10.1111/j.1083-6101.2010.01534.x; Shang HL, 2016, INT J FORECASTING, V32, P629, DOI 10.1016/j.ijforecast.2015.10.002; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Sing CC, 2006, EDUC TECHNOL SOC, V9, P250; Szell M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01214; Szell M, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525912500646; Szell M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00457; Szell M, 2010, SOC NETWORKS, V32, P313, DOI 10.1016/j.socnet.2010.06.001; Szell M, 2010, P NATL ACAD SCI USA, V107, P13636, DOI 10.1073/pnas.1004008107; Tayman J, 2007, POPUL RES POLICY REV, V26, P347, DOI 10.1007/s11113-007-9034-9; Thurner S, 2012, PLOS ONE, V7; Waddell JC, 2014, COMPUT HUM BEHAV, V38, P331, DOI 10.1016/j.chb.2014.06.017; Ward EJ, 2014, OIKOS, V123, P652, DOI 10.1111/j.1600-0706.2014.00916.x; Wisniowski A, 2015, DEMOGRAPHY, V52, P1035, DOI 10.1007/s13524-015-0389-y; Xie W-J, 2015, ARXIV150303746; Xie WJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep18727; Xie WJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05244; Yu D., 2013, 2013 IEEE INT C AC S	59	3	3	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167153	10.1371/journal.pone.0167153	http://dx.doi.org/10.1371/journal.pone.0167153			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936009	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100067
J	Liao, M; Xiao, JJ; Zhou, LJ; Liu, Y; Wu, XW; Hua, RM; Wang, GR; Cao, HQ				Liao, Min; Xiao, Jin-Jing; Zhou, Li-Jun; Liu, Yang; Wu, Xiang-Wei; Hua, Ri-Mao; Wang, Gui-Rong; Cao, Hai-Qun			Insecticidal Activity of Melaleuca alternifolia Essential Oil and RNA-Seq Analysis of Sitophilus zeamais Transcriptome in Response to Oil Fumigation	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; PLANT ESSENTIAL OILS; CHEMICAL-COMPOSITION; FLOUR BEETLE; GENES; EXPRESSION; DETOXIFICATION; TOOL; ACETYLCHOLINESTERASE; SUSCEPTIBILITY	Background The cereal weevil, Sitophilus zeamais is one of the most destructive pests of stored cereals worldwide. Frequent use of fumigants for managing stored-product insects has led to the development of resistance in insects. Essential oils from aromatic plants including the tea oil plant, Melaleuca alternifolia may provide environmentally friendly alternatives to currently used pest control agents. However, little is known about molecular events involved in stored-product insects in response to plant essential oil fumigation. Results M. alternifolia essential oil was shown to possess the fumigant toxicity against S. zeamais. The constituent, terpinen-4-ol was the most effective compound for fumigant toxicity. M. alternifolia essential oil significantly inhibited the activity of three enzymes in S. zeamais, including two detoxifying enzymes, glutathione S-transferase (GST), and carboxylesterase (CarE), as well as a nerve conduction enzyme, acetylcholinesterase (AChE). Comparative transcriptome analysis of S. zeamais through RNA-Seq identified a total of 3,562 differentially expressed genes (DEGs), of which 2,836 and 726 were up-regulated and down-regulated in response to M. alternifolia essential oil fumigation, respectively. Based on gene ontology (GO) analysis, the majority of DEGs were involved in insecticide detoxification and mitochondrial function. Furthermore, an abundance of DEGs mapped into the metabolism pathway in the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database were associated with respiration and metabolism of xenobiotics, including cytochrome P450s, CarEs, GSTs, and ATP-binding cassette transporters (ABC transporters). Some DEGs mapped into the proteasome and phagosome pathway were found to be significantly enriched. These results led us to propose a model of insecticide action that M. alternifolia essential oil likely directly affects the hydrogen carrier to block the electron flow and interfere energy synthesis in mitochondrial respiratory chain. Conclusion This is the first study to perform a comparative transcriptome analysis of S. zeamais in response to M. alternifolia essential oil fumigation. Our results provide new insights into the insecticidal mechanism of M. alternifolia essential oil fumigation against S. zeamais and eventually contribute to the management of this important agricultural pest.	[Liao, Min; Xiao, Jin-Jing; Zhou, Li-Jun; Cao, Hai-Qun] Anhui Agr Univ, Sch Plant Protect, Hefei, Peoples R China; [Liu, Yang; Wang, Gui-Rong] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China; [Wu, Xiang-Wei; Hua, Ri-Mao; Cao, Hai-Qun] Prov Key Lab Agri Food Safety, Hefei, Peoples R China	Anhui Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Cao, HQ (corresponding author), Anhui Agr Univ, Sch Plant Protect, Hefei, Peoples R China.; Cao, HQ (corresponding author), Prov Key Lab Agri Food Safety, Hefei, Peoples R China.	haiquncao@163.com	Zhou, Li/GSE-4531-2022	Liu, Yang/0000-0002-3424-7111	National forestry public welfare profession scientific research special project of China [201404601]	National forestry public welfare profession scientific research special project of China	This work was supported by National forestry public welfare profession scientific research special project of China (NO. 201404601). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgaleil SAM, 2016, J PEST SCI, V89, P219, DOI 10.1007/s10340-015-0665-z; Abouseadaa HH, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0570-x; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Altincicek B, 2013, PLOS ONE, V8, P11; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders S, 2014, BIOINFORMATICS; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Athanassiou CG, 2015, J ECON ENTOMOL, V108, P1422, DOI 10.1093/jee/tov069; Azeez S, 2012, J MOL MODEL, V18, P151, DOI 10.1007/s00894-011-1035-2; Bajda S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2157-1; Balyan R, 2015, CHEM-BIOL INTERACT, V240, P208, DOI 10.1016/j.cbi.2015.08.011; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Benjamini Y, 2001, ANN STAT, V29, P1165; Chen Y., 2016, SCI REPORTS, V6; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coronado-Puchau M, 2013, NANO TODAY, V8, P461, DOI 10.1016/j.nantod.2013.08.008; Cunha V, 2016, ENVIRON SCI POLLUT R, V23, P10615, DOI 10.1007/s11356-016-6547-y; Dippel S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1141; Du ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep21827; Finley D, 2016, TRENDS BIOCHEM SCI, V41, P77, DOI 10.1016/j.tibs.2015.10.009; Fong DKH, 2016, PSYCHOMETRIKA, V81, P161, DOI 10.1007/s11336-014-9437-6; Francis F, 2005, ARCH INSECT BIOCHEM, V58, P166, DOI 10.1002/arch.20049; Gong YH, 2016, ECOTOXICOLOGY, V25, P655, DOI 10.1007/s10646-016-1624-z; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haddi K, 2015, J ECON ENTOMOL, V108, P362, DOI 10.1093/jee/tou049; Hao YB, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0150717, 10.1371/journal.pone.0163147]; Hoi KK, 2014, ANAL CHEM, V86, P3525, DOI 10.1021/ac404188g; Huang YZ, 2011, INSECT SCI, V18, P181, DOI 10.1111/j.1744-7917.2010.01358.x; Inouye S, 2001, J ANTIMICROB CHEMOTH, V47, P565, DOI 10.1093/jac/47.5.565; Isman MB, 2000, CROP PROT, V19, P603, DOI 10.1016/S0261-2194(00)00079-X; Jagadeesan R, 2015, PEST MANAG SCI, V71, P1379, DOI 10.1002/ps.3940; Janmohamed A, 2001, BIOCHEM PHARMACOL, V62, P777, DOI 10.1016/S0006-2952(01)00718-3; Kang JS, 2013, PESTIC BIOCHEM PHYS, V105, P184, DOI 10.1016/j.pestbp.2013.02.001; Kavitha K, 2013, BIOCHIMIE, V95, P1629, DOI 10.1016/j.biochi.2013.05.004; Korkina L, 2016, EXPERT OPIN DRUG MET, V12, P377, DOI 10.1517/17425255.2016.1149569; Li SG, 2013, J PEST SCI, V86, P677, DOI 10.1007/s10340-013-0520-z; Lins RF, 2016, COLLOID SURFACE A, V497, P271, DOI 10.1016/j.colsurfa.2016.02.024; Mansour SA, 2015, IND CROP PROD, V76, P900, DOI 10.1016/j.indcrop.2015.08.004; Herrera JM, 2015, IND CROP PROD, V70, P435, DOI 10.1016/j.indcrop.2015.03.074; Matthews HJ, 2010, ARCH INSECT BIOCHEM, V75, P139, DOI 10.1002/arch.20376; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Mostofa MG, 2015, PROTOPLASMA, V252, P461, DOI 10.1007/s00709-014-0691-3; Nascimento SS, 2015, INT J MOL SCI, V16, P547, DOI 10.3390/ijms16010547; Nouri-Ganbalani G, 2016, J ESSENT OIL BEAR PL, V19, P1234, DOI 10.1080/0972060X.2016.1178606; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pan HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129482; Pan L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155682; Papadopoulou D, 2008, INT J FOOD SCI TECH, V43, P1053, DOI 10.1111/j.1365-2621.2007.01562.x; Pegard A., 2015, Phytotherapie (Paris), V13, P384, DOI 10.1007/s10298-015-0966-7; Prophiro JS, 2012, PARASITOL RES, V110, P713, DOI 10.1007/s00436-011-2547-5; Rajashekar Y, 2014, J FOOD SCI TECH MYS, V51, P3494, DOI 10.1007/s13197-012-0884-8; Riazanski V, 2015, P NATL ACAD SCI USA, V112, pE6486, DOI 10.1073/pnas.1518966112; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schuler MA, 2012, MOL ECOL, V21, P4157, DOI 10.1111/j.1365-294X.2012.05657.x; Sfara V, 2009, J MED ENTOMOL, V46, P511, DOI 10.1603/033.046.0315; Shelton D, 2002, PLANT SCI, V162, P9, DOI 10.1016/S0168-9452(01)00504-0; SINGER TP, 1994, BBA-BIOENERGETICS, V1187, P198, DOI 10.1016/0005-2728(94)90110-4; Tak JH, 2016, J PEST SCI, V89, P183, DOI 10.1007/s10340-015-0655-1; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Thompson BM, 2016, FLA ENTOMOL, V99, P67, DOI 10.1653/024.099.0112; Thomsen NA, 2013, INT J ANTIMICROB AG, V41, P343, DOI 10.1016/j.ijantimicag.2012.12.011; Wang GB, 2015, J INVERTEBR PATHOL, V128, P37, DOI 10.1016/j.jip.2015.04.001; Zhang JQ, 2013, CHEMOSPHERE, V93, P1207, DOI 10.1016/j.chemosphere.2013.06.081; Zhang MX, 2013, PESTIC BIOCHEM PHYS, V107, P44, DOI 10.1016/j.pestbp.2013.05.002	67	56	61	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167748	10.1371/journal.pone.0167748	http://dx.doi.org/10.1371/journal.pone.0167748			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936192	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100174
J	Mecacci, F; Serena, C; Avagliano, L; Cozzolino, M; Baroni, E; Rambaldi, MP; Simeone, S; Castiglione, F; Taddei, GL; Bulfamante, G				Mecacci, Federico; Serena, Caterina; Avagliano, Laura; Cozzolino, Mauro; Baroni, Eleonora; Rambaldi, Marianna Pina; Simeone, Serena; Castiglione, Francesca; Taddei, Gian Luigi; Bulfamante, Gaetano			Stillbirths at Term: Case Control Study of Risk Factors, Growth Status and Placental Histology	PLOS ONE			English	Article							FETAL-GROWTH; REACTION PATTERNS; RESTRICTION; DEATH; REPRODUCIBILITY; IDENTIFICATION; NOSOLOGY; AGE	Objective To investigate the proportion of stillbirths at term associated with abnormal growth using customized birth weight percentiles and to compare histological placental findings both in underweight stillborn fetuses and in live births. Methods A retrospective case-control study of 150 singleton term stillbirths. The livebirth control groups included 586 cases of low-risk pregnancies and 153 late fetal growth restriction fetuses. Stillbirths and livebirths from low-risk pregnancies were classified using customized standards for fetal weight at birth, as adequate for gestational age (AGA; 10-90th percentile), small (SGA; <10th percentile) or large for gestational age (LGA; > 90th percentile). Placental characteristics in stillbirth were compared with those from livebirths using four categories: inflammation, disruptive, obstructive and adaptive lesions. Results There was a higher rate of SGA (26% vs 6%, p<0.001) and LGA fetuses (10.6% vs 5.6%, p<0.05) in the stillbirth group. Among stillbirth fetuses, almost half of the SGA were very low birthweight (<= 3 degrees percentile) (12% vs 0.3%, p<0.001). The disruptive (7.3% vs 0.17%; p<0.001), obstructive (54.6% vs 7.5%; p<0.001) and adaptive (46.6% vs 35.8%; p<0.001) findings were significantly more common in than in livebirth-low risk. Placental characteristics of AGA and SGA stillbirth were compared with those of AGA and FGR livebirth. In stillbirths-SGA we found a higher number of disruptive (12.8% vs 0%; p<0.001), obstructive (58.9% vs 23.5%; p<0.001) and adaptive lesions (56.4% vs 49%; p 0.47) than in livebirth-FGR. Conclusion The assessment of fetal weight with customized curves can identify fetuses which have not reached their genetically determined growth potential and are therefore at risk for adverse outcomes. Placental evaluation in stillbirths can reveal chronic histological signs that might be useful to clinical assessment, especially in underweight fetuses.	[Mecacci, Federico; Serena, Caterina; Baroni, Eleonora; Rambaldi, Marianna Pina; Simeone, Serena] Careggi Hosp, Dept Sci Hlth Women & Children, Florence, Italy; [Avagliano, Laura; Bulfamante, Gaetano] Univ Milan, Dept Hlth Sci, Sch Med, San Paolo Hosp, Milan, Italy; [Cozzolino, Mauro] Univ Florence, Div Obstet & Gynaecol, Dept Biomed Expt & Clin Sci, Florence, Italy; [Castiglione, Francesca; Taddei, Gian Luigi] Careggi Hosp, Dept Biomed, Florence, Italy	University of Florence; Azienda Ospedaliero Universitaria Careggi; San Paolo-Polo Universitaria Hospital; University of Milan; University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi	Serena, C (corresponding author), Careggi Hosp, Dept Sci Hlth Women & Children, Florence, Italy.	caterinaserena79@gmail.com	Avagliano, Laura/AAM-3412-2021	AVAGLIANO, LAURA/0000-0002-7808-7578				American College of Obstetricians and Gynecologists, 2009, OBSTET GYNECOL, V113; [Anonymous], ULTRASOUND GUIDELINE; Avagliano L, 2013, PLACENTA, V34, P1091, DOI 10.1016/j.placenta.2013.09.004; Avagliano L, 2015, EARLY HUM DEV, V91, P339, DOI 10.1016/j.earlhumdev.2015.03.004; Avagliano L, 2012, J MATERN-FETAL NEO M, V25, P2789, DOI 10.3109/14767058.2012.705395; Avagliano L, 2010, HUM PATHOL, V41, P971, DOI 10.1016/j.humpath.2009.07.026; Bukowski R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001633; Clausson B, 2001, BRIT J OBSTET GYNAEC, V108, P830, DOI 10.1111/j.1471-0528.2001.00205.x; DIVON MY, 1986, AM J OBSTET GYNECOL, V155, P1197, DOI 10.1016/0002-9378(86)90144-4; Figueras F, 2014, FETAL DIAGN THER, V36, P86, DOI 10.1159/000357592; Flenady V, 2009, PSANZ CLIN PRACT GUI; Fretts R, 2010, CLIN OBSTET GYNECOL, V53, P588, DOI 10.1097/GRF.0b013e3181eb63fc; Gardosi J, 2014, PUBLIC HEALTH, V128, P698, DOI 10.1016/j.puhe.2014.06.022; Gardosi J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f108; Kidron D, 2009, PLACENTA, V30, P700, DOI 10.1016/j.placenta.2009.05.009; Korteweg FJ, 2009, OBSTET GYNECOL, V114, P809, DOI 10.1097/AOG.0b013e3181b72ebe; Langston C, 1997, ARCH PATHOL LAB MED, V121, P449; Monari F, 2012, EARLY HUM DEV, V88, P251, DOI 10.1016/j.earlhumdev.2011.08.013; Ptacek I, 2014, PLACENTA, V35, P552, DOI 10.1016/j.placenta.2014.05.011; Redline RW, 2004, PEDIATR DEVEL PATHOL, V7, P443, DOI 10.1007/s10024-004-2020-x; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; Seravalli V, 2015, OBSTET GYN CLIN N AM, V42, P275, DOI 10.1016/j.ogc.2015.01.005; Serena C, 2013, J MATERN-FETAL NEO M, V26, P16, DOI 10.3109/14767058.2012.718389; Smith NA, 2014, ULTRASOUND OBST GYN, V44, P595, DOI 10.1002/uog.13333; SOGC clinical practice guideline, 2006, J OBSTET GYNAECOL CA, V28, P540; Stanek J, 2013, ARCH PATHOL LAB MED, V137, P706, DOI 10.5858/arpa.2011-0645-RA; Stanek J, 2012, PEDIATR DEVEL PATHOL, V15, P13, DOI 10.2350/11-03-1000-OA.1; Tellefsen CH, 2011, PEDIATR DEVEL PATHOL, V14, P99, DOI 10.2350/10-07-0870-OA.1; Waldenstrom U, 2015, OBSTET GYNECOL, V126, P355, DOI 10.1097/AOG.0000000000000947	29	17	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166514	10.1371/journal.pone.0166514	http://dx.doi.org/10.1371/journal.pone.0166514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936018	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100031
J	Moruzzi, S; Udali, S; Ruzzenente, A; Guglielmi, A; Guarini, P; Martinelli, N; Conci, S; Mazzi, F; Pattini, P; Tammen, SA; Olivieri, O; Pizzolo, F; Choi, SW; Friso, S				Moruzzi, Sara; Udali, Silvia; Ruzzenente, Andrea; Guglielmi, Alfredo; Guarini, Patrizia; Martinelli, Nicola; Conci, Simone; Mazzi, Filippo; Pattini, Patrizia; Tammen, Stephanie A.; Olivieri, Oliviero; Pizzolo, Francesca; Choi, Sang-Woon; Friso, Simonetta			The RFC1 80G>A, among Common One-Carbon Polymorphisms, Relates to Survival Rate According to DNA Global Methylation in Primary Liver Cancers	PLOS ONE			English	Article							REDUCED FOLATE CARRIER; ACUTE LYMPHOBLASTIC-LEUKEMIA; NEURAL-TUBE DEFECTS; COLORECTAL-CANCER; METHIONINE SYNTHASE; METABOLIZING GENES; TOTAL HOMOCYSTEINE; BREAST-CANCER; COLON-CANCER; METHYLENETETRAHYDROFOLATE REDUCTASE	Polymorphisms within one-carbon metabolism genes have been largely studied in relation to cancer risk for the function of this pathway in nucleotide synthesis and DNA methylation. Aims of this study were to explore the possible link among several common functional gene polymorphisms within one-carbon metabolism and survival rate in primary liver cancers, i.e., hepatocellular carcinoma and cholangiocarcinoma, and to assess the additional effect of global DNA methylation on survival rate and mortality risk. Forty-seven primary liver cancer patients were genotyped for ten polymorphisms: DHFR 19bp ins/del, TS 2rpt-3rpt, MTHFD1 1958G>A, MTHFR 677C>T, MTR 2756A>G, MTRR 66A>G, RFC1 80G>A, SHMT1 1420C>T, BHMT 716 A>G, TC II 776C>G. Methylation was determined in peripheral blood mononuclear cells (PBMCs) DNA as methylcytosine (mCyt) content using LC/MS/MS. Among the polymorphisms analysed, the RFC1 80G>A (rs1051266) influenced the survival rate in primary liver cancers. The RFC1 80AA was associated to a significantly reduced survival rate (22.2%) as compared to both GG and GA genotypes (61.5% and 76% respectively, p = 0.005). When the cancer patients were stratified according to the mCyt median value as high (>5.34%) or low (<= 5.34%), the concomitant presence of AA genotype and low mCyt level led to a significantly worse survival rate as compared to the G allele carriership (p<0.0001) with a higher Hazard Ratio (HR = 6.62, p = 0.001). The subjects carrying the AA genotype in association with high mCyt did not show a significant difference in survival rate as compared with the G allele carriers (p = 0.919). The RFC1 80G>A polymorphism influenced the survival rate, and the presence of RFC1 80AA genotype with low global methylation in PBMCs DNA was associated with poorer prognosis and higher mortality risk, therefore highlighting novel molecular signatures potentially helpful to define prognostic markers for primary liver cancers.	[Moruzzi, Sara; Udali, Silvia; Guarini, Patrizia; Martinelli, Nicola; Mazzi, Filippo; Pattini, Patrizia; Olivieri, Oliviero; Pizzolo, Francesca; Friso, Simonetta] Univ Verona, Dept Med, Sch Med, Verona, Italy; [Ruzzenente, Andrea; Guglielmi, Alfredo; Conci, Simone] Univ Verona, Sch Med, Dept Surg, Verona, Italy; [Tammen, Stephanie A.; Choi, Sang-Woon] Tufts Univ, Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Choi, Sang-Woon] CHA Univ, Chaum Life Ctr, Seoul, South Korea	University of Verona; University of Verona; Tufts University; Pochon Cha University	Friso, S (corresponding author), Univ Verona, Dept Med, Sch Med, Verona, Italy.	simonetta.friso@univr.it	Friso, Simonetta/K-4715-2016; Olivieri, Oliviero/A-9126-2008; conci, simone/AAB-6516-2022; Pizzolo, Francesca/AAF-6581-2020; Ruzzenente, Andrea/R-5850-2019	Olivieri, Oliviero/0000-0001-8209-9056; conci, simone/0000-0001-7110-1974; Pizzolo, Francesca/0000-0003-4419-3994; Ruzzenente, Andrea/0000-0001-6911-563X; Mazzi, Filippo/0000-0001-5623-2108				Leyva-Vazquez MA, 2012, J INVEST MED, V60, P1064, DOI 10.2310/JIM.0b013e31826803c1; ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; BRIGLE KE, 1995, J BIOL CHEM, V270, P22974, DOI 10.1074/jbc.270.39.22974; Chango A, 2000, MOL GENET METAB, V70, P310, DOI 10.1006/mgme.2000.3034; Chen J, 2004, INT J CANCER, V110, P617, DOI 10.1002/ijc.20148; Choi SW, 2002, J NUTR, V132, p2413S, DOI 10.1093/jn/132.8.2413S; de Jonge R, 2009, BLOOD, V113, P2284, DOI 10.1182/blood-2008-07-165928; Deroo LA, 2014, CARCINOGENESIS, V35, P333, DOI 10.1093/carcin/bgt342; Devlin AM, 2006, AM J CLIN NUTR, V83, P708, DOI 10.1093/ajcn.83.3.708; DeVos L, 2008, AM J CLIN NUTR, V88, P1149, DOI 10.1093/ajcn/88.4.1149; DIXON KH, 1994, J BIOL CHEM, V269, P17; Ehrlich M, 2006, CURR TOP MICROBIOL, V310, P251; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fabris S, 2011, EPIGENETICS-US, V6, P188, DOI 10.4161/epi.6.2.13528; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Friso S, 2002, ANAL CHEM, V74, P4526, DOI 10.1021/ac020050h; Friso S, 2013, CANCER EPIDEM BIOMAR, V22, P348, DOI 10.1158/1055-9965.EPI-12-0859; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Goel A, 2012, GASTROENTEROLOGY, V143, P1442, DOI 10.1053/j.gastro.2012.09.032; Gotze T, 2007, CANCER LETT, V251, P228, DOI 10.1016/j.canlet.2006.11.021; Han SS, 2012, CANCER EPIDEM BIOMAR, V21, P417, DOI 10.1158/1055-9965.EPI-11-0782; Hazra A, 2007, CARCINOGENESIS, V28, P1510, DOI 10.1093/carcin/bgm062; Heil SG, 2001, MOL GENET METAB, V73, P164, DOI 10.1006/mgme.2001.3175; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Hol FA, 1998, CLIN GENET, V53, P119; Jacques PF, 2003, ATHEROSCLEROSIS, V166, P49, DOI 10.1016/S0021-9150(02)00204-6; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jang MJ, 2014, GENE, V533, P558, DOI 10.1016/j.gene.2013.09.056; Johnson WG, 2004, AM J MED GENET A, V124A, P339, DOI 10.1002/ajmg.a.20505; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kim YI, 2003, J NUTR, V133, p3731S, DOI 10.1093/jn/133.11.3731S; Klerk M, 2003, THROMB RES, V110, P87, DOI 10.1016/S0049-3848(03)00341-4; Kotsopoulos J, 2008, BREAST CANCER RES TR, V112, P585, DOI 10.1007/s10549-008-9895-6; Laverdiere C, 2002, BLOOD, V100, P3832, DOI 10.1182/blood.V100.10.3832; Levine AJ, 2010, CANCER EPIDEM BIOMAR, V19, P1812, DOI 10.1158/1055-9965.EPI-10-0151; Ma DWL, 2005, CANCER RES, V65, P887; Matherly LH, 2007, CANCER METAST REV, V26, P111, DOI 10.1007/s10555-007-9046-2; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Galbiatti ALS, 2012, EUR J CANCER, V48, P1525, DOI 10.1016/j.ejca.2011.09.025; Galbiatti ALS, 2012, MOL BIOL REP, V39, P635, DOI 10.1007/s11033-011-0781-7; Stanislawska-Sachadyn A, 2009, ANN HUM GENET, V73, P484, DOI 10.1111/j.1469-1809.2009.00529.x; Tangkijvanich P, 2007, CLIN CHIM ACTA, V379, P127, DOI 10.1016/j.cca.2006.12.029; Udali S, 2015, HEPATOLOGY, V62, P496, DOI 10.1002/hep.27823; Ulrich CM, 2005, CANCER EPIDEM BIOMAR, V14, P2509, DOI 10.1158/1055-9965.EPI-05-0261; Ulrich CM, 2002, CANCER RES, V62, P3361; Wang LN, 2006, EUR J CANCER, V42, P3206, DOI 10.1016/j.ejca.2006.04.022; Winkelmayer WC, 2003, KIDNEY INT, V63, P2280, DOI 10.1046/j.1523-1755.2003.00025.x; Woo HD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034615; Xu XR, 2008, CANCER EPIDEM BIOMAR, V17, P2109, DOI 10.1158/1055-9965.EPI-07-2900; Yates Z, 2005, LIFE SCI, V77, P2735, DOI 10.1016/j.lfs.2005.02.029; Zhu ZZ, 2011, CANCER CAUSE CONTROL, V22, P437, DOI 10.1007/s10552-010-9715-2	54	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167534	10.1371/journal.pone.0167534	http://dx.doi.org/10.1371/journal.pone.0167534			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936032	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100116
J	Yoshinaga, T; Uwabe, K; Naito, S; Higashino, K; Nakano, T; Numata, Y; Kihara, A				Yoshinaga, Tomoyo; Uwabe, Kenichiro; Naito, Shoichi; Higashino, Kenichi; Nakano, Toru; Numata, Yoshito; Kihara, Akio			AM251 Suppresses Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CHRONIC KIDNEY-DISEASE; CANNABINOID RECEPTOR 1; GROWTH FACTOR-BETA; TGF-BETA; MOLECULAR-MECHANISMS; FIBROSIS; MYOFIBROBLASTS; SYSTEM; GPR55	Epithelial-mesenchymal transition (EMT) of renal tubular epithelial cells is one of the causative mechanisms of kidney fibrosis. In our study, we screened lipophilic compounds using a lipid library including approximately 200 lipids to identify those that suppressed EMT induced by a transforming growth factor (TGF)-beta 1 stimulus. Initial screening was performed with the immortalized HK-2 renal tubule epithelial cell line. The most promising compounds were further tested in RPTEC primary renal tubule epithelial cells. We found that the synthetic lipid AM251 suppressed two hallmark events associated with EMT, the upregulation of collagen 1A1 (COL1A1) and downregulation of E-cadherin. Though AM251 is known to act as an antagonist for the cannabinoid receptor type 1 (CB1) and an agonist for the G protein-coupled receptor 55 (GRP55), the suppression of EMT by AM251 was not mediated through either receptor. Microarray analyses revealed that AM251 inhibited induction of several EMT transcription factors such as SNAIL1, which is the key inducer of EMT, and the AP-1 transcription factors FOSB and JUNB. Activation of SMAD2/3 and p38 mitogen-activated protein kinase (MAPK) was inhibited by AM251, with greater inhibition of the latter, indicating that AM251 acted upstream of SMAD/p38 MAPK in the TGF-beta signaling pathway. Our findings regarding the effects of AM251 on the TGF-beta signaling pathway may inform development of a novel therapeutic agent suppressing EMT, thus preventing kidney fibrosis.	[Yoshinaga, Tomoyo; Kihara, Akio] Hokkaido Univ, Grad Sch Life Sci, Biochem Lab, Sapporo, Hokkaido, Japan; [Yoshinaga, Tomoyo; Naito, Shoichi; Higashino, Kenichi] Shionogi & Co Ltd, Biomarker R&D Dept, Toyonaka, Osaka, Japan; [Uwabe, Kenichiro] Shionogi & Co Ltd, Global Innovat Off, Div Pharmaceut Res, Toyonaka, Osaka, Japan; [Nakano, Toru] Shionogi & Co Ltd, Corp GxP Compliance Off, Toyonaka, Osaka, Japan; [Numata, Yoshito] Shionogi & Co Ltd, Drug Discovery Dis Lab, Sapporo, Hokkaido, Japan; [Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Biochem Lab, Sapporo, Hokkaido, Japan	Hokkaido University; Shionogi & Company Limited; Shionogi & Company Limited; Shionogi & Company Limited; Shionogi & Company Limited; Hokkaido University	Kihara, A (corresponding author), Hokkaido Univ, Grad Sch Life Sci, Biochem Lab, Sapporo, Hokkaido, Japan.; Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Biochem Lab, Sapporo, Hokkaido, Japan.	kihara@pharm.hokudai.ac.jp	KIHARA, AKIO/A-3802-2012	KIHARA, AKIO/0000-0001-5889-0788	Shionogi Co., Ltd.	Shionogi Co., Ltd.	Shionogi & Co., Ltd., funded the work presented in this manuscript but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	DERYNCK R, 1988, EMBO J, V7, P3737, DOI 10.1002/j.1460-2075.1988.tb03257.x; Gao JF, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0072-1; Gatley SJ, 1996, EUR J PHARMACOL, V307, P331, DOI 10.1016/0014-2999(96)00279-8; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; He JH, 2013, CLIN EXP NEPHROL, V17, P488, DOI 10.1007/s10157-013-0781-0; Hinz B, 2003, THROMB HAEMOSTASIS, V90, P993, DOI 10.1160/TH03-05-0328; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jenkin KA, 2015, J ENDOCRINOL, V225, P113, DOI 10.1530/JOE-15-0004; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kargl J, 2013, J PHARMACOL EXP THER, V346, P54, DOI 10.1124/jpet.113.204180; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lecru L, 2015, KIDNEY INT, V88, P72, DOI 10.1038/ki.2015.63; Lin CL, 2014, J MOL MED, V92, P779, DOI 10.1007/s00109-014-1125-6; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Lopez-Hernandez FJ, 2012, CELL TISSUE RES, V347, P141, DOI 10.1007/s00441-011-1275-6; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Lv ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022806; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Ovadya Y, 2015, NAT MED, V21, P975, DOI 10.1038/nm.3938; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Phanish MK, 2006, BIOCHEM J, V393, P601, DOI 10.1042/BJ20051106; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Rowe RG, 2011, MOL CELL BIOL, V31, P2392, DOI 10.1128/MCB.01218-10; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Sakai N, 2008, J HYPERTENS, V26, P780, DOI 10.1097/HJH.0b013e3282f3e9e6; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sebe A, 2008, NEPHROL DIAL TRANSPL, V23, P1537, DOI 10.1093/ndt/gfm789; Skaper SD, 2012, PHILOS T R SOC B, V367, P3193, DOI 10.1098/rstb.2012.0313; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5	35	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167848	10.1371/journal.pone.0167848	http://dx.doi.org/10.1371/journal.pone.0167848			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936102	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100215
J	Ferres, MA; Bianchi, DW; Siegel, AE; Bronson, RT; Huggins, GS; Guedj, F				Ferres, Millie A.; Bianchi, Diana W.; Siegel, Ashley E.; Bronson, Roderick T.; Huggins, Gordon S.; Guedj, Faycal			Perinatal Natural History of the Ts1Cje Mouse Model of Down Syndrome: Growth Restriction, Early Mortality, Heart Defects, and Delayed Development	PLOS ONE			English	Article							MIDTRIMESTER AMNIOCENTESIS; BEHAVIORAL ABNORMALITIES; CARDIAC ANOMALIES; SYNDROME FETUSES; SYNDROME MICE; MATERNAL AGE; SURVIVAL; PHENOTYPE; REGIONS; TRENDS	Background The Ts1Cje model of Down syndrome is of particular interest for perinatal studies because affected males are fertile. This permits affected pups to be carried in wild-type females, which is similar to human pregnancies. Here we describe the early natural history and growth profiles of Ts1Cje embryos and neonates and determine if heart defects are present in this strain. Methods Pups were studied either on embryonic (E) day 15.5, or from postnatal (P) day 3 through weaning on P21. PCR amplification targeting the neomycin cassette (present in Ts1Cje) and Sry (present in males) was used to analyze pup genotypes and sex ratios. Body weights and lengths, as well as developmental milestones, were recorded in Ts1Cje mice and compared to their wild-type (WT) littermates. Histological evaluations were performed at E15.5 to investigate the presence or absence of heart defects. Pups were divided into two groups: Ts1Cje-I pups survived past weaning and Ts1Cje-II pups died at some point before P21. Results Ts1Cje mouse embryos showed expected Mendelian ratios (45.8%, n = 66 for Ts1Cje embryos; 54.2%, n = 78 for WT embryos). Histological analysis revealed the presence of ventricular septal defects (VSDs) in 21% of Ts1Cje E15.5 embryos. After weaning, only 28.2% of pups were Ts1Cje (185 Ts1Cje out of 656 total pups generated), with males predominating (male: female ratio of 1.4:1). Among the recovered dead pups (n = 207), Ts1Cje (63.3%, n = 131, p<0.01) genotype was found significantly more often than WT (36.7%, n = 76). Retrospective analysis of Ts1Cje-II (pre-weaning deceased) pups showed that they were growth restricted compared to Ts1Cje-I pups (post-weaning survivors). Growth restriction correlated with statistically significant delays in achieving several neonatal milestones between P3 and P21 compared to Ts1Cje-I (post-weaning survivors) neonates and WT littermates. Conclusions Ts1Cje genotype is not associated with increased early in utero mortality. Cardiac defects, specifically VSDs, are part of the phenotype in this strain. There is increased neonatal mortality in Ts1Cje pups, with sex differences observed. Ts1Cje mice that died in the neonatal period were more likely to be growth restricted and delayed in achieving neonatal developmental milestones.	[Ferres, Millie A.; Bianchi, Diana W.; Siegel, Ashley E.; Guedj, Faycal] Tufts Med Ctr, MIRI, Boston, MA 02111 USA; [Ferres, Millie A.; Bianchi, Diana W.; Siegel, Ashley E.; Guedj, Faycal] Floating Hosp Children, Boston, MA 02116 USA; [Ferres, Millie A.] Beth Israel Deaconess Med Ctr, Div Maternal Fetal Med, Dept Obstet & Gynecol, Boston, MA 02215 USA; [Bronson, Roderick T.] Dana Farber Harvard Canc Ctr, Rodent Histopathol Core, Boston, MA USA; [Huggins, Gordon S.] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA USA	Tufts Medical Center; Floating Hospital For Children; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Tufts Medical Center	Ferres, MA; Guedj, F (corresponding author), Tufts Med Ctr, MIRI, Boston, MA 02111 USA.; Ferres, MA; Guedj, F (corresponding author), Floating Hosp Children, Boston, MA 02116 USA.; Ferres, MA (corresponding author), Beth Israel Deaconess Med Ctr, Div Maternal Fetal Med, Dept Obstet & Gynecol, Boston, MA 02215 USA.	mferres@bidmc.harvard.edu; faycal.guedj@tufts.edu			Verinata Health, Inc., an Illumina company [250-10396-12547000001]; Tufts Clinical and Translational Science Institute (CTSI, NIH) [UL1TR001064]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001064] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200399] Funding Source: NIH RePORTER	Verinata Health, Inc., an Illumina company; Tufts Clinical and Translational Science Institute (CTSI, NIH); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was sponsored by a research grant from Verinata Health, Inc., an Illumina company, Grant Number: 250-10396-12547000001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the Department of Laboratory Animal Medicine (DLAM) for providing helpful advice concerning breeding strategies; Tufts University Histology Core for their help in sectioning and staining the embryo hearts; and Dr. Lauren Richey (DLAM); and Tufts Clinical and Translational Science Institute (CTSI, NIH award UL1TR001064) for assistance with the statistical analysis. After submission of this paper for consideration of publication, another study was published demonstrating the presence of heart defects in the Ts1Cje mouse model of DS (Li et al, 2016, PMID 27029737) [35].	Bray IC, 1998, PRENATAL DIAG, V18, P1045, DOI 10.1002/(SICI)1097-0223(1998100)18:10<1045::AID-PD403>3.3.CO;2-I; Cocchi G, 2010, BIRTH DEFECTS RES A, V88, P474, DOI 10.1002/bdra.20666; DAVISSON MT, 1990, PROG CLIN BIOL RES, V360, P263; Delabar JM, 2006, THESCIENTIFICWORLDJO, V6, P1945, DOI 10.1100/tsw.2006.322; Duchon A, 2011, MAMM GENOME, V22, P674, DOI 10.1007/s00335-011-9356-0; Egan JFX, 2011, PRENATAL DIAG, V31, P389, DOI 10.1002/pd.2702; Glasson EJ, 2002, CLIN GENET, V62, P390, DOI 10.1034/j.1399-0004.2002.620506.x; Goodliffe JW, 2016, J NEUROSCI, V36, P2926, DOI 10.1523/JNEUROSCI.2513-15.2016; Guedj F, 2015, AM J MED GENET A, V167, P1993, DOI 10.1002/ajmg.a.37156; Guedj F, 2015, BRAIN PATHOL, V25, P11, DOI 10.1111/bpa.12151; Guedj F, 2012, NEUROBIOL DIS, V46, P190, DOI 10.1016/j.nbd.2012.01.007; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hill Joanna M., 2008, V39, P131, DOI 10.1007/978-1-60327-099-1_10; HOOK EB, 1989, AM J HUM GENET, V45, P855; HOOK EB, 1983, AM J HUM GENET, V35, P110; HOOK EB, 1978, NEW ENGL J MED, V299, P1036, DOI 10.1056/NEJM197811092991903; HOOK EB, 1978, LANCET, V1, P1053; Johnson KL, 2010, FERTIL STERIL, V93, P1718, DOI 10.1016/j.fertnstert.2009.08.042; Kucik JE, 2013, PEDIATRICS, V131, pE27, DOI 10.1542/peds.2012-1616; Lana-Elola E, 2016, ELIFE, V5, DOI 10.7554/eLife.11614; Leonard S, 2000, PAEDIATR PERINAT EP, V14, P163; Li HQ, 2016, GENETICS, V203, P763, DOI 10.1534/genetics.116.188045; Li ZY, 2007, HUM MOL GENET, V16, P1359, DOI 10.1093/hmg/ddm086; Liu CH, 2011, HUM GENET, V130, P623, DOI 10.1007/s00439-011-0980-2; Moore CS, 2006, MAMM GENOME, V17, P1005, DOI 10.1007/s00335-006-0032-8; Moore CS, 2010, MAMM GENOME, V21, P543, DOI 10.1007/s00335-010-9300-8; Mutton D, 1996, J MED GENET, V33, P387, DOI 10.1136/jmg.33.5.387; Raveau M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002724; Roper RJ, 2006, GENETICS, V172, P437, DOI 10.1534/genetics.105.050898; Sago H, 2000, PEDIATR RES, V48, P606, DOI 10.1203/00006450-200011000-00009; Sago H, 1998, P NATL ACAD SCI USA, V95, P6256, DOI 10.1073/pnas.95.11.6256; Savolainen SM, 2009, TOXICOL PATHOL, V37, P395, DOI 10.1177/0192623309335060; Wessels MW, 2003, AM J MED GENET A, V116A, P147, DOI 10.1002/ajmg.a.10823; Williams AD, 2008, DEV DYNAM, V237, P426, DOI 10.1002/dvdy.21416; Yu T, 2010, HUM MOL GENET, V19, P2780, DOI 10.1093/hmg/ddq179	35	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0168009	10.1371/journal.pone.0168009	http://dx.doi.org/10.1371/journal.pone.0168009			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930746	Green Published, Green Submitted, gold			2022-12-27	WOS:000389580900070
J	Kashiyama, N; Miyagawa, S; Fukushima, S; Kawamura, T; Kawamura, A; Yoshida, S; Harada, A; Watabe, T; Kanai, Y; Toda, K; Hatazawa, J; Sawa, Y				Kashiyama, Noriyuki; Miyagawa, Shigeru; Fukushima, Satsuki; Kawamura, Takuji; Kawamura, Ai; Yoshida, Shohei; Harada, Akima; Watabe, Tadashi; Kanai, Yasukazu; Toda, Koichi; Hatazawa, Jun; Sawa, Yoshiki			Development of PET Imaging to Visualize Activated Macrophages Accumulated in the Transplanted iPSc-Derived Cardiac Myocytes of Allogeneic Origin for Detecting the Immune Rejection of Allogeneic Cell Transplants in Mice	PLOS ONE			English	Article							ALLOGRAFT-REJECTION; SURVIVAL; LIGAND; SHEETS; BRAIN; HEART; MODEL; TSPO	Allogeneic transplantation (Tx) of induced pluripotent stem cells (iPSCs) is a promising tissue regeneration therapy. However, this inevitably induces macrophage-mediated immune response against the graft, limiting its therapeutic efficacy. Monitoring the magnitude of the immune response using imaging tools would be useful for prolonging graft survival and increasing the therapy longevity. Minimally invasive quantitative detection of activated macrophages by medical imaging technologies such as positron emission tomography (PET) imaging targets translocator protein (TSPO), which is highly expressed on mitochondrial membrane, especially in activated macrophage. N,N-diethyl-2-[4-(2-fluoroethoxy)phenyl]5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-acetamide (DPA-714) is known as a TSPO ligand used in clinical settings. We herein hypothesized that immune rejection of the transplanted iPSC-derived cardiomyocytes (iPSC-CMs) of allogeneic origin may be quantitated using F-18-DPA-714-PET imaging study. iPSC-CM cell-sheets of C57BL/6 mice origin were transplanted on the surface of the left ventricle (LV) of C57BL/6 mice as a syngeneic cell-transplant model (syngeneic Tx group), or Balb/c mice as an allogeneic model (allogeneic Tx group). F-18-DPA-714-PET was used to determine the uptake ratio, calculated as the maximum standardized uptake value in the anterior and septal wall of the LV. The uptake ratio was significantly higher in the allogeneic Tx group than in the syngeneic group or the sham group at days 7 and day 10 after the cell transplantation. In addition, the immunochemistry showed significant presence of CD68 and CD3-positive cells at day 7 and 10 in the transplanted graft of the allogeneic Tx group. The expression of TSPO, CD68, IL-1 beta, and MCP-1 was significantly higher in the allogeneic Tx group than in the syngeneic Tx and the sham groups at day 7. The F-18-DPA-714-PET imaging study enabled quantitative visualization of the macrophages-mediated immune rejection of the allogeneic iPSC-cardiac. This imaging tool may enable the understanding and monitoring host-immune response of the host, allogeneic cell transplantation therapy.	[Kashiyama, Noriyuki; Miyagawa, Shigeru; Fukushima, Satsuki; Kawamura, Takuji; Kawamura, Ai; Yoshida, Shohei; Harada, Akima; Toda, Koichi; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Osaka, Japan; [Watabe, Tadashi; Hatazawa, Jun] Osaka Univ, Grad Sch Med, Dept Nucl Med & Tracer Kinet, Osaka, Japan; [Watabe, Tadashi; Hatazawa, Jun] Osaka Univ, Grad Sch Med, PET Mol Imaging Ctr, Osaka, Japan; [Kanai, Yasukazu] Osaka Univ, Grad Sch Med, Dept Mol Imaging Med, Osaka, Japan; [Hatazawa, Jun] Osaka Univ, Immunol Frontier Res Ctr, Osaka, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Osaka University	Sawa, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Osaka, Japan.	sawa-p@surg1.med.osaka-u.ac.jp	Watabe, Tadashi/AHD-6866-2022; Fukushima, Satsuki/ABE-6582-2020	Watabe, Tadashi/0000-0001-8658-2395; Fukushima, Satsuki/0000-0002-9481-8860; Miyagawa, Shigeru/0000-0003-0015-6569				Arlicot N, 2012, NUCL MED BIOL, V39, P570, DOI 10.1016/j.nucmedbio.2011.10.012; Bao Q, 2009, J NUCL MED, V50, P401, DOI 10.2967/jnumed.108.056374; Ching ASC, 2012, INSIGHTS IMAGING, V3, P111, DOI 10.1007/s13244-011-0128-x; Cooper LT, 2007, CIRCULATION, V116, P2216, DOI 10.1161/CIRCULATIONAHA.107.186093; Daly KP, 2015, TRANSPLANTATION, V99, pE132, DOI 10.1097/TP.0000000000000618; Dhingra S, 2015, CELL TRANSPLANT, V24, P1013, DOI 10.3727/096368914X681036; Fairweather D, 2014, J CARDIOVASC TRANSL, V7, P192, DOI 10.1007/s12265-013-9538-0; Gabriel SA, 2013, INFLAMMATORY RESPONS, P203; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; James ML, 2008, J NUCL MED, V49, P814, DOI 10.2967/jnumed.107.046151; Kawamura A, 2016, SCI REP-UK, V6, DOI 10.1038/srep19464; Kawamura M, 2013, CIRCULATION, V128, pS87, DOI 10.1161/CIRCULATIONAHA.112.000366; Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343; Kawamura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111064; Morizane A, 2013, STEM CELL REP, V1, P283, DOI 10.1016/j.stemcr.2013.08.007; Nahrendorf M, 2008, CIRCULATION, V117, P379, DOI 10.1161/CIRCULATIONAHA.107.741181; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Sasaki H, 2015, TRANSPLANTATION, V99, P2301, DOI 10.1097/TP.0000000000000875; Spahn JH, 2014, CURR OPIN ORGAN TRAN, V19, P14, DOI 10.1097/MOT.0000000000000041; Ueno T, 2013, CIRC-CARDIOVASC IMAG, V6, P568, DOI 10.1161/CIRCIMAGING.113.000481; Vicidomini C, 2015, NUCL MED BIOL, V42, P309, DOI 10.1016/j.nucmedbio.2014.11.009; Wyburn KR, 2005, TRANSPLANTATION, V80, P1641, DOI 10.1097/01.tp.0000173903.26886.20; Ye Q, 2008, CIRCULATION, V118, P149, DOI 10.1161/CIRCULATIONAHA.107.746354; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	25	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0165748	10.1371/journal.pone.0165748	http://dx.doi.org/10.1371/journal.pone.0165748			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930666	Green Submitted, Green Published, gold			2022-12-27	WOS:000389580900006
J	Niediek, J; Bostrom, J; Elger, CE; Mormann, F				Niediek, Johannes; Bostroem, Jan; Elger, Christian E.; Mormann, Florian			Reliable Analysis of Single-Unit Recordings from the Human Brain under Noisy Conditions: Tracking Neurons over Hours	PLOS ONE			English	Article							SPIKE; QUALITY; LONG	Recording extracellulary from neurons in the brains of animals in vivo is among the most established experimental techniques in neuroscience, and has recently become feasible in humans. Many interesting scientific questions can be addressed only when extracellular recordings last several hours, and when individual neurons are tracked throughout the entire recording. Such questions regard, for example, neuronal mechanisms of learning and memory consolidation, and the generation of epileptic seizures. Several difficulties have so far limited the use of extracellular multi-hour recordings in neuroscience: Datasets become huge, and data are necessarily noisy in clinical recording environments. No methods for spike sorting of such recordings have been available. Spike sorting refers to the process of identifying the contributions of several neurons to the signal recorded in one electrode. To overcome these difficulties, we developed Combinato: a complete data-analysis framework for spike sorting in noisy recordings lasting twelve hours or more. Our framework includes software for artifact rejection, automatic spike sorting, manual optimization, and efficient visualization of results. Our completely automatic framework excels at two tasks: It outperforms existing methods when tested on simulated and real data, and it enables researchers to analyze multi-hour recordings. We evaluated our methods on both short and multi-hour simulated datasets. To evaluate the performance of our methods in an actual neuroscientific experiment, we used data from from neurosurgical patients, recorded in order to identify visually responsive neurons in the medial temporal lobe. These neurons responded to the semantic content, rather than to visual features, of a given stimulus. To test our methods with multi-hour recordings, we made use of neurons in the human medial temporal lobe that respond selectively to the same stimulus in the evening and next morning.	[Niediek, Johannes; Elger, Christian E.; Mormann, Florian] Univ Bonn, Dept Epileptol, Bonn, Germany; [Bostroem, Jan] Univ Bonn, Dept Neurosurg, Bonn, Germany	University of Bonn; University of Bonn	Niediek, J (corresponding author), Univ Bonn, Dept Epileptol, Bonn, Germany.	jonied@posteo.de	Mormann, Florian/K-1582-2014	Mormann, Florian/0000-0003-1305-8028; Niediek, Johannes/0000-0003-3323-2986	Volkswagen Foundation (Lichtenberg) [86 507]; German Research Council [DFG MO 930/4-1, SFB 1089]; Seventh Framework Program [602102 EPITARGET]	Volkswagen Foundation (Lichtenberg); German Research Council(German Research Foundation (DFG)); Seventh Framework Program(European Commission)	This work was supported by Volkswagen Foundation (Lichtenberg 86 507, https:/www.volkswagenstiftung.de): FM; German Research Council (DFG MO 930/4-1, SFB 1089, http://www.dfg.de): FM, JN; and Seventh Framework Program (602102 EPITARGET, https://ec.europa.eu/research/fp7/index_en.cfm): FM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berenyi A, 2014, J NEUROPHYSIOL, V111, P1132, DOI 10.1152/jn.00785.2013; Blatt M, 1996, PHYS REV LETT, V76, P3251, DOI 10.1103/PhysRevLett.76.3251; Bondar IV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008222; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Einevoll GT, 2012, CURR OPIN NEUROBIOL, V22, P11, DOI 10.1016/j.conb.2011.10.001; Friedman A, 2015, P NATL ACAD SCI USA, V112, P4477, DOI 10.1073/pnas.1503940112; Gast H, 2016, CLIN NEUROPHYSIOL, V127, P3329, DOI 10.1016/j.clinph.2016.08.010; Hagen E, 2015, J NEUROSCI METH, V245, P182, DOI 10.1016/j.jneumeth.2015.01.029; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hill DN, 2011, J NEUROSCI, V31, P8699, DOI 10.1523/JNEUROSCI.0971-11.2011; Kadir SN, 2014, NEURAL COMPUT, V26, P2379, DOI 10.1162/NECO_a_00661; Knieling S, 2016, INT J NEURAL SYST, V26, DOI 10.1142/S0129065715500422; Martinez J, 2009, J NEUROSCI METH, V184, P285, DOI 10.1016/j.jneumeth.2009.08.017; Misra A, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/026013; Mormann F, 2008, J NEUROSCI, V28, P8865, DOI 10.1523/JNEUROSCI.1640-08.2008; Mormann F, 2007, BRAIN, V130, P314, DOI 10.1093/brain/awl241; Mormann F, 2015, NAT NEUROSCI, V18, P1568, DOI 10.1038/nn.4139; Mormann F, 2011, NAT NEUROSCI, V14, P1247, DOI 10.1038/nn.2899; Pedreira C, 2012, J NEUROSCI METH, V211, P58, DOI 10.1016/j.jneumeth.2012.07.010; Quiroga RQ, 2009, CURR BIOL, V19, P1308, DOI 10.1016/j.cub.2009.06.060; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Rey HG, 2015, BRAIN RES BULL, V119, P106, DOI 10.1016/j.brainresbull.2015.04.007; Rossant C, 2016, NAT NEUROSCI, V19, P634, DOI 10.1038/nn.4268; Rutishauser U, 2006, J NEUROSCI METH, V154, P204, DOI 10.1016/j.jneumeth.2005.12.033; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Tolias AS, 2007, J NEUROPHYSIOL, V98, P3780, DOI 10.1152/jn.00260.2007	30	38	38	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0166598	10.1371/journal.pone.0166598	http://dx.doi.org/10.1371/journal.pone.0166598			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930664	Green Submitted, gold, Green Published			2022-12-27	WOS:000389580900012
J	Sauve, S; Aubin, Y				Sauve, Simon; Aubin, Yves			Dodecylphosphocholine Micelles Induce Amyloid Formation of the PrP(110-136) Peptide via an alpha-Helical Metastable Conformation	PLOS ONE			English	Article							THIOFLAVIN-T-BINDING; PRION PROTEIN; MULTIDIMENSIONAL NMR; SYNUCLEIN; SCRAPIE; VISUALIZATION; RESOLUTION; MECHANISM; FIBRILS; SYSTEM	A peptide encompassing the conserved hydrophobic region and the first beta-strand of the prion protein (PrP(110-136)) shown to interact with the surface of dodecylphosphocholine micelles adopts an alpha-helical conformation that is localized below the head-group layer. This surface-bound peptide has a half-life of one day, and readily initiates the formation of amyloid fibrils. The presence of the latter was confirmed using birefringence microscopy upon Congo red binding and thioflavin T-binding induced fluorescence. The observation of this metastable alpha-helical conformer provides a unique snapshot of the early steps of the interconversion pathway. These findings together with the body of evidence from the prion literature allowed us to propose a mechanism for the conversion of PrPC to amyloid material.	[Sauve, Simon; Aubin, Yves] Hlth Canada, Biol & Genet Therapies Directorate, Ctr Biol Evaluat, Ottawa, ON, Canada; [Aubin, Yves] Carleton Univ, Dept Chem, Ottawa, ON, Canada	Health Canada; Carleton University	Aubin, Y (corresponding author), Hlth Canada, Biol & Genet Therapies Directorate, Ctr Biol Evaluat, Ottawa, ON, Canada.; Aubin, Y (corresponding author), Carleton Univ, Dept Chem, Ottawa, ON, Canada.	yves.aubin@hc-sc.gc.ca		Aubin, Yves/0000-0002-8554-0297	Government of Canada	Government of Canada(CGIAR)	The Government of Canada.	Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Coleman BM, 2014, J VIROL, V88, P2690, DOI 10.1128/JVI.02720-13; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Du HN, 2003, BIOCHEMISTRY-US, V42, P8870, DOI 10.1021/bi034028+; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Holscher C, 1998, J VIROL, V72, P1153; Hornemann S, 2009, J BIOL CHEM, V284, P22713, DOI 10.1074/jbc.M109.000430; Hyberts SG, 2012, TOP CURR CHEM, V316, P125, DOI 10.1007/128_2011_187; Jaravine V, 2006, NAT METHODS, V3, P605, DOI 10.1038/NMETH900; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Lawson VA, 2001, J BIOL CHEM, V276, P35265, DOI 10.1074/jbc.M103799200; Luhrs TT, 2006, J MOL BIOL, V357, P833, DOI 10.1016/j.jmb.2006.01.016; Norstrom EM, 2005, J BIOL CHEM, V280, P27236, DOI 10.1074/jbc.M413441200; Orekhov VY, 2003, J BIOMOL NMR, V27, P165, DOI 10.1023/A:1024944720653; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Sauve S, 2012, J BIOL CHEM, V287, P1915, DOI 10.1074/jbc.M111.279364; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Supattapone S, 2014, J BIOL CHEM, V289, P19850, DOI 10.1074/jbc.R113.511329; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; VASSAR PS, 1959, ARCH PATHOL, V68, P487; Vilches S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070881	30	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0168021	10.1371/journal.pone.0168021	http://dx.doi.org/10.1371/journal.pone.0168021			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930722	Green Published, gold			2022-12-27	WOS:000389580900071
J	Garcia-Morales, R; Moreno, CE; Badano, EI; Zuria, I; Galindo-Gonzalez, J; Rojas-Martinez, AE; Avila-Gomez, ES				Garcia-Morales, Rodrigo; Moreno, Claudia E.; Badano, Ernesto I.; Zuria, Iriana; Galindo-Gonzalez, Jorge; Rojas-Martinez, Alberto E.; Avila-Gomez, Eva S.			Deforestation Impacts on Bat Functional Diversity in Tropical Landscapes	PLOS ONE			English	Article							SPECIES RICHNESS; COMMUNITY-LEVEL; FOREST; RESPONSES; BIODIVERSITY; ASSEMBLAGES; CONFIGURATION; FRAMEWORK; PATTERNS; FAUNA	Functional diversity is the variability in the functional roles carried out by species within ecosystems. Changes in the environment can affect this component of biodiversity and can, in turn, affect different processes, including some ecosystem services. This study aimed to determine the effect of forest loss on species richness, abundance and functional diversity of Neotropical bats. To this end, we identified six landscapes with increasing loss of forest cover in the Huasteca region of the state of Hidalgo, Mexico. We captured bats in each landscape using mist nets, and calculated functional diversity indices (functional richness and functional evenness) along with species richness and abundance. We analyzed these measures in terms of percent forest cover. We captured 906 bats (Phyllostomidae and Mormoopidae), including 10 genera and 12 species. Species richness, abundance and functional richness per night are positively related with forest cover. Generalized linear models show that species richness, abundance and functional richness per night are significantly related with forest cover, while seasonality had an effect on abundance and functional richness. Neither forest cover nor season had a significant effect on functional evenness. All these findings were consistent across three spatial scales (1, 3 and 5 km radius around sampling sites). The decrease in species, abundance and functional richness of bats with forest loss may have implications for the ecological processes they carry out such as seed dispersal, pollination and insect predation, among others.	[Garcia-Morales, Rodrigo; Moreno, Claudia E.; Zuria, Iriana; Rojas-Martinez, Alberto E.; Avila-Gomez, Eva S.] Univ Autonoma Estado Hidalgo, Inst Ciencias Basicas & Ingn, Ctr Invest Biol, Mineral De La Reforma, Hidalgo, Mexico; [Badano, Ernesto I.] Inst Potosino Invest Cient & Tecnol AC, Div Ciencias Ambientales, San Luis Potosi, San Luis Potosi, Mexico; [Galindo-Gonzalez, Jorge] Univ Veracruzana, Inst Biotecnol & Ecol Aplicada INBIOTECA, Xalapa, Veracruz, Mexico; [Garcia-Morales, Rodrigo] Ctr Cambio Global & Sustentabilidad Sureste AC, Villahermosa, Tabasco, Mexico	Universidad Autonoma del Estado de Hidalgo; Instituto Potosino Investigacion Cientifica y Tecnologica; Universidad Veracruzana	Moreno, CE (corresponding author), Univ Autonoma Estado Hidalgo, Inst Ciencias Basicas & Ingn, Ctr Invest Biol, Mineral De La Reforma, Hidalgo, Mexico.	cmoreno@uaeh.edu.mx	García-Morales, Rodrigo/AAB-3594-2022; Zuria, Iriana/A-8490-2018; Moreno, Claudia/GRJ-1036-2022; Galindo-González, Jorge/M-2585-2014; Badano, Ernesto I./C-3585-2013; Moreno, Claudia E./B-2733-2013	García-Morales, Rodrigo/0000-0001-7417-8192; Zuria, Iriana/0000-0002-0004-3540; Galindo-González, Jorge/0000-0003-2583-2754; Badano, Ernesto I./0000-0002-9591-0984; Moreno, Claudia E./0000-0002-9584-2619	CONACYT [270780]; FOMIX CONACYT [191908]; SEP-CONACYT Basic Science project [222632]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); FOMIX CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); SEP-CONACYT Basic Science project	RGM is grateful to CONACYT for the doctoral studies scholarship (270780). This study was funded by FOMIX CONACYT, project No. 191908 "Diversidad Biologica del Estado de Hidalgo (tercera etapa)", and SEP-CONACYT Basic Science project No. 222632, "Evaluacion de la diversidad de especies mediante el analisis e integracion de elementos ecologicos, funcionales y evolutivos", awarded to CEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Aguirre LF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158170; AHLEN I, 1983, OIKOS, V41, P352, DOI 10.2307/3544093; Alanis FGJ, 2004, BIODIVERSIDAD SIERRA, P503; Arita HT, 1997, TRENDS ECOL EVOL, V12, P53, DOI 10.1016/S0169-5347(96)10058-6; Arroyo-Rodriguez V, 2016, BIOL CONSERV, V198, P84, DOI 10.1016/j.biocon.2016.03.026; AUGUST PV, 1983, ECOLOGY, V64, P1495, DOI 10.2307/1937504; Avila-Gomez ES, 2015, TROP CONSERV SCI, V8, P646, DOI 10.1177/194008291500800305; Brigham RM, 1997, CAN J ZOOL, V75, P131, DOI 10.1139/z97-017; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Casanoves F, 2011, METHODS ECOL EVOL, V2, P233, DOI 10.1111/j.2041-210X.2010.00082.x; Castro-Luna AA, 2007, ANIM CONSERV, V10, P219, DOI 10.1111/j.1469-1795.2007.00097.x; Challenger A, 2009, CAPITAL NATURAL MEXI, V2; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Chillo V, 2012, J ARID ENVIRON, V87, P95, DOI 10.1016/j.jaridenv.2012.06.016; Cisneros LM, 2015, DIVERS DISTRIB, V21, P523, DOI 10.1111/ddi.12277; Colwell RK, 2013, ESTIMATES STAT ESTIM; Comision Nacional de Areas Naturales Protegidas-Deutsche Gesellschaft fur Internationale Zusammenarbeit (CONANP-GIZ), 2013, PROGR AD CAMB CLIM R; Avila-Cabadilla LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035228; de la Pena-Cuellar E, 2012, BIODIVERS CONSERV, V21, P1381, DOI 10.1007/s10531-012-0249-7; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Estrada A, 2002, BIOL CONSERV, V103, P237, DOI 10.1016/S0006-3207(01)00135-5; Farias AA, 2009, OIKOS, V118, P591, DOI 10.1111/j.1600-0706.2009.16859.x; Fenton MB, 2001, J TROP ECOL, V17, P511, DOI 10.1017/S0266467401001389; Galindo-González Jorge, 2004, Acta Zool. Mex, V20, P239; Galindo-Gonzalez J, 2009, J TROP ECOL, V25, P205, DOI 10.1017/S0266467409005859; Garcia-Morales R, 2014, COMMUNITY ECOL, V15, P158, DOI [10.1556/COMEC.15.2014.2.4, 10.1556/ComEc.15.2014.2.4]; Garcia-Morales R, 2013, CONSERV BIOL, V27, P1096, DOI 10.1111/cobi.12099; Garcia-Morales R, 2012, ACTA CHIROPTEROL, V14, P357, DOI 10.3161/150811012X661675; Gorresen PM, 2005, ECOL APPL, V15, P2126, DOI 10.1890/04-0532; Gorresen PM, 2004, J MAMMAL, V85, P688, DOI 10.1644/BWG-125; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jimenez-Ortega A, 2008, REV I U TECNOLOGICA, V27, P100, DOI [10.18636/ribd, DOI 10.18636/RIBD]; Kalko EKV, 2001, PLANT ECOL, V153, P319, DOI 10.1023/A:1017590007861; Klingbeil BT, 2010, OIKOS, V119, P1654, DOI 10.1111/j.1600-0706.2010.18328.x; Klingbeil BT, 2009, J APPL ECOL, V46, P203, DOI 10.1111/j.1365-2664.2008.01594.x; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; Mace GM, 2003, SCIENCE, V300, P1707, DOI 10.1126/science.1085510; Mayfield MM, 2010, GLOBAL ECOL BIOGEOGR, V19, P423, DOI 10.1111/j.1466-8238.2010.00532.x; Medellin R, 2008, IDENTIFICACION MURCI; Moreno CE, 2000, J APPL ECOL, V37, P149, DOI 10.1046/j.1365-2664.2000.00483.x; Moreno CE, 2006, OECOLOGIA, V149, P133, DOI 10.1007/s00442-006-0417-0; Norberg Ulla M., 1994, P205; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Patriquin KJ, 2003, J APPL ECOL, V40, P646, DOI 10.1046/j.1365-2664.2003.00831.x; Patterson BD, 2003, BAT ECOLOGY, P536; Pech-Canche JM, 2011, REV MEX BIODIVERS, V82, P896; Petchey OL, 2002, P ROY SOC B-BIOL SCI, V269, P1721, DOI 10.1098/rspb.2002.2073; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Pineda E, 2005, CONSERV BIOL, V19, P400, DOI 10.1111/j.1523-1739.2005.00531.x; PUIC H., 1991, VEGETACION HUASTECA; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Ramirez-Pulido J., 2014, LIST RECENT LAND MAM; Ricotta C, 2005, BASIC APPL ECOL, V6, P479, DOI 10.1016/j.baae.2005.02.008; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Saldana-Vazquez RA, 2010, BIODIVERS CONSERV, V19, P2111, DOI 10.1007/s10531-010-9829-6; Schleuter D, 2010, ECOL MONOGR, V80, P469, DOI 10.1890/08-2225.1; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Soriano Pascual J., 2006, Ecotropicos, V19, P1; Soriano Pascual J., 2000, Ecotropicos (Caracas), V13, P1; SPP (Secretaria de Programacion y Presupuesto), 1992, SINT GEOGR EST HID; Stevens RD, 2003, ECOL LETT, V6, P1099, DOI 10.1046/j.1461-0248.2003.00541.x; Strauss Axel, 2010, BMC Ecology, V10, P12, DOI 10.1186/1472-6785-10-12; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Vandewalle M, 2010, BIODIVERS CONSERV, V19, P2921, DOI 10.1007/s10531-010-9798-9; Villavicencio Nicto MA, 2010, CIENCIA U, V1, P23; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Vleut I, 2015, BIOTROPICA, V47, P606, DOI 10.1111/btp.12238; Weiher Evan, 2011, P175; Williams-Guillen K, 2010, BIOTROPICA, V42, P605, DOI 10.1111/j.1744-7429.2010.00626.x	72	34	40	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2016	11	12							e0166765	10.1371/journal.pone.0166765	http://dx.doi.org/10.1371/journal.pone.0166765			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4NG	27926923	gold, Green Published, Green Submitted			2022-12-27	WOS:000389578800005
J	Takagi, A; Beckers, N; Burdet, E				Takagi, Atsushi; Beckers, Niek; Burdet, Etienne			Motion Plan Changes Predictably in Dyadic Reaching	PLOS ONE			English	Article								Parents can effortlessly assist their child to walk, but the mechanism behind such physical coordination is still unknown. Studies have suggested that physical coordination is achieved by interacting humans who update their movement or motion plan in response to the partner's behaviour. Here, we tested rigidly coupled pairs in a joint reaching task to observe such changes in the partners' motion plans. However, the joint reaching movements were surprisingly consistent across different trials. A computational model that we developed demonstrated that the two partners had a distinct motion plan, which did not change with time. These results suggest that rigidly coupled pairs accomplish joint reaching movements by relying on a pre-programmed motion plan that is independent of the partner's behaviour.	[Takagi, Atsushi; Burdet, Etienne] Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Beckers, Niek] Univ Twente, Dept Biomech Engn, Enschede, Netherlands	Imperial College London; University of Twente	Burdet, E (corresponding author), Imperial Coll Sci Technol & Med, Dept Bioengn, London, England.	e.burdet@imperial.ac.uk		Takagi, Atsushi/0000-0003-4733-7471; Beckers, Niek/0000-0001-7077-9812; Burdet, Etienne/0000-0002-2123-0185	European Union's Seventh Framework Programme grant CONTEST [ITN-317488]; European Union's Horizon 2020 grant COGI MON [ICT-23-2014]; European Union's Seventh Framework Programme grant BALANCE [ICT-601003]; European Union's Seventh Framework Programme grant SYMBITRON [ICT-661626]; European Union's Seventh Framework Programme grant COST [TD1006]	European Union's Seventh Framework Programme grant CONTEST; European Union's Horizon 2020 grant COGI MON; European Union's Seventh Framework Programme grant BALANCE; European Union's Seventh Framework Programme grant SYMBITRON; European Union's Seventh Framework Programme grant COST	This research was supported by the European Union's Seventh Framework Programme grants CONTEST (ITN-317488, http://cordis.europa.eu/project/rcn/104707_en.html), BALANCE (ICT-601003, http://cordis.europa.eu/project/rcn/106654_en.html), SYMBITRON (ICT-661626, http://cordis.europa.eu/project/rcn/110314_en.html) and COST (TD1006, http://www.cost.eu/COST_Actions/brnbs/TD1006) and the European Union's Horizon 2020 grant COGI MON (ICT-23-2014, http://cordis.europa.eu/project/rcn/194239_en.html), all awarded to EB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Feth D, 2009, WORLD HAPTICS 2009: THIRD JOINT EUROHAPTICS CONFERENCE AND SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P338, DOI 10.1109/WHC.2009.4810854; Franklin DW, 2008, J NEUROSCI, V28, P11165, DOI 10.1523/JNEUROSCI.3099-08.2008; Ganesh G, 2014, SCI REP-UK, V4, DOI 10.1038/srep03824; Gentry S., 2005, 2005 IEEE/RSJ International Conference on Intelligent Robots and Systems, P3402; Groten Raphaela, 2009, RO-MAN 2009 - The 18th IEEE International Symposium on Robot and Human Interactive Communication, P723, DOI 10.1109/ROMAN.2009.5326315; Jarrasse N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049945; McKay JL, 2013, J NEUROPHYSIOL, V109, P591, DOI 10.1152/jn.00447.2012; Melendez-Calderon A, 2015, PHYSIOL BEHAV, V147, P348, DOI 10.1016/j.physbeh.2015.04.046; Melendez-Calderon A., 2011, 2011 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2011), P2578, DOI 10.1109/IROS.2011.6048068; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Reed KB, 2008, IEEE T HAPTICS, V1, P108, DOI [10.1109/TOH.2008.13, 10.1109/ToH.2008.13]; Sawers A, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-142; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Stefanov N, 2009, WORLD HAPTICS 2009: THIRD JOINT EUROHAPTICS CONFERENCE AND SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P51, DOI 10.1109/WHC.2009.4810846; Stengel RF, 2012, Optimal control and estimation; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; van der Wel RPRD, 2011, J EXP PSYCHOL HUMAN, V37, P1420, DOI 10.1037/a0022337; Winter D., 2009, BIOMECHANICS MOTOR C, V4th	18	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167314	10.1371/journal.pone.0167314	http://dx.doi.org/10.1371/journal.pone.0167314			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3TF	27911938	Green Published, Green Submitted, gold			2022-12-27	WOS:000389520600028
J	Dentovskaya, SV; Platonov, ME; Svetoch, TE; Kopylov, PK; Kombarova, TI; Ivanov, SA; Shaikhutdinova, RZ; Kolombet, LV; Chauhan, S; Ablamunits, VG; Motin, VL; Uversky, VN; Anisimov, AP				Dentovskaya, Svetlana V.; Platonov, Mikhail E.; Svetoch, Tat'yana E.; Kopylov, Pavel Kh.; Kombarova, Tat'yana I.; Ivanov, Sergey A.; Shaikhutdinova, Rima Z.; Kolombet, Lyubov' V.; Chauhan, Sadhana; Ablamunits, Vitaly G.; Motin, Vladimir L.; Uversky, Vladimir N.; Anisimov, Andrey P.			Two Isoforms of Yersinia pestis Plasminogen Activator Pla: Intraspecies Distribution, Intrinsic Disorder Propensity, and Contribution to Virulence	PLOS ONE			English	Article							MOLECULAR RECOGNITION FEATURES; FLEA-BORNE TRANSMISSION; MEMBRANE-PROTEIN OMPA; UNSTRUCTURED PROTEINS; ESCHERICHIA-COLI; SURFACE PROTEASE; PESTOIDES-F; WEB SERVER; SEQUENCE; BINDING	It has been shown previously that several endemic Y. pestis isolates with limited virulence contained the I259 isoform of the outer membrane protease Pla, while the epidemic highly virulent strains possessed only the T259 Pla isoform. Our sequence analysis of the pla gene from 118 Y. pestis subsp. microtus strains revealed that the I259 isoform was present exclusively in the endemic strains providing a convictive evidence of more ancestral origin of this isoform. Analysis of the effects of the I259T polymorphism on the intrinsic disorder propensity of Pla revealed that the I259T mutation slightly increases the intrinsic disorder propensity of the C-terminal tail of Pla and makes this protein slightly more prone for disorder-based protein-protein interactions, suggesting that the T259 Pla could be functionally more active than the I259 Pla. This assumption was proven experimentally by assessing the coagulase and fibrinolytic activities of the two Pla isoforms in human plasma, as well as in a direct fluorometric assay with the Pla peptide substrate. The virulence testing of Pla-negative or expressing the I259 and T259 Pla isoforms Y. pestis subsp. microtus and subsp. pestis strains did not reveal any significant difference in LD50 values and dose-dependent survival assays between them by using a subcutaneous route of challenge of mice and guinea pigs or intradermal challenge of mice. However, a significant decrease in time-todeath was observed in animals infected with the epidemic T259 Pla-producing strains as compared to the parent Pla-negative variants. Survival curves of the endemic I259 Pla(+) strains fit between them, but significant difference in mean time to death post infection between the Pla(-) strains and their I259 Pla(+) variants could be seen only in the isogenic set of subsp. pestis strains. These findings suggest an essential role for the outer membrane protease Pla evolution in Y. pestis bubonic infection exacerbation that is necessary for intensification of epidemic process from endemic natural focality with sporadic cases in men to rapidly expanding epizootics followed by human epidemic outbreaks, local epidemics or even pandemics.	[Dentovskaya, Svetlana V.; Platonov, Mikhail E.; Svetoch, Tat'yana E.; Kopylov, Pavel Kh.; Kombarova, Tat'yana I.; Ivanov, Sergey A.; Shaikhutdinova, Rima Z.; Kolombet, Lyubov' V.; Anisimov, Andrey P.] State Res Ctr Appl Microbiol & Biotechnol, Obolensk, Moscow Region, Russia; [Chauhan, Sadhana; Motin, Vladimir L.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Chauhan, Sadhana; Motin, Vladimir L.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Ablamunits, Vitaly G.] St Petersburg Med Pediat Univ, St Petersburg, Russia; [Uversky, Vladimir N.] Univ S Florida, Dept Mol Med, Tampa, FL USA; [Uversky, Vladimir N.] Univ S Florida, Morsani Coll Med, Byrd Alzheimers Res Inst, Tampa, FL USA; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino, Moscow Region, Russia	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Russian Academy of Sciences	Anisimov, AP (corresponding author), State Res Ctr Appl Microbiol & Biotechnol, Obolensk, Moscow Region, Russia.	a-p-anisimov@yandex.ru	Dentovskaya, Svetlana/F-4623-2017; Shaykhutinova, Rima/ABG-3321-2021; Anisimov, Andrey P./H-5257-2012; Svetoch, Tatyana/ABG-3315-2021; Michael, Platonov/GZG-8615-2022; Platonov, Mikhail E/S-1209-2016; Motin, Vladimir L/O-1535-2013; Ivanov, Sergey/GSD-3061-2022; Uversky, Vladimir N./F-4515-2011	Dentovskaya, Svetlana/0000-0002-1996-8949; Shaykhutinova, Rima/0000-0002-6985-6822; Anisimov, Andrey P./0000-0002-5499-7999; Uversky, Vladimir N./0000-0002-4037-5857; Platonov, Mihail/0000-0003-3946-1755; Govorunov, Igor/0000-0002-6366-1223; Motin, Vladimir/0000-0002-4762-457X	Russian Science Foundation [14-15-00599]	Russian Science Foundation(Russian Science Foundation (RSF))	This research and PKK, MEP, TIK, SAI, RZS, LVK, SVD, and APA were supported by the Russian Science Foundation (Ru) (grant 14-15-00599; http://www.rscf.ru/en/).; We thank Dr. Stephan Willias (UTMB) for his contribution for statistical analysis of the Pla activity by the fluorometric assay. The work was supported by the Russian Science Foundation (grant no. 14-15-00599).	Agarkov A, 2008, BIOORG MED CHEM LETT, V18, P427, DOI 10.1016/j.bmcl.2007.09.104; Anisimov A. P., 2002, Molekulyarnaya Genetika Mikrobiologiya i Virusologiya, P3; Anisimov AP, 2009, J MED MICROBIOL, V58, P26, DOI 10.1099/jmm.0.005678-0; Anisimov AP, 2004, CLIN MICROBIOL REV, V17, P434, DOI 10.1128/CMR.17.2.434-464.2004; Bahmanyar M, 1976, PLAGUE MANUAL; BEESLEY ED, 1967, J BACTERIOL, V94, P19, DOI 10.1128/JB.94.1.19-26.1967; BRUBAKER RR, 1965, SCIENCE, V149, P422, DOI 10.1126/science.149.3682.422; BRUBAKER RR, 1991, CLIN MICROBIOL REV, V4, P309, DOI 10.1128/CMR.4.3.309-324.1991; Campen A, 2008, PROTEIN PEPTIDE LETT, V15, P956, DOI 10.2174/092986608785849164; Caulfield AJ, 2014, CELL HOST MICROBE, V15, P424, DOI 10.1016/j.chom.2014.03.005; Cui YJ, 2013, P NATL ACAD SCI USA, V110, P577, DOI 10.1073/pnas.1205750110; Daughdrill GW, 2005, HDB PROTEIN FOLDING, P271; DOMARADSKII I V, 1987, Molekulyarnaya Genetika Mikrobiologiya i Virusologiya, P3; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; DROZDOV IG, 1995, J MED MICROBIOL, V42, P264, DOI 10.1099/00222615-42-4-264; Dunker AK, 2008, NAT CHEM BIOL, V4, P229, DOI 10.1038/nchembio0408-229; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Eddy JL, 2016, J THROMB HAEMOST, V14, P1833, DOI 10.1111/jth.13408; Eddy JL, 2015, INFECT IMMUN, V83, P4837, DOI 10.1128/IAI.01086-15; Eren E, 2010, STRUCTURE, V18, P809, DOI 10.1016/j.str.2010.03.013; Fan X, 2014, J BIOMOL STRUCT DYN, V32, P448, DOI 10.1080/07391102.2013.775969; FINNEY D. J., 1978, STAT METHOD BIOL ASS; Garcia E, 2007, ADV EXP MED BIOL, V603, P17; Gonzalez RJ, 2015, INFECT IMMUN, V83, P2855, DOI 10.1128/IAI.00140-15; Guinet F, 2003, ADV EXP MED BIOL, V529, P73; Guinet F, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005222; Guinet F, 2012, ADV EXP MED BIOL, V954, P211, DOI 10.1007/978-1-4614-3561-7_26; Haiko J, 2010, J BACTERIOL, V192, P4553, DOI 10.1128/JB.00458-10; Haiko J, 2009, J BACTERIOL, V191, P4758, DOI 10.1128/JB.00489-09; Haiko J, 2009, INNATE IMMUN-LONDON, V15, P67, DOI 10.1177/1753425909102559; Hinnebusch BJ, 2005, CURR ISSUES MOL BIOL, V7, P197, DOI 10.21775/cimb.007.197; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Kiefer D, 2012, VECTOR-BORNE ZOONOT, V12, P183, DOI 10.1089/vbz.2011.0748; Koebnik R, 1999, J MOL BIOL, V285, P1801, DOI 10.1006/jmbi.1998.2405; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Koebnik R, 1999, J BACTERIOL, V181, P3688, DOI 10.1128/JB.181.12.3688-3694.1999; Korenberg EI, 2010, BIOL BULL+, V37, P665, DOI 10.1134/S1062359010070010; Korhonen TK, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00035; Kukkonen M, 2001, MOL MICROBIOL, V40, P1097, DOI 10.1046/j.1365-2958.2001.02451.x; Kutyrev V, 1999, INFECT IMMUN, V67, P1359, DOI 10.1128/IAI.67.3.1359-1367.1999; Lahteenmaki K, 1998, INFECT IMMUN, V66, P5755; Lahteenmaki K, 2001, FEBS LETT, V504, P69, DOI 10.1016/S0014-5793(01)02775-2; Lane MC, 2013, J MED MICROBIOL, V62, P1124, DOI 10.1099/jmm.0.056275-0; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Lawrenz MB, 2013, MOL MICROBIOL, V89, P276, DOI 10.1111/mmi.12273; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Oyston PCF, 2005, ANTON LEEUW INT J G, V87, P171, DOI 10.1007/s10482-004-4619-3; Pejaver V, 2014, PROTEIN SCI, V23, P1077, DOI 10.1002/pro.2494; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Peng Kang, 2005, Journal of Bioinformatics and Computational Biology, V3, P35, DOI 10.1142/S0219720005000886; Peng ZL, 2012, CURR PROTEIN PEPT SC, V13, P6, DOI 10.2174/138920312799277938; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Platonov M E, 2013, Mol Gen Mikrobiol Virusol, P3; Prentice MB, 2007, LANCET, V369, P1196, DOI 10.1016/S0140-6736(07)60566-2; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Rasmussen S, 2015, CELL, V163, P571, DOI 10.1016/j.cell.2015.10.009; Riehm JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030624; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Samoilova SV, 1996, J MED MICROBIOL, V45, P440, DOI 10.1099/00222615-45-6-440; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P5526, DOI 10.1073/pnas.0509544103; SODEINDE OA, 1988, INFECT IMMUN, V56, P2749, DOI 10.1128/IAI.56.10.2749-2752.1988; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; SODEINDE OA, 1989, INFECT IMMUN, V57, P1517, DOI 10.1128/IAI.57.5.1517-1523.1989; SODEINDE OA, 1988, INFECT IMMUN, V56, P2743, DOI 10.1128/IAI.56.10.2743-2748.1988; Song YJ, 2004, DNA RES, V11, P179, DOI 10.1093/dnares/11.3.179; Sun YC, 2014, CELL HOST MICROBE, V15, P578, DOI 10.1016/j.chom.2014.04.003; Tiner BL, 2015, INFECT IMMUN, V83, P1318, DOI 10.1128/IAI.02778-14; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uversky VN, 2013, CURR PHARM DESIGN, V19, P4191, DOI 10.2174/1381612811319230005; Uversky VN, 2013, BBA-PROTEINS PROTEOM, V1834, P932, DOI 10.1016/j.bbapap.2012.12.008; Uversky VN, 2012, J MOL BIOL, V418, P267, DOI 10.1016/j.jmb.2012.02.034; Uversky VN, 2011, CHEM SOC REV, V40, P1623, DOI 10.1039/c0cs00057d; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Valls SM, 2010, J THROMB HAEMOST, V8, P2232; van Lier CJ, 2015, MICROB PATHOGENESIS, V80, P27, DOI 10.1016/j.micpath.2015.02.005; Welkos SL, 1997, MICROB PATHOGENESIS, V23, P211, DOI 10.1006/mpat.1997.0154; Worsham PL, 2003, ADV EXP MED BIOL, V529, P129; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xie HB, 2007, J PROTEOME RES, V6, P1917, DOI 10.1021/pr060394e; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yun TH, 2009, BLOOD, V113, P1139, DOI 10.1182/blood-2008-05-157180; Zhang SS, 2008, J BIOL CHEM, V283, P31511, DOI 10.1074/jbc.M804646200; Zhou DS, 2006, MICROBES INFECT, V8, P273, DOI 10.1016/j.micinf.2005.06.006; Zimbler DL, 2016, INFECT IMMUN, V84, P365, DOI 10.1128/IAI.01168-15; Zimbler DL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8487	99	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168089	10.1371/journal.pone.0168089	http://dx.doi.org/10.1371/journal.pone.0168089			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936190	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100272
J	Dueker, ND; Beecham, A; Wang, LY; Blanton, SH; Guo, SR; Rundek, T; Sacco, RL				Dueker, Nicole D.; Beecham, Ashley; Wang, Liyong; Blanton, Susan H.; Guo, Shengru; Rundek, Tatjana; Sacco, Ralph L.			Rare Variants in NOD1 Associated with Carotid Bifurcation Intima-Media Thickness in Dominican Republic Families	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ARTERY INTIMA; SUBCLINICAL ATHEROSCLEROSIS; LINKAGE ANALYSIS; ISCHEMIC-STROKE; RISK; HERITABILITY; HEART; GENES	Cardiovascular disorders including ischemic stroke (IS) and myocardial infarction (MI) are heritable; however, few replicated loci have been identified. One strategy to identify loci influencing these complex disorders is to study subclinical phenotypes, such as carotid bifurcation intima-media thickness (bIMT). We have previously shown bIMT to be heritable and found evidence for linkage and association with common variants on chromosome 7p for bIMT. In this study, we aimed to characterize contributions of rare variants (RVs) in 7p to bIMT. To achieve this aim, we sequenced the 1 LOD unit down region on 7p in nine extended families from the Dominican Republic (DR) with strong evidence for linkage to bIMT. We then performed the family-based sequence kernel association test (famSKAT) on genes within the 7p region. Analyses were restricted to single nucleotide variants (SNVs) with population based minor allele frequency (MAF) <5%. We first analyzed all exonic RVs and then the subset of only non-synonymous RVs. There were 68 genes in our analyses. Nucleotide-binding oligomerization domain (NOD1) was the most significantly associated gene when analyzing exonic RVs (famSKAT p = 9.2x10(-4); number of SNVs = 14). We achieved suggestive replication of NOD1 in an independent sample of twelve extended families from the DR (p = 0.055). Our study provides suggestive statistical evidence for a role of rare variants in NOD1 in bIMT. Studies in mice have shown Nod1 to play a role in heart function and atherosclerosis, providing biologic plausibility for a role in bIMT thus making NOD1 an excellent bIMT candidate.	[Dueker, Nicole D.; Beecham, Ashley; Wang, Liyong; Blanton, Susan H.; Guo, Shengru] Univ Miami, John P Hussman Inst Human Genom, Miami, FL USA; [Wang, Liyong; Blanton, Susan H.; Sacco, Ralph L.] Univ Miami, Dr John T Macdonald Fdn, Dept Human Genet, Miami, FL USA; [Rundek, Tatjana; Sacco, Ralph L.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Rundek, Tatjana; Sacco, Ralph L.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami	Sacco, RL (corresponding author), Univ Miami, Dr John T Macdonald Fdn, Dept Human Genet, Miami, FL USA.; Sacco, RL (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.; Sacco, RL (corresponding author), Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.	rsacco@med.miami.edu	Sacco, Ralph/Y-9278-2019; Blanton, Susan Halloran/ABF-1323-2021		National Institutes of Health [R01NS040807, R37NS29992, R01NS047655]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040807] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grants from the National Institutes of Health R01NS040807, R37NS29992, and R01NS047655. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bis JC, 2014, CIRC-CARDIOVASC GENE, V7, P359, DOI 10.1161/CIRCGENETICS.113.000116; Bis JC, 2011, NAT GENET, V43, P940, DOI 10.1038/ng.920; Bowden DW, 2010, HUM MOL GENET, V19, P4112, DOI 10.1093/hmg/ddq327; Cao XT, 2016, NAT REV IMMUNOL, V16, P35, DOI 10.1038/nri.2015.8; Chambless LE, 2000, AM J EPIDEMIOL, V151, P478; Chen H, 2013, GENET EPIDEMIOL, V37, P196, DOI 10.1002/gepi.21703; Cvjetkovic N, 2015, MOL GENET GENOM MED, V3, P440, DOI 10.1002/mgg3.155; Duan S., 2012, ABSTRACT APPL ANAL, V2012, P1, DOI DOI 10.1109/SPC0M.2012.6290252; Elkind MSV, 2006, STROKE, V37, P13, DOI 10.1161/01.STR.0000195048.86810.5b; Eyre S, 2011, ARTHRITIS RHEUM-US, V63, P1522, DOI 10.1002/art.30315; Fenstad MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012993; Fernandez-Velasco M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045260; Fox CS, 2004, AM J HUM GENET, V74, P253, DOI 10.1086/381559; Fox CS, 2003, STROKE, V34, P397, DOI 10.1161/01.STR.0000048214.56981.6F; Gertow K, 2012, CIRC-CARDIOVASC GENE, V5, P656, DOI 10.1161/CIRCGENETICS.112.963660; Grady BJ, 2010, BIOCOMPUT-PAC SYM, P315; Iwakiri T, 2012, ATHEROSCLEROSIS, V225, P359, DOI 10.1016/j.atherosclerosis.2012.10.033; Kanno S, 2015, J IMMUNOL, V194, P773, DOI 10.4049/jimmunol.1302841; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lange LA, 2002, STROKE, V33, P1876, DOI 10.1161/01.STR.0000019909.71547.AA; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liao YC, 2008, STROKE, V39, P3159, DOI 10.1161/STROKEAHA.108.522789; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Lu MF, 2005, NAT IMMUNOL, V6, P989, DOI 10.1038/ni1246; Melton PE, 2013, CIRC-CARDIOVASC GENE, V6, P211, DOI 10.1161/CIRCGENETICS.113.000079; Moreira LO, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00328; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nishio H, 2011, ARTERIOSCL THROM VAS, V31, P1093, DOI 10.1161/ATVBAHA.110.216325; O'Donnell CJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S4; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Philpott DJ, 2014, NAT REV IMMUNOL, V14, P9, DOI 10.1038/nri3565; Procino G, 2011, AM J HYPERTENS, V24, P822, DOI 10.1038/ajh.2011.47; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rundek T, 2002, STROKE, V33, P1420, DOI 10.1161/01.STR.0000015558.63492.B6; Saad M, 2014, GENET EPIDEMIOL, V38, P1, DOI 10.1002/gepi.21776; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Sacco RL, 2007, ETHNIC DIS, V17, P351; Sacco RL, 2009, STROKE, V40, P2307, DOI 10.1161/STROKEAHA.109.554121; Sacco RL, 2004, STROKE, V35, P2263, DOI 10.1161/01.STR.0000142374.33919.92; Shanahan CM, 1999, J VASC RES, V36, P353, DOI 10.1159/000025674; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Tiszlavicz Z, 2009, EUR J NEUROL, V16, P1224, DOI 10.1111/j.1468-1331.2009.02698.x; Touboul PJ, 2005, STROKE, V36, P1741, DOI 10.1161/01.STR.0000174490.23495.57; Wang D, 2005, STROKE, V36, P540, DOI 10.1161/01.STR.0000155746.65185.4e; Wang LY, 2015, HUM GENET, V134, P1127, DOI 10.1007/s00439-015-1592-z; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wijsman EM, 2012, HUM GENET, V131, P1555, DOI 10.1007/s00439-012-1190-2; Xiang AH, 2002, ARTERIOSCL THROM VAS, V22, P843, DOI 10.1161/01.ATV.0000015329.15481.E8; Zeller T, 2012, CLIN CHEM, V58, P92, DOI 10.1373/clinchem.2011.170431	49	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167202	10.1371/journal.pone.0167202	http://dx.doi.org/10.1371/journal.pone.0167202			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936005	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100072
J	Franca, SL; Lima, SS; Vieira, JRS				Franca, Sergio Lobato; Lima, Sandra Souza; Dos Santos Vieira, Jose Ricardo			Metabolic Syndrome and Associated Factors in Adults of the Amazon Region	PLOS ONE			English	Article							RISK-FACTORS; OBESITY; PREVALENCE; POPULATION; HEALTH; MEN	Metabolic syndrome (MS) plays a key role in the origin of cardiovascular diseases. Studies on the MS in Brazil are recent, and its epidemiology in more isolated regions such as the Amazon is still unknown. The study aimed to estimate the prevalence of MS and associated factors in adults of the Brazilian Amazon. This study was conducted in 2012-2013. It is a cross-sectional population-based study, involving 787 adults randomly selected from the urban area of four cities in the state of Para A, in the Brazilian Eastern Amazon. The participants underwent anthropometric measurements, laboratory examination, and were questioned about their lifestyle. MS was defined by the Joint Interim Statement criteria, using the multiple logistic regression to investigate the potential association of risk factors with the presence of MS. The overall prevalence of MS was 34.1% (95% CI = 30.8-37.4), increasing linearly with the increasing body mass index and age. From 40-49 years of age, MS was observed in about half of the women (46.0%), while men only experienced a high prevalence in the fifth decade of life (43.3%). The low HDL-c (64.4%) and abdominal obesity (58.9%) were higher in women (p < 0.001), while for men, high blood pressure was significantly higher (p < 0.001). Individuals aged 40-59 years old (odds ratio [OR] = 3.35 [95% CI = 2.30-4.90]), >= 60 years old (OR = 5.80 [3.63-9.27]), overweight (OR = 4.17 [2.77-6.29]), and obese (OR = 8.82 [5.56-13.98]) were more likely to have MS. The study population experienced high cardiometabolic risk, requiring government efforts to control MS and related risk factors, especially obesity.	[Franca, Sergio Lobato; Lima, Sandra Souza; Dos Santos Vieira, Jose Ricardo] Fed Univ Para, Inst Biol Sci, Belem, Para, Brazil	Universidade Federal do Para	Vieira, JRS (corresponding author), Fed Univ Para, Inst Biol Sci, Belem, Para, Brazil.	jrvieira@ufpa.br			Amazon Foundation for Support of Studies and Research of Para (FAPESPA) [014/2012]	Amazon Foundation for Support of Studies and Research of Para (FAPESPA)(Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA))	This work is part of a multicenter study entitled "Epidemiological Markers in the Health of the Marajo Archipelago", which was funded by the Amazon Foundation for Support of Studies and Research of Para (FAPESPA) (Project No 014/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar M, 2015, JAMA-J AM MED ASSOC, V313, P1973, DOI 10.1001/jama.2015.4260; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; de Oliveira BFA, 2013, CAD SAUDE PUBLICA, V29, P1617, DOI [10.1590/S0102-311X2013001200014, 10.1590/0102-311X00146212]; Martins MSAS, 2010, ARQ BRAS CARDIOL, V94, P639, DOI 10.1590/S0066-782X2010005000028; [Anonymous], 2011, REV BRAS CARDIOL; [Anonymous], CENS DEM 2010 INF MU; Ayres M, 2011, BIOESTAT 5 3 APLICAC; Bettelheim A., 2013, INTRO GEN ORGANIC BI; Bezerra APM, 2013, DEMETRA, V8, P63; Brasil, 2015, VIGITEL BRAS VIG FAT; Carr MC, 2003, J CLIN ENDOCR METAB, V88, P2404, DOI 10.1210/jc.2003-030242; Conceicao L, 2010, 5 C PESQ IN RED NORT; de Oliveira A, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-141; Dean A, 1996, EPI INFO VERSION 6 W; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Dutra ES, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-20; Escobar FA, 2009, CADERNOS UNIFOA, V11, P69; Escobedo J, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-52; Franca F. C. O, 2012, AN SEM AL CULT BAH 2; Freiberg MS, 2004, DIABETES CARE, V27, P2954, DOI 10.2337/diacare.27.12.2954; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gomes R, 2007, CAD SAUDE PUBLICA, V23, P565, DOI 10.1590/S0102-311X2007000300015; Governo do estado do Para, 2012, IND QUAL AMB MUN REG; Haab RS., 2012, REV BRAS MED FAM COM, V7, P90, DOI [10.5712/rbmfc7(23)237, DOI 10.5712/RBMFC7(23)237]; Hausenloy DJ, 2008, HEART, V94, P706, DOI 10.1136/hrt.2007.125401; Huxley RR, 2011, CIRCULATION, V124, P2056, DOI 10.1161/CIRCULATIONAHA.111.028373; Instituto Brasileiro de Geografia e Estatistica, CENS DEM 2010 CAR PO; Instituto Brasileiro de Geografia e Estatistica (BR), 2013, PROJ LEV CLASS USO T; Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48; Lopez-Jaramillo P, 2014, ARQ BRAS ENDOCRINOL, V58, P205, DOI 10.1590/0004-2730000003019; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luscher TF, 2014, CIRC RES, V114, P171, DOI 10.1161/CIRCRESAHA.114.300935; Mady C, 2008, ARQ BRAS CARDIOL, V91, P46; Mancini MC, 2010, TRATADO DE OBESIDADE, P253; Mariath AB, 2007, CAD SAUDE PUBLICA, V23, P897, DOI 10.1590/S0102-311X2007000400017; Marquez-Sandoval F, 2011, PUBLIC HEALTH NUTR, V14, P1702, DOI 10.1017/S1368980010003320; Milici NA, 2010, P ROM ACAD, V1, P13; Moreira GC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105056; Muñoz Contreras Angélica M, 2013, Colomb. Med., V44, P57; Oliveira AG, 2015, J AMAZON HLTH SCI, V1, P1, DOI DOI 10.1016/JJTRANGE0.2015.01.001; Ouchi N, 2012, NAGOYA J MED SCI, V74, P19; Papakonstantinou E, 2013, CURR VASC PHARMACOL, V11, P858, DOI 10.2174/15701611113116660176; Peralta N, 2008, CAMPOS, V9, P109; Rodrigo CP, 2013, NUTR HOSP, V28, P21, DOI 10.3305/nh.2013.28.sup5.6915; Ponce-Garcia Isabel, 2015, PLoS One, V10, pe0127369, DOI 10.1371/journal.pone.0127369; Portinho J.A., 2012, INT J NUTROLOGY, V5, P15, DOI [10.1055/s-0040-1701423, DOI 10.1055/S-0040-1701423]; Programa das Nacoes Unidas para o Desenvolvimento (BR), ATL BRAS 2013 RANK R; Rocha E, 2012, REV PORT CARDIOL, V31, P637, DOI 10.1016/j.repc.2012.07.001; Salas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105581; Silva DAS, 2013, EUR J NUTR, V52, P237, DOI 10.1007/s00394-012-0314-8; Schelbert KB, 2009, PRIMARY CARE, V36, P271, DOI 10.1016/j.pop.2009.01.009; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Silva AR, 2013, MATURITAS, V76, P64, DOI DOI 10.1016/J.MATURITAS.2013.05.015; Silva RJ, 2012, SEGUR ALIMENT NUTR, V19, P1; [Anonymous], 2010, Arq. Bras. Cardiol., V95, pI, DOI 10.1590/S0066-782X2010001700001; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Spalding A, 2009, J CLIN HYPERTENS, V11, P755, DOI 10.1111/j.1751-7176.2009.00191.x; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Universidade Federal do Para, 2012, REL AN TERR MAR; Vidigal FD, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1198; World Health Organization,, 1998, WHO TECHN REP SER; Zhao YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091578; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	64	12	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167320	10.1371/journal.pone.0167320	http://dx.doi.org/10.1371/journal.pone.0167320			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936021	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100084
J	Lu, ZM; Pan, Q; Wang, LH; Wen, XM				Lu, Zhaoming; Pan, Qi; Wang, Luhan; Wen, Xiangming			Overload Control for Signaling Congestion of Machine Type Communications in 3GPP Networks	PLOS ONE			English	Article								Because of the limited resources on radio access channels of third generation partnership projection (3GPP) network, one of the most challenging tasks posted by 3GPP cellular-based machine type communications (MTC) is congestion due to massive requests for connection to radio access network (RAN). In this paper, an overload control algorithm in 3GPP RAN is proposed, which proactively disperses the simultaneous access attempts in evenly distributed time window. Through periodic reservation strategy, massive access requests of MTC devices are dispersed in time, which reduces the probability of confliction of signaling. By the compensation and prediction mechanism, each device can communicate with MTC server with dynamic load of air interface. Numerical results prove that proposed method makes MTC applications friendly to 3GPP cellular network.	[Lu, Zhaoming; Pan, Qi; Wang, Luhan; Wen, Xiangming] Beijing Key Lab Network Syst Architecture & Conve, Beijing, Peoples R China; [Lu, Zhaoming; Pan, Qi; Wang, Luhan; Wen, Xiangming] Beijing Lab Adv Informat Network, Beijing, Peoples R China; [Lu, Zhaoming; Wang, Luhan; Wen, Xiangming] Beijing Adv Innovat Ctr Future Internet Technol, Beijing, Peoples R China; [Lu, Zhaoming; Wang, Luhan; Wen, Xiangming] Beijing Univ Posts & Telecommun, Sch Informat & Commun Engn, Beijing, Peoples R China	Beijing University of Posts & Telecommunications	Lu, ZM (corresponding author), Beijing Key Lab Network Syst Architecture & Conve, Beijing, Peoples R China.; Lu, ZM (corresponding author), Beijing Lab Adv Informat Network, Beijing, Peoples R China.; Lu, ZM (corresponding author), Beijing Adv Innovat Ctr Future Internet Technol, Beijing, Peoples R China.; Lu, ZM (corresponding author), Beijing Univ Posts & Telecommun, Sch Informat & Commun Engn, Beijing, Peoples R China.	lzy_0372@163.com	Pan, Qi/K-3532-2019	Pan, Qi/0000-0003-3354-0559	 [D151100000115002]		This work was supported by Grant number: D151100000115002, URL: http://www.bjkw.gov.cn/n8785584/index.html; Author who received the funding: Xiangming Wen.	[Anonymous], 2011, 37868 3GPP TR; [Anonymous], 2014, 43868 3GPP TR; [Anonymous], 2012, 23888 3GPP TR; Cheng MY, 2012, IEEE COMMUN MAG, V50, P38, DOI 10.1109/MCOM.2012.6211484; Gotsis AG, 2013, T EMERG TELECOMMUN T, V24, P378, DOI 10.1002/ett.2629; Hasan M, 2013, IEEE COMMUN MAG, V51, P86, DOI 10.1109/MCOM.2013.6525600; Ho C, IEEE WIRELESS COMMUN, V1, P209; Ksentini A, 2012, IEEE NETWORK, V26, P54, DOI 10.1109/MNET.2012.6375894; Larmo A, 2012, IEEE GLOBE WORK, P1626, DOI 10.1109/GLOCOMW.2012.6477829; Lee KD, 2011, IEEE GLOBE WORK, P373, DOI 10.1109/GLOCOMW.2011.6162474; Lien SY, 2012, IEEE T WIREL COMMUN, V11, P27, DOI 10.1109/TWC.2011.111611.110350; Lien SY, 2011, IEEE COMMUN MAG, V49, P66, DOI 10.1109/MCOM.2011.5741148; Service Requirements for Machine- Type Communications (MTC), 2011, 22368 3GPP TS	13	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167380	10.1371/journal.pone.0167380	http://dx.doi.org/10.1371/journal.pone.0167380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936011	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100089
J	Nakhaeizadeh, H; Amin, E; Nakhaei-Rad, S; Dvorsky, R; Ahmadian, MR				Nakhaeizadeh, Hossein; Amin, Ehsan; Nakhaei-Rad, Saeideh; Dvorsky, Radovan; Ahmadian, Mohammad Reza			The RAS-Effector Interface: Isoform-Specific Differences in the Effector Binding Regions	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-OH KINASE; GTPASE-ACTIVATING PROTEINS; SWITCH I-REGION; K-RAS; H-RAS; R-RAS; N-RAS; SIGNAL-TRANSDUCTION; BCL-XL; RAF-1	RAS effectors specifically interact with the GTP-bound form of RAS in response to extracellular signals and link them to downstream signaling pathways. The molecular nature of effector interaction by RAS is well-studied but yet still incompletely understood in a comprehensive and systematic way. Here, structure-function relationships in the interaction between different RAS proteins and various effectors were investigated in detail by combining our in vitro data with in silico data. Equilibrium dissociation constants were determined for the binding of HRAS, KRAS, NRAS, RRAS1 and RRAS2 to both the RAS binding (RB) domain of CRAF and PI3K alpha, and the RAS association (RA) domain of RASSF5, RALGDS and PLC epsilon, respectively, using fluorescence polarization. An interaction matrix, constructed on the basis of available crystal structures, allowed identification of hotspots as critical determinants for RAS-effector interaction. New insights provided by this study are the dissection of the identified hotspots in five distinct regions (R1 to R5) in spite of high sequence variability not only between, but also within, RB/RA domain-containing effectors proteins. Finally, we propose that intermolecular beta-sheet interaction in R1 is a central recognition region while R3 may determine specific contacts of RAS versus RRAS isoforms with effectors.	[Nakhaeizadeh, Hossein; Amin, Ehsan; Nakhaei-Rad, Saeideh; Dvorsky, Radovan; Ahmadian, Mohammad Reza] Heinrich Heine Univ, Inst Biochem & Mol Biol 2, Fac Med, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Ahmadian, MR (corresponding author), Heinrich Heine Univ, Inst Biochem & Mol Biol 2, Fac Med, Dusseldorf, Germany.	reza.ahmadian@uni-duesseldorf.de	Amin, Ehsan/GPC-5382-2022; Dvorsky, Radovan/ABE-3042-2020; Nakhaeirad, Saeideh/AAV-1771-2020	Nakhaeirad, Saeideh/0000-0001-8966-8960; Amin, Ehsan/0000-0003-2995-8864	German Research Foundation (Deutsche Forschungsgemeinschaft or DFG) through the Collaborative Research Center 974 [SFB 974]; International Research Training Group 1902 "Intra- and interorgan communication of the cardiovascular system" [IRTG 1902]; German Federal Ministry of Education and Research (BMBF) - German Network of RASopathy Research (GeNeRARe) [01GM1519D]; European Network on Noonan Syndrome and Related Disorders (NSEuroNet) [01GM16026]	German Research Foundation (Deutsche Forschungsgemeinschaft or DFG) through the Collaborative Research Center 974(German Research Foundation (DFG)); International Research Training Group 1902 "Intra- and interorgan communication of the cardiovascular system"; German Federal Ministry of Education and Research (BMBF) - German Network of RASopathy Research (GeNeRARe)(Federal Ministry of Education & Research (BMBF)); European Network on Noonan Syndrome and Related Disorders (NSEuroNet)	This study was supported in part by the German Research Foundation (Deutsche Forschungsgemeinschaft or DFG) through the Collaborative Research Center 974 (SFB 974) "Communication and Systems Relevance during Liver Injury and Regeneration", the International Research Training Group 1902 (IRTG 1902) "Intra- and interorgan communication of the cardiovascular system", the German Federal Ministry of Education and Research (BMBF) - German Network of RASopathy Research (GeNeRARe; fund number 01GM1519D), and the European Network on Noonan Syndrome and Related Disorders (NSEuroNet; fund number 01GM16026).	Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Abraham SJ, 2009, BIOCHEMISTRY-US, V48, P7575, DOI 10.1021/bi900769j; Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Ahmadian MR, 1997, BIOCHEMISTRY-US, V36, P4535, DOI 10.1021/bi962556y; Amin E, 2016, J BIOL CHEM; Athuluri-Divakar SK, 2016, CELL, V165, P643, DOI 10.1016/j.cell.2016.03.045; Baljuls A, 2013, MOL BIOSYST, V9, P551, DOI 10.1039/c2mb25393c; Beeram M, 2005, J CLIN ONCOL, V23, P6771, DOI 10.1200/JCO.2005.08.036; Beeram Muralidhar, 2003, Clin Adv Hematol Oncol, V1, P476; Berzat AC, 2006, METHOD ENZYMOL, V407, P575, DOI 10.1016/S0076-6879(05)07046-1; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Boettner B, 2001, METHOD ENZYMOL, V332, P151; Bryant KL, 2014, TRENDS BIOCHEM SCI, V39, P91, DOI 10.1016/j.tibs.2013.12.004; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; Bunney TD, 2006, TRENDS CELL BIOL, V16, P640, DOI 10.1016/j.tcb.2006.10.007; Bunney TD, 2011, TRENDS BIOCHEM SCI, V36, P88, DOI 10.1016/j.tibs.2010.08.003; Calvo F, 2009, MOL BIOL CELL, V20, P4289, DOI 10.1091/mbc.E09-03-0212; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Castellano Esther, 2011, Genes Cancer, V2, P216, DOI 10.1177/1947601911408081; Castellano E, 2010, CURR TOP MICROBIOL, V346, P143, DOI 10.1007/82_2010_56; Chan Jia Jia, 2013, Advances in Biological Regulation, V53, P258, DOI [10.1016/j.jbior.2013.07.008, 10.1016/j.jbior.2012.12.001]; Chavan TS, 2015, BIOPHYS J, V109, P2602, DOI 10.1016/j.bpj.2015.09.034; Cirstea IC, 2013, HUM MOL GENET, V22, P262, DOI 10.1093/hmg/dds426; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Cromm PM, 2015, ANGEW CHEM INT EDIT, V54, P13516, DOI 10.1002/anie.201504357; de la Vega M, 2010, J BIOL CHEM, V285, P12028, DOI 10.1074/jbc.M109.081448; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Desideri E, 2015, CELL, V161, P967, DOI 10.1016/j.cell.2015.04.045; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Donninger H, 2016, SEM CELL DEV BIOL; Drugan JK, 1996, J BIOL CHEM, V271, P233, DOI 10.1074/jbc.271.1.233; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Elad-Sfadia G, 2002, J BIOL CHEM, V277, P37169, DOI 10.1074/jbc.M205698200; Erijman A, 2016, MINI-REV MED CHEM, V16, P370, DOI 10.2174/1389557515666151001141838; Feig LA, 2002, CURR BIOL, V12, pR259, DOI 10.1016/S0960-9822(02)00787-X; Ferro E, 2010, CELL SIGNAL, V22, P1804, DOI 10.1016/j.cellsig.2010.05.010; Fischer A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M607458200; Flex E, 2014, HUM MOL GENET, V23, P4315, DOI 10.1093/hmg/ddu148; Furuhjelm J, 2003, J CELL SCI, V116, P3729, DOI 10.1242/jcs.00689; Gentry LR, 2014, BBA-MOL CELL RES, V1843, P2976, DOI 10.1016/j.bbamcr.2014.09.004; Gorman C, 1996, J BIOL CHEM, V271, P6713, DOI 10.1074/jbc.271.12.6713; Gremer L, 2011, HUM MUTAT, V32, P33, DOI 10.1002/humu.21377; Gremer L, 2010, HUM MOL GENET, V19, P790, DOI 10.1093/hmg/ddp548; Gutierrez-Erlandsson S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-127; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harjes E, 2006, STRUCTURE, V14, P881, DOI 10.1016/j.str.2006.03.008; Hennig A, 2015, BIOL CHEM, V396, P831, DOI 10.1515/hsz-2014-0257; Herrmann C, 2003, CURR OPIN STRUC BIOL, V13, P122, DOI 10.1016/S0959-440X(02)00007-6; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; Holly SP, 2005, MOL BIOL CELL, V16, P2458, DOI 10.1091/mbc.E03-12-0917; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Hunter JC, 2015, MOL CANCER RES, V13, P1325, DOI 10.1158/1541-7786.MCR-15-0203; Hwang MCC, 1996, J BIOL CHEM, V271, P8196, DOI 10.1074/jbc.271.14.8196; Jaiswal M, 2013, J BIOL CHEM, V288, P4486, DOI 10.1074/jbc.M112.429746; Jang H, 2015, J BIOL CHEM, V290, P9465, DOI 10.1074/jbc.M114.620724; Jura N, 2006, MOL CELL, V21, P679, DOI 10.1016/j.molcel.2006.02.011; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Katz ME, 1997, CURR OPIN GENET DEV, V7, P75, DOI 10.1016/S0959-437X(97)80112-8; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Knyphausen P, 2016, BIOL CHEM; KOLCH W, 1991, NATURE, V349, P426, DOI 10.1038/349426a0; Kurig B, 2009, P NATL ACAD SCI USA, V106, P20312, DOI 10.1073/pnas.0905506106; Linnemann T, 2002, VIROLOGY, V294, P246, DOI 10.1006/viro.2002.1365; LINNEMANN T, 1999, THE JOURNAL OF BIOLO, V274, P13556; Lissewski C, 2015, AM J MED GENET A, V167, P2685, DOI 10.1002/ajmg.a.37155; Lu S, 2016, CHEM SOC REV; Lynch SJ, 2015, J CELL PHYSIOL, V230, P610, DOI 10.1002/jcp.24779; Mazhab-Jafari MT, 2015, P NATL ACAD SCI USA, V112, P6625, DOI 10.1073/pnas.1419895112; McCormick F, 2015, CLIN CANCER RES, V21, P1797, DOI 10.1158/1078-0432.CCR-14-2662; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; Mott HR, 2015, CRIT REV BIOCHEM MOL, V50, P85, DOI 10.3109/10409238.2014.999191; Muratcioglu S, 2015, STRUCTURE, V23, P1325, DOI 10.1016/j.str.2015.04.019; Nakhaei-Rad S, 2016, J BIOL CHEM, V291, P8399, DOI 10.1074/jbc.M115.700088; Nakhaei-Rad S, 2015, J BIOL CHEM, V290, P15892, DOI 10.1074/jbc.M115.640607; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nussinov R, 2015, EXPERT REV PROTEOMIC, V12, P669, DOI 10.1586/14789450.2015.1100079; Oertli B, 2000, ONCOGENE, V19, P4961, DOI 10.1038/sj.onc.1203876; Ostrem JM, 2016, NAT REV DRUG DISCOV; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; Parker JA, 2015, MOL CANCER RES, V13, P595, DOI 10.1158/1541-7786.MCR-14-0535; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qamra R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072473; Raines RT, 2015, METHODS MOL BIOL, V1278, P323, DOI 10.1007/978-1-4939-2425-7_19; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Repasky GA, 2004, TRENDS CELL BIOL, V14, P639, DOI 10.1016/j.tcb.2004.09.014; Rodriguez-Viciana P, 2006, MOL CELL, V22, P217, DOI 10.1016/j.molcel.2006.03.027; Rodriguez-Viciana P, 2006, CANCER CELL, V9, P243, DOI 10.1016/j.ccr.2006.03.025; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Rudolph MG, 2001, J BIOL CHEM, V276, P23914, DOI 10.1074/jbc.M011600200; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Shima Fumi, 2013, Enzymes, V34 Pt. B, P1, DOI 10.1016/B978-0-12-420146-0.00001-9; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Stieglitz B, 2008, EMBO J, V27, P1995, DOI 10.1038/emboj.2008.125; Sung PJ, 2013, P NATL ACAD SCI USA, V110, P20593, DOI 10.1073/pnas.1306431110; Sydor JR, 1999, FEBS LETT, V452, P375, DOI 10.1016/S0014-5793(99)00633-X; Sydor JR, 1998, BIOCHEMISTRY-US, V37, P14292, DOI 10.1021/bi980764f; Thapar R, 2004, J MOL BIOL, V343, P1391, DOI 10.1016/j.jmb.2004.08.106; Vandal G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084745; Vavvas D, 1998, J BIOL CHEM, V273, P5439, DOI 10.1074/jbc.273.10.5439; Vetter IR, 1999, FEBS LETT, V451, P175, DOI 10.1016/S0014-5793(99)00555-4; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wang MT, 2015, CELL, V163, P1237, DOI 10.1016/j.cell.2015.10.041; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Wing Michele R, 2003, Mol Interv, V3, P273, DOI 10.1124/mi.3.5.273; WITTINGHOFER A, 1995, FEBS LETT, V369, P52, DOI 10.1016/0014-5793(95)00667-X; Wohlgemuth S, 2005, J MOL BIOL, V348, P741, DOI 10.1016/j.jmb.2005.02.048; Wurtzel JGT, 2015, BIOCHEM BIOPH RES CO, V467, P785, DOI 10.1016/j.bbrc.2015.10.064; Yang MH, 2013, MOL CANCER RES, V11, P1072, DOI 10.1158/1541-7786.MCR-13-0040-T; Yang MH, 2012, P NATL ACAD SCI USA, V109, P10843, DOI 10.1073/pnas.1201487109; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0; Zheng ZY, 2012, ONCOGENE, V31, P4630, DOI 10.1038/onc.2011.607; Zhou M, 2016, J CELL BIOL, V214, P445, DOI 10.1083/jcb.201604061	118	37	38	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167145	10.1371/journal.pone.0167145	http://dx.doi.org/10.1371/journal.pone.0167145			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936046	Green Submitted, gold, Green Published			2022-12-27	WOS:000389587100066
J	Sharif, S; Nakatani, Y; Wise, L; Corbett, M; Real, NC; Stuart, GS; Lateef, Z; Krause, K; Mercer, AA; Fleming, SB				Sharif, Saeed; Nakatani, Yoshio; Wise, Lyn; Corbett, Michael; Real, Nicola C.; Stuart, Gabriella S.; Lateef, Zabeen; Krause, Kurt; Mercer, Andrew A.; Fleming, Stephen B.			A Broad-Spectrum Chemokine-Binding Protein of Bovine Papular Stomatitis Virus Inhibits Neutrophil and Monocyte Infiltration in Inflammatory and Wound Models of Mouse Skin	PLOS ONE			English	Article							ORF VIRUS; CYTOKINE SYNTHESIS; DENDRITIC CELLS; PARAPOXVIRUS; INFECTION; MIGRATION; POXVIRUS; INTERLEUKIN-10; RECEPTOR; SITES	Bovine papular stomatitis virus (BPSV) is a Parapoxvirus that induces acute pustular skin lesions in cattle and is transmissible to humans. Previous studies have shown that BPSV encodes a distinctive chemokine-binding protein (CBP). Chemokines are critically involved in the trafficking of immune cells to sites of inflammation and infected tissue, suggesting that the CBP plays a role in immune evasion by preventing immune cells reaching sites of infection. We hypothesised that the BPSV-CBP binds a wide range of inflammatory chemokines particularly those involved in BPSV skin infection, and inhibits the recruitment of immune cells from the blood into inflamed skin. Molecular analysis of the purified protein revealed that the BPSV-CBP is a homodimeric polypeptide with a MW of 82.4 kDa whilst a comprehensive screen of inflammatory chemokines by surface plasmon resonance showed high affinity binding to a range of chemokines within the CXC, CC and XC subfamilies. Structural analysis of BPSV-CBP, based on the crystal structure of orf virus CBP, provided a probable explanation for these chemokine specificities at a molecular level. Functional analysis of the BPSV-CBP using transwell migration assays demonstrated that it potently inhibited chemotaxis of murine neutrophils and monocytes in response to CXCL1, CXCL2 as well as CCL2, CCL3 and CCL5 chemokines. In order to examine the effects of CBP in vivo, we used murine skin models to determine its impact on inflammatory cell recruitment such as that observed during BPSV infection. Intradermal injection of BPSV-CBP blocked the influx of neutrophils and monocytes in murine skin in which inflammation was induced with lipopolysaccharide. Furthermore, intradermal injection of BPSV-CBP into injured skin, which more closely mimics BPSV lesions, delayed the influx of neutrophils and reduced the recruitment of MHC-II+ immune cells to the wound bed. Our findings suggest that the CBP could be important in pathogenesis of BPSV infections.	[Sharif, Saeed; Nakatani, Yoshio; Wise, Lyn; Corbett, Michael; Real, Nicola C.; Stuart, Gabriella S.; Lateef, Zabeen; Mercer, Andrew A.; Fleming, Stephen B.] Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand; [Krause, Kurt] Univ Otago, Dept Biochem, Dunedin, New Zealand	University of Otago; University of Otago	Fleming, SB (corresponding author), Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand.	stephen.fleming@otago.ac.nz	Mercer, Andrew A/G-6635-2015	Lateef, Zabeen/0000-0001-5987-7665; Mercer, Andrew/0000-0003-3697-1071; Wise, Lyn/0000-0003-0646-8424	Health Research Council of New Zealand; University of Otago Special Health Research Scholarship; Health Research Council Explorer Grant; Maurice Wilkins Centre	Health Research Council of New Zealand(Health Research Council of New Zealand); University of Otago Special Health Research Scholarship; Health Research Council Explorer Grant; Maurice Wilkins Centre	This research was supported by funding from the Health Research Council of New Zealand and the University of Otago Special Health Research Scholarship. Yoshio Nakatani was funded by a Health Research Council Explorer Grant and the Maurice Wilkins Centre.; This research was supported by funding from the Health Research Council of New Zealand and the University of Otago Special Health Research Scholarship. Yoshio Nakatani was funded by a Health Research Council Explorer Grant and the Maurice Wilkins Centre. The authors would like to thank Norihito Ueda and Ellena Whelan (Department of Microbiology & Immunology, University of Otago) for cloning of the BPSV-CBP gene, Michelle Wilson (Department of Microbiology & Immunology, University of Otago) for FAGS technical assistance, Amanda Fisher, Janine Neill, Sharon White and Alisha Shaw (Histology Unit, Department Pathology, University of Otago) for histological processing, and Marcel Hijnen (Biacore product specialist) for SPR technical support.	Abdel-Latif D, 2004, BLOOD, V104, P832, DOI 10.1182/blood-2003-07-2624; Alejo A, 2006, P NATL ACAD SCI USA, V103, P5995, DOI 10.1073/pnas.0510462103; Alexander JM, 2002, CELL, V111, P343, DOI 10.1016/S0092-8674(02)01007-3; Bahar MW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040005; Bennett JR, 2016, VIRUS RES, V213, P230, DOI 10.1016/j.virusres.2015.12.015; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bosio CF, 2012, INFECT IMMUN, V80, P4034, DOI 10.1128/IAI.00606-12; BOWMAN KF, 1981, JAMA-J AM MED ASSOC, V246, P2813, DOI 10.1001/jama.246.24.2813; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Bryant NA, 2003, EMBO J, V22, P833, DOI 10.1093/emboj/cdg092; Buttner M, 2002, J VET MED B, V49, P7, DOI 10.1046/j.1439-0450.2002.00539.x; Byrne MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085726; Chazov EI, 2007, CAN J PHYSIOL PHARM, V85, P332, DOI 10.1139/Y07-008; Costantini C, 2011, J LEUKOCYTE BIOL, V89, P221, DOI 10.1189/jlb.0510250; Costes B, 2005, J GEN VIROL, V86, P3209, DOI 10.1099/vir.0.81388-0; Counago RM, 2015, STRUCTURE, V23, P1199, DOI 10.1016/j.str.2015.04.023; Dal Pozzo F, 2011, J CLIN MICROBIOL, V49, P4397, DOI 10.1128/JCM.05281-11; de Sant'Ana FJF, 2012, J VET DIAGN INVEST, V24, P442, DOI 10.1177/1040638711434799; Delhon G, 2004, J VIROL, V78, P168, DOI 10.1128/JVI.78.1.168-177.2004; Fenner F, 1987, CHAPTER 21 POXVIRIDA, P387; Fleming S. B., 2007, GENUS PARAPOXVIRUS P, P127; Fleming SB, 1997, J VIROL, V71, P4857, DOI 10.1128/JVI.71.6.4857-4861.1997; Fleming SB, 2015, VIRUSES-BASEL, V7, P1505, DOI 10.3390/v7031505; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Francke A, 2011, J HISTOCHEM CYTOCHEM, V59, P813, DOI 10.1369/0022155411416007; Gaines P, 2005, J LEUKOCYTE BIOL, V77, P669, DOI 10.1189/jlb.1004567; Galani IE, 2015, J LEUKOCYTE BIOL, V98, P557, DOI 10.1189/jlb.4VMR1114-555R; Grimsey NL, 2012, J BIOMOL SCREEN, V17, P386, DOI 10.1177/1087057111428985; Haig DM, 2002, VIRUS RES, V88, P3, DOI 10.1016/S0168-1702(02)00117-X; Hemmers S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022043; Huang T, 2015, ARCH VIROL, V160, P1527, DOI 10.1007/s00705-015-2394-2; Iketani Y, 2002, MICROBIOL IMMUNOL, V46, P285, DOI 10.1111/j.1348-0421.2002.tb02697.x; Imlach W, 2002, J GEN VIROL, V83, P1049, DOI 10.1099/0022-1317-83-5-1049; Jenne CN, 2013, CELL HOST MICROBE, V13, P169, DOI 10.1016/j.chom.2013.01.005; King A.M.Q., 2011, VIRUS TAXONOMY, V1st ed; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kumar V, 2010, INT IMMUNOPHARMACOL, V10, P1325, DOI 10.1016/j.intimp.2010.08.012; Lalani AS, 1997, J LEUKOCYTE BIOL, V62, P570, DOI 10.1002/jlb.62.5.570; Lateef Z, 2003, J GEN VIROL, V84, P1101, DOI 10.1099/vir.0.18978-0; Lateef Z, 2010, CELL MICROBIOL, V12, P665, DOI 10.1111/j.1462-5822.2009.01425.x; Lateef Z, 2009, J GEN VIROL, V90, P1477, DOI 10.1099/vir.0.009589-0; Lee S, 2015, STROKE, V46, P537, DOI 10.1161/STROKEAHA.114.007298; Leire E, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-28; Li JQ, 2013, INFECT IMMUN, V81, P974, DOI 10.1128/IAI.01218-12; Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358; Mattar EH, 2015, CYTOKINE GROWTH FACT; Mocsai A, 2013, J EXP MED, V210, P1283, DOI 10.1084/jem.20122220; Murphy K., 2011, JANEWAYS IMMUNOBIOLO, V8th ed.; Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013; Nelson CA, 2015, VIRUSES-BASEL, V7, P4873, DOI 10.3390/v7092848; Parry CM, 2000, J EXP MED, V191, P573, DOI 10.1084/jem.191.3.573; PYE D, 1990, AUST VET J, V67, P182, DOI 10.1111/j.1751-0813.1990.tb07751.x; Robinson AJ, 1992, RECOMBINANT POXVIRUS, V96, P285; Roess AA, 2013, ZOONOSES PUBLIC HLTH, V60, P543, DOI 10.1111/zph.12036; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Ruiz-Arguello MB, 2008, J VIROL, V82, P917, DOI 10.1128/JVI.02111-07; Rziha HJ, 2003, J GEN VIROL, V84, P1111, DOI 10.1099/vir.0.18850-0; Sadik CD, 2011, TRENDS IMMUNOL, V32, P452, DOI 10.1016/j.it.2011.06.008; Saitoh T, 2012, CELL HOST MICROBE, V12, P109, DOI 10.1016/j.chom.2012.05.015; Schwartzkopff F, 2012, INNATE IMMUN-LONDON, V18, P124, DOI 10.1177/1753425910388833; Seet BT, 2003, P NATL ACAD SCI USA, V100, P15137, DOI 10.1073/pnas.2336648100; Seet BT, 2001, J BIOL CHEM, V276, P30504, DOI 10.1074/jbc.M011401200; Sentsui H, 1999, VET MICROBIOL, V70, P143, DOI 10.1016/S0378-1135(99)00138-8; Shi GX, 2007, J EXP MED, V204, P2705, DOI 10.1084/jem.20071267; Straschewski S, 2011, J VIROL, V85, P5150, DOI 10.1128/JVI.02100-10; Sun J, 2007, AM J PHYSIOL-CELL PH, V293, pC696, DOI 10.1152/ajpcell.00060.2007; Van Berkel V, 2000, J VIROL, V74, P6741, DOI 10.1128/JVI.74.15.6741-6747.2000; Wallace AE, 2009, CANCER RES, V69, P5726, DOI 10.1158/0008-5472.CAN-09-0390; Wise L, 2007, J GEN VIROL, V88, P1677, DOI 10.1099/vir.0.82765-0; Wise LM, 2014, WOUND REPAIR REGEN, V22, P356, DOI 10.1111/wrr.12169; Wise LM, 2012, CELL MICROBIOL, V14, P1376, DOI 10.1111/j.1462-5822.2012.01802.x; Xue XG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002162; Zhou LB, 1996, EUR J IMMUNOL, V26, P120, DOI 10.1002/eji.1830260119	73	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168007	10.1371/journal.pone.0168007	http://dx.doi.org/10.1371/journal.pone.0168007			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936239	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100250
J	To, MJ; Brothers, TD; Van Zoost, C				To, Matthew J.; Brothers, Thomas D.; Van Zoost, Colin			Foot Conditions among Homeless Persons: A Systematic Review	PLOS ONE			English	Review							HEALTH NEEDS; MEDICAL-CARE; PREVALENCE; ADULTS; POPULATIONS	Introduction Foot problems are common among homeless persons, but are often overlooked. The objectives of this systematic review are to summarize what is known about foot conditions and associated interventions among homeless persons. Methods A literature search was conducted on MEDLINE (1966-2016), EMBASE (1947-2016), and CINAHL (1982-2016) and complemented by manual searches of reference lists. Articles that described foot conditions in homeless persons or associated interventions were included. Data were independently extracted on: general study characteristics; participants; foot assessment methods; foot conditions and associated interventions; study findings; quality score assessed using the Downs and Black checklist. Results Of 333 articles screened, 17 articles met criteria and were included in the study. Prevalence of any foot problem ranged from 9% to 65% across study populations. Common foot-related concerns were corns and calluses, nail pathologies, and infections. Foot pathologies related to chronic diseases such as diabetes were identified. Compared to housed individuals across studies, homeless individuals were more likely to have foot problems including tinea pedis, foot pain, functional limitations with walking, and improperly-fitting shoes. Discussion Foot conditions were highly prevalent among homeless individuals with up to two thirds reporting a foot health concern, approximately one quarter of individuals visiting a health professional, and one fifth of individuals requiring further follow-up due to the severity of their condition. Homeless individuals often had inadequate foot hygiene practices and improperly-fitting shoes. These findings have service provision and public health implications, highlighting the need for evidence-based interventions to improve foot health in this population. An effective interventional approach could include optimization of foot hygiene and footwear, provision of comprehensive medical treatment, and addressing social factors that lead to increased risk of foot problems. Targeted efforts to screen for and treat foot problems could result in improved health and social outcomes for homeless individuals.	[To, Matthew J.; Brothers, Thomas D.; Van Zoost, Colin] Dalhousie Univ, Fac Med, Halifax, NS, Canada; [To, Matthew J.; Brothers, Thomas D.; Van Zoost, Colin] Walk Our Shoes Foot Care Assoc, Halifax, NS, Canada	Dalhousie University	To, MJ (corresponding author), Dalhousie Univ, Fac Med, Halifax, NS, Canada.; To, MJ (corresponding author), Walk Our Shoes Foot Care Assoc, Halifax, NS, Canada.	mto3@alumni.uwo.ca	Brothers, Thomas/ABH-5700-2020	Brothers, Thomas/0000-0002-5570-5556	Dalhousie Medical Research Foundation (DMRF) Music in Medicine Summer Research Studentship	Dalhousie Medical Research Foundation (DMRF) Music in Medicine Summer Research Studentship	Matthew J. To held a summer studentship with funding provided by the Dalhousie Medical Research Foundation (DMRF) Music in Medicine Summer Research Studentship. The funding organization had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; and in the preparation, review, and approval of the manuscript.	[Anonymous], 2013, STATE HOMELESSNESS C; Argintaru N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-577; Arnaud A, 2010, EUR J PUBLIC HEALTH, V20, P601, DOI 10.1093/eurpub/ckp197; Badiaga S, 2005, EUR J DERMATOL, V15, P382; Chen Bright, 2014, J Am Podiatr Med Assoc, V104, P269, DOI 10.7547/0003-0538-104.3.269; Chen B, 2012, J AM PODIAT MED ASSN, V102, P54, DOI 10.7547/1020054; Chong MT, 2014, J RES PHARM PRACT, V3, P56, DOI 10.4103/2279-042X.137073; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Gelberg L, 2000, HEALTH SERV RES, V34, P1273; GELBERG L, 1990, ARCH INTERN MED, V150, P2325, DOI 10.1001/archinte.150.11.2325; Hwang SW, 2001, CAN MED ASSOC J, V164, P229; Ilkit M, 2015, CRIT REV MICROBIOL, V41, P374, DOI 10.3109/1040841X.2013.856853; JONES CL, 1990, J AM PODIAT MED ASSN, V80, P41, DOI 10.7547/87507315-80-1-41; Kleinman LC, 1996, HEALTH SERV RES, V31, P533; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; MACINTYRE D, 1979, SCOT MED J, V24, P240, DOI 10.1177/003693307902400313; Macnee C L, 1996, J Community Health Nurs, V13, P167, DOI 10.1207/s15327655jchn1303_4; Matteoli M, 2015, J AM PODIAT MED ASSN, V105, P424, DOI 10.7547/13-152; MOY JA, 1992, ARCH DERMATOL, V128, P829, DOI 10.1001/archderm.128.6.829; Muirhead L, 2011, J AM ACAD NURSE PRAC, V23, P209, DOI 10.1111/j.1745-7599.2011.00598.x; Robbins JM, 1996, J AM PODIAT MED ASSN, V86, P275, DOI 10.7547/87507315-86-6-275; Schanzer B, 2007, AM J PUBLIC HEALTH, V97, P464, DOI 10.2105/AJPH.2005.076190; Schwarzkopf R, 2011, J FOOT ANKLE SURG, V50, P391, DOI 10.1053/j.jfas.2011.04.030; Shtasel DL, 2015, NEW ENGL J MED, V373, P2563, DOI 10.1056/NEJMcpc1405204; Stratigos AJ, 1999, J AM ACAD DERMATOL, V41, P197, DOI 10.1016/S0190-9622(99)70048-4; The 2012 Point-in-Time Estimates of Homelessness, 2012, ANN HOM ASS REP; Thomas MJ, 2011, PAIN, V152, P2870, DOI 10.1016/j.pain.2011.09.019; TOON PD, 1987, J ROY COLL GEN PRACT, V37, P120; WRENN K, 1990, ANN INTERN MED, V113, P567, DOI 10.7326/0003-4819-113-8-567	29	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167463	10.1371/journal.pone.0167463	http://dx.doi.org/10.1371/journal.pone.0167463			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936071	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100103
J	Xu, L; He, JZ; Kaiser, A; Graber, N; Schlager, L; Ritze, Y; Scholz, H				Xu, Li; He, Jianzheng; Kaiser, Andrea; Graeber, Nikolas; Schlaeger, Laura; Ritze, Yvonne; Scholz, Henrike			A Single Pair of Serotonergic Neurons Counteracts Serotonergic Inhibition of Ethanol Attraction in Drosophila	PLOS ONE			English	Article							ADULT DROSOPHILA; PLACE PREFERENCE; OLFACTORY CENTER; COCAINE REWARD; ANTENNAL LOBE; TRANSPORTER; MELANOGASTER; EXPRESSION; DOPAMINE; AVERSION	Attraction to ethanol is common in both flies and humans, but the neuromodulatory mechanisms underlying this innate attraction are not well understood. Here, we dissect the function of the key regulator of serotonin signaling-the serotonin transporter-in innate olfactory attraction to ethanol in Drosophila melanogaster. We generated a mutated version of the serotonin transporter that prolongs serotonin signaling in the synaptic cleft and is targeted via the Gal4 system to different sets of serotonergic neurons. We identified four serotonergic neurons that inhibit the olfactory attraction to ethanol and two additional neurons that counteract this inhibition by strengthening olfactory information. Our results reveal that compensation can occur on the circuit level and that serotonin has a bidirectional function in modulating the innate attraction to ethanol. Given the evolutionarily conserved nature of the serotonin transporter and serotonin, the bidirectional serotonergic mechanisms delineate a basic principle for how random behavior is switched into targeted approach behavior.	[Xu, Li; He, Jianzheng; Kaiser, Andrea; Graeber, Nikolas; Schlaeger, Laura; Scholz, Henrike] Albertus Magnus Univ Cologne, Zool, Cologne, Germany; [Ritze, Yvonne; Scholz, Henrike] Julius Maximillian Univ Wurzburg, Inst Genet & Neurobiol, Wurzburg, Germany	University of Cologne; University of Wurzburg	Scholz, H (corresponding author), Albertus Magnus Univ Cologne, Zool, Cologne, Germany.; Scholz, H (corresponding author), Julius Maximillian Univ Wurzburg, Inst Genet & Neurobiol, Wurzburg, Germany.	henrike.scholz@uni-koeln.de	Scholz, Henrike/ABE-1063-2020		Chinese Academy of Science; German Science Foundation; Thyssen Stiftung [DFG656-7, SFB1340]; BMBF-SysMedAlc; PhD CSC fellowships	Chinese Academy of Science(Chinese Academy of Sciences); German Science Foundation(German Research Foundation (DFG)); Thyssen Stiftung; BMBF-SysMedAlc; PhD CSC fellowships	Financial support was provided by the Chinese Academy of Science, the German Science Foundation, and Thyssen Stiftung. DFG656-7 to HS, SFB1340 to HS, Thyssen Stiftung to HS, BMBF-SysMedAlc to HS; PhD CSC fellowships to LX and JH.	Albin SD, 2015, CURR BIOL, V25, P2435, DOI 10.1016/j.cub.2015.08.005; Alekseyenko OV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010806; Androutsellis-Theotokis A, 2002, J NEUROSCI, V22, P8370; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Bari A, 2013, PROG NEUROBIOL, V108, P44, DOI 10.1016/j.pneurobio.2013.06.005; Bellmann D, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00027; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buschges A, 2011, CURR BIOL, V21, pR513, DOI 10.1016/j.cub.2011.05.029; Chang AS, 1998, BIOCHEM BIOPH RES CO, V249, P416, DOI 10.1006/bbrc.1998.9158; Cools R, 2011, NEUROPSYCHOPHARMACOL, V36, P98, DOI 10.1038/npp.2010.121; COREY JL, 1994, P NATL ACAD SCI USA, V91, P1188, DOI 10.1073/pnas.91.3.1188; Dacks AM, 2006, J COMP NEUROL, V498, P727, DOI 10.1002/cne.21076; Dacks AM, 2009, J NEUROGENET, V23, P366, DOI 10.3109/01677060903085722; DEMCHYSHYN LL, 1994, P NATL ACAD SCI USA, V91, P5158, DOI 10.1073/pnas.91.11.5158; Devineni Anita V, 2010, Commun Integr Biol, V3, P357; Dierick HA, 2007, NAT GENET, V39, P678, DOI 10.1038/ng2029; Ellen CW, 2012, J MOL HISTOL, V43, P401, DOI 10.1007/s10735-012-9401-7; Fujioka M, 2003, DEVELOPMENT, V130, P5385, DOI 10.1242/dev.00770; Giang T, 2011, J NEUROGENET, V25, P17, DOI 10.3109/01677063.2011.553002; Gupta N, 2012, J NEUROSCI, V32, P8138, DOI 10.1523/JNEUROSCI.1066-12.2012; Haynes PR, 2015, ELIFE, V4, DOI 10.7554/eLife.03868; Kilic F, 2000, P NATL ACAD SCI USA, V97, P3106, DOI 10.1073/pnas.060408997; Lee PT, 2011, P NATL ACAD SCI USA, V108, P13794, DOI 10.1073/pnas.1019483108; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Liang L, 2013, NEURON, V79, P917, DOI 10.1016/j.neuron.2013.06.014; Liang L, 2010, SCI CHINA LIFE SCI, V53, P472, DOI 10.1007/s11427-010-0099-z; Logue SF, 2014, PHARMACOL BIOCHEM BE, V123, P45, DOI 10.1016/j.pbb.2013.08.007; Matsutani S, 2008, ANAT SCI INT, V83, P218, DOI 10.1111/j.1447-073X.2007.00223.x; Ogueta M, 2010, CHEM SENSES, V35, P813, DOI 10.1093/chemse/bjq084; Park JB, 2006, INT J INNOVATIONS EN, V1, P1, DOI DOI 10.1038/NATURE04788; Park SK, 2006, J NEUROBIOL, V66, P452, DOI 10.1002/neu.20222; Roy B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-20; Schneider A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052007; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Singh AP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003452; Sitte HH, 2003, EUR J PHARMACOL, V479, P229, DOI 10.1016/j.ejphar.2003.08.072; Sora I, 2001, P NATL ACAD SCI USA, V98, P5300, DOI 10.1073/pnas.091039298; Sora I, 1998, P NATL ACAD SCI USA, V95, P7699, DOI 10.1073/pnas.95.13.7699; Strutz A, 2014, ELIFE, V3, DOI 10.7554/eLife.04147; Su CY, 2014, CURR OPIN NEUROBIOL, V29, P9, DOI 10.1016/j.conb.2014.04.008; Tanaka NK, 2012, J COMP NEUROL, V520, P4131, DOI 10.1002/cne.23149; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Zhu JW, 2003, J CHEM ECOL, V29, P899, DOI 10.1023/A:1022931816351	45	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167518	10.1371/journal.pone.0167518	http://dx.doi.org/10.1371/journal.pone.0167518			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936023	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100113
J	Cirkovic, I; Bozic, DD; Draganic, V; Lozo, J; Beric, T; Kojic, M; Arsic, B; Garalejic, E; Djukic, S; Stankovic, S				Cirkovic, Ivana; Bozic, Dragana D.; Draganic, Veselin; Lozo, Jelena; Beric, Tanja; Kojic, Milan; Arsic, Biljana; Garalejic, Eliana; Djukic, Slobodanka; Stankovic, Slavisa			Licheniocin 50.2 and Bacteriocins from Lactococcus lactis subsp lactis biovar. diacetylactis BGBU1-4 Inhibit Biofilms of Coagulase Negative Staphylococci and Listeria monocytogenes Clinical Isolates	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; MECHANISMS; PEPTIDES; SURVIVAL; IMMUNITY	Background Coagulase negative staphylococci (CoNS) and Listeria monocytogenes have important roles in pathogenesis of various genital tract infections and fatal foetomaternal infections, respectively. The aim of our study was to investigate the inhibitory effects of two novel bacteriocins on biofilms of CoNS and L. monocytogenes genital isolates. Methods The effects of licheniocin 50.2 from Bacillus licheniformis VPS50.2 and crude extract of bacteriocins produced by Lactococcus lactis subsp. lactis biovar. diacetylactis BGBU1-4 (BGBU1-4 crude extract) were evaluated on biofilm formation and formed biofilms of eight CoNS (four S. epidermidis, two S. hominis, one S. lugdunensis and one S. haemolyticus) and 12 L. monocytogenes genital isolates. Results Licheniocin 50.2 and BGBU1-4 crude extract inhibited the growth of both CoNS and L. monocytogenes isolates, with MIC values in the range between 200-400 AU/ml for licheniocin 50.2 and 400-3200 AU/ml for BGBU1-4 crude extract. Subinhibitory concentrations (1/2 x and 1/4 x MIC) of licheniocin 50.2 inhibited biofilm formation by all CoNS isolates (p < 0.05, respectively), while BGBU1-4 crude extract inhibited biofilm formation by all L. monocytogenes isolates (p < 0.01 and p < 0.05, respectively). Both bacteriocins in concentrations of 100 AU/mL and 200 AU/mL reduced the amount of 24 h old CoNS and L. monocytogenes biofilms (p < 0.05, p < 0.01, p < 0.001). Conclusions This study suggests that novel bacteriocins have potential to be used for genital application, to prevent biofilm formation and/or to eradicate formed biofilms, and consequently reduce genital and neonatal infections by CoNS and L. monocytogenes.	[Cirkovic, Ivana; Djukic, Slobodanka] Univ Belgrade, Inst Microbiol & Immunol, Fac Med, Belgrade, Serbia; [Bozic, Dragana D.] Univ Belgrade, Dept Microbiol & Immunol, Fac Pharm, Belgrade, Serbia; [Draganic, Veselin; Arsic, Biljana; Garalejic, Eliana] Univ Belgrade, Fac Med, Clin Gynecol & Obstet Narodni Front, Belgrade, Serbia; [Lozo, Jelena; Beric, Tanja; Stankovic, Slavisa] Univ Belgrade, Fac Biol, Belgrade, Serbia; [Kojic, Milan] Univ Belgrade, Inst Mol Genet & Genet Engn, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade; University of Belgrade; University of Belgrade	Cirkovic, I (corresponding author), Univ Belgrade, Inst Microbiol & Immunol, Fac Med, Belgrade, Serbia.	cirkoviciv@yahoo.com	Lozo, Jelena/R-7354-2018; Beric, Tanja/GLR-4901-2022; Stanković, Slaviša/S-6273-2018; Kojic, Milan/I-4528-2019	Lozo, Jelena/0000-0001-9888-5270; Stanković, Slaviša/0000-0003-0527-8741; Kojic, Milan/0000-0001-5645-750X; Bozic, Dragana/0000-0002-5373-5540; Beric, Tanja/0000-0002-4860-2225; Cirkovic, Ivana/0000-0003-1515-1824	Ministry of Education, Science and Technological Development of Serbia [175039, 173026]	Ministry of Education, Science and Technological Development of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the Ministry of Education, Science and Technological Development of Serbia, Grants No. 175039 and 173026, http://www.mpn.gov.rs/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldunate M, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00164; Amer EI, 2014, EXP PARASITOL, V146, P52, DOI 10.1016/j.exppara.2014.09.005; Balaji K, 2013, INDIAN J MED RES, V137, P963; Beric T, 2014, J APPL MICROBIOL, V116, P502, DOI 10.1111/jam.12393; Borges S, 2013, J APPL MICROBIOL, V115, P527, DOI 10.1111/jam.12232; Borges SF, 2011, FEMS IMMUNOL MED MIC, V62, P315, DOI 10.1111/j.1574-695X.2011.00815.x; Bozic DD, 2014, BRAZ J MICROBIOL, V45, P263, DOI 10.1590/S1517-83822014000100038; Clinical and Laboratory Standards Institute (CLSI), 2007, CLSI DOCUMENT M100 S; Cotter PD, 2014, MOL MICROBIOL, V92, P1159, DOI 10.1111/mmi.12645; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Diep DB, 2007, P NATL ACAD SCI USA, V104, P2384, DOI 10.1073/pnas.0608775104; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Fan AP, 2013, ARCH GYNECOL OBSTET, V287, P329, DOI 10.1007/s00404-012-2571-4; Fraczek M, 2012, ANDROLOGIA, V44, P315, DOI 10.1111/j.1439-0272.2012.01283.x; GAJIC O, 1999, ARCH BIOL SCI, V51, P69; Hassan M, 2012, J APPL MICROBIOL, V113, P723, DOI 10.1111/j.1365-2672.2012.05338.x; Ivanov Yuri Boris, 2007, Journal of Microbiology Immunology and Infection, V40, P157; KOJIC M, 1991, APPL ENVIRON MICROB, V57, P1753, DOI 10.1128/AEM.57.6.1753-1757.1991; Lawton EM, 2007, MINI-REV MED CHEM, V7, P1236, DOI 10.2174/138955707782795638; Leong D, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00683, 10.3389/fmicb.2014.00436, 10.3389/fmicb.2014.00241]; Nishie M, 2012, BIOCONTROL SCI, V17, P1; Piper Clare, 2009, Curr Drug Discov Technol, V6, P1; Robichon D, 1997, J BACTERIOL, V179, P7591, DOI 10.1128/jb.179.23.7591-7594.1997; Ruiz FO, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv013; Saising J, 2012, ANTIMICROB AGENTS CH, V56, P5804, DOI 10.1128/AAC.01296-12; Stepanovic S., 2007, Acta Microbiologica et Immunologica Hungarica, V54, P195, DOI 10.1556/AMicr.54.2007.2.9; Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x; Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Tansarli GS, 2013, EUR J CLIN MICROBIOL, V32, P977, DOI 10.1007/s10096-013-1846-4; van Reenen CA, 1998, J APPL MICROBIOL, V84, P1131	32	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167995	10.1371/journal.pone.0167995	http://dx.doi.org/10.1371/journal.pone.0167995			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930711	Green Published, Green Submitted, gold			2022-12-27	WOS:000389580900068
J	Chiu, SW; Chen, SW; Chang, CK; Chiu, YSP				Chiu, Singa Wang; Chen, Shin-Wei; Chang, Chih-Kai; Chiu, Yuan-Shyi Peter			Optimization of a Multi-Product Intra-Supply Chain System with Failure in Rework	PLOS ONE			English	Article							MULTIPLE SALES LOCATIONS; QUALITY-ASSURANCE; ALGEBRAIC APPROACH; INVENTORY SYSTEMS; SHIPMENT POLICY; DELIVERY POLICY; ECONOMIC-LOT; MODEL; MULTIITEM; QUANTITY	Globalization has created tremendous opportunities, but also made business environment highly competitive and turbulent. To gain competitive advantage, management of presentday transnational firms always seeks options to trim down various transaction and coordination costs, especially in the area of controllable intra-supply chain system. This study investigates a multi-product intra-supply chain system with failure in rework. To achieve maximum machine utilization, multiple products are fabricated in succession on a single machine. During the process, production of some defective items is inevitable. Reworking of nonconforming items is used to reduce the quality cost in production and achieving the goal of lower overall production cost. Because reworks are sometimes unsuccessful, failures in rework are also considered in this study. Finished goods for each product are transported to the sales offices when the entire production lot is quality assured after rework. A multi-delivery policy is used, wherein fixed quantity n installments of the finished lot are transported at fixed intervals during delivery time. The objective is to jointly determine the common production cycle time and the number of deliveries needed to minimize the long-term expected production-inventory-delivery costs for the problem. With the help of a mathematical model along with optimization technique, the optimal production-shipment policy is obtained. We have used a numerical example to demonstrate applicability of the result of our research.	[Chiu, Singa Wang] Chaoyang Univ Technol, Dept Business Adm, Taichung, Taiwan; [Chen, Shin-Wei; Chang, Chih-Kai; Chiu, Yuan-Shyi Peter] Chaoyang Univ Technol, Dept Ind Engn & Management, Taichung, Taiwan	Chaoyang University of Technology; Chaoyang University of Technology	Chiu, YSP (corresponding author), Chaoyang Univ Technol, Dept Ind Engn & Management, Taichung, Taiwan.	ypchiu@cyut.edu.tw			Ministry of Science and Technology (MOST) of Taiwan [MOST 102-2410-H-324-015-MY2]	Ministry of Science and Technology (MOST) of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology (MOST) of Taiwan and #MOST 102-2410-H-324-015-MY2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors would like to express their gratefulness to Ministry of Science and Technology (MOST) of Taiwan for sponsoring this study under grant number: MOST 102-2410-H-324-015-MY2.	AGNIHOTHRI SR, 1995, EUR J OPER RES, V80, P308, DOI 10.1016/0377-2217(94)00173-A; Archetti C, 2013, EUR J OPER RES, V230, P245, DOI 10.1016/j.ejor.2013.04.039; ArreolaRisa A, 1996, EUR J OPER RES, V89, P326, DOI 10.1016/0377-2217(94)00248-7; BANERJEE A, 1986, DECISION SCI, V17, P292, DOI 10.1111/j.1540-5915.1986.tb00228.x; Bjork KM, 2012, INT J PROD ECON, V135, P702, DOI 10.1016/j.ijpe.2011.10.003; Caggiano KE, 2009, EUR J OPER RES, V199, P744, DOI 10.1016/j.ejor.2008.08.002; Chiu SW, 2015, J SCI IND RES INDIA, V74, P555; Chiu SW, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1498-1; Chiu SGW, 2013, EXPERT SYST APPL, V40, P2669, DOI 10.1016/j.eswa.2012.11.008; Chiu Y-S P, 2012, INT J ENG MODEL, V25, P51; Chiu YSP, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1487-4; Chiu YSP, 2014, J SCI IND RES INDIA, V73, P648; Chiu YSP, 2010, MATH COMP MODEL DYN, V16, P373, DOI 10.1080/13873954.2010.511199; Chiu YSP, 2009, J SCI IND RES INDIA, V68, P505; Dixon P, 1981, J OPERATIONS MANAGEM, V2, P23; Gaalman GJ, 1978, MANAGE SCI, V24, P1733; Gomez J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152743; GOYAL SK, 1977, INT J PROD RES, V15, P107, DOI 10.1080/00207547708943107; Guerrero WJ, 2013, EUR J OPER RES, V231, P98, DOI 10.1016/j.ejor.2013.05.030; HAHM J, 1992, INT J PROD ECON, V28, P235, DOI 10.1016/0925-5273(92)90036-7; Haider A, 2015, ADV PROD ENG MANAG, V10, P5; Hishamuddin H, 2014, ECON MODEL, V38, P555, DOI 10.1016/j.econmod.2014.02.004; Jang W, 2013, EUR J OPER RES, V227, P464, DOI 10.1016/j.ejor.2013.01.013; Khedlekar UK, 2014, J SCI IND RES INDIA, V73, P294; Khoury BN, 2001, INT J PROD ECON, V73, P189, DOI 10.1016/S0925-5273(00)00175-4; Kuhn H, 2011, INT J PROD RES, V49, P3795, DOI 10.1080/00207543.2010.492406; Kwok JJM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132844; Li LH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134343; Lin GC, 2014, J SCI IND RES INDIA, V73, P149; Ma WN, 2010, MATH COMPUT MODEL, V52, P724, DOI 10.1016/j.mcm.2010.04.024; Masoumik SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143115; Meng XK, 2016, PHYSICA A, V442, P388, DOI 10.1016/j.physa.2015.08.031; Nahmias S, 2009, PRODUCTION OPERATIO; Ocampo LA, 2015, ADV PROD ENG MANAG, V10, P40; Pal S, 2015, ECON MODEL, V46, P334, DOI 10.1016/j.econmod.2014.12.031; Perez C, 2014, EUR J OPER RES, V237, P528, DOI 10.1016/j.ejor.2014.02.049; Rardin R.L., 1998, OPTIMIZATION OPERATI; ROSENBLATT MJ, 1990, OPER RES, V38, P686, DOI 10.1287/opre.38.4.686; Safaei M, 2014, ECON MODEL, V37, P224, DOI 10.1016/j.econmod.2013.10.018; Sarker BR, 2008, EUR J OPER RES, V184, P915, DOI 10.1016/j.ejor.2006.12.005; Silver E. A., 1998, INVENTORY MANAGEMENT; Taft EW., 1918, IRON AGE, V101, P1410; Teunter RH, 2003, OR SPECTRUM, V25, P85, DOI 10.1007/s00291-002-0105-3; Thomas DJ, 2003, EUR J OPER RES, V148, P363, DOI 10.1016/S0377-2217(02)00398-3; Tseng CT, 2014, ECON MODEL, V36, P30, DOI 10.1016/j.econmod.2013.09.013; Wee HM, 2013, OMEGA-INT J MANAGE S, V41, P941, DOI 10.1016/j.omega.2012.12.001; Wu M-F, 2014, J ENG RES, V2, P51; Xia CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129542; Xia CY, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/58002; ZIPKIN PH, 1986, OPER RES, V34, P91, DOI 10.1287/opre.34.1.91	50	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2016	11	12							e0167511	10.1371/journal.pone.0167511	http://dx.doi.org/10.1371/journal.pone.0167511			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4MR	27918588	Green Submitted, Green Published, gold			2022-12-27	WOS:000389577100012
J	Nguyen, PH; Young, M; Gonzalez-Casanova, I; Pham, HQ; Nguyen, H; Truong, TV; Nguyen, SV; Harding, KB; Reinhart, GA; Martorell, R; Ramakrishnan, U				Nguyen, Phuong H.; Young, Melissa; Gonzalez-Casanova, Ines; Pham, Hoa Q.; Hieu Nguyen; Truong, Truong V.; Nguyen, Son V.; Harding, Kimberly B.; Reinhart, Gregory A.; Martorell, Reynaldo; Ramakrishnan, Usha			Impact of Preconception Micronutrient Supplementation on Anemia and Iron Status during Pregnancy and Postpartum: A Randomized Controlled Trial in Rural Vietnam	PLOS ONE			English	Article							FOLIC-ACID SUPPLEMENTATION; REPRODUCTIVE AGE; INFANT OUTCOMES; HIGH PREVALENCE; BIRTH-WEIGHT; WOMEN; DEFICIENCY; NUTRITION; UNDERNUTRITION; FERRITIN	Objective Preconception micronutrient interventions may be a promising approach to reduce anemia and iron deficiency during pregnancy, but currently we have limited data to inform policies. We evaluated whether providing additional pre-pregnancy weekly iron-folic acid (IFA) or multiple micronutrient (MM) supplements compared to only folic acid (FA) improves iron status and anemia during pregnancy and early postpartum. Methods We conducted a double blind randomized controlled trial in which 5011 Vietnamese women were provided with weekly supplements containing either only 2800 mu g FA (control group), IFA (60 mg Fe and 2800 mu g FA) or MM (15 micronutrients with similar amounts of IFA). All women who became pregnant (n = 1813) in each of the 3 groups received daily IFA (60 mg Fe and 400 mu g FA) through delivery. Hematological indicators were assessed at baseline (pre-pregnancy), during pregnancy, 3 months post-partum, and in cord blood. Adjusted generalized linear models were applied to examine the impact of preconception supplementation on anemia and iron stores, using both intention to treat and per protocol analyses (women consumed supplements >= 26 weeks before conception). Results At baseline, 20% of women were anemic, but only 14% had low iron stores (ferritin < 30 mu g/L) and 3% had iron deficiency (ferritin < 12 mu g/L). The groups were balanced for baseline characteristics. Anemia prevalence increased during pregnancy and post-partum but was similar among intervention groups. In intention to treat analyses, prenatal ferritin was significantly higher among women receiving MM (geometric mean (mu g/ L) [95% CI]: 93.6 [89.3-98.2]) and IFA (91.9 [87.6-96.3]) compared to control (85.3 [81.5-89.2]). In per protocol analyses, women receiving MM or IFA had higher ferritin 3 months postpartum (MM 118.2 [109.3- 127.8]), IFA 117.8 [108.7-127.7] vs control 101.5 [94.0-109.7]) and gave birth to infants with greater iron stores (MM 184.3 [176.1-192.9]), IFA 189.9 [181.6-198.3] vs control 175.1 [167.9-182.6]). Conclusion Preconception supplementation with MM or IFA resulted in modest increases in maternal and infant iron stores but did not impact anemia. Further research is needed to characterize the etiology of anemia in this population and identify effective interventions for reducing prenatal anemia.	[Nguyen, Phuong H.] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Washington, DC 20036 USA; [Nguyen, Phuong H.; Pham, Hoa Q.; Hieu Nguyen; Truong, Truong V.; Nguyen, Son V.] Thai Nguyen Univ Pharm & Med, Thai Nguyen, Vietnam; [Young, Melissa; Gonzalez-Casanova, Ines; Martorell, Reynaldo] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Harding, Kimberly B.] Micronutr Initiat, Ottawa, ON, Canada; [Reinhart, Gregory A.] Mathile Inst Adv Human Nutr, Dayton, OH USA	CGIAR; International Food Policy Research Institute (IFPRI); Thai Nguyen University; Emory University; Rollins School Public Health	Nguyen, PH (corresponding author), Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Washington, DC 20036 USA.; Nguyen, PH (corresponding author), Thai Nguyen Univ Pharm & Med, Thai Nguyen, Vietnam.	P.H.Nguyen@cgiar.org	Gonzalez-Casanova, Ines/S-7398-2019; Martorell, Reynaldo/I-2539-2012	Gonzalez-Casanova, Ines/0000-0001-5747-8636; 	Mathile Institute for the Advancement of Human Nutrition; Micronutrient Initiative	Mathile Institute for the Advancement of Human Nutrition; Micronutrient Initiative	Funding for this research was provided by the Mathile Institute for the Advancement of Human Nutrition and the Micronutrient Initiative. KBH and GAR are employed by the institutions that funded the research. They participated in study design, but were not directly involved in the implementation of the study both during data collection and analysis.; Funding for this research was provided by the Mathile Institute for the Advancement of Human Nutrition and the Micronutrient Initiative. We would also like to express special thanks to Sight and Life for its generous donation of premixes from DSM Nutritional Products to produce all supplements for the research.	Allen LH, 2001, J NUTR, V131, p581S, DOI 10.1093/jn/131.2.581S; Angeles-Agdeppa I, 2005, NUTR REV, V63, pS116, DOI 10.1301/nr.2005.dec.S116-S125; [Anonymous], 2011, WEEKL IR FOL AC SUPP; [Anonymous], 2001, WHO TECHN REP SER; Berger J, 2005, NUTR REV, V63, pS95, DOI 10.1301/nr.2005.dec.S95-S108; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Cavalli-Sforza T, 2005, NUTR REV, V63, pS77, DOI 10.1301/nr.2005.dec.S77-S80; Cetin I, 2010, HUM REPROD UPDATE, V16, P80, DOI 10.1093/humupd/dmp025; Christian P, 2010, ANNU REV NUTR, V30, P83, DOI 10.1146/annurev.nutr.012809.104813; COOK JD, 1989, J INTERN MED, V226, P349, DOI 10.1111/j.1365-2796.1989.tb01408.x; Crape BL, 2005, NUTR REV, V63, pS134, DOI 10.1301/nr.2005.dec.S134-S138; De-Regil LM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007950.pub2; Dean SV, 2014, REPROD HEALTH, V11, DOI [10.1186/1742-4755-11-S3-S1, 10.1186/1742-4755-11-S3-S3]; Erhardt JG, 2004, J NUTR, V134, P3127, DOI 10.1093/jn/134.11.3127; Fernandez-Gaxiola AC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009218.pub2; Gibson R, 2005, PRINCIPLES NUTR ASSE; Gunaratna NS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121552; Haider BA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004905.pub4; Haider BA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3443; Institute of Medicine (IOM), 2009, WEIGHT GAIN PREGN RE; IOM, 2011, DIETARY REFERENCE IN; Karakochuk CD, 2015, J NUTR, V145, P134, DOI 10.3945/jn.114.198945; Khambalia AZ, 2009, AM J CLIN NUTR, V90, P1295, DOI 10.3945/ajcn.2009.28350; Kusama K, 2005, J AM COLL NUTR, V24, P466, DOI 10.1080/07315724.2005.10719492; Laillou A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034906; Lutter CK, 2011, PEDIATRICS, V128, pE1418, DOI 10.1542/peds.2011-1392; Merrill RD, 2012, ASIA PAC J CLIN NUTR, V21, P416; Khan NC, 2008, ASIA PAC J CLIN NUTR, V17, P409; Nguyen PH, 2015, EUR J CLIN NUTR, V69, P107, DOI 10.1038/ejcn.2014.181; Nguyen PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089504; Nguyen PH, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-126; Nguyen PH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-898; Nguyen Phuong H., 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P865; Otten J.J., 2006, DIETARY REFERENCE IN, DOI DOI 10.17226/11537; Pena-Rosas JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004736.pub4; Ramakrishnan U, 2016, J NUTR, V146, p1445S, DOI 10.3945/jn.115.223420; Ramakrishnan U, 2012, PAEDIATR PERINAT EP, V26, P153, DOI 10.1111/j.1365-3016.2012.01276.x; Ramakrishnan U, 2012, PAEDIATR PERINAT EP, V26, P285, DOI 10.1111/j.1365-3016.2012.01281.x; Rasmussen KM, 2003, AM J CLIN NUTR, V78, P673, DOI 10.1093/ajcn/78.4.673; Scholl TO, 2008, NESTLE NUTR WORKS SE, V61, P79, DOI 10.1159/0000113172; Siyame EWP, 2013, INT J VITAM NUTR RES, V83, P176, DOI 10.1024/0300-9831/a000158; Stevens GA, 2013, LANCET, V1, P16, DOI DOI 10.1016/S2214-109X(13)70001-9; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; UNICEF/WHO/United Nations University, 1999, COMP MULT SUPPL BE U; Viteri FE, 2005, NUTR REV, V63, pS65, DOI 10.1301/nr.2005.dec.S65-S76; World Health Organization, 2011, VITAMIN MINERAL NUTR; World Health Organization, 2011, GUID INT IR FOL AC S; World Health Organization (WHO), 2015, GLOB PREV AN 2011, DOI DOI 10.1017/S1368980008002401	49	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2016	11	12							e0167416	10.1371/journal.pone.0167416	http://dx.doi.org/10.1371/journal.pone.0167416			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MR	27918586	Green Published, gold, Green Submitted			2022-12-27	WOS:000389577100010
J	Benfatto, MN; Seimyr, GO; Ygge, J; Pansell, T; Rydberg, A; Jacobson, C				Benfatto, Mattias Nilsson; Seimyr, Gustaf Oqvist; Ygge, Jan; Pansell, Tony; Rydberg, Agneta; Jacobson, Christer			Screening for Dyslexia Using Eye Tracking during Reading	PLOS ONE			English	Article							BINOCULAR COORDINATION; SWEDISH POPULATION; MOVEMENTS; CLASSIFICATION; FIXATIONS; STUDENTS; MODEL	Dyslexia is a neurodevelopmental reading disability estimated to affect 5-10% of the population. While there is yet no full understanding of the cause of dyslexia, or agreement on its precise definition, it is certain that many individuals suffer persistent problems in learning to read for no apparent reason. Although it is generally agreed that early intervention is the best form of support for children with dyslexia, there is still a lack of efficient and objective means to help identify those at risk during the early years of school. Here we show that it is possible to identify 9-10 year old individuals at risk of persistent reading difficulties by using eye tracking during reading to probe the processes that underlie reading ability. In contrast to current screening methods, which rely on oral or written tests, eye tracking does not depend on the subject to produce some overt verbal response and thus provides a natural means to objectively assess the reading process as it unfolds in real-time. Our study is based on a sample of 97 high-risk subjects with early identified word decoding difficulties and a control group of 88 low-risk subjects. These subjects were selected from a larger population of 2165 school children attending second grade. Using predictive modeling and statistical resampling techniques, we develop classification models from eye tracking records less than one minute in duration and show that the models are able to differentiate high-risk subjects from low-risk subjects with high accuracy. Although dyslexia is fundamentally a language-based learning disability, our results suggest that eye movements in reading can be highly predictive of individual reading ability and that eye tracking can be an efficient means to identify children at risk of long-term reading difficulties.	[Benfatto, Mattias Nilsson; Seimyr, Gustaf Oqvist; Ygge, Jan; Pansell, Tony; Rydberg, Agneta] Karolinska Inst, Marianne Bernadotte Ctr, Div Ophthalmol & Vis, Dept Clin Neurosci, Stockholm, Sweden; [Jacobson, Christer] Linnaeus Univ, Dept Pedag, Vaxjo, Sweden	Karolinska Institutet; Linnaeus University	Benfatto, MN (corresponding author), Karolinska Inst, Marianne Bernadotte Ctr, Div Ophthalmol & Vis, Dept Clin Neurosci, Stockholm, Sweden.	mattias.nilsson@ki.se	Pansell, Tony/L-9487-2017	Nilsson, Mattias/0000-0002-8616-5273	Ulla and Ingemar Dahlberg Foundation; Sweden's Innovation Agency (VINNOVA); Promobilia Foundation	Ulla and Ingemar Dahlberg Foundation; Sweden's Innovation Agency (VINNOVA)(Vinnova); Promobilia Foundation	This work was supported by The Ulla and Ingemar Dahlberg Foundation; Sweden's Innovation Agency (VINNOVA), http://www.vinnova.se/; and The Promobilia Foundation, http://www.promobilia.se/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander-Passe N, 2006, DYSLEXIA, V12, P256, DOI 10.1002/dys.318; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Benson PJ, 2012, BIOL PSYCHIAT, V72, P716, DOI 10.1016/j.biopsych.2012.04.019; Bucci MP, 2008, GRAEF ARCH CLIN EXP, V246, P417, DOI 10.1007/s00417-007-0723-1; Clifton Charles Jr., 2007, P341, DOI 10.1016/B978-008044980-7/50017-3; Corinna C, 1995, MACH LEARN, V20, P1, DOI DOI 10.1007/BF00994018; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; EDEN GF, 1994, VISION RES, V34, P1345, DOI 10.1016/0042-6989(94)90209-7; Ellis AW, 1984, READING WRITING DYSL; ELTERMAN RD, 1980, J LEARN DISABIL, V13, P11, DOI 10.1177/002221948001300104; Fouganthine A., 2012, THESIS; Ghassemi E, 2013, J EYE MOVEMENT RES, V6; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Habib M, 2000, BRAIN, V123, P2373, DOI 10.1093/brain/123.12.2373; Huey E.B., 1908, PSYCHOL PEDAGOGY REA; Jacobson C, 1998, THESIS; Jainta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018694; JUST MA, 1980, PSYCHOL REV, V87, P329, DOI 10.1037/0033-295X.87.4.329; Kirkby JA, 2008, PSYCHOL BULL, V134, P742, DOI 10.1037/a0012979; Kirkby JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027105; Long L, 2007, J ADOLESC ADULT LIT, V51, P124, DOI 10.1598/JAAL.51.2.4; OLSON RK, 1983, EYE MOVEMENTS READIN, P467; PAVLIDIS GT, 1981, NEUROPSYCHOLOGIA, V19, P57, DOI 10.1016/0028-3932(81)90044-0; Pennington BF, 2012, J ABNORM PSYCHOL, V121, P212, DOI 10.1037/a0025823; Pennington BF, 2009, ANNU REV PSYCHOL, V60, P283, DOI 10.1146/annurev.psych.60.110707.163548; Platt J, 1998, ADV KERNEL METHODS S, V185, P208; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1981, J EXP PSYCHOL HUMAN, V7, P167, DOI 10.1037/0096-1523.7.1.167; Rayner K, 2003, PSYCHOL SCI, V14, P385, DOI 10.1111/1467-9280.24483; Rayner K., 2012, PSYCHOL READING, V2nd, DOI [10.4324/9780203155158, DOI 10.4324/9780203155158]; Rayner K, 1985, DEV NEUROPSYCHOL, V1, P3, DOI 10.1080/87565648509540294; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Riddick B., 1996, LIVING DYSLEXIA SOCI; RODGERS B, 1983, BRIT J EDUC PSYCHOL, V53, P369, DOI 10.1111/j.2044-8279.1983.tb02570.x; Rubino C A, 1973, Cortex, V9, P217; Sandak R, 2004, SCI STUD READ, V8, P273, DOI 10.1207/s1532799xssr0803_6; SBU, 2014, DYSL CHILDR AD TESTS; Shaywitz BA, 2004, BIOL PSYCHIAT, V55, P926, DOI 10.1016/j.biopsych.2003.12.019; Shaywitz SE, 2005, BIOL PSYCHIAT, V57, P1301, DOI 10.1016/j.biopsych.2005.01.043; Shaywitz SE, 1998, NEW ENGL J MED, V338, P307, DOI 10.1056/NEJM199801293380507; SHAYWITZ SE, 1992, NEW ENGL J MED, V326, P145, DOI 10.1056/NEJM199201163260301; Siegel Linda S, 2006, Paediatr Child Health, V11, P581; SIEGEL LS, 1989, J LEARN DISABIL-US, V22, P469, DOI 10.1177/002221948902200803; Stein J, 2001, Dyslexia, V7, P12, DOI 10.1002/dys.186; Tseng PH, 2013, J NEUROL, V260, P275, DOI 10.1007/s00415-012-6631-2; Vapnik V., 1998, STAT LEARNING THEORY; Vaughn S, 2010, SCHOOL PSYCHOL REV, V39, P3; Vellutino FR, 2004, J CHILD PSYCHOL PSYC, V45, P2, DOI 10.1046/j.0021-9630.2003.00305.x; Wang S, 2015, NEURON, V88, P604, DOI 10.1016/j.neuron.2015.09.042; Willcutt EG, 2000, J CHILD PSYCHOL PSYC, V41, P1039, DOI 10.1017/S0021963099006368; YGGE J, 1993, ACTA OPHTHALMOL, V71, P10; YGGE J, 1993, ACTA OPHTHALMOL, V71, P1	52	79	79	5	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0165508	10.1371/journal.pone.0165508	http://dx.doi.org/10.1371/journal.pone.0165508			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936148	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100011
J	Chen, CC; Hsu, YC; Lee, CT; Hsu, CC; Tai, CM; Wang, WL; Tseng, CH; Hsu, CT; Lin, JT; Chang, CY				Chen, Chih-Cheng; Hsu, Yao-Chun; Lee, Ching-Tai; Hsu, Chia-Chang; Tai, Chi-Ming; Wang, Wen-Lun; Tseng, Cheng-Hao; Hsu, Chao-Tien; Lin, Jaw-Town; Chang, Chi-Yang			Central Obesity and H-pylori Infection Influence Risk of Barrett's Esophagus in an Asian Population	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; BODY-MASS INDEX; CHINESE POPULATION; GENERAL-POPULATION; ABDOMINAL OBESITY; PREVALENCE; ASSOCIATION; SYMPTOMS; METAANALYSIS; DEFINITION	Background and Aim The prevalence rates of Barrett's esophagus (BE) in western countries are higher than Asian ones, but little is known about their difference among risk factors of BE. The aim of this study is to investigate the associations of various risk factors including central obesity, body mass index (BMI), metabolic syndrome and H. pylori infection, with BE. Methods A total of 161 subjects with BE were enrolled and compared to age-and gender-matched controls randomly sampled (1: 4) from check-up center in same hospital. Central obesity was defined by waist circumference (female>80cm; male> 90cm), metabolic syndrome by the modified National Cholesterol Education Program Adult Treatment Panel III criteria in Taiwan. Independent risk factors for BE were identified by multiple logistic regression analyses. Results The mean age for BE was 53.8 +/- 13.7 years and 75.8% was male. H. pylori infection status was detected by the rapid urease test with the prevalence of 28.4% and 44.4% in the BE patients and controls, respectively. The univariate logistic regression analyses showed the risk was associated with higher waist circumference (odds ratio [OR], 2.53; 95% confidence interval [CI], 1.78-3.60), metabolic syndrome (OR, 2.02; 95% CI, 1.38-2.96) and negative H. pylori infection (OR, 0.50; 95% CI, 0.34-0.74). However, multivariate logistic regression analyses revealed that BE associated with higher waist circumference (adjusted OR, 2.79; 95% CI, 1.89-4.12) and negative H. pylori infection (adjusted OR, 0.46; 95% CI, 0.30-0.70). Conclusions Central obesity is associated with a higher risk of BE whereas H. pylori infection with a lower risk in an ethnic Chinese population.	[Chen, Chih-Cheng; Hsu, Yao-Chun; Lee, Ching-Tai; Hsu, Chia-Chang; Tai, Chi-Ming; Wang, Wen-Lun; Tseng, Cheng-Hao; Lin, Jaw-Town; Chang, Chi-Yang] I Shou Univ, E Da Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Hsu, Chao-Tien] I Shou Univ, E Da Hosp, Dept Pathol, Kaohsiung, Taiwan; [Hsu, Yao-Chun; Lin, Jaw-Town; Chang, Chi-Yang] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Hsu, Yao-Chun; Lin, Jaw-Town; Chang, Chi-Yang] Fu Jen Catholic Univ, Big Data Res Ctr, New Taipei, Taiwan	E-Da Hospital; I Shou University; E-Da Hospital; I Shou University; Fu Jen Catholic University; Fu Jen Catholic University	Chang, CY (corresponding author), I Shou Univ, E Da Hosp, Dept Internal Med, Kaohsiung, Taiwan.; Chang, CY (corresponding author), Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan.; Chang, CY (corresponding author), Fu Jen Catholic Univ, Big Data Res Ctr, New Taipei, Taiwan.	chiyang1112@gmail.com	CHEN, CHIH-CHENG/L-6568-2019; Wang, Wen-Lun/AAJ-1281-2020; Lee, Ching-Tai/AAI-2048-2021	CHEN, CHIH-CHENG/0000-0003-0266-1534; 				Akiyama T, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-56; Amano Y, 2006, SCAND J GASTROENTERO, V41, P873, DOI 10.1080/00365520500535485; Anderson LA, 2007, WORLD J GASTROENTERO, V13, P1585, DOI 10.3748/wjg.v13.i10.1585; Cameron AJ, 1999, AM J GASTROENTEROL, V94, P2054; Campos GMR, 2001, ARCH SURG-CHICAGO, V136, P1267, DOI 10.1001/archsurg.136.11.1267; Chang CY, 2009, AM J GASTROENTEROL, V104, P13, DOI 10.1038/ajg.2008.43; Chen Q. Y., 2006, PRIMARY MEDICAL CARE, V21, P367; Cook MB, 2008, AM J GASTROENTEROL, V103, P292, DOI 10.1111/j.1572-0241.2007.01621.x; Corley DA, 2008, GUT, V57, P727, DOI 10.1136/gut.2007.132068; Corley DA, 2007, GASTROENTEROLOGY, V133, P34, DOI 10.1053/j.gastro.2007.04.046; Dore MP, 2016, SCAND J GASTROENTERO, P1; Edelstein ZR, 2007, GASTROENTEROLOGY, V133, P403, DOI 10.1053/j.gastro.2007.05.026; El-Serag HB, 2006, SCAND J GASTROENTERO, V41, P887, DOI 10.1080/00365520500535402; El-Serag HB, 2005, AM J GASTROENTEROL, V100, P2151, DOI 10.1111/j.1572-0241.2005.00251.x; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Fischbach LA, 2014, AM J GASTROENTEROL, V109, P357, DOI 10.1038/ajg.2013.443; International Diabetes Federation, IDF CONS WORLDW DEF; Kendall BJ, 2016, CLIN GASTROENTEROL H, V14, P1412, DOI 10.1016/j.cgh.2016.05.032; Kubo A, 2013, GUT, V62, P1684, DOI 10.1136/gutjnl-2012-303753; Mathew P, 2011, J GASTROEN HEPATOL, V26, P1151, DOI 10.1111/j.1440-1746.2011.06714.x; Peng S, 2009, ENDOSCOPY, V41, P1011, DOI 10.1055/s-0029-1215291; Rajendra S, 2004, DIGEST DIS SCI, V49, P237, DOI 10.1023/B:DDAS.0000017444.30792.94; Rex DK, 2003, GASTROENTEROLOGY, V125, P1670, DOI 10.1053/j.gastro.2003.09.030; Ronkainen J, 2005, GASTROENTEROLOGY, V129, P1825, DOI 10.1053/j.gastro.2005.08.053; Seidel D, 2009, DIS ESOPHAGUS, V22, P564, DOI 10.1111/j.1442-2050.2009.00967.x; Shaheen NJ, 2016, AM J GASTROENTEROL, V111, P30, DOI 10.1038/ajg.2015.322; Sharifi A, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/696294; Shaw MJ, 2001, AM J GASTROENTEROL, V96, P52; Shiota S, 2015, CLIN GASTROENTEROL H, V13, P1907, DOI 10.1016/j.cgh.2015.07.050; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Toruner M, 2004, J GASTROEN HEPATOL, V19, P535, DOI 10.1111/j.1440-1746.2003.03342.x; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Watari J, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-143; Wu JCY, 2007, GASTROENTEROLOGY, V132, P883, DOI 10.1053/j.gastro.2006.12.032; Xiong LS, 2010, J DIGEST DIS, V11, P83, DOI 10.1111/j.1751-2980.2010.00419.x; Yilmaz Nevin, 2006, Turk J Gastroenterol, V17, P79; Zagari RM, 2008, GUT, V57, P1354, DOI 10.1136/gut.2007.145177; Zhang HZ, 2012, CHIN J CANCER, V31, P281, DOI 10.5732/cjc.011.10390	38	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167815	10.1371/journal.pone.0167815	http://dx.doi.org/10.1371/journal.pone.0167815			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936223	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100204
J	Deiss, R; Bower, RJ; Co, E; Mesner, O; Sanchez, JL; Masel, J; Ganesan, A; Macalino, GE; Agan, BK				Deiss, Robert; Bower, Richard J.; Co, Edgie; Mesner, Octavio; Sanchez, Jose L.; Masel, Jennifer; Ganesan, Anuradha; Macalino, Grace E.; Agan, Brian K.			The Association between Sexually Transmitted Infections, Length of Service and Other Demographic Factors in the US Military	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS; GONORRHEA; SOLDIERS; SYSTEM; SURVEILLANCE; INSTALLATION; PREVALENCE; PERSONNEL; RATES; RISK	Background Numerous studies have found higher rates of sexually transmitted infections (STIs) among military personnel than the general population, but the cumulative risk of acquiring STIs throughout an individual's military career has not been described. Methods Using ICD-9 diagnosis codes, we analyzed the medical records of 100,005 individuals from all service branches, divided in equal cohorts (n = 6,667) between 1997 and 2011. As women receive frequent STI screening compared to men, these groups were analyzed separately. Incidence rates were calculated for pathogen-specific STIs along with syndromic diagnoses. Descriptive statistics were used to characterize the individuals within each accession year cohort; repeat infections were censored. Results The total sample included 29,010 females and 70,995 males. The STI incidence rates (per 100 person-years) for women and men, respectively, were as follows: chlamydia (3.5 and 0.7), gonorrhea (1.1 and 0.4), HIV (0.04 and 0.07) and syphilis (0.14 and 0.15). During the study period, 22% of women and 3.3% of men received a pathogen-specific STI diagnosis; inclusion of syndromic diagnoses increased STI prevalence to 41% and 5.5%, respectively. In multivariate analyses, factors associated with etiologic and syndromic STIs among women included African American race, younger age and fewer years of education. In the overall sample, increasing number of years of service was associated with an increased likelihood of an STI diagnosis (p<0.001 for trend). Conclusion In this survey of military personnel, we found very high rates of STI acquisition throughout military service, especially among women, demonstrating that STI-related risk is significant and ongoing throughout military service. Lower STI incidence rates among men may represent under-diagnosis and demonstrate a need for enhancing male-directed screening and diagnostic interventions.	[Deiss, Robert; Mesner, Octavio; Ganesan, Anuradha; Macalino, Grace E.; Agan, Brian K.] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Dept Prevent Med & Biostat, Bethesda, MD 20814 USA; [Deiss, Robert; Mesner, Octavio; Ganesan, Anuradha; Macalino, Grace E.; Agan, Brian K.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Deiss, Robert; Bower, Richard J.] Naval Med Ctr San Diego, San Diego, CA USA; [Co, Edgie] William Beaumont Army Med Ctr, El Paso, TX 79920 USA; [Sanchez, Jose L.] Def Hlth Agcy, Publ Hlth Div, Armed Forces Hlth Surveillance Branch, Silver Spring, MD USA; [Masel, Jennifer; Ganesan, Anuradha] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA	Uniformed Services University of the Health Sciences - USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; United States Department of Defense; United States Navy; Naval Medical Center San Diego; William Beaumont Army Medical Center; Walter Reed National Military Medical Center	Deiss, R (corresponding author), Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Dept Prevent Med & Biostat, Bethesda, MD 20814 USA.; Deiss, R (corresponding author), Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA.; Deiss, R (corresponding author), Naval Med Ctr San Diego, San Diego, CA USA.	rgdeiss@gmail.com	Co, Edgie-Mark/P-6825-2019	Agan, Brian/0000-0002-5114-1669	Department of Defense, National Institute of Allergic and Infectious Diseases; DoD Global Emerging Infections Surveillance and Response System (GEIS) Division of the Armed Forces Health Surveillance Center [IDCRP-069]; Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) program; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) [Y1-Al-5072];  [C0689-12-HS]	Department of Defense, National Institute of Allergic and Infectious Diseases; DoD Global Emerging Infections Surveillance and Response System (GEIS) Division of the Armed Forces Health Surveillance Center; Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) program; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); 	This work was supported by the Department of Defense, National Institute of Allergic and Infectious Diseases. Support for this work (IDCRP-069) was provided by the DoD Global Emerging Infections Surveillance and Response System (GEIS) Division of the Armed Forces Health Surveillance Center, award C0689-12-HS, and the Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) program executed through the Uniformed Services University of the Health Sciences. This project has been funded in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), under Inter-Agency Agreement Y1-Al-5072. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous WK, 2011, MIL MED, V176, P705, DOI 10.7205/MILMED-D-10-00218; Armed Forces Health Surveillance Center, 2013, MSMR, V20, P5; Armed Forces Health Surveillance Center (AFHSC), 2010, MED SURVEILLANCE MON, V17, P2; Barnett SD, 2001, SEX TRANSM INFECT, V77, P33, DOI 10.1136/sti.77.1.33; Berry-Caban CS, 2011, J VACCINES VACCIN; Brodine SK, 1998, J INFECT DIS, V178, P1202, DOI 10.1086/515685; Gaydos CA, 2000, CLIN INFECT DIS, V30, P719, DOI 10.1086/313758; Gaydos CA, 1998, NEW ENGL J MED, V339, P739, DOI 10.1056/NEJM199809103391105; Goyal V, 2012, J WOMENS HEALTH, V21, P1155, DOI 10.1089/jwh.2012.3605; Hakre S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-181; Jenkins PR, 2000, CLIN INFECT DIS, V30, P730, DOI 10.1086/313743; Jordan NN, 2011, MIL MED, V176, P312, DOI 10.7205/MILMED-D-10-00212; Masel J, 2015, SEX TRANSM DIS, V42, P253, DOI 10.1097/OLQ.0000000000000277; Nsouli-Maktabi Hala, 2013, MSMR, V20, P17; Rasnake Mark S, 2005, Mil Med, V170, P61; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; Sena AC, 2000, CLIN INFECT DIS, V30, P742, DOI 10.1086/313742; Shen-Gunther J, 2011, GYNECOL ONCOL, V123, P272, DOI 10.1016/j.ygyno.2011.07.094; Sutton TL, 2003, SEX TRANSM DIS, V30, P901, DOI 10.1097/01.OLQ.0000091136.14932.8B; US Centers for Disease Control and Prevention (CDC), 2000, CHLAM SCREEN PERC RE; Zenilman JM, 1999, SEX TRANSM DIS, V26, P75, DOI 10.1097/00007435-199902000-00002; Zenilman JM, 2002, SEX TRANSM INFECT, V78, P40, DOI 10.1136/sti.78.1.40	22	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167892	10.1371/journal.pone.0167892	http://dx.doi.org/10.1371/journal.pone.0167892			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936092	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100223
J	Gray, AE; Williams, ID; Stamoulis, KA; Boland, RC; Lino, KC; Hauk, BB; Leonard, JC; Rooney, JJ; Asher, JM; Lopes, KH; Kosaki, RK				Gray, Andrew E.; Williams, Ivor D.; Stamoulis, Kostantinos A.; Boland, Raymond C.; Lino, Kevin C.; Hauk, Brian B.; Leonard, Jason C.; Rooney, John J.; Asher, Jacob M.; Lopes, Keolohilani H., Jr.; Kosaki, Randall K.			Comparison of Reef Fish Survey Data Gathered by Open and Closed Circuit SCUBA Divers Reveals Differences in Areas With Higher Fishing Pressure	PLOS ONE			English	Article							FLIGHT INITIATION DISTANCE; UNDERWATER VISUAL SURVEYS; MARINE PROTECTED AREA; STRIP TRANSECT; IMPACTS; DENSITY; BIOMASS; SPEAR; SIZE; ASSEMBLAGES	Visual survey by divers using open-circuit (OC) SCUBA is the most widely used approach to survey coral reef fishes. Therefore, it is important to quantify sources of bias in OC surveys, such as the possibility that avoidance of OC divers by fishes can lead to undercounting in areas where targeted species have come to associate divers with a risk of being speared. One potential way to reduce diver avoidance is to utilize closed circuit rebreathers (CCRs), which do not produce the noise and bubbles that are a major source of disturbance associated with OC diving. For this study, we conducted 66 paired OC and CCR fish surveys in the Main Hawaiian Islands at locations with relatively high, moderate, and light fishing pressure. We found no significant differences in biomass estimates between OC and CCR surveys when data were pooled across all sites, however there were differences at the most heavily fished location, Oahu. There, biomass estimates from OC divers were significantly lower for several targeted fish groups, including surgeonfishes, targeted wrasses, and snappers, as well as for all targeted fishes combined, with mean OC biomass between 32 and 68% of mean CCR biomass. There were no clear differences between OC and CCR biomass estimates for these groups at sites with moderate or low fishing pressure, or at any location for other targeted fish groups, including groupers, parrotfishes, and goatfishes. Bias associated with avoidance of OC divers at heavily fished locations could be substantially reduced, or at least calibrated for, by utilization of CCR. In addition to being affected by fishing pressure, the extent to which avoidance of OC divers is problematic for visual surveys varies greatly among taxa, and is likely to be highly influenced by the survey methodology and dimensions used.	[Gray, Andrew E.; Williams, Ivor D.; Lino, Kevin C.; Rooney, John J.; Asher, Jacob M.] NOAA, Coral Reef Ecosyst Program, Ecosyst Sci Div, Pacific Isl Fisheries Sci Ctr, Honolulu, HI 96822 USA; [Gray, Andrew E.; Lino, Kevin C.; Rooney, John J.; Asher, Jacob M.] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Stamoulis, Kostantinos A.; Asher, Jacob M.] Curtin Univ, Dept Environm & Agr, Perth, WA, Australia; [Stamoulis, Kostantinos A.] Univ Hawaii Manoa, Dept Biol, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA; [Boland, Raymond C.] NOAA, Ecosyst Sci Div, Pacific Isl Fisheries Sci Ctr, Honolulu, HI USA; [Hauk, Brian B.; Leonard, Jason C.; Kosaki, Randall K.] NOAA, Papahanaumokuakea Marine Natl Monument, Honolulu, HI USA; [Lopes, Keolohilani H., Jr.] Univ Hawaii, Trop Conservat Biol & Environm Sci, Hilo, HI 96720 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System; University of Hawaii Manoa; Curtin University; University of Hawaii System; University of Hawaii Manoa; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System; University Hawaii Hilo	Gray, AE; Williams, ID (corresponding author), NOAA, Coral Reef Ecosyst Program, Ecosyst Sci Div, Pacific Isl Fisheries Sci Ctr, Honolulu, HI 96822 USA.; Gray, AE (corresponding author), Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA.	andrew.e.gray@noaa.gov; ivor.williams@noaa.gov		Stamoulis, Kostantinos/0000-0003-2688-4695; Kosaki, Randall/0000-0003-1363-5702; Williams, Ivor/0000-0002-9444-1020	NOAA's Coral Reef Conservation Program; NOAA Pacific Islands Fisheries Science Center	NOAA's Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA Pacific Islands Fisheries Science Center	Funding for surveys and to support program operation were provided by NOAA's Coral Reef Conservation Program (http://coralreef.noaa.gov) and by NOAA Pacific Islands Fisheries Science Center.	Allen SD, 2008, H0804 NOAA ADM; Ayotte P, 2015, PACIFIC ISLANDS FISH, P33; Bejarano I, 2014, CORAL REEFS, V33, P313, DOI 10.1007/s00338-014-1125-6; Bozec YM, 2011, MAR BIOL, V158, P969, DOI 10.1007/s00227-011-1623-9; CHAPMAN CJ, 1974, MAR BIOL, V27, P357, DOI 10.1007/BF00394372; Cole RG, 2007, MAR BIOL, V150, P1379, DOI 10.1007/s00227-006-0420-3; Colvocoresses J, 2007, FISH RES, V85, P130, DOI 10.1016/j.fishres.2007.01.012; Coral Reef Ecosystem Program; Pacific Islands Fisheries Science Center National Coral Reef Monitoring Program, 2015, NAT COR REEF MON PRO; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Dickens LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018965; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Dulvy NK, 2004, CAN J FISH AQUAT SCI, V61, P466, DOI 10.1139/F03-169; Everson A, 2001, P 2001 FISH S AM FIS, P108; Feary DA, 2011, CONSERV BIOL, V25, P341, DOI 10.1111/j.1523-1739.2010.01613.x; Feitoza BM, 2005, B MAR SCI, V76, P725; Fertl Dagmar, 1997, Aquatic Mammals, V23, P113; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Friedlander AM, 2003, CORAL REEFS, V22, P291, DOI 10.1007/s00338-003-0317-2; Froese R., 2015, WORLD WIDE WEB ELECT; Garcia-Sais JR, 2010, CORAL REEFS, V29, P277, DOI 10.1007/s00338-009-0582-9; Gillett R., 2006, SPEARFISHING PACIFIC; Glazier EW, 2012, SEAFOOD COMMUNITY RE; Gotanda KM, 2009, BEHAV ECOL SOCIOBIOL, V63, P1563, DOI 10.1007/s00265-009-0750-5; Harvey ES, 1998, MAR TECHNOL SOC J, V32, P3; Hawkins JP, 2004, BIOL CONSERV, V115, P213, DOI 10.1016/S0006-3207(03)00119-8; Holmes TH, 2013, LIMNOL OCEANOGR-METH, V11, P337, DOI 10.4319/lom.2013.11.337; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Januchowski-Hartley FA, 2013, ECOL LETT, V16, P191, DOI 10.1111/ele.12028; Januchowski-Hartley FA, 2012, MAR ECOL PROG SER, V469, P113, DOI 10.3354/meps09971; Januchowski-Hartley FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022761; JENNINGS S, 1995, J FISH BIOL, V47, P733, DOI 10.1111/j.1095-8649.1995.tb01938.x; Jennings S, 1997, CORAL REEFS, V16, P71, DOI 10.1007/s003380050061; Kittinger JN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123856; Kulbicki M, 1998, J EXP MAR BIOL ECOL, V222, P11, DOI 10.1016/S0022-0981(97)00133-0; Kulbicki M, 2005, CYBIUM, V29, P235; Kulbicki M, 1999, AQUAT LIVING RESOUR, V12, P315, DOI 10.1016/S0990-7440(99)00116-3; Kulbicki M, 2004, QUANTITATIVE ECOSYST; Lindfield SJ, 2014, METHODS ECOL EVOL, V5, P1061, DOI 10.1111/2041-210X.12262; Lobel P.S., 2005, P AM AC UND SCI U CO, P49; Meyer CG, 2007, FISH RES, V84, P301, DOI 10.1016/j.fishres.2006.11.004; Meyer CG, 2003, THESIS; Nadon MO, 2012, CONSERV BIOL, V26, P493, DOI 10.1111/j.1523-1739.2012.01835.x; Parrish FA, 2002, MAR TECHNOL SOC J, V36, P13, DOI 10.4031/002533202787914052; Pyle R., 1999, MIXED GAS CLOSED CIR; Pyle RL, 2000, MAR TECHNOL SOC J, V34, P82, DOI 10.4031/MTSJ.34.4.11; Pyle RL, 2015, VALUE CLOSED CIRCUIT; Radford CA, 2005, MAR FRESHW BEHAV PHY, V38, P259, DOI 10.1080/10236240500333908; Richards BL, 2011, B MAR SCI, V87, P55, DOI 10.5343/bms.2010.1019; Sala E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032742; Schmidt MB, 2006, FISH RES, V82, P131, DOI 10.1016/j.fishres.2006.08.014; Sieber A, 2010, UNDERWATER TECHNOL, V29, DOI 10.3723/ut.29.073; STANLEY DR, 1995, T AM FISH SOC, V124, P946, DOI 10.1577/1548-8659(1995)124<0946:EOSDOF>2.3.CO;2; STARCK WC, 1969, OCEANS, V1, P45; Stoffle BW, 2012, SOCIOCULTURAL IMPORT; Thompson AA, 1997, MAR ECOL PROG SER, V154, P53, DOI 10.3354/meps154053; Wagner Daniel, 2014, Marine Biodiversity Records, V7, pe68, DOI 10.1017/S1755267214000785; Williams ID, 2008, ENVIRON CONSERV, V35, P261, DOI 10.1017/S0376892908004876; Williams ID, 2006, MAR ECOL PROG SER, V310, P185, DOI 10.3354/meps310185; Williams ID, 2013, 1304 PIFSC ADM; Williams ID, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120516	60	22	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167724	10.1371/journal.pone.0167724	http://dx.doi.org/10.1371/journal.pone.0167724			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936044	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100164
J	Karakulah, G; Kurtoglu, KY; Unver, T				Karakulah, Gokhan; Kurtoglu, Kuaybe Yucebilgili; Unver, Turgay			PeTMbase: A Database of Plant Endogenous Target Mimics (eTMs)	PLOS ONE			English	Article							LONG NONCODING RNAS; MICRORNAS; STRESS; ROLES	MicroRNAs (miRNA) are small endogenous RNA molecules, which regulate target gene expression at post-transcriptional level. Besides, miRNA activity can be controlled by a newly discovered regulatory mechanism called endogenous target mimicry (eTM). In target mimicry, eTMs bind to the corresponding miRNAs to block the binding of specific transcript leading to increase mRNA expression. Thus, miRNA-eTM-target-mRNA regulation modules involving a wide range of biological processes; an increasing need for a comprehensive eTM database arose. Except miRSponge with limited number of Arabidopsis eTM data no available database and/or repository was developed and released for plant eTMs yet. Here, we present an online plant eTM database, called PeTMbase (http://petmbase.org), with a highly efficient search tool. To establish the repository a number of identified eTMs was obtained utilizing from high-throughput RNA-sequencing data of 11 plant species. Each transcriptome libraries is first mapped to corresponding plant genome, then long non-coding RNA (lncRNA) transcripts are characterized. Furthermore, additional lncRNAs retrieved from GREENC and PNRD were incorporated into the lncRNA catalog. Then, utilizing the lncRNA and miRNA sources a total of 2,728 eTMs were successfully predicted. Our regularly updated database, PeTMbase, provides high quality information regarding miRNA: eTM modules and will aid functional genomics studies particularly, on miRNA regulatory networks.	[Karakulah, Gokhan; Unver, Turgay] Dokuz Eylul Univ, Izmir Int Biomed & Genome Inst iBG Izmir, Izmir, Turkey; [Kurtoglu, Kuaybe Yucebilgili] Istanbul Medeniyet Univ, Dept Mol Biol & Genet, Istanbul, Turkey	Dokuz Eylul University; Istanbul Medeniyet University	Karakulah, G; Unver, T (corresponding author), Dokuz Eylul Univ, Izmir Int Biomed & Genome Inst iBG Izmir, Izmir, Turkey.	gokhan.karakulah@deu.edu.tr; turgay.unver@deu.edu.tr	Unver, Turgay/B-4819-2009; Kurtoglu, Kuaybe Yucebilgili/AAE-9731-2020; Karakulah, Gokhan/N-1342-2018	Unver, Turgay/0000-0001-6760-443X; Karakulah, Gokhan/0000-0001-6706-1375	Turkish Academy of Science (TUBA)	Turkish Academy of Science (TUBA)(Turkish Academy of Sciences)	This work was supported by Turkish Academy of Science (TUBA) with grant type GEBIP.	Banks IR, 2012, PLANT SIGNAL BEHAV, V7, P1188, DOI 10.4161/psb.21299; Chen DJ, 2012, NUCLEIC ACIDS RES, V40, pD1187, DOI 10.1093/nar/gkr823; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gupta PK, 2015, CURR SCI INDIA, V108, P1624; Ivashuta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021330; Jin JJ, 2013, BIOINFORMATICS, V29, P1068, DOI 10.1093/bioinformatics/btt107; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kersey PJ, 2016, NUCLEIC ACIDS RES, V44, pD574, DOI 10.1093/nar/gkv1209; Kurtoglu KY, 2014, FUNCT INTEGR GENOMIC, V14, P363, DOI 10.1007/s10142-013-0357-9; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Liu X, 2015, GENOM PROTEOM BIOINF, V13, P137, DOI 10.1016/j.gpb.2015.02.003; Gallart AP, 2016, NUCLEIC ACIDS RES, V44, pD1161, DOI 10.1093/nar/gkv1215; Poole Rebecca L., 2007, V406, P179; Quek XC, 2014, NUCLEIC ACIDS RES; Rodriguez RE, 2010, DEVELOPMENT, V137, P103, DOI 10.1242/dev.043067; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Szczesniak MW, 2016, PLANT CELL PHYSIOL, V57, DOI 10.1093/pcp/pcv201; Team RC, 2015, R LANG ENV STAT COMP; Thomson DW, 2016, NAT REV GENET, V17, P272, DOI 10.1038/nrg.2016.20; Todesco M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001031; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Unver Turgay, 2009, Int J Plant Genomics, V2009, P262463, DOI 10.1155/2009/262463; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang P, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav098; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Wu HJ, 2013, PLANT PHYSIOL, V161, P1875, DOI 10.1104/pp.113.215962; Yan J, 2012, PLANT CELL, V24, P415, DOI 10.1105/tpc.111.094144; Ye CY, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00743; Yi X, 2015, NUCLEIC ACIDS RES, V43, pD982, DOI 10.1093/nar/gku1162; Zhang H, 2013, MOL BIOL REP, V40, P6245, DOI 10.1007/s11033-013-2736-7; Zhao Y, 2016, NUCLEIC ACIDS RES, V44, pD203, DOI 10.1093/nar/gkv1252	34	38	40	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167698	10.1371/journal.pone.0167698	http://dx.doi.org/10.1371/journal.pone.0167698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936097	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100156
J	Kareva, I; Abou-Slaybi, A; Dodd, O; Dashevsky, O; Klement, GL				Kareva, Irina; Abou-Slaybi, Abdo; Dodd, Oliver; Dashevsky, Olga; Klement, Giannoula Lakka			Normal Wound Healing and Tumor Angiogenesis as a Game of Competitive Inhibition	PLOS ONE			English	Article							PLATELET HEMOSTATIC FUNCTIONS; ENDOTHELIAL GROWTH-FACTOR; ALPHA-GRANULE PROTEINS; HEPARIN AFFINITY; RELEASE; ENDOSTATIN; CANCER; STROMA; CELLS	Both normal wound healing and tumor angiogenesis are mitigated by the sequential, carefully orchestrated release of growth stimulators and inhibitors. These regulators are released from platelet clots formed at the sites of activated endothelium in a temporally and spatially controlled manner, and the order of their release depends on their affinity to glycosaminoglycans (GAG) such as heparan sulfate (HS) within the extracellular matrix, and platelet open canallicular system. The formation of vessel sprouts, triggered by angiogenesis regulating factors with lowest affinities for heparan sulfate (e.g. VEGF), is followed by vessel-stabilizing PDGF-B or bFGF with medium affinity for HS, and by inhibitors such as PF-4 and TSP-1 with the highest affinities for HS. The invasive wound-like edge of growing tumors has an overabundance of angiogenesis stimulators, and we propose that their abundance out-competes angiogenesis inhibitors, effectively preventing inhibition of angiogenesis and vessel maturation. We evaluate this hypothesis using an experimentally motivated agent-based model, and propose a general theoretical framework for understanding mechanistic similarities and differences between the processes of normal wound healing and pathological angiogenesis from the point of view of competitive inhibition.	[Kareva, Irina; Abou-Slaybi, Abdo; Dodd, Oliver; Dashevsky, Olga; Klement, Giannoula Lakka] Tufts Med Ctr, Floating Hosp Children, Boston, MA 02111 USA; [Kareva, Irina] Arizona State Univ, Math Computat & Modeling Sci Ctr, Tempe, AZ USA; [Dodd, Oliver] MIT, Boston, MA USA; [Dashevsky, Olga] Harvard Med Sch, Dana Farber Canc Inst, Dept Med, Dept Med Oncol, Boston, MA USA; [Klement, Giannoula Lakka] Tufts Med Ctr, Floating Hosp Children, Pediat Hematol Oncol, Boston, MA 02111 USA; [Klement, Giannoula Lakka] Tufts Univ, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA	Floating Hospital For Children; Tufts Medical Center; Arizona State University; Arizona State University-Tempe; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Floating Hospital For Children; Tufts Medical Center; Tufts University	Klement, GL (corresponding author), Tufts Med Ctr, Floating Hosp Children, Boston, MA 02111 USA.; Klement, GL (corresponding author), Tufts Med Ctr, Floating Hosp Children, Pediat Hematol Oncol, Boston, MA 02111 USA.; Klement, GL (corresponding author), Tufts Univ, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA.	Giannoula.Klement@tufts.edu	Klement, Giannoula Lakka/U-3091-2019		NIH [R01GM093050];  [R01GM093050-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093050] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by R01GM093050-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the editorial help of Allison Jenks in preparation of this manuscript. GLK would like to acknowledge funding from NIH R01GM093050 grant.	Abramovitch R, 1998, FEBS LETT, V425, P441, DOI 10.1016/S0014-5793(98)00283-X; Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; Blanco R, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006569; Boas SEM, 2013, MECH CHEM SIGNALING, P161; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Cervi D, 2008, BLOOD, V111, P1201, DOI 10.1182/blood-2007-04-084798; Chaplain MAJ, 2006, ANNU REV BIOMED ENG, V8, P233, DOI 10.1146/annurev.bioeng.8.061505.095807; Dejana E, 2009, CELL TISSUE RES, V335, P17, DOI 10.1007/s00441-008-0694-5; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; ELDOR A, 1987, SEMIN THROMB HEMOST, V13, P475, DOI 10.1055/s-2007-1003524; Estrella V, 2013, CANCER RES, V73, P1524, DOI 10.1158/0008-5472.CAN-12-2796; Etulain J, 2011, J THROMB HAEMOST, V9, P1562, DOI 10.1111/j.1538-7836.2011.04394.x; Etulain J, 2012, THROMB HAEMOSTASIS, V107, P99, DOI 10.1160/TH11-06-0443; FOLKMAN J, 1992, ADV EXP MED BIOL, V313, P355; Fukumura D, 2001, CANCER RES, V61, P6020; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gerhardt Holger, 2008, P68, DOI 10.1007/978-0-387-78632-2_6; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Italiano JE, 2009, J THROMB HAEMOST, V7, P173, DOI 10.1111/j.1538-7836.2009.03387.x; Italiano JE, 2003, J THROMB HAEMOST, V1, P1174, DOI 10.1046/j.1538-7836.2003.00290.x; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Jakobsson L, 2009, BIOCHEM SOC T, V37, P1233, DOI 10.1042/BST0371233; KLAGSBRUN M, 1985, P NATL ACAD SCI USA, V82, P805, DOI 10.1073/pnas.82.3.805; Klement GL, 2011, CURR PROTEOMICS, V8, P169; Klement GL, 2009, BLOOD, V113, P2835, DOI 10.1182/blood-2008-06-159541; Levine HA, 2001, B MATH BIOL, V63, P801, DOI 10.1006/bulm.2001.0240; Ma L, 2005, P NATL ACAD SCI USA, V102, P216, DOI 10.1073/pnas.0406682102; Ma L, 2001, BRIT J PHARMACOL, V134, P701, DOI 10.1038/sj.bjp.0704312; Mehdizadeh H, 2013, BIOMATERIALS, V34, P2875, DOI 10.1016/j.biomaterials.2012.12.047; Mekhail K, 2004, NAT CELL BIOL, V6, P642, DOI 10.1038/ncb1144; Peirce S, 2008, MICROCIRCULATION, V15, P739, DOI 10.1080/10739680802220331; Peterson JE, 2010, AM J HEMATOL, V85, P487, DOI 10.1002/ajh.21732; SHING Y, 1984, SCIENCE, V223, P1296, DOI 10.1126/science.6199844; VLODAVSKY I, 1995, THROMB HAEMOSTASIS, V74, P534; Vlodavsky I, 1988, Adv Exp Med Biol, V233, P201; Vlodavsky I, 2011, RAMBAM MAIMONIDES ME, V2, DOI 10.5041/RMMJ.10019; Xie L, 2011, P NATL ACAD SCI USA, V108, P9939, DOI 10.1073/pnas.1105041108	37	21	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166655	10.1371/journal.pone.0166655	http://dx.doi.org/10.1371/journal.pone.0166655			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935954	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100039
J	Kattke, MD; Chan, AH; Duong, A; Sexton, DL; Sawaya, MR; Cascio, D; Elliot, MA; Clubb, RT				Kattke, Michele D.; Chan, Albert H.; Duong, Andrew; Sexton, Danielle L.; Sawaya, Michael R.; Cascio, Duilio; Elliot, Marie A.; Clubb, Robert T.			Crystal Structure of the Streptomyces coelicolor Sortase E1 Transpeptidase Provides Insight into the Binding Mode of the Novel Class E Sorting Signal	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; STAPHYLOCOCCUS-AUREUS; SURFACE-PROTEINS; CELL-WALL; SUBSTRATE-SPECIFICITY; KINETIC MECHANISM; ACCURATE DOCKING; LIGATION; SITE; DATABASE	Many species of Gram-positive bacteria use sortase transpeptidases to covalently affix proteins to their cell wall or to assemble pili. Sortase-displayed proteins perform critical and diverse functions for cell survival, including cell adhesion, nutrient acquisition, and morphological development, among others. Based on their amino acid sequences, there are at least six types of sortases (class A to F enzymes); however, class E enzymes have not been extensively studied. Class E sortases are used by soil and freshwater-dwelling Actinobacteria to display proteins that contain a non-canonical LAXTG sorting signal, which differs from 90% of known sorting signals by substitution of alanine for proline. Here we report the first crystal structure of a class E sortase, the 1.93 angstrom resolution structure of the SrtE1 enzyme from Streptomyces coelicolor. The active site is bound to a tripeptide, providing insight into the mechanism of substrate binding. SrtE1 possesses beta 3/beta 4 and beta 6/beta 7 active site loops that contact the LAXTG substrate and are structurally distinct from other classes. We propose that SrtE1 and other class E sortases employ a conserved tyrosine residue within their beta 3/beta 4 loop to recognize the amide nitrogen of alanine at position P3 of the sorting signal through a hydrogen bond, as seen here. Incapability of hydrogen-bonding with canonical proline-containing sorting signals likely contributes to class E substrate specificity. Furthermore, we demonstrate that surface anchoring of proteins involved in aerial hyphae formation requires an N-terminal segment in SrtE1 that is presumably positioned within the cytoplasm. Combined, our results reveal unique features within class E enzymes that enable them to recognize distinct sorting signals, and could facilitate the development of substrate-based inhibitors of this important enzyme family.	[Kattke, Michele D.; Sawaya, Michael R.; Cascio, Duilio] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Kattke, Michele D.] Univ Calif Los Angeles, Mol Biol Interdept Program, Los Angeles, CA USA; [Chan, Albert H.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Duong, Andrew; Sexton, Danielle L.; Elliot, Marie A.] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Duong, Andrew; Sexton, Danielle L.; Elliot, Marie A.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Clubb, Robert T.] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [Clubb, Robert T.] Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Yale University; McMaster University; McMaster University; University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles	Clubb, RT (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.; Clubb, RT (corresponding author), Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Los Angeles, CA USA.	rclubb@mbi.ucla.edu		Sawaya, Michael/0000-0003-0874-9043	Canadian Institutes of Health Research [MOP-137004]; National Institutes of Health [R01 AI52217, P41 GM103403, S10 RR029205, AI52217]; U.S. Department of Energy Office of Science, Office of Biological and Environmental Research [DE-FC02-02ER63421, DE-AC02-06CH11357]; UCLA Eugene V. Cota-Robles Fellowship; UCLA Philip Whitcome Pre-doctoral Fellowship in Molecular Biology through the UCLA Molecular Biology Institute; National Center for Research Resources [5P41RR015301-10]; National Institute of General Medical Sciences from the National Institutes of Health [P41 GM103403]; National Institutes of Health Office of Research Infrastructure Programs High-End Instrumentation Grant Program [S10 RR029205]; DOE Office of Science [DE-AC02-06CH11357]; Eugene V. Cota-Robles Fellowship through the UCLA Graduate Division; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301, S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016336] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); UCLA Eugene V. Cota-Robles Fellowship; UCLA Philip Whitcome Pre-doctoral Fellowship in Molecular Biology through the UCLA Molecular Biology Institute; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); National Institutes of Health Office of Research Infrastructure Programs High-End Instrumentation Grant Program; DOE Office of Science(United States Department of Energy (DOE)); Eugene V. Cota-Robles Fellowship through the UCLA Graduate Division; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) under award number MOP-137004 and the National Institutes of Health (https://www.nih.gov/) under award number R01 AI52217, P41 GM103403 and S10 RR029205. This work was also partially supported by the U.S. Department of Energy Office of Science, Office of Biological and Environmental Research program under award number DE-FC02-02ER63421 and DE-AC02-06CH11357. MDK was supported by a UCLA Eugene V. Cota-Robles Fellowship and a UCLA Philip Whitcome Pre-doctoral Fellowship in Molecular Biology through the UCLA Molecular Biology Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge Michael Collazo from the UCLA-DOE Institute Macromolecular Crystallization Core Technology Facility, as well as M. Capel, K. Rajashankar, N. Sukumar, J. Schuermann, I. Kourinov, F. Murphy, S. Banerjee, K. Perry, and D. Neau at NECAT beamline 24-ID-C of the Argonne National Laboratory APS for assistance with X-ray data collection. The Pilatus 6M detector on 24-ID-C beam line is supported by grants from the National Center for Research Resources (5P41RR015301-10), the National Institute of General Medical Sciences (P41 GM103403) from the National Institutes of Health, and the National Institutes of Health Office of Research Infrastructure Programs High-End Instrumentation Grant Program (S10 RR029205). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. This material is based upon work supported by the U.S. Department of Energy Office of Science, Office of Biological and Environmental Research under award number DE-FC02-02ER63421, the National Institutes of Health under award number AI52217, and the Canadian Institutes of Health Research under award number MOP-137004. We would also like to thank David Capstick, Christina Di Berardo, and Kanishk Jain for their technical assistance. M.D.K. was supported by the Eugene V. Cota-Robles Fellowship through the UCLA Graduate Division and the Philip Whitcome Pre-doctoral Fellowship in Molecular Biology through the UCLA Molecular Biology Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amer BR, 2016, J BIOMOL NMR, V64, P197, DOI 10.1007/s10858-016-0019-z; Antos JM, 2016, CURR OPIN STRUC BIOL, V38, P111, DOI 10.1016/j.sbi.2016.05.021; Atilano ML, 2010, P NATL ACAD SCI USA, V107, P18991, DOI 10.1073/pnas.1004304107; Bradshaw WJ, 2015, FEBS J, V282, P2097, DOI 10.1111/febs.13288; Cascioferro S, 2014, MICROB PATHOGENESIS, V77, P105, DOI 10.1016/j.micpath.2014.10.007; Case D.A., 2022, AMBER; Chan AH, 2015, J BIOL CHEM, V290, P25461, DOI 10.1074/jbc.M115.670984; Clancy KW, 2010, BIOPOLYMERS, V94, P385, DOI 10.1002/bip.21472; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Dorr BM, 2014, P NATL ACAD SCI; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Duong A, 2016, LIQUID CHROMATOGRAPH, P99; Duong A, 2012, MOL MICROBIOL, V83, P992, DOI 10.1111/j.1365-2958.2012.07983.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elliot MA, 2003, GENE DEV, V17, P1727, DOI 10.1101/gad.264403; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fitzgerald-Hughes D, 2012, FEMS IMMUNOL MED MIC, V65, P399, DOI 10.1111/j.1574-695X.2012.00954.x; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Frankel BA, 2005, BIOCHEMISTRY-US, V44, P11188, DOI 10.1021/bi050141j; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gregory MA, 2003, J BACTERIOL, V185, P5320, DOI 10.1128/JB.185.17.5320-5323.2003; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; Huang XY, 2003, BIOCHEMISTRY-US, V42, P11307, DOI 10.1021/bi034391g; Jacobitz AW, 2014, J BIOL CHEM, V289, P8891, DOI 10.1074/jbc.M113.509273; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keijser BJF, 2000, J MOL MICROB BIOTECH, V2, P565; Krishnan V, 2015, IUBMB LIFE, V67, P533, DOI 10.1002/iub.1400; Kruger RG, 2004, BIOCHEMISTRY-US, V43, P1541, DOI 10.1021/bi035920j; Kruger RG, 2004, ANAL BIOCHEM, V326, P42, DOI 10.1016/j.ab.2003.10.023; Liew CK, 2004, FEBS LETT, V571, P221, DOI 10.1016/j.febslet.2004.06.070; Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Popp MWL, 2011, ANGEW CHEM INT EDIT, V50, P5024, DOI 10.1002/anie.201008267; Proft T, 2010, BIOTECHNOL LETT, V32, P1, DOI 10.1007/s10529-009-0116-0; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Ritzefeld M, 2014, CHEM-EUR J, V20, P8516, DOI 10.1002/chem.201402072; Ruzin A, 2002, J BACTERIOL, V184, P2141, DOI 10.1128/JB.184.8.2141-2147.2002; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schmohl L, 2014, CURR OPIN CHEM BIOL, V22, P122, DOI 10.1016/j.cbpa.2014.09.020; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Schneewind O, 2014, BBA-MOL CELL RES, V1843, P1687, DOI 10.1016/j.bbamcr.2013.11.009; Scott JR, SURFACE PROTEINS GRA; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Spirig T, 2011, MOL MICROBIOL, V82, P1044, DOI 10.1111/j.1365-2958.2011.07887.x; Suree N, 2007, MINI-REV MED CHEM, V7, P991, DOI 10.2174/138955707782110097; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Suryadinata R, 2015, ACTA CRYST, V71; Ta HT, 2012, TRENDS CARDIOVAS MED, V22, P105, DOI 10.1016/j.tcm.2012.07.004; Tsukiji S, 2009, CHEMBIOCHEM, V10, P787, DOI 10.1002/cbic.200800724; Tubert-Brohman I, 2013, J CHEM INF MODEL, V53, P1689, DOI 10.1021/ci400128m; van't Hof W, 2015, BIOL CHEM, V396, P283, DOI 10.1515/hsz-2014-0260; Zhang J, 2014, P NATL ACAD SCI USA, V111, P13517, DOI 10.1073/pnas.1408601111; Zong YN, 2004, J BIOL CHEM, V279, P31383, DOI 10.1074/jbc.M401374200	60	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167763	10.1371/journal.pone.0167763	http://dx.doi.org/10.1371/journal.pone.0167763			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936128	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100179
J	Ortner, CNM; Ste Marie, M; Corno, D				Ortner, Catherine Nicole Marie; Ste Marie, Mark; Corno, Daniela			Cognitive Costs of Reappraisal Depend on Both Emotional Stimulus Intensity and Individual Differences in Habitual Reappraisal	PLOS ONE			English	Article							SEX-DIFFERENCES; CONSEQUENCES; METAANALYSIS; DISTRACTION; ABILITY; MEMORY	Recent models of emotion regulation suggest that the cognitive costs of reappraisal depend on stimulus intensity and habitual reappraisal. In the current experiment, we tested these hypotheses by manipulating the intensity of unpleasant and pleasant images, which participants reappraised, viewed, or suppressed their emotions to. To assess cognitive costs, we measured participants' performance on a concurrent simple reaction time task. Participants also reported on their everyday use of reappraisal and suppression. Higher intensity stimuli were associated with greater cognitive costs of reappraisal, for unpleasant, but not pleasant pictures. Also, greater habitual reappraisal predicted lower cognitive costs of reappraisal and greater reductions in subjective feelings. Results support the role of stimulus intensity and habitual use of reappraisal in predicting the cognitive costs of reappraisal.	[Ortner, Catherine Nicole Marie; Ste Marie, Mark; Corno, Daniela] Thompson Rivers Univ, Kamloops, BC, Canada		Ortner, CNM (corresponding author), Thompson Rivers Univ, Kamloops, BC, Canada.	cortner@tru.ca	Corno, Daniela/T-7217-2019	Ortner, Catherine/0000-0002-2250-3608	Social Sciences and Humanities Research Council of Canada [430-2014-00626]	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This work was supported by the Social Sciences and Humanities Research Council of Canada, http://www.sshrc.crsh.gc.ca/, Grant number 430-2014-00626. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguley T, 2009, BRIT J PSYCHOL, V100, P603, DOI 10.1348/000712608X377117; Codispoti M, 2008, INT J PSYCHOPHYSIOL, V69, P90, DOI 10.1016/j.ijpsycho.2008.03.004; Denny BT, 2014, EMOTION, V14, P425, DOI 10.1037/a0035276; Domes G, 2010, HUM BRAIN MAPP, V31, P758, DOI 10.1002/hbm.20903; Gardener EKT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073475; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Gross JJ, 2001, CURR DIR PSYCHOL SCI, V10, P214, DOI 10.1111/1467-8721.00152; Hoffman L, 2007, BEHAV RES METHODS, V39, P101, DOI 10.3758/BF03192848; Hopp H, 2011, COGNITION EMOTION, V25, P532, DOI 10.1080/02699931.2010.532606; Judd CM, 2012, J PERS SOC PSYCHOL, V103, P54, DOI 10.1037/a0028347; Kalisch R, 2009, NEUROSCI BIOBEHAV R, V33, P1215, DOI 10.1016/j.neubiorev.2009.06.003; Kalokerinos E. K., 2014, EMOTION; Lang P.J., 2008, A8 U FLOR; McRae K, 2012, J RES PERS, V46, P2, DOI 10.1016/j.jrp.2011.10.003; Nelis D, 2011, PSYCHOL BELG, V51, P49, DOI 10.5334/pb-51-1-49; Ortner CNM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062750; Ortner CNM, 2013, MOTIV EMOTION, V37, P346, DOI 10.1007/s11031-012-9310-9; Parvaz MA, 2012, COGN AFFECT BEHAV NE, V12, P730, DOI 10.3758/s13415-012-0107-9; Pe ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069071; Richards JM, 2000, J PERS SOC PSYCHOL, V79, P410, DOI 10.1037//0022-3514.79.3.410; Richards JM, 1999, PERS SOC PSYCHOL B, V25, P1033, DOI 10.1177/01461672992511010; Riediger M, 2011, EMOTION, V11, P656, DOI 10.1037/a0022756; Riediger M, 2009, PSYCHOL SCI, V20, P1529, DOI 10.1111/j.1467-9280.2009.02473.x; Shafir R, 2016, SOC COGN AFFECT NEUR; Sheppes G, 2007, PERS SOC PSYCHOL B, V33, P1518, DOI 10.1177/0146167207305537; Sheppes G, 2014, J EXP PSYCHOL GEN, V143, P163, DOI 10.1037/a0030831; Sheppes G, 2011, PERS SOC PSYCHOL REV, V15, P319, DOI 10.1177/1088868310395778; Sheppes G, 2009, INT J PSYCHOPHYSIOL, V71, P91, DOI 10.1016/j.ijpsycho.2008.06.006; Sheppes G, 2008, EMOTION, V8, P870, DOI 10.1037/a0013711; Smith JC, 2005, BIOL PSYCHOL, V69, P247, DOI 10.1016/j.biopsycho.2004.09.001; Stevens JS, 2012, NEUROPSYCHOLOGIA, V50, P1578, DOI 10.1016/j.neuropsychologia.2012.03.011; Thiruchselvam R, 2011, BIOL PSYCHOL, V87, P84, DOI 10.1016/j.biopsycho.2011.02.009; Troy AS, 2010, EMOTION, V10, P783, DOI 10.1037/a0020262; Webb TL, 2012, PSYCHOL BULL, V138, P775, DOI 10.1037/a0027600; Weber H, 2014, COGNITION EMOTION, V28, P345, DOI 10.1080/02699931.2013.832152	38	25	25	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167253	10.1371/journal.pone.0167253	http://dx.doi.org/10.1371/journal.pone.0167253			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936022	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100079
J	Qi, L; Xiong, Y; Xiao, BZ; Tang, WG; Ling, H; Long, J; Xiao, DY; Zhao, H; Ye, S; Chen, S; Yu, Z; Li, Q				Qi, Li; Xiong, Yu; Xiao, Bangzhong; Tang, Wenge; Ling, Hua; Long, Jiang; Xiao, Dayong; Zhao, Han; Ye, Sheng; Chen, Shuang; Yu, Zhen; Li, Qin			Epidemiological and Virological Characteristics of Influenza in Chongqing, China, 2011-2015	PLOS ONE			English	Article							SENTINEL SURVEILLANCE; MORTALITY; SEASONALITY; PNEUMONIA; ILLNESS; VIRUSES	Background Chongqing is the largest municipality and located in Southwestern of China, with over 30 million registered inhabitants. There are few reports regarding the epidemiology of influenza in Chongqing. The objective of the paper is to explore the epidemiology of influenza in Chongqing, in order to provide scientific basis for prevention and control of influenza. Methodology /Principal Findings From 2011 to 2015, we collected information on influenza-like illness (ILI) patients fulfilling the case definition, and took nasalpharyngeal or throat swabs specimens from ILI cases per week at the 7 sentinel hospitals. Specimens were tested by reverse transcription-polymerase chain reaction(RT-PCR) for influenza. Descriptive epidemiology was applied to analyze the epidemiology and etiology of influenza. A total of 9,696,212 cases were enrolled, of which 111,589 were ILI. Of those 24,868 samples from ILI cases, 13.3% (3,314/24,868) tested positive for influenza virus (65.7% influenza A, 34.1% influenza B, and 0.2% influenza A and B co-infection). Among the influenza A viruses, 71.3% were seasonal influenza A (H3N2) and 28.7% were influenza A(H1N1)pdm09. No cases of seasonal A(H1N1) were detected. The isolation rate was highest in children aged 5-14 years old. Influenza activity consistently peaked during January-March in 2011-2015, and June-July in 2012, 2014 and 2015. Conclusions Influenza is an important public health problem among ILI patients in Chongqing, especially among school-aged children. It might be beneficial to prioritize influenza vaccination for school-aged children and implement the school-based intervention to prevent and mitigating influenza outbreaks in Chongqing, particularly during the seasonal peaks.	[Qi, Li; Xiong, Yu; Xiao, Bangzhong; Tang, Wenge; Ling, Hua; Long, Jiang; Xiao, Dayong; Zhao, Han; Ye, Sheng; Chen, Shuang; Yu, Zhen; Li, Qin] Chongqing Municipal Ctr Dis Control & Prevent, Chongqing, Peoples R China; [Qi, Li] 8,Changjiang 2nd Rd, Chongqing, Peoples R China		Li, Q (corresponding author), Chongqing Municipal Ctr Dis Control & Prevent, Chongqing, Peoples R China.	qili19812012@126.com			Chinese Center for Disease Control and Prevention; Chongqing Health and Family Planning Commission	Chinese Center for Disease Control and Prevention; Chongqing Health and Family Planning Commission	Our study was funded by the Chinese Center for Disease Control and Prevention (http://www.chinaivdc.cn/cnic/en/) and Chongqing Health and Family Planning Commission (http://www.cqwsjsw.gov.cn/).	Beckett CG, 2004, CLIN INFECT DIS, V39, P443, DOI 10.1086/422314; Bennet R, 2016, VACCINE, V34, P3298, DOI 10.1016/j.vaccine.2016.04.082; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Blair PJ, 2010, EPIDEMIOL INFECT, V138, P199, DOI 10.1017/S095026880999063X; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Caini S, 2015, INFLUENZA OTHER RESP, V9, P3, DOI 10.1111/irv.12319; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Arango AE, 2015, INFLUENZA OTHER RESP, V9, P1, DOI 10.1111/irv.12271; Feng LZ, 2012, B WORLD HEALTH ORGAN, V90, P279, DOI 10.2471/BLT.11.096958; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; Grohskopf LA, 2015, AM J TRANSPLANT, V15, P2767, DOI 10.1111/ajt.13505; Jhung MA, 2011, CLIN INFECT DIS, V52, pS13, DOI 10.1093/cid/ciq008; Lutwama JJ, 2012, J INFECT DIS, V206, pS87, DOI 10.1093/infdis/jis578; Moura FEA, 2009, AM J TROP MED HYG, V81, P180, DOI 10.4269/ajtmh.2009.81.180; Nguyen HT, 2009, VACCINE, V28, P398, DOI 10.1016/j.vaccine.2009.09.139; Nguyen YT, 2013, VACCINE, V31, P4368, DOI 10.1016/j.vaccine.2013.07.018; Oliveira WK, 2009, EUROSURVEILLANCE, V14, P16; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Simmerman JM, 2009, PLOS ONE, V4, pA107, DOI 10.1371/journal.pone.0007776; Tarnagda Z, 2014, INFLUENZA OTHER RESP, V8, P524, DOI 10.1111/irv.12259; Vongphrachanh P, 2010, INFLUENZA OTHER RESP, V4, P47, DOI 10.1111/j.1750-2659.2009.00120.x; Wang H, 2014, VACCINE, V32, P973, DOI 10.1016/j.vaccine.2013.12.013; Wang W, 2010, J CLIN VIROL, V49, P211, DOI 10.1016/j.jcv.2010.08.005; WHO, WHO REC SURV STAND S; Yaka P, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-34; Yu HJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001552; Zaman RU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008452	27	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167866	10.1371/journal.pone.0167866	http://dx.doi.org/10.1371/journal.pone.0167866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936139	Green Submitted, gold, Green Published			2022-12-27	WOS:000389587100221
J	Sarpras, M; Gaur, R; Sharma, V; Chhapekar, SS; Das, J; Kumar, A; Yadava, SK; Nitin, M; Brahma, V; Abraham, SK; Ramchiary, N				Sarpras, M.; Gaur, Rashmi; Sharma, Vineet; Chhapekar, Sushil Satish; Das, Jharna; Kumar, Ajay; Yadava, Satish Kumar; Nitin, Mukesh; Brahma, Vijaya; Abraham, Suresh K.; Ramchiary, Nirala			Comparative Analysis of Fruit Metabolites and Pungency Candidate Genes Expression between Bhut Jolokia and Other Capsicum Species	PLOS ONE			English	Article							ANNUUM L.; CAPSAICINOID CONTENT; VOLATILE COMPOUNDS; PROVIDES INSIGHTS; ASCORBIC-ACID; PEPPERS; BIOSYNTHESIS; ACCUMULATION; CHINENSE; ANALOGS	Bhut jolokia, commonly known as Ghost chili, a native Capsicum species found in North East India was recorded as the naturally occurring hottest chili in the world by the Guinness Book of World Records in 2006. Although few studies have reported variation in pungency content of this particular species, no study till date has reported detailed expression analysis of candidate genes involved in capsaicinoids (pungency) biosynthesis pathway and other fruit metabolites. Therefore, the present study was designed to evaluate the diversity of fruit morphology, fruiting habit, capsaicinoids and other metabolite contents in 136 different genotypes mainly collected from North East India. Significant intra and inter-specific variations for fruit morphological traits, fruiting habits and 65 fruit metabolites were observed in the collected Capsicum germplasm belonging to three Capsicum species i.e., Capsicum chinense (Bhut jolokia, 63 accessions), C. frutescens (17 accessions) and C. annuum (56 accessions). The pungency level, measured in Scoville Heat Unit (SHU) and antioxidant activity measured by 2, 2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging assay showed maximum levels in C. chinense accessions followed by C. frutescens accessions, while C. annuum accessions showed the lowest value for both the traits. The number of different fruit metabolites detected did not vary significantly among the different species but the metabolite such as benzoic acid hydroxyl esters identified in large percentage in majority of C. annuum genotypes was totally absent in the C. chinense genotypes and sparingly present in few genotypes of C. frutescens. Significant correlations were observed between fruit metabolites capsaicin, dihydrocapsaicin, hexadecanoic acid, cyclopentane, a-tocopherol and antioxidant activity. Furthermore, comparative expression analysis (through qRTPCR) of candidate genes involved in capsaicinoid biosynthesis pathway revealed many fold higher expression of majority of the genes in C. chinense compared to C. frutescens and C. annuum suggesting that the possible reason for extremely high pungency might be due to the higher level of candidate gene(s) expression although nucleotide variation in pungency related genes may also be involved in imparting variations in level of pungency.	[Sarpras, M.; Gaur, Rashmi; Sharma, Vineet; Chhapekar, Sushil Satish; Kumar, Ajay; Nitin, Mukesh; Ramchiary, Nirala] Jawaharlal Nehru Univ, Sch Life Sci, Translat & Evolutionary Genom Lab, New Delhi, India; [Das, Jharna] Gauhati Univ, Dept Biol Sci, Gauhati, Assam, India; [Kumar, Ajay] Cent Univ Kerala, Sch Biol Sci, Dept Plant Sci, Kasaragod, Kerala, India; [Yadava, Satish Kumar] Univ Delhi, Ctr Genet Manipulat Crop Plants, South Campus,Benito Juarez Rd, New Delhi, India; [Brahma, Vijaya] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi, India; [Abraham, Suresh K.] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi, India	Jawaharlal Nehru University, New Delhi; Gauhati University; Central University of Kerala; University of Delhi; Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Ramchiary, N (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Translat & Evolutionary Genom Lab, New Delhi, India.	nrudsc@gmail.com	Ramchiary, Nirala/AAM-7695-2021; Chhapekar, sushil Satish/C-3945-2019; Kumar, Ajay/AAP-9180-2021	Chhapekar, sushil Satish/0000-0002-9802-884X; Kumar, Ajay/0000-0001-7436-5000; Nitin, Dr. Mukesh/0000-0001-6540-0783	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/RLF/Re-entry/46/2011]; Jawaharlal Nehru University (JNU); University Grants Commission, India	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Jawaharlal Nehru University (JNU); University Grants Commission, India(University Grants Commission, India)	This work was supported by the Department of Biotechnology, Ministry of Science and Technology, Government of India, in the form of prestigious Ramalingaswami Fellowship cum Project Grant (No. BT/RLF/Re-entry/46/2011) to Nirala Ramchiary. The authors are highly thankful to Jawaharlal Nehru University (JNU) for providing financial assistance for publication.; This work was supported by the Department of Biotechnology, Ministry of Science and Technology, Government of India, in the form of prestigious Ramalingaswami Fellowship cum Project Grant (No. BT/RLF/Re-entry/46/2011) to Nirala Ramchiary. Financial help in the form of Junior and Senior Research Fellowships to Mr. Sarpras M by University Grants Commission, India, is highly acknowledged. We also acknowledge the kind help of Ms Deepa Bisht in correcting typographical mistakes and references.	Abraham SK, 2013, MUTAT RES-GEN TOX EN, V757, P167, DOI 10.1016/j.mrgentox.2013.08.004; Aluru MR, 2003, J EXP BOT, V54, P1655, DOI 10.1093/jxb/erg176; Alvarez-Parrilla E, 2011, J AGR FOOD CHEM, V59, P163, DOI 10.1021/jf103434u; Anandakumar P, 2013, INT IMMUNOPHARMACOL, V17, P254, DOI 10.1016/j.intimp.2013.05.015; [Anonymous], 2006, GUINNESS BOOK WORLD; Antonious GF, 2006, J ENVIRON SCI HEAL B, V41, P717, DOI 10.1080/03601230600701908; Blum E, 2003, THEOR APPL GENET, V108, P79, DOI 10.1007/s00122-003-1405-y; Canto-Flick A, 2008, HORTSCIENCE, V43, P1344, DOI 10.21273/HORTSCI.43.5.1344; Careaga M, 2003, INT J FOOD MICROBIOL, V83, P331, DOI 10.1016/S0168-1605(02)00382-3; Chanda S, 2004, MUTAT RES-GEN TOX EN, V557, P85, DOI 10.1016/j.mrgentox.2003.10.001; Chinn MS, 2011, FOOD BIOPROD PROCESS, V89, P340, DOI 10.1016/j.fbp.2010.08.003; COLLINS MD, 1995, HORTSCIENCE, V30, P137, DOI 10.21273/HORTSCI.30.1.137; Constant HL, 1996, J NAT PROD, V59, P425, DOI 10.1021/np9600816; Contreras-Padilla M, 1998, J AGR FOOD CHEM, V46, P2075, DOI 10.1021/jf970972z; Curry J, 1999, PLANT SCI, V148, P47, DOI 10.1016/S0168-9452(99)00118-1; Abraham-Juarez MD, 2008, PLANTA, V227, P681, DOI 10.1007/s00425-007-0651-7; Dubey RK, 2015, FOOD CHEM, V188, P119, DOI 10.1016/j.foodchem.2015.04.088; Dyah Juliana S, 1997, Asia Pacific Journal of Clinical Nutrition, V6, P99; Foreror MD, 2009, FLAVOUR FRAG J, V24, P25, DOI 10.1002/ffj.1913; Gbolade AA, 1997, J PHARMACEUT BIOMED, V15, P545, DOI 10.1016/S0731-7085(96)01858-4; Giuffrida D, 2013, FOOD CHEM, V140, P794, DOI 10.1016/j.foodchem.2012.09.060; Gnayfeed MH, 2001, J SCI FOOD AGR, V81, P1580, DOI 10.1002/jsfa.982; GOVINDARAJAN VS, 1987, CRIT REV FOOD SCI, V25, P185, DOI 10.1080/10408398709527453; Howard LR., 2000, HDB NUTRACEUTICALS F; Huang XF, 2013, CURR MED CHEM, V20, P2661, DOI 10.2174/0929867311320210004; Islam MA, 2015, SCI HORTIC-AMSTERDAM, V183, P66, DOI 10.1016/j.scienta.2014.12.011; IWAI K, 1979, AGR BIOL CHEM TOKYO, V43, P2493, DOI 10.1080/00021369.1979.10863843; Kehie M, 2016, META GENE, V7, P56, DOI 10.1016/j.mgene.2015.11.006; Keum YS, 2012, J KOREAN SOC APPL BI, V55, P189, DOI 10.1007/s13765-012-1163-0; Kim S, 2014, NAT GENET, V46, P270, DOI 10.1038/ng.2877; Kobata K, 2010, J AGR FOOD CHEM, V58, P3627, DOI 10.1021/jf904280z; Koek MM, 2010, ANAL CHEM, V82, P156, DOI 10.1021/ac9015787; Kumar O. A., 2009, Notulae Scientia Biologicae, V1, P50; Lang YQ, 2009, PLANT J, V59, P953, DOI 10.1111/j.1365-313X.2009.03921.x; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mathur R, 2000, CURR SCI INDIA, V79, P287; Nwokem C.O., 2010, NY SCI J, V3, P17; Ogawa K, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0476-7; Oyagbemi AA, 2010, INDIAN J CANCER, V47, P53, DOI 10.4103/0019-509X.58860; Perucka I, 2000, FOOD CHEM, V71, P287, DOI 10.1016/S0308-8146(00)00153-9; Perucka I., 2001, Innovative Food Science & Emerging Technologies, V2, P189, DOI 10.1016/S1466-8564(01)00022-4; Pino J, 2006, FOOD CHEM, V94, P394, DOI 10.1016/j.foodchem.2004.11.040; Purkayastha J, 2012, J BIOSCIENCES, V37, P757, DOI 10.1007/s12038-012-9249-8; Qin C, 2014, P NATL ACAD SCI USA, V111, P5135, DOI 10.1073/pnas.1400975111; Ramchiary N, 2014, PLANT BIOTECHNOL REP, V8, P101, DOI 10.1007/s11816-013-0306-z; Reddy UK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086393; Rodriguez-Uribe L, 2012, J EXP BOT, V63, P517, DOI 10.1093/jxb/err302; Sanatombi K, 2008, NOT BOT HORTI AGROBO, V36, P89; Sora GTS, 2015, J FOOD SCI TECH MYS, V52, P8086, DOI 10.1007/s13197-015-1935-8; Spiller F, 2008, J PHARM PHARMACOL, V60, P473, DOI 10.1211/jpp.60.4.0010; Stewart C, 2005, PLANT J, V42, P675, DOI 10.1111/j.1365-313X.2005.02410.x; Stewart C, 2007, J EXP BOT, V58, P979, DOI 10.1093/jxb/erl243; SURH YJ, 1995, CARCINOGENESIS, V16, P2467, DOI 10.1093/carcin/16.10.2467; Taylor P., 2009, CHARACTERISTIC SOLID, P37, DOI [DOI 10.1080/10408390701764245, 10.1080/09507110009549297, DOI 10.1080/09507110009549297]; TODD PH, 1977, J FOOD SCI, V42, P660, DOI 10.1111/j.1365-2621.1977.tb12573.x; Topuz A, 2007, J FOOD COMPOS ANAL, V20, P596, DOI 10.1016/j.jfca.2007.03.007; Wahyuni Y, 2011, PHYTOCHEMISTRY, V72, P1358, DOI 10.1016/j.phytochem.2011.03.016; Zewdie Y, 2001, BIOCHEM SYST ECOL, V29, P161, DOI 10.1016/S0305-1978(00)00041-7; Ziino M, 2009, J SCI FOOD AGR, V89, P774, DOI 10.1002/jsfa.3511	60	44	46	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167791	10.1371/journal.pone.0167791	http://dx.doi.org/10.1371/journal.pone.0167791			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936081	gold, Green Submitted, Green Published			2022-12-27	WOS:000389587100192
J	Amiri, M; Khosravi, A; Eghtesadi, AR; Sadeghi, Z; Abedi, G; Ranjbar, M; Mehrabian, F				Amiri, Mohammad; Khosravi, Ahmad; Eghtesadi, Ahmad Reza; Sadeghi, Zakieh; Abedi, Ghasem; Ranjbar, Mansour; Mehrabian, Fardin			Burnout and its Influencing Factors among Primary Health Care Providers in the North East of Iran	PLOS ONE			English	Article							JOB-SATISFACTION; COMPASSION SATISFACTION; NURSES; STRESS; RESOURCES; WORKERS; ENVIRONMENT; PREVALENCE; RESIDENTS; DEMANDS	Introduction Burnout is a popular research topics in service providing jobs, including the health care field. This study aimed at assessing the level of job burnout and to consider the important antecedents which might be related to job burnout among primary health care providers in Iran. Methods The participants in this applied cross-sectional study which was conducted in 2013 were 548 primary health care providers who were randomly selected from among those working in Shahroud, Sabzevar, Neishabour, Bojnord (provinces located in the north east of Iran). Maslach Burnout Inventory (MBI) was administered to the participants and the collected data were analyzed using SPSS through chi-square test and ordinal logistic regression model. Results The burnout mean score among the participants was 54.1 +/- 27.2 and the mean scores of burnout components i. e., emotional exhaustion, depersonalization and personal accomplishment were 15.5 +/- 13.6, 3.7 +/- 5.4 and 35.5 +/- 13.5 respectively. In terms of levels of burnout, 64.2% of the participants showed low levels (n = 352), 18.4% average levels (n = 101) and 17.3% high levels (n = 95). A significant relationship was observed between burnout, job resources and interest in job (p <= 0.05). However, no significant relationship was observed between burnout and the place (university) of working, age, satisfaction with income, experience, gender, level of education, marital status, housing status, having a second job and place of residence (p >= 0.05). Conclusion Lack of personal accomplishment was highly prevalent among the participating primary health care providers. Lack of career advancement and job transfer opportunities may play a role in the burnout of primary health care providers. Therefore, paying attention to this aspect may help to reduce burnout and even increase job engagement.	[Amiri, Mohammad] Shahroud Univ Med Sci, Sch Publ Hlth, Dept Publ Hlth, Shahroud, Iran; [Khosravi, Ahmad] Shahroud Univ Med Sci, Ctr Hlth Related Social & Behav Sci Res, Shahroud, Iran; [Eghtesadi, Ahmad Reza] Farhangian Univ, Dept English Language Teaching, Shahid Beheshti Campus, Mashhad, Iran; [Abedi, Ghasem] Mazandaran Univ Med Sci, Hlth Sci Res Ctr, Sari, Iran; [Ranjbar, Mansour] Mazandaran Univ Med Sci, Dept Publ Hlth, Sari, Iran; [Mehrabian, Fardin] Guilan Univ Med Sci, Sch Hlth, Dept Hlth Educ & Promot, Rasht, Iran	Shahroud University Medical Sciences; Shahroud University Medical Sciences; Mazandaran University Medical Sciences; Mazandaran University Medical Sciences	Mehrabian, F (corresponding author), Guilan Univ Med Sci, Sch Hlth, Dept Hlth Educ & Promot, Rasht, Iran.	mehrabian@gums.ac.ir	Amiri, Mohammd -/P-6088-2018; Mehrabian, Fardin/A-6706-2018	Amiri, Mohammd -/0000-0003-2151-8530; 	Shahroud University of Medical Sciences [9121]	Shahroud University of Medical Sciences	The present work was supported by Shahroud University of Medical Sciences (# 9121).	Adriaenssens J, 2015, INT J NURS STUD, V52, P649, DOI 10.1016/j.ijnurstu.2014.11.004; Adwan JZ, 2014, J PEDIATR NURS, V29, P329, DOI 10.1016/j.pedn.2014.01.011; Allen J, 2002, WESTERN J NURS RES, V24, P905, DOI 10.1177/019394502237701; Anagnostopoulos F, 2012, J CLIN PSYCHOL MED S, V19, P401, DOI 10.1007/s10880-011-9278-8; Arab M, 2012, J SHAHREKORD U MED S, V14, P62; Arefi M, 2010, LEVELS BURN OUT ITS; Ashill NJ, 2011, J BUS RES, V64, P1116, DOI 10.1016/j.jbusres.2010.11.004; Bakker A., 2014, BURNOUT RES, V1, P112, DOI [10.1016/j.burn.2014.04.003, DOI 10.1016/J.BURN.2014.04.003]; Boyas J, 2012, CHILD YOUTH SERV REV, V34, P50, DOI 10.1016/j.childyouth.2011.08.033; Burisch M, 2002, WORK STRESS, V16, P1, DOI 10.1080/02678370110112506; Caliskan A, 2012, PROCD SOC BEHV, V47, P1392, DOI 10.1016/j.sbspro.2012.06.831; Chin WS, 2015, INT J NURS STUD, V52, P297, DOI 10.1016/j.ijnurstu.2014.09.003; Craiovan PM, 2014, PROCD SOC BEHV, V127, P534, DOI 10.1016/j.sbspro.2014.03.304; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Felton JS, 1998, OCCUP MED-OXFORD, V48, P237, DOI 10.1093/occmed/48.4.237; Fletcher CE, 2001, J NURS ADMIN, V31, P324, DOI 10.1097/00005110-200106000-00011; Garrosa E, 2011, INT J NURS STUD, V48, P479, DOI 10.1016/j.ijnurstu.2010.08.004; Gil-Monte PR, 2002, SALUD PUBLICA MEXICO, V44, P33; Hillhouse JJ, 1997, SOC SCI MED, V45, P1781, DOI 10.1016/S0277-9536(97)00109-3; Kalliath T, 2002, J NURS ADMIN, V32, P648, DOI 10.1097/00005110-200212000-00010; Kendrick P, 2000, AANA J, V68, P115; Ksiazek I, 2011, EUR J ONCOL NURS, V15, P347, DOI 10.1016/j.ejon.2010.09.002; Li A, 2014, J PROF NURS, V30, P89, DOI 10.1016/j.profnurs.2013.04.004; Lizano EL, 2012, CHILD YOUTH SERV REV, V34, P1769, DOI 10.1016/j.childyouth.2012.02.006; Losa Iglesias ME, 2010, INT J NURS STUD, V47, P30, DOI 10.1016/j.ijnurstu.2009.06.014; Martini S, 2006, ACAD PSYCHIATR, V30, P352, DOI 10.1176/appi.ap.30.4.352; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C, 2001, PSYCHOL HEALTH, V16, P607, DOI 10.1080/08870440108405530; Maslach C, 2016, MASLACH BURNOUT INVE; Meyer RML, 2015, J PEDIATR NURS, V30, P174, DOI 10.1016/j.pedn.2013.12.008; Miller, 2011, J RADIOLOGICAL NURSI, V30, P146, DOI DOI 10.1016/J.JRADNU.2011.07.004; Mirabzadeh A, 2007, BURNOUT ITS EFFECTIV; Olley B O, 2003, Afr J Med Med Sci, V32, P297; Organization WHO, 1998, PRIM PREV MENT NEUR, P91; Pardakhtchi M, 2009, QUALITY WORK LIFE BU; Piko BF, 2006, INT J NURS STUD, V43, P311, DOI 10.1016/j.ijnurstu.2005.05.003; Portoghese I, 2014, SAF HEALTH WORK-KR, V5, P152, DOI 10.1016/j.shaw.2014.05.004; Rashedi V, 2012, J KERMANSHAH U MED S, V16, P28; Rudman A, 2011, INT J NURS STUD, V48, P292, DOI 10.1016/j.ijnurstu.2010.07.012; Sahebzadeh M, 2011, JOB BURNOUT NURSING; Scarnera P, 2009, COMMUNITY MENT HLT J, V45, P222, DOI 10.1007/s10597-008-9178-z; Schmitz N, 2000, INT J NURS STUD, V37, P95, DOI 10.1016/S0020-7489(99)00069-3; Sherman DW, 2004, AM J NURS, V104, P48, DOI 10.1097/00000446-200405000-00020; Sotudeh Asl N, 2006, SCI J KURDISTAN U ME, V11, P77; Stechmiller J, 1992, HEART LUNG J CRITICA, V22, P534; Talaei A., 2008, Koomesh, V9, P237; Thomsen S, 1999, PSYCHOTHER PSYCHOSOM, V68, P157, DOI 10.1159/000012325; Van Bogaert P, 2013, INT J NURS STUD, V50, P357, DOI 10.1016/j.ijnurstu.2012.05.006; Williams S, 2013, J MANIP PHYSIOL THER, V36, P376, DOI 10.1016/j.jmpt.2013.05.025; Zalaquett CP, 1998, EVALUATING STRESS; Zhang LF, 2014, NURS OUTLOOK, V62, P128, DOI 10.1016/j.outlook.2013.10.010	51	21	24	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167648	10.1371/journal.pone.0167648	http://dx.doi.org/10.1371/journal.pone.0167648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4OA	27930726	gold, Green Submitted, Green Published			2022-12-27	WOS:000389580900033
J	Kurobe, M; Kojima, T; Nishimura, K; Kandori, S; Kawahara, T; Yoshino, T; Ueno, S; Iizumi, Y; Mitsuzuka, K; Arai, Y; Tsuruta, H; Habuchi, T; Kobayashi, T; Matsui, Y; Ogawa, O; Sugimoto, M; Kakehi, Y; Nagumo, Y; Tsutsumi, M; Oikawa, T; Kikuchi, K; Nishiyama, H				Kurobe, Masahiro; Kojima, Takahiro; Nishimura, Kouichi; Kandori, Shuya; Kawahara, Takashi; Yoshino, Takayuki; Ueno, Satoshi; Iizumi, Yuichi; Mitsuzuka, Koji; Arai, Yoichi; Tsuruta, Hiroshi; Habuchi, Tomonori; Kobayashi, Takashi; Matsui, Yoshiyuki; Ogawa, Osamu; Sugimoto, Mikio; Kakehi, Yoshiyuki; Nagumo, Yoshiyuki; Tsutsumi, Masakazu; Oikawa, Takehiro; Kikuchi, Koji; Nishiyama, Hiroyuki			Development of RNA-FISH Assay for Detection of Oncogenic FGFR3-TACC3 Fusion Genes in FFPE	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-3; LETHAL SKELETAL DYSPLASIA; UROTHELIAL CARCINOMA; URINARY-BLADDER; FGFR3 MUTATIONS; LUNG-CANCER; CELL-LINES; LOW-GRADE; ACTIVATION; IDENTIFICATION	Introduction and Objectives Oncogenic FGFR3-TACC3 fusions and FGFR3 mutations are target candidates for small molecule inhibitors in bladder cancer (BC). Because FGFR3 and TACC3 genes are located very closely on chromosome 4p16.3, detection of the fusion by DNA-FISH (fluorescent in situ hybridization) is not a feasible option. In this study, we developed a novel RNA-FISH assay using branched DNA probe to detect FGFR3-TACC3 fusions in formaldehyde-fixed paraffin-embedded (FFPE) human BC samples. Materials and Methods The RNA-FISH assay was developed and validated using a mouse xenograft model with human BC cell lines. Next, we assessed the consistency of the RNA-FISH assay using 104 human BC samples. In this study, primary BC tissues were stored as frozen and FFPE tissues. FGFR3-TACC3 fusions were independently detected in FFPE sections by the RNA-FISH assay and in frozen tissues by RT-PCR. We also analyzed the presence of FGFR3 mutations by targeted sequencing of genomic DNA extracted from deparaffinized FFPE sections. Results FGFR3-TACC3 fusion transcripts were identified by RNA-FISH and RT-PCR in mouse xenograft FFPE tissues using the human BC cell lines RT112 and RT4. These cell lines have been reported to be fusion-positive. Signals for FGFR3-TACC3 fusions by RNA-FISH were positive in 2/60 (3%) of non-muscle-invasive BC (NMIBC) and 2/44 (5%) muscle-invasive BC (MIBC) patients. The results of RT-PCR of all 104 patients were identical to those of RNA-FISH. FGFR3 mutations were detected in 27/60 (45%) NMIBC and 8/44 (18%) MIBC patients. Except for one NMIBC patient, FGFR3 mutation and FGFR3-TACC3 fusion were mutually exclusive. Conclusions We developed an RNA-FISH assay for detection of the FGFR3-TACC3 fusion in FFPE samples of human BC tissues. Screening for not only FGFR3 mutations, but also for FGFR3-TACC3 fusion transcripts has the potential to identify additional patients that can be treated with FGFR inhibitors.	[Kurobe, Masahiro; Kojima, Takahiro; Kandori, Shuya; Kawahara, Takashi; Yoshino, Takayuki; Nishiyama, Hiroyuki] Univ Tsukuba, Dept Urol, Fac Med, Tsukuba, Ibaraki, Japan; [Nishimura, Kouichi] Astellas Pharma Inc, Tsukuba, Ibaraki, Japan; [Ueno, Satoshi; Iizumi, Yuichi] Univ Tsukuba, Fac Med, Tsukuba Clin Res & Dev Org T CReDO, Tsukuba, Ibaraki, Japan; [Mitsuzuka, Koji; Arai, Yoichi] Tohoku Univ, Grad Sch Med, Dept Urol, Sendai, Miyagi, Japan; [Tsuruta, Hiroshi; Habuchi, Tomonori] Akita Univ, Grad Sch Med, Dept Urol, Akita, Japan; [Kobayashi, Takashi; Matsui, Yoshiyuki; Ogawa, Osamu] Kyoto Univ, Grad Sch Med, Dept Urol, Kyoto, Japan; [Sugimoto, Mikio; Kakehi, Yoshiyuki] Kagawa Univ, Dept Urol, Fac Med, Takamatsu, Kagawa, Japan; [Nagumo, Yoshiyuki; Tsutsumi, Masakazu] Hitachi Gen Hosp, Dept Urol, Hitachi, Ibaraki, Japan; [Oikawa, Takehiro; Kikuchi, Koji] Tsukuba Med Ctr Hosp, Dept Urol, Tsukuba, Ibaraki, Japan	University of Tsukuba; Astellas Pharmaceuticals; University of Tsukuba; Tohoku University; Akita University; Kyoto University; Kagawa University	Nishiyama, H (corresponding author), Univ Tsukuba, Dept Urol, Fac Med, Tsukuba, Ibaraki, Japan.	nishiuro@md.tsukuba.ac.jp	Kandori, Shuya/V-4257-2019; KUROBE, MASAHIRO/AAE-7786-2021; MATSUI, Yoshiyuki/I-2323-2019	Kandori, Shuya/0000-0003-4621-8470; UENO, Satoshi/0000-0001-9495-737X	Astellas; Japan Society for the Promotion of Science (JSPS) [26670696, 26293349]	Astellas(Astellas Pharmaceuticals); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The study was funded by Astellas (H.N.), and designed and analyzed by the authors in collaboration with Astellas. Astellas had a role in the design and conduct of the study; management, analysis, and interpretation of the data; and preparation, review, and approval of the manuscript. This work was also supported in part by a Grant-in-Aid for Challenging Exploratory Research (H.N.) (grant number 26670696) and a Grant-in-Aid for Scientific Research B (H.N.) (grant number 26293349) from the Japan Society for the Promotion of Science (JSPS) (https://www.jsps.go.jp/english/). The JSPS had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar R, 2002, J BONE MINER RES, V17, P860, DOI 10.1359/jbmr.2002.17.5.860; Al-Ahmadie HA, 2011, J PATHOL, V224, P270, DOI 10.1002/path.2892; Bakkar AA, 2003, CANCER RES, V63, P8108; Battich N, 2013, NAT METHODS, V10, P1127, DOI 10.1038/nmeth.2657; Bernard-Pierrot I, 2006, CARCINOGENESIS, V27, P740, DOI 10.1093/carcin/bgi290; Billerey C, 2001, AM J PATHOL, V158, P1955, DOI 10.1016/S0002-9440(10)64665-2; BUBENIK J, 1973, INT J CANCER, V11, P765, DOI 10.1002/ijc.2910110327; Carneiro BA, 2015, GYNECOL ONCOL REP, V13, P53, DOI 10.1016/j.gore.2015.06.005; d'Avis PY, 1998, CELL GROWTH DIFFER, V9, P71; Di Stefano AL, 2015, CLIN CANCER RES, V21, P3307, DOI 10.1158/1078-0432.CCR-14-2199; Elliott K, 2015, J CLIN PATHOL, V68, P766, DOI 10.1136/jclinpath-2015-203178; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Guancial EA, 2014, CANCER MED-US, V3, P835, DOI 10.1002/cam4.262; Guo GW, 2013, NAT GENET, V45, P1459, DOI 10.1038/ng.2798; Hayat M A., 2006, HDB IMMUNOHISTOCHEMI, V1, P8; Kiflemariam S, 2014, J PATHOL, V234, P253, DOI 10.1002/path.4392; Kimura T, 2001, CANCER-AM CANCER SOC, V92, P2555, DOI 10.1002/1097-0142(20011115)92:10<2555::AID-CNCR1607>3.0.CO;2-M; Knowles MA, 2015, NAT REV CANCER, V15, P25, DOI 10.1038/nrc3817; Kwon S, 2013, BMB REP, V46, P65, DOI 10.5483/BMBRep.2013.46.2.016; Lu B, 2009, UROLOGY, V74, P1156, DOI 10.1016/j.urology.2009.01.087; Majewski IJ, 2013, J PATHOL, V230, P270, DOI 10.1002/path.4209; Markey FB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093488; MARSHALL CJ, 1977, J NATL CANCER I, V58, P1743, DOI 10.1093/jnci/58.6.1743; Nakanishi Y, 2015, MOL CANCER THER, V14, P704, DOI 10.1158/1535-7163.MCT-14-0927-T; Parker BC, 2013, J CLIN INVEST, V123, P855, DOI 10.1172/JCI67144; Perner S, 2008, NEOPLASIA, V10, P298, DOI 10.1593/NEO.07878; Poyet C, 2015, ONCOL LETT, V10, P2753, DOI 10.3892/ol.2015.3691; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rieger-Christ KM, 2003, CANCER-AM CANCER SOC, V98, P737, DOI 10.1002/cncr.11536; RIGBY CC, 1970, BRIT J CANCER, V24, P746, DOI 10.1038/bjc.1970.89; Ross JS, 2014, MODERN PATHOL, V27, P271, DOI 10.1038/modpathol.2013.135; Semrau S, 2014, CELL REP, V6, P18, DOI 10.1016/j.celrep.2013.12.002; Shinmura K, 2014, ONCOL REP, V31, P1219, DOI 10.3892/or.2014.2984; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Smal M. P., 2014, Experimental Oncology, V36, P246; TKACHUK DC, 1990, SCIENCE, V250, P559, DOI 10.1126/science.2237408; Tomlinson D, 2007, ONCOGENE, V26, P5889, DOI 10.1038/sj.onc.1210399; Tomlinson DC, 2007, J PATHOL, V213, P91, DOI 10.1002/path.2207; Urdinguio RG, 2013, CANCER RES, V73, P395, DOI 10.1158/0008-5472.CAN-12-0806; van Rhijn BSW, 2004, CANCER RES, V64, P1911, DOI 10.1158/0008-5472.CAN-03-2421; van Rhijn BWG, 2002, EUR J HUM GENET, V10, P819, DOI 10.1038/sj.ejhg.5200883; Webster MK, 1996, MOL CELL BIOL, V16, P4081; Weier C, 2013, J PATHOL, V230, P174, DOI 10.1002/path.4186; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Williams SV, 2013, HUM MOL GENET, V22, P795, DOI 10.1093/hmg/dds486; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050; YANAGIHARA K, 1991, CANCER RES, V51, P381	47	12	12	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0165109	10.1371/journal.pone.0165109	http://dx.doi.org/10.1371/journal.pone.0165109			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930669	Green Published, Green Submitted, gold			2022-12-27	WOS:000389580900002
J	Purcell, SW; Ngaluafe, P; Foale, SJ; Cocks, N; Cullis, BR; Lalavanua, W				Purcell, Steven W.; Ngaluafe, Poasi; Foale, Simon J.; Cocks, Nicole; Cullis, Brian R.; Lalavanua, Watisoni			Multiple Factors Affect Socioeconomics and Wellbeing of Artisanal Sea Cucumber Fishers	PLOS ONE			English	Article							JOB-SATISFACTION; FOOD SECURITY; MANAGEMENT; LIVELIHOODS; GOVERNANCE; TRADE; WOMEN	Small-scale fisheries are important to livelihoods and subsistence seafood consumption of millions of fishers. Sea cucumbers are fished worldwide for export to Asia, yet few studies have assessed factors affecting socioeconomics and wellbeing among fishers. We interviewed 476 men and women sea cucumber fishers at multiple villages within multiple locations in Fiji, Kiribati, Tonga and New Caledonia using structured questionnaires. Low rates of subsistence consumption confirmed a primary role of sea cucumbers in income security. Prices of sea cucumbers sold by fishers varied greatly among countries, depending on the species. Gender variation in landing prices could be due to women catching smaller sea cucumbers or because some traders take advantage of them. Dissatisfaction with fishery income was common (44% of fishers), especially for i-Kiribati fishers, male fishers, and fishers experiencing difficulty selling their catch, but was uncorrelated with sale prices. Income dissatisfaction worsened with age. The number of livelihood activities averaged 2.2-2.5 across countries, and varied significantly among locations. Sea cucumbers were often a primary source of income to fishers, especially in Tonga. Other common livelihood activities were fishing other marine resources, copra production in Kiribati, agriculture in Fiji, and salaried jobs in New Caledonia. Fishing other coastal and coral reef resources was the most common fall-back livelihood option if fishers were forced to exit the fishery. Our data highlight large disparities in subsistence consumption, gender-related price equity, and livelihood diversity among parallel artisanal fisheries. Improvement of supply chains in dispersed small-scale fisheries appears as a critical need for enhancing income and wellbeing of fishers. Strong evidence for co-dependence among small-scale fisheries, through fall-back livelihood preferences of fishers, suggests that resource managers must mitigate concomitant effects on other fisheries when considering fishery closures. That is likely to depend on livelihood diversification programs to take pressure off co-dependent fisheries.	[Purcell, Steven W.] Southern Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia; [Ngaluafe, Poasi] Minist Agr & Food Forests & Fisheries, Nukualofa, Tonga; [Foale, Simon J.] James Cook Univ, Coll Arts Soc & Educ, Townsville, Qld, Australia; [Cocks, Nicole; Cullis, Brian R.] Univ Wollongong, Fac Engn & Informat Sci, Natl Inst Appl Stat Res Australia, Sch Math & Appl Stat, Wollongong, NSW, Australia; [Lalavanua, Watisoni] Partners Community Dev Fiji, Suva, Fiji; [Lalavanua, Watisoni] Wildlife Conservat Soc, Suva, Fiji	Southern Cross University; James Cook University; University of Wollongong	Purcell, SW (corresponding author), Southern Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia.	steven.w.purcell@gmail.com	Purcell, Steven/I-2554-2013; Purcell, Steven/AAQ-1326-2021; Foale, Simon/M-5872-2014	Purcell, Steven/0000-0002-6227-6454; Purcell, Steven/0000-0002-6227-6454; Foale, Simon/0000-0003-0809-872X; Cullis, Brian/0000-0001-6319-8155	Australian Centre for International Agricultural Research (ACIAR) [PARDI/2010/004, FIS/2010/096]; Southern Cross University; Kiribati Ministry of Fisheries and Marine Resources Development; Tonga Ministry of Agriculture & Food, Forests and Fisheries, Department of Fisheries Fiji; Partners in Community Development Fiji	Australian Centre for International Agricultural Research (ACIAR)(Australian Ctr Intl Agr Res); Southern Cross University; Kiribati Ministry of Fisheries and Marine Resources Development; Tonga Ministry of Agriculture & Food, Forests and Fisheries, Department of Fisheries Fiji; Partners in Community Development Fiji	This study was funded by The Australian Centre for International Agricultural Research (ACIAR) through projects PARDI/2010/004 and FIS/2010/096. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Chris Barlow for guidance on the research. We are grateful for constructive criticisms and suggestions by the academic editor and two anonymous reviewers, which improved the quality of the manuscript. We acknowledge and thank Karibanang Tamuera-Aram for data collection in Kiribati, Sailasa Tagica for assistance with data collection in Fiji, and Natacha Agudo for data collection in New Caledonia. Support was also provided by Southern Cross University, Kiribati Ministry of Fisheries and Marine Resources Development, Tonga Ministry of Agriculture & Food, Forests and Fisheries, Department of Fisheries Fiji, and Partners in Community Development Fiji.	Allison EH, 2001, MAR POLICY, V25, P377, DOI 10.1016/S0308-597X(01)00023-9; [Anonymous], 2008, SPC BECHE DE MER INF; Bailey R. A., 2008, DESIGN COMP EXPT; Bene C, 2010, DEV POLICY REV, V28, P325, DOI 10.1111/j.1467-7679.2010.00486.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett Judith A., 1987, WEALTH SOLOMONS HIST; Berkes F., 2001, MANAGING SMALL SCALE; Brien CJ, 2009, J AGR BIOL ENVIR ST, V14, P253, DOI 10.1198/jabes.2009.08001; Browne C., 2006, PACIFIC ISLAND EC; Butler D, 2009, ASREML ASREML FITS L; Caldwell J, 2001, POPULATION OCEANIA 2; Campbell JR, 2015, REG ENVIRON CHANGE, V15, P1313, DOI 10.1007/s10113-014-0697-6; Carleton C., 2013, SPC FISHERIES NEWSLE, V140, P24; Catala R.L.A., 1957, ATOLL RES B, V59; Choo PohSze, 2008, FAO Fisheries and Aquaculture Technical Paper, P81; Christensen AE, 2010, MAKING ISLAND LIVING; Christensen AE, 2011, NAT RESOUR FORUM, V35, P9, DOI 10.1111/j.1477-8947.2011.01343.x; Cinner JE, 2009, CONSERV BIOL, V23, P124, DOI 10.1111/j.1523-1739.2008.01041.x; Cinner JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011999; Conand C., 2008, FAO Fisheries and Aquaculture Technical Paper, P143; Conand C, 1990, 2722 FAO; Connell J., 2005, REMITTANCES PACIFIC; Connell J, 2013, ISLANDS AT RISK?: ENVIRONMENTS, ECONOMIES AND CONTEMPORARY CHANGE, P230; Coulthard S, 2015, EXPLORING WELLBEING; Coulthard S, 2012, CURR OPIN ENV SUST, V4, P358, DOI 10.1016/j.cosust.2012.06.001; Coulthard S, 2011, GLOBAL ENVIRON CHANG, V21, P453, DOI 10.1016/j.gloenvcha.2011.01.003; Coulthard S, 2011, MAR POLICY, V35, P405, DOI 10.1016/j.marpol.2010.11.006; Demmke A., 2011, VULNERABILITY TROPIC, P733; Eriksson BH, 2010, AQUAT LIVING RESOUR, V23, P387, DOI 10.1051/alr/2011002; Eriksson H, 2015, MAR POLICY, V56, P16, DOI 10.1016/j.marpol.2015.02.005; Fabinyi M, 2015, FISH FISH, V16, P471, DOI 10.1111/faf.12069; FAO, 2011, STAT WORLD FISH AQ O; Foale S, 1997, FISH RES, V33, P1, DOI 10.1016/S0165-7836(97)00062-3; Foale SJ, 2005, SEA SLUGS SKIRMISHES; Friedman K, 2009, PAPUA NEW GUINEA COU; Friedman K, 2011, FISH FISH, V12, P75, DOI 10.1111/j.1467-2979.2010.00384.x; Frocklin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091161; Gillett R, 2009, FISHERIES EC PACIFIC; Gillett R, 2011, FISHERIES PACIFIC IS; Gillett R., 2001, CONTRIBUTION FISHERI; Green A., 2006, SOLOMON ISLANDS MARI; Hair C, 2016, REG STUD MAR SCI, V5, P69, DOI 10.1016/j.rsma.2016.02.001; Hamel J. F., 2008, FAO Fisheries and Aquaculture Technical Paper, P257; Harper S, 2013, MAR POLICY, V39, P56, DOI 10.1016/j.marpol.2012.10.018; Jentoft S, 2010, MAR POLICY, V34, P1315, DOI 10.1016/j.marpol.2010.06.004; Kinch J., 2008, FAO Fisheries and Aquaculture Technical Paper, P57; Kinch J., 2008, FAO Fisheries and Aquaculture Technical Paper, P7; KIRCH PV, 2000, ROAD WINDS ARCHAEOLO; Kittinger JN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123856; Kleiber D, 2015, FISH FISH, V16, P547, DOI 10.1111/faf.12075; Koczberski G, 2006, VILLAGE BASED MARINE; Lambeth L., 2014, SPC WOMEN FISH INF B, V25, P21; Lindsay S, 2009, SEA CUCUMBER FISHERI; Militz TA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151624; Muallil RN, 2011, FISH RES, V111, P74, DOI 10.1016/j.fishres.2011.06.013; Namudu MT, 2006, J APPL PHYCOL, V18, P241, DOI 10.1007/s10811-006-9023-0; Ochiewo J, 2010, OCEAN COAST MANAGE, V53, P192, DOI 10.1016/j.ocecoaman.2010.01.010; Otero-Villanueva M., 2007, SPC BECHE DE MER INF, V25, P32; Pakoa K, 2013, STATUS SEA CUCUMBER; Pakoa K, 2013, BECHE INF BULL, V33, P49; Pakoa KM, 2013, STATUS TONGAS SEA CU; Pollnac RB, 2001, OCEAN COAST MANAGE, V44, P531, DOI 10.1016/S0964-5691(01)00064-3; Pollnac RB, 2006, HUM ORGAN, V65, P329, DOI 10.17730/humo.65.3.3j2w39a21tq3j4l1; Purcell S., 2016, BECHE INF BULL, V36, P58; Purcell SW, 2014, MAR POLICY, V45, P240, DOI 10.1016/j.marpol.2013.11.005; Purcell S.W., 2010, FAO FISH AQUAC TECH, V520, P157; Purcell S. W., 2009, WORLDFISH CTR STUDIE; Purcell SW, 2016, FISH RES, V183, P99, DOI 10.1016/j.fishres.2016.05.010; Purcell SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095075; Purcell SW, 2013, FISH FISH, V14, P34, DOI 10.1111/j.1467-2979.2011.00443.x; Purcell SW, 2009, SPC BECHE DE MER INF, V29, P3; R Core Team, 2021, R LANGUAGE ENV STAT; Ram R., 2008, IMPACTS HARVEST POST; Reddy SMW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096817; Ruiz V, 2012, SOC INDIC RES, V109, P81, DOI 10.1007/s11205-012-0057-1; SHINEBERG D, 1966, J PAC HIST, V1, P129, DOI 10.1080/00223346608572084; Skewes T, 2004, CONVERSION RATIOS CO; Sugiyama S, 2004, USITC PUBL, V2004/25; Teh LSL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065397; Thomas FR, 2002, GEOGR J, V168, P163, DOI 10.1111/1475-4959.00045; Trimble M, 2013, MAR POLICY, V37, P37, DOI 10.1016/j.marpol.2012.04.002; United Nations Development Programme (UNDP), 2015, HUM DEV REP 2015 WOR; Ward Gerard, 1972, MAN PACIFIC ISLANDS, P91; Weeratunge N, 2010, FISH FISH, V11, P405, DOI 10.1111/j.1467-2979.2010.00368.x; Young MAL, 2016, MAR POLICY, V66, P114, DOI 10.1016/j.marpol.2016.01.018; Zhao MH, 2013, MAR POLICY, V37, P69, DOI 10.1016/j.marpol.2012.04.013	86	18	19	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0165633	10.1371/journal.pone.0165633	http://dx.doi.org/10.1371/journal.pone.0165633			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4OA	27930649	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000389580900005
J	Yeh, TC; Huang, TT; Yeh, TS; Chen, YR; Hsu, KW; Yin, PH; Lee, HC; Tseng, LM				Yeh, Ting-Chih; Huang, Tzu-Ting; Yeh, Tien-Shun; Chen, Yu-Ren; Hsu, Kai-Wen; Yin, Pen-Hui; Lee, Hsin-Chen; Tseng, Ling-Ming			miR-151-3p Targets TWIST1 to Repress Migration of Human Breast Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; FOCAL-ADHESION KINASE; GASTRIC CARCINOGENESIS; GENE-EXPRESSION; METASTASIS; TUMOR; MICRORNAS; PROGNOSIS; CISPLATIN; SURVIVAL	TWIST1 is a highly conserved basic helix-loop-helix transcription factor that contributes to cancer metastasis by promoting an epithelial-mesenchymal transition and repressing E-cadherin gene expression in breast cancer. In this study, we explored the potential role of miR-151 in TWIST1 expression and cancer properties in human breast cancer cells. We found that the human TWIST1 3'UTR contains a potential binging site for miR-151-3p at the putative target sequence 5'-CAGUCUAG-3'. Using a TWIST1-3'UTR luciferase reporter assay, we demonstrated that the target sequence within the TWIST1 3'UTR is required for miR-151-3p regulation of TWIST1 expression. Moreover, we found that ectopic expression of miR-151-3p by infection with adenoviruses expressing miR-151 significantly decreased TWIST1 expression, migration and invasion, but did not affect cell growth and tumorsphere formation of human breast cancer cells. In addition, overexpression of the protein coding region without the 3'UTR of TWIST1 reversed the repression of cell migration by miR-151-3p. Furthermore, knockdown of miR-151-3p increased TWIST1 expression, reduced E-cadherin expression, and enhanced cell migration. In conclusion, these results suggest that miR-151-3p directly regulates TWIST1 expression by targeting the TWIST1 3'UTR and thus repressing the migration and invasion of human breast cancer cells by enhancing E-cadherin expression. Our findings add to accumulating evidence that microRNAs are involved in breast cancer progression by modulating TWIST1 expression.	[Yeh, Ting-Chih; Huang, Tzu-Ting; Yeh, Tien-Shun; Hsu, Kai-Wen] Natl Yang Ming Univ, Inst Anat & Cell Biol, Sch Med, Taipei, Taiwan; [Yeh, Ting-Chih; Huang, Tzu-Ting; Chen, Yu-Ren; Lee, Hsin-Chen] Natl Yang Ming Univ, Sch Med, Dept & Inst Pharmacol, Taipei, Taiwan; [Yin, Pen-Hui] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan; [Tseng, Ling-Ming] Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan; [Tseng, Ling-Ming] Natl Yang Ming Univ, Taipei, Taiwan; [Tseng, Ling-Ming] Taipei Veterans Gen Hosp, Comprehens Breast Hlth Ctr, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Lee, HC (corresponding author), Natl Yang Ming Univ, Sch Med, Dept & Inst Pharmacol, Taipei, Taiwan.; Tseng, LM (corresponding author), Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan.; Tseng, LM (corresponding author), Natl Yang Ming Univ, Taipei, Taiwan.; Tseng, LM (corresponding author), Taipei Veterans Gen Hosp, Comprehens Breast Hlth Ctr, Taipei, Taiwan.	hclee2@ym.edu.tw; lmtseng@vghtpe.gov.tw	Lee, Hsin-Chen/H-6767-2019; Huang, Tzu-Ting/S-9455-2019	Huang, Tzu-Ting/0000-0002-3675-2760; Hsu, Kai-Wen/0000-0002-9736-8869; Lee, Hsin-Chen/0000-0001-7455-9593	Center of Excellence for Cancer Research at Taipei Veterans General; Ministry of Health and Welfare [MOHW103-TD-B-111-02, MOHW104-TDU-B-211-124-001, MOHW105-TDU-B-211-134003]; Executive Yuan; Ministry of Education, Aim for the Top University Plan; Ministry of Science and Technology, Taiwan [MOST101-2320-B-010-068-MY3, MOST101-2314-B-075-015-MY3, MOST 104-2320-B-075-006, MOST 104-2320-B-010-031, MOST 105-2320-B-010-034]	Center of Excellence for Cancer Research at Taipei Veterans General; Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Executive Yuan; Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was partly supported by grants from the Center of Excellence for Cancer Research at Taipei Veterans General, the Ministry of Health and Welfare (MOHW103-TD-B-111-02; MOHW104-TDU-B-211-124-001; MOHW105-TDU-B-211-134003), Executive Yuan; the grant from the Ministry of Education, Aim for the Top University Plan; and the grants MOST101-2320-B-010-068-MY3, MOST101-2314-B-075-015-MY3, MOST 104-2320-B-075-006, MOST 104-2320-B-010-031, and MOST 105-2320-B-010-034 from the Ministry of Science and Technology, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba ML, 2016, J CLIN MED, V5, DOI 10.3390/jcm5010008; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bourgeois P, 1996, MAMM GENOME, V7, P915, DOI 10.1007/s003359900269; Chang YS, 2015, CANCER RES, V75, P3077, DOI 10.1158/0008-5472.CAN-14-3380; Chou YS, 2015, J CHIN MED ASSOC, V78, P438, DOI 10.1016/j.jcma.2015.05.002; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; Edmonds MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101802; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gu J, 2013, CURR PHARM DESIGN, V19, P1292; Guidi M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-95; Haga CL, 2012, J BIOL CHEM, V287, P42695, DOI 10.1074/jbc.M112.387761; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hernandez JM, 2013, ANN SURG ONCOL, V20, pS625, DOI 10.1245/s10434-013-3106-3; Hsu KW, 2016, ONCOTARGET, V7, P38036, DOI 10.18632/oncotarget.9342; Hsu KW, 2014, CARCINOGENESIS, V35, P208, DOI 10.1093/carcin/bgt285; Huang TT, 2015, ONCOTARGET, V6, P18012, DOI 10.18632/oncotarget.4000; Hui ABY, 2013, CLIN CANCER RES, V19, P2154, DOI 10.1158/1078-0432.CCR-12-3572; Iorio MV, 2012, CARCINOGENESIS, V33, P1126, DOI 10.1093/carcin/bgs140; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Krell J, 2012, MOL DIAGN THER, V16, P167, DOI 10.2165/11632740-000000000-00000; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li LZ, 2014, CARCINOGENESIS, V35, P469, DOI 10.1093/carcin/bgt330; Liu S, 2014, TUMOR BIOL, V35, P9131, DOI 10.1007/s13277-014-2177-5; Luedde L, 2010, HEPATOLOGY, V52, P1164, DOI [10.1002/hep.23854, DOI 10.1002/HEP23854]; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; McNally ME, 2013, HPB, V15, P260, DOI 10.1111/j.1477-2574.2012.00523.x; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nairismagi ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066070; Puisieux A, 2006, BRIT J CANCER, V94, P13, DOI 10.1038/sj.bjc.6602876; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Steeg PS, 2016, NAT REV CANCER, V16, P201, DOI 10.1038/nrc.2016.25; Sun EH, 2014, EUR REV MED PHARMACO, V18, P2783; Tsukerman P, 2014, ONCOTARGET, V5, P12141, DOI 10.18632/oncotarget.2559; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Wang AM, 2014, ONCOTARGET, V5, P5002, DOI 10.18632/oncotarget.2073; Wei H, 2015, J CELL PHYSIOL, V230, P1003, DOI 10.1002/jcp.24793; Xu Y, 2014, INT J BIOL SCI, V10, P396, DOI 10.7150/ijbs.8193; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang LH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13677; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Zhou Y, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-12; Zhu X, 2016, ONCOGENE, V35, P323, DOI 10.1038/onc.2015.84	43	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0168171	10.1371/journal.pone.0168171	http://dx.doi.org/10.1371/journal.pone.0168171			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930738	gold, Green Submitted, Green Published			2022-12-27	WOS:000389580900084
J	Jungmann, PM; Baum, T; Nevitt, MC; Nardo, L; Gersing, AS; Lane, NE; McCulloch, CE; Rummeny, EJ; Link, TM				Jungmann, Pia M.; Baum, Thomas; Nevitt, Michael C.; Nardo, Lorenzo; Gersing, Alexandra S.; Lane, Nancy E.; McCulloch, Charles E.; Rummeny, Ernst J.; Link, Thomas M.			Degeneration in ACL Injured Knees with and without Reconstruction in Relation to Muscle Size and Fat Content-Data from the Osteoarthritis Initiative	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; PATIENT RELEVANT OUTCOMES; PHYSICAL-ACTIVITY; FOLLOW-UP; ARTICULAR-CARTILAGE; IMAGING TECHNIQUES; RANDOMIZED-TRIAL; HIGH PREVALENCE; SOCCER PLAYERS; ROTATOR CUFF	Background Anterior cruciate ligaments (ACL) injuries represent a major risk factor for early osteoarthritis (OA). Purpose To evaluate the prevalence and 4-year progression of knee OA measured with 3T MR-imaging in individuals with ruptured, reconstructed or normal ACL and to assess the impact of thigh muscle characteristics. Methods A total of 54 knees (23/54 male, 31/54 female) were recruited from the Osteoarthritis Initiative (OAI). At baseline, 15/54 subjects had prevalent ACL ruptures and 15/54 subjects had prevalent ACL reconstruction (24/54 normal ACL). Western Ontario and McMasters Universities Arthritis Index (WOMAC) scores, Physical Activity Scores of the Elderly (PASE) and thigh muscle characteristics including strength, fat infiltration (Goutallier score) and thigh muscle cross-sectional area (CSA) MR measurements were obtained at baseline. Wholeorgan MR-imaging Scores (WORMS) were obtained at baseline and at a 4-year follow-up time-point. Multivariate regression models, adjusting for covariates (age, gender, body mass index), were used for statistical analysis. Results At baseline, subjects with prevalent ACL ruptures had worse WORMS total scores (mean +/- SEM, 44.1 +/- 3.5) than subjects with ACL reconstruction (30.8 +/- 4.0; P = 0.015) and worse than subjects with normal ACL (21.3 +/- 3.0; P<0.001). Cartilage scores were worse in both femorotibial compartments in ACL injured knees than in knees with normal ACL (P<0.05). Knees with ACL reconstruction showed an increased degeneration of the medial meniscus (P = 0.036), cartilage degeneration at the medial femoral condyle (P = 0.011). In a multivariate regression model, including both ACL groups and total muscle characteristics as influence parameters, high thigh muscle CSA, high muscle/fat ratio and low Goutallier scores were associated with less degenerative changes at the knee, independent of ACL status. Knees with ACL reconstruction showed an increased progression of cartilage degeneration at the medial tibia compared to the normal ACL group (P = 0.027). Conclusions High thigh muscle CSA is associated with less degenerative changes at the knee, independent of the ACL status and may potentially be advantageous in the prevention of early OA.	[Jungmann, Pia M.; Baum, Thomas; Gersing, Alexandra S.; Rummeny, Ernst J.] Tech Univ Munich, Dept Radiol, Munich, Germany; [Nevitt, Michael C.; McCulloch, Charles E.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Nardo, Lorenzo; Link, Thomas M.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, Musculoskeletal & Quantitat Imaging Res, San Francisco, CA 94143 USA; [Lane, Nancy E.] UC Davis Med Ctr, Dept Internal Med, Sacramento, CA USA	Technical University of Munich; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis	Jungmann, PM (corresponding author), Tech Univ Munich, Dept Radiol, Munich, Germany.	pia.jungmann@tum.de	Link, Thomas M. M/E-7522-2012; Baum, Thomas/M-6522-2014	Baum, Thomas/0000-0002-4574-5212; Jungmann, Pia/0000-0003-2198-3678	German Research Foundation (DFG); Technische Universitat Munchen; Commission for Clinical Research, Technische Universitaet Muenchen (TUM), TUM School of Medicine, Munich, Germany [8762152]; NIH [U01-AR055079, P50-AR060752, K24-AR04884, R01-AR052000]; OAI; National Institutes of Health, a branch of the Department of Health and Human Services [N01-AR-2-2258, N01-AR-2-2259, N01-AR-2-2260, N01-AR-2-2261, N01-AR-2-2262]; Pfizer, Inc.; Novartis Pharmaceuticals Corporation; Merck Research Laboratories; GlaxoSmithKline; NIH (National Institute of Arthritis and Musculoskeletal and Skin Diseases) [P50-AR060752, R01AR064771]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR066262] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen; Commission for Clinical Research, Technische Universitaet Muenchen (TUM), TUM School of Medicine, Munich, Germany; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OAI; National Institutes of Health, a branch of the Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer, Inc.(Pfizer); Novartis Pharmaceuticals Corporation(Novartis); Merck Research Laboratories(Merck & Company); GlaxoSmithKline(GlaxoSmithKline); NIH (National Institute of Arthritis and Musculoskeletal and Skin Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding programme Open Access Publishing. The study was supported by the Commission for Clinical Research, Technische Universitaet Muenchen (TUM), TUM School of Medicine, Munich, Germany (Project Number 8762152). This study was funded by NIH U01-AR055079 and P50-AR060752, by NIH K24-AR04884 and R01-AR052000 and by the OAI. The OAI is a public private partnership comprised of five contracts (N01-AR-2-2258; N01-AR-2-2259; N01-AR-2-2260; N01-AR-2-2261; N01-AR-2-2262) funded by the National Institutes of Health, a branch of the Department of Health and Human Services, and conducted by the OAI Study Investigators. Private funding partners include Pfizer, Inc.; Novartis Pharmaceuticals Corporation; Merck Research Laboratories; and GlaxoSmithKline. The analyses in this study were funded through the NIH (National Institute of Arthritis and Musculoskeletal and Skin Diseases grants R01AR064771 and P50-AR060752). Private sector funding for the OAI is managed by the Foundation for the National Institutes of Health. This manuscript was prepared using an OAI public use data set and does not necessarily reflect the opinions or views of the OAI investigators, the NIH, or the private funding partners. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizai H, 2012, EUR RADIOL, V22, P1592, DOI 10.1007/s00330-012-2404-7; Alshewaier S, 2016, CLINICAL REHABILITAT; Asano H, 2004, ARTHROSCOPY, V20, P474, DOI 10.1016/j.arthro.2004.03.006; Asik M, 2007, KNEE SURG SPORT TR A, V15, P965, DOI 10.1007/s00167-007-0344-6; Bellabarba C, 1997, Am J Orthop (Belle Mead NJ), V26, P18; Bellamy N, 2005, CLIN EXP RHEUMATOL, V23, pS148; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; BENEKE R, 1991, EUR J APPL PHYSIOL O, V63, P424, DOI 10.1007/BF00868073; Crema MD, 2011, RADIOGRAPHICS, V31, P37, DOI 10.1148/rg.311105084; DANIEL DM, 1994, AM J SPORT MED, V22, P632, DOI 10.1177/036354659402200511; Desai N, 2014, KNEE SURG SPORT TR A, V22, P379, DOI 10.1007/s00167-013-2803-6; FERRETTI A, 1991, INT ORTHOP, V15, P367, DOI 10.1007/BF00186881; Fithian DC, 2005, AM J SPORT MED, V33, P335, DOI 10.1177/0363546504269590; Fleming Braden C, 2005, Curr Opin Orthop, V16, P354, DOI 10.1097/01.bco.0000176423.07865.d2; Frobell RB, 2015, BRIT J SPORT MED, V49, P700, DOI 10.1136/bjsports-2014-f232rep; Fuchs B, 1999, J SHOULDER ELB SURG, V8, P599, DOI 10.1016/S1058-2746(99)90097-6; Gersing AS, 2016, EUR RADIOL; Goldstein MG, 1999, ANN BEHAV MED, V21, P40, DOI 10.1007/BF02895032; Hanypsiak BT, 2008, AM J SPORT MED, V36, P671, DOI 10.1177/0363546508315468; Harris KP, 2015, JOURNAL OF ATHLETIC; Haughom B, 2012, KNEE, V19, P482, DOI 10.1016/j.knee.2011.06.015; Jomha NM, 1999, CLIN ORTHOP RELAT R, P188; Jungmann PM, 2015, OSTEOARTHR CARTILAGE, V23, P1144, DOI 10.1016/j.joca.2015.03.022; Jungmann PM, 2013, J MAGN RESON IMAGING, V38, P1415, DOI 10.1002/jmri.24137; Jungmann PM, 2012, AM J SPORT MED, V40, P2700, DOI 10.1177/0363546512461594; KANNUS P, 1987, J BONE JOINT SURG AM, V69A, P1007, DOI 10.2106/00004623-198769070-00008; Li XJ, 2011, RADIOLOGY, V258, P505, DOI 10.1148/radiol.10101006; Lippe J, 2012, ARTHROSCOPY, V28, P154, DOI 10.1016/j.arthro.2011.07.016; Lohmander LS, 2007, AM J SPORT MED, V35, P1756, DOI 10.1177/0363546507307396; Lohmander LS, 2004, ARTHRITIS RHEUM-US, V50, P3145, DOI 10.1002/art.20589; Louboutin H, 2009, KNEE, V16, P239, DOI 10.1016/j.knee.2008.11.004; Maletius W, 1999, AM J SPORT MED, V27, P711, DOI 10.1177/03635465990270060501; Meunier A, 2007, SCAND J MED SCI SPOR, V17, P230, DOI 10.1111/j.1600-0838.2006.00547.x; Mihelic R, 2011, INT ORTHOP; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; Murray MM, 2009, CLIN SPORT MED, V28, P51, DOI 10.1016/j.csm.2008.08.005; Nardo L, 2014, J MAGN RESON IMAGING, V39, P1178, DOI 10.1002/jmri.24278; Nishimori M, 2008, KNEE SURG SPORT TR A, V16, P270, DOI 10.1007/s00167-007-0458-x; Nordenvall R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104681; Oiestad BE, 2013, KNEE SURG SPORT TR A, V21, P942, DOI 10.1007/s00167-012-2161-9; Pan J, 2011, OSTEOARTHR CARTILAGE, V19, P65, DOI 10.1016/j.joca.2010.10.023; Peterfy CG, 2008, OSTEOARTHR CARTILAGE, V16, P1433, DOI 10.1016/j.joca.2008.06.016; Peterfy CG, 2004, OSTEOARTHR CARTILAGE, V12, P177, DOI 10.1016/j.joca.2003.11.003; Piasecki M, 2016, J PHYSIOL-LONDON, V594, P4525, DOI 10.1113/JP271087; Racine Jennifer, 2014, R I Med J (2013), V97, P25; Rau R, 2003, Z RHEUMATOL, V62, P555, DOI 10.1007/s00393-003-0516-9; Ronga M., 2014, JOINTS, V2, P137; Roos H, 1995, OSTEOARTHR CARTILAGE, V3, P261, DOI 10.1016/S1063-4584(05)80017-2; Safran M R, 1995, Am J Knee Surg, V8, P168; Selmi TAS, 2006, KNEE, V13, P353, DOI 10.1016/j.knee.2006.02.014; Slemenda C, 1998, ARTHRITIS RHEUM, V41, P1951, DOI 10.1002/1529-0131(199811)41:11<1951::AID-ART9>3.0.CO;2-9; Slemenda C, 1997, ANN INTERN MED, V127, P97, DOI 10.7326/0003-4819-127-2-199707150-00001; Stehling C, 2010, OSTEOARTHR CARTILAGE, V18, P776, DOI 10.1016/j.joca.2010.02.008; Stehling C, 2010, RADIOLOGY, V254, P509, DOI 10.1148/radiol.09090596; Tashman S, 2004, AM J SPORT MED, V32, P975, DOI 10.1177/0363546503261709; Theologis AA, 2011, ARTHROSCOPY, V27, P65, DOI 10.1016/j.arthro.2010.06.026; van der Hart Cor P, 2008, J Orthop Surg Res, V3, P24, DOI 10.1186/1749-799X-3-24; von Porat A, 2004, ANN RHEUM DIS, V63, P269, DOI 10.1136/ard.2003.008136; Wakahara T, 2015, CLIN PHYSIOL FUNCT I; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4	60	16	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2016	11	12							e0166865	10.1371/journal.pone.0166865	http://dx.doi.org/10.1371/journal.pone.0166865			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MR	27918596	Green Published, gold			2022-12-27	WOS:000389577100005
J	Van der Ploeg, MA; Poortvliet, RKE; van Blijswijk, SCE; den Elzen, WPJ; van Peet, PG; de Ruijter, W; Blom, JW; Gussekloo, J				Van der Ploeg, Milly A.; Poortvliet, Rosalinde K. E.; van Blijswijk, Sophie C. E.; den Elzen, Wendy P. J.; van Peet, Petra G.; de Ruijter, Wouter; Blom, Jeanet W.; Gussekloo, Jacobijn			Statin Use and Self-Reported Hindering Muscle Complaints in Older Persons: A Population Based Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; MANAGEMENT; THERAPY; SYMPTOMS; DISEASE; PEOPLE; COHORT; ADULTS; RISK; CARE	Purpose Statins are widely used by older persons in primary and secondary prevention of cardiovascular disease. Although serious adverse events are rare, many statin users report mild muscle pain and/or muscle weakness. It's unclear what impact statins exert on a patient's daily life. Research on statin related side effects in older persons is relatively scarce. We therefore investigated the relation between statin use and self-reported hindering muscle complaints in older persons in the general population. Methods The present research was performed within the Integrated Systematic Care for Older Persons (ISCOPE) study in the Netherlands (Netherlands trial register, NTR1946). All registered adults aged >= 75 years from 59 participating practices (n = 12,066) were targeted. Information about the medical history and statin use at baseline and after 9 months was available for 4355 participants from the Electronic Patient Records of the general practitioners. In the screening questionnaire at baseline we asked participants: 'At the moment, which health complaints limit you the most in your day-to-day life?' Answers indicating muscle or musculoskeletal complaints were coded as such. No specific questions about muscle complaints were asked. Results The participants had a median age of 80.3 (IQR 77.6 +/- 84.4) years, 60.8% were female and 28.5% had a history of CVD. At baseline 29% used a statin. At follow-up, no difference was found in the prevalence of self-reported hindering muscle complaints in statin users compared to non-statin users (3.3% vs. 2.5%, OR 1.39, 95% CI 0.94 +/- 2.05; P = 0.98). Discontinuation of statin use during follow-up was independent of self-reported hindering muscle complaints. Conclusion Based on the present findings, prevalent statin use in this community-dwelling older population is not associated with self-reported hindering muscle complaints; however, the results might be different for incident users.	[Van der Ploeg, Milly A.; Poortvliet, Rosalinde K. E.; van Blijswijk, Sophie C. E.; den Elzen, Wendy P. J.; van Peet, Petra G.; de Ruijter, Wouter; Blom, Jeanet W.; Gussekloo, Jacobijn] Leiden Univ, Dept Publ Hlth & Primary Care, Med Ctr, Leiden, Netherlands; [den Elzen, Wendy P. J.] Leiden Univ, Dept Clin Chem & Lab Med, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Poortvliet, RKE (corresponding author), Leiden Univ, Dept Publ Hlth & Primary Care, Med Ctr, Leiden, Netherlands.	R.K.E.Poortvliet@lumc.nl	Gussekloo, Jacobijn/ABE-3879-2021; de Ruijter, Wouter/GRF-3867-2022; Poortvliet, Rosalinde/AAR-1982-2020	Gussekloo, Jacobijn/0000-0001-7186-8278; den Elzen, Wendy/0000-0002-6774-4077; van Peet, Petra/0000-0002-7963-6575; van der Ploeg, Milly/0000-0001-9415-338X	ZonMw, the Netherlands; Organization for Health Research and Development: ZonMw [311060201]	ZonMw, the Netherlands(Netherlands Organization for Health Research and DevelopmentNetherlands Government); Organization for Health Research and Development: ZonMw(Netherlands Organization for Health Research and Development)	This study was funded by ZonMw, the Netherlands, Organization for Health Research and Development: ZonMw No. 311060201. The sponsor had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Abramson JD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6123; Alexander KP, 2009, J CARDIOVASC PHARM T, V14, P49, DOI 10.1177/1074248408328927; [Anonymous], 2012, HUISARTS WET, V55, P14; Barsky AJ, 2002, JAMA-J AM MED ASSOC, V287, P622, DOI 10.1001/jama.287.5.622; Bhardwaj S, 2013, CLIN INTERV AGING, V8, P47, DOI 10.2147/CIA.S29686; Blom J, 2016, AGE AGEING, V45, P30, DOI 10.1093/ageing/afv174; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Cham S, 2010, PHARMACOTHERAPY, V30, P541, DOI 10.1592/phco.30.6.541; Chodick G, 2008, CLIN THER, V30, P2167, DOI 10.1016/j.clinthera.2008.11.012; Chowdhury R, 2013, EUR HEART J, V34, P2940, DOI 10.1093/eurheartj/eht295; Cohen JD, 2012, J CLIN LIPIDOL, V6, P208, DOI 10.1016/j.jacl.2012.03.003; Colloca L, 2012, JAMA-J AM MED ASSOC, V307, P567, DOI 10.1001/jama.2012.115; Finegold JA, 2014, EUR J PREV CARDIOL, V21, P464, DOI 10.1177/2047487314525531; IMS Institute for Health Informatics, US MED US REV 2011; Joy TR, 2009, ANN INTERN MED, V150, P858, DOI 10.7326/0003-4819-150-12-200906160-00009; Law M, 2006, AM J CARDIOL, V97, p52C, DOI 10.1016/j.amjcard.2005.12.010; National Clinical Guideline Centre (UK), 2014, LIP MOD CARD RISK AS; Omar MA, 2001, ANN PHARMACOTHER, V35, P1096, DOI 10.1345/aph.10228; Parker BA, 2013, CIRCULATION, V127, P96, DOI 10.1161/CIRCULATIONAHA.112.136101; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; Petersen LK, 2010, AGE AGEING, V39, P674, DOI 10.1093/ageing/afq129; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Rich MW, 2014, J AM GERIATR SOC, V62, P945, DOI 10.1111/jgs.12788_2; Rosenbaum D, 2013, NUTR METAB CARDIOVAS, V23, P871, DOI 10.1016/j.numecd.2012.04.012; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Stroes ES, 2015, EUR HEART J, V36, P1012, DOI 10.1093/eurheartj/ehv043; Thompson Paul D, 2010, Prev Cardiol, V13, P104, DOI 10.1111/j.1751-7141.2009.00063.x; van Blijswijk SCE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142416; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	30	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0166857	10.1371/journal.pone.0166857	http://dx.doi.org/10.1371/journal.pone.0166857			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911918	gold, Green Submitted, Green Published			2022-12-27	WOS:000389520600016
J	Akhdar, H; El Shamieh, S; Musso, O; Desert, R; Joumaa, W; Guyader, D; Aninat, C; Corlu, A; Morel, F				Akhdar, Hanane; El Shamieh, Said; Musso, Orlando; Desert, Romain; Joumaa, Wissam; Guyader, Dominique; Aninat, Caroline; Corlu, Anne; Morel, Fabrice			The rs3957357C>T SNP in GSTA1 Is Associated with a Higher Risk of Occurrence of Hepatocellular Carcinoma in European Individuals	PLOS ONE			English	Article							CANCER-RISK; ENDOSTATIN PRECURSOR; COLLAGEN-XVIII; POLYMORPHISMS; CELLS; PROGRESSION; EXPRESSION; SOFTWARE; GENOTYPE; M1	Glutathione S-transferases (GSTs) detoxify toxic molecules by conjugation with reduced glutathione and regulate cell signaling. Single nucleotide polymorphisms (SNPs) of GST genes have been suggested to affect GST functions and thus to increase the risk of human hepatocellular carcinoma (HCC). As GSTA1 is expressed in hepatocytes and the rs3957 357C>T (TT) SNP is known to downregulate GSTA1 mRNA expression, the aims of this study were: (i) to explore the relationship between the TT SNP in GSTA1 and the occurrence of HCC; (ii) to measure GSTA1 mRNA expression in HCCs. For that purpose, we genotyped non-tumor-tissue-derived DNA from 48 HCC patients and white-blood-cell-derived DNA from 37 healthy individuals by restriction fragment length polymorphism (RFLP). In addition, expression of GSTA1 mRNA was assessed by real-time PCR in 18 matching pairs of HCCs and non-tumor livers. Survival analysis was performed on an annotated microarray dataset containing 247 HCC patients (GSE14520). The GSTA1 TT genotype was more frequent in HCC than in non-HCC patients (27% versus 5%, respectively), suggesting that individuals carrying this genotype could be associated with 2-fold higher risk of developing HCCs (odds ratio = 2.1; p = 0.02). Also, we found that GSTA1 mRNA expression was lower in HCCs than in non-tumor livers. HCCs expressing the highest GSTA1 mRNA levels were the smallest in size (R = -0.67; p = 0.007), expressed the highest levels of liver-enriched genes such as ALB (albumin, R = -0.67; p = 0.007) and COL18A1 (procollagen type XVIII, R = -0.50; p = 0.03) and showed the most favorable disease-free (OR = 0.54; p<0.001) and overall (OR = 0.56; p = 0.006) outcomes. Moreover, GSTA1 was found within a 263-gene network involved in well-differentiated hepatocyte functions. In conclusion, HCCs are characterized by two GSTA1 features: the TT SNP and reduced GSTA1 gene expression in a context of hepatocyte de-differentiation.	[Akhdar, Hanane; Musso, Orlando; Desert, Romain; Guyader, Dominique; Aninat, Caroline; Corlu, Anne; Morel, Fabrice] INSERM, UMR991, Rennes, France; [Akhdar, Hanane; Musso, Orlando; Desert, Romain; Guyader, Dominique; Aninat, Caroline; Corlu, Anne; Morel, Fabrice] Univ Rennes 1, Rennes, France; [El Shamieh, Said; Joumaa, Wissam] Beirut Arab Univ, Fac Hlth Sci, Dept Med Lab Technol, Beirut, Lebanon; [El Shamieh, Said] INSERM, UMR1122, Nancy, France; [Guyader, Dominique] CHU Rennes, Serv Malad Foie, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Beirut Arab University; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Rennes	Akhdar, H; Musso, O; Corlu, A (corresponding author), INSERM, UMR991, Rennes, France.; Akhdar, H; Musso, O; Corlu, A (corresponding author), Univ Rennes 1, Rennes, France.	hanane.akhdar@liu.edu.lb; orlando.musso@inserm.fr; anne.corlu@inserm.fr	Shamieh, Said El/J-6343-2019; Musso, Orlando/N-5756-2017; Corlu, Anne/U-8030-2018; Aninat, Caroline/AAL-8446-2020	Shamieh, Said El/0000-0002-8522-0445; Corlu, Anne/0000-0002-7370-0564; Aninat, Caroline/0000-0002-9008-0686; Musso, Orlando/0000-0001-8881-6925	INSERM; CNRS; University of Rennes 1; la Ligue Contre le Cancer (Comites d'Ille-et-Vilaine et des COtes d'Armor) France; Region Bretagne; Agence Nationale de la Recherche; Institut National du Cancer; Fondation pour la Recherche Medcale and Contrat de Plan Etat Region; Conseil National de la Recherche Scientifique du Liban	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Rennes 1; la Ligue Contre le Cancer (Comites d'Ille-et-Vilaine et des COtes d'Armor) France; Region Bretagne(Region Bretagne); Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut National du Cancer(Institut National du Cancer (INCA) France); Fondation pour la Recherche Medcale and Contrat de Plan Etat Region; Conseil National de la Recherche Scientifique du Liban	This research was supported by INSERM; CNRS; University of Rennes 1; la Ligue Contre le Cancer (Comites d'Ille-et-Vilaine et des COtes d'Armor) France; Region Bretagne; Agence Nationale de la Recherche; Institut National du Cancer; Fondation pour la Recherche Medcale and Contrat de Plan Etat Region 2007-2013 projet CanceropOle. Hanane Akhdar was the recipient of a fellowship from the Conseil National de la Recherche Scientifique du Liban. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2006, CARCINOGENESIS, V27, P1876, DOI 10.1093/carcin/bgl038; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Chen KJ, 2014, TUMOR BIOL, V35, P213, DOI 10.1007/s13277-013-1026-2; Choudhury JH, 2015, TUMOUR BIOL; Coles BF, 2005, METHOD ENZYMOL, V401, P9, DOI 10.1016/S0076-6879(05)01002-5; Davies A, 2014, CLIN PHARMACOL THER, V96, P694, DOI 10.1038/clpt.2014.176; Deng QW, 2015, J BUON, V20, P287; Desert R, 2016, INT J BIOCH CELL BIO; Dubois-Pot-Schneider H, 2014, HEPATOLOGY, V60, P2077, DOI 10.1002/hep.27353; Frau M, 2013, J HEPATOL, V59, P830, DOI 10.1016/j.jhep.2013.04.031; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gougelet A, 2014, HEPATOLOGY, V59, P2344, DOI 10.1002/hep.26924; Govaere O, 2014, GUT, V63, P674, DOI 10.1136/gutjnl-2012-304351; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Hu MM, 2014, BIOMED REP, V2, P898, DOI 10.3892/br.2014.319; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Kadouri L, 2008, BRIT J CANCER, V98, P2006, DOI 10.1038/sj.bjc.6604394; Klusek Justyna, 2014, Contemp Oncol (Pozn), V18, P219, DOI 10.5114/wo.2014.41388; Kruger M, 2015, CLIN ORAL INVESTIG; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lei ZY, 2015, INT J CLIN EXP MED, V8, P377; Liu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057043; Mebarki S, 2016, ONCOTARGET, V7, P39026, DOI 10.18632/oncotarget.9346; Musso O, 2001, CANCER RES, V61, P45; Musso O, 2001, HEPATOLOGY, V33, P868, DOI 10.1053/jhep.2001.23189; Osman AM, 2010, REPROD TOXICOL, V30, P322, DOI 10.1016/j.reprotox.2010.05.084; Pajaud J, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/137676; Pan CG, 2014, ONCOL RES TREAT, V37, P164, DOI 10.1159/000361083; Panczyk M, 2014, WORLD J GASTROENTERO, V20, P9775, DOI 10.3748/wjg.v20.i29.9775; Quelard D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001878; Ramsay EE, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00181; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singal AG, 2015, CLIN GASTROENTEROL H, V13, P2140, DOI 10.1016/j.cgh.2015.08.014; Song K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048924; Villanueva A, 2015, HEPATOLOGY, V61, P1945, DOI 10.1002/hep.27732; Wang B, 2010, SCI CHINA MATH, V53, P1, DOI 10.1007/s11425-010-0014-x; Zucman-Rossi J, 2015, GASTROENTEROLOGY, V149, P1226, DOI 10.1053/j.gastro.2015.05.061	40	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167543	10.1371/journal.pone.0167543	http://dx.doi.org/10.1371/journal.pone.0167543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936036	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100119
J	Campbell, LG; Shukla, K; Sneck, ME; Chaplin, C; Mercer, KL				Campbell, Lesley G.; Shukla, Kruti; Sneck, Michelle E.; Chaplin, Colleen; Mercer, Kristin L.			The Effect of Altered Soil Moisture on Hybridization Rate in a Crop-Wild System (Raphanus spp.)	PLOS ONE			English	Article							CLIMATE-CHANGE; FLORAL DISPLAY; GENE FLOW; RADISH; POPULATIONS; WEEDY; INTROGRESSION; EVOLUTION; HYBRIDS; TRAITS	Since plant mating choices are flexible and responsive to the environment, rates of spontaneous hybridization may vary across ecological clines. Developing a robust and predictive framework for rates of plant gene flow requires assessing the role of environmental sensitivity on plant reproductive traits, relative abundance, and pollen vectors. Therefore, across a soil moisture gradient, we quantified pollinator movement, life-history trait variation, and unidirectional hybridization rates from crop (Raphanus sativus) to wild (Raphanus raphanistrum) radish populations. Both radish species were grown together in relatively dry (no rain), relatively wet (double rain), or control soil moisture conditions in Ohio, USA. We measured wild and crop radish life-history, phenology and pollinator visitation patterns. To quantify hybridization rates from crop-to-wild species, we used a simply inherited morphological marker to detect F-1 hybrid progeny. Although crop-to-wild hybridization did not respond to watering treatments, the abundance of hybrid offspring was higher in fruits produced late in the period of phenological overlap, when both species had roughly equal numbers of open flowers. Therefore, the timing of fruit production and its relationship to flowering overlap may be more important to hybrid zone formation in Raphanus spp. than soil moisture or pollen vector movements.	[Campbell, Lesley G.; Shukla, Kruti; Chaplin, Colleen] Ryerson Univ, Dept Biol & Chem, Toronto, ON, Canada; [Campbell, Lesley G.; Sneck, Michelle E.] Rice Univ, Dept Biosci, Houston, TX USA; [Mercer, Kristin L.] Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA	Toronto Metropolitan University; Rice University; University System of Ohio; Ohio State University	Mercer, KL (corresponding author), Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA.	mercer.97@osu.edu			Shell Center for Sustainability; Rice University; Ohio State University; Natural Sciences and Engineering Research Council Discovery grant [402305-2011]; Ryerson University	Shell Center for Sustainability; Rice University; Ohio State University(Ohio State University); Natural Sciences and Engineering Research Council Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ryerson University	Funds from Shell Center for Sustainability (to K. Whitney), Rice University (to LGC), Ohio State University (to KLM), Natural Sciences and Engineering Research Council Discovery grant (#402305-2011 to LGC), and Ryerson University (to LGC) supported this work.	Alsos IG, 2012, P ROY SOC B-BIOL SCI, V279, P2042, DOI 10.1098/rspb.2011.2363; Angert AL, 2011, ECOL LETT, V14, P677, DOI 10.1111/j.1461-0248.2011.01620.x; Anjum SA, 2011, AFR J AGR RES, V6, P2026; Arnold ML, 2010, TRENDS ECOL EVOL, V25, P530, DOI 10.1016/j.tree.2010.06.005; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Bates B.C., 2008, CLIMATE CHANGE WATER; Bleeker W, 2001, MOL ECOL, V10, P2013, DOI 10.1046/j.1365-294X.2001.01341.x; Bolmgren K, 2005, INT J PLANT SCI, V166, P663, DOI 10.1086/430097; Borror DJ, 1981, INTRO STUDY INSECTS; BROCHMANN C, 1984, NORD J BOT, V4, P729, DOI 10.1111/j.1756-1051.1984.tb02001.x; Brunet J, 2006, EVOLUTION, V60, P234, DOI 10.1111/j.0014-3820.2006.tb01102.x; Burgess KS, 2005, MOL ECOL, V14, P3471, DOI 10.1111/j.1365-294X.2005.02670.x; Campbell DR, 2013, AM J BOT, V100, P1322, DOI 10.3732/ajb.1200473; Campbell LG, 2006, ECOL LETT, V9, P1198, DOI 10.1111/j.1461-0248.2006.00974.x; Campbell LG, 2015, INT J PLANT SCI, V176, P393, DOI 10.1086/680683; Campbell LG, 2009, NEW PHYTOL, V184, P806, DOI 10.1111/j.1469-8137.2009.03036.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chunco AJ, 2014, ECOL EVOL, V4, P2019, DOI 10.1002/ece3.1052; CLEGG MT, 1980, BIOSCIENCE, V30, P814, DOI 10.2307/1308373; CONNER J, 1993, EVOLUTION, V47, P704, DOI 10.1111/j.1558-5646.1993.tb02128.x; Conner JK, 1996, EVOLUTION, V50, P1127, DOI [10.2307/2410653, 10.1111/j.1558-5646.1996.tb02353.x]; CRUZAN MB, 1994, HEREDITY, V72, P95, DOI 10.1038/hdy.1994.12; Cummings CL, 2002, OECOLOGIA, V130, P274, DOI 10.1007/s004420100806; De La Torre A, 2015, HEREDITY, V115, P153, DOI 10.1038/hdy.2015.19; Duminil J, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-195; ECKHART VM, 1991, EVOL ECOL, V5, P370, DOI 10.1007/BF02214154; Ellstrand NC, 2013, ANNU REV ECOL EVOL S, V44, P325, DOI 10.1146/annurev-ecolsys-110512-135840; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Field DL, 2008, J ECOL, V96, P1198, DOI 10.1111/j.1365-2745.2008.01434.x; Field DL, 2011, MOL ECOL, V20, P2367, DOI 10.1111/j.1365-294X.2011.05054.x; Forrest J, 2010, ECOLOGY, V91, P431, DOI 10.1890/09-0099.1; Franks SJ, 2007, P NATL ACAD SCI USA, V104, P1278, DOI 10.1073/pnas.0608379104; Garroway CJ, 2010, GLOBAL CHANGE BIOL, V16, P113, DOI 10.1111/j.1365-2486.2009.01948.x; Gomez C, 2016, ECOL EVOL; Halpin PN, 1997, ECOL APPL, V7, P828; Hamrick JL, 1997, CROP SCI, V37, P26, DOI 10.2135/cropsci1997.0011183X003700010004x; Hegde SG, 2006, EVOLUTION, V60, P1187, DOI 10.1111/j.0014-3820.2006.tb01197.x; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; IPCC, 2012, MAN RISKS EXTR EV DI; Kennedy BF, 2008, OECOLOGIA, V155, P469, DOI 10.1007/s00442-007-0924-7; KLINGER T, 1991, CONSERV BIOL, V5, P531, DOI 10.1111/j.1523-1739.1991.tb00360.x; Lee TN, 1998, AM J BOT, V85, P333, DOI 10.2307/2446325; Li Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116411; Ma X, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-164; Marques I, 2007, AM J BOT, V94, P1352, DOI 10.3732/ajb.94.8.1352; Matthews HD, 2009, NATURE, V459, P829, DOI 10.1038/nature08047; Meehl GA, 2007, CLIM DYNAM, V29, P779, DOI 10.1007/s00382-007-0268-3; Meehl GA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030948; Mimura M, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0209-9; Muhlfeld CC, 2014, NAT CLIM CHANGE, V4, P620, DOI [10.1038/NCLIMATE2252, 10.1038/nclimate2252]; Myers N, 2001, P NATL ACAD SCI USA, V98, P5389, DOI 10.1073/pnas.091092498; PANETSOS CA, 1968, GENETICA, V38, P243, DOI 10.1007/BF01507462; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pertl M, 2002, HEREDITY, V89, P212, DOI 10.1038/sj.hdy.6800131; Pirimova N, 2015, AM J UNDERGRADUATE R, V12, P63; Prentis PJ, 2007, NEW PHYTOL, V176, P902, DOI 10.1111/j.1469-8137.2007.02217.x; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Sanchez-Guillen RA, 2015, BIOL REV; Schiegg K, 2002, P ROY SOC B-BIOL SCI, V269, P1153, DOI 10.1098/rspb.2002.1966; Schwarzbach AE, 2001, AM J BOT, V88, P270, DOI 10.2307/2657018; Sedlacek J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047415; Seehausen O, 2006, CURR BIOL, V16, pR334, DOI 10.1016/j.cub.2006.03.080; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Snow AA, 2010, NEW PHYTOL, V186, P537, DOI 10.1111/j.1469-8137.2009.03172.x; Snow AA, 2005, CROP FERALITY AND VOLUNTEERISM, P193, DOI 10.1201/9781420037999.ch13; Snow AA, 2005, ECOL APPL, V15, P377, DOI 10.1890/04-0539; Snow AA, 2001, ECOL APPL, V11, P934, DOI 10.1890/1051-0761(2001)011[0934:FOHBWA]2.0.CO;2; STANTON ML, 1987, AM J BOT, V74, P178, DOI 10.2307/2444019; Teitel Z, 2016, WEED RES, V56, P149, DOI 10.1111/wre.12194; Vigouroux Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019563; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Whitney KD, 2006, AM NAT, V167, P794, DOI 10.1086/504606; Whitney KD, 2010, PERSPECT PLANT ECOL, V12, P175, DOI 10.1016/j.ppees.2010.02.002; Zhu K, 2012, GLOBAL CHANGE BIOL, V18, P1042, DOI 10.1111/j.1365-2486.2011.02571.x	74	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166802	10.1371/journal.pone.0166802	http://dx.doi.org/10.1371/journal.pone.0166802			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936159	gold, Green Submitted, Green Published			2022-12-27	WOS:000389587100044
J	Christenson, A; Johansson, E; Reynisdottir, S; Torgerson, J; Hemmingsson, E				Christenson, Anne; Johansson, Eva; Reynisdottir, Signy; Torgerson, Jarl; Hemmingsson, Erik			Women's Perceived Reasons for Their Excessive Postpartum Weight Retention: A Qualitative Interview Study	PLOS ONE			English	Article							LOW-INCOME OVERWEIGHT; PREGNANT-WOMEN; RISK-FACTORS; GAIN; DEPRESSION; OUTCOMES; ANXIETY; OBESITY; STRESS; IMPACT	Introduction Obesity in Sweden has doubled to 14% over the last 20 years. New strategies for treatment and prevention are needed. Excessive gestational weight gain has been found to contribute substantially to obesity, and there is a consistent association between postpartum weight retention and obesity later in life. We aimed to explore what factors women perceive as reasons for having substantial postpartum weight retention, to identify areas for new and improved interventions. Methods Qualitative interview study (semi-structured) using an emergent design. Fifteen women, with a postpartum weight retention >= 10 kg, were interviewed by a trained cognitive therapist. Eight women had pre-pregnancy BMI below 30 kg/m(2). Interviews were transcribed verbatim and data analysed using inductive manifest content analysis. Salient text passages were extracted, shortened, coded and clustered into categories. Results Participants reported no knowledge of current gestational weight gain recommendations or of risks for adverse pregnancy outcomes with excessive weight gain or postpartum weigh retention. Excessive eating emerged as a common strategy to provide relief of psychological, emotional and physical discomfort, such as depression and morning sickness. Women perceived medical staff as being unconcerned about weight, and postpartum weight loss support was scarce or absent. Some women reported eating more due to a belief that breastfeeding would automatically lead to weight loss. Conclusion There is a need to raise awareness about risks with unhealthy gestational weight development and postpartum weight retention in women of childbearing age. The common strategy to cope with psychological, emotional or physical discomfort by eating is an important factor to target with intervention. The postpartum year is a neglected period where additional follow-up on weight and weight loss support is strongly indicated.	[Christenson, Anne; Reynisdottir, Signy] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Obes Ctr, Stockholm, Sweden; [Johansson, Eva] Karolinska Inst, Dept Publ Hlth Sci IHCAR, Stockholm, Sweden; [Torgerson, Jarl] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden; [Hemmingsson, Erik] Karolinska Inst, Dept Med, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Gothenburg; Karolinska Institutet	Christenson, A (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Med, Obes Ctr, Stockholm, Sweden.	anne.christenson@ki.se		Hemmingsson, Erik/0000-0001-7335-3796				Anderson CK, 2015, J NUTR EDUC BEHAV, V47, P404, DOI 10.1016/j.jneb.2015.05.011; Atkinson L, 2016, BRIT J HLTH PSYCHOL; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bogaerts A, 2013, OBSTET GYNECOL, V122, P999, DOI 10.1097/AOG.0b013e3182a7f63e; Bogaerts AFL, 2013, OBESITY, V21, P1942, DOI 10.1002/oby.20352; Braden A, 2016, J BEHAV MED; Brownfoot FC, 2016, BJOG-INT J OBSTET GY, V123, P254, DOI 10.1111/1471-0528.13735; Chang MW, 2015, MATERN CHILD HLTH J, V19, P1060, DOI 10.1007/s10995-014-1605-x; Cnattingius S, 2016, LANCET, V387, P558, DOI 10.1016/S0140-6736(15)00990-3; Duthie EA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-231; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Falah-Hassani K, 2016, J AFFECT DISORDERS, V198, P142, DOI 10.1016/j.jad.2016.03.010; Finch LE, 2015, APPETITE, V95, P239, DOI 10.1016/j.appet.2015.07.017; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Harris HE, 1999, J PSYCHOSOM OBST GYN, V20, P65, DOI 10.3109/01674829909075579; Hartley E, 2015, WOMEN BIRTH, V28, pE99, DOI 10.1016/j.wombi.2015.04.004; Institute of Medicine Committee on Nutritional Status During Pregnancy and Lactation, 1990, NUTR PREGN 1; Johnson J, 2013, OBSTET GYNECOL, V121, P969, DOI 10.1097/AOG.0b013e31828aea03; Krakowiak P, 2015, MATERN CHILD HLTH J, V19, P1925, DOI 10.1007/s10995-015-1723-0; Liamputtong P, 2009, HEALTH PROMOT J AUST, V20, P133, DOI 10.1071/HE09133; Lindholm ES, 2010, ACTA OBSTET GYN SCAN, V89, P840, DOI 10.3109/00016340903428370; Linne Y, 2003, ACTA OBSTET GYN SCAN, V82, P318, DOI 10.1034/j.1600-0412.2003.00150.x; Lopez-Olmedo N, 2016, MATERN CHILD HLTH J, V20, P270, DOI 10.1007/s10995-015-1826-7; Mannan M, 2013, NUTR REV, V71, P343, DOI 10.1111/nure.12034; Neville CE, 2014, INT J OBESITY, V38, P577, DOI 10.1038/ijo.2013.132; Ohlendorf JM, 2015, J ADV NURS, V71, P1833, DOI 10.1111/jan.12640; Olander EK, 2016, WOMEN BIRTH, V29, pE67, DOI 10.1016/j.wombi.2015.11.005; Olander EK, 2011, SEX REPROD HEALTHC, V2, P43, DOI 10.1016/j.srhc.2010.10.004; Ostbye T, 2010, PREV MED, V51, P368, DOI 10.1016/j.ypmed.2010.07.017; Phelan S, 2011, AM J CLIN NUTR, V93, P772, DOI 10.3945/ajcn.110.005306; Phillips J, 2014, BRIT J HEALTH PSYCH, V19, P751, DOI 10.1111/bjhp.12074; Rasmussen KM, 2009, CURR OPIN OBSTET GYN, V21, P521, DOI 10.1097/GCO.0b013e328332d24e; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Redding JQRCA, 2008, ENCY EPIDEMIOLOGY; Samura Tirah, 2016, Glob Adv Health Med, V5, P87, DOI 10.7453/gahmj.2015.094; SBU, 2002, OB PROBL INT; SCB, 2015, STAT; Skouteris H, 2016, BRIT J HEALTH PSYCH, V21, P31, DOI 10.1111/bjhp.12154; Smith DM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-157; Staneva AA, 2015, MIDWIFERY, V31, P563, DOI 10.1016/j.midw.2015.03.015; Sui Zhixian, 2013, Australas Med J, V6, P565, DOI 10.4066/AMJ.2013.1881; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; van Strien T, 2016, APPETITE, V100, P216, DOI 10.1016/j.appet.2016.02.034; Vesco KK, 2016, OBESITY, V24, P2042, DOI 10.1002/oby.21597; Villamor E, 2016, OBESITY SILVER SPRI; Waring ME, 2014, BIRTH-ISS PERINAT C, V41, P353, DOI 10.1111/birt.12131; Wennberg AL, 2014, SEX REPROD HEALTHC, V5, P107, DOI 10.1016/j.srhc.2014.07.001; Xiao RS, 2014, J PSYCHOSOM RES, V77, P351, DOI 10.1016/j.jpsychores.2014.09.016	50	23	23	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167731	10.1371/journal.pone.0167731	http://dx.doi.org/10.1371/journal.pone.0167731			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936110	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100166
J	Consoli, P; Esposito, V; Battaglia, P; Altobelli, C; Perzia, P; Romeo, T; Canese, S; Andaloro, F				Consoli, Pierpaolo; Esposito, Valentina; Battaglia, Pietro; Altobelli, Chiara; Perzia, Patrizia; Romeo, Teresa; Canese, Simonepietro; Andaloro, Franco			Fish Distribution and Habitat Complexity on Banks of the Strait of Sicily (Central Mediterranean Sea) from Remotely-Operated Vehicle (ROV) Explorations	PLOS ONE			English	Article							SPECIES-DIVERSITY; VISUAL CENSUSES; NORTH-ATLANTIC; PREY REFUGES; DYNAMICS; CORAL; ASSEMBLAGES; CIRCULATION; PREDATION; ABUNDANCE	The Strait of Sicily was recognized internationally as an "Ecologically or Biologically Significant Area" by the Contracting Parties of the Convention on Biological Diversity in 2014. However, basic aspects of its fish diversity are still unknown and most of the information comes from traditional trawl surveys. This paper provides the first detailed description, using a Remotely Operated Vehicle (ROV), of the composition and depth distribution of the demersal fish assemblages found on banks of the Strait of Sicily and the related habitat complexity from 35 to 240 m depth. A total of 24 families and 52 fish species were recorded and depth was consistently associated with a significant proportion of the variation of the fish assemblage. The highest species richness was observed at the shallowest depth layer (0-50 m) and significantly decreased, remaining almost constant, in deeper layers. Similarly the highest abundance was recorded at 0-50 m, where C. julis represented the most abundant species, and decreased progressively throughout the whole depth gradient. Although the factor habitat complexity explained only a small proportion of the fish assemblage variation, significant differences among different degrees of habitat complexity were observed, together with a general positive trend for species richness and abundance with increasing habitat complexity. The ROV also allowed us to observe some rare or poorly known fish species such as Scorpaenodes arenai, Hyporthodus haifensis, Myliobatis aquila, Gadella maraldi, Epinephelus caninus and Lappanella fasciata. These findings show that banks serve as reservoirs for fish abundance and biodiversity and that immediate environmental conservation and management actions represent a priority not only for Italy but also for other countries which share the same area.	[Consoli, Pierpaolo; Esposito, Valentina; Battaglia, Pietro; Romeo, Teresa] ISPRA, Lab Ittiol & Eol Marina, Milazzo, Italy; [Altobelli, Chiara; Perzia, Patrizia; Andaloro, Franco] ISPRA, STS Palermo, Dipartimento Uso Sostenibile Risorse 4, Palermo, Italy; [Canese, Simonepietro] ISPRA, Dipartimento Tutela Habitat & Biodiversita Marina, Rome, Italy	European Commission Joint Research Centre; EC JRC ISPRA Site; European Commission Joint Research Centre; EC JRC ISPRA Site; Italian Institute for Environmental Protection & Research (ISPRA)	Consoli, P (corresponding author), ISPRA, Lab Ittiol & Eol Marina, Milazzo, Italy.	pierpaolo.consoli@isprambiente.it	Consoli, Pierpaolo/C-9265-2017; Esposito, Valentina/AAE-3561-2019; Battaglia, Pietro/X-2180-2019; Canese, Simonepietro/AAA-5499-2019; Romeo, Teresa/AAA-1711-2020; Consoli, Pierpaolo/AAD-5604-2019; Perzia, Patrizia/GSI-4575-2022	Consoli, Pierpaolo/0000-0001-8135-3876; Esposito, Valentina/0000-0001-7595-8369; Battaglia, Pietro/0000-0003-1822-7775; Canese, Simonepietro/0000-0001-6049-4506; Consoli, Pierpaolo/0000-0001-8135-3876; Perzia, Patrizia/0000-0001-6143-349X	D.R.A. Assessorato Territorio Ambiente Regione Siciliana-Asse 3 Linea di intervento 3.2.1.2 of POR FESR Sicilia	D.R.A. Assessorato Territorio Ambiente Regione Siciliana-Asse 3 Linea di intervento 3.2.1.2 of POR FESR Sicilia	This project was financed by D.R.A. Assessorato Territorio Ambiente Regione Siciliana-Asse 3 Linea di intervento 3.2.1.2 of POR FESR Sicilia 2007-2013 aimed to assess the marine biodiversity in Sicily. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla Ameer, 2008, MARITIME TRAFFIC EFF; Almany GR, 2004, OECOLOGIA, V141, P105, DOI 10.1007/s00442-004-1617-0; Andaloro F, 2013, HELGOLAND MAR RES, V67, P241, DOI 10.1007/s10152-012-0319-y; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Astraldi M, 2001, J PHYS OCEANOGR, V31, P3457, DOI 10.1175/1520-0485(2001)031<3457:DWDATS>2.0.CO;2; Barbagallo Rosi, 2015, Biodiversity Journal, V6, P115; Battaglia P, 2015, ITAL J ZOOL, V82, P454, DOI 10.1080/11250003.2015.1028485; BELL JD, 1983, J APPL ECOL, V20, P357, DOI 10.2307/2403513; Beranger K, 2004, DEEP-SEA RES PT II, V51, P411, DOI 10.1016/j.dsr2.2003.08.004; Bo M, 2014, MAR ECOL-EVOL PERSP, V35, P332, DOI 10.1111/maec.12089; Bo M, 2012, HYDROBIOLOGIA, V687, P163, DOI 10.1007/s10750-011-0964-1; Bo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016357; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Canese S, 2015, P 1 MED S CONS DARK; Civile D, 2016, GEOL MAG, V153, P160, DOI 10.1017/S0016756815000485; Civile D, 2015, GLOBAL PLANET CHANGE, V125, P36, DOI 10.1016/j.gloplacha.2014.12.003; Colantoni P, 1985, GIORNALE GEOLOGIA, V47, P2; Colloca F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119590; Consoli P, 2015, J MAR BIOL ASSOC UK, V95, P17, DOI 10.1017/S0025315414000940; Danovaro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011832; Deidun A, 2015, ITAL J ZOOL, V82, P271, DOI 10.1080/11250003.2014.986544; Falzone G, 2009, GEOITALIA, V29; Fiorentino F, 2004, MEDSUDMED TECHNICAL, V2, P50; Fortibuoni T, 2010, J CRUSTACEAN BIOL, V30, P167, DOI 10.1651/09-3167.1; Frontier S, 1986, EVALUATION OPTIMISAT; Garcia-Charton JA, 1998, MAR ECOL-P S Z N I, V19, P111; Garofalo G, 2007, HYDROBIOLOGIA, V580, P117, DOI 10.1007/s10750-006-0460-1; Garofalo G, 2011, J SEA RES, V66, P29, DOI 10.1016/j.seares.2011.04.008; Garofalo G., 2004, GIS SPATIAL ANAL FIS, V2, P101; Garofalo G, 2008, GCPRER010ITAMSMTD19; GIBSON RN, 1972, J ANIM ECOL, V41, P189, DOI 10.2307/3512; Gorley C.K., 2006, GETTING STARTED PRIM; GOSLINE WA, 1965, ECOLOGY, V46, P823, DOI 10.2307/1934015; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; Gristina M, 2006, FISH RES, V81, P60, DOI 10.1016/j.fishres.2006.05.010; HIXON MA, 1993, ECOL MONOGR, V63, P77, DOI 10.2307/2937124; HIXON MA, 1991, THEOR POPUL BIOL, V39, P178, DOI 10.1016/0040-5809(91)90035-E; Holtzhausen JA, 2016, MYLIOBATIS AQUILA IU; Lermusiaux PFJ, 2001, DEEP-SEA RES PT I, V48, P1953, DOI 10.1016/S0967-0637(00)00114-X; Lodolo E, 2015, J ARCHAEOL SCI-REP, V3, P398, DOI 10.1016/j.jasrep.2015.07.003; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MACPHERSON E, 1994, MAR ECOL PROG SER, V114, P211, DOI 10.3354/meps114211; Magnussen E, 2002, MAR ECOL PROG SER, V238, P211, DOI 10.3354/meps238211; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; MERRETT NR, 1991, J MAR BIOL ASSOC UK, V71, P329, DOI 10.1017/S0025315400051638; Misic C, 2012, DEEP-SEA RES PT I, V67, P1, DOI 10.1016/j.dsr.2012.04.012; Moranta J, 1998, MAR ECOL PROG SER, V171, P247, DOI 10.3354/meps171247; Morato T, 2013, BIOGEOSCIENCES, V10, P3039, DOI 10.5194/bg-10-3039-2013; Ohman MC, 1998, ENVIRON BIOL FISH, V53, P19, DOI 10.1023/A:1007445226928; Omrani H, 2016, PROG OCEANOGR, V140, P54, DOI 10.1016/j.pocean.2015.10.007; Oral N, 2008, MARITIME TRAFFIC EFF; Porteiro FM, 2013, DEEP-SEA RES PT II, V98, P114, DOI 10.1016/j.dsr2.2013.09.015; Ross SW, 2007, DEEP-SEA RES PT I, V54, P975, DOI 10.1016/j.dsr.2007.03.010; Ross SW, 2015, DEEP-SEA RES PT I, V103, P137, DOI 10.1016/j.dsr.2015.06.004; Ross SW, 2009, MAR ECOL-EVOL PERSP, V30, P74, DOI 10.1111/j.1439-0485.2008.00260.x; Rovere M., 2015, ATLAS MEDITERRANEAN; Russo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086222; Schultz AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096798; StatSoft inc, 2010, STAT WIND VERS 10 CO; Staudigel H, 2010, OCEANOGRAPHY, V23, P20, DOI 10.5670/oceanog.2010.85; Tessier E, 2005, J EXP MAR BIOL ECOL, V315, P17, DOI 10.1016/j.jembe.2004.08.027	62	30	31	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167809	10.1371/journal.pone.0167809	http://dx.doi.org/10.1371/journal.pone.0167809			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936221	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100201
J	Ho, GJ; Liew, SM; Ng, CJ; Shunmugam, RH; Glasziou, P				Ho, Gah Juan; Liew, Su May; Ng, Chirk Jenn; Shunmugam, Ranita Hisham; Glasziou, Paul			Development of a Search Strategy for an Evidence Based Retrieval Service	PLOS ONE			English	Article							BIBLIOGRAPHIC DATABASES; INFORMATION; QUALITY	Background Physicians are often encouraged to locate answers for their clinical queries via an evidence-based literature search approach. The methods used are often not clearly specified. Inappropriate search strategies, time constraint and contradictory information complicate evidence retrieval. Aims Our study aimed to develop a search strategy to answer clinical queries among physicians in a primary care setting Methods Six clinical questions of different medical conditions seen in primary care were formulated. A series of experimental searches to answer each question was conducted on 3 commonly advocated medical databases. We compared search results from a PICO (patients, intervention, comparison, outcome) framework for questions using different combinations of PICO elements. We also compared outcomes from doing searches using text words, Medical Subject Headings (MeSH), or a combination of both. All searches were documented using screenshots and saved search strategies. Results Answers to all 6 questions using the PICO framework were found. A higher number of systematic reviews were obtained using a 2 PICO element search compared to a 4 element search. A more optimal choice of search is a combination of both text words and MeSH terms. Despite searching using the Systematic Review filter, many non-systematic reviews or narrative reviews were found in PubMed. There was poor overlap between outcomes of searches using different databases. The duration of search and screening for the 6 questions ranged from 1 to 4 hours. Conclusion This strategy has been shown to be feasible and can provide evidence to doctors' clinical questions. It has the potential to be incorporated into an interventional study to determine the impact of an online evidence retrieval system.	[Ho, Gah Juan; Liew, Su May; Ng, Chirk Jenn; Shunmugam, Ranita Hisham] Univ Malaya, Dept Primary Care Med, Fac Med, Kuala Lumpur, Malaysia; [Glasziou, Paul] Bond Univ, Fac Hlth Sci & Med, Southport, Qld 4229, Australia	Universiti Malaya; Bond University	Liew, SM (corresponding author), Univ Malaya, Dept Primary Care Med, Fac Med, Kuala Lumpur, Malaysia.	su_mayliew@um.edu.my	Glasziou, Paul/A-7832-2008; Hisham Shunmugam, Ranita/F-5073-2011; LIEW, Su May/B-8852-2010; NG, CHIRK JENN/C-1344-2010	Glasziou, Paul/0000-0001-7564-073X; Hisham Shunmugam, Ranita/0000-0002-3356-2291; LIEW, Su May/0000-0003-2865-7955; Ng, Chirk Jenn/0000-0002-8320-1603	University of Malaya Research Grant (UMRG) [RP037A-15HTM]	University of Malaya Research Grant (UMRG)	This work was supported by the University of Malaya Research Grant (UMRG) under the Grant Number RP037A-15HTM, which was received by SML. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoritsas T, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0125-9; Agoritsas T, 2012, J MED INTERNET RES, V14, P389, DOI 10.2196/jmir.2021; Alper BS, 2001, J FAM PRACTICE, V50, P960; Bastian H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000326; Booth A, 2006, HEALTH INFO LIBR J, V23, P229, DOI 10.1111/j.1471-1842.2006.00663.x; Brettle AJ, 2001, B MED LIBR ASSOC, V89, P353; Cheng GYT, 2004, J MED LIBR ASSOC, V92, P445; Clark E, 2006, INT J QUAL HEALTH C, V18, P165, DOI 10.1093/intqhc/mzl007; Del Mar CB, 2001, MED J AUSTRALIA, V175, P134, DOI 10.5694/j.1326-5377.2001.tb143060.x; Gehanno JF, 1998, OCCUP ENVIRON MED, V55, P562, DOI 10.1136/oem.55.8.562; Glasziou P, 2008, EVIDENCE BASED PRACT, P24; Grandage KK, 2002, J MED LIBR ASSOC, V90, P298; Greenhalgh T, 2002, BRIT MED J, V324, P524, DOI 10.1136/bmj.324.7336.524; Huang Xiaoli, 2006, AMIA Annu Symp Proc, P359; Jankowski TA, 2008, MED LIB ASS ESSENTIA, P131; Lefebvre C, 2011, COCHRANE COLLABORATI; McGowan J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003785; Montori VM, 2002, EVID BASED MED, V7, P104; Perrier L, 2014, J AM MED INFORM ASSN, V21, P1118, DOI 10.1136/amiajnl-2014-002825; Prorok JC, 2012, J CLIN EPIDEMIOL, V65, P1289, DOI 10.1016/j.jclinepi.2012.05.003; Royle PL, 2005, DIABETIC MED, V22, P1386, DOI 10.1111/j.1464-5491.2005.01645.x; Sampson M, 2009, J CLIN EPIDEMIOL, V62, P944, DOI 10.1016/j.jclinepi.2008.10.012; Sanders S, 2005, BRIT MED J, V330, P1162, DOI 10.1136/bmj.330.7501.1162; Savoie I, 2003, INT J TECHNOL ASSESS, V19, P168, DOI 10.1017/S0266462303000163; Schwartz K, 2003, FAM MED, V35, P251; Slawson DC, 1997, BRIT MED J, V314, P947, DOI 10.1136/bmj.314.7085.947; Straus S.E., 2004, BMJ-BRIT MED J, V329, P1029, DOI DOI 10.1136/BMJ.329.7473; Straus SE, 2005, EVIDENCE BASED MED P; Tsafnat G, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-74; Walton J, PRIORY MED J; Wilczynski NL, 2013, J AM MED INFORM ASSN, V20, P363, DOI 10.1136/amiajnl-2012-001075	31	18	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167170	10.1371/journal.pone.0167170	http://dx.doi.org/10.1371/journal.pone.0167170			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27935993	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100069
J	Hu, J; Zhu, MM; Liu, KH; Fan, H; Zhao, WF; Mao, Y; Zhang, YG				Hu, Jing; Zhu, Manman; Liu, Kehai; Fan, Hua; Zhao, Wenfang; Mao, Yuan; Zhang, Yaguang			A Biodegradable Polyethylenimine-Based Vector Modified by Trifunctional Peptide R18 for Enhancing Gene Transfection Efficiency In Vivo	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION SIGNAL; DELIVERY; DNA; CHITOSAN; VITRO; PEI; NANOSPHERES; DERIVATIVES; PARTICLES; COMPLEXES	Lack of capacity to cross the nucleus membrane seems to be one of the main reasons for the lower transfection efficiency of gene vectors observed in vivo study than in vitro. To solve this problem, a new non-viral gene vector was designed. First, a degradable polyethylenimine (PEI) derivate was synthesized by crosslinking low-molecular-weight (LMW) PEI with N-octyl-N-quaternary chitosan (OTMCS), and then adopting a designed trifunctional peptide (RGDC-TAT-NLS) with good tumor targeting, cell uptake and nucleus transport capabilities to modify OTMCS-PEI. The new gene vector was termed as OTMCS-PEI-R18 and characterized in terms of its chemical structure and biophysical parameters. Gene transfection efficiency and nucleus transport mechanism of this vector were also evaluated. The polymer showed controlled degradation and remarkable buffer capabilities with the particle size around 100-300 nm and the zeta potential ranged from 5 mV to 40 mV. Agraose gel electrophoresis showed that OTMCS-PEI-R18 could effectively condensed plasmid DNA at a ratio of 1.0. Besides, the polymer was stable in the presence of sodium heparin and could resist digestion by DNase I at a concentration of 63U DNase I/DNA. OTMCS-PEI-R18 also showed much lower cytotoxicity and better transfection rates compared to polymers OTMCS-PEI-R13, OTMCS-PEI and PEI 25 KDa in vitro and in vivo. Furthermore, OTMCS-PEI-R18/DNA complexes could accumulate in the nucleus well soon and not rely on mitosis absolutely due to the newly incorporated ligand peptide NLS with the specific nuclear delivery pathway indicating that the gene delivery system OTMCS-PEI-R18 could reinforce gene transfection efficiency in vivo.	[Hu, Jing; Zhu, Manman; Liu, Kehai; Zhao, Wenfang; Mao, Yuan; Zhang, Yaguang] Shanghai Ocean Univ, Dept Biopharmaceut, Coll Food Sci & Technol, Shanghai, Peoples R China; [Fan, Hua] Charite Univ Med Berlin, Inst Lab Med, Campus Virchow Klinikum, Berlin, Germany	Shanghai Ocean University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Liu, KH (corresponding author), Shanghai Ocean Univ, Dept Biopharmaceut, Coll Food Sci & Technol, Shanghai, Peoples R China.	khliu@shou.edu.cn			National Natural Science Foundation of China [81001024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China, Grant number: 81001024, http://www.letpub.com.cn/?page=grant&name=&person=%E5%88%98%E5% 85%8B%E6%B5%B7&no=&company=&addcomment_s1-0&addcomment_ s2= 0&addcomment_s3_0&money1=&money2=&startTime=2011&endTime=2015&subcategory= &searchsubmit=true&submit.x=69&submit.y= 22&submit=advSearch#fundlisttable. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation, China (81001024).	And HR, 1998, ANAL CHEM, V70, P131; Arocena M, 2006, CELL BIOL INT, V30, P1007, DOI 10.1016/j.cellbi.2006.07.008; Aufort M, 2009, EUR J MED CHEM, V44, P3394, DOI 10.1016/j.ejmech.2009.02.022; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Dailey LA, 2004, J CONTROL RELEASE, V100, P425, DOI 10.1016/j.jconrel.2004.08.031; Deng R, 2009, J CONTROL RELEASE, V140, P40, DOI 10.1016/j.jconrel.2009.07.009; Deshpande MC, 2007, J CONTROL RELEASE, V118, P126, DOI 10.1016/j.jconrel.2006.12.010; Eguchi A, 2005, J CONTROL RELEASE, V104, P507, DOI 10.1016/j.jconrel.2005.02.019; Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017; Godbey WT, 2001, BIOMATERIALS, V22, P471, DOI 10.1016/S0142-9612(00)00203-9; Guo ST, 2011, BIOMATERIALS, V32, P4283, DOI 10.1016/j.biomaterials.2011.02.034; Hao JG, 2009, ARCH PHARM RES, V32, P1045, DOI 10.1007/s12272-009-1710-3; Hyndman L, 2004, J CONTROL RELEASE, V99, P435, DOI 10.1016/j.jconrel.2004.07.023; Ito T, 2010, BIOMATERIALS, V31, P2912, DOI 10.1016/j.biomaterials.2009.12.032; Javeed A, 2009, EUR J PHARM SCI, V38, P283, DOI 10.1016/j.ejps.2009.08.009; Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009; Lai WF, 2009, J CONTROL RELEASE, V134, P158, DOI 10.1016/j.jconrel.2008.11.021; Lee DE, 2010, APPL RADIAT ISOTOPES, V68, P1896, DOI 10.1016/j.apradiso.2010.04.029; Levchenko TS, 2003, METHOD ENZYMOL, V372, P339; Lin EH, 2011, BIOMATERIALS, V32, P1978, DOI 10.1016/j.biomaterials.2010.11.026; Liu CC, 2012, INT J NANOMED, V7, P5339, DOI 10.2147/IJN.S36179; Liu HM, 2014, BIOMATERIALS, V35, P5407, DOI 10.1016/j.biomaterials.2014.03.040; Lv H, 2014, INT J NANOMED, V9, P1311, DOI 10.2147/IJN.S59726; Ma K, 2009, BIOMATERIALS, V30, P6109, DOI 10.1016/j.biomaterials.2009.07.036; Mansouri S, 2004, EUR J PHARM BIOPHARM, V57, P1, DOI 10.1016/S0939-6411(03)00155-3; Martin ME, 2007, AAPS J, V9, pE18, DOI 10.1208/aapsj0901003; Meng Y, 2016, BIOMATERIALS, V100, P134, DOI 10.1016/j.biomaterials.2016.05.033; Ping Y, 2013, BIOMATERIALS, V34, P6482, DOI 10.1016/j.biomaterials.2013.03.071; Reschel T, 2002, J CONTROL RELEASE, V81, P201, DOI 10.1016/S0168-3659(02)00045-7; Solak Y, 2010, MED HYPOTHESES, V74, P314, DOI 10.1016/j.mehy.2009.08.041; Talsma SS, 2006, J CONTROL RELEASE, V112, P271, DOI 10.1016/j.jconrel.2006.02.008; Trentin D, 2005, J CONTROL RELEASE, V102, P263, DOI 10.1016/j.jconrel.2004.09.029; Yang J., 2010, EURASIP J J IMAGE VI, V2010, P2, DOI DOI 10.1371/J0URNAL.PGEN.1000955; You J, 2013, BIOMATERIALS, V34, P4510, DOI 10.1016/j.biomaterials.2013.02.069; Zanta MA, 1999, P NATL ACAD SCI USA, V96, P91, DOI 10.1073/pnas.96.1.91	35	10	10	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166673	10.1371/journal.pone.0166673	http://dx.doi.org/10.1371/journal.pone.0166673			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935984	Green Submitted, gold, Green Published			2022-12-27	WOS:000389587100040
J	Jeon, MJ; Song, DE; Jung, CK; Kim, WG; Kwon, H; Lee, YM; Sung, TY; Yoon, JH; Chung, KW; Hong, SJ; Baek, JH; Lee, JH; Kim, TY; Shong, YK; Kim, WB				Jeon, Min Ji; Song, Dong Eun; Jung, Chan Kwon; Kim, Won Gu; Kwon, Hyemi; Lee, Yu-Mi; Sung, Tae-Yon; Yoon, Jong Ho; Chung, Ki-Wook; Hong, Suck Joon; Baek, Jung Hwan; Lee, Jeong Hyun; Kim, Tae Yong; Shong, Young Kee; Kim, Won Bae			Impact of Reclassification on Thyroid Nodules with Architectural Atypia: From Non-Invasive Encapsulated Follicular Variant Papillary Thyroid Carcinomas to Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features	PLOS ONE			English	Article							CORE-NEEDLE-BIOPSY; UNDETERMINED SIGNIFICANCE; MALIGNANCY; MANAGEMENT; ASPIRATION; LESIONS; RISK	Background The follicular variant of papillary thyroid cancer (FVPTC), especially the encapsulated non-invasive subtype, is a controversial entity. Recent study suggested using 'non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)' for these indolent carcinomas. We evaluated the impact of reclassification from non-invasive encapsulated FVPTCs (EFVPTCs) to NIFTPs in the diagnosis of thyroid nodules with architectural atypia. Methods We reviewed 1301 thyroid nodules with architectural atypia in core needle biopsy (CNB) specimens obtained from March 2012 to February 2013. Nodules were classified into atypia of undetermined significance with architectural atypia (AUS-A, 984, 76%) or follicular neoplasm/suspicious for a follicular neoplasm (FN/SFN, 317, 24%). Among them, diagnostic surgery was performed in 384 nodules (30%). Results In total, 160 nodules (42%) presented final malignant diagnoses including 39 non-invasive encapsulated FVPTCs (10%). The malignancy rate was estimated to be 7-35% in AUS-A nodules and 28-49% in FN/SFN nodules. After reclassification, the malignancy rate was much decreased and estimated to be 5-24% in AUS-A nodules, and 23-39% in FN/SFN nodules. Thyroid nodules with final malignant diagnoses were significantly more likely to have a FN/SFN CNB diagnosis, malignant US features and concomitant nuclear atypia in CNB specimens. However, these factors could not differentiate NIFTPs from other malignancies. Conclusions After reclassification of non-invasive EFVPTCs to NIFTPs, the malignancy rate of thyroid nodules with architectural atypia in CNB specimens was decreased. However, there were no preoperative factors differentiating other malignancies from NIFTPs. The presence of malignant US features or concomitant nuclear atypia might help clinicians deciding diagnostic surgery but, these features also might indicate NIFTPs.	[Jeon, Min Ji; Kim, Won Gu; Kwon, Hyemi; Kim, Tae Yong; Shong, Young Kee; Kim, Won Bae] Univ Ulsan, Dept Internal Med, Asan Med Ctr, Coll Med, Seoul, South Korea; [Song, Dong Eun] Univ Ulsan, Dept Pathol, Asan Med Ctr, Coll Med, Seoul, South Korea; [Jung, Chan Kwon] Catholic Univ Korea, Dept Hosp Pathol, Coll Med, Seoul, South Korea; [Lee, Yu-Mi; Sung, Tae-Yon; Yoon, Jong Ho; Chung, Ki-Wook; Hong, Suck Joon] Univ Ulsan, Dept Surg, Asan Med Ctr, Coll Med, Seoul, South Korea; [Baek, Jung Hwan; Lee, Jeong Hyun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Baek, Jung Hwan; Lee, Jeong Hyun] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Catholic University of Korea; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Song, DE (corresponding author), Univ Ulsan, Dept Pathol, Asan Med Ctr, Coll Med, Seoul, South Korea.	hipuha@hanmail.net	Kim, Tae Yong/C-1272-2009; Jung, Chan Kwon/C-7578-2014	Kim, Tae Yong/0000-0003-4982-4441; Jung, Chan Kwon/0000-0001-6843-3708; Shong, Young Kee/0000-0002-7911-9471	Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea [2016-633]	Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea	This study was supported by a grant (No. 2016-633) from the Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi SH, 2015, THYROID, V25, P897, DOI 10.1089/thy.2014.0606; Choi YJ, 2014, THYROID, V24, P494, DOI 10.1089/thy.2012.0635; Cibas ES, 2009, AM J CLIN PATHOL, V132, P658, DOI 10.1309/AJCPPHLWMI3JV4LA; Faquin WC, 2015, CANC CYTOPATHOLOGY; Ha EJ, 2015, KOREAN J RADIOL, V16, P749, DOI 10.3348/kjr.2015.16.4.749; Ho AS, 2014, THYROID, V24, P832, DOI 10.1089/thy.2013.0317; Jang EK, 2015, CLIN ENDOCRINOL, V83, P968, DOI 10.1111/cen.12674; Jung CK, 2015, J PATHOL TRANSL MED, V49, P288, DOI 10.4132/jptm.2015.06.04; Kamaya A, 2015, J ULTRAS MED, V34, P767, DOI 10.7863/ultra.34.5.767; Kwak JY, 2013, ENDOCRINOL METAB, V28, P81, DOI 10.3803/EnM.2013.28.2.81; Macias CA, 2015, ANN SURG ONCOL, V22, P1527, DOI 10.1245/s10434-014-4190-8; Maletta F, 2016, HUMAN PATHOLOGY; Moon WJ, 2011, KOREAN J RADIOL, V12, P1, DOI 10.3348/kjr.2011.12.1.1; Nikiforov YE, 2016, JAMA ONCOLOGY; Strickland KC, 2015, THYROID, V25, P987, DOI 10.1089/thy.2014.0612; Suh CH, 2016, THYROID, V26, P395, DOI 10.1089/thy.2015.0404; Thompson LD, 2016, MODERN PATHOLOGY OFF; Yoon RG, 2014, THYROID, V24, P1612, DOI 10.1089/thy.2014.0140	18	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167756	10.1371/journal.pone.0167756	http://dx.doi.org/10.1371/journal.pone.0167756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936121	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100175
J	Kalsi, G; Euesden, J; Coleman, JRI; Ducci, F; Aliev, F; Newhouse, SJ; Liu, XH; Ma, XH; Wang, YC; Collier, DA; Asherson, P; Li, T; Breen, G				Kalsi, Gursharan; Euesden, Jack; Coleman, Jonathan R. I.; Ducci, Francesca; Aliev, Fazil; Newhouse, Stephen J.; Liu, Xiehe; Ma, Xiaohong; Wang, Yingcheng; Collier, David A.; Asherson, Philip; Li, Tao; Breen, Gerome			Genome-Wide Association of Heroin Dependence in Han Chinese	PLOS ONE			English	Article							OPIOID RECEPTOR GENE; DENDRITIC SPINES; ACTIN CYTOSKELETON; RHO-GTPASES; STRUCTURAL PLASTICITY; DRUG-ADDICTION; ABUSE; POLYMORPHISMS; RISK; VARIANTS	Drug addiction is a costly and recurring healthcare problem, necessitating a need to understand risk factors and mechanisms of addiction, and to identify new biomarkers. To date, genome-wide association studies (GWAS) for heroin addiction have been limited; moreover they have been restricted to examining samples of European and African-American origin due to difficulty of recruiting samples from other populations. This is the first study to test a Han Chinese population; we performed a GWAS on a homogeneous sample of 370 Han Chinese subjects diagnosed with heroin dependence using the DSM-IV criteria and 134 ethnically matched controls. Analysis using the diagnostic criteria of heroin dependence yielded suggestive evidence for association between variants in the genes CCDC42 (coiled coil domain 42; p = 2.8x10(-7)) and BRSK2 (BR serine/threonine 2; p = 4.110(-6)). In addition, we found evidence for risk variants within the ARHGEF10 (Rho guanine nucleotide exchange factor 10) gene on chromosome 8 and variants in a region on chromosome 20q13, which is gene-poor but has a concentration of mRNAs and predicted miRNAs. Gene-based association analysis identified genome-wide significant association between variants in CCDC42 and heroin addiction. Additionally, when we investigated shared risk variants between heroin addiction and risk of other addiction-related and psychiatric phenotypes using polygenic risk scores, we found a suggestive relationship with variants predicting tobacco addiction, and a significant relationship with variants predicting schizophrenia. Our genome wide association study of heroin dependence provides data in a novel sample, with functionally plausible results and evidence of genetic data of value to the field.	[Kalsi, Gursharan; Coleman, Jonathan R. I.; Ducci, Francesca; Newhouse, Stephen J.; Collier, David A.; Asherson, Philip; Breen, Gerome] Kings Coll London, MRC SGDP Ctr, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England; [Euesden, Jack] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Aliev, Fazil] Karabuk Univ, Dept Actuarial Sci & Risk Management, Fac Business, Karabuk, Turkey; [Newhouse, Stephen J.; Liu, Xiehe; Ma, Xiaohong] Sichuan Univ, West China Hosp, Mental Hlth Ctr, Chengdu, Sichuan, Peoples R China; [Liu, Xiehe; Ma, Xiaohong; Wang, Yingcheng] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Psychiat Lab, Chengdu, Sichuan, Peoples R China; [Collier, David A.] Lilly UK, Windlesham, Surrey, England; [Li, Tao] Sichuan Univ, Sch Med, West China Hosp, Dept Psychiat, Chengdu, Sichuan, Peoples R China	University of London; King's College London; University of Bristol; Karabuk University; Sichuan University; Sichuan University; Sichuan University	Breen, G (corresponding author), Kings Coll London, MRC SGDP Ctr, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England.	gerome.breen@kcl.ac.uk	Breen, Gerome D/A-5540-2010; Aliev, Fazil/D-7172-2013; Coleman, Jonathan/T-9412-2019; Breen, Gerome/Y-2706-2019; Collier, David/D-1649-2011	Breen, Gerome D/0000-0003-2053-1792; Aliev, Fazil/0000-0001-8357-4699; Coleman, Jonathan/0000-0002-6759-0944; Breen, Gerome/0000-0003-2053-1792; Li, Tao/0000-0003-3831-901X; Ma, Xiaohong/0000-0003-2627-9946; Asherson, Philip/0000-0003-2667-2254; Collier, David/0000-0003-4087-1559; Kalsi, Gursharan/0000-0002-5156-7176	European Union [302040]; Lilly UK; MRC [MC_UU_12013/5] Funding Source: UKRI; Medical Research Council [1242800, MC_UU_12013/5] Funding Source: researchfish	European Union(European Commission); Lilly UK(Eli Lilly); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under the REA grant agreement no 302040. Lilly UK, provided support in the form of salaries for authors DAC and GB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Baas S, 2011, DEVELOPMENT, V138, P553, DOI 10.1242/dev.055376; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Caspi A, 2014, CLIN PSYCHOL SCI, V2, P119, DOI 10.1177/2167702613497473; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Coleman JR, 2015, BRIEF FUNCT GENOMICS; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Ekenstedt KJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004635; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Euesden J., 2014, BIOINFORMATICS; Fuchsberger C, 2015, BIOINFORMATICS, V31, P782, DOI 10.1093/bioinformatics/btu704; Gao F, 2011, BIOCHEM BIOPH RES CO, V412, P450, DOI 10.1016/j.bbrc.2011.07.114; Gelernter J, 2014, BIOL PSYCHIAT, V76, P66, DOI 10.1016/j.biopsych.2013.08.034; Goldstein JI, 2012, BIOINFORMATICS, V28, P2543, DOI 10.1093/bioinformatics/bts479; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hou QF, 2009, NEUROSCI LETT, V464, P127, DOI 10.1016/j.neulet.2009.08.004; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Inoue E, 2006, NEURON, V50, P261, DOI 10.1016/j.neuron.2006.03.018; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kendler KS, 2003, AM J PSYCHIAT, V160, P687, DOI 10.1176/appi.ajp.160.4.687; Kim H, 2014, SCI WORLD J, DOI 10.1155/2014/683045; Kreek MJ, 2005, PHARMACOL REV, V57, P1, DOI 10.1124/pr.57.1.1; LaForge KS, 2000, EUR J PHARMACOL, V410, P249, DOI 10.1016/S0014-2999(00)00819-0; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Levran O, 2008, GENES BRAIN BEHAV, V7, P720, DOI 10.1111/j.1601-183X.2008.00410.x; Levran O, 2012, HUM GENET, V131, P823, DOI 10.1007/s00439-012-1172-4; Li CY, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040002; Li T, 2000, AM J MED GENET, V96, P616, DOI 10.1002/1096-8628(20001009)96:5<616::AID-AJMG6>3.0.CO;2-7; Li T, 2000, ADDICT BIOL, V5, P181, DOI 10.1080/13556210050003775; Li T, 2002, AM J MED GENET, V114, P329, DOI 10.1002/ajmg.10200; Li T, 1997, MOL PSYCHIATR, V2, P413, DOI 10.1038/sj.mp.4000310; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lilley BN, 2014, P NATL ACAD SCI USA, V111, P1138, DOI 10.1073/pnas.1321990111; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Loh EW, 2007, AM J MED GENET B, V144B, P439, DOI 10.1002/ajmg.b.30429; Lotsch J, 2005, TRENDS MOL MED, V11, P82, DOI 10.1016/j.molmed.2004.12.006; Mishra A, 2015, TWIN RES HUM GENET, V18, P86, DOI 10.1017/thg.2014.79; Neale BM, 2010, J AM ACAD CHILD PSY, V49, P906, DOI 10.1016/j.jaac.2010.06.007; Nelson EC, 2015, MOL PSYCHIAT; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nielsen DA, 2008, MOL PSYCHIATR, V13, P417, DOI 10.1038/sj.mp.4002147; Nielsen DA, 2010, PSYCHIAT GENET, V20, P207, DOI 10.1097/YPG.0b013e32833a2106; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Pierucci-Lagha A, 2005, DRUG ALCOHOL DEPEN, V80, P303, DOI 10.1016/j.drugalcdep.2005.04.005; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Robinson TE, 2002, SYNAPSE, V46, P271, DOI 10.1002/syn.10146; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Rothenfluh A, 2013, CURR OPIN NEUROBIOL, V23, P507, DOI 10.1016/j.conb.2013.01.027; Schwantes-An TH, 2016, BEHAV GENET, V46, P151, DOI 10.1007/s10519-015-9737-3; Shao CH, 2006, PSYCHOPHARMACOLOGY, V186, P185, DOI 10.1007/s00213-006-0375-6; Shen HW, 2011, P NATL ACAD SCI USA, V108, P19407, DOI 10.1073/pnas.1112052108; Shi JX, 2002, HUM MUTAT, V19, DOI 10.1002/humu.9026; SILMAN AJ, 1990, LANCET, V335, P1078; Sit ST, 2011, J CELL SCI, V124, P679, DOI 10.1242/jcs.064964; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Szeto CYK, 2001, NEUROREPORT, V12, P1103, DOI 10.1097/00001756-200105080-00011; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Tsuang MT, 1996, AM J MED GENET, V67, P473, DOI 10.1002/(SICI)1096-8628(19960920)67:5<473::AID-AJMG6>3.3.CO;2-D; Verhoeven K, 2003, AM J HUM GENET, V73, P926, DOI 10.1086/378159; Vink JM, 2014, ADDICTION, V109, P1141, DOI 10.1111/add.12491; Wang TY, 2013, PROG NEURO-PSYCHOPH, V43, P134, DOI 10.1016/j.pnpbp.2012.12.011; Xu K, 2002, AM J MED GENET, V110, P45, DOI 10.1002/ajmg.10374; Xu K, 2004, ARCH GEN PSYCHIAT, V61, P597, DOI 10.1001/archpsyc.61.6.597; Yuferov V, 2010, ANN NY ACAD SCI, V1187, P184, DOI 10.1111/j.1749-6632.2009.05275.x	74	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167388	10.1371/journal.pone.0167388	http://dx.doi.org/10.1371/journal.pone.0167388			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936112	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100090
J	Li, HX; Liao, Y; Wang, YL; Liu, P; Sun, CF; Chen, YH; Tang, CS; Jin, HF; Du, JB				Li, Hongxia; Liao, Ying; Wang, Yuli; Liu, Ping; Sun, Chufan; Chen, Yonghong; Tang, Chaoshu; Jin, Hongfang; Du, Junbao			Baroreflex Sensitivity Predicts Short-Term Outcome of Postural Tachycardia Syndrome in Children	PLOS ONE			English	Article							CHRONIC ORTHOSTATIC INTOLERANCE; QUALITY-OF-LIFE; BLOOD-PRESSURE; SYNDROME POTS; NEUROCARDIOGENIC SYNCOPE; MIDODRINE HYDROCHLORIDE; HEART-RATE; ADOLESCENTS; MANAGEMENT; EXERCISE	Objective The study was designed to examine if baroreflex sensitivity (BRS) could predict the short-term outcome of postural tachycardia syndrome (POTS) in children. Methods Seventy-seven children subjects were included in the study. Among them, 45 children were in the POTS group and another 32 healthy children were in the control group. A ninety-day clinical follow-up was conducted and the symptom score before and after the follow-up was calculated for POTS patients by using POTS score system. Hemodynamics and continuous BRS monitoring were recorded by Finapres Medical System-FMS (FinometerPRO, FMS Company, Netherlands). According to the symptom score change during follow-up period, POTS patients were further divided into subgroup A (n = 24) with symptom score decreased by at least two points and subgroup B (n = 21) with symptom score decreased by less than two points. The predictive value of BRS in the short-term outcome of POTS in children was analyzed using receiver-operating characteristic (ROC) curve. Results BRS of POTS children was significantly higher than that of the healthy children (18.76 +/- 9.96 ms/mmHg vs 10 +/- 5.42 ms/mmHg, P<0.01). It was higher in subgroup B than that of subgroup A (24.7 +/- 9.9 ms/mmHg vs 13.5 +/- 6.6 ms/mmHg, P < 0.01). BRS was positively correlated with HR change in POTS Group (r = 0.304, P < 0.05). Area under curve (AUC) was 0.855 (95% of confidence interval 0.735-0.975), and BRS of 17.01 ms/mmHg as a cut-off value yielded the predictive sensitivity of 85.7% and specificity of 87.5%. Conclusions BRS is a useful index to predict the short-term outcome of POTS in children.	[Li, Hongxia; Liao, Ying; Wang, Yuli; Liu, Ping; Sun, Chufan; Chen, Yonghong; Jin, Hongfang; Du, Junbao] Peking Univ, Hosp 1, Dept Pediat, Beijing, Peoples R China; [Tang, Chaoshu] Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing, Peoples R China; [Du, Junbao] Minist Educ, Key Lab Cardiovasc Sci, Beijing, Peoples R China	Peking University; Peking University	Du, JB (corresponding author), Peking Univ, Hosp 1, Dept Pediat, Beijing, Peoples R China.; Du, JB (corresponding author), Minist Educ, Key Lab Cardiovasc Sci, Beijing, Peoples R China.	junbaodu1@126.com		Jin, Hongfang/0000-0002-1606-8988	Major Basic Research Project of China [2012BA103B03]	Major Basic Research Project of China	Major Basic Research Project of China (2012BA103B03); JD received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2007, POSTGRAD MED J, V83, P478, DOI 10.1136/pgmj.2006.055046; Bagai K, 2011, J CLIN SLEEP MED, V7, P204; Benrud-Larson LM, 2002, MAYO CLIN PROC, V77, P531, DOI 10.4065/77.6.531; Bogert LWJ, 2005, CLIN SCI, V109, P493, DOI 10.1042/CS20050094; Convertino VA, 1997, AVIAT SPACE ENVIR MD, V68, P838; Ector H, 1998, PACE, V21, P193, DOI 10.1111/j.1540-8159.1998.tb01087.x; Fu Q, 2010, J AM COLL CARDIOL, V55, P2858, DOI 10.1016/j.jacc.2010.02.043; Furlan R, 1998, CIRCULATION, V98, P2154, DOI 10.1161/01.CIR.98.20.2154; Galbreath MM, 2011, CLIN AUTON RES, V21, P73, DOI 10.1007/s10286-010-0091-5; Grubb BP, 2008, CIRCULATION, V117, P2814, DOI 10.1161/CIRCULATIONAHA.107.761643; Harrington F, 2000, J HYPERTENS, V18, P1629, DOI 10.1097/00004872-200018110-00014; Ianaka H, 2009, PEDIATR INT, V511, P69; Jarjour IT, 2013, SEMIN PEDIATR NEUROL, V20, P18, DOI 10.1016/j.spen.2013.01.001; Kanjwal Y, 2003, PACE, V26, P1747, DOI 10.1046/j.1460-9592.2003.t01-1-00262.x; Kimpinski K, 2012, MAYO CLIN PROC, V87, P746, DOI 10.1016/j.mayocp.2012.02.020; Langewouters GJ, 1998, J MED ENG TECHNOL, V22, P37, DOI 10.3109/03091909809009997; Liao Y, 2010, AM J CARDIOL, V106, P378, DOI 10.1016/j.amjcard.2010.03.034; Lin J, 2015, PLOS ONE, V26; Lin J, 2014, CARDIOL YOUNG, V24, P792, DOI 10.1017/S1047951114000316; Low PA, 2009, J CARDIOVASC ELECTR, V20, P352, DOI 10.1111/j.1540-8167.2008.01407.x; Ma W, 2003, SHANGHAI MED J S, V26, P73; Medow MS, 2005, CIRCULATION, V112, P2611, DOI 10.1161/CIRCULATIONAHA.104.526764; Mizumaki K, 2011, J ARRYTHM, V27, P289; Mustafa HI, 2012, CIRC-ARRHYTHMIA ELEC, V5, P173, DOI 10.1161/CIRCEP.111.965343; Numata T, 2000, JPN CIRC J, V64, P406, DOI 10.1253/jcj.64.406; Ojha A, 2011, J PEDIATR-US, V158, P119, DOI 10.1016/j.jpeds.2010.07.005; Parati G, 1996, Arq Bras Cardiol, V67, P131; Raamat R, 2009, MED ENG PHYS, V31, P522, DOI 10.1016/j.medengphy.2008.10.002; Raj Satish R, 2006, Indian Pacing Electrophysiol J, V6, P84; Raj SR, 2007, AM J MED SCI, V334, P57, DOI 10.1097/MAJ.0b013e318063c6c0; Raj SR, 2013, CIRCULATION, V127, P2336, DOI 10.1161/CIRCULATIONAHA.112.144501; Remmen JJ, 2006, CLIN SCI, V111, P153, DOI 10.1042/CS20050372; Robertson D, 1999, AM J MED SCI, V317, P75, DOI 10.1097/00000441-199902000-00001; Shannon JR, 2000, NEW ENGL J MED, V342, P541, DOI 10.1056/NEJM200002243420803; Sidhu B, 2013, BMJ CASE REP, V16, P2013; Singer W, 2012, J PEDIATR-US, V160, P222, DOI 10.1016/j.jpeds.2011.08.054; Sousa A, 2012, CLIN AUTON RES, V22, P151, DOI 10.1007/s10286-011-0155-1; Stewart JM, 2000, PEDIATR RES, V48, P218, DOI 10.1203/00006450-200008000-00016; Stewart JM, 2004, J PEDIATR-US, V145, P725, DOI 10.1016/j.jpeds.2004.06.084; Stewart JM, 2004, AM J PHYSIOL-HEART C, V286, pH1216, DOI 10.1152/ajpheart.00738.2003; Wieling W, 2004, HEART, V90, P1094, DOI 10.1136/hrt.2003.022996; Winker R, 2005, HYPERTENSION, V45, P391, DOI 10.1161/01.HYP.0000156540.25707.af; Winker R, 2004, WIEN KLIN WOCHENSCHR, V116, P40; Yan JY, 2014, INT J PEDIAT, V41, P195, DOI DOI 10.3760/cma.j.issn.1673-4408.2014.02.024; Yang JY, 2013, J PEDIATR-US, V163, P1169, DOI 10.1016/j.jpeds.2013.04.039; Zhang FW, 2012, J AM COLL CARDIOL, V60, P315, DOI 10.1016/j.jacc.2012.04.025; Zhang Qing-you, 2005, Zhonghua Er Ke Za Zhi, V43, P165; Zhao J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007356; Zhu L, 2011, CHIN J APPL CLIN PED, V26, P684	49	16	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167525	10.1371/journal.pone.0167525	http://dx.doi.org/10.1371/journal.pone.0167525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936059	Green Submitted, gold, Green Published			2022-12-27	WOS:000389587100114
J	Luczkiewicz, P; Daszkiewicz, K; Chroscielewski, J; Witkowski, W; Winklewski, PJ				Luczkiewicz, Piotr; Daszkiewicz, Karol; Chroscielewski, Jacek; Witkowski, Wojciech; Winklewski, Pawel J.			The Influence of Articular Cartilage Thickness Reduction on Meniscus Biomechanics	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; MAGNETIC-RESONANCE IMAGES; CONTACT STRESS; KNEE OSTEOARTHRITIS; BONE; JOINT; SHAPE; GEOMETRY; PLANE	Objective Evaluation of the biomechanical interaction between meniscus and cartilage in medial compartment knee osteoarthritis. Methods The finite element method was used to simulate knee joint contact mechanics. Three knee models were created on the basis of knee geometry from the Open Knee project. We reduced the thickness of medial cartilages in the intact knee model by approximately 50% to obtain a medial knee osteoarthritis (OA) model. Two variants of medial knee OA model with congruent and incongruent contact surfaces were analysed to investigate the influence of congruency. A nonlinear static analysis for one compressive load case was performed. The focus of the study was the influence of cartilage degeneration on meniscal extrusion and the values of the contact forces and contact areas. Results In the model with incongruent contact surfaces, we observed maximal compressive stress on the tibial plateau. In this model, the value of medial meniscus external shift was 95.3% greater, while the contact area between the tibial cartilage and medial meniscus was 50% lower than in the congruent contact surfaces model. After the non-uniform reduction of cartilage thickness, the medial meniscus carried only 48.4% of load in the medial compartment in comparison to 71.2% in the healthy knee model. Conclusions We have shown that the change in articular cartilage geometry may significantly reduce the role of meniscus in load transmission and the contact area between the meniscus and cartilage. Additionally, medial knee OA may increase the risk of meniscal extrusion in the medial compartment of the knee joint.	[Luczkiewicz, Piotr] Med Univ Gdansk, Clin Orthopaed & Kinet Organ Traumatol 2, Gdansk, Poland; [Daszkiewicz, Karol; Chroscielewski, Jacek; Witkowski, Wojciech] Gdansk Univ Technol, Fac Civil & Environm Engn, Dept Mech Mat, Gdansk, Poland; [Winklewski, Pawel J.] Med Univ Gdansk, Inst Human Physiol, Gdansk, Poland; [Winklewski, Pawel J.] Pomeranian Univ Slupsk, Inst Hlth Sci, Slupsk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Gdansk University of Technology; Fahrenheit Universities; Medical University Gdansk	Luczkiewicz, P (corresponding author), Med Univ Gdansk, Clin Orthopaed & Kinet Organ Traumatol 2, Gdansk, Poland.	plucz@gumed.edu.pl	Chróścielewski, Jacek/N-5959-2018; Witkowski, Wojciech/E-3550-2017; Luczkiewicz, Piotr/AAC-2970-2020	Chróścielewski, Jacek/0000-0002-7648-2785; Witkowski, Wojciech/0000-0003-2832-7892; Luczkiewicz, Piotr/0000-0001-8988-1251; Daszkiewicz, Karol/0000-0002-0522-7752; Winklewski, Pawel/0000-0002-1671-2163	Faculty of Civil and Environmental Engineering, Gdansk University of Technology; Medical University of Gdansk, Gdansk University of Technology	Faculty of Civil and Environmental Engineering, Gdansk University of Technology; Medical University of Gdansk, Gdansk University of Technology	Abaqus calculations were carried out at the Academic Computer Center in Gdansk. Karol Daszkiewicz is supported with grants for the development of young scientists from the Faculty of Civil and Environmental Engineering, Gdansk University of Technology. The study was financed by Medical University of Gdansk, Gdansk University of Technology and private donation from Dr Luczkiewicz.	[Anonymous], AB 6 14 2 US MAN; Arno S, 2012, KNEE, V19, P896, DOI 10.1016/j.knee.2012.04.005; Bae JY, 2012, MED BIOL ENG COMPUT, V50, P53, DOI 10.1007/s11517-011-0840-1; Baek J, 2016, TISSUE ENGINEERING P; Bao HRC, 2013, J ORTHOP SCI, V18, P256, DOI 10.1007/s00776-012-0334-5; Blanc R, 2012, MED IMAGE ANAL, V16, P1156, DOI 10.1016/j.media.2012.04.004; Burkhart TA, 2013, J BIOMECH, V46, P1477, DOI 10.1016/j.jbiomech.2013.03.022; D'Angeli V, 2014, J BIOMECH, V47, P1198, DOI 10.1016/j.jbiomech.2014.01.045; Englund M, 2008, NEW ENGL J MED, V359, P1108, DOI 10.1056/NEJMoa0800777; Englund M, 2010, BEST PRACT RES CL RH, V24, P39, DOI 10.1016/j.berh.2009.08.008; Englund M, 2009, RADIOL CLIN N AM, V47, P703, DOI 10.1016/j.rcl.2009.03.003; Erdemir A, OPEN KNEE 3 DIMENSIO; Erdemir Ahmet, 2013, J Med Device, V7, P0409101; Erdemir A, 2016, J KNEE SURG, V29, P107, DOI 10.1055/s-0035-1564600; Felson DT, 2013, OSTEOARTHR CARTILAGE, V21, P10, DOI 10.1016/j.joca.2012.09.012; Gardiner JC, 2003, J ORTHOP RES, V21, P1098, DOI 10.1016/S0736-0266(03)00113-X; Halder A, 2012, J BONE JOINT SURG AM, V94A, P1023, DOI 10.2106/JBJS.K.00927; Hauch KN, 2010, J BIOMECH, V43, P463, DOI 10.1016/j.jbiomech.2009.09.043; Holzapfel G.A., 2001, NONLINEAR SOLID MECH; Hunter DJ, 2006, ARTHRITIS RHEUM-US, V54, P2488, DOI 10.1002/art.22016; Hunziker EB, 2016, J ORTHOPAEDIC RES; Jung KA, 2010, RHEUMATOL INT, V30, P1325, DOI 10.1007/s00296-009-1153-7; Kluess D, 2009, COMPUT METH PROG BIO, V95, P23, DOI 10.1016/j.cmpb.2009.01.004; KRAUSE WR, 1976, J BONE JOINT SURG AM, V58, P599, DOI 10.2106/00004623-197658050-00003; KUROSAWA H, 1980, CLIN ORTHOP RELAT R, P283; Laxafoss E, 2013, SKELETAL RADIOL, V42, P531, DOI 10.1007/s00256-012-1509-z; Li G, 2001, J BIOMECH ENG-T ASME, V123, P341, DOI 10.1115/1.1385841; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Luczkiewicz P, 2015, J BIOMECH, V48, P1356, DOI 10.1016/j.jbiomech.2015.03.002; Marques J, 2013, MAGN RESON MED, V70, P568, DOI 10.1002/mrm.24477; McAlindon TE, 2015, ARTHRITIS RHEUMATOL, V67, P1987, DOI 10.1002/art.39177; Meakin JR, 2003, KNEE, V10, P33, DOI 10.1016/S0968-0160(02)00106-0; Pena E, 2006, INT J NUMER METH ENG, V68, P836, DOI 10.1002/nme.1726; Pena E, 2006, J BIOMECH, V39, P1686, DOI 10.1016/j.jbiomech.2005.04.030; Pena E, 2005, CLIN BIOMECH, V20, P498, DOI 10.1016/j.clinbiomech.2005.01.009; Segal NA, 2012, OSTEOARTHR CARTILAGE, V20, P1120, DOI 10.1016/j.joca.2012.05.013; Shepherd DET, 1999, RHEUMATOLOGY, V38, P124, DOI 10.1093/rheumatology/38.2.124; Walker PS, 2015, J BIOMECH, V48, P1383, DOI 10.1016/j.jbiomech.2015.02.055; WALKER PS, 1975, CLIN ORTHOP RELAT R, P184; Weiss JA, 1996, COMPUT METHOD APPL M, V135, P107, DOI 10.1016/0045-7825(96)01035-3; Wenger A, 2013, ARTHRITIS RHEUM-US, V65, P1804, DOI 10.1002/art.37947; Yang NH, 2010, J APPL BIOMECH, V26, P432, DOI 10.1123/jab.26.4.432; Yao J, 2006, J BIOMECH ENG-T ASME, V128, P399, DOI 10.1115/1.2191077	43	7	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167733	10.1371/journal.pone.0167733	http://dx.doi.org/10.1371/journal.pone.0167733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936066	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100168
J	Modi, S; Cavanaugh, JS; Shiraishi, RW; Alexander, HL; McCarthy, KD; Burmen, B; Muttai, H; Heilig, CM; Nakashima, AK; Cain, KP				Modi, Surbhi; Cavanaugh, Joseph S.; Shiraishi, Ray W.; Alexander, Heather L.; McCarthy, Kimberly D.; Burmen, Barbara; Muttai, Hellen; Heilig, Chad M.; Nakashima, Allyn K.; Cain, Kevin P.			Performance of Clinical Screening Algorithms for Tuberculosis Intensified Case Finding among People Living with HIV in Western Kenya	PLOS ONE			English	Article							INFECTED PREGNANT-WOMEN; ANTIRETROVIRAL THERAPY; ACTIVE TUBERCULOSIS; DIAGNOSIS	Objective To assess the performance of symptom-based screening for tuberculosis (TB), alone and with chest radiography among people living with HIV (PLHIV), including pregnant women, in Western Kenya. Design Prospective cohort study Methods PLHIV from 15 randomly-selected HIV clinics were screened with three clinical algorithms [World Health Organization (WHO), Ministry of Health (MOH), and "Improving Diagnosis of TB in HIV-infected persons" (ID-TB/HIV) study], underwent chest radiography (unless pregnant), and provided two or more sputum specimens for smear microscopy, liquid culture, and Xpert MTB/RIF. Performance of clinical screening was compared to laboratory results, controlling for the complex design of the survey. Results Overall, 738 (85.6%) of 862 PLHIV enrolled were included in the analysis. Estimated TB prevalence was 11.2% (95% CI, 9.9-12.7). Sensitivity of the three screening algorithms was similar [WHO, 74.1% (95% CI, 64.1-82.2); MOH, 77.5% (95% CI, 68.6-84.5); and IDTB/HIV, 72.5% (95% CI, 60.9-81.7)]. Sensitivity of the WHO algorithm was significantly lower among HIV-infected pregnant women [28.2% (95% CI, 14.9-46.7)] compared to nonpregnant women [78.3% (95% CI, 67.3-86.4)] and men [77.2% (95% CI, 68.3-84.2)]. Chest radiography increased WHO algorithm sensitivity and negative predictive value to 90.9% (95% CI, 86.4-93.9) and 96.1% (95% CI, 94.4-97.3), respectively, among asymptomatic men and non-pregnant women. Conclusions Clinical screening missed approximately 25% of laboratory-confirmed TB cases among all PLHIV and more than 70% among HIV-infected pregnant women. National HIV programs should evaluate the feasibility of laboratory-based screening for TB, such as a single Xpert MTB/RIF test for all PLHIV, especially pregnant women, at enrollment in HIV services.	[Modi, Surbhi; Shiraishi, Ray W.; Alexander, Heather L.; Nakashima, Allyn K.] United States Ctr Dis Control & Prevent CDC, Div Global HIV & TB, Atlanta, GA 30333 USA; [Cavanaugh, Joseph S.; McCarthy, Kimberly D.; Heilig, Chad M.; Cain, Kevin P.] CDC, Div TB Eliminat, Atlanta, GA 30333 USA; [Burmen, Barbara] Ctr Global Hlth Res, Kenya Med Res Inst KEMRI, Kisumu, Kenya; [Burmen, Barbara] KEMRI CDC Res & Publ Hlth Collaborat, Kisumu, Kenya; [Muttai, Hellen; Cain, Kevin P.] CDC, Kisumu, Kenya	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute	Modi, S (corresponding author), United States Ctr Dis Control & Prevent CDC, Div Global HIV & TB, Atlanta, GA 30333 USA.	smodi@cdc.gov	Muttai, Hellen/ABH-7164-2020	Shiraishi, Ray/0000-0001-7640-0666; Burmen, Barbara/0000-0002-4382-2747; Heilig, Charles/0000-0003-1075-1310	U.S. President's Emergency Plan for AIDS Relief through Centers for Disease Control and Prevention [5U19GH000041]; United States Agency for International Development	U.S. President's Emergency Plan for AIDS Relief through Centers for Disease Control and Prevention; United States Agency for International Development(United States Agency for International Development (USAID))	Primary funding for this study was provided by the U.S. President's Emergency Plan for AIDS Relief through Cooperative Agreement 5U19GH000041 from the Centers for Disease Control and Prevention to the Kenya Medical Research Institute. Additional funding was provided by the United States Agency for International Development. Approval for study design was obtained from the U.S. President's Emergency Plan for AIDS Relief Public Health Evaluation Scientific Committee. The funders had no role in data collection, analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2011, GUID INT TUB CAS FIN; Auld AF, 2015, MMWR-MORBID MORTAL W, V64, P1281, DOI 10.15585/mmwr.mm6446a2; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Cavanaugh JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152364; Division of Leprosy Tuberculosis and Lung Diseases, 2009, GUID MAN LEPR TUB; Getahun H, 2012, J INFECT DIS, V205, pS216, DOI 10.1093/infdis/jis009; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Gounder CR, 2011, JAIDS-J ACQ IMM DEF, V57, pE77, DOI 10.1097/QAI.0b013e31821ac9c1; Gupta A, 2011, CLIN INFECT DIS, V53, DOI 10.1093/cid/cir605; Hoffmann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066019; Kenya National AIDS and STI Control Programme, 2011, GUID ANT THER KEN; Kenya National AIDS and STI Control Programme, 2005, PROGR NAASC; Kenya National AIDS and STI Control Programme Ministry of Public Health and Sanitation Kenya, 2008, GUID HIV TEST COUNS; Khan FA, 2014, AIDS, V28, P1463, DOI 10.1097/QAD.0000000000000278; Kosgei RJ, 2013, PUBLIC HEALTH ACTION, V3, P294, DOI 10.5588/pha.13.0073; Kufa T, 2012, JAIDS-J ACQ IMM DEF, V60, pE22, DOI 10.1097/QAI.0b013e318251ae0b; LaCourse SM, 2016, JAIDS-J ACQ IMM DEF, V71, P219, DOI 10.1097/QAI.0000000000000826; Lawn SD, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-231; Lawn SD, 2011, J INFECT DIS, V204, pS1159, DOI 10.1093/infdis/jir411; Lawn SD, 2010, AIDS, V24, P1323, DOI 10.1097/QAD.0b013e3283390dd1; Lawn SD, 2009, INT J TUBERC LUNG D, V13, P1186; Rangaka MX, 2012, CLIN INFECT DIS, V55, P1698, DOI 10.1093/cid/cis775; Siddiqui S.H., 2006, MGIT PROCEDURE MANUA; Sugarman J, 2014, LANCET GLOB HEALTH, V2, pE710, DOI 10.1016/S2214-109X(14)70330-4; Swindells S, 2013, INT J TUBERC LUNG D, V17, P532, DOI 10.5588/ijtld.12.0737; Turnbull ER, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/565049; UNAIDS, 2014, AIDS CHANG EV FACT S; UNAIDS, 2014, THE GAP REP; World Health Organization, 2012, WHO POL COLL TB HIV; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization, 2013, DEFINITIONS REPORTIN; World Health Organization, 2014, WHO POL UPD XPERT MT; Zenner D, 2012, AM J RESP CRIT CARE, V185, P779, DOI 10.1164/rccm.201106-1083OC	33	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167685	10.1371/journal.pone.0167685	http://dx.doi.org/10.1371/journal.pone.0167685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936146	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100150
J	Nikfarjam, F; Beyer, K; Konig, A; Hofmann, M; Butting, M; Valesky, E; Kippenberger, S; Kaufmann, R; Heidemann, D; Bernd, A; Zoller, NN				Nikfarjam, Frangis; Beyer, Kim; Koenig, Anke; Hofmann, Matthias; Butting, Manuel; Valesky, Eva; Kippenberger, Stefan; Kaufmann, Roland; Heidemann, Detlef; Bernd, August; Zoeller, Nadja Nicole			Influence of Biodentine (R) - A Dentine Substitute - On Collagen Type I Synthesis in Pulp Fibroblasts In Vitro	PLOS ONE			English	Article							TRICALCIUM SILICATE CEMENTS; MINERAL TRIOXIDE AGGREGATE; GROWTH-FACTOR-II; STEM-CELLS; GENE-EXPRESSION; ALVEOLAR BONE; MTA; DIFFERENTIATION; BIOMINERALIZATION; BIOCOMPATIBILITY	Preserving a patient's own teeth even in a difficult situation is nowadays preferable to surgical intervention and therefore promotes development of suitable dental repair materials. Biodentine (R), a mineral trioxide aggregate substitute, has been used to replace dentine in a bioactive and biocompatible manner in both the dental crown and the root. The aim of our study was to evaluate the influence of Biodentine (R) on pulp fibroblasts in vitro. For this study, one to five Biodentine (R) discs with a diameter of 5.1 mm were incubated in DMEM. To obtain Biodentine (R) suspensions the media were collected and replaced with fresh medium every 24h for 4 days. Primary pulp cells were isolated from freshly extracted wisdom teeth of 20-23 year old patients and incubated with the Biodentine (R) suspensions. Proliferation, cell morphology, cell integrity and cell viability were monitored. To evaluate the effect of Biodentine (R) on collagen type I synthesis, the secretion of the N-terminal domain of pro-collagen type I (P1NP) and the release of transforming growth factor-beta 1 (TGF-beta 1) were quantified. None of the Biodentine (R) suspensions tested influenced cell morphology, proliferation or cell integrity. The cell viability varied slightly depending on the suspension used. However, the concentrations of P1NP of all pulp fibroblast cultures treated for 24h with the moderate to high Biodentine (R) concentration containing suspensions of day 1 were reduced to 5% of the control. Furthermore, a significant TGF-beta 1 reduction was observed after treatment with these suspensions. It could be shown that Biodentine (R) is biocompatible. However, dissolved particles of the moderate to high concentrated Biodentine (R) suspensions 24h after mixing induce a significant reduction of TGF-beta 1 release and reduce the secretion of collagen type I of primary pulp fibroblasts.	[Nikfarjam, Frangis; Beyer, Kim; Koenig, Anke; Hofmann, Matthias; Butting, Manuel; Valesky, Eva; Kippenberger, Stefan; Kaufmann, Roland; Bernd, August; Zoeller, Nadja Nicole] Goethe Univ Frankfurt, Dept Dermatol Venereol & Allergol, Frankfurt, Germany; [Nikfarjam, Frangis; Beyer, Kim; Heidemann, Detlef] Goethe Univ Frankfurt, Ctr Dent & Oral Med Carolinum, Dept Operat Dent, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Zoller, NN (corresponding author), Goethe Univ Frankfurt, Dept Dermatol Venereol & Allergol, Frankfurt, Germany.	Nadja.Zoeller@kgu.de		Hofmann, Matthias/0000-0003-4107-7197				A Saberi Eshagh, 2016, J Dent Res Dent Clin Dent Prospects, V10, P75, DOI 10.15171/joddd.2016.012; Aleksova P, 2013, CONTRIBUTIONS MACEDO, V34, P159; ANDUJAR MB, 1991, DEVELOPMENT, V111, P691; BEGUEKIRN C, 1992, INT J DEV BIOL, V36, P491; Bidar Maryam, 2014, J Dent Res Dent Clin Dent Prospects, V8, P134, DOI 10.5681/joddd.2014.025; Blum IR, 2011, EUR J PROSTHODONT RE, V19, P56, DOI 10.1922/EJPRD_973Blum06; Cornelio AL, 2015, INT ENDODONTIC J; Cuadros-Fernandez C, 2015, CLIN ORAL INVESTIGAT; Du R, 2013, J ENDODONT, V39, P1023, DOI 10.1016/j.joen.2013.03.002; Dujic J, 2009, INT J CANCER, V124, P1422, DOI 10.1002/ijc.23997; Fayazi Sara, 2011, Indian J Dent Res, V22, P190, DOI 10.4103/0970-9290.84278; Guven G, 2007, MED PRIN PRACT, V16, P454, DOI 10.1159/000107751; Hakki SS, 2012, INT ENDOD J, V45, P240, DOI 10.1111/j.1365-2591.2011.01968.x; HELDER MN, 1993, MATRIX, V13, P415, DOI 10.1016/S0934-8832(11)80047-8; Howard C, 2010, J ENDODONT, V36, P1963, DOI 10.1016/j.joen.2010.08.046; Kenchappa Mallikarjuna, 2015, J Indian Soc Pedod Prev Dent, V33, P250, DOI 10.4103/0970-4388.160404; Khedmat Sedigheh, 2014, Restor Dent Endod, V39, P149, DOI 10.5395/rde.2014.39.3.149; Kim Jia, 2016, Restor Dent Endod, V41, P29, DOI 10.5395/rde.2016.41.1.29; Koziel J, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0408-9; Kucukkaya S, 2016, SCIENTIFICA, V2016, DOI 10.1155/2016/9203932; Laurent P, 2012, INT ENDOD J, V45, P439, DOI 10.1111/j.1365-2591.2011.01995.x; Lee BN, 2014, J ENDODONT, V40, P1217, DOI 10.1016/j.joen.2014.01.036; Lee BN, 2012, J ENDODONT, V38, P1627, DOI 10.1016/j.joen.2012.09.004; Leiendecker AP, 2012, J ENDODONT, V38, P829, DOI 10.1016/j.joen.2012.01.004; Malkondu O, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/160951; Margunato S, 2015, J ENDODONT, V41, P1646, DOI 10.1016/j.joen.2015.05.012; Mayard-Pons ML, 2015, J DIABETES COMPLICAT, V29, P993, DOI 10.1016/j.jdiacomp.2015.09.007; Michel A, 2016, CLIN ORAL INVESTIGAT; Mizuno M, 2003, J CELL BIOCHEM, V88, P1112, DOI 10.1002/jcb.10466; Mullaguri H, 2016, J ENDODONT, V42, P766, DOI 10.1016/j.joen.2016.02.009; Nagy-Bota MCM, 2014, ROM J MORPHOL EMBRYO, V55, P43; Nayak Gurudutt, 2014, Restor Dent Endod, V39, P120, DOI 10.5395/rde.2014.39.2.120; Niranjani K, 2015, J CLIN DIAGN RES, V9, pZC35, DOI 10.7860/JCDR/2015/13153.5823; Nowicka A, 2015, J ENDODONT, V41, P1234, DOI 10.1016/j.joen.2015.03.017; Oncel Torun Z, 2015, INT ENDOD J, V48, P986, DOI 10.1111/iej.12393; Pelliccioni GA, 2004, J MATER SCI-MATER M, V15, P167, DOI 10.1023/B:JMSM.0000011819.26935.47; Perard M, 2013, J MATER SCI-MATER M, V24, P1527, DOI 10.1007/s10856-013-4908-3; Peters OA, 2015, INT ENDODONTIC J; Poggio Claudio, 2014, Ann Stomatol (Roma), V5, P69; Poggio C, 2015, ARH HIG RADA TOKSIKO, V66, P181, DOI 10.1515/aiht-2015-66-2589; Raskin A, 2012, J ADHES DENT, V14, P535, DOI 10.3290/j.jad.a25690; Rathinam E, 2015, J ENDODONT, V41, P1805, DOI 10.1016/j.joen.2015.07.015; Rosenthal R, 1991, METAANALYTIC PROCEDU; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Soydan SS, 2015, HUM EXP TOXICOL, V34, P1073, DOI 10.1177/0960327115569808; STRONG DD, 1991, J BONE MINER RES, V6, P15; Tomson P. L., 2016, INT ENDODONTIC J; Torabinejad M, 2010, J ENDODONT, V36, P190, DOI 10.1016/j.joen.2009.09.010; Tziafas D, 1998, ARCH ORAL BIOL, V43, P431, DOI 10.1016/S0003-9969(98)00026-0; Utneja Shivani, 2015, Restor Dent Endod, V40, P1, DOI 10.5395/rde.2015.40.1.1; Villat C, 2010, DENT MATER, V26, P1127, DOI 10.1016/j.dental.2010.07.013; Widbiller M, 2016, CLIN ORAL INVEST, V20, P237, DOI 10.1007/s00784-015-1515-3; Widbiller M, 2016, CLIN ORAL INVESTIGAT; Willershausen I, 2013, ARCH ORAL BIOL, V58, P1232, DOI 10.1016/j.archoralbio.2013.04.002; Zanini M, 2012, J ENDODONT, V38, P1220, DOI 10.1016/j.joen.2012.04.018; Zoller NN, 2008, TOXICOL IN VITRO, V22, P747, DOI 10.1016/j.tiv.2007.11.022	56	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167633	10.1371/journal.pone.0167633	http://dx.doi.org/10.1371/journal.pone.0167633			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936042	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100136
J	O'Dea, KP; Porter, JR; Tirlapur, N; Katbeh, U; Singh, S; Handy, JM; Takata, M				O'Dea, Kieran P.; Porter, John R.; Tirlapur, Nikhil; Katbeh, Umar; Singh, Suveer; Handy, Jonathan M.; Takata, Masao			Circulating Microvesicles Are Elevated Acutely following Major Burns Injury and Associated with Clinical Severity	PLOS ONE			English	Article							CELL-DERIVED MICROPARTICLES; EXTRACELLULAR VESICLES; EMERGING ROLE; SEPSIS; HYPERCOAGULABILITY; GENERATION; COMPLEXES; BLOOD	Microvesicles are cell-derived signaling particles emerging as important mediators and biomarkers of systemic inflammation, but their production in severe burn injury patients has not been described. In this pilot investigation, we measured circulating microvesicle levels following severe burns, with severe sepsis patients as a comparator group. We hypothesized that levels of circulating vascular cell-derived microvesicles are elevated acutely following burns injury, mirroring clinical severity due to the early onset and prevalence of systemic inflammatory response syndrome (SIRS) in these patients. Blood samples were obtained from patients with moderate to severe thermal injury burns, with severe sepsis, and from healthy volunteers. Circulating microvesicles derived from total leukocytes, granulocytes, monocytes, and endothelial cells were quantified in plasma by flow cytometry. All circulating microvesicle subpopulations were elevated in burns patients on day of admission (day 0) compared to healthy volunteers (leukocyte-microvesicles: 3.5-fold, p = 0.005; granulocyte-microvesicles: 12.8-fold, p< 0.0001; monocyte-microvesicles: 20.4-fold, p< 0.0001; endothelial-microvesicles: 9.6-fold, p = 0.01), but decreased significantly by day 2. Microvesicle levels were increased with severe sepsis, but less consistently between patients. Leukocyte- and granulocyte-derived microvesicles on day 0 correlated with clinical assessment scores and were higher in burns ICU non-survivors compared to survivors (leukocyte MVs 4.6 fold, p = 0.002; granulocyte MVs 4.8 fold, p = 0.003). Mortality prediction analysis of area under receiver operating characteristic curve was 0.92 (p = 0.01) for total leukocyte microvesicles and 0.85 (p = 0.04) for granulocyte microvesicles. These findings demonstrate, for the first time, acute increases in circulating microvesicles following burns injury in patients and point to their potential role in propagation of sterile SIRS-related pathophysiology.	[O'Dea, Kieran P.; Porter, John R.; Tirlapur, Nikhil; Katbeh, Umar; Singh, Suveer; Handy, Jonathan M.; Takata, Masao] Imperial Coll London, Sect Anaesthet Pain Med & Intens Care, Dept Surg Canc, London, England; [Porter, John R.; Singh, Suveer; Handy, Jonathan M.] Chelsea & Westminster Hosp, Intens Care Unit, London, England	Imperial College London; Imperial College London	Takata, M (corresponding author), Imperial Coll London, Sect Anaesthet Pain Med & Intens Care, Dept Surg Canc, London, England.	m.takata@imperial.ac.uk			Chelsea and Westminster Health Charity, London, UK [1067412]; Chelsea and Westminster Health Charity, London, UK; National Institute for Health Research [ACF-2014-21-019] Funding Source: researchfish	Chelsea and Westminster Health Charity, London, UK; Chelsea and Westminster Health Charity, London, UK; National Institute for Health Research(National Institute for Health Research (NIHR))	Chelsea and Westminster Health Charity, London, UK http://www.cwplus.org.uk/ CW+ 2016 Registered charity number 1067412. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr Richard Keays (FRCA, FFICM), Dr Michelle Hayes (FRCA, FFICM), Dr Marcela Vizcaychipi (MD, PhD) and the staff at Chelsea and Westminster Hospital Intensive Care Unit. This work was supported by grants from the Chelsea and Westminster Health Charity, London, UK.	Aras O, 2004, BLOOD, V103, P4545, DOI 10.1182/blood-2003-03-0713; Augustine D, 2014, CIRC RES, V114, P109, DOI 10.1161/CIRCRESAHA.114.301904; Blot S, 2009, BRIT J SURG, V96, P111, DOI 10.1002/bjs.6329; Buzas EI, 2014, NAT REV RHEUMATOL, V10, P356, DOI 10.1038/nrrheum.2014.19; Cabrera-Benitez NE, 2015, CRIT CARE MED; CAVAILLON JM, 1992, CIRC SHOCK, V38, P145; Clayton M C, 1995, J Burn Care Rehabil, V16, P451, DOI 10.1097/00004630-199507000-00013; Curry N, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.25625; Evers LH, 2010, EXP DERMATOL, V19, P777, DOI 10.1111/j.1600-0625.2010.01105.x; Farina JA, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/715645; GOLDIE AS, 1995, JAMA-J AM MED ASSOC, V274, P172, DOI 10.1001/jama.274.2.172; Greenhalgh DG, 2007, J BURN CARE RES, V28, P776, DOI 10.1097/BCR.0b013e3181599bc9; Gyorgy B, 2011, BLOOD, V117, pE39, DOI 10.1182/blood-2010-09-307595; Jayachandran M, 2012, J IMMUNOL METHODS, V375, P207, DOI 10.1016/j.jim.2011.10.012; Johnson BL, 2014, ENDOCR METAB IMMUNE, V14, P210, DOI 10.2174/1871530314666140722083717; Joop K, 2001, THROMB HAEMOSTASIS, V85, P810; Jy W, 2004, J THROMB HAEMOST, V2, P1842, DOI 10.1111/j.1538-7836.2004.00936.x; LACELLE P, 1990, BLOOD, V75, P470; Linehan E, 2014, AGING CELL, V13, P699, DOI 10.1111/acel.12223; Lorincz AM, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.25465; Loyer X, 2014, CIRC RES, V114, P345, DOI 10.1161/CIRCRESAHA.113.300858; Lu Rommel P, 2013, J Trauma Acute Care Surg, V74, P1474, DOI 10.1097/TA.0b013e3182923193; Markiewicz Margaret, 2013, J Aging Res, V2013, P734509, DOI 10.1155/2013/734509; Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004; Martins VR, 2013, CURR OPIN ONCOL, V25, P66, DOI 10.1097/CCO.0b013e32835b7c81; Midura EF, 2016, SHOCK, V45, P82, DOI 10.1097/SHK.0000000000000460; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Mostefai HA, 2008, AM J RESP CRIT CARE, V178, P1148, DOI 10.1164/rccm.200712-1835OC; Nieuwland R, 2000, BLOOD, V95, P930, DOI 10.1182/blood.V95.3.930.003k46_930_935; Nieuwland R, 1997, CIRCULATION, V96, P3534; Nomellini V, 2008, J LEUKOCYTE BIOL, V83, P1493, DOI 10.1189/jlb.1007672; Ogura H, 2004, J TRAUMA, V56, P823, DOI 10.1097/01.TA.0000084517.39244.46; Park MS, 2012, SURGERY, V151, P831, DOI 10.1016/j.surg.2011.12.022; Prakash PS, 2012, J TRAUMA ACUTE CARE, V73, P401, DOI 10.1097/TA.0b013e31825a776d; Reid VL, 2012, BRIT J ANAESTH, V109, P503, DOI 10.1093/bja/aes321; Sheridan RL, 1998, BURNS, V24, P307, DOI 10.1016/S0305-4179(97)00062-4; TOBIASEN J, 1982, ANN EMERG MED, V11, P260, DOI 10.1016/S0196-0644(82)80096-6; Van Haren RM, 2013, J TRAUMA ACUTE CARE, V75, P37, DOI 10.1097/TA.0b013e3182984911; Venet F, 2007, CRIT CARE MED, V35, P1910, DOI 10.1097/01.CCM.0000275271.77350.B6	39	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167801	10.1371/journal.pone.0167801	http://dx.doi.org/10.1371/journal.pone.0167801			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936199	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100197
J	Taylor, CE; Machtinger, ET; Geden, CJ; Kramer, M				Taylor, Caitlin E.; Machtinger, Erika T.; Geden, Christopher J.; Kramer, Matthew			Manure Preferences and Postemergence Learning of Two Filth Fly Parasitoids, Spalangia cameroni and Muscidifurax raptor (Hymenoptera: Pteromalidae)	PLOS ONE			English	Article							PATCH TIME ALLOCATION; DIADEGMA-SEMICLAUSUM HYMENOPTERA; HOUSE-FLIES DIPTERA; STABLE FLIES; HOST-SEEKING; MORMONIELLA-VITRIPENNIS; ZARAPTOR HYMENOPTERA; BIOLOGICAL-CONTROL; MUSCA-DOMESTICA; MUSCIDAE	The efficiency of host-seeking behavior is crucial to the reproductive performance of female parasitoids. Initially, parasitoids may use chemical information garnered from the microhabitat in which they emerge to locate hosts. Spalangia cameroni and Muscidifurax raptor are commercially available parasitoids of filth flies. Postemergence exposure to a specific manure may provide a way to increase parasitism in specific microhabitats found at livestock facilities upon release. In this study, female parasitoids of both species were exposed to equine manure, bovine manure, or clean pupae. Females from each emergence exposure were tested in a two-choice arena (house fly hosts in bovine manure versus clean pupae, equine manure versus clean pupae, and equine manure versus bovine manure) for progeny production. There was a detectable but small effect of postemergence exposure on S. cameroni, but it was not sufficient to reverse innate preferences. Females consistently produced more progeny in hosts found in any manure over clean pupae, and in equine manure over bovine manure. The effect of postemergence exposure on M. raptor was also detectable but small. Females produced equal numbers of progeny in bovine manure versus clean pupae, as opposed to preferring to oviposit in clean pupae as with all other treatments. Preferences by M. raptor were overall less marked than for S. cameroni; indeed most of the variability observed for this species did not result from the treatment design. Residual host mortality was also detectably altered by exposure in both species, but the effect was small. Thus, postemergence exposure did not consistently and effectively manipulate these parasitoids to producing progeny in different exposure manures, suggesting that microhabitat preferences are largely determined by other factors.	[Taylor, Caitlin E.] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA; [Machtinger, Erika T.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA; [Geden, Christopher J.] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL USA; [Kramer, Matthew] USDA ARS, Stat Grp, Beltsville, MD USA; [Machtinger, Erika T.] USDA ARS, Invas Insect Biocontrol & Behav Lab, Beltsville, MD USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Machtinger, ET (corresponding author), Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA.; Machtinger, ET (corresponding author), USDA ARS, Invas Insect Biocontrol & Behav Lab, Beltsville, MD USA.	erika.machtinger@ars.usda.gov	Geden, Christopher J/J-5413-2016; Machtinger, Erika/B-4197-2016	Machtinger, Erika/0000-0002-6492-0901				Abram PK, 2016, BIOL CONTROL, V98, P52, DOI 10.1016/j.biocontrol.2016.04.002; Asgari S, 2011, ANNU REV ENTOMOL, V56, P313, DOI 10.1146/annurev-ento-120709-144849; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Boivin G, 2004, OECOLOGIA, V138, P640, DOI 10.1007/s00442-003-1469-z; Boone CK, 2009, CAN ENTOMOL, V141, P172, DOI 10.4039/n09-004; CAMPBELL ROBERT W., 1963, CANADIAN ENTOMOL, V95, P337; CAUBET Y, 1991, ANIM BEHAV, V42, P977, DOI 10.1016/S0003-3472(05)80150-2; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; CRESPO DIANA C., 2002, Neotrop. entomol., V31, P141, DOI 10.1590/S1519-566X2002000100019; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; De Moraes CM, 1999, ECOL ENTOMOL, V24, P402, DOI 10.1046/j.1365-2311.1999.00212.x; Desneux N, 2009, OECOLOGIA, V160, P387, DOI 10.1007/s00442-009-1289-x; DRIESSEN G, 1995, J ANIM ECOL, V64, P117, DOI 10.2307/5832; Driessen G, 1999, J ANIM ECOL, V68, P445, DOI 10.1046/j.1365-2656.1999.00296.x; EDWARDS RL, 1954, BEHAVIOUR, V7, P88, DOI 10.1163/156853955X00049; Geden CJ, 2006, ENVIRON ENTOMOL, V35, P75, DOI 10.1603/0046-225X-35.1.75; Geden CJ, 2002, ENVIRON ENTOMOL, V31, P411, DOI 10.1603/0046-225X-31.2.411; Geervliet JBF, 1998, ENTOMOL EXP APPL, V86, P241, DOI 10.1023/A:1003186706517; Godfray H. C. J., 1994, Parasitoids: behavioral and evolutionary ecology.; Goubault M, 2005, BEHAV ECOL, V16, P693, DOI 10.1093/beheco/ari043; Hogsette J. A., 1981, Patterson, R. S. (Chairman): Status of biological control of filth flies. Proceedings of a workshop. February 4-5, 1981, University of Florida, Gainesville., P105; JERVIS MA, 1986, BIOL REV, V61, P395, DOI 10.1111/j.1469-185X.1986.tb00660.x; JONES RL, 1971, SCIENCE, V173, P842, DOI 10.1126/science.173.3999.842; Kapongo JP, 2007, HORTSCIENCE, V42, P1400, DOI 10.21273/HORTSCI.42.6.1400; Kaufman PE, 2002, J APPL POULTRY RES, V11, P90, DOI 10.1093/japr/11.1.90; Kaufman PE, 2001, J ECON ENTOMOL, V94, P593, DOI 10.1603/0022-0493-94.2.593; KESTER KM, 1991, J INSECT BEHAV, V4, P727, DOI 10.1007/BF01052227; Laing J, 1937, J ANIM ECOL, V6, P298, DOI 10.2307/1186; LASHOMB J, 1987, CAN ENTOMOL, V119, P75, DOI 10.4039/Ent11975-1; LEE CN, 1990, ENVIRON ENTOMOL, V19, P1296, DOI 10.1093/ee/19.5.1296; Lentz-Ronning AJ, 2013, J INSECT BEHAV, V26, P165, DOI 10.1007/s10905-012-9345-5; Li X., 2002, ACTA ENTOMOL SINICA, V46, P749; Machtinger ET, 2015, ENVIRON ENTOMOL, V44, P330, DOI 10.1093/ee/nvu063; Machtinger ET, 2013, BIOL CONTROL, V65, P130, DOI 10.1016/j.biocontrol.2013.01.004; Machtinger ET, 2015, ENV ENTOMOL; Machtinger ET, 2016, NEOTROP ENTOMOL; MANDEVILLE JD, 1990, ANN ENTOMOL SOC AM, V83, P1203, DOI 10.1093/aesa/83.6.1203; McKay T, 2003, J KANSAS ENTOMOL SOC, V76, P31; McKay T, 1999, CAN ENTOMOL, V131, P743, DOI 10.4039/Ent131743-6; Pitzer JB, 2011, J ECON ENTOMOL, V104, P1108, DOI 10.1603/EC10227; Potting RPJ, 1997, ANIM BEHAV, V53, P1211, DOI 10.1006/anbe.1996.0382; R Core Team, 2021, R LANGUAGE ENV STAT; RUEDA LM, 1985, ENVIRON ENTOMOL, V14, P217, DOI 10.1093/ee/14.3.217; Rutz DA, 1990, BIOCONTROL ARTHRO BI; SHEEHAN W, 1989, J INSECT BEHAV, V2, P743, DOI 10.1007/BF01049398; Skovgard H, 2004, B ENTOMOL RES, V94, P555, DOI 10.1079/BER2004322; STAFFORD KC, 1984, ENVIRON ENTOMOL, V13, P228, DOI 10.1093/ee/13.1.228; STRAND MR, 1986, J INSECT PHYSIOL, V32, P389, DOI 10.1016/0022-1910(86)90052-1; Thiel A, 2006, ANIM BIOL, V56, P233, DOI 10.1163/157075606777304212; Tormos JJ, 2002, B ENTOMOL RES, V102, P51; Turlings Ted C. J., 1993, P51; Van Dijken MJ, 1998, ECOL ENTOMOL, V23, P265, DOI 10.1046/j.1365-2311.1998.00130.x; VET LEM, 1983, NETH J ZOOL, V33, P225, DOI 10.1163/002829683X00101; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; Vet Louise E.M., 1995, P65; VINSON SB, 1976, ANNU REV ENTOMOL, V21, P109, DOI 10.1146/annurev.en.21.010176.000545; VINSON SB, 1975, ENTOMOL EXP APPL, V18, P443, DOI 10.1007/BF00304647; WAAGE JK, 1979, J ANIM ECOL, V48, P353, DOI 10.2307/4166; WACKERS FL, 1994, BIOL CONTROL, V4, P105, DOI 10.1006/bcon.1994.1018; Wajnberg E, 1999, J ANIM ECOL, V68, P121, DOI 10.1046/j.1365-2656.1999.00270.x; Wang XG, 2005, J INSECT BEHAV, V18, P171, DOI 10.1007/s10905-005-0473-z; Wang XG, 2004, J INSECT BEHAV, V17, P761, DOI 10.1023/B:JOIR.0000048987.10357.a6; Wang XG, 2003, J INSECT BEHAV, V16, P279, DOI 10.1023/A:1023924103884; Weinzierl RA, 1998, J ECON ENTOMOL, V91, P1114, DOI 10.1093/jee/91.5.1114; WYLIE H. G., 1958, CANADIAN ENT, V90, P597	65	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167893	10.1371/journal.pone.0167893	http://dx.doi.org/10.1371/journal.pone.0167893			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936090	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100224
J	George, G; Govender, K; Beckett, S; Montague, C; Frohlich, J				George, Gavin; Govender, Kaymarlin; Beckett, Sean; Montague, Carl; Frohlich, Janet			Early Resumption of Sex following Voluntary Medical Male Circumcision amongst School-Going Males	PLOS ONE			English	Article							RISK COMPENSATION; HIV; MEN; OPPORTUNITIES; ADOLESCENTS; CHALLENGES; PREVENTION; BEHAVIOR	Voluntary medical male circumcision is an integral part of the South African government's response to the HIV and AIDS epidemic. Following circumcision, it is recommended that patients abstain from sexual activity for six weeks, as sex may increase the risk of female-to-male HIV transmission and prolong the healing period. This paper investigates the resumption of sexual activity during the healing period among a cohort of school-going males in the KwaZulu-Natal province of South Africa. The analysis for this paper compares two groups of sexually active school-going males: the first group reported having sex during the healing period (n = 40) and the second group (n = 98) reported no sex during the healing period (mean age: 17.7, SD: 1.7). The results show that 29% (n = 40) of young males (mean age: 17.9, SD: 1.8) who were previously sexually active, resumed sexual activity during the healing period, had on average two partners and used condoms inconsistently. In addition, those males that engage in sexual activity during the healing period were less inclined to practice safe sex in the future (AOR = 0.055, p = 0.002) than the group of males who reported no sex during the healing period. These findings suggest that a significant proportion of young males may currently and in the future, subject themselves to high levels of risk for contracting HIV post circumcision. Education, as part of a VMMC campaign, must emphasize the high risk of HIV transmission for both the males their partners during the healing period.	[George, Gavin; Govender, Kaymarlin; Beckett, Sean] Univ KwaZulu Natal, Hlth Econ & HIV & AIDS Res Div, Durban, South Africa; [Montague, Carl; Frohlich, Janet] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa, Durban, South Africa	University of Kwazulu Natal; University of Kwazulu Natal	George, G (corresponding author), Univ KwaZulu Natal, Hlth Econ & HIV & AIDS Res Div, Durban, South Africa.	georgeg@ukzn.ac.za	Govender, Kaymarlin/M-1660-2019; George, Gavin L/N-5756-2013	George, Gavin L/0000-0001-7258-8470; govender, kaymarlin/0000-0002-9586-1510	Swedish International Development Cooperation Agency (Sida) [51040023-01]	Swedish International Development Cooperation Agency (Sida)	This work was supported by Grant Number: 51040023-01, Swedish International Development Cooperation Agency (Sida).	Abbott SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053809; Albert LM, 2011, AIDS CARE, V23, P1578, DOI 10.1080/09540121.2011.579939; [Anonymous], 2011, S AFRICAN NATL STRAT; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Brener ND, 2003, J ADOLESCENT HEALTH, V33, P436, DOI 10.1016/S1054-139X(03)00052-1; Eaton Lisa A, 2007, Curr HIV/AIDS Rep, V4, P165, DOI 10.1007/s11904-007-0024-7; Fenton KA, 2001, SEX TRANSM INFECT, V77, P84, DOI 10.1136/sti.77.2.84; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Herman-Roloff A, 2012, AIDS BEHAV, V16, P1173, DOI 10.1007/s10461-011-0073-1; Hewett PC, 2012, AIDS, V26, P749, DOI 10.1097/QAD.0b013e32835097ff; HIV/AIDS JUNPo, 2011, JOINT STRAT ACT FRAM; INTERNATIONAL BUSINESS MACHINES (IBM) Corporation, IBM SPSS STAT WINDOW; Kharsany ABM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-231; Lanham M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044825; Mattson CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002443; Mehta SD, 2009, AIDS, V23, P1557, DOI 10.1097/QAD.0b013e32832afe95; Montague C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096468; Njeuhmeli E, 2014, JAIDS-J ACQ IMM DEF, V66, pS193, DOI 10.1097/QAI.0000000000000179; Ombere SO, 2015, CULT HEALTH SEX, V17, P1147, DOI 10.1080/13691058.2015.1018949; Wawer MJ, 2007, LANCET, V374, P229; Westercamp N, 2014, AIDS BEHAV, V18, P1764, DOI 10.1007/s10461-014-0846-4	22	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0168091	10.1371/journal.pone.0168091	http://dx.doi.org/10.1371/journal.pone.0168091			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4OA	27930720	Green Published, gold, Green Submitted			2022-12-27	WOS:000389580900080
J	Horayama, M; Shinha, K; Kabayama, K; Fujii, T; Kimura, H				Horayama, Masayuki; Shinha, Kenta; Kabayama, Kazuya; Fujii, Teruo; Kimura, Hiroshi			Spatial Chemical Stimulation Control in Microenvironment by Microfluidic Probe Integrated Device for Cell-Based Assay	PLOS ONE			English	Article							ON-A-CHIP	Cell-cell interactions play an important role in the development and function of multicellular organisms. To investigate these interactions in detail, it is necessary to evaluate the behavior of a cell population when the minimum number of cells in the population is stimulated by some chemical factors. We propose a microfluidic device integrated with microfluidic probe (MFP) functionality; this device is capable of imparting a chemical stimulus to cells within a microenvironment, for cell-based assays. The device contains MFP channels at the walls of the cell culture microchannels, and it can control a localized chemical stimulation area at the scale of a single cell to a few cells using MFP fluid control in a microspace. The results of a finite element method-based simulation indicated that it is possible to control the chemical stimulation area at the scale of a single cell to a few cells by optimizing the MFP channel apex width and the flow ratio. In addition, localized cell staining was demonstrated successfully using a spatial chemical stimulus. We confirmed the device functionality as a novel cell-based assay tool. We succeeded in performing localized cell collection using this method, which suggested that the single cell analysis of a cell monolayer that is subjected to a specific chemical stimulus is possible. The method proposed in this paper can contribute significantly to the fields of cell biology and drug development.	[Horayama, Masayuki; Shinha, Kenta; Kimura, Hiroshi] Tokai Univ, Dept Mech Engn, Hiratsuka, Kanagawa, Japan; [Kabayama, Kazuya] Osaka Univ, Dept Chem, Toyonaka, Osaka, Japan; [Kabayama, Kazuya; Kimura, Hiroshi] Tokai Univ, Micro Nano Technol Ctr, Hiratsuka, Kanagawa, Japan; [Fujii, Teruo] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo, Japan	Tokai University; Osaka University; Tokai University; University of Tokyo	Kimura, H (corresponding author), Tokai Univ, Dept Mech Engn, Hiratsuka, Kanagawa, Japan.; Kimura, H (corresponding author), Tokai Univ, Micro Nano Technol Ctr, Hiratsuka, Kanagawa, Japan.	hkimura@tokai-u.jp	Kimura, Hiroshi/ABA-5971-2021; Kabayama, Kazuya/ABD-5748-2020	Kimura, Hiroshi/0000-0003-0623-0248; Kabayama, Kazuya/0000-0002-7583-5454	Ministry of Education, Culture, Sports, Science and Technology [25127716]; CREST(Japan Science and Technology Agency); MEXT; Ministry of Education, Culture, Sports, Science and Technology (MEXT); CREST from Japan Science and Technology Agency (JST)	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST(Japan Science and Technology Agency)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST from Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (the Ministry of Education, Culture, Sports, Science and Technology) Project Number:25127716 to HK; CREST(Japan Science and Technology Agency) to TF HK; MEXT-Supported Program for the Strategic Research Foundation at Private Universities(the Ministry of Education, Culture, Sports, Science and Technology) to HK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Mr. T. Ohkubo and Mr. K. Arai for their technical assistance. This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and CREST from Japan Science and Technology Agency (JST).	Abhyankar VV, 2006, LAB CHIP, V6, P389, DOI 10.1039/b514133h; Beebe DJ, 2002, ANNU REV BIOMED ENG, V4, P261, DOI 10.1146/annurev.bioeng.4.112601.125916; Cors JF, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4866976; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Hung PJ, 2005, BIOTECHNOL BIOENG, V89, P1, DOI 10.1002/bit.20289; Irimia D, 2006, ANAL CHEM, V78, P3472, DOI 10.1021/ac0518710; Jang KJ, 2013, INTEGR BIOL-UK, V5, P1119, DOI 10.1039/c3ib40049b; Juncker D, 2005, NAT MATER, V4, P622, DOI 10.1038/nmat1435; Kaigala GV, 2011, LANGMUIR, V27, P5686, DOI 10.1021/la2003639; Kim HJ, 2016, P NATL ACAD SCI USA, V113, pE7, DOI 10.1073/pnas.1522193112; Kim HJ, 2013, INTEGR BIOL-UK, V5, P1130, DOI 10.1039/c3ib40126j; Kraus T, 2006, LAB CHIP, V6, P218, DOI 10.1039/b511768b; McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ostromohov N, 2016, LAB CHIP, V16, P3015, DOI 10.1039/c6lc00473c; Queval A, 2010, LAB CHIP, V10, P326, DOI 10.1039/b916669f; Sarkar A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4421; Shao JB, 2009, LAB CHIP, V9, P3118, DOI 10.1039/b909312e; Takagi M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2779350; Takayama S, 2001, NATURE, V411, P1016, DOI 10.1038/35082637; Walker GM, 2005, LAB CHIP, V5, P611, DOI 10.1039/b417245k; Young EWK, 2010, CHEM SOC REV, V39, P1036, DOI 10.1039/b909900j; Zaari N, 2004, ADV MATER, V16, P2133, DOI 10.1002/adma.200400883	23	6	6	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0168158	10.1371/journal.pone.0168158	http://dx.doi.org/10.1371/journal.pone.0168158			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930750	Green Submitted, Green Published, gold			2022-12-27	WOS:000389580900083
J	Muselimyan, N; Swift, LM; Asfour, H; Chahbazian, T; Mazhari, R; Mercader, MA; Sarvazyan, NA				Muselimyan, Narine; Swift, Luther M.; Asfour, Huda; Chahbazian, Tigran; Mazhari, Ramesh; Mercader, Marco A.; Sarvazyan, Narine A.			Seeing the Invisible: Revealing Atrial Ablation Lesions Using Hyperspectral Imaging Approach	PLOS ONE			English	Article							PULMONARY VEIN ISOLATION; OPTICAL-PROPERTIES; RADIOFREQUENCY ABLATION	Background Currently, there are limited means for high-resolution monitoring of tissue injury during radio-frequency ablation procedures. Objective To develop the next generation of visualization catheters that can reveal irreversible atrial muscle damage caused by ablation and identify viability gaps between the lesions. Methods Radiofrequency lesions were placed on the endocardial surfaces of excised human and bovine atria and left ventricles of blood perfused rat hearts. Tissue was illuminated with 365nm light and a series of images were acquired from individual spectral bands within 420-720nm range. By extracting spectral profiles of individual pixels and spectral unmixing, the relative contribution of ablated and unablated spectra to each pixel was then displayed. Results of spectral unmixing were compared to lesion pathology. Results RF ablation caused significant changes in the tissue autofluorescence profile. The magnitude of these spectral changes in human left atrium was relatively small (<10% of peak fluorescence value), yet highly significant. Spectral unmixing of hyperspectral datasets enabled high spatial resolution, in-situ delineation of radiofrequency lesion boundaries without the need for exogenous markers. Lesion dimensions derived from hyperspectral imaging approach strongly correlated with histological outcomes. Presence of blood within the myocardium decreased the amplitude of the autofluorescence spectra while having minimal effect on their overall shapes. As a result, the ability of hyperspectral imaging to delineate ablation lesions in vivo was not affected. Conclusions Hyperspectral imaging greatly increases the contrast between ablated and unablated tissue enabling visualization of viability gaps at clinically relevant locations. Data supports the possibility for developing percutaneous hyperspectral catheters for high-resolution ablation guidance.	[Muselimyan, Narine; Swift, Luther M.; Asfour, Huda; Sarvazyan, Narine A.] George Washington Univ, Sch Med & Hlth Sci, Dept Physiol & Pharmacol, Washington, DC 20052 USA; [Chahbazian, Tigran] Strasbourg Med Univ, Strasbourg, France; [Mazhari, Ramesh; Mercader, Marco A.] George Washington Univ, Div Cardiol, Med Fac Associates, Washington, DC USA	George Washington University; George Washington University	Sarvazyan, NA (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Physiol & Pharmacol, Washington, DC 20052 USA.	phynas@gwu.edu	Swift, Luther/AGI-6464-2022; Swift, Luther/AGI-6431-2022	Swift, Luther/0000-0002-0050-1329; Swift, Luther/0000-0002-0050-1329; Asfour, Huda/0000-0003-1968-1881; Sarvazyan, Narine/0000-0002-2002-5630	LuxCath-GW Research Agreement, awards from the National Institutes of Health [R41HL120511, R42 HL120511]; intramural George Washington University funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R42HL120511] Funding Source: NIH RePORTER	LuxCath-GW Research Agreement, awards from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); intramural George Washington University funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by LuxCath-GW Research Agreement, R41HL120511 & R42 HL120511 awards from the National Institutes of Health, and intramural George Washington University funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agah R, 1996, IEEE T BIO-MED ENG, V43, P839, DOI 10.1109/10.508546; Armstrong K, 2015, HEAR RHYTHM, V20, pS117; Baxter WT, 2001, BIOPHYS J, V80, P516, DOI 10.1016/S0006-3495(01)76034-1; Calin MA, 2014, APPL SPECTROSC REV, V49, P435, DOI 10.1080/05704928.2013.838678; Chin MS, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.2.026010; Dana N, 2014, HEART RHYTHM, V11, P150, DOI 10.1016/j.hrthm.2013.09.071; Deshpande Sanjay, 2014, Card Electrophysiol Clin, V6, P1, DOI 10.1016/j.ccep.2013.10.006; Dickfeld T, 2006, J AM COLL CARDIOL, V47, P370, DOI 10.1016/j.jacc.2005.07.070; Dukkipati SR, 2015, J AM COLL CARDIOL, V66, P1350, DOI 10.1016/j.jacc.2015.07.036; Gan Y, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.10.101407; Gandjbakhche AH, 1999, AM J PHYSIOL-HEART C, V277, pH698, DOI 10.1152/ajpheart.1999.277.2.H698; Gil D.A., 2016, J BIOPHOTONICS; Kay M, 2008, AM J PHYSIOL-HEART C, V294, pH2400, DOI 10.1152/ajpheart.01158.2007; Koruth J, 2015, HEAR RHYTHM, V20, pS111; Lu GL, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.010901; Lu GL, 2014, PROC SPIE, V9034, DOI 10.1117/12.2043796; Mansfield JR, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2032458; Mercader M, 2012, AM J PHYSIOL-HEART C, V302, pH2131, DOI 10.1152/ajpheart.01141.2011; Nakai Kanji, 1999, Frontiers of Medical and Biological Engineering, V9, P241; Oral H, 2002, J AM COLL CARDIOL, V40, P100, DOI 10.1016/S0735-1097(02)01939-3; PICKERING JW, 1993, APPL OPTICS, V32, P367, DOI 10.1364/AO.32.000367; PRIES AR, 1983, AM J PHYSIOL, V245, pH167, DOI 10.1152/ajpheart.1983.245.1.H167; Saito T, 2000, J CARDIOVASC ELECTR, V11, P888, DOI 10.1111/j.1540-8167.2000.tb00068.x; Schade A, 2012, EXPERT REV CARDIOVAS, V10, P995, DOI [10.1586/ERC.12.86, 10.1586/erc.12.86]; Schwartzman D, 2013, EUROPACE, V15, P1557, DOI 10.1093/europace/eut099; Silverman DA, 1996, MICROVASC RES, V52, P143, DOI 10.1006/mvre.1996.0050; Swartling J, 2003, MED BIOL ENG COMPUT, V41, P403, DOI 10.1007/BF02348082; Swift L, 2008, PHYSIOL MEAS, V29, P269, DOI 10.1088/0967-3334/29/2/009; Swift L, 2014, CIRC-ARRHYTHMIA ELEC, V7, P929, DOI 10.1161/CIRCEP.114.001750; THOMSEN S, 1990, P SOC PHOTO-OPT INS, V1202, P2, DOI 10.1117/12.17605	30	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167760	10.1371/journal.pone.0167760	http://dx.doi.org/10.1371/journal.pone.0167760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930718	gold, Green Submitted, Green Published			2022-12-27	WOS:000389580900043
J	Pegolo, S; Cecchinato, A; Mach, N; Babbucci, M; Pauletto, M; Bargelloni, L; Schiavon, S; Bittante, G				Pegolo, Sara; Cecchinato, Alessio; Mach, Nuria; Babbucci, Massimiliano; Pauletto, Marianna; Bargelloni, Luca; Schiavon, Stefano; Bittante, Giovanni			Transcriptomic Changes in Liver of Young Bulls Caused by Diets Low in Mineral and Protein Contents and Supplemented with n-3 Fatty Acids and Conjugated Linoleic Acid	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; MUSCLED PIEMONTESE BULLS; GENE-EXPRESSION; DAIRY-COWS; MAMMARY-GLAND; CHOLESTEROL HOMEOSTASIS; INFLAMMATORY DISEASES; GLUCOSE-HOMEOSTASIS; LIPOGENIC GENES; BEEF STEERS	The aim of the present study was to identify transcriptional modifications and regulatory networks accounting for physiological and metabolic responses to specific nutrients in the liver of young Belgian Blue x Holstein bulls using RNA-sequencing. A larger trial has been carried out in which animals were fed with different diets: 1] a conventional diet; 2] a low-protein/low-mineral diet (low-impact diet) and 3] a diet enriched in n-3 fatty acids (FAs), conjugated linoleic acid (CLA) and vitamin E (nutraceutical diet). The initial hypothesis was that the administration of low-impact and nutraceutical diets might influence the transcriptional profiles in bovine liver and the resultant nutrient fluxes, which are essential for optimal liver function and nutrient interconversion. Results showed that the nutraceutical diet significantly reduced subcutaneous fat covering in vivo and liver pH. Dietary treatments did not affect overall liver fat content, but significantly modified the liver profile of 33 FA traits (out of the total 89 identified by gas-chromatography). In bulls fed nutraceutical diet, the percentage of n-3 and CLA FAs increased around 2.5-fold compared with the other diets, whereas the ratio of n6/n3 decreased 2.5-fold. Liver transcriptomic analyses revealed a total of 198 differentially expressed genes (DEGs) when comparing low-impact, nutraceutical and conventional diets, with the nutraceutical diet showing the greatest effects on liver transcriptome. Functional analyses using ClueGo and Ingenuity Pathway Analysis evidenced that DEGs in bovine liver were variously involved in energy reserve metabolic process, glutathione metabolism, and carbohydrate and lipid metabolism. Modifications in feeding strategies affected key transcription factors regulating the expression of several genes involved in fatty acid metabolism, e.g. insulin-induced gene 1, insulin receptor substrate 2, and RAR-related orphan receptor C. This study provides noteworthy insights into the molecular changes occurring as a result of nutrient variation in diets (aimed at reducing the environmental impact and improving human health) and broadens our understanding of the relationship between nutrients variation and phenotypic effects.	[Pegolo, Sara; Cecchinato, Alessio; Schiavon, Stefano; Bittante, Giovanni] Univ Padua, Dept Agron Food Nat Resources Anim & Environm DAF, Padua, Italy; [Mach, Nuria] Univ Paris Saclay, AgroParisTech, INRA, Anim Genet & Integrat Biol Unit GABI, Jouy En Josas, France; [Babbucci, Massimiliano; Pauletto, Marianna; Bargelloni, Luca] Univ Padua, Dept Comparat Biomed & Food Sci, Padua, Italy	University of Padua; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Padua	Pegolo, S (corresponding author), Univ Padua, Dept Agron Food Nat Resources Anim & Environm DAF, Padua, Italy.	sara.pegolo@unipd.it	Bittante, Giovanni/M-4521-2019; Mach, Núria/C-5985-2012; Pauletto, Marianna/K-5518-2019; Schiavon, Stefano/C-6253-2011; Bittante, Giovanni/B-2332-2010	Bittante, Giovanni/0000-0001-7137-7049; Mach, Núria/0000-0002-8001-6314; Pauletto, Marianna/0000-0002-2424-7484; Schiavon, Stefano/0000-0002-5539-8947; Bittante, Giovanni/0000-0001-7137-7049; BABBUCCI, MASSIMILIANO/0000-0002-4060-4728; pegolo, sara/0000-0001-6390-9826	University of Padova (Ricerca Scientifica fondi quota) [EX 60% -649 60A08-7943/14]	University of Padova (Ricerca Scientifica fondi quota)	This research was supported by the University of Padova (Ricerca Scientifica fondi quota EX 60% -649 60A08-7943/14).	Ahnadi CE, 2002, J DAIRY RES, V69, P521, DOI 10.1017/S0022029902005769; Alonso ML, 2000, FOOD ADDIT CONTAM A, V17, P447, DOI 10.1080/02652030050034028; Alonso ML, 2004, BIOMETALS, V17, P389, DOI 10.1023/B:BIOM.0000029434.89679.a2; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Andrews S., 2010, FASTQC QUALITY CONTR, DOI DOI 10.1038/NPROT.2013.099; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azain MJ, 2000, J NUTR, V130, P1548; Bagashev A, 2010, J INTERF CYTOK RES, V30, P843, DOI 10.1089/jir.2010.0017; Baldwin RL, 2012, PHYSIOL GENOMICS, V44, P543, DOI 10.1152/physiolgenomics.00144.2011; Baldwin RL VI, 2012, GENE REGUL SYST BIO, V6, P67, DOI 10.4137/GRSB.S9687; Baumgard LH, 2002, J DAIRY SCI, V85, P2155, DOI 10.3168/jds.S0022-0302(02)74294-X; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Bernard L, 2008, ADV EXP MED BIOL, V606, P67, DOI 10.1007/978-0-387-74087-4_2; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; BOYER JL, 1992, ANNU REV PHYSIOL, V54, P415, DOI 10.1146/annurev.ph.54.030192.002215; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cannell IG, 2008, BIOCHEM SOC T, V36, P1224, DOI 10.1042/BST0361224; Cildir G, 2013, TRENDS MOL MED, V19, P487, DOI 10.1016/j.molmed.2013.05.001; Corl BA, 2003, J NUTR, V133, P2893, DOI 10.1093/jn/133.9.2893; Coyne GS, 2008, THERIOGENOLOGY, V70, P772, DOI 10.1016/j.theriogenology.2008.05.048; Dacasto M, 2005, VET RES, V36, P179, DOI 10.1051/vetres:2004066; Davidson AJ, 2004, LIVER INT, V24, P179, DOI 10.1111/j.1478-3231.2004.00917.x; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong XY, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-173; Dray S, 2003, ECOLOGY, V84, P3078, DOI 10.1890/03-0178; Fernandez ML, 2005, J NUTR, V135, P2075, DOI 10.1093/jn/135.9.2075; Frost RJA, 2011, P NATL ACAD SCI USA, V108, P21075, DOI 10.1073/pnas.1118922109; Gleeson M, 2000, IMMUNOL CELL BIOL, V78, P554, DOI 10.1046/j.1440-1711.2000.00953.x; Gruffat D, 2011, ANIMAL, V5, P1090, DOI 10.1017/S1751731111000073; da Costa ASH, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-65; Hiller B, 2013, LIPIDS, V48, P357, DOI 10.1007/s11745-012-3737-3; Jacobs AAA, 2013, ANIMAL, V7, P1508, DOI 10.1017/S175173111300061X; Jenkins TC, 2010, J DAIRY SCI, V93, P1170, DOI 10.3168/jds.2009-2509; Jeoung NH, 2006, BIOCHEM J, V397, P417, DOI 10.1042/BJ20060125; Jump DB, 2008, CURR OPIN LIPIDOL, V19, P242, DOI 10.1097/MOL.0b013e3282ffaf6a; KOTULA AW, 1982, J ANIM SCI, V54, P544, DOI 10.2527/jas1982.543544x; Kreipe L, 2011, J DAIRY SCI, V94, P5435, DOI 10.3168/jds.2011-4208; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Loewen CJR, 2002, CURR BIOL, V12, pR779, DOI 10.1016/S0960-9822(02)01292-7; Lopez-Alonso Marta, 2012, ISRN Vet Sci, V2012, P704825, DOI 10.5402/2012/704825; Mach N, 2013, J ANIM PHYSIOL AN N, V97, P89, DOI 10.1111/jpn.12042; Mach N, 2011, ANIMAL, V5, P1217, DOI 10.1017/S1751731111000103; Madron MS, 2002, J ANIM SCI, V80, P1135; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; Matsunami T, 2011, METABOLISM, V60, P805, DOI 10.1016/j.metabol.2010.07.032; Matthews JC, 2014, BIOL TRACE ELEM RES, V160, P321, DOI 10.1007/s12011-014-0050-4; Mattos R, 2000, REV REPROD, V5, P38, DOI 10.1530/revreprod/5.1.38; Mir Z, 2000, SMALL RUMINANT RES, V36, P25, DOI 10.1016/S0921-4488(99)00087-5; Nakamura TJ, 2010, STEROIDS, V75, P203, DOI 10.1016/j.steroids.2010.01.007; Nuernberg K, 2005, LIVEST PROD SCI, V94, P137, DOI 10.1016/j.livprodsci.2004.11.036; Ogata H., 1999, NUCLEIC ACIDS RES, V27, P29, DOI DOI 10.1093/nar/27.1.29; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Palmiter RD, 2004, P NATL ACAD SCI USA, V101, P4918, DOI 10.1073/pnas.0401022101; Park Y, 1999, LIPIDS, V34, P235, DOI 10.1007/s11745-999-0358-8; Pellattiero E, 2015, J AGR FOOD CHEM, V63, P963, DOI 10.1021/jf504956x; Ravi S, 2015, J NUTR, V145, P841, DOI 10.3945/jn.114.203216; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roden M, 1996, J CLIN INVEST, V97, P642, DOI 10.1172/JCI118460; Schiavon S, 2013, LIVEST SCI, V157, P462, DOI 10.1016/j.livsci.2013.09.015; Schiavon S, 2012, ANIM FEED SCI TECH, V174, P96, DOI 10.1016/j.anifeedsci.2012.02.011; Schiavon S, 2011, MEAT SCI, V89, P133, DOI 10.1016/j.meatsci.2011.03.025; Schiavon S, 2010, J ANIM SCI, V88, P3372, DOI 10.2527/jas.2009-2558; Schiavon S, 2016, J DAIRY SCI IN PRESS; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Shen SH, 2014, P NATL ACAD SCI USA, V111, pE5593, DOI 10.1073/pnas.1419161111; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun CZ, 2015, INT J MOL MED, V35, P847, DOI 10.3892/ijmm.2015.2076; White ES, 2011, IUBMB LIFE, V63, P538, DOI 10.1002/iub.493; Yang MH, 2014, J LIPID RES, V55, P226, DOI 10.1194/jlr.M041335; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050	71	8	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167747	10.1371/journal.pone.0167747	http://dx.doi.org/10.1371/journal.pone.0167747			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930681	gold, Green Published, Green Submitted			2022-12-27	WOS:000389580900042
J	Sanchez, O; Campuzano, O; Fernandez-Falgueras, A; Sarquella-Brugada, G; Cesar, S; Mademont, I; Mates, J; Perez-Serra, A; Coll, M; Pico, F; Iglesias, A; Tiron, C; Allegue, C; Carro, E; Gallego, MA; Ferrer-Costa, C; Hospital, A; Bardalet, N; Borondo, JC; Vingut, A; Arbelo, E; Brugada, J; Castella, J; Medallo, J; Brugada, R				Sanchez, Olallo; Campuzano, Oscar; Fernandez-Falgueras, Anna; Sarquella-Brugada, Georgia; Cesar, Sergi; Mademont, Irene; Mates, Jesus; Perez-Serra, Alexandra; Coll, Monica; Pico, Ferran; Iglesias, Anna; Tiron, Coloma; Allegue, Catarina; Carro, Esther; Gallego, Maria Angeles; Ferrer-Costa, Carles; Hospital, Anna; Bardalet, Narcis; Borondo, Juan Carlos; Vingut, Albert; Arbelo, Elena; Brugada, Josep; Castella, Josep; Medallo, Jordi; Brugada, Ramon			Natural and Undetermined Sudden Death: Value of Post-Mortem Genetic Investigation	PLOS ONE			English	Article							CHANNEL MOLECULAR AUTOPSY; 2015 ESC GUIDELINES; LONG QT SYNDROME; CARDIAC DEATH; UNEXPLAINED DEATH; VENTRICULAR-ARRHYTHMIAS; YOUNG-ADULTS; CHANNELOPATHIES; MUTATIONS; DISEASE	Background Sudden unexplained death may be the first manifestation of an unknown inherited cardiac disease. Current genetic technologies may enable the unraveling of an etiology and the identification of relatives at risk. The aim of our study was to define the etiology of natural deaths, younger than 50 years of age, and to investigate whether genetic defects associated with cardiac diseases could provide a potential etiology for the unexplained cases. Methods and Findings Our cohort included a total of 789 consecutive cases (77.19% males) <50 years old (average 38.6 +/- 12.2 years old) who died suddenly from non-violent causes. A comprehensive autopsy was performed according to current forensic guidelines. During autopsy a cause of death was identified in most cases (81.1%), mainly due to cardiac alterations (56.87%). In unexplained cases, genetic analysis of the main genes associated with sudden cardiac death was performed using Next Generation Sequencing technology. Genetic analysis was performed in suspected inherited diseases (cardiomyopathy) and in unexplained death, with identification of potentially pathogenic variants in nearly 50% and 40% of samples, respectively. Conclusions Cardiac disease is the most important cause of sudden death, especially after the age of 40. Close to 10% of cases may remain unexplained after a complete autopsy investigation. Molecular autopsy may provide an explanation for a significant part of these unexplained cases. Identification of genetic variations enables genetic counseling and undertaking of preventive measures in relatives at risk.	[Sanchez, Olallo; Campuzano, Oscar; Fernandez-Falgueras, Anna; Mademont, Irene; Mates, Jesus; Perez-Serra, Alexandra; Coll, Monica; Pico, Ferran; Iglesias, Anna; Allegue, Catarina; Brugada, Ramon] Univ Girona, Cardiovasc Genet Ctr, IDIBGI, Girona, Spain; [Campuzano, Oscar; Brugada, Ramon] Univ Girona, Dept Med Sci, Sch Med, Girona, Spain; [Fernandez-Falgueras, Anna; Tiron, Coloma; Brugada, Ramon] Hosp Josep Trueta, Cardiovasc Genet Unit, Girona, Spain; [Sarquella-Brugada, Georgia; Cesar, Sergi; Carro, Esther; Brugada, Josep] Univ Barcelona, Hosp St Joan de Deu, Arrhythmia Unit, Barcelona, Spain; [Gallego, Maria Angeles; Castella, Josep; Medallo, Jordi] Inst Med Legal Ciencies Med Catalunya, Forens Pathol Serv, Barcelona, Spain; [Ferrer-Costa, Carles] Gendiag SL, Barcelona, Spain; [Hospital, Anna; Bardalet, Narcis] Inst Med Legal & Ciencies Forenses Catalunya, Forens Pathol Serv, Girona, Spain; [Borondo, Juan Carlos; Vingut, Albert] Inst Nacl Toxicol & Ciencias Forenses, Histopathol Unit, Barcelona, Spain; [Arbelo, Elena; Brugada, Josep] Univ Barcelona, Hosp Clin Barcelona, Arrhythmia Unit, Barcelona, Spain	Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Universitat de Girona; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona	Brugada, R (corresponding author), Univ Girona, Cardiovasc Genet Ctr, IDIBGI, Girona, Spain.; Brugada, R (corresponding author), Univ Girona, Dept Med Sci, Sch Med, Girona, Spain.; Brugada, R (corresponding author), Hosp Josep Trueta, Cardiovasc Genet Unit, Girona, Spain.	ramon@brugada.org	Arbelo, Elena/GRS-2793-2022; Arbelo, Elena/GMX-0351-2022; Sarquella-Brugada, Georgia/W-9278-2018; campuzano, oscar/J-1968-2014; Cesar, Sergi/ABH-4429-2020	Sarquella-Brugada, Georgia/0000-0002-6857-8904; campuzano, oscar/0000-0001-5298-5276; CESAR, SERGI/0000-0002-2798-1756; ARBELO, ELENA/0000-0003-0424-6393; Tiron, Coloma/0000-0002-8424-5907; Mademont-Soler, Irene/0000-0002-6501-9250; ALLEGUE TOSCANO, CATARINA/0000-0002-5121-3159	Fondo Investigacion Sanitaria-FIS - from the Institute de Salud Carlos III (ISCIII) [PI14/01773]; Fundacio Academia de Ciencies Mediques i de la Salut de Catalunya i de Balears [ACMCB-2013]; Gendiag S.L	Fondo Investigacion Sanitaria-FIS - from the Institute de Salud Carlos III (ISCIII); Fundacio Academia de Ciencies Mediques i de la Salut de Catalunya i de Balears; Gendiag S.L	This work was supported by Fondo Investigacion Sanitaria-FIS PI14/01773- from the Institute de Salud Carlos III (ISCIII); Fundacio Academia de Ciencies Mediques i de la Salut de Catalunya i de Balears (ACMCB-2013). The commercial funder Gendiag S.L provided support in the form of salaries for authors CF and RB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ackerman MJ, 2011, EUROPACE, V13, P1077, DOI 10.1093/europace/eur245; Ackerman MJ, 2009, PACE, V32, pS86, DOI 10.1111/j.1540-8159.2009.02393.x; Amendola LM, 2016, AM J HUM GENET, V98, P1067, DOI 10.1016/j.ajhg.2016.03.024; Anderson JH, 2016, CIRC CARDIOVASC GENE; Arzamendi D, 2011, AM HEART J, V161, P574, DOI 10.1016/j.ahj.2010.10.040; Bagnall RD, 2016, NEW ENGL J MED, V374, P2441, DOI 10.1056/NEJMoa1510687; Bagnall RD, 2014, HEART RHYTHM, V11, P655, DOI 10.1016/j.hrthm.2014.01.017; Basso C, 2008, VIRCHOWS ARCH, V452, P11, DOI 10.1007/s00428-007-0505-5; Behr E, 2003, LANCET, V362, P1457, DOI 10.1016/S0140-6736(03)14692-2; Brion M, 2010, FORENSIC SCI INT, V203, P15, DOI 10.1016/j.forsciint.2010.07.015; Brion M, 2012, FORENSIC SCI INT, V219, P278, DOI 10.1016/j.forsciint.2012.01.018; Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; Campuzano O, 2016, INT J CARDIOL, V214, P404, DOI 10.1016/j.ijcard.2016.03.194; Campuzano O, 2015, J AM COLL CARDIOL, V66, P2913, DOI 10.1016/j.jacc.2015.10.049; Campuzano O, 2014, FORENSIC SCI INT, V245, P30, DOI 10.1016/j.forsciint.2014.10.004; Campuzano O, 2014, INT J LEGAL MED, V128, P599, DOI 10.1007/s00414-014-0966-4; Campuzano O, 2010, GENET MED, V12, P260, DOI 10.1097/GIM.0b013e3181d81636; Cerrone M, 2014, TRENDS CARDIOVAS MED, V24, P184, DOI 10.1016/j.tcm.2014.02.001; Cerrone M, 2014, CIRCULATION, V129, P1092, DOI 10.1161/CIRCULATIONAHA.113.003077; CORRADO D, 1994, CIRCULATION, V90, P2315, DOI 10.1161/01.CIR.90.5.2315; Corrado D, 2001, CARDIOVASC RES, V50, P399, DOI 10.1016/S0008-6363(01)00254-1; Davies MJ, 1999, HISTOPATHOLOGY, V34, P93; Eckart RE, 2011, J AM COLL CARDIOL, V58, P1254, DOI 10.1016/j.jacc.2011.01.049; Faragli A, 2016, J CARDIOVASC ELECTRO; Farrugia A, 2015, FORENSIC SCI INT, V254, P5, DOI 10.1016/j.forsciint.2015.06.023; Giudicessi JR, 2013, TRANSL RES, V161, P1, DOI 10.1016/j.trsl.2012.08.005; Gladding PA, 2010, HEART RHYTHM, V7, P481, DOI 10.1016/j.hrthm.2009.12.023; Hayashi M, 2015, CIRC RES, V116, P1887, DOI 10.1161/CIRCRESAHA.116.304521; Hertz CL, 2016, INT J LEGAL MED, V130, P91, DOI 10.1007/s00414-015-1261-8; Hertz CL, 2016, EUR J HUM GENET, V24, P817, DOI 10.1038/ejhg.2015.198; Ingles J, 2007, INTERN MED J, V37, P32, DOI 10.1111/j.1445-5994.2006.01241.x; Langlois NEI, 2009, FORENSIC SCI MED PAT, V5, P210, DOI 10.1007/s12024-009-9099-3; LAWLER W, 1990, J CLIN PATHOL, V43, P977, DOI 10.1136/jcp.43.12.977; LEACH IH, 1995, EUR HEART J, V16, P1181, DOI 10.1093/oxfordjournals.eurheartj.a061073; Lombardi R, 2013, CURR OPIN CARDIOL, V28, P272, DOI 10.1097/HCO.0b013e32835fb7f3; Loporcaro CG, 2014, ARCH PATHOL LAB MED, V138, P1083, DOI 10.5858/arpa.2013-0479-SA; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; McNair WP, 2011, J AM COLL CARDIOL, V57, P2160, DOI 10.1016/j.jacc.2010.09.084; Miles CJ, 2016, TRANSL RES, V168, P59, DOI 10.1016/j.trsl.2015.06.007; Narula N, 2015, PEDIATR CARDIOL, V36, P768, DOI 10.1007/s00246-014-1082-4; Neubauer J, 2016, INT J LEGAL MED; Nunn LM, 2016, EUROPACE, V18, P888, DOI 10.1093/europace/euv285; Oliva A, 2011, AM J FOREN MED PATH, V32, P1, DOI 10.1097/PAF.0b013e3181c2dc96; Priori SG, 2015, EUR HEART J, V36, P2793, DOI 10.1093/eurheartj/ehv316; Priori SG, 2015, EUROPACE, V17, P1601, DOI 10.1093/europace/euv319; Puranik R, 2005, HEART RHYTHM, V2, P1277, DOI 10.1016/j.hrthm.2005.09.008; Rodriguez-Calvo MS, 2008, FORENSIC SCI INT, V182, P1, DOI 10.1016/j.forsciint.2008.09.013; Sarquella-Brugada G, 2016, INT J LEGAL MED, V130, P415, DOI 10.1007/s00414-016-1330-7; Semsarian C, 2015, EUR HEART J, V36, P1290, DOI 10.1093/eurheartj/ehv063; SHEN WK, 1995, AM J CARDIOL, V76, P148, DOI 10.1016/S0002-9149(99)80047-2; Sinard JH, 2013, ARCH PATHOL LAB MED, V137, P228, DOI 10.5858/arpa.2012-0012-CP; Skinner JR, 2011, HEART RHYTHM, V8, P412, DOI 10.1016/j.hrthm.2010.11.016; Stattin EL, 2016, INT J LEGAL MED, V130, P59, DOI 10.1007/s00414-015-1237-8; Tester DJ, 2007, J AM COLL CARDIOL, V49, P240, DOI 10.1016/j.jacc.2006.10.010; Tester DJ, 2012, MAYO CLIN PROC, V87, P524, DOI 10.1016/j.mayocp.2012.02.017; Tester DJ, 2012, PEDIATR CARDIOL, V33, P461, DOI 10.1007/s00246-012-0160-8; Tester DJ, 2011, MAYO CLIN PROC, V86, P941, DOI 10.4065/mcp.2011.0373; Tester DJ, 2004, MAYO CLIN PROC, V79, P1380, DOI 10.4065/79.11.1380; Vassalini M, 2016, J CARDIOVASC MED, V17, P446, DOI 10.2459/JCM.0000000000000234; Wang D, 2014, FORENSIC SCI INT, V237, P90, DOI 10.1016/j.forsciint.2014.01.014; Wilhelm M, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14129; Yu J, 2014, HERZ, V39, P271, DOI 10.1007/s00059-013-3998-5	62	39	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167358	10.1371/journal.pone.0167358	http://dx.doi.org/10.1371/journal.pone.0167358			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930701	gold, Green Published			2022-12-27	WOS:000389580900026
J	Adeyemi, IR; Razak, SA; Salleh, M; Venter, HS				Adeyemi, Ikuesan Richard; Razak, Shukor Abd; Salleh, Mazleena; Venter, Hein S.			Observing Consistency in Online Communication Patterns for User Re-Identification	PLOS ONE			English	Article							TIME	Comprehension of the statistical and structural mechanisms governing human dynamics in online interaction plays a pivotal role in online user identification, online profile development, and recommender systems. However, building a characteristic model of human dynamics on the Internet involves a complete analysis of the variations in human activity patterns, which is a complex process. This complexity is inherent in human dynamics and has not been extensively studied to reveal the structural composition of human behavior. A typical method of anatomizing such a complex system is viewing all independent inter-connectivity that constitutes the complexity. An examination of the various dimensions of human communication pattern in online interactions is presented in this paper. The study employed reliable server-side web data from 31 known users to explore characteristics of human-driven communications. Various machine-learning techniques were explored. The results revealed that each individual exhibited a relatively consistent, unique behavioral signature and that the logistic regression model and model tree can be used to accurately distinguish online users. These results are applicable to one-to-one online user identification processes, insider misuse investigation processes, and online profiling in various areas.	[Adeyemi, Ikuesan Richard; Razak, Shukor Abd; Salleh, Mazleena] Univ Teknol Malaysia, Fac Comp, Informat Assurance & Secur Res Grp, Skudai, Johor Bahru, Malaysia; [Adeyemi, Ikuesan Richard; Venter, Hein S.] Univ Pretoria, Informat & Comp Secur Architecture Res Grp, Dept Comp Sci, Lynnwood, South Africa	Universiti Teknologi Malaysia; University of Pretoria	Adeyemi, IR (corresponding author), Univ Teknol Malaysia, Fac Comp, Informat Assurance & Secur Res Grp, Skudai, Johor Bahru, Malaysia.; Adeyemi, IR (corresponding author), Univ Pretoria, Informat & Comp Secur Architecture Res Grp, Dept Comp Sci, Lynnwood, South Africa.	raikuesan@live.utm.my	Ikuesan, Adeyemi Richard/D-2583-2018; razak, shukor abd/AAN-1035-2020; Venter, H. S./N-2724-2017; razak, shukor abd/F-5651-2011	Ikuesan, Adeyemi Richard/0000-0001-7355-2314; razak, shukor abd/0000-0002-8824-6069; Venter, H. S./0000-0002-3607-8630; razak, shukor abd/0000-0002-8824-6069	Ministry of Education, Malaysia [R.J130000.7813.4F193]; Universiti Teknologi Malaysia	Ministry of Education, Malaysia(Ministry of Education, Malaysia); Universiti Teknologi Malaysia	Ministry of Education, Malaysia grant: vote: R.J130000.7813.4F193 and Universiti Teknologi Malaysia http://www.utm.my/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Ministry of Education, Malaysia for sponsoring this research grant: vote: R.J130000.7813.4F193 and the Universiti Teknologi Malaysia	Abramson M., 2013, 2013 AAAI FALL S SER; Abramson M., 2013, FLORIDA ARTIF INTELL, P268; Adeyemi IR, 2014, 2014 INTERNATIONAL SYMPOSIUM ON BIOMETRICS AND SECURITY TECHNOLOGIES (ISBAST), P198, DOI 10.1109/ISBAST.2014.7013121; Amatriain X, 2011, RECOMMENDER SYSTEMS HANDBOOK, P39, DOI 10.1007/978-0-387-85820-3_2; Banse C, 2012, IFIP ADV INF COMM TE, V376, P235; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; CATLEDGE LD, 1995, COMPUT NETWORKS ISDN, V27, P1065, DOI 10.1016/0169-7552(95)00043-7; Dezso Z, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.066132; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Fisher D. H., 1987, Machine Learning, V2, P139, DOI 10.1007/BF00114265; Geczy P, 2007, P WWW INT VIL REAL P, P163; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hamalainen W., 2010, HDB ED DATA MINING, P57; Herder E., 2005, P WORKSH AD US MOD I, P19; Jones Rosie, 2008, CIKM, P699, DOI DOI 10.1145/1458082.1458176; Kowol A., 2008, THEORY COGNITIVE DIS; Kumar Ravi, 2010, P 19 INT C WORLD WID, P561, DOI DOI 10.1145/1772690.1772748; Lee JJJ, 2007, NEW TRAFFIC MODEL CU, P1; Liao HT, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/321549; Liao H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112022; Lin J., 2002, P 2 WORKSH TEMP DAT; Lin J, 2012, J INTELL INF SYST, V39, P287, DOI 10.1007/s10844-012-0196-5; McCallum A., 2000, Proceedings. KDD-2000. Sixth ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, P169, DOI 10.1145/347090.347123; Nguyen TTT, 2008, IEEE COMMUN SURV TUT, V10, P56, DOI 10.1109/SURV.2008.080406; Peter G, 2010, ADV INFORM KNOWLEDGE, P199; Schneider P, 2007, P EUR S ART NEUR NET; Senin Pavel, 2014, Machine Learning and Knowledge Discovery in Databases. European Conference, ECML PKDD 2014. Proceedings: LNCS 8726, P468, DOI 10.1007/978-3-662-44845-8_37; Vazquez A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036127; Xia YN, 2007, PROC INT C TOOLS ART, P329, DOI 10.1109/ICTAI.2007.135; Yang Y.C., 2007, CLICKPRINTS WEB ARE; Yang YH, 2010, DECIS SUPPORT SYST, V48, P548, DOI 10.1016/j.dss.2009.11.005; Zhou T., 2008, SCI MATTERS HUMANITI, P207	32	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2016	11	12							e0166930	10.1371/journal.pone.0166930	http://dx.doi.org/10.1371/journal.pone.0166930			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MR	27918593	Green Published, Green Submitted, gold			2022-12-27	WOS:000389577100006
J	Etiaba, E; Onwujekwe, O; Torpey, K; Uzochukwu, B; Chiegil, R				Etiaba, Enyi; Onwujekwe, Obinna; Torpey, Kwasi; Uzochukwu, Benjamin; Chiegil, Robert			What Is the Economic Burden of Subsidized HIV/AIDS Treatment Services on Patients in Nigeria and Is This Burden Catastrophic to Households?	PLOS ONE			English	Article							INEQUALITIES; COSTS; CARE	Background A gap in knowledge exists regarding the economic burden on households of subsidized anti-retroviral treatment (ART) programs in Nigeria. This is because patients also incur non ART drug costs, which may constrain the delivery and utilisation of subsidized services. Methods An exit survey of adults (18+years) attending health facilities for HIV/AIDS treatment was conducted in three states in Nigeria (Adamawa, Akwa Ibom and Anambra). In the states, ART was fully subsidized but there were different payment modalities for other costs of treatment. Data was collected and analysed for direct and indirect costs of treatment of HIV/AIDS and co-morbidities' during out-and in-patient visits. The levels of catastrophic health expenditure (CHE) were computed and disaggregated by state, socio-economic status (SES) and urban-rural location of the respondents. Catastrophic Health Expenditure (CHE) in this study measures the number of respondents whose monthly ART-related household expenditure (for in-patient and out-patient visits) as a proportion of monthly non-food expenditure was greater than 40% and 10% respectively. Results The average out-patient and in-patient direct costs were $5.49 and $122.10 respectively. Transportation cost was the highest non-medical cost and it was higher than most medical costs. The presence of co-morbidities contributed to household costs. All the costs were catastrophic to households at 10% and 40% thresholds in the three states, to varying degrees. The poorest SES quintile had the highest incidence of CHE for out-patient costs (p<0.0001).Rural dwellers incurred more CHE for all categories of costs compared to urban dwellers, but the costs were statistically significant for only outpatient costs. Conclusion ART subsidization is not enough to eliminate economic burden of treatment on HIV patients. Service decentralization to reduce travel costs, and subsidy on other components of HIV treatment services should be introduced to eliminate the persisting inequitable and high cost burden of ART services. Full inclusion of ART services within the benefit package of the National Health Insurance Scheme should be considered.	[Etiaba, Enyi; Onwujekwe, Obinna; Uzochukwu, Benjamin] Univ Nigeria, Dept Hlth Adm & Management, Coll Med, Enugu Campus, Enugu, Nigeria; [Etiaba, Enyi; Onwujekwe, Obinna; Uzochukwu, Benjamin] Univ Nigeria, Dept Pharmacol & Pharmacotherapeut, Coll Med, Hlth Policy Res Grp, Enugu Campus, Enugu, Nigeria; [Torpey, Kwasi; Chiegil, Robert] Strengthening Integrated Delivery HIV AIDS Serv, FHI 360,Plot 1073 JS Tarka St, Pmb, Abuja, Nigeria; [Uzochukwu, Benjamin] Univ Nigeria, Coll Med, Dept Community Med, Enugu Campus, Enugu, Nigeria	University of Nigeria; University of Nigeria; University of Nigeria	Etiaba, E (corresponding author), Univ Nigeria, Dept Hlth Adm & Management, Coll Med, Enugu Campus, Enugu, Nigeria.; Etiaba, E (corresponding author), Univ Nigeria, Dept Pharmacol & Pharmacotherapeut, Coll Med, Hlth Policy Res Grp, Enugu Campus, Enugu, Nigeria.	enyi.etiaba@unn.edu.ng	Onwujekwe, Obinna/O-6232-2014	Onwujekwe, Obinna/0000-0002-1214-4285; Torpey, Kwasi/0000-0003-1628-2922	U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through U.S. Agency for International Development (USAID) [620-A-11-00002]	U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Support for this paper was provided by FH1360's Strengthening Integrated Delivery of HIV/AID Services with funds from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through U.S. Agency for International Development (USAID) Cooperative Agreement No. 620-A-11-00002. The views expressed in this publication do not necessarily reflect those of FHI360, nor the United States Government.; Support for this paper was provided by FHI360's Strengthening Integrated Delivery of HIV/AID Services with funds from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through U.S. Agency for International Development (USAID) Cooperative Agreement No. 620-A-11-00002. The views expressed in this publication do not necessarily reflect those of FHI360, nor the United States Government.	Apanga S, 2012, PAN AFRICAN MED J, V12; Beauliere A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011213; Central Bank of Nigeria (CBN), 2013, CURR EXCH RAT; Centre for Disease Control (CDC), 2014, CHALL HIV PREV FACT; Centre for Disease Control (CDC) Centre for Disease Control (CDC), COST AN; Chuma J, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-413; Dray-Spira R, 2003, AIDS, V17, P283, DOI 10.1097/00002030-200302140-00001; Federal Ministry of Health (FMOH), 2010, NAT HIV SER SER SENT, V2010; Kumarasamy N, 2007, INDIAN J MED RES, V126, P509; Mari-Dell'Olmo M, 2007, J EPIDEMIOL COMMUN H, V61, P232, DOI 10.1136/jech.2006.048017; Moon S, 2008, AIDS CARE, V20, P984, DOI 10.1080/09540120701768446; Onoka C, 2012, WHY ARE STATES NOT A; Onwujekwe O, 2009, HEALTH POLICY, V90, P223, DOI 10.1016/j.healthpol.2008.10.006; Wabiri N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1037; WHO, 2013, GLOB UPD HIV TREATM	15	14	16	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167117	10.1371/journal.pone.0167117	http://dx.doi.org/10.1371/journal.pone.0167117			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911921	Green Published, Green Submitted, gold			2022-12-27	WOS:000389520600022
J	Xu, X; Dechesne, A; Visser, RGF; Trindade, LM				Xu, Xuan; Dechesne, Annemarie; Visser, Richard G. F.; Trindade, Luisa M.			Expression of an (Engineered) 4,6-alpha-Glucanotransferase in Potato Results in Changes in Starch Characteristics	PLOS ONE			English	Article							BRANCHING ENZYME; BINDING DOMAIN; GRANULE SIZE; AMYLOSE; AMYLOPECTIN; GENE; PLANTS; GELATINIZATION; INHIBITION; REDUCTION	Starch structure strongly influences starch physicochemical properties, determining the end uses of starch in various applications. To produce starches with novel structure and exploit the mechanism of starch granule formation, an (engineered) 4, 6-alpha-glucanotransferase (GTFB) from Lactobacillus reuteri 121 was introduced into two potato genetic backgrounds: amylose-containing line Kardal and amylose-free mutant amf. The resulting starches showed severe changes in granule morphology regardless of genetic backgrounds. Modified starches from amf background exhibited a significant increase in granule size and starch phosphate content relative to the control, while starches from Kardal background displayed a higher digestibility, but did not show changes in granule size and phosphate content. Transcriptome analysis revealed the existence of a mechanism to restore the regular packing of double helices in starch granules, which possibly resulted in the removal of novel glucose chains potentially introduced by the (engineered) GTFB. This amendment mechanics would also explain the difficulties to detect alterations in starch fine structure in the transgenic lines.	[Xu, Xuan; Dechesne, Annemarie; Visser, Richard G. F.; Trindade, Luisa M.] Wageningen Univ & Res, Wageningen UR Plant Breeding, POB 386, NL-6700 AJ Wageningen, Netherlands; [Xu, Xuan] Huazhong Agr Univ, Natl Ctr Vegetable Improvement Cent China, Key Lab Hort Plant Biol, Minist Educ, Wuhan 430070, Peoples R China	Wageningen University & Research; Huazhong Agricultural University	Trindade, LM (corresponding author), Wageningen Univ & Res, Wageningen UR Plant Breeding, POB 386, NL-6700 AJ Wageningen, Netherlands.	luisa.trindade@wur.nl	Visser, Richard GF/B-3423-2012; Xu, Xuan/AAK-5677-2020; Trindade, Luisa M/F-8824-2010	Visser, Richard GF/0000-0002-0213-4016; Xu, Xuan/0000-0003-1410-0873; 				Av?rous L, 2014, STARCH POLYM GENETIC, P79; Bai YX, 2015, APPL ENVIRON MICROB, V81, P7223, DOI 10.1128/AEM.01860-15; Blauth SL, 2002, PLANT MOL BIOL, V48, P287, DOI 10.1023/A:1013335217744; Blennow A, 2002, TRENDS PLANT SCI, V7, P445, DOI 10.1016/S1360-1385(02)02332-4; Capriles VD, 2008, J FOOD SCI, V73, pH160, DOI 10.1111/j.1750-3841.2008.00869.x; Dobruchowska JM, 2012, GLYCOBIOLOGY, V22, P517, DOI 10.1093/glycob/cwr167; Edwards A, 1999, PLANT J, V17, P251, DOI 10.1046/j.1365-313X.1999.00371.x; Firouzabadi FN, 2007, TRANSGENIC RES, V16, P645, DOI 10.1007/s11248-006-9053-z; Fredriksson H, 1998, CARBOHYD POLYM, V35, P119, DOI 10.1016/S0144-8617(97)00247-6; HOVENKAMPHERMELINK JHM, 1988, POTATO RES, V31, P241, DOI 10.1007/BF02365532; Huang XF, 2014, PLANTA, V240, P409, DOI 10.1007/s00425-014-2095-1; Huang XF, 2013, PLANT BIOTECHNOL J, V11, P470, DOI 10.1111/pbi.12033; Jane J, 1999, CEREAL CHEM, V76, P629, DOI 10.1094/CCHEM.1999.76.5.629; JENKINS JPJ, 1993, STARCH-STARKE, V45, P417; Ji Q, 2004, PLANT BIOTECHNOL J, V2, P251, DOI 10.1111/j.1467-7652.2004.00069.x; Jobling SA, 2002, NAT BIOTECHNOL, V20, P295, DOI 10.1038/nbt0302-295; Katayama K, 2002, STARCH-STARKE, V54, P51, DOI 10.1002/1521-379X(200202)54:2&lt;51::AID-STAR51&gt;3.0.CO;2-6; Kaur B, 2012, FOOD HYDROCOLLOID, V26, P398, DOI 10.1016/j.foodhyd.2011.02.016; Kaur L, 2007, J FOOD ENG, V82, P383, DOI 10.1016/j.jfoodeng.2007.02.059; Kim HS, 2008, J CEREAL SCI, V48, P159, DOI 10.1016/j.jcs.2007.09.002; Kok-Jacon GA, 2005, PLANT BIOTECHNOL J, V3, P341, DOI 10.1111/j.1467-7652.2005.00128.x; Kortstee AJ, 1996, PLANT J, V10, P83, DOI 10.1046/j.1365-313X.1996.10010083.x; KUIPERS AGJ, 1994, PLANT CELL, V6, P43, DOI 10.1105/tpc.6.1.43; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leemhuis H, 2014, J AGR FOOD CHEM, V62, P12034, DOI 10.1021/jf503970a; Lindeboom N, 2004, STARCH-STARKE, V56, P89, DOI 10.1002/star.200300218; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorberth R, 1998, NAT BIOTECHNOL, V16, P473, DOI 10.1038/nbt0598-473; Moire L, 2003, J PLANT PHYSIOL, V160, P831, DOI 10.1078/0176-1617-01030; Naguleswaran S, 2011, CEREAL CHEM, V88, P87, DOI 10.1094/CCHEM-04-10-0062; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Safford R, 1998, CARBOHYD POLYM, V35, P155, DOI 10.1016/S0144-8617(97)00249-X; Satoh H, 2003, PLANT PHYSIOL, V133, P1111, DOI 10.1104/pp.103.021527; Snell KD, 2015, CURR OPIN BIOTECH, V32, P68, DOI 10.1016/j.copbio.2014.11.005; Streb S, 2008, PLANT CELL, V20, P3448, DOI 10.1105/tpc.108.063487; Tan I, 2014, STRUCTURE PROPERTY R, V1947; Tester RF, 2006, ANIM FEED SCI TECH, V130, P39, DOI 10.1016/j.anifeedsci.2006.01.016; Umemoto T, 2002, THEOR APPL GENET, V104, P1, DOI 10.1007/s001220200000; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vincken QJJP, 2003, PLANT MOL BIOL, V51, P789, DOI 10.1023/A:1022528705590; VISSER RGF, 1991, PLANT MOL BIOL, V17, P691, DOI 10.1007/BF00037054; Warren FJ, 2015, CARBOHYD POLYM, V117, P192, DOI 10.1016/j.carbpol.2014.09.043; Wu AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065768	43	1	2	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0166981	10.1371/journal.pone.0166981	http://dx.doi.org/10.1371/journal.pone.0166981			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911907	Green Published, Green Submitted, gold			2022-12-27	WOS:000389520600019
J	Eng, F; Haroth, S; Feussner, K; Meldau, D; Rekhter, D; Ischebeck, T; Brodhun, F; Feussner, I				Eng, Felipe; Haroth, Sven; Feussner, Kirstin; Meldau, Dorothea; Rekhter, Dmitrij; Ischebeck, Till; Brodhun, Florian; Feussner, Ivo			Optimized Jasmonic Acid Production by Lasiodiplodia theobromae Reveals Formation of Valuable Plant Secondary Metabolites	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; ALLENE OXIDE SYNTHASE; BOTRYODIPLODIA-THEOBROMAE; INDOLE-3-CARBOXYLIC ACID; GIBBERELLA-FUJIKUROI; FUSARIUM-OXYSPORUM; SALICYLIC-ACID; L-ISOLEUCINE; FERMENTATION; BIOSYNTHESIS	Jasmonic acid is a plant hormone that can be produced by the fungus Lasiodiplodia theobromae via submerged fermentation. From a biotechnological perspective jasmonic acid is a valuable feedstock as its derivatives serve as important ingredients in different cosmetic products and in the future it may be used for pharmaceutical applications. The objective of this work was to improve the production of jasmonic acid by L. theobromae strain 2334. We observed that jasmonic acid formation is dependent on the culture volume. Moreover, cultures grown in medium containing potassium nitrate as nitrogen source produced higher amounts of jasmonic acid than analogous cultures supplemented with ammonium nitrate. When cultivated under optimal conditions for jasmonic acid production, L. theobromae secreted several secondary metabolites known from plants into the medium. Among those we found 3-oxo-2-(pent-2-enyI)-cyclopentane-1-butanoic acid (OPC-4) and hydroxy-jasmonic acid derivatives, respectively, suggesting that fungal jasmonate metabolism may involve similar reaction steps as that of plants. To characterize fungal growth and jasmonic acid-formation, we established a mathematical model describing both processes. This model may form the basis of industrial upscaling attempts. Importantly, it showed that jasmonic acid-formation is not associated to fungal growth. Therefore, this finding suggests that jasmonic acid, despite its enormous amount being produced upon fungal development, serves merely as secondary metabolite.	[Eng, Felipe] Cuban Res Inst Sugar Cane Byprod, Via Blanca & Carretera Cent 804, Havana, Cuba; [Eng, Felipe; Haroth, Sven; Feussner, Kirstin; Meldau, Dorothea; Rekhter, Dmitrij; Ischebeck, Till; Brodhun, Florian; Feussner, Ivo] Georg August Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, Gottingen, Germany; [Feussner, Ivo] Georg August Univ Gottingen, Gottingen Ctr Mol Biosci GZMB, Dept Plant Biochem, Gottingen, Germany	University of Gottingen; University of Gottingen	Feussner, I (corresponding author), Georg August Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, Gottingen, Germany.; Feussner, I (corresponding author), Georg August Univ Gottingen, Gottingen Ctr Mol Biosci GZMB, Dept Plant Biochem, Gottingen, Germany.	ifeussn@uni-goettingen.de	Eng, Felipe FE/J-6087-2018; Ischebeck, Till/AAM-4327-2020; Feussner, Ivo/H-9320-2013	Eng, Felipe FE/0000-0002-1137-3721; Ischebeck, Till/0000-0003-0737-3822; Feussner, Ivo/0000-0002-9888-7003	Deutscher Akademischer Austauschdienst scholarship (DAAD) [50015559]; Deutsche Forschungsgemeinschaft (ZUK) [45/2010]; IRTG "PRoTECT" of the Gottingen Graduate School of Neuroscience and Molecular Biology (GGNB) [2172]	Deutscher Akademischer Austauschdienst scholarship (DAAD); Deutsche Forschungsgemeinschaft (ZUK); IRTG "PRoTECT" of the Gottingen Graduate School of Neuroscience and Molecular Biology (GGNB)	FE was supported through a Deutscher Akademischer Austauschdienst scholarship (DAAD, 50015559) and IF by the Deutsche Forschungsgemeinschaft (ZUK 45/2010). IF, SH and DR were supported by the IRTG 2172 "PRoTECT" of the Gottingen Graduate School of Neuroscience and Molecular Biology (GGNB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; FE was supported through a Deutscher Akademischer Austauschdienst scholarship (DAAD, 50015559) and IF by the Deutsche Forschungsgemeinschaft (ZUK 45/2010). IF, SH and DR were supported by the IRTG 2172 "PRoTECT" of the Gottingen Graduate School of Neuroscience and Molecular Biology (GGNB). We thank Pia Meyer and Pablo Tarazona for excellent assistance and Dr. Otto Miersch (IPB, Halle/Saale, Germany) for providing jasmonate standards as well as for fruitful discussions.	ALDRIDGE DC, 1971, J CHEM SOC C, P1623, DOI 10.1039/j39710001623; Andolfi A, 2016, CHEM BIODIVERS, V13, P395, DOI 10.1002/cbdv.201500104; Andolfi A, 2014, PHYTOCHEMISTRY, V103, P145, DOI 10.1016/j.phytochem.2014.03.016; Bao JY, 2014, RAPID COMMUN MASS SP, V28, P457, DOI 10.1002/rcm.6803; Biermann U, 2011, ANGEW CHEM INT EDIT, V50, P3854, DOI 10.1002/anie.201002767; Bottcher C, 2014, PLANT PHYSIOL, V165, P841, DOI 10.1104/pp.114.235630; Brodhun F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064919; Brodhun F, 2011, FEBS J, V278, P1047, DOI 10.1111/j.1742-4658.2011.08027.x; Busch Rainer, 2006, Biotechnology Journal, V1, P770, DOI 10.1002/biot.200600057; Castillo G, 2014, WORLD J MICROB BIOT, V30, P1937, DOI 10.1007/s11274-014-1612-5; Christensen SA, 2011, FUNGAL GENET BIOL, V48, P4, DOI 10.1016/j.fgb.2010.05.005; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; CROSS BE, 1970, J CHEM SOC C, P1839, DOI 10.1039/j39700001839; DAVIS PJ, 1976, J BACTERIOL, V126, P544, DOI 10.1128/JB.126.1.544-546.1976; DEEG R, 1980, J CLIN CHEM CLIN BIO, V18, P49; DEMOLE E, 1962, HELV CHIM ACTA, V45, P675, DOI 10.1002/hlca.19620450233; Dhandhukia PC, 2008, J APPL MICROBIOL, V105, P636, DOI 10.1111/j.1365-2672.2008.03803.x; Dhandhukia PC, 2007, AFR J BIOTECHNOL, V6, P707; Durgbanshi A, 2005, J AGR FOOD CHEM, V53, P8437, DOI 10.1021/jf050884b; Eng F, 1998, PROCESS BIOCHEM, V33, P715, DOI 10.1016/S0032-9592(98)00035-1; GHASEMI PA, 2014, ARCH PHARM, V347, P229, DOI DOI 10.1002/ARDP.201300287; Heitz T, 2012, J BIOL CHEM, V287, P6296, DOI 10.1074/jbc.M111.316364; Hoffmann I, 2013, J LIPID RES, V54, P3471, DOI 10.1194/jlr.M044347; Iven T, 2012, MOL PLANT, V5, P1389, DOI 10.1093/mp/sss044; Jerneren F, 2012, LIPIDS, V47, P65, DOI 10.1007/s11745-011-3622-5; Kitaoka N, 2014, PHYTOCHEMISTRY, V99, P6, DOI 10.1016/j.phytochem.2013.12.019; Kitaoka N, 2011, PLANT CELL PHYSIOL, V52, P1757, DOI 10.1093/pcp/pcr110; Koo AJK, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00019; Koo AJK, 2011, P NATL ACAD SCI USA, V108, P9298, DOI 10.1073/pnas.1103542108; Lin L, 2011, CHEM REV, V111, P2734, DOI 10.1021/cr100061j; Luedeking R, 2000, BIOTECHNOL BIOENG, V67, P636, DOI 10.1002/(SICI)1097-0290(20000320)67:6<636::AID-BIT3>3.0.CO;2-U; Mano Y, 2012, J EXP BOT, V63, P2853, DOI 10.1093/jxb/ers091; MARQUES AM, 1986, APPL ENVIRON MICROB, V52, P1221; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; MIERSCH O, 1991, PHYTOCHEMISTRY, V30, P4049, DOI 10.1016/0031-9422(91)83464-V; Miersch O, 1999, PHYTOCHEMISTRY, V50, P1147, DOI 10.1016/S0031-9422(98)00698-0; Miersch O, 1999, PHYTOCHEMISTRY, V50, P517, DOI 10.1016/S0031-9422(98)00596-2; MIERSCH O, 1987, PHYTOCHEMISTRY, V26, P1037, DOI 10.1016/S0031-9422(00)82345-6; MIERSCH O, 1992, PHYTOCHEMISTRY, V31, P3835, DOI 10.1016/S0031-9422(00)97537-X; Patkar RN, 2015, NAT CHEM BIOL, V11, P733, DOI [10.1038/nchembio.1885, 10.1038/NCHEMBIO.1885]; Poudel AN, 2016, BIOCH BIOPHYS ACTA; Qian CD, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0297-0; Raviv Z, 2013, CANCER CHEMOTH PHARM, V71, P275, DOI 10.1007/s00280-012-2039-z; Schaller A, 2009, PHYTOCHEMISTRY, V70, P1532, DOI 10.1016/j.phytochem.2009.07.032; Scognamiglio J, 2012, FOOD CHEM TOXICOL, V50, pS572, DOI 10.1016/j.fct.2012.03.035; Segarra G, 2006, PHYTOCHEMISTRY, V67, P395, DOI 10.1016/j.phytochem.2005.11.017; Sembdner G., 1993, NAT PROD LETT, V2, P293, DOI [10.1080/10575639308043825, DOI 10.1080/10575639308043825]; Sirrenberg A, 2007, PHYSIOL PLANTARUM, V131, P581, DOI 10.1111/j.1399-3054.2007.00983.x; Song MC, 2014, NAT PROD REP, V31, P1497, DOI 10.1039/c4np00057a; Tsukada K, 2010, PHYTOCHEMISTRY, V71, P2019, DOI 10.1016/j.phytochem.2010.09.013; UEDA J, 1991, Bulletin of the University of Osaka Prefecture Series B Agriculture and Life Sciences, V43, P103; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; WEISS RM, 1980, BIOTECHNOL BIOENG, V22, P859, DOI 10.1002/bit.260220410; Widemann E, 2015, PHYTOCHEMISTRY, V117, P388, DOI 10.1016/j.phytochem.2015.06.027; Widemann E, 2015, METABOLOMICS, V11, P991, DOI 10.1007/s11306-014-0754-7; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108	56	18	18	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167627	10.1371/journal.pone.0167627	http://dx.doi.org/10.1371/journal.pone.0167627			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907207	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700213
J	Lee, YB; Lee, SE; Jun, JE; Jee, JH; Bae, JC; Jin, SM; Kim, JH				Lee, You-Bin; Lee, Seung-Eun; Jun, Ji Eun; Jee, Jae Hwan; Bae, Ji Cheol; Jin, Sang-Man; Kim, Jae Hyeon			Change in Serum Bilirubin Level as a Predictor of Incident Metabolic Syndrome	PLOS ONE			English	Article							HEME OXYGENASE-1; HEART-DISEASE; RISK; MEN; ACTIVATION; OUTCOMES; SYSTEM; CELLS	Aim Serum bilirubin level was negatively associated with the prevalence of metabolic syndrome (MetS) in previous cross-sectional studies. However, bilirubin variance preceding the development of MetS has yet to be investigated. We aimed to determine the effect of change in bilirubin concentration on the risk of incident MetS in healthy Korean adults. Methods We conducted a retrospective longitudinal study of subjects who had undergone at least four yearly health check-ups between 2006 and 2012. Of 24,185 total individuals who received annual check-ups, 11,613 non-MetS participants with a baseline bilirubin level not exceeding 34.2 mu mol/l were enrolled. We evaluated the association between percent change in bilirubin and risk of incident MetS. Results During 55,407 person-years of follow-up, 2,439 cases of incident MetS developed (21.0%). Baseline serum bilirubin level clearly showed no association with the development of MetS in men but an independent significant inverse association in women which attenuated (hence may be mediated) by elevated homeostatic model assessment index 2 for insulin resistance (HOMA2-IR). However, increased risk for incident MetS was observed in higher percent change in bilirubin quartiles, with hazard ratios of 2.415 (95% CI 2.094-2.785) in men and 2.156 (95% CI 1.738-2.675) in women in the fourth quartile, compared to the lowest quartile, after adjusting for age, smoking status, medication history, alanine aminotransferase, uric acid, estimated glomerular filtration rate, fasting glucose, baseline diabetes mellitus prevalence, systolic blood pressure, waist circumference, and body mass index. The hazard ratios per one standard deviation increase in percent change in bilirubin as a continuous variable were 1.277 (95% CI 1.229-1.326) in men and 1.366 (95% CI 1.288-1.447) in women. Conclusions Increases in serum bilirubin concentration were positively associated with a higher risk of incident MetS. Serum bilirubin increment might be a sensitive marker for the development of MetS.	[Lee, You-Bin; Lee, Seung-Eun; Jun, Ji Eun; Jin, Sang-Man; Kim, Jae Hyeon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Med, Seoul, South Korea; [Jee, Jae Hwan] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Hlth Promot Ctr, Seoul, South Korea; [Bae, Ji Cheol] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Div Endocrinol & Metab,Dept Med, Changwon Si, Gyeongsangnam D, South Korea; [Kim, Jae Hyeon] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Clin Res Design & Evaluat, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, JH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Med, Seoul, South Korea.; Kim, JH (corresponding author), Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Clin Res Design & Evaluat, Seoul, South Korea.	jaehyeon@skku.edu	Jin, Sang-Man/AFO-5933-2022	Lee, You-Bin/0000-0003-4058-1738				Abraham NG, 2005, FREE RADICAL BIO MED, V39, P1, DOI 10.1016/j.freeradbiomed.2005.03.010; Bao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012371; Barbagallo I, 2014, CURR PHARM DESIGN, V20, P4970; BREIMER LH, 1995, CLIN CHEM, V41, P1504; Chung JO, 2015, INTERNAL MED, V54, P141, DOI 10.2169/internalmedicine.54.2858; Giral P, 2010, ATHEROSCLEROSIS, V210, P607, DOI 10.1016/j.atherosclerosis.2009.12.026; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Jonas JC, 2003, DIABETOLOGIA, V46, P1234, DOI 10.1007/s00125-003-1174-9; Kapitulnik J, 2004, MOL PHARMACOL, V66, P773, DOI 10.1124/mol.104.002832; Kappas A, 2004, PEDIATRICS, V113, P119, DOI 10.1542/peds.113.1.119; Kawamura K, 2005, ARTERIOSCL THROM VAS, V25, P155, DOI 10.1161/01.ATV.0000148405.18071.6a; Kunutsor SK, 2015, ARTERIOSCL THROM VAS, V35, P716, DOI 10.1161/ATVBAHA.114.304929; Laybutt DR, 2003, J BIOL CHEM, V278, P2997, DOI 10.1074/jbc.M210581200; Lee MJ, 2014, DIABETES METAB, V40, P305, DOI 10.1016/j.diabet.2014.04.006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Lin JP, 2006, CIRCULATION, V114, P1476, DOI 10.1161/CIRCULATIONAHA.106.633206; NEUZIL J, 1994, J BIOL CHEM, V269, P16712; Oda E, 2013, ACTA DIABETOL, V50, P417, DOI 10.1007/s00592-012-0447-5; Onat A, 2015, EXP CLIN ENDOCR DIAB, V123, P11, DOI 10.1055/s-0034-1385922; Onat A, 2016, J INVEST MED, V64, P392, DOI 10.1136/jim-2015-000003; Onat A, 2013, INT J CARDIOL, V168, P4500, DOI 10.1016/j.ijcard.2013.06.119; Onat A, 2012, OBESITY, V20, P842, DOI 10.1038/oby.2011.136; Ota T, 2013, DIABETES METAB J, V37, P165, DOI 10.4093/dmj.2013.37.3.165; Rutter MK, 2004, CIRCULATION, V110, P380, DOI 10.1161/01.CIR.0000136581.59584.0E; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Song FF, 2007, EUR J NUTR, V46, P61, DOI 10.1007/s00394-006-0632-9; Vitek L, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00055; Won KC, 2006, J KOREAN MED SCI, V21, P418, DOI 10.3346/jkms.2006.21.3.418; WU TW, 1994, LIFE SCI, V54, pPL477, DOI 10.1016/0024-3205(94)90140-6	30	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168253	10.1371/journal.pone.0168253	http://dx.doi.org/10.1371/journal.pone.0168253			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936224	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100284
J	Li, N; Yan, LJL; Niu, WY; Yao, C; Feng, XX; Zhang, JX; Shi, JP; Zhang, YH; Zhang, RJ; Hao, ZX; Chu, HL; Zhang, J; Li, X; Pan, JH; Li, ZF; Sun, JX; Zhou, B; Zhao, Y; Yu, Y; Engelgau, M; Labarthe, D; Ma, JX; MacMahon, S; Elliott, P; Wu, YF; Neal, B				Li, Nicole; Yan, Lijing L.; Niu, Wenyi; Yao, Chen; Feng, Xiangxian; Zhang, Jianxin; Shi, Jingpu; Zhang, Yuhong; Zhang, Ruijuan; Hao, Zhixin; Chu, Hongling; Zhang, Jing; Li, Xian; Pan, Jianhong; Li, Zhifang; Sun, Jixin; Zhou, Bo; Zhao, Yi; Yu, Yan; Engelgau, Michael; Labarthe, Darwin; Ma, Jixiang; MacMahon, Stephen; Elliott, Paul; Wu, Yangfeng; Neal, Bruce			The Effects of a Community-Based Sodium Reduction Program in Rural China - A Cluster-Randomized Trial	PLOS ONE			English	Article							BLOOD-PRESSURE; SALT SUBSTITUTE; UNITED-KINGDOM; ENRICHED SALT; MINERAL SALT; POTASSIUM; MAGNESIUM; POPULATION; DISEASE; STATES	Background Average sodium intake and stroke mortality in northern China are both among the highest in the world. An effective, low-cost strategy to reduce sodium intake in this population is urgently needed. Objective We sought to determine the effects of a community-based sodium reduction program on salt consumption in rural northern China. Design This study was a cluster-randomized trial done over 18 months in 120 townships (one village from each township) from five provinces. Sixty control villages were compared to 60 intervention villages that were given access to a reduced-sodium, added-potassium salt substitute in conjunction with a community-based health education program focusing on sodium reduction. The primary outcome was the difference in 24-hour urinary sodium excretion between randomized groups. Results Among 1,903 people with valid 24-hour urine collections, mean urinary sodium excretion in intervention compared with control villages was reduced by 5.5% (-14mmol/day, 95% confidence interval -26 to -1; p = 0.03), potassium excretion was increased by 16% (+7mmol/day, +4 to +10; p<0.001), and sodium to potassium ratio declined by 15% (-0.9, -1.2 to -0.5; p<0.001). Mean blood pressure differences were -1.1 mm Hg systolic (-3.3 to +1.1; p = 0.33) and -0.7 mm Hg diastolic (-2.2 to +0.8, p = 0.35) and the difference in the proportion with hypertension was -1.3% (-5.1 to 2.5, p = 0.56). Conclusion There were clear differences in population sodium and potassium intake between villages that were most likely a consequence of increased use of salt substitute. The absence of effects on blood pressure reflects the moderate changes in sodium and potassium intake achieved.	[Li, Nicole; Yan, Lijing L.; Hao, Zhixin; Chu, Hongling; Zhang, Jing; Li, Xian; Wu, Yangfeng] Peking Univ, Hlth Sci Ctr, George Inst Global Hlth, Beijing, Peoples R China; [Li, Nicole; MacMahon, Stephen; Neal, Bruce] George Inst Global Hlth, Sydney, NSW, Australia; [Li, Nicole; MacMahon, Stephen; Neal, Bruce] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Yan, Lijing L.; Labarthe, Darwin] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Niu, Wenyi; Chu, Hongling; Wu, Yangfeng] Peking Univ, Sch Publ Hlth, Hlth Sci Ctr, Beijing, Peoples R China; [Yao, Chen; Pan, Jianhong; Wu, Yangfeng] Peking Univ, Clin Res Inst, Beijing, Peoples R China; [Feng, Xiangxian; Li, Zhifang] Changzhi Med Coll, Changzhi, Shanxi, Peoples R China; [Zhang, Jianxin; Sun, Jixin] Hebei Prov Ctr Dis Prevent & Control, Shijiazhuang, Hebei, Peoples R China; [Shi, Jingpu; Zhou, Bo] China Med Univ, Hosp 1, Shenyang, Liaoning, Peoples R China; [Zhang, Yuhong; Zhao, Yi] Ningxia Med Univ, Ningxia, Peoples R China; [Zhang, Ruijuan; Yu, Yan] Xi An Jiao Tong Univ, Xian, Shaanxi, Peoples R China; [Engelgau, Michael] US Ctr Dis Control & Prevent, Beijing, Peoples R China; [Ma, Jixiang] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Elliott, Paul; Neal, Bruce] Imperial Coll London, London, England; [Neal, Bruce] Royal Prince Alfred Hosp, Sydney, NSW, Australia	Peking University; George Institute for Global Health; University of Sydney; University of Sydney; Northwestern University; Feinberg School of Medicine; Peking University; Peking University; Changzhi Medical College; China Medical University; Ningxia Medical University; Xi'an Jiaotong University; Chinese Center for Disease Control & Prevention; Imperial College London; University of Sydney	Yan, LJL; Wu, YF (corresponding author), Peking Univ, Hlth Sci Ctr, George Inst Global Hlth, Beijing, Peoples R China.; Yan, LJL (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA.; Wu, YF (corresponding author), Peking Univ, Sch Publ Hlth, Hlth Sci Ctr, Beijing, Peoples R China.; Wu, YF (corresponding author), Peking Univ, Clin Res Inst, Beijing, Peoples R China.	lyan@georgeinstitute.org.cn; ywu@georgeinstitute.org.cn	Zhang, Yuhong/I-5056-2012	Zhang, Yuhong/0000-0002-7110-8401; Neal, Bruce/0000-0002-0490-7465; Li, Xian/0000-0001-5445-4022; Elliott, Paul/0000-0002-7511-5684; MacMahon, Stephen/0000-0003-2064-7699	National Center for Chronic Disease Prevention and Health Promotion (CDC) [HHSN268200900027C]; National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services; United Health Group Chronic Disease Initiative; Australian Research Council Future Fellowship; National Health and Medical Research Council Senior Research Fellowship; Australian National Health and Medical Research Council Overseas Fellowship; MRC-PHE Centre for Environment and Health; Imperial College London; National Institute for Health Research (NIHR) Biomedical Research Centre at Imperial College Healthcare NHS Trust; MRC [MR/L01341X/1] Funding Source: UKRI; Medical Research Council [MR/L01341X/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10136] Funding Source: researchfish	National Center for Chronic Disease Prevention and Health Promotion (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); United Health Group Chronic Disease Initiative; Australian Research Council Future Fellowship(Australian Research Council); National Health and Medical Research Council Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian National Health and Medical Research Council Overseas Fellowship(National Health and Medical Research Council (NHMRC) of Australia); MRC-PHE Centre for Environment and Health(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Imperial College London(General Electric); National Institute for Health Research (NIHR) Biomedical Research Centre at Imperial College Healthcare NHS Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This project has been funded in part with Federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, and National Center for Chronic Disease Prevention and Health Promotion (CDC), under Contract No. HHSN268200900027C. Additional support has been received from the United Health Group Chronic Disease Initiative. Bruce Neal is supported by an Australian Research Council Future Fellowship and National Health and Medical Research Council Senior Research Fellowship and Nicole Li by an Australian National Health and Medical Research Council Overseas Fellowship. Paul Elliott is supported through the MRC-PHE Centre for Environment and Health, Imperial College London, and by the National Institute for Health Research (NIHR) Biomedical Research Centre at Imperial College Healthcare NHS Trust and Imperial College London; he is an NIHR Senior Investigator. The views expressed are those of the authors and not necessarily those of any sponsors.	Anderson CAM, 2010, J AM DIET ASSOC, V110, P736, DOI 10.1016/j.jada.2010.02.007; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Chang HY, 2006, AM J CLIN NUTR, V83, P1289, DOI 10.1093/ajcn/83.6.1289; Charlton KE, 2008, PUBLIC HEALTH NUTR, V11, P1397, DOI 10.1017/S136898000800342X; China Ministry of Health, 2013, CHIN ANN HLTH STAT Y; ELLIOTT P, 1988, BRIT MED J, V297, P319; GELEIJNSE JM, 1994, BRIT MED J, V309, P436, DOI 10.1136/bmj.309.6952.436; Gilleran G, 1996, J HUM HYPERTENS, V10, P517; He F. J., 2013, BMJ, V346; KARPPANEN H, 1984, J CARDIOVASC PHARM, V6, pS236, DOI 10.1097/00005344-198400061-00037; Kawasaki T, 1998, HYPERTENS RES-CLIN E, V21, P235, DOI 10.1291/hypres.21.235; Li N, 2007, J HYPERTENS, V25, P2011, DOI 10.1097/HJH.0b013e3282b9714b; Li N, 2013, AM HEART J, V166, P815, DOI 10.1016/j.ahj.2013.07.009; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MERVAALA EMA, 1994, BRIT J PHARMACOL, V111, P1189, DOI 10.1111/j.1476-5381.1994.tb14871.x; Mu J, 2009, AM J HYPERTENS, V22, P943, DOI 10.1038/ajh.2009.136; Neutel J, 1996, AM J HYPERTENS, V9, p94A; ROSE G, 1986, J HYPERTENS, V4, P781; Sarkkinen ES, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-88; Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574; Turnbull F, 2003, LANCET, V362, P1527; Vandevijvere S, 2010, EUR J CLIN NUTR, V64, P1260, DOI 10.1038/ejcn.2010.148; Venezia A, 2010, EUR J CLIN NUTR, V64, P518, DOI 10.1038/ejcn.2010.22; Zhou BF, 2003, J HUM HYPERTENS, V17, P623, DOI 10.1038/sj.jhh.1001605; Zhou X, 2009, AM J HYPERTENS, V22, P934, DOI 10.1038/ajh.2009.135	26	43	43	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166620	10.1371/journal.pone.0166620	http://dx.doi.org/10.1371/journal.pone.0166620			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935977	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100037
J	Saad, SM; Randhawa, G; Pang, D				Saad, Sadiq M.; Randhawa, Gurch; Pang, Dong			Absence of Association between Behavior Problems in Childhood and Hypertension in Midlife	PLOS ONE			English	Article							BLOOD-PRESSURE; BIRTH-WEIGHT; TIME; RISK	Background It is known that behavior in childhood is associated with certain physical and mental health problems in midlife. However, there is limited evidence on the role of childhood behavior problems in the development of hypertension in adulthood. The present study aimed to examine whether behavior problems in childhood influenced the risk of hypertension in midlife in the United Kingdom 1958 birth cohort. Methods The 1958 British birth cohort comprised 17,638 individuals born in the first week of March 1958 in the United Kingdom. Behavior problems were assessed at 7, 11, and 16 years of age by parents and teachers. At age 45, blood pressure was measured and hypertension was recorded if blood pressure was >= 140/90 mm Hg or if the participants were informed by their health professionals that they had high blood pressure. Behavioral information was reported according to the Rutter Children's Behaviour Questionnaire (RCBQ) and the Bristol Social Adjustment Guide (BSAG). Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to examine behavior problems in childhood in relation to hypertension at 45 years of age according to logistic regression analysis, with adjustment for sex, social class in childhood and adulthood, childhood cognition, birth weight, gestational age at birth, body mass index (BMI), smoking, alcohol consumption, and physical activity. Results Behavior problems reported by parents at 7, 11, and 16 years were not associated with hypertension in midlife (OR, 0.93; 95% CI, 0.81, 1.07; OR, 0.95; 95% CI, 0.81, 1.11; OR, 0.98; 95% CI, 0.85, 1.12, respectively). Similarly, teacher-reported behavior problems at 7, 11, and 16 years were not associated with hypertension in midlife (OR, 0.92; 95% CI, 0.72, 1.18; OR, 0.92; 95% CI, 0.84, 1.02; OR, 1.03; 95% CI, 0.92, 1.15, respectively). Further separate analyses showed similar results for males and females. Conclusion There is no association between behavior problems in childhood and hypertension in midlife.	[Saad, Sadiq M.; Randhawa, Gurch; Pang, Dong] Univ Bedfordshire, Inst Hlth Res, Luton, Beds, England	University of Bedfordshire	Pang, D (corresponding author), Univ Bedfordshire, Inst Hlth Res, Luton, Beds, England.	dong.pang@beds.ac.uk	QQ, Simon/D-3888-2014	randhawa, gurch/0000-0002-2289-5859				Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Atherton K, 2008, J EPIDEMIOL COMMUN H, V62, P216, DOI 10.1136/jech.2006.058966; Babor TF., 2001, AUDIT ALCOHOL USE DI; Barker D J, 1997, Rev Reprod, V2, P105, DOI 10.1530/ror.0.0020105; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Chalmers J, 1999, J HYPERTENS, V17, P151; Colman I, 2009, BMJ-BRIT MED J, V338, DOI [10.1136/bmj.a2981, 10.1136/bmj.b777]; El Assaad MA, 2003, BLOOD PRESS MONIT, V8, P127, DOI 10.1097/00126097-200306000-00006; Franklin SS, 2001, HYPERTENSION, V37, P869, DOI 10.1161/01.HYP.37.3.869; FRIEDMAN M, 1959, JAMA-J AM MED ASSOC, V169, P1286, DOI 10.1001/jama.1959.03000290012005; Jokela M, 2009, J CHILD PSYCHOL PSYC, V50, P1541, DOI 10.1111/j.1469-7610.2009.02122.x; Jokela M, 2009, J AM ACAD CHILD PSY, V48, P19, DOI 10.1097/CHI.0b013e31818b1c76; Kintscher U, 2013, EUROINTERVENTION, V9, pR12, DOI 10.4244/EIJV9SRA3; Klein John M., 2009, Psico-USF, V14, P157; Moore VM, 1999, J HYPERTENS, V17, P883, DOI 10.1097/00004872-199917070-00003; Mu M, 2012, ARCH CARDIOVASC DIS, V105, P99, DOI 10.1016/j.acvd.2011.10.006; OPCS [Office of Population Censuses and Surveys], 1991, STAND OCC CLASS; Pang D, 2010, RHEUMATOLOGY, V49, P1882, DOI 10.1093/rheumatology/keq052; PICKERING GW, 1952, BRIT MED BULL, V8, P305, DOI 10.1093/oxfordjournals.bmb.a074193; Rosenman RH, 1966, PREVENTION ISCHEMIC; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; RUTTER M, 1967, J CHILD PSYCHOL PSYC, V8, P1, DOI 10.1111/j.1469-7610.1967.tb02175.x; Rutter M., 1970, ED HLTH BEHAV; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sourander A, 2007, J AM ACAD CHILD PSY, V46, P1148, DOI 10.1097/chi.0b013e31809861e9; Starr JM, 2004, J HYPERTENS, V22, P893, DOI 10.1097/00004872-200405000-00009; Stata C, 2013, STAT REL 13 DAT AN S; Stott D. H., 1987, SOCIAL ADJUSTMENT CH; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; VEERMAN DP, 1994, HYPERTENSION, V24, P120, DOI 10.1161/01.HYP.24.1.120; von Stumm S, 2011, J CHILD PSYCHOL PSYC, V52, P992, DOI 10.1111/j.1469-7610.2011.02373.x; World Health Organization, 2000, WHO TECH REP SER, V894, p[i, 1]	33	1	1	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167831	10.1371/journal.pone.0167831	http://dx.doi.org/10.1371/journal.pone.0167831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936147	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100211
J	Shabnam, N; Sharmila, P; Kim, H; Pardha-Saradhi, P				Shabnam, Nisha; Sharmila, P.; Kim, Hyunook; Pardha-Saradhi, P.			Light Mediated Generation of Silver Nanoparticles by Spinach Thylakoids/Chloroplasts	PLOS ONE			English	Article							GREEN SYNTHESIS; LEAVES; FATE	The unique potential of chloroplasts/thylakoids to harness light energy to transport electrons from H2O to various entities was exploited for reduction of Ag+ to generate nanoparticles (NPs). Spinach thylakoids/chloroplasts turned AgNO3 solutions brown in light, but not in dark. Besides showing Ag-NPs specific surface plasmon resonance band, these brown solutions showed presence of 5-30 nm crystalline NPs composed of Ag. Powder X-ray diffraction (PXRD) analysis revealed that Ag-NPs were biphasic composed of face-centered cubic Ag-0 and cubic Ag2O. X-ray photoelectron spectroscopy (XPS) data further corroborated the presence of Ag2O in Ag-NPs. Limited formation of Ag-NPs in dark and increased generation of Ag-0/Ag2O-NPs with increase in light intensity (photon flux density) by thylakoids/chloroplasts, established the role of light-harvesting photosynthetic machinery in generation of Ag-0/Ag2O-NPs. Potential of thylakoids/chloroplasts to generate Ag-NPs from Ag+ on exposure to red and blue wavelength regions of visible light of electromagnetic spectrum, further confirmed the involvement of photosynthetic electron transport in reduction of Ag+ and generation of Ag-NPs. While light energy mediated photosynthetic electron transport donates energized electrons extracted from H2O to Ag+ to form Ag-0-NPs, O-2 released as a by-product during photolysis of H2O oxidizes Ag-0 to form Ag2O-NPs. Our findings furnish a novel, simple, economic and green method that can be exploited for commercial production of Ag-0/Ag2O-NPs.	[Shabnam, Nisha; Pardha-Saradhi, P.] Univ Delhi, Dept Environm Studies, Delhi, India; [Sharmila, P.] Indian Inst Technol Delhi, Dept Chem, New Delhi, India; [Kim, Hyunook] Univ Seoul, Dept Energy & Environm Syst Engn, Seoul, South Korea	University of Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; University of Seoul	Pardha-Saradhi, P (corresponding author), Univ Delhi, Dept Environm Studies, Delhi, India.; Kim, H (corresponding author), Univ Seoul, Dept Energy & Environm Syst Engn, Seoul, South Korea.	h_kim@uos.ac.kr; ppsaradhi@gmail.com	Kim, Hyunook/C-9316-2012; Shabnam, Nisha/J-7470-2019	Kim, Hyunook/0000-0003-1256-480X; Shabnam, Nisha/0000-0002-1855-8497	Department of Biotechnology, Ministry of Science and Technology [BT/Bio-CARe/02/604/2011-12]; University of Delhi (IN) [RC/2015/9677]; Korea Environmental Industry and Technology Institute [2015001790002]; University Grants Commission [3625]	Department of Biotechnology, Ministry of Science and Technology; University of Delhi (IN); Korea Environmental Industry and Technology Institute; University Grants Commission(University Grants Commission, India)	Support was provided by: the Department of Biotechnology, Ministry of Science and Technology (Award Number: BT/Bio-CARe/02/604/2011-12, Recipient: P.Sharmila); University of Delhi (IN) (Award Number: RC/2015/9677, Recipient: P.Pardha-Saradhi, Ph.D.); Korea Environmental Industry and Technology Institute (Award Number: 2015001790002, Recipient: Hyunook Kim); and University Grants Commission (Award Number: 3625(NET-DEC.2012), Recipient: Nisha Shabnam). The funding received during this specific study had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	ATAL N, 1991, PLANT CELL PHYSIOL, V32, P943, DOI 10.1093/oxfordjournals.pcp.a078181; Beattie IR, 2011, METALLOMICS, V3, P628, DOI 10.1039/c1mt00044f; Dahoumane SA, 2012, J NANOPART RES, V14, P17; Duncan DB, 1955, BIOMETRICS, V39, P205; Li C, 2012, INT J NANOMED, V7, P5995, DOI 10.2147/IJN.S38043; Lowry GV, 2012, ENVIRON SCI TECHNOL, V46, P7027, DOI 10.1021/es204608d; Merzlyak MN, 2009, PHOTOSYNTH RES, V102, P31, DOI 10.1007/s11120-009-9481-8; Mohan S, 2014, CARBOHYD POLYM, V106, P469, DOI 10.1016/j.carbpol.2014.01.008; Pardha-Saradhi P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106715; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Sarkar D, 2013, ACS APPL MATER INTER, V5, P331, DOI 10.1021/am302136y; Shabnam N, 2016, FUNCT PLANT BIOL, V43, P346, DOI 10.1071/FP15293; Shabnam N, 2015, PHOTOSYNTH RES, V125, P305, DOI 10.1007/s11120-014-0051-3; Shabnam N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085242; Shabnam N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071123; Sharma VK, 2014, ADV COLLOID INTERFAC, V204, P15, DOI 10.1016/j.cis.2013.12.002; Sharma VK, 2009, ADV COLLOID INTERFAC, V145, P83, DOI 10.1016/j.cis.2008.09.002; Sicard C, 2010, J MATER CHEM, V20, P9342, DOI 10.1039/c0jm01735c; Song JY, 2009, BIOPROC BIOSYST ENG, V32, P79, DOI 10.1007/s00449-008-0224-6; Terfa MT, 2013, PHYSIOL PLANTARUM, V148, P146, DOI 10.1111/j.1399-3054.2012.01698.x; Thanh NTK, 2014, CHEM REV, V114, P7610, DOI 10.1021/cr400544s; Yamal G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061750	22	13	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167937	10.1371/journal.pone.0167937	http://dx.doi.org/10.1371/journal.pone.0167937			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936248	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100234
J	Wang, LS; Lee, CT; Su, WL; Huang, SC; Wang, SC				Wang, Lung-Shuo; Lee, Chun-Ting; Su, Wei-Lieh; Huang, Shih-Che; Wang, Shu-Chi			Delonix regia Leaf Extract (DRLE): A Potential Therapeutic Agent for Cardioprotection	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE SYNTHASE; DOWN-REGULATES ENOS; ANTIINFLAMMATORY ACTIVITY; PHENOLIC-COMPOUNDS; HEART-FAILURE; FLAVONOIDS; HYPERTROPHY; RAT; ANTIOXIDANTS	Delonix regia (Boj. Ex. Hook) is a flowering plant in the pea family found in tropical areas and its leaves are used informally to treat diseases in folk medicine. However, the cardioprotective effects in this plant are still unclear. In this study, we found that the Delonix regia leaf extract (DRLE) (400 mg/kg/d) can reduce the mortality rate in an isoproterenol (ISO)-induced heart injury and hypertrophy mouse model. Decreased serum levels of creatine phosphokinase, LDH, GOT, TNF-alpha and increased nitric oxide levels were found in DRLE-treated ISO-injured mice. In the in vitro study, the porcine coronary artery exhibited vasodilation effect induced by DRLE in a dose-dependent manner. In the DRLE toxic test, overdose of DRLE showed the high safety in normal mice and may have the ability to remove the metabolic wastes in blood. In conclusion, we demonstrated for the first time that DRLE has the cardioprotective effects by activating the vasodilation through NO pathway and preventing the myocyte injury via inhibition of TNF-alpha pathway. We suggest that DRLE may act as a promising novel herbal medicine for cardioprotection.	[Wang, Lung-Shuo] Tainan Sin Lau Hosp, Dept Chinese Med, Tainan, Taiwan; [Lee, Chun-Ting] Kaohsiung Chang Gung Mem Hosp, Dept Chinese Med, Kaohsiung, Taiwan; [Su, Wei-Lieh] Kaohsiung Med Univ, Dept Occupat Therapy, Kaohsiung, Taiwan; [Huang, Shih-Che; Wang, Shu-Chi] I Shou Univ, Sch Med Int Students, Kaohsiung, Taiwan; [Huang, Shih-Che] E DA Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Wang, Shu-Chi] I Shou Univ, Sch Chinese Med Postbaccalaureate, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Kaohsiung Medical University; I Shou University; E-Da Hospital; I Shou University	Wang, SC (corresponding author), I Shou Univ, Sch Med Int Students, Kaohsiung, Taiwan.; Wang, SC (corresponding author), I Shou Univ, Sch Chinese Med Postbaccalaureate, Kaohsiung, Taiwan.	wansuchi@isu.edu.tw			Intramural Industry-University Collaboration Projects in I-Shou university; E-Da hospital, Kaohsiung, Taiwan [ISU-103-INT-05E]	Intramural Industry-University Collaboration Projects in I-Shou university; E-Da hospital, Kaohsiung, Taiwan	This study was sponsored by the Intramural Industry-University Collaboration Projects in I-Shou university and E-Da hospital, Kaohsiung, Taiwan (ISU-103-INT-05E). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnoletti L, 1999, CIRCULATION, V100, P1983, DOI 10.1161/01.CIR.100.19.1983; Ahmed J, 2011, PHYTOPHARMACOL, V5, P118; Alves MJ, 2013, J APPL MICROBIOL, V115, P346, DOI 10.1111/jam.12196; Anderson HDI, 2004, J BIOL CHEM, V279, P963, DOI 10.1074/jbc.M309552200; Arul V., 1999, Journal of Pharmacy and Pharmacology, V51, P252; Azab SS, 2013, MED CHEM RES, V22, P4269, DOI 10.1007/s00044-012-0420-4; Barros L, 2009, FOOD CHEM TOXICOL, V47, P1076, DOI 10.1016/j.fct.2009.01.039; Bi FangJie, 2012, African Journal of Biotechnology, V11, P9270; BOLUYT MO, 1995, AM J PHYSIOL-HEART C, V269, pH638; Bouic P J, 1999, Altern Med Rev, V4, P170; Bouic PJD, 2002, DRUG DISCOV TODAY, V7, P775, DOI 10.1016/S1359-6446(02)02343-7; Carocho M, 2013, ANTI-CANCER AGENT ME, V13, P1236, DOI 10.2174/18715206113139990301; Condorelli G, 2002, FASEB J, V16, P1732, DOI 10.1096/fj.02-0419com; Fatmawaty, 2013, Journal of Natural Products (India), V6, P61; Fuhrman B, 2001, CURR OPIN LIPIDOL, V12, P41, DOI 10.1097/00041433-200102000-00008; Ganapathy P, 2014, J ACAD IND RES, V3, P209; Geetha T, 2001, J ETHNOPHARMACOL, V76, P77, DOI 10.1016/S0378-8741(01)00175-1; Gomes A, 2012, BIOFACTORS, V38, P378, DOI 10.1002/biof.1033; Grassi D, 2010, NUTRIENTS, V2, P889, DOI 10.3390/nu2080889; Heleno SA, 2015, FOOD CHEM, V173, P501, DOI 10.1016/j.foodchem.2014.10.057; Huang CC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/364741; Huang SC, 2010, NEUROGASTROENT MOTIL, V22, P1009, DOI 10.1111/j.1365-2982.2010.01513.x; Huang SC, 2011, REGUL PEPTIDES, V167, P246, DOI 10.1016/j.regpep.2011.02.007; Husain A, 2012, AM J PHARMTECH RES, V2, P380; Izzi V, 2012, FRONT BIOSCI-LANDMRK, V17, P2396, DOI 10.2741/4061; Jahan I, 2010, ACTA PHARMACEUT, V60, P207, DOI 10.2478/v10007-010-0018-7; Kleinbongard P, 2002, METHOD ENZYMOL, V359, P158; Krenek P, 2009, EUR J HEART FAIL, V11, P140, DOI 10.1093/eurjhf/hfn026; LAKSHMI V, 1987, NATL ACAD SCI LETT, V10, P197; Lee MC, 2013, SCAND J GASTROENTERO, V48, P205, DOI 10.3109/00365521.2012.741615; Leifert WR, 2008, NUTR RES, V28, P729, DOI 10.1016/j.nutres.2008.09.001; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048872; Li XB, 2012, J PHARM PHARMACOL, V64, P1107, DOI 10.1111/j.2042-7158.2012.01502.x; Loizou S, 2010, MOL NUTR FOOD RES, V54, P551, DOI 10.1002/mnfr.200900012; Lotito SB, 2006, FREE RADICAL BIO MED, V41, P1727, DOI 10.1016/j.freeradbiomed.2006.04.033; Maity P, 2009, INDIAN J EXP BIOL, V47, P849; Mehta JL, 1999, CARDIOVASC RES, V43, P291, DOI 10.1016/S0008-6363(99)00132-7; MIETTINEN TA, 1995, NEW ENGL J MED, V333, P1308, DOI 10.1056/NEJM199511163332002; Modi A, 2016, CHIN J NAT MEDICINES, V14, P31, DOI 10.3724/SP.J.1009.2016.00031; Nakamura K, 1998, CIRCULATION, V98, P794, DOI 10.1161/01.CIR.98.8.794; Ozaki M, 2002, CIRC J, V66, P851, DOI 10.1253/circj.66.851; Ragasa CY, 2011, MANILA J SCI, V7, P7; Rahman M, 2011, AFR J TRADIT COMPLEM, V8, P34; Rani P. M. J., 2011, African Journal of Biochemistry Research, V5, P341; Romagnolo Donato F., 2012, Journal of Nutrition in Gerontology and Geriatrics, V31, P206, DOI 10.1080/21551197.2012.702534; Rosenthal K, 2003, RODENT REFERENCE RAN; Sack MN, 2000, CARDIOVASC RES, V45, P688, DOI 10.1016/S0008-6363(99)00228-X; Sama K, 2011, INT J PHARM LIFE SCI, V2, P42; Shabir G, 2011, MOLECULES, V16, P7302, DOI 10.3390/molecules16097302; Shanmukha I, 2011, INT J CHEMTECH RES, V3, P280; Shewale VD, 2012, ADV PHARM SCI, V2012, P1; Shiramane RS, 2011, INT J RES PHARM CHEM, V1, P2231; Shiramane RS, 2011, INT J RES PHARM CHEM, V2, P234; Siasos G, 2013, CURR MED CHEM, V20, P2641, DOI 10.2174/0929867311320210003; Song F, 2013, J ETHNOPHARMACOL, V150, P125, DOI 10.1016/j.jep.2013.08.019; Sun M, 2007, CIRCULATION, V115, P1398, DOI 10.1161/CIRCULATIONAHA.106.643585; Takaki Miyako, 2012, Pathophysiology, V19, P163, DOI 10.1016/j.pathophys.2012.04.004; Valerio A, 2006, J CLIN INVEST, V116, P2791, DOI [10.1172/JCI28570, 10.1172/JCI28570.]; Verma SK, 2012, CIRCULATION, V126, P418, DOI 10.1161/CIRCULATIONAHA.112.112185; WEXLER BC, 1978, AM HEART J, V96, P70, DOI 10.1016/0002-8703(78)90128-X; White RE, 2005, AM J PHYSIOL-HEART C, V289, pH1468, DOI 10.1152/ajpheart.01173.2004; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Xie J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2240; Yang AL, 2011, CHINESE J PHYSIOL, V54, P87, DOI 10.4077/CJP.2011.AMM011	64	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167768	10.1371/journal.pone.0167768	http://dx.doi.org/10.1371/journal.pone.0167768			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936072	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100181
J	Su, CC; Lee, KI; Chen, MK; Kuo, CY; Tang, CH; Liu, SH				Su, Chin-Chuan; Lee, Kuan-I; Chen, Mu-Kuan; Kuo, Chun-Ying; Tang, Chih-Hsin; Liu, Shing Hwa			Cantharidin Induced Oral Squamous Cell Carcinoma Cell Apoptosis via the JNK-Regulated Mitochondria and Endoplasmic Reticulum Stress-Related Signaling Pathways	PLOS ONE			English	Article							CANCER CELLS; GROWTH-INHIBITION; NECK-CANCER; TREATING PATIENTS; NEURONAL CELLS; ER STRESS; ACTIVATION; CHEMOTHERAPY; KINASE; DEATH	Oral cancer is a subtype of head and neck cancer which represents 2.65% of all human malignancies. Most of oral cancer is histopathologically diagnosed as oral squamous cell carcinoma (OSCC). OSCC is characterized by a high degree of local invasion and a high rate of metastasis to the cervical lymph nodes. How to prevention and treatment of OSCC is important and imperative. Here, we investigated the therapeutic effect and molecular mechanism of cantharidin, an active compound isolated from blister beetles, on OSCC in vitro. Results showed that cantharidin significantly decreased cell viability in human tongue squamous carcinoma-derived SAS, CAL-27, and SCC-4 cell lines. The further mechanistic studies were carried out in SAS cells. Cantharidin also significantly increased apoptosis-related signals, including caspase-9, caspase-7 and caspase-3 proteins. Besides, cantharidin decreased mitochondrial transmembrane potential (MMP) and induced cytochrome c and apoptosis inducing factor (AIF) release. Cantharidin also increased Bax, Bid, and Bak protein expressions and decreased Bcl-2 protein expression. Cantharidin could also increase the endoplasmic reticulum (ER) stress signals, including the expressions of phosphorylated eIF-2 alpha and CHOP, but not Grp78 and Grp94. Furthermore, cantharidin reduced pro-caspase-12 protein expression. In signals of mitogen-activated protein kinases, cantharidin increased the phosphorylation of JNK, but not ERK and p38. Transfection of shRNA-JNK to OSCC cells effectively reversed the cantharidin-induced cell apoptotic signals, including the mitochondrial and ER stress-related signaling molecules. Taken together, these findings suggest that cantharidin induces apoptosis in OSCC cells via the JNK-regulated mitochondria and ER stress-related signaling pathways.	[Su, Chin-Chuan; Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Coll Med, Taichung, Taiwan; [Su, Chin-Chuan; Chen, Mu-Kuan; Kuo, Chun-Ying] Changhua Christian Hosp, Dept Otorhinolaryngol Head & Neck Surg, Changhua, Taiwan; [Lee, Kuan-I] Taichung Tzu Chi Hosp, Dept Emergency, Buddhist Tzu Chi Med Fdn, Taichung, Taiwan; [Liu, Shing Hwa] Natl Taiwan Univ, Inst Toxicol, Coll Med, Taipei, Taiwan; [Liu, Shing Hwa] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan	China Medical University Taiwan; Changhua Christian Hospital; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; National Taiwan University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Tang, CH (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Coll Med, Taichung, Taiwan.; Liu, SH (corresponding author), Natl Taiwan Univ, Inst Toxicol, Coll Med, Taipei, Taiwan.; Liu, SH (corresponding author), China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	chtang@mail.cmu.edu.tw; shinghwaliu@ntu.edu.tw		LIU, SHING-HWA/0000-0002-9976-1197	National Science Council of Taiwan [NSC 102-2314-B-371-007]; Changhua Christian Hospital, Changhua, Taiwan [100-CCH-IRP-53]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Changhua Christian Hospital, Changhua, Taiwan	This work was supported by research grants from the National Science Council of Taiwan (NSC 102-2314-B-371-007), and the Changhua Christian Hospital, Changhua, Taiwan (100-CCH-IRP-53). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bologna MA, 2001, SYST ENTOMOL, V26, P33, DOI 10.1046/j.1365-3113.2001.00132.x; Chen CH, 2013, TOXICOLOGY, V303, P72, DOI 10.1016/j.tox.2012.10.008; Chen YW, 2012, ARCH TOXICOL, V86, P1547, DOI 10.1007/s00204-012-0873-8; Chen YJ, 2008, CANCER SCI, V99, P1507, DOI 10.1111/j.1349-7006.2008.00863.x; De Lima PO, 2014, ANTICANCER RES, V34, P605; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Eckert AW, 2010, J ORAL PATHOL MED, V39, P313, DOI 10.1111/j.1600-0714.2009.00829.x; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Gopalan A, 2013, CANCER LETT, V329, P9, DOI 10.1016/j.canlet.2012.08.031; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hsia TC, 2015, ENVIRON TOXICOL, V30, P1135, DOI 10.1002/tox.21986; Huan SKH, 2006, TOXICOLOGY, V223, P136, DOI 10.1016/j.tox.2006.03.012; Huang WW, 2011, INT J ONCOL, V38, P1067, DOI 10.3892/ijo.2011.922; HUNDT HKL, 1990, HUM EXP TOXICOL, V9, P35, DOI 10.1177/096032719000900108; Hung CM, 2013, INT J MOL SCI, V14, P17147, DOI 10.3390/ijms140817147; Johnson NW, 2011, PERIODONTOL 2000, V57, P19, DOI 10.1111/j.1600-0757.2011.00401.x; Karras DJ, 1996, AM J EMERG MED, V14, P478, DOI 10.1016/S0735-6757(96)90158-8; Kim DM, 2010, APOPTOSIS, V15, P1540, DOI 10.1007/s10495-010-0531-7; Kim JY, 2013, PHYTOTHER RES, V27, P493, DOI 10.1002/ptr.4746; Kim SY, 2011, ANN SURG ONCOL, V18, P2310, DOI 10.1245/s10434-011-1614-6; Kok SH, 2005, CANCER LETT, V217, P43, DOI 10.1016/j.canlet.2004.07.045; Kuo JH, 2010, INT J ONCOL, V37, P1243, DOI 10.3892/ijo_00000775; Lee JY, 2014, BIOCHEM BIOPH RES CO, V447, P371, DOI 10.1016/j.bbrc.2014.04.035; Li W, 2010, CANCER SCI, V101, P1226, DOI 10.1111/j.1349-7006.2010.01523.x; Liu B, 2012, ASIAN PAC J CANCER P, V13, P3705, DOI 10.7314/APJCP.2012.13.8.3705; Liu SH, 2014, AM J CHINESE MED, V42, P869, DOI 10.1142/S0192415X14500554; Lorenzo PI, 2008, NEOPLASIA, V10, P418, DOI 10.1593/neo.07985; Lu TH, 2015, CHEM-BIOL INTERACT, V225, P1, DOI 10.1016/j.cbi.2014.10.022; Lu TH, 2014, TOXICOL LETT, V224, P130, DOI 10.1016/j.toxlet.2013.10.013; Lu TH, 2011, TOXICOL LETT, V204, P71, DOI 10.1016/j.toxlet.2011.04.013; Massano J, 2006, ORAL SURG ORAL MED O, V102, P67, DOI 10.1016/j.tripleo.2005.07.038; McCluskey A, 2003, BIOORG CHEM, V31, P68, DOI 10.1016/S0045-2068(02)00524-2; Mod D, 2014, J NEPAL HLTH RES COU, V11, P300; Nam W, 2007, HEAD NECK-J SCI SPEC, V29, P335, DOI 10.1002/hed.20524; OAKS WW, 1960, ARCH INTERN MED, V105, P574, DOI 10.1001/archinte.1960.00270160072009; Oliveira LR, 2011, INT J ORAL MAX SURG, V40, P298, DOI 10.1016/j.ijom.2010.12.003; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Patil TT, 2014, J ORAL ONCOL, V2014; PEREZSAYANS GM, 2012, CANC LETT, V323, P11, DOI DOI 10.1016/J.CANLET.2012.03.040; Prasad SB, 2013, MICROSC MICROANAL, V19, P1377, DOI 10.1017/S143192761301324X; Galvis CEP, 2013, CHEM BIOL DRUG DES, V82, P477, DOI 10.1111/cbdd.12180; Rahman MA, 2010, NUTR CANCER, V62, P973, DOI 10.1080/01635581.2010.509538; Ryu MJ, 2015, IN VITRO CELL DEV-AN, V51, P92, DOI 10.1007/s11626-014-9806-6; Sagawa M, 2008, CANCER SCI, V99, P1820, DOI 10.1111/j.1349-7006.2008.00872.x; Sappayatosok K, 2015, HEAD NECK PATHOL, V9, P173, DOI 10.1007/s12105-014-0559-z; Selimovic D, 2011, CARCINOGENESIS, V32, P1268, DOI 10.1093/carcin/bgr112; Simon C, 2008, HNO, V56, P575, DOI 10.1007/s00106-008-1718-x; State Pharmacopoeia Commission, 2010, PHARMACOPOEIA OF PEO; Tan S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.95; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang CC, 2000, TOXICOLOGY, V147, P77, DOI 10.1016/S0300-483X(00)00185-2; WANG GS, 1989, J ETHNOPHARMACOL, V26, P147, DOI 10.1016/0378-8741(89)90062-7; Wang L, 2014, ASIAN PAC J CANCER P, V15, P5597, DOI 10.7314/APJCP.2014.15.14.5597; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wei G, 2010, J CELL PHYSIOL, V224, P112, DOI 10.1002/jcp.22099; World Health Organization, 2007, INT CLASS DIS; Wu JY, 2010, ORAL ONCOL, V46, P226, DOI 10.1016/j.oraloncology.2010.01.007; Yang YH, 2005, J ORAL PATHOL MED, V34, P596, DOI 10.1111/j.1600-0714.2005.00266.x; Yu Z J, 1993, Zhongguo Zhong Xi Yi Jie He Za Zhi, V13, P327; Zhan YP, 2012, ASIAN PAC J CANCER P, V13, P4773, DOI 10.7314/APJCP.2012.13.9.4773; Ziegler DS, 2008, CURR OPIN ONCOL, V20, P97, DOI 10.1097/CCO.0b013e3282f310f6; Zong WX, 2003, J CELL BIOL, V162, P59, DOI 10.1083/jcb.200302084	62	35	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0168095	10.1371/journal.pone.0168095	http://dx.doi.org/10.1371/journal.pone.0168095			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930712	Green Submitted, Green Published, gold			2022-12-27	WOS:000389580900081
J	Maass, JC; Gu, RD; Cai, TT; Wan, YW; Cantellano, SC; Asprer, JST; Zhang, HY; Jen, HI; Edlund, RK; Liu, ZD; Groves, AK				Maass, Juan C.; Gu, Rende; Cai, Tiantian; Wan, Ying-Wooi; Cantellano, Silvia C.; Asprer, Joanna S. T.; Zhang, Hongyuan; Jen, Hsin-i; Edlund, Renee K.; Liu, Zhandong; Groves, Andrew K.			Transcriptomic Analysis of Mouse Cochlear Supporting Cell Maturation Reveals Large-Scale Changes in Notch Responsiveness Prior to the Onset of Hearing	PLOS ONE			English	Article							OUTER HAIR-CELLS; EXPRESSION ANALYSIS; SIGNALING PATHWAY; BETA-CATENIN; STEM-CELLS; GENE; REGENERATION; GENERATION; INHIBITION; PILLAR	Neonatal mouse cochlear supporting cells have a limited ability to divide and trans-differentiate into hair cells, but this ability declines rapidly in the two weeks after birth. This decline is concomitant with the morphological and functional maturation of the organ of Corti prior to the onset of hearing. However, despite this association between maturation and loss of regenerative potential, little is known of the molecular changes that underlie these events. To identify these changes, we used RNA-seq to generate transcriptional profiles of purified cochlear supporting cells from 1-and 6-day-old mice. We found many significant changes in gene expression during this period, many of which were related to regulation of proliferation, differentiation of inner ear components and the maturation of the organ of Corti prior to the onset of hearing. One example of a change in regenerative potential of supporting cells is their robust production of hair cells in response to a blockade of the Notch signaling pathway at the time of birth, but a complete lack of response to such blockade just a few days later. By comparing our supporting cell transcriptomes to those of supporting cells cultured in the presence of Notch pathway inhibitors, we show that the transcriptional response to Notch blockade disappears almost completely in the first postnatal week. Our results offer some of the first molecular insights into the failure of hair cell regeneration in the mammalian cochlea.	[Gu, Rende; Cai, Tiantian; Asprer, Joanna S. T.; Zhang, Hongyuan; Edlund, Renee K.; Groves, Andrew K.] Baylor Coll Med, Dept Neurosci, 1 Baylor Plaza, Houston, TX 77030 USA; [Jen, Hsin-i; Groves, Andrew K.] Baylor Coll Med, Program Dev Biol, 1 Baylor Plaza, Houston, TX 77030 USA; [Groves, Andrew K.] Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA; [Wan, Ying-Wooi; Liu, Zhandong] Baylor Coll Med, Dept Pediat, 1 Baylor Plaza, Houston, TX 77030 USA; [Wan, Ying-Wooi; Liu, Zhandong] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Maass, Juan C.; Cantellano, Silvia C.] Univ Chile, Dept Otolaryngol, Hosp Clin Univ Chile, Santiago, Chile; [Maass, Juan C.; Cantellano, Silvia C.] Univ Chile, Interdisciplinary Program Physiol & Biophys ICBM, Santiago, Chile; [Maass, Juan C.] Univ Desarrollo, Dept Otolaryngol, Clin Alemana Santiago, Fac Med Clin Alemana, Santiago, Chile; [Gu, Rende] Sound Pharmaceut, Seattle, WA USA; [Asprer, Joanna S. T.] Thermo Fisher Sci, Stem Cell Res Unit, Waltham, MA USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Universidad de Chile; Universidad de Chile; Clinica Alemana; Universidad del Desarrollo; Thermo Fisher Scientific	Groves, AK (corresponding author), Baylor Coll Med, Dept Neurosci, 1 Baylor Plaza, Houston, TX 77030 USA.; Groves, AK (corresponding author), Baylor Coll Med, Program Dev Biol, 1 Baylor Plaza, Houston, TX 77030 USA.; Groves, AK (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	akgroves@bcm.edu		Maass, Juan/0000-0002-1586-4608; Liu, Zhandong/0000-0002-7608-0831; Groves, Andrew/0000-0002-0784-7998	Genomic and RNA Profiling Core; RNA In Situ Core at Baylor College of Medicine; NIH from the Eunice Kennedy Shriver National Institute of Child Health and Human Development [P30HD024064]; Cytometry and Cell Sorting Core at Baylor College of Medicine; NIH [P30 AI036211, P30 CA125123, S10 RR024574, DC006185, DC011657]; Department of Defense [DOD W81XWH-11-2-004]; Hearing Restoration Project consortium grant from the Hearing Health Foundation; CONICYT (Chile) [FONDECYT 11130247]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011657, R01DC014832, R01DC006185] Funding Source: NIH RePORTER	Genomic and RNA Profiling Core; RNA In Situ Core at Baylor College of Medicine; NIH from the Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Cytometry and Cell Sorting Core at Baylor College of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Hearing Restoration Project consortium grant from the Hearing Health Foundation; CONICYT (Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This project was supported in part by (1) The Genomic and RNA Profiling Core and the RNA In Situ Core at Baylor College of Medicine with the expert assistance of Dr. Lisa D. White, Ph.D., Cecilia Ljunberg, Ph.D., and funding from the NIH grant P30HD024064 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development; (2) The Cytometry and Cell Sorting Core at Baylor College of Medicine with the expert assistance of Joel M. Sederstrom and funding from the NIH grants P30 AI036211, P30 CA125123, and S10 RR024574; (3) NIH Grants DC006185 and DC011657 to A.K.G.; (4) Department of Defense Grant DOD W81XWH-11-2-004 to A.K.G.; (5) A Hearing Restoration Project consortium grant from the Hearing Health Foundation to A.K.G.; and (6) An Initiation into Research grant FONDECYT 11130247 from CONICYT (Chile) to J.C.M.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Atkinson PJ, 2015, DEVELOPMENT, V142, P1561, DOI 10.1242/dev.114926; Barkalow K, 1996, J CELL BIOL, V134, P389, DOI 10.1083/jcb.134.2.389; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Bramhall NF, 2014, STEM CELL REP, V2, P311, DOI 10.1016/j.stemcr.2014.01.008; Burns JC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9557; Cai TT, 2015, J NEUROSCI, V35, P5870, DOI 10.1523/JNEUROSCI.5083-14.2015; Chai RJ, 2012, P NATL ACAD SCI USA, V109, P8167, DOI 10.1073/pnas.1202774109; Cox BC, 2014, DEVELOPMENT, V141, P816, DOI 10.1242/dev.103036; Doetzlhofer A, 2009, DEV CELL, V16, P58, DOI 10.1016/j.devcel.2008.11.008; Engel J, 2006, NEUROSCIENCE, V143, P837, DOI 10.1016/j.neuroscience.2006.08.060; Geschwind D, 2004, LANCET NEUROL, V3, P82, DOI 10.1016/S1474-4422(03)00658-6; Groves AK, 2010, EXP BIOL MED, V235, P434, DOI 10.1258/ebm.2009.009281; Hayashi T, 2008, DEV BIOL, V316, P87, DOI 10.1016/j.ydbio.2008.01.006; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang W, 2014, J CELL PHYSIOL, V229, P580, DOI 10.1002/jcp.24480; Jacques BE, 2007, DEVELOPMENT, V134, P3021, DOI 10.1242/dev.02874; Jansson L, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00066; Katayama K, 2009, PLOS ONE, V4; Kelly MC, 2012, J NEUROSCI, V32, P6699, DOI 10.1523/JNEUROSCI.5420-11.2012; Khatri SB, 2013, GENE EXPR PATTERNS, V13, P38, DOI 10.1016/j.gep.2012.10.001; Kiernan AE, 2005, DEVELOPMENT, V132, P4353, DOI 10.1242/dev.02002; Kiernan AE, 2013, SEMIN CELL DEV BIOL, V24, P470, DOI 10.1016/j.semcdb.2013.04.002; Kuo BR, 2015, J NEUROSCI, V35, P10786, DOI 10.1523/JNEUROSCI.0967-15.2015; Lanford PJ, 1999, NAT GENET, V21, P289, DOI 10.1038/6804; Lee C, 2007, DEVELOPMENT, V134, P1431, DOI 10.1242/dev.02828; Lelli A, 2009, J NEUROPHYSIOL, V101, P2961, DOI 10.1152/jn.00136.2009; Leonova EV, 1997, HEARING RES, V113, P14, DOI 10.1016/S0378-5955(97)00130-5; Li WY, 2015, P NATL ACAD SCI USA, V112, P166, DOI 10.1073/pnas.1415901112; LIM DJ, 1985, ACTA OTO-LARYNGOL, P1; Lin V, 2011, J NEUROSCI, V31, P15329, DOI 10.1523/JNEUROSCI.2057-11.2011; Liu ZM, 2014, INT J ANTENN PROPAG, V2014, DOI 10.1155/2014/959386; Liu ZY, 2012, J NEUROSCI, V32, P6600, DOI 10.1523/JNEUROSCI.0818-12.2012; Maass JC, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00110; Mann ZF, 2011, HEARING RES, V276, P2, DOI 10.1016/j.heares.2011.01.011; Mansour SL, 2013, GENE DEV, V27, P2320, DOI 10.1101/gad.228957.113; Mizutari K, 2013, NEURON, V77, P58, DOI 10.1016/j.neuron.2012.10.032; Monroe JD, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00131; Mueller KL, 2002, J NEUROSCI, V22, P9368; Orosz F, 2008, FEBS LETT, V582, P3757, DOI 10.1016/j.febslet.2008.10.011; Oshima K, 2007, JARO-J ASSOC RES OTO, V8, P18, DOI 10.1007/s10162-006-0058-3; Puligilla C, 2007, DEV DYNAM, V236, P1905, DOI 10.1002/dvdy.21192; Raphael Y, 2003, BRAIN RES BULL, V60, P397, DOI 10.1016/S0361-9230(03)00047-9; Roccio M, 2015, SCI REP-UK, V5, DOI 10.1038/srep17886; Schmidt EF, 2013, COLD SPRING HARB PRO, V2013, P3; Shi FX, 2013, P NATL ACAD SCI USA, V110, P13851, DOI 10.1073/pnas.1219952110; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; Slepecky N. B., 1996, COCHLEA, V8, P44; Slowik AD, 2013, JARO-J ASSOC RES OTO, V14, P813, DOI 10.1007/s10162-013-0414-z; Son EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040735; Stern CD, 1998, CURR TOP DEV BIOL, V36, P223; Stone JS, 2007, INT J DEV BIOL, V51, P633, DOI 10.1387/ijdb.072408js; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Takebayashi S, 2007, DEV BIOL, V307, P165, DOI 10.1016/j.ydbio.2007.04.035; Tateya T, 2011, DEV BIOL, V352, P329, DOI 10.1016/j.ydbio.2011.01.038; Thomas ED, 2015, WIRES DEV BIOL, V4, P1, DOI 10.1002/wdev.160; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Waldhaus J, 2015, CELL REP, V11, P1385, DOI 10.1016/j.celrep.2015.04.062; Walters BJ, 2014, J NEUROSCI, V34, P15751, DOI 10.1523/JNEUROSCI.3200-14.2014; Walters BJ, 2013, HEARING RES, V297, P68, DOI 10.1016/j.heares.2012.11.009; White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849; White PM, 2012, DEV BIOL, V363, P191, DOI 10.1016/j.ydbio.2011.12.035; Wong ACY, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00058; Yang CH, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fncel.2015.0026, 10.3389/fncel.2015.00276]; Zheng JL, 2000, DEVELOPMENT, V127, P4551; Zine A, 2001, J NEUROSCI, V21, P4712, DOI 10.1523/JNEUROSCI.21-13-04712.2001	72	29	31	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2016	11	12							e0167286	10.1371/journal.pone.0167286	http://dx.doi.org/10.1371/journal.pone.0167286			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MR	27918591	Green Published, gold, Green Submitted			2022-12-27	WOS:000389577100009
J	Oakley, MS; Verma, N; Zheng, H; Anantharaman, V; Takeda, K; Gao, YM; Myers, TG; Pham, PT; Mahajan, B; Kumar, N; Sangweme, D; Tripathi, AK; Mlambo, G; Aravind, L; Kumar, S				Oakley, Miranda S.; Verma, Nitin; Zheng, Hong; Anantharaman, Vivek; Takeda, Kazuyo; Gao, Yamei; Myers, Timothy G.; Phuong Thao Pham; Mahajan, Babita; Kumar, Nirbhay; Sangweme, Davison; Tripathi, Abhai K.; Mlambo, Godfree; Aravind, L.; Kumar, Sanjai			Molecular Markers of Radiation Induced Attenuation in Intrahepatic Plasmodium falciparum Parasites	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PROTEIN PALMITOYLATION; MALARIA; IDENTIFICATION; IMMUNIZATION; SPOROZOITES; EXPRESSION; PROTECTION; UBIQUITIN; GENE	Experimental immunization with radiation attenuated sporozoites (RAS) and genetically attenuated sporozoites has proved to be a promising approach for malaria vaccine development. However, parasite biomarkers of growth attenuation and enhanced immune protection in response to radiation remain poorly understood. Here, we report on the effect of an attenuating dose of.-irradiation (15 krad) on the Plasmodium falciparum sporozoite (PfSPZ) ultrastructure by electron microscopy, growth rate of liver stage P. falciparum in liver cell cultures, and genome-wide transcriptional profile of liver stage parasites by microarray. We find that.-irradiation treated PfSPZ retained a normal cellular structure except that they were vacuous with a partially disrupted plasma membrane and inner membrane complex. A similar infection rate was observed by.-irradiation-treated and untreated PfSPZ in human HCO-4 liver cells (0.47% versus 0.49%, respectively) on day 3 post-infection. In the microarray studies, cumulatively, 180 liver stage parasite genes were significantly transcriptionally altered on day 3 and/or 6 post-infection. Among the transcriptionally altered biomarkers, we identified a signature of seven candidate parasite genes that associated with functionally diverse pathways that may regulate radiation induced cell cycle arrest of the parasite within the hepatocyte. A repertoire of 14 genes associated with protein translation is transcriptionally overexpressed within the parasite by radiation. Additionally, 37 genes encode proteins expressed on the cell surface or exported into the host cell, 4 encode membrane associated transporters, and 10 encode proteins related to misfolding and stress-related protein processing. These results have significantly increased the repertoire of novel targets for 1) biomarkers of safety to define proper attenuation, 2) generating genetically attenuated parasite vaccine candidates, and 3) subunit candidate vaccines against liver stage malaria.	[Oakley, Miranda S.; Verma, Nitin] US FDA, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Zheng, Hong; Phuong Thao Pham; Mahajan, Babita; Kumar, Sanjai] US FDA, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Anantharaman, Vivek; Aravind, L.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA; [Takeda, Kazuyo; Gao, Yamei] US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Myers, Timothy G.] NIAID, Genom Technol Sect, Res Technol Branch, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Kumar, Nirbhay; Sangweme, Davison; Tripathi, Abhai K.; Mlambo, Godfree] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kumar, S (corresponding author), US FDA, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	Sanjai.kumar@fda.hhs.gov	Anantharaman, Vivek/ABB-9991-2021	Anantharaman, Vivek/0000-0001-8395-0009; Aravind, L/0000-0003-0771-253X; Tripathi, Abhai/0000-0001-9848-0142; Myers, Timothy Gene/0000-0002-7059-5906	FDA intramural research program; PATH-Malaria Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI001051] Funding Source: NIH RePORTER	FDA intramural research program; PATH-Malaria Vaccine Initiative(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the FDA intramural research program and a research grant from the PATH-Malaria Vaccine Initiative.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aravind L, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-20; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; DAVIS JR, 1994, VACCINE, V12, P321, DOI 10.1016/0264-410X(94)90096-5; Dumoulin PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129623; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Era S, 2012, BIOCHEM BIOPH RES CO, V426, P310, DOI 10.1016/j.bbrc.2012.08.066; Fujii K, 2009, GENE DEV, V23, P963, DOI 10.1101/gad.1775609; Goyal M, 2012, NUCLEIC ACIDS RES, V40, P1174, DOI 10.1093/nar/gkr821; Hoffman BU, 2008, EXP PARASITOL, V118, P247, DOI 10.1016/j.exppara.2007.08.014; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Issar N, 2008, CELL MICROBIOL, V10, P1999, DOI 10.1111/j.1462-5822.2008.01183.x; Jackson KE, 2011, TRENDS PARASITOL, V27, P467, DOI 10.1016/j.pt.2011.05.005; Jones ML, 2012, TRENDS PARASITOL, V28, P496, DOI 10.1016/j.pt.2012.08.009; Jones ML, 2012, CELL HOST MICROBE, V12, P246, DOI 10.1016/j.chom.2012.06.005; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Khan SM, 2012, CURR OPIN BIOTECH, V23, P908, DOI 10.1016/j.copbio.2012.04.003; KINOSHITA N, 1991, MOL CELL BIOL, V11, P5839, DOI 10.1128/MCB.11.12.5839; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kudryashev M, 2010, CELL MICROBIOL, V12, P362, DOI 10.1111/j.1462-5822.2009.01399.x; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Lassmann T, 2006, NUCLEIC ACIDS RES, V34, pW596, DOI 10.1093/nar/gkl191; Lee I, 2004, TRENDS BIOCHEM SCI, V29, P567, DOI 10.1016/j.tibs.2004.09.005; Lin JW, 2013, MOL MICROBIOL, V88, P318, DOI 10.1111/mmi.12187; Mair GR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000767; Mani J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022463; March S, 2015, NAT PROTOC, V10, P2027, DOI 10.1038/nprot.2015.128; MELLOUK S, 1990, LANCET, V335, P721, DOI 10.1016/0140-6736(90)90832-P; Michel JJ, 2003, J BIOL CHEM, V278, P22828, DOI 10.1074/jbc.M210358200; Murakami H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000317; Murphy SC, 2013, P NATL ACAD SCI USA, V110, P6055, DOI 10.1073/pnas.1303834110; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Oakley MS, 2008, INFECT IMMUN, V76, P4518, DOI 10.1128/IAI.00525-08; Oakley MS, 2013, J INFECT DIS, V207, P164, DOI 10.1093/infdis/jis645; Oakley MS, 2011, INFECT IMMUN, V79, P1244, DOI 10.1128/IAI.00964-10; Oakley MSM, 2007, INFECT IMMUN, V75, P2012, DOI 10.1128/IAI.01236-06; OZAKI LS, 1984, J PARASITOL, V70, P831, DOI 10.2307/3281779; Pei JM, 2003, BIOINFORMATICS, V19, P427, DOI 10.1093/bioinformatics/btg008; Ponder EL, 2011, CHEM BIOL, V18, P711, DOI 10.1016/j.chembiol.2011.04.010; Ponts N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002386; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; RIECKMANN KH, 1990, B WORLD HEALTH ORGAN, V68, P13; Rivier C, 2001, EMBO J, V20, P1765, DOI 10.1093/emboj/20.7.1765; Sattabongkot J, 2006, AM J TROP MED HYG, V74, P708, DOI 10.4269/ajtmh.2006.74.708; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Schmidt-Christensen A, 2008, CELL MICROBIOL, V10, P1723, DOI 10.1111/j.1462-5822.2008.01162.x; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Shi L, 1997, MUTAT RES-DNA REPAIR, V384, P145, DOI 10.1016/S0921-8777(97)00023-2; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Song SS, 2012, CELL RES, V22, P1285, DOI 10.1038/cr.2012.107; Spring M, 2013, VACCINE, V31, P4975, DOI 10.1016/j.vaccine.2013.08.007; Subota I, 2011, MOL BIOL CELL, V22, P4205, DOI 10.1091/mbc.E11-06-0511; Trosch R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023039; van Dooren GG, 2002, J BIOL CHEM, V277, P23612, DOI 10.1074/jbc.M201748200; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; Zou XY, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-394	58	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0166814	10.1371/journal.pone.0166814	http://dx.doi.org/10.1371/journal.pone.0166814			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911910	Green Published, gold			2022-12-27	WOS:000389520600014
J	Shirazi, AH; Modiri, AB; Heydari, S; Rohn, JL; Jafari, GR; Mani, AR				Shirazi, Amir H.; Modiri, Arash Badie; Heydari, Sara; Rohn, Jennifer L.; Jafari, Gholam R.; Mani, Ali R.			Evolution of Communities in the Medical Sciences: Evidence from the Medical Words Network	PLOS ONE			English	Article								Background Classification of medical sciences into its sub-branches is crucial for optimum administration of healthcare and specialty training. Due to the rapid and continuous evolution of medical sciences, development of unbiased tools for monitoring the evolution of medical disciplines is required. Methodology/Principal Findings Network analysis was used to explore how the medical sciences have evolved between 1980 and 2015 based on the shared words contained in more than 9 million PubMed abstracts. The k-clique percolation method was used to extract local research communities within the network. Analysis of the shared vocabulary in research papers reflects the trends of collaboration and splintering among different disciplines in medicine. Our model identifies distinct communities within each discipline that preferentially collaborate with other communities within other domains of specialty, and overturns some common perceptions. Conclusions/Significance Our analysis provides a tool to assess growth, merging, splitting and contraction of research communities and can thereby serve as a guide to inform policymakers about funding and training in healthcare.	[Shirazi, Amir H.; Modiri, Arash Badie; Heydari, Sara] Shahid Beheshti Univ, Dept Phys, Tehran, Iran; [Rohn, Jennifer L.] UCL, Ctr Nephrol, Div Med, Royal Free Campus, London, England; [Mani, Ali R.] UCL, Div Med, Inst Liver & Digest Hlth, Royal Free Campus, London, England	Shahid Beheshti University; University of London; University College London; University of London; University College London	Shirazi, AH (corresponding author), Shahid Beheshti Univ, Dept Phys, Tehran, Iran.; Mani, AR (corresponding author), UCL, Div Med, Inst Liver & Digest Hlth, Royal Free Campus, London, England.	shirazi@ipm.ir; a.r.mani@ucl.ac.uk	Mani, Alireza/H-3236-2015; Jafari, Gholamreza/D-8181-2011	Mani, Alireza/0000-0003-0830-2022; Rohn, Jennifer/0000-0001-8766-6056; Badie Modiri, Arash/0000-0002-2027-360X; Jafari, G. Reza/0000-0003-4308-207X				Barabasi A.-L., 2016, NETWORK SCI; Borner K, 2010, SCIENTOMETRICS, V83, P863, DOI 10.1007/s11192-009-0149-0; Chen H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-147; de Chadarevian S., 2002, DESIGNS LIFE MOL BIO; Derenyi I, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.160202; Frick A., 1995, LNCS, V894, P388, DOI [10.1007/3 -540-58950-3_393, DOI 10.1007/3-540-58950-3_393]; Glenisson P, 2005, SCIENTOMETRICS, V63, P163, DOI 10.1007/s11192-005-0208-0; Manning C.D., 1999, FDN STAT NATURAL LAN; Mohammadi E, 2012, SCIENTOMETRICS, V92, P593, DOI 10.1007/s11192-012-0644-6; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Perzynski AT, 2010, JAMA-J AM MED ASSOC, V304, P2243, DOI 10.1001/jama.2010.1703; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Wilson E. O., 1998, CONSILIENCE UNITY KN	14	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167546	10.1371/journal.pone.0167546	http://dx.doi.org/10.1371/journal.pone.0167546			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3TF	27911929	Green Published, Green Submitted, gold			2022-12-27	WOS:000389520600041
J	Hu, HB; Kortner, TM; Gajardo, K; Chikwati, E; Tinsley, J; Krogdahl, A				Hu, Haibin; Kortner, Trond M.; Gajardo, Karina; Chikwati, Elvis; Tinsley, John; Krogdahl, Ashild			Intestinal Fluid Permeability in Atlantic Salmon (Salmo salar L.) Is Affected by Dietary Protein Source	PLOS ONE			English	Article							SOYBEAN-MEAL; RAINBOW-TROUT; SEAWATER ACCLIMATION; FISH-MEAL; EXPRESSION; PLANT; SMOLTIFICATION; SALINITY; SUPPLEMENTATION; ENTEROPATHY	In Atlantic salmon (Salmo salar L.), and also in other fish species, certain plant protein ingredients can increase fecal water content creating a diarrhea-like condition which may impair gut function and reduce fish growth. The present study aimed to strengthen understanding of the underlying mechanisms by observing effects of various alternative plant protein sources when replacing fish meal on expression of genes encoding proteins playing key roles in regulation of water transport across the mucosa of the distal intestine (DI). A 48-day feeding trial was conducted with five diets: A reference diet (FM) in which fish meal (72%) was the only protein source; Diet SBMWG with a mix of soybean meal (30%) and wheat gluten (22%); Diet SPCPM with a mix of soy protein concentrate (30%) and poultry meal (6%); Diet GMWG with guar meal (30%) and wheat gluten (14.5%); Diet PM with 58% poultry meal. Compared to fish fed the FM reference diet, fish fed the soybean meal containing diet (SBMWG) showed signs of enteritis in the DI, increased fecal water content of DI chyme and higher plasma osmolality. Altered DI expression of a battery of genes encoding aquaporins, ion transporters, tight junction and adherens junction proteins suggested reduced transcellular transport of water as well as a tightening of the junction barrier in fish fed the SBMWG diet, which may explain the observed higher fecal water content and plasma osmolality. DI structure was not altered for fish fed the other experimental diets but alterations in target gene expression and fecal water content were observed, indicating that alterations in water transport components may take place without clear effects on intestinal structure.	[Hu, Haibin; Kortner, Trond M.; Gajardo, Karina; Chikwati, Elvis; Krogdahl, Ashild] Norwegian Univ Life Sci, Dept Basic Sci & Aquat Med, Fac Vet Med & Biosci, Oslo, Norway; [Hu, Haibin] Ocean Univ China, Key Lab Aquaculture Nutr & Feed, Minist Agr, Qingdao, Shandong, Peoples R China; [Hu, Haibin] Ocean Univ China, Key Lab Mariculture, Minist Educ, Qingdao, Shandong, Peoples R China; [Tinsley, John] BioMar Ltd, Grangemouth Docks, Grangemouth, Scotland	Norwegian University of Life Sciences; Ministry of Agriculture & Rural Affairs; Ocean University of China; Ocean University of China	Gajardo, K (corresponding author), Norwegian Univ Life Sci, Dept Basic Sci & Aquat Med, Fac Vet Med & Biosci, Oslo, Norway.	karina.gajardo@nmbu.no		Chikwati, Elvis Mashingaidze/0000-0003-2630-0653	BioMar Ltd.; China Scholarship Council (CSC)	BioMar Ltd.; China Scholarship Council (CSC)(China Scholarship Council)	The present paper publishes results of contract research partly funded by BioMar Ltd. The funding body participated in study design, but had no role in data collection, analysis and interpretation, decision to publish or preparation of the manuscript. Other costs related to this study were covered by The NMBU School of Veterinary Medicine and Biosciences. In addition, the China Scholarship Council (CSC) provided financial assistance to H. H. to visit, as a PhD student, the Norwegian University of Life Sciences.; The authors thank BioMar AS for making the investigated samples available for this study. Thanks are also due to technician Ellen K. Hage in the nutrition laboratory at NMBU School of Veterinary Science for excellent technical assistance. The authors thank China Scholarship Council (CSC) for providing financial assistance to H. H. as a visiting PhD student at the Norwegian University of Life Sciences.	Ando M, 2014, AM J PHYSIOL-REG I, V307, pR653, DOI 10.1152/ajpregu.00543.2013; [Anonymous], 2011, AQUACULTURE, V310, P267; [Anonymous], 1994, ACTA AGR SCAND A-AN, V44, P185; Baeverfjord G, 1996, J FISH DIS, V19, P375, DOI 10.1111/j.1365-2761.1996.tb00376.x; Bureau D, 2006, ESSENTIAL RENDERING; Cerda J, 2010, J EXP ZOOL PART A, V313A, P623, DOI 10.1002/jez.634; Chen H, 2013, BRIT J NUTR, V110, P1837, DOI 10.1017/S0007114513001293; Chikwati EM, 2012, BRIT J NUTR, V107, P1570, DOI 10.1017/S0007114511004892; De Santis C, 2015, COMP BIOCHEM PHYS D, V15, P1, DOI 10.1016/j.cbd.2015.04.001; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Grammes F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083213; Gu JN, 2013, BRIT J NUTR, V109, P1408, DOI 10.1017/S000711451200325X; Hartviksen M, 2014, FISH PHYSIOL BIOCHEM, V40, P1621, DOI 10.1007/s10695-014-9953-4; Hu HB, 2015, AQUACULTURE, V444, P13, DOI 10.1016/j.aquaculture.2015.03.008; Hussain M, 2012, WORLD POULTRY SCI J, V68, P253, DOI 10.1017/S0043933912000311; Javid SH, 2005, CARCINOGENESIS, V26, P587, DOI 10.1093/carcin/bgh346; Knepper MA, 2015, NEW ENGL J MED, V372, P1349, DOI 10.1056/NEJMra1404726; Kortner TM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-101; Kortner TM, 2011, AQUACULTURE, V318, P355, DOI 10.1016/j.aquaculture.2011.05.038; Kosinska A, 2013, FOOD RES INT, V54, P951, DOI 10.1016/j.foodres.2012.12.038; Krogdahl A, 2003, AQUACULT NUTR, V9, P361, DOI 10.1046/j.1365-2095.2003.00264.x; Krogdahl A, 2015, J AGR FOOD CHEM, V63, P3887, DOI 10.1021/jf506242t; Lambert J, 2015, FASEB J, V29, P922; Liu N, 2008, J ANIM SCI, V86, P3432, DOI 10.2527/jas.2008-1234; Liu Y, 2013, J ANIM SCI, V91, P5294, DOI 10.2527/jas.2012-6194; Madsen SS, 2009, J EXP BIOL, V212, P78, DOI 10.1242/jeb.024612; MCCORMICK SD, 1993, CAN J FISH AQUAT SCI, V50, P656, DOI 10.1139/f93-075; Muller PY, 2002, BIOTECHNIQUES, V33, P514; Nordrum S, 2000, COMP BIOCHEM PHYS B, V125, P317, DOI 10.1016/S0305-0491(99)00190-X; Refstie S, 1997, AQUACULTURE, V153, P263, DOI 10.1016/S0044-8486(97)00025-2; Refstie Stale, 2001, Aquaculture, V193, P91, DOI 10.1016/S0044-8486(00)00473-7; Ricanek P, 2015, CLIN EXP GASTROENTER, V8, P49, DOI 10.2147/CEG.S70119; Romarheim OH, 2006, AQUACULTURE, V256, P354, DOI 10.1016/j.aquaculture.2006.02.006; Selle PH, 2012, NUTR RES REV, V25, P1, DOI 10.1017/S0954422411000151; Storebakken T, 2000, AQUACULTURE, V184, P115, DOI 10.1016/S0044-8486(99)00316-6; Sundell KS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00388; Sundh H, 2014, J FISH BIOL, V85, P1227, DOI 10.1111/jfb.12531; Suzuki T, 2011, J NUTR BIOCHEM, V22, P401, DOI 10.1016/j.jnutbio.2010.08.001; Takei Y, 2007, GEN COMP ENDOCR, V152, P339, DOI 10.1016/j.ygcen.2007.05.005; Tipsmark CK, 2012, COMP BIOCHEM PHYS A, V162, P378, DOI 10.1016/j.cbpa.2012.04.020; Tipsmark CK, 2010, J EXP BIOL, V213, P368, DOI 10.1242/jeb.034785; Tipsmark CK, 2010, COMP BIOCHEM PHYS A, V155, P361, DOI 10.1016/j.cbpa.2009.11.025; VANDENINGH TSGAM, 1991, AQUACULTURE, V94, P297, DOI 10.1016/0044-8486(91)90174-6; Venold FF, 2012, AQUACULTURE, V364, P281, DOI 10.1016/j.aquaculture.2012.08.035; Yang BC, 2008, J AGR FOOD CHEM, V56, P7522, DOI 10.1021/jf8012508; Yuge S, 2007, ZOOL SCI, V24, P1222, DOI 10.2108/zsj.24.1222; Zhang JX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058115, 10.1371/journal.pone.0076378]; Zhou XL, 2014, NUTR RES, V34, P780, DOI 10.1016/j.nutres.2014.08.008	48	39	41	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167515	10.1371/journal.pone.0167515	http://dx.doi.org/10.1371/journal.pone.0167515			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907206	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700178
J	Chang, NY; Chan, YJ; Ding, ST; Lee, YH; HuangFu, WC; Liu, IH				Chang, Nai-Yun; Chan, Yen-Ju; Ding, Shih-Torng; Lee, Yen-Hua; HuangFu, Wei-Chun; Liu, I-Hsuan			Sterol O-Acyltransferase 2 Contributes to the Yolk Cholesterol Trafficking during Zebrafish Embryogenesis	PLOS ONE			English	Article							ACYL-COENZYME; APOLIPOPROTEIN-E; EMBRYONIC-DEVELOPMENT; SYNCYTIAL LAYER; SAC MEMBRANE; HUMAN LIVER; ACAT2; COA; EXPRESSION; CELLS	To elucidate whether Sterol O-acyltransferase (Soat) mediates the absorption and transportation of yolk lipids to the developing embryo, zebrafish soat1 and soat2 were cloned and studied. In the adult zebrafish, soat1 was detected ubiquitously while soat2 mRNA was detected specifically in the liver, intestine, brain and testis. Whole mount in situ hybridization demonstrated that both soat1 and soat2 expressed in the yolk syncytial layer, hatching gland and developing cardiovascular as well as digestive systems, suggesting that Soats may play important roles in the lipid trafficking and utilization during embryonic development. The enzymatic activity of zebrafish Soat2 was confirmed by Oil Red O staining in the HEK293 cells overexpressing this gene, and could be quenched by Soat2 inhibitor Pyripyropene A (PPPA). The zebrafish embryos injected with PPPA or morpholino oligo against soat2 in the yolk showed significantly larger yolk when compared with wild-type embryos, especially at 72 hpf, indicating a slower rate of yolk consumption. Our result indicated that zebrafish Soat2 is catalytically active in synthesizing cholesteryl esters and contributes to the yolk cholesterol trafficking during zebrafish embryogenesis.	[Chang, Nai-Yun; Chan, Yen-Ju; Ding, Shih-Torng; Lee, Yen-Hua; Liu, I-Hsuan] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan; [Ding, Shih-Torng] Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan; [HuangFu, Wei-Chun] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Canc Biol & Drug Discovery, Taipei, Taiwan; [Liu, I-Hsuan] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei, Taiwan	National Taiwan University; National Taiwan University; Taipei Medical University; National Taiwan University	Liu, IH (corresponding author), Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan.; Liu, IH (corresponding author), Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei, Taiwan.	ihliu@ntu.edu.tw	Liu, I-Hsuan/D-9043-2017	Liu, I-Hsuan/0000-0002-4524-3263; Lee, Yen-Hua/0000-0001-8812-6094	Ministry of Science and Technology, Taiwan [105-2628-B-002-005-MY4, 104R7602D2]; Ministry of Science and Technology of Taiwan, ROC [103-2321-B-400-010, 103-2321-B-001-050]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology of Taiwan, ROC	This work was financially supported by Ministry of Science and Technology, Taiwan (105-2628-B-002-005-MY4; https://www.most.gov.tw/) and National Taiwan University (104R7602D2; http://www.ntu.edu.tw/) to IHL. The funding agencies had no role on in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Ju-Ahng Lee for the reviewing and revising of this manuscript, Dr. Jeff Shyh-Jye Lee for helpful discussion, and Ms. Ke-Hsuan Wei for the zebrafish husbandry. The authors would also like to acknowledge the materials and services provided by Taiwan Zebrafish Core Facility at ZeTH (103-2321-B-400-010) and Academia Sinica (103-2321-B-001-050), which are supported by Ministry of Science and Technology of Taiwan, ROC.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; An SJ, 2006, FEBS LETT, V580, P2741, DOI 10.1016/j.febslet.2006.04.035; Arrington CB, 2009, DEVELOPMENT, V136, P3143, DOI 10.1242/dev.031492; Babin PJ, 1997, P NATL ACAD SCI USA, V94, P8622, DOI 10.1073/pnas.94.16.8622; Bhattacharyya R, 2010, BBA-MOL CELL BIOL L, V1801, P960, DOI 10.1016/j.bbalip.2010.04.003; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Buhman KK, 2000, NAT MED, V6, P1341, DOI 10.1038/82153; CADIGAN KM, 1988, J BIOL CHEM, V263, P274; Carvalho L, 2010, TRENDS CELL BIOL, V20, P586, DOI 10.1016/j.tcb.2010.06.009; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; Chang CCY, 2010, BIOCHEMISTRY-US, V49, P9957, DOI 10.1021/bi1013936; Chang CCY, 2000, J BIOL CHEM, V275, P28083; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; Chang TY, 2001, CURR OPIN LIPIDOL, V12, P289, DOI 10.1097/00041433-200106000-00008; Chang YC, 2013, AMINO ACIDS, V44, P615, DOI 10.1007/s00726-012-1386-8; Das A, 2009, BIOCHEMISTRY AND MOL; Das A, 2008, J BIOL CHEM, V283, P10453, DOI 10.1074/jbc.M709460200; Ding ST, 2000, POULTRY SCI, V79, P1460, DOI 10.1093/ps/79.10.1460; Dove DE, 2006, ATHEROSCLEROSIS, V186, P267, DOI 10.1016/j.atherosclerosis.2005.08.005; falseZhao X.-P., 2009, FOUNDRY TECHNOL, V30, P745; Guo ZM, 2001, J LIPID RES, V42, P1282; Guo ZY, 2005, J BIOL CHEM, V280, P37814, DOI 10.1074/jbc.M508384200; Joyce CW, 2000, MOL BIOL CELL, V11, P3675, DOI 10.1091/mbc.11.11.3675; Karasinska JM, 2011, NAT REV NEUROL, V7, P561, DOI 10.1038/nrneurol.2011.132; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lada AT, 2004, J LIPID RES, V45, P378, DOI 10.1194/jlr.D300037-JLR200; Lee RG, 2000, J LIPID RES, V41, P1991; Leung CF, 1998, DEV GROWTH DIFFER, V40, P313; Li BL, 1999, J BIOL CHEM, V274, P11060, DOI 10.1074/jbc.274.16.11060; Liang JJ, 2004, J BIOL CHEM, V279, P44938, DOI 10.1074/jbc.M408507200; Lin S, 2003, MOL BIOL CELL, V14, P2447, DOI 10.1091/mbc.E02-11-0725; Llaverias G, 2002, EUR J PHARMACOL, V451, P11, DOI 10.1016/S0014-2999(02)02152-0; Matsuda D, 2015, J ANTIBIOT, V68, P27, DOI 10.1038/ja.2014.91; Miyares RL, 2014, DIS MODEL MECH, V7, P915, DOI 10.1242/dmm.015800; Nguyen TM, 2012, J LIPID RES, V53, P95, DOI 10.1194/jlr.M018820; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; Ohshiro T, 2015, J PHARMACOL EXP THER, V355, P297, DOI 10.1124/jpet.115.227348; Ohshiro T, 2011, ARTERIOSCL THROM VAS, V31, P1108, DOI 10.1161/ATVBAHA.111.223552; Parini P, 2004, CIRCULATION, V110, P2017, DOI 10.1161/01.CIR.0000143163.76212.0B; Pickart MA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000104; Poupard G, 2000, CELL TISSUE RES, V300, P251, DOI 10.1007/s004419900158; Repa JJ, 2004, HEPATOLOGY, V40, P1088, DOI 10.1002/hep.20439; Rodriguez A, 2002, ATHEROSCLEROSIS, V161, P45, DOI 10.1016/S0021-9150(01)00620-7; Schlegel A, 2006, BIOCHEMISTRY-US, V45, P15179, DOI 10.1021/bi0619268; Schwend T, 2011, J LIPID RES, V52, P1328, DOI 10.1194/jlr.M012377; Seo T, 2001, BIOCHEMISTRY-US, V40, P4756, DOI 10.1021/bi0022947; SHAND JH, 1993, LIPIDS, V28, P621, DOI 10.1007/BF02536056; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Spady DK, 2000, J BIOL CHEM, V275, P27005; Tardif JC, 2004, CIRCULATION, V110, P3372, DOI 10.1161/01.CIR.0000147777.12010.EF; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Willner EL, 2003, P NATL ACAD SCI USA, V100, P1262, DOI 10.1073/pnas.0336398100; Zhan Y, 2016, ORG BIOMOL CHEM, V14, P747, DOI 10.1039/c5ob02019k; Zhang J, 2014, CIRC RES, V115, P826, DOI 10.1161/CIRCRESAHA.115.304378; Zhang J, 2012, J LIPID RES, V53, P1144, DOI 10.1194/jlr.M024356	55	10	10	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167644	10.1371/journal.pone.0167644	http://dx.doi.org/10.1371/journal.pone.0167644			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936201	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100139
J	Heiss-Blanquet, S; Fayolle-Guichard, F; Lombard, V; Hebert, A; Coutinho, PM; Groppi, A; Barre, A; Henrissat, B				Heiss-Blanquet, Senta; Fayolle-Guichard, Francoise; Lombard, Vincent; Hebert, Agnes; Coutinho, Pedro M.; Groppi, Alexis; Barre, Aurelien; Henrissat, Bernard			Composting-Like Conditions Are More Efficient for Enrichment and Diversity of Organisms Containing Cellulase-Encoding Genes than Submerged Cultures	PLOS ONE			English	Article							ENZYME DISCOVERY; PLANT BIOMASS; DNA; HYDROLASES; CONVERSION; DYNAMICS; GENOMES; SOIL	Cost-effective biofuel production from lignocellulosic biomass depends on efficient degradation of the plant cell wall. One of the major obstacles for the development of a cost-efficient process is the lack of resistance of currently used fungal enzymes to harsh conditions such as high temperature. Adapted, thermophilic microbial communities provide a huge reservoir of potentially interesting lignocellulose-degrading enzymes for improvement of the cellulose hydrolysis step. In order to identify such enzymes, a leaf and wood chip compost was enriched on a mixture of thermo-chemically pretreated wheat straw, poplar and Miscanthus under thermophile conditions, but in two different set-ups. Unexpectedly, metagenome sequencing revealed that incubation of the lignocellulosic substrate with compost as inoculum in a suspension culture resulted in an impoverishment of putative cellulase-and hemicellulase-encoding genes. However, mimicking composting conditions without liquid phase yielded a high number and diversity of glycoside hydrolase genes and an enrichment of genes encoding cellulose binding domains. These identified genes were most closely related to species from Actinobacteria, which seem to constitute important players of lignocellulose degradation under the applied conditions. The study highlights that subtle changes in an enrichment set-up can have an important impact on composition and functions of the microcosm. Composting-like conditions were found to be the most successful method for enrichment in species with high biomass degrading capacity.	[Heiss-Blanquet, Senta; Fayolle-Guichard, Francoise; Hebert, Agnes] IFP Energies Nouvelles, Dept Biotechnol, Rueil Malmaison, France; [Lombard, Vincent; Coutinho, Pedro M.; Henrissat, Bernard] Aix Marseille Univ, CNRS, Architecture & Fonct Macromol Biol, Marseille, France; [Groppi, Alexis; Barre, Aurelien] Univ Bordeaux, Ctr Genom Fonct Bordeaux, Bordeaux, France; [Lombard, Vincent; Coutinho, Pedro M.; Henrissat, Bernard] INRA, AFMB, Marseille, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah, Saudi Arabia; [Hebert, Agnes] Univ Evry Val Essonne, CNRS FRE 3561, Inst Syst & Synthet Biol, Evry, France	IFP Energies Nouvelles; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite de Bordeaux; INRAE; UDICE-French Research Universities; Aix-Marseille Universite; King Abdulaziz University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Heiss-Blanquet, S (corresponding author), IFP Energies Nouvelles, Dept Biotechnol, Rueil Malmaison, France.	Senta.Blanquet@ifpen.fr	Henrissat, Bernard/J-2475-2012	Henrissat, Bernard/0000-0002-3434-8588; Lombard, Vincent/0000-0002-9684-7067; Barre, annick/0000-0002-1360-8491; Groppi, Alexis/0000-0002-3341-8281	Agence Nationale de Recherche (ANR) [ANR-12-BIO-ME-006-01]	Agence Nationale de Recherche (ANR)(French National Research Agency (ANR))	This work was supported by Agence Nationale de Recherche (ANR), Grant number: ANR-12-BIO-ME-006-01 (http://www.agence-nationale-recherche.fr/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; Brethauer S, 2015, CHIMIA, V69, P572, DOI 10.2533/chimia.2015.572; Courtois S, 2001, ENVIRON MICROBIOL, V3, P431, DOI 10.1046/j.1462-2920.2001.00208.x; Crusoe Michael R, 2015, F1000Res, V4, P900, DOI 10.12688/f1000research.6924.1; Darling AE, 2014, PEERJ, V2, DOI 10.7717/peerj.243; DeAngelis KM, 2010, BIOENERG RES, V3, P146, DOI 10.1007/s12155-010-9089-z; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Ferrer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038134; Cairo JPLF, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-50; Gladden JM, 2011, APPL ENVIRON MICROB, V77, P5804, DOI 10.1128/AEM.00032-11; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Jimenez DJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13845; Jimenez DJ, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-92; Le Digabel Y, 2013, APPL MICROBIOL BIOT, V97, P10531, DOI 10.1007/s00253-013-4803-3; Liguori R, 2013, APPL MICROBIOL BIOT, V97, P6129, DOI 10.1007/s00253-013-5014-7; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lopez-Gonzalez JA, 2013, BIORESOURCE TECHNOL, V146, P574, DOI 10.1016/j.biortech.2013.07.122; Martins LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061928; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mhuantong W, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0200-8; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mori T, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-365; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Reddy A. P., 2013, PLoS ONE, V8, pe77985, DOI 10.1371/journal.pone.0077985; Rosewarne CP, 2011, MICROB ECOL, V61, P448, DOI 10.1007/s00248-010-9745-z; Ryckeboer J, 2003, J APPL MICROBIOL, V94, P127, DOI 10.1046/j.1365-2672.2003.01800.x; Thompson CE, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-65; van der Lelie D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036740; VANSOEST PJ, 1973, P NUTR SOC, V32, P123, DOI 10.1079/PNS19730029; Wang C, 2016, BIOTECHNOLOGY BIOFUE, V22; Wei H, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-20; Wongwilaiwalin S, 2013, APPL MICROBIOL BIOT, V97, P8941, DOI 10.1007/s00253-013-4699-y; Ximenes E, 2011, ENZYME MICROB TECH, V48, P54, DOI 10.1016/j.enzmictec.2010.09.006	35	7	7	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167216	10.1371/journal.pone.0167216	http://dx.doi.org/10.1371/journal.pone.0167216			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936240	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100074
J	Jeffries, MD; Gannon, TW; Brosnan, JT; Breeden, GK				Jeffries, Matthew D.; Gannon, Travis W.; Brosnan, James T.; Breeden, Gregory K.			Comparing Dislodgeable 2,4-D Residues across Athletic Field Turfgrass Species and Time	PLOS ONE			English	Article							2,4-DICHLOROPHENOXYACETIC ACID; ANNUAL BLUEGRASS; CREEPING BENTGRASS; METABOLISM; ABSORPTION; EXPOSURE; TRANSLOCATION; PERSISTENCE; AIR	2,4-dimethylamine salt (2,4-D) is an herbicide commonly applied on athletic fields for broad-leaf weed control that can dislodge from treated turfgrass. Dislodge potential is affected by numerous factors, including turfgrass canopy conditions. Building on previous research confirming herbicide-turfgrass dynamics can vary widely between species, field research was initiated in 2014 and 2015 in Raleigh, NC, USA to quantify dislodgeable 2,4-D residues from dormant hybrid bermudagrass (Cynodon dactylon L. x C. transvaalensis) and hybrid bermudagrass overseeded with perennial ryegrass (Lolium perenne L.), which are common athletic field playing surfaces in subtropical climates. Additionally, dislodgeable 2,4-D was compared at AM (7: 00 eastern standard time) and PM (14: 00) sample timings within a day. Samples collected from perennial ryegrass consistently resulted in greater 2,4-D dislodgment immediately after application (9.4 to 9.9% of applied) compared to dormant hybrid bermudagrass (2.3 to 2.9%), as well as at all AM compared to PM timings from 1 to 3 d after treatment (DAT; 0.4 to 6.3% compared to 0.1 to 0.8%). Dislodgeable 2,4-D did not differ across turfgrass species at PM sample collections, with <= 0.1% of the 2,4-D applied dislodged from 1 to 6 DAT, and 2,4-D detection did not occur at 12 and 24 DAT. In conclusion, dislodgeable 2,4-D from treated turfgrass can vary between species and over short time-scales within a day. This information should be taken into account in human exposure risk assessments, as well as by turfgrass managers and athletic field event coordinators to minimize 2,4-D exposure.	[Jeffries, Matthew D.; Gannon, Travis W.] North Carolina State Univ, Dept Crop & Soil Sci, Raleigh, NC 27695 USA; [Brosnan, James T.; Breeden, Gregory K.] Univ Tennessee, Dept Plant Sci, Knoxville, TN USA	University of North Carolina; North Carolina State University; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Jeffries, MD (corresponding author), North Carolina State Univ, Dept Crop & Soil Sci, Raleigh, NC 27695 USA.	mdjeffri@ncsu.edu		Gannon, Travis/0000-0001-7140-8896				[Anonymous], 2013, REC GOAL FIELD BALL; [Anonymous], 2016, OV RISK ASS PEST PRO; [Anonymous], 2015, OCSPP HARM TEST GUID; [Anonymous], 2012, STAND OP PROC RES PE; [Anonymous], 2007, 2 4 D CHEM SUMM; BAIER W., 1966, AGR METEOROL, V3, P103, DOI 10.1016/0002-1571(66)90008-2; Bus JS, 2007, CROP PROT, V26, P266, DOI 10.1016/j.cropro.2005.06.010; CARMER SG, 1989, AGRON J, V81, P665, DOI 10.2134/agronj1989.00021962008100040021x; CDC (Centers for Disease Control and Prevention), 2005, NCEH PUB; Garabrant DH, 2002, CRIT REV TOXICOL, V32, P233, DOI 10.1080/20024091064237; HARRIS SA, 1992, J ENVIRON SCI HEAL B, V27, P9, DOI 10.1080/03601239209372764; Jeffries MD, 2016, WEED TECHNOL, V30, P154, DOI 10.1614/WT-D-15-00069.1; Jeffries MD, PLOS ONE; Junge A, 2004, AM J SPORT MED, V32, p23S, DOI 10.1177/0363546503261246; Kennepohl E, 2001, HDB PESTICIDE TOXICO, V2, P1623; Kohler EA, 2002, WEED SCI, V50, P576, DOI 10.1614/0043-1745(2002)050[0576:SOUATA]2.0.CO;2; Kruit RJW, 2008, ATMOS ENVIRON, V42, P5304, DOI 10.1016/j.atmosenv.2008.02.061; Lawrence MG, 2005, B AM METEOROL SOC, V86, P225, DOI 10.1175/BAMS-86-2-225; Lutgens FK, 2007, ATMOSPHERE INTRO MET, P110; McCullough PE, 2009, WEED SCI, V57, P470, DOI 10.1614/WS-09-025.1; Moody RP, 1997, TOXICOL IN VITRO, V11, P251, DOI 10.1016/S0887-2333(97)00013-1; Morgan MK, 2008, J EXPO SCI ENV EPID, V18, P486, DOI 10.1038/sj.jes.7500641; Mueller TC, 2015, WEED SCI, V63, P133, DOI 10.1614/WS-D-13-00157.1; MUNRO IC, 1992, J AM COLL TOXICOL, V11, P559, DOI 10.3109/10915819209141893; Nishioka MG, 2001, ENVIRON HEALTH PERSP, V109, P1185, DOI 10.2307/3454867; Nishioka MG, 1996, ENVIRON SCI TECHNOL, V30, P3313, DOI 10.1021/es960111r; Puhalla J, 1999, SPORTS FIELDS MANUAL, P119; Shaner DL, 2014, HERBICIDE HDB, P16; Sidhu SS, 2014, WEED SCI, V62, P433, DOI 10.1614/WS-D-13-00182.1; Steel RGD, 1997, PRINCIPLES PROCEDURE, V3, P352; Steffen K, 2007, BRIT J SPORT MED, V41, pI33, DOI 10.1136/bjsm.2007.036665; THOMPSON DG, 1984, PESTIC SCI, V15, P353, DOI 10.1002/ps.2780150405; Turgeon AJ, 2008, TURFGRASS MANAGEMENT, p[179, 356]; U.S. Environmental Protection Agency, 1996, OCC RES EXP TEST GUI; U.S. EPA, 2005, MEM 24 D HES REV HUM; Walters J, 2004, ENV MONITORING PEST; WEINTRAUB RL, 1954, PLANT PHYSIOL, V29, P303, DOI 10.1104/pp.29.3.303; Wilson TB, 1999, AGR FOREST METEOROL, V93, P111, DOI 10.1016/S0168-1923(98)00116-6; Yu JL, 2013, WEED SCI, V61, P217, DOI 10.1614/WS-D-12-00136.1	39	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168086	10.1371/journal.pone.0168086	http://dx.doi.org/10.1371/journal.pone.0168086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936174	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100271
J	Vieira, VMNCS; Engelen, AH; Huanel, OR; Guillemin, ML				Vieira, Vasco M. N. C. S.; Engelen, Aschwin H.; Huanel, Oscar R.; Guillemin, Marie-Laure			Linear-In-The-Parameters Oblique Least Squares (LOLS) Provides More Accurate Estimates of Density-Dependent Survival	PLOS ONE			English	Article							BIPHASIC LIFE-CYCLES; PLANT SIZE; RHODOPHYTA; TETRASPOROPHYTES; SIGNIFICANCES; GAMETOPHYTES; TEMPERATURE; POPULATIONS; MAZZAELLA; DYNAMICS	Survival is a fundamental demographic component and the importance of its accurate estimation goes beyond the traditional estimation of life expectancy. The evolutionary stability of isomorphic biphasic life-cycles and the occurrence of its different ploidy phases at uneven abundances are hypothesized to be driven by differences in survival rates between haploids and diploids. We monitored Gracilaria chilensis, a commercially exploited red alga with an isomorphic biphasic life-cycle, having found density-dependent survival with competition and Allee effects. While estimating the linear-in-the-parameters survival function, all model I regression methods (i.e, vertical least squares) provided biased line-fits rendering them inappropriate for studies about ecology, evolution or population management. Hence, we developed an iterative two-step non-linear model II regression (i.e, oblique least squares), which provided improved line-fits and estimates of survival function parameters, while robust to the data aspects that usually turn the regression methods numerically unstable.	[Vieira, Vasco M. N. C. S.] Univ Tecn Lisboa, Inst Super Tecn, MARETEC, Ave Rovisco Pais, Lisbon, Portugal; [Engelen, Aschwin H.] Univ Algarve, CIMAR Lab Associado, FCT, CCMAR,Ctr Marine Sci, Campus Gambelas, Faro, Portugal; [Huanel, Oscar R.; Guillemin, Marie-Laure] Univ Austral Chile, Inst Ciencias Ambientales & Evolut, Fac Ciencias, Valdivia, Chile; [Guillemin, Marie-Laure] UPMC Univ Paris VI, Sorbonne Univ, CNRS,CS, UMI 3614,Evolutionary Biol & Ecol Algae,Stn Biol, Pl G Tessier, Roscoff, France	Universidade de Lisboa; Instituto Superior Tecnico; Universidade do Algarve; Universidad Austral de Chile; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	Vieira, VMNCS (corresponding author), Univ Tecn Lisboa, Inst Super Tecn, MARETEC, Ave Rovisco Pais, Lisbon, Portugal.	vasco.vieira@tecnico.ulisboa.pt	Engelen, Aschwin H/M-3432-2013	Engelen, Aschwin H/0000-0002-9579-9606; Vieira, Vasco/0000-0001-9858-6254	Fondo Nacional de Desarrollo Cientifico y Tecnologico [1090360]; European Regional Development Funds of the Competitiveness Factors Operational Programme-COMPETE; national funds of the Foundation for Science and Technology (FCT) [UID/EEA/50009/2013]; FCT [SFRH/BPD/63703/2009, SFRH/BPD/107878/2015]	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); European Regional Development Funds of the Competitiveness Factors Operational Programme-COMPETE; national funds of the Foundation for Science and Technology (FCT); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the Research on Gracilaria chilensis was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico (http://www.conicyt.cl/fondecyt/fondecyt-program/) under grant number 1090360. VV was funded by European Regional Development Funds (http://ec.europa.eu/regional_policy/en/funding/erdf/) of the Competitiveness Factors Operational Programme-COMPETE and national funds of the Foundation for Science and Technology (FCT-www.fct.pt) under the project UID/EEA/50009/2013. AHE was supported by fellowships SFRH/BPD/63703/2009 and SFRH/BPD/107878/2015 of the FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cragg JG, 1997, RAND J ECON, V28, pS71, DOI 10.2307/3087456; Creed JC, 1998, J PHYCOL, V34, P39, DOI 10.1046/j.1529-8817.1998.340039.x; Vieira VMNDD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092602; Vieira VMNCS, 2012, J PHYCOL, V48, P1012, DOI 10.1111/j.1529-8817.2012.01192.x; Vieira VMNDD, 2010, J PHYCOL, V46, P1128, DOI 10.1111/j.1529-8817.2010.00924.x; Draper NR, 1992, P KANS STAT U C APPL, P1; Engel C, 2001, J ECOL, V89, P436, DOI 10.1046/j.1365-2745.2001.00567.x; Garza-Sanchez F, 2000, BOT MAR, V43, P205, DOI 10.1515/BOT.2000.022; Gillard J. W., 2005, METHOD MOMENTS ESTIM; Gillard J, 2010, REVSTAT-STAT J, V8, P57; Gonzalez J, 1996, AQUACULTURE, V143, P91, DOI 10.1016/0044-8486(95)01203-6; Guillemin M-L, 2012, J APPL PHYCOL; Hughes JS, 1999, AM NAT, V154, P306, DOI 10.1086/303241; Jackson JE, 1991, USERS GUIDE PRINCIPA; Kamiya M, 2002, PHYCOLOGIA, V41, P107, DOI 10.2216/i0031-8884-41-2-107.1; Keeley ER, 2003, OIKOS, V102, P543, DOI 10.1034/j.1600-0706.2003.12035.x; King MR, 2010, NUMERICAL STAT METHO; LONSDALE WM, 1983, J ECOL, V71, P285, DOI 10.2307/2259977; Mudge B, 2003, J MAR BIOL ASSOC UK, V83, P701, DOI 10.1017/S0025315403007665h; Rincon PA, 2002, ECOLOGY, V83, P1808, DOI 10.2307/3071766; SCHIEL DR, 1985, J ECOL, V73, P199, DOI 10.2307/2259778; Scrosati R, 1998, J PHYCOL, V34, P228, DOI 10.1046/j.1529-8817.1998.340228.x; Smith RJ, 2009, AM J PHYS ANTHROPOL, V140, P476, DOI 10.1002/ajpa.21090; Sokal R. R., 1981, BIOMETRY; Steen H, 2004, MAR BIOL, V144, P61, DOI 10.1007/s00227-003-1175-8; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Thornber CS, 2003, MAR ECOL PROG SER, V258, P65, DOI 10.3354/meps258065; Oppliger LV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039289; Vieira Vasco M. N. C. S., 2013, Computational Ecology and Software, V3, P44; Vieira VMNCS, 2012, J BIOL DYNAM, V6, P1067, DOI 10.1080/17513758.2012.721901; Vieira VMNCS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119670; VIEIRA VMNCS, 2013, COMPUT ECOL SOFTW, V3, P102; Vieira VMNCS., 2016, ANN RES REV BIOL, V10, P1, DOI [10.9734/arrb/2016/25219, DOI 10.9734/ARRB/2016/25219]; WHITE J, 1970, J ECOL, V58, P467, DOI 10.2307/2258284; YODA KYOJI, 1963, J BIOL OSAKA CITY UNIV, V14, P107	36	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167418	10.1371/journal.pone.0167418	http://dx.doi.org/10.1371/journal.pone.0167418			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936048	gold, Green Published			2022-12-27	WOS:000389587100095
J	Yang, J; Du, XL; Li, ST; Wang, BY; Wu, YY; Chen, ZL; Lv, M; Shen, YW; Wang, X; Dong, DF; Li, D; Wang, F; Li, EX; Yi, M; Yang, J				Yang, Jiao; Du, Xiang Lin; Li, Shu Ting; Wang, Bi Yuan; Wu, Yin Ying; Chen, Zhe Ling; Lv, Meng; Shen, Yan Wei; Wang, Xin; Dong, Dan Feng; Li, Dan; Wang, Fan; Li, En Xiao; Yi, Min; Yang, Jin			Characteristics of Differently Located Colorectal Cancers Support Proximal and Distal Classification: A Population-Based Study of 57,847 Patients	PLOS ONE			English	Article							PRIMARY TUMOR SITE; MOLECULAR-FEATURES; PROSPECTIVE COHORT; NATIONWIDE COHORT; MISMATCH REPAIR; RECTAL-CANCER; SURVIVAL; STAGE; METASTASIS; PREDICTOR	Background It has been suggested that colorectal cancer be regarded as several subgroups defined according to tumor location rather than as a single entity. The current study aimed to identify the most useful method for grouping colorectal cancer by tumor location according to both baseline and survival characteristics. Methods Cases of pathologically confirmed colorectal adenocarcinoma diagnosed from 2000 to 2012 were identified from the Surveillance, Epidemiology, and End Results database and categorized into three groups: right colon cancer (RCC), left colon cancer (LCC), and rectal cancer (ReC). Adjusted hazard ratios for known predictors of disease-specific survival (DSS) in colorectal cancer were obtained using a Cox proportional hazards regression model. Results The study included 57847 patients: 43.5% with RCC, 37.7% with LCC, and 18.8% with ReC. Compared with LCC and ReC, RCC was more likely to affect old patients and women, and to be at advanced stage, poorly differentiated or un-differentiated, and mucinous. Patients with LCC or ReC had better DSS than those with RCC in subgroups including stage III or IV disease, age <= 70 years and non-mucinous adenocarcinoma. Conversely, patients with LCC or ReC had worse DSS than those with RCC in subgroups including age >70 years and mucinous adenocarcinoma. Conclusions RCC differed from both LCC and ReC in several clinicopathologic characteristics and in DSS. It seems reasonable to group colorectal cancer into right-sided (i.e., proximal) and left-sided (i.e., distal) ones.	[Yang, Jiao; Li, Shu Ting; Wang, Bi Yuan; Wu, Yin Ying; Chen, Zhe Ling; Lv, Meng; Shen, Yan Wei; Wang, Xin; Dong, Dan Feng; Li, Dan; Wang, Fan; Li, En Xiao; Yi, Min; Yang, Jin] Xi An Jiao Tong Univ, Dept Med Oncol, Affiliated Hosp 1, Xian, Shaanxi Provinc, Peoples R China; [Du, Xiang Lin] Univ Texas Houston, Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX USA; [Yi, Min] Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, Houston, TX 77030 USA	Xi'an Jiaotong University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; UTMD Anderson Cancer Center	Yi, M; Yang, J (corresponding author), Xi An Jiao Tong Univ, Dept Med Oncol, Affiliated Hosp 1, Xian, Shaanxi Provinc, Peoples R China.; Yi, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, Houston, TX 77030 USA.	myi@mdanderson.org; yangjin@mail.xjtu.edu.cn	Yi, Min/J-8963-2017; Chen, Zheling/L-6089-2019	Yi, Min/0000-0001-8662-6546; 				Agesen TH, 2012, GUT, V61, P1560, DOI 10.1136/gutjnl-2011-301179; Alves Izabela Sinara Silva, 2016, J Gastrointest Cancer, V47, P278, DOI 10.1007/s12029-016-9829-1; Bernstein AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135959; Bretthauer M, 2016, JAMA INTERN MED, V176, P894, DOI 10.1001/jamainternmed.2016.0960; Brule SY, 2015, EUR J CANCER, V51, P1405, DOI 10.1016/j.ejca.2015.03.015; BUFILL JA, 1990, ANN INTERN MED, V113, P779, DOI 10.7326/0003-4819-113-10-779; Chen Jeffrey, 2016, Hosp Pract (1995), V44, P120, DOI 10.1080/21548331.2016.1200949; Chen KH, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2358-2; de Kort S, 2016, EUR J GASTROEN HEPAT, V28, P896, DOI 10.1097/MEG.0000000000000626; Erning v. RE, 2015, JNCI J NATL CANC I; Ghazi S, 2012, J GASTROENTEROL, V47, P619, DOI 10.1007/s00535-011-0520-9; Graziano F, 2016, PHARMACOGENOMICS J; Huh JW, 2014, J SURG ONCOL, V109, P848, DOI 10.1002/jso.23592; Jayasekara H, 2016, INT J CANCER, V139, P1081, DOI 10.1002/ijc.30153; Keeler BD, 2016, ANN MED SURG, V6, P6, DOI 10.1016/j.amsu.2015.12.052; Korphaisarn K, 2015, WORLD J GASTROENTERO, V21, P926, DOI 10.3748/wjg.v21.i3.926; Loupakis F, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju427; Meguid RA, 2008, ANN SURG ONCOL, V15, P2388, DOI 10.1245/s10434-008-0015-y; Moretto R, 2016, ONCOLOGIST, V21, P988, DOI 10.1634/theoncologist.2016-0084; Nash GM, 2009, DIS COLON RECTUM, V52, P577, DOI 10.1007/DCR.0b013e3181a0adbd; Nayani R, 2015, CURR COLORECT CANC R, V11, P408, DOI 10.1007/s11888-015-0302-5; Plummer JM, 2016, ANN MED SURG, V6, P26, DOI 10.1016/j.amsu.2016.01.018; Price TJ, 2015, CANCER-AM CANCER SOC, V121, P830, DOI 10.1002/cncr.29129; Pugh SA, 2015, ANN SURG; Rotondano G, 2015, DIGEST LIVER DIS, V47, P512, DOI 10.1016/j.dld.2015.03.005; Sideris M, 2015, ANTICANCER RES, V35, P2345; Steffen A, 2014, MED J AUSTRALIA, V201, P523, DOI 10.5694/mja14.00197; Tarantino I, 2015, ANN SURG ONCOLOGY; Lopez PJT, 2014, CLIN MED INSIGHTS-GA, V7, P33, DOI 10.4137/CGast.S14039; TEIXEIRA Yolanda, 2015, Arq. Gastroenterol., V52, P293, DOI 10.1590/S0004-28032015000400008; Vaish V, 2016, GENE CHROMOSOME CANC, V55, P577, DOI 10.1002/gcc.22361; Vulcan A, 2015, BRIT J NUTR, V114, P959, DOI 10.1017/S0007114515002743; Wang MJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002350; Weiss JM, 2011, J CLIN ONCOL, V29, P4401, DOI 10.1200/JCO.2011.36.4414; Wong HL, 2016, CLIN COLORECTAL CANC, V15, pE9, DOI 10.1016/j.clcc.2016.02.007; Xu S Z, 2016, Zhonghua Yi Xue Za Zhi, V96, P1578, DOI 10.3760/cma.j.issn.0376-2491.2016.20.007; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865; You YN, 2007, ANN SURG, V245, P726, DOI 10.1097/01.sla.0000252590.95116.4f; Zhang Jian, 2016, Zhonghua Wei Chang Wai Ke Za Zhi, V19, P780	39	43	46	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167540	10.1371/journal.pone.0167540	http://dx.doi.org/10.1371/journal.pone.0167540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936129	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100118
J	Yao, CH; Carlisi, C; Li, YN; Chen, D; Ding, JF; Feng, YL				Yao, Chunhe; Carlisi, Cristina; Li, Yuning; Chen, Da; Ding, Jianfu; Feng, Yong-Lai			Interaction Potency of Single-Walled Carbon Nanotubes with DNAs: A Novel Assay for Assessment of Hazard Risk	PLOS ONE			English	Article							PHYSICOCHEMICAL PROPERTIES; STRANDED-DNA; IN-VITRO; CYTOTOXICITY; CELLS; NANOMATERIALS; ADSORPTION; TOXICITY; EXPOSURE; DELIVERY	Increasing use of single-walled carbon nanotubes (SWCNTs) necessitates a novel method for hazard risk assessment. In this work, we investigated the interaction of several types of commercial SWCNTs with single-stranded (ss) and double-stranded (ds) DNA oligonucleotides (20-mer and 20 bp). Based on the results achieved, we proposed a novel assay that employed the DNA interaction potency to assess the hazard risk of SWCNTs. It was found that SWCNTs in different sizes or different batches of the same product number of SWCNTs showed dramatically different potency of interaction with DNAs. In addition, the same SWCNTs also exerted strikingly different interaction potency with ss-versus ds-DNAs. The interaction rates of SWCNTs with DNAs were investigated, which could be utilized as the indicator of potential hazard for acute exposure. Compared to solid SWCNTs, the SWCNTs dispersed in liquid medium (2% sodium cholate solution) exhibited dramatically different interaction potency with DNAs. This indicates that the exposure medium may greatly influence the subsequent toxicity and hazard risk produced by SWCNTs. Based on the findings of dose-dependences and time-dependences from the interactions between SWCNTs and DNAs, a new chemistry based assay for hazard risk assessment of nanomaterials including SWCNTs has been presented.	[Yao, Chunhe; Carlisi, Cristina; Feng, Yong-Lai] Hlth Canada, Exposure & Biomonitoring Div, Environm Hlth Sci & Res Bur, Environm & Radiat Hlth Sci Directorate,Hlth Envir, Ottawa, ON, Canada; [Li, Yuning] Univ Waterloo, Dept Chem Engn, Dept Chem, Waterloo, ON, Canada; [Li, Yuning] Univ Waterloo, WIN, Waterloo, ON, Canada; [Chen, Da] Southern Illinois Univ, Cooperat Wildlife Res Lab, Carbondale, IL 62901 USA; [Chen, Da] Southern Illinois Univ, Dept Zool, Carbondale, IL 62901 USA; [Ding, Jianfu] Natl Res Council Canada, Secur & Disrupt Technol, Ottawa, ON, Canada	Health Canada; University of Waterloo; University of Waterloo; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; National Research Council Canada	Feng, YL (corresponding author), Hlth Canada, Exposure & Biomonitoring Div, Environm Hlth Sci & Res Bur, Environm & Radiat Hlth Sci Directorate,Hlth Envir, Ottawa, ON, Canada.	yong-lai.feng@canada.ca	Li, Yuning/G-4546-2010; Chen, Da/F-5821-2014	Li, Yuning/0000-0003-3679-8133; Chen, Da/0000-0001-5563-0091	Natural Sciences and Engineering Research Council (NSERC) Canada; Health Canada; Canadian Government under the Chemicals Management Plan (CMP); NSERC Canada	Natural Sciences and Engineering Research Council (NSERC) Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Health Canada; Canadian Government under the Chemicals Management Plan (CMP); NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Dr. Yao is grateful to Natural Sciences and Engineering Research Council (NSERC) Canada and Health Canada for financial support in the form of post-doctoral fellowship. The Canadian Government under the Chemicals Management Plan (CMP) financially supported this project.; We are grateful to NSERC Canada and Health Canada for financial support in the form of post-doctoral fellowship to Chunhe Yao. The Canadian Government under the Chemicals Management Plan (CMP) financially supported this project.	Berges MG, 2013, NANOMATERIALS, P25; Bhirde AA, 2009, ACS NANO, V3, P307, DOI 10.1021/nn800551s; Bianco A, 2003, ADV MATER, V15, P1765, DOI 10.1002/adma.200301646; Cancino J, 2013, TOXICOL LETT, V219, P18, DOI 10.1016/j.toxlet.2013.02.009; Cui H, 2000, J APPL PHYS, V88, P6072, DOI 10.1063/1.1320024; Cui HF, 2010, CHEM RES TOXICOL, V23, P1131, DOI 10.1021/tx100050h; Du J, 2013, ENV TOXIC PHARM; Feng YL, 2009, ENVIRON TOXICOL CHEM, V28, P2044, DOI 10.1897/09-015.1; Gavina JMA, 2011, J ENVIRON MONITOR, V13, P3145, DOI 10.1039/c1em10511f; Geys J, 2010, TOXICOL IN VITRO, V24, P620, DOI 10.1016/j.tiv.2009.10.007; Hayashida T, 2013, COLLOID SURFACE B, V101, P49, DOI 10.1016/j.colsurfb.2012.06.018; Heller DA, 2006, SCIENCE, V311, P508, DOI 10.1126/science.1120792; Hughes ME, 2007, NANO LETT, V7, P1191, DOI 10.1021/nl062906u; HUNTER CA, 1990, J AM CHEM SOC, V112, P5525, DOI 10.1021/ja00170a016; Jia G, 2005, ENVIRON SCI TECHNOL, V39, P1378, DOI 10.1021/es048729l; Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102; Kato Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00733; Liu ZD, 2011, ANAL CHIM ACTA, V706, P171, DOI 10.1016/j.aca.2011.08.032; Lu G, 2005, NANO LETT, V5, P897, DOI 10.1021/nl050354u; Manshian BB, 2013, NANOTOXICOLOGY, V7, P144, DOI 10.3109/17435390.2011.647928; Maynard AD, 2004, J TOXICOL ENV HEAL A, V67, P87, DOI 10.1080/15287390490253688; Mayo ML, 2012, J PHYS CHEM LETT, V3, P2790, DOI 10.1021/jz3011145; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Ong LC, 2016, ARCH TOXICOL, V90, P103, DOI 10.1007/s00204-014-1376-6; Raffa V, 2010, NANOMEDICINE-UK, V5, P89, DOI 10.2217/NNM.09.95; Rajendra J, 2005, CHEM-EUR J, V11, P4841, DOI 10.1002/chem.200500093; Ren HX, 2010, MATER TODAY, V13, P6, DOI 10.1016/S1369-7021(10)70002-X; Saito R, 1998, PHYS PROPERTIES CARB; Shvedova AA, 2003, J TOXICOL ENV HEAL A, V66, P1909, DOI 10.1080/713853956; Speit Gunter, 2006, Methods Mol Biol, V314, P275; Thomas SP, 2013, ARAB J SCI ENG, V38, P457, DOI 10.1007/s13369-012-0324-0; Vashist SK, 2011, CARBON, V49, P4077, DOI 10.1016/j.carbon.2011.05.049; Vashist SK, 2011, BIOTECHNOL ADV, V29, P169, DOI 10.1016/j.biotechadv.2010.10.002; Walter D, 2001, J THERM ANAL CALORIM, V63, P733, DOI 10.1023/A:1010187921227; Weizmann Y, 2011, J AM CHEM SOC, V133, P3238, DOI 10.1021/ja109180d; Yan H, 2006, CHEMOSPHERE, V62, P142, DOI 10.1016/j.chemosphere.2005.03.075; Yun Y, 2012, J NANOMEDIC BIOTHERA, V2, P2, DOI DOI 10.4172/2155-983X.1000104; Zheng D, 2009, BIOELECTROCHEMISTRY, V74, P240, DOI 10.1016/j.bioelechem.2008.08.006; Zheng M, 2003, NAT MATER, V2, P338, DOI 10.1038/nmat877; Zheng M, 2003, SCIENCE, V302, P1545, DOI 10.1126/science.1091911	40	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167796	10.1371/journal.pone.0167796	http://dx.doi.org/10.1371/journal.pone.0167796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936089	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100195
J	Casilari, E; Santoyo-Ramon, JA; Cano-Garcia, JM				Casilari, Eduardo; Antonio Santoyo-Ramon, Jose; Manuel Cano-Garcia, Jose			Analysis of a Smartphone-Based Architecture with Multiple Mobility Sensors for Fall Detection	PLOS ONE			English	Article							EFFICIENT; CHALLENGES	During the last years, many research efforts have been devoted to the definition of Fall Detection Systems (FDSs) that benefit from the inherent computing, communication and sensing capabilities of smartphones. However, employing a smartphone as the unique sensor in a FDS application entails several disadvantages as long as an accurate characterization of the patient's mobility may force to transport this personal device on an unnatural position. This paper presents a smartphone-based architecture for the automatic detection of falls. The system incorporates a set of small sensing motes that can communicate with the smartphone to help in the fall detection decision. The deployed architecture is systematically evaluated in a testbed with experimental users in order to determine the number and positions of the sensors that optimize the effectiveness of the FDS, as well as to assess the most convenient role of the smartphone in the architecture.	[Casilari, Eduardo; Antonio Santoyo-Ramon, Jose; Manuel Cano-Garcia, Jose] Univ Malaga, Dept Tecnol Elect, Malaga, Spain	Universidad de Malaga	Casilari, E (corresponding author), Univ Malaga, Dept Tecnol Elect, Malaga, Spain.	ecasilari@uma.es	Garcia, Jose Manuel Cano/F-3960-2016; CASILARI, EDUARDO/L-6007-2014	Garcia, Jose Manuel Cano/0000-0002-8211-7602; CASILARI, EDUARDO/0000-0003-2573-1048; Santoyo Ramon, Jose Antonio/0000-0003-4252-1077	European FEDER funds; Spanish Ministry of Economy and Competitiveness [TEC2013-42711-R]	European FEDER funds(European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by European FEDER funds and the Spanish Ministry of Economy and Competitiveness [grant TEC2013-42711-R] [http://www.mineco.gob.es/portal/site/mineco/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036556; Albinali F, 2012, PERVASIVE MOB COMPUT, V8, P103, DOI 10.1016/j.pmcj.2011.04.006; Alvi AN, 2016, IEEE ACCESS, V4, P312, DOI 10.1109/ACCESS.2016.2515096; Atallah L, 2011, IEEE T BIOMED CIRC S, V5, P320, DOI 10.1109/TBCAS.2011.2160540; Baccarelli E, 2016, IEEE NETWORK, V30, P54, DOI 10.1109/MNET.2016.7437025; Banos O, 2012, EXPERT SYST APPL, V39, P8013, DOI 10.1016/j.eswa.2012.01.164; Bao L, 2004, LECT NOTES COMPUT SC, V3001, P1, DOI 10.1007/978-3-540-24646-6_1; Boehner A., 2013, P NAT C UND RES NCUR; Casilari E, UMAFALL REPOSITORY M; Casilari E, UMAFALL FALL DETECTI; Casilari E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140929; Casilari E, 2015, SENSORS-BASEL, V15, P17827, DOI 10.3390/s150817827; CDC (Centers for Disease Control and Prevention), 2014, COSTS TALLS OLD AD; Chang KM, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16071126; Cleland I, 2013, SENSORS-BASEL, V13, P9183, DOI 10.3390/s130709183; Conte V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034473, 10.1371/journal.pone.0037062]; Dong B, 2012, P 2012 4 INT C COMM; Figueiredo Isabel N., 2016, mUX: The Journal of Mobile User Experience, V5, DOI 10.1186/s13678-016-0004-1; Habib MA, 2014, SENSORS-BASEL, V14, P7181, DOI 10.3390/s140407181; Jiangpeng Dai, 2010, 2010 8th IEEE International Conference on Pervasive Computing and Communications Workshops (PERCOM Workshops), P292, DOI 10.1109/PERCOMW.2010.5470652; Kangas M., 2011, THESIS; Kau L, 2014, P IEEE INT S BIOEL B, P1; Klenk J, 2011, MED ENG PHYS, V33, P368, DOI 10.1016/j.medengphy.2010.11.003; Koshmak G, 2015, J SENSORS, V2016, P1; Kozina S, 2013, INT COMPETITION EVAL, P13, DOI DOI 10.1007/978-3-642-41043-72; Luque R, 2014, SENSORS-BASEL, V14, P18543, DOI 10.3390/s141018543; Maglogiannis I, 2014, IFIP ADV INF COMMUN, P70, DOI DOI 10.1007/978-3-662-44654-6_7; Ozdemir AT, 2014, SENSORS-BASEL, V14, P10691, DOI 10.3390/s140610691; Pannurat N, 2014, SENSORS-BASEL, V14, P12900, DOI 10.3390/s140712900; Pedley M., 2013, FREESCALE SEMICONDUC, V1, P2012; Shih-Hau Fang, 2012, 2012 Computing, Communications and Applications Conference (ComComAp 2012), P143, DOI 10.1109/ComComAp.2012.6154019; Shojafar M, 2019, IEEE T CLOUD COMPUT, V7, P196, DOI 10.1109/TCC.2016.2551747; Shojafar M, 2015, IEEE INT CONF COMM, P1800, DOI 10.1109/ICCW.2015.7247442; Sposaro F, 2009, IEEE ENG MED BIO, P6119, DOI 10.1109/IEMBS.2009.5334912; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Vilarinho Thomas, 2015, 2015 IEEE International Conferences on Computer and Information Technology; Ubiquitous Computing and Communications; Dependable, Autonomic and Secure Computing; and Pervasive Intelligence and Computing (CIT/IUCC/DASC/PICOM). Proceedings, P1443, DOI 10.1109/CIT/IUCC/DASC/PICOM.2015.216; Wang L, 2012, PERVASIVE MOB COMPUT, V8, P115, DOI 10.1016/j.pmcj.2010.12.001; WILD D, 1981, BRIT MED J, V282, P266, DOI 10.1136/bmj.282.6260.266; World Health Organization World Health Organization. Ageing and Life Course Unit, 2008, WHO GLOB REP FALLP; Xiong JP, 2016, IEEE ACCESS, V4, P3076, DOI 10.1109/ACCESS.2016.2580594; Yi W-J, 2014, P IEEE INT TECHN MAN, P1; Yin J, 2008, IEEE T KNOWL DATA EN, V20, P1082, DOI 10.1109/TKDE.2007.1042; Yoshida T., 2005, P 12 INT C BIOM ENG; Zhang L, 2012, 2012 7TH INTERNATIONAL CONFERENCE ON COMPUTING AND CONVERGENCE TECHNOLOGY (ICCCT2012), P261	45	39	41	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0168069	10.1371/journal.pone.0168069	http://dx.doi.org/10.1371/journal.pone.0168069			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930736	Green Published, gold			2022-12-27	WOS:000389580900078
J	Fachi, MM; Cerqueira, LB; Leonart, LP; de Francisco, TMG; Pontarolo, R				Fachi, Mariana Millan; Cerqueira, Leticia Bonancio; Leonart, Leticia Paula; Guimaraes de Francisco, Thais Martins; Pontarolo, Roberto			Simultaneous Quantification of Antidiabetic Agents in Human Plasma by a UPLC-QToF-MS Method	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHIC DETERMINATION; HPLC METHOD; METFORMIN; ROSIGLITAZONE; VALIDATION; DRUGS; IDENTIFICATION; PIOGLITAZONE; VILDAGLIPTIN	An ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry method for the simultaneous quantification of chlorpropamide, glibenclamide, gliclazide, glimepiride, metformin, nateglinide, pioglitazone, rosiglitazone, and vildagliptin in human plasma was developed and validated, using isoniazid and sulfaquinoxaline as internal standards. Following plasma protein precipitation using acetonitrile with 1% formic acid, chromatographic separation was performed on a cyano column using gradient elution with water and acetonitrile, both containing 0.1% formic acid. Detection was performed in a quadrupole time-of-flight analyzer, using electrospray ionization operated in the positive mode. Data from validation studies demonstrated that the new method is highly sensitive, selective, precise (RSD < 10%), accurate (RE < 12%), linear (r > 0.99), free of matrix and has no residual effects. The developed method was successfully applied to volunteers' plasma samples. Hence, this method was demonstrated to be appropriate for clinical monitoring of antidiabetic agents.	[Fachi, Mariana Millan; Cerqueira, Leticia Bonancio; Leonart, Leticia Paula; Guimaraes de Francisco, Thais Martins; Pontarolo, Roberto] Univ Fed Parana, Dept Pharm, Curitiba, Parana, Brazil	Universidade Federal do Parana	Pontarolo, R (corresponding author), Univ Fed Parana, Dept Pharm, Curitiba, Parana, Brazil.	pontarolo@ufpr.br	Pontarolo, Roberto/G-6948-2014	Pontarolo, Roberto/0000-0002-7049-4363; Leonart, Leticia/0000-0003-0927-3120	Ministerio da Ciencia e Tecnologia-MCT, Ministerio da Saude, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(MCT/CNPq/CT-SAUDE/MS/SCTIE/DECIT); Secretaria da Ciencia, Tecnologia e Ensino Superior (SETI-PR)	Ministerio da Ciencia e Tecnologia-MCT, Ministerio da Saude, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(MCT/CNPq/CT-SAUDE/MS/SCTIE/DECIT); Secretaria da Ciencia, Tecnologia e Ensino Superior (SETI-PR)	The authors would like to thank the Ministerio da Ciencia e Tecnologia-MCT, Ministerio da Saude, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(MCT/CNPq/CT-SAUDE/MS/SCTIE/DECIT) and Secretaria da Ciencia, Tecnologia e Ensino Superior (SETI-PR) for the financial support of laboratory infrastructure.	Rojas LBA, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-6; [Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; [Anonymous], 2012, RDC 27 17 MAIO 2012; Attimarad MV, 2015, J IRAN CHEM SOC, V12, P1629, DOI 10.1007/s13738-015-0637-5; BAKARE MT, 1994, CHROMATOGRAPHIA, V39, P107, DOI 10.1007/BF02320468; Barrett T., 2013, PAEDIAT CHILD HLTH, V23, P163; Ben-Hander GM, 2015, TALANTA, V131, P590, DOI 10.1016/j.talanta.2014.08.037; Binz TM, 2012, FORENSIC SCI INT, V223, P119, DOI 10.1016/j.forsciint.2012.08.014; Chen LY, 2011, J CHROMATOGR SCI, V49, P94, DOI 10.1093/chrsci/49.2.94; Viana IMD, 2014, J PHARMACEUT BIOMED, V96, P241, DOI 10.1016/j.jpba.2014.03.042; Ding CG, 2007, BIOMED CHROMATOGR, V21, P132, DOI 10.1002/bmc.723; European Medicines Agency (EMA), 2012, GUID BIOAN METH VAL; Food and Drug Administration, 2001, GUID IND BIOAN METH; Frid A, 2009, DIABETOLOGIA, V52, pS8; Garcia-Perez LE, 2013, DIABETES THER, V4, P175, DOI 10.1007/s13300-013-0034-y; Gedeon C, 2008, CLIN BIOCHEM, V41, P167, DOI 10.1016/j.clinbiochem.2007.07.025; Georgita C, 2007, J CHROMATOGR B, V854, P211, DOI 10.1016/j.jchromb.2007.04.032; Handelsman Y, 2015, ENDOCR PRACT, V21, P1, DOI [10.4158/EP15672.GLSUPPL, 10.4158/EP15672.GL]; He YL, 2007, J CLIN PHARMACOL, V47, P633, DOI 10.1177/0091270006299137; He YL, 2009, CURR MED RES OPIN, V25, P1265, DOI [10.1185/03007990902869102, 10.1185/03007990902869102 ]; Hess C, 2011, ANAL BIOANAL CHEM, V400, P33, DOI 10.1007/s00216-011-4698-8; Hoizey G, 2005, CLIN CHEM, V51, P1666, DOI 10.1373/clinchem.2005.050864; International Diabetes Federation, 2015, INT DIAB FED DIAB AT; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Jagadeesh B, 2013, J CHROMATOGR B, V930, P136, DOI 10.1016/j.jchromb.2013.04.024; Jingar JN, 2008, CHROMATOGRAPHIA, V67, P951, DOI 10.1365/s10337-008-0633-3; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Kang Ju-Seop, 2009, Korean Journal of Internal Medicine, V24, P1, DOI 10.3904/kjim.2009.24.1.1; Kawaguchi-Suzuki M, 2014, J CHROMATOGR B, V969, P219, DOI 10.1016/j.jchromb.2014.08.019; Klein S, 2004, DIABETES CARE, V27, P2067, DOI 10.2337/diacare.27.8.2067; Krentz AJ, 2005, DRUGS, V65, P385, DOI 10.2165/00003495-200565030-00005; Li N, 2013, BIOMED CHROMATOGR, V27, P191, DOI 10.1002/bmc.2768; Lin ZPJ, 2004, J CHROMATOGR B, V801, P265, DOI 10.1016/j.jchromb.2003.11.019; Magni F, 2000, ANAL BIOCHEM, V282, P136, DOI 10.1006/abio.2000.4597; Malli D, 2007, ANAL CHIM ACTA, V599, P143, DOI 10.1016/j.aca.2007.08.004; Matsuki M, 2007, ENDOCR J, V54, P571, DOI 10.1507/endocrj.K06-052; Maurer HH, 2002, J CHROMATOGR B, V773, P63, DOI 10.1016/S1570-0232(01)00618-3; Mistri HN, 2007, J PHARMACEUT BIOMED, V45, P97, DOI 10.1016/j.jpba.2007.06.003; Naraharisetti SB, 2007, J CHROMATOGR B, V860, P34, DOI 10.1016/j.jchromb.2007.10.010; Ni XJ, 2014, J CHROMATOGR B, V960, P247, DOI 10.1016/j.jchromb.2014.04.039; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Odunola MTB, 2007, AFR J BIOTECHNOL, V6, P1378; Ovalle F, 2011, CLIN THER, V33, P393, DOI 10.1016/j.clinthera.2011.04.006; Pontarolo R, 2014, J CHROMATOGR B, V965, P133, DOI 10.1016/j.jchromb.2014.06.023; Pratley RE, 2013, AM J MED, V126, pS2, DOI 10.1016/j.amjmed.2013.06.007; Ranetti MC, 2009, FARMACIA, V57, P728; Rashid A, 2014, PAK J PHARM SCI, V27, P153; Reddy S, 2015, J CHROMATOGR SCI, V53, P1549, DOI 10.1093/chromsci/bmv055; Reitman ML, 2007, J CLIN INVEST, V117, P1226, DOI 10.1172/JCI32133; Sengupta P, 2009, CHROMATOGRAPHIA, V69, P1243, DOI 10.1365/s10337-009-1056-5; Sesti G, 2006, J CLIN ENDOCR METAB, V91, P2334, DOI 10.1210/jc.2005-2323; Shantikumar S, 2015, ANAL METHODS-UK, V7, P6198, DOI 10.1039/c5ay00342c; Shikata E, 2007, J HUM GENET, V52, P117, DOI 10.1007/s10038-006-0087-0; Shu Y, 2007, J CLIN INVEST, V117, P1422, DOI 10.1172/JCI30558; Simonson G, 2011, DIABTES MANAG, V1, P175; Society Ac: American cancer Society, 2015, CANC FACTS FIG 2015, P1; Tirumala R, 2009, J PHARM PHARMACOL, V61, pA102; Yardimci C, 2007, TALANTA, V72, P1416, DOI 10.1016/j.talanta.2007.01.042; Zhang L, 2007, J CHROMATOGR B, V854, P91, DOI 10.1016/j.jchromb.2007.04.002; Zhong GP, 2005, J MASS SPECTROM, V40, P1462, DOI 10.1002/jms.907	60	11	12	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167107	10.1371/journal.pone.0167107	http://dx.doi.org/10.1371/journal.pone.0167107			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930700	Green Published, Green Submitted, gold			2022-12-27	WOS:000389580900021
J	Harun-Or-Rashid, M; Konjusha, D; Galindo-Romero, C; Hallbook, F				Harun-Or-Rashid, Mohammad; Konjusha, Dardan; Galindo-Romero, Caridad; Hallbook, Finn			Endothelin B Receptors on Primary Chicken Muller Cells and the Human MIO-M1 Muller Cell Line Activate ERK Signaling via Transactivation of Epidermal Growth Factor Receptors	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; SMOOTH-MUSCLE-CELLS; PRIMARY OPEN-ANGLE; EGF RECEPTOR; KINASE ACTIVATION; RETINAL NEURONS; RAS ACTIVATION; AQUEOUS-HUMOR; ETB-RECEPTOR; NITRIC-OXIDE	Injury to the eye or retina triggers Muller cells, the major glia cell of the retina, to dedifferentiate and proliferate. In some species they attain retinal progenitor properties and have the capacity to generate new neurons. The epidermal growth factor receptor (EGFR) system and extracellular signal-regulated kinase (ERK) signaling are key regulators of these processes in Muller cells. The extracellular signals that modulate and control these processes are not fully understood. In this work we studied whether endothelin receptor signaling can activate EGFR and ERK signaling in Muller cells. Endothelin expression is robustly upregulated at retinal injury and endothelin receptors have been shown to transactivate EGFRs in other cell types. We analyzed the endothelin signaling system in chicken retina and cultured primary chicken Muller cells as well as the human Muller cell line MIO-M1. The Muller cells were stimulated with receptor agonists and treated with specific blockers to key enzymes in the signaling pathway or with siRNAs. We focused on endothelin receptor mediated transactivation of EGFRs by using western blot analysis, quantitative reverse transcriptase PCR and immunocytochemistry. The results showed that chicken Muller cells and the human Muller cell line MIO-M1 express endothelin receptor B. Stimulation by the endothelin receptor B agonist IRL1620 triggered phosphorylation of ERK1/2 and autophosphorylation of (Y1173) EGFR. The effects could be blocked by Src-kinase inhibitors (PP1, PP2), EGFR-inhibitor (AG1478), EGFR-siRNA and by inhibitors to extracellular matrix metalloproteinases (GM6001), consistent with a Src-kinase mediated endothelin receptor response that engage ligand-dependent and ligand-independent EGFR activation. Our data suggest a mechanism for how injury-induced endothelins, produced in the retina, may modulate the Muller cell responses by Src-mediated transactivation of EGFRs. The data give support to a view in which endothelins among several other functions, serve as an injury-signal that regulate the gliotic response of Muller cells.	[Harun-Or-Rashid, Mohammad; Konjusha, Dardan; Galindo-Romero, Caridad; Hallbook, Finn] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Galindo-Romero, Caridad] Univ Murcia, Fac Med, Dept Oftalmol, Murcia, Spain; [Galindo-Romero, Caridad] Inst Murciano Invest Biosanitaria Virgen Arrixaca, Murcia, Spain	Uppsala University; University of Murcia; Hospital Clinico Universitario Virgen de la Arrixaca	Hallbook, F (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	Finn.Hallbook@neuro.uu.se	GALINDO-ROMERO, CARIDAD/AAF-8324-2021	GALINDO-ROMERO, CARIDAD/0000-0001-9469-9868; Hallbook, Finn/0000-0001-7552-187X	Swedish Research Council [M 12187]; Ogonfonden, FH; Stiftelsen Kronprinsessan Margaretas Arbetsnamnd for synskadade [34:2015]; FPU-UM Universidad de Murcia Spain [R-480/2014]; Red Tem'atica de Investigaci'on Cooperativa en Salud (RETICS) [RD12/0034/0014]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Ogonfonden, FH; Stiftelsen Kronprinsessan Margaretas Arbetsnamnd for synskadade; FPU-UM Universidad de Murcia Spain; Red Tem'atica de Investigaci'on Cooperativa en Salud (RETICS)(European Commission)	This work was supported by the Swedish Research Council M 12187, FH; Ogonfonden, FH; Stiftelsen Kronprinsessan Margaretas Arbetsnamnd for synskadade 34:2015, FH; FPU-UM Universidad de Murcia Spain R-480/2014, CGR; Red Tem'atica de Investigaci'on Cooperativa en Salud (RETICS) RD12/0034/0014, CGR.	BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Boije H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050890; BOULTON TG, 1991, CELL REGUL, V2, P357, DOI 10.1091/mbc.2.5.357; Bramall AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058023; Braunger BM, 2013, NEUROBIOL DIS, V50, P1, DOI 10.1016/j.nbd.2012.09.008; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Chen HY, 2013, J GLAUCOMA, V22, P117, DOI 10.1097/IJG.0b013e31822e8c65; Choritz L, 2012, INVEST OPHTH VIS SCI, V53, P7336, DOI 10.1167/iovs.12-10216; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Du T, 2009, NEUROCHEM INT, V55, P593, DOI 10.1016/j.neuint.2009.05.016; Fischer AJ, 2009, GLIA, V57, P1538, DOI 10.1002/glia.20868; Fischer AJ, 2009, GLIA, V57, P166, DOI 10.1002/glia.20743; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; Grantcharova E, 2006, ARTERIOSCL THROM VAS, V26, P1288, DOI 10.1161/01.ATV.0000220377.51354.30; Gutwein P, 2000, J BIOL CHEM, V275, P15490, DOI 10.1074/jbc.275.20.15490; HAEFLIGER IO, 1992, INVEST OPHTH VIS SCI, V33, P2340; Han YC, 1996, CANCER RES, V56, P3859; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Harun-Or-Rashid M, 2015, INVEST OPHTH VIS SCI, V56, P5933, DOI 10.1167/iovs.15-16816; Harun-Or-Rashid M, 2014, INVEST OPHTH VIS SCI, V55, P3385, DOI 10.1167/iovs.13-13823; HAWES BE, 1995, J BIOL CHEM, V270, P17148, DOI 10.1074/jbc.270.29.17148; He SQ, 2015, INVEST OPHTH VIS SCI, V56, P6144, DOI 10.1167/iovs.15-16569; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; ISHIKAWA K, 1994, P NATL ACAD SCI USA, V91, P4892, DOI 10.1073/pnas.91.11.4892; Joly S, 2008, J NEUROSCI, V28, P13765, DOI 10.1523/JNEUROSCI.5114-08.2008; Ka S, 2013, PHYSIOL GENOMICS, V45, P367, DOI 10.1152/physiolgenomics.00078.2012; Karkoulias G, 2006, CELL SIGNAL, V18, P729, DOI 10.1016/j.cellsig.2005.06.014; Kim H, 2005, ONCOGENE, V24, P7599, DOI 10.1038/sj.onc.1208898; Krishnamoorthy RR, 2008, CAN J PHYSIOL PHARM, V86, P380, DOI 10.1139/Y08-040; Lahav R, 1996, P NATL ACAD SCI USA, V93, P3892, DOI 10.1073/pnas.93.9.3892; Lawrence JM, 2007, STEM CELLS, V25, P2033, DOI 10.1634/stemcells.2006-0724; Lecoin L, 1998, P NATL ACAD SCI USA, V95, P3024, DOI 10.1073/pnas.95.6.3024; Li YA, 2010, AM J PHYSIOL-HEART C, V299, pH1959, DOI 10.1152/ajpheart.00526.2010; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; Ling L, 2013, BRIT J PHARMACOL, V168, P283, DOI 10.1111/j.1476-5381.2011.01786.x; Linser PJ, 1997, DEV GENET, V20, P186; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mi XS, 2012, INVEST OPHTH VIS SCI, V53, P4842, DOI 10.1167/iovs.12-9999; Nakazawa T, 2008, J NEUROSCI RES, V86, P136, DOI 10.1002/jnr.21472; Ochrietor JD, 2010, MOL VIS, V16, P961; Oku H, 2008, EXP EYE RES, V86, P118, DOI 10.1016/j.exer.2007.10.001; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Rattner A, 2005, J NEUROSCI, V25, P4540, DOI 10.1523/JNEUROSCI.0492-05.2005; Rogers SD, 1997, EXP NEUROL, V145, P180, DOI 10.1006/exnr.1997.6468; Rojas M, 1996, J BIOL CHEM, V271, P27456, DOI 10.1074/jbc.271.44.27456; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; Santiskulvong C, 2003, EXP CELL RES, V290, P437, DOI 10.1016/S0014-4827(03)00355-0; Sarthy VP, 2015, CURR EYE RES, P1; Schinelli S, 2001, J NEUROSCI, V21, P8842, DOI 10.1523/JNEUROSCI.21-22-08842.2001; TAKAI M, 1992, BIOCHEM BIOPH RES CO, V184, P953, DOI 10.1016/0006-291X(92)90683-C; TAKIGAWA M, 1995, EUR J BIOCHEM, V228, P102, DOI 10.1111/j.1432-1033.1995.0102o.x; Tezel G, 1997, J GLAUCOMA, V6, P83; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan J, 2012, DEV CELL, V22, P334, DOI 10.1016/j.devcel.2011.11.020; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	58	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167778	10.1371/journal.pone.0167778	http://dx.doi.org/10.1371/journal.pone.0167778			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930693	Green Published, gold			2022-12-27	WOS:000389580900045
J	Tominag, T; Nonaka, T; Sumida, Y; Hidaka, S; Sawai, T; Nagayasu, T				Tominag, Tetsuro; Nonaka, Takashi; Sumida, Yorihisa; Hidaka, Shigekazu; Sawai, Terumitsu; Nagayasu, Takeshi			The C-Reactive Protein to Albumin Ratio as a Predictor of Severe Side Effects of Adjuvant Chemotherapy in Stage III Colorectal Cancer Patients	PLOS ONE			English	Article							NEUTROPHIL-LYMPHOCYTE RATIO; COLON-CANCER; PROTEIN/ALBUMIN RATIO; PROGNOSTIC SCORE; GASTRIC-CANCER; FLUOROURACIL; OXALIPLATIN; LEUCOVORIN; CARCINOMA; SURVIVAL	Background/Aims Adjuvant chemotherapy (AC) has been reported to improve the prognosis for patients with Stage III colorectal cancer (CRC). However, some patients experience severe side effects and must stop AC. The C-reactive protein (CRP) to albumin ratio (CAR) is a novel inflammation-based score that could reflect the patient's general condition. The aim of this study was to evaluate the predictive value of the CAR for side effects of AC in CRC. Methods A total of 136 CRC patients who received AC were retrospectively analyzed. The patients were subdivided into two groups by the CAR level (CAR >= 0.1, n = 30; CD < 0.1, n = 106). Results The presence of lymphatic invasion, severe side effects, and discontinuation of AC were associated with high CAR levels (p = 0.02, <0.01, and 0.02; respectively). High levels of the Glasgow Prognostic Score (GPS) and the neutrophil to lymphocyte ratio (NLR) appeared to be associated with the CAR (p = 0.04, p<0.01; respectively). Multivariate analysis identified CAR >= 0.1 (HR: 7.06, 95% CI: 2.51-19.88, p<0.01) as a significant determinant of severe side effects of AC. CAR had the highest area under the curve (0.79) among several inflammation-based scores. Conclusion The present study showed that the CAR is a novel and promising inflammation-based score for >= grade 3 side effects of AC in node-positive CRC.	[Tominag, Tetsuro; Nonaka, Takashi; Sumida, Yorihisa; Hidaka, Shigekazu; Nagayasu, Takeshi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg Oncol, Nagasaki, Japan; [Sawai, Terumitsu] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cardiopulm Rehabil Sci, Nagasaki, Japan; [Tominag, Tetsuro; Nonaka, Takashi; Sumida, Yorihisa; Hidaka, Shigekazu; Sawai, Terumitsu; Nagayasu, Takeshi] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki, Japan	Nagasaki University; Nagasaki University; Nagasaki University	Sawai, T (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Cardiopulm Rehabil Sci, Nagasaki, Japan.; Sawai, T (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki, Japan.	sawai@nagasaki-u.ac.jp		Sawai, Terumitsu/0000-0003-2217-7950				Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; [Anonymous], 2012, CAS TREAT 2003 2004, V30; Aquino VM, 2012, J PEDIAT HEMATOL ONC, V34, pE241, DOI 10.1097/MPH.0b013e31824e498d; Choi KW, 2014, ANN SURG TREAT RES, V86, P309, DOI 10.4174/astr.2014.86.6.309; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; HALL WH, 1990, JAMA-J AM MED ASSOC, V264, P1444; Hasenberg T, 2010, COLORECTAL DIS, V12, pE190, DOI 10.1111/j.1463-1318.2009.02111.x; Hattori H, 2009, INT J GERIATR PSYCH, V24, P1304, DOI 10.1002/gps.2262; Ishizuka M, 2016, ANN SURG ONCOL, V23, P900, DOI 10.1245/s10434-015-4948-7; Josse JM, 2016, COLORECTAL DIS, V10; Kinoshita A, 2015, ANN SURG ONCOL, V22, P803, DOI 10.1245/s10434-014-4048-0; Ko JJ, 2016, CLIN COLORECTAL CANC, V15, P179, DOI 10.1016/j.clcc.2015.09.002; Kuebler JP, 2007, J CLIN ONCOL, V25, P2198, DOI 10.1200/JCO.2006.08.2974; Lee S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-350; Lembersky BC, 2006, J CLIN ONCOL, V24, P2059, DOI 10.1200/JCO.2005.04.7498; Liu XC, 2015, TRANSL ONCOL, V8, P339, DOI 10.1016/j.tranon.2015.06.006; McMillan DC, 2013, CANCER TREAT REV, V39, P534, DOI 10.1016/j.ctrv.2012.08.003; Moro-Sibilot D, 2005, EUR RESPIR J, V26, P480, DOI 10.1183/09031936.05.00146004; Nakanishi M, 2016, ANTICANCER RES, V36, P1851; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; O'Connell MJ, 1998, J CLIN ONCOL, V16, P295, DOI 10.1200/JCO.1998.16.1.295; Ohrmalm L, 2013, J INTERN MED, V274, P363, DOI 10.1111/joim.12100; Sakamoto K, 2006, ONCOL REP, V16, P381; Sargent DJ, 2001, NEW ENGL J MED, V345, P1091, DOI 10.1056/NEJMoa010957; SCHEITHAUER W, 1993, BRIT MED J, V306, P752, DOI 10.1136/bmj.306.6880.752; Smith RA, 2009, AM J SURG, V197, P466, DOI 10.1016/j.amjsurg.2007.12.057; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Tromp YH, 2009, EUR J CANCER, V45, P596, DOI 10.1016/j.ejca.2008.10.041; Xiao LX, 2015, PROS ONE, V21, P10; Zou ZY, 2016, ONCOL LETT, V11, P2241, DOI 10.3892/ol.2016.4216	31	26	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167967	10.1371/journal.pone.0167967	http://dx.doi.org/10.1371/journal.pone.0167967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930703	Green Published, Green Submitted, gold			2022-12-27	WOS:000389580900064
J	Wren, JLK; Kobayashi, DR; Jia, Y; Toonen, RJ				Wren, Johanna L. K.; Kobayashi, Donald R.; Jia, Yanli; Toonen, Robert J.			Modeled Population Connectivity across the Hawaiian Archipelago	PLOS ONE			English	Article							CORAL-REEF FISH; CALIFORNIA CURRENT SYSTEM; MARINE POPULATIONS; LARVAL DISPERSAL; GENETIC-STRUCTURE; BUILDING CORAL; JOHNSTON ATOLL; OCEAN CURRENTS; F-STATISTICS; IN-SITU	We present the first comprehensive estimate of connectivity of passive pelagic particles released from coral reef habitat throughout the Hawaiian Archipelago. Potential connectivity is calculated using a Lagrangian particle transport model coupled offline with currents generated by an oceanographic circulation model, MITgcm. The connectivity matrices show a surprising degree of self-recruitment and directional dispersal towards the northwest, from the Main Hawaiian Islands (MHI) to the northwestern Hawaiian Islands (NWHI). We identify three predicted connectivity breaks in the archipelago, that is, areas in the mid and northern part of the archipelago that have limited connections with surrounding islands and reefs. Predicted regions of limited connectivity generally match observed patterns of genetic structure reported for coral reef species in the uninhabited NWHI, but multiple genetic breaks observed in the inhabited MHI are not explained by passive dispersal. The better congruence in our modeling results based on physical transport of passive particles in the low-lying atolls of the uninhabited NWHI, but not in the anthropogenically impacted high islands of the MHI begs the question: what ultimately controls connectivity in this system?	[Wren, Johanna L. K.] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Wren, Johanna L. K.; Toonen, Robert J.] Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Hawaii Inst Marine Biol, Honolulu, HI 96822 USA; [Kobayashi, Donald R.] NOAA, Ecosyst & Oceanog Program, Pacific Isl Fisheries Sci Ctr, Honolulu, HI USA; [Jia, Yanli] Univ Hawaii Manoa, Int Pacific Res Ctr, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System; University of Hawaii Manoa	Wren, JLK (corresponding author), Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA.; Wren, JLK (corresponding author), Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Hawaii Inst Marine Biol, Honolulu, HI 96822 USA.	jwren@hawaii.edu	Toonen, Rob/V-6230-2019	Toonen, Rob/0000-0001-6339-4340; Kobayashi, Donald/0000-0002-1582-1544; Wren, Johanna/0000-0002-5014-8105	NSF [OCE12-60169]; National Oceanic and Atmospheric Administration [R/SS-13]; University of Hawaii Sea Grant College Program, SOEST, under NOAA Office of Sea Grant, Department of Commerce [NA14OAR4170071];  [NIHI-SEAGRANT-JC-13-16]; Division Of Ocean Sciences [1260169] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); University of Hawaii Sea Grant College Program, SOEST, under NOAA Office of Sea Grant, Department of Commerce; ; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This paper was funded by NSF (OCE12-60169), and in part by a grant/cooperative agreement from the National Oceanic and Atmospheric Administration, Project R/SS-13, which is sponsored by the University of Hawaii Sea Grant College Program, SOEST, under Institutional Grant No. NA14OAR4170071 from NOAA Office of Sea Grant, Department of Commerce (for RJT and JLKW). The views expressed herein are those of the authors and do not necessarily reflect the views of NOM or any of its subagencies This is Sea Grant contribution UNIHI-SEAGRANT-JC-13-16, SOEST contribution number 9638 and contribution number 1661 from the Hawaii Institute of Marine Biology.	Andrews KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091665; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Battista T. A., 2007, 61 NOAA NOS NCCOS BI; Baums IB, 2006, LIMNOL OCEANOGR, V51, P1969, DOI 10.4319/lo.2006.51.5.1969; Bird CE, 2007, MOL ECOL, V16, P3173, DOI 10.1111/j.1365-294X.2007.03385.x; Botsford LW, 2009, REV FISH BIOL FISHER, V19, P69, DOI 10.1007/s11160-008-9092-z; Bradbury IR, 2008, P ROY SOC B-BIOL SCI, V275, P1803, DOI 10.1098/rspb.2008.0216; Bradbury IR, 2007, MAR ECOL PROG SER, V340, P245, DOI 10.3354/meps340245; Burgess SC, 2014, ECOL APPL, V24, P257, DOI 10.1890/13-0710.1; Burgess SC, 2012, ECOLOGY, V93, P1378; Bushnell ME, 2010, J FISH BIOL, V76, P1343, DOI 10.1111/j.1095-8649.2010.02569.x; Calabrese JM, 2004, FRONT ECOL ENVIRON, V2, P529, DOI 10.1890/1540-9295(2004)002[0529:ACGTCM]2.0.CO;2; Carson HS, 2010, CURR BIOL, V20, P1926, DOI 10.1016/j.cub.2010.09.057; Chassignet EP, 2009, OCEANOGRAPHY, V22, P64, DOI 10.5670/oceanog.2009.39; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; Concepcion G.T., 2016, Galaxea - Tokyo, V18, P9; Concepcion GT, 2014, B MAR SCI, V90, P257, DOI 10.5343/bms.2012.1109; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2015, GULF CARIBB RES, V14, P129; Crandall ED, 2012, MOL ECOL, V21, P5579, DOI 10.1111/mec.12031; DeMartini EE, 2013, MAR ECOL PROG SER, V485, P165, DOI 10.3354/meps10306; Donahue MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130694; Drake PT, 2013, J MAR RES, V71, P317, DOI 10.1357/002224013808877099; Eble JA, 2011, MAR ECOL PROG SER, V428, P245, DOI 10.3354/meps09083; Fox HE, 2012, MAR ECOL PROG SER, V463, P259, DOI 10.3354/meps09838; Franklin EC, 2013, MAR ECOL PROG SER, V481, P121, DOI 10.3354/meps10252; Friedlander A, 2009, MARINE BIOGEOGRAPHIC, P291; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; GRIGG RW, 1981, PAC SCI, V35, P15; Hastings A, 2006, P NATL ACAD SCI USA, V103, P6067, DOI 10.1073/pnas.0506651103; Hijmans RJ., 2015, GEOSPHERE SPHERICAL; Holstein DM, 2014, MAR ECOL PROG SER, V499, P1, DOI 10.3354/meps10647; HOURIGAN TF, 1987, TRENDS ECOL EVOL, V2, P187, DOI 10.1016/0169-5347(87)90018-8; HUGHES TP, 1990, ECOLOGY, V71, P12, DOI 10.2307/1940242; Jia Y, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007305; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; KAY EA, 1987, TRENDS ECOL EVOL, V2, P183, DOI 10.1016/0169-5347(87)90017-6; Kittinger J. N., 2011, J MAR BIOL, V2011; Kobayashi Donald R., 2006, Atoll Research Bulletin, P365; Kobayashi DR, 2006, CORAL REEFS, V25, P407, DOI 10.1007/s00338-006-0118-5; Kolinski Steven P., 2003, Pacific Science, V57, P17, DOI 10.1353/psc.2003.0005; Kool JT, 2015, MAR ECOL PROG SER, V539, P77, DOI 10.3354/meps11477; KOSAKI R K, 1991, Pacific Science, V45, P186; Kough AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064970; Kritzer JP, 2004, FISH FISH, V5, P131, DOI 10.1111/j.1467-2979.2004.00131.x; Leis JM, 2007, MAR ECOL PROG SER, V347, P185, DOI 10.3354/meps06977; Leis JM, 2014, MAR ECOL PROG SER, V505, P193, DOI 10.3354/meps10792; Lester SE, 2007, ECOL LETT, V10, P745, DOI 10.1111/j.1461-0248.2007.01070.x; Liggins L, 2016, J BIOGEOGR, V43, P256, DOI 10.1111/jbi.12647; Lipcius RN, 2008, REV FISH SCI, V16, P101, DOI 10.1080/10641260701812574; Lobel PS, 2011, DYNAM ATMOS OCEANS, V52, P119, DOI 10.1016/j.dynatmoce.2011.01.001; LOBEL PS, 1989, ENVIRON BIOL FISH, V24, P161, DOI 10.1007/BF00001221; Lobel PS, 1983, REEF FISHES SEA OCEA, P29; MARAGOS JE, 1986, CORAL REEFS, V4, P141, DOI 10.1007/BF00427935; Marshall J, 1997, J GEOPHYS RES-OCEANS, V102, P5753, DOI 10.1029/96JC02775; Maximenko NA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022728; Mitarai S, 2008, J MARINE SYST, V69, P295, DOI 10.1016/j.jmarsys.2006.02.017; Mitarai S, 2016, P NATL ACAD SCI; Mora C, 2002, TRENDS ECOL EVOL, V17, P422, DOI 10.1016/S0169-5347(02)02584-3; Morgan S., 2014, ADV OCEANOGRAPHY; Neuheimer AB, 2007, CAN J FISH AQUAT SCI, V64, P375, DOI 10.1139/F07-003; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Padilla-Gamino JL, 2012, MAR ECOL PROG SER, V449, P145, DOI 10.3354/meps09530; Paris CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072808; Pogson GH, 2001, EVOLUTION, V55, P131, DOI 10.1111/j.0014-3820.2001.tb01279.x; Polato NR, 2010, MOL ECOL, V19, P4661, DOI 10.1111/j.1365-294X.2010.04836.x; Polovina JJ, 1999, FISH B-NOAA, V97, P132; Puritz JB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1238; Putman NF, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0979; Qiu B, 1997, J PHYS OCEANOGR, V27, P431, DOI 10.1175/1520-0485(1997)027<0431:EAFMOT>2.0.CO;2; Rasmuson LK, 2014, MAR ECOL PROG SER, V511, P143, DOI 10.3354/meps10926; RICHMOND RH, 1990, MAR ECOL PROG SER, V60, P185, DOI 10.3354/meps060185; Riginos C, 2013, GEOGR COMPASS, V7, P197, DOI 10.1111/gec3.12032; Riginos C, 2011, ECOGRAPHY, V34, P566, DOI 10.1111/j.1600-0587.2010.06511.x; Rivera Malia Ana J., 2011, Journal of Marine Biology, V2011, P1, DOI 10.1155/2011/765353; Robins PE, 2013, LIMNOL OCEANOGR, V58, P505, DOI 10.4319/lo.2013.58.2.0505; ROUGHGARDEN J, 1985, ECOLOGY, V66, P54, DOI 10.2307/1941306; ROUGHGARDEN J, 1988, SCIENCE, V241, P1460, DOI 10.1126/science.11538249; Rousset F, 1997, GENETICS, V145, P1219; Ruttenberg BI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021062; Seki MP, 2002, J OCEANOGR, V58, P739, DOI 10.1023/A:1022854609312; Selkoe KA, 2009, CORAL REEFS, V28, P635, DOI 10.1007/s00338-009-0490-z; Selkoe KA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0354; Selkoe KA, 2014, MOL ECOL, V23, P3064, DOI 10.1111/mec.12804; Selkoe KA, 2010, MOL ECOL, V19, P3708, DOI 10.1111/j.1365-294X.2010.04658.x; Shanks AL, 2009, BIOL BULL-US, V216, P373; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; Skillings DJ, 2011, J MAR BIOL; Staaterman E, 2014, ICES J MAR SCI, V71, P918, DOI 10.1093/icesjms/fst103; Staaterman E, 2012, J THEOR BIOL, V304, P188, DOI 10.1016/j.jtbi.2012.03.016; STIMSON JS, 1978, MAR BIOL, V48, P173, DOI 10.1007/BF00395017; Swearer SE, 2002, B MAR SCI, V70, P251; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Szabo Z, 2014, B MAR SCI, V90, P493, DOI 10.5343/bms.2013.1032; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Timmers MA, 2011, J MAR BIOL; Toonen RJ, 2007, MAR ECOL PROG SER, V349, P43, DOI 10.3354/meps06963; Toonen RJ, 2013, MAR POLLUT BULL, V77, P7, DOI 10.1016/j.marpolbul.2013.10.039; Toonen Robert J, 2011, J Mar Biol, V2011, DOI 10.1155/2011/460173; Treml EA, 2008, LANDSCAPE ECOL, V23, P19, DOI 10.1007/s10980-007-9138-y; Treml EA, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0045-6; Vaz AC, 2013, GEOPHYS RES LETT, V40, P332, DOI 10.1029/2012GL054519; Weiss J, 2009, 84 NOAA NOS NCCOS, P65; Wessel P., 1991, EOS T AM GEOPHYS UN, V72, P445, DOI [10.1029/90EO00319, DOI 10.1029/90EO00319, DOI 10.1029/90E000319]; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; Wolanski E, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0209; Wood S, 2014, GLOBAL ECOL BIOGEOGR, V23, P1, DOI 10.1111/geb.12101; Wren JLK, 2016, PEERJ, V4, DOI 10.7717/peerj.1636; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Wright S, 1943, GENETICS, V28, P114	112	21	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167626	10.1371/journal.pone.0167626	http://dx.doi.org/10.1371/journal.pone.0167626			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930680	gold, Green Submitted, Green Published			2022-12-27	WOS:000389580900032
J	Enzenhofer, E; Parzefall, T; Haymerle, G; Schneider, S; Kadletz, L; Heiduschka, G; Pammer, J; Oberndorfer, F; Wrba, F; Loader, B; Grasl, MC; Perisanidis, C; Erovic, BM				Enzenhofer, Elisabeth; Parzefall, Thomas; Haymerle, Georg; Schneider, Sven; Kadletz, Lorenz; Heiduschka, Gregor; Pammer, Johannes; Oberndorfer, Felicitas; Wrba, Fritz; Loader, Benjamin; Grasl, Matthaeus Christoph; Perisanidis, Christos; Erovic, Boban M.			Impact of Sonic Hedgehog Pathway Expression on Outcome in HPV Negative Head and Neck Carcinoma Patients after Surgery and Adjuvant Radiotherapy	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; OROPHARYNGEAL CANCER; IMPROVED SURVIVAL; ACTIVATION; GROWTH; PROFILES; GENOMICS; MARKERS; PROTEIN	Introduction HPV positive patients suffering from head and neck cancer benefit from intensified radiotherapy when applied as a primary as well as an adjuvant treatment strategy. However, HPV negative patients treated with surgery and adjuvant radiotherapy lack validated prognostic biomarkers. It is therefore important to define prognostic biomarkers in this particular patient population. Especially, A high-risk groups A need to be defined in order to adapt treatment protocols. Since dysregulation of the sonic hedgehog pathway plays an important role in carcinogenesis, we aimed to assess whether members of the sonic hedgehog-signaling pathway may act as prognostic factors in patients with HPV negative head and neck squamous cell carcinoma. Materials and Methods In this prospective study, pretreatment tumor biopsies of patients with head and neck squamous cell carcinoma were taken during panendoscopy (2005 to 2008). All patients were treated with surgery and postoperative radiotherapy. After assessment of HPV and p16 status, protein expression profiles of the Sonic hedgehog-signaling pathway were determined by immunohistochemistry and tissue microarray analyses in 36 HPV negative tumor biopsies. Expression profiles of Sonic hedgehog, Indian hedgehog, Patched, Smoothened, Gli1, Gli-2 and Gli-3 were correlated with patients A clinical data, local-control rate, disease-free as well as overall survival. Data from The Cancer Genome Atlas databank were used for external validation of our results. Results Gli-1 (p = 0.04) and Gli-2 (p = 0.02) overexpression was significantly linked to improved overall survival of HPV negative patients. Gli-2 (p = 0.04) overexpression correlated significantly with prolonged disease-free survival. Cox-multivariate analysis showed that overexpression of Gli-2 correlated independently (HR 0.40, 95% CI 0.16-0.95, p = 0.03) with increased overall survival. Discussion Gli-1 and Gli-2 overexpression represents a substantial prognostic factor for overall and disease-free survival in patients with locally advanced HPV negative head and neck cancer undergoing surgery and postoperative radiotherapy.	[Enzenhofer, Elisabeth; Parzefall, Thomas; Haymerle, Georg; Schneider, Sven; Kadletz, Lorenz; Heiduschka, Gregor; Grasl, Matthaeus Christoph; Erovic, Boban M.] Med Univ Vienna, Dept Otorhinolaryngol Head & Neck Surg, Vienna, Austria; [Pammer, Johannes; Oberndorfer, Felicitas; Wrba, Fritz] Med Univ Vienna, Dept Clin Pathol, Vienna, Austria; [Loader, Benjamin] Rudolfstiftung, Dept Otorhinolaryngol Head & Neck Surg, Vienna, Austria; [Perisanidis, Christos] Med Univ Vienna, Dept Oral & Maxillofacial Surg, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Rudolfstiftung Hospital; Medical University of Vienna	Erovic, BM (corresponding author), Med Univ Vienna, Dept Otorhinolaryngol Head & Neck Surg, Vienna, Austria.	boban.erovic@meduniwien.ac.at	Erovic, Boban/S-7824-2018	Erovic, Boban/0000-0002-7404-2583; Schneider, Sven/0000-0002-7631-3746; Parzefall, Thomas/0000-0002-7817-5789				Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Brunner M, 2012, EUR ARCH OTO-RHINO-L, V269, P2265, DOI 10.1007/s00405-011-1894-2; Caro I, 2010, CLIN CANCER RES, V16, P3335, DOI 10.1158/1078-0432.CCR-09-2570; Carpenter RL, 2012, DISCOV MED, V13, P105; Buim MEC, 2011, HUM PATHOL, V42, P1484, DOI 10.1016/j.humpath.2010.12.015; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chaudary N, 2012, CANCER-AM CANCER SOC, V118, P3105, DOI 10.1002/cncr.26635; Dayyani F, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-15; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Farnebo L, 2013, INT J CANCER, V133, P1994, DOI 10.1002/ijc.28200; Farnebo L, 2011, J ORAL PATHOL MED, V40, P739, DOI 10.1111/j.1600-0714.2011.01036.x; Fertig EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078127; Fotopoulos G, 2015, EUR J CLIN INVEST, V45, P1145, DOI 10.1111/eci.12518; Gan GN, 2014, CANCER RES, V74, P7024, DOI 10.1158/0008-5472.CAN-14-1346; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gupta S, 2009, INT J CANCER, V125, P2159, DOI 10.1002/ijc.24533; Heiduschka G, 2015, STRAHLENTHER ONKOL, V191, P209, DOI 10.1007/s00066-014-0753-7; Heiduschka G, 2014, STRAHLENTHER ONKOL, V190, P832, DOI 10.1007/s00066-014-0652-y; Inman GJ, 2011, CURR OPIN GENET DEV, V21, P93, DOI 10.1016/j.gde.2010.12.004; Jordan RC, 2012, AM J SURG PATHOL, V36, P945, DOI 10.1097/PAS.0b013e318253a2d1; Kasper M, 2006, MOL CELL BIOL, V26, P6283, DOI 10.1128/MCB.02317-05; Kim JE, 2013, ANN SURG ONCOL, V20, pS570, DOI 10.1245/s10434-013-3022-6; Lill C, 2011, WIEN KLIN WOCHENSCHR, V123, P215, DOI 10.1007/s00508-011-1553-z; Polanska H, 2016, TUMOR BIOL, V37, P7193, DOI 10.1007/s13277-015-4569-6; Rades D, 2016, ANTICANCER RES, V36, P2989; Rusthoven KE, 2008, INT J RADIAT ONCOL, V72, P343, DOI 10.1016/j.ijrobp.2007.12.046; Seto M, 2009, MOL CARCINOGEN, V48, P703, DOI 10.1002/mc.20516; SHAH JP, 1995, CA-CANCER J CLIN, V45, P352, DOI 10.3322/canjclin.45.6.352; Sharma N, 2015, ONCOTARGET, V6, P32039, DOI 10.18632/oncotarget.5055; Sims-Mourtada J, 2006, CLIN CANCER RES, V12, P6565, DOI 10.1158/1078-0432.CCR-06-0176; Vickova K, 2016, CELL DEATH DIS, V14, pe2048, DOI 10.1038/cddis.2015.389; Wang S, 2013, RADIAT RES, V179, P69, DOI 10.1667/RR3091.1; Yan M, 2011, ORAL ONCOL, V47, P504, DOI 10.1016/j.oraloncology.2011.03.027; Zhu H, 2010, CURR GENOMICS, V11, P238, DOI 10.2174/138920210791233108	38	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2016	11	12							e0167665	10.1371/journal.pone.0167665	http://dx.doi.org/10.1371/journal.pone.0167665			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MR	27918595	Green Published, gold, Green Submitted			2022-12-27	WOS:000389577100015
J	Zhang, Y; Chen, SG; Wei, CY; Gong, H; Li, LQ; Ye, XQ				Zhang, Yu; Chen, Shiguo; Wei, Chaoyang; Gong, Hui; Li, Lanqi; Ye, Xingqian			Chemical and Cellular Assays Combined with In Vitro Digestion to Determine the Antioxidant Activity of Flavonoids from Chinese Bayberry (Myrica rubra Sieb. et Zucc.) Leaves	PLOS ONE			English	Article							MYRICITRIN; CYTOTOXICITY; EXTRACTS; DISEASE; HEALTH; FRUITS; CELLS	Oxidative stress is highly associated with the development of cardiovascular diseases and cancer and has drawn great attention. Natural products suggest a potential role in prevention of these disorders. The aim of this study was to investigate the antioxidant and anti-cancer properties of Chinese bayberry leaves (Myrica rubra Sieb. et Zucc.) flavonoids (BLF) comprehensively through the combination of in vitro digestion, chemical and cellular antioxidant assays. Based on the LC/MS data, the major flavonoids of BLF were myricitrin and quercetin 3-rhamnoside. BLF owned strong chemical and cellular antioxidant activity (CAA) with its CAA value at 4253.884 +/- 435.366 mu mol of QE/100 g DW. After the in vitro digestion, the total flavonoids content, myricitrin and quercetin 3-rhamnoside decreased significantly (P < 0.05). Lower levels of the total flavonoid content and cellular uptake of myricitrin and quercetin 3-rhamnoside might contribute to the lower CAA value of digested BLF (DBLF). However, DBLF still owns considerable chemical antioxidant activities and CAA compared with many plants. Furthermore, both BLF and DBLF exhibited dose-dependent relationship against HepG2 proliferation. Taken together, BLF has a great potential to be developed as a natural antioxidant for promoting public health.	[Zhang, Yu; Chen, Shiguo; Wei, Chaoyang; Gong, Hui; Li, Lanqi; Ye, Xingqian] Zhejiang Univ, Zhejiang Key Lab Agrofood Proc, Dept Food Sci & Nutr, Fuli Inst Food Sci,Zhejiang R&D Ctr Food Technol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Ye, XQ (corresponding author), Zhejiang Univ, Zhejiang Key Lab Agrofood Proc, Dept Food Sci & Nutr, Fuli Inst Food Sci,Zhejiang R&D Ctr Food Technol, Hangzhou, Zhejiang, Peoples R China.	psu@zju.edu.cn	CHEN, SHIGUO/AGP-0850-2022	Li, Lanqi/0000-0002-1518-6480; CHEN, SHIGUO/0000-0001-8470-7983; Zhang, Yu/0000-0002-6488-0591	National Natural Science Foundation of China [C200501]; National Key Research and Development Program [2016YFD0400805]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program	This research project was supported by the National Natural Science Foundation of China (C200501) and the National Key Research and Development Program (2016YFD0400805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa-Ogawa Y, 2015, FREE RADICAL BIO MED, V79, P164, DOI 10.1016/j.freeradbiomed.2014.12.004; Bao JS, 2005, J AGR FOOD CHEM, V53, P2327, DOI 10.1021/jf048312z; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Boyer J, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-1; Boaventura BCB, 2015, FOOD RES INT, V77, P257, DOI 10.1016/j.foodres.2015.05.004; Chamani J, 2011, J PHARMACEUT BIOMED, V55, P114, DOI 10.1016/j.jpba.2010.12.029; Chen R. R., 1999, J GUIZHOU NORMAL U N, V17, P30; Chen W, 2013, FOOD CHEM, V141, P927, DOI 10.1016/j.foodchem.2013.04.033; De Martino L, 2012, INT J MOL SCI, V13, P5406, DOI 10.3390/ijms13055406; Dong M, 2007, J AGR FOOD CHEM, V55, P6044, DOI 10.1021/jf070706d; Edenharder R, 2003, MUTAT RES-GEN TOX EN, V540, P1, DOI 10.1016/S1383-5718(03)00114-1; Felice DL, 2009, J FUNCT FOODS, V1, P109, DOI 10.1016/j.jff.2008.09.014; Giampieri F, 2016, FOOD CHEM TOXICOL, V94, P128, DOI 10.1016/j.fct.2016.06.003; Gumienna M, 2011, INT J FOOD SCI NUTR, V62, P226, DOI 10.3109/09637486.2010.532115; Huang DJ, 2002, J AGR FOOD CHEM, V50, P4437, DOI 10.1021/jf0201529; Huang HZ, 2014, FOOD CHEM, V146, P363, DOI 10.1016/j.foodchem.2013.09.071; Rodriguez-Roque MJ, 2013, J AGR FOOD CHEM, V61, P1859, DOI 10.1021/jf3044204; Kim HH, 2013, ARCH PHARM RES, V36, P1533, DOI 10.1007/s12272-013-0147-x; Faller ALK, 2012, J AGR FOOD CHEM, V60, P4826, DOI 10.1021/jf300602w; Meotti FC, 2008, FREE RADICAL BIO MED, V44, P109, DOI 10.1016/j.freeradbiomed.2007.09.017; Moosavi-Movahedi AA, 2003, BIOORGAN MED CHEM, V11, P4303, DOI 10.1016/S0968-0896(03)00524-8; Odegaard AO, 2011, CIRCULATION, V124, P2847, DOI 10.1161/CIRCULATIONAHA.111.048843; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Rufian-Henares JA, 2009, FOOD RES INT, V42, P394, DOI 10.1016/j.foodres.2009.01.011; Shen JianGuo, 2004, Journal of Fujian Agriculture and Forestry University (Natural Science Edition), V33, P441; Shiomi K, 2013, FOOD CHEM, V139, P910, DOI 10.1016/j.foodchem.2013.01.009; Vauzour D, 2010, NUTRIENTS, V2, P1106, DOI 10.3390/nu2111106; Wen LR, 2015, FOOD CHEM, V186, P54, DOI 10.1016/j.foodchem.2015.03.017; Wolfe KL, 2008, J AGR FOOD CHEM, V56, P8418, DOI 10.1021/jf801381y; Wolfe KL, 2007, J AGR FOOD CHEM, V55, P8896, DOI 10.1021/jf0715166; [夏其乐 Xia Qile], 2004, [食品科学, Food Science], V25, P80; Xu RR, 2013, FOOD CHEM, V138, P48, DOI 10.1016/j.foodchem.2012.09.102; Yang HH, 2011, FOOD CHEM, V128, P1128, DOI 10.1016/j.foodchem.2011.03.118; Yokomizo A, 2005, BIOSCI BIOTECH BIOCH, V69, P693, DOI 10.1271/bbb.69.693; Yokomizo A, 2014, BIOSCIENCE BIOTECHNO, V69, P693; Zhang Y, 2016, J FUNCT FOODS, V27, P645, DOI 10.1016/j.jff.2016.10.004; Zhao P, 2015, FOOD CHEM, V173, P54, DOI 10.1016/j.foodchem.2014.10.010; Zheng H, 2011, J AGR FOOD CHEM, V59, P592, DOI 10.1021/jf1032476; Zinov'eva VN, 2011, BIOCHEM MOSC-SUPPL S, V5, P113, DOI 10.1134/S1990750811020181	39	26	28	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167484	10.1371/journal.pone.0167484	http://dx.doi.org/10.1371/journal.pone.0167484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911932	Green Published, gold, Green Submitted			2022-12-27	WOS:000389520600038
J	Gunnala, R; Ogbuanu, IU; Adegoke, OJ; Scobie, HM; Uba, BV; Wannemuehler, KA; Ruiz, A; Elmousaad, H; Ohuabunwo, CJ; Mustafa, M; Nguku, P; Waziri, NE; Vertefeuille, JF				Gunnala, Rajni; Ogbuanu, Ikechukwu U.; Adegoke, Oluwasegun J.; Scobie, Heather M.; Uba, Belinda V.; Wannemuehler, Kathleen A.; Ruiz, Alicia; Elmousaad, Hashim; Ohuabunwo, Chima J.; Mustafa, Mahmud; Nguku, Patrick; Waziri, Ndadilnasiya Endie; Vertefeuille, John F.			Routine Vaccination Coverage in Northern Nigeria: Results from 40 District-Level Cluster Surveys, 2014-2015	PLOS ONE			English	Article							ERADICATION	Background Despite recent success towards controlling poliovirus transmission, Nigeria has struggled to achieve uniformly high routine vaccination coverage. A lack of reliable vaccination coverage data at the operational level makes it challenging to target program improvement. To reliably estimate vaccination coverage, we conducted district-level vaccine coverage surveys using a pre-existing infrastructure of polio technical staff in northern Nigeria. Methods Household-level cluster surveys were conducted in 40 polio high risk districts of Nigeria during 2014-2015. Global positioning system technology and intensive supervision by a pool of qualified technical staff were used to ensure high survey quality. Vaccination status of children aged 12-23 months was documented based on vaccination card or caretaker's recall. District-level coverage estimates were calculated using survey methods. Results Data from 7,815 children across 40 districts were analyzed. District-level coverage with the third dose of diphtheria-pertussis-tetanus vaccine (DPT3) ranged widely from 1-63%, with all districts having DPT3 coverage below the target of 80%. Median coverage across all districts for each of eight vaccine doses (1 Bacille Calmette-Guerin dose, 3 DPT doses, 3 oral poliovirus vaccine doses, and 1 measles vaccine dose) was < 50%. DPT3 coverage by survey was substantially lower (range: 28%-139%) than the 2013 administrative coverage reported among children aged < 12 months. Common reported reasons for non-vaccination included lack of knowledge about vaccines and vaccination services (50%) and factors related to access to routine immunization services (15%). Conclusions Survey results highlighted vaccine coverage gaps that were systematically underestimated by administrative reporting across 40 polio high risk districts in northern Nigeria. Given the limitations of administrative coverage data, our approach to conducting quality district-level coverage surveys and providing data to assess and remediate issues contributing to poor vaccination coverage could serve as an example in countries with sub-optimal vaccination coverage, similar to Nigeria.	[Gunnala, Rajni; Ogbuanu, Ikechukwu U.; Scobie, Heather M.; Wannemuehler, Kathleen A.; Ruiz, Alicia; Elmousaad, Hashim; Vertefeuille, John F.] US Ctr Dis Control & Prevent, Global Immunizat Div, Atlanta, GA 30333 USA; [Adegoke, Oluwasegun J.; Uba, Belinda V.; Ohuabunwo, Chima J.; Waziri, Ndadilnasiya Endie] Nigeria Natl Stop Transmiss Polio, Abuja, Nigeria; [Mustafa, Mahmud] Natl Primary Hlth Care Dev Agcy, Abuja, Nigeria; [Nguku, Patrick] Nigeria Field Epidemiol & Lab Training Program, Abuja, Nigeria	Centers for Disease Control & Prevention - USA	Gunnala, R (corresponding author), US Ctr Dis Control & Prevent, Global Immunizat Div, Atlanta, GA 30333 USA.	rajni.gunnala@gmail.com		Wannemuehler, Kathleen/0000-0001-9535-6277	US Centers for Disease Control and Prevention	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the US Centers for Disease Control and Prevention. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], IMM VACC BIOL DAT ST; Dunkle SE, 2014, J INFECT DIS, V210, pS523, DOI 10.1093/infdis/jiu373; Etsano A, 2015, MMWR-MORBID MORTAL W, V64, P878, DOI 10.15585/mmwr.mm6432a5; Federal Ministry of Health Nigeria, 2011, COMPR EPI MULT PLAN; Johri M, 2015, B WORLD HEALTH ORGAN, V93, P339, DOI 10.2471/BLT.14.146951; Miles M, 2013, VACCINE, V31, P1560, DOI 10.1016/j.vaccine.2012.10.089; National Population Commission (NPC) [Nigeria] and ICF International, 2014, NIG DEM HLTH SURV 20; National Primary Healthcare Development Agency, 2015, NIG POL ER EM PLAN 0; Shuaib F, 2014, MMWR-MORBID MORTAL W, V63, P867; Upfill-Brown AM, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-92; Waziri NE, 2014, J INFECT DIS, V210, pS111, DOI 10.1093/infdis/jiu199; WHO, 2005, IMM COV CLUST SURV R; World Health Organization, IMM SURV ASS MON VAC; World Health Organization, 2015, VACC COV CLUST SURV; World Health Organization, IMM VACC BIOL	16	30	31	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167835	10.1371/journal.pone.0167835	http://dx.doi.org/10.1371/journal.pone.0167835			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936077	Green Submitted, gold, Green Published			2022-12-27	WOS:000389587100212
J	Kuroki, S; Hagura, N; Nishida, S; Haggard, P; Watanabe, J				Kuroki, Scinob; Hagura, Nobuhiro; Nishida, Shin'ya; Haggard, Patrick; Watanabe, Junji			Sanshool on The Fingertip Interferes with Vibration Detection in a Rapidly-Adapting (RA) Tactile Channel	PLOS ONE			English	Article							MECHANORECEPTIVE AFFERENTS; MECHANICAL FREQUENCY; DETECTION THRESHOLDS; SENSORY NEURONS; HUMAN HAND; VIBROTACTILE; CAPACITY; EVENTS; MICROSTIMULATION; DISCRIMINATION	An Asian spice, Szechuan pepper (sanshool), is well known for the tingling sensation it induces on the mouth and on the lips. Electrophysiological studies have revealed that its active ingredient can induce firing of mechanoreceptor fibres that typically respond to mechanical vibration. Moreover, a human behavioral study has reported that the perceived frequency of sanshool-induced tingling matches with the preferred frequency range of the tactile rapidly adapting (RA) channel, suggesting the contribution of sanshool-induced RA channel firing to its unique perceptual experience. However, since the RA channel may not be the only channel activated by sanshool, there could be a possibility that the sanshool tingling percept may be caused in whole or in part by other sensory channels. Here, by using a perceptual interference paradigm, we show that the sanshool-induced RA input indeed contributes to the human tactile processing. The absolute detection thresholds for vibrotactile input were measured with and without sanshool application on the fingertip. Sanshool significantly impaired detection of vibrations at 30 Hz (RA channel dominant frequency), but did not impair detection of higher frequency vibrations at 240 Hz (Pacinian-corpuscle (PC) channel dominant frequency) or lower frequency vibrations at 1 Hz (slowly adapting 1 (SA1) channel dominant frequency). These results show that the sanshool induces a peripheral RA channel activation that is relevant for tactile perception. This anomalous activation of RA channels may contribute to the unique tingling experience of sanshool.	[Kuroki, Scinob; Nishida, Shin'ya; Watanabe, Junji] NTT Corp, NTT Commun Sci Labs, Tokyo, Kanagawa, Japan; [Hagura, Nobuhiro; Haggard, Patrick] UCL, Inst Cognit Neurosci, London, England; [Hagura, Nobuhiro] Natl Inst Commun & Technol, Ctr Informat & Neural Networks CiNet, 1-4 Yamadaoka, Suita, Osaka, Japan	Nippon Telegraph & Telephone Corporation; University of London; University College London; National Institute of Information & Communications Technology (NICT) - Japan	Kuroki, S (corresponding author), NTT Corp, NTT Commun Sci Labs, Tokyo, Kanagawa, Japan.; Hagura, N (corresponding author), UCL, Inst Cognit Neurosci, London, England.; Hagura, N (corresponding author), Natl Inst Commun & Technol, Ctr Informat & Neural Networks CiNet, 1-4 Yamadaoka, Suita, Osaka, Japan.	kuroki.shinobu@lab.ntt.co.jp; n.hagura@gmail.com		Kuroki, Scinob/0000-0002-7585-0099; Haggard, Patrick/0000-0001-7798-793X	JSPS KAKENHI [JP 15H05915]; JSPS Postdoctoral fellowships; KAKENHI [JP 26119535]; NTT Communication Science Laboratories; Nippon Telegraph and Telephone Corporation; Grants-in-Aid for Scientific Research [15H05915, 16H01524] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS Postdoctoral fellowships(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NTT Communication Science Laboratories; Nippon Telegraph and Telephone Corporation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP 15H05915. NH was supported by JSPS Postdoctoral fellowships for research abroad and KAKENHI Grant Number JP 26119535. NTT Communication Science Laboratories, Nippon Telegraph and Telephone Corporation, provides support in the form of salaries for authors SK, SN, and JW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreatta RD, 2006, CLIN ORAL INVEST, V10, P17, DOI 10.1007/s00784-005-0005-4; BARLOW SM, 1987, EXP NEUROL, V96, P253, DOI 10.1016/0014-4886(87)90044-6; Bautista DM, 2008, NAT NEUROSCI, V11, P772, DOI 10.1038/nn.2143; Bhattacharya MRC, 2008, P NATL ACAD SCI USA, V105, P20015, DOI 10.1073/pnas.0810801105; BOLANOWSKI SJ, 1988, J ACOUST SOC AM, V84, P1680, DOI 10.1121/1.397184; BOLANOWSKI SJ, 1982, J NEUROPHYSIOL, V48, P836, DOI 10.1152/jn.1982.48.3.836; Bryant BP, 1999, BRAIN RES, V842, P452, DOI 10.1016/S0006-8993(99)01878-8; CAUNA N, 1961, J COMP NEUROL, V117, P309, DOI 10.1002/cne.901170304; Efron B., 1993, MONOGRAPHS STAT APPL; Gescheider G. A., 2009, INFORM PROCESSING CH; Gescheider GA, 1995, J ACOUST SOC AM, V98, P3188, DOI 10.1121/1.413808; GESCHEIDER GA, 1985, J ACOUST SOC AM, V78, P534, DOI 10.1121/1.392475; Hagura N, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1680; Hollins M, 2000, PERCEPT PSYCHOPHYS, V62, P695, DOI 10.3758/BF03206916; Hollins M, 2001, SOMATOSENS MOT RES, V18, P253; Julius David, 2005, Harvey Lect, V101, P89; Klein AH, 2011, J NEUROPHYSIOL, V105, P1701, DOI 10.1152/jn.00922.2010; Koo JY, 2007, EUR J NEUROSCI, V26, P1139, DOI 10.1111/j.1460-9568.2007.05743.x; LABS SM, 1978, SENS PROCESS, V2, P231; LAMOTTE RH, 1975, J NEUROPHYSIOL, V38, P539, DOI 10.1152/jn.1975.38.3.539; Lederman SJ, 1997, J EXP PSYCHOL HUMAN, V23, P1680, DOI 10.1037/0096-1523.23.6.1680; Lennertz RC, 2010, J NEUROSCI, V30, P4353, DOI 10.1523/JNEUROSCI.4666-09.2010; Morioka M, 2005, SOMATOSENS MOT RES, V22, P69, DOI 10.1080/08990220500084644; MOUNTCASTLE VB, 1972, J NEUROPHYSIOL, V35, P122, DOI 10.1152/jn.1972.35.1.122; MOUNTCASTLE VB, 1990, J NEUROSCI, V10, P3032; Riera CE, 2009, BRIT J PHARMACOL, V157, P1398, DOI 10.1111/j.1476-5381.2009.00307.x; Sugai E, 2005, BIOSCI BIOTECH BIOCH, V69, P1958, DOI 10.1271/bbb.69.1958; Sugai E, 2005, BIOSCI BIOTECH BIOCH, V69, P1951, DOI 10.1271/bbb.69.1951; TALBOT WH, 1968, J NEUROPHYSIOL, V31, P301, DOI 10.1152/jn.1968.31.2.301; Tommerdahl M, 2005, BRAIN RES, V1057, P1, DOI 10.1016/j.brainres.2005.04.031; Trulsson M, 2010, J NEUROPHYSIOL, V103, P1741, DOI 10.1152/jn.01146.2009; Tsunozaki M, 2013, J PHYSIOL-LONDON, V591, P3325, DOI 10.1113/jphysiol.2013.252106; VALLBO AB, 1984, HUM NEUROBIOL, V3, P3; VALLBO AB, 1984, BRAIN, V107, P727, DOI 10.1093/brain/107.3.727; Vazquez Y, 2013, P NATL ACAD SCI USA, V110, pE2635, DOI 10.1073/pnas.1309728110; VERRILLO RT, 1966, PSYCHON SCI, V4, P135; Weber AI, 2013, P NATL ACAD SCI USA, V110, P17107, DOI 10.1073/pnas.1305509110; WEBER DL, 1978, J ACOUST SOC AM, V64, P1392, DOI 10.1121/1.382105; Wells C, 2005, PSYCHOL SCI, V16, P313, DOI 10.1111/j.0956-7976.2005.01533.x; Yamashita T, 1999, ACTA ORTHOP SCAND, V70, P137, DOI 10.3109/17453679909011251	40	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0165842	10.1371/journal.pone.0165842	http://dx.doi.org/10.1371/journal.pone.0165842			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935970	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100017
J	Lykiardopoulos, B; Hagstrom, H; Fredrikson, M; Ignatova, S; Stal, P; Hultcrantz, R; Ekstedt, M; Kechagias, S				Lykiardopoulos, Byron; Hagstrom, Hannes; Fredrikson, Mats; Ignatova, Simone; Stal, Per; Hultcrantz, Rolf; Ekstedt, Mattias; Kechagias, Stergios			Development of Serum Marker Models to Increase Diagnostic Accuracy of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: The New LINKI Algorithm Compared with Established Algorithms	PLOS ONE			English	Article							SIMPLE NONINVASIVE INDEX; SCORING SYSTEM; STIFFNESS MEASUREMENT; CIRRHOSIS; VALIDATION; NAFLD; PREDICT; TESTS; HYALURONAN; BIOPSY	Background and Aim Detection of advanced fibrosis (F3-F4) in nonalcoholic fatty liver disease (NAFLD) is important for ascertaining prognosis. Serum markers have been proposed as alternatives to biopsy. We attempted to develop a novel algorithm for detection of advanced fibrosis based on a more efficient combination of serological markers and to compare this with established algorithms. Methods We included 158 patients with biopsy-proven NAFLD. Of these, 38 had advanced fibrosis. The following fibrosis algorithms were calculated: NAFLD fibrosis score, BARD, NIKEI, NASH-CRN regression score, APRI, FIB-4, King's score, GUCI, Lok index, Forns score, and ELF. Study population was randomly divided in a training and a validation group. A multiple logistic regression analysis using bootstrapping methods was applied to the training group. Among many variables analyzed age, fasting glucose, hyaluronic acid and AST were included, and a model (LINKI-1) for predicting advanced fibrosis was created. Moreover, these variables were combined with platelet count in a mathematical way exaggerating the opposing effects, and alternative models (LINKI-2) were also created. Models were compared using area under the receiver operator characteristic curves (AUROC). Results Of established algorithms FIB-4 and King's score had the best diagnostic accuracy with AUROCs 0.84 and 0.83, respectively. Higher accuracy was achieved with the novel LINKI algorithms. AUROCs in the total cohort for LINKI-1 was 0.91 and for LINKI-2 models 0.89. Conclusion The LINKI algorithms for detection of advanced fibrosis in NAFLD showed better accuracy than established algorithms and should be validated in further studies including larger cohorts.	[Lykiardopoulos, Byron; Ekstedt, Mattias; Kechagias, Stergios] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Hagstrom, Hannes; Stal, Per; Hultcrantz, Rolf] Karolinska Inst, Dept Med, Stockholm, Sweden; [Fredrikson, Mats; Ignatova, Simone] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	Linkoping University; Karolinska Institutet; Linkoping University	Kechagias, S (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden.	stergios.kechagias@liu.se	Stål, Per/J-2154-2019; Ekstedt, Mattias/AAP-9770-2020; Hagström, Hannes/I-2036-2019	Stål, Per/0000-0003-2915-1964; Ekstedt, Mattias/0000-0002-5590-8601; Hagström, Hannes/0000-0002-8474-1759; Kechagias, Stergios/0000-0001-7614-739X	Royal Swedish Academy of Sciences Foundations [ME2015-0011]; Medical Research Council of Southeast Sweden [F2004-303]	Royal Swedish Academy of Sciences Foundations; Medical Research Council of Southeast Sweden(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Royal Swedish Academy of Sciences Foundations (http://www.kva.se/en/), grant ME2015-0011 (HH), and the Medical Research Council of Southeast Sweden (http://www.fou.nu/is/forss), grant F2004-303 (SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, J HEPATOL, V42, P132, DOI 10.1016/j.jhep.2004.09.012; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; Armstrong MJ, 2012, J HEPATOL, V56, P234, DOI 10.1016/j.jhep.2011.03.020; BERG S, 1988, SCAND J CLIN LAB INV, V48, P727, DOI 10.3109/00365518809088752; Boursier J, 2016, J HEPATOL, V65, P570, DOI 10.1016/j.jhep.2016.04.023; Cales P, 2010, LIVER INT, V30, P1346, DOI 10.1111/j.1478-3231.2010.02314.x; Cross TJS, 2009, EUR J GASTROEN HEPAT, V21, P730, DOI 10.1097/MEG.0b013e32830dfcb3; Demir M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058360; Dyson JK, 2014, FRONTLINE GASTROENTE, V5, P211, DOI 10.1136/flgastro-2013-100403; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; GOLDBERG RL, 1991, ARTHRITIS RHEUM, V34, P799, DOI 10.1002/art.1780340704; Guha IN, 2008, HEPATOLOGY, V47, P455, DOI 10.1002/hep.21984; Harrison SA, 2008, GUT, V57, P1441, DOI 10.1136/gut.2007.146019; Islam S, 2005, SCAND J GASTROENTERO, V40, P867, DOI 10.1080/00365520510015674; Kaneda H, 2006, J GASTROEN HEPATOL, V21, P1459, DOI 10.1111/j.1440-1746.2006.04447.x; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kruger FC, 2011, SAMJ S AFR MED J, V101, P477; Lok ASF, 2005, HEPATOLOGY, V42, P282, DOI 10.1002/hep.20772; Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004; Melita SH, 2009, J HEPATOL, V50, P36, DOI 10.1016/j.jhep.2008.07.039; Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623; Myara A, 2008, HEPATOLOGY, V47, P1100, DOI 10.1002/hep.22128; Poynard T, 2007, CLIN CHEM, V53, P1615, DOI 10.1373/clinchem.2007.085795; Raszeja-Wyszomirska J, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-67; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Rossi E, 2003, CLIN CHEM, V49, P450, DOI 10.1373/49.3.450; Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Targher G, 2007, DIABETES CARE, V30, P1212, DOI 10.2337/dc06-2247; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; West DC, 1997, CLIN NEPHROL, V48, P9; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Wong VWS, 2010, HEPATOLOGY, V51, P454, DOI 10.1002/hep.23312	38	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167776	10.1371/journal.pone.0167776	http://dx.doi.org/10.1371/journal.pone.0167776			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936091	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100185
J	Nieuwenhuis, J; Yu, RQ; Branje, S; Meeus, W; Hooimeijer, P				Nieuwenhuis, Jaap; Yu, Rongqin; Branje, Susan; Meeus, Wim; Hooimeijer, Pieter			Neighbourhood Poverty, Work Commitment and Unemployment in Early Adulthood: A Longitudinal Study into the Moderating Effect of Personality	PLOS ONE			English	Article							MULTIPLE IMPUTATION; ADOLESCENCE; BEHAVIOR; ASSOCIATIONS; ENVIRONMENT; EDUCATION; IDENTITY; BIAS	We studied how personality moderates the effect of neighbourhood disadvantage on work commitment and unemployment in early adulthood. Using a personality typology of resilients, overcontrollers, and undercontrollers, we hypothesised that the association between neighbourhood poverty and both work commitment and unemployment would be stronger for overcontrollers and undercontrollers than for resilients. We used longitudinal data (N = 249) to test whether the length of exposure to neighbourhood poverty between age 16 and 21 predicts work commitment and unemployment at age 25. In line with our hypothesis, the findings showed that longer exposure was related to weaker work commitment among undercontrollers and overcontrollers and to higher unemployment among undercontrollers. Resilients' work commitment and unemployment were not predicted by neighbourhood poverty.	[Nieuwenhuis, Jaap] Delft Univ Technol, Fac Architecture, OTB Res Built Environm, Delft, Netherlands; [Yu, Rongqin] Univ Oxford, Dept Psychiat, Oxford, England; [Branje, Susan; Meeus, Wim] Univ Utrecht, Fac Social & Behav Sci, Res Ctr Adolescent Dev, Utrecht, Netherlands; [Hooimeijer, Pieter] Univ Utrecht, Fac Geosci, Urban & Reg Res Ctr Utrecht URU, Utrecht, Netherlands; [Meeus, Wim] Tilburg Univ, Dept Dev Psychol, Tilburg, Netherlands	Delft University of Technology; University of Oxford; Utrecht University; Utrecht University; Tilburg University	Nieuwenhuis, J (corresponding author), Delft Univ Technol, Fac Architecture, OTB Res Built Environm, Delft, Netherlands.	j.g.nieuwenhuis@tudelft.nl	Branje, Susan/A-7813-2010; Meeus, Wim/H-8099-2013	Branje, Susan/0000-0002-9999-5313; Nieuwenhuis, Jaap/0000-0002-6872-553X	European Research Council under the European Union [615159]; Utrecht University strategic theme Dynamics of Youth	European Research Council under the European Union(European Research Council (ERC)); Utrecht University strategic theme Dynamics of Youth	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement n. 615159 (ERC Consolidator Grant DEPRIVEDHOODS, Socio-spatial inequality, deprived neighbourhoods, and neighbourhood effects); and from the Utrecht University strategic theme Dynamics of Youth.	Aiken L. S., 1991, MULTIPLE REGRESSION; AKERS RL, 1979, AM SOCIOL REV, V44, P636, DOI 10.2307/2094592; Asendorpf JB, 2003, J PERS, V71, P629, DOI 10.1111/1467-6494.7104005; Asendorpf JB, 2014, INT J BEHAV DEV, V38, P453, DOI 10.1177/0165025414542713; Block J, 1996, J PERS SOC PSYCHOL, V70, P349, DOI 10.1037/0022-3514.70.2.349; Block JH, 1980, MINNESOTA S CHILD PS, V13; Branje S, 2014, EMERG ADULTHOOD, V2, P6, DOI 10.1177/2167696813515851; Branje SJT, 2007, EUR J PERSONALITY, V21, P45, DOI 10.1002/per.596; Branje SJT, 2010, J ABNORM CHILD PSYCH, V38, P751, DOI 10.1007/s10802-010-9401-6; Brattbakk I, 2013, URBAN STUD, V50, P391, DOI 10.1177/0042098012448548; Buck N, 2001, URBAN STUD, V38, P2251, DOI 10.1080/00420980120087153; Caspi A, 1996, INT J METHOD PSYCH, V6, P101, DOI 10.1002/(SICI)1234-988X(199607)6:2<101::AID-MPR156>3.3.CO;2-E; CBS, 2006, KEY FIG POSTC AR 200; Crocetti E, 2008, J ADOLESCENCE, V31, P207, DOI 10.1016/j.adolescence.2007.09.002; Dietz RD, 2002, SOC SCI RES, V31, P539, DOI 10.1016/S0049-089X(02)00005-4; Dubas JS, 2002, J ADOLESCENCE, V25, P79, DOI 10.1006/jado.2001.0450; Durlauf S.N., 2004, HDB REGIONAL URBAN E, V4, P343; Ellen IG, 1997, HOUS POLICY DEBATE, V8, P833, DOI 10.1080/10511482.1997.9521280; Friedrichs J, 2005, LIFE POVERTY NEIGHBO, P11; Galster G, 2002, J HOUS ECON, V11, P303, DOI 10.1016/S1051-1377(02)00122-5; Galster GC, 2012, NEIGHBOURHOOD EFFECT, DOI [DOI 10.1007/978-94-007-2309-2_2, 10.1007/978-94-007-2309-2_2]; Galster G, 2007, HOUSING STUD, V22, P723, DOI 10.1080/02673030701474669; Goldberg L. R., 1992, PSYCHOL ASSESSMENT, V4, P26, DOI [10.1037/1040-3590.4.1.26, DOI 10.1037/1040-3590.4.1.26]; Kearns A, 2001, URBAN STUD, V38, P2103, DOI 10.1080/00420980120087063; Kifle T, 2013, APPL RES QUAL LIFE, V8, P125, DOI 10.1007/s11482-012-9186-6; Klimstra TA, 2010, EUR J PERSONALITY, V24, P309, DOI 10.1002/per.744; Larson RW, 1996, DEV PSYCHOL, V32, P744, DOI 10.1037/0012-1649.32.4.744; Li C, 2013, STATA J, V13, P795, DOI 10.1177/1536867X1301300407; Manley D., 2012, NEIGHBOURHOOD EFFECT, P147, DOI DOI 10.1007/978-94-007-2309-2_7; Meeus W, 1997, CAREER DEV Q, V45, P369, DOI 10.1002/j.2161-0045.1997.tb00540.x; Meeus W, 2011, DEV PSYCHOL, V47, P1181, DOI 10.1037/a0023816; Musterd S, 2012, ENVIRON PLANN A, V44, P605, DOI 10.1068/a44298; Nagin D. S., 2005, GROUP BASED MODELING, DOI DOI 10.4159/9780674041318; Netherlands Statistics, 2015, STATL POP ACC OR GEN; Nieuwenhuis J, URBAN STUD IN PRESS; Nieuwenhuis J, 2016, J HOUS BUILT ENVIRON, V31, P321, DOI 10.1007/s10901-015-9460-7; Nieuwenhuis J, 2016, GEOFORUM, V70, P89, DOI 10.1016/j.geoforum.2016.02.017; Nieuwenhuis J, 2015, SOC SCI RES, V50, P100, DOI 10.1016/j.ssresearch.2014.11.011; O'Connor BP, 2001, J RES PERS, V35, P1, DOI 10.1006/jrpe.2000.2295; Oberwittler D, 2009, PUTTING CRIME IN ITS PLACE: UNITS OF ANALYSIS IN GEOGRAPHIC CRIMINOLOGY, P35, DOI 10.1007/978-0-387-09688-9_2; Robins RW, 1996, J PERS SOC PSYCHOL, V70, P157, DOI 10.1037/0022-3514.70.1.157; Rubin DB, 2004, MULTIPLE IMPUTATION; StataCorp, 2013, STATA STAT SOFTW REL; van Aken MAG, 2004, EUR J DEV PSYCHOL, V1, P331, DOI 10.1080/17405620444000166; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; van de Wouden R, 2001, CITY PERIMETER; van Ham M., 2012, NEIGHBOURHOOD EFFECT; van Ham M, 2014, T I BRIT GEOGR, V39, P402, DOI 10.1111/tran.12040; Vermulst A. A., 2005, QUICK BIG 5 PERSONAL; Visser P, 2008, TIJDSCHR ECON SOC GE, V99, P348, DOI 10.1111/j.1467-9663.2008.00472.x; Wilson W.J., 1987, TRULY DISADVANTAGED; Yu RQ, 2016, BIOL PSYCHOL, V120, P96, DOI 10.1016/j.biopsycho.2016.08.004; Yu RQ, 2013, J PERS, V81, P499, DOI 10.1111/jopy.12027	53	9	9	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167830	10.1371/journal.pone.0167830	http://dx.doi.org/10.1371/journal.pone.0167830			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936132	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100210
J	Ramratnam, M; Salama, G; Sharma, RK; Wang, DWR; Smith, SH; Banerjee, SK; Huang, XN; Gifford, LM; Pruce, ML; Gabris, BE; Saba, S; Shroff, SG; Ahmad, F				Ramratnam, Mohun; Salama, Guy; Sharma, Ravi K.; Wang, David Wen Rui; Smith, Stephen H.; Banerjee, Sanjay K.; Huang, Xueyin N.; Gifford, Lindsey M.; Pruce, Michele L.; Gabris, Bethann E.; Saba, Samir; Shroff, Sanjeev G.; Ahmad, Ferhaan			Gene-Targeted Mice with the Human Troponin T R141W Mutation Develop Dilated Cardiomyopathy with Calcium Desensitization	PLOS ONE			English	Article							HEART-FAILURE; MOUSE HEARTS; MODEL; TRANSIENTS; PROTEINS	Most studies of the mechanisms leading to hereditary dilated cardiomyopathy (DCM) have been performed in reconstituted in vitro systems. Genetically engineered murine models offer the opportunity to dissect these mechanisms in vivo. We generated a gene-targeted knock-in murine model of the autosomal dominant Arg141Trp (R141W) mutation in Tnnt2, which was first described in a human family with DCM. Mice heterozygous for the mutation (Tnnt2(R141W/+)) recapitulated the human phenotype, developing left ventricular dilation and reduced contractility. There was a gene dosage effect, so that the phenotype in Tnnt2(R141W/+) mice was attenuated by transgenic overexpression of wildtype Tnnt2 mRNA transcript. Male mice exhibited poorer survival than females. Biomechanical studies on skinned fibers from Tnnt2(R141W/+) hearts showed a significant decrease in pCa(50) (-log[Ca2+] required for generation of 50% of maximal force) relative to wildtype hearts, indicating Ca2+ desensitization. Optical mapping studies of Langendorff-perfused Tnnt2(R141W/+) hearts showed marked increases in diastolic and peak systolic intracellular Ca2+ ([Ca2+] i), and prolonged systolic rise and diastolic fall of [Ca2+] i. Perfused Tnnt2(R141W/+) hearts had slower intrinsic rates in sinus rhythm and reduced peak heart rates in response to isoproterenol. Tnnt2(R141W/+) hearts exhibited a reduction in phosphorylated phospholamban relative to wildtype mice. However, crossing Tnnt2(R141W/+) mice with phospholamban knockout (Pln(-/-)) mice, which exhibit increased Ca2+ transients and contractility, had no effect on the DCM phenotype. We conclude that the Tnnt2(R141W) mutation causes a Ca2+ desensitization and mice adapt by increasing Ca2+-transient amplitudes, which impairs Ca2+ handling dynamics, metabolism and responses to beta-adrenergic activation.	[Ramratnam, Mohun] Univ Wisconsin, Dept Med, Div Cardiovasc Med, Madison, WI USA; [Ramratnam, Mohun] William S Middleton Mem Vet Adm Med Ctr, Med Serv, Cardiol Sect, Madison, WI USA; [Ramratnam, Mohun; Salama, Guy; Sharma, Ravi K.; Wang, David Wen Rui; Banerjee, Sanjay K.; Huang, Xueyin N.; Pruce, Michele L.; Gabris, Bethann E.; Saba, Samir; Ahmad, Ferhaan] Univ Pittsburgh, UPMC Heart & Vasc Inst, Pittsburgh, PA 15260 USA; [Ramratnam, Mohun; Salama, Guy; Sharma, Ravi K.; Wang, David Wen Rui; Banerjee, Sanjay K.; Huang, Xueyin N.; Pruce, Michele L.; Gabris, Bethann E.; Saba, Samir; Ahmad, Ferhaan] Univ Pittsburgh, Dept Med, Div Cardiol, Pittsburgh, PA 15260 USA; [Smith, Stephen H.; Shroff, Sanjeev G.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Gifford, Lindsey M.; Ahmad, Ferhaan] Univ Iowa, Dept Internal Med, Carver Coll Med, Div Cardiovasc Med, Iowa City, IA 52242 USA; [Gifford, Lindsey M.; Ahmad, Ferhaan] Univ Iowa, Abboud Cardiovasc Res Ctr, Iowa City, IA 52242 USA; [Banerjee, Sanjay K.] Translat Hlth Sci & Technol Inst, Gurgaon, India	University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Iowa; University of Iowa; Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI)	Ahmad, F (corresponding author), Univ Pittsburgh, UPMC Heart & Vasc Inst, Pittsburgh, PA 15260 USA.; Ahmad, F (corresponding author), Univ Pittsburgh, Dept Med, Div Cardiol, Pittsburgh, PA 15260 USA.; Ahmad, F (corresponding author), Univ Iowa, Dept Internal Med, Carver Coll Med, Div Cardiovasc Med, Iowa City, IA 52242 USA.; Ahmad, F (corresponding author), Univ Iowa, Abboud Cardiovasc Res Ctr, Iowa City, IA 52242 USA.	ferhaan-ahmad@uiowa.edu	Salama, Guy/GWQ-9862-2022	Ahmad, Ferhaan/0000-0003-2877-4641; Banerjee, Sanjay k/0000-0002-0044-0984; Banerjee, Sanjay/0000-0002-0008-0480	National Heart, Lung, and Blood Institute (US) [U01 HL108642]; Ferhaan Ahmad National Heart, Lung, and Blood Institute (US) [R21 HL1098121]; Ferhaan Ahmad American Heart Association (US) [053531N, 0725359U]	National Heart, Lung, and Blood Institute (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Ferhaan Ahmad National Heart, Lung, and Blood Institute (US); Ferhaan Ahmad American Heart Association (US)	National Heart, Lung, and Blood Institute (US) Award Number: U01 HL108642 vertical bar Recipient: Ferhaan Ahmad National Heart, Lung, and Blood Institute (US) Award Number: R21 HL1098121 vertical bar Recipient: Ferhaan Ahmad American Heart Association (US) Award Number: Scientist Development Grant 053531N vertical bar Recipient: Ferhaan Ahmad American Heart Association (US) Award Number: 0725359U vertical bar Recipient: Sanjay Banerjee	Adhikari BB, 2004, BIOPHYS J, V87, P1784, DOI 10.1529/biophysj.103.039131; Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132; Ahmad F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002642; Baker LC, 2004, AM J PHYSIOL-HEART C, V287, pH1771, DOI 10.1152/ajpheart.00234.2004; Baker LC, 2000, CIRC RES, V86, P396, DOI 10.1161/01.RES.86.4.396; Banerjee SK, 2007, BIOCHEM BIOPH RES CO, V360, P381, DOI 10.1016/j.bbrc.2007.06.067; Banerjee SK, 2010, J MOL CELL CARDIOL, V49, P683, DOI 10.1016/j.yjmcc.2010.06.003; Banerjee SK, 2009, CARDIOVASC RES, V84, P111, DOI 10.1093/cvr/cvp190; BANERJEE SK, 2009, BIOCH BIOPHYS ACTA; Bozkurt B., 2007, CARDIOVASCULAR MED, P1233; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Choi BR, 2000, J PHYSIOL-LONDON, V529, P171, DOI 10.1111/j.1469-7793.2000.00171.x; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI [10.1161/CIRCULATIONAHA.105, DOI 10.1161/CIRCULATIONAHA.105]; del Nido PJ, 1998, AM J PHYSIOL-HEART C, V274, pH728, DOI 10.1152/ajpheart.1998.274.2.H728; Du CK, 2007, CIRC RES, V101, P185, DOI 10.1161/CIRCRESAHA.106.146670; Du XJ, 2004, CARDIOVASC RES, V63, P510, DOI 10.1016/j.cardiores.2004.03.027; Dyer EC, 2009, CIRC-HEART FAIL, V2, P456, DOI 10.1161/CIRCHEARTFAILURE.108.818237; Gollapudi SK, 2015, AM J PHYSIOL-HEART C, V308, pH884, DOI 10.1152/ajpheart.00528.2014; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hershberger RE, 2013, NAT REV CARDIOL, V10, P531, DOI 10.1038/nrcardio.2013.105; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Li DX, 2001, CIRCULATION, V104, P2188, DOI 10.1161/hc4301.098285; Lombardi R, 2008, CARDIOVASC RES, V79, P109, DOI 10.1093/cvr/cvn078; London B, 2003, AM J PHYSIOL-HEART C, V284, pH431, DOI 10.1152/ajpheart.00431.2002; Lu QW, 2003, J MOL CELL CARDIOL, V35, P1421, DOI 10.1016/j.yjmcc.2003.09.003; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; Marston SB, 2011, J CARDIOVASC TRANSL, V4, P245, DOI 10.1007/s12265-011-9266-2; Memo M, 2013, CARDIOVASC RES, V99, P65, DOI 10.1093/cvr/cvt071; Morimoto S, 2002, P NATL ACAD SCI USA, V99, P913, DOI 10.1073/pnas.022628899; Pemberton CJ, 2007, J HYPERTENS, V25, P2008, DOI 10.1097/HJH.0b013e3282ef5632; Rajkumar R, 2010, AM J PHYSIOL-HEART C, V298, pH1235, DOI 10.1152/ajpheart.00254.2009; Ramratnam M, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000899; Redwood C, 2000, CIRC RES, V86, P1146; Ruiz-Hurtado G, 2012, CARDIOVASC RES; Salama G., 2009, CURR PROTOC CYTOM; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Sommese RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083403; Song WH, 2010, J MOL CELL CARDIOL, V49, P380, DOI 10.1016/j.yjmcc.2010.05.009; Venkatraman G, 2003, J BIOL CHEM, V278, P41670, DOI 10.1074/jbc.M302148200; Wang YB, 2007, CIRCULATION, V116, P1413, DOI 10.1161/CIRCULATIONAHA.106.679589; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031; Zhang LT, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-40	42	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167681	10.1371/journal.pone.0167681	http://dx.doi.org/10.1371/journal.pone.0167681			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936050	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100148
J	Reetzke, R; Lam, BPW; Xie, ZL; Sheng, L; Chandrasekaran, B				Reetzke, Rachel; Lam, Boji Pak-Wing; Xie, Zilong; Sheng, Li; Chandrasekaran, Bharath			Effect of Simultaneous Bilingualism on Speech Intelligibility across Different Masker Types, Modalities, and Signal-to-Noise Ratios in School-Age Children	PLOS ONE			English	Article							AUDIOVISUAL PERCEPTION; SOCIOECONOMIC-STATUS; ATTENTIONAL CONTROL; EXECUTIVE FUNCTION; ADVERSE CONDITIONS; LANGUAGE; RECOGNITION; VOCABULARY; EFFICIENCY; LISTENERS	Recognizing speech in adverse listening conditions is a significant cognitive, perceptual, and linguistic challenge, especially for children. Prior studies have yielded mixed results on the impact of bilingualism on speech perception in noise. Methodological variations across studies make it difficult to converge on a conclusion regarding the effect of bilingualism on speech-in-noise performance. Moreover, there is a dearth of speech-in-noise evidence for bilingual children who learn two languages simultaneously. The aim of the present study was to examine the extent to which various adverse listening conditions modulate differences in speech-in-noise performance between monolingual and simultaneous bilingual children. To that end, sentence recognition was assessed in twenty-four school-aged children (12 monolinguals; 12 simultaneous bilinguals, age of English acquisition <= 3 yrs.). We implemented a comprehensive speech-in-noise battery to examine recognition of English sentences across different modalities (audio-only, audiovisual), masker types (steady-state pink noise, two-talker babble), and a range of signal-to-noise ratios (SNRs; 0 to -16 dB). Results revealed no difference in performance between monolingual and simultaneous bilingual children across each combination of modality, masker, and SNR. Our findings suggest that when English age of acquisition and socioeconomic status is similar between groups, monolingual and bilingual children exhibit comparable speech-in-noise performance across a range of conditions analogous to everyday listening environments.	[Reetzke, Rachel; Lam, Boji Pak-Wing; Xie, Zilong; Sheng, Li; Chandrasekaran, Bharath] Univ Texas Austin, Dept Commun Sci & Disorders, Austin, TX 78712 USA; [Chandrasekaran, Bharath] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA; [Chandrasekaran, Bharath] Univ Texas Austin, Cognit Neurosci, Austin, TX 78712 USA; [Sheng, Li] Univ Delaware, Dept Commun Sci & Disorders, Newark, DE USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Delaware	Chandrasekaran, B (corresponding author), Univ Texas Austin, Dept Commun Sci & Disorders, Austin, TX 78712 USA.; Chandrasekaran, B (corresponding author), Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA.; Chandrasekaran, B (corresponding author), Univ Texas Austin, Cognit Neurosci, Austin, TX 78712 USA.	bchandra@utexas.edu		Sheng, Li/0000-0001-7092-6798; Reetzke, Rachel/0000-0003-1307-540X; Chandrasekaran, Bharath/0000-0002-3673-9435; Xie, Zilong/0000-0002-6851-7554	University of Texas at Austin Academic Excellence Funding; University of Texas at Austin Undergraduate Research Fellowship	University of Texas at Austin Academic Excellence Funding; University of Texas at Austin Undergraduate Research Fellowship	This project was supported through University of Texas at Austin Academic Excellence Funding to BC, and a University of Texas at Austin Undergraduate Research Fellowship to Nicole Tsao (mentored by LS and RR).; The authors thank the children and parents who made this study possible. The authors would also like to thank Nicole Tsao, Rachel Tessmer, and other members of the SoundBrain Laboratory and the Language Learning and Bilingualism Laboratory for assistance with stimulus generation, participant recruitment, and data collection. This project was supported through University of Texas at Austin Academic Excellence Funding to BC, and a University of Texas at Austin Undergraduate Research Fellowship to Nicole Tsao (mentored by LS and RR).	[Anonymous], 2014, J ACOUSTICAL SOC AM, V135, pEL88, DOI [10.1121/1.4862879, DOI 10.1121/1.4862879]; Baker M, 2014, J SPEECH LANG HEAR R, V57, P327, DOI 10.1044/1092-4388(2013/12-0287); Baskent D, 2016, J ACOUST SOC AM, V139, pEL51, DOI 10.1121/1.4942628; Bell NL, 2001, J CLIN PSYCHOL, V57, P417, DOI 10.1002/jclp.1024; Besson M., 2007, RESTORATIVE NEUROLOG, V25, P399; Bialystok E, 2004, DEVELOPMENTAL SCI, V7, P325, DOI 10.1111/j.1467-7687.2004.00351.x; Bialystok E., 2001, BILINGUALISM DEV LAN, DOI [10.1017/CBO9780511605963, DOI 10.1017/CBO9780511605963]; Bialystok E, 2014, PSYCHOL AGING, V29, P696, DOI 10.1037/a0037254; Bialystok E, 2012, TRENDS COGN SCI, V16, P240, DOI 10.1016/j.tics.2012.03.001; Bialystok E, 2010, BILING-LANG COGN, V13, P525, DOI 10.1017/S1366728909990423; Bialystok E, 2009, BILING-LANG COGN, V12, P3, DOI 10.1017/S1366728908003477; BILGER RC, 1984, J SPEECH HEAR RES, V27, P32, DOI 10.1044/jshr.2701.32; Blumenfeld H. K., 2007, LANG COGNITIVE PROC, V22, P633, DOI 10.1080/01690960601000746; Boebinger D, 2015, J ACOUST SOC AM, V137, P378, DOI 10.1121/1.4904537; Boersma Paul, 2002, GLOT INT, V5, P341; Bradley JS, 1999, J ACOUST SOC AM, V106, P1820, DOI 10.1121/1.427932; Bradlow AR, 2007, J ACOUST SOC AM, V121, P2339, DOI 10.1121/1.2642103; Brungart DS, 2009, J ACOUST SOC AM, V125, P4006, DOI 10.1121/1.3117686; Burfin S, 2014, FRONT PSYCHOL, P5; Calandruccio L, 2014, J SPEECH LANG HEAR R, V57, P1089, DOI 10.1044/2013_JSLHR-H-12-0378; Calandruccio L, 2014, AM J AUDIOL, V23, P158, DOI 10.1044/2014_AJA-13-0055; Calandruccio L, 2012, J SPEECH LANG HEAR R, V55, P1342, DOI 10.1044/1092-4388(2012/11-0260); Calvo A, 2014, COGNITION, V130, P278, DOI 10.1016/j.cognition.2013.11.015; Chen YC, 2009, J ACOUST SOC AM, V126, P858, DOI 10.1121/1.3158823; Conway ARA, 2001, PSYCHON B REV, V8, P331, DOI 10.3758/BF03196169; Cooke M, 2008, J ACOUST SOC AM, V123, P414, DOI 10.1121/1.2804952; Crandell C. C., 1996, AM J AUDIOL, V5, P47, DOI [10.1044/1059-0889.0503.47, DOI 10.1044/1059-0889.0503.47]; Cunningham J, 2001, CLIN NEUROPHYSIOL, V112, P758, DOI 10.1016/S1388-2457(01)00465-5; Fallon M, 2000, J ACOUST SOC AM, V108, P3023, DOI 10.1121/1.1323233; Fuller CD, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00179; Gollan TH, 2005, MEM COGNITION, V33, P1220, DOI 10.3758/BF03193224; Gullifer JW, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00278; Gutierrez-Clellen VF, 2003, APPL PSYCHOLINGUIST, V24, P267, DOI 10.1017/S0142716403000158; Hazan V, 2006, J ACOUST SOC AM, V119, P1740, DOI 10.1121/1.2166611; Hazan V, 2010, SPEECH COMMUN, V52, P996, DOI 10.1016/j.specom.2010.05.003; Hoff E, 2003, CHILD DEV, V74, P1368, DOI 10.1111/1467-8624.00612; Hollingshead AB, 2001, YALE J SOCIOLOGY, P21; HUTTENLOCHER J, 1991, DEV PSYCHOL, V27, P236, DOI 10.1037/0012-1649.27.2.236; KALIKOW DN, 1977, J ACOUST SOC AM, V61, P1337, DOI 10.1121/1.381436; Kapa LL, 2013, COGNITIVE DEV, V28, P233, DOI 10.1016/j.cogdev.2013.01.011; Kaufman A. S., 2004, KAUFMANN BRIEF INTEL, VSecond; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Krizman J, 2015, NEUROSCI LETT, V585, P48, DOI 10.1016/j.neulet.2014.11.011; Krizman J, 2014, BRAIN LANG, V128, P34, DOI 10.1016/j.bandl.2013.11.006; Krizman J, 2012, P NATL ACAD SCI USA, V109, P7877, DOI 10.1073/pnas.1201575109; Kuhnis J, 2014, J OF COGNITIVE; Leibold LJ, 2013, J SPEECH LANG HEAR R, V56, P1144, DOI 10.1044/1092-4388(2012/12-0011); LINDBLOM B, 1990, AAC (Augmentative and Alternative Communication), V6, P220, DOI 10.1080/07434619012331275504; Magne C, 2006, J COGNITIVE NEUROSCI, V18, P199, DOI 10.1162/089892906775783660; Marian V., 2003, BILING-LANG COGN, V6, P97, DOI DOI 10.1017/S1366728903001068; Mattys SL, 2012, LANG COGNITIVE PROC, V27, P953, DOI 10.1080/01690965.2012.705006; Mayo LH, 1997, J SPEECH LANG HEAR R, V40, P686, DOI 10.1044/jslhr.4003.686; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Nelson P, 2005, LANG SPEECH HEAR SER, V36, P219, DOI 10.1044/0161-1461(2005/022); NICOLADIS E, 1997, J SPEECH LANGUAGE PA, V0021; Paap KR, 2016, CORTEX, V74, P305, DOI 10.1016/j.cortex.2015.09.010; PAPSO CF, 1989, EAR HEARING, V10, P235, DOI 10.1097/00003446-198908000-00004; Parbery-Clark A, 2009, EAR HEARING, V30, P653, DOI 10.1097/AUD.0b013e3181b412e9; PLOMP R, 1979, J ACOUST SOC AM, V66, P1333, DOI 10.1121/1.383554; Pons F, 2015, PSYCHOL SCI; Pons F, 2009, P NATL ACAD SCI USA, V106, P10598, DOI 10.1073/pnas.0904134106; Portocarrero JS, 2007, ARCH CLIN NEUROPSYCH, V22, P415, DOI 10.1016/j.acn.2007.01.015; Poulin-Dubois D, 2011, J EXP CHILD PSYCHOL, V108, P567, DOI 10.1016/j.jecp.2010.10.009; Rogers CL, 2006, APPL PSYCHOLINGUIST, V27, P465, DOI 10.1017/S014271640606036X; Ronnberg J, 2013, EASE LANGUAGE UNDERS; Ross LA, 2007, CEREB CORTEX, V17, P1147, DOI 10.1093/cercor/bhl024; Ross LA, 2011, EUR J NEUROSCI, V33, P2329, DOI 10.1111/j.1460-9568.2011.07685.x; Ruggles DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086980; Schafer EC, 2012, EAR HEARING, V33, pE32, DOI 10.1097/AUD.0b013e318258c616; Schellenberg EG, 2008, TRENDS COGN SCI, V12, P45, DOI 10.1016/j.tics.2007.11.005; Sebastian-Galles N, 2012, PSYCHOL SCI, V23, P994, DOI 10.1177/0956797612436817; Shi LF, 2015, AM J AUDIOL, V24, P53, DOI 10.1044/2014_AJA-14-0041; Shi LF, 2010, J SPEECH LANG HEAR R, V53, P821, DOI 10.1044/1092-4388(2010/09-0081); Shin HB, 2011, FED FOR C APRIL; Shinn-Cunningham BG, 2008, TRENDS COGN SCI, V12, P182, DOI 10.1016/j.tics.2008.02.003; Smayda KE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152773; Strait DL, 2009, EUR J NEUROSCI, V29, P661, DOI 10.1111/j.1460-9568.2009.06617.x; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Swaminathan J, 2015, SCI REPORTS, V5; Team RC R, 2013, R LANG ENV STAT COMP; Thordardottir E, 2011, INT J BILINGUAL, V15, P426, DOI 10.1177/1367006911403202; Tun PA, 2002, PSYCHOL AGING, V17, P453, DOI 10.1037//0882-7974.17.3.453; Van Engen KJ, 2014, J SPEECH LANG HEAR R, V57, P1908, DOI 10.1044/JSLHR-H-13-0076; Van Engen KJ, 2010, LANG SPEECH, V53, P510, DOI 10.1177/0023830910372495; van Heuven WJB, 1998, J MEM LANG, V39, P458, DOI 10.1006/jmla.1998.2584; Wang Y, 2008, J ACOUST SOC AM, V124, P1716, DOI 10.1121/1.2956483; Wang Y, 2009, J PHONETICS, V37, P344, DOI 10.1016/j.wocn.2009.04.002; Weikum WM, 2007, SCIENCE, V316, P1159, DOI 10.1126/science.1137686; Werker JF, 2009, PHILOS T R SOC B, V364, P3649, DOI 10.1098/rstb.2009.0105; Wong PCM, 2008, J SPEECH LANG HEAR R, V51, P1026, DOI 10.1044/1092-4388(2008/075); Xie ZL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114439; Yi HG, 2013, J ACOUST SOC AM, V134, pEL387, DOI 10.1121/1.4822320	92	23	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							0168048	10.1371/journal.pone.0168048	http://dx.doi.org/10.1371/journal.pone.0168048			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936212	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100262
J	van Helmond, N; Steegers, MA; Moor, GPFD; Vissers, KC; Wilder-Smith, OH				van Helmond, Noud; Steegers, Monique A.; Moor, Gertie P. Filippini-de; Vissers, Kris C.; Wilder-Smith, Oliver H.			Hyperalgesia and Persistent Pain after Breast Cancer Surgery: A Prospective Randomized Controlled Trial with Perioperative COX-2 Inhibition	PLOS ONE			English	Article							QUALITY-OF-LIFE; LAPAROSCOPIC CHOLECYSTECTOMY; CENTRAL SENSITIZATION; CHRONIC-PANCREATITIS; PARAVERTEBRAL BLOCK; POSTMASTECTOMY PAIN; CLINICAL IMPORTANCE; KNEE REPLACEMENT; NEUROPATHIC PAIN; SENSORY CHANGES	Background Persistent pain is a challenging clinical problem after breast cancer treatment. After surgery, inflammatory pain and nociceptive input from nerve injury induce central sensitization which may play a role in the genesis of persistent pain. Using quantitative sensory testing, we tested the hypothesis that adding COX-2 inhibition to standard treatment reduces hyperalgesia after breast cancer surgery. A secondary hypothesis was that patients developing persistent pain would exhibit more postoperative hyperalgesia. Methods 138 women scheduled for lumpectomy/mastectomy under general anesthesia with paravertebral block were randomized to COX-2 inhibition (2x40mg parecoxib on day of surgery, thereafter 2x200mg celecoxib/day until day five) or placebo. Preoperatively and 1, 5, 15 days and 1, 3, 6, 12 months postoperatively, we determined electric and pressure pain tolerance thresholds in dermatomes C6/T4/L1 and a 100mm VAS score for pain. We calculated the sum of pain tolerance thresholds and analyzed change in these versus preoperatively using mixed models analysis with factor medication. To assess hyperalgesia in persistent pain patients we performed an additional analysis on patients reporting VAS>30 at 12 months. Results 48 COX-2 inhibition and 46 placebo patients were analyzed in a modified intention to treat analysis. Contrary to our primary hypothesis, change in the sum of tolerance thresholds in the COX-2 inhibition group was not different versus placebo. COX-2 inhibition had an effect on pain on movement at postoperative day 5 (p<0.01). Consistent with our secondary hypothesis, change in sum of pressure pain tolerance thresholds in 11 patients that developed persistent pain was negative versus patients without pain (p<0.01) from day 5 to 1 year postoperatively. Conclusions Perioperative COX-2 inhibition has limited value in preventing sensitization and persistent pain after breast cancer surgery. Central sensitization may play a role in the genesis of persistent postsurgical pain.	[van Helmond, Noud; Steegers, Monique A.; Vissers, Kris C.; Wilder-Smith, Oliver H.] Radboud Univ Nijmegen, Dept Anaesthesiol Pain & Palliat Med, Nijmegen Med Ctr, Nijmegen, Netherlands; [Moor, Gertie P. Filippini-de] Bernhoven Hosp, Dept Anesthesiol, Uden, Netherlands; [Wilder-Smith, Oliver H.] Aalborg Univ, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact SMI, Aalborg, Denmark	Radboud University Nijmegen; Aalborg University	van Helmond, N (corresponding author), Radboud Univ Nijmegen, Dept Anaesthesiol Pain & Palliat Med, Nijmegen Med Ctr, Nijmegen, Netherlands.	Noud.vanHelmond@radboudumc.nl	Steegers, M.A.H./L-4668-2015; Vissers, Kris/H-8110-2014; van Helmond, Noud/E-2607-2016; Vissers, Kris C.P./D-3569-2009	Vissers, Kris/0000-0002-2919-6356; Vissers, Kris C.P./0000-0002-2919-6356; Steegers, Monique/0000-0003-0812-5089	Pfizer	Pfizer(Pfizer)	This study was supported by a grant from Pfizer. They had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Andersen KG, 2011, J PAIN, V12, P725, DOI 10.1016/j.jpain.2010.12.005; Andersen KG, 2015, ACTA ANAESTHESIOLOGI; Andreae MH, 2013, BRIT J ANAESTH, V111, P711, DOI 10.1093/bja/aet213; Bisgaard T, 2005, SCAND J GASTROENTERO, V40, P1358, DOI 10.1080/00365520510023675; Blichfeldt-Eckhardt MR, 2014, PAIN, V155, P2400, DOI 10.1016/j.pain.2014.09.019; Bouwense SAW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042096; Bouwense SAW, 2011, REGION ANESTH PAIN M, V36, P303, DOI 10.1097/AAP.0b013e3182177022; Breuer AJ, 2014, PAIN PHYSICIAN, V17, P127; Callesen T, 1999, BRIT J SURG, V86, P1528, DOI 10.1046/j.1365-2168.1999.01320.x; Caraceni A, 2004, J CLIN ONCOL, V22, P2909, DOI 10.1200/jco.2004.08.141; Collins SL, 1997, PAIN, V72, P95, DOI 10.1016/S0304-3959(97)00005-5; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Eichenberger U, 2008, ANESTH ANALG, V106, P1265, DOI 10.1213/ane.0b013e3181685014; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Fernandez-Lao C, 2011, PAIN MED, V12, P72, DOI 10.1111/j.1526-4637.2010.01027.x; Gartner R, 2009, JAMA-J AM MED ASSOC, V302, P1985, DOI 10.1001/jama.2009.1568; Geber C, 2011, PAIN, V152, P548, DOI 10.1016/j.pain.2010.11.013; Gottrup H, 2000, PAIN, V87, P275, DOI 10.1016/S0304-3959(00)00291-8; Gwilym SE, 2011, J BONE JOINT SURG BR, V93B, P498, DOI 10.1302/0301-620X.93B4.25054; Hickey OT, 2010, CLIN J PAIN, V26, P556, DOI 10.1097/AJP.0b013e3181dee988; Hinz A, 2012, EUR J CANCER CARE, V21, P677, DOI 10.1111/j.1365-2354.2012.01367.x; Marti MLI, 2011, REV ESP ANEST REANIM, V58, P290, DOI 10.1016/S0034-9356(11)70064-0; Ilfeld BM, 2015, ANN SURG ONCOL, V22, P2017, DOI 10.1245/s10434-014-4248-7; Kairaluoma PM, 2006, ANESTH ANALG, V103, P703, DOI 10.1213/01.ane.0000230603.92574.4e; Karmakar MK, 2014, REGION ANESTH PAIN M, V39, P289, DOI 10.1097/AAP.0000000000000113; Katz J, 1996, CLIN J PAIN, V12, P50, DOI 10.1097/00002508-199603000-00009; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Koppert W, 2004, PAIN, V108, P148, DOI 10.1016/j.pain.2003.12.017; Lakdja F, 1997, B CANCER, V84, P259; Lavand'homme P, 2006, ACTA ANAESTH BELG, V57, P373; Lavand'homme P, 2005, ANESTHESIOLOGY, V103, P813, DOI 10.1097/00000542-200510000-00020; Lee JS, 2003, ACAD EMERG MED, V10, P1128, DOI 10.1197/S1069-6563(03)00372-5; Lundblad H, 2008, J BONE JOINT SURG BR, V90B, P166, DOI 10.1302/0301-620X.90B2.19640; Ma WY, 2002, BRAIN RES, V937, P94, DOI 10.1016/S0006-8993(02)02593-3; McMahon SB, 2016, WALL MELZACKS TXB PA; Moore RA, 2013, ANAESTHESIA, V68, P400, DOI 10.1111/anae.12148; Nir RR, 2011, EUR J PAIN, V15, P491, DOI 10.1016/j.ejpain.2010.10.001; Olesen SS, 2011, GASTROENTEROLOGY, V141, P536, DOI 10.1053/j.gastro.2011.04.003; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Romundstad L, 2006, PAIN, V124, P92, DOI 10.1016/j.pain.2006.03.020; Samad TA, 2002, TRENDS MOL MED, V8, P390, DOI 10.1016/S1471-4914(02)02383-3; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Schreiber KL, 2013, PAIN, V154, P660, DOI 10.1016/j.pain.2012.11.015; Solomkin JS, 2001, ANN SURG, V233, P79, DOI 10.1097/00000658-200101000-00013; Svensson CI, 2002, ANNU REV PHARMACOL, V42, P553, DOI 10.1146/annurev.pharmtox.42.092401.143905; Sycha T, 2005, PAIN, V113, P316, DOI 10.1016/j.pain.2004.11.002; Tasmuth T, 1997, ACTA ONCOL, V36, P625, DOI 10.3109/02841869709001326; Tasmuth T, 1999, EUR J SURG ONCOL, V25, P38, DOI 10.1053/ejso.1998.0597; Treede RD, 2002, PAIN, V98, P235, DOI 10.1016/S0304-3959(02)00203-8; TREEDE RD, 1992, PROG NEUROBIOL, V38, P397, DOI 10.1016/0301-0082(92)90027-C; Turk DC, 2011, LANCET, V377, P2226, DOI 10.1016/S0140-6736(11)60402-9; Vahdat LT, 2009, J CLIN ONCOL, V27, P2954, DOI 10.1200/JCO.2008.17.7618; Vilholm OJ, 2009, ACTA ANAESTH SCAND, V53, P800, DOI 10.1111/j.1399-6576.2009.01938.x; Walsh TJ, 1999, NEW ENGL J MED, V340, P764, DOI 10.1056/NEJM199903113401004; Wilder-Smith O, 2013, PARADIGM SHIFT PAIN; Wilder-Smith OHG, 1998, ANESTH ANALG, V86, P95, DOI 10.1097/00000539-199801000-00019; Wilder-Smith OHG, 2003, ANESTHESIOLOGY, V98, P1214, DOI 10.1097/00000542-200305000-00025; Wilder-Smith Oliver Hamilton, 2010, J Pain Palliat Care Pharmacother, V24, P119, DOI 10.3109/15360281003706069; WilderSmith OHG, 1996, BRIT J ANAESTH, V76, P816, DOI 10.1093/bja/76.6.816; Woolf CJ, 2004, LIFE SCI, V74, P2605, DOI 10.1016/j.lfs.2004.01.003; Woolf CJ, 2001, ANESTHESIOLOGY, V95, P241, DOI 10.1097/00000542-200107000-00034; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Wylde V, 2015, PAIN, V156, P47, DOI 10.1016/j.pain.0000000000000002; Yarnitsky D, 2008, PAIN, V138, P22, DOI 10.1016/j.pain.2007.10.033; Yarnitsky D, 2010, CURR OPIN ANESTHESIO, V23, P611, DOI 10.1097/ACO.0b013e32833c348b	66	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166601	10.1371/journal.pone.0166601	http://dx.doi.org/10.1371/journal.pone.0166601			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935990	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100035
J	Williams, AN; Evans, LH; Herron, JE; Wilding, EL				Williams, Angharad N.; Evans, Lisa H.; Herron, Jane E.; Wilding, Edward L.			On the Antecedents of an Electrophysiological Signature of Retrieval Mode	PLOS ONE			English	Article							EPISODIC MEMORY; PREFRONTAL CORTEX; TASK-SET; BRAIN; INSIGHTS	It has been proposed that people employ a common set of sustained operations (retrieval mode) when preparing to remember different kinds of episodic information. In two experiments, however, there was no evidence for the pattern of brain activity commonly assumed to index these operations. In both experiments event-related potentials (ERPs) were recorded time-locked to alternating preparatory cues signalling that participants should prepare for different retrieval tasks. One cue signalled episodic retrieval: remember the location where the object was presented in a prior study phase. The other signalled semantic retrieval: identify the location where the object is most commonly found (Experiment 1) or identify the typical size of the object (Experiment 2). In both experiments, only two trials of the same task were completed in succession. This enabled ERP contrasts between 'repeat' trials (the cue on the preceding trial signalled the same retrieval task), and 'switch' trials (the cue differed from the preceding trial). There were differences between the ERPs elicited by the preparatory task cues in Experiment 1 only: these were evident only on switch trials and comprised more positive-going activity over right-frontal scalp for the semantic than for the episodic task. These findings diverge from previous outcomes where the activity differentiating cues signalling preparation for episodic or semantic retrieval has been restricted to right-frontal scalp sites, comprising more positive-going activity for the episodic than for the semantic task. While these findings are consistent with the view that there is not a common set of operations engaged when people prepare to remember different kinds of episodic information, an alternative account is offered here, which is that these outcomes are a consequence of structural and temporal components of the experiment designs.	[Williams, Angharad N.; Evans, Lisa H.; Herron, Jane E.] Cardiff Univ, CUBRIC, Sch Psychol, Cardiff, S Glam, Wales; [Williams, Angharad N.] Cardiff Univ, Sch Med, IPMCN, Cardiff, S Glam, Wales; [Williams, Angharad N.] Cardiff Univ, Sch Med, MRC Ctr Neuropsychiat Genet & Genom, Cardiff, S Glam, Wales; [Wilding, Edward L.] Univ Nottingham, Sch Psychol, Nottingham, England	Cardiff University; Cardiff University; Cardiff University; University of Nottingham	Williams, AN (corresponding author), Cardiff Univ, CUBRIC, Sch Psychol, Cardiff, S Glam, Wales.; Williams, AN (corresponding author), Cardiff Univ, Sch Med, IPMCN, Cardiff, S Glam, Wales.; Williams, AN (corresponding author), Cardiff Univ, Sch Med, MRC Ctr Neuropsychiat Genet & Genom, Cardiff, S Glam, Wales.	WilliamsAN@cardiff.ac.uk	Herron, Jane/L-1340-2013; Wilding, Edward/ABC-8750-2021	Herron, Jane/0000-0002-2443-0713; Wilding, Edward/0000-0002-9495-1418; Evans, Lisa/0000-0002-3874-4676; Williams, Angharad Nia/0000-0001-9363-8537	School of Psychology at Cardiff University; Wellcome Trust [106278/Z/14/Z]; BBSRC [BB/E009921/1] Funding Source: UKRI	School of Psychology at Cardiff University; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	AW was supported by a PhD studentship from the School of Psychology at Cardiff University. JH is supported by the Wellcome Trust (106278/Z/14/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1983, CANADIAN PSYCHOL; Azimian-Faridani N, 2004, PSYCHON B REV, V11, P926, DOI 10.3758/BF03196723; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Duzel E, 1999, P NATL ACAD SCI USA, V96, P1794, DOI 10.1073/pnas.96.4.1794; Duzel E, 2001, HUM BRAIN MAPP, V13, P104, DOI 10.1002/hbm.1028; Evans LH, 2012, COGN NEUROSCI-UK, V3, P168, DOI 10.1080/17588928.2012.662217; Evans LH, 2015, NEUROIMAGE, V108, P435, DOI 10.1016/j.neuroimage.2014.12.068; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Herron JE, 2006, NEUROIMAGE, V32, P863, DOI 10.1016/j.neuroimage.2006.03.046; Herron JE, 2004, NEUROIMAGE, V22, P1554, DOI 10.1016/j.neuroimage.2004.04.011; Hicks JL, 1998, J EXP PSYCHOL LEARN, V24, P1105, DOI 10.1037/0278-7393.24.5.1105; Johnson JD, 2006, J COGNITIVE NEUROSCI, V18, P1531, DOI 10.1162/jocn.2006.18.9.1531; KAPUR S, 1995, NEUROREPORT, V6, P1880, DOI 10.1097/00001756-199510020-00014; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lepage M, 2000, P NATL ACAD SCI USA, V97, P506, DOI 10.1073/pnas.97.1.506; MCGRAW KO, 1992, PSYCHOL BULL, V111, P361, DOI 10.1037/0033-2909.111.2.361; Meiran N, 2000, COGNITIVE PSYCHOL, V41, P211, DOI 10.1006/cogp.2000.0736; Monsell S, 2003, MEM COGNITION, V31, P327, DOI 10.3758/BF03194391; Morcom AM, 2002, NEUROREPORT, V13, P149, DOI 10.1097/00001756-200201210-00034; Nyberg L, 1995, NEUROREPORT, V7, P249, DOI 10.1097/00001756-199512000-00060; Nyberg L, 1996, PSYCHON B REV, V3, P135, DOI 10.3758/BF03212412; Nyberg L, 2000, J COGNITIVE NEUROSCI, V12, P163, DOI 10.1162/089892900561805; Peynircioglu Z.F., 1988, PRACTICAL ASPECTS ME, V2, P518; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Rugg MD, 2000, TRENDS COGN SCI, V4, P108, DOI 10.1016/S1364-6613(00)01445-5; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Szekely A, 2004, J MEM LANG, V51, P247, DOI 10.1016/j.jml.2004.03.002; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2012, DOI 10.1073/pnas.91.6.2012; Verde MF, 2004, PSYCHON B REV, V11, P560, DOI 10.3758/BF03196611; Verde MF, 2003, J EXP PSYCHOL LEARN, V29, P739, DOI 10.1037/0278-7393.29.5.739; Verhagen J, 2014, J EXP PSYCHOL GEN, V143, P1457, DOI 10.1037/a0036731; Wasserman L., 2004, ALL STAT CONCISE COU, V26; WATKINS MJ, 1990, J EXP PSYCHOL LEARN, V16, P1012, DOI 10.1037/0278-7393.16.6.1012; Werkle-Bergner M, 2005, COGNITIVE BRAIN RES, V24, P599, DOI 10.1016/j.cogbrainres.2005.03.011; Wetzels R, 2011, PERSPECT PSYCHOL SCI, V6, P291, DOI 10.1177/1745691611406923; Wilckens KA, 2011, NEUROIMAGE, V55, P1384, DOI 10.1016/j.neuroimage.2010.12.059; Wilding EL, 2006, CLIN EEG NEUROSCI, V37, P315, DOI 10.1177/155005940603700409; Wilding EL, 2001, NEUROREPORT, V12, P3613, DOI 10.1097/00001756-200111160-00048	39	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167574	10.1371/journal.pone.0167574	http://dx.doi.org/10.1371/journal.pone.0167574			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936062	gold, Green Accepted, Green Published			2022-12-27	WOS:000389587100127
J	Zhang, MX; Chen, CY; Fang, QQ; Xu, JH; Wang, XF; Shi, BH; Wu, LH; Tan, WQ				Zhang, Min-Xia; Chen, Chun-Ye; Fang, Qing-Qing; Xu, Ji-Hua; Wang, Xiao-Feng; Shi, Bang-Hui; Wu, Li-Hong; Tan, Wei-Qiang			Risk Factors for Complications after Reduction Mammoplasty: A Meta-Analysis	PLOS ONE			English	Article							BODY-MASS INDEX; BREAST REDUCTION; OBESITY; SMOKING; NICOTINE; OUTCOMES; VOLUME	Background Reduction mammoplasty (RM) is a proven method of treating macromastia, but the risk factors for postoperative complications have not been clearly identified. Through this meta-analysis, the authors aimed to identify the risk factors of RM complications. Methods An extensive search of the literature describing complications after RM was performed using the PubMed Central, Embase, and Cochrane databases. The following risk factors were extracted: age, body mass index (BMI), tissue resection weight per breast (TRW), smoking and radiation therapy. Odds ratios (OR) were pooled with 95% confidence intervals (CI) to evaluate the relationship between these risk factors and complications after RM. Results A total of 16 unique studies including 10 593 patients were included in the final analysis. It showed that there was a significant difference in complications in BMI >= 30 kg/m(2) (OR 0.73; 95% CI: 0.61-0.89, p = 0.001) and smoking (OR 1.56; 95% CI: 0.98-2.49, p = 0.06). Infection in those with BMI >= 30 kg/m(2) showed a significant difference (OR 0.68; 95% CI: 0.52-0.89, p = 0.004), as well as wound dehiscence in smokers (OR 2.73; 95% CI: 1.60-4.67, p = 0.0002) and infection in irradiated breasts (OR 20.38; 95% CI: 3.42-121.35, p = 0.0009). However, there was no significant difference in age >= 50 years (OR 0.96; 95% CI: 0.71-1.29, p = 0.78), combined TRW >= 1000 g (OR 1.04; 95% CI: 0.43-2.50, p = 0.93). Conclusions BMI >= 30 kg/m(2) and smoking increase the risk of complications. Persons who are obese or irradiated are more likely to develop infections, and smokers experienced a higher incidence of wound dehiscence than did nonsmokers. However, patients aged >= 50 years and TRW >= 1000 g are not associated with complications from RM.	[Zhang, Min-Xia; Chen, Chun-Ye; Fang, Qing-Qing; Xu, Ji-Hua; Wang, Xiao-Feng; Shi, Bang-Hui; Tan, Wei-Qiang] Zhejiang Univ, Affiliated Hosp 1, Dept Plast Surg, Coll Med, Hangzhou, Zhejiang, Peoples R China; [Zhang, Min-Xia; Chen, Chun-Ye; Fang, Qing-Qing; Wang, Xiao-Feng; Shi, Bang-Hui; Wu, Li-Hong; Tan, Wei-Qiang] Zhejiang Univ, Affiliated Hosp 4, Coll Med, Dept Plast Surg, Yiwu, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Tan, WQ (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Dept Plast Surg, Coll Med, Hangzhou, Zhejiang, Peoples R China.; Tan, WQ (corresponding author), Zhejiang Univ, Affiliated Hosp 4, Coll Med, Dept Plast Surg, Yiwu, Zhejiang, Peoples R China.	tanweixxxx@163.com	fang, qingqing/GZK-4330-2022; Tan, Wei-Qiang/GYI-8422-2022	Tan, Wei-Qiang/0000-0001-5610-2418	National Natural Science Foundation of China [81372072, 81671918]; Zhejiang Provincial Science and Technology Project of China [2016C33134]; Zhejiang Provincial Medical and Healthy Science Foundation of China [2016KYB103, 2016KYB093]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Science and Technology Project of China; Zhejiang Provincial Medical and Healthy Science Foundation of China	This work was supported by grants from the National Natural Science Foundation of China (No. 81372072 and 81671918), Zhejiang Provincial Science and Technology Project of China (No. 2016C33134), and Zhejiang Provincial Medical and Healthy Science Foundation of China (No. 2016KYB103 and 2016KYB093).	Baldwin CJ, 2010, J PLAST RECONSTR AES, V63, P663, DOI 10.1016/j.bjps.2009.06.001; Bikhchandani J, 2007, J PLAST RECONSTR AES, V60, P1050, DOI 10.1016/j.bjps.2007.01.073; Brown AP, 2000, BRIT J PLAST SURG, V53, P584, DOI 10.1054/bjps.2000.3380; Chan LKW, 2006, ANN PLAS SURG, V56, P111, DOI 10.1097/01.sap.0000197635.26473.a2; Chen Chieh-Fan, 2011, Comput Math Methods Med, V2011, P395690, DOI 10.1155/2011/395690; Chun YS, 2012, PLAST RECONSTR SURG, V129, p228E, DOI 10.1097/PRS.0b013e31823ae949; Cunningham BL, 2005, PLAST RECONSTR SURG, V115, P1597, DOI 10.1097/01.PRS.0000160695.33457.DB; DABBAH A, 1995, ANN PLAS SURG, V35, P337, DOI 10.1097/00000637-199510000-00001; Dafydd H, 2011, J PLAST RECONSTR AES, V64, P160, DOI 10.1016/j.bjps.2010.04.043; Dal Cin A, 2012, CAN J PLAST SURG, V20, pE6; DAVIS GM, 1995, PLAST RECONSTR SURG, V96, P1106, DOI 10.1097/00006534-199510000-00015; Deliaert AEK, 2012, EUR J PLAST SURG, V35, P421, DOI 10.1007/s00238-011-0661-3; Gamboa-Bobadilla GM, 2007, ANN PLAS SURG, V58, P246, DOI 10.1097/01.sap.0000248108.52837.6c; Guemes A, 2016, AESTHET PLAST SURG, V40, P62, DOI 10.1007/s00266-015-0601-x; Henry SL, 2009, PLAST RECONSTR SURG, V124, P1040, DOI 10.1097/PRS.0b013e3181b45410; Nelson JA, 2014, J PLAST SURG HAND SU, V48, P334, DOI 10.3109/2000656X.2014.886582; Nelson JA, 2014, AESTHET SURG J, V34, P409, DOI 10.1177/1090820X14525393; O'Grady KF, 2005, PLAST RECONSTR SURG, V115, P736, DOI 10.1097/01.PRS.0000152428.43300.19; Parrett BM, 2010, BREAST J, V16, P498, DOI 10.1111/j.1524-4741.2010.00965.x; Platt AJ, 2003, ANN PLAS SURG, V51, P552, DOI 10.1097/01.sap.0000095656.18023.6b; Roehl K, 2008, PLAST RECONSTR SURG, V122, P370, DOI 10.1097/PRS.0b013e31817d60f4; Roje Z, 2012, COLLEGIUM ANTROPOL, V36, P657; Schnur PL, 1997, PLAST RECONSTR SURG, V100, P875, DOI 10.1097/00006534-199709001-00008; Schumacher HHA, 2005, ANN PLAS SURG, V54, P117, DOI 10.1097/01.sap.0000146878.14207.9d; Setala L, 2009, J PLAST RECONSTR AES, V62, P195, DOI 10.1016/j.bjps.2007.10.043; Shah R, 2011, J PLAST RECONSTR AES, V64, P508, DOI 10.1016/j.bjps.2010.07.001; Shermak MA, 2011, PLAST RECONSTR SURG, V128, P1182, DOI 10.1097/PRS.0b013e318230c467; SU C, 1982, PHARMACOL THERAPEUT, V17, P129, DOI 10.1016/0163-7258(82)90050-X; Wagner DS, 2005, PLAST RECONSTR SURG, V115, P1034, DOI 10.1097/01.PRS.0000154213.06888.F9; Weichman KE, 2015, PLAST RECONSTR SURG, V135, P1276, DOI 10.1097/PRS.0000000000001147; WHO, BMI CLASSIFICATION, DOI DOI 11/44679/INDEX.HTM; Xiao SW, 2015, EUR SPINE J, V24, P31, DOI 10.1007/s00586-014-3607-1; Yosipovitch G, 2007, J AM ACAD DERMATOL, V56, P901, DOI 10.1016/j.jaad.2006.12.004; Zubowski R, 2000, PLAST RECONSTR SURG, V106, P998, DOI 10.1097/00006534-200010000-00006	34	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167746	10.1371/journal.pone.0167746	http://dx.doi.org/10.1371/journal.pone.0167746			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936188	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100173
J	Kang, YJ; Kang, MY				Kang, Young Joong; Kang, Mo-Yeol			Chronic Diseases, Health Behaviors, and Demographic Characteristics as Predictors of Ill Health Retirement: Findings from the Korea Health Panel Survey (2008-2012)	PLOS ONE			English	Article							LABOR-FORCE PARTICIPATION; POPULATION; EMPLOYMENT; HEPATITIS; RISK	Purpose The research aim was to identify demographic characteristics, chronic diseases, and unhealthy behaviors predicting ill health retirement in South Korea. Methods Data were collected from 15,407 individuals enrolled in the first through the fifth phases of the Korea Health Panel Survey (2008-2012) using structured questionnaires examining retirement, morbidities, and health-related behaviors. The Cox proportional hazard model was used to examine demographic and clinical characteristics' effects on ill health retirement. Lost years of working life expectancy were calculated for demographic and clinical characteristics. Results Older, female, and manual workers were more likely to experience ill health retirement, as were respondents reporting poor health-related habits (e.g., heavy drinking, irregular meals, less sleep hours, obesity, and no regular exercise). The chronic diseases most closely associated with ill health retirement were, in order, psychiatric disease, ophthalmologic disease, neurologic disease, infectious disease, and musculoskeletal diseases. The average reduction in working life expectancy was 9.73 years. Conclusions Our study results can help contribute to the development of strategies for reducing the risk of ill health retirement and promoting sustainable labor force participation in an aging society.	[Kang, Young Joong] Korea Occupat Safety & Hlth Agcy, Occupat Safety & Hlth Res Inst, Ulsan, South Korea; [Kang, Mo-Yeol] Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul, South Korea	Seoul National University (SNU)	Kang, MY (corresponding author), Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul, South Korea.	snaptoon@snu.ac.kr		Kang, Young Joong/0000-0002-2043-985X				Alavinia SM, 2008, INT ARCH OCC ENV HEA, V82, P39, DOI 10.1007/s00420-008-0304-6; [Anonymous], 2012, POPULATION IOMCOTL R; Bloom DE, 2010, OXFORD REV ECON POL, V26, P583, DOI 10.1093/oxrep/grq038; Brinton MC, 2001, WOMENS WORKING LIVES, P1; Chung Woo-Jin, 2006, J Prev Med Public Health, V39, P21; Ciulla TA, 2003, DIABETES CARE, V26, P2653, DOI 10.2337/diacare.26.9.2653; Clemens Tom, 2009, Health Stat Q, P7; Daley M, 2009, SLEEP MED, V10, P427, DOI 10.1016/j.sleep.2008.04.005; Eckert KA, 2015, OPHTHAL EPIDEMIOL, V22, P349, DOI 10.3109/09286586.2015.1066394; Flippen C, 2000, J GERONTOL B-PSYCHOL, V55, pS14; Hassan MM, 2002, HEPATOLOGY, V36, P1206, DOI 10.1053/jhep.2002.36780; Ilmarinen JE, 2001, OCCUP ENVIRON MED, V58, P546, DOI 10.1136/oem.58.8.546; Kang MY, 2015, J OCCUP HEALTH, V57, P28, DOI 10.1539/joh.14-0117-OA; Kang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113495; Karpansalo M, 2002, J OCCUP ENVIRON MED, V44, P930, DOI 10.1097/00043764-200210000-00012; Ko C-F, 2010, CRISIS WELFARE E ASI, P43; Krueger PM, 2009, AM J EPIDEMIOL, V169, P1052, DOI 10.1093/aje/kwp023; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; MacDonald Z, 2004, HEALTH ECON, V13, P139, DOI 10.1002/hec.816; OECD, 2013, STATEXTRACTS LAB FOR; OECD, 2012, OECD EC SURV KOR 201; Palmer KT., 2007, FITNESS WORK MED ASP; Schofield DJ, 2008, MED J AUSTRALIA, V189, P447, DOI 10.5694/j.1326-5377.2008.tb02119.x; Schofield DJ, 2013, BMJ OPEN, V3; Stattin M, 2005, OCCUP ENVIRON MED, V62, P135, DOI 10.1136/oem.2004.015669; Tuomi K, 1997, SCAND J WORK ENV HEA, V23, P58; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; Yu WH, 2005, DEMOGRAPHY, V42, P693, DOI 10.1353/dem.2005.0039	28	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0166921	10.1371/journal.pone.0166921	http://dx.doi.org/10.1371/journal.pone.0166921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4OA	27930661	gold, Green Published, Green Submitted			2022-12-27	WOS:000389580900017
J	Sousa, JD; Temudo, MP; Hewlett, BS; Camacho, RJ; Muller, V; Vandamme, AM				Sousa, Joao Dinis; Temudo, Marina Padrao; Hewlett, Barry Stephen; Camacho, Ricardo Jorge; Mueller, Viktor; Vandamme, Anne-Mieke			Male Circumcision and the Epidemic Emergence of HIV-2 in West Africa	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GENITAL ULCER DISEASES; SUB-SAHARAN AFRICA; GUINEA-BISSAU; COTE-DIVOIRE; MOLECULAR EPIDEMIOLOGY; DEVELOPING-COUNTRIES; GENETIC DIVERSITY; SOOTY MANGABEYS; RISK-FACTORS	Background Epidemic HIV-2 (groups A and B) emerged in humans circa 1930-40. Its closest ancestors are SIVsmm infecting sooty mangabeys from southwestern Cote d'Ivoire. The earliest large-scale serological surveys of HIV-2 in West Africa (1985-91) show a patchy spread. Cote d'Ivoire and Guinea-Bissau had the highest prevalence rates by then, and phylogeographical analysis suggests they were the earliest epicenters. Wars and parenteral transmission have been hypothesized to have promoted HIV-2 spread. Male circumcision (MC) is known to correlate negatively with HIV-1 prevalence in Africa, but studies examining this issue for HIV-2 are lacking. Methods We reviewed published HIV-2 serosurveys for 30 cities of all West African countries and obtained credible estimates of real prevalence through Bayesian estimation. We estimated past MC rates of 218 West African ethnic groups, based on ethnographic literature and fieldwork. We collected demographic tables specifying the ethnic partition in cities. Uncertainty was incorporated by defining plausible ranges of parameters (e.g. timing of introduction, proportion circumcised). We generated 1,000 sets of past MC rates per city using Latin Hypercube Sampling with different parameter combinations, and explored the correlation between HIV-2 prevalence and estimated MC rate (both logit-transformed) in the 1,000 replicates. Results and Conclusions Our survey reveals that, in the early 20th century, MC was far less common and geographically more variable than nowadays. HIV-2 prevalence in 1985-91 and MC rates in 1950 were negatively correlated (Spearman rho = -0.546, IQR: -0.553--0.546, p <= 0.0021). Guinea-Bissau and Cote d'Ivoire cities had markedly lower MC rates. In addition, MC was uncommon in rural southwestern Cote d'Ivoire in 1930. The differential HIV-2 spread in West Africa correlates with different historical MC rates. We suggest HIV-2 only formed early substantial foci in cities with substantial uncircumcised populations. Lack of MC in rural areas exposed to bushmeat may have had a role in successful HIV-2 emergence.	[Sousa, Joao Dinis; Camacho, Ricardo Jorge; Vandamme, Anne-Mieke] KU Leuven Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res Clin & Epidemiol Virol, B-3000 Leuven, Belgium; [Sousa, Joao Dinis; Vandamme, Anne-Mieke] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Microbiol Med, Ctr Global Hlth & Trop Med, Lisbon, Portugal; [Temudo, Marina Padrao] Univ Lisbon, CEF, Sch Agr, Dept Nat Resources Environm & Land, Lisbon, Portugal; [Hewlett, Barry Stephen] Washington State Univ, Dept Anthropol, Vancouver, WA USA; [Mueller, Viktor] Eotvos Lorand Univ, Inst Biol, Budapest, Hungary; [Mueller, Viktor] Parmenides Ctr Conceptual Fdn Sci, Pullach Munich, Germany	KU Leuven; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade de Lisboa; Washington State University; Eotvos Lorand University	Sousa, JD; Vandamme, AM (corresponding author), KU Leuven Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res Clin & Epidemiol Virol, B-3000 Leuven, Belgium.; Sousa, JD; Vandamme, AM (corresponding author), Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Microbiol Med, Ctr Global Hlth & Trop Med, Lisbon, Portugal.	joao.sousa@kuleuven.be; annemie.vandamme@uzleuven.be	Vandamme, Anne-Mieke/I-4127-2012; Müller, Viktor/B-3493-2009	Vandamme, Anne-Mieke/0000-0002-6594-2766; Müller, Viktor/0000-0001-8212-4880; Temudo, Marina/0000-0002-8254-4233; Sousa, Joao/0000-0002-7604-3109	Fonds voor Wetenschappelijk Onderzoek Flanders (FWO), Belgium [G.0611.09N]; Fundacao para a Ciencia e Tecnologia, (FCT), Portugal [PTDC/AFR/111546/2009]	Fonds voor Wetenschappelijk Onderzoek Flanders (FWO), Belgium(FWO); Fundacao para a Ciencia e Tecnologia, (FCT), Portugal(Portuguese Foundation for Science and Technology)	The research done by JDS and AMV in this study has been supported in part by grant G.0611.09N, funded by the Fonds voor Wetenschappelijk Onderzoek Flanders (FWO, http://www.fwo.be/en/), Belgium. MPTs fieldwork in Guinea-Bissau was conducted within the framework of the project The prophetess and the rice farmer: innovations in religion, agriculture and gender in Guinea-Bissau, PTDC/AFR/111546/2009, funded by Fundacao para a Ciencia e Tecnologia, (FCT, http://www.fct.pt/), Portugal. VM is a Fellow of the Parmenides Center for the Conceptual Foundations of Science, part of Parmenides Foundation (https://www.parmenides-foundation.org/home/), Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	agencia Geral das Colonias, 1929, B GER COL, V44; Andreasson PA, 1989, 5 INT C AIDS JUN 4 9, V5, P1000; Auguie B, 2017, GRIDEXTRA MISCELLANE; Auvert B, 2001, AIDS, V15, pS31, DOI 10.1097/00002030-200108004-00004; Auvert B, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001509; Ayouba A, 2013, AIDS, V27, P2488, DOI 10.1097/01.aids.0000432443.22684.50; Banton M, 1957, W AFRICAN CITY STUDY; Baumann H, 1962, PEUPLES CIVILIZATION; Biyi E, 1929, TRIBES LIBERIAN HINT, V29, P181; Biyi E, 1929, W AFRICA J ROY AFR S, V29, P71; BONGAARTS J, 1989, AIDS, V3, P373, DOI 10.1097/00002030-198906000-00006; Booth A. H., 1958, Bull Inst franY Afr N, V20A, P587; Botas J, 1989, 5 INT C AIDS JUN 4 9, V5, P90; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Brun-Vezinet F, 1988, MED MALADIES INFECT, V18, P698; Carvalho Viegas LA, 1936, HIST GUINE PORTUGUES, VIII; Carvalho Viegas LA, 1936, HIST GUINE PORTUGUES, VII; Chen ZW, 1997, J VIROL, V71, P3953, DOI 10.1128/JVI.71.5.3953-3960.1997; Chevannes B., 2001, ENCY AFRICAN AFRICAN, P282; Chitnis A, 2000, AIDS RES HUM RETROV, V16, P5, DOI 10.1089/088922200309548; Clozel FJ, 1902, COUTUMES COTE LVOIRE; Coquery-Vidrovitch Catherine, 1994, AFRICAINES HIST FEMM; Cunha L, 2007, J MED VIROL, V79, P1832, DOI 10.1002/jmv.21010; D'arc M, 2015, P NATL ACAD SCI USA, V112, pE1343, DOI 10.1073/pnas.1502022112; DAZEVEDO WL, 1962, ANN NY ACAD SCI, V96, P512, DOI 10.1111/j.1749-6632.1962.tb50146.x; de Sousa JD, 2012, VIRUSES-BASEL, V4, P1950, DOI 10.3390/v4101950; DECOCK KM, 1991, AIDS, V5, pS21; DECOCK KM, 1989, AIDS, V3, pS89, DOI 10.1097/00002030-198901001-00013; Delafosse M., 1912, HAUT SENEGAL NIGER P; Delval R., 1980, MUSULMANS TOGO; DIALLO MO, 1992, AIDS, V6, P581, DOI 10.1097/00002030-199206000-00010; Dorai-Raj S., 2014, BINOMIAL CONFIDENCE; Drain PK, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-172; Drain PK, 2004, JAIDS-J ACQ IMM DEF, V35, P407, DOI 10.1097/00126334-200404010-00011; Faria NR, 2014, SCIENCE, V346, P56, DOI 10.1126/science.1256739; Faria NR, 2012, J GEN VIROL, V93, P889, DOI 10.1099/vir.0.038638-0; Fischetti L, 2004, J MED VIROL, V73, P158, DOI 10.1002/jmv.20070; FROBENIUS L, 1929, ATLAS AFRICANUS BELE; Froelich JC, 1955, CARTE POPULATIONS AF; GAO F, 1994, J VIROL, V68, P7433, DOI 10.1128/JVI.68.11.7433-7447.1994; GAO F, 1992, NATURE, V358, P495, DOI 10.1038/358495a0; Gebremedhin S, 2011, SAHARA J-J SOC ASP H, V8, P13, DOI 10.1080/17290376.2011.9724979; Gisselquist D, 2003, AIDS RES HUM RETROV, V19, P1071, DOI 10.1089/088922203771881158; GOERG O, 1990, CAH ETUD AFR, V30, P73, DOI 10.3406/cea.1990.2127; Gomes P, 2003, LANCET INFECT DIS, V3, P683, DOI 10.1016/S1473-3099(03)00797-7; Gottlieb GS, 2008, AIDS, V22, P2069, DOI 10.1097/QAD.0b013e32830edd44; Gottlieb GS, 2003, AIDS RES HUM RETROV, V19, P575, DOI 10.1089/088922203322230941; Gray J.P., 1999, ETHNOGRAPHIC ATLAS R; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; GRIMES BF, 1996, ETHNOLOGUE; GROVES C P, 1978, Primates, V19, P1, DOI 10.1007/BF02373224; HOLAS B, 1957, AFRICA, V27, P241, DOI 10.2307/1156631; Jensen Adolf E., 1933, BESCHNEIDUNG REIFEZE; Kanki PJ, 1994, REPROD BIOL, V8, pS85; Kannangai R, 2000, CLIN DIAGN LAB IMMUN, V7, P987, DOI 10.1128/CDLI.7.6.987-989.2000; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Kurtz RJ, 1969, ETHNOGRAPHIC SURVEY; Lauret P, GUERRA COLONIAL 1961; Lee S., 2012, CERCOCEBUS ATYS; Lemey P, 2004, GENETICS, V167, P1059, DOI 10.1534/genetics.104.026666; Lemey P, 2003, P NATL ACAD SCI USA, V100, P6588, DOI 10.1073/pnas.0936469100; Lewis M. P., 2015, ETHNOLOGUE LANGUAGES, V18th; Marx PA, 2001, PHILOS T R SOC B, V356, P911, DOI 10.1098/rstb.2001.0867; Ministerio dos Negocios Estrangeiros, 1978, 9 REC GER POP LISB; MOSES S, 1990, INT J EPIDEMIOL, V19, P693, DOI 10.1093/ije/19.3.693; Mota-Miranda A, 2004, LANCET INFECT DIS, V4, P265, DOI 10.1016/S1473-3099(04)01001-1; Mota-Miranda A, 1993, 9 INT C AIDS JUN 6 1, V9, P683; Murdock G.P., 1967, ETHNOGRAPHIC ATLAS; Niang CI, 2007, REPROD HEALTH MATTER, V15, P22, DOI 10.1016/S0968-8080(07)29312-7; PELISSIER R., 1989, HIST GUINE PORTUGUES; PEPIN J, 1992, AIDS, V6, P489, DOI 10.1097/00002030-199205000-00008; PEPIN J, 1991, AIDS, V5, P69, DOI 10.1097/00002030-199101000-00010; PEPIN J, 2008, TROP MED INT HEALTH, V13, P1; Pepin J, 2006, AIDS, V20, P1303, DOI 10.1097/01.aids.0000232239.05545.33; Peterson Dale, 2003, EATING APES; Pieniazek D, 1999, AIDS RES HUM RETROV, V15, P603, DOI 10.1089/088922299311132; Poulsen AG, 2000, SCAND J INFECT DIS, V32, P169, DOI 10.1080/003655400750045286; POULSEN AG, 1989, LANCET, V333, P827; Remy G., 1993, Medecine d'Afrique Noire, V40, P15; Remy G., 1993, Medecine d'Afrique Noire, V40, P9; ROUCH J, 1957, ETUDES EBURNEENNES, V6, P231; Salemi M, 2001, FASEB J, V15, P276, DOI 10.1096/fj.00-0449fje; Santiago ML, 2005, J VIROL, V79, P12515, DOI 10.1128/JVI.79.19.12515-12527.2005; SARPONG PK, 1967, ANTHROPOS, V62, P1; Schwab C., 1947, TRIBES LIBERIAN HINT; Smith SM, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-103; SOUSA JDD, 2010, PLOS ONE, V0005; Temudo M, 2015, DEV CHANGE, V46, P464, DOI 10.1111/dech.12166; The DHS Program, 2015, DEM HLTH SURV; Valadas E, 2009, CLIN INFECT DIS, V48, P1166, DOI 10.1086/597504; van der Loeff MFS, 1999, AIDS, V13, pS69; Vidal N, 2000, J VIROL, V74, P10498, DOI 10.1128/JVI.74.22.10498-10507.2000; Viegas L. A. C, 1936, GUINE PORTUGUESA, V1-3; VILLAMUR R., 1903, NOTRE COLONIE COTE I; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; Weiss HA, 2008, AIDS, V22, P567, DOI 10.1097/QAD.0b013e3282f3f406; White Luise, 1990, COMFORTS HOME PROSTI; WILKINS A, 1991, AIDS, V5, P1127, DOI 10.1097/00002030-199109000-00012; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390; Zaborowski M, 1896, ANTHROPOLOGIE, V7, P653; Zetterstrom K, 1969, ETHNOGRAPHIC SURVEY	103	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2016	11	12							e0166805	10.1371/journal.pone.0166805	http://dx.doi.org/10.1371/journal.pone.0166805			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4NG	27926927	Green Submitted, Green Published, gold			2022-12-27	WOS:000389578800006
J	Fu, F; Zhang, T				Fu, Fang; Zhang, Tao			A New Model for Solving Time-Cost-Quality Trade-Off Problems in Construction	PLOS ONE			English	Article							FROG-LEAPING ALGORITHM; PROJECT SCHEDULING PROBLEMS; DECISION-MAKING; OPTIMIZATION; MANAGEMENT	A poor quality affects project makespan and its total costs negatively, but it can be recovered by repair works during construction. We construct a new non-linear programming model based on the classic multi-mode resource constrained project scheduling problem considering repair works. In order to obtain satisfactory quality without a high increase of project cost, the objective is to minimize total quality cost which consists of the prevention cost and failure cost according to Quality-Cost Analysis. A binary dependent normal distribution function is adopted to describe the activity quality; Cumulative quality is defined to determine whether to initiate repair works, according to the different relationships among activity qualities, namely, the coordinative and precedence relationship. Furthermore, a shuffled frog-leaping algorithm is developed to solve this discrete trade-off problem based on an adaptive serial schedule generation scheme and adjusted activity list. In the program of the algorithm, the frog-leaping progress combines the crossover operator of genetic algorithm and a permutation-based local search. Finally, an example of a construction project for a framed railway overpass is provided to examine the algorithm performance, and it assist in decision making to search for the appropriate makespan and quality threshold with minimal cost.	[Fu, Fang; Zhang, Tao] China Univ Petr East China, Sch Econ & Management, Qingdao, Shandong, Peoples R China	China University of Petroleum	Zhang, T (corresponding author), China Univ Petr East China, Sch Econ & Management, Qingdao, Shandong, Peoples R China.	zhangtao@upc.edu.cn			Shandong provincial Natural Science Foundation of China [BS2015SF010]	Shandong provincial Natural Science Foundation of China(Natural Science Foundation of Shandong Province)	The authors received the support from Shandong provincial Natural Science Foundation of China (Grant NO. BS2015SF010).	Azadeh A, 2015, RELIAB ENG SYST SAFE, V136, P62, DOI 10.1016/j.ress.2014.11.009; Babu AJG, 1996, EUR J OPER RES, V88, P320, DOI 10.1016/0377-2217(94)00202-9; Cheng JZL, 2015, COMPUT OPER RES, V53, P275, DOI 10.1016/j.cor.2014.04.018; Dou H, 2016, PERS UBIQUIT COMPUT, V20, P681, DOI 10.1007/s00779-016-0941-9; Eusuff M, 2006, ENG OPTIMIZ, V38, P129, DOI 10.1080/03052150500384759; Fang C, 2012, COMPUT OPER RES, V39, P890, DOI 10.1016/j.cor.2011.07.010; Jiang D, 2016, IEEE INTERN IN PRESS; Khang D. B., 1999, INT J PROJ MANAG, V17, P249, DOI [DOI 10.1016/S0263-7863(98)00043-X, 10.1016/S0263-7863(98)00043-X]; Kim J, 2012, INT J PROJ MANAG, V30, P264, DOI 10.1016/j.ijproman.2011.05.004; Li JQ, 2012, APPL MATH COMPUT, V218, P9353, DOI 10.1016/j.amc.2012.03.018; Liberatore MJ, 2013, IEEE T ENG MANAGE, V60, P518, DOI 10.1109/TEM.2012.2219586; Monghasemi S, 2015, EXPERT SYST APPL, V42, P3089, DOI 10.1016/j.eswa.2014.11.032; Omachonu V. K., 2004, International Journal of Quality Reliability Management, V21, P277, DOI 10.1108/02656710410522720; Paquin JP, 2000, IEEE T ENG MANAGE, V47, P88, DOI 10.1109/17.820728; Pollack-Johnson B, 2006, IEEE T ENG MANAGE, V53, P534, DOI 10.1109/TEM.2006.883705; Salmasnia A, 2012, INT J ADV MANUF TECH, V60, P631, DOI 10.1007/s00170-011-3627-5; Tareghian HR, 2007, APPL MATH COMPUT, V190, P1136, DOI 10.1016/j.amc.2007.01.100; Tavana M, 2014, EXPERT SYST APPL, V41, P1830, DOI 10.1016/j.eswa.2013.08.081; Tiwari V, 2009, EUR J OPER RES, V193, P780, DOI 10.1016/j.ejor.2007.11.005; Wei W, 2018, IEEE T SERV COMPUT, V11, P78, DOI 10.1109/TSC.2016.2528246; Zhang H, 2010, AUTOMAT CONSTR, V19, P1067, DOI 10.1016/j.autcon.2010.07.014	22	9	9	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167142	10.1371/journal.pone.0167142	http://dx.doi.org/10.1371/journal.pone.0167142			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3TF	27911939	Green Submitted, Green Published, gold			2022-12-27	WOS:000389520600023
J	Jones, SM; de Sompel, HV; Shankar, H; Klein, M; Tobin, R; Grover, C				Jones, Shawn M.; de Sompel, Herbert Van; Shankar, Harihar; Klein, Martin; Tobin, Richard; Grover, Claire			Scholarly Context Adrift: Three out of Four URI References Lead to Changed Content	PLOS ONE			English	Article							WEB; CITATIONS; INTERNET	Increasingly, scholarly articles contain URI references to "web at large" resources including project web sites, scholarly wikis, ontologies, online debates, presentations, blogs, and videos. Authors reference such resources to provide essential context for the research they report on. A reader who visits a web at large resource by following a URI reference in an article, some time after its publication, is led to believe that the resource's content is representative of what the author originally referenced. However, due to the dynamic nature of the web, that may very well not be the case. We reuse a dataset from a previous study in which several authors of this paper were involved, and investigate to what extent the textual content of web at large resources referenced in a vast collection of Science, Technology, and Medicine (STM) articles published between 1997 and 2012 has remained stable since the publication of the referencing article. We do so in a two-step approach that relies on various well-established similarity measures to compare textual content. In a first step, we use 19 web archives to find snapshots of referenced web at large resources that have textual content that is representative of the state of the resource around the time of publication of the referencing paper. We find that representative snapshots exist for about 30% of all URI references. In a second step, we compare the textual content of representative snapshots with that of their live web counterparts. We find that for over 75% of references the content has drifted away from what it was when referenced. These results raise significant concerns regarding the long term integrity of the web-based scholarly record and call for the deployment of techniques to combat these problems.	[Jones, Shawn M.; de Sompel, Herbert Van; Shankar, Harihar; Klein, Martin] Los Alamos Natl Lab, Digital Lib Res & Prototyping Team, Res Lib, Los Alamos, NM 87544 USA; [Tobin, Richard; Grover, Claire] Univ Edinburgh, Language Technol Grp, Edinburgh, Midlothian, Scotland	United States Department of Energy (DOE); Los Alamos National Laboratory; University of Edinburgh	Jones, SM (corresponding author), Los Alamos Natl Lab, Digital Lib Res & Prototyping Team, Res Lib, Los Alamos, NM 87544 USA.	smjones@lanl.gov	Jones, Shawn/ABE-6140-2020	Jones, Shawn/0000-0002-4372-870X; Klein, Martin/0000-0003-0130-2097				Adar E., 2009, WSDM; Adar E, 2008, UIST 2008: PROCEEDINGS OF THE 21ST ANNUAL ACM SYMPOSIUM ON USER INTERFACE SOFTWARE AND TECHNOLOGY, P239, DOI 10.1145/1449715.1449756; Ainsworth S., 2015, ORIGINAL HEADER REPL; AlNoamany Y, 2015, LECT NOTES COMPUT SC, V9316, P225, DOI 10.1007/978-3-319-24592-8_17; AlSum Ahmed, 2014, Advances in Information Retrieval. 36th European Conference on IR Research, ECIR 2014. Proceedings: LNCS 8416, P299, DOI 10.1007/978-3-319-06028-6_25; [Anonymous], 1948, BIOL SKRIFTER; Besancon R, 1999, DAT EXP SYST APPL 19, P180; Brunhill P, 2015, HIBERLINK; Casserly MF, 2003, COLL RES LIBR, V64, P300, DOI 10.5860/crl.64.4.300; Charikar M.S., 2002, P 34 ANN ACM S THEOR, V34, P380, DOI DOI 10.1145/509907.509965; Cho J., 2000, PROCEEDING VLDB 2000, P200; Cho J., 2003, ACM T INTERNET TECHN, V3, P256, DOI [10.1145/857166.857170, DOI 10.1145/857166.857170]; Clausen L., 2004, 4 INT WEB ARCH WORKS; Cournapeau D, 2015, 4 7 PAIRWISE METRICS; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Duda JJ, 2008, FRONT ECOL ENVIRON, V6, P145, DOI 10.1890/070022; Falagas ME, 2008, INT J MED INFORM, V77, P280, DOI 10.1016/j.ijmedinf.2007.07.001; Fenniak M., 2013, PYPDF; Fetterly D., 2003, PROCEEDING WWW 2003, P669, DOI DOI 10.1145/775152.775246; Fielding R., 2014, 7232 RFC; Figuerola CG, 2011, ADV INTEL SOFT COMPU, V90, P117; Franceschini A, 1997, ARXIVASTROPH9707064; Hajishirzi H, 2010, SIGIR 2010: PROCEEDINGS OF THE 33RD ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH DEVELOPMENT IN INFORMATION RETRIEVAL, P419; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [10.1111/j.1469-8137.1912.tb05611.x, DOI 10.1111/J.1469-8137.1912.TB05611.X, DOI 10.1371/journal.pbio.1001889]; Jackson A, 2015, 10 YEARS UK WEB ARCH; Jones SM, 2016, RULES ACQUISITION ME; Karun AK, 2013, 2013 INTERNATIONAL CONFERENCE ON GREEN COMPUTING, COMMUNICATION AND CONSERVATION OF ENERGY (ICGCE), P857, DOI 10.1109/ICGCE.2013.6823554; Kelley JL, 2009, NUCL PHYS A, V827, p507C, DOI 10.1016/j.nuclphysa.2009.05.110; Klein M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115253; Kornblum J., 2011, 7 SMALL FILES FAIL S; Kornblum J, 2006, DIGIT INVESTIG, pS91, DOI 10.1016/j.diin.2006.06.015; Lawrence S, 2001, COMPUTER, V34, P26, DOI 10.1109/2.901164; Manku G.S., 2007, P 16 INT C WORLD WID, P141; McCandlish VL, 2012, SMALL IDENTICAL TEXT; McCown F, 2005, P IWAW 05; Meyer M., 2013, DISTANCE 0 1 3 PYTHO; Mohammad Esmaeel S., 2010, INT J INFORM SCI MAN, V8, P57, DOI DOI 10.1108/02640471211204042; Niwattanakul Suphakit, 2013, IMECS 2013 Proceedings of International Multiconference of Engineers and Computer Scientists, P380; Pawlik M, 2011, PROC VLDB ENDOW, V5, P334, DOI 10.14778/2095686.2095692; Rordorf D., 2015, WEBLOCK PRESERVING; Sahami M, 2006, P 19 INT FLAIRS C, P14; Sanderson R., 2011, ARXIV11053459; Sandhya N, 2012, ADV INTEL SOFT COMPU, V132, P703; Sellitto C, 2005, J AM SOC INF SCI TEC, V56, P695, DOI 10.1002/asi.20159; Sim L., 2013, PYTHON IMPLEMENTATIO; Sivakumar P, 2015, WIRELESS PERS COMMUN, V84, P99, DOI 10.1007/s11277-015-2596-7; Van de Sompel H, 2015, TIME TRAVEL; Van de Sompel H, 2015, ROBUST LINKS D LINKS; Van de Sompel H., 2013, 7089 RFC; Van de Sompel H, 2015, ROBUST LINKS D LINK; Van de Sompel Herbert, 2015, D LIB MAGAZINE, V21; VANRIJSBERGEN C, 1979, INFORM RETRIEVAL; Wagner C, 2010, J MED LIBR ASSOC, V98, P194; Yeonjung Kim, 2007, 2007 International Conference on Convergence Information Technology - ICCIT '07, P2455, DOI 10.1109/ICCIT.2007.19; Zhou K., 2014, P 14 ACM IEEE CS JOI, P451; Zittrain J, 2014, LEG INF MANAG, V14, P88, DOI 10.1017/S1472669614000255	57	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167475	10.1371/journal.pone.0167475	http://dx.doi.org/10.1371/journal.pone.0167475			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911955	gold, Green Submitted, Green Published			2022-12-27	WOS:000389520600036
J	Pan, F; Den, J; Zhang, CF; Wang, H; Cheng, J; Wu, WZ; Hong, N; Wang, Y				Pan, Feng; Den, Jie; Zhang, Chunfang; Wang, He; Cheng, Jin; Wu, Weizhen; Hong, Nan; Wang, Yi			The Therapeutic Response of Gastrointestinal Stromal Tumors to Imatinib Treatment Assessed by Intravoxel Incoherent Motion Diffusion-Weighted Magnetic Resonance Imaging with Histopathological Correlation	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; TYROSINE KINASE; MESYLATE; PERFUSION; PET; GIST; DIFFERENTIATION; EXPRESSION; PARAMETERS; CRITERIA	Purpose To exploit the intravoxel incoherent motion (IVIM) diffusion-weighted (DW) MRI when evaluating the therapeutic response of gastrointestinal stromal tumors (GIST) to Imatinib in a mouse model. Materials and Methods Mice with xenografts bearing cells from the GIST-T1 cell line were randomly divided into a treated group receiving Imatinib and a control group. DWMRI scans with 14 b-values (0- 1500 s/mm(2)) were performed before and after treatment (days 1, 3 and 7). IVIM related parameters perfusion fractions (fp) and perfusion-related diffusion coefficients (D*) and the conventional apparent diffusion coefficients (ADC) were calculated by fitting the DWMRI signal decay. The mean changes from baseline to each post-treatment time point for each measurement (Delta ADC,Delta fp and Delta D*) were calculated. The differences of mean changes between the two groups were tested for statistical significance. Histopathological analyses including Ki-67, CD31, TUNEL and H&E were conducted in conjunction with the MRI scans. Results Increases in ADC of the treated group were higher than those of the control group after treatment, whereas statistical significances were not observed. Compared to the control group, D* in the treated group decreased significantly (Delta D*(treated) = -41%, -49%, and -49% with P = 0.0001, 0.0001 and 0.0001), and fp increased significantly (Delta fp(treated) = 79%, 82% and 110%, with P = 0.001, 0.0001 and P = 0.0007) on days 1, 3 and 7 after treatment. Histopathological analyses demonstrated different tumor tissue characteristics between the treated and control groups. Conclusion IVIM measurements may serve as more sensitive imaging biomarkers than ADC when assessing GIST response to Imatinib as early as one day after treatment.	[Pan, Feng; Cheng, Jin; Wu, Weizhen; Hong, Nan; Wang, Yi] Peking Univ, Peoples Hosp, Dept Radiol, Beijing, Peoples R China; [Den, Jie] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Feinberg Sch Med, Dept Med Imaging,Dept Radiol, Chicago, IL 60611 USA; [Zhang, Chunfang] Peking Univ, Clin Epidemiol & Med Stat, Peoples Hosp, Beijing, Peoples R China; [Wang, He] GE Healthcare, Shanghai, Peoples R China	Peking University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Peking University; General Electric	Wang, Y (corresponding author), Peking Univ, Peoples Hosp, Dept Radiol, Beijing, Peoples R China.	wangyi@pkuph.edu.cn			National Nature Science Foundation of China	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	Our study was supported by the National Nature Science Foundation of China, which provided support in the implementation of the experiments and preparation of the manuscript. No salary support was given to any author.	Abdulkader I, 2005, HISTOPATHOLOGY, V46, P470, DOI 10.1111/j.1365-2559.2005.02014.x; [Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Blanke CD, 2008, J CLIN ONCOL, V26, P626, DOI 10.1200/JCO.2007.13.4452; Choi H, 2004, AM J ROENTGENOL, V183, P1619, DOI 10.2214/ajr.183.6.01831619; Choi H, 2008, ONCOLOGIST, V13, P4, DOI 10.1634/theoncologist.13-S2-4; Choi H, 2007, J CLIN ONCOL, V25, P1753, DOI 10.1200/JCO.2006.07.3049; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Doblas S, 2013, INVEST RADIOL, V48, P722, DOI 10.1097/RLI.0b013e3182915912; Dzik-Jurasz A, 2002, LANCET, V360, P307, DOI 10.1016/S0140-6736(02)09520-X; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ganten MK, 2013, CANCER IMAGING, V13, P548, DOI 10.1102/1470-7330.2013.0045; Gong NJ, 2013, NMR BIOMED, V26, P185, DOI 10.1002/nbm.2834; Hauser T, 2013, NEURORADIOLOGY, V55, P527, DOI 10.1007/s00234-013-1154-9; Holdsworth CH, 2007, AM J ROENTGENOL, V189, pW324, DOI 10.2214/AJR.07.2496; Jin TF, 2006, WORLD J GASTROENTERO, V12, P703, DOI 10.3748/wjg.v12.i5.703; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Joensuu H, 2013, LANCET, V382, P973, DOI 10.1016/S0140-6736(13)60106-3; Joo I, 2014, RADIOLOGY; Kang KM, 2014, RADIOLOGY, V270, P444, DOI 10.1148/radiol.13122712; Le Bihan D, 2008, RADIOLOGY, V249, P748, DOI 10.1148/radiol.2493081301; Le Bihan DJ, 1998, RADIOLOGY, V207, P305, DOI 10.1148/radiology.207.2.9577472; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Lewin M, 2011, EUR RADIOL, V21, P281, DOI 10.1007/s00330-010-1914-4; Liu CL, 2013, EUR J RADIOL, V82, pE782, DOI 10.1016/j.ejrad.2013.08.006; Lopes LF, 2010, J CELL MOL MED, V14, P42, DOI 10.1111/j.1582-4934.2009.00983.x; Patterson DM, 2008, NAT CLIN PRACT ONCOL, V5, P220, DOI 10.1038/ncponc1073; Revheim ME, 2014, ACTA ONCOL, V53, P143, DOI 10.3109/0284186X.2013.798428; Schmidt S, 2013, ACTA RADIOL, V54, P837, DOI 10.1177/0284185113485732; Shinto A, 2008, CLIN NUCL MED, V33, P486, DOI 10.1097/RLU.0b013e31817792a3; Sumi M, 2013, AM J NEURORADIOL, V34, P410, DOI 10.3174/ajnr.A3227; Sumi M, 2012, RADIOLOGY, V263, P770, DOI 10.1148/radiol.12111248; Tang L, 2011, RADIOLOGY, V258, P729, DOI 10.1148/radiol.10100402; Treglia G, 2012, CLIN IMAG, V36, P167, DOI 10.1016/j.clinimag.2011.08.012; Van den Abbeele AID, 2012, J NUCL MED, V53, P567, DOI 10.2967/jnumed.111.094425; Woo S, 2014, RADIOLOGY, V270, P758, DOI 10.1148/radiol.13130444	35	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167720	10.1371/journal.pone.0167720	http://dx.doi.org/10.1371/journal.pone.0167720			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911930	gold, Green Published, Green Submitted			2022-12-27	WOS:000389520600050
J	Zhao, XK; Che, PL; Cheng, ML; Zhang, Q; Mu, M; Li, H; Luo, Y; Liang, YD; Luo, XH; Gao, CQ; Jackson, PL; Wells, JM; Zhou, Y; Hu, M; Cai, GQ; Thannickal, VJ; Steele, C; Blalock, JE; Han, XS; Chen, CY; Ding, Q				Zhao, Xue-Ke; Che, Pulin; Cheng, Ming-Liang; Zhang, Quan; Mu, Mao; Li, Hong; Luo, Yuan; Liang, Yue-Dong; Luo, Xin-Hua; Gao, Chang-Qing; Jackson, Patricia L.; Wells, J. Michael; Zhou, Yong; Hu, Meng; Cai, Guoqiang; Thannickal, Victor J.; Steele, Chad; Blalock, J. Edwin; Han, Xiaosi; Chen, Ching-Yi; Ding, Qiang			Tristetraprolin Down-Regulation Contributes to Persistent TNF-Alpha Expression Induced by Cigarette Smoke Extract through a Post-Transcriptional Mechanism	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AU-RICH ELEMENTS; MESSENGER-RNA TURNOVER; ZINC-FINGER PROTEINS; AIRWAY INFLAMMATION; ACTIN-FILAMENTS; N-WASP; LUNG; CANCER; DESTABILIZATION	Rationale Tumor necrosis factor-alpha (TNF-alpha) is a potent pro-inflammatory mediator and its expression is up-regulated in chronic obstructive pulmonary disease (COPD). Tristetraprolin (TTP) is implicated in regulation of TNF-alpha expression; however, whether TTP is involved in cigarette smoke-induced TNF-alpha expression has not been determined. Methods TTP expression was examined by western blot analysis in murine alveolar macrophages and alveolar epithelial cells challenged without or with cigarette smoke extract (CSE). TNF-alpha mRNA stability, and the decay of TNF-alpha mRNA, were determined by real-time quantitative RT-PCR. TNF-alpha protein levels were examined at the same time in these cells. To identify the molecular mechanism involved, a construct expressing the human beta-globin reporter mRNA containing the TNF-alpha 3'-untranslated region was generated to characterize the TTP targeted site within TNF-alpha mRNA. Results CSE induced TTP down-regulation in alveolar macrophages and alveolar epithelial cells. Reduced TTP expression resulted in significantly increased TNF-alpha mRNA stability. Importantly, increased TNF-alpha mRNA stability due to impaired TTP function resulted in significantly increased TNF-alpha levels in these cells. Forced TTP expression abrogated the increased TNF-alpha mRNA stability and expression induced by CSE. By using the globin reporter construct containing TNF-alpha mRNA 3'-untranslated region, the data indicate that TTP directly targets the adenine-and uridine-rich region (ARE) of TNF-alpha mRNA and negatively regulates TNF-alpha expression at the post-transcriptional level. Conclusion The data demonstrate that cigarette smoke exposure reduces TTP expression and impairs TTP function, resulting in significantly increased TNF-alpha mRNA stability and excessive TNF-alpha expression in alveolar macrophages and epithelial cells. The data suggest that TTP is a novel post-transcriptional regulator and limits excessive TNF-alpha expression and inflammatory response induced by cigarette smoke.	[Zhao, Xue-Ke; Cheng, Ming-Liang; Zhang, Quan; Mu, Mao; Li, Hong] Guizhou Med Univ, Hosp Affiliated, Dept Infect Dis, Guiyang, Guizhou, Peoples R China; [Zhao, Xue-Ke; Che, Pulin; Gao, Chang-Qing; Jackson, Patricia L.; Wells, J. Michael; Zhou, Yong; Hu, Meng; Cai, Guoqiang; Thannickal, Victor J.; Steele, Chad; Blalock, J. Edwin; Ding, Qiang] Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Luo, Yuan] Fudan Univ, Shanghai Stomatol Hosp, Dept Oral Surg, Shanghai, Peoples R China; [Liang, Yue-Dong] Publ Hlth Ctr Guiyang, Dept Infect Dis, Guiyang, Guizhou, Peoples R China; [Luo, Xin-Hua] Peoples Hosp Guizhou Prov, Dept Infect Dis, Guiyang, Guizhou, Peoples R China; [Han, Xiaosi] Univ Alabama Birmingham, Neurol, Birmingham, AL USA; [Chen, Ching-Yi] Univ Alabama Birmingham, Dept Biochem, Birmingham, AL USA	Guizhou Medical University; University of Alabama System; University of Alabama Birmingham; Fudan University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Cheng, ML (corresponding author), Guizhou Med Univ, Hosp Affiliated, Dept Infect Dis, Guiyang, Guizhou, Peoples R China.; Ding, Q (corresponding author), Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA.	mlcheng@yeah.net; qding@uab.edu			Flight Attendant Medical Research Institute (FAMRI) [HL085324, HL127338]; National Natural Science Foundation of China [81560104]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127338, K08HL123940, R01HL077783, R01HL085324, R01HL124076] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute (FAMRI); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Flight Attendant Medical Research Institute (FAMRI), HL085324 and HL127338 (to QD) and National Natural Science Foundation of China (#81560104) (to XKZ).; This work was supported by Flight Attendant Medical Research Institute (FAMRI), HL085324, HL127338 (to Q.D.) and National Natural Science Foundation of China (#81560104) (to XKZ). We thank Anni Zheng for her technical assistance for this study. The authors declare no conflict of interest.	Adcock IM, 2011, RESPIRATION, V81, P265, DOI 10.1159/000324601; BAKER RR, 1990, ENVIRON INT, V16, P231, DOI 10.1016/0160-4120(90)90117-O; BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.immunol.7.1.625; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Boutaud O, 2003, ADV EXP MED BIOL, V525, P157; Brooks SA, 2004, J IMMUNOL, V172, P7263, DOI 10.4049/jimmunol.172.12.7263; Cai GQ, 2012, AM J PHYSIOL-LUNG C, V303, pL692, DOI 10.1152/ajplung.00390.2011; Cai GQ, 2010, EXP CELL RES, V316, P1600, DOI 10.1016/j.yexcr.2010.01.021; Canonica GW, 2006, CHEST, V130, p21S, DOI 10.1378/chest.130.1_suppl.21S; Cao HP, 2008, OBESITY, V16, P1208, DOI 10.1038/oby.2008.65; Cao H, 2007, EXPERT REV PROTEOMIC, V4, P711, DOI 10.1586/14789450.4.6.711; Cao HP, 2006, BIOCHEM J, V394, P285, DOI 10.1042/BJ20051316; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carrick DM, 2004, ARTHRITIS RES THER, V6, P248, DOI 10.1186/ar1441; Che PL, 2015, SCI REP-UK, V5, DOI 10.1038/srep08453; Chou CF, 2006, MOL CELL BIOL, V26, P3695, DOI 10.1128/MCB.26.10.3695-3706.2006; Churg A, 2007, AM J RESP CELL MOL, V37, P144, DOI 10.1165/rcmb.2006-0345OC; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Croxton TL, 2003, AM J RESP CRIT CARE, V167, P1142, DOI 10.1164/rccm.200207-756WS; Datta S, 2008, J IMMUNOL, V180, P2545, DOI 10.4049/jimmunol.180.4.2545; Deleault KM, 2008, MOL IMMUNOL, V45, P13, DOI 10.1016/j.molimm.2007.05.017; Di YP, 2012, J BIOL CHEM, V287, P27948, DOI 10.1074/jbc.M111.334375; DIFRANCIA M, 1994, AM J RESP CRIT CARE, V150, P1453, DOI 10.1164/ajrccm.150.5.7952575; Ding Q, 2008, J BIOL CHEM, V283, P26839, DOI 10.1074/jbc.M803645200; Dominguez R, 2009, CRIT REV BIOCHEM MOL, V44, P351, DOI 10.3109/10409230903277340; Eid AA, 2001, AM J RESP CRIT CARE, V164, P1414, DOI 10.1164/ajrccm.164.8.2008109; Fine-Schi S, 2008, AM J RESP CELL MOL, V39, P458, DOI 10.1165/rcmb.2007-0320OC; Keatings VM, 2000, CHEST, V118, P971, DOI 10.1378/chest.118.4.971; Kim Victor, 2008, Proc Am Thorac Soc, V5, P478, DOI 10.1513/pats.200802-014ET; Kolsum Umme, 2009, Int J Chron Obstruct Pulmon Dis, V4, P149; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; LAI WS, 1990, J BIOL CHEM, V265, P16556; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Matera MG, 2010, PULM PHARMACOL THER, V23, P121, DOI 10.1016/j.pupt.2009.10.007; MUSSALORAUHAMAA H, 1986, ARCH ENVIRON HEALTH, V41, P49, DOI 10.1080/00039896.1986.9935765; Oudijk EJD, 2003, EUR RESPIR J, V22, p5S, DOI 10.1183/09031936.03.00004603a; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Rennard Stephen I, 2006, Proc Am Thorac Soc, V3, P703, DOI 10.1513/pats.200605-121SF; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rutgers SR, 2000, CHEST, V117, p262S, DOI 10.1378/chest.117.5_suppl_1.262S; Schaub MC, 2008, BIOCHEM BIOPH RES CO, V369, P247, DOI 10.1016/j.bbrc.2007.10.082; Shapiro SD, 2005, AM J RESP CELL MOL, V32, P367, DOI 10.1165/rcmb.F296; Su YC, 1998, AM J RESP CELL MOL, V19, P819, DOI 10.1165/ajrcmb.19.5.3091; Suzuki K, 2003, J EXP MED, V198, P1717, DOI 10.1084/jem.20031701; Takenawa T, 2001, J CELL SCI, V114, P1801; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Togo S, 2008, AM J RESP CRIT CARE, V178, P248, DOI 10.1164/rccm.200706-929OC; TURATO G, 1995, AM J RESP CRIT CARE, V152, P1262, DOI 10.1164/ajrccm.152.4.7551380; Wagener BM, 2016, FASEB J, V30, P2557, DOI 10.1096/fj.201600102R; Wells JM, 2014, AM J RESP CRIT CARE, V190, P51, DOI 10.1164/rccm.201401-0145OC; Willemse BWM, 2005, EUR RESPIR J, V26, P835, DOI 10.1183/09031936.05.00108904; Yao HW, 2009, CURR OPIN PHARMACOL, V9, P375, DOI 10.1016/j.coph.2009.06.009; Young LE, 2009, GASTROENTEROLOGY, V136, P1669, DOI 10.1053/j.gastro.2009.01.010; Zhan SQ, 2011, BBA-MOL BASIS DIS, V1812, P565, DOI 10.1016/j.bbadis.2010.11.003; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	60	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167451	10.1371/journal.pone.0167451	http://dx.doi.org/10.1371/journal.pone.0167451			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911957	gold, Green Published, Green Submitted			2022-12-27	WOS:000389520600035
J	Che, L; Xu, MM; Yang, ZG; Xu, SY; Che, LQ; Lin, Y; Fang, ZF; Feng, B; Li, J; Chen, DW; Wu, D				Che, Long; Xu, Mengmeng; Yang, Zhenguo; Xu, Shengyu; Che, Lianqiang; Lin, Yan; Fang, Zhengfeng; Feng, Bin; Li, Jian; Chen, Daiwen; Wu, De			Detection of Placental Proteomes at Different Uterine Positions in Large White and Meishan Gilts on Gestational Day 90	PLOS ONE			English	Article							WITHIN-LITTER VARIATION; BIRTH-WEIGHT; FETAL; PROTEIN; GROWTH; RESTRICTION; GLUCOSE; PERFORMANCE; METABOLISM; EXPRESSION	Within-litter uniformity in pigs is a major factor affecting piglet survival and growth performance. We know that Meishan (MS) gilts have higher piglet survival rate than Large White (LW) gilts because their foetal weight is less varied. To understand the molecular basis for placental nutritional transport during the late stages of gestation in LW and MS, we employed the isobaric tags for relative and absolute quantification (iTRAQ) method to investigate alterations in the placental proteomes of LW and MS gilts on gestational day 90. Investigation of foetal weight at different uterine positions revealed that the foetal and placental weights as well as the foetal concentration of glucose were significantly higher in LW gilts positioned towards the utero-tubal junction than in those positioned toward the cervix; however, no such differences were observed in MS gilts, and MS gilts had a greater uniformity in foetal weight on day 90 of gestation. Comparisons of the proteomes between placentas positioned toward the cervix and those positioned toward the utero-tubal junction identified 38 differentially expressed proteins in the two breeds. These proteins play a central role in nutrient transport and metabolism, as well as in transcriptional and translational regulation. Of particular interest is the finding that the placentas of LW gilts showed 14 differential expression of proteins mainly related to lipid transport and energy metabolism (including solute carrier family 27, mitochondrial trifunctional protein, and NADH dehydrogenase [ ubiquinone] flavoprotein 2), but only 2 proteins in MS gilts. In contrast, the differentially expressed proteins in MS gilts were primarily involved in transcriptional and translational regulation (such as ribosome-sec61 and 40S ribosomal protein S23), with a few related to glucose and coenzyme transport and metabolism (including glucose transport protein and ferrochelatase). Our results revealed that placental lipid and energy metabolism might play a crucial role in the regulation of foetal weight, based on uterine position in two distinct pig breeds. These findings provide a deeper understanding of placental efficiency that can be utilized to provide a new method to enhance the efficiency of livestock production.	[Che, Long; Xu, Mengmeng; Yang, Zhenguo; Xu, Shengyu; Che, Lianqiang; Lin, Yan; Fang, Zhengfeng; Feng, Bin; Li, Jian; Chen, Daiwen; Wu, De] Sichuan Agr Univ, Inst Anim Nutr, Key Lab Anim Dis Resistance Nutr, Minist Educ China, Yaan Shi, Sichuan Sheng, Peoples R China	Ministry of Education, China; Sichuan Agricultural University	Wu, D (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Key Lab Anim Dis Resistance Nutr, Minist Educ China, Yaan Shi, Sichuan Sheng, Peoples R China.	sow_nutrition@sina.com	Xu, Shengyu/AFN-8288-2022	Xu, Shengyu/0000-0002-4415-8542	Program for Changjiang Scholars and Innovative Research Team in University [IRT13083]; National Basic Research Program of China (973 Program) [2012CB124701]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the Program for Changjiang Scholars and Innovative Research Team in University (IRT13083) and the National Basic Research Program of China (973 Program) (2012CB124701). The funder, De Wu, had a role in conceived and designed the experiments and contributed reagents/materials/analysis tools.	Abumrad N, 1999, BBA-MOL CELL BIOL L, V1441, P4, DOI 10.1016/S1388-1981(99)00137-7; BAZER FW, 1988, J REPROD FERTIL, V84, P37, DOI 10.1530/jrf.0.0840037; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Benit P, 2003, HUM MUTAT, V21, P582, DOI 10.1002/humu.10225; Biensen NJ, 1998, J ANIM SCI, V76, P2169; BOILEAU P, 1995, J CLIN INVEST, V96, P309, DOI 10.1172/JCI118036; Cetin I, 2009, PLACENTA, V30, pS77, DOI 10.1016/j.placenta.2008.12.006; Dai Y, 2012, ENDOCRINOLOGY, V153, P4216, DOI 10.1210/en.2012-1206; Deltour L, 1999, DEV GENET, V25, P1, DOI 10.1002/(SICI)1520-6408(1999)25:1<1::AID-DVG1>3.0.CO;2-W; Ganapathi KA, 2007, BLOOD, V110, P1458, DOI 10.1182/blood-2007-02-075184; Gondret F, 2006, J ANIM SCI, V84, P93, DOI 10.2527/2006.84193x; Haggarty P, 1997, PLACENTA, V18, P635, DOI 10.1016/S0143-4004(97)90004-7; Han YK, 2009, ANIM SCI J, V80, P57, DOI 10.1111/j.1740-0929.2008.00604.x; Hernandez SC, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104679; Hu L, 2015, BRIT J NUTR, V114, P53, DOI 10.1017/S0007114515001579; Ibdah JA, 2005, GASTROENTEROLOGY, V128, P1381, DOI 10.1053/j.gastro.2005.02.001; Jansson N, 2006, J PHYSIOL-LONDON, V576, P935, DOI 10.1113/jphysiol.2003.550004; Jobgen WS, 2006, J NUTR BIOCHEM, V17, P571, DOI 10.1016/j.jnutbio.2005.12.001; Johnson RK, 1999, J ANIM SCI, V77, P541; Kim S W, 2009, J Anim Sci, V87, pE123, DOI 10.2527/jas.2008-1452; Kim S. W., 2013, J ANIM SCI BIOTECHNO, V4, P26, DOI DOI 10.1186/2049-1891-4-26; Kimura RE, 1991, LIPID METABOLISM FET, P291; KNOPP R H, 1981, Clinical Obstetrics and Gynecology, V24, P21, DOI 10.1097/00003081-198103000-00006; Knopp RH, 1997, ANN NY ACAD SCI, V817, P251, DOI 10.1111/j.1749-6632.1997.tb48212.x; Lager S, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/179827; LEE GJ, 1995, ANIM SCI, V60, P269, DOI 10.1017/S1357729800008432; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Major CA, 1998, AM J OBSTET GYNECOL, V179, P1038, DOI 10.1016/S0002-9378(98)70211-X; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; MOREADITH RW, 1984, J BIOL CHEM, V259, P6222; Murphy VE, 2006, ENDOCR REV, V27, P141, DOI 10.1210/er.2005-0011; OSHINO N, 1971, J BIOCHEM, V69, P155, DOI 10.1093/oxfordjournals.jbchem.a129444; PERE MC, 1995, J ANIM SCI, V73, P2994; Quesnel H, 2014, J ANIM SCI, V92, P1445, DOI 10.2527/jas.2013-6701; Ramadoss J, 2012, REPROD TOXICOL, V34, P538, DOI 10.1016/j.reprotox.2012.08.008; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; Wanzel M, 2008, NAT CELL BIOL, V10, P1051, DOI 10.1038/ncb1764; Wilson ME, 1998, BIOL REPROD, V58, P905, DOI 10.1095/biolreprod58.4.905; Wilson ME, 1998, SELECTION LITTER SIZ; Wise T, 1997, J ANIM SCI, V75, P2197; Wu GY, 2012, PAEDIATR PERINAT EP, V26, P4, DOI 10.1111/j.1365-3016.2012.01291.x; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934; Yuan TL, 2015, J ZHEJIANG UNIV-SC B, V16, P417, DOI 10.1631/jzus.B1500010	44	10	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167799	10.1371/journal.pone.0167799	http://dx.doi.org/10.1371/journal.pone.0167799			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936087	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100196
J	Chen, I; Chau, G; Wang, J; Clarke, W; Marzinke, MA; Cummings, V; Breaud, A; Laeyendecker, O; Fields, SD; Griffith, S; Scott, HM; Shoptaw, S; del Rio, C; Magnus, M; Mannheimer, S; Tieu, HV; Wheeler, DP; Mayer, KH; Koblin, BA; Eshleman, SH				Chen, Iris; Chau, Gordon; Wang, Jing; Clarke, William; Marzinke, Mark A.; Cummings, Vanessa; Breaud, Autumn; Laeyendecker, Oliver; Fields, Sheldon D.; Griffith, Sam; Scott, Hyman M.; Shoptaw, Steven; del Rio, Carlos; Magnus, Manya; Mannheimer, Sharon; Hong-Van Tieu; Wheeler, Darrell P.; Mayer, Kenneth H.; Koblin, Beryl A.; Eshleman, Susan H.			Analysis of HIV Diversity in HIV-Infected Black Men Who Have Sex with Men (HPTN 061)	PLOS ONE			English	Article							RESOLUTION MELTING ASSAY; GENETIC DIVERSITY; SEQUENCE DIVERSITY; ENV; EVOLUTION; VIREMIA; GAG	Background HIV populations often diversify in response to selective pressures, such as the immune response and antiretroviral drug use. We analyzed HIV diversity in Black men who have sex with men who were enrolled in the HIV Prevention Trials Network 061 study. Methods A high resolution melting (HRM) diversity assay was used to measure diversity in six regions of the HIV genome: two in gag, one in pot, and three in env. HIV diversity was analyzed for 146 men who were HIV infected at study enrollment, including three with acute infection and 13 with recent infection (identified using a multi-assay algorithm), and for 21 men who seroconverted during the study. HIV diversification was analyzed in a paired analysis for 62 HIV-infected men using plasma samples from the enrollment and 12-month (end of study) visits. Results Men with acute or recent infection at enrollment and seroconverters had lower median HRM scores (lower HIV diversity) than men with non-recent infection in all six regions analyzed. In univariate analyses, younger age, higher CD4 cell count, and HIV drug resistance were associated with lower median HRM scores in multiple regions; ARV drug detection was marginally associated with lower diversity in the po/region. In multivariate analysis, acute or recent infection (all six regions) and HIV drug resistance (both gag regions) were associated with lower median HRM scores. Diversification in the pol region over 12 months was greater for men with acute or recent infection, higher CD4 cell count, and lower HIV viral load at study enrollment. Conclusions HIV diversity was significantly associated with duration of HIV infection, and lower gag diversity was observed in men who had HIV drug resistance. HIV po/diversification was more pronounced in men with acute or recent infection, higher CD4 cell count, and lower HIV viral load.	[Chen, Iris; Clarke, William; Marzinke, Mark A.; Cummings, Vanessa; Breaud, Autumn; Eshleman, Susan H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Chau, Gordon; Wang, Jing] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Laeyendecker, Oliver] NIAID, Immunoregulat Lab, NIA, Baltimore, MD USA; [Laeyendecker, Oliver] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Fields, Sheldon D.] Charles R Drew Univ Med & Sci, Mervyn M Dymally Sch Nursing, 1621 E 120th St, Los Angeles, CA 90059 USA; [Griffith, Sam] Sci Facilitat Dept, FHI 360, Durham, NC USA; [Scott, Hyman M.] Bridge HIV, San Francisco Dept Publ Hlth, San Francisco, CA USA; [Shoptaw, Steven] Univ Calif Los Angeles, Dept Family Med, Los Angeles, CA USA; [del Rio, Carlos] Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA; [Magnus, Manya] George Washington Univ, Dept Epidemiol & Biostat, Milken Inst Sch Publ Hlth, Washington, DC USA; [Mannheimer, Sharon] Columbia Univ, Dept Med, Harlem Hosp, Mailman Sch Publ Hlth, New York, NY USA; [Hong-Van Tieu; Koblin, Beryl A.] New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Infect Dis Prevent, New York, NY 10021 USA; [Wheeler, Darrell P.] SUNY Albany, Sch Social Welf, Albany, NY 12222 USA; [Mayer, Kenneth H.] Fenway Hlth, Fenway Inst, Boston, MA USA; [Mayer, Kenneth H.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Mayer, Kenneth H.] Harvard Med Sch, Dept Med, Boston, MA USA	Johns Hopkins University; Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); NIH National Institute on Aging (NIA); Johns Hopkins University; Charles R. Drew University of Medicine & Science; FHI 360; San Francisco Department of Public Health; University of California System; University of California Los Angeles; Emory University; Rollins School Public Health; George Washington University; Columbia University; New York Blood Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Fenway Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Eshleman, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	seshlem@jhmi.edu	del Rio, Carlos/B-3763-2012	del Rio, Carlos/0000-0002-0153-3517; Shoptaw, Steven/0000-0002-3583-0026; Laeyendecker, Oliver/0000-0002-6429-4760	National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Child Health and Human Development (NICH/HD); National Institute of Drug Abuse (NIDA); National Institute of Mental Health (NIMH), Office of AIDS Research, National Institutes of Health (NIH), Department of Health and Human Services [UM1-A1068613, R01-A1095068]; Division of Intramural Research, NIAID; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R25HD045810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095068, UM1AI069412, UM1AI069424, UM1AI068613, ZIAAI000361, UM1AI069470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107, T32MH019105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA031035] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Child Health and Human Development (NICH/HD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health (NIMH), Office of AIDS Research, National Institutes of Health (NIH), Department of Health and Human Services; Division of Intramural Research, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The HIV Prevention Trials Network (HPTN) is funded by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Child Health and Human Development (NICH/HD), National Institute of Drug Abuse (NIDA) and the National Institute of Mental Health (NIMH), Office of AIDS Research, National Institutes of Health (NIH), Department of Health and Human Services (UM1-A1068613), and R01-A1095068 (Eshleman). Additional support was provided by the Division of Intramural Research, NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brookmeyer R, 2013, AM J EPIDEMIOL, V177, P264, DOI 10.1093/aje/kws436; Carter CC, 2015, VIROLOGY, V474, P34, DOI 10.1016/j.virol.2014.10.019; Chen I, 2015, JAIDS-J ACQ IMM DEF, V69, P446, DOI 10.1097/QAI.0000000000000633; Chen I, 2014, JAIDS-J ACQ IMM DEF, V67, P405, DOI 10.1097/QAI.0000000000000298; Chen I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081213; Cousins MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051359; Cousins MM, 2013, J MOL DIAGN, V15, P130, DOI 10.1016/j.jmoldx.2012.08.008; Cousins MM, 2012, J CLIN MICROBIOL, V50, P3054, DOI 10.1128/JCM.01460-12; Cousins MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027211; Frahm Nicole, 2007, Curr Infect Dis Rep, V9, P161, DOI 10.1007/s11908-007-0012-5; Hong SL, 2009, MICROBIOL IMMUNOL, V53, P535, DOI 10.1111/j.1348-0421.2009.00153.x; James MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057350; James MM, 2012, PEDIATR INFECT DIS J, V31, pE222, DOI 10.1097/INF.0b013e3182678c3f; James MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018642; Joos B, 2005, J VIROL, V79, P9026, DOI 10.1128/JVI.79.14.9026-9037.2005; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keele BF, 2010, CURR OPIN HIV AIDS, V5, P327, DOI 10.1097/COH.0b013e32833a0b9b; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070413; Lemey P, 2007, PLOS COMPUT BIOL, V3, P282, DOI 10.1371/journal.pcbi.0030029; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Maldarelli F, 2013, J VIROL, V87, P10313, DOI 10.1128/JVI.01225-12; Mani I, 2002, J VIROL, V76, P10745, DOI 10.1128/JVI.76.21.10745-10755.2002; Marzinke MA, 2014, CLIN INFECT DIS, V58, P117, DOI 10.1093/cid/cit672; Mayer KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087298; McBurney SP, 2008, EXPERT REV VACCINES, V7, P1405, DOI 10.1586/14760584.7.9.1405; Novitsky V, 2013, INFECT GENET EVOL, V19, P361, DOI 10.1016/j.meegid.2013.02.023; Piantadosi A, 2009, AIDS, V23, P579, DOI 10.1097/QAD.0b013e328328f76e; Richman Douglas D, 2004, Trans Am Clin Climatol Assoc, V115, P289; Sagar M, 2006, AIDS RES HUM RETROV, V22, P430, DOI 10.1089/aid.2006.22.430; Towler WI, 2010, AIDS RES HUM RETROV, V26, P913, DOI 10.1089/aid.2009.0259; Williamson S, 2003, MOL BIOL EVOL, V20, P1318, DOI 10.1093/molbev/msg144; Zanini F, 2015, ELIFE, V4, DOI 10.7554/eLife.11282	33	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167629	10.1371/journal.pone.0167629	http://dx.doi.org/10.1371/journal.pone.0167629			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936098	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100134
J	Huang, XL; Knoble, JL; Zeng, M; Aguila, FN; Patel, T; Chambers, LW; Hu, HL; Liu, H				Huang, Xiaolun; Knoble, Jeanna L.; Zeng, Ming; Aguila, Fernando N.; Patel, Tara; Chambers, Lowell W.; Hu, Honglin; Liu, Hao			Neoadjuvant Gemcitabine Chemotherapy followed by Concurrent IMRT Simultaneous Boost Achieves High R0 Resection in Borderline Resectable Pancreatic Cancer Patients	PLOS ONE			English	Article							RADIATION-THERAPY; INDUCTION CHEMOTHERAPY; CHEMORADIATION; RADIOTHERAPY; LUNG; OXALIPLATIN; CARCINOMA; OUTCOMES; PHASE-2; TRIAL	Background To study the feasibility of down stage the borderline resectable pancreatic cancer (BRPC) to resectable disease, we reported our institutional results using an intensity-modulated radiation therapy (IMRT) simultaneous integrated boost (SIB) dose escalation approach to improve R0 resectability. Methods We reviewed our past 7 years of experience of using neoadjuvant induction chemotherapy with Gemcitabine followed by concurrent chemoradiaiton for BRPC. During the concurrent, chemo was 5-FU and radiation were IMRT with SIB technique to target the key areas with dose escalation to 5600 in 28 fractions. The key areas were defined by PET positive area. This was followed by restaging imaging to rule out distant metastases before resection. Results 25 finished dose escalation protocol. 2 of the 25 cases developed distant metastases, 23 (92%) patients without distant metastases underwent pancreatectomy. Among the those received pancreatectomy, 22 (95%) achieved negative margin (R0). The gastrointestinal toxicity > grade 2 was 8% and there was no grade 4 toxicity. Conclusion Neoadjuvant Gemcitabine-based induction chemotherapy followed by 5-FU-based IMRT-SIB is a feasible option in improving the likelihood of R0 resection rate in BRPC without compromising the organs at risk for toxicity.	[Huang, Xiaolun] Univ Elect Sci & Technol, Dept Hepatobiliary Pancreat Surg, Chengdu, Sichuan, Peoples R China; [Huang, Xiaolun] Univ Elect Sci & Technol, Affiliated Hosp, Cell Transplant Ctr, Chengdu, Sichuan, Peoples R China; [Knoble, Jeanna L.; Patel, Tara] Mt Carmel Hlth Syst, Dept Hematol & Oncol, Zangmeister Canc Ctr, Columbus, OH USA; [Zeng, Ming] Mt Carmel Hlth Syst, Dept Radiat Oncol, Columbus, OH 43215 USA; [Aguila, Fernando N.; Chambers, Lowell W.] Cent Ohio Surg Associates Inc, Columbus, OH USA; [Hu, Honglin; Liu, Hao] Univ Elect Sci & Technol, Ctr Canc, Affiliated Hosp, Chengdu, Sichuan, Peoples R China	University of Electronic Science & Technology of China; University of Electronic Science & Technology of China; University of Electronic Science & Technology of China	Zeng, M (corresponding author), Mt Carmel Hlth Syst, Dept Radiat Oncol, Columbus, OH 43215 USA.	miller2002@yahoo.com		zeng, ming/0000-0002-4294-2077				Assifi MM, 2011, SURGERY, V150, P466, DOI 10.1016/j.surg.2011.07.006; Ben-Josef E, 2012, INT J RADIAT ONCOL, V84, P1166, DOI 10.1016/j.ijrobp.2012.02.051; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Compton CC, 2012, AJCC CANC STAGING MA, DOI [DOI 10.1007/978-1-4614-2080-4, 10.1007/978-1-4614-2080-4]; COX JD, 1993, INT J RADIAT ONCOL, V27, P493, DOI 10.1016/0360-3016(93)90371-2; Dirkx MLP, 2004, LUNG CANCER-J IASLC, V45, P57, DOI 10.1016/j.lungcan.2004.01.003; Esnaola NF, 2014, INT J RADIAT ONCOL, V88, P837, DOI 10.1016/j.ijrobp.2013.12.030; Gillen S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000267; Jabbour SK, 2014, PRACT RADIAT ONCOL, V4, P82, DOI 10.1016/j.prro.2013.06.004; Katz MHG, 2012, CANCER-AM CANCER SOC, V118, P5749, DOI 10.1002/cncr.27636; Katz MHG, 2011, ANN SURG ONCOL, V18, P608, DOI 10.1245/s10434-010-1460-y; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim EJ, 2013, CANCER-AM CANCER SOC, V119, P2692, DOI 10.1002/cncr.28117; Krishnan S, 2007, CANCER-AM CANCER SOC, V110, P47, DOI 10.1002/cncr.22735; Machtay M, 2005, INT J RADIAT ONCOL, V63, P667, DOI 10.1016/j.ijrobp.2005.03.037; Mellon EA, 2015, ACTA ONCOL, V54, P979, DOI 10.3109/0284186X.2015.1004367; Murphy JD, 2007, INT J RADIAT ONCOL, V68, P801, DOI 10.1016/j.ijrobp.2006.12.053; Patel M, 2011, J SURG ONCOL, V104, P155, DOI 10.1002/jso.21954; Takahashi H, 2013, ANN SURG, V258, P1040, DOI 10.1097/SLA.0b013e31829b3ce4; Yates F., 1934, JR STATIST SOC     S, V1, P217, DOI DOI 10.2307/2983604	20	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166606	10.1371/journal.pone.0166606	http://dx.doi.org/10.1371/journal.pone.0166606			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935952	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100036
J	Khaddaj-Mallat, R; Sirois, C; Sirois, M; Rizcallah, E; Marouan, S; Morin, C; Rousseau, E				Khaddaj-Mallat, Rayan; Sirois, Chantal; Sirois, Marco; Rizcallah, Edmond; Marouan, Sofia; Morin, Caroline; Rousseau, Eric			Pro-Resolving Effects of Resolvin D-2 in LTD4 and TNF-alpha Pre-Treated Human Bronchi	PLOS ONE			English	Article							AIRWAY SMOOTH-MUSCLE; CA2+ SENSITIVITY; CYSTEINYL-LEUKOTRIENES; D2; INFLAMMATION; RESOLUTION; RECEPTOR; ACTIVATION; MEDIATORS; HISTAMINE	Inflammation is a major burden in respiratory diseases, resulting in airway hyperresponsiveness. Our hypothesis is that resolution of inflammation may represent a long-term solution in preventing human bronchial dysfunctions. The aim of the present study was to assess the anti-inflammatory effects of RvD(2), a member of the D-series resolving family, with concomitant effects on ASM mechanical reactivity. The role and mode of action of RvD(2) were assessed in an in vitro model of human bronchi under pro-inflammatory conditions, induced either by 1 mu M LTD4 or 10 ng/ml TNF-alpha pre-treatment for 48h. TNF-alpha and LTD4 both induced hyperreactivity in response to pharmacological stimuli. Enhanced 5-Lipoxygenase (5-LOX) and cysteinyl leukotriene receptor 1 (CysLTR1) detection was documented in LTD4 or TNF-alpha pre-treated human bronchi when compared to control (untreated) human bronchi. In contrast, RvD(2) treatments reversed 5-LOX/beta-actin and CysLTR1/beta-actin ratios and decreased the phosphorylation levels of AP-1 subunits (c-Fos, c-Jun) and p38-MAP kinase, while increasing the detection of the ALX/FPR2 receptor. Moreover, various pharmacological agents revealed the blunting effects of RvD(2) on LTD4 or TNF-alpha induced hyper-responsiveness. Combined treatment with 300 nM RvD(2) and 1 mu M WRW4 (an ALX/FPR2 receptor inhibitor) blunted the pro-resolving and broncho-modulatory effects of RvD(2). The present data provide new evidence regarding the role of RvD(2) in a human model of airway inflammation and hyperrresponsiveness.	[Khaddaj-Mallat, Rayan; Rousseau, Eric] Univ Sherbrooke, Dept Obstet Gynecol, Fac Med & Hlth Sci, Sherbrooke, PQ, Canada; [Sirois, Chantal; Sirois, Marco] CHUS Felurimont, Serv Thorac Surg, Sherbrooke, PQ, Canada; [Rizcallah, Edmond; Marouan, Sofia] Univ Sherbrooke, Dept Pathol, Fac Med & Hlth Sci, Sherbrooke, PQ, Canada; [Morin, Caroline] Univ Montreal, Nursery Sch, Montreal, PQ, Canada	University of Sherbrooke; University of Sherbrooke; Universite de Montreal	Rousseau, E (corresponding author), Univ Sherbrooke, Dept Obstet Gynecol, Fac Med & Hlth Sci, Sherbrooke, PQ, Canada.	Eric.Rousseau@USherbrooke.ca	Khaddaj-Mallat, Rayan/W-8228-2019; Rizcallah, Edmond/AAI-3986-2021	Khaddaj-Mallat, Rayan/0000-0002-8850-6342; 	Canadian Institute of Health Research (CIHR) [MOP-111112]; Health Respiratory Training Program of Quebec	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Health Respiratory Training Program of Quebec	This work was initially supported by the Canadian Institute of Health Research (CIHR) grant MOP-111112 to ER, who is a member of the Respiratory Health Network of the FRQS: www.rsr-frqs.ca. RKM is a recipient of a Ph.D. studentship from the Health Respiratory Training Program of Quebec formerly supported by the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.	Accomazzo MR, 2001, AM J RESP CRIT CARE, V163, P266, DOI 10.1164/ajrccm.163.1.9912019; Al-Zaubai N, 2014, J PHARMACOL EXP THER, V351, P172, DOI 10.1124/jpet.114.214403; BARNES PJ, 1987, AM REV RESPIR DIS, V135, pS26; Basil MC, 2016, NAT REV IMMUNOL; Bohr S, 2013, WOUND REPAIR REGEN, V21, P35, DOI 10.1111/j.1524-475X.2012.00853.x; Carbajal V, 2005, AM J PHYSIOL-LUNG C, V288, pL84, DOI 10.1152/ajplung.00446.2003; Casale Thomas B, 2003, Postgrad Med, V113, P7, DOI 10.3810/pgm.02.2003.suppl25.131; Chiang N, 2015, J EXP MED, V212, P1203, DOI 10.1084/jem.20150225; Clarke DL, 2009, PULM PHARMACOL THER, V22, P426, DOI 10.1016/j.pupt.2008.12.003; ELLIS JL, 1994, AM J RESP CRIT CARE, V149, P118, DOI 10.1164/ajrccm.149.1.8111568; Figueroa DJ, 2001, AM J RESP CRIT CARE, V163, P226, DOI 10.1164/ajrccm.163.1.2003101; Fredman G, 2014, P NATL ACAD SCI USA, V111, P14530, DOI 10.1073/pnas.1410851111; Giudetti AM, 2012, PROSTAG OTH LIPID M, V99, P57, DOI 10.1016/j.prostaglandins.2012.09.006; Henderson WR, 1996, J EXP MED, V184, P1483, DOI 10.1084/jem.184.4.1483; Hiram R, 2015, AM J PHYSIOL-LUNG C, V309, pL776, DOI 10.1152/ajplung.00177.2015; HUBER M, 1988, EUR J IMMUNOL, V18, P2085, DOI 10.1002/eji.1830181233; Kanaoka Y, 2004, J IMMUNOL, V173, P1503, DOI 10.4049/jimmunol.173.3.1503; Kankaanranta H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090298; Khaddaj Mallat R, 2016, PHARM RES P IN PRESS; Khaddaj-Mallat R, 2015, PROSTAG OTH LIPID M, V121, P145, DOI 10.1016/j.prostaglandins.2015.04.005; Khaddaj-Mallat R, 2015, PFLUG ARCH EUR J PHY, V467, P1591, DOI 10.1007/s00424-014-1584-1; Kumar A, 2016, NUTR RES REV, V29, P1, DOI 10.1017/S0954422415000116; Kurihara T, 2013, FASEB J, V27, P2270, DOI 10.1096/fj.12-219519; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; LAM S, 1988, J ALLERGY CLIN IMMUN, V81, P711, DOI 10.1016/0091-6749(88)91043-3; Lee IT, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/791231; Lin HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107890; Mas E, 2012, CLIN CHEM, V58, P1476, DOI 10.1373/clinchem.2012.190199; Mashima R, 2015, REDOX BIOL, V6, P297, DOI 10.1016/j.redox.2015.08.006; Morin C, 2006, CAN J PHYSIOL PHARM, V84, P1029, DOI 10.1139/Y06-048; Morin C, 2011, AM J RESP CELL MOL, V45, P366, DOI 10.1165/rcmb.2010-0156OC; Mukhopadhyay S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-125; Ono E, 2014, AM J RESP CRIT CARE, V190, P886, DOI 10.1164/rccm.201403-0544OC; Parameswaran K, 2007, AM J RESP CELL MOL, V37, P240, DOI 10.1165/rcmb.2006-0172OC; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shinohara M, 2016, J ATHEROSCLER THROMB; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Suzuki M, 2003, J ASTHMA, V40, P395, DOI 10.1081/JAS-120018709; Tulic MK, 2002, SEMIN RESP CRIT CARE, V23, P347, DOI 10.1055/s-2002-34330; Uddin M, 2011, PROG LIPID RES, V50, P75, DOI 10.1016/j.plipres.2010.09.002	40	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167058	10.1371/journal.pone.0167058	http://dx.doi.org/10.1371/journal.pone.0167058			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935998	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100057
J	Khalil, S; El-Badri, N; El-Mokhtaar, M; Al-Mofty, S; Farghaly, M; Ayman, R; Habib, D; Mousa, N				Khalil, Sabreen; El-Badri, Nagwa; El-Mokhtaar, Mohamed; Al-Mofty, Saif; Farghaly, Mohamed; Ayman, Radwa; Habib, Dina; Mousa, Noha			A Cost-Effective Method to Assemble Biomimetic 3D Cell Culture Platforms	PLOS ONE			English	Article							HUMAN AMNIOTIC MEMBRANE; MESENCHYMAL STEM-CELLS; UMBILICAL-CORD BLOOD; SURFACE RECONSTRUCTION; EPITHELIAL-CELLS; EXPANSION; PROTEINS; MATRIX; NICHE; FATE	Developing effective stem cell based therapies requires the design of complex in vitro culture systems for more accurate representation of the stem cell niche. Attempts to improve conventional cell culture platforms include the use of biomaterial coated culture plates, sphere culture, microfluidic systems and bioreactors. Most of these platforms are not cost-effective, require industrial technical expertise to fabricate, and remain too simplistic compared to the physiological cell niche. The human amniotic membrane (hAM) has been used successfully in clinical grafting applications due to its unique biological composition and regenerative properties. In this study, we present a combinatorial platform that integrates the hAM with biomolecular, topographic and mechanical cues in one versatile model. Methods We utilized the hAM to provide the biological and the three dimensional (3D) topographic components of the prototype. The 3D nano-roughness of the hAM was characterized using surface electron microscopy and surface image analysis (ImageJ and SurfaceJ). We developed additional macro-scale and micro-scale versions of the platform which provided additional shear stress factors to simulate the fluid dynamics of the in vivo extracellular fluids. Results Three models of varying complexities of the prototype were assembled. A well-defined 3D surface modulation of the hAM in comparable to commercial 3D biomaterial culture substrates was achieved without complex fabrication and with significantly lower cost. Performance of the prototype was demonstrated through culture of primary human umbilical cord mononuclear blood cells (MNCs), human bone marrow mesenchymal stem cell line (hBMSC), and human breast cancer tissue. Conclusion This study presents methods of assembling an integrated, flexible and low cost biomimetic cell culture platform for diverse cell culture applications.	[Khalil, Sabreen; El-Badri, Nagwa; Al-Mofty, Saif; Farghaly, Mohamed; Ayman, Radwa] Zewail City Sci & Technol, Ctr Excellence Stem Cells & Regenerat Med, Giza, Egypt; [El-Badri, Nagwa; Al-Mofty, Saif; Mousa, Noha] Univ Sci & Technol, Zewail City Sci & Technol, Giza, Egypt; [El-Mokhtaar, Mohamed] Assiut Univ, Dept Microbiol & Immunol, Fac Med, Assiut, Egypt; [Habib, Dina] Assiut Univ, Dept Obstet & Gynecol, Fac Med, Assiut, Egypt	Egyptian Knowledge Bank (EKB); Zewail City of Science & Technology; Egyptian Knowledge Bank (EKB); Misr University for Science & Technology; Zewail City of Science & Technology; Egyptian Knowledge Bank (EKB); Assiut University; Egyptian Knowledge Bank (EKB); Assiut University	El-Badri, N (corresponding author), Zewail City Sci & Technol, Ctr Excellence Stem Cells & Regenerat Med, Giza, Egypt.; El-Badri, N; Mousa, N (corresponding author), Univ Sci & Technol, Zewail City Sci & Technol, Giza, Egypt.	nelbadri@zewailcity.edu.eg; noha.mousa@utoronto.ca	El-Mokhtar, Mohamed A./AAP-4906-2020; El-Mofty, saif El-din/ABE-3017-2021	El-Mokhtar, Mohamed A./0000-0003-1943-8419; Farghaly, Mohamed/0000-0002-0428-9185; Elmofty, saif/0000-0001-7708-7413	Science and Technology Development Fund STDF Egypt [5300]	Science and Technology Development Fund STDF Egypt(Science and Technology Development Fund (STDF))	Funded by Science and Technology Development Fund STDF (governmental funding) Egypt, grant #5300.	Ahmed O, 2014, BIOM ENG C CIBEC 201; Cooper LJ, 2005, CORNEA, V24, P722, DOI 10.1097/01.ico.0000154237.49112.29; DAVIS GE, 1987, SCIENCE, V236, P1106, DOI 10.1126/science.3576223; Pena Janethe Deolinda de Oliveira, 2007, Arq. Bras. Oftalmol., V70, P756, DOI 10.1590/S0004-27492007000500006; Eberwein P, 2015, STEM CELLS, V33, P916, DOI 10.1002/stem.1886; Eggenhofer E, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00297; Garfias Y, 2011, IMMUNOL INVEST, V40, P183, DOI 10.3109/08820139.2010.532266; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Hardy JG, 2015, BIOENGINEERING-BASEL, V2, P15, DOI 10.3390/bioengineering2010015; ISKI P, 2012, CENTRAL EUROPEAN J I, V37, P114; Jerman UD, 2014, TISSUE ENG PART C-ME, V20, P317, DOI [10.1089/ten.TEC.2013.0298, 10.1089/ten.tec.2013.0298]; Jin HJ, 2013, INT J MOL SCI, V14, P17986, DOI 10.3390/ijms140917986; Kang NH, 2012, CANCER GENE THER, V19, P517, DOI 10.1038/cgt.2012.30; Kang NH, 2012, INT J ONCOL, V40, P2022, DOI 10.3892/ijo.2012.1372; KIM JC, 1995, CORNEA, V14, P473; Kjaergaard N, 2001, EUR J OBSTET GYN R B, V94, P224, DOI 10.1016/S0301-2115(00)00345-6; Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Li HC, 2005, INVEST OPHTH VIS SCI, V46, P900, DOI 10.1167/iovs.04-0495; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; Mamede AC, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0702-z; Mamede AC, 2012, CELL TISSUE RES, V349, P447, DOI 10.1007/s00441-012-1424-6; Mamede AC, 2014, J MEMBRANE BIOL, V247, P357, DOI 10.1007/s00232-014-9642-3; Meller D, 2002, BRIT J OPHTHALMOL, V86, P463, DOI 10.1136/bjo.86.4.463; Mrugala A, 2015, INT WOUND J; Nourazarian S.M, 2015, BULL ENVIRON PHARMAC, V4, P61; Pei XF, 2004, IN VITRO CELL DEV-AN, V40, P14; Peirovi H, 2012, J VASC SURG, V56, P1098, DOI 10.1016/j.jvs.2012.02.036; Pham PV, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-56; Plaks V, 2015, CELL STEM CELL, V16, P225, DOI 10.1016/j.stem.2015.02.015; Ravi M, 2015, J CELL PHYSIOL, V230, P16, DOI 10.1002/jcp.24683; ROBSON MC, 1973, ANN SURG, V177, P144, DOI 10.1097/00000658-197302000-00003; Rocha SCM, 2015, BIOCH PROPERTIES AMN, P19; Saghizadeh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079632; Scadden DT, 2014, CELL, V157, P41, DOI 10.1016/j.cell.2014.02.013; Solomon A, 2001, BRIT J OPHTHALMOL, V85, P444, DOI 10.1136/bjo.85.4.444; Stock SJ, 2007, AM J OBSTET GYNECOL, V196, P255, DOI 10.1016/j.ajog.2006.10.908; Tseng Scheffer C G, 2004, Ocul Surf, V2, P177; Ueta M, 2002, CLIN EXP IMMUNOL, V129, P464, DOI 10.1046/j.1365-2249.2002.01945.x; Walasek MA, 2012, ANN NY ACAD SCI, V1266, P138, DOI 10.1111/j.1749-6632.2012.06549.x; WELLS WJC, 1946, BRIT MED J, V2, P624, DOI 10.1136/bmj.2.4477.624-c; Westekemper H, 2016, BRIT J OPHTHALMOLOGY; Yam GHF, 2013, INVEST OPHTH VIS SCI, V54	43	14	14	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167116	10.1371/journal.pone.0167116	http://dx.doi.org/10.1371/journal.pone.0167116			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935982	gold, Green Submitted, Green Published			2022-12-27	WOS:000389587100062
J	Lin, R; Zhang, YX; Yan, DJ; Liao, XP; Wang, XS; Fu, YX; Cai, WW				Lin, Rong; Zhang, Yunxia; Yan, Dongjing; Liao, Xiaoping; Wang, Xianshou; Fu, Yunxin; Cai, Wangwei			Genetic Association Analysis of Common Variants in FOXO3 Related to Longevity in a Chinese Population	PLOS ONE			English	Article							LONG-LIVED INDIVIDUALS; EXTREME LONGEVITY; CENTENARIANS; METAANALYSIS; LOCI	Recent studies suggested that forkhead box class O3 (FOXO3) functions as a key regulator for the insulin/insulin-like growth factor-1signaling pathway that influence aging and longevity. This study aimed to comprehensively elucidate the association of common genetic variants in FOXO3 with human longevity in a Chinese population. Eighteen single-nucleotide polymorphisms (SNPs) in FOXO3 were successfully genotyped in 616 unrelated long-lived individuals and 846 younger controls. No nominally significant effects were found. However, when stratifying by gender, four SNPs (rs10499051, rs7762395, rs4946933 and rs3800230) previously reported to be associated with longevity and one novel SNP (rs4945815) showed significant association with male longevity (P-values: 0.007-0.032), but all SNPs were not associated with female longevity. Correspondingly, males carrying the G-G-T-G haplotype of rs10499051, rs7762395, rs4945815 and rs3800230 tended to have longer lifespan than those carrying the most common haplotype A-G-C-T (odds ratio = 2.36, 95% confidence interval = 1.20-4.63, P = 0.013). However, none of the associated SNPs and haplotype remained significant after Bonferroni correction. In conclusion, our findings revealed that the FOXO3 variants we tested in our population of Chinese men and women were associated with longevity in men only. None of these associations passed Bonferroni correction. Bonferroni correction is very stringent for association studies. We therefore believe the effects of these nominally significant variants on human longevity will be confirmed by future studies.	[Lin, Rong] Hainan Med Coll, Dept Biol, Haikou, Hainan, Peoples R China; [Zhang, Yunxia; Yan, Dongjing; Cai, Wangwei] Hainan Med Coll, Dept Biochem & Mol Biol, Haikou, Hainan, Peoples R China; [Liao, Xiaoping] Hainan Med Coll, Affiliated Hosp 1, Dept Neurol, Haikou, Hainan, Peoples R China; [Wang, Xianshou] Hainan Med Coll, Specialized Biotechnol Lab, Haikou, Hainan, Peoples R China; [Fu, Yunxin] Univ Texas Hlth Sci Ctr Houston, Div Biostat, Houston, TX 77030 USA; [Fu, Yunxin] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Fu, Yunxin] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming, Yunnan, Peoples R China	Hainan Medical University; Hainan Medical University; Hainan Medical University; Hainan Medical University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Yunnan University	Lin, R (corresponding author), Hainan Med Coll, Dept Biol, Haikou, Hainan, Peoples R China.; Cai, WW (corresponding author), Hainan Med Coll, Dept Biochem & Mol Biol, Haikou, Hainan, Peoples R China.	xianronglin@gmail.com; caiww591020@163.com	Lin, Rong/AAY-3001-2020	Lin, Rong/0000-0001-9161-6844	National Natural Science Foundation of China [31460290, 81460184, 31660309]; Department of Science and Technology of Hainan Province [KJHZ2013-16, ZDXM20090805]; Research Start-Up Fund in Hainan Medical College	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Hainan Province; Research Start-Up Fund in Hainan Medical College	This study was supported by grants from the National Natural Science Foundation of China (31460290, 81460184 and 31660309), (http://www.nsfc.gov.cn/), Department of Science and Technology of Hainan Province (KJHZ2013-16 and ZDXM20090805) (http://dost.hainan.gov.cn/), and the Research Start-Up Fund in Hainan Medical College for Dr.Lin (http://www.hainmc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Anselmi CV, 2009, REJUV RES, V12, P95, DOI 10.1089/rej.2008.0827; Austad SN, 2016, CELL METAB, V23, P1022, DOI 10.1016/j.cmet.2016.05.019; Bao JM, 2014, ASIAN J ANDROL, V16, P446, DOI 10.4103/1008-682X.123673; Bonkowski MS, 2006, P NATL ACAD SCI USA, V103, P7901, DOI 10.1073/pnas.0600161103; Brooks-Wilson AR, 2013, HUM GENET, V132, P1323, DOI 10.1007/s00439-013-1342-z; Chen X, 2012, J THROMB HAEMOST, V10, P1508, DOI 10.1111/j.1538-7836.2012.04815.x; Daumer C, 2014, AGE, V36, P911, DOI 10.1007/s11357-013-9578-z; Donlon TA, 2012, J GERONTOL A-BIOL, V67, P1132, DOI 10.1093/gerona/gls067; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Franceschi C, 2000, AGING-CLIN EXP RES, V12, P77, DOI 10.1007/BF03339894; He YH, 2014, AGING-US, V6, P944, DOI 10.18632/aging.100703; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Li N, 2016, INT J DISTRIB SENS N, DOI 10.1155/2016/4583147; Li XiangJuan, 2010, Journal of Environment and Health, V27, P54; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Morris BJ, 2015, GERONTOLOGY, V61, P515, DOI 10.1159/000375235; Murabito JM, 2012, J GERONTOL A-BIOL, V67, P470, DOI 10.1093/gerona/gls089; Nygaard M, 2014, EXP GERONTOL, V57, P41, DOI 10.1016/j.exger.2014.04.018; Pawlikowska L, 2009, AGING CELL, V8, P460, DOI 10.1111/j.1474-9726.2009.00493.x; Skytthe A, 2003, TWIN RES, V6, P448, DOI 10.1375/twin.6.5.448; Soerensen M, 2015, AGING CELL, V14, P60, DOI 10.1111/acel.12295; Soerensen M, 2010, AGING CELL, V9, P1010, DOI 10.1111/j.1474-9726.2010.00627.x; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Sun L, 2015, SCI REP-UK, V5, DOI 10.1038/srep09852; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Willcox BJ, 2016, AGING CELL, V15, P617, DOI 10.1111/acel.12452; Xm F, 2013, POPUL J, V35, P14; Yunfeng LI, 2009, CHINA MINING MAGAZIN, V8, P1, DOI DOI 10.1093/HMG/DDP459; Zeng Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep21243; Zeng Y, 2010, J GERONTOL A-BIOL, V65, P1285, DOI 10.1093/gerona/glq156	33	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167918	10.1371/journal.pone.0167918	http://dx.doi.org/10.1371/journal.pone.0167918			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936216	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100231
J	Lind, T; Gustafson, AM; Calounova, G; Hu, LJ; Rasmusson, A; Jonsson, KB; Wernersson, S; Aring;brink, M; Andersson, G; Larsson, S; Melhus, H; Pejler, G				Lind, Thomas; Gustafson, Ann-Marie; Calounova, Gabriela; Hu, Lijuan; Rasmusson, Annica; Jonsson, Kenneth B.; Wernersson, Sara; Abrink, Magnus; Andersson, Goran; Larsson, Sune; Melhus, Hakan; Pejler, Gunnar			Increased Bone Mass in Female Mice Lacking Mast Cell Chymase	PLOS ONE			English	Article							INDOLENT SYSTEMIC MASTOCYTOSIS; INFLAMMATION; OSTEOPOROSIS; INHIBITOR; DIFFERENTIATION; OSTEOBLAST; PROTEASE-4; HAMSTERS; TISSUE; ACCUMULATION	Here we addressed the potential impact of chymase, a mast-cell restricted protease, on mouse bone phenotype. We show that female mice lacking the chymase Mcpt4 acquired a persistent expansion of diaphyseal bone in comparison with wild type controls, reaching a 15% larger diaphyseal cross sectional area at 12 months of age. Mcpt4(-/-) mice also showed increased levels of a bone anabolic serum marker and higher periosteal bone formation rate. However, they were not protected from experimental osteoporosis, suggesting that chymase regulates normal bone homeostasis rather than the course of osteoporosis. Further, the absence of Mcpt4(-/-) resulted in age-dependent upregulation of numerous genes important for bone formation but no effects on osteoclast activity. In spite of the latter, Mcpt4(-/-) bones had increased cortical porosity and reduced endocortical mineralization. Mast cells were found periosteally and, notably, bone-proximal mast cells in Mcpt4(-/-) mice were degranulated to a larger extent than in wild type mice. Hence, chymase regulates degranulation of bone mast cells, which could affect the release of mast cell-derived factors influencing bone remodelling. Together, these findings reveal a functional impact of mast cell chymase on bone. Further studies exploring the possibility of using chymase inhibitors as a strategy to increase bone volume may be warranted.	[Lind, Thomas; Gustafson, Ann-Marie; Hu, Lijuan; Rasmusson, Annica; Melhus, Hakan] Univ Uppsala Hosp, Clin Pharmacol Sect, Dept Med Sci, Uppsala, Sweden; [Gustafson, Ann-Marie; Calounova, Gabriela; Pejler, Gunnar] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Jonsson, Kenneth B.; Larsson, Sune] Univ Uppsala Hosp, Dept Surg Sci, Uppsala, Sweden; [Wernersson, Sara; Pejler, Gunnar] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Abrink, Magnus] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden; [Andersson, Goran] Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Pathol, Dept Lab Med, Stockholm, Sweden	Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University; Uppsala University Hospital; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Karolinska Institutet; Karolinska University Hospital	Lind, T (corresponding author), Univ Uppsala Hosp, Clin Pharmacol Sect, Dept Med Sci, Uppsala, Sweden.	thomas.lind@medsci.uu.se	, kenneth/GPF-8006-2022; Åbrink, Magnus/AAK-8346-2020; Wernersson, Sara/D-4580-2011; Wernersson, Sara/N-8830-2019	Wernersson, Sara/0000-0003-3067-7875; Wernersson, Sara/0000-0003-3067-7875; Abrink, Magnus/0000-0002-1335-3927; Lind, Thomas/0000-0003-2791-688X; Rasmusson, Annica/0000-0002-7228-7755	Uppsala Bio-X; Svenska Lakaresallskapet; Medicinska forskningsradet	Uppsala Bio-X; Svenska Lakaresallskapet; Medicinska forskningsradet	The funders of this study were: Uppsala Bio-X, Svenska Lakaresallskapet and Medicinska forskningsradet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AS, 2006, CLIN CHEM LAB MED, V44, P672, DOI 10.1515/CCLM.2006.117; Arron JR, 2000, NATURE, V408, P535, DOI 10.1038/35046196; Berahovich RD, 2005, J IMMUNOL, V174, P7341, DOI 10.4049/jimmunol.174.11.7341; Blair HC, 1999, VIRCHOWS ARCH, V435, P50, DOI 10.1007/s004280050394; Bot I, 2011, CARDIOVASC RES, V89, P244, DOI 10.1093/cvr/cvq260; Braga T, 2007, BIOCHEM J, V403, P49, DOI 10.1042/BJ20061257; Chen H, 2004, HISTOL HISTOPATHOL, V19, P677, DOI 10.14670/HH-19.677; Chiappetta N, 2006, SEMIN ARTHRITIS RHEU, V36, P32, DOI 10.1016/j.semarthrit.2006.03.004; Dhillon RS, 2013, J BONE MINER RES, V28, P586, DOI 10.1002/jbmr.1765; Di Benedetto A, 2010, J CELL SCI, V123, P2640, DOI 10.1242/jcs.067777; EkRylander B, 1997, BIOCHEM J, V321, P305, DOI 10.1042/bj3210305; Farber CR, 2011, J BONE MINER RES, V26, P2174, DOI 10.1002/jbmr.436; FEIK SA, 1979, PATHOLOGY, V11, P641, DOI 10.3109/00313027909059044; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Galli SJ, 2015, ADV IMMUNOL, V126, P45, DOI 10.1016/bs.ai.2014.11.002; Gannon FH, 2001, HUM PATHOL, V32, P842, DOI 10.1053/hupa.2001.26464; Groschwitz KR, 2009, P NATL ACAD SCI USA, V106, P22381, DOI 10.1073/pnas.0906372106; Guillaume N, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.07.018; He AN, 2013, CURR PHARM DESIGN, V19, P1114; Hendrix S, 2013, FASEB J, V27, P920, DOI 10.1096/fj.12-204800; Hernlund E, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0136-1; Hoshino F, 2003, J CARDIOVASC PHARM, V41, pS11; Houde M, 2016, LIFE SCI, V159, P71, DOI 10.1016/j.lfs.2016.03.018; Huang YC, 2005, GENE THER, V12, P418, DOI 10.1038/sj.gt.3302439; Imada T, 2002, JPN J PHARMACOL, V90, P214, DOI 10.1254/jjp.90.214; Inoue K, 2006, J BIOL CHEM, V281, P33814, DOI 10.1074/jbc.M607290200; Jarvinen TLN, 2015, J INTERN MED, V277, P662, DOI 10.1111/joim.12366; Johnzon CF, 2016, AM J PATHOL, V186, P4, DOI 10.1016/j.ajpath.2015.06.024; Khosla S, 2009, NEW ENGL J MED, V361, P818, DOI 10.1056/NEJMe0905480; Lesclous P, 2001, CALCIFIED TISSUE INT, V68, P297, DOI 10.1007/BF02390837; Lin L, 2011, J BIOL CHEM, V286, P37358, DOI 10.1074/jbc.M111.272401; Lind T, 2012, CALCIFIED TISSUE INT, V90, P219, DOI 10.1007/s00223-011-9561-6; Lind T, 2011, BONE, V48, P496, DOI 10.1016/j.bone.2010.10.169; Magnusson SE, 2009, FASEB J, V23, P875, DOI 10.1096/fj.08-120394; Maryanoff BE, 2010, AM J RESP CRIT CARE, V181, P247, DOI 10.1164/rccm.200904-0627OC; Motakis E, 2014, BLOOD, V123, pE58, DOI 10.1182/blood-2013-02-483792; Nelissen S, 2014, NEUROBIOL DIS, V62, P260, DOI 10.1016/j.nbd.2013.09.012; Nyman JS, 2011, J BONE MINER RES, V26, P1252, DOI 10.1002/jbmr.326; Okamoto Y, 2002, JPN J PHARMACOL, V90, P94, DOI 10.1254/jjp.90.94; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Pejler G, 2009, TRENDS IMMUNOL, V30, P401, DOI 10.1016/j.it.2009.04.008; RAMESH BL, 2005, BONE, V36, P555, DOI DOI 10.1016/J.B0NE.2004.12.005; Rossini M, 2014, IMMUNOL ALLERGY CLIN, V34, P383, DOI 10.1016/j.iac.2014.01.011; Rossini M, 2011, BONE, V49, P880, DOI 10.1016/j.bone.2011.07.004; Roy A, 2014, J BIOL CHEM, V289, P237, DOI 10.1074/jbc.M112.435156; Scandiuzzi L, 2010, J IMMUNOL, V185, P624, DOI 10.4049/jimmunol.0902129; Seitz S, 2013, OSTEOPOROSIS INT, V24, P2325, DOI 10.1007/s00198-013-2305-x; Sun JS, 2009, CIRCULATION, V120, P973, DOI 10.1161/CIRCULATIONAHA.109.849679; Tchougounova E, 2005, J BIOL CHEM, V280, P9291, DOI 10.1074/jbc.M410396200; Tchougounova E, 2003, J EXP MED, V198, P423, DOI 10.1084/jem.20030671; Tsunemi K, 2004, J PHARMACOL EXP THER, V309, P879, DOI 10.1124/jpet.103.063974; Turner RT, 2010, J BONE MINER RES, V25, P1637, DOI 10.1002/jbmr.49; van der Veer E, 2012, ALLERGY, V67, P431, DOI 10.1111/j.1398-9995.2011.02780.x; Voehringer D, 2013, NAT REV IMMUNOL, V13, P362, DOI 10.1038/nri3427; Waern I, 2013, MUCOSAL IMMUNOL, V6, P911, DOI 10.1038/mi.2012.129; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Wu LA, 2016, J CELL PHYSIOL, V231, P1189, DOI 10.1002/jcp.25266; Zhao W, 2005, J IMMUNOL, V175, P2635, DOI 10.4049/jimmunol.175.4.2635	59	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167964	10.1371/journal.pone.0167964	http://dx.doi.org/10.1371/journal.pone.0167964			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936149	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100241
J	Liu, XL; Liu, CJ				Liu, Xinlun; Liu, Chunji			Effects of Drought-Stress on Fusarium Crown Rot Development in Barley	PLOS ONE			English	Article							ESTIMATING DISEASE LOSSES; HEAD BLIGHT; BREAD WHEAT; RESISTANCE; SEVERITY	Fusarium crown rot (FCR), caused by various Fusarium species, is a chronic disease of cereals in many semi-arid regions worldwide. To clarify what effects drought-stress may have on FCR development, visual assessment, histological analysis and quantitative PCR were used to analyse the infection process of F. pseudograminearum in barley. This study observed for the first time that the severity of FCR symptom reflects the quantity of pathogens in infected tissues of barley under both drought-stressed and well-watered conditions. Drought-stress prolongs the initial infection phase but enhances the proliferation and spread of Fusarium pathogens after the initial infection phase. Under drought-stressed conditions, the invading hyphae were frequently observed to re-emerge from stomata and invade again the surrounding epidermis cells. Under the well-watered conditions, however, very few hyphae re-emerged from stomata and most infection was caused by hyphae intracellularly grown. It was also observed that drought-stress increased the length and density of trichomes dramatically especially in the susceptible genotypes, and that the length and density of trichomes were positively related to fungal biomass of F. pseudograminearum in plants.	[Liu, Xinlun] Northwest A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Liu, Xinlun; Liu, Chunji] CSIRO Agr & Food, St Lucia, Qld, Australia; [Liu, Chunji] Univ Western Australia, Sch Plant Biol, Perth, WA, Australia	Northwest A&F University - China; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia	Liu, XL (corresponding author), Northwest A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Liu, XL (corresponding author), CSIRO Agr & Food, St Lucia, Qld, Australia.	liuxinlun@nwafu.edu.cn	Liu, Chunji/B-5243-2009		Northwest AF University; China Scholarship Council; Grains Research and Development Corporation, Australia [CSP00149]	Northwest AF University; China Scholarship Council(China Scholarship Council); Grains Research and Development Corporation, Australia(Grains R&D Corp)	XL is grateful to the Northwest A&F University and the China Scholarship Council for funding her visit to CSIRO Agriculture & Food. Work reported in this paper is supported by the Grains Research and Development Corporation, Australia (CSP00149). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinsanmi OA, 2004, AUST J AGR RES, V55, P97, DOI 10.1071/AR03090; Bai ZY, 2015, J PHYTOPATHOL, V163, P91, DOI 10.1111/jph.12283; Chakraborty S, 2006, AUSTRALAS PLANT PATH, V35, P643, DOI 10.1071/AP06068; Clement JA, 1998, EUR J PLANT PATHOL, V104, P323, DOI 10.1023/A:1008681618351; COOK RJ, 1980, PLANT DIS, V64, P102, DOI 10.1094/PD-64-1061; DODMAN RL, 1987, AUST J AGR RES, V38, P475; EHLERINGER JR, 1978, OECOLOGIA, V37, P183, DOI 10.1007/BF00344990; Fernandez MR, 2009, CAN J PLANT PATHOL, V31, P96, DOI 10.1080/07060660909507577; Hulburt DJ, 2004, J ECON ENTOMOL, V97, P621, DOI 10.1603/0022-0493-97.2.621; Knight NL, 2013, AUSTRALAS PLANT PATH, V42, P609, DOI 10.1007/s13313-013-0225-z; Knight NL, 2013, PLANT PATHOL, V62, P679, DOI 10.1111/j.1365-3059.2012.02663.x; Li HB, 2010, THEOR APPL GENET, V121, P941, DOI 10.1007/s00122-010-1363-0; Li XM, 2008, J PHYTOPATHOL, V156, P751, DOI 10.1111/j.1439-0434.2008.01425.x; Liu YX, 2010, PHYTOPATHOLOGY, V100, P1276, DOI 10.1094/PHYTO-05-10-0142; Liu YX, 2012, J PHYTOPATHOL, V160, P412, DOI 10.1111/j.1439-0434.2012.01920.x; Ma J, 2010, THEOR APPL GENET, V120, P1119, DOI 10.1007/s00122-009-1239-3; McMullen M, 1997, PLANT DIS, V81, P1340, DOI 10.1094/PDIS.1997.81.12.1340; Murray GM, 2010, AUSTRALAS PLANT PATH, V39, P85, DOI 10.1071/AP09064; Murray GM, 2009, AUSTRALAS PLANT PATH, V38, P558, DOI 10.1071/AP09053; PAPENDICK RI, 1974, PHYTOPATHOLOGY, V64, P358, DOI 10.1094/Phyto-64-358; Paulitz TC, 2002, CAN J PLANT PATHOL, V24, P416; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rittenour WR, 2010, MOL PLANT PATHOL, V11, P361, DOI [10.1111/J.1364-3703.2010.00609.X, 10.1111/j.1364-3703.2010.00609.x]; Schafer P, 2004, MOL PLANT MICROBE IN, V17, P366, DOI 10.1094/MPMI.2004.17.4.366; Smiley RW, 2005, PLANT DIS, V89, P595, DOI 10.1094/PD-89-0595; Wallwork H, 2004, AUSTRALAS PLANT PATH, V33, P1, DOI 10.1071/AP03073; Yan W, 2011, PLANT PATHOL, V60, P506, DOI 10.1111/j.1365-3059.2011.02426.x; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	28	18	19	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167304	10.1371/journal.pone.0167304	http://dx.doi.org/10.1371/journal.pone.0167304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936004	gold, Green Submitted, Green Published			2022-12-27	WOS:000389587100081
J	Rossi, S; Sanchez-Sarmiento, AM; Vanstreels, RET; dos Santos, RG; Prioste, FES; Gattamorta, MA; Grisi, JHH; Matushima, ER				Rossi, Silmara; Sanchez-Sarmiento, Angelica Maria; Thijl Vanstreels, Ralph Eric; dos Santos, Robson Guimaraes; Setim Prioste, Fabiola Eloisa; Gattamorta, Marco Aurelio; Hildebrand Grisi-Filho, Jose Henrique; Matushima, Eliana Reiko			Challenges in Evaluating the Severity of Fibropapillomatosis: A Proposal for Objective Index and Score System for Green Sea Turtles (Chelonia mydas) in Brazil	PLOS ONE			English	Article							CARETTA-CARETTA; HERPESVIRUS; SPIRORCHIDIASIS; ASSOCIATION; INFECTION	Fibropapillomatosis (FP) is a neoplastic disease that affects marine turtles worldwide, especially green sea turtles (Chelonia mydas). FP tumors can develop on the body surface of marine turtles and also internally in the oral cavity and viscera. Depending on their quantity, size and anatomical distribution, these tumors can interfere with hydrodynamics and the ability to feed, hence scoring systems have been proposed in an attempt to quantify the clinical manifestation of FP. In order to establish a new scoring system adapted to geographic regions, we examined 214 juvenile green sea turtles with FP caught or rescued at Brazilian feeding areas, counted their 7466 tumors and classified them in relation to their size and anatomical distribution. The patterns in quantity, size and distribution of tumors revealed interesting aspects in the clinical manifestation of FP in specimens studied in Brazil, and that FP scoring systems developed for other areas might not perform adequately when applied to sea turtles on the Southwest Atlantic Ocean. We therefore propose a novel method to evaluate the clinical manifestation of FP: fibropapillomatosis index (FPI) that provides the Southwest Atlantic fibropapillomatosis score (FPSswA). In combination, these indexing and scoring systems allow for a more objective, rapid and detailed evaluation of the severity of FP in green sea turtles. While primarily designed for the clinical manifestation of FP currently witnessed in our dataset, this index and the score system can be adapted for other areas and compare the characteristics of the disease across regions. In conclusion, scoring systems to classify the severity of FP can assist our understanding on the environmental factors that modulate its development and its impacts on the individual and population health of green sea turtles.	[Rossi, Silmara; Setim Prioste, Fabiola Eloisa; Gattamorta, Marco Aurelio; Matushima, Eliana Reiko] Univ Sao Paulo, Res Grp Fibropapillomatosis Sea Turtles, Sao Paulo, SP, Brazil; [Sanchez-Sarmiento, Angelica Maria; Thijl Vanstreels, Ralph Eric; Setim Prioste, Fabiola Eloisa; Matushima, Eliana Reiko] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Patol, Lab Patol Comparada Anim Selvagens LAPCOM, Sao Paulo, SP, Brazil; [dos Santos, Robson Guimaraes] Univ Fed Alagoas, Inst Ciencias Biol & Saude, Maceio, AL, Brazil; [Gattamorta, Marco Aurelio] FMU, Sao Paulo, SP, Brazil; [Hildebrand Grisi-Filho, Jose Henrique] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Med Vet Prevent & Saude Anim, LEB, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Alagoas; Universidade de Sao Paulo	Rossi, S (corresponding author), Univ Sao Paulo, Res Grp Fibropapillomatosis Sea Turtles, Sao Paulo, SP, Brazil.	smara.rossi@gmail.com	Grisi-Filho, Jose/Q-3106-2019; Rossi, Silmara/AAS-3371-2020; Grisi-Filho, Jose/J-2523-2012; Sánchez-Sarmiento, Angélica María/AAH-9474-2020; Santos, Robson Guimaraes/E-7183-2010; Sanchez-Sarmiento, Angélica María/B-8764-2019	Grisi-Filho, Jose/0000-0002-3263-2147; Grisi-Filho, Jose/0000-0002-3263-2147; Sánchez-Sarmiento, Angélica María/0000-0001-6818-4609; Santos, Robson Guimaraes/0000-0001-5240-6799; Sanchez-Sarmiento, Angélica María/0000-0001-6818-4609	Fundagao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP [2009/53956-9, 2010/01781-8, 2011/04565-7, 2012/14319-6]; Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior-CAPES; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/01781-8, 2011/04565-7, 2012/14319-6]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundagao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior-CAPES; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by: Fundagao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP (www.fapesp.br): process number 2009/53956-9 (RETV), 2010/01781-8 (SR), 2011/04565-7 (AMSS), 2012/14319-6 (ERM); Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior-CAPES (www.capes.gov.br): RGS, FESP, MAG.; We would like to thank to Projeto TAMAR-ICMBio, Instituto Chico Mendes de Conservacao da Biodiversidade (ICMBio) and Comissao de Etica no Uso de Animais (FMVZ-USP). We are indebted to Jose Luiz Cataro-Dias, Jorge Oyakawa and Ticiana Zwarg. Financial support was provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2010/01781-8, 2011/04565-7, 2012/14319-6) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).	Adnyana W, 1997, AUST VET J, V75, P737, DOI 10.1111/j.1751-0813.1997.tb12258.x; Aguirre AA, 1998, J WILDLIFE DIS, V34, P91, DOI 10.7589/0090-3558-34.1.91; Aguirre AA, 2000, COMP HAEMATOL INT, V10, P132, DOI 10.1007/s005800070004; Aguirre AA., 2004, ECOHEALTH, V1, P275, DOI [10.1007/s10393-004-0097-3, DOI 10.1007/S10393-004-0097-3]; Alfaro-Nunez A, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0206-z; [Anonymous], 2021, LANG ENV STAT COMP; BALAZS G.H., 1991, RES PLAN MARINE TURT, P47; Balazs George H., 1997, Marine Turtle Newsletter, V76, P1; Baptistotte C, 2007, THESIS; Borrowman KM, 2008, PREVALENCE SEVERITY; BRITO F. L. C., 2004, MARINE TURTLE NEWSLE, V106, P12; Bugoni L, 2001, MAR POLLUT BULL, V42, P1330, DOI 10.1016/S0025-326X(01)00147-3; Chaloupka M, 2009, J WILDLIFE DIS, V45, P1138, DOI 10.7589/0090-3558-45.4.1138; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; dos Santos RG, 2010, DIS AQUAT ORGAN, V89, P87, DOI 10.3354/dao02178; Ene A, 2005, J WILDLIFE DIS, V41, P489, DOI 10.7589/0090-3558-41.3.489; Gamer M, 2012, IRR VARIOUS COEFFICI; George Robert H., 1997, P363; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Herbst L, 2004, CURR BIOL, V14, pR697, DOI 10.1016/j.cub.2004.08.040; HERBST LH, 1995, ENVIRON HEALTH PERSP, V103, P27, DOI 10.2307/3432408; Herbst LH, 1998, J WILDLIFE DIS, V34, P496, DOI 10.7589/0090-3558-34.3.496; HERBST LH, 1995, DIS AQUAT ORGAN, V22, P1, DOI 10.3354/dao022001; Hirama Shigetomo, 2007, Florida Scientist, V70, P435; Hirth H.F., 1997, BIOL REPORT; Lackovich JK, 1999, DIS AQUAT ORGAN, V37, P89, DOI 10.3354/dao037089; Mascarenhas Rita, 2008, Marine Turtle Newsletter, P3; NORTON TM, 1990, J WILDLIFE DIS, V26, P265, DOI 10.7589/0090-3558-26.2.265; Page-Karjian A, 2015, DIS AQUAT ORGAN, V115, P185, DOI 10.3354/dao02878; Page-Karjian A, 2014, J ZOO WILDLIFE MED, V45, P507, DOI 10.1638/2013-0132R1.1; Patricio AR, 2012, J GEN VIROL, V93, P1035, DOI 10.1099/vir.0.038950-0; PRITCHARD P.C.H., 2000, TECNICAS INVESTIGACI, P23; Quackenbush SL, 2001, VIROLOGY, V287, P105, DOI 10.1006/viro.2001.1023; Rodenbusch CR, 2014, DIS AQUAT ORGAN, V111, P207, DOI 10.3354/dao02782; Rossi S, 2009, PESQUISA VET BRASIL, V29, P974, DOI 10.1590/S0100-736X2009001200004; SMITH G. M., 1938, ZOOLOGICA [NEW YORK], V23, P93; Spotila JR, 2004, SEA TURTLES COMPLETE; Tapia AC, 2004, THESIS; Torezani E, 2010, J MAR BIOL ASSOC UK, V90, P233, DOI 10.1017/S0025315409990579; Van Houtan KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012900; WOOD F, 1993, HERPETOL J, V3, P84; Work TM, 2009, J GEN VIROL, V90, P1943, DOI 10.1099/vir.0.011650-0; Work TM, 1999, J WILDLIFE DIS, V35, P804, DOI 10.7589/0090-3558-35.4.804; Work TM, 2004, DIS AQUAT ORGAN, V62, P163, DOI 10.3354/dao062163; Work TM, 2003, DIS AQUAT ORGAN, V53, P41, DOI 10.3354/dao053041; Work TM, 2014, VET PATHOL, V52, P1; Zwarg T, 2014, PESQUI VET BRASIL, V34, P682, DOI 10.1590/S0100-736X2014000700013	47	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167632	10.1371/journal.pone.0167632	http://dx.doi.org/10.1371/journal.pone.0167632			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936118	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100135
J	Vito, A; Alarabi, H; Czorny, S; Beiraghi, O; Kent, J; Janzen, N; Genady, AR; Alkarmi, SA; Rathmann, S; Naperstkow, Z; Blacker, M; Llano, L; Berti, PJ; Valliant, JF				Vito, Alyssa; Alarabi, Hussain; Czorny, Shannon; Beiraghi, Omid; Kent, Jeff; Janzen, Nancy; Genady, Afaf R.; Alkarmi, Salma A.; Rathmann, Stephanie; Naperstkow, Zoya; Blacker, Megan; Llano, Lisset; Berti, Paul J.; Valliant, John F.			A Tc-99m-Labelled Tetrazine for Bioorthogonal Chemistry. Synthesis and Biodistribution Studies with Small Molecule trans-Cyclooctene Derivatives	PLOS ONE			English	Article							ALDER CLICK CHEMISTRY; BACTERIAL-INFECTIONS; CO-LIGANDS; TC-99M; BONE; RADIOPHARMACEUTICALS; BISPHOSPHONATE; PEPTIDES; LIGATION; STRATEGY	A convenient strategy to radiolabel a hydrazinonicotonic acid (HYNIC)-derived tetrazine with Tc-99m was developed, and its utility for creating probes to image bone metabolism and bacterial infection using both active and pretargeting strategies was demonstrated. The Tc-99m-labelled HYNIC-tetrazine was synthesized in 75% yield and exhibited high stability in vitro and in vivo. A trans-cyclooctene (TCO)-labelled bisphosphonate (TCO-BP) that binds to regions of active calcium metabolism was used to evaluate the utility of the labelled tetrazine for bioorthogonal chemistry. The pretargeting approach, with Tc-99m-HYNIC-tetrazine administered to mice one hour after TCO-BP, showed significant uptake of radioactivity in regions of active bone metabolism (knees and shoulders) at 6 hours post-injection. For comparison, TCO-BP was reacted with Tc-99m-HYNIC-tetrazine before injection and this active targeting also showed high specific uptake in the knees and shoulders, whereas control Tc-99m-HYNIC-tetrazine alone did not. A TCO-vancomycin derivative was similarly employed for targeting Staphylococcus aureus infection in vitro and in vivo. Pretargeting and active targeting strategies showed 2.5- and 3-fold uptake, respectively, at the sites of a calf-muscle infection in a murine model, compared to the contralateral control muscle. These results demonstrate the utility of the Tc-99m-HYNIC-tetrazine for preparing new technetium radiopharmaceuticals, including those based on small molecule targeting constructs containing TCO, using either active or pretargeting strategies.	[Vito, Alyssa; Alarabi, Hussain; Czorny, Shannon; Beiraghi, Omid; Kent, Jeff; Janzen, Nancy; Genady, Afaf R.; Alkarmi, Salma A.; Rathmann, Stephanie; Naperstkow, Zoya; Llano, Lisset; Berti, Paul J.; Valliant, John F.] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON, Canada; [Genady, Afaf R.] Tanta Univ, Dept Chem, Fac Sci, Tanta, Egypt; [Blacker, Megan; Valliant, John F.] McMaster Univ, Ctr Probe Dev & Commercializat, Hamilton, ON, Canada; [Berti, Paul J.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada	McMaster University; Egyptian Knowledge Bank (EKB); Tanta University; McMaster University; McMaster University	Valliant, JF (corresponding author), McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON, Canada.; Valliant, JF (corresponding author), McMaster Univ, Ctr Probe Dev & Commercializat, Hamilton, ON, Canada.	valliant@mcmaster.ca		Alarabi Hussain, Hussain/0000-0003-2027-719X	Natural Sciences and Engineering Research Council of Canada (NSERC) [227514, 227511]; Canadian Cancer Society (CCS) [703857]; Canadian Institutes for Health Research (CIHR) [493840-16]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Cancer Society (CCS)(Canadian Cancer Society (CCS)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Funding was provided by the following government and cancer research agencies within Canada through standard, peer-reviewed research grants: 1)The Natural Sciences and Engineering Research Council of Canada (NSERC) [www.nserc-crsng.gc.ca] research grants: #227514 held by JFV and #227511 held by PJB. 2)The Canadian Cancer Society (CCS) [www.cancer.ca] grant #703857 held by JFV. 3)The Canadian Institutes for Health Research (CIHR) [www.cihr-irsc.gc.ca] grant #493840-16 held by JFV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS MJ, 1990, J NUCL MED, V31, P2022; Amato I, 2009, CHEM ENG NEWS, V87, P58, DOI 10.1021/cen-v087n036.p058; [Anonymous], 2003, HDB RADIOPHARMACEUTI; BABICH JW, 1995, NUCL MED BIOL, V22, P25, DOI 10.1016/0969-8051(94)00081-T; Bettegowda C, 2005, P NATL ACAD SCI USA, V102, P1145, DOI 10.1073/pnas.0408861102; CALAME W, 1991, J NUCL MED, V32, P468; Chung HJ, 2011, ACS NANO, V5, P8834, DOI 10.1021/nn2029692; Cole LE, 2016, ADV DRUG DELIVER REV, V99, P12, DOI 10.1016/j.addr.2015.10.005; Decristoforo C, 1999, NUCL MED BIOL, V26, P389, DOI 10.1016/S0969-8051(98)00118-8; Devaraj NK, 2012, P NATL ACAD SCI USA, V109, P4762, DOI 10.1073/pnas.1113466109; Devaraj NK, 2011, ACCOUNTS CHEM RES, V44, P816, DOI 10.1021/ar200037t; Garcia MF, 2016, BIOORGAN MED CHEM, V24, P1209, DOI 10.1016/j.bmc.2016.01.046; Garcia MF, 2015, ANTI-CANCER AGENT ME, V15, P122; Herth MM, 2013, CHEM COMMUN, V49, P3805, DOI 10.1039/c3cc41027g; Hertlein T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018246; Jewett JC, 2010, CHEM SOC REV, V39, P1272, DOI 10.1039/b901970g; Karver MR, 2011, BIOCONJUGATE CHEM, V22, P2263, DOI 10.1021/bc200295y; Kluba CA, 2013, MOLECULES, V18, P3206, DOI 10.3390/molecules18033206; Li ZB, 2010, CHEM COMMUN, V46, P8043, DOI 10.1039/c0cc03078c; Liu S, 2008, ADV DRUG DELIVER REV, V60, P1347, DOI 10.1016/j.addr.2008.04.006; Maresca KP, 2012, INORG CHIM ACTA, V389, P168, DOI 10.1016/j.ica.2012.03.002; Meszaros LK, 2011, DALTON T, V40, P6260, DOI 10.1039/c0dt01608j; Ning XH, 2014, ANGEW CHEM INT EDIT, V53, P14096, DOI 10.1002/anie.201408533; Ogawa K, 2006, J NUCL MED, V47, P2042; Rieder U, 2014, ANGEW CHEM INT EDIT, V53, P9168, DOI 10.1002/anie.201403580; Rosch F, 2011, DALTON T, V40, P6104, DOI 10.1039/c0dt01504k; Rossin R, 2010, ANGEW CHEM INT EDIT, V49, P3375, DOI 10.1002/anie.200906294; Sletten EM, 2011, ACCOUNTS CHEM RES, V44, P666, DOI 10.1021/ar200148z; Sohaib M, 2014, J LABELLED COMPD RAD, V57, P652, DOI 10.1002/jlcr.3235; Su ZF, 2003, NUCL MED BIOL, V30, P141, DOI 10.1016/S0969-8051(02)00390-6; Sugawara Y, 1999, EUR J NUCL MED, V26, P333, DOI 10.1007/s002590050395; Surfraz MBU, 2009, J INORG BIOCHEM, V103, P971, DOI 10.1016/j.jinorgbio.2009.04.007; WANG TST, 1980, J NUCL MED, V21, P767; Welling MM, 2015, BIOCONJUGATE CHEM, V26, P839, DOI 10.1021/acs.bioconjchem.5b00062; Welling MM, 2000, EUR J NUCL MED, V27, P292, DOI 10.1007/s002590050036; Zeglis BM, 2013, J NUCL MED, V54, P1389, DOI 10.2967/jnumed.112.115840; Zeglis BM, 2011, BIOCONJUGATE CHEM, V22, P2048, DOI 10.1021/bc200288d	37	14	14	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167425	10.1371/journal.pone.0167425	http://dx.doi.org/10.1371/journal.pone.0167425			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936007	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100096
J	White, T; Westgate, K; Wareham, NJ; Brage, S				White, Tom; Westgate, Kate; Wareham, Nicholas J.; Brage, Soren			Estimation of Physical Activity Energy Expenditure during Free-Living from Wrist Accelerometry in UK Adults	PLOS ONE			English	Article							COMBINED HEART-RATE; VALIDITY; SENSOR	Background Wrist-worn accelerometers are emerging as the most common instrument for measuring physical activity in large-scale epidemiological studies, though little is known about the relationship between wrist acceleration and physical activity energy expenditure (PAEE). Methods 1695 UK adults wore two devices simultaneously for six days; a combined sensor and a wrist accelerometer. The combined sensor measured heart rate and trunk acceleration, which was combined with a treadmill test to yield a signal of individually-calibrated PAEE. Multi-level regression models were used to characterise the relationship between the two time-series, and their estimations were evaluated in an independent holdout sample. Finally, the relationship between PAEE and BMI was described separately for each source of PAEE estimate (wrist acceleration models and combined-sensing). Results Wrist acceleration explained 44-47% between-individual variance in PAEE, with RMSE between 34-39 J.min(-1).kg(-1). Estimations agreed well with PAEE in cross-validation (mean bias [95% limits of agreement]: 0.07 [-70.6: 70.7]) but overestimated in women by 3% and underestimated in men by 4%. Estimation error was inversely related to age (-2.3 J.min(-1).kg(-1) per 10y) and BMI (-0.3 J.min(-1).kg(-1) per kg/m(2)). Associations with BMI were similar for all PAEE estimates (approximately -0.08 kg/m(2) per J.min(-1).kg(-1)). Conclusions A strong relationship exists between wrist acceleration and PAEE in free-living adults, such that irrespective of the objective method of PAEE assessment, a strong inverse association between PAEE and BMI was observed.	[White, Tom; Westgate, Kate; Wareham, Nicholas J.; Brage, Soren] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England	University of Cambridge	Brage, S (corresponding author), Univ Cambridge, MRC Epidemiol Unit, Cambridge, England.	soren.brage@mrc-epid.cam.ac.uk	Brage, Soren/C-6415-2013	Brage, Soren/0000-0002-1265-7355; White, Thomas/0000-0001-8456-0803	Medical Research Council [MC_UU_12015/3]; MedImmune; MRC [MC_UU_12015/3, MC_UU_12015/1, MC_U106179473] Funding Source: UKRI; Medical Research Council [MC_UU_12015/1, MC_U106179473, MC_U106179471] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10135] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MedImmune(AstraZenecaMedimmune); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by the Medical Research Council (MC_UU_12015/3), and Tom White is the recipient of a studentship from MedImmune. The funders had no role in the design, conduct, analysis, and decision to publish results from this study.	Assah FK, 2011, INT J EPIDEMIOL, V40, P112, DOI 10.1093/ije/dyq098; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Brage S, 2004, J APPL PHYSIOL, V96, P343, DOI 10.1152/japplphysiol.00703.2003; Brage S, 2007, J APPL PHYSIOL, V103, P682, DOI 10.1152/japplphysiol.00092.2006; Brage S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137206; Esliger DW, 2011, MED SCI SPORT EXER, V43, P1085, DOI 10.1249/MSS.0b013e31820513be; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; O'Connor L, 2015, BRIT J NUTR, V114, P1286, DOI 10.1017/S000711451500269X; Stegle O, 2008, IEEE T BIO-MED ENG, V55, P2143, DOI 10.1109/TBME.2008.923118; Strath SJ, 2005, MED SCI SPORT EXER, V37, pS563, DOI 10.1249/01.mss.0000185650.68232.3f; Thompson D, 2006, J NUTR, V136, P1037, DOI 10.1093/jn/136.4.1037; Troiano R, 2012, P 8 INT C DIET ACT M; UK Biobank, 2009, CAT 2 ENH PHEN BAS A; van Hees VT, 2014, J APPL PHYSIOL, V117, P738, DOI 10.1152/japplphysiol.00421.2014; van Hees VT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061691; van Hees VT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022922; Villars C, 2012, J APPL PHYSIOL, V113, P1763, DOI 10.1152/japplphysiol.01413.2011; Wareham NJ, 2002, INT J EPIDEMIOL, V31, P168, DOI 10.1093/ije/31.1.168; Wijndaele K, 2015, MED SCI SPORT EXER, V47, P2129, DOI 10.1249/MSS.0000000000000661	20	55	56	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167472	10.1371/journal.pone.0167472	http://dx.doi.org/10.1371/journal.pone.0167472			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936024	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100104
J	ten Berge, JC; van Rosmalen, J; Vermeer, J; Hellstrom, C; Lindskog, C; Nilsson, P; Qundos, U; Rothova, A; Schreurs, MWJ				ten Berge, Josianne C.; van Rosmalen, Joost; Vermeer, Jacolien; Hellstrom, Cecilia; Lindskog, Cecilia; Nilsson, Peter; Qundos, Ulrika; Rothova, Aniki; Schreurs, Marco W. J.			Serum Autoantibody Profiling of Patients with Paraneoplastic and Non-Paraneoplastic Autoimmune Retinopathy	PLOS ONE			English	Article							MELANOMA-ASSOCIATED RETINOPATHY; CANCER-ASSOCIATED RETINOPATHY; ANTI-RETINAL ANTIBODIES; ANTIRETINAL ANTIBODIES; MULTIPLE-SCLEROSIS; CATION CHANNELS; BINDING PROTEIN; BIPOLAR CELLS; RECOVERIN; RECEPTOR	Purpose Although multiple serum antiretinal autoantibodies (ARAs) have been reported in patients with paraneoplastic and non-paraneoplastic autoimmune retinopathy ((n)pAIR), not all retinal antigens involved in (n)pAIR are specified. This study aims to serologically identify patients with presumed (n)pAIR through determination of both known and unknown ARAs by autoantibody profiling. Methods An antigen suspension bead array using 188 different antigens representing 97 ocular proteins was performed to detect ARAs in serum samples of patients with presumed (n)pAIR (n = 24), uveitis (n = 151) and cataract (n = 21). Logistic regressions were used to estimate the associations between ocular antigens and diagnosis. Validation of interphotoreceptor matrix proteoglycan 2 (IMPG2) and recoverin antigens was performed by immunohistochemistry and immunoblot, respectively. Results Samples of patients with presumed (n)pAIR exhibited a broad spectrum of ARAs. We identified retinal antigens that have already been described previously (e.g. recoverin), but also identified novel ARA targets. Most ARAs were not specific for (n)pAIR since their presence was also observed in patients with cataract or uveitis. High titers of autoantibodies directed against photoreceptor-specific nuclear receptor and retinol-binding protein 3 were more common in patients with presumed (n)pAIR compared to uveitis (p = 0.015 and p = 0.018, respectively). The presence of all other ARAs did not significantly differ between groups. In patients with presumed (n)pAIR, anti-recoverin autoantibodies were the most prevalent ARAs. Validation of bead array results by immunohistochemistry (anti-IMPG2) and immunoblot (anti-recoverin) showed concordant results in (n)pAIR patients. Conclusions Patients with (n)pAIR are characterized by the presence of a broad spectrum of ARAs. The diagnosis of (n)pAIR cannot be based on the mere presence of serum ARAs, as these are also commonly present in uveitis as well as in age-related cataract patients.	[ten Berge, Josianne C.; Rothova, Aniki] Erasmus Univ, Med Ctr, Dept Ophthalmol, Rotterdam, Netherlands; [van Rosmalen, Joost] Erasmus Univ, Med Ctr, Dept Biostat, Rotterdam, Netherlands; [Vermeer, Jacolien; Schreurs, Marco W. J.] Erasmus Univ, Med Ctr, Dept Immunol, Rotterdam, Netherlands; [Hellstrom, Cecilia; Nilsson, Peter; Qundos, Ulrika] KTH Royal Inst Technol, Sch Biotechnol, SciLifeLab, Affin Prote, Stockholm, Sweden; [Lindskog, Cecilia] Uppsala Univ, SciLifeLab, Dept Immunol Genet & Pathol, Uppsala, Sweden	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Royal Institute of Technology; SciLifeLab; SciLifeLab; Uppsala University	ten Berge, JC (corresponding author), Erasmus Univ, Med Ctr, Dept Ophthalmol, Rotterdam, Netherlands.	j.tenberge@erasmusmc.nl	Lindskog, Cecilia/AAE-5462-2019; Nilsson, Peter/E-4547-2010; Lindskog, Cecilia/AAO-2441-2021	Nilsson, Peter/0000-0002-4657-8532; Lindskog, Cecilia/0000-0001-5611-1015	Stichting Lijf en Leven	Stichting Lijf en Leven	This research was supported by Stichting Lijf en Leven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamus G, 1996, CLIN IMMUNOL IMMUNOP, V78, P120, DOI 10.1006/clin.1996.0021; Adamus Grazyna, 2004, BMC Ophthalmol, V4, P5, DOI 10.1186/1471-2415-4-5; Adamus G, 2011, J OPHTHALMIC INFLAMM, V1, P111, DOI 10.1007/s12348-011-0028-8; Adamus Grazyna, 2002, Int Rev Immunol, V21, P209, DOI 10.1080/08830180212068; Adamus G, 2009, EXP MOL PATHOL, V87, P195, DOI 10.1016/j.yexmp.2009.08.003; Adamus G, 2009, J AUTOIMMUN, V32, P133, DOI 10.1016/j.jaut.2009.02.001; Adamus G, 2009, AUTOIMMUN REV, V8, P410, DOI 10.1016/j.autrev.2009.01.002; Ayoglu B, 2016, BIOANALYSIS, V8, P1105, DOI 10.4155/bio.16.31; Ayoglu B, 2016, P NATL ACAD SCI USA, V113, P2188, DOI 10.1073/pnas.1518553113; Ayoglu B, 2013, MOL CELL PROTEOMICS, V12, P2657, DOI 10.1074/mcp.M112.026757; Bazhin AV, 2009, INT J CANCER, V124, P140, DOI 10.1002/ijc.23909; Bazhin AV, 2004, LUNG CANCER, V44, P193, DOI 10.1016/j.lungcan.2003.10.006; Bianciotto C, 2010, BRIT J OPHTHALMOL, V94, P1684, DOI 10.1136/bjo.2008.151480; Braithwaite T, 2014, AUTOIMMUN REV, V13, P534, DOI 10.1016/j.autrev.2014.01.039; Cai Y, 2014, OCUL IMMUNOL INFLAMM, V22, P330, DOI 10.3109/09273948.2013.836543; Comlekoglu DU, 2013, CURR OPIN OPHTHALMOL, V24, P598, DOI 10.1097/ICU.0b013e3283654e1e; Coon SL, 1996, GENOMICS, V34, P76, DOI 10.1006/geno.1996.0243; Dhingra A, 2011, J NEUROSCI, V31, P3962, DOI 10.1523/JNEUROSCI.6007-10.2011; Eksandh L, 2008, ARCH OPHTHALMOL-CHIC, V126, P432, DOI 10.1001/archopht.126.3.432; Faez S, 2013, JAMA OPHTHALMOL, V131, P113, DOI 10.1001/jamaophthalmol.2013.574; Ferreyra HA, 2009, ARCH OPHTHALMOL-CHIC, V127, P390, DOI 10.1001/archophthalmol.2009.24; Flynn MF FG, 2000, ARVO; Forooghian F, 2008, AM J OPHTHALMOL, V146, P489, DOI 10.1016/j.ajo.2008.05.046; Forooghian F, 2015, JAMA OPHTHALMOL, V133, P744, DOI 10.1001/jamaophthalmol.2015.0812; Fox AR, 2016, AM J OPHTHALMOL; Grange L, 2014, AM J OPHTHALMOL, V157, P266, DOI 10.1016/j.ajo.2013.09.019; Grewal DS, 2014, RETINA-J RET VIT DIS, V34, P827, DOI 10.1097/IAE.0000000000000119; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Haggmark A, 2015, AM J RESP CRIT CARE, V191, P574, DOI 10.1164/rccm.201407-1341OC; Hartmann TB, 2005, INT J CANCER, V114, P88, DOI 10.1002/ijc.20762; Heckenlively JR, 2008, SEMIN IMMUNOPATHOL, V30, P127, DOI 10.1007/s00281-008-0114-7; Heckenlively JR, 1999, AM J OPHTHALMOL, V127, P565, DOI 10.1016/S0002-9394(98)00446-2; Kampf C, 2012, JOVE-J VIS EXP, DOI 10.3791/3620; Kikuchi T, 2000, J NEUROIMMUNOL, V103, P26, DOI 10.1016/S0165-5728(99)00163-0; Kobayashi M, 1999, P NATL ACAD SCI USA, V96, P4814, DOI 10.1073/pnas.96.9.4814; Kondo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019911; KORF HW, 1992, ACTA NEUROPATHOL, V83, P482, DOI 10.1007/BF00310024; Lu Y, 2009, ARCH OPHTHALMOL-CHIC, V127, P1572, DOI 10.1001/archophthalmol.2009.311; Miyagawa Y, 2003, BIOCHEM BIOPH RES CO, V300, P669, DOI 10.1016/S0006-291X(02)02888-7; Nakamura M, 2010, MOL VIS, V16, P425; Ohguro HN, 1999, INVEST OPHTH VIS SCI, V40, P82; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Persson A, 2006, CURR OPIN MOL THER, V8, P185; POLANS AS, 1995, P NATL ACAD SCI USA, V92, P9176, DOI 10.1073/pnas.92.20.9176; Potter MJ, 2002, AM J OPHTHALMOL, V134, P128, DOI 10.1016/S0002-9394(02)01431-9; Shimazaki K, 2008, J NEURO-OPHTHALMOL, V28, P5, DOI 10.1097/WNO.0b013e318167549f; Team RC, 2013, LANG ENV STAT COMP 2; Ten Berge JC, 2016, ACTA OPHTHALMOL; THIRKILL CE, 1992, INVEST OPHTH VIS SCI, V33, P2768; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Wang YJ, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-56	51	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167909	10.1371/journal.pone.0167909	http://dx.doi.org/10.1371/journal.pone.0167909			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930731	gold, Green Published, Green Submitted			2022-12-27	WOS:000389580900058
J	Fernandez-Gallardo, M; Gonzalez-Ramirez, R; Sandoval, A; Felix, R; Monjaraz, E				Fernandez-Gallardo, Miriam; Gonzalez-Ramirez, Ricardo; Sandoval, Alejandro; Felix, Ricardo; Monjaraz, Eduardo			Adenosine Stimulate Proliferation and Migration in Triple Negative Breast Cancer Cells	PLOS ONE			English	Article							GATED SODIUM-CHANNEL; RECEPTOR EXPRESSION; GROWTH; A(2B); MICROENVIRONMENT; PHARMACOLOGY; ACTIVATION; NAV1.5; LINES	Emerging evidence suggests that the adenosine (Ado) receptors may play crucial roles in tumor progression. Here, we show that Ado increases proliferation and migration in a triple negative breast cancer model, the MDA-MB 231 cell line. The use of specific agonists and antagonists evidenced that these effects depend on the activation of the A(2B) receptor, which then triggers an intracellular response mediated by the adenylate cyclase/PKA/cAMP signaling pathway. Ado also increases the expression of Na(V)1.5 channels, a potential bio-marker in breast cancer. Together, these data suggest important roles of the A(2B) receptors and Na(V)1.5 channels in the Ado-induced increase in proliferation and migration of the MDA-MB 231 cells.	[Fernandez-Gallardo, Miriam; Monjaraz, Eduardo] Benemerita Univ Autonoma Puebla BUAP, Lab Neuroendocrinol Mol, Puebla, Mexico; [Gonzalez-Ramirez, Ricardo] Hosp Gen Dr Manuel Gea Gonzalez, Dept Biol Mol & Histocompatibilidad, Secretaria Salud, Ciudad De Mexico, Mexico; [Sandoval, Alejandro] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Tlalnepantla, Mexico; [Felix, Ricardo] Inst Politecn Nacl Cinvestav IPN, Ctr Invest & Estudios Avanzados, Dept Biol Celular, Ciudad De Mexico, Mexico	Benemerita Universidad Autonoma de Puebla; Universidad Nacional Autonoma de Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Monjaraz, E (corresponding author), Benemerita Univ Autonoma Puebla BUAP, Lab Neuroendocrinol Mol, Puebla, Mexico.	emguzman360@hotmail.com	Felix, Ricardo/A-6989-2008; González-Ramírez, Ricardo/O-1792-2014	Felix, Ricardo/0000-0002-5383-7176; González-Ramírez, Ricardo/0000-0003-1399-8036; Sandoval, Alejandro/0000-0002-8558-6033	National Council for Science and Technology (Conacyt, Mexico) [221660]	National Council for Science and Technology (Conacyt, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was partially supported by funds from The National Council for Science and Technology (Conacyt, Mexico; Grant 221660) to RF.	Aherne CM, 2011, BBA-BIOMEMBRANES, V1808, P1329, DOI 10.1016/j.bbamem.2010.05.016; Bieber D., 2008, NAUNYN SCHMIEDEBERGS, V377, P1; Blay J, 1997, CANCER RES, V57, P2602; Brackenbury WJ, 2007, BREAST CANCER RES TR, V101, P149, DOI 10.1007/s10549-006-9281-1; Burnstock G, 2002, ARTERIOSCL THROM VAS, V22, P364, DOI 10.1161/hq0302.105360; Decking UKM, 1997, CIRC RES, V81, P154, DOI 10.1161/01.RES.81.2.154; Dominguez B, 2009, AM J PHYSIOL-ENDOC M, V296, pE1148, DOI 10.1152/ajpendo.90954.2008; Dubey RK, 2002, HYPERTENSION, V39, P530, DOI 10.1161/hy0202.103075; Feoktistov I, 2003, CIRC RES, V92, P485, DOI 10.1161/01.RES.0000061572.10929.2D; Feoktistov I, 2002, CIRC RES, V90, P531, DOI 10.1161/01.RES.0000012203.21416.14; Fraser SP, 2005, CLIN CANCER RES, V11, P5381, DOI 10.1158/1078-0432.CCR-05-0327; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fredholm BB, 2010, EXP CELL RES, V316, P1284, DOI 10.1016/j.yexcr.2010.02.004; Gao R, 2010, ONCOL REP, V23, P1293, DOI 10.3892/or_00000763; Gessi S, 2007, J CELL PHYSIOL, V211, P826, DOI 10.1002/jcp.20994; Gessi S, 2011, BBA-BIOMEMBRANES, V1808, P1400, DOI 10.1016/j.bbamem.2010.09.020; Ghiringhelli F, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/473712; Gorlach A, 2009, CURR PHARM DESIGN, V15, P3844, DOI 10.2174/138161209789649420; Headrick JP, 2013, PHARMACOL THERAPEUT, V140, P92, DOI 10.1016/j.pharmthera.2013.06.002; HOSKIN DW, 1994, INT J CANCER, V59, P854, DOI 10.1002/ijc.2910590625; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; Merighi S, 2003, PHARMACOL THERAPEUT, V100, P31, DOI 10.1016/S0163-7258(03)00084-6; Mittal D, 2016, CANCER RES, V76, P4372, DOI 10.1158/0008-5472.CAN-16-0544; Mujoomdar M, 2004, J CELL PHYSIOL, V201, P429, DOI 10.1002/jcp.20089; Onkal R, 2009, EUR J PHARMACOL, V625, P206, DOI 10.1016/j.ejphar.2009.08.040; Panjehpour M, 2005, BRIT J PHARMACOL, V145, P211, DOI 10.1038/sj.bjp.0706180; Poth JM, 2013, J MOL MED, V91, P183, DOI 10.1007/s00109-012-0988-7; Quezada C, 2013, J CELL PHYSIOL, V228, P602, DOI 10.1002/jcp.24168; ROY ML, 1992, J NEUROSCI, V12, P2104; Schneider BP, 2008, CLIN CANCER RES, V14, P8010, DOI 10.1158/1078-0432.CCR-08-1208; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Spychala J, 2000, PHARMACOL THERAPEUT, V87, P161, DOI 10.1016/S0163-7258(00)00053-X; Stagg J, 2010, P NATL ACAD SCI USA, V107, P1547, DOI 10.1073/pnas.0908801107; Zhi XL, 2012, IUBMB LIFE, V64, P911, DOI 10.1002/iub.1086	34	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167445	10.1371/journal.pone.0167445	http://dx.doi.org/10.1371/journal.pone.0167445			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911956	Green Published, gold, Green Submitted			2022-12-27	WOS:000389520600034
J	Gouda, HN; Hodge, A; Bermejo, R; Zeck, W; Jimenez-Soto, E				Gouda, Hebe N.; Hodge, Andrew; Bermejo, Raoul, III; Zeck, Willibald; Jimenez-Soto, Eliana			The Impact of Healthcare Insurance on the Utilisation of Facility-Based Delivery for Childbirth in the Philippines	PLOS ONE			English	Article							PROPENSITY SCORE; INSTITUTIONAL DELIVERY; MATCHING ESTIMATORS; POOR; SCHEMES; HOMEOWNERSHIP; SERVICES; PROGRAM; EQUITY; BIAS	Objectives In recent years, the government of the Philippines embarked upon an ambitious Universal Health Care program, underpinned by the rapid scale-up of subsidized insurance coverage for poor and vulnerable populations. With a view of reducing the stubbornly high maternal mortality rates in the country, the program has a strong focus on maternal health services and is supported by a national policy of universal facility-based delivery (FBD). In this study, we examine the impact that recent reforms expanding health insurance coverage have had on FBD. Results Data from the most recent Philippines 2013 Demographic Health Survey was employed. This study applies quasi-experimental methods using propensity scores along with alternative matching techniques and weighted regression to control for self-selection and investigate the impact of health insurance on the utilization of FBD. Findings Our findings reveal that the likelihood of FBD for women who are insured is between 5 to 10 percent higher than for those without insurance. The impact of health insurance is more pronounced amongst rural and poor women for whom insurance leads to a 9 to 11 per cent higher likelihood of FBD. Conclusions We conclude that increasing health insurance coverage is likely to be an effective approach to increase women's access to FBD. Our findings suggest that when such coverage is subsidized, as it is the case in the Philippines, women from poor and rural populations are likely to benefit the most.	[Gouda, Hebe N.; Hodge, Andrew] Univ Queensland, Sch Publ Hlth, Publ Hlth Bldg, Brisbane, Qld, Australia; [Gouda, Hebe N.] Queensland Ctr Mental Hlth Res, Pk Ctr Mental Hlth, Wacol, Qld, Australia; [Bermejo, Raoul, III; Zeck, Willibald] UNICEF Philippines Country Off, Manila, Philippines; [Bermejo, Raoul, III] Inst Trop Med, Antwerp, Belgium; [Zeck, Willibald] Med Univ Graz, Dept Obstet & Gynaecol, Graz, Austria; [Jimenez-Soto, Eliana] Abt Associates Inc, Brisbane, Qld, Australia	University of Queensland; Queensland Centre for Mental Health Research; Institute of Tropical Medicine (ITM); Medical University of Graz; ABT Associates	Gouda, HN (corresponding author), Univ Queensland, Sch Publ Hlth, Publ Hlth Bldg, Brisbane, Qld, Australia.; Gouda, HN (corresponding author), Queensland Ctr Mental Hlth Res, Pk Ctr Mental Hlth, Wacol, Qld, Australia.	h.gouda@uq.edu.au		Gouda, Hebe/0000-0002-5709-4509				Aali B. S., 2005, Eastern Mediterranean Health Journal, V11, P663; Abadie A, MATCHING ESTIMATED P; Abadie A, 2011, J BUS ECON STAT, V29, P1, DOI 10.1198/jbes.2009.07333; Agha S, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-31; Aldaba B, 2011, PHILIPPINES SCALE RE; [Anonymous], 2014, REP OP WORK GROUP GE; [Anonymous], 2014, NAT DEM HLTH SURV 20; [Anonymous], 2015, JOINT LEARNING NETWO; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Blundell R., 2000, FISC STUD, V21, P427, DOI [DOI 10.1111/J.1475-5890.2000.TB00031.X, 10.1111/j.1475-5890.2000.tb00031.x]; Bohren MA, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-71; Bredenkamp C, 2015, 7258 POL RES; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Comfort AB, 2013, J HEALTH POPUL NUTR, V31, P81; Do M, 2015, MATERN CHILD HLTH J, V19, P755, DOI 10.1007/s10995-014-1561-5; Dzakpasu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049430; Filipski MJ, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0871-7; Freedman DA, 2008, EVALUATION REV, V32, P392, DOI 10.1177/0193841X08317586; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Giedion U, 2010, IMPACT OF HEALTH INSURANCE IN LOW- AND MIDDLE-INCOME COUNTRIES, P155; Grinstein-Weiss M, 2013, SOC WORK RES, V37, P37, DOI 10.1093/swr/svs035; Grinstein-Weiss M, 2012, URBAN STUD, V49, P3545, DOI 10.1177/0042098012443861; Heckman JJ, 1997, REV ECON STUD, V64, P605, DOI 10.2307/2971733; Hindle D, 2001, Aust Health Rev, V24, P96; Hirano K., 2001, HLTH SERVICES OUTCOM, V2, P259, DOI [10.1023/A:1020371312283, DOI 10.1023/A:1020371312283]; Jones Andrew., 2007, APPL ECONOMETRICS HL; Jutting JP, 2004, WORLD DEV, V32, P273, DOI 10.1016/j.worlddev.2003.10.001; Kesterton AJ, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-30; Kozhimannil KB, 2009, HEALTH POLICY, V92, P55, DOI 10.1016/j.healthpol.2009.02.009; Kruk ME, 2015, TROP MED INT HEALTH, V20, P1057, DOI 10.1111/tmi.12518; Liao Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152091; Lu CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039282; Mayne SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144962; Mensah J, 2010, HEALTH ECON, V19, P95, DOI 10.1002/hec.1633; Murray CJ, 2014, LANCET; Ndao-Brumblay SK, 2012, HLTH POLICY PLANNING; Obermann K, 2006, SOC SCI MED, V62, P3177, DOI 10.1016/j.socscimed.2005.11.047; Parmar D, 2014, HEALTH POLICY PLANN, V29, P76, DOI 10.1093/heapol/czs136; Patrick AR, 2011, PHARMACOEPIDEM DR S, V20, P551, DOI 10.1002/pds.2098; Quick Jonathan, 2014, PLoS Med, V11, pe1001580, DOI 10.1371/journal.pmed.1001580; Quimbo S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003379; Ravallion M, 2008, HBK ECON, V9, P3787, DOI 10.1016/S1573-4471(07)04059-4; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Rutstein SO, 2004, DHS WEALTH INDEX DHS, V6; Sachs JD, 2012, LANCET, V380, P944, DOI 10.1016/S0140-6736(12)61149-0; Sedgwick P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1286; Singh K, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0762-y; Smith JA, 2005, J ECONOMETRICS, V125, P305, DOI 10.1016/j.jeconom.2004.04.011; Sparrow R, 2013, SOC SCI MED, V96, P264, DOI 10.1016/j.socscimed.2012.09.043; Tobe M, 2013, HEALTH POLICY PLANN, V28, P536, DOI 10.1093/heapol/czs092; Vogel JP, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0047-2; Wang W., 2014, HLTH INSURANCE COVER; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; World Bank, 2011, TRANSF PHIL HLTH SEC; Zhou ZX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112918; Zhou ZL, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-23	61	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167268	10.1371/journal.pone.0167268	http://dx.doi.org/10.1371/journal.pone.0167268			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3TF	27911935	Green Submitted, Green Published, gold			2022-12-27	WOS:000389520600027
J	Lazarus, L; Patel, S; Shaw, A; Leblanc, S; Lalonde, C; Hladio, M; Mandryk, K; Horvath, C; Petrcich, W; Kendall, C; Tyndall, MW				Lazarus, Lisa; Patel, Sheetal; Shaw, Ashley; Leblanc, Sean; Lalonde, Christine; Hladio, Manisha; Mandryk, Kira; Horvath, Cynthia; Petrcich, William; Kendall, Claire; Tyndall, Mark W.		Proud Community Advisory Comm	Uptake of Community-Based Peer Administered HIV Point-of-Care Testing: Findings from the PROUD Study	PLOS ONE			English	Article							INJECTION-DRUG USERS; PREVENTION INTERVENTION; EXPANDING ACCESS; HEALTH-CARE; SEX WORKERS; CANADA; SETTINGS	Objectives HIV prevalence among people who inject drugs (PWID) in Ottawa is estimated at about 10%. The successful integration of peers into outreach efforts and wider access to HIV point-of-care testing (POCT) create opportunities to explore the role of peers in providing HIV testing. The PROUD study, in partnership with Ottawa Public Health (OPH), sought to develop a model for community-based peer-administered HIV POCT. Methods PROUD draws on community-based participatory research methods to better understand the HIV risk environment of people who use drugs in Ottawa. From March-October 2013, 593 people who reported injecting drugs or smoking crack cocaine were enrolled through street-based recruitment. Trained peer or medical student researchers administered a quantitative survey and offered an HIV POCT (bioLytical INSTI test) to participants who did not self-report as HIV positive. Results 550 (92.7%) of the 593 participants were offered a POCT, of which 458 (83.3%) consented to testing. Of those participants, 74 (16.2%) had never been tested for HIV. There was no difference in uptake between testing offered by a peer versus a non-peer interviewer (OR = 1.05; 95% CI = 0.67-1.66). Despite testing those at high risk for HIV, only one new reactive test was identified. Conclusion The findings from PROUD demonstrate high uptake of community-based HIV POCT. Peers were able to successfully provide HIV POCT and reach participants who had not previously been tested for HIV. Community-based and peer testing models provide important insights on ways to scale-up HIV prevention and testing among people who use drugs.	[Lazarus, Lisa; Patel, Sheetal; Shaw, Ashley; Petrcich, William; Kendall, Claire; Tyndall, Mark W.] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Leblanc, Sean; Lalonde, Christine] PROUD Community Advisory Comm, Ottawa, ON, Canada; [Leblanc, Sean] Drug Users Advocacy League, Ottawa, ON, Canada; [Hladio, Manisha] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Mandryk, Kira; Horvath, Cynthia] Ottawa Publ Hlth, Ottawa, ON, Canada; [Kendall, Claire] Univ Ottawa, Bruyere Res Inst, Dept Family Med, CT Lamont Primary Hlth Care Res Ctr, Ottawa, ON, Canada; [Tyndall, Mark W.] Univ Ottawa, Ottawa Hosp, Div Infect Dis, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Lazarus, L (corresponding author), Ottawa Hosp Res Inst, Ottawa, ON, Canada.	lis_laz@yahoo.com		Tyndall, Mark/0000-0003-4450-5679; Kendall, Claire/0000-0003-2686-1135	Canadian Institutes of Health Research [FRN 134048]; Ontario HIV Treatment Network; Ottawa Hospital, Department of Medicine and Division of Infectious Diseases	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network; Ottawa Hospital, Department of Medicine and Division of Infectious Diseases	Funding has been received for this work from the Canadian Institutes of Health Research (FRN 134048; http.//www.cihr-irsc.gc.ca/e/193.html), the Ontario HIV Treatment Network (http.//www.ohtn.on.ca), and The Ottawa Hospital, Department of Medicine and Division of Infectious Diseases (https://www.ottawahospital.on.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Barry D, 2011, J Int AIDS Soc, V14 Suppl 2, pS2, DOI 10.1186/1758-2652-14-S2-S2; Bowles KE, 2008, PUBLIC HEALTH REP, V123, P78, DOI 10.1177/00333549081230S310; Champenois K, 2012, BMJ OPEN, V2, DOI [10.1136/bmjopen-2011-000693, DOI 10.1136/bmjopen-2011-000693]; Coupland H, 2005, INT J DRUG POLICY, V16, P191, DOI 10.1016/j.drugpo.2004.12.002; Davidson P, 2012, AM J PUBLIC HEALTH, V102, P1254, DOI 10.2105/AJPH.2011.300418; Dickson-Gomez J, 2006, SUBST USE MISUSE, V41, P669, DOI 10.1080/10826080500411403; Girardi E, 2007, JAIDS-J ACQ IMM DEF, V46, pS3, DOI 10.1097/01.qai.0000286597.57066.2b; Gordon MS, 2013, AIDS BEHAV, V17, P2022, DOI 10.1007/s10461-013-0456-6; Grigoryan A, 2009, PLOS ONE, V4, pe4445, DOI DOI 10.1371/JOURNAL.PONE.0004445; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Johnston KM, 2010, AIDS, V24, P1929, DOI 10.1097/QAD.0b013e32833af85d; Kim SR, 2015, INT J GYNECOL OBSTET, V128, P201, DOI 10.1016/j.ijgo.2014.09.026; Kouyoumdjian F, 2016, CAN FAM PHYSICIAN, V62, P215; Latkin C A, 1998, Public Health Rep, V113 Suppl 1, P151; Laupland KB, 2012, CAN J INFECT DIS MED, V23, P106, DOI 10.1155/2012/297530; Lazarus L, 2014, HARM REDUCT J, V11, DOI 10.1186/1477-7517-11-26; Lazarus L, 2012, CULT HEALTH SEX, V14, P139, DOI 10.1080/13691058.2011.628411; Marwick N, 2014, J EPIDEMIOL COMMUNIT, V68, P675, DOI [10.1136/jech-2013-203707, DOI 10.1136/JECH-2013-203707]; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Ottawa Public Health, 2014, OV HIV HEP C INF PEO; Ottawa Public Health, 2013, SUBST MIS OTT; Pujol F, 2010, INT AIDS C VIENN AUS, P18; Remis RS, 2012, REPORT HIV AIDS ONTA; Rhodes T., 2002, INT J DRUG POLICY, V13, P85, DOI [10.1016/S0955-3959(02)00007-5, DOI 10.1016/S0955-3959(02)00007-5]; Ruutel K, 2012, SCAND J PUBLIC HEALT, V40, P629, DOI 10.1177/1403494812458987; Tobin KE, 2011, ADDICTION, V106, P366, DOI 10.1111/j.1360-0443.2010.03146.x; Tolson M., 2011, SEEK TREAT OPTIMALLY; Walter SD, 2000, J CLIN EPIDEMIOL, V53, P931, DOI 10.1016/S0895-4356(00)00210-9; Wood E, 2008, AIDS, V22, P1247, DOI 10.1097/QAD.0b013e3282fbd1ed; Yan HJ, 2014, SEX TRANSM INFECT, V90, P388, DOI 10.1136/sextrans-2013-051397	30	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0166942	10.1371/journal.pone.0166942	http://dx.doi.org/10.1371/journal.pone.0166942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3TF	27911908	Green Published, Green Submitted, gold			2022-12-27	WOS:000389520600017
J	Orfano, AS; Duarte, APM; Molina-Cruz, A; Pimenta, PF; Barillas-Mury, C				Orfano, Alessandra S.; Duarte, Ana Paula M.; Molina-Cruz, Alvaro; Pimenta, Paulo F.; Barillas-Mury, Carolina			Plasmodium yoelii nigeriensis (N67) Is a Robust Animal Model to Study Malaria Transmission by South American Anopheline Mosquitoes	PLOS ONE			English	Article							COMPLEMENT; SUSCEPTIBILITY; DETERMINANT; AQUASALIS; DARLINGI; IMMUNITY; EVASION; VECTOR	Malaria is endemic in the American continent and the Amazonian rainforest is the region with the highest risk of transmission. However, the lack of suitable experimental models to infect malaria vectors from the Americas has limited the progress to understand the biology of transmission in this region. Anopheles aquasalis, a major vector in coastal areas of South America, was found to be highly refractory to infection with two strains of Plasmodium falciparum (NF54 and 7G8) and with Plasmodium berghei (mouse malaria), even when the micro biota was eliminated with antibiotics and oxidative stress was reduced with uric acid. In contrast, An. aquasalis females treated with antibiotics and uric acid are susceptible to infection with a second murine parasite, Plasmodium yoelii nigeriensis N67 (PyN67). Anopheles albimanus, one of the main malaria vectors in Central America, Southern Mexico and the Caribbean, was more susceptible to infection with PyN67 than An. aquasalis, even in the absence of any pre-treatment, but was still less susceptible than Anopheles stephensi. Disruption of the complement-like system in An. albimanus significantly enhanced PyN67 infection, indicating that the mosquito immune system is mounting effective antiplasmodial responses. PyN67 has the ability to infect a broad range of anophelines and is an excellent model to study malaria transmission by South American vectors.	[Orfano, Alessandra S.; Duarte, Ana Paula M.; Molina-Cruz, Alvaro; Barillas-Mury, Carolina] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA; [Orfano, Alessandra S.; Duarte, Ana Paula M.; Pimenta, Paulo F.] Fundacao Oswaldo Cruz FIOCRUZ, Ctr Pesquisas Rene Rachou, Lab Med Entomol, Belo Horizonte, MG, Brazil; [Duarte, Ana Paula M.; Pimenta, Paulo F.] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fundacao Oswaldo Cruz	Molina-Cruz, A; Barillas-Mury, C (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.; Pimenta, PF (corresponding author), Fundacao Oswaldo Cruz FIOCRUZ, Ctr Pesquisas Rene Rachou, Lab Med Entomol, Belo Horizonte, MG, Brazil.; Pimenta, PF (corresponding author), Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.	amolina-cruz@niaid.nih.gov; pimenta@cpqrr.fiocruz.br; cbarillas@niaid.nih.gov	Pimenta, Paulo/AAH-1502-2020		Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Conselho Nacional de Desenvolvimento Tecnologico (CNPq-PAPES); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacoes de Amparo a Pesquisas do Amazonas e de Minas Gerais (FAPEAM e FAPEMIG); FIOCRUZ; CNPq; CAPES post-doctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000947] Funding Source: NIH RePORTER	Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Conselho Nacional de Desenvolvimento Tecnologico (CNPq-PAPES); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacoes de Amparo a Pesquisas do Amazonas e de Minas Gerais (FAPEAM e FAPEMIG); FIOCRUZ; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES post-doctoral fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health and the following Brazilian agencies: Conselho Nacional de Desenvolvimento Tecnologico (CNPq-PAPES), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and the Fundacoes de Amparo a Pesquisas do Amazonas e de Minas Gerais (FAPEAM e FAPEMIG). ASO was supported by PhD fellowships from FIOCRUZ and CNPq; and APMD by a CAPES post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahia AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057014; Bahia AC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001317; Billker O, 1997, PARASITOLOGY, V115, P1, DOI 10.1017/S0031182097008895; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Contreras-Garduno J, 2015, DEV COMP IMMUNOL, V52, P172, DOI 10.1016/j.dci.2015.05.004; da Silva ANM, 2006, MEM I OSWALDO CRUZ, V101, P547, DOI 10.1590/S0074-02762006000500011; DeJong RJ, 2007, P NATL ACAD SCI USA, V104, P2121, DOI 10.1073/pnas.0608407104; FELDMANN AM, 1989, MED VET ENTOMOL, V3, P41, DOI 10.1111/j.1365-2915.1989.tb00473.x; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Garver LS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002737; Gendrin M, 2015, NATURE COMMUNICATION, V6, DOI [10.1073/pnas.0608407104, DOI 10.1073/PNAS.0608407104]; Harbach RE, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P3, DOI 10.5772/54695; Horosko S, 1997, J AM MOSQUITO CONTR, V13, P95; Jaramillo-Gutierrez G, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-154; Laubach HE, 2001, W INDIAN MED J, V50, P319; Molina-Cruz A, 2012, P NATL ACAD SCI US; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Molina-Cruz A, 2015, P NATL ACAD SCI USA, V112, P15178, DOI 10.1073/pnas.1520426112; Molina-Cruz A, 2013, SCIENCE, V340, P984, DOI 10.1126/science.1235264; Moreno M, 2014, AM J TROP MED HYG, V90, P612, DOI 10.4269/ajtmh.13-0708; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Pimenta PFP, 2015, MEM I OSWALDO CRUZ, V110, P23, DOI 10.1590/0074-02760140266; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Reidenbach KR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-298; VALENCIO DA, 1969, NATURE, V223, P1353, DOI 10.1038/2231353a0; WHO, 2013, WORLD MALARIA REPORT 2013, P1; World Health Organization, 2015, WORLD MAL REP 2015; Zerpa Noraida, 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P173, DOI 10.1590/S0036-46651998000300007	28	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167178	10.1371/journal.pone.0167178	http://dx.doi.org/10.1371/journal.pone.0167178			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911924	gold, Green Published, Green Submitted			2022-12-27	WOS:000389520600025
J	Song, DG; Pan, KW; Tariq, A; Azizullah, A; Sun, F; Li, ZL; Xiong, QL				Song, Dagang; Pan, Kaiwen; Tariq, Akash; Azizullah, Azizullah; Sun, Feng; Li, Zilong; Xiong, Qinli			Adsorptive Removal of Toxic Chromium from Waste-Water Using Wheat Straw and Eupatorium adenophorum	PLOS ONE			English	Article							AQUEOUS-SOLUTIONS; AGRICULTURAL WASTE; ACTIVATED CARBON; HEXAVALENT CHROMIUM; CR(VI); BIOSORPTION; CU(II); THERMODYNAMICS; REDUCTION; KINETICS	Environmental pollution with heavy metals is a serious issue worldwide posing threats to humans, animals and plants and to the stability of overall ecosystem. Chromium (Cr) is one of most hazardous heavy metals with a high carcinogenic and recalcitrant nature. Aim of the present study was to select low-cost biosorbent using wheat straw and Eupatorium adenophorum through simple carbonization process, capable of removing Cr (VI) efficiently from wastewater. From studied plants a low cost adsorbent was prepared for removing Cr (VI) from aqueous solution following very simple carbonization method excluding activation process. Several factors such as pH, contact time, sorbent dosage and temperature were investigated for attaining ideal condition. For analysis of adsorption equilibrium isotherm data, Langmuir, Freundlich and Temkin models were used while pseudo-first-order, pseudo-second-order, external diffusion and intra-particle diffusion models were used for the analysis of kinetic data. The obtained results revealed that 99.9% of Cr (VI) removal was observed in the solution with a pH of 1.0. Among all the tested models Langmuir model fitted more closely according to the data obtained. Increase in adsorption capacity was observed with increasing temperature revealing endothermic nature of Cr (VI). The maximum Cr (VI) adsorption potential of E. adenophorum and wheat straw was 89.22 mg per 1 gram adsorbent at 308K. Kinetic data of absorption precisely followed pseudo-second-order model. Present study revealed highest potential of E. adenophorum and wheat straw for producing low cost adsorbent and to remove Cr (VI) from contaminated water.	[Song, Dagang; Pan, Kaiwen; Tariq, Akash; Sun, Feng; Li, Zilong; Xiong, Qinli] Chinese Acad Sci, Chengdu Inst Biol, Key Lab Mt Ecol Restorat & Bioresource Utilizat, Chengdu, Peoples R China; [Song, Dagang; Pan, Kaiwen; Tariq, Akash; Sun, Feng; Li, Zilong; Xiong, Qinli] Chinese Acad Sci, Chengdu Inst Biol, Ecol Restorat Biodivers Conservat Key Lab Sichuan, Chengdu, Peoples R China; [Song, Dagang; Tariq, Akash; Sun, Feng; Li, Zilong; Xiong, Qinli] Univ Chinese Acad Sci, Beijing, Peoples R China; [Azizullah, Azizullah] Kohat Univ Sci & Technol, Dept Bot, Kohat, Pakistan	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Kohat University of Science & Technology	Pan, KW; Tariq, A (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Key Lab Mt Ecol Restorat & Bioresource Utilizat, Chengdu, Peoples R China.; Pan, KW; Tariq, A (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Ecol Restorat Biodivers Conservat Key Lab Sichuan, Chengdu, Peoples R China.; Tariq, A (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	pankw@cib.ac.cn; atm_bot@hotmail.com	Tariq, Akash/AAI-9880-2020; Xiong, Qinli/Y-7212-2018	Xiong, Qinli/0000-0003-3827-3437; Pan, Kaiwen/0000-0003-1770-8219; Song, Dagang/0000-0002-0362-3591; Tariq, Akash/0000-0002-5382-9336	National Natural Science Foundation of China [31370632]; Ministry of Sciences and Technology of China [2011BAC09B04-01-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Sciences and Technology of China(Ministry of Science and Technology, China)	Present study was financially supported by National Natural Science Foundation of China (Grant No. 31370632) and by the Ministry of Sciences and Technology of China (Grant No. 2011BAC09B04-01-03).	Acar FN, 2004, BIORESOURCE TECHNOL, V94, P13, DOI 10.1016/j.biortech.2003.10.032; ALAERTS GJ, 1989, WATER SCI TECHNOL, V21, P1701, DOI 10.2166/wst.1989.0148; Bansal M, 2009, J HAZARD MATER, V162, P312, DOI 10.1016/j.jhazmat.2008.05.037; Bayrak Y, 2013, J DISPER SCI TECHNOL, V34, P1248, DOI 10.1080/01932691.2012.743347; Bhattacharya AK, 2008, CHEM ENG J, V137, P529, DOI 10.1016/j.cej.2007.05.021; Bhattacharyya KG, 2007, J COLLOID INTERF SCI, V310, P411, DOI 10.1016/j.jcis.2007.01.080; Brito F, 1997, POLYHEDRON, V16, P3835, DOI 10.1016/S0277-5387(97)00128-9; Chen JF, 2014, FRONT ENV SCI ENG, V8, P960, DOI 10.1007/s11783-013-0612-2; [陈金发 Chen Jinfa], 2013, [环境工程学报, Chinese Journal of Environmental Engineering], V7, P2197; Chen SH, 2011, CHEM ENG J, V168, P909, DOI 10.1016/j.cej.2011.01.063; COTTON FA, 1972, ADV INORGANIC CHEM C; Dakiky M, 2002, ADV ENVIRON RES, V6, P533, DOI 10.1016/S1093-0191(01)00079-X; De Lasa H, 2010, INT J CHEM REACT ENG, V8, P47; Deng LP, 2009, MINER ENG, V22, P372, DOI 10.1016/j.mineng.2008.10.006; Deveci H, 2013, J IND ENG CHEM, V19, P190, DOI 10.1016/j.jiec.2012.08.001; El Nemr A, 2009, J HAZARD MATER, V161, P132, DOI 10.1016/j.jhazmat.2008.03.093; Fu FL, 2011, J ENVIRON MANAGE, V92, P407, DOI 10.1016/j.jenvman.2010.11.011; Gao RY, 2007, J HAZARD MATER, V145, P398, DOI 10.1016/j.jhazmat.2006.11.036; Garbisu C, 1998, BIODEGRADATION, V9, P133, DOI 10.1023/A:1008358816529; Garg UK, 2007, J HAZARD MATER, V140, P60, DOI 10.1016/j.jhazmat.2006.06.056; Goyal N, 2003, ADV ENVIRON RES, V7, P311, DOI 10.1016/S1093-0191(02)00004-7; Gupta S, 2009, CHEM ENG J, V150, P352, DOI 10.1016/j.cej.2009.01.013; Gupta VK, 2009, J COLLOID INTERF SCI, V335, P24, DOI 10.1016/j.jcis.2009.03.056; Jain AK, 2004, ENVIRON SCI TECHNOL, V38, P1195, DOI 10.1021/es034412u; Khamis M, 2009, J HAZARD MATER, V169, P948, DOI 10.1016/j.jhazmat.2009.04.053; Kiran B, 2008, BIOCHEM ENG J, V38, P47, DOI 10.1016/j.bej.2007.06.007; Kobya M, 2004, BIORESOURCE TECHNOL, V91, P317, DOI 10.1016/j.biortech.2003.07.001; Li KB, 2014, CLEAN-SOIL AIR WATER, V42, P1549, DOI 10.1002/clen.201300399; Lin QY, 2013, SEP SCI TECHNOL, V48, P2843, DOI 10.1080/01496395.2013.808216; Louhab K, 2006, EUROPEAN J SCI RES; Memon JR, 2009, COLLOID SURFACE B, V70, P232, DOI 10.1016/j.colsurfb.2008.12.032; Mittal A, 2010, J COLLOID INTERF SCI, V343, P463, DOI 10.1016/j.jcis.2009.11.060; Namasivayam C, 1998, BIORESOURCE TECHNOL, V64, P77, DOI 10.1016/S0960-8524(97)86722-3; Park D, 2008, BIORESOURCE TECHNOL, V99, P8810, DOI 10.1016/j.biortech.2008.04.042; Park D, 2008, CHEM ENG J, V136, P173, DOI 10.1016/j.cej.2007.03.039; Ponou J, 2011, CHEM ENG J, V172, P906, DOI 10.1016/j.cej.2011.06.081; Praveen P, 2016, J HAZARD MATER, V314, P204, DOI 10.1016/j.jhazmat.2016.04.054; Qiu JY, 2009, J HAZARD MATER, V166, P270, DOI 10.1016/j.jhazmat.2008.11.053; Ramon GZ, 2013, CHEM ENG J, V218, P173, DOI 10.1016/j.cej.2012.12.006; Ronghua LI, 2009, ACTA SCI CIRCUMSTANT; Shanthi T, 2013, J CHEM-NY, V2013, DOI 10.1155/2013/304970; Singh KK, 2009, CHEM ENG J, V151, P113, DOI 10.1016/j.cej.2009.02.003; Stout MD, 2009, ENVIRON HEALTH PERSP, V117, P716, DOI 10.1289/ehp.0800208; Sun Kang, 2010, Scientia Silvae Sinicae, V46, P178; Tarley CRT, 2004, CHEMOSPHERE, V54, P987, DOI 10.1016/j.chemosphere.2003.09.001; Tian YH, 2007, TROP GRASSLANDS, V41, P285; Uluozlu OD, 2009, J HAZARD MATER, V172, P395, DOI 10.1016/j.jhazmat.2009.07.021; Venugopal V, 2011, CHEM ENG J, V174, P151, DOI 10.1016/j.cej.2011.08.068; Wang XS, 2008, J HAZARD MATER, V153, P1176, DOI 10.1016/j.jhazmat.2007.09.079; Wang XS, 2009, CHEM ENG J, V148, P217, DOI 10.1016/j.cej.2008.08.020; Weber WJ, 2015, J SANITARY ENG DIVIS, V89, P53	51	24	24	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167037	10.1371/journal.pone.0167037	http://dx.doi.org/10.1371/journal.pone.0167037			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911906	gold, Green Published			2022-12-27	WOS:000389520600020
J	Bassani, GA; Lonati, C; Brambilla, D; Rapido, F; Valenza, F; Gatti, S				Bassani, Giulia Alessandra; Lonati, Caterina; Brambilla, Daniela; Rapido, Francesca; Valenza, Franco; Gatti, Stefano			Ex Vivo Lung Perfusion in the Rat: Detailed Procedure and Videos	PLOS ONE			English	Article							EXPERIMENTAL-MODEL; DONOR LUNGS; TRANSPLANTATION; PRESERVATION; INCREASE; VENTILATION; EXPRESSION; EXPERIENCE; IMPROVE; INJURY	Ex vivo lung perfusion (EVLP) is a promising procedure for evaluation, reconditioning, and treatment of marginal lungs before transplantation. Small animal models can contribute to improve clinical development of this technique and represent a substantial platform for bio-molecular investigations. However, to accomplish this purpose, EVLP models must sustain a prolonged reperfusion without pharmacological interventions. Currently available protocols only partly satisfy this need. The aim of the present research was accomplishment and optimization of a reproducible model for a protracted rat EVLP in the absence of anti-inflammatory treatment. A 180 min, uninjured and untreated perfusion was achieved through a stepwise implementation of the protocol. Flow rate, temperature, and tidal volume were gradually increased during the initial reperfusion phase to reduce hemodynamic and oxidative stress. Low flow rate combined with open atrium and protective ventilation strategy were applied to prevent lung damage. The videos enclosed show management of the most critical technical steps. The stability and reproducibility of the present procedure were confirmed by lung function evaluation and edema assessment. The meticulous description of the protocol provided in this paper can enable other laboratories to reproduce it effortlessly, supporting research in the EVLP field.	[Bassani, Giulia Alessandra; Lonati, Caterina; Brambilla, Daniela; Gatti, Stefano] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Surg Res Ctr, Milan, Italy; [Bassani, Giulia Alessandra; Lonati, Caterina; Valenza, Franco] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Ctr Preclin Invest, Dipartimento Anestesia Rianimaz & Emergenza Urgen, Milan, Italy; [Rapido, Francesca; Valenza, Franco] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Bassani, GA (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Surg Res Ctr, Milan, Italy.; Bassani, GA (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Ctr Preclin Invest, Dipartimento Anestesia Rianimaz & Emergenza Urgen, Milan, Italy.	giulia.bassani@outlook.it	Gatti, Stefano/AAE-3281-2022; Gatti, Stefano/M-1780-2015; Fernandes, Paulo Manuel Pego/AAC-8319-2020; lonati, caterina/GVT-5843-2022; Bassani, Giulia A./AAC-3634-2022; Pego-Fernandes, Paulo Manuel/C-2756-2012; lonati, caterina/ABI-1503-2020; lonati, caterina/M-3748-2015	Gatti, Stefano/0000-0003-2209-4338; Gatti, Stefano/0000-0003-2209-4338; Fernandes, Paulo Manuel Pego/0000-0001-7243-5343; Bassani, Giulia A./0000-0001-9196-6975; Pego-Fernandes, Paulo Manuel/0000-0001-7243-5343; lonati, caterina/0000-0001-7855-7851; Brambilla, Daniela/0000-0002-9669-278X	Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico; MILTA (Milano Liver Transplant Association)	Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico; MILTA (Milano Liver Transplant Association)	This work was supported by the Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico and MILTA (Milano Liver Transplant Association) paid publication fees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075592; Cypel M, 2012, J THORAC CARDIOV SUR, V144, P1200, DOI 10.1016/j.jtcvs.2012.08.009; Cypel M, 2011, CURR OPIN ORGAN TRAN, V16, P469, DOI 10.1097/MOT.0b013e32834ab15a; Cypel M, 2008, J HEART LUNG TRANSPL, V27, P1319, DOI 10.1016/j.healun.2008.09.003; Dacho C, 2013, IN VIVO, V27, P49; Fehrenbach H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-60; Hirata T, 2001, RESPIRATION, V68, P292, DOI 10.1159/000050513; Hodyc D, 2008, J HEART LUNG TRANSPL, V27, P890, DOI 10.1016/j.healun.2008.05.019; Ibrahim AM, 2016, J LAPAROENDOSC ADV S, V26, P240, DOI 10.1089/lap.2016.0100; Ingemansson R, 2009, ANN THORAC SURG, V87, P255, DOI 10.1016/j.athoracsur.2008.09.049; Inokawa H, 2006, ANN THORAC SURG, V82, P1219, DOI 10.1016/j.athoracsur.2006.05.004; Laumonier T, 2003, TRANSPLANTATION, V76, P838, DOI 10.1097/01.TP.0000078898.28399.0A; Liu MY, 2000, AM J PHYSIOL-LUNG C, V278, pL1071, DOI 10.1152/ajplung.2000.278.5.L1071; Markou T, 2014, J THORAC CARDIOV SUR, V148, P2335, DOI 10.1016/j.jtcvs.2014.04.037; Silva CAM, 2010, INTERACT CARDIOV TH, V11, P46, DOI 10.1510/icvts.2009.222018; Motoyama H, 2013, J HEART LUNG TRANSPL, V32, P505, DOI 10.1016/j.healun.2013.02.007; Nelson K, 2015, JOVE-J VIS EXP, DOI 10.3791/52309; Nelson Kevin, 2014, World J Exp Med, V4, P7, DOI 10.5493/wjem.v4.i2.7; Noda K, 2014, EUR J CARDIO-THORAC, V45, pE54, DOI 10.1093/ejcts/ezt598; Parker JC, 1998, J APPL PHYSIOL, V85, P1753, DOI 10.1152/jappl.1998.85.5.1753; Pego-Fernandes PM, 2010, TRANSPL P, V42, P444, DOI 10.1016/j.transproceed.2010.01.016; Pego-Fernandes PM, 2010, J BRAS PNEUMOL, V36, P490, DOI 10.1590/S1806-37132010000400015; Pierre L, 2013, PERFUSION-UK, V28, P322, DOI 10.1177/0267659113479424; Reeb J, 2016, CLIN TRANSPLANT, V30, P183, DOI 10.1111/ctr.12680; Russell WMS., 1959, MED J AUSTRALIA; Steen S, 2001, LANCET, V357, P825, DOI 10.1016/S0140-6736(00)04195-7; Steen S, 2007, ANN THORAC SURG, V83, P2191, DOI 10.1016/j.athoracsur.2007.01.033; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; Valenza F, 2000, CRIT CARE MED, V28, P3697, DOI 10.1097/00003246-200011000-00027; Valenza F, 2016, AM J TRANSPLANT, V16, P1312, DOI 10.1111/ajt.13612; Valenza F, 2012, TRANSPL P, V44, P1826, DOI 10.1016/j.transproceed.2012.06.023; Valenza F, 2014, TRANSPL INT; Valenza F, 2012, J HEART LUNG TRANSPL, V31, P524, DOI 10.1016/j.healun.2012.02.001	33	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167898	10.1371/journal.pone.0167898	http://dx.doi.org/10.1371/journal.pone.0167898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936178	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100226
J	Haller, S; Montandon, ML; Lazeyras, F; Scheffler, M; Meckel, S; Herrmann, FR; Giannakopoulos, P; Kovari, E				Haller, Sven; Montandon, Marie-Louise; Lazeyras, Francois; Scheffler, Max; Meckel, Stephan; Herrmann, Francois R.; Giannakopoulos, Panteleimon; Koevari, Eniko			Radiologic-Histopathologic Correlation of Cerebral Microbleeds Using Pre-Mortem and Post-Mortem MRI	PLOS ONE			English	Article							7.0-TESLA MAGNETIC-RESONANCE; CEREBROVASCULAR DISEASES; CORTICAL MICROINFARCTS; VASCULAR DEMENTIA; BRAINS; IRON; PREVALENCE; IMAGES; FOCI	Introduction Cerebral microbleeds (CMB), also known as cerebral microhemorrhages, are small areas of susceptibility on brain magnetic resonance imaging (MRI), that are increasingly detected due to the higher availability of high-field MRI systems and dedicated pulse sequences. The prevalence of CMBs increases in cases with cognitive decline. The current investigation assessed the poorly investigated radiologic-histopathologic correlation of CMBs on MRI. Methods The local ethical committee approved the current investigation. We retrospectively assessed a consecutive series of 1303 autopsy cases hospitalized in Geneva University Hospitals between 2000-2014. Of 112 cases with pre-mortem T2* sequences, we included 25 cases (mean age 77.3 +/- 9.6, 9 females) with at least one CMB. We compared pre-mortem CMBs with targeted histopathology and post-mortem MRI. Results 25 cases had 31 CMB lesions detected by pre-mortem MRI. 25 additional CMB were detected on histopathology. 4 CMBs on pre-mortem MRI were false positives, resulting in a total of 52 CMBs. 27 CMBs on pre-mortem MRI were confirmed on histopathology, corresponding to a sensitivity or true positive rate of 51.9% (95% CI 37.6 +/- 66.0%). The false negative rate of pre-mortem MRI was 48.1% (95% CI 4.0 +/- 62.4%). Post-mortem MRI showed only 3 cases with additional CMBs. Overall, pre-mortem MRI significantly underestimated CMBs (p = 0.0001). Conclusions Routine clinical brain MRI underestimates the prevalence of CMBs by approximately 50%, and 12% of radiologic pre-mortem MRI CMBs were false positives. Post-mortem MRI confirmed that this discordance is not explained by microbleeds occurring after the pre-mortem MRI.	[Haller, Sven] Affidea Ctr Diagnost Radiol Carouge CDRC, Carouge, Switzerland; [Haller, Sven; Montandon, Marie-Louise; Herrmann, Francois R.; Giannakopoulos, Panteleimon; Koevari, Eniko] Med Sch Univ, Geneva, Switzerland; [Haller, Sven] Uppsala Univ, Dept Surg Sci, Radiol, Uppsala, Sweden; [Haller, Sven; Meckel, Stephan] Univ Hosp Freiburg, Dept Neuroradiol, Freiburg, Germany; [Lazeyras, Francois; Scheffler, Max] Univ Geneva, Dept Mental Hlth & Psychiat, Geneva, Switzerland; [Herrmann, Francois R.] Univ Hosp Geneva, Dept Internal Med Rehabil & Geriatr, Div Geriatr, Geneva, Switzerland; [Giannakopoulos, Panteleimon] Univ Hosp Geneva, Geneva, Switzerland	Uppsala University; University of Freiburg; University of Geneva; University of Geneva; University of Geneva	Haller, S (corresponding author), Affidea Ctr Diagnost Radiol Carouge CDRC, Carouge, Switzerland.; Haller, S (corresponding author), Med Sch Univ, Geneva, Switzerland.; Haller, S (corresponding author), Uppsala Univ, Dept Surg Sci, Radiol, Uppsala, Sweden.; Haller, S (corresponding author), Univ Hosp Freiburg, Dept Neuroradiol, Freiburg, Germany.	sven.haller@gmail.com	HERRMANN, Francois/M-7390-2019; Haller, Sven/AAY-2564-2020; Meckel, Stephan/I-5810-2018; HERRMANN, Francois R/B-6710-2011	HERRMANN, Francois/0000-0003-1312-1517; Haller, Sven/0000-0001-7433-0203; Meckel, Stephan/0000-0001-6468-4526; HERRMANN, Francois R/0000-0003-1312-1517	Swiss National Foundation [SNF 320030_159990/1, SNF 320030_159990]; Association Suisse pour la Recherche Alzheimer, Geneva	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Association Suisse pour la Recherche Alzheimer, Geneva	This work is supported in part by Swiss National Foundation Grant SNF 320030_159990/1 and an unrestricted grant from the Association Suisse pour la Recherche Alzheimer, Geneva.; This work was supported by Swiss National Foundation grant SNF 320030_159990.	Akoudad S, 2015, CIRCULATION, V132, P509, DOI 10.1161/CIRCULATIONAHA.115.016261; Ayaz M, 2010, J MAGN RESON IMAGING, V31, P142, DOI 10.1002/jmri.22001; Cordonnier C, 2006, NEUROLOGY, V66, P1356, DOI 10.1212/01.wnl.0000210535.20297.ae; Cordonnier C, 2007, BRAIN, V130, P1988, DOI 10.1093/brain/awl387; De Reuck J, 2015, AGING DIS, V6, P437, DOI 10.14336/AD.2015.0429; De Reuck J, 2014, J NEUROL SCI, V346, P85, DOI 10.1016/j.jns.2014.07.061; De Reuck J, 2012, EUR J NEUROL, V19, P1355, DOI 10.1111/j.1468-1331.2012.03776.x; De Reuck J, 2011, CEREBROVASC DIS, V31, P511, DOI 10.1159/000324391; De Reuck JL, 2014, EUR J NEUROL, V21, P1026, DOI 10.1111/ene.12432; De Reuck J, 2014, FOLIA NEUROPATHOL, V52, P421, DOI 10.5114/fn.2014.47843; De Reuck JL, 2015, EUR NEUROL, V74, P158, DOI 10.1159/000441057; De Reuck JL, 2015, CEREBROVASC DIS, V39, P138, DOI 10.1159/000371488; De Reuck JL, 2013, ALZ DIS ASSOC DIS, V27, P162, DOI 10.1097/WAD.0b013e318256ecd8; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; Fisher M, 2010, STROKE, V41, P2782, DOI 10.1161/STROKEAHA.110.593657; Goos JDC, 2011, STROKE, V42, P1894, DOI 10.1161/STROKEAHA.110.599837; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Haller S, 2013, EUR RADIOL, V23, P3393, DOI 10.1007/s00330-013-2957-0; Haller S, 2010, RADIOLOGY, V257, P764, DOI 10.1148/radiol.10100612; Kikuta K, 2007, NEUROL MED-CHIR, V47, P564, DOI 10.2176/nmc.47.564; Kirsch W, 2009, J ALZHEIMERS DIS, V17, P599, DOI 10.3233/JAD-2009-1073; Kovari E, 2015, ACTA NEUROPATHOL COM, P349; Mackinnon A, 2000, COMPUT BIOL MED, V30, P127, DOI 10.1016/S0010-4825(00)00006-8; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; Schrag M, 2010, ACTA NEUROPATHOL, V119, P291, DOI 10.1007/s00401-009-0615-z; Shoamanesh A, 2011, CEREBROVASC DIS, V32, P528, DOI 10.1159/000331466; Tanaka A, 1999, STROKE, V30, P1637, DOI 10.1161/01.STR.30.8.1637; Tanskanen M, 2012, FRONT NEUROL, P3103; Tatsumi S, 2008, CEREBROVASC DIS, V26, P142, DOI 10.1159/000139661; Uetani H, 2013, AM J NEURORADIOL, V34, P984, DOI 10.3174/ajnr.A3332; van Veluw SJ, 2015, J CEREBR BLOOD F MET, V35, P676, DOI 10.1038/jcbfm.2014.258	31	20	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167743	10.1371/journal.pone.0167743	http://dx.doi.org/10.1371/journal.pone.0167743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936213	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100171
J	Low, LL; Liu, N; Wang, SJ; Thumboo, J; Ong, MEH; Lee, KH				Low, Lian Leng; Liu, Nan; Wang, Sijia; Thumboo, Julian; Ong, Marcus Eng Hock; Lee, Kheng Hock			Predicting 30-Day Readmissions in an Asian Population: Building a Predictive Model by Incorporating Markers of Hospitalization Severity	PLOS ONE			English	Article							RISK-FACTORS; MEDICAL PATIENTS; CARE PROGRAM; INDEX; REHOSPITALIZATION; PERFORMANCE; VALIDATION; DERIVATION; MORTALITY; ICD-9-CM	Background To reduce readmissions, it may be cost-effective to consider risk stratification, with targeting intervention programs to patients at high risk of readmissions. In this study, we aimed to derive and validate a prediction model including several novel markers of hospitalization severity, and compare the model with the LACE index (Length of stay, Acuity of admission, Charlson comorbidity index, Emergency department visits in past 6 months), an established risk stratification tool. Method This was a retrospective cohort study of all patients >= 21 years of age, who were admitted to a tertiary hospital in Singapore from January 1, 2013 through May 31, 2015. Data were extracted from the hospital's electronic health records. The outcome was defined as unplanned readmissions within 30 days of discharge from the index hospitalization. Candidate predictive variables were broadly grouped into five categories: Patient demographics, social determinants of health, past healthcare utilization, medical comorbidities, and markers of hospitalization severity. Multivariable logistic regression was used to predict the outcome, and receiver operating characteristic analysis was performed to compare our model with the LACE index. Results 74,102 cases were enrolled for analysis. Of these, 11,492 patient cases (15.5%) were readmitted within 30 days of discharge. A total of fifteen predictive variables were strongly associated with the risk of 30-day readmissions, including number of emergency department visits in the past 6 months, Charlson Comorbidity Index, markers of hospitalization severity such as 'requiring inpatient dialysis during index admission, and 'treatment with intravenous furosemide 40 milligrams or more' during index admission. Our predictive model outperformed the LACE index by achieving larger area under the curve values: 0.78 (95% confidence interval [CI]: 0.77-0.79) versus 0.70 (95% CI: 0.69-0.71). Conclusion Several factors are important for the risk of 30-day readmissions, including proxy markers of hospitalization severity.	[Low, Lian Leng; Lee, Kheng Hock] Singapore Gen Hosp, Dept Family Med & Continuing Care, Singapore, Singapore; [Low, Lian Leng; Lee, Kheng Hock] Duke NUS Med Sch, Family Med Program, Singapore, Singapore; [Liu, Nan; Thumboo, Julian] Singapore Hlth Serv, Hlth Serv Res Ctr, Singapore, Singapore; [Liu, Nan] Duke NUS Med Sch, Ctr Quantitat Med, Singapore, Singapore; [Wang, Sijia] Integrated Hlth Informat Syst, Singapore, Singapore; [Thumboo, Julian] Singapore Gen Hosp, Dept Rheumatol & Immunol, Singapore, Singapore; [Ong, Marcus Eng Hock] Singapore Gen Hosp, Dept Emergency Med, Singapore, Singapore; [Ong, Marcus Eng Hock] Duke NUS Med Sch, Hlth Serv & Syst Res, Singapore, Singapore	Singapore General Hospital; National University of Singapore; National University of Singapore; Singapore General Hospital; Singapore General Hospital; National University of Singapore	Low, LL (corresponding author), Singapore Gen Hosp, Dept Family Med & Continuing Care, Singapore, Singapore.; Low, LL (corresponding author), Duke NUS Med Sch, Family Med Program, Singapore, Singapore.; Liu, N (corresponding author), Singapore Hlth Serv, Hlth Serv Res Ctr, Singapore, Singapore.; Liu, N (corresponding author), Duke NUS Med Sch, Ctr Quantitat Med, Singapore, Singapore.	low.lian.leng@singhealth.com.sg; liu.nan@singhealth.com.sg	Liu, Nan/L-9529-2013; Low, Lian Leng/M-2853-2016; Liu, Nan/HCS-2632-2022	Low, Lian Leng/0000-0003-4228-2862; Liu, Nan/0000-0003-3610-4883	Singapore Ministry of Health (MOH) Health Services Research New Investigator Grant [HSRNIG14nov002]; SingHealth Foundation Health Services Research (Ageing) Grant [SHF/HSRAg004/2015]	Singapore Ministry of Health (MOH) Health Services Research New Investigator Grant; SingHealth Foundation Health Services Research (Ageing) Grant	This study was supported by Singapore Ministry of Health (MOH) Health Services Research New Investigator Grant HSRNIG14nov002 and the SingHealth Foundation Health Services Research (Ageing) Grant SHF/HSRAg004/2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaudeen N, 2011, J HOSP MED, V6, P54, DOI 10.1002/jhm.805; Amarasingham R, 2010, MED CARE, V48, P981, DOI 10.1097/MLR.0b013e3181ef60d9; Arbaje AI, 2008, GERONTOLOGIST, V48, P495, DOI 10.1093/geront/48.4.495; Billings J, 2006, BRIT MED J, V333, P327, DOI 10.1136/bmj.38870.657917.AE; Billings J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001667; Bottle A, 2006, J ROY SOC MED, V99, P406, DOI 10.1258/jrsm.99.8.406; Centers for Medicare & Medicaid Services, 2014, READM RED PROGR; Choudhry Shahid A, 2013, Online J Public Health Inform, V5, P219, DOI 10.5210/ojphi.v5i2.4726; Cooksley T, 2015, QJM; Cotter PE, 2012, AGE AGEING, V41, P784, DOI 10.1093/ageing/afs073; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Donze J, 2013, JAMA INTERN MED, V173, P632, DOI 10.1001/jamainternmed.2013.3023; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fiest KM, 2014, BMC PSYCHIATRY, V14, P1; Glasgow JM, 2010, J GEN INTERN MED, V25, P926, DOI 10.1007/s11606-010-1371-4; Graham KL, 2015, ANN INTERN MED, V162, P741, DOI 10.7326/M14-2159; Hansen LO, 2011, ANN INTERN MED, V155, P520, DOI 10.7326/0003-4819-155-8-201110180-00008; Hasan O, 2010, J GEN INTERN MED, V25, P211, DOI 10.1007/s11606-009-1196-1; Howell S, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-96; Hu JH, 2014, HEALTH AFFAIR, V33, P778, DOI 10.1377/hlthaff.2013.0816; Jasti H, 2008, CLIN INFECT DIS, V46, P550, DOI 10.1086/526526; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Kripalani S, 2014, ANNU REV MED, V65, P471, DOI 10.1146/annurev-med-022613-090415; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; Lim E, 2011, BMC HEALTH SERV RES, V2011, P1; Low LL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/169870; Low LL, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0750-2; Luthi JC, 2003, INT J QUAL HEALTH C, V15, P413, DOI 10.1093/intqhc/mzg055; Luthi JC, 2004, QUAL SAF HEALTH CARE, V13, P46, DOI 10.1136/qshc.2003.006999; Ministry of Health, 2010, CHRONIC DIS; Ministry of Health Singapore, 2012, HLTH FACTS SING HEAL; Neupane B, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-22; Onukwugha E, 2011, MED CARE, V49, P215, DOI 10.1097/MLR.0b013e31820192a5; Pederson JL, 2016, J HOSP MED; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Shadmi E, 2015, MED CARE, V53, P283, DOI 10.1097/MLR.0000000000000315; Smith DM, 1996, J GEN INTERN MED, V11, P762, DOI 10.1007/BF02598996; Taha M, 2014, INT J QUAL HEALTH C, V26, P271, DOI 10.1093/intqhc/mzu038; Tan SY, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-366; van Walraven C, 2010, CAN MED ASSOC J, V182, P551, DOI 10.1503/cmaj.091117; Wee SL, 2014, J AM GERIATR SOC, V62, P747, DOI 10.1111/jgs.12750; Zhou HQ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011060	45	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167413	10.1371/journal.pone.0167413	http://dx.doi.org/10.1371/journal.pone.0167413			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936053	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100093
J	Su, D; Wang, XT; Campbell, MR; Porter, DK; Pittman, GS; Bennett, BD; Wan, M; Englert, NA; Crowl, CL; Gimple, RN; Adamski, KN; Huang, ZQ; Murphy, SK; Bell, DA				Su, Dan; Wang, Xuting; Campbell, Michelle R.; Porter, Devin K.; Pittman, Gary S.; Bennett, Brian D.; Wan, Ma; Englert, Neal A.; Crowl, Christopher L.; Gimple, Ryan N.; Adamski, Kelly N.; Huang, Zhiqing; Murphy, Susan K.; Bell, Douglas A.			Distinct Epigenetic Effects of Tobacco Smoking in Whole Blood and among Leukocyte Subtypes	PLOS ONE			English	Article							HYDROCARBON RECEPTOR REPRESSOR; DNA METHYLATION; CIGARETTE-SMOKING; IMMUNE-SYSTEM; EXPRESSION; MTSS1; DIFFERENTIATION; LANDSCAPE; FREQUENCY; CANCER	Tobacco smoke exposure dramatically alters DNA methylation in blood cells and may mediate smoking-associated complex diseases through effects on immune cell function. However, knowledge of smoking effects in specific leukocyte subtypes is limited. To better characterize smoking-associated methylation changes in whole blood and leukocyte subtypes, we used Illumina 450K arrays and Reduced Representation Bisulfite Sequencing (RRBS) to assess genome-wide DNA methylation. Differential methylation analysis in whole blood DNA from 172 smokers and 81 nonsmokers revealed 738 CpGs, including 616 previously unreported CpGs, genome-wide significantly associated with current smoking (p < 1.2x10(-7), Bonferroni correction). Several CpGs (MTSS1, NKX6-2, BTG2) were associated with smoking duration among heavy smokers (>22 cigarettes/day, n = 86) which might relate to long-term heavy-smoking pathology. In purified leukocyte subtypes from an independent group of 20 smokers and 14 nonsmokers we further examined methylation and gene expression for selected genes among CD14+ monocytes, CD15+ granulocytes, CD19 + B cells, and CD2+ T cells. In 10 smokers and 10 nonsmokers we used RRBS to fine map differential methylation in CD4+ T cells, CD8+ T cells, CD14+, CD15+, CD19+, and CD56+ natural killer cells. Distinct cell-type differences in smoking-associated methylation and gene expression were identified. AHRR (cg05575921), ALPPL2 (cg21566642), GFI1 (cg09935388), IER3 (cg06126421) and F2RL3 (cg03636183) showed a distinct pattern of significant smoking-associated methylation differences across cell types: granulocytes> monocytes >> B cells. In contrast GPR15 (cg19859270) was highly significant in T and B cells and ITGAL (cg09099830) significant only in T cells. Numerous other CpGs displayed distinctive cell-type responses to tobacco smoke exposure that were not apparent in whole blood DNA. Assessing the overlap between these CpG sites and differential methylated regions (DMRs) with RRBS in 6 cell types, we confirmed cell-type specificity in the context of DMRs. We identified new CpGs associated with current smoking, pack-years, duration, and revealed unique profiles of smoking-associated DNA methylation and gene expression among immune cell types, providing potential clues to hematopoietic lineage-specific effects in disease etiology.	[Su, Dan; Wang, Xuting; Campbell, Michelle R.; Porter, Devin K.; Pittman, Gary S.; Wan, Ma; Englert, Neal A.; Crowl, Christopher L.; Gimple, Ryan N.; Adamski, Kelly N.; Bell, Douglas A.] NIEHS, Environm Genom Grp, Genome Integr & Struct Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Bennett, Brian D.] NIEHS, Integrated Bioinformat, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Huang, Zhiqing; Murphy, Susan K.] Duke Univ, Sch Med, Durham, NC 27708 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University	Bell, DA (corresponding author), NIEHS, Environm Genom Grp, Genome Integr & Struct Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	BELL1@niehs.nih.gov	su, dan/GYJ-1940-2022; Bell, Douglas A/C-7687-2019; Murphy, Susan/R-3903-2019; Gimple, Ryan/AAU-8944-2020	Bell, Douglas A/0000-0001-7700-0840; Murphy, Susan/0000-0001-8298-7272; Wang, Xuting/0000-0001-6781-8008; Gimple, Ryan/0000-0002-7189-3243	Intramural Research Program of National Institute of Environmental Health Sciences-National Institutes of Health [Z01-ES100475]; NIH/FDA Intramural Center for Tobacco Research; NIEHS Clinical Research Unit and Hematology Core; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES046008, ZICES102445] Funding Source: NIH RePORTER	Intramural Research Program of National Institute of Environmental Health Sciences-National Institutes of Health; NIH/FDA Intramural Center for Tobacco Research; NIEHS Clinical Research Unit and Hematology Core; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Work was funded by the Intramural Research Program of National Institute of Environmental Health Sciences-National Institutes of Health (Z01-ES100475) (www.niehs.nih.gov) and a grant from NIH/FDA Intramural Center for Tobacco Research (https://prevention.nih.gov/tobacco-regulatory-science-program) to D.A.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the NIEHS Clinical Research Unit and Hematology Core for support and the NIEHS Molecular Genetics Core, NIH Intramural Sequencing Center, and NCI DCEG Center for Genomics Research for methylation analysis.	Ablain J, 2011, BLOOD, V117, P5795, DOI 10.1182/blood-2011-02-329367; Adalsteinsson BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046705; Arlt A, 2011, EUR J CELL BIOL, V90, P545, DOI 10.1016/j.ejcb.2010.10.002; Bauer M, 2016, CLIN EPIGENETICS, V8, DOI [10.1186/s13148-015-0113-1, 10.1186/s13148-016-0249-7]; BELL DA, 1995, JNCI-J NATL CANCER I, V87, P223, DOI 10.1093/jnci/87.3.223; Birney E, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006105; Bjornson ZB, 2013, CURR OPIN IMMUNOL, V25, P484, DOI 10.1016/j.coi.2013.07.004; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Breton CV, 2014, PLOS ONE, V9; Chung W, 2011, CANCER EPIDEM BIOMAR, V20, P1483, DOI 10.1158/1055-9965.EPI-11-0067; Costa BM, 2010, CANCER RES, V70, P453, DOI 10.1158/0008-5472.CAN-09-2189; Dogan MV, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-151; Elliott HR, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-4; Flanagan JM, 2015, CANCER EPIDEM BIOMAR, V24, P221, DOI 10.1158/1055-9965.EPI-14-0767; Fox J, 2011, R COMPANION APPL REG, P449; Harlid S, 2014, ENVIRON HEALTH PERSP, V122, P673, DOI 10.1289/ehp.1307480; Houseman EA, 2014, BIOINFORMATICS, V30, P1431, DOI 10.1093/bioinformatics/btu029; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; JONES IM, 1993, CANCER EPIDEM BIOMAR, V2, P249; Joubert BR, 2014, CANCER EPIDEM BIOMAR, V23, P1007, DOI 10.1158/1055-9965.EPI-13-1256; Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412; Kayser G, 2015, BRIT J CANCER, V112, P866, DOI 10.1038/bjc.2015.2; Kim S, 2016, BIOFABRICATION, V8, DOI 10.1088/1758-5090/8/1/015021; Koestler DC, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0943-7; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lunn RM, 1999, CANCER RES, V59, P2557; Mao BJ, 2015, INT J ONCOL, V46, P459, DOI 10.3892/ijo.2014.2765; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mertz KD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4465; Michaud DS, 2015, CANCER EPIDEM BIOMAR, V24, P1811, DOI 10.1158/1055-9965.EPI-15-0681; Monick MM, 2012, AM J MED GENET B, V159B, P141, DOI 10.1002/ajmg.b.32021; Morris TJ, 2014, BIOINFORMATICS, V30, P428, DOI 10.1093/bioinformatics/btt684; Nechanitzky R, 2013, NAT IMMUNOL, V14, P867, DOI 10.1038/ni.2641; Nguyen LP, 2015, NAT IMMUNOL, V16, P207, DOI 10.1038/ni.3079; Parr C, 2009, EUR J CANCER, V45, P1673, DOI 10.1016/j.ejca.2009.02.019; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Phelan JD, 2010, CURR OPIN HEMATOL, V17, P300, DOI 10.1097/MOH.0b013e32833a06f8; Philibert RA, 2012, EPIGENETICS-US, V7, P1331, DOI 10.4161/epi.22520; PHILLIPS DH, 1988, NATURE, V336, P790, DOI 10.1038/336790a0; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Reynolds LM, 2015, CIRC-CARDIOVASC GENE, V8, P707, DOI 10.1161/CIRCGENETICS.115.001097; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Smith MR, 2003, ATHEROSCLEROSIS, V169, P331, DOI 10.1016/S0021-9150(03)00200-4; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Sun YV, 2013, HUM GENET, V132, P1027, DOI 10.1007/s00439-013-1311-6; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tsaprouni LG, 2014, EPIGENETICS-US, V9, P1382, DOI 10.4161/15592294.2014.969637; van Grevenynghe J, 2003, J IMMUNOL, V170, P2374, DOI 10.4049/jimmunol.170.5.2374; Wan ES, 2012, HUM MOL GENET, V21, P3073, DOI 10.1093/hmg/dds135; Wiencke JK, 2016, EPIGENETICS-US, V11, P363, DOI 10.1080/15592294.2016.1163454; Zeilinger S, 2013, PLOS ONE, V8; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	55	69	73	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166486	10.1371/journal.pone.0166486	http://dx.doi.org/10.1371/journal.pone.0166486			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935972	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100029
J	Wang, LH; Dong, F; Reinach, PS; He, DD; Zhao, XT; Chen, XY; Hu, DN; Yan, DS				Wang, Lihua; Dong, Feng; Reinach, Peter S.; He, Dandan; Zhao, Xiaoting; Chen, Xiaoyan; Hu, Dan-Ning; Yan, Dongsheng			MicroRNA-182 Suppresses HGF/SF-Induced Increases in Retinal Pigment Epithelial Cell Proliferation and Migration through Targeting c-Met	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MESENCHYMAL TRANSITION; VITREORETINOPATHY; DISEASE; DETACHMENT; PHYSIOLOGY; P53	As increases in hepatocyte growth factor/scatter factor (HGF/SF) induce retinal pigment epithelial (RPE) migration and proliferation into the vitreous cavity and contribute to proliferative vitreoretinopathy (PVR) development, we determined if changes in miR-182 expression affect such behavioral changes. We found that miR-182 expression was less in PVR clinical samples than in primary RPE cells whereas c-Met was upregulated. Ectopic miR-182 inhibited RPE cell proliferation, cell cycle, and migration. Bioinformatic analysis identified c-Met as a miR-182 target, which was confirmed with the luciferase reporter assay. Transfection of miR-182 into RPE cells induced c-Met downregulation, which led to reduced cell proliferation and migration through declines in p-Akt formation. MiR-182 downregulation along with c-Met upregulation in PVR tissues suggest that these two opposing effects play important roles in PVR development. As ectopic miR-182 expression suppressed RPE cell proliferation and migration, strategies to selectively upregulate miR-182 expression in a clinical setting may provide a novel option to treat this disease.	[Wang, Lihua; Reinach, Peter S.; He, Dandan; Zhao, Xiaoting; Chen, Xiaoyan; Yan, Dongsheng] Wenzhou Med Univ, Hosp Eye, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Wang, Lihua; Reinach, Peter S.; He, Dandan; Zhao, Xiaoting; Chen, Xiaoyan; Hu, Dan-Ning; Yan, Dongsheng] Minist Hlth Peoples Republ China, Zhejiang Prov Key Lab Ophthalmol & Optometry, State Key Lab Cultivat Base, Wenzhou, Zhejiang, Peoples R China; [Wang, Lihua; Reinach, Peter S.; He, Dandan; Zhao, Xiaoting; Chen, Xiaoyan; Hu, Dan-Ning; Yan, Dongsheng] Minist Hlth Peoples Republ China, Zhejiang Prov Key Lab Ophthalmol & Optometry, Key Lab Vis Sci, Wenzhou, Zhejiang, Peoples R China; [Hu, Dan-Ning] New York Med Coll, New York Eye & Ear Infirm, Tissue Culture Ctr, New York, NY USA; [Dong, Feng] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China	Wenzhou Medical University; New York Eye & Ear Infirmary of Mount Sinai; New York Medical College; Zhejiang University	Yan, DS (corresponding author), Wenzhou Med Univ, Hosp Eye, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China.; Yan, DS (corresponding author), Minist Hlth Peoples Republ China, Zhejiang Prov Key Lab Ophthalmol & Optometry, State Key Lab Cultivat Base, Wenzhou, Zhejiang, Peoples R China.; Yan, DS (corresponding author), Minist Hlth Peoples Republ China, Zhejiang Prov Key Lab Ophthalmol & Optometry, Key Lab Vis Sci, Wenzhou, Zhejiang, Peoples R China.	dnaprotein@hotmail.com	chen, xia/GXM-5435-2022; Reinach, Peter/AAI-3582-2021; Yan, Dongsheng/B-1861-2018; chen, xi/GXH-3653-2022; chen, xia/GYR-3948-2022	Yan, Dongsheng/0000-0003-0551-2219; wang, lihua/0000-0001-6133-7940	973 Project from the Ministry of Science and Technology of China [2012CB722303]; Wenzhou Municipal Science-technology Program Project of China [Y20130164]; Science Foundation of Wenzhou Medical University [QTJ11020]	973 Project from the Ministry of Science and Technology of China(National Basic Research Program of China); Wenzhou Municipal Science-technology Program Project of China; Science Foundation of Wenzhou Medical University	This work was supported, in part, by the 973 Project (2012CB722303) from the Ministry of Science and Technology of China, Wenzhou Municipal Science-technology Program Project of China (Y20130164), and Science Foundation of Wenzhou Medical University (QTJ11020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Briggs MC, 2000, INVEST OPHTH VIS SCI, V41, P3085; Cai N, 2012, INT J OPHTHALMOL-CHI, V5, P675, DOI 10.3980/j.issn.2222-3959.2012.06.05; Cardillo JA, 1997, OPHTHALMOLOGY, V104, P1166, DOI 10.1016/S0161-6420(97)30167-5; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Chen XY, 2014, INT J MOL MED, V33, P1195, DOI 10.3892/ijmm.2014.1688; Chen Zhenna, 2015, Mol Vis, V21, P706; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hou Q, 2013, INVEST OPHTH VIS SCI, V54, P6481, DOI 10.1167/iovs.13-11873; Hu DN, 2002, INT J TOXICOL, V21, P465, DOI 10.1080/10915810290169891; Jun JH, 2016, INVEST OPHTH VIS SCI, V57, P12, DOI 10.1167/iovs.15-17111; Kasaoka M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040771; Kim Ivana K, 2002, Ophthalmol Clin North Am, V15, P81; Kwon OW, 2016, DEV OPHTHALMOL, V55, P154, DOI 10.1159/000438972; Lashkari K, 1999, INVEST OPHTH VIS SCI, V40, P149; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lei HT, 2012, AM J PATHOL, V181, P866, DOI 10.1016/j.ajpath.2012.05.036; Lei HT, 2011, MOL CELL BIOL, V31, P1788, DOI 10.1128/MCB.01321-10; Lin HJ, 2011, INVEST OPHTH VIS SCI, V52, P6308, DOI 10.1167/iovs.10-6632; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACHEMER R, 1978, AM J OPHTHALMOL, V85, P181, DOI 10.1016/S0002-9394(14)75946-X; Murad N, 2014, FEBS J, V281, P5251, DOI 10.1111/febs.13066; Nair AR, 2005, CELL CYCLE, V4, P697, DOI 10.4161/cc.4.5.1672; Pastor JC, 2015, PROLIFERATIVE VITREO; Pennock S, 2014, AM J PATHOL, V184, P3052, DOI 10.1016/j.ajpath.2014.07.026; Pennock S, 2014, PROG RETIN EYE RES, V40, P16, DOI 10.1016/j.preteyeres.2013.12.006; Sadaka A, 2012, CLIN OPHTHALMOL, V6, P1325, DOI 10.2147/OPTH.S27896; Tamiya S, 2016, EXP EYE RES, V142, P26, DOI 10.1016/j.exer.2015.02.008; Tosi GM, 2014, J CELL PHYSIOL, V229, P1577, DOI 10.1002/jcp.24606; Wang FE, 2010, FASEB J, V24, P1552, DOI 10.1096/fj.08-125856; Yan DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040967; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511; Yan DS, 2009, INVEST OPHTH VIS SCI, V50, P1559, DOI 10.1167/iovs.08-2681; Yang S, 2015, DISCOV MED, V20, P207	36	17	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167684	10.1371/journal.pone.0167684	http://dx.doi.org/10.1371/journal.pone.0167684			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936052	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100149
J	Wang, Y; Sun, T; Li, TT; Wang, M; Yang, GX; He, GY				Wang, Yan; Sun, Tao; Li, Tingting; Wang, Meng; Yang, Guangxiao; He, Guangyuan			A CBL-Interacting Protein Kinase TaCIPK2 Confers Drought Tolerance in Transgenic Tobacco Plants through Regulating the Stomatal Movement	PLOS ONE			English	Article							CIPK GENE FAMILIES; ARABIDOPSIS-THALIANA; CALCIUM SENSORS; SIGNALING NETWORK; STRESS TOLERANCE; SALT STRESS; ECTOPIC EXPRESSION; OSMOTIC-STRESS; ABSCISIC-ACID; K+ CHANNEL	In plants, the CBL-CIPK signaling pathways play key roles in the response to abiotic stresses. However, functional studies of CIPKs in the important staple crop wheat are very rare. In this study, we identified a CIPKgene from wheat, designated TaCIPK2. Expression analysis results showed that TaCIPK2 could be up-regulated in wheat leaves by polyethylene glycol, abscisic acid and H2O2 treatments. Subcellular localization analyses revealed that TaCIPK2 was present in whole wheat epidermal cells. A yeast two-hybrid assay indicated that TaCIPK2 interacted with TaCBL1, 2, 3 and 4 in vitro. Transgenic tobacco plants over-expressing TaCIPK2 exhibited increased drought tolerance, indicated by a larger proportion of green cotyledons and higher survival rates under the osmotic and drought stress conditions compared with control plants. Additionally, physiological index analyses revealed that the transgenic tobacco plants had lower water loss rates and ion leakage, accumulated less malondialdehyde and H2O2, and had higher catalase and superoxide dismutase activities than the control plants. The transgenic plants also exhibited faster stomatal closure following exposure to osmotic stress conditions. The seed germination rates and stomatal aperture of TaC/PK2-overexpressing tobacco plants decreased after exogenous abscisic acid treatment was applied, implying that the transgenic tobacco plants were more sensitive to exogenous abscisic acid than the control plants. Our results indicate that TaCIPK2 plays a positive regulatory role in drought stress responses in transgenic tobacco plants.	[Wang, Yan; Sun, Tao; Li, Tingting; Wang, Meng; Yang, Guangxiao; He, Guangyuan] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Mol Biophys,Chinese Minist Educ, Genet Engn Int Cooperat Base,Chinese Minist Sci &, Wuhan, Peoples R China	Huazhong University of Science & Technology	He, GY (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Mol Biophys,Chinese Minist Educ, Genet Engn Int Cooperat Base,Chinese Minist Sci &, Wuhan, Peoples R China.	hegy@hust.edu.cn			National Genetically Modified New Varieties of Major Projects of China [2016ZX08010004-004]; International S & T Cooperation Key Projects of MoST [2009DFB30340]; Research Fund for the Doctoral Program of Higher Education of China [2012014211075]	National Genetically Modified New Varieties of Major Projects of China; International S & T Cooperation Key Projects of MoST; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Genetically Modified New Varieties of Major Projects of China (2016ZX08010004-004), International S & T Cooperation Key Projects of MoST (grant No. 2009DFB30340) and Research Fund for the Doctoral Program of Higher Education of China (Grant no. 2012014211075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Genetically Modified New Varieties of Major Projects of China (2016ZX08010004-004), International S & T Cooperation Key Projects of MoST (grant No. 2009DFB30340) and Research Fund for the Doctoral Program of Higher Education of China (Grant no. 2012014211075).	Abdula SE, 2016, PLANT MOL BIOL REP, V34, P501, DOI 10.1007/s11105-015-0939-x; Batistic O, 2012, BBA-GEN SUBJECTS, V1820, P1283, DOI 10.1016/j.bbagen.2011.10.012; Batistic O, 2010, PLANT J, V61, P211, DOI 10.1111/j.1365-313X.2009.04045.x; Chen XF, 2011, J GENET GENOMICS, V38, P77, DOI 10.1016/j.jcg.2011.01.005; Chen XJ, 2014, INT J MOL SCI, V15, P14819, DOI 10.3390/ijms150814819; Deng XM, 2013, PHYSIOL PLANTARUM, V149, P367, DOI 10.1111/ppl.12046; Deng Xinyang, 2013, ScientificWorldJournal, V2013, P123731, DOI 10.1155/2013/123731; Du WM, 2011, PLANT PHYSIOL, V156, P2235, DOI 10.1104/pp.111.173377; Eckert C, 2014, PLANT J, V78, P146, DOI 10.1111/tpj.12456; Guo Y, 2004, PLANT CELL, V16, P435, DOI 10.1105/tpc.019174; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hu HC, 2009, PLANT J, V57, P264, DOI 10.1111/j.1365-313X.2008.03685.x; Huang CJ, 2013, PHYSIOL PLANTARUM, V149, P297, DOI 10.1111/ppl.12031; Huang XS, 2011, J EXP BOT, V62, P5191, DOI 10.1093/jxb/err229; Kim KN, 2000, PLANT PHYSIOL, V124, P1844, DOI 10.1104/pp.124.4.1844; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Kolukisaoglu U, 2004, PLANT PHYSIOL, V134, P43, DOI 10.1104/pp.103.033068; Laanemets K, 2013, PLANT PHYSIOL, V163, P504, DOI 10.1104/pp.113.220343; Li J, 2014, PLANT CELL, V26, P3387, DOI 10.1105/tpc.114.123455; Li LG, 2006, P NATL ACAD SCI USA, V103, P12625, DOI 10.1073/pnas.0605129103; Li RF, 2012, PLANT CELL ENVIRON, V35, P1582, DOI 10.1111/j.1365-3040.2012.02511.x; Liu JP, 2000, P NATL ACAD SCI USA, V97, P3730, DOI 10.1073/pnas.060034197; Liu L., 2013, J FOOD SCI ENG, V3, P161; Liu Y, 2013, PLANT CELL PHYSIOL, V54, P944, DOI 10.1093/pcp/pct047; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; Mahs A, 2013, MOL PLANT, V6, P1149, DOI 10.1093/mp/sst095; Nieves-Cordones M, 2012, PLANT CELL PHYSIOL, V53, P423, DOI 10.1093/pcp/pcr194; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Piao HL, 2010, MOL CELLS, V30, P19, DOI 10.1007/s10059-010-0084-1; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Reilly C A, 2001, Curr Protoc Toxicol, VChapter 2, DOI 10.1002/0471140856.tx0204s00; SANO H, 1994, P NATL ACAD SCI USA, V91, P2582, DOI 10.1073/pnas.91.7.2582; Sun T, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0657-4; Sun YD, 2015, PLANT CELL REP, V34, P1295, DOI 10.1007/s00299-015-1787-8; Tai FJ, 2016, PLANT CELL TISS ORG, V124, P459, DOI 10.1007/s11240-015-0906-0; Tang RJ, 2015, P NATL ACAD SCI USA, V112, P3134, DOI 10.1073/pnas.1420944112; Verslues PE, 2007, MOL CELL BIOL, V27, P7771, DOI 10.1128/MCB.00429-07; Weinl S, 2009, NEW PHYTOL, V184, P517, DOI 10.1111/j.1469-8137.2009.02938.x; Xiong L, 2002, PLANT CELL ENVIRON, V25, P131, DOI 10.1046/j.1365-3040.2002.00782.x; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Zhang HF, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-8; Zhang HC, 2013, PLANT CELL REP, V32, P611, DOI 10.1007/s00299-013-1394-5	44	24	28	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167962	10.1371/journal.pone.0167962	http://dx.doi.org/10.1371/journal.pone.0167962			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936160	gold, Green Submitted, Green Published			2022-12-27	WOS:000389587100239
J	Yang, Z; Zhao, Q; Gao, YA; Zhang, W				Yang, Zhe; Zhao, Qing; Gao, Yun-An; Zhang, Wei			Combined Oral and Intravenous Immunization Stimulates Strong IgA Responses in Both Systemic and Mucosal Compartments	PLOS ONE			English	Article							ANTIBODY-SECRETING CELLS; IMMUNE-RESPONSES; CHOLERA-TOXIN; INTRANASAL IMMUNIZATION; VACCINE; EXPRESSION; ANTIGEN; PRIME; SERUM; MICE	To investigate the influence of immunization routes onIgG, IgA and IgM production in systemic and mucosal compartments, we immunized mice with keyhole limpet hemocyanin (KLH) via oral, intranasal (i.n.) or subcutaneous (s.c.) routes alone or combined with the intravenous (i.v.) route. We found that administering antigen intravenously could affect antibody production and formation of antibody secreting cells (ASCs) depending on the immunization route previously used. Combined oral/i.v. immunization but not s.c./i.v. immunization caused a great increase of IgA ASCs in the spleen and enhanced IgA production in the small intestine and serum. Combined i.n./i.v. immunization could also increase IgA ASCs in the spleen and enhance IgA production in serum but had no effect on IgA production in the small intestine. Oral/i.v. immunization caused increase of IgG ASCs in both the spleen and bone marrow. In comparison, combined i.n./i.v. and s.c./i.v. immunization could increase IgG ASCs in the spleen but not in bone marrow. Intravenous administration of KLH in mice that had been immunized via oral, i.n. or s.c. routes caused some increase of IgM ASCs in the spleen but not in bone marrow. In conclusion, combined oral and i.v. administration of an antigen can induce fast and strong immune responses, especially for IgA, in both systemic and mucosal compartments.	[Yang, Zhe; Zhao, Qing; Gao, Yun-An; Zhang, Wei] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Immunol,Sch Basic Med, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Zhang, W (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Immunol,Sch Basic Med, Beijing, Peoples R China.	zw83423@hotmail.com			Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences	Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences	This work was partially supported by a grant for Young Lecturers from Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences. QZ received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other specific fundings for our work, the additional cost of our work supported by the funding from our laboratory.	Agnello D, 2013, J IMMUNOL, V190, P4836, DOI 10.4049/jimmunol.1202979; Batra A, 2007, NEPHROL DIAL TRANSPL, V22, P2540, DOI 10.1093/ndt/gfm228; Belyakov IM, 2007, J IMMUNOL, V178, P7211, DOI 10.4049/jimmunol.178.11.7211; Bouvet JP, 2002, TRENDS IMMUNOL, V23, P209, DOI 10.1016/S1471-4906(02)02186-5; Brandtzaeg P, 2009, SCAND J IMMUNOL, V70, P505, DOI 10.1111/j.1365-3083.2009.02319.x; Brandtzaeg P, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00222; Bruhl P, 1998, AIDS RES HUM RETROV, V14, P401, DOI 10.1089/aid.1998.14.401; Chadwick S, 2009, EXPERT OPIN BIOL TH, V9, P427, DOI [10.1517/14712590902849224 , 10.1517/14712590902849224]; Chen DX, 2001, J VIROL, V75, P7956, DOI 10.1128/JVI.75.17.7956-7965.2001; CRAIG SW, 1971, J EXP MED, V134, P188, DOI 10.1084/jem.134.1.188; Dickinson BL, 1999, J CLIN INVEST, V104, P903, DOI 10.1172/JCI6968; Eriksson K, 1998, INFECT IMMUN, V66, P5889, DOI 10.1128/IAI.66.12.5889-5896.1998; Gloudemans AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059822; Goodsell A, 2008, IMMUNOLOGY, V123, P378, DOI 10.1111/j.1365-2567.2007.02702.x; GOWANS JL, 1964, PROC R SOC SER B-BIO, V159, P257, DOI 10.1098/rspb.1964.0001; GRISCELLI C, 1969, J EXP MED, V130, P1427, DOI 10.1084/jem.130.6.1427; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; HAQ JA, 1991, INFECT IMMUN, V59, P3094, DOI 10.1128/IAI.59.9.3094-3100.1991; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Israel ZR, 1999, AIDS RES HUM RETROV, V15, P1121, DOI 10.1089/088922299310412; Jertborn M, 2001, INFECT IMMUN, V69, P4125, DOI 10.1128/IAI.69.6.4125-4128.2001; Johansson EL, 2004, VACCINE, V22, P984, DOI 10.1016/j.vaccine.2003.09.002; Johansson EL, 2001, INFECT IMMUN, V69, P7481, DOI 10.1128/IAI.69.12.7481-7486.2001; Kanellos TS, 2000, IMMUNOL LETT, V74, P215, DOI 10.1016/S0165-2478(00)00257-1; Kantele A, 1999, VACCINE, V17, P229, DOI 10.1016/S0264-410X(98)00193-5; Koga T, 2000, J IMMUNOL, V165, P5352, DOI 10.4049/jimmunol.165.9.5352; Kowalczyk DW, 2001, VACCINE, V19, P3583, DOI 10.1016/S0264-410X(01)00070-6; Kozlowski PA, 1997, INFECT IMMUN, V65, P1387, DOI 10.1128/IAI.65.4.1387-1394.1997; Kunkel EJ, 2003, NAT REV IMMUNOL, V3, P822, DOI 10.1038/nri1203; Lee CK, 1999, VACCINE, V17, P3072, DOI 10.1016/S0264-410X(99)00144-9; LEHNER T, 1994, J VIROL, V68, P1624, DOI 10.1128/JVI.68.3.1624-1632.1994; Mantis NJ, 2001, VACCINE, V19, P3990, DOI 10.1016/S0264-410X(01)00115-3; MARX PA, 1993, SCIENCE, V260, P1323, DOI 10.1126/science.8493576; McCluskie MJ, 2000, MOL MED, V6, P867, DOI 10.1007/BF03401824; McCluskie MJ, 2002, FEMS IMMUNOL MED MIC, V32, P179, DOI 10.1016/S0928-8244(01)00305-4; MCGHEE JR, 1992, VACCINE, V10, P75, DOI 10.1016/0264-410X(92)90021-B; Mestecky J, 1989, CURR TOP MICROBIOL I, V146, P1; Mestecky J, 2013, ANNU REV PATHOL-MECH, V8, P217, DOI 10.1146/annurev-pathol-011110-130216; Nardelli-Haefliger D, 2003, JNCI-J NATL CANCER I, V95, P1128, DOI 10.1093/jnci/djg018; Ogra Pearay L., 1996, P3, DOI 10.1016/B978-012410580-5/50002-9; Pakkanen SH, 2010, CLIN VACCINE IMMUNOL, V17, P393, DOI 10.1128/CVI.00475-09; Pavot V, 2012, VACCINE, V30, P142, DOI 10.1016/j.vaccine.2011.11.003; QUIDING M, 1991, J CLIN INVEST, V88, P143, DOI 10.1172/JCI115270; QuidingJarbrink M, 1997, J CLIN INVEST, V99, P1281, DOI 10.1172/JCI119286; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Tanaka N, 2007, VACCINE, V25, P2680, DOI 10.1016/j.vaccine.2006.10.014; Yanagita M, 1999, J IMMUNOL, V162, P3559; Yu HH, 2011, CLIN REV ALLERG IMMU, V41, P198, DOI 10.1007/s12016-010-8232-0	49	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168037	10.1371/journal.pone.0168037	http://dx.doi.org/10.1371/journal.pone.0168037			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936222	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100258
J	Talens-Perales, D; Gorska, A; Huson, DH; Polaina, J; Marin-Navarro, J				Talens-Perales, David; Gorska, Anna; Huson, Daniel H.; Polaina, Julio; Marin-Navarro, Julia			Analysis of Domain Architecture and Phylogenetics of Family 2 Glycoside Hydrolases (GH2)	PLOS ONE			English	Article							GALACTOSIDASE ESCHERICHIA-COLI; BETA-GALACTOSIDASE; ACTIVE-SITE; CRYSTAL-STRUCTURE; OLIGOSACCHARIDES; LACTOSE; BINDING; SPECIFICITY; GENERATION; EFFICIENCY	In this work we report a detailed analysis of the topology and phylogenetics of family 2 glycoside hydrolases (GH2). We distinguish five topologies or domain architectures based on the presence and distribution of protein domains defined in Pfam and Interpro databases. All of them share a central TIM barrel (catalytic module) with two beta-sandwich domains (non-catalytic) at the N-terminal end, but differ in the occurrence and nature of additional non-catalytic modules at the C-terminal region. Phylogenetic analysis was based on the sequence of the Pfam Glyco_hydro_2_C catalytic module present in most GH2 proteins. Our results led us to propose a model in which evolutionary diversity of GH2 enzymes is driven by the addition of different non-catalytic domains at the C-terminal region. This model accounts for the divergence of beta-galactosidases from beta-glucuronidases, the diversification of beta-galactosidases with different transglycosylation specificities, and the emergence of bicistronic beta-galactosidases. This study also allows the identification of groups of functionally uncharacterized protein sequences with potential biotechnological interest.	[Talens-Perales, David; Polaina, Julio; Marin-Navarro, Julia] CSIC, Inst Agroquim & Tecnol Alimentos, Valencia, Spain; [Gorska, Anna; Huson, Daniel H.] Univ Tubingen, Ctr Bioinformat, Tubingen, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); Eberhard Karls University of Tubingen	Marin-Navarro, J (corresponding author), CSIC, Inst Agroquim & Tecnol Alimentos, Valencia, Spain.	jumana@iata.csic.es	Polaina, Julio/H-4498-2012; Talens-Perales, David/E-8558-2017; Talens-Perales, David/AAE-9116-2020; Huson, Daniel H./AAC-5494-2019; Marin-Navarro, Julia/F-7630-2016	Talens-Perales, David/0000-0002-8693-4239; Marin-Navarro, Julia/0000-0001-7893-3423; Polaina, Julio/0000-0001-9912-0640	European Union [H2020 - 634486 - INMARE]; Spain 'Secretaria de Estado de Investigacion, Desarrollo e Innovacion' [BIO2013-48779-C4-3-R]; Ministerio de Economia y Competitividad	European Union(European Commission); Spain 'Secretaria de Estado de Investigacion, Desarrollo e Innovacion'; Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by a grant from the European Union, H2020 - 634486 - INMARE (JP) (https://ec.europa.eu/programmes/horizon2020/); and a grant from Spain 'Secretaria de Estado de Investigacion, Desarrollo e Innovacion' BIO2013-48779-C4-3-R (JP) (http://www.mineco.gob.es/portal/site/mineco/idi). DT-P was supported by a FPU predoctoral fellowship from 'Ministerio de Economia y Competitividad'.	Adam AC, 2004, CRIT REV FOOD SCI, V44, P553, DOI 10.1080/10408690490931411; Bae T, 2003, J BACTERIOL, V185, P2910, DOI 10.1128/JB.185.9.2910-2919.2003; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Baumgartner S, 1998, PROTEIN SCI, V7, P1626, DOI 10.1002/pro.5560070717; Cheng W, 2012, J BIOL CHEM, V287, P22910, DOI 10.1074/jbc.M112.367128; Crittenden RG, 1996, TRENDS FOOD SCI TECH, V7, P353, DOI 10.1016/S0924-2244(96)10038-8; DeDent A, 2008, EMBO J, V27, P2656, DOI 10.1038/emboj.2008.185; GEBLER JC, 1992, J BIOL CHEM, V267, P11126; Huber RE, 2003, BIOCHEMISTRY-US, V42, P1796, DOI 10.1021/bi0270642; Huber RE, 2001, BIOCHEM CELL BIOL, V79, P183, DOI 10.1139/o00-101; Hung MN, 2001, APPL ENVIRON MICROB, V67, P4256, DOI 10.1128/AEM.67.9.4256-4263.2001; Husain Q, 2010, CRIT REV BIOTECHNOL, V30, P41, DOI 10.3109/07388550903330497; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Ishikawa K, 2015, FEBS J, V282, P2540, DOI 10.1111/febs.13298; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; Jain S, 1996, NAT STRUCT BIOL, V3, P375, DOI 10.1038/nsb0496-375; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jorgensen F, 2001, APPL MICROBIOL BIOT, V57, P647, DOI 10.1007/s00253-001-0845-z; Juers DH, 2001, BIOCHEMISTRY-US, V40, P14781, DOI 10.1021/bi011727i; Juers DH, 1999, PROTEIN SCI, V8, P122; Juers DH, 2012, PROTEIN SCI, V21, P1792, DOI 10.1002/pro.2165; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Marin-Navarro J, 2014, WORLD J MICROB BIOT, V30, P989, DOI 10.1007/s11274-013-1517-8; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Pereira-Rodriguez A, 2012, J STRUCT BIOL, V177, P392, DOI 10.1016/j.jsb.2011.11.031; Petzelbauer I, 2000, EUR J BIOCHEM, V267, P5055, DOI 10.1046/j.1432-1327.2000.01562.x; Rigden DJ, 2005, FEBS LETT, V579, P5466, DOI 10.1016/j.febslet.2005.09.011; Rodriguez-Colinas B, 2011, J AGR FOOD CHEM, V59, P10477, DOI 10.1021/jf2022012; Roth NJ, 1996, J BIOL CHEM, V271, P14296, DOI 10.1074/jbc.271.24.14296; RUTENBER E, 1987, NATURE, V326, P624, DOI 10.1038/326624a0; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh AK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004364; Skalova T, 2005, J MOL BIOL, V353, P282, DOI 10.1016/j.jmb.2005.08.028; Song JY, 2011, BIOSCI BIOTECH BIOCH, V75, P1194, DOI 10.1271/bbb.110014; Splechtna B, 2006, J AGR FOOD CHEM, V54, P4999, DOI 10.1021/jf053127m; Talens-Perales D, 2016, J AGR FOOD CHEM, V64, P2917, DOI 10.1021/acs.jafc.6b00222; Tamura K., 2013, MOL BIOL EVOL, P197; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Torres DPM, 2010, COMPR REV FOOD SCI F, V9, P438, DOI 10.1111/j.1541-4337.2010.00119.x; Wallace BD, 2015, CHEM BIOL, V22, P1238, DOI 10.1016/j.chembiol.2015.08.005; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; Warmerdam A, 2013, APPL BIOCHEM BIOTECH, V170, P340, DOI 10.1007/s12010-013-0181-7; Wheatley RW, 2012, ARCH BIOCHEM BIOPHYS, V521, P51, DOI 10.1016/j.abb.2012.03.014; Xu J, 2004, BIOCHEM CELL BIOL, V82, P275, DOI 10.1139/o04-004; YANAHIRA S, 1995, BIOSCI BIOTECH BIOCH, V59, P1021, DOI 10.1271/bbb.59.1021	47	19	19	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0168035	10.1371/journal.pone.0168035	http://dx.doi.org/10.1371/journal.pone.0168035			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930742	Green Submitted, Green Published, gold			2022-12-27	WOS:000389580900073
J	Hsu, SD; Chen, CJ; Chang, WK; Hu, YJ				Hsu, Sheng-Der; Chen, Cheng-Jueng; Chang, Wei-Kuo; Hu, Yih-Jin			An Investigation of the Outcomes of PGY Students' Cognition of and Persistent Behavior in Learning through the Intervention of the Flipped Classroom in Taiwan	PLOS ONE			English	Article							MODELS	The Postgraduate Year (PGY) Program allows doctors-in-training to learn about the diagnosis, treatment and nursing of various common, general diseases. These items form the core curriculum and are mostly learned through caring for patients and clinical teaching. Doctorsin- training are evaluated for their knowledge through written tests or assignments, based on which the effectiveness of their training is also assessed; however, this generally produces a negative learning attitude among them. So we introduced the flipped classroom into PGY training program to change PGY students' learning behavior. Although the flipped classroom is highly valued and has been practiced by teachers in schools of various levels, very few attempts have been made until now to report the learning outcomes achieved through the flipped classroom by means of rigorous research methods. Therefore we tried to employed Ajzen and Fishbein's (1980) theory of reasoned action and Bandura's self-efficacy to predict and explain the participants' behavioral intention when participating in the core curriculum learning of the flipped classroom and to assess the change in students' learning behavior and learning effectiveness. From August 2013 to July 2014, 39 PGY students from the General Surgery of the Tri-Service General Hospital were selected as the participants of this study. The control group included 43 students of the previous year, that is, the year before the intervention of the flipped classroom. A comparative analysis was performed. The questionnaire's related matrices indicated highest correlation between self-efficacy and behavioral intention (r = 0.491, P < 0.01), followed by attitude (r = 0.365, P < 0.01) and subjective norms (r = 0.360, P < 0.01.) All three showed positive correlations with behavioral intention; among attitude, subjective norms, and self-efficacy, the pairwise correlations also reached significance level. The flipped classroom can indeed change PGY students' the learning behavior from "passive learning" to "active learning."	[Hsu, Sheng-Der; Chen, Cheng-Jueng] Tri Serv Gen Hosp, Div Gen Surg, Dept Surg, Natl Def Med Ctr, Taipei, Taiwan; [Hsu, Sheng-Der; Chen, Cheng-Jueng] Tri Serv Gen Hosp, Div Trauma Surg, Dept Surg, Natl Def Med Ctr, Taipei, Taiwan; [Chang, Wei-Kuo] Tri Serv Gen Hosp, Div Gastroenterol, Dept Internal Med, Natl Def Med Ctr, Taipei, Taiwan; [Hsu, Sheng-Der; Hu, Yih-Jin] Natl Taiwan Normal Univ, Dept Hlth Promot & Hlth Educ, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Taiwan Normal University	Hu, YJ (corresponding author), Natl Taiwan Normal Univ, Dept Hlth Promot & Hlth Educ, Taipei, Taiwan.	yjhub1@yahoo.com		Hsu, Sheng-Der/0000-0001-9698-8954				Baker JW, 2000, SELECTED PAPERS FROM THE 11TH INTERNATIONAL CONFERENCE ON COLLEGE TEACHING AND LEARNING, P9; BANDURA A, 1980, COGNITIVE THER RES, V4, P263, DOI 10.1007/BF01173659; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bishop J. L., 2013, AM SOC ENG ED ATL GA; Brame C. J., 2013, FLIPPING CLASSROOM; Brown L. J., 2005, J SPORT BEHAV, V28, P136; Cartoni A. C., 2005, J SPORTS BEHAV, V28, P3; Chang WP, 2013, J MED EDUC, V17, P92; Chaplin S., 2009, J COLL SCI TEACH, V39, P72; Chu TS, 2009, J FORMOS MED ASSOC, V108, P830, DOI 10.1016/S0929-6646(09)60413-7; Classroom Window, 2012, FLIPP CLASSR IMPR TE; Forsey M, 2013, J SOCIOL, V49, P471, DOI 10.1177/1440783313504059; Goodwin B, 2013, EDUC LEADERSHIP, V70, P78; Hamer L.O., 2000, J MARKETING ED, V22, DOI [10.1177/0273475300221004, DOI 10.1177/0273475300221004]; Herreid C. F., 2013, J COLL SCI TEACH, V42, P62, DOI DOI 10.4108/EL.1.3.E1; Josh C., 2013, 6 STEPS FLIPPED CLAS; Lage MJ, 2000, J ECON EDUC, V31, P30, DOI 10.2307/1183338; Lee FY, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000200; Lo WL, 2014, TZU CHI MED J, V26, P64, DOI 10.1016/j.tcmj.2014.05.002; Marshall H., 2013, 3 REASONS FLIP YOUR; Marshall H. W., 2013, MAKING TRANSITION CU; Mayer R., 2007, LEARNING INSTRUCTION; McLaughlin JE, 2013, AM J PHARM EDUC, V77, DOI 10.5688/ajpe779196; Musallam R, 2010, EFFECTS SCREENCASTIN; O'Dowd DK, 2009, CBE-LIFE SCI EDUC, V8, P118, DOI 10.1187/cbe.09-01-0001; SooHoo S., 2004, J SPORT BEHAV, V27, P349; University of Minnesota Center forEducational Innovation, 2008, WHAT IS ACT LEARN; Van der Pligt J, 1998, PSYCHOL HEALTH, V13, P289, DOI 10.1080/08870449808406752; Walvoord B. E., 2009, EFFECTIVE GRADING TO; Williams David M., 2004, J SPORT BEHAV, V27, P170	30	16	16	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167598	10.1371/journal.pone.0167598	http://dx.doi.org/10.1371/journal.pone.0167598			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3TF	27911937	Green Published, gold, Green Submitted			2022-12-27	WOS:000389520600044
J	Zhang, CM; Liu, JJ; Jin, N; Zhang, GM; Xi, YH; Liu, HL				Zhang, Chunmei; Liu, Jingjing; Jin, Na; Zhang, Guiming; Xi, Yahui; Liu, Hongling			SiRNA Targeting mTOR Effectively Prevents the Proliferation and Migration of Human Lens Epithelial Cells	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE; MESENCHYMAL TRANSITION; CANCER; GROWTH; SURVIVAL; PATHWAY; AKT; RAPAMYCIN; BETA; PHOSPHORYLATION	Posterior capsule opacification (PCO) is the most common complication that causes visual decrease after extracapsular cataract surgery. The primary cause of PCO formation is the proliferation of the residual lens epithelial cells (LECs). The mammalian target of rapamycin (mTOR) plays an important role in the growth and migration of LECs. In the current study, we used small interfering RNA (siRNA) to specifically attenuate mTOR in human lens epithelial B3 cells (HLE B3). We aimed to examine the effect of mTOR-siRNA on the proliferation, migration and epithelial-to-mesenchymal transition (EMT) of HLE B3 cells and explore the underlying mechanisms. The mTOR-siRNA was transfected into HLE B3 cells using lipofectamine 2000. The mRNA and protein levels of mTOR were examined to confirm the efficiency of mTOR-siRNA. The levels of mRNA and protein as well as the activity of mTOR down-stream effectors p70 ribosomal protein S6 kinase (p70S6K) and protein kinase B (PKB, AKT) were examined using real-time PCR or Western blot, respectively. The cell proliferation was determined using cell counting kit (CCK) 8 and cell growth curve assay. The cell migration was examined using Transwell system and Scratch assay. MTOR-siRNA effectively eliminated mTOR mRNA and protein. The proliferation and migration were significantly suppressed by mTOR-siRNA transfection. mTOR-siRNA reduced the mRNA of p70S6K and AKT in a time-dependent manner. Furthermore, the phosphorylation of p70S6K and AKT was decreased by mTOR-siRNA. MTOR-siRNA also eliminated the formation of mTORC1 and mTORC2 protein complex and blocked the transforming growth factor (TGF)-beta-induced EMT. Our results suggested that mTOR-siRNA could effectively inhibit the proliferation, migration and EMT of HLE B3 cells through the inhibition of p70S6K and AKT. These results indicated that mTOR-siRNA might be an effective agent inhibiting HLE cells growth and EMT following cataract surgery and provide an alternative therapy for preventing PCO.	[Zhang, Chunmei; Liu, Jingjing; Jin, Na; Xi, Yahui; Liu, Hongling] Harbin Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Harbin, Peoples R China; [Zhang, Guiming] 2 Hosp Xiamen, Dept Ophthalmol, Xiamen, Fujian, Peoples R China	Harbin Medical University	Liu, HL (corresponding author), Harbin Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Harbin, Peoples R China.	hydliuhl@163.com			National Natural Science Foundation (NSFC) [81301325]	National Natural Science Foundation (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Natural Science Foundation (NSFC: 81301325) to HL.	Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Boonanuntanasarn S, 2004, PIGM CELL RES, V17, P413, DOI 10.1111/j.1600-0749.2004.00166.x; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carayol N, 2010, P NATL ACAD SCI USA, V107, P12469, DOI 10.1073/pnas.1005114107; Cho HJ, 2007, BIOCHEM BIOPH RES CO, V353, P337, DOI 10.1016/j.bbrc.2006.12.035; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Gotoh N, 2007, INVEST OPTHAMOL VIS, V48, P4079; Grewe M, 1999, CANCER RES, V59, P3581; Higashi Y, 2000, J NEUROCHEM, V75, P1771, DOI 10.1046/j.1471-4159.2000.0751771.x; Hou GQ, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/845763; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lamouille S, 2012, J CELL SCI, V125, P1259, DOI 10.1242/jcs.095299; Lawrence Jr JC, 2003, SCI STKE, V212, P1; Liu HL, 2010, MOL VIS, V16, P1646; Marques M, 2009, P NATL ACAD SCI USA, V106, P7525, DOI 10.1073/pnas.0812000106; Matsubara H, 2012, INT J CLIN EXP PATHO, V5, P119; Meng QL, 2013, GRAEF ARCH CLIN EXP, V251, P2363, DOI 10.1007/s00417-013-2435-z; Moore SM, 1998, CANCER RES, V58, P5239; Noh WC, 2011, BREAST CANC RES TREA, V110, P477; Plasterk RHA, 2002, SCIENCE, V296, P1263, DOI 10.1126/science.1072148; Saika S, 2002, BRIT J OPHTHALMOL, V86, P1428, DOI 10.1136/bjo.86.12.1428; Saika S, 2001, EXP EYE RES, V72, P679, DOI 10.1006/exer.2001.1002; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Tato I, 2011, J BIOL CHEM, V286, P6128, DOI 10.1074/jbc.M110.166991; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Zhang YJ, 2009, ANN SURG ONCOL, V16, P2617, DOI 10.1245/s10434-009-0555-9; Zhang Zhi-yong, 2011, Zhonghua Yi Xue Za Zhi, V91, P2899; Zhou Y, 2007, BRIT J CANCER, V97, P218, DOI 10.1038/sj.bjc.6603838	32	10	11	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167349	10.1371/journal.pone.0167349	http://dx.doi.org/10.1371/journal.pone.0167349			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911920	Green Published, Green Submitted, gold			2022-12-27	WOS:000389520600031
J	Annarapu, GK; Singhal, R; Gupta, A; Chawla, S; Batra, H; Seth, T; Guchhait, P				Annarapu, Gowtham K.; Singhal, Rashi; Gupta, Avinash; Chawla, Sheetal; Batra, Harish; Seth, Tulika; Guchhait, Prasenjit			HbS Binding to GP1b alpha Activates Platelets in Sickle Cell Disease	PLOS ONE			English	Article							INTRAVASCULAR HEMOLYSIS; HEMOGLOBIN; MECHANISM; ADAMTS-13	Intravascular hemolysis increases the risk of thrombosis in hemolytic disorders. Our previous study showed that the binding of adult hemoglobin (HbA) to glycoprotein (GP) 1b alpha induced the activation of platelets. The elevated plasma Hb or platelet surface bound Hb positively correlated with platelet activation in patients with paroxysmal nocturnal hemoglobinuria (PNH). Furthermore, this study shows that the sickle Hb [HbS, occurs due to single nucleotide polymorphism at A>T of beta-globin gene of Hb and causes sickle cell disease (SCD)] also bound to GP1b alpha and activated platelets in a concentration-dependent manner. The HbS bound to glycocalicin (extramembranous part of GP1ba) with K-D similar to 10.46 +/- 3 mu M. HbS induced phosphorylation of signaling adapter proteins, such as Lyn, PI3K, Akt and ERK in platelets, and also increased the surface expression of platelet activation markers such as P-selectin (10.7 fold) and PAC1 binding (10.4 fold) in platelet surface in a concentration-dependent manner. HbS also increased the platelet microparticle-generation (4.7 fold) and thrombus-formation (4.3 fold) in a concentration-dependent manner. An elevated level of extracellular Hb in plasma correlated directly with platelet activation markers such as P-selectin (r = 0.7947), PAC1 binding (r = 0.5914) on platelet surface and plasma levels of platelet-derived microparticles (r = 0.7834) in patients with SCD. Our study therefore suggests that the HbS-induced platelet activation may play a crucial role in intravascular clot formation observed in SCD patients characterized by high propensity to vascular occlusion and hypercoagulable states.	[Annarapu, Gowtham K.; Singhal, Rashi; Gupta, Avinash; Chawla, Sheetal; Guchhait, Prasenjit] Natl Capital Reg Biotech Sci Cluster, Dis Biol Lab, Reg Ctr Biotechnol, Faridabad, India; [Annarapu, Gowtham K.; Singhal, Rashi] Manipal Univ, Dept Biotechnol, Manipal, Karnataka, India; [Batra, Harish; Seth, Tulika] All India Inst Med Sci, Dept Med Hematol, New Delhi, India	Department of Biotechnology (DBT) India; Regional Centre for Biotechnology; Manipal Academy of Higher Education (MAHE); All India Institute of Medical Sciences (AIIMS) New Delhi	Guchhait, P (corresponding author), Natl Capital Reg Biotech Sci Cluster, Dis Biol Lab, Reg Ctr Biotechnol, Faridabad, India.	prasenjit@rcb.res.in	Annarapu, Gowtham K/N-5829-2017	Annarapu, Gowtham K/0000-0002-6761-0976				[Anonymous], 2008, REPORT SICKLE CELL D; [Anonymous], 2006, WHO REPORT SICKLE CE; ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; Ataga Kenneth I, 2007, Hematology Am Soc Hematol Educ Program, P91; Chirico EN, 2015, SPORTS MED; De Franceschi L, 2011, SEMIN THROMB HEMOST, V37, P226, DOI 10.1055/s-0031-1273087; Dong JF, 2003, J BIOL CHEM, V278, P29633, DOI 10.1074/jbc.M301385200; Du XP, 2007, CURR OPIN HEMATOL, V14, P262, DOI 10.1097/MOH.0b013e3280dce51a; Gowtham K, 2016, PLOS ONE; Helms CC, 2013, J THROMB HAEMOST, V11, P2148, DOI 10.1111/jth.12422; RADOMSKI MW, 1987, LANCET, V2, P1057, DOI 10.1016/S0140-6736(87)91481-4; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Romo GM, 1999, J EXP MED, V190, P803, DOI 10.1084/jem.190.6.803; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; Singhal R, 2015, HAEMATOLOGICA, V100, P1526, DOI 10.3324/haematol.2015.132183; Villagra J, 2007, BLOOD, V110, P2166, DOI 10.1182/blood-2006-12-061697; Zhang D, 2016, BLOOD; Zhou Z, 2012, CURR VASC PHARMACOL, V10, P756, DOI 10.2174/157016112803520738; Zhou Z, 2009, THROMB HAEMOSTASIS, V101, P1070, DOI 10.1160/TH08-10-0677	20	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167899	10.1371/journal.pone.0167899	http://dx.doi.org/10.1371/journal.pone.0167899			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936141	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100227
J	Azuma, K; Uchiyama, I; Tanigawa, M; Bamba, I; Azuma, M; Takano, H; Yoshikawa, T; Sakabe, K				Azuma, Kenichi; Uchiyama, Iwao; Tanigawa, Mari; Bamba, Ikuko; Azuma, Michiyo; Takano, Hirohisa; Yoshikawa, Toshikazu; Sakabe, Kou			Association of Odor Thresholds and Responses in Cerebral Blood Flow of the Prefrontal Area during Olfactory Stimulation in Patients with Multiple Chemical Sensitivity	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; IDENTIFICATION TEST; AIRBORNE CHEMICALS; GENERAL-POPULATION; EPISODIC MEMORY; BRAIN; PROVOCATION; DYSFUNCTION; COMPONENTS; EXPOSURE	Multiple chemical sensitivity (MCS) is a disorder characterized by nonspecific and recurrent symptoms from various organ systems associated with exposure to low levels of chemicals. Patients with MCS process odors differently than controls do. Previously, we suggested that this odor processing was associated with increased regional cerebral blood flow (rCBF) in the prefrontal area during olfactory stimulation using near-infrared spectroscopic (NIRS) imaging. The aim of this study was to investigate the association of odor thresholds and changes in rCBF during olfactory stimulation at odor threshold levels in patients with MCS. We investigated changes in the prefrontal area using NIRS imaging and a T&T olfactometer during olfactory stimulation with two different odorants (sweet and fecal) at three concentrations (zero, odor recognition threshold, and normal perceived odor level) in 10 patients with MCS and six controls. The T&T olfactometer threshold test and subjective assessment of irritating and hedonic odors were also performed. The results indicated that the scores for both unpleasant and pungent odors were significantly higher for those for sweet odors at the normal perceived level in patients with MCS than in controls. The brain responses at the recognition threshold (fecal odor) and normal perceived levels (sweet and fecal odors) were stronger in patients with MCS than in controls. However, significant differences in the odor detection and recognition thresholds and odor intensity score between the two groups were not observed. These brain responses may involve cognitive and memory processing systems during past exposure to chemicals. Further research regarding the cognitive features of sensory perception and memory due to past exposure to chemicals and their associations with MCS symptoms is needed.	[Azuma, Kenichi] Kindai Univ, Fac Med, Dept Environm Med & Behav Sci, Osaka, Japan; [Azuma, Kenichi; Uchiyama, Iwao] Louis Pasteur Ctr Med Res, Basic Res Div, Sick House Med Sci Lab, Kyoto, Japan; [Uchiyama, Iwao] Hyakumanben Clin, Outpatient Dept Sick House Syndrome, Kyoto, Japan; [Tanigawa, Mari] Louis Pasteur Ctr Med Res, Clin Immune Funct Lab, Basic Res Div, Kyoto, Japan; [Tanigawa, Mari] Hyakumanben Clin, Div Internal Med, Kyoto, Japan; [Bamba, Ikuko] Tokyo Gakugei Univ, Fac Educ, Home Econ, Koganei, Tokyo, Japan; [Azuma, Michiyo] Kio Univ, Fac Hlth Sci, Dept Human Environm Design, Koryo, Nara, Japan; [Takano, Hirohisa] Kyoto Univ, Grad Sch Engn, Dept Environm Engn, Kyoto, Japan; [Yoshikawa, Toshikazu] Kyoto Prefectural Univ Med, Dept Internal Med, Kyoto, Japan; [Sakabe, Kou] Tokai Univ, Dept Anat & Cellular Biol, Sch Med, Isehara, Kanagawa, Japan	Kindai University (Kinki University); Tokyo Gakugei University; Kyoto University; Kyoto Prefectural University of Medicine; Tokai University	Azuma, K (corresponding author), Kindai Univ, Fac Med, Dept Environm Med & Behav Sci, Osaka, Japan.; Azuma, K (corresponding author), Louis Pasteur Ctr Med Res, Basic Res Div, Sick House Med Sci Lab, Kyoto, Japan.	kenazuma@med.kindai.ac.jp		Azuma, Kenichi/0000-0002-6382-9807	Japan Ministry of the Environment [H25-5962]; Japan Ministry of Health, Labour and Welfare [H25-008]; Grants-in-Aid for Scientific Research [16K09116] Funding Source: KAKEN	Japan Ministry of the Environment(Ministry of the Environment, Japan); Japan Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was financially supported by a health science research grant (H25-5962) from the Japan Ministry of the Environment and a Grant-in-Aid for Health and Labour Sciences Research Grant (H25-008) provided by the Japan Ministry of Health, Labour and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was financially supported by a health science research grant (H25-5962) from the Japan Ministry of the Environment and a Grant-in-Aid for Health and Labour Sciences Research Grant (H25-008) provided by the Japan Ministry of Health, Labour and Welfare. We express our sincere appreciation to the staff members of the Hyakumanben Clinic for their assistance in data collection.	Alessandrini M, 2016, BRAIN TOPOGR, V29, P243, DOI 10.1007/s10548-015-0453-3; Andersson L, 2014, J PSYCHOSOM RES, V77, P401, DOI 10.1016/j.jpsychores.2014.09.014; Azuma K, 2015, ARCH ENVIRON OCCUP H, V70, P341, DOI 10.1080/19338244.2014.926855; Azuma K, 2015, ENVIRON HEALTH PREV, V20, P185, DOI 10.1007/s12199-015-0448-4; Azuma K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080567; Berg ND, 2008, INT ARCH OCC ENV HEA, V81, P881, DOI 10.1007/s00420-007-0282-0; Berg ND, 2009, INT ARCH OCC ENV HEA, V82, P509, DOI 10.1007/s00420-008-0352-y; Bornschein S, 2008, CLIN TOXICOL, V46, P443, DOI 10.1080/15563650701742438; Chiaravalloti A, 2015, EUR J NUCL MED MOL I, V42, P733, DOI 10.1007/s00259-014-2969-2; CULLEN MR, 1987, OCCUP MED, V2, P655; Dade LA, 2002, BRAIN, V125, P86, DOI 10.1093/brain/awf003; Dantoft TM, 2015, CURR RHEUMATOL REV, V11, P167, DOI 10.2174/157339711102150702111101; Das-Munshi J, 2006, J ALLERGY CLIN IMMUN, V118, P1257, DOI 10.1016/j.jaci.2006.07.046; DOTY RL, 1994, PERCEPT PSYCHOPHYS, V56, P701, DOI 10.3758/BF03208363; ENGEN T, 1987, AM SCI, V75, P497; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fujii M, 2002, AURIS NASUS LARYNX, V29, P35, DOI 10.1016/S0385-8146(01)00118-3; Graveling RA, 1999, OCCUP ENVIRON MED, V56, P73, DOI 10.1136/oem.56.2.73; Hasegawa Maki, 2009, JAPANESE J ALLERGY, V58, p112 ; Hashimoto Y, 2004, CHEM SENSES, V29, P565, DOI 10.1093/chemse/bjh061; Hillert L, 2007, HUM BRAIN MAPP, V28, P172, DOI 10.1002/hbm.20266; HINTON PB, 1993, B PSYCHONOMIC SOC, V31, P595, DOI 10.3758/BF03337365; HOCK C, 1995, J CEREBR BLOOD F MET, V15, P1103, DOI 10.1038/jcbfm.1995.137; IKEDA K, 1988, J LARYNGOL OTOL, V102, P1111, DOI 10.1017/S0022215100107467; Kameyama M, 2006, NEUROIMAGE, V29, P172, DOI 10.1016/j.neuroimage.2005.07.025; Kondo H, 1998, AM J RHINOL, V12, P353, DOI 10.2500/105065898780182390; Lacour M, 2005, INT J HYG ENVIR HEAL, V208, P141, DOI 10.1016/j.ijheh.2005.01.017; Miller CS, 1999, TOXICOL IND HEALTH, V15, P370, DOI 10.1177/074823379901500311; Okamoto M, 2006, NEUROIMAGE, V31, P796, DOI 10.1016/j.neuroimage.2005.12.021; Orriols R, 2009, J NEUROL SCI, V287, P72, DOI 10.1016/j.jns.2009.09.003; Saive AL, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00240; Savic I, 2000, NEURON, V26, P735, DOI 10.1016/S0896-6273(00)81209-X; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Skovbjerg S, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/304314; Sorg BA, 1999, CRIT REV NEUROBIOL, V13, P283, DOI 10.1615/CritRevNeurobiol.v13.i3.30; STAUDENMAYER H, 1993, REGUL TOXICOL PHARM, V18, P44, DOI 10.1006/rtph.1993.1043; TAKAGI SF, 1987, ANN NY ACAD SCI, V510, P113; Tanida M, 2004, NEUROSCI LETT, V369, P69, DOI 10.1016/j.neulet.2004.07.076; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; TULVING E, 1984, BEHAV BRAIN SCI, V7, P223, DOI 10.1017/S0140525X0004440X; Tulving E., 1972, ORG MEMORY, DOI DOI 10.1017/S0140525X00047257; Winder C, 2002, TOXICOL LETT, V128, P85, DOI 10.1016/S0378-4274(01)00536-7; Yoshida T, 2012, JPN SOC OCCUP MED TR, V60, P11; ZUSHO H, 1983, Rhinology (Utrecht), V21, P281; Zusho H, 1981, Auris Nasus Larynx, V8, P19; 1999, ARCH ENVIRON HEALTH, V54, P147, DOI DOI 10.1080/00039899909602251	46	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168006	10.1371/journal.pone.0168006	http://dx.doi.org/10.1371/journal.pone.0168006			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936122	gold, Green Submitted, Green Published			2022-12-27	WOS:000389587100249
J	Cloonan, KR; Andreadis, SS; Chen, HB; Jenkins, NE; Baker, TC				Cloonan, Kevin R.; Andreadis, Stefanos S.; Chen, Haibin; Jenkins, Nina E.; Baker, Thomas C.			Attraction, Oviposition and Larval Survival of the Fungus Gnat, Lycoriella ingenua, on Fungal Species Isolated from Adults, Larvae, and Mushroom Compost	PLOS ONE			English	Article							MALI DIPTERA; SCIARID FLY; DROSOPHILA-MELANOGASTER; PERMETHRIN RESISTANCE; PENICILLIUM-CITRINUM; AURIPILA; INSECTICIDES; IDENTIFICATION; VOLATILES; ALLERGEN	We previously showed that the females of the mushroom sciarid, Lycoriella ingenua (Dufour, 1839) (Diptera: Sciaridae), one of the most severe pests of the cultivated white button mushroom, Agaricus bisporus (J. E. Lange) Emil J. Imbach (Agaricales: Agaricaceae), are attracted to the mushroom compost that mushrooms are grown on and not to the mushrooms themselves. We also showed that females are attracted to the parasitic green mold, Trichoderma aggressivum. In an attempt to identify what is in the mushroom compost that attracts female L. ingenua, we isolated several species of fungi from adult males and females, third instar larvae, and mushroom compost itself. We then analyzed the attraction of females to these substrates using a static-flow two choice olfactometer, as well as their oviposition tendencies in another type of assay under choice and no-choice conditions. We also assessed the survival of larvae to adulthood when first instar larvae were placed on each of the isolated fungal species. We found that female flies were attracted most to the mycoparasitic green mold, T. aggressivum, to Penicilium citrinum isolated from adult female bodies, and to Scatylidium thermophilium isolated from the mushroom compost. Gravid female flies laid the most eggs on T. aggressivum, Aspergillus flavus isolated from third instar larval frass, Aspergillus fumigatus isolated from adult male bodies, and on P. citrinum. This egg-laying trend remained consistent under no-choice conditions as females aged. First instar larvae developed to adulthood only on S. thermophilium and Chaetomium sp. isolated from mushroom compost, and on P. citrinum. Our results indicate that the volatiles from a suite of different fungal species act in tandem in the natural setting of mushroom compost, with some first attracting gravid female flies and then others causing them to oviposit. The ecological context of these findings is important for creating an optimal strategy for using possible semiochemicals isolated from these fungal species to better monitor and control this pestiferous mushroom fly species.	[Cloonan, Kevin R.; Andreadis, Stefanos S.; Jenkins, Nina E.; Baker, Thomas C.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Chen, Haibin] Wenzhou Med Univ, Inst Hlth & Environm Ecol, Wenzhou, Zhejiang, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Wenzhou Medical University	Baker, TC (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	tcb10@psu.edu	Andreadis, Stefanos/GWR-2360-2022		United States Department of Agriculture/National Institute of Food and Agriculture/Specialty Crop Research Initiative Grant [2012-51181-19912]	United States Department of Agriculture/National Institute of Food and Agriculture/Specialty Crop Research Initiative Grant	United States Department of Agriculture/National Institute of Food and Agriculture/Specialty Crop Research Initiative Grant number 2012-51181-19912 URL: https://nifa.usda.gov/program/specialty crop-research initiative-sal The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreadis SS, 2015, FRONTIERS ECOLOGY EV, V3; Andreadis SS, 2015, J CHEM ECOL, V41, P1127, DOI 10.1007/s10886-015-0650-2; Bartlett GR, 1997, PESTIC BIOCHEM PHYS, V58, P173, DOI 10.1006/pest.1997.2306; Becher PG, 2012, FUNCT ECOL, V26, P822, DOI 10.1111/j.1365-2435.2012.02006.x; Binns E. S, 1980, ENTOMOLOGISTS MONTHL, V115, P77; BINNS ES, 1980, ANN APPL BIOL, V96, P143, DOI 10.1111/j.1744-7348.1980.tb02973.x; Bogart HGG, MYCOPATHOLOGIA, V122, P21; Braun SE, 2012, ENTOMOL EXP APPL, V145, P89, DOI 10.1111/j.1570-7458.2012.01315.x; BREWER KK, 1989, J ECON ENTOMOL, V82, P17, DOI 10.1093/jee/82.1.17; CANTELO WW, 1979, J ECON ENTOMOL, V72, P703, DOI 10.1093/jee/72.5.703; CANTELO WW, 1983, J ECON ENTOMOL, V76, P1433, DOI 10.1093/jee/76.6.1433; CANTELO WW, 1988, J ECON ENTOMOL, V81, P195, DOI 10.1093/jee/81.1.195; Cloonan KR, 2016, ENTOMOL EXP APPL, V159, P298, DOI 10.1111/eea.12439; Cloyd RA, 2008, FLORICULTURE ORNAMEN; Cloyd RA, 2009, HORTSCIENCE, V44, P1366, DOI 10.21273/HORTSCI.44.5.1366; Davis TS, 2011, MICROB ECOL, V61, P626, DOI 10.1007/s00248-010-9773-8; Davis TS, 2013, J CHEM ECOL, V39, P860, DOI 10.1007/s10886-013-0278-z; de Bruyne M, 2008, J CHEM ECOL, V34, P882, DOI 10.1007/s10886-008-9485-4; DOWD PF, 1992, J IND MICROBIOL, V9, P149, DOI 10.1007/BF01569619; Fakruddin M, 2015, SPRINGERPLUS, P4; Frouz J, 2002, GLOBAL CHANGE BIOL, V8, P339, DOI 10.1046/j.1354-1013.2001.00474.x; Frouz J, 2001, PEDOBIOLOGIA, V45, P329, DOI 10.1078/0031-4056-00090; Geib SM, 2008, P NATL ACAD SCI USA, V105, P12932, DOI 10.1073/pnas.0805257105; Gotoh T, 1999, JPN J APPL ENTOMOL Z, V43, P181, DOI 10.1303/jjaez.43.181; GREWAL PS, 1993, ANN APPL BIOL, V123, P695, DOI 10.1111/j.1744-7348.1993.tb04939.x; HAUSMANN SM, 1989, J ECON ENTOMOL, V82, P426, DOI 10.1093/jee/82.2.426; Hung R, 2015, APPL MICROBIOL BIOT, V99, P3395, DOI 10.1007/s00253-015-6494-4; Hussey N.W., 1968, MUSHROOM GROWERS ASS, V236, P338; HUSSEY NW, 1968, ANN APPL BIOL, V62, P395, DOI 10.1111/j.1744-7348.1968.tb05451.x; Jess S, 2009, PEST MANAG SCI, V65, P1195, DOI 10.1002/ps.1809; KIELBASA R, 1980, PENN AES BULL, P1; Kielbasa R, 1981, MELSHEIMER ENTOMOLOG, V31, P15; Kimura H.N. Shashi, 2013, Journal of Biopesticides, V6, P133; KOSTELC JG, 1980, J CHEM ECOL, V6, P1, DOI 10.1007/BF00987522; Kwon-Chung KJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003743; Lai HY, 2002, INT ARCH ALLERGY IMM, V127, P181, DOI 10.1159/000053862; LLEWELLYN GC, 1983, J FOOD SAFETY, V5, P113, DOI 10.1111/j.1745-4565.1983.tb00463.x; Mehelis N, 1995, BIOL MANAGEMENT MUSH; Nasir H, 2003, ARCH INSECT BIOCHEM, V52, P175, DOI 10.1002/arch.10079; Ramirez-Camejo LA, 2014, MED MYCOL, V52, P211, DOI 10.1093/mmy/myt008; Sakai Renata Kazuko, 2007, Revista Universidade Rural Serie Ciencias da Vida, V27, P161; Schiott M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-40; Shamshad A, 2009, J APPL ENTOMOL, V133, P484, DOI 10.1111/j.1439-0418.2008.01362.x; Shirvani-Farsani N, 2013, J PEST SCI, V86, P591, DOI 10.1007/s10340-013-0486-x; Srivoramas T, 2012, INT J PARASITOL RES, V4, P4; Stotefeld L, 2015, CHEMOECOLOGY, V25, P271, DOI 10.1007/s00049-015-0197-2; STRAATSMA G, 1994, APPL ENVIRON MICROB, V60, P454, DOI 10.1128/AEM.60.2.454-458.1994; Su NY, 1999, EUR J BIOCHEM, V261, P115, DOI 10.1046/j.1432-1327.1999.00242.x; Tibbles LL, 2005, ENTOMOL EXP APPL, V116, P73, DOI 10.1111/j.1570-7458.2005.00272.x; Trienens M, 2010, OIKOS, V119, P1765, DOI 10.1111/j.1600-0706.2010.18088.x; USDA, 2014, SPEC CROPS MUSHR PRO; Wetzel HA, 1982, SIGNIFICANT PESTS CO; White P. F., 1989, Mushroom Science, V12, P851; WHITE PF, 1986, ANN APPL BIOL, V109, P11, DOI 10.1111/j.1744-7348.1986.tb03179.x; Witzgall P, 2012, J CHEM ECOL, V38, P949, DOI 10.1007/s10886-012-0158-y; Yang Y, 2015, APPL ENTOMOL ZOOL, V50, P443, DOI 10.1007/s13355-015-0351-x; Zhang L, 2014, BIORESOURCE TECHNOL, V171, P274, DOI 10.1016/j.biortech.2014.08.079	57	11	12	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167074	10.1371/journal.pone.0167074	http://dx.doi.org/10.1371/journal.pone.0167074			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936070	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100058
J	Favre, M; Wittwer, A; Heinimann, HR; Yukalov, VI; Sornette, D				Favre, Maroussia; Wittwer, Amrei; Heinimann, Hans Rudolf; Yukalov, Vyacheslav I.; Sornette, Didier			Quantum Decision Theory in Simple Risky Choices	PLOS ONE			English	Article							GENDER-DIFFERENCES; PROSPECT-THEORY; PROBABILITY; BEHAVIOR; THINKING; AVERSION; UTILITY; WOMEN	Quantum decision theory (QDT) is a recently developed theory of decision making based on the mathematics of Hilbert spaces, a framework known in physics for its application to quantum mechanics. This framework formalizes the concept of uncertainty and other effects that are particularly manifest in cognitive processes, which makes it well suited for the study of decision making. QDT describes a decision maker's choice as a stochastic event occurring with a probability that is the sum of an objective utility factor and a subjective attraction factor. QDT offers a prediction for the average effect of subjectivity on decision makers, the quarter law. We examine individual and aggregated (group) data, and find that the results are in good agreement with the quarter law at the level of groups. At the individual level, it appears that the quarter law could be refined in order to reflect individual characteristics. This article revisits the formalism of QDT along a concrete example and offers a practical guide to researchers who are interested in applying QDT to a dataset of binary lotteries in the domain of gains.	[Favre, Maroussia; Yukalov, Vyacheslav I.; Sornette, Didier] ETH, Dept Management Technol & Econ, Scheuchzerstr 7, CH-8092 Zurich, Switzerland; [Sornette, Didier] Univ Geneva, Swiss Finance Inst, 40 Blvd Du Pont Arve, CH-1211 Geneva 4, Switzerland; [Yukalov, Vyacheslav I.] Joint Inst Nucl Res, Bogolubov Lab Theoret Phys, Dubna 141980, Russia; [Wittwer, Amrei] Univ Zurich, Coll Helveticum, Schmelzbergstr 25, CH-8092 Zurich, Switzerland; [Wittwer, Amrei] ETH, Schmelzbergstr 25, CH-8092 Zurich, Switzerland; [Heinimann, Hans Rudolf] Swiss Fed Inst Technol, Future Resilient Syst Singapore ETH Ctr SEC, Singapore, Singapore	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Geneva; Joint Institute for Nuclear Research - Russia; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Favre, M (corresponding author), ETH, Dept Management Technol & Econ, Scheuchzerstr 7, CH-8092 Zurich, Switzerland.	maroussiafavre@ethz.ch			Cogito Foundation; Swiss National Science Foundation [2-77095-15]	Cogito Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Cogito Foundation: AW, and Swiss National Science Foundation (grant 2-77095-15): MF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Najjar NI, 2009, ECON PHILOS, V25, P249, DOI 10.1017/S026626710999023X; Allais M, 1953, ECONOMETRICA, V21, P503, DOI 10.2307/1907921; Ashtiani M, 2015, MATH SOC SCI, V75, P49, DOI 10.1016/j.mathsocsci.2015.02.004; Bernoulli D, 1954, ECONOMETRICA, V22, P23, DOI 10.2307/1909829; Bohr N, 1933, NATURWISSENSCHAFTEN, V21, P245, DOI 10.1007/BF01504277; Bohr N, 1929, NATURWISSENSCHAFTEN, V17, P483, DOI 10.1007/BF01505680; Bohr N., 1936, KAUSALITAT KOMPLEMEN, P293; Bohr N., 1920, Z PHYS, V2, P423; Brinig M., 1995, WM MARY J WOMEN L, V2, P1; Busemeyer J.R., 2015, DECISION, V2, P1, DOI 10.1037/dec0000017; Busemeyer J. R., 2011, P QUANT COGN MEETS T; Busemeyer JR, 2006, J MATH PSYCHOL, V50, P220, DOI 10.1016/j.jmp.2006.01.003; Byrnes JP, 1999, PSYCHOL BULL, V125, P367, DOI 10.1037/0033-2909.125.3.367; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; Daruvala D, 2007, J RISK UNCERTAINTY, V35, P265, DOI 10.1007/s11166-007-9024-7; Douglas M., 1982, RISK CULTURE ESSAY S; EAGLY AH, 1995, AM PSYCHOL, V50, P145, DOI 10.1037/0003-066X.50.3.145; Eckel CC., 2008, HDB EXPT EC RESULTS, DOI 10.1016/S1574-0722(07)00113-8; Favre M, 2016, MODELING SOCIAL INTE; Favre M, 2012, J THEOR BIOL, V310, P43, DOI 10.1016/j.jtbi.2012.06.026; Fehr-Duda H, 2006, THEOR DECIS, V60, P283, DOI 10.1007/s11238-005-4590-0; Fehr-Duda H, 2012, ANNU REV ECON, V4, P567, DOI 10.1146/annurev-economics-080511-110950; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Gollier C, 2004, EC RISK TIME; Gonzalez R, 1999, COGNITIVE PSYCHOL, V38, P129, DOI 10.1006/cogp.1998.0710; HARLESS DW, 1994, ECONOMETRICA, V62, P1251, DOI 10.2307/2951749; Harrison GW, 2008, RES EXP ECON, V12, P41, DOI 10.1016/S0193-2306(08)00003-3; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; HEY JD, 1994, ECONOMETRICA, V62, P1291, DOI 10.2307/2951750; Hibbert Ann Marie, 2008, ARE WOMEN MORE RISK; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kahneman D., 2011, THINKING FAST SLOW; Luce, 1959, INDIVIDUAL CHOICE BE, DOI [10.1037/14396-000, DOI 10.1037/14396-000]; Mosteller F, 1951, J POLIT ECON, V59, P371, DOI 10.1086/257106; Murphy RO, 2014, ETH RISK CTR WORKING; Poncela-Casasnovas J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600451; Powell M, 1997, J ECON PSYCHOL, V18, P605, DOI 10.1016/S0167-4870(97)00026-3; Safra Z, 2008, ECONOMETRICA, V76, P1143, DOI 10.3982/ECTA6175; Schubert R, 1999, AM ECON REV, V89, P381, DOI 10.1257/aer.89.2.381; SHAFIR E, 1992, COGNITIVE PSYCHOL, V24, P449, DOI 10.1016/0010-0285(92)90015-T; Slovic P, 2016, ENVIRONMENT, V58, P25, DOI 10.1080/00139157.2016.1112169; Sornette D., 2016, CALIBRATION QUANTUM; Stott HP, 2006, J RISK UNCERTAINTY, V32, P101, DOI 10.1007/s11166-006-8289-6; Strangman G, KOLMOGOROV SMIRNOV T; TVERSKY A, 1983, PSYCHOL REV, V90, P293, DOI 10.1037/0033-295X.90.4.293; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; von Neumann J., 1953, THEORY GAMES EC BEHA; Von Neumann J, 1955, MATH FDN QUANTUM MEC, DOI [10.1063/1.3061789, DOI 10.1063/1.3061789]; Wakker P. P., 2010, PROSPECT THEORY RISK; Wittwer AMJ., 2009, PHYSL PSYCHOL ASPECT; Yukalov VI, 2014, ADV COMPLEX SYST, V17, DOI 10.1142/S0219525914500167; Yukalov VI, 2013, LASER PHYS, V23, DOI 10.1088/1054-660X/23/10/105502; Yukalov VI, 2011, THEOR DECIS, V70, P283, DOI 10.1007/s11238-010-9202-y; Yukalov VI, 2010, PHYS ATOM NUCL+, V73, P559, DOI 10.1134/S106377881003021X; Yukalov VI, 2009, LASER PHYS LETT, V6, P833, DOI 10.1002/lapl.200910086; Yukalov VI, 2009, EUR PHYS J B, V71, P533, DOI 10.1140/epjb/e2009-00245-9; Yukalov VI, 2008, PHYS LETT A, V372, P6867, DOI 10.1016/j.physleta.2008.09.053; Yukalov VI, 2016, IEEE T SYST IN PRESS; Yukalov VI, 2015, INT J INF TECH DECIS, V14, P1129, DOI 10.1142/S0219622014500564; Yukalov VI, 2014, IEEE T SYST MAN CY-S, V44, P1155, DOI 10.1109/TSMC.2014.2314283; Yukalov VI, 2014, TOP COGN SCI, V6, P79, DOI 10.1111/tops.12065; Yukalov VI, 2010, ADV COMPLEX SYST, V13, P659, DOI 10.1142/S0219525910002803; Yukalov VI, 2009, ENTROPY-SWITZ, V11, P1073, DOI 10.3390/e11041073	63	8	8	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168045	10.1371/journal.pone.0168045	http://dx.doi.org/10.1371/journal.pone.0168045			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936217	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100261
J	Guillaud, A; Darbois, N; Monvoisin, R; Pinsault, N				Guillaud, Albin; Darbois, Nelly; Monvoisin, Richard; Pinsault, Nicolas			Reliability of Diagnosis and Clinical Efficacy of Cranial Osteopathy: A Systematic Review	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; CRANIOSACRAL THERAPY; INTEREXAMINER RELIABILITY; INTERRATER RELIABILITY; PALPATION; INTRAEXAMINER; PLACEBO; INTERVENTIONS; AGREEMENT; HEART	Context In 2010, the World Health Organization released benchmarks for training in osteopathy in which they considered cranial osteopathy as an important osteopathic skill. However, the evidence supporting the reliability of diagnosis and the efficacy of treatment in this field appears scientifically weak and inconsistent. Objectives To identify and critically evaluate the scientific literature dealing with the reliability of diagnosis and the clinical efficacy of techniques and therapeutic strategies used in cranial osteopathy. Methods Relevant keywords were used to search the electronic databases MEDLINE, PEDro, OSTMED.DR, Cochrane Library, and in Google Scholar, Journal of American Osteopathy Association and International Journal of Osteopathic Medicine websites. Searches were conducted up to end June 2016 with no date restriction as to when the studies were completed. As a complementary approach we explored the bibliography of included articles and consulted available previous reviews dealing with this topic. Study selection Regarding diagnostic processes in cranial osteopathy, we analyzed studies that compared the results obtained by at least two examiners or by the same examiner on at least two occasions. For efficacy studies, only randomized-controlled-trials or crossover-studies were eligible. We excluded articles that were not in English or French, and for which the full-text version was not openly available. We also excluded studies with unsuitable study design, in which there was no clear indication of the use of techniques or therapeutic strategies concerning the cranial field, looked at combined treatments, used a non-human examiner and subjects or used healthy subjects for efficacy studies. There was no restriction regarding the type of disease. Search Results In our electronic search we found 1280 references concerning reliability of diagnosis studies plus four references via our complementary strategy. Based on the title 18 articles were selected for analysis. Nine were retained after applying our exclusion criteria. Regarding efficacy, we extracted 556 references from the databases plus 14 references through our complementary strategy. Based on the title 46 articles were selected. Thirty two articles were not retained on the grounds of our exclusion criteria. Data extraction and analysis Risk of bias in reliability studies was assessed using a modified version of the quality appraisal tool for studies of diagnostic reliability. The methodological quality of the efficacy studies was assessed using the Cochrane risk of bias tool. Two screeners conducted these analyses. Results For reliability studies, our analysis leads us to conclude that the diagnostic procedures used in cranial osteopathy are unreliable in many ways. For efficacy studies, the Cochrane risk of bias tool we used shows that 2 studies had a high risk of bias, 9 were rated as having major doubt regarding risk of bias and 3 had a low risk of bias. In the 3 studies with a low risk of bias alternative interpretations of the results, such as a non-specific effect of treatment, were not considered. Conclusion Our results demonstrate, consistently with those of previous reviews, that methodologically strong evidence on the reliability of diagnostic procedures and the efficacy of techniques and therapeutic strategies in cranial osteopathy is almost non-existent.	[Guillaud, Albin; Darbois, Nelly; Monvoisin, Richard] Univ Grenoble Alpes, CORTECS Team, Grenoble, France; [Pinsault, Nicolas] ThEMAS Team, TIMC IMAG Lab, UMR CNRS UGA 5525, Grenoble, France; [Pinsault, Nicolas] Grenoble Alpes Univ Hosp, Sch Physiotherapy, Grenoble, France; [Guillaud, Albin; Darbois, Nelly; Monvoisin, Richard; Pinsault, Nicolas] Univ Grenoble Alpes, Crit Thinking Res Federat, FED 4270, Grenoble, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Pinsault, N (corresponding author), ThEMAS Team, TIMC IMAG Lab, UMR CNRS UGA 5525, Grenoble, France.; Pinsault, N (corresponding author), Grenoble Alpes Univ Hosp, Sch Physiotherapy, Grenoble, France.; Pinsault, N (corresponding author), Univ Grenoble Alpes, Crit Thinking Res Federat, FED 4270, Grenoble, France.	npinsault@chu-grenoble.fr	Pinsault, Nicolas/AAE-7538-2019; Pinsault, Nicolas/M-7627-2017	Pinsault, Nicolas/0000-0001-5034-0802; Darbois, Nelly/0000-0001-9467-9832	French national council of physiotherapists (Conseil National de l'Ordre des Masseurs Kinesitherapeutes, CNOMK)	French national council of physiotherapists (Conseil National de l'Ordre des Masseurs Kinesitherapeutes, CNOMK)	This study was supported by the French national council of physiotherapists (Conseil National de l'Ordre des Masseurs Kinesitherapeutes, CNOMK). The sponsor had no influence or editorial control over the content of the study.	Amrovabady Z, 2013, IRAN REHABIL J, V11, P41; Arnadottir TS, 2013, COMPLEMENT THER CLIN, V19, P11, DOI 10.1016/j.ctcp.2012.09.003; Atkins D, 2011, J CLIN EPIDEMIOL, V64, P1198, DOI 10.1016/j.jclinepi.2010.11.021; Bialoszewski Dariusz, 2014, Ortop Traumatol Rehabil, V16, P605, DOI 10.5604/15093492.1135120; Burke SR, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-227; Castro-Sanchez AM, 2016, J ALTERN COMPLEMENT; Cuthbert Scott C, 2007, Chiropr Osteopat, V15, P4, DOI 10.1186/1746-1340-15-4; Delgado-Rodriguez M, 2004, J EPIDEMIOL COMMUN H, V58, P635, DOI 10.1136/jech.2003.008466; Di Blasi Z, 2001, LANCET, V357, P757, DOI 10.1016/S0140-6736(00)04169-6; Elden H, 2013, ACTA OBSTET GYN SCAN, V92, P775, DOI 10.1111/aogs.12096; Ernst E., 2012, FOCUS ALTERNATIVE CO, V17, P197; Fadipe GT, 2009, THESIS; Fleiss JL., 1986, DESIGN ANAL CLIN EXP, DOI [10.1002/9781118032923.ch1, DOI 10.1002/9781118032923.CH1, DOI 10.1002/9781118032923]; GRACELY RH, 1985, LANCET, V1, P43; Green CJ, 1999, SYSTEMATIC REV CRITI; Haller H, 2016, CLIN J PAIN, V32, P441, DOI 10.1097/AJP.0000000000000290; Halma KD, 2008, J AM OSTEOPATH ASSOC, V108, P493; Haneline MT, 2009, J MANIP PHYSIOL THER, V32, P379, DOI 10.1016/j.jmpt.2009.04.010; Hanten WP, 1998, J ORTHOP SPORT PHYS, V27, P213, DOI 10.2519/jospt.1998.27.3.213; Hanten WP., 1999, J MANUAL MANIPULATIV, V7, P64, DOI [10.1179/106698199790811816, DOI 10.1179/106698199790811816, DOI 10.1016/S0161-4754(00)90190-8]; Hartling L, 2013, J CLIN EPIDEMIOL, V66, P973, DOI 10.1016/j.jclinepi.2012.07.005; Hartman SE, 2002, SCI REV ALTEM MED, V6, P23; Hayden Clive, 2006, Complement Ther Clin Pract, V12, P83, DOI 10.1016/j.ctcp.2005.12.005; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Jakel A, 2012, COMPLEMENT THER MED, V20, P456, DOI 10.1016/j.ctim.2012.07.009; JAKEL A., 2011, AUSTRALAS MUSCULOSKE, V111, P685; Jakel A, 2011, J AM OSTEOPATH ASSOC, V111, P685; Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Laslett M, 2008, J MAN MANIP THER, V16, P142, DOI 10.1179/jmt.2008.16.3.142; Lucas NP, 2010, J CLIN EPIDEMIOL, V63, P854, DOI 10.1016/j.jclinepi.2009.10.002; Castro-Sanchez AM, 2011, CLIN REHABIL, V25, P25, DOI 10.1177/0269215510375909; Mataran-Penarrocha GA, 2011, EVID-BASED COMPL ALT, V2011; Mehl-Madrona L, 2007, EXPLORE-NY, V3, P28, DOI 10.1016/j.explore.2006.10.003; Moran RW, 2001, J MANIP PHYSIOL THER, V24, P183; Morton G, 1983, J SOC PSYCHOL, V125, P143; Norton JM, 1996, CHALLENGE CONCEPT CR; Nourbakhsh MR, 2008, J HAND THER, V21, P4, DOI 10.1197/j.jht.2007.09.005; Raith W, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-0984-5; Rogers JS, 1998, PHYS THER, V78, P1175, DOI 10.1093/ptj/78.11.1175; Sandhouse ME, 2010, J AM OSTEOPATH ASSOC, V110, P239; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.1186/1741-7015-8-18, 10.1016/j.ijsu.2011.09.004, 10.4103/0976-500X.72352]; Sommerfeld P, 2004, MANUAL THER, V9, P22, DOI 10.1016/S1356-689X(03)00099-7; Still AT, 1897, STILL WITH A HISTORY; UPLEDGER JE, 1977, J AM OSTEOPATH ASSOC, V76, P890; White P, 2012, PAIN, V153, P455, DOI 10.1016/j.pain.2011.11.007; WHO, 2010, BENCKM TRAIN TRAD CO; Wilkinson J, 2015, INT J OSTEOPATH MED, V18, P13, DOI 10.1016/j.ijosm.2014.04.008; WIRTHPATTULLO V, 1994, PHYS THER, V74, P908, DOI 10.1093/ptj/74.10.908	49	16	16	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167823	10.1371/journal.pone.0167823	http://dx.doi.org/10.1371/journal.pone.0167823			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936211	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100206
J	Janssen, RJ; Jylanki, P; van Gerven, MAJ				Janssen, Ronald J.; Jylanki, Pasi; van Gerven, Marcel A. J.			Let's Not Waste Time: Using Temporal Information in Clustered Activity Estimation with Spatial Adjacency Restrictions (CAESAR) for Parcellating FMRI Data	PLOS ONE			English	Article							RESTING-STATE FMRI; FUNCTIONAL PARCELLATION; BRAIN; CONNECTIVITY	We have proposed a Bayesian approach for functional parcellation of whole-brain FMRI measurements which we call Clustered Activity Estimation with Spatial Adjacency Restrictions (CAESAR). We use distance-dependent Chinese restaurant processes (dd-CRPs) to define a flexible prior which partitions the voxel measurements into clusters whose number and shapes are unknown a priori. With dd-CRPs we can conveniently implement spatial constraints to ensure that our parcellations remain spatially contiguous and thereby physiologically meaningful. In the present work, we extend CAESAR by using Gaussian process (GP) priors to model the temporally smooth haemodynamic signals that give rise to the measured FMRI data. A challenge for GP inference in our setting is the cubic scaling with respect to the number of time points, which can become computationally prohibitive with FMRI measurements, potentially consisting of long time series. As a solution we describe an efficient implementation that is practically as fast as the corresponding time-independent non-GP model with typically-sized FMRI data sets. We also employ a population Monte-Carlo algorithm that can significantly speed up convergence compared to traditional single-chain methods. First we illustrate the benefits of CAESAR and the GP priors with simulated experiments. Next, we demonstrate our approach by parcellating resting state FMRI data measured from twenty participants as taken from the Human Connectome Project data repository. Results show that CAESAR affords highly robust and scalable whole-brain clustering of FMRI timecourses.	[Janssen, Ronald J.; Jylanki, Pasi; van Gerven, Marcel A. J.] Radboud Univ Nijmegen, Donders Ctr Brain Cognit & Behav, Nijmegen, Netherlands	Radboud University Nijmegen	Janssen, RJ (corresponding author), Radboud Univ Nijmegen, Donders Ctr Brain Cognit & Behav, Nijmegen, Netherlands.	janssen.rj@gmail.com	van Gerven, Marcel A. J./D-7800-2012	van Gerven, Marcel A. J./0000-0002-2206-9098; Janssen, Ronald/0000-0001-9622-5420	The Netherlands Organization for Scientific Research (NWO) [612.001.211, 639.072.513]; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER	The Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by grant numbers 612.001.211 and 639.072.513 of The Netherlands Organization for Scientific Research (NWO; http://www.nwo.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by grant numbers 612.001.211 and 639.072.513 of The Netherlands Organization for Scientific Research (NWO). Data were provided by the Human Connectome Project, WU-Minn Consortium (Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657).	Andersen Kasper Winther, 2012, Machine Learning and Interpretation in Neuroimaging. International Workshop (MLINI 2011). Held at NIPS 2011. Revised and Selected and Invited Contributions, P226, DOI 10.1007/978-3-642-34713-9_29; Baldassano C, 2015, PEERJ, V3, DOI 10.7717/peerj.784; Bartunov S, 2014, PR MACH LEARN RES, V32, P1404; Bedard C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.118102; Blei DM, 2006, BAYESIAN ANAL, V1, P121, DOI 10.1214/06-BA104; Blei DM, 2011, J MACH LEARN RES, V12, P2461; Blumensath T, 2013, NEUROIMAGE, V76, P313, DOI 10.1016/j.neuroimage.2013.03.024; Cappe O, 2004, J COMPUT GRAPH STAT, V13, P907, DOI 10.1198/106186004X12803; Cohen AL, 2008, NEUROIMAGE, V41, P45, DOI 10.1016/j.neuroimage.2008.01.066; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Harrison SJ, 2015, NEUROIMAGE, V109, P217, DOI 10.1016/j.neuroimage.2015.01.013; Hartikainen Jouni, 2010, Proceedings of the 2010 IEEE International Workshop on Machine Learning for Signal Processing (MLSP), P379, DOI 10.1109/MLSP.2010.5589113; Hinne M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117179; Honnorat N, 2015, NEUROIMAGE, V106, P207, DOI 10.1016/j.neuroimage.2014.11.008; Janssen RJ, 2015, NEUROIMAGE, V119, P398, DOI 10.1016/j.neuroimage.2015.06.084; Janssen RJ, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00126; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Neal RM, 2000, J COMPUT GRAPH STAT, V9, P249, DOI 10.2307/1390653; Pitman J, 2006, COMBINATORIAL STOCHA; Poldrack RA, 2011, HDB FUNCTIONAL MRI D; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Shah A, 2014, JMLR WORKSH CONF PRO, V33, P877; Shen X, 2013, NEUROIMAGE, V82, P403, DOI 10.1016/j.neuroimage.2013.05.081; Smith SM, 2013, NEUROIMAGE, V80, P144, DOI 10.1016/j.neuroimage.2013.05.039; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Thirion B, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00167; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Van Essen DC, 2012, CEREB CORTEX, V22, P2241, DOI 10.1093/cercor/bhr291; Vinh NX, 2010, J MACH LEARN RES, V11, P2837; Wig GS, 2014, CEREB CORTEX, V24, P2036, DOI 10.1093/cercor/bht056; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027	34	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0164703	10.1371/journal.pone.0164703	http://dx.doi.org/10.1371/journal.pone.0164703			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935937	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100007
J	Kunwar, RM; Baral, K; Paudel, P; Acharya, RP; Thapa-Magar, KB; Cameron, M; Bussmann, RW				Kunwar, Ripu M.; Baral, Kedar; Paudel, Prashant; Acharya, Ram P.; Thapa-Magar, Khum B.; Cameron, Mary; Bussmann, Rainer W.			Land-Use and Socioeconomic Change, Medicinal Plant Selection and Biodiversity Resilience in Far Western Nepal	PLOS ONE			English	Article							TIMBER FOREST PRODUCTS; TRADITIONAL MEDICINE; DADELDHURA DISTRICT; MAPUCHE COMMUNITY; CLIMATE-CHANGE; KNOWLEDGE; CONSERVATION; ETHNOBOTANY; VEGETATION; MANAGEMENT	Indigenous plant use-systems have evolved under, and constantly adapted to human and non-human impacts. In the last decades however, increasing socioeconomic and cultural transformations, including land-use change, outmigration, globalized markets, the introduction of new species, and climate change have led to a decreasing availability of indigenous resources, and are ultimately leading to a reduction of local use-knowledge. Participant observations, discussions, walks-in-the-woods, semi-structured interviews and informal meetings were carried out in 12 villages of far western Nepal between 2011 and 2015 to assess how sociocultural changes have affected the sustenance of indigenous systems and local biodiversity, when compared to studies carried out in the previous decades. Our findings show that there were no statistically significant differences in subject variable means, but differences were relatively important to plant parts-use and plant growth-forms (p = 0.183 and 0.088 respectively). Cissampelos pareira, Acorus calamus, Calotropis gigantea were found to have the greatest relative importance, whereas Ageratina adenophora, Melia azedarach, Carum carvi were most important based on use values. Among them, C. pareira and A. adenophora were introduced. The spatial distribution of species collected for medicine showed that all habitats were important for collection however, habitats close to villages were more favored. The use of non-indigenous and easily available species and more accessible habitats is becoming more prevalent as primary forests become increasingly overexploited, indigenous species become limited, and sociocultural cause of land use change expand. The utilization of indigenous and non-indigenous species and nearby habitats, although possibly affecting the quality of medicinal species, nonetheless reveals the dynamism of indigenous medicines as an adaptive asset mitigating human and non-human environmental changes.	[Kunwar, Ripu M.] Florida Atlantic Univ, Dept Geosci, Boca Raton, FL 33431 USA; [Baral, Kedar] Dist Forest Off, Baitadi, Nepal; [Paudel, Prashant] Georg August Univ, Trop & Int Forestry Program, Gottingen, Germany; [Acharya, Ram P.] Pract Solut, Kathmandu, Nepal; [Thapa-Magar, Khum B.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY USA; [Cameron, Mary] Florida Atlantic Univ, Dept Anthropol, Boca Raton, FL 33431 USA; [Bussmann, Rainer W.] Missouri Bot Garden, William L Brown Ctr, St Louis, MO USA	State University System of Florida; Florida Atlantic University; University of Gottingen; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University System of Florida; Florida Atlantic University; Missouri Botanical Gardens	Kunwar, RM (corresponding author), Florida Atlantic Univ, Dept Geosci, Boca Raton, FL 33431 USA.	rkunwar@fau.edu	Kunwar, Ripu M/A-2242-2012; Kunwar, Ripu/AAR-8887-2021; Bussmann, Rainer W/A-6105-2010	Kunwar, Ripu/0000-0002-9303-0932; Bussmann, Rainer W/0000-0002-3524-5273; Paudel, Prashant/0000-0003-0982-4818	William L Brown Center, Missouri Botanical Garden, Garden Club of America; AS Catham Fellowship from US and Rufford Foundation UK	William L Brown Center, Missouri Botanical Garden, Garden Club of America; AS Catham Fellowship from US and Rufford Foundation UK	William L Brown Center, Missouri Botanical Garden, Garden Club of America and AS Catham Fellowship from US and Rufford Foundation UK provided partial financial supports.	Adnan M HD, 2011, ECON BOT, V66, P344; Alcorn J. B., 1984, Huastec Mayan ethnobotany.; Alencar NL, 2014, REV BRAS FARMACOGN, V24, P506, DOI 10.1016/j.bjp.2014.09.003; Alves R. R. N., 2007, Journal of Ethnobiology and Ethnomedicine, V3; [Anonymous], MILLENN ECOSYST ASSE, DOI DOI 10.1017/CBO9781107415324.004; [Anonymous], 2007, EX SUMM INT PAN CLIM; [Anonymous], 2010, KAILASH SACRED LANDS; [Anonymous], 2012, BOT EXPLORATION DARC; ANYINAM C, 1995, SOC SCI MED, V40, P321, DOI 10.1016/0277-9536(94)E0098-D; Arbonnier M., 2000, ARBRES ARBUSTES LIAN, P541; Arnold JEM, 2001, ECOL ECON, V39, P437, DOI 10.1016/S0921-8009(01)00236-1; Balick Michael J., 1996, PLANTS PEOPLE CULTUR; Bennett BC, 2000, ECON BOT, V54, P90, DOI 10.1007/BF02866603; Bhandari G., 2013, International Journal of Plant, Animal and Environmental Sciences, V3, P247; Bhandari G, 2013, EFFECTS RAINFALL YIE, P205; BHATTARAI NK, 1992, ECON BOT, V46, P257, DOI 10.1007/BF02866624; BILLINGS W D, 1974, Arctic and Alpine Research, V6, P129, DOI 10.2307/1550081; Bista S, 2006, ENVIRON CONSERV, V33, P244, DOI 10.1017/S0376892906003195; Burlakoti C., 2008, MED PLANTS NEPAL ANT, P187; Byg A, 2010, HUM ECOL, V38, P177, DOI 10.1007/s10745-009-9300-z; Cadena-Gonzalez AL, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-23; Cameron M, 1993, EDGE AUSPICIOUS PRAC, P367; Cameron MM, 1996, HUM ORGAN, V55, P84, DOI 10.17730/humo.55.1.g206551211750h58; Cameron MM., 2010, CULTURE ENV HIMALAYA, P40; CBS, 2012, NAT POP HOUS CENS 20, V1, P1; Chand PB, 1987, BANKO JANAKARI, V1, P20; Chazdon RL, 1999, CONSERV BIOL, V13, P1312, DOI 10.1046/j.1523-1739.1999.98352.x; Chettri N, 2008, P INT MOUNT BIOD C, P201; Clarke R. C., 2007, Journal of Industrial Hemp, V12, P19, DOI 10.1300/J237v12n02_03; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; da Silva TC, 2014, ETHNOBIOL CONSERV, V3, DOI 10.15451/ec2014-6-3.4-1-12; De Albuquerque UP, 2007, J ETHNOPHARMACOL, V114, P325, DOI 10.1016/j.jep.2007.08.017; Albuquerque UP, 2007, J ETHNOPHARMACOL, V113, P156, DOI 10.1016/j.jep.2007.05.025; de Albuquerque UP, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-30; Devkota R., 2003, BOT ORIENTALIS, P135; DFO, 2015, MED PLANT TRAD DAT; Diamond J., 1997, GUNS GEMS STEEL FATE; Dolan JR, 2016, ISME J, V10, P2174, DOI 10.1038/ismej.2016.19; Ebbell B, 1937, PAPYRUS EBERS GREATE; Estomba D, 2006, J ETHNOPHARMACOL, V103, P109, DOI 10.1016/j.jep.2005.07.015; Etuk EU, 2009, AFR J PHARM PHARMACO, V3, P496; Farooquee NA, 1996, ENVIRON CONSERV, V23, P75, DOI 10.1017/S0376892900038273; Fassil H, 2003, WE DO WHAT WE KNOW L; Fitzgibbon J, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-2; Folmar S., 2007, HIMALAYA, V27, P41; Fortier J., 2009, KINGS FOREST CULTURA, P232; Galeano G, 2000, ECON BOT, V54, P358, DOI 10.1007/BF02864787; Garbyal SS, 2005, CURR SCI INDIA, V88, P722; Geissler PW, 2002, J ETHNOPHARMACOL, V83, P39, DOI 10.1016/S0378-8741(02)00191-5; Giday M, 2003, J ETHNOPHARMACOL, V85, P43, DOI 10.1016/S0378-8741(02)00359-8; GOLDSTEIN MC, 1983, MT RES DEV, V3, P61, DOI 10.2307/3673129; GoN, 2015, HAMR BAN OUR FOR; GoN, 2011, NEP POP REP 2011; GOTTLIEB OR, 1995, BIOTROPICA, V27, P401, DOI 10.2307/2388927; Harlan H, 1992, TECHNOMETRICS; Harris H, 2010, PLANTS HLTH HEALING, P53; Hodgson Burnett Frances, 1911, THE SECRET GARDEN; HU SY, 1990, J ARNOLD ARBORETUM, V71, P487; Hutchen AR, 1992, HDB NATIVE AM HERBS; ISE, 2008, INT SOC ETHN COD ETH; Janes Craig R, 2002, Anthropol Med, V9, P267, DOI 10.1080/13648470216337; Janni KD, 2004, ECON BOT, V58, pS274, DOI 10.1663/0013-0001(2004)58[S274:EBITKP]2.0.CO;2; Jones L, 2011, GLOBAL ENVIRON CHANG, V21, P1262, DOI 10.1016/j.gloenvcha.2011.06.002; Joshi K, 2008, MED PLANTS NEPAL ANT, P178; Kala CP, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-32; Khuankaew S, 2014, J ETHNOPHARMACOL, V151, P829, DOI 10.1016/j.jep.2013.11.033; Kohn Eduardo O., 1992, Journal of Ethnobiology, V12, P141; Kumar M, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-32; Kunwar R.M., 2003, HIMALAYAN J SCI, V1, P129, DOI DOI 10.3126/HJS.V1I2.213; Kunwar RM, 2015, J ETHNOPHARMACOL, V163, P210, DOI 10.1016/j.jep.2015.01.035; Kunwar RM, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/792789; Kunwar RM, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-24; Kunwar RM, 2012, J MT SCI-ENGL, V9, P589, DOI 10.1007/s11629-012-2315-8; Ladio AH, 2004, BIODIVERS CONSERV, V13, P1153, DOI 10.1023/B:BIOC.0000018150.79156.50; Ladio AH, 2003, BIODIVERS CONSERV, V12, P937, DOI 10.1023/A:1022873725432; Ladio AH, 2001, HUM ECOL, V29, P367, DOI 10.1023/A:1013199103440; Lanning, 2012, HLTH IS WEALTH HLTH; Lilleso J.-P.-B., 2005, MAP POTENTIAL VEGETA; Lulekal E, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-63; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Maharjan KL JN, 2007, POVERTY ANAL BAITADI; Malik ZA, 2015, J ETHNOPHARMACOL, V172, P133, DOI 10.1016/j.jep.2015.06.002; Manandhar NP, 1998, J ETHNOPHARMACOL, V60, P199, DOI 10.1016/S0378-8741(97)00150-5; Mander M., 1998, MARKETING INDIGENOUS, P1; Manzardo A E, 1976, Contrib Nepalese Stud, V3, P83; Manzardo A.E., 1977, CONTRIB NEPAL STUD, V4, P63; Maren IE, 2014, ENVIRON CONSERV, V41, P73, DOI 10.1017/S0376892913000258; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Milliken W, 1996, ECON BOT, V50, P10, DOI 10.1007/BF02862108; Moerman DE, 2003, J ETHNOPHARMACOL, V87, P51, DOI 10.1016/S0378-8741(03)00105-3; Molares S, 2009, J ETHNOPHARMACOL, V122, P251, DOI 10.1016/j.jep.2009.01.003; MUNTHE J, 1983, NATURE, V303, P331, DOI 10.1038/303331a0; Mutchnick PA, 1997, GUATEMALA EC BOT, V51, P158; Palmer CT, 2004, ECON BOT, V58, pS280, DOI 10.1663/0013-0001(2004)58[S280:TIORIP]2.0.CO;2; Pandey GD, 1989, NITYANANDA SMARAK SA, P546; Pant S.R., 2004, BOT ORIENT, P79; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parrotta J. A., 2001, Healing plants of peninsular India, DOI 10.1079/9780851995014.0000; Peretti JH, 1998, ENVIRON VALUE, V7, P183, DOI 10.3197/096327198129341537; PHILLIPS O, 1993, ECON BOT, V47, P33, DOI 10.1007/BF02862204; Pirker H, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-44; Poertner E, 2011, CRIT ASIAN STUD, V43, P23, DOI 10.1080/14672715.2011.537850; Polunin A, 1984, FLOWERS OF HIMALAYA; Pradhan K., 1998, ANC NEPAL, V107, P15; Prance G. T., 1998, Plants for food and medicine. Proceedings of the joint conference of the Society for Economic Botany and the International Society for Ethnopharmacology, London, UK, 1-6 July 1996., P185; Quinlan MB, 2002, J ETHNOPHARMACOL, V80, P75, DOI 10.1016/S0378-8741(02)00002-8; Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853; Reyes-Garcia V, 2006, ECON BOT, V60, P62, DOI 10.1663/0013-0001(2006)60[62:CPAEVO]2.0.CO;2; Rhoades D.F., 1976, RECENT ADV PHYTOCHEM, P168, DOI DOI 10.1007/978-1-4684-2646-5_4; SALICK J, 1995, ECOL APPL, V5, P878, DOI 10.2307/2269339; Salick J, 1999, BIODIVERS CONSERV, V8, P797, DOI 10.1023/A:1008853413930; Salick J, 2014, J ETHNOBIOL, V34, P276, DOI 10.2993/0278-0771-34.3.276; Santoro FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119826; Shrestha S, 2001, ANC NEPAL, P1; SINGH MP, 1979, ECON BOT, V33, P185, DOI 10.1007/BF02858287; Soldati GT, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/364564; Stainton A, 1988, FLOWERS HIMALAYA SUP; Stepp JR, 2001, J ETHNOPHARMACOL, V75, P19, DOI 10.1016/S0378-8741(00)00385-8; Thomas E, 2008, HUM ECOL, V36, P861, DOI 10.1007/s10745-008-9208-z; Thomas E, 2009, J ETHNOPHARMACOL, V122, P60, DOI 10.1016/j.jep.2008.11.021; Toledo B. Arias, 2007, Journal of Ethnobiology, V27, P218; TOLEDO VM, 1995, INTERCIENCIA, V20, P177; Trudgen MS, 2012, P ROY SOC B-BIOL SCI, V279, P4115, DOI 10.1098/rspb.2012.1545; Turner NJ, 2009, GLOBAL ENVIRON CHANG, V19, P180, DOI 10.1016/j.gloenvcha.2009.01.005; Uddin K, 2015, LANDSCAPE URBAN PLAN, V141, P1, DOI 10.1016/j.landurbplan.2015.04.003; UNWFP, 2006, UNWFP FOOD SEC B, V38, P1; Vandebroek I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037643; Voeks RA, 2004, ECON BOT, V58, pS294, DOI 10.1663/0013-0001(2004)58[S294:FTFAMP]2.0.CO;2; Voeks RA, 1996, ECON BOT, V50, P381, DOI 10.1007/BF02866520; Wang WM, 2013, PALAEOWORLD, V22, P86, DOI 10.1016/j.palwor.2013.08.001; Weckerle CS, 2006, ECON BOT, V60, P3, DOI 10.1663/0013-0001(2006)60[3:PKOTSI]2.0.CO;2; Xu JC, 2004, BIODIVERS CONSERV, V13, P959, DOI 10.1023/B:BIOC.0000014464.80847.02; Zomer RJ, 2013, ENV STRATIFICATION K	133	23	23	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167812	10.1371/journal.pone.0167812	http://dx.doi.org/10.1371/journal.pone.0167812			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936247	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100202
J	Luo, RB; Hu, J; Jiang, LB; Zhang, M				Luo, Rubin; Hu, Jian; Jiang, Libing; Zhang, Mao			Prognostic Value of Red Blood Cell Distribution Width in Non-Cardiovascular Critically or Acutely Patients: A Systematic Review	PLOS ONE			English	Review							ALL-CAUSE MORTALITY; INDEPENDENT PREDICTOR; HOSPITAL MORTALITY; SEVERE SEPSIS; RISK; ASSOCIATION; BIOMARKERS; MEDICINE; FAILURE	Background RDW (red cell distribution width) has been reported to been associated with the prognosis of patients with cardiovascular diseases. However, RDW is often overlooked by clinicians in treating patients with non-cardiovascular diseases, especially in an emergency. The objective of this systematic review is to explore the prognostic value of RDW in non-cardiovascular emergencies. Methods PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials were systematically searched from their inception to December 31, 2015. We included studies examining the relationship between RDW and mortality rate by adjusting important covariables in noncardiovascular emergencies. All included studies were divided into three groups. Group A: general critically ill patients; Group B: patients with infectious disease; Group C: other conditions. We extracted each study' characteristics, outcomes, covariables, and other items independently. Results A total of 32 studies were eligible for inclusion in our meta-analysis. Six studies belonged to Group A, 9 studies belonged to Group B and 17 studies belonged to Group C. Among these included studies, RDW was assessed as a continuous variable (per 1% increase) in 16 studies, as a binary variable in 8 studies, and as a categorical variable in 8 studies. In addition, AUCs (area under the receiver operating characteristic curve) of RDW for predicting mortality were reported in 25 studies. All studies were published between 2011 -2015. The qualities of included 32 studies were moderate or high. Conclusion The present systematic review indicates that the increased RDW is significantly associated with a higher mortality rate in an non-cardiovascular emergency. The low cost and readily accessible of this laboratory variable may strengthen its usefulness in daily practice in the future.	[Zhang, Mao] Zhejiang Univ, Affiliated Hosp 2, Dept Emergency Med, Sch Med, Hangzhou, Zhejiang, Peoples R China; Zhejiang Univ, Inst Emergency Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zhang, M (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Dept Emergency Med, Sch Med, Hangzhou, Zhejiang, Peoples R China.	zmhzjzk@163.com			Zhejiang education fund [Y201226266]	Zhejiang education fund	RBL received the funding of Zhejiang education fund (Y201226266). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afessa B, 2007, CRIT CARE CLIN, V23, P639, DOI 10.1016/j.ccc.2007.05.004; Aung N, 2013, INT J CARDIOL, V168, P1997, DOI 10.1016/j.ijcard.2012.12.091; Balta S, 2013, J TRAUMA ACUTE CARE, V75, P345, DOI 10.1097/TA.0b013e31829957c0; Bazick HS, 2011, CRIT CARE MED, V39, P1913, DOI 10.1097/CCM.0b013e31821b85c6; Bilgic I, 2014, PERFUSION, V30; Braun E, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-129; Braun E, 2011, CRIT CARE, V15, DOI 10.1186/cc10355; Chen ZY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/819324; CHIARI MM, 1995, J AM GERIATR SOC, V43, P767, DOI 10.1111/j.1532-5415.1995.tb07047.x; Dabbah S, 2010, AM J CARDIOL, V105, P312, DOI 10.1016/j.amjcard.2009.09.027; Davies HTO, 1998, BRIT MED J, V316, P989, DOI 10.1136/bmj.316.7136.989; Deswal A, 2001, CIRCULATION, V103, P2055; Dinc T, 2014, PERFUSION, V30; Du B, 2010, CRIT CARE, V14, DOI 10.1186/cc8222; Felker GM, 2007, J AM COLL CARDIOL, V50, P40, DOI 10.1016/j.jacc.2007.02.067; Garbharran U, 2013, AGE AGEING, V42, P258, DOI 10.1093/ageing/afs176; Ghaffari S, 2008, ANTIOXID REDOX SIGN, V10, P1923, DOI 10.1089/ars.2008.2142; Guray Y, 2014, ARCH CARDIOVASC DIS, V107, P299, DOI 10.1016/j.acvd.2014.04.008; Hong N, 2012, CLIN CHIM ACTA, V413, P992, DOI 10.1016/j.cca.2012.02.024; Hunziker S, 2012, CRIT CARE, V16, DOI 10.1186/cc11351; Jo YH, 2013, AM J EMERG MED, V31, P545, DOI 10.1016/j.ajem.2012.10.017; Kang C, 2014, AM J EMERG MED, V32, P743, DOI 10.1016/j.ajem.2014.02.048; Karagoz E, 2013, WORLD J EMERG SURG, V8, DOI 10.1186/1749-7922-8-54; Kim CH, 2013, CRIT CARE, V17, DOI 10.1186/cc13145; Kim J, 2012, RESUSCITATION, V83, P1248, DOI 10.1016/j.resuscitation.2012.01.038; Ku NS, 2012, SHOCK, V38, P123, DOI 10.1097/SHK.0b013e31825e2a85; Lam AP, 2013, AM J HEMATOL, V88, pE245, DOI 10.1002/ajh.23529; Lee JH, 2013, AM J EMERG MED, V31, P72, DOI 10.1016/j.ajem.2012.06.004; Leekha S, 2011, CRIT CARE MED, V39, P1995, DOI 10.1097/CCM.0b013e318223b94b; Lippi G, 2013, EUR J INTERN MED, V24, pE15, DOI 10.1016/j.ejim.2012.09.005; Lv HC, 2016, J BONE MINER RES, V31, P223, DOI 10.1002/jbmr.2597; Majercik S, 2013, J TRAUMA ACUTE CARE, V74, P1021, DOI 10.1097/TA.0b013e3182826f02; Meynaar IA, 2013, NETH J MED, V71, P488; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mucsi I, 2014, INT UROL NEPHROL, V46, P641, DOI 10.1007/s11255-013-0530-z; Oh HJ, 2012, NEPHROL DIAL TRANSPL, V27, P589, DOI 10.1093/ndt/gfr307; Ozdogan HK, 2015, ULUS TRAVMA ACIL CER, V21, P352, DOI 10.5505/tjtes.2015.26737; Ozsu S, 2014, THE CLINICAL RESPIRA, V9, P34; Patel KV, 2009, ARCH INTERN MED, V169, P515, DOI 10.1001/archinternmed.2009.11; Perlstein TS, 2009, ARCH INTERN MED, V169, P588, DOI 10.1001/archinternmed.2009.55; Pierce CN, 2005, PERFUSION-UK, V20, P83, DOI 10.1191/0267659105pf793oa; Purtle SW, 2014, CRIT CARE MED, V42, P918, DOI 10.1097/CCM.0000000000000118; Rhodes CJ, 2011, HEART, V97, P1054, DOI 10.1136/hrt.2011.224857; Sadaka Farid, 2013, J Intensive Care Med, V28, P307, DOI 10.1177/0885066612452838; Sen HS, 2014, WIEN KLIN WOCHENSCHR, V126, P347, DOI 10.1007/s00508-014-0537-1; Senol K, 2013, AM J EMERG MED, V31, P687, DOI 10.1016/j.ajem.2012.12.015; Seyhan EC, 2013, RED BLOOD CELL DISTR, V10, P416, DOI [10.3109/15412555.2012.758697, DOI 10.3109/15412555.2012.758697]; Shteinshnaider M, 2015, EUR J INTERN MED, V26, P616, DOI 10.1016/j.ejim.2015.07.018; [田李均 Tian Lijun], 2014, [中国急救医学, Chinese Journal of Critical Care Medicine], V34, P31; van Kimmenade RRJ, 2010, EUR J HEART FAIL, V12, P129, DOI 10.1093/eurjhf/hfp179; Veeranna V, 2012, CARDIOLOGY, V122, P129, DOI 10.1159/000339225; Vincent JL, 2010, CRIT CARE, V14, DOI 10.1186/cc8204; Wang D, 2015, J RES MED SCI, V20, P424; Wang FL, 2011, ANN MED, V43, P40, DOI 10.3109/07853890.2010.521766; Yao JM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004721; Zhang ZH, 2013, J THORAC DIS, V5, P730, DOI 10.3978/j.issn.2072-1439.2013.11.14; Zorlu A, 2012, AM J CARDIOL, V109, P128, DOI 10.1016/j.amjcard.2011.08.015	57	28	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167000	10.1371/journal.pone.0167000	http://dx.doi.org/10.1371/journal.pone.0167000			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936006	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100053
J	Newman, MA; Zebeli, Q; Velde, K; Grull, D; Molnar, T; Kandler, W; Metzler-Zebeli, BU				Newman, M. A.; Zebeli, Q.; Velde, K.; Gruell, D.; Molnar, T.; Kandler, W.; Metzler-Zebeli, B. U.			Enzymatically Modified Starch Favorably Modulated Intestinal Transit Time and Hindgut Fermentation in Growing Pigs	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; RESISTANT STARCH; DIETARY FIBER; WEANED PIGS; GASTROINTESTINAL-TRACT; NONSTARCH POLYSACCHARIDES; NUTRIENT DIGESTIBILITY; BACTERIAL-POPULATIONS; BODY-WEIGHT; HUMAN-COLON	Aside from being used as stabilizing agents in many processed foods, chemically modified starches may act as functional dietary ingredients. Therefore, development of chemically modified starches that are less digestible in the upper intestinal segments and promote fermentation in the hindgut receives considerable attention. This study aimed to investigate the impact of an enzymatically modified starch (EMS) on nutrient flow, passage rate, and bacterial activity at ileal and post-ileal level. Eight ileal-cannulated growing pigs were fed 2 diets containing 72% purified starch (EMS or waxy cornstarch as control) in a cross-over design for 10 d, followed by a 4-d collection of feces and 2-d collection of ileal digesta. On d 17, solid and liquid phase markers were added to the diet to determine ileal digesta flow for 8 h after feeding. Reduced small intestinal digestion after the consumption of the EMS diet was indicated by a 10%-increase in ileal flow and fecal excretion of dry matter and energy compared to the control diet (P< 0.05). Moreover, EMS feeding reduced ileal transit time of both liquid and solid fractions compared to the control diet (P< 0.05). The greater substrate flow to the large intestine with the EMS diet increased the concentrations of total and individual short-chain fatty acids (SCFA) in feces (P< 0.05). Total bacterial 16S rRNA gene abundance was not affected by diet, whereas the relative abundance of the Lactobacillus group decreased (P< 0.01) by 50% and of Enterobacteriaceae tended (P< 0.1) to increase by 20% in ileal digesta with the EMS diet compared to the control diet. In conclusion, EMS appears to resemble a slowly digestible starch by reducing intestinal transit and increasing SCFA in the distal large intestine.	[Newman, M. A.; Zebeli, Q.] Univ Vet Med Vienna, Inst Anim Nutr & Funct Plant Cpds, Vienna, Austria; [Newman, M. A.; Zebeli, Q.; Metzler-Zebeli, B. U.] Univ Vet Med Vienna, Dept Farm Anim & Vet Publ Hlth, Res Cluster Anim Gut Hlth, Vienna, Austria; [Velde, K.] Univ Vet Med, Dept Compan Anim & Horses, Equine Univ Clin, Vienna, Austria; [Gruell, D.; Molnar, T.] Agrana Res & Innovat Ctr GmbH, Tulln, Austria; [Kandler, W.] Univ Nat Resources & Life Sci, IFA Tulln, Dept Agrobiotechnol, Ctr Analyt Chem, Vienna, Austria; [Metzler-Zebeli, B. U.] Univ Vet Med, Univ Clin Swine, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Natural Resources & Life Sciences, Vienna; University of Veterinary Medicine Vienna	Metzler-Zebeli, BU (corresponding author), Univ Vet Med Vienna, Dept Farm Anim & Vet Publ Hlth, Res Cluster Anim Gut Hlth, Vienna, Austria.; Metzler-Zebeli, BU (corresponding author), Univ Vet Med, Univ Clin Swine, Vienna, Austria.	barbara.metzler@vetmeduni.ac.at			Austrian Research Promotion Agency (FFG) [836447]; Agrana Research & Innovation Center GmbH	Austrian Research Promotion Agency (FFG); Agrana Research & Innovation Center GmbH	This project was funded by the Austrian Research Promotion Agency (FFG), BRIDGE programme (no. 836447-"Healthy Carbohydrates"), http://www.ffg.at/en/bridge. Agrana Research & Innovation Center GmbH provided support in the form of salaries for authors [DG, TM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bird AR, 2007, BRIT J NUTR, V97, P134, DOI 10.1017/S0007114507250433; Bird AR, 2009, DIGEST DIS SCI, V54, P947, DOI 10.1007/s10620-008-0451-3; Birt DF, 2013, ADV NUTR, V4, P587, DOI 10.3945/an.113.004325; Canfora EE, 2015, NAT REV ENDOCRINOL, V11, P577, DOI 10.1038/nrendo.2015.128; Chambers ES, 2015, GUT, V64, P1744, DOI 10.1136/gutjnl-2014-307913; CUMMINGS JH, 1980, CAN MED ASSOC J, V123, P1109; da Silva CS, 2014, ANIMAL, V8, P1402, DOI 10.1017/S1751731114001116; da Silva CS, 2012, PHYSIOL BEHAV, V107, P218, DOI 10.1016/j.physbeh.2012.07.001; Englyst KN, 2003, BRIT J NUTR, V89, P329, DOI 10.1079/BJN2002786; Gerrits WJJ, 2012, J NUTR, V142, P238, DOI 10.3945/jn.111.147496; Guilloteau P, 2010, NUTR RES REV, V23, P4, DOI 10.1017/S0954422410000077; Haenen D, 2013, J NUTR, V143, P274, DOI 10.3945/jn.112.169672; Han JA, 2007, CARBOHYD POLYM, V67, P366, DOI 10.1016/j.carbpol.2006.06.011; Heo JM, 2014, J ANIM SCI, V92, P3906, DOI 10.2527/jas.2013-7289; Hooda S, 2011, BRIT J NUTR, V106, P664, DOI 10.1017/S0007114511000985; Khan IUH, 2007, J MICROBIOL METH, V69, P480, DOI 10.1016/j.mimet.2007.02.016; Khol-Parisini A, 2015, ANIM FEED SCI TECH, V210, P74, DOI 10.1016/j.anifeedsci.2015.09.028; LI S, 1993, J ANIM PHYSIOL AN N, V70, P26, DOI [10.1111/j.1439-0396.1993.tb00303.x, 10.1111/j.1439-0396.1993.tb00314.x]; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Martinez I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015046; McCleary BV, 2010, J AOAC INT, V93, P221; Metzler BU, 2008, J ANIM SCI, V86, P1544, DOI 10.2527/jas.2007-0267; Metzler-Zebeli BU, 2010, J ANIM SCI, V88, P3351, DOI 10.2527/jas.2010-2906; Metzler-Zebeli BU, 2015, APPL ENVIRON MICROB, V81, P8489, DOI 10.1128/AEM.02756-15; Metzler-Zebeli BU, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130553; Metzler-Zebeli BU, 2013, APPL ENVIRON MICROB, V79, P7264, DOI 10.1128/AEM.02691-13; Metzler-Zebeli BU, 2011, FEMS MICROBIOL ECOL, V75, P402, DOI 10.1111/j.1574-6941.2010.01017.x; Morais MB, 1996, PEDIATR RES, V39, P872, DOI 10.1203/00006450-199605000-00022; Moran AW, 2010, BRIT J NUTR, V104, P647, DOI 10.1017/S0007114510000954; Nielsen KL, 2014, AM J CLIN NUTR, V99, P941, DOI 10.3945/ajcn.113.074724; NRC, 2012, NUTRIENT REQUIREMENT; PHILLIPS J, 1995, AM J CLIN NUTR, V62, P121; POND WG, 1986, J ANIM SCI, V63, P1140, DOI 10.2527/jas1986.6341140x; Psichas A, 2015, INT J OBESITY, V39, P424, DOI 10.1038/ijo.2014.153; Regmi PR, 2011, J NUTR, V141, P398, DOI 10.3945/jn.110.132449; Shimotoyodome A, 2010, AM J PHYSIOL-ENDOC M, V298, pE652, DOI 10.1152/ajpendo.00468.2009; Singh J, 2010, TRENDS FOOD SCI TECH, V21, P168, DOI 10.1016/j.tifs.2009.12.001; Stein HH, 1998, J ANIM SCI, V76, P1433; Suarez-Belloch J, 2013, SPAN J AGRIC RES, V11, P780, DOI 10.5424/sjar/2013113-3958; Sun Y, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00779; Sun Y, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00877; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Umu OCO, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0078-5; van Kempen TATG, 2010, J NUTR, V140, P1227, DOI 10.3945/jn.109.120584; VDLUFA, 2007, METHODENBUCH BUCH II; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wilfart A, 2007, BRIT J NUTR, V98, P54, DOI 10.1017/S0007114507682981; Zaman SA, 2015, CRIT REV BIOTECHNOL, V7, P1	48	8	8	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167784	10.1371/journal.pone.0167784	http://dx.doi.org/10.1371/journal.pone.0167784			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936165	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100187
J	Oh, SY; Lee, JY; Park, KA; Oh, SY				Oh, Shin Yeop; Lee, Ju-Yeun; Park, Kyung-Ah; Oh, Sei Yeul			Long-Term Changes in Refractive Error and Clinical Evaluation in Partially Accommodative Esotropia after Surgery	PLOS ONE			English	Article							CONGENITAL ESOTROPIA; CHILDREN; OUTCOMES; GROWTH	We investigate the changes in refractive error and clinical evaluation in partially accommodative esotropia (PAET) after surgery. A total of 68 patients PAET who received at least 2 years of follow-up after surgery were enrolled in this study. We performed a retrospective study in patients who underwent unilateral or bilateral medial rectus recession for a non-accommodative component of PAET between January 2005 and March 2013. Patients were divided into groups according to the presence of dominancy (dominant, non-dominant, alternative eye), and presence of amblyopia (amblyopic, fellow, normal eye). Changes and changing pattern in SE refractive error were analyzed in all patients and compared between groups. Patients were divided into two groups, those weaned off of hyperopic glasses and those who continued using them, then factors that significantly influenced the continued use of glasses were analyzed. The changes and changing pattern in SE refractive error according to time after operation and presence of amblyopia or dominancy. The mean length of follow-up was 4.89 +/- 1.74 years after surgery and the mean change in SE refractive error rate per year was -0.284 +/- 0.411 diopters (D). The pattern of changes in the mean SE refractive error for those with dominant, non-dominant, and alternative eyes was not significantly different (p = 0.292). The pattern of changes in the mean SE refractive error for those with amblyopic, fellow, and normal eyes was significantly different (p = 0.0002). Patients were successfully weaned off of hyperopic glasses at an average age of 9.41 +/- 2.74 years. The average SE refractive error in the group weaned off of hyperopic glasses was significantly lower than that in the group maintained on hyperopic glasses (p = 0.0002). The change of SE refractive error in amblyopic eyes decreased less than that in fellow or normal eyes, which may be correlated with the presence of amblyopia. Patients with a smaller esodeviated angle without hyperopic correction, a lower degree of hyperopia, and who were older at the time of disease onset were discontinued from hyperopic glasses sooner after surgery.	[Oh, Shin Yeop] Sungkyunkwan Univ, Sch Med, Dept Ophthalmol, Samsung Changwon Hosp, Chang Won, South Korea; [Lee, Ju-Yeun; Park, Kyung-Ah; Oh, Sei Yeul] Sungkyunkwan Univ, Sch Med, Dept Ophthalmol, Samsung Med Ctr, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Oh, SY (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Ophthalmol, Samsung Med Ctr, Seoul, South Korea.	syoh@skku.edu						BAKER JD, 1980, AM J OPHTHALMOL, V90, P11, DOI 10.1016/S0002-9394(14)75070-6; Berk AT, 2004, J AAPOS, V8, P384, DOI 10.1016/j.jaapos.2004.02.001; Birch EE, 2008, EYE LOND, V24, P1814; Black Bradley Charles, 2006, Trans Am Ophthalmol Soc, V104, P303; Brian G. Mohney, 2011, OPHTHALMOLOGY, V118, P581, DOI [10.1016/j.ophtha.2010.07.017, DOI 10.1016/J.OPHTHA.2010.07.017]; Burtolo C, 2002, J PEDIAT OPHTH STRAB, V39, P209, DOI 10.3928/0191-3913-20020701-08; Cho YA, 2009, ACTA OPHTHALMOL, V87, P532, DOI 10.1111/j.1755-3768.2008.01255.x; Donders FC, 1864, ANOMALIES ACCOMMODAT, V22, P292; Elham AT, 2015, STRABISMUS, V23, P111, DOI [10.3109/09273972.2015.1058401, DOI 10.3109/09273972.2015.1058401]; Fujikado T, 1997, GRAEF ARCH CLIN EXP, V235, P320, DOI 10.1007/BF01739642; Giordano L, 2009, OPHTHALMOLOGY, V116, P739, DOI 10.1016/j.ophtha.2008.12.030; Ing MR, 1995, OPHTHALMOLOGY, V102, P2041, DOI 10.1016/S0161-6420(95)30756-7; Kutluturk I, 2014, J PEDIAT OPHTH STRAB, V51, P171, DOI 10.3928/01913913-20140305-01; Lambert SR, 2006, BRIT J OPHTHALMOL, V90, P357, DOI 10.1136/bjo.2005.078105; Lambert SR, 2003, J AAPOS, V7, P7, DOI 10.1016/S1091-8531(02)42010-1; LEPARD CW, 1975, AM J OPHTHALMOL, V80, P485, DOI 10.1016/0002-9394(75)90212-3; Lowery R Scott, 2006, Compr Ophthalmol Update, V7, P145; Mulvihill A, 2000, BRIT J OPHTHALMOL, V84, P746, DOI 10.1136/bjo.84.7.746; NASTRI G, 1984, DOC OPHTHALMOL, V56, P265, DOI 10.1007/BF00159077; Parks MM, 1987, CLIN OPHTHALMOLOGY, P1; Repka MX, 1989, BINOC VIS, V4, P5; Rutstein RP, 1998, OPTOMETRY VISION SCI, V75, P97, DOI 10.1097/00006324-199802000-00013; Smith EL, 1999, VISION RES, V39, P1415, DOI 10.1016/S0042-6989(98)00229-6; SWAN KC, 1983, OPHTHALMOLOGY, V90, P1141; Varma R, 2010, OPHTHALMOLOGY, V117, P140, DOI 10.1016/j.ophtha.2009.06.009; VONNOORDEN GK, 1990, AM J OPHTHALMOL, V110, P287, DOI 10.1016/S0002-9394(14)76346-9; WRIGHT KW, 1994, ARCH OPHTHALMOL-CHIC, V112, P913, DOI 10.1001/archopht.1994.01090190061022	27	4	4	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166695	10.1371/journal.pone.0166695	http://dx.doi.org/10.1371/journal.pone.0166695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936115	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100041
J	Shi, CL; Guo, Y; Lv, YC; Nanding, A; Shi, TF; Qin, HD; He, JJ				Shi, Chenlei; Guo, Yong; Lv, Yichen; Nanding, Abiyasi; Shi, Tiefeng; Qin, Huadong; He, Jianjun			Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAF(V600E) Mutational Status and Expression of Angiogenic Factors	PLOS ONE			English	Article							EPITHELIUM-DERIVED FACTOR; TALL CELL VARIANT; UNFAVORABLE PROGNOSIS; CARCINOMA; GROWTH; CANCER; OVEREXPRESSION; PROTEINS	Objective To investigate the clinicopathological characteristics of papillary thyroid microcarcinoma (PTMC) for surgery by comparing the difference between PTMC and larger papillary thyroid carcinoma (LPTC). Methods We analyzed the differences in the clinicopathological characteristics, prognosis, B-type RAF kinase (BRAF)(V600E) mutational status and expression of angiogenic factors, including pigment epithelium-derived factor (PEDF), Vascular Endothelial Growth Factor (VEGF), and hypoxia-inducible factor alpha subunit (HIF-1 alpha), between PTMC and LPTC by retrospectively reviewing the records of 251 patients with papillary thyroid carcinoma, 169 with PTMC, and 82 with LPTC (diameter >1 cm). Results There were no significant differences in the gender, age, multifocality, Hashimoto's thyroiditis, TNM stage, PEDF protein expression, rate of recurrence, or mean follow-up duration between patients with PTMC or LPTC. The prevalence of extrathyroidal invasion (EI), lymph node metastasis (LNM), and BRAF mutation in patients with PTMC was significantly lower than in patients with LPTC. In addition, in PTMC patients with EI and/or LNM and/or positive BRAF (high-risk PTMC patients), the prevalence of extrathyroidal invasion, Hashimoto's disease, lymph node metastasis, tumor TNM stage, PEDF positive protein expression, the rate of recurrent disease, and the mRNA expression of anti-angiogenic factors was almost as high as in patients with larger PTC, but with no significant difference. Conclusions Extrathyroid invasion, lymph node metastases, and BRAF(V600E) mutation were the high risk factors of PTMC. PTMC should be considered for the same treatment strategy as LPTC when any of these factors is found. Particularly, PTMC with BRAF(V600E) gene mutations needed earlier surgical treatment. In addition, the high cell subtype of PTMC with BRAF(V600E) gene mutation is recommended for total thyroidectomy in primary surgery to reduce the risk of recurrence.	[Shi, Chenlei; He, Jianjun] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Breast Surg, Xian, Peoples R China; [Shi, Chenlei; Lv, Yichen; Shi, Tiefeng; Qin, Huadong] Harbin Med Univ, Affiliated Hosp 2, Dept Gen Surg 4, Harbin, Peoples R China; [Guo, Yong] Heze Municipal Hosp, Dept Breast & Thyroid, Heze, Shandong, Peoples R China; [Nanding, Abiyasi] Harbin Med Univ, Affiliated Hosp 3, Dept Pathol, Harbin, Peoples R China	Xi'an Jiaotong University; Harbin Medical University; Harbin Medical University	He, JJ (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Breast Surg, Xian, Peoples R China.	chinahjjjj@163.com			Programs of Science and Technology of Heilongjiang Educational Committee [12541490]	Programs of Science and Technology of Heilongjiang Educational Committee	This research was supported by the Programs of Science and Technology of Heilongjiang Educational Committee (12541490). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Bernstein J, 2013, THYROID, V23, P1525, DOI 10.1089/thy.2013.0154; Birner P, 2000, CANCER RES, V60, P4693; Brito JP, 2014, CURR OPIN ENDOCRINOL, V21, P405, DOI 10.1097/MED.0000000000000094; Brown RL, 2011, J CANCER, V2, P193, DOI 10.7150/jca.2.193; Browne M, 2006, PEDIATR RES, V60, P282, DOI 10.1203/01.pdr.0000232789.86632.91; Castro MR, 2015, CANCER-AM CANCER SOC, V121, P3364, DOI 10.1002/cncr.29468; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Ghossein RA, 2007, THYROID, V17, P655, DOI 10.1089/thy.2007.0061; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Hay ID, 2006, J SURG ONCOL, V94, P692, DOI 10.1002/jso.20696; HEDINGER C, 1989, CANCER-AM CANCER SOC, V63, P908, DOI 10.1002/1097-0142(19890301)63:5<908::AID-CNCR2820630520>3.0.CO;2-I; Ito Y, 2004, WORLD J SURG, V28, P1115, DOI 10.1007/s00268-004-7644-5; Koperek O, 2013, VIRCHOWS ARCH, V463, P795, DOI 10.1007/s00428-013-1484-3; Koperek O, 2011, J PATHOL, V225, P63, DOI 10.1002/path.2926; Lan L, 2013, INT J ONCOL, V43, P113, DOI 10.3892/ijo.2013.1913; Lee JH, 2007, CANCER, V1, P38; Lian YZ, 2011, INT J LAB MED, V32, P644; Lupi C, 2007, J CLIN ENDOCR METAB, V92, P4085, DOI 10.1210/jc.2007-1179; MacCorkle RA, 2005, CELL BIOCHEM BIOPHYS, V43, P451, DOI 10.1385/CBB:43:3:451; Mercer KE, 2003, BBA-REV CANCER, V1653, P25, DOI 10.1016/S0304-419X(03)00016-7; Ming J, 2015, INT J CLIN EXP PATHO, V8, P15155; Park YJ, 2010, HEAD NECK-J SCI SPEC, V32, P38, DOI 10.1002/hed.21142; Paterson ICM, 1999, CLIN ONCOL-UK, V11, P245, DOI 10.1053/clon.1999.9057; Pelizzo MR, 2004, NUCL MED COMMUN, V25, P547, DOI 10.1097/01.mnm.0000126625.17166.36; Sapio MR, 2006, EUR J ENDOCRINOL, V154, P341, DOI 10.1530/eje.1.02072; Schindl M, 2002, CLIN CANCER RES, V8, P1831; Shi CL, 2015, GENET MOL RES, V14, P7377, DOI 10.4238/2015.July.3.13; Shi Chenlei, 2015, Zhonghua Zhong Liu Za Zhi, V37, P123; Soares P, 2003, ONCOGENE, V22, P4578, DOI 10.1038/sj.onc.1206706; Stratmann M, 2012, CHIRURG, V83, P646, DOI 10.1007/s00104-011-2216-3; Tuttle RM, 2010, J NATL COMPR CANC NE, V8, P1228, DOI 10.6004/jnccn.2010.0093; Udelsman R, 1999, Adv Surg, V33, P1; [汪杰 WANG Jie], 2011, [中华实验外科杂志, Chinese Journal of Experimental Surgery], V28, P1102; Wang LZ, 2009, CANCER CELL, V16, P336, DOI 10.1016/j.ccr.2009.08.016; Yang HS, 2009, CANCER SCI, V100, P2419, DOI 10.1111/j.1349-7006.2009.01332.x; Yang J, 2010, CANCER BIOL THER, V9, P967, DOI 10.4161/cbt.9.12.11635; Yoon JH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002435; Zhang Y, 2011, ONCOL REP, V26, P681, DOI 10.3892/or.2011.1318	38	13	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167414	10.1371/journal.pone.0167414	http://dx.doi.org/10.1371/journal.pone.0167414			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936049	Green Submitted, gold, Green Published			2022-12-27	WOS:000389587100094
J	van Rein, N; Lijfering, WM; Bos, MHA; Herruer, MH; Vermaas, HW; van der Meer, FJM; Reitsma, PH				van Rein, Nienke; Lijfering, Willem M.; Bos, Mettine H. A.; Herruer, Martien H.; Vermaas, Helga W.; van der Meer, Felix J. M.; Reitsma, Pieter H.			Objectives and Design of BLEEDS: A Cohort Study to Identify New Risk Factors and Predictors for Major Bleeding during Treatment with Vitamin K Antagonists	PLOS ONE			English	Article							ORAL ANTICOAGULANT-THERAPY; ATRIAL-FIBRILLATION PATIENTS; WARFARIN; COMPLICATIONS; HEMORRHAGE; THROMBOEMBOLISM; THROMBOMODULIN; INTENSITY; EVENTS; STROKE	Background Risk scores for patients who are at high risk for major bleeding complications during treatment with vitamin K antagonists (VKAs) do not perform that well. BLEEDS was initiated to search for new biomarkers that predict bleeding in these patients. Objectives To describe the outline and objectives of BLEEDS and to examine whether the study population is generalizable to other VKA treated populations. Methods A cohort was created consisting of all patients starting VKA treatment at three Dutch anticoagulation clinics between January-2012 and July-2014. We stored leftover plasma and DNA following analysis of the INR. Results Of 16,706 eligible patients, 16,570 (99%) were included in BLEEDS and plasma was stored from 13,779 patients (83%). Patients had a mean age of 70 years (SD 14), 8713 were male (53%). The most common VKA indications were atrial fibrillation (10,876 patients, 66%) and venous thrombosis (3920 patients, 24%). 326 Major bleeds occurred during 17,613 years of follow-up (incidence rate 1.85/100 person years, 95% CI 1.66-2.06). The risk for major bleeding was highest in the initial three months of VKA treatment and increased when the international normalized ratio increased. These results and characteristics are in concordance with results from other VKA treated populations. Conclusion BLEEDS is generalizable to other VKA treated populations and will permit innovative and unbiased research of biomarkers that may predict major bleeding during VKA treatment.	[van Rein, Nienke; Lijfering, Willem M.; Bos, Mettine H. A.; van der Meer, Felix J. M.; Reitsma, Pieter H.] Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Leiden, Netherlands; [van Rein, Nienke; Lijfering, Willem M.; Bos, Mettine H. A.; Reitsma, Pieter H.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Lijfering, Willem M.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Herruer, Martien H.] Atalmedial Med Diagnost Ctr, Hoofddorp, Netherlands; [Vermaas, Helga W.] Anticoagulat Clin Hague, The Hague, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Rein, N (corresponding author), Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Leiden, Netherlands.; van Rein, N (corresponding author), Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands.	n.van_rein@lumc.nl	Lijfering, Willem/J-7442-2019; Bos, Mettine/S-5317-2016	Lijfering, Willem/0000-0002-4638-4623; Bos, Mettine/0000-0002-8164-817X	Hartstichting [2011 T12, 99.165]; Center for Translational Molecular Medicine [01 C-201]	Hartstichting; Center for Translational Molecular Medicine	Hartstichting (2011 T12) https://www.hartstichting.nl/, Center for Translational Molecular Medicine (01 C-201) http://www.ctmm.nl/nl, and Hartstichting (99.165) https://www.hartstichting.nl/.	Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Beyth RJ, 1998, AM J MED, V105, P91, DOI 10.1016/S0002-9343(98)00198-3; CANNEGIETER SC, 1995, NEW ENGL J MED, V333, P11, DOI 10.1056/NEJM199507063330103; Connolly SJ, 2008, CIRCULATION, V118, P2029, DOI 10.1161/CIRCULATIONAHA.107.750000; Fang MC, 2011, J AM COLL CARDIOL, V58, P395, DOI 10.1016/j.jacc.2011.03.031; Fang MC, 2004, ANN INTERN MED, V141, P745, DOI 10.7326/0003-4819-141-10-200411160-00005; FIHN SD, 1993, ANN INTERN MED, V118, P511, DOI 10.7326/0003-4819-118-7-199304010-00005; Gage BF, 2006, AM HEART J, V151, P713, DOI 10.1016/j.ahj.2005.04.017; Go AS, 2003, JAMA-J AM MED ASSOC, V290, P2685, DOI 10.1001/jama.290.20.2685; Kuijer PMM, 1999, ARCH INTERN MED, V159, P457, DOI 10.1001/archinte.159.5.457; LANDEFELD CS, 1989, AM J MED, V87, P144; Lind M, 2009, ARCH INTERN MED, V169, P1210, DOI 10.1001/archinternmed.2009.170; Linkins LA, 2013, BLOOD REV, V27, P111, DOI 10.1016/j.blre.2013.02.004; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; PETITTI DB, 1986, AM J MED, V81, P255, DOI 10.1016/0002-9343(86)90260-3; Roldan V, 2011, J AM COLL CARDIOL, V57, P2496, DOI 10.1016/j.jacc.2010.12.033; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Schulman S, 2008, CHEST, V133, p257S, DOI 10.1378/chest.08-0674; Shireman TI, 2004, STROKE, V35, P2362, DOI 10.1161/01.STR.0000141933.75462.c2; Singer DE, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000067; Van Der Heijden JF, 2004, J THROMB HAEMOST, V2, P1104, DOI 10.1111/j.1538-7836.2004.00768.x; van Rein N, 2014, J CLIN EPIDEMIOL, V67, P232, DOI 10.1016/j.jclinepi.2013.05.011; VANDERMEER FJM, 1993, ARCH INTERN MED, V153, P1557, DOI 10.1001/archinte.153.13.1557; White HD, 2007, ARCH INTERN MED, V167, P239, DOI 10.1001/archinte.167.3.239; Zhu WG, 2015, CLIN CARDIOL, V38, P555, DOI 10.1002/clc.22435	27	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0164485	10.1371/journal.pone.0164485	http://dx.doi.org/10.1371/journal.pone.0164485			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935941	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100005
J	Yates, NJ; Robertson, D; Rodger, J; Martin-Iverson, MT				Yates, Nathanael J.; Robertson, Donald; Rodger, Jennifer; Martin-Iverson, Mathew T.			Effects of Neonatal Dexamethasone Exposure on Adult Neuropsychiatric Traits in Rats	PLOS ONE			English	Article							SENSORIMOTOR GATING DEFICITS; PREPULSE INHIBITION; PRENATAL STRESS; STARTLE REFLEX; POSTNATAL DEXAMETHASONE; BRONCHOPULMONARY DYSPLASIA; DOPAMINE HYPOTHESIS; OBJECT RECOGNITION; LOCOMOTOR RESPONSE; NUCLEUS-ACCUMBENS	The effects of early life stress in utero or in neonates has long-term consequences on hypothalamic-pituitary-adrenal (HPA) stress axis function and neurodevelopment. These effects extend into adulthood and may underpin a variety of mental illnesses and be related to various developmental and cognitive changes. We examined the potential role of neonatal HPA axis activation on adult psychopathology and dopamine sensitivity in the mature rat using neonatal exposure to the synthetic glucocorticoid receptor agonist and stress hormone, dexamethasone. We utilized a comprehensive battery of assessments for behaviour, brain function and gene expression to determine if elevated early life HPA activation is associated with adult-onset neuropsychiatric traits. Dexamethasone exposure increased startle reactivity under all conditions tested, but decreased sensitivity of sensorimotor gating to dopaminergic disruption-contrasting with what is observed in several neuropsychiatric diseases. Under certain conditions there also appeared to be mild long-term changes in stress and anxiety-related behaviours with neonatal dexamethasone exposure. Electrophysiology revealed that there were no consistent neuropsychiatric abnormalities in auditory processing or resting state brain function with dexamethasone exposure. However, neonatal dexamethasone altered auditory cortex glucocorticoid activation, and auditory cortex synchronization. Our results indicate that neonatal HPA axis activation by dexamethasone alters several aspects of adult brain function and behaviour and may induce long-term changes in emotional stress-reactivity. However, neonatal dexamethasone exposure is not specifically related to any particular neuropsychiatric disease.	[Yates, Nathanael J.; Rodger, Jennifer] Univ Western Australia, Sch Anim Biol, Fac Sci, Crawley, WA, Australia; [Robertson, Donald] Univ Western Australia, Fac Sci, Sch Anat Physiol & Human Biol, Crawley, WA, Australia; [Martin-Iverson, Mathew T.] Univ Western Australia, Fac Med Dent & Hlth Sci, Sch Med & Pharmacol, Crawley, WA, Australia	University of Western Australia; University of Western Australia; University of Western Australia	Yates, NJ (corresponding author), Univ Western Australia, Sch Anim Biol, Fac Sci, Crawley, WA, Australia.	nathanael.yates@uwa.edu.au	Rodger, Jennifer/H-5735-2014; Yates, Nathanael J/K-8358-2018	Rodger, Jennifer/0000-0003-3413-4229; Yates, Nathanael J/0000-0003-2742-6952; Martin-Iverson, Mathew/0000-0003-4855-6748				Abduljawad KAJ, 1997, J PSYCHOPHARMACOL, V11, P29, DOI 10.1177/026988119701100110; ALONSO SJ, 1994, PHARMACOL BIOCHEM BE, V49, P353, DOI 10.1016/0091-3057(94)90433-2; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; Beaulieu E, 2011, NAT REV RHEUMATOL, V7, P340, DOI 10.1038/nrrheum.2011.59; Berk M, 2007, ACTA PSYCHIAT SCAND, V116, P41, DOI 10.1111/j.1600-0447.2007.01058.x; Brabham T, 2000, AM J PHYSIOL-REG I, V279, pR1899, DOI 10.1152/ajpregu.2000.279.5.R1899; Braff DL, 2010, CURR TOP BEHAV NEURO, V4, P349, DOI 10.1007/7854_2010_61; Brenner CA, 2009, SCHIZOPHRENIA BULL, V35, P1065, DOI 10.1093/schbul/sbp091; Broberg BV, 2010, BEHAV BRAIN RES, V213, P142, DOI 10.1016/j.bbr.2010.04.026; Brown AS, 2012, DEV NEUROBIOL, V72, P1272, DOI 10.1002/dneu.22024; Buchmann AF, 2014, PSYCHOPHARMACOLOGY, V231, P3089, DOI 10.1007/s00213-014-3484-7; BUCHSBAUM MS, 1977, SCHIZOPHRENIA BULL, V3, P93, DOI 10.1093/schbul/3.1.93; CADOR M, 1993, NEUROSCIENCE, V56, P981, DOI 10.1016/0306-4522(93)90144-5; CAPASSO A, 1995, PROG NEURO-PSYCHOPH, V19, P1063, DOI 10.1016/0278-5846(95)00197-2; Cheong JLY, 2014, J PEDIATR-US, V164, P737, DOI 10.1016/j.jpeds.2013.10.083; Chitty K, 2014, PSYCHOPHARMACOLOGY, V231, P2327, DOI 10.1007/s00213-013-3395-z; Claessens SEF, 2012, HORM BEHAV, V62, P433, DOI 10.1016/j.yhbeh.2012.07.011; Clunas NJ, 2005, PSYCHIAT RES, V136, P17, DOI 10.1016/j.psychres.2005.05.009; Cole MA, 2000, PSYCHONEUROENDOCRINO, V25, P151, DOI 10.1016/S0306-4530(99)00045-1; Lopes-de-Morais AAC, 2014, BRAIN RES, V1591, P93, DOI 10.1016/j.brainres.2014.09.075; Davidson JO, 2011, J PHYSIOL-LONDON, V589, P3823, DOI 10.1113/jphysiol.2011.212043; de Kloet ER, 1999, TRENDS NEUROSCI, V22, P422, DOI 10.1016/S0166-2236(99)01438-1; deKloet ER, 1996, CELL MOL NEUROBIOL, V16, P345; Denys D, 2004, J CLIN PSYCHIAT, V65, P11; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Ellenbroek BA, 2003, CLIN NEUROSCI RES, V3, P297, DOI 10.1016/S1566-2772(03)00090-2; Entringer S, 2009, HORM BEHAV, V55, P292, DOI 10.1016/j.yhbeh.2008.11.006; Felszeghy K, 1996, J NEUROENDOCRINOL, V8, P493, DOI 10.1046/j.1365-2826.1996.04822.x; Felszeghy K, 2000, J NEUROENDOCRINOL, V12, P1014, DOI 10.1046/j.1365-2826.2000.00551.x; Ferguson SA, 2001, NEUROTOXICOL TERATOL, V23, P57, DOI 10.1016/S0892-0362(00)00115-X; Ferguson SA, 1999, NEUROTOXICOL TERATOL, V21, P71, DOI 10.1016/S0892-0362(98)00029-4; Flagel SB, 2002, AM J PHYSIOL-REG I, V282, pR55, DOI 10.1152/ajpregu.2002.282.1.R55; FRIDE E, 1988, LIFE SCI, V42, P1059, DOI 10.1016/0024-3205(88)90561-9; Grillon C, 2003, CLIN NEUROPHYSIOL, V114, P1557, DOI 10.1016/S1388-2457(03)00202-5; Grillon C, 1997, J AM ACAD CHILD PSY, V36, P925, DOI 10.1097/00004583-199707000-00014; Grillon C, 2008, PSYCHOPHARMACOLOGY, V199, P421, DOI 10.1007/s00213-007-1019-1; Hauser J, 2006, BEHAV BRAIN RES, V175, P51, DOI 10.1016/j.bbr.2006.07.026; Heckers S, 2000, BIOL PSYCHIAT, V48, P651, DOI 10.1016/S0006-3223(00)00919-7; HENRY C, 1995, BRAIN RES, V685, P179, DOI 10.1016/0006-8993(95)00430-X; Hoek HW, 1998, SOC PSYCH PSYCH EPID, V33, P373, DOI 10.1007/s001270050068; Holstein DH, 2010, J AFFECT DISORDERS, V126, P188, DOI 10.1016/j.jad.2010.02.122; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Hultman CM, 1999, BRIT MED J, V318, P421, DOI 10.1136/bmj.318.7181.421; Ichinohashi Y, 2013, EARLY HUM DEV, V89, P283, DOI 10.1016/j.earlhumdev.2012.10.007; Jancsik V, 1999, BRAIN RES, V831, P200, DOI 10.1016/S0006-8993(99)01445-6; Kamphuis PJGH, 2002, NEUROENDOCRINOLOGY, V76, P158, DOI 10.1159/000064526; Kessler RC, 2010, BRIT J PSYCHIAT, V197, P378, DOI 10.1192/bjp.bp.110.080499; Koenig JI, 2006, HORM BEHAV, V50, P602, DOI 10.1016/j.yhbeh.2006.06.027; Koenig JI, 2002, NEUROPSYCHOPHARMACOL, V27, P309; Kohl S, 2013, J PSYCHIATR RES, V47, P445, DOI 10.1016/j.jpsychires.2012.11.018; Leao P, 2007, SYNAPSE, V61, P40, DOI 10.1002/syn.20341; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; LEVINE S, 1994, ANN NY ACAD SCI, V746, P275, DOI 10.1111/j.1749-6632.1994.tb39245.x; Li SX, 2014, NEUROBIOL DIS, V62, P124, DOI 10.1016/j.nbd.2013.09.004; Ludewig K, 2003, BIOL PSYCHIAT, V54, P121, DOI 10.1016/S0006-3223(02)01925-X; Martin-Iverson M, 2003, J PSYCHOPHARMACOLOGY; Martin-Iverson MT, 2000, PSYCHOPHARMACOLOGY, V151, P38, DOI 10.1007/s002130000483; McArthur S, 2016, BRAIN STRUCT FUNCT, V221, P2459, DOI 10.1007/s00429-015-1049-0; Menshanov PN, 2014, BEHAV BRAIN RES, V271, P43, DOI 10.1016/j.bbr.2014.05.053; MUKUNDAN CR, 1986, BIOL PSYCHIAT, V21, P1097, DOI 10.1016/0006-3223(86)90295-7; Nagano M, 2008, NEUROSCI RES, V60, P364, DOI 10.1016/j.neures.2007.12.005; Neal CR, 2004, AM J PHYSIOL-REG I, V287, pR375, DOI 10.1152/ajpregu.00012.2004; Onland W, 2009, PEDIATRICS, V123, P367, DOI 10.1542/peds.2008-0016; Papakostas GI, 2006, EUR NEUROPSYCHOPHARM, V16, P391, DOI 10.1016/j.euroneuro.2005.12.002; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Perry W, 2001, BIOL PSYCHIAT, V50, P418, DOI 10.1016/S0006-3223(01)01184-2; Perry W, 2007, BIOL PSYCHIAT, V61, P482, DOI 10.1016/j.biopsych.2005.09.025; Potter D, 2006, SCHIZOPHRENIA BULL, V32, P692, DOI 10.1093/schbul/sbj050; Price GW, 2006, BIOL PSYCHIAT, V60, P1, DOI 10.1016/j.biopsych.2005.09.010; Raikkonen K, 2011, STRESS, V14, P590, DOI 10.3109/10253890.2011.602147; Rajagopal L, 2014, CURR PHARM DESIGN, V20, P5104; Ralph RJ, 1999, J NEUROSCI, V19, P4627; Roach BJ, 2008, SCHIZOPHRENIA BULL, V34, P907, DOI 10.1093/schbul/sbn093; Roberts AD, 2004, NEUROTOXICOL TERATOL, V26, P169, DOI 10.1016/j.ntt.2003.12.003; Rosburg T, 2008, PSYCHIAT RES, V161, P259, DOI 10.1016/j.psychres.2008.03.017; Sabeti M, 2009, J ART INTELL MED, V47, P263; Scholes KE, 2010, PSYCHOPHYSIOLOGY, V47, P223, DOI 10.1111/j.1469-8986.2009.00927.x; Seckl JR, 2007, NAT CLIN PRACT ENDOC, V3, P479, DOI 10.1038/ncpendmet0515; Shinwell ES, 2000, ARCH DIS CHILD-FETAL, V83, pF177, DOI 10.1136/fn.83.3.F177; St Clair D, 2005, JAMA-J AM MED ASSOC, V294, P557, DOI 10.1001/jama.294.5.557; Struber N, 2014, NEUROSCI BIOBEHAV R, V38, P17, DOI 10.1016/j.neubiorev.2013.10.015; Sun W, 2005, NEUROSCI LETT, V374, P63, DOI 10.1016/j.neulet.2004.10.032; SWERDLOW NR, 1990, PSYCHOPHARMACOLOGY, V100, P413, DOI 10.1007/BF02244616; SWERDLOW NR, 1992, PSYCHOPHARMACOLOGY, V108, P189, DOI 10.1007/BF02245306; TANDON R, 1991, BIOL PSYCHIAT, V29, P953, DOI 10.1016/0006-3223(91)90353-N; Teale P, 2003, BIOL PSYCHIAT, V54, P1149, DOI 10.1016/S0006-3223(03)00411-6; Thaker GK, 2008, SCHIZOPHRENIA BULL, V34, P760, DOI 10.1093/schbul/sbn049; Watson JB, 1999, DEV PSYCHOPATHOL, V11, P457, DOI 10.1017/S0954579499002151; Webster M, 2002, MOL PSYCHIAT; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; Wrobel A, 2005, PHARMACOL REP, V57, P451; Yachi K, 2007, BRAIN RES, V1159, P141, DOI 10.1016/j.brainres.2007.05.024	92	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167220	10.1371/journal.pone.0167220	http://dx.doi.org/10.1371/journal.pone.0167220			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936175	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100075
J	Das, JK; Das, P; Ray, KK; Choudhury, PP; Jana, SS				Das, Jayanta Kumar; Das, Provas; Ray, Korak Kumar; Choudhury, Pabitra Pal; Jana, Siddhartha Sankar			Mathematical Characterization of Protein Sequences Using Patterns as Chemical Group Combinations of Amino Acids	PLOS ONE			English	Article							MYOSIN MOTOR DOMAIN; LIGHT-CHAIN KINASE; GRAPHICAL REPRESENTATION; PHYLOGENETIC ANALYSIS; MOLECULAR EVOLUTION; KINESIN; ALIGNMENT; SIMILARITY/DISSIMILARITY; IDENTIFICATION; SENSITIVITY	Comparison of amino acid sequence similarity is the fundamental concept behind the protein phylogenetic tree formation. By virtue of this method, we can explain the evolutionary relationships, but further explanations are not possible unless sequences are studied through the chemical nature of individual amino acids. Here we develop a new methodology to characterize the protein sequences on the basis of the chemical nature of the amino acids. We design various algorithms for studying the variation of chemical group transitions and various chemical group combinations as patterns in the protein sequences. The amino acid sequence of conventional myosin II head domain of 14 family members are taken to illustrate this new approach. We find two blocks of maximum length 6 aa as 'FPKATD' and 'Y/FTNEKL' without repeating the same chemical nature and one block of maximum length 20 aa with the repetition of chemical nature which are common among all 14 members. We also check commonality with another motor protein sub-family kinesin, KIF1A. Based on our analysis we find a common block of length 8 aa both in myosin II and KIF1A. This motif is located in the neck linker region which could be responsible for the generation of mechanical force, enabling us to find the unique blocks which remain chemically conserved across the family. We also validate our methodology with different protein families such as MYOI, Myosin light chain kinase (MLCK) and Rho-associated protein kinase (ROCK), Na+/K+-ATPase and Ca2+-ATPase. Altogether, our studies provide a new methodology for investigating the conserved amino acids' pattern in different proteins.	[Das, Jayanta Kumar; Choudhury, Pabitra Pal] Indian Stat Inst, Appl Stat Unit, 203 BT Rd, Kolkata 700108, W Bengal, India; [Das, Provas; Jana, Siddhartha Sankar] Indian Assoc Cultivat Sci, Dept Biol Chem, 2A & 2B Raja SC Mullick Rd, Kolkata 700032, W Bengal, India; [Ray, Korak Kumar] Indian Inst Technol, Dept Chem, Bombay 400076, Maharashtra, India	Indian Statistical Institute; Indian Statistical Institute Kolkata; Department of Science & Technology (India); Indian Association for the Cultivation of Science (IACS) - Jadavpur; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Das, JK (corresponding author), Indian Stat Inst, Appl Stat Unit, 203 BT Rd, Kolkata 700108, W Bengal, India.; Das, P (corresponding author), Indian Assoc Cultivat Sci, Dept Biol Chem, 2A & 2B Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	dasjayantakumar89@gmail.com; bcpd@iacs.res.in	Das, Provas/AAW-5814-2020	Das, Jayanta Kumar/0000-0002-7630-7194; Das, Provas/0000-0002-4339-7445; Ray, Korak Kumar/0000-0001-5390-698X	ISI; IACS	ISI; IACS(Department of Science & Technology (India)Indian Association for the Cultivation of Science (IACS) - Jadavpur)	We thank to group members of Dr. S S Jana and Prof. P Pal Choudhury for their helpful discussion. J. K. D and P. D thank ISI and IACS respectively for supporting their fellowships.	Al-Bassam J, 2003, J CELL BIOL, V163, P743, DOI 10.1083/jcb.200308020; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; Brini M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004168; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CHENEY RE, 1993, CELL MOTIL CYTOSKEL, V24, P215, DOI 10.1002/cm.970240402; Coluccio LM, 1997, AM J PHYSIOL-CELL PH, V273, pC347, DOI 10.1152/ajpcell.1997.273.2.C347; Connell LE, 2006, J CELL SCI, V119, P2269, DOI 10.1242/jcs.02926; Cope MJTV, 1996, STRUCTURE, V4, P969, DOI 10.1016/S0969-2126(96)00103-7; Dode L, 2001, J BIOL CHEM, V276, P3911, DOI 10.1074/jbc.M007719200; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; Forrest MD, FRONT PHYSIOL, V5, DOI [10.3389/fphys.2014.00472, DOI 10.3389/FPHYS2014.00472]; Forrest MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051169; Gao Y, 2001, IUBMB LIFE, V51, P337; Gillespie PG, 2001, J CELL BIOL, V155, P703, DOI 10.1083/jcb.200110032; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Gromiha MM, 2002, FEBS LETT, V526, P129, DOI 10.1016/S0014-5793(02)03122-8; Hahmann C, 2010, CELL MOL LIFE SCI, V67, P171, DOI 10.1007/s00018-009-0189-x; Hariharan V, 2009, CELL MOL BIOENG, V2, P177, DOI 10.1007/s12195-009-0059-5; Heintzelman MB, 1997, J MOL BIOL, V271, P139, DOI 10.1006/jmbi.1997.1167; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Houdusse A, 1999, CELL, V97, P459, DOI 10.1016/S0092-8674(00)80756-4; Jensen TP, 2007, J PHYSIOL-LONDON, V579, P85, DOI 10.1113/jphysiol.2006.123901; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Kull FJ, 1998, J MUSCLE RES CELL M, V19, P877, DOI 10.1023/A:1005489907021; Lewis JH, 2006, BIOCHEMISTRY-US, V45, P11589, DOI 10.1021/bi0611917; Li C, 2008, BMB REP, V41, P217, DOI 10.5483/BMBRep.2008.41.3.217; Li J, 2006, PROG BIOCHEM BIOPHYS, V33, P1215; Li TP, 2003, PROTEIN ENG, V16, P323, DOI 10.1093/protein/gzg044; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Munteanu CR, 2008, J THEOR BIOL, V254, P476, DOI 10.1016/j.jtbi.2008.06.003; PEARSON WR, 1991, GENOMICS, V11, P635, DOI 10.1016/0888-7543(91)90071-L; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pearson WR, 2013, CURR PROTOC BIOINFOR, V42, DOI 10.1002/0471250953.bi0301s42; PENNY D, 1992, J CLASSIF, V9, P169, DOI 10.1007/BF02618482; Pereira TV, 2006, P NATL ACAD SCI USA, V103, P5676, DOI 10.1073/pnas.0509562103; Perry GH, 2005, MOL BIOL EVOL, V22, P379, DOI 10.1093/molbev/msi004; Peterson EL, 2009, BIOINFORMATICS, V25, P1356, DOI 10.1093/bioinformatics/btp164; Pham TD, 2004, BIOINFORMATICS, V20, P3455, DOI 10.1093/bioinformatics/bth426; Randic M, 1997, CHEM PHYS LETT, V272, P115, DOI 10.1016/S0009-2614(97)00447-8; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rokas A., 2011, CURR PROTOC MOL BIOL, V96, P19; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Smith CA, 1996, BIOPHYS J, V70, P1590, DOI 10.1016/S0006-3495(96)79745-X; Smith SA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003223; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stedman HH, 2004, NATURE, V428, P415, DOI 10.1038/nature02358; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 1997, ANNU REV CELL DEV BI, V13, P745, DOI 10.1146/annurev.cellbio.13.1.745; Wen J, 2009, CHEM PHYS LETT, V476, P281, DOI 10.1016/j.cplett.2009.06.017; Xie XL, 2012, J ZHEJIANG UNIV-SC B, V13, P152, DOI 10.1631/jzus.B1100052; Yao YH, 2010, J COMPUT CHEM, V31, P1045, DOI 10.1002/jcc.21391; Yao YH, 2008, PROTEINS, V73, P864, DOI 10.1002/prot.22110; Yau SST, 2008, DNA CELL BIOL, V27, P241, DOI 10.1089/dna.2007.0676; Zhang SL, 2010, MATCH-COMMUN MATH CO, V63, P701; Zhang S, 2009, J MOL STRUC-THEOCHEM, V909, P102, DOI 10.1016/j.theochem.2009.05.031	60	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167651	10.1371/journal.pone.0167651	http://dx.doi.org/10.1371/journal.pone.0167651			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930687	gold, Green Published, Green Submitted			2022-12-27	WOS:000389580900035
J	Salles, JI; Duarte, MEL; Guimaraes, JM; Lopes, LR; Cardoso, JV; Aguiar, DP; Neto, JOM; Machado, DE; Perini, JA				Salles, Jose Inacio; Leite Duarte, Maria Eugenia; Guimaraes, Joao Matheus; Lopes, Lucas Rafael; Cardoso, Jessica Vilarinho; Aguiar, Diego Pinheiro; Machado Neto, Joao Olyntho; Machado, Daniel Escorsim; Perini, Jamila Alessandra			Vascular Endothelial Growth Factor Receptor-2 Polymorphisms Have Protective Effect against the Development of Tendinopathy in Volleyball Athletes	PLOS ONE			English	Article							TORN ROTATOR CUFF; ACHILLES-TENDON; COL5A1 GENE; FACTOR VEGF; EXPRESSION; ULTRASONOGRAPHY; ANGIOGENESIS; ASSOCIATION; PATHOLOGY; DOPPLER	The aim of the study was to investigate whether genetic variants in VEGF and KDR genes can be correlated with susceptibility of tendinopathy in volleyball athletes. This study was conducted at the Brazilian Volleyball Federation, and comprised 179 volleyball athletes: 88 had a confirmed diagnosis of tendinopathy (cases), whereas 91 had no evidence of the disease (controls). The VEGF (-2578C>A, -460T>C and +936C>T) and KDR (-604C>T, 1192G>A and 1719T>A) polymorphisms were determined by TaqMan real-time polymerase chain reaction. The odds ratio (OR) with their 95% confidence intervals (CI) were calculated using an unconditional logistic regression model. The evaluation of demographic and clinical characteristics revealed the athlete age (P < 0.001), years of practice in volleyball (P < 0.001) and presence of pain (P = 0.001) were risk factors for tendinopathy. KDR 1192 GA and GA + AA genotypes were associated with lower risk of tendinopathy (OR: 0.41, 95% CI: 0.19-0.88 and OR: 0.47, 95% CI: 0.23-0.98, respectively). The KDR (-604C>T, 1192G>A and 1719T>A) haplotypes CGA and CAT were associated with decreased tendinopathy risk (OR: 0.46, 95% CI: 0.21-0.99 and OR: 0.23, 95% CI: 0.07-0.76, respectively). With regards to pain, traumatic lesion and away from training due to injury, VEGF and KDR polymorphisms were not associated with clinical symptoms complaints. The present results provide evidence that the KDR polymorphisms were associated with development of tendinopathy, and can contribute to identify new therapeutic targets or personalized training programs to avoid tendinopathy development in athletes.	[Salles, Jose Inacio; Leite Duarte, Maria Eugenia; Guimaraes, Joao Matheus; Lopes, Lucas Rafael; Aguiar, Diego Pinheiro; Perini, Jamila Alessandra] Inst Nacl Traumatol & Ortopedia, Div Pesquisa, Rio De Janeiro, Brazil; [Salles, Jose Inacio] Federat Int Volleyball FIVB Coach Commiss, Rio De Janeiro, Brazil; [Lopes, Lucas Rafael; Cardoso, Jessica Vilarinho; Machado, Daniel Escorsim; Perini, Jamila Alessandra] Ctr Univ Estadual Zona Oeste, Unidade Farm, Lab Pesquisa Ciencias Farmaceut, Rio De Janeiro, Brazil; [Cardoso, Jessica Vilarinho; Perini, Jamila Alessandra] Fundacao Osvaldo Cruz, Escola Nacl Saude Publ, Programa Posgrad Saude Publ & Meio Ambiente, Rio De Janeiro, Brazil; [Machado Neto, Joao Olyntho] Brazilian Volleyball Federat, Rio De Janeiro, Brazil	Centro Universitario Estadual da Zona Oeste; Fundacao Oswaldo Cruz	Perini, JA (corresponding author), Inst Nacl Traumatol & Ortopedia, Div Pesquisa, Rio De Janeiro, Brazil.; Perini, JA (corresponding author), Ctr Univ Estadual Zona Oeste, Unidade Farm, Lab Pesquisa Ciencias Farmaceut, Rio De Janeiro, Brazil.; Perini, JA (corresponding author), Fundacao Osvaldo Cruz, Escola Nacl Saude Publ, Programa Posgrad Saude Publ & Meio Ambiente, Rio De Janeiro, Brazil.	jamilaperini@yahoo.com.br		Lopes, Lucas Rafael/0000-0003-0488-0730	Brazilian agency Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ, Brazil; Brazilian Volleyball Federation	Brazilian agency Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ, Brazil; Brazilian Volleyball Federation	This study was supported by the Brazilian agency Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the support of Brazilian Volleyball Federation and Mayara Calixto da Silva from State University of West Zone (UEZO), Brazil, for her technical assistance.	Alfredson H, 2003, KNEE SURG SPORT TR A, V11, P334, DOI 10.1007/s00167-003-0391-6; Baroneza JE, 2014, GENE, V547, P334, DOI 10.1016/j.gene.2014.07.001; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; de Vos RJ, 2007, AM J SPORT MED, V35, P1696, DOI 10.1177/0363546507303116; El Khoury L, 2013, J SCI MED SPORT, V16, P493, DOI 10.1016/j.jsams.2013.02.006; Eriksen HA, 2002, J ORTHOPAED RES, V20, P1352, DOI 10.1016/S0736-0266(02)00064-5; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Kaux JF, 2011, J SPORT SCI MED, V10, P238; Kulig K, 2015, INT J SPORTS MED, V36, P400, DOI 10.1055/s-0034-1395586; Laguette MJ, 2011, MATRIX BIOL, V30, P338, DOI 10.1016/j.matbio.2011.05.001; Lakemeier S, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-230; Maffulli N, 2003, CLIN SPORT MED, V22, P675, DOI 10.1016/S0278-5919(03)00004-8; Maffulli N, 2004, MED SCI SPORT EXER, V36, P1470, DOI 10.1249/01.MSS.0000139895.94846.8D; Maffulli Nicola, 2013, Muscles Ligaments Tendons J, V3, P173; Matthews TJW, 2006, J BONE JOINT SURG BR, V88B, P489, DOI 10.1302/0301-620X.88B4.16845; Mokone GG, 2006, SCAND J MED SCI SPOR, V16, P19, DOI 10.1111/j.1600-0838.2005.00439.x; Ohberg L, 2001, KNEE SURG SPORT TR A, V9, P233, DOI 10.1007/s001670000189; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Perini JA, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-117; Petersen W, 2004, CLIN ORTHOP RELAT R, P286, DOI 10.1097/01.blo.0000126228.78639.76; Petersen W, 2003, ARCH ORTHOP TRAUM SU, V123, P168, DOI 10.1007/s00402-002-0462-z; Pingel J, 2013, AM J SPORT MED, V41, P2400, DOI 10.1177/0363546513498988; Pufe T, 2005, ANN ANAT, V187, P461, DOI 10.1016/j.aanat.2005.06.008; Pufe T, 2001, VIRCHOWS ARCH, V439, P579, DOI 10.1007/s004280100422; Puthucheary Z, 2011, SPORTS MED, V41, P845, DOI 10.2165/11593200-000000000-00000; Rahim M, 2016, OMICS, V20, P520, DOI 10.1089/omi.2016.0116; Rees JD, 2006, RHEUMATOLOGY, V45, P508, DOI 10.1093/rheumatology/kel046; Seminati E, 2015, SPORT BIOMECH, V14, P216, DOI 10.1080/14763141.2015.1052747; September A V, 2012, Recent Pat DNA Gene Seq, V6, P216; Walsh DA, 2001, ARTHRITIS RES, V3, P147, DOI 10.1186/ar292; Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011; Wang Y, 2007, J AM COLL CARDIOL, V50, P760, DOI 10.1016/j.jacc.2007.04.074; Watson CJ, 2000, CYTOKINE, V12, P1232, DOI 10.1006/cyto.2000.0692	34	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167717	10.1371/journal.pone.0167717	http://dx.doi.org/10.1371/journal.pone.0167717			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930691	Green Published, Green Submitted, gold			2022-12-27	WOS:000389580900039
J	Zhang, J; Yuan, YP; Chu, HT				Zhang, Jing; Yuan, Yiping; Chu, Haitao			The Impact of Excluding Trials from Network Meta-Analyses - An Empirical Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; RANDOMIZED CONTROLLED-TRIALS; SYSTEMATIC REVIEWS; CLINICAL-TRIALS; INTERVENTIONS; INCONSISTENCY; PREVENTION; EFFICACY; THERAPY; DRUGS	Network meta-analysis (NMA) expands the scope of a conventional pairwise meta-analysis to simultaneously compare multiple treatments, which has an inherent appeal for clinicians, patients, and policy decision makers. Two recent reports have shown that the impact of excluding a treatment on NMAs can be substantial. However, no one has assessed the impact of excluding a trial from NMAs, which is important because many NMAs selectively include trials in the analysis. This article empirically examines the impact of trial exclusion using both the arm-based (AB) and contrast-based (CB) approaches, by reanalyzing 20 published NMAs involving 725 randomized controlled trials and 449,325 patients. For the population-averaged absolute risk estimates using the AB approach, the average fold changes across all networks ranged from 1.004 (with standard deviation 0.004) to 1.072 (with standard deviation 0.184); while the maximal fold changes ranged from 1.032 to 2.349. In 12 out of 20 NMAs, a 1.20-fold or larger change is observed in at least one of the population-averaged absolute risk estimates. In addition, while excluding a trial can substantially change the estimated relative effects (e.g., log odds ratios), there is no systematic difference in terms of changes between the two approaches. Changes in treatment rankings are observed in 7 networks and changes in inconsistency are observed in 3 networks. We do not observe correlations between changes in treatment effects, treatment rankings and inconsistency. Finally, we recommend rigorous inclusion and exclusion criteria, logical study selection process, and reasonable network geometry to ensure robustness and generalizability of the results of NMAs.	[Zhang, Jing] Univ Maryland, Sch Publ Hlth, Dept Epidemiol & Biostat, College Pk, MD 20742 USA; [Yuan, Yiping] Univ Minnesota, Sch Stat, Minneapolis, MN 55455 USA; [Chu, Haitao] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN USA	University System of Maryland; University of Maryland College Park; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Zhang, J (corresponding author), Univ Maryland, Sch Publ Hlth, Dept Epidemiol & Biostat, College Pk, MD 20742 USA.	jzhang86@umd.edu		Chu, Haitao/0000-0003-0932-598X	NIAID [AI103012]; University of Maryland; US NIAID [AI103012]; NIDCR [R03DE024750]; NLM [R21LM012197]; NCI [P30CA077598]; NIMHD [U54-MD008620]; NIDDK [U01DK106786]; UMD Libraries' Open Access Publishing Fund; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI103012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE024750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK106786] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD008620] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R21LM012197] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Maryland; US NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); UMD Libraries' Open Access Publishing Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	J.Z. was supported in part by the NIAID AI103012 and a start-up fund from the University of Maryland. H.C. is supported in part by the US NIAID AI103012, NIDCR R03DE024750, NLM R21LM012197, NCI P30CA077598, NIMHD U54-MD008620, and NIDDK U01DK106786. Partial funding for open access provided by the UMD Libraries' Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; J.Z. was supported in part by the NIAID AI103012 and a start-up fund from the University of Maryland. H.C. is supported in part by the US NIAID AI103012, NIDCR R03DE024750, NLM R21LM012197, NCI P30CA077598, NIMHD U54-MD008620, and NIDDK U01DK106786. Partial funding for open access provided by the UMD Libraries' Open Access Publishing Fund.	Ara R, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13340; Baker WL, 2009, PHARMACOTHERAPY, V29, P891, DOI 10.1592/phco.29.8.891; Ballesteros J, 2005, J CLIN PSYCHOPHARM, V25, P127, DOI 10.1097/01.jcp.0000155826.05327.c1; Bansback N, 2009, DERMATOLOGY, V219, P209, DOI 10.1159/000233234; Bhaumik DK, 2012, J AM STAT ASSOC, V107, P555, DOI 10.1080/01621459.2012.664484; Brown TJ, 2006, HEALTH TECHNOL ASSES, V10, P1; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Cook DJ, 1996, JAMA-J AM MED ASSOC, V275, P308, DOI 10.1001/jama.275.4.308; Dias S, 2015, RES SYNTHESIS METHOD; Efron B., 1994, INTRO BOOTSTRAP; Eisenberg MJ, 2008, CAN MED ASSOC J, V179, P135, DOI 10.1503/cmaj.070256; Elliott WJ, 2007, LANCET, V369, P201, DOI 10.1016/S0140-6736(07)60108-1; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Govan L, 2010, STAT MED, V29, P1340, DOI 10.1002/sim.3869; Hong H, 2015, RES SYNTHESIS METHOD; Hong H, 2016, RES SYNTH METHODS, V7, P6, DOI 10.1002/jrsm.1153; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Jadad AR, 1997, CAN MED ASSOC J, V156, P1411; Li TJ, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-79; Lin LF, 2016, EPIDEMIOLOGY, V27, P562, DOI 10.1097/EDE.0000000000000482; Linde K, 2003, J ROY SOC MED, V96, P17, DOI 10.1258/jrsm.96.1.17; Lu GB, 2006, J AM STAT ASSOC, V101, P447, DOI 10.1198/016214505000001302; Lu GB, 2009, BIOSTATISTICS, V10, P792, DOI 10.1093/biostatistics/kxp032; Ma Y, 2014, COMMUNICATIONS STAT; Macfadyen CA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004618.pub2; Middleton LJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3929; Mills EJ, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5195; Mills EJ, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-25; Peinemann F, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-41; Picard P, 2000, ANESTH ANALG, V90, P963; Plummer M., 2003, P 3 INT WORKSH DISTR; Poolman RW, 2007, J BONE JOINT SURG AM, V89A, P1542, DOI 10.2106/JBJS.F.01292; Puhan MA, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-2; Thijs V, 2008, EUR HEART J, V29, P1086, DOI 10.1093/eurheartj/ehn106; Trikalinos TA, 2009, LANCET, V373, P911, DOI 10.1016/S0140-6736(09)60319-6; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Veroniki AA, 2013, INT J EPIDEMIOL, V42, P332, DOI 10.1093/ije/dys222; Wang H, 2010, J HOSP INFECT, V76, P1, DOI 10.1016/j.jhin.2010.04.025; Yu CH, 2006, CAN J ANAESTH, V53, P906, DOI 10.1007/BF03022834; Zhang J, 2016, STATISTICAL METHODS; Zhang J, 2015, STAT MED, V34, P2695, DOI 10.1002/sim.6509; Zhang J, 2014, CLIN TRIALS, V11, P246, DOI 10.1177/1740774513498322; Zhao H, 2016, STAT MED	44	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2016	11	12							e0165889	10.1371/journal.pone.0165889	http://dx.doi.org/10.1371/journal.pone.0165889			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4NG	27926924	Green Published, gold			2022-12-27	WOS:000389578800002
J	Wellard, R; Lightbody, K; Fouda, L; Blewitt, M; Riggs, D; Erbe, C				Wellard, Rebecca; Lightbody, Keith; Fouda, Leila; Blewitt, Michelle; Riggs, David; Erbe, Christine			Killer Whale (Orcinus orca) Predation on Beaked Whales (Mesoplodon spp.) in the Bremer Sub-Basin, Western Australia	PLOS ONE			English	Article							NORTH-ATLANTIC; MEDITERRANEAN SEA; HUMPBACK WHALES; MARINE MAMMALS; 1ST RECORD; WATERS; POPULATIONS; ZIPHIIDAE; STRANDINGS; MOVEMENT	Observations of killer whales (Orcinus orca) feeding on the remains of beaked whales have been previously documented; however, to date, there has been no published account of killer whales actively preying upon beaked whales. This article describes the first field observations of killer whales interacting with, hunting and preying upon beaked whales (Mesoplodon spp.) on four separate occasions during 2014, 2015 and 2016 in the Bremer Sub-Basin, off the south coast of Western Australia.	[Wellard, Rebecca; Fouda, Leila; Erbe, Christine] Curtin Univ, Ctr Marine Sci & Technol, GPO Box U1987, Perth, WA 6845, Australia; [Blewitt, Michelle] Univ Sydney, Marine Studies Inst, Sydney, NSW 2006, Australia; [Riggs, David] Riggs Australia Pty Ltd, POB 2076, Esperance, WA 6450, Australia	Curtin University; University of Sydney	Wellard, R (corresponding author), Curtin Univ, Ctr Marine Sci & Technol, GPO Box U1987, Perth, WA 6845, Australia.	becwellard@gmail.com	Erbe, Christine/AAA-3801-2021; Wellard, Rebecca/AAW-7310-2020	Erbe, Christine/0000-0002-7884-9907; Wellard, Rebecca/0000-0001-8427-564X; Fouda, Leila/0000-0002-0723-3697	Holsworth Wildlife Research Endowment; Australian Geographic Society	Holsworth Wildlife Research Endowment; Australian Geographic Society	This research was supported by the Holsworth Wildlife Research Endowment and The Australian Geographic Society. The author who received the funding was RW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DR was employed by Riggs Australia Pty Ltd. which provided support in the form of salary for co-author DR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AN, 2014, MAR MAMMAL SCI, V30, P154, DOI 10.1111/mms.12028; Amico AD, 2003, IEEE J OCEANIC ENG, V28, P29; ARNBOM T, 1987, J MAMMAL, V68, P450, DOI 10.2307/1381497; Baird RW, 2006, PAC SCI, V60, P523, DOI 10.1353/psc.2006.0024; Baird RW, 1996, BEHAV ECOL, V7, P408, DOI 10.1093/beheco/7.4.408; Baird RW, 1994, FORAGING BEHAV ECOLO; Barrett-Lennard LG, 2011, MAR ECOL PROG SER, V421, P229, DOI 10.3354/meps08906; Barrett-Lennard LG, 2001, POPULATION STRUCTURE; BarrettLennard LG, 1996, ANIM BEHAV, V51, P553, DOI 10.1006/anbe.1996.0059; Beck S, 2012, BEHAV ECOL, V23, P246, DOI 10.1093/beheco/arr151; Bigg M, 1982, ASSESSMENT KILLER WH, P655; Bigg M.A., 1987, KILLER WHALES STUDY; Bisther A, 2001, 14 BIENN C BIOL MAR; Cato DH, 2009, HABITAT MODELING BEA; Cosentino A. Mel, 2015, Marine Biodiversity Records, V8, pe108, DOI 10.1017/S1755267215000895; Dahlheim ME, 2008, MAR MAMMAL SCI, V24, P719, DOI 10.1111/j.1748-7692.2008.00206.x; de Bruyn PJN, 2013, BIOL REV, V88, P62, DOI 10.1111/j.1469-185X.2012.00239.x; Durban J. W., 2016, POLAR BIOL, V40, P1; Exon NF, 2005, AUST J EARTH SCI, V52, P101, DOI 10.1080/08120090500100036; Fearnbach Holly, 2011, Endangered Species Research, V13, P173, DOI 10.3354/esr00330; Ferguson Megan C., 2005, Journal of Cetacean Research and Management, V7, P287; Foote AD, 2011, MOL ECOL, V20, P629, DOI 10.1111/j.1365-294X.2010.04957.x; Foote AD, 2010, EVOL ECOL, V24, P803, DOI 10.1007/s10682-009-9337-x; Foote AD, 2009, MOL ECOL, V18, P5207, DOI 10.1111/j.1365-294X.2009.04407.x; Ford J. K. B., 2000, KILLER WHALES NATURA; Ford JKB, 1998, CAN J ZOOL, V76, P1456, DOI 10.1139/cjz-76-8-1456; FORD JKB, 1989, CAN J ZOOL, V67, P727, DOI 10.1139/z89-105; Ford JKB, 2010, BIOL LETTERS, V6, P139, DOI 10.1098/rsbl.2009.0468; Forney KA, 2006, WHALES WHALING ECOSY, P25; Gannier A, 2008, J MAR BIOL ASSOC UK, V88, P1245, DOI 10.1017/S0025315408000428; Gemmell GL, 2015, AQUAT MAMM, V41, P265, DOI 10.1578/AM.41.3.2015.265; GLADSTONE W, 1988, J MAMMAL, V69, P629, DOI 10.2307/1381360; Groom Christine J., 2014, Marine Biodiversity Records, V7, pe50, DOI 10.1017/S1755267214000475; Hamilton L. J., 2014, Journal of Cetacean Research and Management, V14, P171; Hamilton L. J., 2014, Journal of Cetacean Research and Management, V14, P1; Hancock D., 1965, Journal of Mammalogy, V46, P341, DOI 10.2307/1377867; Hanson MB, 2014, AQUAT MAMM, V40, P274, DOI 10.1578/AM.40.3.2014.274; HOELZEL AR, 1991, BEHAV ECOL SOCIOBIOL, V29, P197, DOI 10.1007/BF00166401; JEFFERSON TA, 1991, MAMMAL REV, V21, P151, DOI 10.1111/j.1365-2907.1991.tb00291.x; Jongard A, 1968, NORSK HVALFANGST TID, V57, P84; MacLeod CD, 2005, MAR BIOL, V147, P1, DOI 10.1007/s00227-004-1546-9; MacLeod Colin D., 2005, Journal of Cetacean Research and Management, V7, P271; McCordic JA, 2014, J MAR BIOL ASSOC UK, V94, P1311, DOI 10.1017/S0025315413001008; Morrice M.G., 2004, KILLER WHALES ORCINU; Moulins A, 2007, J MAR BIOL ASSOC UK, V87, P177, DOI 10.1017/S0025315407055002; Mustoe S, 2008, VICTORIAN NAT, V125, P76, DOI DOI 10.1371/J0URNAL.P0NE.0136535; Nishiwaki M., 1958, Scientific Reports of the Whales Research Institute Tokyo, VNo. 13, P85; Notarbartolo di Sciara G., 1987, MARINE MAMMAL SCI, V3, P356; Olesiuk P.F., 1990, Reports of the International Whaling Commission Special Issue, P209; Pitman RL, 2001, MAR MAMMAL SCI, V17, P494, DOI 10.1111/j.1748-7692.2001.tb01000.x; Pitman Robert L., 2003, Journal of Cetacean Research and Management, V5, P131; Pitman RL, 2015, MAR MAMMAL SCI, V31, P629, DOI 10.1111/mms.12182; Pitman RL, 2012, MAR MAMMAL SCI, V28, P16, DOI 10.1111/j.1748-7692.2010.00453.x; Pitman RL, 2010, POLAR BIOL, V33, P1589, DOI 10.1007/s00300-010-0853-5; Pitman RL, 2011, POLAR BIOL, V34, P303, DOI 10.1007/s00300-010-0871-3; Ryan Conor, 2012, Marine Biodiversity Records, V5, pe10, DOI 10.1017/S1755267211001187; Tyack PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017009; Visser IN, 2010, AQUAT MAMM, V36, P195, DOI 10.1578/AM.36.2.2010.195; Vongraven D, 2014, J MAR BIOL ASSOC UK, V94, P1357, DOI 10.1017/S0025315413001707; Waring GT, 2001, MAR MAMMAL SCI, V17, P703, DOI 10.1111/j.1748-7692.2001.tb01294.x; Weir CR, 2010, J MAR BIOL ASSOC UK, V90, P1601, DOI 10.1017/S002531541000072X; WHITEHEAD H, 1985, J MAMMAL, V66, P183, DOI 10.2307/1380982; Yamada T, 2007, BIOL INDICES OBTAINE, P15	63	17	19	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2016	11	12							e0166670	10.1371/journal.pone.0166670	http://dx.doi.org/10.1371/journal.pone.0166670			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MY	27923044	gold, Green Published, Green Submitted			2022-12-27	WOS:000389577900002
J	Hornstein, BD; Roman, D; Arevalo-Soliz, LM; Engevik, MA; Zechiedrich, L				Hornstein, Benjamin D.; Roman, Dany; Arevalo-Soliz, Lirio M.; Engevik, Melinda A.; Zechiedrich, Lynn			Effects of Circular DNA Length on Transfection Efficiency by Electroporation into HeLa Cells	PLOS ONE			English	Article							GENE-THERAPY; MINIVECTOR DNA; NUCLEIC-ACID; EXPRESSION; DELIVERY; VECTORS; PROTEIN; DESIGN; LEVEL; SIZE	The ability to produce extremely small and circular supercoiled vectors has opened new territory for improving non-viral gene therapy vectors. In this work, we compared transfection of supercoiled DNA vectors ranging from 383 to 4,548 bp, each encoding shRNA against GFP under control of the H1 promoter. We assessed knockdown of GFP by electroporation into HeLa cells. All of our vectors entered cells in comparable numbers when electroporated with equal moles of DNA. Despite similar cell entry, we found length-dependent differences in how efficiently the vectors knocked down GFP. As vector length increased up to 1,869 bp, GFP knockdown efficiency per mole of transfected DNA increased. From 1,869 to 4,257 bp, GFP knockdown efficiency per mole was steady, then decreased with increasing vector length. In comparing GFP knockdown with equal masses of vectors, we found that the shorter vectors transfect more efficiently per nanogram of DNA transfected. Our results rule out cell entry and DNA mass as determining factors for gene knockdown efficiency via electroporation. The length-dependent effects we have uncovered are likely explained by differences in nuclear translocation or transcription. These data add an important step towards clinical applications of non-viral vector delivery.	[Hornstein, Benjamin D.; Arevalo-Soliz, Lirio M.; Zechiedrich, Lynn] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Roman, Dany] Baylor Coll Med, Postbaccaleureate Res Educ Program, Houston, TX 77030 USA; [Arevalo-Soliz, Lirio M.; Zechiedrich, Lynn] Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Arevalo-Soliz, Lirio M.; Zechiedrich, Lynn] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Engevik, Melinda A.] Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA; [Roman, Dany] Baylor Coll Med, Integrat Mol & Biomed Sci Grad Program, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Zechiedrich, L (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.; Zechiedrich, L (corresponding author), Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA.; Zechiedrich, L (corresponding author), Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA.	elz@bcm.edu	Zechiedrich, Elizabeth Lynn/S-4720-2019; Engevik, Mindy/P-9725-2018	Engevik, Mindy/0000-0002-9742-9932; Zechiedrich, Lynn/0000-0003-0533-1637	Baylor College of Medicine PREP program NIH [R25 GM069234]; Baylor UT Houston Center for AIDS Research Core Support Grant [P30 A1036211]; NIH [R56 A1054830, R01 GM115501]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115501] Funding Source: NIH RePORTER	Baylor College of Medicine PREP program NIH; Baylor UT Houston Center for AIDS Research Core Support Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	D.R. was supported by the Baylor College of Medicine PREP program NIH R25 GM069234 (Slaughter, PI). This project was supported in part by the Baylor UT Houston Center for AIDS Research Core Support Grant number P30 A1036211 (Butel, PI), and in part by NIH grants R56 A1054830 and R01 GM115501 to L.Z.	Akita H, 2015, PHARMACEUTICS, V7, P64, DOI 10.3390/pharmaceutics7020064; Carnes AE, 2010, J GENE MED, V12, P818, DOI 10.1002/jgm.1499; Catanese DJ, 2012, GENE THER, V19, P94, DOI 10.1038/gt.2011.77; Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Dean DA, 2005, GENE THER, V12, P881, DOI 10.1038/sj.gt.3302534; Gowers DM, 2005, P NATL ACAD SCI USA, V102, P15883, DOI 10.1073/pnas.0505378102; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Kim JA, 2008, BIOSENS BIOELECTRON, V23, P1353, DOI 10.1016/j.bios.2007.12.009; Kobelt D, 2013, MOL BIOTECHNOL, V53, P80, DOI 10.1007/s12033-012-9535-6; Kohn DB, 2003, NAT REV CANCER, V3, P477, DOI 10.1038/nrc1122; Kreiss P, 1999, NUCLEIC ACIDS RES, V27, P3792, DOI 10.1093/nar/27.19.3792; Layek B, 2015, INT J MOL SCI, V16, P28912, DOI 10.3390/ijms161226142; Ludtke JJ, 1999, J CELL SCI, V112, P2033; Maniar LEG, 2013, MOL THER, V21, P131, DOI 10.1038/mt.2012.244; Martin T., 2015, IEEE T NANOBIOSCIENC; Myer VE, 1998, J BIOL CHEM, V273, P27757, DOI 10.1074/jbc.273.43.27757; Rao RC, 2014, DEV OPHTHALMOL, V53, P167, DOI 10.1159/000357376; Rosazza C, 2016, MOL THER-NUCL ACIDS, V5, P1, DOI 10.1038/mtna.2015.59; Rosazza C, 2013, MOL THER, V21, P2217, DOI 10.1038/mt.2013.182; Safinya CR, 2014, NEW J CHEM, V38, P5164, DOI 10.1039/c4nj01314j; Stenler S, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2013.67; Szafran AT, 2014, ASSAY DRUG DEV TECHN, V12, P87, DOI 10.1089/adt.2013.532; Wen Q, 2015, BMC SYST BIOL, V9, DOI 10.1186/1752-0509-9-S5-S4; Williams JA, 2014, CURR GENE THER, V14, P170, DOI 10.2174/156652321403140819122538; Wirth T, 2013, GENE, V525, P162, DOI 10.1016/j.gene.2013.03.137; Zhao N, 2011, GENE THER, V18, P220, DOI 10.1038/gt.2010.123	27	41	42	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2016	11	12							e0167537	10.1371/journal.pone.0167537	http://dx.doi.org/10.1371/journal.pone.0167537			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MR	27918590	Green Published, gold, Green Submitted			2022-12-27	WOS:000389577100014
J	Gomez-Vaquero, C; Martin, I; Loza, E; Carmona, L; Ivorra, J; Narvaez, JA; Hernandez-Ganan, J; Alia, P; Narvaez, J				Gomez-Vaquero, Carmen; Martin, Irene; Loza, Estibaliz; Carmona, Loreto; Ivorra, Jose; Narvaez, Jose Antonio; Hernandez-Ganan, Javier; Alia, Pedro; Narvaez, Javier			Effect of Osteoprotegerin and Dickkopf-Related Protein 1 on Radiological Progression in Tightly Controlled Rheumatoid Arthritis	PLOS ONE			English	Article							KAPPA-B LIGAND; CLINICAL REMISSION; RECEPTOR ACTIVATOR; RADIOGRAPHIC PROGRESSION; BONE; EXPRESSION; MARKERS; INCREASES; SYNOVITIS; TISSUE	Objective To analyze the association between circulating osteoprotegerin (OPG) and Dickkopf-related protein 1 (DKK-1) and radiological progression in patients with tightly controlled rheumatoid arthritis (RA). Methods Serum levels of OPG and DKK-1 were measured in 97 RA patients who were treated according to a treat-to-target strategy (T2T) aimed at remission (DAS28 < 2.6). Radiologic joint damage progression was assessed by changes in the total Sharp-van der Heijde score (SHS) on serial radiographs of the hands and feet. The independent association between these biomarker levels and the structural damage endpoint was examined using regression analysis Results The mean age of the 97 RA patients (68 women) at the time of the study was 54 +/- 14 years, and the median disease duration was 1.6 +/- 1.5 years. Most patients were seropositive for either RF or ACPA, and the large majority (76%) were in remission or had low disease activity. After a median follow-up time of 3.3 +/- 1.5 years (range, 1 +/- 7.5 yrs.), the mean total SHS annual progression was 0.88 +/- 2.20 units. Fifty-two percent of the patients had no progression (defined as a total SHS of zero). The mean serum OPG level did not change significantly over the study period (from 3.9 +/- 1.8 to 4.07 +/- 2.23 pmol/L), whereas the mean serum DKK-1 level decreased, although not significantly (from 29.9 +/- 10.9 to 23.6 +/- 18.8 pmol/L). In the multivariate analysis, the predictive factors increasing the likelihood of total SHS progression were age (OR per year = 1.10; p = 0.003) and a high mean C-reactive protein level over the study period (OR = 1.29; p = 0.005). Circulating OPG showed a protective effect reducing the likelihood of joint space narrowing by 60% (95% CI: 0.38 +/- 0.94) and the total SHS progression by 48% (95% CI: 0.28 +/- 0.83). The DKK-1 levels were not associated with radiological progression. Conclusion In patients with tightly controlled RA, serum OPG was inversely associated with progression of joint destruction. This biomarker may be useful in combination with other risk factors to improve prediction in patients in clinical remission or low disease activity state.	[Gomez-Vaquero, Carmen; Martin, Irene; Narvaez, Javier] Hosp Univ Bellvitge, Dept Rheumatol, Barcelona, Spain; [Loza, Estibaliz; Carmona, Loreto] Inst Salud Musculoesquelet, Madrid, Spain; [Ivorra, Jose] Hosp Univ La Fe, Dept Rheumatol, Valencia, Spain; [Narvaez, Jose Antonio; Hernandez-Ganan, Javier] Hosp Univ Bellvitge, Dept Radiol, Barcelona, Spain; [Alia, Pedro] Hosp Univ Bellvitge, Dept Clin Lab, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Hospital Universitari i Politecnic La Fe; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Gomez-Vaquero, C; Narvaez, J (corresponding author), Hosp Univ Bellvitge, Dept Rheumatol, Barcelona, Spain.	carmen.gomez@bellvitgehospital.cat; fjnarvaez@bellvitgehospital.cat	Narvaez, Javier/AAD-7434-2020; Carmona, Loreto/A-2748-2014	Carmona, Loreto/0000-0002-4401-2551; Loza Santamaria, Estibaliz/0000-0002-4607-9178; Ivorra, Jose/0000-0001-6554-7451; Hernandez-Ganan, Javier/0000-0002-1161-9904; Narvaez, Jose A./0000-0003-1898-1225; Narvaez, Javier/0000-0002-1614-8064				Adami G, 2016, CALCIFIED TISSUE INT, V99, P360, DOI 10.1007/s00223-016-0161-3; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Anandarajah A, 2014, J RHEUMATOL, V41, P2153, DOI 10.3899/jrheum.140411; Audo R, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0705-3; Bernardi S, 2014, MOL CELL ENDOCRINOL, V394, P13, DOI 10.1016/j.mce.2014.06.004; Brown AK, 2008, ARTHRITIS RHEUM-US, V58, P2958, DOI 10.1002/art.23945; Catrina AI, 2006, ARTHRITIS RHEUM-US, V54, P76, DOI 10.1002/art.21528; Chan BYY, 2003, CLIN CHEM, V49, P2083, DOI 10.1373/clinchem.2003.023747; Ciubotariu E, 2014, J RHEUMATOL, V41, P1576, DOI 10.3899/jrheum.130767; Coiffier G, 2013, JOINT BONE SPINE, V80, P250, DOI 10.1016/j.jbspin.2012.08.004; Crotti TN, 2002, ANN RHEUM DIS, V61, P1047, DOI 10.1136/ard.61.12.1047; Drouin J, 2010, J RHEUMATOL, V37, P1405, DOI 10.3899/jrheum.090838; Fardellone P, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/484280; Fautrel B, 2015, RMD OPEN, V1, DOI 10.1136/rmdopen-2014-000018; Gandjbakhch F, 2011, J RHEUMATOL, V38, P2039, DOI 10.3899/jrheum.110421; Garnero P, 2008, J RHEUMATOL, V35, P2313, DOI 10.3899/jrheum.080356; Geusens PP, 2006, ARTHRITIS RHEUM-US, V54, P1772, DOI 10.1002/art.21896; Geusens P, 2012, THER ADV MUSCULOSKEL, V4, P225, DOI 10.1177/1759720X12438080; Goldring SR, 2007, NAT MED, V13, P133, DOI 10.1038/nm0207-133; Gonzalez-Alvaro I, 2007, ANN RHEUM DIS, V66, P1675, DOI 10.1136/ard.2007.071910; Heiland GR, 2010, ANN RHEUM DIS, V69, P2152, DOI 10.1136/ard.2010.132852; Nguyen H, 2014, RHEUMATOLOGY, V53, P2110, DOI 10.1093/rheumatology/keu217; Knevel R, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4558; Krabben A, 2015, CURR PHARM DESIGN, V21, P147; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lee CK, 2004, ARTHRITIS RHEUM-US, V50, P3831, DOI 10.1002/art.20637; Lillegraven S, 2012, ANN RHEUM DIS, V71, P681, DOI 10.1136/ard.2011.154625; Lorenzo J, 2008, ENDOCR REV, V29, P403, DOI 10.1210/er.2007-0038; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Nahidi L, 2013, DIGEST DIS SCI, V58, P3144, DOI 10.1007/s10620-013-2851-2; Revu S, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4398; Skoumal M, 2005, RHEUMATOL INT, V26, P63, DOI 10.1007/s00296-004-0579-1; Smolen JS, 2016, ANN RHEUM DIS, V75, P3, DOI 10.1136/annrheumdis-2015-207524; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Sreerangaiah D, 2016, RHEUMATOLOGY, V55, P89, DOI 10.1093/rheumatology/kev305; van Steenbergen HW, 2016, RHEUMATOLOGY, V55, P949, DOI 10.1093/rheumatology/kev415; van Tuyl LHD, 2010, ANN RHEUM DIS, V69, P1623, DOI 10.1136/ard.2009.121764; Wang SY, 2011, J RHEUMATOL, V38, P821, DOI 10.3899/jrheum.100089; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894	39	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0166691	10.1371/journal.pone.0166691	http://dx.doi.org/10.1371/journal.pone.0166691			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911913	Green Published, gold			2022-12-27	WOS:000389520600011
J	Mashock, MJ; Zanon, T; Kappell, AD; Petrella, LN; Andersen, EC; Hristova, KR				Mashock, Michael J.; Zanon, Tyler; Kappell, Anthony D.; Petrella, Lisa N.; Andersen, Erik C.; Hristova, Krassimira R.			Copper Oxide Nanoparticles Impact Several Toxicological Endpoints and Cause Neurodegeneration in Caenorhabditis elegans	PLOS ONE			English	Article							NATURAL VARIATION; DAPHNIA-MAGNA; TOXICITY; SILVER; SENSITIVITY; ALZHEIMERS; RESISTANCE; DISORDERS; MECHANISM; GENETICS	Engineered nanoparticles are becoming increasingly incorporated into technology and consumer products. In 2014, over 300 tons of copper oxide nanoparticles were manufactured in the United States. The increased production of nanoparticles raises concerns regarding the potential introduction into the environment or human exposure. Copper oxide nanoparticles commonly release copper ions into solutions, which contribute to their toxicity. We quantified the inhibitory effects of both copper oxide nanoparticles and copper sulfate on C. elegans toxicological endpoints to elucidate their biological effects. Several toxicological endpoints were analyzed in C. elegans, including nematode reproduction, feeding behavior, and average body length. We examined three wild C. elegans isolates together with the Bristol N2 laboratory strain to explore the influence of different genotypic backgrounds on the physiological response to copper challenge. All strains exhibited greater sensitivity to copper oxide nanoparticles compared to copper sulfate, as indicated by reduction of average body length and feeding behavior. Reproduction was significantly reduced only at the highest copper dose, though still more pronounced with copper oxide nanoparticles compared to copper sulfate treatment. Furthermore, we investigated the effects of copper oxide nanoparticles and copper sulfate on neurons, cells with known vulnerability to heavy metal toxicity. Degeneration of dopaminergic neurons was observed in up to 10% of the population after copper oxide nanoparticle exposure. Additionally, mutants in the divalent-metal transporters, smf-1 or smf-2, showed increased tolerance to copper exposure, implicating both transporters in copper-induced neurodegeneration. These results highlight the complex nature of CuO nanoparticle toxicity, in which a nanoparticle-specific effect was observed in some traits (average body length, feeding behavior) and a copper ion specific effect was observed for other traits (neurodegeneration, response to stress).	[Mashock, Michael J.; Zanon, Tyler; Kappell, Anthony D.; Petrella, Lisa N.; Hristova, Krassimira R.] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA; [Andersen, Erik C.] Northwestern Univ, Dept Mol Biosci, Evanston, IL USA	Marquette University; Northwestern University	Hristova, KR (corresponding author), Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA.	krassimira.hristova@marquette.edu			National Institute of Environmental Health Sciences; Children's Environmental Health Sciences Core Center grant [P30ES004184-24, ES-04184]; National Institute of Health R01 [GM107227]; Marquette University	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Children's Environmental Health Sciences Core Center grant; National Institute of Health R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marquette University	This work was supported by a National Institute of Environmental Health Sciences, Children's Environmental Health Sciences Core Center grant number P30ES004184-24, subcontract ES-04184 to K.R.H. and a National Institute of Health R01 subcontract GM107227 to ECA. Additional funding was provided by Marquette University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen EC, 2015, G3 GENES GENOMES GEN; Andersen EC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004156; Andersen EC, 2012, NAT GENET, V44, P285, DOI 10.1038/ng.1050; Au C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007792; Baek YW, 2011, SCI TOTAL ENVIRON, V409, P1603, DOI 10.1016/j.scitotenv.2011.01.014; Bergin Ingrid L, 2013, Int J Biomed Nanosci Nanotechnol, V3, DOI 10.1504/IJBNN.2013.054515; Bondarenko O, 2013, ARCH TOXICOL, V87, P1181, DOI 10.1007/s00204-013-1079-4; Boyd WA, 2003, ENVIRON TOXICOL CHEM, V22, P2768, DOI 10.1897/02-573; Boyd WA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001259; Boyd WA, 2010, NEUROTOXICOL TERATOL, V32, P68, DOI 10.1016/j.ntt.2008.12.004; BRENNER S, 1974, GENETICS, V77, P71; Browne RA, 2002, J EXP MAR BIOL ECOL, V267, P107, DOI 10.1016/S0022-0981(01)00363-X; Bush AI, 2003, TRENDS NEUROSCI, V26, P207, DOI 10.1016/S0166-2236(03)00067-5; Calafato S, 2008, TOXICOL SCI, V106, P384, DOI 10.1093/toxsci/kfn180; Cerpa Waldo, 2005, Molecular Aspects of Medicine, V26, P405, DOI 10.1016/j.mam.2005.07.011; Cha YJ, 2012, CHEMOSPHERE, V87, P49, DOI 10.1016/j.chemosphere.2011.11.054; Chen P, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00018; Chu KW, 2005, AQUAT TOXICOL, V74, P320, DOI 10.1016/j.aquatox.2005.06.006; Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093; Cook DE, 2016, GENETICS; Deng SB, 2005, WATER RES, V39, P2167, DOI 10.1016/j.watres.2005.03.033; Dengg Marlene, 2004, Journal of Pharmacological and Toxicological Methods, V50, P209, DOI 10.1016/j.vascn.2004.04.002; Du M, 2009, ENVIRON TOXICOL PHAR, V27, P314, DOI 10.1016/j.etap.2008.11.011; Ellegaard-Jensen L, 2012, ECOTOX ENVIRON SAFE, V80, P216, DOI 10.1016/j.ecoenv.2012.03.003; Farhadifar R, 2015, CURR BIOL, V25, P732, DOI 10.1016/j.cub.2014.12.060; Frezal L, 2015, ELIFE, V4, DOI 10.7554/eLife.05849; Gaertner BE, 2010, GENET RES, V92, P331, DOI 10.1017/S0016672310000601; Gaggelli E, 2006, CHEM REV, V106, P1995, DOI 10.1021/cr040410w; Ghosh R, 2012, SCIENCE, V335, P574, DOI 10.1126/science.1214318; Gomes SIL, 2012, COMP BIOCHEM PHYS C, V155, P219, DOI 10.1016/j.cbpc.2011.08.008; Harada H, 2007, ECOTOX ENVIRON SAFE, V66, P378, DOI 10.1016/j.ecoenv.2006.02.017; Heinlaan M, 2011, WATER RES, V45, P179, DOI 10.1016/j.watres.2010.08.026; Hodgkin J, 1997, GENETICS, V146, P149; Kasemets K, 2013, CHEM RES TOXICOL, V26, P356, DOI 10.1021/tx300467d; Keller AA, 2014, ENVIRON SCI TECH LET, V1, P65, DOI 10.1021/ez400106t; Keller AA, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1692-4; Koch R, 2000, GENOME RES, V10, P1690, DOI 10.1101/gr.GR-1471R; Lim D, 2012, ENVIRON TOXICOL CHEM, V31, P585, DOI 10.1002/etc.1706; Ma HB, 2009, ENVIRON TOXICOL CHEM, V28, P1324, DOI 10.1897/08-262.1; Madsen E, 2007, ANNU REV NEUROSCI, V30, P317, DOI 10.1146/annurev.neuro.30.051606.094232; Martinez-Finley EJ, 2011, METALLOMICS, V3, P271, DOI 10.1039/c0mt00064g; Mashock MJ, 2015, ENV TOXICOLOGY CHEM; Maydan JS, 2007, GENOME RES, V17, P337, DOI 10.1101/gr.5690307; Mudunkotuwa IA, 2012, ENVIRON SCI TECHNOL, V46, P7001, DOI 10.1021/es203851d; Peterson RT, 2008, NEUROTOXICOLOGY, V29, P546, DOI 10.1016/j.neuro.2008.04.006; Petrella LN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112377; R Core Team, 2012, R LANG ENV STAT COMP; Raizen David, 2012, WormBook, P1, DOI 10.1895/wormbook.1.154.1; Rui-xia PJ-hL, SURFACE REACTION BAC; Schrand AM, 2010, WIRES NANOMED NANOBI, V2, P544, DOI 10.1002/wnan.103; Semisch A, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-10; Settivari R, 2009, J BIOL CHEM, V284, P35758, DOI 10.1074/jbc.M109.051409; Shi JY, 2011, ENVIRON POLLUT, V159, P1277, DOI 10.1016/j.envpol.2011.01.028; Shimko TC, COPASUTILS R PACKAGE; So SH, 2011, GENES CELLS, V16, P639, DOI 10.1111/j.1365-2443.2011.01514.x; Song SJ, 2014, ARCH ENVIRON CON TOX, V66, P390, DOI 10.1007/s00244-013-9991-4; Sterken MG, TRENDS GENETICS, V31, P224; Stiernagle Theresa, 2006, WormBook, P1; Thompson OA, 2015, GENETICS, V200, P975, DOI 10.1534/genetics.115.175950; Unrine JM, 2010, J ENVIRON QUAL, V39, P1942, DOI 10.2134/jeq2009.0387; Warming TP, 2009, ENVIRON TOXICOL CHEM, V28, P374, DOI 10.1897/08-279.1; Weston DP, 2013, P NATL ACAD SCI USA, V110, P16532, DOI 10.1073/pnas.1302023110; Wu QL, 2013, CHEMOSPHERE, V90, P1123, DOI 10.1016/j.chemosphere.2012.09.019; Yang XY, 2012, ENVIRON SCI TECHNOL, V46, P1119, DOI 10.1021/es202417t; Yu ZY, 2012, CHEMOSPHERE, V87, P1361, DOI 10.1016/j.chemosphere.2012.02.029; Zhang YC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044465, 10.1155/2012/583417]	66	33	34	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167613	10.1371/journal.pone.0167613	http://dx.doi.org/10.1371/journal.pone.0167613			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911941	gold, Green Published, Green Submitted			2022-12-27	WOS:000389520600047
J	Choi, YM; Yeo, HK; Park, YW; Lee, JY				Choi, Yong Mi; Yeo, Hyun Ku; Park, Young Woo; Lee, Jae Young			Structural Analysis of Thymidylate Synthase from Kaposi's Sarcoma-Associated Herpesvirus with the Anticancer Drug Raltitrexed	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; LIGAND-BINDING; DNA-SEQUENCES; 5-FLUOROURACIL; AUTOREGULATION; IDENTIFICATION; INDUCTION; MECHANISM; DELETION; TOMUDEX	Kaposi's sarcoma-associated herpesvirus (KSHV) is a highly infectious human herpesvirus that causes Kaposi's sarcoma. KSHV encodes functional thymidylate synthase, which is a target for anticancer drugs such as raltitrexed or 5-fluorouracil. Thymidylate synthase catalyzes the conversion of 2'-deoxyuridine-5'-monophosphate (dUMP) to thymidine-5'-mono-phosphate (dTMP) using 5,10-methylenetetrahydrofolate (mTHF) as a co-substrate. The crystal structures of thymidylate synthase from KSHV (apo), complexes with dUMP (binary), and complexes with both dUMP and raltitrexed (ternary) were determined at 1.7 angstrom, 2.0 angstrom, and 2.4 angstrom, respectively. While the ternary complex structures of human thymidylate synthase and E. co/ithymidylate synthase had a closed conformation, the ternary complex structure of KSHV thymidylate synthase was observed in an open conformation, similar to that of rat thymidylate synthase. The complex structures of KSHV thymidylate synthase did not have a covalent bond between the sulfhydryl group of Cys219 and C6 atom of dUMP, unlike the human thymidylate synthase. The catalytic Cys residue demonstrated a dual conformation in the apo structure, and its sulfhydryl group was oriented toward the C6 atom of dUMP with no covalent bond upon ligand binding in the complex structures. These structural data provide the potential use of antifolates such as raltitrexed as a viral induced anticancer drug and structural basis to design drugs for targeting the thymidylate synthase of KSHV.	[Choi, Yong Mi; Yeo, Hyun Ku; Park, Young Woo; Lee, Jae Young] Dongguk Univ Seoul, Dept Life Sci, Goyang Si, Gyeonggi Do, South Korea	Dongguk University	Lee, JY (corresponding author), Dongguk Univ Seoul, Dept Life Sci, Goyang Si, Gyeonggi Do, South Korea.	jylee001@dongguk.edu			National Research Foundation of Korea [2014R1A1A1A050 08017]; Ministry for Food, Agriculture, Forestry and Fisheries, Korea / ARC [710003-03]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry for Food, Agriculture, Forestry and Fisheries, Korea / ARC	This work was supported by the National Research Foundation of Korea / 2014R1A1A1A050 08017 / (www.nrf.re.kr/) to JYL and the Ministry for Food, Agriculture, Forestry and Fisheries, Korea / ARC; 710003-03, (www.ipet.re.kr/) to JYL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Almog R, 2001, PROTEIN SCI, V10, P988, DOI 10.1110/ps.47601; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berger SH, 2004, BBA-PROTEINS PROTEOM, V1696, P15, DOI 10.1016/j.bbapap.2003.09.005; Brunn ND, 2014, BIOSCIENCE REP, V34, P905, DOI 10.1042/BSR20140137; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chu E, 2003, CANCER CHEMOTH PHARM, V52, pS80, DOI 10.1007/s00280-003-0625-9; Chu E, 1996, Cancer Treat Res, V87, P175; CHU E, 1993, P NATL ACAD SCI USA, V90, P517, DOI 10.1073/pnas.90.2.517; CHU E, 1991, P NATL ACAD SCI USA, V88, P8977, DOI 10.1073/pnas.88.20.8977; Chu E, 1999, MOL CELL BIOL, V19, P1582; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans DR, 2004, J BIOL CHEM, V279, P33035, DOI 10.1074/jbc.R400007200; Fox KM, 1999, PROTEIN SCI, V8, P538; Gaspar G, 2002, J VIROL, V76, P10530, DOI 10.1128/JVI.76.20.10530-10532.2002; Hew K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143947; Jackman AL, 1996, INVEST NEW DRUG, V14, P305, DOI 10.1007/BF00194534; Kitchens ME, 1999, J BIOL CHEM, V274, P12544, DOI 10.1074/jbc.274.18.12544; Lin XK, 2000, NUCLEIC ACIDS RES, V28, P1381, DOI 10.1093/nar/28.6.1381; Longley DB, 2002, CANCER RES, V62, P2644; MONTFORT WR, 1990, BIOCHEMISTRY-US, V29, P6964, DOI 10.1021/bi00482a004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PERRY KM, 1993, BIOCHEMISTRY-US, V32, P7116, DOI 10.1021/bi00079a007; Phan J, 2001, BIOCHEMISTRY-US, V40, P1897, DOI 10.1021/bi002413i; Schiffer CA, 1995, BIOCHEMISTRY-US, V34, P16279, DOI 10.1021/bi00050a007; Sotelo-Mundo RR, 1999, BIOCHEMISTRY-US, V38, P1087, DOI 10.1021/bi981881d; Spencer HT, 1997, BIOCHEMISTRY-US, V36, P4212, DOI 10.1021/bi961794q; Van Triest B, 2000, ANN ONCOL, V11, P385, DOI 10.1023/A:1008351221345	31	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168019	10.1371/journal.pone.0168019	http://dx.doi.org/10.1371/journal.pone.0168019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936107	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100255
J	Fadda, A; Bartschi, M; Hemphill, A; Widmer, HR; Zurbriggen, A; Perona, P; Vidondo, B; Oevermann, A				Fadda, A.; Bartschi, M.; Hemphill, A.; Widmer, H. R.; Zurbriggen, A.; Perona, P.; Vidondo, B.; Oevermann, A.			Primary Postnatal Dorsal Root Ganglion Culture from Conventionally Slaughtered Calves	PLOS ONE			English	Article							SATELLITE GLIAL-CELLS; E-CADHERIN EXPRESSION; NERVE GROWTH-FACTOR; PRIMARY AFFERENT NEURONS; PRIMARY SENSORY NEURONS; GENE-RELATED PEPTIDE; SCHWANN-CELLS; IN-VITRO; IMMUNOHISTOCHEMICAL CHARACTERIZATION; SPINAL GANGLIA	Neurological disorders in ruminants have an important impact on veterinary health, but very few host-specific in vitro models have been established to study diseases affecting the nervous system. Here we describe a primary neuronal dorsal root ganglia (DRG) culture derived from calves after being conventionally slaughtered for food consumption. The study focuses on the in vitro characterization of bovine DRG cell populations by immunofluorescence analysis. The effects of various growth factors on neuron viability, neurite outgrowth and arborisation were evaluated by morphological analysis. Bovine DRG neurons are able to survive for more than 4 weeks in culture. GF supplementation is not required for neuronal survival and neurite outgrowth. However, exogenously added growth factors promote neurite outgrowth. DRG cultures from regularly slaughtered calves represent a promising and sustainable host specific model for the investigation of pain and neurological diseases in bovines.	[Fadda, A.; Bartschi, M.; Zurbriggen, A.; Oevermann, A.] Univ Bern, Vetsuisse Fac, Div Neurol Sci, Bern, Switzerland; [Fadda, A.] Univ Bern, Theodor Kocher Inst, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Hemphill, A.] Univ Bern, Vetsuisse Fac, Inst Parasitol, Bern, Switzerland; [Widmer, H. R.] Univ Hosp, Neuroctr & Regenerat Neurosci Cluster, Bern, Switzerland; [Widmer, H. R.] Univ Bern, Bern, Switzerland; [Perona, P.] Univ Edinburgh, Sch Engn, Edinburgh, Midlothian, Scotland; [Vidondo, B.] Univ Bern, Vetsuisse Fac, VPHI, Bern, Switzerland	University of Bern; University of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University of Edinburgh; University of Bern	Oevermann, A (corresponding author), Univ Bern, Vetsuisse Fac, Div Neurol Sci, Bern, Switzerland.	anna.oevermann@vetsuisse.unibe.ch	Widmer, Hans Rudolf/O-5172-2017	Widmer, Hans Rudolf/0000-0003-3378-8765; Vidondo, Beatriz/0000-0001-9693-2301; Oevermann, Anna/0000-0002-3569-8547; Hemphill, Andrew/0000-0002-0622-2128	Swiss National Foundation (SNF) [CRSII3_147692]; Charlotte and Ernst Frauchiger-Reyher Foundation	Swiss National Foundation (SNF)(Swiss National Science Foundation (SNSF)); Charlotte and Ernst Frauchiger-Reyher Foundation	This work was financially supported by a Swiss National Foundation (SNF) Sinergia grant (CRSII3_147692). The professorship of Anna Oevermann for comparative neuropathology is funded by the Charlotte and Ernst Frauchiger-Reyher Foundation.; This work was financially supported by a Swiss National Foundation (SNF) Sinergia grant (CRSII3_147692). The professorship of Anna Oevermann for comparative neuropathology is funded by the Charlotte and Ernst Frauchiger-Reyher foundation.	Arce V, 1998, J NEUROSCI, V18, P1440; AVERILL S, 1995, EUR J NEUROSCI, V7, P1484, DOI 10.1111/j.1460-9568.1995.tb01143.x; Barabas ME, 2014, J BIOL CHEM, V289, P34241, DOI 10.1074/jbc.M114.570101; Bauer A, 2014, J VIROL, V88, P14172, DOI 10.1128/JVI.02254-14; Benmerah A, 2013, CURR OPIN CELL BIOL, V25, P78, DOI 10.1016/j.ceb.2012.10.011; Chowdhury SI, 2011, VET MICROBIOL, V152, P270, DOI 10.1016/j.vetmic.2011.05.012; Christie K, 2015, MOL CELL NEUROSCI, V67, P1, DOI 10.1016/j.mcn.2015.05.001; Colangelo AM, 2005, P NATL ACAD SCI USA, V102, P18658, DOI 10.1073/pnas.0508734102; Crawford AT, 2008, GLIA, V56, P1637, DOI 10.1002/glia.20716; Curanovic Dusica, 2009, Curr Protoc Cell Biol, VChapter 26, DOI 10.1002/0471143030.cb2604s43; de Lahunta A., 2015, VET NEUROANATOMY CLI, V4th ed; Deister C, 2006, J NEURAL ENG, V3, P172, DOI 10.1088/1741-2560/3/2/011; DEKONINCK P, 1993, J NEUROSCI, V13, P577; Dupraz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054462; Ferreira TA, 2014, NAT METHODS, V11, P982, DOI 10.1038/nmeth.3125; Forgie A, 1999, MOL CELL NEUROSCI, V13, P430, DOI 10.1006/mcne.1999.0760; Franco NH, 2014, LAB ANIM-UK, V48, P50, DOI 10.1177/0023677213498717; Frey E, 2015, EXP NEUROL, V263, P350, DOI 10.1016/j.expneurol.2014.10.012; Gavazzi I, 1999, EUR J NEUROSCI, V11, P3405, DOI 10.1046/j.1460-9568.1999.00756.x; Gerhauser I, 2012, VET REC, V170, DOI 10.1136/vr.100255; Goldberg JL, 2004, CURR OPIN NEUROBIOL, V14, P551, DOI 10.1016/j.conb.2004.08.012; GRILLO MA, 1963, J CELL BIOL, V16, P430, DOI 10.1083/jcb.16.2.430; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P31, DOI 10.1113/jphysiol.1985.sp015573; Harrington AW, 2013, NAT REV NEUROSCI, V14, P177, DOI 10.1038/nrn3253; Hatzig SV, 2015, J EXP BOT, V66, P5617, DOI 10.1093/jxb/erv235; Hemphill Andrew, 1997, P227; Huang LYM, 2013, GLIA, V61, P1571, DOI 10.1002/glia.22541; Huang TY, 2005, BRAIN RES, V1036, P42, DOI 10.1016/j.brainres.2004.12.021; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Kalous A, 2010, NEUROSCIENCE, V166, P107, DOI 10.1016/j.neuroscience.2009.12.019; Khan AA, 2009, BIOMED RES-INDIA, V20, P45; Kobayashi S, 2005, SPINE, V30, P276, DOI 10.1097/01.brs.0000152377.72468.f4; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Kushnir R, 2011, NEUROPHARMACOLOGY, V61, P739, DOI 10.1016/j.neuropharm.2011.05.019; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; Madarame H, 2011, NEUROPATH APPL NEURO, V37, P753, DOI 10.1111/j.1365-2990.2011.01183.x; Madduri S, 2009, NEUROSCI RES, V65, P88, DOI 10.1016/j.neures.2009.06.003; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; MATSUOKA I, 1991, J NEUROSCI, V11, P3165; Melli G, 2009, EXPERT OPIN DRUG DIS, V4, P1035, DOI 10.1517/17460440903266829; MERIGHI A, 1990, ANAT EMBRYOL, V181, P271; Mills CD, 2007, MOL CELL NEUROSCI, V36, P185, DOI 10.1016/j.mcn.2007.06.011; Mirsky R, 2002, J PHYSIOL-PARIS, V96, P17, DOI 10.1016/S0928-4257(01)00076-6; Morgan BR, 2014, J NEUROSCI RES, V92, P531, DOI 10.1002/jnr.23332; Muratori L, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/860546; Nascimento RS, 2008, BRAZ J MED BIOL RES, V41, P1011, DOI 10.1590/S0100-879X2008005000051; Owen Davina E, 2012, Methods Mol Biol, V846, P179, DOI 10.1007/978-1-61779-536-7_16; PANNESE E, 1975, J COMP NEUROL, V160, P463, DOI 10.1002/cne.901600404; Pannese E, 2010, NEURON GLIA BIOL, V6, P3, DOI 10.1017/S1740925X10000037; Paveliev M, 2004, MOL CELL NEUROSCI, V25, P453, DOI 10.1016/j.mcn.2003.11.010; Peng YR, 2009, NEURON, V61, P71, DOI 10.1016/j.neuron.2008.11.015; Pierce LM, 2006, AM J OBSTET GYNECOL, V195, P987, DOI 10.1016/j.ajog.2006.02.042; PRICE J, 1985, J NEUROSCI, V5, P2051; Price TJ, 2007, J PAIN, V8, P263, DOI 10.1016/j.jpain.2006.09.005; Russo D, 2010, MICROSC RES TECHNIQ, V73, P128, DOI 10.1002/jemt.20764; Scolnick JA, 2008, NEURON, V57, P847, DOI 10.1016/j.neuron.2008.01.027; SHIMAMURA K, 1992, DEV BIOL, V152, P242, DOI 10.1016/0012-1606(92)90132-Z; SHOLL DA, 1953, J ANAT, V87, P387; Tong JX, 1996, EXP NEUROL, V138, P45, DOI 10.1006/exnr.1996.0045; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Valtcheva MV, 2016, NAT PROTOC, V11, P1877, DOI 10.1038/nprot.2016.111; Voigt T, 2004, MICROSC RES TECHNIQ, V63, P149, DOI 10.1002/jemt.20023; Winzer P, 2015, ANTIMICROB AGENTS CH, V59, P6361, DOI 10.1128/AAC.01236-15; Wong AW, 2015, MOL CELL NEUROSCI, V65, P125, DOI 10.1016/j.mcn.2015.03.004; Yamashita S, 2007, PROG HISTOCHEM CYTO, V41, P141, DOI 10.1016/j.proghi.2006.09.001	66	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168228	10.1371/journal.pone.0168228	http://dx.doi.org/10.1371/journal.pone.0168228			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936156	Green Published, gold			2022-12-27	WOS:000389587100281
J	Kim, SH; Hyun, JW; Joung, A; Lee, SH; Kim, HJ				Kim, Su-Hyun; Hyun, Jae-Won; Joung, AeRan; Lee, Sang Hyun; Kim, Ho Jin			Occurrence of Asymptomatic Acute Neuromyelitis Optica Spectrum Disorder-Typical Brain Lesions during an Attack of Optic Neuritis or Myelitis	PLOS ONE			English	Article							ABNORMALITIES; AQUAPORIN-4	We aimed to investigate the frequency of asymptomatic acute brain MRI abnormalities accompanying optic neuritis (ON) or myelitis in neuromyelitis optica spectrum disorder (NMOSD) patients with aquaporin-4 antibodies (AQP4-Ab). We reviewed 324 brain MRI scans that were obtained during acute attacks of ON or myelitis, in 165 NMOSD patients with AQP4-Ab. We observed that acute asymptomatic NMOSD-typical brain lesions accompanied 27 (8%) acute attacks of ON or myelitis in 24 (15%) patients. The most common asymptomatic brain abnormalities included edematous corpus callosum lesions (n = 17), followed by lesions on the internal capsule and/or cerebral peduncle lesions (n = 9), periependymal surfaces of the fourth ventricle (n = 5), large deep white matter lesions (n = 4), periependymal cerebral lesions surrounding the lateral ventricles (n = 3), and hypothalamic lesions (n = 1). If asymptomatic NMOSD-typical brain abnormalities were considered as evidence for DIS, while also assuming that the AQP4-IgG status was unknown, the median time to diagnosis using the 2015 diagnosis criteria for NMOSD was shortened from 28 months to 6 months (p = 0.008). Asymptomatic acute NMOSD-typical brain lesions can be accompanied by an acute attack of ON or myelitis. Identifying these asymptomatic brain lesions may help facilitate earlier diagnosis of NMOSD.	[Kim, Su-Hyun; Hyun, Jae-Won; Joung, AeRan; Kim, Ho Jin] Natl Canc Ctr, Dept Neurol, Res Inst & Hosp, Go Yang, South Korea; [Lee, Sang Hyun] Natl Canc Ctr, Dept Radiol, Res Inst & Hosp, Go Yang, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Kim, HJ (corresponding author), Natl Canc Ctr, Dept Neurol, Res Inst & Hosp, Go Yang, South Korea.	hojinkim@ncc.re.kr			National Research Foundation of Korea [NRF-2016R1D1A1A09916480]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was funded by the National Research Foundation of Korea (Grant No. NRF-2016R1D1A1A09916480).	Bichuetti DB, 2008, ARQ NEURO-PSIQUIAT, V66, P1, DOI 10.1590/S0004-282X2008000100001; Cabrera-Gomez JA, 2007, MULT SCLER, V13, P186, DOI 10.1177/1352458506070725; Chavarro VS, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000286; Ito S, 2009, ANN NEUROL, V66, P425, DOI 10.1002/ana.21753; Jarius S, 2010, J NEUROL SCI, V291, P52, DOI 10.1016/j.jns.2010.01.002; Kim HJ, 2015, NEUROLOGY, V84, P1165, DOI 10.1212/WNL.0000000000001367; Kim SH, 2012, NEUROLOGY, V78, P1179, DOI 10.1212/WNL.0b013e31824f8069; Kim SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108320; Kim W, 2012, MULT SCLER J, V18, P578, DOI 10.1177/1352458511424590; Kim W, 2011, MULT SCLER J, V17, P1107, DOI 10.1177/1352458511404917; Matthews L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137715; Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729; Zandona ME, 2014, MULT SCLER J, V20, P1908, DOI 10.1177/1352458514528763	13	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167783	10.1371/journal.pone.0167783	http://dx.doi.org/10.1371/journal.pone.0167783			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936193	gold, Green Submitted, Green Published			2022-12-27	WOS:000389587100186
J	Leber, A; Bassaganya-Riera, J; Tubau-Juni, N; Zoccoli-Rodriguez, V; Viladomiu, M; Abedi, V; Lu, PY; Hontecillas, R				Leber, Andrew; Bassaganya-Riera, Josep; Tubau-Juni, Nuria; Zoccoli-Rodriguez, Victoria; Viladomiu, Monica; Abedi, Vida; Lu, Pinyi; Hontecillas, Raquel			Modeling the Role of Lanthionine Synthetase C-Like 2 (LANCL2) in the Modulation of Immune Responses to Helicobacter pylori Infection	PLOS ONE			English	Article							REGULATORY T-CELLS; CHRONIC INFLAMMATION; COLON EXPLANTS; IFN-GAMMA; M-CSF; IL-10; MACROPHAGES; MONOCYTES; COLITIS; CX3CR1	Immune responses to Helicobacter pylori are orchestrated through complex balances of host-bacterial interactions, including inflammatory and regulatory immune responses across scales that can lead to the development of the gastric disease or the promotion of beneficial systemic effects. While inflammation in response to the bacterium has been reasonably characterized, the regulatory pathways that contribute to preventing inflammatory events during H. pylori infection are incompletely understood. To aid in this effort, we have generated a computational model incorporating recent developments in the understanding of H. pylori-host interactions. Sensitivity analysis of this model reveals that a regulatory macrophage population is critical in maintaining high H. pylori colonization without the generation of an inflammatory response. To address how this myeloid cell subset arises, we developed a second model describing an intracellular signaling network for the differentiation of macrophages. Modeling studies predicted that LANCL2 is a central regulator of inflammatory and effector pathways and its activation promotes regulatory responses characterized by IL-10 production while suppressing effector responses. The predicted impairment of regulatory macrophage differentiation by the loss of LANCL2 was simulated based on multiscale linkages between the tissue-level gastric mucosa and the intracellular models. The simulated deletion of LANCL2 resulted in a greater clearance of H. pylori, but also greater IFN gamma responses and damage to the epithelium. The model predictions were validated within a mouse model of H. pylori colonization in wild-type (WT), LANCL2 whole body KO and myeloid-specific LANCL2-/- (LANCL2(Myeloid)) mice, which displayed similar decreases in H. pylori burden, CX3CR1+ IL-10-producing macrophages, and type 1 regulatory (Tr1) T cells. This study shows the importance of LANCL2 in the induction of regulatory responses in macrophages and T cells during H. pylori infection.	[Leber, Andrew; Bassaganya-Riera, Josep; Tubau-Juni, Nuria; Zoccoli-Rodriguez, Victoria; Viladomiu, Monica; Abedi, Vida; Lu, Pinyi; Hontecillas, Raquel] Virginia Tech, Biocomplex Inst, Nutr Immunol & Mol Med Lab, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Hontecillas, R (corresponding author), Virginia Tech, Biocomplex Inst, Nutr Immunol & Mol Med Lab, Blacksburg, VA 24061 USA.	rmagarzo@vt.edu	Lu, Pinyi/U-4513-2017; Viladomiu, Monica/GNM-6447-2022	Zoccoli-Rodriguez, Victoria/0000-0002-5487-6521; Abedi, Vida/0000-0001-7689-933X	National Institute of Allergy and Infectious Diseases [HHSN272201000056C]; Nutritional Immunology and Molecular Medicine Laboratory	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Nutritional Immunology and Molecular Medicine Laboratory	This work was supported in part by National Institute of Allergy and Infectious Diseases Contract No. HHSN272201000056C to JB-R and funds from the Nutritional Immunology and Molecular Medicine Laboratory (www.nimml.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136139; Amieva MR, 2008, GASTROENTEROLOGY, V134, P306, DOI 10.1053/j.gastro.2007.11.009; Bassaganya-Riera J, 2007, AM J CLIN NUTR, V85, P824, DOI 10.1093/ajcn/85.3.824; Bassaganya-Riera J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050069; Bassaganya-Riera J, 2009, CELL IMMUNOL, V258, P138, DOI 10.1016/j.cellimm.2009.04.003; Carbo A, 2014, MBIO, V5, DOI 10.1128/mBio.01243-14; Carbo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073365; Carbo A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003027; Caruso R, 2007, J IMMUNOL, V178, P5957, DOI 10.4049/jimmunol.178.9.5957; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Crowe SE, 2005, CURR OPIN GASTROEN, V21, P32; Das L, 2016, BIOCH J; Erreni M, 2016, J IMMUNOL, V196, P902, DOI 10.4049/jimmunol.1501335; Feng X, 2015, ONCOTARGET, V6, P15077, DOI 10.18632/oncotarget.3730; Ferguson LR, 2010, MUTAT RES-FUND MOL M, V690, P3, DOI 10.1016/j.mrfmmm.2010.03.007; Fixe P, 1998, CYTOKINE, V10, P32, DOI 10.1006/cyto.1997.0249; Gregori S, 2010, BLOOD, V116, P935, DOI 10.1182/blood-2009-07-234872; Gu Y, 2008, EUR J IMMUNOL, V38, P1807, DOI 10.1002/eji.200838331; Hontecillas Raquel, 2012, ESPEN J, V7, pe189; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hsu P, 2015, J IMMUNOL, V195, P3665, DOI 10.4049/jimmunol.1402898; Hussain K, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00071; Jarry A, 2008, J CLIN INVEST, V118, P1132, DOI 10.1172/JCI32140; Jepsen K, 2008, GENE DEV, V22, P740, DOI 10.1101/gad.1637108; Kent E, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-91; Kim JE, 2015, IMMUNE NETW, V15, P269, DOI 10.4110/in.2015.15.6.269; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kronsteiner B, 2016, GUT MICROBES, V7, P3, DOI 10.1080/19490976.2015.1116673; Leber A, 2016, J THEOR BIOL, V398, P74, DOI 10.1016/j.jtbi.2016.02.036; Leber A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134849; Lee YS, 2013, CELL, V153, P413, DOI 10.1016/j.cell.2013.03.001; Li C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-92; Li H, 2016, DIG DIS SCI; Lim JH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002609; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; Lu PY, 2014, CURR DRUG TARGETS, V15, P565, DOI 10.2174/1389450115666140313123714; Lu PY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034643; Ma X., 2015, F1000RES, V4, DOI 10.12688/f1000research.7010.1; MARSHALL BJ, 1984, LANCET, V1, P1311; Mayer H, 2001, GENE, V269, P73, DOI 10.1016/S0378-1119(01)00463-2; Medina-Contreras O, 2011, J CLIN INVEST, V121, P4787, DOI 10.1172/JCI59150; Mei YG, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S12-S2; Michalkiewicz J, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/176726; Nelson DE, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130131; Oghumu S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00560; Pan D, 2013, CYTOKINE, V64, P30, DOI 10.1016/j.cyto.2013.06.312; Papadakis KA, 2015, AM J PHYSIOL-GASTR L, V309, pG900, DOI 10.1152/ajpgi.00309.2015; Philipson CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137839; Randle SJ, 2016, CURR PROTEIN PEPT SC; Salama NR, 2013, NAT REV MICROBIOL, V11, P385, DOI 10.1038/nrmicro3016; Schneider KM, 2015, HEPATOLOGY, V62, P1405, DOI 10.1002/hep.27982; Schulz C, 2016, DIGEST DIS, V34, P210, DOI 10.1159/000443353; Sturla L, 2009, J BIOL CHEM, V284, P28045, DOI 10.1074/jbc.M109.035329; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tighe RM, 2016, J IMMUNOL, V196, P2424, DOI 10.4049/jimmunol.1600002; Wendelsdorf K, 2010, J THEOR BIOL, V264, P1225, DOI 10.1016/j.jtbi.2010.03.027; Wendelsdorf KV, 2012, IEEE T NANOBIOSCI, V11, P273, DOI 10.1109/TNB.2012.2211891; WING EJ, 1985, J IMMUNOL, V135, P2052; XIE QW, 1994, J BIOL CHEM, V269, P4705; YASUMOTO K, 1992, J BIOL CHEM, V267, P22506; Zeng M, 2014, MOL BIOL CELL, V25, P3954, DOI 10.1091/mbc.E14-01-0004; Zhou PF, 2004, AM J PHYSIOL-GASTR L, V287, pG599, DOI 10.1152/ajpgi.00063.2004; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012	65	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167440	10.1371/journal.pone.0167440	http://dx.doi.org/10.1371/journal.pone.0167440			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936058	gold, Green Submitted, Green Published			2022-12-27	WOS:000389587100098
J	de Almeida, MLM; Feringer, WH; Carvalho, JRG; Rodrigues, IM; Jordao, LR; Fonseca, MG; de Rezende, ASC; Neto, AD; Weese, JS; da Costa, MC; Lemos, EGD; Ferraz, GD				Mendes de Almeida, Maria Luiza; Feringer Junior, Walter Heinz; Garcia Carvalho, Julia Ribeiro; Rodrigues, Isadora Mestriner; Jordao, Lilian Rezende; Fonseca, Mayara Goncalves; Carneiro de Rezende, Adalgiza Souza; de Queiroz Neto, Antonio; Scott Weese, J.; da Costa, Marcio Carvalho; de Macedo Lemos, Eliana Gertrudes; Ferraz, Guilherme de Camargo			Intense Exercise and Aerobic Conditioning Associated with Chromium or L-Carnitine Supplementation Modified the Fecal Microbiota of Fillies	PLOS ONE			English	Article							GUT MICROBIOTA	Recent studies performed in humans and rats have reported that exercise can alter the intestinal microbiota. Athletic horses perform intense exercise regularly, but studies characterizing horse microbiome during aerobic conditioning programs are still limited. Evidence has indicated that this microbial community is involved in the metabolic homeostasis of the host. Research on ergogenic substances using new sequencing technologies have been limited to the intestinal microbiota and there is a considerable demand for scientific studies that verify the effectiveness of these supplements in horses. L-carnitine and chromium are potentially ergogenic substances for athletic humans and horses since they are possibly able to modify the metabolism of carbohydrates and lipids. This study aimed to assess the impact of acute exercise and aerobic conditioning, associated either with L-carnitine or chromium supplementation, on the intestinal microbiota of fillies. Twelve "Mangalarga Marchador" fillies in the incipient fitness stage were distributed into four groups: control (no exercise), exercise, L-carnitine (10g/day) and chelated chromium (10mg/day). In order to investigate the impact of acute exercise or aerobic conditioning on fecal microbiota all fillies undergoing the conditioning program were analyzed as a separate treatment. The fillies underwent two incremental exercise tests before and after training on a treadmill for 42 days at 70 -80% of the lactate threshold intensity. Fecal samples were obtained before and 48 h after acute exercise (incremental exercise test). Bacterial populations were characterized by sequencing the V4 region of the 16S rRNA gene using the MiSeq Illumina platform, and 5,224,389 sequences were obtained from 48 samples. The results showed that, overall, the two most abundant phyla were Firmicutes (50.22%) followed by Verrucomicrobia (15.13%). The taxa with the highest relative abundances were unclassified Clostridiales (17.06%) and "5 genus incertae sedis" from the phylum Verrucomicrobia (12.98%). There was a decrease in the phylum Chlamydiae and in the genus Mycobacterium after the second incremental exercise test. Intense exercise changed the community's structure and aerobic conditioning was associated with changes in the composition and structure of the intestinal bacterial population of fillies. The intra-group comparison showed that chromium or L-carnitine induced moderate changes in the fecal microbiota of fillies, but the microbiota did not differ from the control group, which was exercised with no supplementation. Fecal pH correlated positively with Simpson's index, while plasma pH correlated negatively. Our results show that exercise and aerobic conditioning can change in the microbiota and provide a basis for further studies enrolling a larger number of horses at different fitness levels to better understand the effects of exercise and training on the intestinal microbiota of horses.	[Mendes de Almeida, Maria Luiza; de Macedo Lemos, Eliana Gertrudes] UNESP Univ Estadual Paulista, Dept Technol, Fac Ciencias Agr & Vet, Lab Bioquim Microrganismos & Plantas, Jaboticabal, SP, Brazil; [Feringer Junior, Walter Heinz; Garcia Carvalho, Julia Ribeiro; Rodrigues, Isadora Mestriner; Fonseca, Mayara Goncalves; de Queiroz Neto, Antonio; Ferraz, Guilherme de Camargo] UNESP Univ Estadual Paulista, Dept Anim Morphol & Physiol, Fac Ciencias Agr & Vet, Lab Farmacol & Fisiol Exercicio Equino LAFEQ, Jaboticabal, SP, Brazil; [Jordao, Lilian Rezende; Fonseca, Mayara Goncalves; Carneiro de Rezende, Adalgiza Souza] Univ Fed Minas Gerais, Dept Anim Sci, Escola Vet, Belo Horizonte, MG, Brazil; [Scott Weese, J.; da Costa, Marcio Carvalho] Univ Guelph, Dept Pathobiol, Ontario Vet Coll, Guelph, ON N1G 2W1, Canada	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Federal de Minas Gerais; University of Guelph	Ferraz, GD (corresponding author), UNESP Univ Estadual Paulista, Dept Anim Morphol & Physiol, Fac Ciencias Agr & Vet, Lab Farmacol & Fisiol Exercicio Equino LAFEQ, Jaboticabal, SP, Brazil.	gferraz@fcav.unesp.br	Ferraz, Guilherme/ADE-4760-2022; de Macedo Lemos, Eliana Gertrudes/AAA-4225-2020; LEMOS, ELIANA GM/A-3604-2008; Ferraz, Guilherme/G-4954-2012; Carvalho, Júlia/ABA-8392-2020	de Macedo Lemos, Eliana Gertrudes/0000-0002-1119-7748; LEMOS, ELIANA GM/0000-0002-1119-7748; Ferraz, Guilherme/0000-0002-6463-6628; Costa, Marcio/0000-0001-5067-7501; REZENDE, ADALGIZA SOUZA CANEIRO/0000-0001-8447-610X; Ribeiro Garcia de Carvalho, Julia/0000-0002-6593-511X; de Rezende Jordao, Lilian/0000-0001-8522-6460	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/14703-3, 2013/15215-2]; National Scientific and Technological Development Council (CNPq) [EditalMCT/CNPq14/2012, 482811/2012-9]; Brazilian Association of Mangalarga Marchador Horse Breeders (Associacao Brasileira de Criadores do Cavalo Mangalarga Marchador- ABCCMM)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Scientific and Technological Development Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Association of Mangalarga Marchador Horse Breeders (Associacao Brasileira de Criadores do Cavalo Mangalarga Marchador- ABCCMM)	The authors are thankful to Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), process numbers 2013/14703-3 and 2013/15215-2. Thanks are also due to the National Scientific and Technological Development Council (CNPq) (EditalMCT/CNPq14/2012, Process number 482811/2012-9) Brazilian Association of Mangalarga Marchador Horse Breeders (Associacao Brasileira de Criadores do Cavalo Mangalarga Marchador-ABCCMM) for their operational and financial support.	Allen JM, 2015, J APPL PHYSIOL, V118, P1059, DOI 10.1152/japplphysiol.01077.2014; [Anonymous], 2007, NUTR REQUIREMENTS HO, V6th; Brancaccio P, 2007, BRIT MED BULL, V81-82, P209, DOI 10.1093/bmb/ldm014; Bunge J, 2011, BIOCOMPUTING, V2011, P121, DOI DOI 10.1142/9789814335058_; Clarke SF, 2014, GUT, V63, P1913, DOI 10.1136/gutjnl-2013-306541; Cole J.R., 2013, NUCL ACIDS RES; Costa MC, 2015, VET J, V205, P74, DOI 10.1016/j.tvjl.2015.03.018; Costa M. C., 2015, EQUINE VET J; Costa MC, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0335-7; Costa MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041484; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Evans CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092193; Ferraz GC, 2010, EQUINE VET J, V42, P191, DOI 10.1111/j.2042-3306.2010.00278.x; Ferraz GC, 2008, AM J VET RES, V69, P1670, DOI 10.2460/ajvr.69.12.1670; Fonseca MG, 2015, LIVEST SCI, V177, P165, DOI 10.1016/j.livsci.2015.03.014; Gronvold AMR, 2010, FEMS MICROBIOL ECOL, V71, P313, DOI 10.1111/j.1574-6941.2009.00808.x; Harlow BE, 2013, VET MICROBIOL, V166, P225, DOI 10.1016/j.vetmic.2013.05.003; Hold GL, 2014, GUT, V63, P1838, DOI 10.1136/gutjnl-2014-307305; Queipo-Ortuno MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065465; Janabi AHD, 2016, COMP EXERC PHYSIOL, V12, P119, DOI 10.3920/CEP160015; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lambert JE, 2015, APPL PHYSIOL NUTR ME, V40, P749, DOI 10.1139/apnm-2014-0452; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; O' Donnell MM, 2013, LETT APPL MICROBIOL, V57, P492, DOI 10.1111/lam.12137; O'Sullivan O, 2015, GUT MICROBES, V6, P131, DOI 10.1080/19490976.2015.1011875; Pagan JD, 1995, EQUINE NUTR PHYSL SO, V14, P96; Proudman CJ, 2015, EQUINE VET J, V47, P580, DOI 10.1111/evj.12324; Rivero JLL, 2002, EQUINE VET J, V34, P269; Robergs RA, 2006, AM J PHYSIOL-REG I, V291, pR238, DOI 10.1152/ajpregu.00081.2006; van den Berg M, 2013, J EQUINE VET SCI, V33, P215, DOI 10.1016/j.jevs.2012.06.004; Weese JS, 2014, EQUINE VET J, V46, P654, DOI 10.1111/evj.12295	33	15	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167108	10.1371/journal.pone.0167108	http://dx.doi.org/10.1371/journal.pone.0167108			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935992	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100061
J	Sorkac, A; Alcantara, IC; Hart, AC				Sorkac, Altar; Alcantara, Ivan C.; Hart, Anne C.			In Vivo Modelling of ATP1A3 G316S-Induced Ataxia in C-elegans Using CRISPR/Cas9-Mediated Homologous Recombination Reveals Dominant Loss of Function Defects	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; MUTATIONS; GENOME; EXPRESSION; DISORDERS; INSIGHTS; GENE	The NIH Undiagnosed Diseases Program admitted a male patient with unclassifiable late onset ataxia-like symptoms. Exome sequencing revealed a heterozygous de novo mutation converting glycine 316 to serine in ATP1A3, which might cause disease. ATP1A3 encodes the Na+/K+ ATPase pump a3-subunit. Using CRISPR/Cas9-mediated homologous recombination for genome editing, we modelled this putative disease-causing allele in Caenorhabditis elegans, recreating the patient amino acid change in eat-6, the orthologue of ATP1A3. The impact of the mutation on eat-6 function at the neuromuscular junction was examined using two behavioural assays: rate of pharyngeal pumping and sensitivity to aldicarb, a drug that causes paralysis over time via the inhibition of acetylcholinesterase. The patient allele decreased pumping rates and caused hypersensitivity to aldicarb. Animals heterozygous for the allele exhibited similar defects, whereas loss of function mutations in eat-6 were recessive. These results indicate that the mutation is dominant and impairs the neuromuscular function. Thus, we conclude that the de novo G316S mutation in ATP1A3 likely causes or contributes to patient symptoms. More broadly, we conclude that, for conserved genes, it is possible to rapidly and easily model human diseases in C. elegans using CRIPSR/Cas9 genome editing.	[Sorkac, Altar; Alcantara, Ivan C.; Hart, Anne C.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Hart, AC (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	anne_hart@brown.edu			National Institutes of Health (NIH) [P01 NS066888]; Brown Institute for Brain Science Suna Kirac Fund for Brain Science; Brown University Karen T. Romer Undergraduate Teaching and Research Awards; NIH Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS066888] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brown Institute for Brain Science Suna Kirac Fund for Brain Science; Brown University Karen T. Romer Undergraduate Teaching and Research Awards; NIH Office of Research Infrastructure Programs; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support was provided by the National Institutes of Health (NIH) grant P01 NS066888 (ACH, project fund), Brown Institute for Brain Science Suna Kirac Fund for Brain Science (AS, fellowship), and Brown University Karen T. Romer Undergraduate Teaching and Research Awards (ICA, summer fellowship). Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Hart Laboratory members for helpful discussions. Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). This work was supported by National Institutes of Health (NIH) grant P01 NS066888 (ACH), Brown Institute for Brain Science Suna Kirac Fund for Brain Science (AS), Brown University Karen T. Romer Undergraduate Teaching and Research Awards (ICA).	Arribere JA, 2014, GENETICS, V198, P837, DOI 10.1534/genetics.114.169730; AVERY L, 1993, GENETICS, V133, P897; Bottger P, 2011, J COMP NEUROL, V519, P376, DOI 10.1002/cne.22524; Davis MW, 1995, J NEUROSCI, V15, P8408; DECARVALHO A, 2004, NEURON, V43, P169, DOI [DOI 10.1016/J.NEUR0N.2004.06.028, 10.1016/j.neuron.2004.06.028]; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI 10.1038/NMETH.2641; Dimitriadi M, 2010, NEUROBIOL DIS, V40, P4, DOI 10.1016/j.nbd.2010.05.012; Doi M, 2008, MOL CELL NEUROSCI, V38, P548, DOI 10.1016/j.mcn.2008.05.003; Faber PW, 1999, P NATL ACAD SCI USA, V96, P179, DOI 10.1073/pnas.96.1.179; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gahl WA, 2012, GENET MED, V14, P51, DOI 10.1038/gim.0b013e318232a005; Govorunova EG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010368; Heinzen EL, 2014, LANCET NEUROL, V13, P503, DOI 10.1016/S1474-4422(14)70011-0; Heinzen EL, 2012, NAT GENET, V44, P1030, DOI 10.1038/ng.2358; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kraemer BC, 2003, P NATL ACAD SCI USA, V100, P9980, DOI 10.1073/pnas.1533448100; Lakso M, 2003, J NEUROCHEM, V86, P165, DOI 10.1046/j.1471-4159.2003.01809.x; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Shima Y, 1998, BIOCHEM BIOPH RES CO, V248, P778, DOI 10.1006/bbrc.1998.8981; Sweadner KJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151429; Wang J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000350	24	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167963	10.1371/journal.pone.0167963	http://dx.doi.org/10.1371/journal.pone.0167963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936181	gold, Green Submitted, Green Published			2022-12-27	WOS:000389587100240
J	Su, HC; Liang, YA; Lai, YJJ; Chiu, YL; Barndt, RB; Shiao, F; Chang, HHD; Lu, DD; Huang, N; Tseng, CC; Wang, JK; Lee, MS; Johnson, MD; Huang, SM; Lin, CY				Su, Hui Chen; Liang, Yan A.; Lai, Ying-Jung J.; Chiu, Yi-Lin; Barndt, Robert B.; Shiao, Frank; Chang, Hsiang-Hua D.; Lu, Dajun D.; Huang, Nanxi; Tseng, Chun-Che; Wang, Jehng-Kang; Lee, Ming-Shyue; Johnson, Michael D.; Huang, Shih-Ming; Lin, Chen-Yong			Natural Endogenous Human Matriptase and Prostasin Undergo Zymogen Activation via Independent Mechanisms in an Uncoupled Manner	PLOS ONE			English	Article							EPIDERMAL BARRIER FUNCTION; BREAST-CANCER CELLS; SERINE-PROTEASE; EPITHELIAL-CELLS; PROTEOLYTIC CASCADE; MOLECULAR-CLONING; IN-VITRO; PH; HAI-1; INHIBITOR	The membrane-associated serine proteases matriptase and prostasin are believed to function in close partnership. Their zymogen activation has been reported to be tightly coupled, either as a matriptase-initiated proteolytic cascade or through a mutually dependent mechanism involving the formation of a reciprocal zymogen activation complex. Here we show that this putative relationship may not apply in the context of human matriptase and prostasin. First, the tightly coupled proteolytic cascade between matriptase and prostasin might not occur when modest matriptase activation is induced by sphingosine 1-phospahte in human mammary epithelial cells. Second, prostasin is not required and/or involved in matriptase autoactivation because matriptase can undergo zymogen activation in cells that do not endogenously express prostasin. Third, matriptase is not required for and/or involved in prostasin activation, since activated prostasin can be detected in cells expressing no endogenous matriptase. Finally, matriptase and prostasin both undergo zymogen activation through an apparently un-coupled mechanism in cells endogenously expressing both proteases, such as in Caco-2 cells. In these human enterocytes, matriptase is detected primarily in the zymogen form and prostasin predominantly as the activated form, either in complexes with protease inhibitors or as the free active form. The negligible levels of prostasin zymogen with high levels of matriptase zymogen suggests that the reciprocal zymogen activation complex is likely not the mechanism for matriptase zymogen activation. Furthermore, high level prostasin activation still occurs in Caco-2 variants with reduced or absent matriptase expression, indicating that matriptase is not required and/or involved in prostasin zymogen activation. Collectively, these data suggest that any functional relationship between natural endogenous human matriptase and prostasin does not occur at the level of zymogen activation.	[Su, Hui Chen] Chi Mei Med Ctr, Dept Pharm, Tainan, Taiwan; [Liang, Yan A.; Lai, Ying-Jung J.; Chiu, Yi-Lin; Barndt, Robert B.; Shiao, Frank; Chang, Hsiang-Hua D.; Lu, Dajun D.; Huang, Nanxi; Tseng, Chun-Che; Johnson, Michael D.; Lin, Chen-Yong] Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [Chang, Hsiang-Hua D.; Wang, Jehng-Kang; Huang, Shih-Ming] Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan; [Lee, Ming-Shyue] Natl Taiwan Univ, Coll Med, Grad Inst Biochem & Mol Biol, Taipei, Taiwan	Chi Mei Hospital; Georgetown University; National Defense Medical Center; National Taiwan University	Lin, CY (corresponding author), Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA.; Huang, SM (corresponding author), Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan.	shihming@mail.ndmctsgh.edu.tw; lincy@georgetown.edu	Chiu, Yilin/ABC-3746-2021; Lin, Chen/GRR-2799-2022	Chiu, Yilin/0000-0002-1827-6924; Liang, Yan/0000-0002-6195-0961; Tseng, Chun-che/0000-0001-9637-4127; LEE, MING-SHYUE/0000-0002-8673-5088	National Cancer Institute (NCI) [RO1 CA 123223]; Department of Defense, Taiwan [MAB104-026]; Chi-Mei Medical Center [CMNDMC10312]; NIH/NCI NIH/NCI [P30-CA051008]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense, Taiwan(United States Department of Defense); Chi-Mei Medical Center; NIH/NCI NIH/NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Cancer Institute (NCI) Grant RO1 CA 123223 (to M. D. Johnson and C.-Y. Lin), Grant (MAB104-026) from the Department of Defense, Taiwan (to J.-K. Wang), and Grant CMNDMC10312 from Chi-Mei Medical Center (to S.-M. Huang). We acknowledge the assistance provided by the Lombardi Comprehensive Cancer Center Tissue Culture and Microscopy and Imaging Shared Resources that are supported in part by NIH/NCI NIH/NCI grant P30-CA051008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ED, 2002, J BIOL CHEM, V277, P12879, DOI 10.1074/jbc.M108740200; BARTEK J, 1991, P NATL ACAD SCI USA, V88, P3520, DOI 10.1073/pnas.88.9.3520; Benaud C, 2002, J BIOL CHEM, V277, P10539, DOI 10.1074/jbc.M109064200; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Buzza MS, 2013, J BIOL CHEM, V288, P10328, DOI 10.1074/jbc.M112.443432; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Chang HHD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120489; Chen CJ, 2011, AM J PHYSIOL-CELL PH, V300, pC406, DOI 10.1152/ajpcell.00403.2010; Chen LM, 2001, PROSTATE, V48, P93, DOI 10.1002/pros.1085; Chen YW, 2014, J INVEST DERMATOL, V134, P405, DOI 10.1038/jid.2013.320; Chen YW, 2010, J BIOL CHEM, V285, P31755, DOI 10.1074/jbc.M110.150367; Chen YW, 2016, J INVEST DERMATOL, V83, P34; CHERNEW I, 1962, J CLIN INVEST, V41, P1945, DOI 10.1172/JCI104652; EDLOW DW, 1971, P SOC EXP BIOL MED, V137, P1328; Fan B, 2005, J BIOL CHEM, V280, P34513, DOI 10.1074/jbc.M502119200; Friis S, 2014, J BIOL CHEM, V289, P22319, DOI 10.1074/jbc.M114.574400; Friis S, 2013, J BIOL CHEM, V288, P19028, DOI 10.1074/jbc.M113.469932; Frns S, 2011, J BIOL CHEM, V286, P5793, DOI [10.1074/jbc.M110.186874, DOI 10.1074/JBC.M110.186874]; Hachem JP, 2003, J INVEST DERMATOL, V121, P345, DOI 10.1046/j.1523-1747.2003.12365.x; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; ICHIHARA K, 1984, AM J PHYSIOL, V246, pH652, DOI 10.1152/ajpheart.1984.246.5.H652; Inouye K, 2010, J BIOCHEM, V147, P485, DOI 10.1093/jb/mvp190; Jin XL, 2005, J CELL BIOCHEM, V95, P632, DOI 10.1002/jcb.20418; Kim MG, 1999, IMMUNOGENETICS, V49, P420, DOI 10.1007/s002510050515; Kiyomiya KI, 2006, AM J PHYSIOL-CELL PH, V291, pC40, DOI 10.1152/ajpcell.00351.2005; KORTING HC, 1990, ACTA DERM-VENEREOL, V70, P429; Lai CH, 2016, BIOL OPEN, V5, P1380, DOI 10.1242/bio.019745; Lai CH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152904; Lai YJJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132163; Lee MS, 2007, AM J PHYSIOL-CELL PH, V293, pC95, DOI 10.1152/ajpcell.00611.2006; Lee MS, 2005, AM J PHYSIOL-CELL PH, V288, pC932, DOI 10.1152/ajpcell.00497.2004; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Lin CY, 1999, J BIOL CHEM, V274, P18231, DOI 10.1074/jbc.274.26.18231; Lin CY, 1997, J BIOL CHEM, V272, P9147; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; Mauro T, 1998, ARCH DERMATOL RES, V290, P215, DOI 10.1007/s004030050293; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Oberst M, 2001, AM J PATHOL, V158, P1301, DOI 10.1016/S0002-9440(10)64081-3; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Shum WWC, 2009, J EXP BIOL, V212, P1753, DOI 10.1242/jeb.027284; SIMMEN HP, 1994, INFECTION, V22, P386, DOI 10.1007/BF01715494; STAMPFER MR, 1985, P NATL ACAD SCI USA, V82, P2394, DOI 10.1073/pnas.82.8.2394; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; Wang JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093899; Wang JK, 2009, AM J PHYSIOL-CELL PH, V297, pC459, DOI 10.1152/ajpcell.00201.2009; Xu H, 2012, AM J PHYSIOL-CELL PH, V302, pC453, DOI 10.1152/ajpcell.00344.2011; Xu ZH, 2011, J MED CHEM, V54, P7567, DOI 10.1021/jm200920s; YU JX, 1995, J BIOL CHEM, V270, P13483, DOI 10.1074/jbc.270.22.13483	50	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167894	10.1371/journal.pone.0167894	http://dx.doi.org/10.1371/journal.pone.0167894			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936035	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100225
J	Torensma, B; Martini, CH; Boon, M; Olofsen, E; In 't Veld, B; Liem, RSL; Knook, MTT; Swank, DJ; Dahan, A				Torensma, Bart; Martini, Chris H.; Boon, Martijn; Olofsen, Erik; In 't Veld, Bas; Liem, Ronald S. L.; Knook, Mireille T. T.; Swank, Dingeman J.; Dahan, Albert			Deep Neuromuscular Block Improves Surgical Conditions during Bariatric Surgery and Reduces Postoperative Pain: A Randomized Double Blind Controlled Trial	PLOS ONE			English	Article							LAPAROSCOPIC SURGERY; LOW-PRESSURE; CHOLECYSTECTOMY; SUGAMMADEX; MODERATE	Background It remains unknown whether the administration of a deep neuromuscular block (NMB) during bariatric surgery improves surgical conditions and patient outcome. The authors studied the effect of deep versus moderate NMB in laparoscopic bariatric surgery on surgical conditions and postoperative pain. Methods and Results One hundred patients scheduled to undergo elective bariatric surgery were randomized to a deep NMB (post-tetanic-count 2-3) or a moderate NMB (train-of-four 1-2). The quality of the surgical field was scored using the Leiden-Surgical Rating Scale (L-SRS), a 5-point scale ranging from 1 (extremely poor conditions) to 5 (optimal conditions). Three surgeons scored the L-SRS at 10-min intervals during surgery; postoperative pain scores were obtained in the postanesthesia-care-unit (PACU) and on the ward. Mean (95% confidence interval) L-SRS scores in moderate NMB 4.2 (4.0-4.4) versus 4.8 (4.7-4.9) in deep NMB (p < 0.001). Moderate NMB resulted in 17% of scores at L-SRS scores of 1-3, while deep NMB resulted in 100% scores at the high end of the L-SRS (4-5). Deep NMB led to improved pain scores in the PACU (4.6 (4.2-4.9) versus 3.9 (3.6-4.4), p = 0.03) and reduced shoulder pain on the ward (1.8 (1.5-2.1) versus 1.3 (1.1-1.5), p = 0.03). A composite score of pain and opioid use in the PACU favoured deep NMB (p = 0.001). Conclusions In bariatric surgery, deep relaxation has advantages for surgeon and patient. Compared to moderate NMB, deep NMB produced stable and improved surgical conditions with less postoperative pain.	[Torensma, Bart; Martini, Chris H.; Boon, Martijn; Olofsen, Erik; Dahan, Albert] Leiden Univ, Dept Anesthesiol, Med Ctr, Leiden, Netherlands; [Torensma, Bart; Liem, Ronald S. L.; Knook, Mireille T. T.; Swank, Dingeman J.] Dutch Obes Clin West, Dept Surg, The Hague, Netherlands; [Torensma, Bart; In 't Veld, Bas] Haaglanden Med Ctr, Dept Anesthesiol, The Hague, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Haaglanden Medical Center	Dahan, A (corresponding author), Leiden Univ, Dept Anesthesiol, Med Ctr, Leiden, Netherlands.	a.dahan@lumc.nl	Torensma, Bart/ACC-5371-2022; Torensma, Bart/AAH-3358-2020; Liem, Ronald/AAI-2582-2021; Dahan, Albert/B-8845-2008	Torensma, Bart/0000-0003-0274-9608; Torensma, Bart/0000-0003-0274-9608; Liem, Ronald/0000-0002-0165-5995; Dahan, Albert/0000-0003-3161-3945	MSD Nederland	MSD Nederland	This investigator initiated trial was supported by MSD Nederland. The sponsor had no influence on any part of the trial, its analysis and the writing of the protocol.	Abrishami A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007362.pub2; Blobner M, 2015, SURG ENDOSC, V29, P627, DOI 10.1007/s00464-014-3711-7; Boon M, 2016, BRIT J ANAESTH, V117, P59, DOI 10.1093/bja/aew114; Castro DS, 2014, SURG LAPARO ENDO PER, V24, P420, DOI 10.1097/SLE.0000000000000049; Dai F, 2013, J PAIN, V14, P767, DOI 10.1016/j.jpain.2013.04.004; Dubois PE, 2014, EUR J ANAESTH, V31, P430, DOI 10.1097/EJA.0000000000000094; Gurusamy KS, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006930.pub2; Hua J, 2014, AM J SURG, V208, P143, DOI 10.1016/j.amjsurg.2013.09.027; Karlsson A, 2016, OBES SURG, V26, P743, DOI 10.1007/s11695-015-1848-7; Kim HJ, 2015, BRIT J ANAESTH, V115, P867, DOI 10.1093/bja/aev368; Kopman AF, 2016, ACTA ANAESTH SCAND, V60, P717, DOI 10.1111/aas.12699; Kopman AF, 2016, ANESTH ANALG, V122, P289, DOI 10.1213/ANE.0000000000000905; Kopman AF, 2015, ANESTH ANALG, V120, P51, DOI 10.1213/ANE.0000000000000471; Loupec T, 2016, ANAESTHESIA, V71, P265, DOI 10.1111/anae.13344; Madsen MV, 2016, ACTA ANAESTH SCAND, V60, P710, DOI 10.1111/aas.12698; Madsen MV, 2015, ACTA ANAESTH SCAND, V59, P1, DOI 10.1111/aas.12419; Martini CH, 2014, BRIT J ANAESTH, V112, P498, DOI 10.1093/bja/aet377; Ozdemir-van Brunschot DMD, 2016, SURG ENDOSC, V30, P2049, DOI 10.1007/s00464-015-4454-9; Romundstad L, 2006, ANESTH ANALG, V102, P418, DOI 10.1213/01.ane.0000194358.46119.e1; Staehr-Rye AK, 2014, ANESTH ANALG, V119, P1084, DOI 10.1213/ANE.0000000000000316; Welliver Mark, 2009, Drug Des Devel Ther, V2, P49; Yoo YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135412	22	64	66	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167907	10.1371/journal.pone.0167907	http://dx.doi.org/10.1371/journal.pone.0167907			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936214	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100229
J	Davis, MJ; Janke, R; Taxon, TN				Davis, Michael J.; Janke, Robert; Taxon, Thomas N.			Assessing Inhalation Exposures Associated with Contamination Events in Water Distribution Systems	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; TAP WATER; CHLOROFORM EXPOSURE; SIZE DISTRIBUTION; ESCHERICHIA-COLI; SENSOR PLACEMENT; SHOWER WATER; INDOOR AIR; VOLATILIZATION; CHEMICALS	When a water distribution system (WDS) is contaminated, short-term inhalation exposures to airborne contaminants could occur as the result of domestic water use. The most important domestic sources of such exposures are likely to be showering and the use of aerosol-producing humidifiers, i.e., ultrasonic and impeller (cool-mist) units. A framework is presented for assessing the potential effects of short-term, system-wide inhalation exposures that could result from such activities during a contamination event. This framework utilizes available statistical models for showering frequency and duration, available exposure models for showering and humidifier use, and experimental results on both aerosol generation and the volatilization of chemicals during showering. New models for the times when showering occurs are developed using time-use data for the United States. Given a lack of similar models for how humidifiers are used, or the information needed to develop them, an analysis of the sensitivity of results to assumptions concerning humidifier use is presented. The framework is applied using network models for three actual WDSs. Simple models are developed for estimating upper bounds on the potential effects of system-wide inhalation exposures associated with showering and humidifier use. From a system-wide, population perspective, showering could result in significant inhalation doses of volatile chemical contaminants, and humidifier use could result in significant inhalation doses of microbial contaminants during a contamination event. From a system-wide perspective, showering is unlikely to be associated with significant doses of microbial contaminants. Given the potential importance of humidifiers as a source of airborne contaminants during a contamination event, an improved understanding of the nature of humidifier use is warranted.	[Davis, Michael J.] Argonne Natl Lab, Div Environm Sci, Argonne Associate Seville, 9700 S Cass Ave, Argonne, IL 60439 USA; [Janke, Robert] US EPA, Natl Homeland Secur Res Ctr, Cincinnati, OH 45268 USA; [Taxon, Thomas N.] Argonne Natl Lab, Global Secur Sci Div, 9700 S Cass Ave, Argonne, IL 60439 USA	United States Department of Energy (DOE); Argonne National Laboratory; United States Environmental Protection Agency; United States Department of Energy (DOE); Argonne National Laboratory	Davis, MJ (corresponding author), Argonne Natl Lab, Div Environm Sci, Argonne Associate Seville, 9700 S Cass Ave, Argonne, IL 60439 USA.; Janke, R (corresponding author), US EPA, Natl Homeland Secur Res Ctr, Cincinnati, OH 45268 USA.	mike_davis@anl.gov; janke.robert@epa.gov			U.S. Environmental Protection Agency through U.S. Department of Energy [DE-AC02-06CH11357]	U.S. Environmental Protection Agency through U.S. Department of Energy	Work at Argonne National Laboratory was sponsored by the U.S. Environmental Protection Agency under interagency agreement through U.S. Department of Energy Contract DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2016, CURR OPIN BIOTECH, V42, P54, DOI 10.1016/j.copbio.2016.02.034; Allmann TP., 2003, THESIS; Allmann TP, 2005, J AMERICAN WATER WOR, V97; ANDELMAN JB, 1985, SCI TOTAL ENVIRON, V47, P443, DOI 10.1016/0048-9697(85)90349-3; ANDELMAN JB, 1985, ENVIRON HEALTH PERSP, V62, P313, DOI 10.2307/3430131; Anderson WB, 2007, J WATER HEALTH, V5, P553, DOI 10.2166/wh.2007.043; Bureau of Labor Statistics, 2013, AMERICAN TIME USE SU; Burgard A, 2016, CURR OPIN BIOTECH, V42, P118, DOI 10.1016/j.copbio.2016.04.016; Carrera M, 2007, J APPL MICROBIOL, V102, P303, DOI 10.1111/j.1365-2672.2006.03111.x; Chen GQ, 2010, MICROBIOL MONOGR, V14, P121, DOI 10.1007/978-3-642-03287_5_6; Chen GQ, 2009, CHEM SOC REV, V38, P2434, DOI 10.1039/b812677c; Chen MJ, 2003, ATMOS ENVIRON, V37, P4325, DOI 10.1016/S1352-2310(03)00578-8; Chen XZ, 2013, BIOTECHNOL ADV, V31, P1200, DOI 10.1016/j.biotechadv.2013.02.009; Cheng YS, 2003, AEROSOL SCI TECH, V37, P659, DOI 10.1080/02786820300906; Choi S, 2015, METAB ENG, V28, P223, DOI 10.1016/j.ymben.2014.12.007; Cowen KA, 2006, J AIR WASTE MANAGE, V56, P1662, DOI 10.1080/10473289.2006.10464571; Davis MJ, 2008, J WATER RES PL-ASCE, V134, P449, DOI 10.1061/(ASCE)0733-9496(2008)134:5(449); Davis MJ, 2015, J WATER RES PLAN MAN, V141, DOI 10.1061/(ASCE)WR.1943-5452.0000436; Davis MJ, 2014, RISK ANAL, V34, P498, DOI 10.1111/risa.12107; Davis MJ, 2011, J WATER RES PL-ASCE, V137, P1, DOI 10.1061/(ASCE)WR.1943-5452.0000084; Du LL, 2012, INT J ENV RES PUB HE, V9, P4639, DOI 10.3390/ijerph9124639; Falkinham JO, 2015, ENVIRON HEALTH PERSP, V123, P749, DOI 10.1289/ehp.1408692; GIARDINO NJ, 1992, ENVIRON SCI TECHNOL, V26, P1602, DOI 10.1021/es00032a017; Giardino NJ, 1996, ENVIRON SCI TECHNOL, V30, P1242, DOI 10.1021/es950448d; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Gutting BW, 2015, RISK ANAL, V35, P811, DOI 10.1111/risa.12326; HIGHSMITH VR, 1988, ENVIRON SCI TECHNOL, V22, P1109, DOI 10.1021/es00174a019; HIGHSMITH VR, 1992, ENVIRON SCI TECHNOL, V26, P673, DOI 10.1021/es00028a003; Hines SA, 2014, WATER RES, V56, P203, DOI 10.1016/j.watres.2014.02.013; Hung DV, 2010, BIOSYST ENG, V107, P54, DOI 10.1016/j.biosystemseng.2010.07.001; Janke R, 2014, PROT CRIT INFRASTRUC, V2, P29, DOI 10.1007/978-3-319-01092-2_2; JO WK, 1990, RISK ANAL, V10, P581, DOI 10.1111/j.1539-6924.1990.tb00542.x; JO WK, 1990, RISK ANAL, V10, P575, DOI 10.1111/j.1539-6924.1990.tb00541.x; JOHNSTON FL, 1994, HEALTH PHYS, V67, P276, DOI 10.1097/00004032-199409000-00009; Keating GA, 1997, ATMOS ENVIRON, V31, P123, DOI 10.1016/1352-2310(96)00227-0; KEATING GA, 1993, AM SOC TEST MATER, V1205, P14, DOI 10.1520/STP13097S; Kerger BD, 2000, RISK ANAL, V20, P637, DOI 10.1111/0272-4332.205058; Khanal N, 2006, J WATER RES PLAN MAN, V132, P283, DOI 10.1061/(ASCE)0733-9496(2006)132:4(283); Kim E, 2001, J ENVIRON SCI HEAL C, V19, P387, DOI 10.1081/GNC-100107581; Kim EY, 2004, ENVIRON SCI TECHNOL, V38, P1799, DOI 10.1021/es026300t; Klise KA, 2013, J INFRASTRUCT SYST, V19, P465, DOI 10.1061/(ASCE)IS.1943-555X.0000156; LITTLE JC, 1992, ENVIRON SCI TECHNOL, V26, P1341, DOI 10.1021/es00031a010; Little JC, 1999, EXPOSURE TO CONTAMIN, P89; Markham KA, 2015, ANNU REV CHEM BIOMOL, V6, P35, DOI 10.1146/annurev-chembioeng-061114-123303; MCKONE TE, 1987, ENVIRON SCI TECHNOL, V21, P1194, DOI 10.1021/es00165a006; MCKONE TE, 1991, J AIR WASTE MANAGE, V41, P832, DOI 10.1080/10473289.1991.10466881; Moya J, 1999, ENVIRON SCI TECHNOL, V33, P2321, DOI 10.1021/es980876u; Murray R, 2006, J WATER RES PLAN MAN, V132, P293, DOI 10.1061/(ASCE)0733-9496(2006)132:4(293); Nilsson KA, 2005, J WATER RES PLAN MAN, V131, P228, DOI 10.1061/(ASCE)0733-9496(2005)131:3(228); Olin SS, 1999, EXPOSURE TO CONTAMIN; Ostfeld A, 2008, J WATER RES PLAN MAN, V134, P556, DOI 10.1061/(ASCE)0733-9496(2008)134:6(556); R Core Team (n.d.), R A LANGUAGE AND ENV; RODES C, 1990, AEROSOL SCI TECH, V13, P220, DOI 10.1080/02786829008959440; Rossman LA, 2000, REPORT NO EPA 600 R; Sain AE, 2015, ENVIRON ENG SCI, V32, P1027, DOI 10.1089/ees.2015.0238; Schijven J, 2016, WATER RES, V96, P148, DOI 10.1016/j.watres.2016.03.057; Sun J, 2015, J IND MICROBIOL BIOT, V42, P423, DOI 10.1007/s10295-014-1539-8; TANCREDE M, 1992, ATMOS ENVIRON A-GEN, V26, P1103, DOI 10.1016/0960-1686(92)90042-J; TYNDALL RL, 1995, INDOOR AIR, V5, P171, DOI 10.1111/j.1600-0668.1995.t01-1-00003.x; U.S. Environmental Protection Agency, 2012, ENERGY STAR MARKET I; U.S. EPA, 2011, REPORT NO EPA 600 R; U.S. EPA, 2016, REPORT NO EPA 600 R; U.S. EPA, 1992, REPORT NO EPA 600 Z, P18; Umezawa M, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-64; Watson JP, 2009, J INFRASTRUCT SYST, V15, P330, DOI 10.1061/(ASCE)1076-0342(2009)15:4(330); Weir MH, 2011, ENVIRON SCI TECHNOL, V45, P5828, DOI 10.1021/es200901e; WILKES CR, 1992, ATMOS ENVIRON A-GEN, V26, P2227, DOI 10.1016/0960-1686(92)90412-E; Wilkes CR, 2005, RISK ANAL, V25, P317, DOI 10.1111/j.1539-6924.2005.00592.x; Xu X, 2003, ENVIRON SCI TECHNOL, V37, P569, DOI 10.1021/es025747; Xu X, 2005, J EXPO ANAL ENV EPID, V15, P6, DOI 10.1038/sj.jea.7500374; Zhen HJ, 2014, J AEROSOL SCI, V70, P67, DOI 10.1016/j.jaerosci.2014.01.002; Zhou Y, 2007, INHAL TOXICOL, V19, P333, DOI 10.1080/08958370601144241	72	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0168051	10.1371/journal.pone.0168051	http://dx.doi.org/10.1371/journal.pone.0168051			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4OA	27930709	Green Submitted, gold, Green Published			2022-12-27	WOS:000389580900074
J	Farah, D; Nunes, J; Sartori, M; Dias, DD; Sirvente, R; Silva, MB; Fiorino, P; Morris, M; Llesuy, S; Farah, V; Irigoyen, MC; De Angelis, KT				Farah, Daniela; Nunes, Jonas; Sartori, Michelle; Dias, Danielle da Silva; Sirvente, Raquel; Silva, Maikon B.; Fiorino, Patricia; Morris, Mariana; Llesuy, Susana; Farah, Vera; Irigoyen, Maria-Claudia; De Angelis, Katia			Exercise Training Prevents Cardiovascular Derangements Induced by Fructose Overload in Developing Rats	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; OXIDATIVE STRESS; METABOLIC SYNDROME; BLOOD-PRESSURE; LIPID-PEROXIDATION; INSULIN-RESISTANCE; EXPERIMENTAL-MODEL; PHYSICAL-ACTIVITY; AUTONOMIC CONTROL; DYSFUNCTION	The risks of chronic diseases associated with the increasing consumption of fructose-laden foods are amplified by the lack of regular physical activity and have become a serious public health issue worldwide. Moreover, childhood eating habits are strongly related to metabolic syndrome in adults. Thus, we aimed to investigate the preventive role of exercise training undertaken concurrently with a high fructose diet on cardiac function, hemodynamics, cardiovascular autonomic modulation and oxidative stress in male rats after weaning. Male Wistar rats were divided into 4 groups (n = 8/group):Sedentary control (SC), Trained control (TC), Sedentary Fructose (SF) and Trained Fructose (TF). Training was performed on a treadmill (8 weeks, 40-60% of maximum exercise test). Evaluations of cardiac function, hemodynamics, cardiovascular autonomic modulation and oxidative stress in plasma and in left ventricle (LV) were performed. Chronic fructose overload induced glucose intolerance and an increase in white adipose tissue (WAT) weight, in myocardial performance index (MPI) (SF:0.42 +/- 0.04 vs. SC:0.24 +/- 0.05) and in arterial pressure (SF:122 +/- 3 vs. SC:113 +/- 1 mmHg) associated with increased cardiac and vascular sympathetic modulation. Fructose also induced unfavorable changes in oxidative stress profile (plasmatic protein oxidationSF: 3.30 +/- 0.09 vs. SC:1.45 +/- 0.08 nmol/mg prot; and LV total antioxidant capacity (TRAP)SF: 2.5 +/- 0.5 vs. SC:12.7 +/- 1.7 uM trolox). The TF group showed reduced WAT, glucose intolerance, MPI (0.35 +/- 0.04), arterial pressure (118 +/- 2mmHg), sympathetic modulation, plasmatic protein oxidation and increased TRAP when compared to SF group. Therefore, our findings indicate that cardiometabolic dysfunctions induced by fructose overload early in life may be prevented by moderate aerobic exercise training.	[Farah, Daniela; Nunes, Jonas; Fiorino, Patricia; Farah, Vera] Univ Presbiteriana Mackenzie, Lab Metab Cardiovasc & Renal Physiopharmacol, Sao Paulo, Brazil; [Farah, Daniela; Sartori, Michelle; Sirvente, Raquel; Silva, Maikon B.; Irigoyen, Maria-Claudia] Sao Paulo Univ FMUSP, Sch Med, Lab Expt Hypertens,Heart Inst INCOR, Sao Paulo, Brazil; [Sartori, Michelle; Dias, Danielle da Silva; De Angelis, Katia] Univ Nove de Julho, Lab Translat Physiol, Sao Paulo, Brazil; [Morris, Mariana] Nova Southeastern Univ, Inst Neuro Immune Med, Ft Lauderdale, FL USA; [Llesuy, Susana] Univ Buenos Aires, Dept Gen & Inorgan Chem, Buenos Aires, DF, Argentina	Universidade Presbiteriana Mackenzie; Universidade de Sao Paulo; Universidade Nove de Julho; Nova Southeastern University; University of Buenos Aires	De Angelis, KT (corresponding author), Univ Nove de Julho, Lab Translat Physiol, Sao Paulo, Brazil.	kangelis@uni9.pro.br	Farah, Vera/ABA-1171-2021; IRIGOYEN, MARIA CLAUDIA C/N-6880-2014; DE ANGELIS, KATIA/I-6098-2016; da Silva Dias, Danielle/AAN-7618-2020	Farah, Vera/0000-0002-5439-3079; IRIGOYEN, MARIA CLAUDIA C/0000-0003-2097-3662; DE ANGELIS, KATIA/0000-0002-3640-9049; da Silva Dias, Danielle/0000-0003-4152-0849; Farah, Daniela/0000-0002-9727-9460; Francisca Llesuy, Susana/0000-0001-6818-051X	CNPq [457200/2014-6, 309292/2014-0]; FAPESP [2015/11223-6, 2012/01873-5]; CAPES [88881.062178/2014-01]; CNPq Fellowship (CNPq-BPQ)	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq Fellowship (CNPq-BPQ)	This study was supported by CNPq (457200/2014-6; 309292/2014-0) and FAPESP (2015/11223-6; 2012/01873-5); CAPES (88881.062178/2014-01). Katia De Angelis and Maria-Claudia Irigoyen are recipients of CNPq Fellowship (CNPq-BPQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; ALESSIO HM, 1988, J APPL PHYSIOL, V64, P1333, DOI 10.1152/jappl.1988.64.4.1333; Amaral SL, 2000, J HYPERTENS, V18, P1563, DOI 10.1097/00004872-200018110-00006; Araujo IC, 2016, EUR J NUTR, V55, P83, DOI 10.1007/s00394-014-0826-5; Bassuk SS, 2005, J APPL PHYSIOL, V99, P1193, DOI 10.1152/japplphysiol.00160.2005; Bertagnolli M, 2006, J HYPERTENS, V24, P2437, DOI 10.1097/01.hjh.0000251905.08547.17; Bidwell AJ, 2014, MED SCI SPORT EXER, V46, P2091, DOI 10.1249/MSS.0000000000000343; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Boa BCS, 2014, MICROVASC RES, V93, P34, DOI 10.1016/j.mvr.2014.02.012; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Brito JO, 2008, BRAZ J MED BIOL RES, V41, P804, DOI 10.1590/S0100-879X2008005000030; Buege J A, 1978, Methods Enzymol, V52, P302; Camm AJ, 1996, CIRCULATION, V93, P1043; Conti FF, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-185; De Angelis K, 2012, AM J PHYSIOL-REG I, V302, pR950, DOI 10.1152/ajpregu.00450.2011; De Angelis KLD, 2000, BRAZ J MED BIOL RES, V33, P635, DOI 10.1590/S0100-879X2000000600004; DeAngelis KLD, 1997, HYPERTENSION, V30, P767, DOI 10.1161/01.HYP.30.3.767; Del Maestro R., 1985, CRC HDB METHODS OXYG, V1, P294; Duffey KJ, 2010, AM J CLIN NUTR, V92, P954, DOI 10.3945/ajcn.2010.29478; Evelson P, 2001, ARCH BIOCHEM BIOPHYS, V388, P261, DOI 10.1006/abbi.2001.2292; Farah V, 2006, AUTON NEUROSCI-BASIC, V130, P41, DOI 10.1016/j.autneu.2006.05.006; Farah VMA, 2004, PHYSIOL BEHAV, V83, P135, DOI 10.1016/j.physbeh.2004.08.004; Giacchetti G, 2000, J HYPERTENS, V18, P695, DOI 10.1097/00004872-200018060-00006; Girard A, 2006, NUTRITION, V22, P758, DOI 10.1016/j.nut.2006.05.006; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Janssen BJA, 2000, AM J PHYSIOL-REG I, V278, pR215, DOI 10.1152/ajpregu.2000.278.1.R215; Kamide K, 2002, AM J HYPERTENS, V15, P66, DOI 10.1016/S0895-7061(01)02232-4; KOKKINOS PF, 1995, NEW ENGL J MED, V333, P1462, DOI 10.1056/NEJM199511303332204; La Rovere MT, 2002, CIRCULATION, V106, P945, DOI 10.1161/01.CIR.0000027565.12764.E1; Lalande S, 2013, APPL PHYSIOL NUTR ME, V38, P545, DOI 10.1139/apnm-2012-0383; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Machi JF, 2013, EUR J APPL PHYSIOL, V113, P41, DOI 10.1007/s00421-012-2411-z; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Marriott BP, 2009, J NUTR, V139, pS1228, DOI 10.3945/jn.108.098277; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Mizuno T, 2004, INT J CARDIOL, V97, P455, DOI 10.1016/j.ijcard.2003.10.035; Moraes-Silva IC, 2013, J APPL PHYSIOL, V114, P786, DOI 10.1152/japplphysiol.00586.2012; Morris M, 2012, CLIN EXP PHARMACOL P, V39, P57, DOI 10.1111/j.1440-1681.2011.05636.x; Mostarda C, 2012, CLINICS, V67, P815, DOI 10.6061/clinics/2012(07)18; Mostarda CT, 2014, J DIABETES COMPLICAT, V28, P273, DOI 10.1016/j.jdiacomp.2013.12.005; NEGRAO CE, 1992, J APPL PHYSIOL, V72, P1749, DOI 10.1152/jappl.1992.72.5.1749; Nestorov J, 2014, NUTR RES, V34, P646, DOI 10.1016/j.nutres.2014.06.006; Quinteiro H, 2015, MENOPAUSE, V22, P534, DOI [10.1097/GME.0000000000000344, 10.1097/gme.0000000000000344]; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Rodrigues B, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-38; Sanches IC, 2009, BRAZ J MED BIOL RES, V42, P942, DOI 10.1590/S0100-879X2009001000011; Sanches IC, 2012, MENOPAUSE, V19, P562, DOI 10.1097/gme.0b013e3182358c9c; Shinozaki K, 2004, HYPERTENSION, V43, P255, DOI 10.1161/01.HYP.0000111136.86976.26; SMITH ML, 1989, MED SCI SPORT EXER, V21, P40, DOI 10.1249/00005768-198902000-00008; Thirunavukkarasu V, 2004, DIABETES OBES METAB, V6, P200, DOI 10.1111/j.1462-8902.2004.00332.x; Verma S, 1997, AM J HYPERTENS, V10, P1010, DOI 10.1016/S0895-7061(97)00107-6; Wichi R, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-14; Xu L, 1999, HORM METAB RES, V31, P278, DOI 10.1055/s-2007-978733	54	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167291	10.1371/journal.pone.0167291	http://dx.doi.org/10.1371/journal.pone.0167291			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930685	Green Submitted, Green Published, gold			2022-12-27	WOS:000389580900023
J	Jaffer, S; Valasek, P; Luke, G; Batarfi, M; Whalley, BJ; Patel, K				Jaffer, Sajjida; Valasek, Petr; Luke, Graham; Batarfi, Munirah; Whalley, Benjamin Jason; Patel, Ketan			Characterisation of Development and Electrophysiological Mechanisms Underlying Rhythmicity of the Avian Lymph Heart	PLOS ONE			English	Article							ACTIVATED INWARD CURRENT; MUSCLE; DIFFERENTIATION; MUSCULATURE; EXPRESSION; CHANNELS; BLOCKER; CELLS; CHICK; SLOW	Despite significant advances in tissue engineering such as the use of scaffolds, bioreactors and pluripotent stem cells, effective cardiac tissue engineering for therapeutic purposes has remained a largely intractable challenge. For this area to capitalise on such advances, a novel approach may be to unravel the physiological mechanisms underlying the development of tissues that exhibit rhythmic contraction yet do not originate from the cardiac lineage. Considerable attention has been focused on the physiology of the avian lymph heart, a discrete organ with skeletal muscle origins yet which displays pacemaker properties normally only found in the heart. A functional lymph heart is essential for avian survival and growth in ovo. The histological nature of the lymph heart is similar to skeletal muscle although molecular and bioelectrical characterisation during development to assess mechanisms that contribute towards lymph heart contractile rhythmicity have not been undertaken. A better understanding of these processes may provide exploitable insights for therapeutic rhythmically contractile tissue engineering approaches in this area of significant unmet clinical need. Here, using molecular and electrophysiological approaches, we describe the molecular development of the lymph heart to understand how this skeletal muscle becomes fully functional during discrete in ovo stages of development. Our results show that the lymph heart does not follow the normal transitional programme of myogenesis as documented in most skeletal muscle, but instead develops through a concurrent programme of precursor expansion, commitment to myogenesis and functional differentiation which offers a mechanistic explanation for its rapid development. Extracellular electrophysiological field potential recordings revealed that the peak-to-peak amplitude of electrically evoked local field potentials elicited from isolated lymph heart were significantly reduced by treatment with carbachol; an effect that could be fully reversed by atropine. Moreover, nifedipine and cyclopiazonic acid both significantly reduced peak-to-peak local field potential amplitude. Optical recordings of lymph heart showed that the organ's rhythmicity can be blocked by the HCN channel blocker, ZD7288; an effect also associated with a significant reduction in peak-to-peak local field potential amplitude. Additionally, we also show that isoforms of HCN channels are expressed in avian lymph heart. These results demonstrate that cholinergic signalling and L-type Ca2+ channels are important in excitation and contraction coupling, while HCN channels contribute to maintenance of lymph heart rhythmicity.	[Jaffer, Sajjida; Valasek, Petr; Luke, Graham; Batarfi, Munirah; Patel, Ketan] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Whalley, Benjamin Jason] Univ Reading, Sch Chem Food & Nutr Sci & Pharm, Reading, Berks, England; [Jaffer, Sajjida] UCL, UCL Canc Inst, London, England	University of Reading; University of Reading; University of London; University College London	Patel, K (corresponding author), Univ Reading, Sch Biol Sci, Reading, Berks, England.	ketan.patel@reading.ac.uk	Valasek, Petr/R-4567-2016	Valasek, Petr/0000-0001-9224-4560	UK Biotechnology and Biological Sciences Research Council; BBSRC [BB/J016454/1, BB/H01022X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H01022X/1, BB/J016454/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	All funding was provided by the UK Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AL R, 1960, THE AVIAN EMBRYO; Amthor H, 1998, CURR BIOL, V8, P642, DOI 10.1016/S0960-9822(98)70251-9; BISCHOF B, 1993, LYMPHOLOGY, V26, P177; Blagden CS, 1997, GENE DEV, V11, P2163, DOI 10.1101/gad.11.17.2163; BOSMITH RE, 1993, BRIT J PHARMACOL, V110, P343, DOI 10.1111/j.1476-5381.1993.tb13815.x; Brodde OE, 1999, PHARMACOL REV, V51, P651; Brucke ET UK, 1930, PFLIIG ARCH, V224, P631; BUDRAS KD, 1987, J MORPHOL, V191, P77, DOI 10.1002/jmor.1051910108; Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131; Cheng L, 2004, DEV BIOL, V274, P348, DOI 10.1016/j.ydbio.2004.07.020; DAY JB, 1963, J CELL COMPAR PHYSL, V62, P33, DOI 10.1002/jcp.1030620106; DELCASTILLO J, 1961, J CELL COMPAR PHYSL, V57, P29, DOI 10.1002/jcp.1030570106; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; McCloskey KD, 1999, J PHYSIOL-LONDON, V521, P201, DOI 10.1111/j.1469-7793.1999.00201.x; MEHRKE G, 1994, J PHARMACOL EXP THER, V271, P1483; Meissner G, 1995, BIOSCIENCE REP, V15, P399, DOI 10.1007/BF01788371; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nieto MA, 1996, METHOD CELL BIOL, V51, P219, DOI 10.1016/S0091-679X(08)60630-5; Ny A, 2005, NAT MED, V11, P998, DOI 10.1038/nm1285; OF K., 1969, EVOLUTION COMP MORPH; OLSON EN, 1992, DEV BIOL, V154, P261, DOI 10.1016/0012-1606(92)90066-P; Peyrot SM, 2010, DEV BIOL, V339, P429, DOI 10.1016/j.ydbio.2010.01.002; SATOH Y, 1983, ARCH HISTOL JAPON, V46, P115, DOI 10.1679/aohc.46.115; Tang W, 2002, FRONT BIOSCI, V7, pD1583, DOI 10.2741/tang; Terrovitis JV, 2010, CIRC RES, V106, P479, DOI 10.1161/CIRCRESAHA.109.208991; Valasek P, 2007, DEVELOPMENT, V134, P4427, DOI 10.1242/dev.004697; VONRAUTENFELD DB, 1981, LYMPHOLOGY, V14, P186; Vunjak-Noyakovic G, 2011, ANNU REV BIOMED ENG, V13, P245, DOI 10.1146/annurev-bioeng-071910-124701; WILLIAMS BA, 1994, DEVELOPMENT, V120, P785; Wilting J, 2002, FASEB J, V16, P1271, DOI 10.1096/fj.01-1010fje; Wu X, 2012, CHANNELS, V6, P438, DOI 10.4161/chan.22209; Yu X, 2007, AM J PHYSIOL-CELL PH, V292, pC1147, DOI 10.1152/ajpcell.00598.2005	35	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0166428	10.1371/journal.pone.0166428	http://dx.doi.org/10.1371/journal.pone.0166428			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930653	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000389580900010
J	Kim, MJ; Schaub, S; Molyneux, K; Koller, MT; Stampf, S; Barratt, J				Kim, Min Jeong; Schaub, Stefan; Molyneux, Karen; Koller, Michael T.; Stampf, Susanne; Barratt, Jonathan			Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy	PLOS ONE			English	Article							HUMAN MESANGIAL CELLS; IMMUNE-COMPLEXES; KAPPA-B; GLYCOSYLATION; PROGRESSION; AUTOANTIBODIES; PROLIFERATION; ANTIBODIES; CYTOKINES; SEVERITY	Galactose-deficient IgA1 (Gd-IgA1) and IgA-IgG complexes are known to play an important role in the pathogenesis of IgA nephropathy (IgAN). We aimed therefore to determine the impact of immunosuppression on the serum levels of Gd-IgA1, total IgA1 and IgA-IgG complexes in IgAN patients. In a retrospective study, serum samples from IgAN patients collected before transplantation (t(0)) and at 3- and 6-month posttransplant (t(3) & t(6)) were used to measure the levels of Gd-IgA1, total IgA1 and IgA-IgG complexes. The area under the curves (AUC) of immunosuppressants was calculated by the plot of plasma trough level or dosage of each immunosuppressant versus time and was interpreted as the extent of drug exposure. Thirty-six out of 64 IgAN patients, who underwent kidney transplantation between 2005 and 2012, were enrolled. From t0 to t3, serum Gd-IgA1 and total IgA1 decreased significantly (24.7 AU (18.6-36.1) to 17.2 (13.1-29.5) (p<0.0001); 4.1 mg/ml (3.6-5.1) to 3.4 (3.0-4.1) (p = 0.0005)), whereas IgA-IgG complexes remained similar. From t(3) to t(6), Gd-IgA1 and IgA-IgG complexes significantly increased (17.2 AU (13.1-29.5) to 23.9 (16.8-32.0) (p = 0.0143); OD 0.16 (0.06-0.31) to 0.26 (0.14-0.35) (p = 0.0242)), while total IgA1 remained similar. According to median regression analysis, AUC of prednisone t(0-6) was significantly associated with the decrease of Gd-IgA1 t(0-6) (P = 0.01) and IgA1 t(0-6) (p = 0.002), whereas AUC of tacrolimus t(0-6) was associated with the decrease of IgA1 t(0-6) (p = 0.02). AUC of prednisone t(0-3) was associated with the decrease of IgA-IgG complexes t(0-3) (p = 0.0036). The association of AUC prednisone t(0-6) with Gd-IgA1 t(0-6) remained highly significant after adjustment for other immunosuppressants (p = 0.0036). Serum levels of Gd-IgA1, total IgA1 and IgA-IgG in patients with IgAN vary according to the changing degrees of immunosuppression. The exposure to prednisone most clearly influenced the serum levels of Gd-IgA1.	[Kim, Min Jeong; Schaub, Stefan; Koller, Michael T.] Univ Basel Hosp, Clin Transplantat Immunol & Nephrol, Basel, Switzerland; [Molyneux, Karen; Barratt, Jonathan] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Koller, Michael T.; Stampf, Susanne] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, Basel, Switzerland	University of Basel; University of Leicester; University of Basel	Kim, MJ (corresponding author), Univ Basel Hosp, Clin Transplantat Immunol & Nephrol, Basel, Switzerland.	min-jeong.kim@usb.ch	Schaub, Stefan/AAL-9087-2020; Koller, Michael/AEN-1656-2022	Koller, Michael/0000-0001-5574-2341; Barratt, Jonathan/0000-0002-9063-7229	Amgen	Amgen(Amgen)	MJK was supported by research funding from Amgen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AC, 2001, KIDNEY INT, V60, P969, DOI 10.1046/j.1523-1755.2001.060003969.x; Amore A, 2001, J AM SOC NEPHROL, V12, P1862, DOI 10.1681/ASN.V1291862; Berthelot L, 2015, KIDNEY INT, V88, P815, DOI 10.1038/ki.2015.158; Berthoux F, 2012, J AM SOC NEPHROL, V23, P1579, DOI 10.1681/ASN.2012010053; Camilla R, 2011, CLIN J AM SOC NEPHRO, V6, P1903, DOI 10.2215/CJN.11571210; Chintalacharuvu SR, 2008, CLIN EXP IMMUNOL, V153, P456, DOI 10.1111/j.1365-2249.2008.03703.x; Chintalacharuvu SR, 1997, J IMMUNOL, V159, P2327; Chintalacharuvu SR, 2001, CLIN EXP IMMUNOL, V126, P326, DOI 10.1046/j.1365-2249.2001.01678.x; Coppo R, 2007, CLIN TRANSPLANT, V21, P728, DOI 10.1111/j.1399-0012.2007.00730.x; Duque N, 1997, J IMMUNOL, V159, P3474; Gharavi AG, 2008, J AM SOC NEPHROL, V19, P1008, DOI 10.1681/ASN.2007091052; Hirt-Minkowski P, 2014, TRANSPL IMMUNOL, V30, P1, DOI 10.1016/j.trim.2013.11.004; KERR MA, 1990, BIOCHEM J, V271, P285, DOI 10.1042/bj2710285; Lai KN, 2003, J AM SOC NEPHROL, V14, P3127, DOI 10.1097/01.ASN.0000095639.56212.BF; Leung JCK, 2003, NEPHROL DIAL TRANSPL, V18, P36, DOI 10.1093/ndt/18.1.36; Leung JCK, 2008, NEPHROL DIAL TRANSPL, V23, P72, DOI 10.1093/ndt/gfm581; Lv JC, 2012, J AM SOC NEPHROL, V23, P1108, DOI 10.1681/ASN.2011111112; Moldoveanu Z, 2007, KIDNEY INT, V71, P1148, DOI 10.1038/sj.ki.5002185; Moura IC, 2008, SEMIN NEPHROL, V28, P88, DOI 10.1016/j.semnephrol.2007.10.010; Novak J, 2005, KIDNEY INT, V67, P504, DOI 10.1111/j.1523-1755.2005.67107.x; Novak J, 2002, KIDNEY INT, V62, P465, DOI 10.1046/j.1523-1755.2002.00477.x; Pozzi C, 2004, J AM SOC NEPHROL, V15, P157, DOI 10.1097/01.ASN.0000103869.08096.4F; Rauen T, 2015, NEW ENGL J MED, V373, P2225, DOI 10.1056/NEJMoa1415463; Suzuki H, 2011, J AM SOC NEPHROL, V22, P1795, DOI 10.1681/ASN.2011050464; Suzuki H, 2009, J CLIN INVEST, V119, P1668, DOI 10.1172/JCI38468; Tam KY, 2009, KIDNEY INT, V75, P1330, DOI 10.1038/ki.2009.71; Tarelli E, 2004, CARBOHYD RES, V339, P2329, DOI 10.1016/j.carres.2004.07.011; Tomana M, 1999, J CLIN INVEST, V104, P73, DOI 10.1172/JCI5535; Xu LX, 2005, KIDNEY INT, V68, P167, DOI 10.1111/j.1523-1755.2005.00390.x; Zhao N, 2012, KIDNEY INT, V82, P790, DOI 10.1038/ki.2012.197	30	10	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0166830	10.1371/journal.pone.0166830	http://dx.doi.org/10.1371/journal.pone.0166830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930655	Green Published, Green Submitted, gold			2022-12-27	WOS:000389580900016
J	McMahan, RH; Porsche, CE; Edwards, MG; Rosen, HR				McMahan, Rachel H.; Porsche, Cara E.; Edwards, Michael G.; Rosen, Hugo R.			Free Fatty Acids Differentially Downregulate Chemokines in Liver Sinusoidal Endothelial Cells: Insights into Non-Alcoholic Fatty Liver Disease (vol 11, e0159217, 2016)	PLOS ONE			English	Correction																		McMahan RH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159217	1	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0168301	10.1371/journal.pone.0168301	http://dx.doi.org/10.1371/journal.pone.0168301			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930747	gold, Green Published, Green Submitted			2022-12-27	WOS:000389580900085
J	Wilfart, A; Espagnol, S; Dauguet, S; Tailleur, A; Gac, A; Garcia-Launay, F				Wilfart, Aurelie; Espagnol, Sandrine; Dauguet, Sylvie; Tailleur, Aurelie; Gac, Armelle; Garcia-Launay, Florence			ECOALIM: A Dataset of Environmental Impacts of Feed Ingredients Used in French Animal Production	PLOS ONE			English	Article							LIFE-CYCLE ASSESSMENT; PRODUCTION SYSTEMS; DISTILLERS GRAINS; FARMING SYSTEMS; CHICKEN SYSTEMS; UNITED-KINGDOM; ENERGY VALUE; SCENARIOS; SOLUBLES; DIETS	Feeds contribute highly to environmental impacts of livestock products. Therefore, formulating low-impact feeds requires data on environmental impacts of feed ingredients with consistent perimeters and methodology for life cycle assessment (LCA). We created the ECOALIM dataset of life cycle inventories (LCIs) and associated impacts of feed ingredients used in animal production in France. It provides several perimeters for LCIs (field gate, storage agency gate, plant gate and harbour gate) with homogeneously collected data from French R&D institutes covering the 2005-2012 period. The dataset of environmental impacts is available as a Microsoft (R) Excel spreadsheet on the ECOALIM website and provides climate change, acidification, eutrophication, non-renewable and total cumulative energy demand, phosphorus demand, and land occupation. LCIs in the ECOALIM dataset are available in the AGRIBALYSE (R) database in SimaPro (R) software. The typology performed on the dataset classified the 149 average feed ingredients into categories of low impact (co-products of plant origin and minerals), high impact (feed-use amino acids, fats and vitamins) and intermediate impact (cereals, oilseeds, oil meals and protein crops). Therefore, the ECOALIM dataset can be used by feed manufacturers and LCA practitioners to investigate formulation of low-impact feeds. It also provides data for environmental evaluation of feeds and animal production systems. Included in AGRIBALYSE (R) database and SimaPro (R), the ECOALIM dataset will benefit from their procedures for maintenance and regular updating. Future use can also include environmental labelling of commercial products from livestock production.	[Wilfart, Aurelie] INRA, UMR SAS, Agrocampus Ouest, Rennes, France; [Espagnol, Sandrine] Inst Porc, IFIP, Le Rheu, France; [Dauguet, Sylvie] Terres Inovia, Pessac, France; [Tailleur, Aurelie] ARVALIS Inst Vegetal, La Chapelle St Sauveur, France; [Gac, Armelle] Inst Elevage, Monvoisin, Le Rheu, France; [Garcia-Launay, Florence] INRA, UMR PEGASE, Agrocampus Ouest, St Gilles, France	INRAE; Institut Agro; Agrocampus Ouest; INRAE; Institut Agro; Agrocampus Ouest	Wilfart, A (corresponding author), INRA, UMR SAS, Agrocampus Ouest, Rennes, France.	aurelie.wilfart@inra.fr	wilfart, Aurelie/A-7502-2009; SAS, ASAE UMR/M-4978-2013; Garcia-Launay, Florence/G-7197-2012	wilfart, Aurelie/0000-0002-3593-0334; SAS, ASAE UMR/0000-0001-6346-7845; Garcia-Launay, Florence/0000-0001-7015-4433	French Ministry of Agriculture (CASDAR partenariat et innovation); French Environment & Energy Management Agency (ADEME REACCTIF) [1260C0061]	French Ministry of Agriculture (CASDAR partenariat et innovation); French Environment & Energy Management Agency (ADEME REACCTIF)	The dataset described in this article was developed in the ECOALIM project, funded by the French Ministry of Agriculture (CASDAR partenariat et innovation-2012) and the French Environment & Energy Management Agency (ADEME REACCTIF-2012, 1260C0061).	Agreste, 2006, ENQ PRAT CULT; [Anonymous], 2014, FEED GRAINS YB TABL; [Anonymous], 2013, GREENHOUSE GAS EMISS; [Anonymous], 2010, QUICK STATS; [Anonymous], 2014, FARM FIN CROP PROD P; [Anonymous], 2015, SIMAPRO DATABASE MAN; [Anonymous], 2007, THESIS; [Anonymous], 2013, FAOSTAT PROD STAT; Auguie B, 2017, GRIDEXTRA MISCELLANE; Basset-Mens C, 2005, AGR ECOSYST ENVIRON, V105, P127, DOI 10.1016/j.agee.2004.05.007; Bertoluci G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150617; BILLEN G, 2015, ENV RES LETT, V10; Boggia A, 2010, WORLD POULTRY SCI J, V66, P95, DOI 10.1017/S0043933910000103; Boissy J, 2011, AQUACULTURE, V321, P61, DOI 10.1016/j.aquaculture.2011.08.033; Colomb V, 2016, 10 INT C LIF CYCL AS; COMIFER, 2001, DIAGN RISG PROP GEST; Cozannet P, 2010, POULTRY SCI, V89, P2230, DOI 10.3382/ps.2010-00833; Cozannet P, 2010, J ANIM SCI, V88, P2382, DOI 10.2527/jas.2009-2510; da Silva VP, 2014, J ENVIRON MANAGE, V133, P222, DOI 10.1016/j.jenvman.2013.12.011; da Silva VP, 2010, J ENVIRON MANAGE, V91, P1831, DOI 10.1016/j.jenvman.2010.04.001; Dalgaard R, 2008, INT J LIFE CYCLE ASS, V13, P240, DOI 10.1065/lca2007.06.342; de Vries M, 2010, LIVEST SCI, V128, P1, DOI 10.1016/j.livsci.2009.11.007; Dourmad JY, 2014, ANIMAL, V8, P2027, DOI 10.1017/S1751731114002134; Durlinger B., 2014, Proceedings of the 9th International Conference on Life Cycle Assessment in the Agri-Food Sector (LCA Food 2014), San Francisco, California, USA, 8-10 October, 2014, P310; EMEP/EEA, 2013, 12 EMEPEEA; EN ISO 14040, 2006, 14040 EN ISO; FAO, 2010, GREENHOUSE GAS EMISS; Food and Agriculture Organization (FAO), 2011, WORLD LIV 2011 LIV F, DOI DOI 10.1080/; FOSTER GR, 2005, REVISED UNIVERSAL SO; Freiermuth R., 2006, MODELL BERECHNUNG SC; Garcia-Launay F, 2014, LIVEST SCI, V161, P158, DOI 10.1016/j.livsci.2013.11.027; Garcia-Launay F, 2016, 10 INT C LIF CYCL AS; Gerber P.J., 2013, TACKLING CLIMATE CHA, P139; IPCC, 2006, IPCC GUID NAT GREENH, V4, P87; JRC, 2012, CHAR FACT ILCD REC L; Koch P, 2015, AGRIBALYSE R METHODO; Leinonen I, 2012, POULTRY SCI, V91, P26, DOI 10.3382/ps.2011-01635; Leinonen I, 2012, POULTRY SCI, V91, P8, DOI 10.3382/ps.2011-01634; Marinussen M, 2010, BLONK MILIEU ADVIES; Meul M, 2012, LIVEST SCI, V149, P215, DOI 10.1016/j.livsci.2012.07.012; Monteiro ANTR, 2016, J ANIMAL SC IN PRESS; Nemecek T, 2007, V20 SWISS CTR LIF CY; Nguyen TTH, 2012, J CLEAN PROD, V28, P215, DOI 10.1016/j.jclepro.2011.06.029; Nguyen TLT, 2010, J CLEAN PROD, V18, P756, DOI 10.1016/j.jclepro.2009.12.023; Roder M, 2014, ENVIRON SCI POLICY, V39, P13, DOI 10.1016/j.envsci.2014.02.002; SOGREAH, 2007, BIL FLUX CONT ENTR S; State Statistics Service of Ukraine, 2012, AGR UKR STAT YB; Steinfeld H., 2006, LIVESTOCKS LONG SHAD, DOI [10.1890/1540-9295(2007)5[4:D]2.0.CO;2, DOI 10.1890/1540-9295(2007)5[4:D]2.0.CO;2]; Tailleur A, 2012, P 8 INT C LIF CYCL A, P903; van der Werf HMG, 2002, AGR ECOSYST ENVIRON, V93, P131, DOI 10.1016/S0167-8809(01)00354-1; Weidema B, 2013, ECOINVENT DATABASE O; Zanten HHE, 2013, INT J LIFE CYCLE ASS, V19, P79	52	46	48	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167343	10.1371/journal.pone.0167343	http://dx.doi.org/10.1371/journal.pone.0167343			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930682	Green Published, Green Submitted, gold			2022-12-27	WOS:000389580900025
J	Yang, J; Saggiomo, V; Velders, AH; Stuart, MAC; Kamperman, M				Yang, Juan; Saggiomo, Vittorio; Velders, Aldrik H.; Stuart, Martien A. Cohen; Kamperman, Marleen			Reaction Pathways in Catechol/Primary Amine Mixtures: A Window on Crosslinking Chemistry	PLOS ONE			English	Article							COFACTOR; PROTEINS	Catechol chemistry is used as a crosslinking tool abundantly in both natural organisms (e.g. mussels, sandcastle worms) and synthetic systems to achieve the desired mechanical properties. Despite this abundance and success, the crosslinking chemistry is still poorly understood. In this study, to simplify the system, yet to capture the essential chemistry, model compounds 4-methyl catechol and propylamine are used. The reaction of 4-methyl catechol (2 mM) with propylamine (6 mM) is carried out in the presence of NaIO4 (2 mM) in 10 mM Na2CO3 aqueous solution. A variety of spectroscopic/spectrometric and chromatographic methods such as H-1 NMR, LC-MS, and UV-VIS are used to track the reaction and identify the products/intermediates. It is found that the crosslinking chemistry of a catechol and an amine is both fast and complicated. Within five minutes, more than 60 products are formed. These products encompass 19 different masses ranging from molecular weight of 179 to 704. By combining time-dependent data, it is inferred that the dominant reaction pathways: the majority is formed via aryloxyl-phenol coupling and Michael-type addition, whereas a small fraction of products is formed via Schiff base reactions.	[Yang, Juan; Stuart, Martien A. Cohen; Kamperman, Marleen] Wageningen Univ, Lab Phys Chem & Soft Matter, Wageningen, Netherlands; [Saggiomo, Vittorio; Velders, Aldrik H.] Wageningen Univ, Lab BioNanoTechnol, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Kamperman, M (corresponding author), Wageningen Univ, Lab Phys Chem & Soft Matter, Wageningen, Netherlands.	marleen.kamperman@wur.nl	v, a/ABA-6163-2021; Kamperman, Marleen/O-1810-2016; Saggiomo, Vittorio/AAE-5715-2019	Kamperman, Marleen/0000-0002-0520-4534; saggiomo, vittorio/0000-0001-7196-602X; Velders, Aldrik/0000-0002-6925-854X	AkzoNobel Global; AkzoNobel	AkzoNobel Global; AkzoNobel	The study was funded by AkzoNobel Global (http://www.akzonobel.com/our_key_market/our_business_areas/decorative_paints/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the funding support from AkzoNobel. J. Yang would like to dedicate this work to her newborn baby, Yiran Ni, and wish him all the best in his forthcoming life!	Akagawa M, 2001, BIOCHEM BIOPH RES CO, V281, P193, DOI 10.1006/bbrc.2001.4315; Bittner S, 2006, AMINO ACIDS, V30, P205, DOI 10.1007/s00726-005-0298-2; Burzio LA, 2000, BIOCHEMISTRY-US, V39, P11147, DOI 10.1021/bi0002434; Faure E, 2012, ADV FUNCT MATER, V22, P5271, DOI 10.1002/adfm.201201106; Floriolli RY, 2000, MAR BIOTECHNOL, V2, P352; Haemers S, 2003, BIOMACROMOLECULES, V4, P632, DOI 10.1021/bm025707n; HOLL SM, 1993, ARCH BIOCHEM BIOPHYS, V302, P255, DOI 10.1006/abbi.1993.1207; Kramer KJ, 2001, TETRAHEDRON, V57, P385, DOI 10.1016/S0040-4020(00)00949-2; Land EJ, 2003, ACCOUNTS CHEM RES, V36, P300, DOI 10.1021/ar020062p; Lee BP, 2002, BIOMACROMOLECULES, V3, P1038, DOI 10.1021/bm025546n; Liu B, 2006, J AM CHEM SOC, V128, P15228, DOI 10.1021/ja065794h; Miserez A, 2008, SCIENCE, V319, P1816, DOI 10.1126/science.1154117; Miserez A, 2010, J BIOL CHEM, V285, P38115, DOI 10.1074/jbc.M110.161174; Mure M, 2003, J AM CHEM SOC, V125, P6113, DOI 10.1021/ja0214274; Smith A. M, 2006, BIOL ADHESIVES; Sorrell T. N., 2005, ORGANIC CHEM; Wang SX, 1996, SCIENCE, V273, P1078, DOI 10.1126/science.273.5278.1078; Wu JJ, 2011, LANGMUIR, V27, P13684, DOI 10.1021/la2027237; Yang JJ, 2016, J CHEM-NY, V2016, DOI 10.1155/2016/9761706; Yang J, 2014, CHEM SOC REV, V43, P8271, DOI 10.1039/c4cs00185k; Yu J, 2011, NAT CHEM BIOL, V7, P588, DOI [10.1038/NCHEMBIO.630, 10.1038/nchembio.630]; Yu ME, 1998, MACROMOLECULES, V31, P4739, DOI 10.1021/ma980268z; Zhao H, 2005, BIOCHEMISTRY-US, V44, P15915, DOI 10.1021/bi051530g	23	54	54	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0166490	10.1371/journal.pone.0166490	http://dx.doi.org/10.1371/journal.pone.0166490			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930671	Green Published, Green Submitted, gold			2022-12-27	WOS:000389580900011
J	Choi, DJ; Yoon, CH; Lee, H; Ahn, SY; Oh, KJ; Park, HY; Lee, HY; Cho, MC; Chung, IM; Shin, MS; Park, SJ; Shim, CY; Han, SW; Chae, IH				Choi, Dong-Ju; Yoon, Chang-Hwan; Lee, Heesun; Ahn, So-Yeon; Oh, Kyung Joon; Park, Hyun-Young; Lee, Hea Young; Cho, Myeong Chan; Chung, Ick-Mo; Shin, Mi-Seung; Park, Sung-Ji; Shim, Chi Young; Han, Seong Woo; Chae, In-Ho			The Association of Family History of Premature Cardiovascular Disease or Diabetes Mellitus on the Occurrence of Gestational Hypertensive Disease and Diabetes	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PREGNANCY COMPLICATIONS; NURSES HEALTH; RISK-FACTORS; WOMEN; PREECLAMPSIA; COHORT; PREVENTION; PREVALENCE; CHILDREN	Background Gestational hypertensive diseases (GHD) and gestational diabetes mellitus (GDM) increase the risk of cardiovascular disease (CVD) later in life. However, the association between gestational medical diseases and familial history of CVD has not been investigated to date. In the present study, we examined the association between familial history of CVD and GHD or GDM via reliable questionnaires in a large cohort of registered nurses. Methods The Korean Nurses' Survey was conducted through a web-based computer-assisted self-interview, which was developed through consultation with cardiologists, gynecologists, and statisticians. We enrolled a total of 9,989 female registered nurses who reliably answered the questionnaires including family history of premature CVD (FHpCVD), hypertension (FHH), and diabetes mellitus (FHDM) based on their medical knowledge. Either multi-variable logistic regression analysis or generalized estimation equation was used to clarify the effect of positive family histories on GHD and GDM in subjects or at each repeated pregnancy in an individual. Results In this survey, 3,695 subjects had at least 1 pregnancy and 8,783 cumulative pregnancies. Among them, 247 interviewees (6.3%) experienced GHD and 120 (3.1%) experienced GDM. In a multivariable analysis adjusted for age, obstetric, and gynecologic variables, age at the first pregnancy over 35 years (adjusted OR 1.61, 95% CI 1.02-2.43) and FHpCVD (adjusted OR 1.60, 95% CI 1.16-2.22) were risk factors for GHD in individuals, whereas FHH was not. FHDM and history of infertility therapy were risk factors for GDM in individuals (adjusted OR 2.68, 95% CI 1.86-3.86; 1.84, 95% CI 1.05-3.23, respectively). In any repeated pregnancies in an individual, age at the current pregnancy and at the first pregnancy, and FHpCVD were risk factors for GHD, while age at the current pregnancy, history of infertility therapy, and FHDM were risk factors for GDM. Conclusions The FHpCVD and FHDM are significantly associated with GHD and GDM, respectively. Meticulous family histories should be obtained, and women with family histories of these conditions should be carefully monitored during pregnancy.	[Choi, Dong-Ju; Yoon, Chang-Hwan; Lee, Heesun; Chae, In-Ho] Seoul Natl Univ, Cardiovasc Ctr, Bundang Hosp, Seongnam, South Korea; [Ahn, So-Yeon] Seoul Natl Univ, MRCC, Bundang Hosp, Seongnam, South Korea; [Oh, Kyung Joon] Seoul Natl Univ, Dept Obstet & Gynecol, Bundang Hosp, Seongnam, South Korea; [Park, Hyun-Young] Natl Inst Hlth, Ctr Biomed Sci, Div Cardiovasc & Rare Dis, Chungbuk, South Korea; [Lee, Hea Young] Korean Nurses Assoc, Seoul, South Korea; [Cho, Myeong Chan] Chungbuk Natl Univ, Dept Internal Med, Chungbuk, South Korea; [Chung, Ick-Mo] Ewha Womans Univ, Sch Med, Div Cardiol, Seoul, South Korea; [Shin, Mi-Seung] Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Cardiol, Inchon, South Korea; [Park, Sung-Ji] Sungkyunkwan Univ, Sch Med, Div Cardiol, Cardiovasc Imaging Ctr,Heart Vasc Stroke Inst,Sam, Seoul, South Korea; [Shim, Chi Young] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Seoul, South Korea; [Han, Seong Woo] Dongtan Sacred Heart Hosp, Dept Cardiovasc Med, Hwaseong, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Chungbuk National University; Ewha Womans University; Gachon University; Sungkyunkwan University (SKKU); Yonsei University	Yoon, CH (corresponding author), Seoul Natl Univ, Cardiovasc Ctr, Bundang Hosp, Seongnam, South Korea.	kunson2@snu.ac.kr	Shim, Chi Young/AAK-1057-2021	Shim, Chi Young/0000-0002-6136-0136; Oh, Kyung Joon/0000-0002-4558-7947	Research of Korea Centers for Disease Control and Prevention [2011-E63009-00]; Industrial Strategic Technology Development Program [10052980]; Ministry of Trade, Industry & Energy of Korea	Research of Korea Centers for Disease Control and Prevention; Industrial Strategic Technology Development Program; Ministry of Trade, Industry & Energy of Korea	This research was supported by a grant (2011-E63009-00) by the Research of Korea Centers for Disease Control and Prevention. Chang-Hwan Yoon is supported by the Industrial Strategic Technology Development Program, 10052980, Development of microbiorobotic systems for surgical treatment of chronic total occlusion, funded by the Ministry of Trade, Industry & Energy of Korea.	Anand SS, 2008, EUR HEART J, V29, P932, DOI 10.1093/eurheartj/ehn018; Ananth CV, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6564; Anna V, 2008, DIABETES CARE, V31, P2288, DOI 10.2337/dc08-1038; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Ben-Haroush A, 2004, DIABETIC MED, V21, P103, DOI 10.1046/j.1464-5491.2003.00985.x; Carr DB, 2006, DIABETES CARE, V29, P2078, DOI 10.2337/dc05-2482; Chambers JC, 2001, JAMA-J AM MED ASSOC, V285, P1607, DOI 10.1001/jama.285.12.1607; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; De Sutter J, 2003, EUR HEART J, V24, P249, DOI 10.1016/S0195-668X(02)00386-X; Fraser A, 2012, CIRCULATION, V125, P1367, DOI 10.1161/CIRCULATIONAHA.111.044784; Geelhoed JJM, 2010, CIRCULATION, V122, P1192, DOI 10.1161/CIRCULATIONAHA.110.936674; Gunderson EP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000490; Hunt KJ, 2007, OBSTET GYN CLIN N AM, V34, P173, DOI 10.1016/j.ogc.2007.03.002; LIPNICK RJ, 1986, JAMA-J AM MED ASSOC, V255, P58, DOI 10.1001/jama.255.1.58; McDonald SD, 2008, AM HEART J, V156, P918, DOI 10.1016/j.ahj.2008.06.042; Michels KB, 1998, CIRCULATION, V97, P1540, DOI 10.1161/01.CIR.97.16.1540; Mosca Lori, 2004, J Am Coll Cardiol, V43, P900, DOI 10.1016/j.jacc.2004.02.001; Qiu CF, 2003, HYPERTENSION, V41, P408, DOI 10.1161/01.HYP.0000056996.25503.F5; Rodie VA, 2004, ATHEROSCLEROSIS, V175, P189, DOI 10.1016/j.atherosclerosis.2004.01.038; Romundstad PR, 2010, CIRCULATION, V122, P579, DOI 10.1161/CIRCULATIONAHA.110.943407; Shah BR, 2008, DIABETES CARE, V31, P1668, DOI 10.2337/dc08-0706; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Ye C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100180	27	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2016	11	12							e0167528	10.1371/journal.pone.0167528	http://dx.doi.org/10.1371/journal.pone.0167528			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MR	27918585	Green Submitted, Green Published, gold			2022-12-27	WOS:000389577100013
J	Quentmeier, H; Drexler, HG; Hauer, V; MacLeod, RAF; Pommerenke, C; Uphoff, CC; Zaborski, M; Berglund, M; Enblad, G; Amini, RM				Quentmeier, Hilmar; Drexler, Hans G.; Hauer, Vivien; MacLeod, Roderick A. F.; Pommerenke, Claudia; Uphoff, Cord C.; Zaborski, Margarete; Berglund, Mattias; Enblad, Gunilla; Amini, Rose-Marie			Diffuse Large B Cell Lymphoma Cell Line U2946: Model for MCL1 Inhibitor Testing	PLOS ONE			English	Article							GENECHIP DATA; EXPRESSION; SUBGROUPS; ABT-199; CLASSIFICATION; TRANSLOCATIONS; IMMUNOGLOBULIN	Diffuse large B cell lymphoma (DLBCL) is the most common form of non-Hodgkin lymphoma worldwide. We describe the establishment and molecular characteristics of the DLBCL cell line U-2946. This cell line was derived from a 52-year-old male with DLBCL. U-2946 cells carried the chromosomal translocation t(8; 14) and strongly expressed MYC, but not the mature B-cell lymphoma associated oncogenes BCL2 and BCL6. Instead, U-2946 cells expressed the antiapoptotic BCL2 family member MCL1 which was highly amplified genomically (14n). MCL1 amplification is recurrent in DLBCL, especially in the activated B cell (ABC) variant. Results of microarray expression cluster analysis placed U-2946 together with ABC-, but apart from germinal center (GC)-type DLBCL cell lines. The 1q21.3 region including MCL1 was focally coamplified with a short region of 17p11.2 (also present at 14n). The MCL1 inhibitor A-1210477 triggered apoptosis in U-2946 (MCL1(pos)/BCL2(neg)) cells. In contrast to BCL2(pos) DLBCL cell lines, U-2946 did not respond to the BCL2 inhibitor ABT-263. In conclusion, the novel characteristics of cell line U-2946 renders it a unique model system to test the function of small molecule inhibitors, especially when constructing a panel of DLBCL cell lines expressing broad combinations of antiapoptotic BCL2-family members.	[Quentmeier, Hilmar; Drexler, Hans G.; Hauer, Vivien; MacLeod, Roderick A. F.; Pommerenke, Claudia; Uphoff, Cord C.; Zaborski, Margarete] Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany; [Berglund, Mattias; Enblad, Gunilla; Amini, Rose-Marie] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Berglund, Mattias; Enblad, Gunilla; Amini, Rose-Marie] Univ Uppsala Hosp, Uppsala, Sweden	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Uppsala University; Uppsala University; Uppsala University Hospital	Quentmeier, H (corresponding author), Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany.	hqu@dsmz.de						Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; CABANILLAS F, 1987, J CLIN ONCOL, V5, P407, DOI 10.1200/JCO.1987.5.3.407; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Ding J, 2015, HAEMATOLOGICA, V100, P801, DOI 10.3324/haematol.2014.120048; Drexler HG, 2016, LEUKEMIA LYMPHOMA, V57, P1015, DOI 10.3109/10428194.2015.1108414; Drexler HG, 2011, METHODS MOL BIOL, V731, P181, DOI 10.1007/978-1-61779-080-5_16; Drexler HG, 2005, DRUG DISCOV TODAY DI, V2, P51; Drexler HG, 2010, GUIDE LEUKEMIA LYMPH; FARRUGIA MM, 1994, BLOOD, V83, P191; Fridberg M, 2007, LEUKEMIA LYMPHOMA, V48, P2221, DOI 10.1080/10428190701636443; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Herlaar E, 1999, MOL MED TODAY, V5, P439, DOI 10.1016/S1357-4310(99)01544-0; Klanova M, 2016, CLIN CANCER RES, V22, P1138, DOI 10.1158/1078-0432.CCR-15-1191; Laursen MB, 2014, EXP HEMATOL, V42, P927, DOI 10.1016/j.exphem.2014.07.263; Lenz G, 2007, J EXP MED, V204, P633, DOI 10.1084/jem.20062041; Leverson JD, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.561; Li L, 2015, LEUKEMIA, V29, P1702, DOI 10.1038/leu.2015.99; MacLeod RAF, 2007, NAT PROTOC, V2, P372, DOI 10.1038/nprot.2007.29; MacLeod RAF, 2011, METHODS MOL BIOL, V731, P57, DOI 10.1007/978-1-61779-080-5_6; Monni O, 1997, BLOOD, V90, P1168, DOI 10.1182/blood.V90.3.1168.1168_1168_1174; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Palanisamy N, 2002, GENE CHROMOSOME CANC, V33, P114, DOI 10.1002/gcc.10016; Pasqualucci L, 2014, CANCER CELL, V25, P132, DOI 10.1016/j.ccr.2013.12.012; Phillips DC, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.88; PICHERT G, 1992, ANN ONCOL, V3, P645, DOI 10.1093/oxfordjournals.annonc.a058295; Quentmeier H, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-3; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Ruminy P, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.84.84; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Swerdlow SH, 2008, WHO CLASSIFICATION T; Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Visco C, 2012, LEUKEMIA, V26, P2103, DOI 10.1038/leu.2012.83; Wenzel SS, 2013, LEUKEMIA, V27, P1381, DOI 10.1038/leu.2012.367	38	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167599	10.1371/journal.pone.0167599	http://dx.doi.org/10.1371/journal.pone.0167599			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907212	gold, Green Submitted, Green Published			2022-12-27	WOS:000389482700210
J	Carton, D; Nitsch, V; Meinzer, D; Wollherr, D				Carton, Daniel; Nitsch, Verena; Meinzer, Dominik; Wollherr, Dirk			Towards Assessing the Human Trajectory Planning Horizon	PLOS ONE			English	Article							COLLISION-AVOIDANCE; OBSTACLE AVOIDANCE; LOCOMOTION; MOVEMENT; DYNAMICS; STEP; PATH; ARM	Mobile robots are envisioned to cooperate closely with humans and to integrate seamlessly into a shared environment. For locomotion, these environments resemble traversable areas which are shared between multiple agents like humans and robots. The seamless integration of mobile robots into these environments requires accurate predictions of human locomotion. This work considers optimal control and model predictive control approaches for accurate trajectory prediction and proposes to integrate aspects of human behavior to improve their performance. Recently developed models are not able to reproduce accurately trajectories that result from sudden avoidance maneuvers. Particularly, the human locomotion behavior when handling disturbances from other agents poses a problem. The goal of this work is to investigate whether humans alter their trajectory planning horizon, in order to resolve abruptly emerging collision situations. By modeling humans as model predictive controllers, the influence of the planning horizon is investigated in simulations. Based on these results, an experiment is designed to identify, whether humans initiate a change in their locomotion planning behavior while moving in a complex environment. The results support the hypothesis, that humans employ a shorter planning horizon to avoid collisions that are triggered by unexpected disturbances. Observations presented in this work are expected to further improve the generalizability and accuracy of prediction methods based on dynamic models.	[Carton, Daniel; Meinzer, Dominik; Wollherr, Dirk] Tech Univ Munich, Chair Automat Control Engn, Theresienstr 90, D-80333 Munich, Germany; [Nitsch, Verena] Univ Bundeswehr Munchen, Human Factors Inst, Werner Heisenberg Weg 39, D-85577 Neubiberg, Germany	Technical University of Munich; Bundeswehr University Munich	Carton, D (corresponding author), Tech Univ Munich, Chair Automat Control Engn, Theresienstr 90, D-80333 Munich, Germany.	dc@tum.de	Wollherr, Dirk/C-3925-2011	Wollherr, Dirk/0000-0003-2810-6790	ERC Advanced Grant SHRINE [267877]; Technische Universitat Munchen - Institute for Advanced Study; German Excellence Initiative	ERC Advanced Grant SHRINE; Technische Universitat Munchen - Institute for Advanced Study; German Excellence Initiative	This work is supported in part within the ERC Advanced Grant SHRINE Agreement No. 267877 (www.shrine-project.eu) and in part by the Technische Universitat Munchen - Institute for Advanced Study (www.tum-ias.de), funded by the German Excellence Initiative.	Ahmadi-Pajouh MA, 2007, MED HYPOTHESES, V68, P1411, DOI 10.1016/j.mehy.2006.06.060; Albrecht S, 2012, INT C MATH MOD, P158; Allgower F., 1999, Advances in Control. Highlights of ECC'99, P391; Arechavaleta G., 2006, PROCEEDING IEEERAS E, P158, DOI [DOI 10.1109/BIOROB.2006.1639077, 10.1109/BIOROB.2006.1639077, DOI 10.1109/BI0R0B.2006.1639077]; Arechavaleta G, 2008, IEEE T ROBOT, V24, P5, DOI 10.1109/TRO.2008.915449; Bascetta L, 2011, IEEE INT C INT ROBOT, P2971, DOI 10.1109/IROS.2011.6048287; Basili P, 2013, GAIT POSTURE, V37, P385, DOI 10.1016/j.gaitpost.2012.08.003; Bitgood S, 2006, ENVIRON BEHAV, V38, P394, DOI 10.1177/0013916505280081; Buss M., 1999, Advances in Control. Highlights of ECC'99, P65; Carton D, 2012, INT S EXP ROB, P199, DOI [DOI 10.1007/978-3-319-00065-7_15, 10.1007/978-3-319-00065-7_15]; Dragan A., 2013, ROBOTICS SCI SYSTEMS, DOI [10.15607/RSS.2013.IX.024, DOI 10.15607/RSS.2013.IX.024]; Elnager A, 2001, 2001 IEEE INTERNATIONAL SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN ROBOTICS AND AUTOMATION, P414, DOI 10.1109/CIRA.2001.1013236; Fajen BR, 2003, J EXP PSYCHOL HUMAN, V29, P343, DOI 10.1037/0096-1523.29.2.343; Ferrer G, 2011, ACMIEEE INT CONF HUM, P135, DOI 10.1145/1957656.1957698; Fink PW, 2007, ACM T APPL PERCEPT, V4, DOI 10.1145/1227134.1227136; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Goffman E., 1971, RELATIONS PUBLIC MIC; Hicheur H, 2005, EXP BRAIN RES, V162, P145, DOI 10.1007/s00221-004-2122-8; Hicheur H, 2007, EUR J NEUROSCI, V26, P2376, DOI 10.1111/j.1460-9568.2007.05836.x; Hoogendoorn S, 2003, OPTIM CONTR APPL MET, V24, P153, DOI 10.1002/oca.727; Houska B, 2011, OPTIM CONTR APPL MET, V32, P298, DOI 10.1002/oca.939; Huber M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089589; Kaelbling LP, 1996, J ARTIF INTELL RES, V4, P237, DOI 10.1613/jair.301; Karamouzas I, 2010, LECT NOTES ARTIF INT, V6356, P180, DOI 10.1007/978-3-642-15892-6_19; Kruse T, 2014, ACMIEEE INT CONF HUM, P350, DOI 10.1145/2559636.2559662; Kruse T, 2012, 2012 IEEE WORKSHOP ON ADVANCED ROBOTICS AND ITS SOCIAL IMPACTS (ARSO), P83, DOI 10.1109/ARSO.2012.6213404; Kuderer M., 2012, ROBOTICS SCI SYSTEMS; Lasota PA, 2015, HUM FACTORS, V57, P21, DOI 10.1177/0018720814565188; Lefevre S, 2014, ROBOMECH J, V1, P1, DOI [DOI 10.1186/S40648-014-0001-Z, 10.1186/s40648-014-0001-z]; Mainprice J, 2015, IEEE INT CONF ROBOT, P885, DOI 10.1109/ICRA.2015.7139282; Mombaur K, 2010, AUTON ROBOT, V28, P369, DOI 10.1007/s10514-009-9170-7; Moussaid M, 2011, P NATL ACAD SCI USA, V108, P6884, DOI 10.1073/pnas.1016507108; Nilsson NJ, 1984, SHAKEY THE ROBOT, P325; Olivier AH, 2013, GAIT POSTURE, V38, P751, DOI 10.1016/j.gaitpost.2013.03.017; Olivier AH, 2012, GAIT POSTURE, V36, P399, DOI 10.1016/j.gaitpost.2012.03.021; OLSON PL, 1986, HUM FACTORS, V28, P91, DOI 10.1177/001872088602800110; Ondrej J, 2010, ACM T GRAPHIC, V29, DOI 10.1145/1778765.1778860; Papadopoulos AV, 2013, IEEE INT C INT ROBOT, P1676, DOI 10.1109/IROS.2013.6696574; Papadopoulos AV, 2014, IFAC P, V47, P12299, DOI [10.3182/20140824-6-ZA-1003.01898, DOI 10.3182/20140824-6-ZA-1003.01898]; Patla AE, 2003, EXP BRAIN RES, V148, P133, DOI 10.1007/s00221-002-1246-y; Pham QC, 2009, J NEUROPHYSIOL, V102, P2800, DOI 10.1152/jn.00284.2009; Puydupin-Jamin AS, 2012, IEEE INT CONF ROBOT, P531, DOI 10.1109/ICRA.2012.6225317; Reich BD, 1997, IRCS TECHNICAL REPOR, P51; Schulz D, 2001, IEEE INT CONF ROBOT, P1665, DOI 10.1109/ROBOT.2001.932850; Sparrow WA, 1998, PSYCHON B REV, V5, P173, DOI 10.3758/BF03212943; Stuart S, 2014, WORLD C INT SOC POST; Tastan B, 2011, PERVASIVE MOB COMPUT, V7, P319, DOI 10.1016/j.pmcj.2011.02.003; Vielledent S, 2001, NEUROSCI LETT, V305, P65, DOI 10.1016/S0304-3940(01)01798-0; Weinrich C, 2013, IEEE INT CONF ROBOT, P376, DOI 10.1109/ICRA.2013.6630603; Wilkie RM, 2008, J EXP PSYCHOL HUMAN, V34, P1150, DOI 10.1037/0096-1523.34.5.1150; WOLFINGER NH, 1995, J CONTEMP ETHNOGR, V24, P323, DOI 10.1177/089124195024003004; Zehr EP, 2004, NEUROSCIENTIST, V10, P347, DOI 10.1177/1073858404264680; Ziebart BD, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P3931, DOI 10.1109/IROS.2009.5354147	53	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167021	10.1371/journal.pone.0167021	http://dx.doi.org/10.1371/journal.pone.0167021			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936015	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100054
J	Hu, WH; Yu, JY; Liu, HW; Zhang, XS; Wang, Y				Hu, Wenhao; Yu, Jiayi; Liu, Huawei; Zhang, Xuesong; Wang, Yan			Shape Osteotomy in Ankylosing Spondylitis, a Prospective Case Series with Minimum 2 Year Follow-Up	PLOS ONE			English	Article							THORACOLUMBAR KYPHOSIS; KYPHOTIC DEFORMITY; SURGICAL-TREATMENT; SAGITTAL BALANCE; SPINAL OSTEOTOMY; WEDGE OSTEOTOMY; ALIGNMENT; IMPACT; ANGLE	The aim of the study is to evaluate the efficacy of a spinal osteotomy technique, Y shape osteotomy, for correcting kyphosis in AS patients planned preoperatively with computer software-assistance. 36 consecutive AS patients with thoracolumbar kyphosis were treated with one-stage posterior Y shape osteotomy and preoperative surgical planning was done with the aid of the Surgimap Spine. Radiological parameters of simulation and immediate postoperation were documented. Clinical and radiological results were evaluated in the preoperative, the early postoperative periods and during the last follow-up. The lumbar lordosis was found as 40.7 +/- 4.1 degrees in the surgical planning and 49.7 +/- 3.9 degrees postoperatively (p< 0.01). PI-LL was 3.8 +/- 0.9 degrees in the simulation procedure and 6.6 +/- 1.5 degrees postoperatively (p< 0.01). At the final follow-up, Global sagittal balance was restored and Both Oswestry Disability Index and Scoliosis Research Society scores improved largely. In conclusion, Y shape osteotomy is a safe and effective treatment option for AS patients with kyphosis deformity.	[Hu, Wenhao; Liu, Huawei; Zhang, Xuesong; Wang, Yan] Chinese Peoples Liberat Army Gen Hosp, Dept Orthoped, Beijing, Peoples R China; [Yu, Jiayi] Peking Univ, Dept Renal Canc & Melanoma, Canc Hosp, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Peking University	Zhang, XS; Wang, Y (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Orthoped, Beijing, Peoples R China.	tonnyzhang301@sina.com; yanwang301spine@sina.com						Akbar M, 2013, NEUROSURG CLIN N AM, V24, P163, DOI 10.1016/j.nec.2012.12.007; Arun R, 2011, EUR SPINE J, V20, P2252, DOI 10.1007/s00586-011-1894-3; Blondel B, 2012, NEUROSURGERY, V71, P341, DOI 10.1227/NEU.0b013e31825d20c0; Bridwell KH, 2003, SPINE, V28, P2093, DOI 10.1097/01.BRS.0000090891.60232.70; Crawford CH, 2015, SPINE, V40, P377, DOI 10.1097/BRS.0000000000000761; Glassman SD, 2005, SPINE, V30, P2024, DOI 10.1097/01.brs.0000179086.30449.96; JACKSON RP, 1994, SPINE, V19, P1611, DOI 10.1097/00007632-199407001-00010; Kiaer T, 2010, EUR SPINE J, V19, P57, DOI 10.1007/s00586-009-1104-8; Kubiak EN, 2005, J AM ACAD ORTHOP SUR, V13, P267, DOI 10.5435/00124635-200507000-00006; Lafage V, 2012, EUR SPINE J, V21, P698, DOI 10.1007/s00586-011-1967-3; Legaye J, 1998, Eur Spine J, V7, P99, DOI 10.1007/s005860050038; Mehdian H, 2015, SPINE J, V15, P771, DOI 10.1016/j.spinee.2015.01.014; MOLL JMH, 1987, SCAND J RHEUMATOL, P12; Murrey DB, 2002, SPINE, V27, P2338, DOI 10.1097/00007632-200211010-00006; Qian BP, 2012, SPINE, V37, P1415, DOI 10.1097/BRS.0b013e318250dc95; Schwab F, 2010, SPINE, V35, P2224, DOI 10.1097/BRS.0b013e3181ee6bd4; Schwab FJ, 2012, J NEUROSURG-SPINE, V16, P539, DOI 10.3171/2012.2.SPINE11120; Smith JS, 2013, SPINE, V38, P1663, DOI 10.1097/BRS.0b013e31829ec563; Smith-Petersen M N, 1969, Clin Orthop Relat Res, V66, P6; Song K, 2013, SPINE, V38, pE616, DOI 10.1097/BRS.0b013e31828b3299; Suk KS, 2003, SPINE, V28, P2001, DOI 10.1097/01.BRS.0000083239.06023.78; Suk SI, 2005, SPINE, V30, pE703, DOI 10.1097/01.brs.0000188190.90034.be; THOMASEN E, 1985, CLIN ORTHOP RELAT R, P142, DOI 10.1097/00003086-198504000-00019; Van Royen BJ, 1999, ANN RHEUM DIS, V58, P399, DOI 10.1136/ard.58.7.399; Wang Y, 2009, EUR SPINE J, V18, P1436, DOI 10.1007/s00586-009-1067-9; Xi YM., 2013, EUR J ORTHOP SURG TR, V23 suppl 1, pS59, DOI DOI 10.1007/S00590-013-1168-3; Zhang X, 2016, BONE JOINT J, V98B, P672, DOI 10.1302/0301-620X.98B5.35726; Zheng GQ, 2014, SPINE, V39, P1055, DOI 10.1097/BRS.0000000000000346	28	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167792	10.1371/journal.pone.0167792	http://dx.doi.org/10.1371/journal.pone.0167792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936020	gold, Green Submitted, Green Published			2022-12-27	WOS:000389587100193
J	Islam, FMA; Bhowmik, JL; Islam, SZ; Renzaho, AMN; Hiller, JE				Islam, Fakir M. Amirul; Bhowmik, Jahar L.; Islam, Silvia Z.; Renzaho, Andre M. N.; Hiller, Janet E.			Factors Associated with Disability in Rural Bangladesh: Bangladesh Population-Based Diabetes and Eye Study (BPDES)	PLOS ONE			English	Article							FREE LIFE EXPECTANCY; PREVALENCE; ADULTS; DISEASES; HEALTH	Background To assess factors associated with disability in a rural district of Bangladesh. Methods Using a population-based systematic sampling technique, data were collected from 3104 adults aged >= 30 years from the Banshgram union of Narail district. Data collected included an interviewer administered questionnaire to report physical disabilities including impairment that prevents engagement with paid work, visual, hearing, and mobility as well as mental disabilities. Socio-demographic and anthropometric factors including educational attainment and body mass index, as well as clinical factors such as blood pressure, and fasting blood glucose were also collected. Binary and multinomial logistic regression techniques were used to explore the association of various socio-demographic and clinical factors with disability. Results The mean (SD), minimum and maximum ages of the participants were 51 (12), 30 and 89 years. Of total participants, 65% were female. The prevalence of disability varied from 29.1% for visual impairment (highest) to 16.5% for hearing, 14.7% for movement difficulties and 1.6% (lowest) for any other disability that prevented engagement with paid work. Overall, the prevalence of a single disability was 28.6% and that of two or more disabilities was 14.7%. Older age, gender (female), lower socio-economic status (SES), and hypertension were associated with a higher prevalence of most of the disability components. The prevalence of hearing problems (24.5% vs. 13.3%, p<0.001) and movement difficulties (24.9% vs. 13.0%, p<0.001) was significantly higher among lower-income participants than their higher-income counterparts after controlling for age. Prevalence of visual impairment (54.6% vs. 9.2%, p<0.001), hearing (32.2% vs. 6.7%, p<0.001) and movement difficulties (29.2% vs. 5.5%, p<0.001) were significantly higher in people of aged 60 years or older than those aged 30-34 years. After multivariate adjustment, the prevalence of single disability (prevalence risk ratio [PRR] 1.25, 95% CI: 1.09-1.42, p<0.001), and multiple disabilities (PRR 1.41, 95% CI 1.14-1.73, p<0.001) was higher among females than males. The prevalence of single disability and multiple disabilities was respectively 21% (PRR 1.21, 95% CI: 1.02-1.42, p<0.001) and 88% (PRR 1.88, 95% CI: 1.38-2.54, p<0.001) higher among participants with low educational attainment (primary level or less) than those with at least a secondary level of education. Conclusions In rural Bangladesh, the prevalence of disability is high. Public health programs should target those of low SES, older age, and female participants and aim to provide necessary supports in order to bridge disability-related inequities.	[Islam, Fakir M. Amirul; Bhowmik, Jahar L.] Swinburne Univ Technol, Dept Stat Data Sci & Epidemiol, Fac Hlth Arts & Design, Hawthorn Campus, Hawthorn, Vic, Australia; [Islam, Fakir M. Amirul; Islam, Silvia Z.] Org Rural Community Dev, Dariapur, Narail, Bangladesh; [Islam, Silvia Z.] RMIT Univ, Sch Econ Finance & Mkt, Melbourne, Vic, Australia; [Renzaho, Andre M. N.] Univ Western Sydney, Sch Social Sci & Psychol, Humanitarian & Dev Studies, Penrith, NSW, Australia; [Renzaho, Andre M. N.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Hiller, Janet E.] Swinburne Univ Technol, Fac Hlth Arts & Design, Sch Hlth Sci, Hawthorn Campus, Hawthorn, Vic, Australia; [Hiller, Janet E.] Univ Adelaide, Sch Populat Hlth, Adelaide, SA, Australia	Swinburne University of Technology; Royal Melbourne Institute of Technology (RMIT); Western Sydney University; Monash University; Swinburne University of Technology; University of Adelaide	Islam, FMA (corresponding author), Swinburne Univ Technol, Dept Stat Data Sci & Epidemiol, Fac Hlth Arts & Design, Hawthorn Campus, Hawthorn, Vic, Australia.; Islam, FMA (corresponding author), Org Rural Community Dev, Dariapur, Narail, Bangladesh.	fislam@swin.edu.au	Bhowmik, Jahar/T-2289-2017; Islam, Fakir M Amirul/P-6665-2015; Hiller, Janet E./A-5633-2008; Renzaho, Andre M.N./AAH-7679-2021	Bhowmik, Jahar/0000-0001-9697-1968; Islam, Fakir M Amirul/0000-0003-3897-3302; Hiller, Janet E./0000-0002-8532-4033; RENZAHO, ANDRE/0000-0002-6844-0833	ARC Future Fellowship [FT 110100345]	ARC Future Fellowship(Australian Research Council)	AMNR is supported by an ARC Future Fellowship (FT 110100345).	Akter S, 2014, B WORLD HEALTH ORGAN, V92, P204, DOI 10.2471/BLT.13.128371; Altman B.M., 2016, INT MEASUREMENT DISA; Andrade FCD, 2010, J GERONTOL B-PSYCHOL, V65, P381, DOI 10.1093/geronb/gbp119; [Anonymous], 2003, REP DIS PERS; [Anonymous], 2001, DISABILITY AND DEVEL, P12; [Anonymous], 2012, DIS GLANC 2012 STREN; [Anonymous], SEER CANC STAT REV; [Anonymous], 2011, POP HOUS; Bangladesh Bureau of Statistics, 2010, POP HOUS CENS; Basgram Union Parisad Office, 2011, EL LIST; Chakrabarti R, 2015, BANGLADESH J MED SCI, V14, P367, DOI 10.3329/bjms.v14i4.25767; Chappell NL, 2010, INT ENCY REHABILITAT; Cheng YH, 2002, SOC SCI MED, V55, P1415, DOI 10.1016/S0277-9536(01)00271-4; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Hairi NN, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-492; Hasan MT, 2014, J INTERPERS VIOLENCE, V29, P3105, DOI 10.1177/0886260514534525; Hosseinpoor AR, 2013, AM J PUBLIC HEALTH, V103, P1278, DOI 10.2105/AJPH.2012.301115; Huq NL, 2013, DISABILITY CBR INCLU, V24, P37, DOI DOI 10.5463/DCID.V24I3.174; IDF, 2012, INT DIAB ATL; International SS, 2003, SUMM REP BANGL NAT B; Islam FMA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133043; Islam FMA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110368; Islam FM, 2015, J HUM HYPERTENS; Islam FM, 2015, J DIABETES; Islam Shiekh Mohammed Shariful, 2015, Glob Cardiol Sci Pract, V2015, P43, DOI 10.5339/gcsp.2015.43; Jagger C, 2007, J GERONTOL A-BIOL, V62, P408, DOI 10.1093/gerona/62.4.408; Kumar S Ganesh, 2008, Indian J Psychiatry, V50, P21, DOI 10.4103/0019-5545.39754; Marella M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2202-7; McGuire LC, 2006, AM J GERIAT PSYCHIAT, V14, P36, DOI 10.1097/01.JGP.0000192502.10692.d6; Mitra S, 2014, DISABIL REHABIL, V36, P940, DOI 10.3109/09638288.2013.825333; Organization WH, 2016, GLOBAL STATUS REPORT; Rashed AMT, 2005, DISABILITY BANGLADES, P1; Saquib N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-434; Sengupta Manisha, 2002, J Cross Cult Gerontol, V17, P313, DOI 10.1023/A:1023079219538; Tareque MI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103681; Tareque MI, 2013, J AGING HEALTH, V25, P1299, DOI 10.1177/0898264313501388; The Economist, 2012, ECONOMIST; USTUN TB, 2010, MANUAL WHO DISABILIT; Wang Z, 2013, J STAT SOFTW, V55, P5, DOI [10.18637/jss.v055.i05, DOI 10.18637/jss.v055.i05]; WHO (World Health Organization), 2011, WORLD INEQUALITY REP; Zheng XY, 2011, B WORLD HEALTH ORGAN, V89, P788, DOI 10.2471/BLT.11.089730	41	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0165625	10.1371/journal.pone.0165625	http://dx.doi.org/10.1371/journal.pone.0165625			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936096	gold, Green Published			2022-12-27	WOS:000389587100013
J	Jeon, I; Cho, ES; Kim, JH; Kim, DJ; Yu, JS; Chung, JJ				Jeon, Inhwan; Cho, Eun-Suk; Kim, Joo Hee; Kim, Dae Jung; Yu, Jeong-Sik; Chung, Jae-Joon			Feasibility of 10-Minute Delayed Hepatocyte Phase Imaging Using a 30 degrees Flip Angle in Gd-EOB-DTPA-Enhanced Liver MRI for the Detection of Hepatocellular Carcinoma in Patients with Chronic Hepatitis or Cirrhosis	PLOS ONE			English	Article							IMPROVE CONSPICUOUSNESS; CLINICAL-EVALUATION; CONTRAST AGENT; LESIONS; GADOXETATE; MARKERS; SAFETY; IMAGES	Objectives To compare 10-minute (min) delayed hepatocyte phase imaging (HPI) using a 30 degrees flip angle (FA) (10m-FA30) and 20-min delayed HPI using a 10 degrees FA (20m-FA10) or 30 degrees FA (20m-FA30) in Gd-EOB-DTPA-enhanced MRI in patients with chronic hepatitis or cirrhosis, in terms of lesion-to-liver contrast-to-noise ratio (CNR) for hepatocellular carcinoma (HCC) and detection sensitivity for focal hepatic lesions (FHLs). Materials and Methods One hundred and four patients with 168 HCCs and 55 benign FHLs who underwent Gd-EOB-DTPA-enhanced MRI with 10m-FA30, 20m-FA10, and 20m-FA30 were enrolled. Patients were divided into two groups according to the Child-Pugh classification: group A with chronic hepatitis or Child-Pugh A cirrhosis and group B with Child-Pugh B or C cirrhosis. Lesion-to-liver CNR for HCCs was compared between 10m-FA30 and 20m-FA10 or 20m-FA30 for each group. The presence of FHLs was evaluated using a four-point scale by two independent reviewers, and the detection sensitivity was analyzed. Results In group A, the CNR for HCCs (n = 86) on 10m-FA30 (165.8 +/- 99.7) was significantly higher than that on 20m-FA10 (113.4 +/- 71.4) and lower than that of 20m-FA30 (210.2 +/- 129.3). However, there was no significant difference in the sensitivity of FHL detection between 10m-FA30 (mean 95.0% for two reviewers) and 20m-FA10 (94.7%) or 20m-FA30 (94.7%). In group B, the CNR (54.0 +/- 36.4) for HCCs (n = 57) and the sensitivity (94.2%) of FHL detection for 10m-FA30 were significantly higher than those for 20m-FA10 (41.8 +/- 36.4 and 80.8%, respectively) and were not different from those for 20m-FA30 (62.7 +/- 44.4 and 93.3%, respectively). Conclusion The diagnostic performance of 10m-FA30 was similar to or higher than 20m-FA10 or 20m-FA30 in both groups A and B. This finding indicates that 10m-FA30 could replace 20-min delayed HPI regardless of patient liver function and reduce the delay time by 10 minutes.	[Jeon, Inhwan; Cho, Eun-Suk; Kim, Joo Hee; Yu, Jeong-Sik; Chung, Jae-Joon] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Dept Radiol, Seoul, South Korea; [Kim, Dae Jung] CHA Univ, Dept Radiol, CHA Bundang Med Ctr, Seongnam Si, South Korea	Yonsei University; Yonsei University Health System; Pochon Cha University	Cho, ES (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Coll Med, Dept Radiol, Seoul, South Korea.	jjondol@yuhs.ac		Cho, Eun-Suk/0000-0002-0007-9869; Chung, Jae-Joon/0000-0002-7447-1193; Yu, Jeong-Sik/0000-0002-8171-5838; KIM, JOO HEE/0000-0001-5383-3602				Bartolozzi C, 2001, EUR RADIOL, V11, P1374, DOI 10.1007/s003300100845; Bashir MR, 2012, J MAGN RESON IMAGING, V35, P611, DOI 10.1002/jmri.22850; Bashir MR, 2011, EUR RADIOL, V21, P291, DOI 10.1007/s00330-010-1917-1; Cho ES, 2015, AM J ROENTGENOL, V204, P69, DOI 10.2214/AJR.13.11903; Grazioli Luigi, 2010, J Gastrointest Cancer, V41, P221, DOI 10.1007/s12029-010-9145-0; HAMM B, 1995, RADIOLOGY, V195, P785, DOI 10.1148/radiology.195.3.7754011; Hammerstingl R, 2008, EUR RADIOL, V18, P457, DOI 10.1007/s00330-007-0716-9; Haradome H, 2012, J MAGN RESON IMAGING, V35, P132, DOI 10.1002/jmri.22805; Horton KM, 1999, RADIOGRAPHICS, V19, P431, DOI 10.1148/radiographics.19.2.g99mr04431; Huppertz A, 2004, RADIOLOGY, V230, P266, DOI 10.1148/radiol.2301020269; Jeong HT, 2012, J MAGN RESON IMAGING, V35, P635, DOI 10.1002/jmri.22880; Katsube T, 2011, INVEST RADIOL, V46, P277, DOI 10.1097/RLI.0b013e318200f67d; Kim S, 2013, AM J ROENTGENOL, V200, P90, DOI 10.2214/AJR.12.8722; Kim YK, 2010, INVEST RADIOL, V45, P740, DOI 10.1097/RLI.0b013e3181e943a7; Kudo M, 2008, INTERVIROLOGY, V51, P17, DOI 10.1159/000122595; Lee D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139863; Lee JM, 2011, ABDOM IMAGING, V36, P282, DOI 10.1007/s00261-011-9692-2; Luo JC, 2002, HEPATO-GASTROENTEROL, V49, P478; Motosugi U, 2009, J MAGN RESON IMAGING, V30, P1042, DOI 10.1002/jmri.21956; Motosugi U, 2009, EUR RADIOL, V19, P2623, DOI 10.1007/s00330-009-1467-6; Myers RP, 2003, J HEPATOL, V39, P222, DOI 10.1016/S0168-8278(03)00171-5; Obrador BD, 2006, EUR J GASTROEN HEPAT, V18, P57, DOI 10.1097/00042737-200601000-00010; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Reimer P, 1996, RADIOLOGY, V199, P177, DOI 10.1148/radiology.199.1.8633143; Rofsky NM, 1999, RADIOLOGY, V212, P876, DOI 10.1148/radiology.212.3.r99se34876; Sofue K, 2011, EUR RADIOL, V21, P2336, DOI 10.1007/s00330-011-2197-0; Tamada T, 2013, J MAGN RESON IMAGING, V37, P1093, DOI 10.1002/jmri.23903; Tamada T, 2011, EUR J RADIOL, V80, pE311, DOI 10.1016/j.ejrad.2011.01.020; Tanimoto A, 2009, EUR RADIOL, V19, pS975, DOI 10.1007/s00330-009-1624-y; Tschirch FTC, 2008, EUR RADIOL, V18, P1577, DOI 10.1007/s00330-008-0929-6; van Kessel CS, 2012, EUR RADIOL, V22, P2153, DOI 10.1007/s00330-012-2486-2; Van Montfoort JE, 1999, J PHARMACOL EXP THER, V290, P153; Verloh N, 2013, EUR J RADIOL, V82, P1710, DOI 10.1016/j.ejrad.2013.05.033; Vogl TJ, 1996, RADIOLOGY, V200, P59, DOI 10.1148/radiology.200.1.8657946; WILLIAMS ALB, 1988, GASTROENTEROLOGY, V95, P734, DOI 10.1016/S0016-5085(88)80022-2	35	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167701	10.1371/journal.pone.0167701	http://dx.doi.org/10.1371/journal.pone.0167701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936106	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100158
J	Ko, G; Davidson, LE; Brennan, AM; Lam, M; Ross, R				Ko, Gifferd; Davidson, Lance E.; Brennan, Andrea M.; Lam, Miu; Ross, Robert			Abdominal Adiposity, Not Cardiorespiratory Fitness, Mediates the Exercise-Induced Change in Insulin Sensitivity in Older Adults	PLOS ONE			English	Article							RISK-FACTORS; WEIGHT-LOSS; RESISTANCE; FAT; MECHANISMS; OBESITY	Abdominal obesity and low cardiorespiratory fitness (CRF) are associated with insulin resistance in older adults. Exercise is associated with improvement in insulin sensitivity. Whether this association is mediated by change in CRF and/or abdominal obesity is unclear. The current study is a secondary analysis of data from a randomized controlled trial in Kingston, Ontario. Sedentary older adults (60-80 years) (N = 80) who completed the exercise (N = 59) or control (N = 21) conditions for 6 months were included. CRF was measured using a treadmill test, adipose tissue (AT) by magnetic resonance imaging, and insulin sensitivity by hyper-insulinemic-euglycemic clamp. Waist circumference (WC) was measured at the iliac crest. Mediation analyses were used to assess whether abdominal AT and/or CRF mediated the exercise-induced change in insulin sensitivity. By comparison to controls, reduction (mean +/- SD) was observed for visceral (-0.4 +/- 0.4 kg) and abdominal subcutaneous (-0.4 +/- 0.4) AT depots, WC (-4.1 +/- 3.2 cm) and BMI (-0.9 +/- 0.8 kg/m(2)) (p < 0.05). Insulin sensitivity (4.2 +/- 5.2 M/I) and CRF (0.2 +/- 0.3 L/min) improved in the exercise group (p < 0.05). All AT variables, BMI and WC were mediators of the change in insulin sensitivity (p < 0.05). After adjustment for change in total AT, abdominal AT remained a mediator with an effect ratio of 0.79 (p < 0.05), whereas total AT was not significant when adjusted for abdominal AT (p > 0.05). The effect ratio for change in WC and BMI combined (0.63, p< 0.05) was greater than either alone. In conclusion, CRF did not mediate the exercise-induced change in insulin sensitivity in older adults. Abdominal adiposity was a strong mediator independent of change in total adiposity.	[Ko, Gifferd; Davidson, Lance E.; Brennan, Andrea M.; Ross, Robert] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada; [Davidson, Lance E.] Brigham Young Univ, Dept Exercise Sci, Provo, UT 84602 USA; [Lam, Miu] Queens Univ, Dept Epidemiol & Community Hlth, Kingston, ON, Canada; [Ross, Robert] Queens Univ, Dept Med, Div Endocrinol & Metab, Kingston, ON, Canada	Queens University - Canada; Brigham Young University; Queens University - Canada; Queens University - Canada	Ross, R (corresponding author), Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada.; Ross, R (corresponding author), Queens Univ, Dept Med, Div Endocrinol & Metab, Kingston, ON, Canada.	rossr@queensu.ca	Davidson, Lance E./AAA-9689-2019	Davidson, Lance E./0000-0002-1383-0666	Canadian Institutes of Health Research [MT 13448]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The original investigation on which this paper is based was supported by research grant MT 13448 from the Canadian Institutes of Health Research (Dr. Ross). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABATE N, 1995, J CLIN INVEST, V96, P88, DOI DOI 10.1172/JCI118083; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; Brennan AM, 2014, DIABETES CARE, V37, pE95, DOI 10.2337/dc13-1791; Davidson LE, 2009, ARCH INTERN MED, V169, P122, DOI 10.1001/archinternmed.2008.558; DEFRONZO RA, 1981, DIABETES CARE, V4, P493, DOI 10.2337/diacare.4.4.493; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Goodpaster BH, 2004, PEDIATR DIABETES, V5, P219, DOI 10.1111/j.1399-543X.2004.00071.x; Goodpaster BH, 1999, DIABETES, V48, P839, DOI 10.2337/diabetes.48.4.839; Goodpaster BH, 1997, DIABETES, V46, P1579, DOI 10.2337/diabetes.46.10.1579; Haufe S, 2010, DIABETES, V59, P1640, DOI [10.2337/DB09-1200, 10.2337/db09-1200]; HOLLENBECK CB, 1985, J AM GERIATR SOC, V33, P273, DOI 10.1111/j.1532-5415.1985.tb07116.x; Jackson AS, 2009, ARCH INTERN MED, V169, P1781, DOI 10.1001/archinternmed.2009.312; Janssen I, 2002, DIABETES CARE, V25, P431, DOI 10.2337/diacare.25.3.431; Kelley DE, 2000, AM J PHYSIOL-ENDOC M, V278, pE941, DOI 10.1152/ajpendo.2000.278.5.E941; KOHRT WM, 1993, DIABETES, V42, P273, DOI 10.2337/diabetes.42.2.273; Kokkinos P, 2010, CIRCULATION, V122, P790, DOI 10.1161/CIRCULATIONAHA.110.938852; Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001; Nazare JA, 2015, AM J CARDIOL, V115, P307, DOI 10.1016/j.amjcard.2014.10.039; O'Leary VB, 2006, J APPL PHYSIOL, V100, P1584, DOI 10.1152/japplphysiol.01336.2005; Pratley RE, 2000, J AM GERIATR SOC, V48, P1055, DOI 10.1111/j.1532-5415.2000.tb04780.x; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; ROSS R, 1992, J APPL PHYSIOL, V72, P787, DOI 10.1152/jappl.1992.72.2.787; Ryan AS, 2013, OBESITY, V21, P1350, DOI 10.1002/oby.20216; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Stewart KJ, 2005, AM J PREV MED, V28, P9, DOI 10.1016/j.amepre.2004.09.006; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Tchkonia T, 2013, CELL METAB, V17, P644, DOI 10.1016/j.cmet.2013.03.008; TONINO RP, 1989, AM J PHYSIOL, V256, pE352, DOI 10.1152/ajpendo.1989.256.3.E352; Yassine HN, 2009, J GERONTOL A-BIOL, V64, P90, DOI 10.1093/gerona/gln032	32	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167734	10.1371/journal.pone.0167734	http://dx.doi.org/10.1371/journal.pone.0167734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936206	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100169
J	Patchett, AL; Darby, JM; Tovar, C; Lyons, AB; Woods, GM				Patchett, Amanda L.; Darby, Jocelyn M.; Tovar, Cesar; Lyons, A. Bruce; Woods, Gregory M.			The Immunomodulatory Small Molecule Imiquimod Induces Apoptosis in Devil Facial Tumour Cell Lines	PLOS ONE			English	Article							RESPONSE MODIFIER IMIQUIMOD; NF-KAPPA-B; TASMANIAN DEVIL; SARCOPHILUS-HARRISII; DENDRITIC CELLS; CANCER-CELLS; IMMUNE-RESPONSES; ER STRESS; IN-VITRO; TRANSMISSIBLE CANCER	The survival of the Tasmanian devil (Sarcophilus harrisii) is threatened by devil facial tumour disease (DFTD). This transmissible cancer is usually fatal, and no successful treatments have been developed. In human studies, the small immunomodulatory molecule imiquimod is a successful immunotherapy, activating anti-tumour immunity via stimulation of toll-like receptor-7 (TLR7) signaling pathways. In addition, imiquimod is a potent inducer of apoptosis in human tumour cell lines via TLR7 independent mechanisms. Here we investigate the potential of imiquimod as a DFTD therapy through analysis of treated DFTD cell lines and Tasmanian devil fibroblasts. WST-8 proliferation assays and annexin V apoptosis assays were performed to monitor apoptosis, and changes to the expression of pro- and anti-apoptotic genes were analysed using qRT-PCR. Our results show that DFTD cell lines, but not Tasmanian devil fibroblasts, are sensitive to imiquimod-induced apoptosis in a time and concentration dependent manner. Induction of apoptosis was accompanied by down-regulation of the anti-apoptotic BCL2 and BCLXL genes, and up-regulation of the pro-apoptotic BIM gene. Continuous imiquimod treatment was required for these effects to occur. These results demonstrate that imiquimod can deregulate DFTD cell growth and survival in direct and targeted manner. In vivo, this may increase DFTD vulnerability to imiquimod-induced TLR7-mediated immune responses. Our findings have improved the current knowledge of imiquimod action in tumour cells for application to both DFTD and human cancer therapy.	[Patchett, Amanda L.; Darby, Jocelyn M.; Tovar, Cesar; Woods, Gregory M.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Lyons, A. Bruce; Woods, Gregory M.] Univ Tasmania, Sch Med, Hobart, Tas, Australia	University of Tasmania; Menzies Institute for Medical Research; University of Tasmania	Patchett, AL (corresponding author), Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia.	amanda.patchett@utas.edu.au	Patchett, Amanda L/A-7468-2015	Patchett, Amanda L/0000-0002-8424-4680; Darby, Jocelyn/0000-0002-1819-6000; Lyons, Alan/0000-0002-8508-5853	Australian Research Council [LP130100218]; Save The Tasmanian Devil Program Appeal	Australian Research Council(Australian Research Council); Save The Tasmanian Devil Program Appeal	GW is supported by funding from the Australian Research Council (LP130100218). URL: http://www.arc.gov.au/. AP is supported by a scholarship from the Save The Tasmanian Devil Program Appeal. URL: http://www.tassiedevil.com.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2012, CLIN CANCER RES, V18, P6748, DOI 10.1158/1078-0432.CCR-12-1149; Almomen A, 2016, PHARM RES-DORDR, V33, P2209, DOI 10.1007/s11095-016-1957-6; Barnetson RSC, 2004, CLIN EXP DERMATOL, V29, P639, DOI 10.1111/j.1365-2230.2004.01614.x; El-Khattouti A, 2016, J CELL MOL MED, V20, P266, DOI 10.1111/jcmm.12718; Gibson SJ, 2002, CELL IMMUNOL, V218, P74, DOI 10.1016/S0008-8749(02)00517-8; Han JH, 2013, INT J ONCOL, V42, P2087, DOI 10.3892/ijo.2013.1898; Hawkins CE, 2006, BIOL CONSERV, V131, P307, DOI 10.1016/j.biocon.2006.04.010; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Howson LJ, 2014, ANAT REC, V297, P925, DOI 10.1002/ar.22904; Huang SW, 2010, BRIT J DERMATOL, V163, P310, DOI 10.1111/j.1365-2133.2010.09827.x; Huang SW, 2016, J DERMATOL SCI, V81, P182, DOI 10.1016/j.jdermsci.2015.12.011; Huang SW, 2014, ONCOTARGET, V5, P1363, DOI 10.18632/oncotarget.1734; Huang SW, 2012, J DERMATOL SCI, V65, P170, DOI 10.1016/j.jdermsci.2011.11.001; Huang SJ, 2009, J INVEST DERMATOL, V129, P2676, DOI 10.1038/jid.2009.151; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Ito T, 2002, J EXP MED, V195, P1507, DOI 10.1084/jem.20020207; Jiang J, 2016, MOL MED REP, V13, P393, DOI 10.3892/mmr.2015.4524; Konno H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005674; Kreiss A, 2015, VACCINE, V33, P3016, DOI 10.1016/j.vaccine.2015.01.039; Kreiss A, 2008, DEV COMP IMMUNOL, V32, P544, DOI 10.1016/j.dci.2007.09.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuzawa A, 2002, ANTIOXID REDOX SIGN, V4, P415, DOI 10.1089/15230860260196218; McCallum H, 2009, ECOLOGY, V90, P3379, DOI 10.1890/08-1763.1; Murchison EP, 2010, SCIENCE, V327, P84, DOI 10.1126/science.1180616; Nyberg WA, 2016, BIOCHEM BIOPH RES CO, V473, P789, DOI 10.1016/j.bbrc.2016.03.080; Ooi T, 2006, BRIT J DERMATOL, V154, P72, DOI 10.1111/j.1365-2133.2005.06932.x; OPIPARI AW, 1992, J BIOL CHEM, V267, P12424; Patchett AL, 2015, DEV COMP IMMUNOL, V53, P123, DOI 10.1016/j.dci.2015.07.003; Pearse AM, 2006, NATURE, V439, P549, DOI 10.1038/439549a; Phalen DN, 2015, VET J, V206, P312, DOI 10.1016/j.tvjl.2015.10.013; Phalen DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065133; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Pye RJ, 2016, P NATL ACAD SCI USA, V113, P374, DOI 10.1073/pnas.1519691113; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Schon M, 2003, J NATL CANCER I, V95, P1138, DOI 10.1093/jnci/djg016; Schon MP, 2004, J INVEST DERMATOL, V122, P1266, DOI 10.1111/j.0022-202X.2004.22528.x; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Siddle HV, 2013, P NATL ACAD SCI USA, V110, P5103, DOI 10.1073/pnas.1219920110; Sohn KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095337; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Telfer NR, 2008, BRIT J DERMATOL, V159, P35, DOI 10.1111/j.1365-2133.2008.08666.x; Thomas LW, 2010, FEBS LETT, V584, P2981, DOI 10.1016/j.febslet.2010.05.061; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Urosevic M, 2005, J NATL CANCER I, V97, P1143, DOI 10.1093/jnci/dji207; Vacchelli E, 2012, ONCOIMMUNOLOGY, V1, P894, DOI 10.4161/onci.20931; Vidal D, 2004, BRIT J DERMATOL, V151, P656, DOI 10.1111/j.1365-2133.2004.06094.x; Wagner TL, 1999, CELL IMMUNOL, V191, P10, DOI 10.1006/cimm.1998.1406; Wang ST, 2015, J DERMATOL SCI, V78, P108, DOI 10.1016/j.jdermsci.2015.02.008; Wolf IH, 2007, AM J DERMATOPATH, V29, P237, DOI 10.1097/01.dad.0000211531.33670.94; Won M, 2010, CELL DEATH DIFFER, V17, P1830, DOI 10.1038/cdd.2010.47; Yi JY, 2009, BIOCHEM BIOPH RES CO, V386, P455, DOI 10.1016/j.bbrc.2009.06.046	51	10	11	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168068	10.1371/journal.pone.0168068	http://dx.doi.org/10.1371/journal.pone.0168068			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936237	Green Published, gold			2022-12-27	WOS:000389587100268
J	Rodriguez-Muniz, LJ; Diaz, P; Mier, V; Alonso, P				Rodriguez-Muniz, Luis J.; Diaz, Patricia; Mier, Veronica; Alonso, Pedro			Washback Effect of University Entrance exams in Applied Mathematics to Social Sciences	PLOS ONE			English	Article							HIGH-SCHOOL; STUDENT-ACHIEVEMENT; TEACHERS BELIEFS; IMPACT; CURRICULUM; KNOWLEDGE	Curricular issues of subject Applied Mathematics to Social Sciences are studied in relation to university entrance exams performed in several Spanish regions between 2009-2014. By using quantitative and qualitative analyses, it has been studied how these exams align with curriculum and how they produce a washback on curriculum and teachers' work. Additionally, one questionnaire about teachers' practices has been performed, in order to find out how the exams are influencing teaching methodology development. Main results obtained show that evaluation is producing a bias on the official curriculum, substantially simplifying the specific orientation that should guide applied mathematics. Furthermore, teachers' practices are influenced by the exams, and they usually approach their teaching methodology to the frequent types of exams. Also, slight differences among the teachers lead to distinguish two behavioral subgroups. Results can also be useful in an international context, because of the importance of standardized exit exams in OECD countries.	[Rodriguez-Muniz, Luis J.; Diaz, Patricia] Univ Oviedo, Dept Stat & OR & Math Educ, Oviedo, Spain; [Mier, Veronica] CES San Eutiquio, La Salle, Gijon, Spain; [Alonso, Pedro] Univ Oviedo, Dept Math, Oviedo, Spain	University of Oviedo; University of Oviedo	Rodriguez-Muniz, LJ (corresponding author), Univ Oviedo, Dept Stat & OR & Math Educ, Oviedo, Spain.	luisj@uniovi.es	Rodriguez-Muñiz, Luis J. J/H-2293-2015	Rodriguez-Muñiz, Luis J. J/0000-0001-8702-8361				[Anonymous], 2008, B OFICIAL ESTADO, V283, P46932; [Anonymous], DAT CIFR CURS ESC 20; [Anonymous], DAT CIFR SIST U CURS; Apple M., 1986, TEACHERS TEXTS POLIT; Apple MW., 1982, ED POWER; Bailey K., 1996, LANG TEST, V13, P257, DOI [DOI 10.1177/026553229601300303, 10.1177/026553229601300303]; Ball DL, 2008, J TEACH EDUC, V59, P389, DOI 10.1177/0022487108324554; Bergqvist E, 2007, J MATH BEHAV, V26, P348, DOI 10.1016/j.jmathb.2007.11.001; Beswick K, 2012, EDUC STUD MATH, V79, P127, DOI 10.1007/s10649-011-9333-2; Bishop JH, 1997, AM ECON REV, V87, P260; Clotfelter CT, 2010, J HUM RESOUR, V45, P655, DOI 10.1353/jhr.2010.0023; de la Fuente AC, 2010, ENSEN CIENC, V28, P367; Cross DI, 2009, J MATH TEACH EDUC, V12, P325, DOI 10.1007/s10857-009-9120-5; Cuxart A., 1997, REV EDUC, V314, P63; Damankesh M, 2015, STUD EDUC EVAL, V45, P62, DOI 10.1016/j.stueduc.2015.03.009; Gaviria J. L., 2005, REV EDUCACION, P351; Goberna MA, 1985, CIENCIAS, V3, P181; Green Thomas F., 1971, ACTIVITIES TEACHING; Hakkinen I, 2004, DO U EXAMS PREDICT A, V2004, P777; Hill HC, 2005, AM EDUC RES J, V42, P371, DOI 10.3102/00028312042002371; Jacob BA, 2001, EDUC EVAL POLICY AN, V23, P99, DOI 10.3102/01623737023002099; Jaworski B, 1994, INVESTIGATING MATH T; Jones MG, 1999, PHI DELTA KAPPAN, V81, P199; Klein E. D., 2011, STUDIES ED EVALUATIO, V37, P180, DOI DOI 10.1016/J.STUEDUC.2012.01.002; Ktihn S. M., 2011, STUDIES ED EVALUATIO, V37, P189; Kupari P., 2003, STUDIES ED EVALUATIO, V29, P243, DOI [10.1016/S0191-491X(03)90012-5, DOI 10.1016/S0191-491X(03)90012-5]; Leatham KR, 2006, J MATH TEACH EDUC, V9, P91, DOI 10.1007/s10857-006-9006-8; Leung KC, 2014, STUD EDUC EVAL, V43, P115, DOI 10.1016/j.stueduc.2014.09.002; Lithner J., 2000, EDUC STUD MATH, V41, P165, DOI [10.1023/A:1003956417456, DOI 10.1023/A:1003956417456]; Lopez-Martin MM, 2016, REV PARANAENSE EDUCA, V5, P33; Lopez-Martin MM, 2015, AVANCES INVESTIGACIO, V9, P65; Luk HS., 2007, INT J MATH ED SCI TE, V36, P161; Maag Merki K., 2011, STUDIES ED EVALUATIO, V37, P196; Madaus GF, 1988, CRITICAL ISSUES CU 1; Munoz-Repiso Izaguirre M., 1997, REV EDUC-MADRID, V314, P29; Neumann M., 2011, STUD EDUC EVAL, V37, P206, DOI [10.1016/j.stueduc.2012.02.002, DOI 10.1016/J.STUEDUC.2012.02.002]; Ou DS, 2010, ECON EDUC REV, V29, P171, DOI 10.1016/j.econedurev.2009.06.002; PAJARES MF, 1992, REV EDUC RES, V62, P307, DOI 10.2307/1170741; Pastor J, PRUEBAS MATEMATICAS; Perrenoud P, 1999, CUADERNOS PEDAGOGIA, V282, P91; POPHAM WJ, 1987, PHI DELTA KAPPAN, V68, P679; Rico L., 2008, SUMA, V58, P7; Rockoff JE, 2004, AM ECON REV, V94, P247, DOI 10.1257/0002828041302244; Ruiz de Gauna J., 2013, REV EDUC, V362, P217, DOI [https://doi.org/10.4438/1988-592X-RE-2011-362-159, DOI 10.4438/1988-592X-RE-2011]; Runte R, 1998, CANADIAN J ED, V23, P166, DOI DOI 10.2307/1585978; Smith M.L., 1991, ED RES, V20, P8, DOI DOI 10.3102/0013189X020005008; Spratt M., 2005, LANG TEACH RES, V9, P5, DOI [DOI 10.1191/1362168805LR1520A, 10.1191/1362168805LR152OA, DOI 10.1191/1362168805LR152OA]; Wall D., 2000, SYSTEM, V28, P499, DOI DOI 10.1016/S0346-251X(00)00035-X; Webb N., 1997, RES MONOGRAPH, V6; Zakharov A, 2014, INT J EDUC DEV, V36, P13, DOI 10.1016/j.ijedudev.2014.01.003	50	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167544	10.1371/journal.pone.0167544	http://dx.doi.org/10.1371/journal.pone.0167544			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936103	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100120
J	Xiao, XR; Hong, YH; Xia, W; Feng, SP; Zhou, X; Fu, XM; Zang, J; Xiao, Y; Niu, XL; Li, CX; Chen, YH				Xiao, Xiaorong; Hong, Yuhui; Xia, Wei; Feng, Shipeng; Zhou, Xi; Fu, Xiumei; Zang, Jian; Xiao, Yong; Niu, Xiaolei; Li, Chunxia; Chen, Yinhua			Transcriptome Analysis of Ceriops tagal in Saline Environments Using RNA-Sequencing	PLOS ONE			English	Article							SALT STRESS; ABIOTIC STRESS; H+-ATPASE; TOLERANCE; ARABIDOPSIS; PROLINE; EXPRESSION; MANGROVES; GENES; TOOL	Identification of genes involved in mangrove species' adaptation to salt stress can provide valuable information for developing salt-tolerant crops and understanding the molecular evolution of salt tolerance in halophiles. Ceriops tagal is a salt-tolerant mangrove tree growing in mudflats and marshes in tropical and subtropical areas, without any prior genome information. In this study, we assessed the biochemical and transcriptional responses of C. tagal to high salt treatment (500 mmol/L NaCl) by hydroponic experiments and RNA-seq. In C. tagal root tissues under salt stress, proline accumulated strongly from 3 to 12 h of treatment; meanwhile, malondialdehyde content progressively increased from 0 to 9 h, then dropped to lower than control levels by 24 h. These implied that C. tagal plants could survive salt stress through biochemical modification. Using the Illumina sequencing platform, approximately 27.39 million RNA-seq reads were obtained from three salt-treated and control (untreated) root samples. These reads were assembled into 47,111 transcripts with an average length of 514 bp and an N50 of 632 bp. Approximately 78% of the transcripts were annotated, and a total of 437 genes were putative transcription factors. Digital gene expression analysis was conducted by comparing transcripts from the untreated control to the three salt treated samples, and 7,330 differentially expressed transcripts were identified. Using k-means clustering, these transcripts were divided into six clusters that differed in their expression patterns across four treatment time points. The genes identified as being up-or downregulated are involved in salt stress responses, signal transduction, and DNA repair. Our study shows the main adaptive pathway of C. tagal in saline environments, under short-term and long-term treatments of salt stress. This provides vital clues as to which genes may be candidates for breeding salt-tolerant crops and clarifying molecular mechanisms of salt tolerance in C. tagal. The expression levels of 20 candidate genes measured by RNA-Seq were validated via qRT-PCR. Eighteen genes showed consistent expression patterns in RNA-Seq and qRT-PCR results, suggesting that the RNA-seq dataset was dependable for gene expression pattern analysis.	[Xiao, Xiaorong; Hong, Yuhui; Xia, Wei; Feng, Shipeng; Zhou, Xi; Fu, Xiumei; Zang, Jian; Xiao, Yong; Niu, Xiaolei; Li, Chunxia; Chen, Yinhua] Hainan Univ, Hainan Key Lab Sustainable Utilizat Trop Bioresou, Haikou, Peoples R China; [Xiao, Xiaorong; Hong, Yuhui; Xia, Wei; Feng, Shipeng; Zhou, Xi; Fu, Xiumei; Zang, Jian; Xiao, Yong; Niu, Xiaolei; Li, Chunxia; Chen, Yinhua] Hainan Univ, Coll Agr, Haikou, Peoples R China	Hainan University; Hainan University	Li, CX; Chen, YH (corresponding author), Hainan Univ, Hainan Key Lab Sustainable Utilizat Trop Bioresou, Haikou, Peoples R China.; Li, CX; Chen, YH (corresponding author), Hainan Univ, Coll Agr, Haikou, Peoples R China.	chun_xia_li@126.com; yhchen@hainu.edu.cn	chen, yh/GRF-5587-2022	Zhou, Xi/0000-0002-6943-5585; Feng, Shipeng/0000-0002-3365-9990	National Natural Science foundation of China [31260345, 31060040]; Special Fund for Agro-scientific Research in the Public Interest of the People's Republic of China [201403075]	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest of the People's Republic of China	The study was supported by a grant from National Natural Science foundation of China (31260345, 31060040) and the Special Fund for Agro-scientific Research in the Public Interest of the People's Republic of China (Grant No. 201403075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (31260345, 31060040). We thank Beidong Liu for manuscript revision and our thanks also go to Beijing Genomics Institute at Shenzhen for technical assistance in data analysis. The authors have no conflicts of interest to declare	Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; BALL MC, 1984, PLANT PHYSIOL, V74, P1, DOI 10.1104/pp.74.1.1; Bohnert HJ, 1996, TRENDS BIOTECHNOL, V14, P89, DOI 10.1016/0167-7799(96)80929-2; Chen SF, 2011, MAR GENOM, V4, P129, DOI 10.1016/j.margen.2011.03.005; Chini A, 2009, FEBS J, V276, P4682, DOI 10.1111/j.1742-4658.2009.07194.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dassanayake M, 2009, NEW PHYTOL, V183, P764, DOI 10.1111/j.1469-8137.2009.02913.x; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; DOWNTON WJS, 1982, AUST J PLANT PHYSIOL, V9, P519, DOI 10.1071/PP9820519; Eckardt Nancy A., 2007, PLANT CELL, V19, P2970; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Fornale S, 2006, PLANT MOL BIOL, V62, P809, DOI 10.1007/s11103-006-9058-2; Gupta B, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/701596; Huang YL, 2008, GENETICA, V133, P47, DOI 10.1007/s10709-007-9182-1; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jo Y, 2015, GENOM DATA, V6, P271, DOI 10.1016/j.gdata.2015.10.013; Krishnan N, 2008, FREE RADICAL BIO MED, V44, P671, DOI 10.1016/j.freeradbiomed.2007.10.054; Li SB, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00047; Lindemose S, 2013, INT J MOL SCI, V14, P5842, DOI 10.3390/ijms14035842; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Low R, 1996, PLANT PHYSIOL, V110, P259, DOI 10.1104/pp.110.1.259; Nagelkerken I, 2008, AQUAT BOT, V89, P155, DOI 10.1016/j.aquabot.2007.12.007; Nanjo T, 1999, FEBS LETT, V461, P205, DOI 10.1016/S0014-5793(99)01451-9; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Oikawa S, 1996, BIOCHEMISTRY-US, V35, P4584, DOI 10.1021/bi9527000; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Parida AK, 2010, TREES-STRUCT FUNCT, V24, P199, DOI 10.1007/s00468-010-0417-x; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; RATAJCZAK R, 1994, PLANT CELL ENVIRON, V17, P1101, DOI 10.1111/j.1365-3040.1994.tb02008.x; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Samanta S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00757; Slack JL, 2001, J MOL DIAGN, V3, P141, DOI 10.1016/S1525-1578(10)60665-4; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Wang Haibo, 2014, Plant Omics, V7, P178; Wang Z, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-619; Weber H, 2004, PLANT J, V37, P877, DOI 10.1111/j.1365-313X.2003.02013.x; Witzel K, 2009, J EXP BOT, V60, P3545, DOI 10.1093/jxb/erp198; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zang J, 2013, J TROPICAL BIOL, V4, P160	42	7	7	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167551	10.1371/journal.pone.0167551	http://dx.doi.org/10.1371/journal.pone.0167551			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936168	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100122
J	Bos, PA; Jap-Tjong, N; Spencer, H; Hofman, D				Bos, Peter A.; Jap-Tjong, Nadine; Spencer, Hannah; Hofman, Dennis			Social Context Modulates Facial Imitation of Children's Emotional Expressions	PLOS ONE			English	Article							GENDER-DIFFERENCES; MIMICRY; EMPATHY; COMMUNICATION; BEHAVIOR; LINK	Children use emotional facial expressions of others for guiding their behavior, a process which is important to a child's social-emotional development. Earlier studies on facial interaction demonstrate that imitation of emotional expressions of others is automatic, yet can be dynamically modulated depending on contextual information. Considering the value of emotional expressions for children especially, we tested whether and to what extent information about children's temperament and domestic situation alters mimicry of their emotional expressions. Results show that angry expressions of children displaying negative behavior resulted in stronger imitation, which may serve as a corrective signal. Sad facial expressions resulted in stronger imitation towards those behaving positively but only when exposed to a difficult domestic situation, indicating increased empathy towards these children. These findings shed new light on the dynamic implicit communicative processes that shape interaction with children of different social-emotional backgrounds.	[Bos, Peter A.; Jap-Tjong, Nadine; Spencer, Hannah; Hofman, Dennis] Univ Utrecht, Dept Expt Psychol, Utrecht, Netherlands	Utrecht University	Bos, PA (corresponding author), Univ Utrecht, Dept Expt Psychol, Utrecht, Netherlands.	p.a.bos@uu.nl		Bos, Peter A/0000-0001-8944-0181; Spencer, Hannah/0000-0002-7251-900X	Netherlands Society of Scientific Research [451-14-015]; Utrecht University	Netherlands Society of Scientific Research; Utrecht University	PAB was supported by a grant from the Netherlands Society of Scientific Research (451-14-015) and a Dynamics of Youth seed grant from Utrecht University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; BUCK R, 1994, BIOL PSYCHOL, V38, P95, DOI 10.1016/0301-0511(94)90032-9; CARVER LJ, 2009, HDB DEV SOCIAL NEURO, P122; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Collins W.A., 2002, HDB PARENTING, P73; Dalrymple KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079131; de Wied M, 2012, J ABNORM CHILD PSYCH, V40, P211, DOI 10.1007/s10802-011-9557-8; DeGarmo DS, 1999, CHILD DEV, V70, P1231, DOI 10.1111/1467-8624.00089; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; DIMBERG U, 1990, BIOL PSYCHOL, V30, P151, DOI 10.1016/0301-0511(90)90024-Q; Du SC, 2014, P NATL ACAD SCI USA, V111, pE1454, DOI 10.1073/pnas.1322355111; Eisenberg N, 1998, PSYCHOL INQ, V9, P317, DOI 10.1207/s15327965pli0904_1; EISENBERG N, 1990, MERRILL PALMER QUART, V36, P507; EISENBERG N, 1990, MOTIV EMOTION, V14, P131, DOI 10.1007/BF00991640; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; Hess U, 2013, PERS SOC PSYCHOL REV, V17, P142, DOI 10.1177/1088868312472607; Hofman D, 2012, P ROY SOC B-BIOL SCI, V279, P3535, DOI 10.1098/rspb.2012.0694; Jennings PA, 2009, REV EDUC RES, V79, P491, DOI 10.3102/0034654308325693; Keltner D, 1999, COGNITION EMOTION, V13, P505, DOI 10.1080/026999399379168; Klinnert M.D., 1983, EMOTION THEORY RES E, P57, DOI DOI 10.1016/B978-0-12-558702-0.50009-1; Likowski KU, 2008, J EXP SOC PSYCHOL, V44, P1065, DOI 10.1016/j.jesp.2007.10.007; Mancini G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066481; Mancini G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01527; McLoyd VC, 1998, AM PSYCHOL, V53, P185, DOI 10.1037/0003-066X.53.2.185; Niedenthal PM, 2010, BEHAV BRAIN SCI, V33, P417, DOI 10.1017/S0140525X10000865; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Putnam S., 2002, HDB PARENTING, P255; Ross MD, 2008, BIOL LETTERS, V4, P27, DOI 10.1098/rsbl.2007.0535; Rudasill KM., 2006, EARLY EDUC DEV, V17, P271, DOI [10.1207/s15566935eed1702_4, DOI 10.1207/S15566935EED1702_4]; Scopa C, 2016, J COMP PSYCHOL, V130, P153, DOI 10.1037/com0000028; Seibt B, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01122; Sonnby-Borgstrom M, 2008, SCAND J PSYCHOL, V49, P111, DOI 10.1111/j.1467-9450.2008.00626.x; SORCE JF, 1985, DEV PSYCHOL, V21, P195, DOI 10.1037/0012-1649.21.1.195; Tomasello Michael, 2014, NATURAL HIST HUMAN T; TRONICK EZ, 1989, AM PSYCHOL, V44, P112, DOI 10.1037/0003-066X.44.2.112	35	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167991	10.1371/journal.pone.0167991	http://dx.doi.org/10.1371/journal.pone.0167991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4OA	27930714	Green Published, Green Submitted, gold			2022-12-27	WOS:000389580900067
J	Chen, YM; Fang, YT; Lai, CH; Rau, KM; Huang, CH; Chang, HC; Chao, TY; Tseng, CC; Fang, WF; Wang, CC; Chen, YC; Chung, YH; Wang, YH; Su, MC; Liu, SF; Huang, KT; Chen, HC; Chang, YC; Chang, YP; Lin, MC				Chen, Yu-Mu; Fang, Ying-Tang; Lai, Chien-Hao; Rau, Kun-Ming; Huang, Cheng-Hua; Chang, Huang-Chih; Chao, Tung-Ying; Tseng, Chia-Cheng; Fang, Wen-Feng; Wang, Chin-Chou; Chen, Yung-Che; Chung, Yu-Hsiu; Wang, Yi-Hsi; Su, Mao-Chang; Liu, Shih-Feng; Huang, Kuo-Tung; Chen, Hung-Chen; Chang, Ya-Chun; Chang, Yu-Ping; Lin, Meng-Chih			A Survival Scoring System for Non-Small Cell Lung Cancer Patients with De Novo Bone Metastases	PLOS ONE			English	Article							FACTOR RECEPTOR MUTATIONS; PHASE-III; TUMOR BURDEN; GEFITINIB; 1ST-LINE; ADENOCARCINOMA; CHEMOTHERAPY; PATHOPHYSIOLOGY; EPIDEMIOLOGY; HISTOLOGY	In the pre-tyrosine kinase inhibitors (TKIs) era, non-small cell lung cancer (NSCLC) patients with de novo bone metastases had a worse prognosis than those without. However, whether epidermal growth factor receptor (EGFR)-TKIs affect the outcomes of EGFR mutant NSCLC patients with de novo bone metastases has not been well studied thus far. We retrospectively studied the effect of EGFR mutation status and first-line EGFR-TKIs on patient outcomes and created a survival scoring system for NSCLC patients with de novo bone metastases. This retrospective study evaluated 1510 NSCLC patients diagnosed between November 2010 and March 2014. Among these patients, 234 patients had de novo bone metastases. We found that 121 of these 234 patients (51.7%) had positive EGFR mutation tests, and a positive EGFR mutation test significantly affected overall survival (OS) (EGFR mutant: 15.2 months, EGFR wild type: 6.5 months; p < 0.001). Other prognostic factors significant in the multivariable analysis for NSCLC with de novo bone metastases included Eastern Cooperative Oncology Group performance status (PS) (OS; PS 0-2: 11.2 months, PS 3-4: 4.9 months; p = 0.002), presence of extraosseous metastases (OS; with extraosseous metastases: 8.8 months, without extraosseous metastases: 14.0 months; p = 0.008), blood lymphocyte-to-monocyte ratio (LMR) (OS; LMR > 3.1: 17.1months, LMR <= 3.1: 6.9months; p < 0.001). A positive EGFR mutation status reversed the poor outcomes of NSCLC patients with de novo bone metastases. A simple and useful survival scoring system including the above clinical parameters was thus created for NSCLC patients with de novo bone metastases.	[Chen, Yu-Mu; Fang, Ying-Tang; Lai, Chien-Hao; Chang, Huang-Chih; Chao, Tung-Ying; Tseng, Chia-Cheng; Fang, Wen-Feng; Wang, Chin-Chou; Chen, Yung-Che; Chung, Yu-Hsiu; Wang, Yi-Hsi; Su, Mao-Chang; Liu, Shih-Feng; Huang, Kuo-Tung; Chen, Hung-Chen; Chang, Ya-Chun; Chang, Yu-Ping; Lin, Meng-Chih] Chang Gung Univ, Coll Med, Div Pulm & Crit Care Med, Dept Internal Med,Chang Gung Mem Hosp,Kaohsiung M, Kaohsiung, Taiwan; [Rau, Kun-Ming; Huang, Cheng-Hua] Kaohsiung Chang Gung Mem Hosp, Div Hematol Oncol, Dept Internal Med, Kaohsiung, Taiwan; [Rau, Kun-Ming; Huang, Cheng-Hua] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Fang, Wen-Feng; Wang, Chin-Chou] Chang Gung Univ Sci & Technol, Dept Resp Care, Chiayi Campus, Chiayi, Taiwan; [Chen, Yung-Che] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; Chang Gung University	Lin, MC (corresponding author), Chang Gung Univ, Coll Med, Div Pulm & Crit Care Med, Dept Internal Med,Chang Gung Mem Hosp,Kaohsiung M, Kaohsiung, Taiwan.	linmengchih@hotmail.com	Fang, Wen-Feng/AAT-6296-2021; Chen, Yung-Che/AAL-5167-2020	Fang, Wen-Feng/0000-0003-0350-9059; Chen, Yung-Che/0000-0001-8695-5227; Liu, Shih-Feng/0000-0003-1394-5401; chen, hong cheng/0000-0001-9713-3835				Cha YK, 2015, CLIN LUNG CANCER, V16, P228, DOI 10.1016/j.cllc.2014.11.002; Charloux A, 1997, INT J EPIDEMIOL, V26, P14, DOI 10.1093/ije/26.1.14; Chen G, 2013, ANN ONCOL, V24, P1615, DOI 10.1093/annonc/mdt012; Chen YM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149722; Chen YM, 2016, LUNG CANCER, V93, P47, DOI 10.1016/j.lungcan.2016.01.001; Chen YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136252; Coleman RE, 2001, CANCER TREAT REV, V27, P165, DOI 10.1053/ctrv.2000.0210; Coleman RE, 1997, CANCER, V80, P1588, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G; Dahlberg SE, 2013, J THORAC ONCOL, V8, P1121, DOI 10.1097/JTO.0b013e31829cf942; Decroisette C, 2011, J THORAC ONCOL, V6, P576, DOI 10.1097/JTO.0b013e318206a1e3; Oliveira MBD, 2016, LUNG CANCER, V96, P19, DOI 10.1016/j.lungcan.2016.03.014; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Hansen BH, 2004, ACTA ORTHOP SCAND, V75, P11, DOI 10.1080/00016470410001708270; Henley SJ, 2014, MMWR-MORBID MORTAL W, V63, P1; Horiike A, 2007, CHEST, V131, P1628, DOI 10.1378/chest.06-1673; Hu PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108062; Inoue A, 2009, J CLIN ONCOL, V27, P1394, DOI 10.1200/JCO.2008.18.7658; Janssen-Heijnen MLG, 2003, LUNG CANCER-J IASLC, V41, P245, DOI 10.1016/S0169-5002(03)00230-7; Kakhki VRD, 2013, NUCL MED REV, V16, P66, DOI 10.5603/NMR.2013.0037; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Kosteva J, 2008, CURR OPIN ONCOL, V20, P155, DOI 10.1097/CCO.0b013e3282f54cf2; Kuo CW, 2000, CHEST, V117, P354, DOI 10.1378/chest.117.2.354; Langer C, 2004, SEMIN ONCOL, V31, P8, DOI 10.1053/j.seminoncol.2004.10.002; Li JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054839; Lie CH, 2011, CLIN LUNG CANCER, V12, P116, DOI 10.1016/j.cllc.2011.03.006; LIN B, 2015, LEUKEMIA LYMPHOMA, V3, P1, DOI DOI 10.3389/FBI0E.2015.00039; Lin GN, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0070-0; Mercadante S, 1997, PAIN, V69, P1, DOI 10.1016/S0304-3959(96)03267-8; Ni XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111886; NOTTEBAERT M, 1989, INT ORTHOP, V13, P119, DOI 10.1007/BF00266372; Oshita F, 1991, Nihon Kyobu Shikkan Gakkai Zasshi, V29, P231; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Park JH, 2013, CLIN LUNG CANCER, V14, P383, DOI 10.1016/j.cllc.2012.10.007; Porrata LF, 2012, LEUKEMIA LYMPHOMA, V53, P2159, DOI 10.3109/10428194.2012.690605; Quraishi NA, 2013, EUR SPINE J, V22, pS27, DOI 10.1007/s00586-012-2648-6; Rades D, 2014, CLIN NEUROL NEUROSUR, V118, P12, DOI 10.1016/j.clineuro.2013.12.007; Sugiura H, 2008, CLIN ORTHOP RELAT R, V466, P729, DOI 10.1007/s11999-007-0051-0; Tabouret E, 2015, SPINE J, V15, P944, DOI 10.1016/j.spinee.2013.06.036; Thongprasert S, 2011, J THORAC ONCOL, V6, P1872, DOI 10.1097/JTO.0b013e31822adaf7; Tokumo M, 2005, CLIN CANCER RES, V11, P1167; Wang BY, 2013, J THORAC ONCOL, V8, P1128, DOI 10.1097/JTO.0b013e31829ceba4; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Yang JCH, 2014, LUNG CANCER, V83, P174, DOI 10.1016/j.lungcan.2013.11.021	43	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167923	10.1371/journal.pone.0167923	http://dx.doi.org/10.1371/journal.pone.0167923			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930702	Green Published, Green Submitted, gold			2022-12-27	WOS:000389580900060
J	Chung, HJ; Lee, J; Shin, JS; Kim, MR; Koh, W; Kim, MJ; Lee, JW; Kim, EJ; Lee, IH; Kim, WK; Lee, YJ; Lee, SK; Ha, IH				Chung, Hwa-Jin; Lee, Jinho; Shin, Joon-Shik; Kim, Me-Riong; Koh, Wonil; Kim, Min-Jeong; Lee, Jae-Woong; Kim, Eun Jee; Lee, In-Hee; Kim, Won Kyung; Lee, Yoon Jae; Lee, Sang Kook; Ha, In-Hyuk			In Vitro and In Vivo Anti-Allergic and Anti-Inflammatory Effects of eBV, a Newly Developed Derivative of Bee Venom, through Modulation of IRF3 Signaling Pathway in a Carrageenan-Induced Edema Model	PLOS ONE			English	Article							KAPPA-B-ALPHA; MAST-CELLS; INDUCED INFLAMMATION; DISC HERNIATION; HONEYBEE VENOM; RBL-2H3 CELLS; RATS; LIPOPOLYSACCHARIDE; ACUPUNCTURE; RECEPTOR	Background Bee venom (BV), a type of toxin extracted from honeybees (Apis mellifera), has been empirically and widely used to treat inflammatory diseases throughout Asia. Essential BV (eBV) was developed by removing phospholipase A2 (PLA2) and histamine to lower occurrence of allergic reaction. This study investigated the anti-allergic and anti-inflammatory activities of eBV in vitro and in vivo and its underlying mechanism of action. Methods The anti-inflammatory potential of eBV was assessed in vivo using a carrageenan-induced paw edema model. To further investigate the mechanism by which eBV exerts anti-allergic and anti-inflammatory effects, compound 48/80-stimulated RBL-2H3 cells and lipopolysaccharide (LPS)-stimulated RAW 264.7 murine macrophage cells were studied in vitro. Results Release of beta-hexosaminidase and histamine was increased by eBV in a dose-dependent manner, but these levels were lower in eBV compared to original BV at the same concentration. In addition, eBV suppressed compound 48/80-induced expression of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) in RBL-2H3 cells. eBV was also shown to suppress nitric oxide (NO) production by down-regulating mRNA expression and subsequent protein expression of inflammatory mediators in LPS-induced RAW 264.7 cells. Phosphorylation of activators and signal transducers of transcription 1/interferon regulatory factor 3 (STAT1/IRF3) was attenuated by eBV treatment. eBV significantly inhibited carrageenan-induced acute edema in vivo. Serum levels of prostaglandin E2 (PGE2), TNF-alpha, and IL-1 beta were also down-regulated by eBV. Conclusions These results demonstrate that eBV inhibits allergic and inflammatory response by reducing inflammatory mediator production via regulation of the STAT1/IRF3 signaling pathway, suggesting that eBV is a feasible candidate for regulation of allergic-inflammatory response in complementary and alternative medicine.	[Chung, Hwa-Jin; Lee, Jinho; Shin, Joon-Shik; Kim, Me-Riong; Koh, Wonil; Kim, Min-Jeong; Lee, Jae-Woong; Kim, Eun Jee; Lee, In-Hee; Lee, Yoon Jae; Ha, In-Hyuk] Jaseng Med Fdn, Jaseng Spine & Joint Res Inst, Seoul, South Korea; [Kim, Won Kyung; Lee, Sang Kook] Seoul Natl Univ, Inst Nat Prod Res, Coll Pharm, Seoul, South Korea	Seoul National University (SNU)	Ha, IH (corresponding author), Jaseng Med Fdn, Jaseng Spine & Joint Res Inst, Seoul, South Korea.	hanihata@gmail.com	Lee, Yoon Jae/ABA-8808-2020	Lee, Yoon Jae/0000-0002-1532-0942; Shin, Joon-Shik/0000-0001-5488-3273; Lee, Sang Kook/0000-0002-4306-7024; HA, IN-HYUK/0000-0002-5020-6723; Lee, Jinho/0000-0003-0672-6892	Traditional Korean Medicine R&D Program - Ministry of Health & Welfare through the Korea Health Industry Development Institute (KHIDI) [HB16C0035]	Traditional Korean Medicine R&D Program - Ministry of Health & Welfare through the Korea Health Industry Development Institute (KHIDI)	Drs. In-Hyuk Ha and Yoon Jae Lee were supported by the Traditional Korean Medicine R&D Program funded by the Ministry of Health & Welfare (http://www.mohw.go.kr/eng/index.jsp) through the Korea Health Industry Development Institute (KHIDI) (HB16C0035). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Amin MA, 2014, ARCH PHARM RES, V37, P1016, DOI 10.1007/s12272-013-0308-y; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; Bellanti JA, 1998, ALLERGY ASTHMA P; Blank S, 2011, PROTEIN PEPTIDE LETT, V18, P415, DOI 10.2174/092986611794653923; Careau E, 2002, AM J RESP CELL MOL, V26, P579, DOI 10.1165/ajrcmb.26.5.4737; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Curcio-Vonlanthen V, 1997, J PEPT SCI, V3, P267; DAINAKA J, 1986, BIOCHEM PHARMACOL, V35, P3739, DOI 10.1016/0006-2952(86)90659-3; Ferrero-Miliani L, 2007, CLIN EXP IMMUNOL, V147, P227, DOI 10.1111/j.1365-2249.2006.03261.x; Rached ICFS, 2010, J ETHNOPHARMACOL, V130, P175, DOI 10.1016/j.jep.2010.04.015; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Gilchrist M, 2002, J LEUKOCYTE BIOL, V71, P618; GOLDEN DBK, 1989, JAMA-J AM MED ASSOC, V262, P240, DOI 10.1001/jama.262.2.240; Gu SM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0344-2; HABERMAN.E, 1972, SCIENCE, V177, P314, DOI 10.1126/science.177.4046.314; Han SM, 2015, CLIN INTERV AGING, V10, DOI 10.2147/CIA.S84940; HARTMAN DA, 1991, AGENTS ACTIONS, V34, P84, DOI 10.1007/BF01993245; Helbling A, 2004, CLIN EXP ALLERGY, V34, P285, DOI 10.1111/j.1365-2222.2004.01882.x; Heo Y, 2015, EVIDENCE BASED COMPL, V2015; HIDER RC, 1988, ENDEAVOUR, V12, P60, DOI 10.1016/0160-9327(88)90082-8; Kim HW, 2003, J VET MED SCI, V65, P349, DOI 10.1292/jvms.65.349; Kim JY, 2015, INT J MOL MED, V35, P1651, DOI 10.3892/ijmm.2015.2180; Kim MR, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003635; Kwon YB, 2001, AM J CHINESE MED, V29, P187, DOI 10.1142/S0192415X01000228; Lee H, 2015, TOX RESEARCH, V31, P33, DOI 10.5487/TR.2015.31.1.033; Lee JH, 2001, J VET MED SCI, V63, P251, DOI 10.1292/jvms.63.251; Lee JA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006140; Lee MJ, 2016, MOL NEUROBIOL, V53, P1977, DOI 10.1007/s12035-015-9131-4; Lee SH, 2012, J PHARMACOPUNCT, V15, P7, DOI 10.3831/KPI.2012.15.011; Lee SH, 2015, TOXINS, V7, P2835, DOI 10.3390/toxins7082835; Lee WR, 2015, TOXINS, V7, P4758, DOI 10.3390/toxins7114758; Lee WR, 2014, EUR J PHARMACOL, V740, P218, DOI 10.1016/j.ejphar.2014.06.058; Lee WR, 2010, AM J CHINESE MED, V38, P1077, DOI 10.1142/S0192415X10008482; LEME JG, 1973, BRIT J PHARMACOL, V48, P88, DOI 10.1111/j.1476-5381.1973.tb08225.x; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; MARQUARDT DL, 1983, J IMMUNOL, V131, P934; Mastuda H, 2002, BIOORGAN MED CHEM, V10, P3123, DOI 10.1016/S0968-0896(02)00227-4; Moon KY, 2001, ANAL BIOCHEM, V292, P17, DOI 10.1006/abio.2001.5059; Morris Christopher J, 2003, Methods Mol Biol, V225, P115; Nambu Aya, 2010, Allergology International, V59, P125, DOI 10.2332/allergolint.10-RAI-0190; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Patel RP, 1999, BBA-BIOENERGETICS, V1411, P385, DOI 10.1016/S0005-2728(99)00028-6; Ryu JS, 2014, ARCH PHARM RES, V37, P239, DOI 10.1007/s12272-013-0208-1; Samy RP, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-100; Seo BK, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-132; Seo BK, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-16; Shacter E, 2002, ONCOLOGY-NY, V16, P217; Shakoory B, 2004, J INTERF CYTOK RES, V24, P271, DOI 10.1089/107999004323065057; Shin JS, 2016, SPINE, V41, pE955, DOI 10.1097/BRS.0000000000001494; Shin JS, 2016, J ALTERN COMPLEM MED, V22, P533, DOI 10.1089/acm.2014.0368; Stankiewicz W, 2002, MEDIAT INFLAMM, V11, P307, DOI 10.1080/09629350210000015719; Strayhorn WD, 2002, ARCH BIOCHEM BIOPHYS, V400, P76, DOI 10.1006/abbi.2002.2760; Tuppo EE, 2005, INT J BIOCHEM CELL B, V37, P289, DOI 10.1016/j.biocel.2004.07.009	56	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0168120	10.1371/journal.pone.0168120	http://dx.doi.org/10.1371/journal.pone.0168120			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930719	gold, Green Submitted, Green Published			2022-12-27	WOS:000389580900082
J	He, KY; Zhao, YQ; McPherson, EW; Li, Q; Xia, F; Weng, CH; Wang, K; He, MM				He, Karen Y.; Zhao, Yiqing; McPherson, Elizabeth W.; Li, Quan; Xia, Fan; Weng, Chunhua; Wang, Kai; He, Max M.			Pathogenic Mutations in Cancer-Predisposing Genes: A Survey of 300 Patients with Whole-Genome Sequencing and Lifetime Electronic Health Records	PLOS ONE			English	Article							P53 GENE; NF1 GENE; GERMLINE MUTATIONS; ADENOMATOUS POLYPOSIS; INCIDENTAL FINDINGS; MEDICAL GENETICS; AMERICAN-COLLEGE; PROSTATE-CANCER; BREAST; BRCA1	Background It is unclear whether and how whole-genome sequencing (WGS) data can be used to implement genomic medicine. Our objective is to retrospectively evaluate whether WGS can facilitate improving prevention and care for patients with susceptibility to cancer syndromes. Methods and Findings We analyzed genetic mutations in 60 autosomal dominant cancer-predisposition genes in 300 deceased patients with WGS data and nearly complete long-term (over 30 years) medical records. To infer biological insights from massive amounts of WGS data and comprehensive clinical data in a short period of time, we developed an in-house analysis pipeline within the SeqHBase software framework to quickly identify pathogenic or likely pathogenic variants. The clinical data of the patients who carried pathogenic and/or likely pathogenic variants were further reviewed to assess their clinical conditions using their lifetime EHRs. Among the 300 participants, 5 (1.7%) carried pathogenic or likely pathogenic variants in 5 cancer-predisposing genes: one in APC, BRCA1, BRCA2, NF1, and TP53 each. When assessing the clinical data, each of the 5 patients had one or more different types of cancers, fully consistent with their genetic profiles. Among these 5 patients, 2 died due to cancer while the others had multiple disorders later in their lifetimes; however, they may have benefited from early diagnosis and treatment for healthier lives, had the patients had genetic testing in their earlier lifetimes. Conclusions We demonstrated a case study where the discovery of pathogenic or likely pathogenic germline mutations from population-wide WGS correlates with clinical outcome. The use of WGS may have clinical impacts to improve healthcare delivery.	[He, Karen Y.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Zhao, Yiqing; McPherson, Elizabeth W.; He, Max M.] Marshfield Clin Res Fdn, Ctr Human Genet, Marshfield, WI 54449 USA; [Li, Quan; Wang, Kai] Univ Southern Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90007 USA; [Xia, Fan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Weng, Chunhua; Wang, Kai] Columbia Univ, Dept Biomed Informat, Med Ctr, New York, NY 10027 USA; [Wang, Kai] Columbia Univ, Inst Genom Med, Med Ctr, New York, NY 10027 USA; [He, Max M.] Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield, WI 54449 USA; [He, Max M.] Univ Wisconsin Madison, Computat & Informat Biol & Med, Madison, WI 53706 USA	Case Western Reserve University; University of Southern California; Baylor College of Medicine; Columbia University; Columbia University; University of Wisconsin System; University of Wisconsin Madison	He, MM (corresponding author), Marshfield Clin Res Fdn, Ctr Human Genet, Marshfield, WI 54449 USA.; Wang, K (corresponding author), Univ Southern Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90007 USA.; Wang, K (corresponding author), Columbia Univ, Dept Biomed Informat, Med Ctr, New York, NY 10027 USA.; Wang, K (corresponding author), Columbia Univ, Inst Genom Med, Med Ctr, New York, NY 10027 USA.; He, MM (corresponding author), Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield, WI 54449 USA.; He, MM (corresponding author), Univ Wisconsin Madison, Computat & Informat Biol & Med, Madison, WI 53706 USA.	kw2701@cumc.columbia.edu; he.max@mcrf.mfldclin.edu	Li, Quan/B-3605-2009; Zhao, Yiqing/AEL-5533-2022	Zhao, Yiqing/0000-0003-2874-8136	National Institutes of Health [HL007567, HG006465, UL1TR000427]; Marshfield Clinic Research Foundation (MCRF); Summer Student Research Internship Program (SSRIP) at MCRF; Summer Student Research Internship Program (SSRIP) at Marshfield Clinic Research Foundation (MCRF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007567] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG008680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marshfield Clinic Research Foundation (MCRF); Summer Student Research Internship Program (SSRIP) at MCRF; Summer Student Research Internship Program (SSRIP) at Marshfield Clinic Research Foundation (MCRF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the National Institutes of Health [HL007567 to K.Y.H., HG006465 to K.W., UL1TR000427 to M.M.H.]; the Marshfield Clinic Research Foundation (MCRF) to M.M.H.; and the Summer Student Research Internship Program (SSRIP) at MCRF to Y.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Y.Z. would like to thank the Summer Student Research Internship Program (SSRIP) at Marshfield Clinic Research Foundation (MCRF) for financial support. The authors would like to thank the staff in the Biomedical Informatics Research Center at MCRF for collecting genomic and clinical data, and providing computing infrastructure support as well.	Al-Sukhni W, 2008, HUM GENET, V124, P271, DOI 10.1007/s00439-008-0554-0; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Amendola LM, 2015, GENOME RES, V25, P305, DOI 10.1101/gr.183483.114; Anderson TI, 1996, AM J HUM GENET, V59, P486; Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Baralle D, 2003, AM J MED GENET A, V119A, P1, DOI 10.1002/ajmg.a.20023; Belkadi A, 2015, P NATL ACAD SCI USA, V112, P5473, DOI 10.1073/pnas.1418631112; Biesecker LG, 2016, JAMA-J AM MED ASSOC, V315, P2467, DOI 10.1001/jama.2016.2918; Brunham LR, 2013, HUM GENET, V132, P603, DOI 10.1007/s00439-013-1286-3; Carter TC, 2016, J HEALTHC ENG, V2016, DOI 10.1155/2016/3617572; CHEN PL, 1990, SCIENCE, V250, P1576, DOI 10.1126/science.2274789; Chen Y, 2013, EUR J HUM GENET, V21, P929, DOI 10.1038/ejhg.2012.281; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Edwards SM, 2003, AM J HUM GENET, V72, P1, DOI 10.1086/345310; Friedenson B, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-152; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gayther SA, 1997, NAT GENET, V15, P103, DOI 10.1038/ng0197-103; Giardiello FM, 2002, NEW ENGL J MED, V346, P1054, DOI 10.1056/NEJMoa012015; Gottesman O, 2013, GENET MED, V15, P761, DOI 10.1038/gim.2013.72; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Gullapalli RR, 2012, CLIN LAB MED, V32, P585, DOI 10.1016/j.cll.2012.07.005; Hampel H, 2015, GENET MED, V17, P70, DOI 10.1038/gim.2014.147; He M, 2015, J MED GENET, V52, P282, DOI 10.1136/jmedgenet-2014-102907; HSU IC, 1991, NATURE, V350, P427, DOI 10.1038/350427a0; Hu CL, 2016, CANCER EPIDEM BIOMAR, V25, P207, DOI 10.1158/1055-9965.EPI-15-0455; James CR, 2007, ONCOLOGIST, V12, P142, DOI 10.1634/theoncologist.12-2-142; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; JOHNSON MR, 1993, P NATL ACAD SCI USA, V90, P5539, DOI 10.1073/pnas.90.12.5539; Komiya Yuko, 2008, Organogenesis, V4, P68; Krauthammer M, 2015, NAT GENET, V47, P996, DOI 10.1038/ng.3361; KYRITSIS AP, 1994, JNCI-J NATL CANCER I, V86, P344, DOI 10.1093/jnci/86.5.344; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; McCarty CA, 2008, J GLAUCOMA, V17, P372, DOI 10.1097/IJG.0b013e31815c5f3f; McCarty CA, 2007, COMMUNITY GENET, V10, P2, DOI 10.1159/000096274; McCarty Catherine A, 2005, Per Med, V2, P49, DOI 10.1517/17410541.2.1.49; McCarty CA, 2008, AM J MED GENET A, V146A, P3026, DOI 10.1002/ajmg.a.32559; Ozcelik H, 1997, NAT GENET, V16, P17, DOI 10.1038/ng0597-17; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Ribeiro RC, 2001, P NATL ACAD SCI USA, V98, P9330, DOI 10.1073/pnas.161479898; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Roche Myra I, 2015, Curr Genet Med Rep, V3, P166; Rutherford J, 2002, BRIT J CANCER, V86, P1592, DOI 10.1038/sj.bjc.6600269; Side L, 1997, NEW ENGL J MED, V336, P1713, DOI 10.1056/NEJM199706123362404; Song W, 2015, GENETICS MED OFFICIA; Sonoyama T, 2011, MOL MED REP, V4, P489, DOI 10.3892/mmr.2011.449; Stacey SN, 2011, NAT GENET, V43, P1098, DOI 10.1038/ng.926; Stein T, 2002, ONCOGENE, V21, P2961, DOI 10.1038/sj.onc.1205372; SUN Y, 1992, P NATL ACAD SCI USA, V89, P6516, DOI 10.1073/pnas.89.14.6516; Surget S, 2014, ONCOTARGETS THER, V7, P57, DOI 10.2147/OTT.S53876; TASSABEHJI M, 1993, AM J HUM GENET, V53, P90; Van Driest SL, 2016, JAMA-J AM MED ASSOC, V315, P47, DOI 10.1001/jama.2015.17701; Vassy JL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2401; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Zhang JH, 2015, NEW ENGL J MED, V373, P2336, DOI 10.1056/NEJMoa1508054	61	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167847	10.1371/journal.pone.0167847	http://dx.doi.org/10.1371/journal.pone.0167847			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930734	Green Published, gold, Green Submitted			2022-12-27	WOS:000389580900051
J	Hellwig, B; Madjar, K; Edlund, K; Marchan, R; Cadenas, C; Heimes, AS; Almstedt, K; Lebrecht, A; Sicking, I; Battista, MJ; Micke, P; Schmidt, M; Hengstler, JG; Rahnenfuhrer, J				Hellwig, Birte; Madjar, Katrin; Edlund, Karolina; Marchan, Rosemarie; Cadenas, Cristina; Heimes, Anne-Sophie; Almstedt, Katrin; Lebrecht, Antje; Sicking, Isabel; Battista, Marco J.; Micke, Patrick; Schmidt, Marcus; Hengstler, Jan G.; Rahnenfuehrer, Joerg			Epsin Family Member 3 and Ribosome-Related Genes Are Associated with Late Metastasis in Estrogen Receptor-Positive Breast Cancer and Long-Term Survival in Non-Small Cell Lung Cancer Using a Genome-Wide Identification and Validation Strategy	PLOS ONE			English	Article							LATE-DISTANT RECURRENCE; ENDOCRINE THERAPY; RISK; SIGNATURE; TAMOXIFEN; GROWTH; SCORE; INDEX; POPULATION; MASTECTOMY	Background In breast cancer, gene signatures that predict the risk of metastasis after surgical tumor resection are mainly indicative of early events. The purpose of this study was to identify genes linked to metastatic recurrence more than three years after surgery. Methods Affymetrix HG U133A and Plus 2.0 array datasets with information on metastasis-free, disease-free or overall survival were accessed via public repositories. Time restricted Cox regression models were used to identify genes associated with metastasis during or after the first three years post-surgery (early-and late-type genes). A sequential validation study design, with two non-adjuvantly treated discovery cohorts (n = 409) and one validation cohort (n = 169) was applied and identified genes were further evaluated in tamoxifen-treated breast cancer patients (n = 923), as well as in patients with non-small cell lung (n = 1779), colon (n = 893) and ovarian (n = 922) cancer. Results Ten late-and 243 early-type genes were identified in adjuvantly untreated breast cancer. Adjustment to clinicopathological factors and an established proliferation-related signature markedly reduced the number of early-type genes to 16, whereas nine late-type genes still remained significant. These nine genes were associated with metastasis-free survival (MFS) also in a non-time restricted model, but not in the early period alone, stressing that their prognostic impact was primarily based on MFS more than three years after surgery. Four of the ten late-type genes, the ribosome-related factors EIF4B, RPL5, RPL3, and the tumor angiogenesis modifier EPN3 were significantly associated with MFS in the late period also in a meta-analysis of tamoxifen-treated breast cancer cohorts. In contrast, only one late-type gene (EPN3) showed consistent survival associations in more than one cohort in the other cancer types, being associated with worse outcome in two non-small cell lung cancer cohorts. No late-type gene was validated in ovarian and colon cancer. Conclusions Ribosome-related genes were associated with decreased risk of late metastasis in both adjuvantly untreated and tamoxifen-treated breast cancer patients. In contrast, high expression of epsin (EPN3) was associated with increased risk of late metastasis. This is of clinical relevance considering the well-understood role of epsins in tumor angiogenesis and the ongoing development of epsin antagonizing therapies.	[Hellwig, Birte; Madjar, Katrin; Rahnenfuehrer, Joerg] TU Dortmund Univ, Dept Stat, Dortmund, Germany; [Heimes, Anne-Sophie; Almstedt, Katrin; Lebrecht, Antje; Sicking, Isabel; Battista, Marco J.; Schmidt, Marcus] Univ Hosp, Dept Obstet & Gynaecol, Mainz, Germany; [Edlund, Karolina; Marchan, Rosemarie; Cadenas, Cristina; Hengstler, Jan G.] TU Dortmund Univ, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany; [Micke, Patrick] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden	Dortmund University of Technology; University Hospital Mainz; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Uppsala University	Rahnenfuhrer, J (corresponding author), TU Dortmund Univ, Dept Stat, Dortmund, Germany.	rahnenfuehrer@statistik.tu-dortmund.de	Schmidt, Marcus/H-3383-2013	Schmidt, Marcus/0000-0003-1365-2414; Cadenas, Cristina/0000-0003-3374-6418; Rahnenfuhrer, Jorg/0000-0002-8947-440X; Marchan, Rosemarie/0000-0003-4414-1633; Hengstler, Jan/0000-0002-1427-5246; Madjar, Katrin/0000-0001-6169-8105	German Research Foundation (DFG) [RA 870/5-1]; Federal Ministry of Education and Research of Germany (BMBF, NGFN project Oncoprofile) [01GR0816]	German Research Foundation (DFG)(German Research Foundation (DFG)); Federal Ministry of Education and Research of Germany (BMBF, NGFN project Oncoprofile)	This work was supported by the German Research Foundation (DFG, contract number RA 870/5-1) and the Federal Ministry of Education and Research of Germany (BMBF, NGFN project Oncoprofile, no. 01GR0816). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brewster AM, 2008, JNCI-J NATL CANCER I, V100, P1179, DOI 10.1093/jnci/djn233; Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006; Cheng Q, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0407-9; Chia SK, 2004, J CLIN ONCOL, V22, P1630, DOI 10.1200/JCO.2004.09.070; Chiocchetti A, 2007, EXP GERONTOL, V42, P275, DOI 10.1016/j.exger.2006.11.002; Cianfrocca M, 2008, CLIN BREAST CANCER, V8, P493, DOI 10.3816/CBC.2008.n.059; Coon Brian G, 2011, Commun Integr Biol, V4, P95, DOI 10.4161/cib.4.1.14129; Coon BG, 2010, J BIOL CHEM, V285, P33073, DOI 10.1074/jbc.M110.124123; Cuzick J, 2011, J CLIN ONCOL, V29, P4273, DOI 10.1200/JCO.2010.31.2835; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; De Keersmaecker K, 2013, NAT GENET, V45, P186, DOI 10.1038/ng.2508; Demicheli R, 1996, BREAST CANCER RES TR, V41, P177, DOI 10.1007/BF01807163; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dong YZ, 2015, J CLIN INVEST, V125, P4349, DOI 10.1172/JCI80349; Dowsett M, 2013, J CLIN ONCOL, V31, P2783, DOI 10.1200/JCO.2012.46.1558; Esposito D, 2014, ONCOTARGET, V5, P11737, DOI 10.18632/oncotarget.2591; Goudarzi KM, 2016, INT J ONCOL, V48, P1313, DOI 10.3892/ijo.2016.3387; Hao YQ, 2011, BIOCHEM BIOPH RES CO, V407, P169, DOI 10.1016/j.bbrc.2011.02.132; Karrison TG, 1999, JNCI-J NATL CANCER I, V91, P80, DOI 10.1093/jnci/91.1.80; Kennecke HF, 2007, ANN ONCOL, V18, P45, DOI 10.1093/annonc/mdl334; Kim RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035569; Knoll M, 2016, ONCOTARGET, V7, P418, DOI 10.18632/oncotarget.6225; Konstantinopoulos PA, 2010, J CLIN ONCOL, V28, P3555, DOI 10.1200/JCO.2009.27.5719; Lindstrom MS, 2010, PLOS ONE, V5, pA116, DOI 10.1371/journal.pone.0009578; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Lohr M, 2012, J TOXICOL ENV HEAL A, V75, P447, DOI 10.1080/15287394.2012.674912; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Ma XJ, 2008, CLIN CANCER RES, V14, P2601, DOI 10.1158/1078-0432.CCR-07-5026; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007; Maia CJB, 2008, ENDOCRINE, V34, P108, DOI 10.1007/s12020-008-9113-7; Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Mittempergher L, 2013, MOL ONCOL, V7, P987, DOI 10.1016/j.molonc.2013.07.006; Moreaux J, 2012, BIOCHEM BIOPH RES CO, V429, P148, DOI 10.1016/j.bbrc.2012.10.123; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Nishimura R, 2013, ONCOLOGY-BASEL, V85, P100, DOI 10.1159/000353099; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; R Core Team, 2013, R LANG ENV STAT COMP; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Russo A, 2013, CELL CYCLE, V12, P76, DOI 10.4161/cc.22963; Saphner T, 1996, J CLIN ONCOL, V14, P2738, DOI 10.1200/JCO.1996.14.10.2738; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Schmidt M, 2012, CLIN CANCER RES, V18, P2695, DOI 10.1158/1078-0432.CCR-11-2210; Schwarzer G., 2015, META GEN PACKAGE MET; Sestak I, 2013, JNCI-J NATL CANCER I, V105, P1504, DOI 10.1093/jnci/djt244; Sgroi DC, 2013, LANCET ONCOL, V14, P1067, DOI 10.1016/S1470-2045(13)70387-5; Shahbazian D, 2010, CELL CYCLE, V9, P4106, DOI 10.4161/cc.9.20.13630; Takeuchi Hideya, 2005, Breast Cancer, V12, P161, DOI 10.2325/jbcs.12.161; Tessneer Kandice L, 2013, J Can Res Updates, V2, P144; Therneau T. M., 2015, A PACKAGE FOR SURVIV; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zhang Y, 2013, CLIN CANCER RES, V19, P4196, DOI 10.1158/1078-0432.CCR-13-0804	54	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2016	11	12							e0167585	10.1371/journal.pone.0167585	http://dx.doi.org/10.1371/journal.pone.0167585			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4NG	27926932	Green Published, Green Submitted, gold			2022-12-27	WOS:000389578800011
J	Yeung, HH; Denison, S; Johnson, SP				Yeung, H. Henny; Denison, Stephanie; Johnson, Scott P.			Infants' Looking to Surprising Events: When Eye-Tracking Reveals More than Looking Time	PLOS ONE			English	Article							SELECTIVE ATTENTION; FALSE BELIEF; PROBABILITIES; IMPLICIT; EXPECTATIONS; INTUITIONS; INFERENCE; MOVEMENTS; MOUTH	Research on infants' reasoning abilities often rely on looking times, which are longer to surprising and unexpected visual scenes compared to unsurprising and expected ones. Few researchers have examined more precise visual scanning patterns in these scenes, and so, here, we recorded 8- to 11-month-olds' gaze with an eye tracker as we presented a sampling event whose outcome was either surprising, neutral, or unsurprising: A red (or yellow) ball was drawn from one of three visible containers populated 0%, 50%, or 100% with identically colored balls. When measuring looking time to the whole scene, infants were insensitive to the likelihood of the sampling event, replicating failures in similar paradigms. Nevertheless, a new analysis of visual scanning showed that infants did spend more time fixating specific areas-of-interest as a function of the event likelihood. The drawn ball and its associated container attracted more looking than the other containers in the 0% condition, but this pattern was weaker in the 50% condition, and even less strong in the 100% condition. Results suggest that measuring where infants look may be more sensitive than simply how much looking there is to the whole scene. The advantages of eye tracking measures over traditional looking measures are discussed.	[Yeung, H. Henny] Simon Fraser Univ, Dept Linguist, Burnaby, BC, Canada; [Denison, Stephanie] Univ Waterloo, Dept Psychol, Waterloo, ON, Canada; [Johnson, Scott P.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA	Simon Fraser University; University of Waterloo; University of California System; University of California Los Angeles	Yeung, HH (corresponding author), Simon Fraser Univ, Dept Linguist, Burnaby, BC, Canada.	henny_yeung@sfu.ca			National Institutes of Health grant [R01-HD73535]; NIH [R01-HD73535]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD073535] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by a National Institutes of Health grant (R01-HD73535) to SPJ. Please note that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Bryan Nguyen for an immense amount of technical support, and assistance with data collection. This research was supported by a NIH grant (R01-HD73535) to S. P. Johnson.	Albareda-Castellot B, 2011, DEVELOPMENTAL SCI, V14, P395, DOI 10.1111/j.1467-7687.2010.00989.x; Aslin RN, 2007, DEVELOPMENTAL SCI, V10, P48, DOI 10.1111/j.1467-7687.2007.00563.x; BAILLARGEON R, 1985, COGNITION, V20, P191, DOI 10.1016/0010-0277(85)90008-3; CLEMENTS WA, 1994, COGNITIVE DEV, V9, P377, DOI 10.1016/0885-2014(94)90012-4; Daum MM, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00370; Denison S, 2014, DEV PSYCHOL, V50, P2009, DOI 10.1037/a0037158; Denison S, 2014, COGNITION, V130, P335, DOI 10.1016/j.cognition.2013.12.001; Denison S, 2013, DEV PSYCHOL, V49, P243, DOI 10.1037/a0028278; Denison S, 2010, DEVELOPMENTAL SCI, V13, P798, DOI 10.1111/j.1467-7687.2009.00943.x; Denison S, 2010, COGNITIVE SCI, V34, P885, DOI 10.1111/j.1551-6709.2010.01111.x; FANTZ RL, 1964, SCIENCE, V146, P668, DOI 10.1126/science.146.3644.668; Gredeback G, 2010, DEV NEUROPSYCHOL, V35, P1, DOI 10.1080/87565640903325758; Gweon H, 2010, P NATL ACAD SCI USA, V107, P9066, DOI 10.1073/pnas.1003095107; Johnson SP, 2004, PSYCHOL SCI, V15, P769, DOI 10.1111/j.0956-7976.2004.00754.x; Kovacs AM, 2009, P NATL ACAD SCI USA, V106, P6556, DOI 10.1073/pnas.0811323106; Kovacs AM, 2009, SCIENCE, V325, P611, DOI 10.1126/science.1173947; Kulke L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142505; Laeng B, 2012, PERSPECT PSYCHOL SCI, V7, P18, DOI 10.1177/1745691611427305; Lawson CA, 2013, INFANCY, V18, P961, DOI 10.1111/infa.12014; Lewkowicz DJ, 2012, P NATL ACAD SCI USA, V109, P1431, DOI 10.1073/pnas.1114783109; McMurray B, 2005, COGNITION, V95, pB15, DOI 10.1016/j.cognition.2004.07.005; McMurray B, 2004, INFANCY, V6, P203, DOI 10.1207/s15327078in0602_4; Pons F, 2015, PSYCHOL SCI, V26, P490, DOI 10.1177/0956797614568320; Schneider D, 2013, COGNITION, V129, P410, DOI 10.1016/j.cognition.2013.08.004; Southgate V, 2007, PSYCHOL SCI, V18, P587, DOI 10.1111/j.1467-9280.2007.01944.x; Teglas E, 2007, P NATL ACAD SCI USA, V104, P19156, DOI 10.1073/pnas.0700271104; Teglas E, 2015, DEVELOPMENTAL SCI, V18, P183, DOI 10.1111/desc.12196; Teglas E, 2011, SCIENCE, V332, P1054, DOI 10.1126/science.1196404; Thoermer C, 2012, BRIT J DEV PSYCHOL, V30, P172, DOI 10.1111/j.2044-835X.2011.02067.x; Tummeltshammer KS, 2014, CHILD DEV, V85, P1981, DOI 10.1111/cdev.12239; Tummeltshammer KS, 2013, DEVELOPMENTAL SCI, V16, P760, DOI 10.1111/desc.12064; Wang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030884; Xu F, 2008, P NATL ACAD SCI USA, V105, P5012, DOI 10.1073/pnas.0704450105; Xu F, 2009, COGNITION, V112, P97, DOI 10.1016/j.cognition.2009.04.006; Yu C, 2011, DEVELOPMENTAL SCI, V14, P165, DOI 10.1111/j.1467-7687.2010.00958.x	35	6	6	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2016	11	12							e0164277	10.1371/journal.pone.0164277	http://dx.doi.org/10.1371/journal.pone.0164277			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4NG	27926920	Green Published, Green Submitted, gold			2022-12-27	WOS:000389578800001
J	Ma, JQ; Sun, QQ; Liu, JR; Hu, YQ; Liu, SS; Zhang, J; Sheng, XY; Hambidge, KM				Ma, Jingqiu; Sun, Qianqian; Liu, Jinrong; Hu, Yanqi; Liu, Shanshan; Zhang, Jie; Sheng, Xiaoyang; Hambidge, K. Michael			The Effect of Iron Fortification on Iron (Fe) Status and Inflammation: A Randomized Controlled Trial	PLOS ONE			English	Article							BREAST-FED INFANTS; COMPLEMENTARY FOOD; CHILDREN; MEAT; DEFICIENCY; GROWTH; MICROBIOTA; TODDLERS; IMPACT	Background Iron deficiency (ID) is common in toddlers in developing countries. Iron fortified or meat-based complementary foods may be effective to prevent ID. Objective Our objective was to compare iron status at 18 months and growth from 6 to 18 months in rural poor toddlers fed 3 different complementary foods. Methods The study was nested within a larger trial in which 6-month-old infants were randomized to receive 50g/d meat (MG), an equi-caloric fortified cereal supplement (FG) or local cereal supplement (LG) for 1 year. Hb, sTfR, HsCRP, ferritin and AGP were measured in 410 blood samples collected by a random sampling (MG, 137; FG, 140; LG, 133); calprotectin was measured in feces. Body iron = -[log (sTfR x1000/ferritin)-2.8229]/0.1207. ID = ferritin<12ug/L. Results The toddlers in FG had the significantly highest levels in serum ferritin and body iron (P = 0.043, 0.004), and the rates of both ID and iron deficiency anemia (IDA) were the lowest in FG (P = 0.010, 0.021). The rate of systemic inflammation in FG was 30.71%, which was the highest among three groups (P = 0.042). No intervention effects on either the rates of ID and IDA or iron stores (serum ferritin and body iron) were shown in MG. The change in length-for-age z scores (LAZ) from 6 to 18 months among three groups was significantly different (P = 0.021) and a smaller decrease of LAZ in MG and a larger decrease of LAZ in FG were observed. Conclusion Iron fortified cereal improved iron status of poor rural toddlers but was also associated with systemic inflammation which was likely to impair their growth.	[Ma, Jingqiu; Sun, Qianqian; Liu, Jinrong; Hu, Yanqi; Liu, Shanshan; Zhang, Jie; Sheng, Xiaoyang] Shanghai Jiao Tong Univ, Shanghai Inst Pediat Res, MOE Shanghai Key Lab Childrens Environm Hlth, Sch Med,Xin Hua Hosp,Dept Children & Adolescents, Kongjiang Rd, Shanghai, Peoples R China; [Hambidge, K. Michael] Univ Colorado, Denver, CO 80202 USA	Shanghai Jiao Tong University; University of Colorado System; University of Colorado Denver	Sheng, XY (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Pediat Res, MOE Shanghai Key Lab Childrens Environm Hlth, Sch Med,Xin Hua Hosp,Dept Children & Adolescents, Kongjiang Rd, Shanghai, Peoples R China.	shengxiaoyangcn@aliyun.com		Ma, Jingqiu/0000-0002-9011-353X	National Natural Science Foundation of China [81172686, 81302446]; Thrasher Foundation [02827-4]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Thrasher Foundation	This study was funded by National Natural Science Foundation of China (No.81172686, No.81302446), with additional support provided by Thrasher Foundation 02827-4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SF, 2013, WORLD REV NUTR DIET, V106, P142, DOI 10.1159/000342529; [Anonymous], 2009, WHO ANTHRO FOR PERSO; [Anonymous], 2004, ASSESSING IRON STATU, V2nd; Atkins LA, 2016, BRIT J NUTR, V115, P285, DOI 10.1017/S0007114515004286; Baker RD, 2010, PEDIATRICS, V126, P1040, DOI 10.1542/peds.2010-2576; Editorial Board of Chinese Journal of Pediatrics, 2008, Zhonghua Er Ke Za Zhi, V46, P502; Gondolf UH, 2013, BRIT J NUTR, V109, P103, DOI 10.1017/S000711451200058X; Goto R, 2009, BRIT J NUTR, V101, P1509, DOI 10.1017/S0007114508083554; Hambidge KM, 2011, NUTR REV, V69, pS57, DOI 10.1111/j.1753-4887.2011.00434.x; Krebs NF, 2007, NESTLE NUTR WORKS SE, V60, P221, DOI 10.1159/000106371; Krebs NF, 2013, J PEDIATR-US, V163, P416, DOI 10.1016/j.jpeds.2013.01.024; Krebs NF, 2012, AM J CLIN NUTR, V96, P840, DOI 10.3945/ajcn.112.041962; Lievin V, 2000, GUT, V47, P646, DOI 10.1136/gut.47.5.646; Liu JR, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-129; MacRae VE, 2006, INT J MOL MED, V18, P1011; Panter-Brick C, 2009, BRIT J NUTR, V101, P558, DOI 10.1017/S000711450802744X; Rivera JA, 2010, AM J CLIN NUTR, V91, P431, DOI 10.3945/ajcn.2009.28104; Sullivan KM, 2008, TROP MED INT HEALTH, V13, P1267, DOI 10.1111/j.1365-3156.2008.02143.x; Szymlek-Gay EA, 2009, AM J CLIN NUTR, V90, P1541, DOI 10.3945/ajcn.2009.27588; Tang MH, 2014, FOOD NUTR BULL, V35, pS188, DOI 10.1177/15648265140354S304; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; Torrejon CS, 2004, NUTRITION, V20, P177, DOI 10.1016/j.nut.2003.10.013; Vendt N, 2007, MEDICINA-LITHUANIA, V43, P947, DOI 10.3390/medicina43120123; Zimmermann MB, 2008, BRIT J NUTR, V99, pS2, DOI 10.1017/S000711450800679X; Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564	25	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2016	11	12							e0167458	10.1371/journal.pone.0167458	http://dx.doi.org/10.1371/journal.pone.0167458			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MY	27923057	gold, Green Submitted, Green Published			2022-12-27	WOS:000389577900004
J	Li, YS; Song, T; Yang, JS; Zhang, Y; Yang, JL				Li, Yushuang; Song, Tian; Yang, Jiasheng; Zhang, Yi; Yang, Jialiang			An Alignment-Free Algorithm in Comparing the Similarity of Protein Sequences Based on Pseudo-Markov Transition Probabilities among Amino Acids	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; STRUCTURAL CLASSES; GRAPHICAL REPRESENTATION; GENERAL-FORM; PREDICTION; 2D; SIMILARITY/DISSIMILARITY; RECONSTRUCTION; IDENTIFICATION; INFORMATION	In this paper, we have proposed a novel alignment-free method for comparing the similarity of protein sequences. We first encode a protein sequence into a 440 dimensional feature vector consisting of a 400 dimensional Pseudo-Markov transition probability vector among the 20 amino acids, a 20 dimensional content ratio vector, and a 20 dimensional position ratio vector of the amino acids in the sequence. By evaluating the Euclidean distances among the representing vectors, we compare the similarity of protein sequences. We then apply this method into the ND5 dataset consisting of the ND5 protein sequences of 9 species, and the F10 and G11 datasets representing two of the xylanases containing glycoside hydrolase families, i.e., families 10 and 11. As a result, our method achieves a correlation coefficient of 0.962 with the canonical protein sequence aligner ClustalW in the ND5 dataset, much higher than those of other 5 popular alignment-free methods. In addition, we successfully separate the xylanases sequences in the F10 family and the G11 family and illustrate that the F10 family is more heat stable than the G11 family, consistent with a few previous studies. Moreover, we prove mathematically an identity equation involving the Pseudo-Markov transition probability vector and the amino acids content ratio vector.	[Li, Yushuang; Song, Tian] Yanshan Univ, Sch Sci, Qinhuangdao, Peoples R China; [Yang, Jiasheng] Natl Univ Singapore, Dept Civil & Environm Engn, Singapore, Singapore; [Zhang, Yi] Hebei Univ Sci & Technol, Dept Math, Shijiazhuang, Hebei, Peoples R China; [Yang, Jialiang] Henan Polytech Univ, Sch Math & Informat Sci, Jiaozuo, Henan, Peoples R China	Yanshan University; National University of Singapore; Hebei University of Science & Technology; Henan Polytechnic University	Song, T (corresponding author), Yanshan Univ, Sch Sci, Qinhuangdao, Peoples R China.; Yang, JL (corresponding author), Henan Polytech Univ, Sch Math & Informat Sci, Jiaozuo, Henan, Peoples R China.	songtian2012@126.com; jialiang.yang@mssm.edu		Yang, Jialiang/0000-0003-4689-8672	National Natural Science Foundation of China [11201409]; Young Talents Plan of Higher School in Hebei Province [BJ2014060]; National Science Foundation of China [11171088]; Science and technology project of Hebei Province [A2015208108, 1520341]; Science Fund of the Hebei University of Science and Technology Foundation [2014PT67]; Hebei Province Foundation for Advanced Talents [A201400121]; Educational Commission of Hebei Province on of Humanities and Social Sciences [SZ16180]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Talents Plan of Higher School in Hebei Province; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and technology project of Hebei Province; Science Fund of the Hebei University of Science and Technology Foundation; Hebei Province Foundation for Advanced Talents; Educational Commission of Hebei Province on of Humanities and Social Sciences	This work was partially supported by the National Natural Science Foundation of China (No. 11201409 to YL), the Young Talents Plan of Higher School in Hebei Province (No. BJ2014060 to YL) and the National Science Foundation of China (No 11171088 to YZ), the Science and technology project of Hebei Province (No A2015208108 and No 1520341 to YZ), the Science Fund of the Hebei University of Science and Technology Foundation (No 2014PT67 to YZ), the Hebei Province Foundation for Advanced Talents (No A201400121 to YZ), the Educational Commission of Hebei Province on of Humanities and Social Sciences (No SZ16180 to YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bora VB, 2016, J DIGIT IMAGING, V29, P115, DOI 10.1007/s10278-015-9813-5; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Ding CHQ, 2001, BIOINFORMATICS, V17, P349, DOI 10.1093/bioinformatics/17.4.349; Dubey AK, 2016, INT J COMPUT ASS RAD, V11, P2033, DOI 10.1007/s11548-016-1437-9; el Maaty MIA, 2010, PHYSICA A, V389, P4668, DOI 10.1016/j.physa.2010.06.031; El-Lakkani A, 2013, CHEM PHYS LETT, V590, P192, DOI 10.1016/j.cplett.2013.10.032; Gao QB, 2012, BIOCHEM BIOPH RES CO, V417, P73, DOI 10.1016/j.bbrc.2011.11.057; Ghosh A, 2016, GENE, V583, P112, DOI 10.1016/j.gene.2016.02.015; Graphical D., 2011, J MATH CHEM, V49, P2345; Gu Q, 2010, PROTEIN PEPTIDE LETT, V17, P559, DOI 10.2174/092986610791112693; Hua HL, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7639397; Kong L, 2014, J THEOR BIOL, V344, P12, DOI 10.1016/j.jtbi.2013.11.021; Lee SH, 2014, COMPUT METH PROG BIO, V116, P10, DOI 10.1016/j.cmpb.2014.04.012; Liao B, 2006, CHEM PHYS LETT, V422, P282, DOI 10.1016/j.cplett.2006.02.081; Liao B, 2010, BIOINFORMATICS, V26, P2678, DOI 10.1093/bioinformatics/btq521; Liao ZJ, 2016, SCIENTIFICA, V2016, DOI 10.1155/2016/8309253; Ma TT, 2014, PHYSICA A, V403, P21, DOI 10.1016/j.physa.2014.01.067; Mu ZC, 2013, PHYSICA A, V392, P6361, DOI 10.1016/j.physa.2013.08.008; Nandy A, 2006, ARKIVOC, P211, DOI 10.3998/ark.5550190.0007.907; Otu HH, 2003, BIOINFORMATICS, V19, P2122, DOI 10.1093/bioinformatics/btg295; Pietal MJ, 2015, BIOINFORMATICS, V31, P3499, DOI 10.1093/bioinformatics/btv390; Randic M, 2009, J MOL GRAPH MODEL, V27, P637, DOI 10.1016/j.jmgm.2008.10.004; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Wang JR, 2014, BIOCHIMIE, V101, P104, DOI 10.1016/j.biochi.2013.12.021; Wei L, 2014, NANOBIOSCIENCE IEEE, V34, P545; Wei LY, 2015, IEEE T NANOBIOSCI, V14, P649, DOI 10.1109/TNB.2015.2450233; Wei LY, 2014, IEEE ACM T COMPUT BI, V11, P192, DOI 10.1109/TCBB.2013.146; Wen J, 2009, CHEM PHYS LETT, V476, P281, DOI 10.1016/j.cplett.2009.06.017; Xiao X, 2006, J COMPUT CHEM, V27, P478, DOI 10.1002/jcc.20354; Xu CR, 2016, J THEOR BIOL, V406, P105, DOI 10.1016/j.jtbi.2016.06.034; Yang JL, 2008, J COMPUT BIOL, V15, P1295, DOI 10.1089/cmb.2007.0209; Yao YH, 2008, PROTEINS, V73, P864, DOI 10.1002/prot.22110; Yao YH, 2014, J THEOR BIOL, V347, P109, DOI 10.1016/j.jtbi.2014.01.001; Yu CL, 2013, GENE, V529, P250, DOI 10.1016/j.gene.2013.07.092; Yu HJ, 2012, CHEM PHYS LETT, V531, P261, DOI 10.1016/j.cplett.2012.02.030; Zhang L, 2014, J THEOR BIOL, P355; Zhang LC, 2014, J THEOR BIOL, V355, P105, DOI 10.1016/j.jtbi.2014.04.008; Zhang SL, 2014, J THEOR BIOL, V341, P71, DOI 10.1016/j.jtbi.2013.10.002; Zhang SL, 2012, J BIOMOL STRUCT DYN, V29, P634, DOI 10.1080/07391102.2011.672627; Zhang Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152238	41	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2016	11	12							e0167430	10.1371/journal.pone.0167430	http://dx.doi.org/10.1371/journal.pone.0167430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MR	27918587	Green Submitted, Green Published, gold			2022-12-27	WOS:000389577100011
J	Costa, FV; Mello, MAR; Bronstein, JL; Guerra, TJ; Muylaert, RL; Leite, AC; Neves, FS				Costa, Fernanda V.; Mello, Marco A. R.; Bronstein, Judith L.; Guerra, Tadeu J.; Muylaert, Renata L.; Leite, Alice C.; Neves, Frederico S.			Few Ant Species Play a Central Role Linking Different Plant Resources in a Network in Rupestrian Grasslands	PLOS ONE			English	Article							HYMENOPTERA-FORMICIDAE; COMPLEX COMMUNITIES; NEOTROPICAL SAVANNA; HONEYDEW; SPECIALIZATION; NECTAR; MODULARITY; DIVERSITY; SYSTEMS; FAUNA	Ant-plant associations are an outstanding model to study the entangled ecological interactions that structure communities. However, most studies of plant-animal networks focus on only one type of resource that mediates these interactions (e.g, nectar or fruits), leading to a biased understanding of community structure. New approaches, however, have made possible to study several interaction types simultaneously through multilayer networks models. Here, we use this approach to ask whether the structural patterns described to date for ant plant networks hold when multiple interactions with plant-derived food rewards are considered. We tested whether networks characterized by different resource types differ in specialization and resource partitioning among ants, and whether the identity of the core ant species is similar among resource types. We monitored ant interactions with extrafloral nectaries, flowers, and fruits, as well as trophobiont hemipterans feeding on plants, for one year, in seven rupestrian grassland (campo rupestre) sites in southeastern Brazil. We found a highly tangled ant-plant network in which plants offering different resource types are connected by a few central ant species. The multilayer network had low modularity and specialization, but ant specialization and niche overlap differed according to the type of resource used. Beyond detecting structural differences across networks, our study demonstrates empirically that the core of most central ant species is similar across them. We suggest that foraging strategies of ant species, such as massive recruitment, may determine specialization and resource partitioning in ant-plant interactions. As this core of ant species is involved in multiple ecosystem functions, it may drive the diversity and evolution of the entire campo rupestre community.	[Costa, Fernanda V.; Mello, Marco A. R.; Leite, Alice C.; Neves, Frederico S.] Univ Fed Minas Gerais, Grad Sch Ecol Conservat & Wildlife Management, Belo Horizonte, MG, Brazil; [Bronstein, Judith L.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Guerra, Tadeu J.] Univ Fed Minas Gerais, Dept Bot, Belo Horizonte, MG, Brazil; [Muylaert, Renata L.] Sao Paulo State Univ UNESP, Dept Ecol, Sao Paulo, Brazil	Universidade Federal de Minas Gerais; University of Arizona; Universidade Federal de Minas Gerais; Universidade Estadual Paulista	Costa, FV (corresponding author), Univ Fed Minas Gerais, Grad Sch Ecol Conservat & Wildlife Management, Belo Horizonte, MG, Brazil.	fecostabio@gmail.com	Guerra, Tadeu J./O-2320-2013; Muylaert, Renata L./AAD-7248-2020; Neves, Frederico/E-5777-2013; Mello, Marco A. R./B-1095-2008	Guerra, Tadeu J./0000-0003-1247-365X; Muylaert, Renata L./0000-0002-6466-6210; Neves, Frederico/0000-0002-2691-3743; Mello, Marco A. R./0000-0002-9098-9427	Brazilian Council for Scientific and Technological Development (CNPq) [478565/2012-7]; Brazilian Coordination for the Improvement of Higher Education Personnel; Minas Gerais Research Foundation (FAPEMIG); Research Dean of Federal University of Minas Gerais (PRPq-UFMG); Alexander von Humboldt Foundation (AvH); Research Program on the Biodiversity of the Atlantic Forest (PPBio-MA); Sao Paulo Research Foundation [Fapesp 2015/17739-4]; Brazilian Council for Scientific and Technological Development (CNPq); Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES)	Brazilian Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Coordination for the Improvement of Higher Education Personnel; Minas Gerais Research Foundation (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Research Dean of Federal University of Minas Gerais (PRPq-UFMG); Alexander von Humboldt Foundation (AvH)(Alexander von Humboldt Foundation); Research Program on the Biodiversity of the Atlantic Forest (PPBio-MA); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Our study was funded by the Brazilian Council for Scientific and Technological Development (CNPq 478565/2012-7 to FSN), Brazilian Coordination for the Improvement of Higher Education Personnel, Minas Gerais Research Foundation (FAPEMIG), Research Dean of Federal University of Minas Gerais (PRPq-UFMG), Alexander von Humboldt Foundation (AvH), and the Research Program on the Biodiversity of the Atlantic Forest (PPBio-MA). RLM was funded by Sao Paulo Research Foundation (Fapesp 2015/17739-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to several colleagues, who helped us in many ways. Nico Bluthgen and two anonymous reviewers helped us to improve the clarity of an earlier version of this manuscript. Affonso H. N. Souza and our colleagues from Insect Ecology Lab, especially Laura D. Braga and Fabio T. Pacelhe, assisted in the field and lab work. We thank Rodrigo Feitosa for ant species identification, Fernando A. O. Silveira and Joao R. Stehmann for plant species identification, Takumasa Kondo for scale insect identification, Sonia M. N. Lazzari for aphid identification, and John Ribeiro and Pavel Dodonov for their help with analyses. We also are grateful to the Chico Mendes Institute for Biodiversity (ICMBio), Serra do Cipo National Park, and Vellozia Reserve for their logistical support. Our study was funded by the Brazilian Council for Scientific and Technological Development (CNPq), Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES), Minas Gerais Research Foundation (FAPEMIG), Research Dean of Federal University of Minas Gerais (PRPq-UFMG), Alexander von Humboldt Foundation (AvH), and the Research Program on the Biodiversity of the Atlantic Forest (PPBio-MA). RLM was funded by Sao Paulo Research Foundation (Fapesp 2015/17739-4).	Adams ES, 2016, MYRMECOL NEWS, V23, P101; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Almeida-Neto M, 2011, ENVIRON MODELL SOFTW, V26, P173, DOI 10.1016/j.envsoft.2010.08.003; Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; Alves RJV, 2014, BRAZ J BIOL, V74, P355, DOI 10.1590/1519-6984.23212; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2016, ECOLOGY CONSERVATION; Baccaro FB, 2015, GUIA FORMIGAS BRASIL; Ballantyne G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043869; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J., 2014, MUTUALISTIC NETWORKS; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Belchior C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158283; Bluthgen N, 2006, INSECT SOC, V53, P194, DOI 10.1007/s00040-005-0858-1; Bluthgen N, 2007, CURR BIOL, V17, P341, DOI 10.1016/j.cub.2006.12.039; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Bluthgen N, 2008, ECOLOGY, V89, P3387, DOI 10.1890/07-2121.1; Bluthgen N, 2004, OIKOS, V106, P344, DOI 10.1111/j.0030-1299.2004.12687.x; Bluthgen N, 2004, AUSTRAL ECOL, V29, P418, DOI 10.1111/j.1442-9993.2004.01380.x; Bluthgen N, 2003, OECOLOGIA, V137, P426, DOI 10.1007/s00442-003-1347-8; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Bronstein JL, 2015, MUTUALISM, P1, DOI 10.1093/acprof:oso/9780199675654.001.0001; Byk J, 2011, POPUL ECOL, V53, P327, DOI 10.1007/s10144-010-0240-7; Cagnolo L, 2015, ECOL ENTOMOL, V40, P553, DOI 10.1111/een.12229; Chamberlain SA, 2014, ECOL LETT, V17, P881, DOI 10.1111/ele.12279; Christianini AV, 2009, OECOLOGIA, V160, P735, DOI 10.1007/s00442-009-1349-2; Costa FV, 2015, SOCIOBIOLOGY, V62, P228; Costa LD, 2006, J STAT PHYS, V125, P845, DOI 10.1007/s10955-006-9130-y; CUSHMAN JH, 1994, ECOLOGY, V75, P1031, DOI 10.2307/1939427; Czechowski W, 2011, ANN ZOOL, V61, P519, DOI 10.3161/000345411X603364; Dattilo W., 2013, OIKOS IN PRESS; Dattilo W, 2014, BIOL J LINN SOC, V113, P405, DOI 10.1111/bij.12350; Davidson DW, 2004, OECOLOGIA, V139, P255, DOI 10.1007/s00442-004-1508-4; Del-Claro K, 1999, BIOTROPICA, V31, P135, DOI 10.2307/2663967; Del-Claro K, 2016, INSECT SOC, V63, P207, DOI 10.1007/s00040-016-0466-2; Diaz-Castelazo C, 2010, ECOLOGY, V91, P793, DOI 10.1890/08-1883.1; Dormann CF, 2014, METHODS ECOL EVOL, V5, P90, DOI 10.1111/2041-210X.12139; Fagundes R, 2016, ARTHROPOD-PLANT INTE, V10, P207, DOI 10.1007/s11829-016-9428-x; Fagundes Roberth, 2011, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/783945; Fernandes G.W., 2016, ECOLOGY CONSERVATION, P3, DOI [10.1007/978-3-319-29808-5_1, DOI 10.1007/978-3-319-29808-5_1, DOI 10.1007/978-3-319-29808-5]; Fokuhl G, 2007, ECOL RES, V22, P845, DOI 10.1007/s11284-006-0331-2; Fontaine C, 2011, ECOL LETT, V14, P1170, DOI 10.1111/j.1461-0248.2011.01688.x; Frund J, 2016, OIKOS, V125, P502, DOI 10.1111/oik.02256; Genini J, 2010, BIOL LETTERS, V6, P494, DOI 10.1098/rsbl.2009.1021; Genrich CM, 2017, OIKOS, V126, P361, DOI 10.1111/oik.03825; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; Ibarra-Isassi J, 2016, ARTHROPOD-PLANT INTE, V10, P221, DOI 10.1007/s11829-016-9429-9; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Ivens ABF, 2016, ANNU REV ENTOMOL, V61, P353, DOI 10.1146/annurev-ento-010715-023719; Kefi S, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002527; Lewinsohn TM, 2012, SCIENCE, V335, P1449, DOI 10.1126/science.1220138; Manly B.F.J., 2006, RANDOMIZATION BOOTST, V3rd, DOI DOI 10.1201/9781315273075; Gonzalez AMM, 2010, ECOL COMPLEX, V7, P36, DOI 10.1016/j.ecocom.2009.03.008; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Powell S, 2008, FUNCT ECOL, V22, P902, DOI 10.1111/j.1365-2435.2008.01436.x; R Dev. Team, 2015, R LANG ENV STAT COMP; Rafael JA., 2012, INSETOS BRASIL DIVER; Mello MAR, 2015, OIKOS, V124, P1031, DOI 10.1111/oik.01613; Rico-Gray V, 1998, AM MIDL NAT, V140, P21, DOI 10.1674/0003-0031(1998)140[0021:RASVOA]2.0.CO;2; Rico-Gray V., 2007, ECOLOGY EVOLUTION AN; Rico-Gray V, 2012, ARTHROPOD-PLANT INTE, V6, P289, DOI 10.1007/s11829-011-9170-3; RICOGRAY V, 1993, BIOTROPICA, V25, P301, DOI 10.2307/2388788; Sauve A.M., 2014, OIKOS, V123, P378, DOI DOI 10.1111/J.1600-0706.2013.00743.X; Sendoya SF, 2016, ARTHROPOD-PLANT INTE, V10, P183, DOI 10.1007/s11829-016-9423-2; Silveira FAO, 2016, PLANT SOIL, V403, P129, DOI 10.1007/s11104-015-2637-8; Styrsky JD, 2007, P ROY SOC B-BIOL SCI, V274, P151, DOI 10.1098/rspb.2006.3701; Trager MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014308	71	29	30	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167161	10.1371/journal.pone.0167161	http://dx.doi.org/10.1371/journal.pone.0167161			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911919	Green Published, Green Submitted, gold			2022-12-27	WOS:000389520600024
J	Reichlin, TS; Vogt, L; Wurbel, H				Reichlin, Thomas S.; Vogt, Lucile; Wurbel, Hanno			The Researchers' View of Scientific Rigor-Survey on the Conduct and Reporting of In Vivo Research	PLOS ONE			English	Article							RESEARCH-AND-DEVELOPMENT; ANIMAL-MODELS; EXPERIMENTAL-DESIGN; REPRODUCIBILITY; STANDARDS; EFFICACY; DRUGS	Reproducibility in animal research is alarmingly low, and a lack of scientific rigor has been proposed as a major cause. Systematic reviews found low reporting rates of measures against risks of bias (e.g., randomization, blinding), and a correlation between low reporting rates and overstated treatment effects. Reporting rates of measures against bias are thus used as a proxy measure for scientific rigor, and reporting guidelines (e.g., ARRIVE) have become a major weapon in the fight against risks of bias in animal research. Surprisingly, animal scientists have never been asked about their use of measures against risks of bias and how they report these in publications. Whether poor reporting reflects poor use of such measures, and whether reporting guidelines may effectively reduce risks of bias has therefore remained elusive. To address these questions, we asked in vivo researchers about their use and reporting of measures against risks of bias and examined how self-reports relate to reporting rates obtained through systematic reviews. An online survey was sent out to all registered in vivo researchers in Switzerland (N = 1891) and was complemented by personal interviews with five representative in vivo researchers to facilitate interpretation of the survey results. Return rate was 28% (N = 530), of which 302 participants (16%) returned fully completed questionnaires that were used for further analysis. According to the researchers' self-report, they use measures against risks of bias to a much greater extent than suggested by reporting rates obtained through systematic reviews. However, the researchers' self-reports are likely biased to some extent. Thus, although they claimed to be reporting measures against risks of bias at much lower rates than they claimed to be using these measures, the self-reported reporting rates were considerably higher than reporting rates found by systematic reviews. Furthermore, participants performed rather poorly when asked to choose effective over ineffective measures against six different biases. Our results further indicate that knowledge of the ARRIVE guidelines had a positive effect on scientific rigor. However, the ARRIVE guidelines were known by less than half of the participants (43.7%); and among those whose latest paper was published in a journal that had endorsed the ARRIVE guidelines, more than half (51%) had never heard of these guidelines. Our results suggest that whereas reporting rates may underestimate the true use of measures against risks of bias, self-reports may overestimate it. To a large extent, this discrepancy can be explained by the researchers' ignorance and lack of knowledge of risks of bias and measures to prevent them. Our analysis thus adds significant new evidence to the assessment of research integrity in animal research. Our findings further question the confidence that the authorities have in scientific rigor, which is taken for granted in the harm-benefit analyses on which approval of animal experiments is based. Furthermore, they suggest that better education on scientific integrity and good research practice is needed. However, they also question reliance on reporting rates as indicators of scientific rigor and highlight a need for more reliable predictors.	[Reichlin, Thomas S.; Vogt, Lucile; Wurbel, Hanno] Univ Bern, Vetsuisse Fac, Vet Publ Hlth Inst, Div Anim Welf, Bern, Switzerland	University of Bern	Wurbel, H (corresponding author), Univ Bern, Vetsuisse Fac, Vet Publ Hlth Inst, Div Anim Welf, Bern, Switzerland.	hanno.wuerbel@vetsuisse.unibe.ch	Wuerbel, Hanno/D-6281-2012	Wuerbel, Hanno/0000-0002-2934-3010	Swiss Federal Food Safety and Veterinary Office (FSVO) [2.13.01]	Swiss Federal Food Safety and Veterinary Office (FSVO)	This study was funded by the Swiss Federal Food Safety and Veterinary Office (FSVO, www.blv.admin.ch/, Grant No. 2.13.01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho K, 2014, ECOLOGY, V95, P631, DOI 10.1890/13-1452.1; [Anonymous], 2014, NATURE, V515, P7, DOI 10.1038/515007a; [Anonymous], 2012, NAT BIOTECHNOL, V30, P806, DOI 10.1038/nbt.2335; Bailoo JD, 2014, ILAR J, V55, P383, DOI 10.1093/ilar/ilu037; Baker D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001756; Barton K., 2014, MUMIN MULTIMODEL INF; Begley CG, 2015, CIRC RES, V116, P116, DOI 10.1161/CIRCRESAHA.114.303819; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Bello S, 2014, J CLIN EPIDEMIOL, V67, P973, DOI 10.1016/j.jclinepi.2014.04.008; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Cressey D., 2016, NATURE NEWS; Currie GL, 2013, PAIN, V154, P917, DOI 10.1016/j.pain.2013.02.033; Editor, 2013, NATURE, V496, P198; Ehrlinger J, 2003, J PERS SOC PSYCHOL, V84, P5, DOI 10.1037/0022-3514.84.1.5; Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010271; Fang FC, 2013, P NATL ACAD SCI USA, V110, P1137, DOI 10.1073/pnas.1220649110; Festing MFW, 2013, ALTERN LAB ANIM ATLA, V41, P19; Frantzias J, 2011, ANN NEUROL, V69, P389, DOI 10.1002/ana.22243; Freedman LP, 2015, CLIN PHARMACOL THER, V97, P16, DOI 10.1002/cpt.9; Freedman LP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002165; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Henderson VC, 2015, ELIFE, V4, DOI 10.7554/eLife.08351; Henderson VC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001489; Hirst JA, 2014, PLOS ONE, V9, DOI [10.1161/01.STR.0000125719.25853.20, DOI 10.1161/01.STR.0000125719.25853.20]; Howells DW, 2012, INT J STROKE, V7, P371, DOI 10.1111/j.1747-4949.2012.00805.x; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Kontinen V, 2015, SCAND J PAIN, V7, P38, DOI 10.1016/j.sjpain.2015.01.004; Kontinen VK, 2013, SCAND J PAIN, V4, P57, DOI 10.1016/j.sjpain.2013.02.004; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Macleod M, 2011, NATURE, V477, P511, DOI 10.1038/477511a; Macleod MR, 2008, STROKE, V39, P2824, DOI 10.1161/STROKEAHA.108.515957; Macleod MR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002273; Macleod MR, 2004, STROKE, V35, P1203, DOI 10.1161/01.STR.0000125719.25853.20; McCann SK, 2014, STROKE, V45, P3055, DOI 10.1161/STROKEAHA.114.006304; McNutt M, 2014, SCIENCE, V343, P231, DOI 10.1126/science.1250475; Minnerup J, 2016, STROKE, V47, P267, DOI 10.1161/STROKEAHA.115.011695; Mullane K, 2015, BIOCHEM PHARMACOL, V97, P225, DOI 10.1016/j.bcp.2015.06.023; Nuzzo R, 2014, NATURE, V506, P150, DOI 10.1038/506150a; Pound P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3387; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; R Core Team, 2014, R LANG ENV STAT COMP, DOI [10.1161/STROKEAHA.115.011695, DOI 10.1161/STROKEAHA.115.011695]; Ransohoff DF, 2005, NAT REV CANCER, V5, P142, DOI 10.1038/nrc1550; Richter SH, 2010, NAT METHODS, V7, P167, DOI 10.1038/nmeth0310-167; Richter SH, 2009, NAT METHODS, V6, P257, DOI [10.1038/NMETH.1312, 10.1038/nmeth.1312]; Rooke EDM, 2011, PARKINSONISM RELAT D, V17, P313, DOI 10.1016/j.parkreldis.2011.02.010; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Schmitz C, 2012, LIMESURVEY OPEN SOUR; Sena E, 2007, TRENDS NEUROSCI, V30, P433, DOI 10.1016/j.tins.2007.06.009; Steckler T, 2015, SPRINGERPLUS, V4, DOI 10.1186/2193-1801-4-1; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Vaux DL, 2012, NATURE, V492, P180, DOI 10.1038/492180a; Vesterinen HM, 2010, MULT SCLER J, V16, P1044, DOI 10.1177/1352458510379612; Voelkl B, 2016, TRENDS PHARMACOL SCI, V37, P509, DOI 10.1016/j.tips.2016.05.003; Wurbel H, 2002, GENES BRAIN BEHAV, V1, P3, DOI 10.1046/j.1601-1848.2001.00006.x	63	37	38	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0165999	10.1371/journal.pone.0165999	http://dx.doi.org/10.1371/journal.pone.0165999			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911901	Green Published, gold, Green Submitted			2022-12-27	WOS:000389520600005
J	Desmonde, S; Avit, D; Petit, J; Folquet, MA; Eboua, FT; Bosse, CA; Dainguy, E; Mea, V; Timite-Konan, M; Ngbeche, S; Ciaranello, A; Leroy, V				Desmonde, Sophie; Avit, Divine; Petit, Junie; Folquet, Madeleine Amorissani; Eboua, Francois Tanoh; Bosse, Clarisse Amani; Dainguy, Evelyne; Mea, Vearonique; Timite-Konan, Marguerite; Ngbeche, Sylvie; Ciaranello, Andrea; Leroy, Valeriane			Costs of Care of HIV-Infected Children Initiating Lopinavir/Ritonavir-Based Antiretroviral Therapy before the Age of Two in Cote d'Ivoire	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; PROGRAMS; EFFICIENCY; NEVIRAPINE; MORBIDITY; MORTALITY; INFANTS; ABIDJAN	Objectives To access the costs of care for Ivoirian children before and after initiating LPV/r-based anti-retroviral therapy (ART) before the age of two. Methods We assessed the direct costs of care for all HIV-infected children over the first 12 months on LPV/r-based ART initiated <2 years of age in Abidjan. We recorded all drug prescriptions, ART and cotrimoxazole prophylaxis delivery, medical analyses/examinations and hospital admissions. We compared these costs to those accrued in the month prior to ART initiation. Costs and 95% confidence intervals (95% CI) were estimated per child-month, according to severe morbidity. Results Of the 114 children screened, 99 initiated LPV/r-based ART at a median age of 13.5 months (IQR: 6.8 - 18.6); 45% had reached World Health Organization stage 3 or 4. During the first 12 months on ART, 5% died and 3% were lost to follow-up. In the month before ART initiation, the mean cost of care per child-month reached $123.39 (95% CI:$121.02-$ 125.74). After ART initiation, it was $42.53 (95% CI:$42.15-$42.91); 50% were ART costs. The remaining costs were non-antiretroviral drugs (18%) and medical analyses/examinations (14%). Mean costs were significantly higher within the first three months on ART ($48.76, 95% CI:$47.95-$49.56) and in children experiencing severe morbidity ($49.76, 95% CI: $48.61-50.90). Conclusion ART reduces the overall monthly cost of care of HIV-infected children < 2 years. Because children were treated at an advanced HIV disease stage, the additional costs of treating severe morbidity on ART remain substantial. Strategies for treating HIV-infected children as early as possible must remain a priority in Cote d'Ivoire.	[Desmonde, Sophie] Bordeaux Univ, INSERM, U1219, Bordeaux, France; [Desmonde, Sophie; Petit, Junie] Bordeaux Univ, Inst Sante Publ Epidemiol & Dev, Bordeaux, France; [Desmonde, Sophie; Ciaranello, Andrea] Massachusetts Gen Hosp, Dept Med, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Avit, Divine; Folquet, Madeleine Amorissani; Eboua, Francois Tanoh; Bosse, Clarisse Amani; Mea, Vearonique; Timite-Konan, Marguerite] Programme PACCI, Site ANRS, Abidjan, Cote Ivoire; [Folquet, Madeleine Amorissani; Dainguy, Evelyne] Ctr Hosp Univ CHU Cocody, Serv Pediat, Abidjan, Cote Ivoire; [Timite-Konan, Marguerite] Ctr Hosp Univ CHU Yopougon, Serv Pediat, Abidjan, Cote Ivoire; [Ngbeche, Sylvie] Ctr Prise Charge Rech & Format CePReF, Serv Enfant, Abidjan, Cote Ivoire; [Ciaranello, Andrea] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Leroy, Valeriane] Univ Toulouse 3, INSERM, Unit 1027, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Desmonde, S (corresponding author), Bordeaux Univ, INSERM, U1219, Bordeaux, France.; Desmonde, S (corresponding author), Bordeaux Univ, Inst Sante Publ Epidemiol & Dev, Bordeaux, France.; Desmonde, S (corresponding author), Massachusetts Gen Hosp, Dept Med, Med Practice Evaluat Ctr, Boston, MA 02114 USA.	Sophie.Desmonde@isped.u-bordeaux2.fr	Leroy, Valeriane/AAO-5175-2020; , Andrea/ABB-3330-2021; Desmonde, Sophie/AAC-3850-2019; Desmonde, Sophie/E-4748-2019; Leroy, Valeriane/GQB-1102-2022; Leroy, Valeriane/F-8129-2013	Leroy, Valeriane/0000-0003-3542-8616; , Andrea/0000-0002-4268-3263; Desmonde, Sophie/0000-0001-9372-2819; Desmonde, Sophie/0000-0001-9372-2819; Leroy, Valeriane/0000-0003-3542-8616; Leroy, Valeriane/0000-0003-3542-8616	INSERM-ANRS; European and Developing Countries Clinical Trials Partnership (EDCTP); Centre pour la Recherche en Sante (CRP-Sante), Luxembourg; National Institute of Health through the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R01HD079214]; Sidaction Young Investigator Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD079214] Funding Source: NIH RePORTER	INSERM-ANRS; European and Developing Countries Clinical Trials Partnership (EDCTP); Centre pour la Recherche en Sante (CRP-Sante), Luxembourg; National Institute of Health through the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Sidaction Young Investigator Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Overall support for the MONOD project was provided by the French INSERM-ANRS, the European and Developing Countries Clinical Trials Partnership (EDCTP) and the Centre pour la Recherche en Sante (CRP-Sante), Luxembourg. This study was supported in part by the National Institute of Health through the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under award number R01HD079214. Sophie Desmonde is supported by the Sidaction Young Investigator Award. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of any of the institutions above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaky MF, 2010, B WORLD HEALTH ORGAN, V88, P490, DOI 10.2471/BLT.09.068015; Beaudrap PD, 2013, PEDIATR INFECT DIS J, V32, P354, DOI DOI 10.1097/INF.0B013E318278B222; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Central Intelligence Agency, 2013, WORLD FACTBOOK; Ciaranello AL, 2015, AIDS, V29, P1247, DOI 10.1097/QAD.0000000000000672; Cleary SM, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000327621.24232.71; Collins I, 2013, JAIDS-J ACQ IMM DEF, V64, P95, DOI 10.1097/QAI.0b013e318298a309; DAIDS NIoAaIDN, 2004, THE DIVISION OF AIDS; Desmonde S, 2014, JAIDS-J ACQ IMM DEF, V65, pE95, DOI 10.1097/QAI.0b013e3182a4ea6f; Desmonde S, 2013, JAIDS-J ACQ IMM DEF, V62, pE14, DOI 10.1097/QAI.0b013e3182739c95; Doherty K, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-201; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Initiative CHA, 2012, ANTIRETROVIRAL ARV C; Jesson J, 2015, PEDIATR INFECT DIS J, V34, pE159, DOI 10.1097/INF.0000000000000734; Jesson J, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0952-6; Leisegang R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000189; Leroy V, 2015, 8TH IAS CONFERENCE O; Losina E, 2006, BASELINE, P1141; McGrath CJ, 2011, AIDS, V25, P345, DOI 10.1097/QAD.0b013e32834171db; Menzies NA, 2011, AIDS, V25, P1753, DOI 10.1097/QAD.0b013e3283463eec; Meyer-Rath G, 2013, AIDS, V27, P243, DOI 10.1097/QAD.0b013e32835a5b92; Mubiana-Mbewe M, 2009, TROP MED INT HEALTH, V14, P1190, DOI 10.1111/j.1365-3156.2009.02360.x; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Palumbo P, 2010, NEW ENGL J MED, V363, P1510, DOI 10.1056/NEJMoa1000931; Prendergast AJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001273; Revill P, 2013, WITHIN TRIAL COSTING; Revill PA, 2015, AIDS, V29, P201, DOI 10.1097/QAD.0000000000000518; Sansom SL, 2006, JAIDS-J ACQ IMM DEF, V41, P521, DOI 10.1097/01.qai.0000191286.70331.7b; The World Bank World Development Indicators, 2012, GNI PER CAPITA; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Violari A, 2012, NEW ENGL J MED, V366, P2380, DOI 10.1056/NEJMoa1113249; Walenda C, 2009, J TROP PEDIATRICS, V55, P170, DOI 10.1093/tropej/fmn106; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; World Health Organisation, 2011, UNAIDS; World Health Organisation, 2014, 2014 PROGRESS REPORT; World Health Organisation, 2010, UNAIDS; World Health Organisation, 2009, CHOOSING INTERVENTIO; World Health Organisation, GLOBAL PRICE REPORTI; World Health Organisation, 2013, UNAIDS; World Health Organisation, 2013, THE USE OF ANTIRETRO; Yonaba C, 2015, 7TH INTERNATIONAL WO	41	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166466	10.1371/journal.pone.0166466	http://dx.doi.org/10.1371/journal.pone.0166466			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935971	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100027
J	Hobbs, CV; Gabriel, EE; Kamthunzi, P; Tegha, G; Tauzie, J; Petzold, E; Barlow-Mosha, L; Chi, BH; Li, YH; Ilmet, T; Kirmse, B; Neal, J; Parikh, S; Deygoo, N; Philippe, PJ; Mofenson, L; Prescott, W; Chen, JY; Musoke, P; Palumbo, P; Duffy, PE; Borkowsky, W				Hobbs, Charlotte V.; Gabriel, Erin E.; Kamthunzi, Portia; Tegha, Gerald; Tauzie, Jean; Petzold, Elizabeth; Barlow-Mosha, Linda; Chi, Benjamin H.; Li, Yonghua; Ilmet, Tiina; Kirmse, Brian; Neal, Jillian; Parikh, Sunil; Deygoo, Nagamah; Philippe, Patrick Jean; Mofenson, Lynne; Prescott, William; Chen, Jingyang; Musoke, Philippa; Palumbo, Paul; Duffy, Patrick E.; Borkowsky, William		P1068s Study Team	Malaria in HIV-Infected Children Receiving HIV Protease-Inhibitor-Compared with Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy, IMPAACT P1068s, Substudy to P1060	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; BLOOD; PREVENTION; NEVIRAPINE; EXPOSURE; PCR	Background HIV and malaria geographically overlap. HIV protease inhibitors kill malaria parasites in vitro and in vivo, but further evaluation in clinical studies is needed. Methods Thirty-one children from Malawi aged 4-62 months were followed every 3 months and at intercurrent illness visits for <= 47 months (September 2009-December 2011). We compared malaria incidence (CCM, or positive BS with malaria symptoms) in children initiated on HIV antiretroviral therapy (ART) with zidovudine, lamivudine, and either nevirapine (NVP), a non-nucleoside reverse transcriptase inhibitor, or lopinavir-ritonavir (LPV-rtv), a protease inhibitor. Results We found an association between increased time to recurrent positive BS, but not CCM, when anti-malarial treatment and LPV-rtv based ART were used concurrently and when accounting for a LPV-rtv and antimalarial treatment interaction (adjusted HR 0.39; 95% CI (0.17,0.89); p = 0.03). Conclusions LPV-rtv in combination with malaria treatment was associated with lower risk of recurrent positive BS, but not CCM, in HIV-infected children. Larger, randomized studies are needed to confirm these findings which may permit ART optimization for malaria-endemic settings.	[Hobbs, Charlotte V.; Neal, Jillian; Chen, Jingyang; Duffy, Patrick E.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD 20852 USA; [Hobbs, Charlotte V.; Li, Yonghua; Ilmet, Tiina; Deygoo, Nagamah; Borkowsky, William] NYU, Sch Med, Div Infect Dis & Immunol, Dept Pediat, New York, NY 10003 USA; [Hobbs, Charlotte V.] Batson Childrens Hosp, Dept Pediat, Div Infect Dis, Jackson, MS 39216 USA; [Hobbs, Charlotte V.] Univ Mississippi, Med Ctr, Dept Microbiol, Jackson, MS 39216 USA; [Gabriel, Erin E.] NIAID, Biostat Res Branch, NIH, Rockville, MD USA; [Kamthunzi, Portia; Tegha, Gerald; Tauzie, Jean] Univ North Carolina Chapel Hill, Lilongwe Project, Kamuzu Cent Hosp, Lilongwe, Malawi; [Petzold, Elizabeth] Duke Clin Res Inst, Durham, NC USA; [Barlow-Mosha, Linda; Musoke, Philippa] Johns Hopkins Univ Res Collaborat, Makerere Univ, Kampala, Uganda; [Chi, Benjamin H.] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC USA; [Ilmet, Tiina] Weill Cornell Med, Cornell Clin Trials Unit, New York, NY USA; [Kirmse, Brian] Univ Mississippi, Med Ctr, Batson Childrens Hosp, Dept Pediat,Div Med Genet, Jackson, MS 39216 USA; [Parikh, Sunil] Yale Sch Publ Hlth, New Haven, CT USA; [Parikh, Sunil] Yale Sch Med, New Haven, CT USA; [Philippe, Patrick Jean] Div Henry M Jackson Fdn Adv Mil Med Inc, HJF DAIDS, Bethesda, MD USA; [Philippe, Patrick Jean] NIAID, DHHS, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Mofenson, Lynne] Elizabeth Glaser Pediat AIDS Fdn, Washington, DC USA; [Prescott, William] HYDAS World Hlth Inc, Hummelstown, PA USA; [Chen, Jingyang] Univ Washington, Seattle Childrens Res Inst, Ben Towne Ctr Childhood Canc Res, Seattle, WA 98195 USA; [Chen, Jingyang] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Musoke, Philippa] Makerere Univ, Dept Pediat & Child Hlth, Kampala, Uganda; [Palumbo, Paul] Geisel Sch Med Dartmouth, Div Infect Dis & Int Hlth, Lebanon, NH USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); New York University; University of Mississippi; University of Mississippi Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Duke University; Makerere University; University of North Carolina; University of North Carolina Chapel Hill; Cornell University; University of Mississippi; University of Mississippi Medical Center; Yale University; Yale University; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Seattle Children's Hospital; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Makerere University; Dartmouth College	Hobbs, CV (corresponding author), NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD 20852 USA.; Hobbs, CV (corresponding author), NYU, Sch Med, Div Infect Dis & Immunol, Dept Pediat, New York, NY 10003 USA.; Hobbs, CV (corresponding author), Batson Childrens Hosp, Dept Pediat, Div Infect Dis, Jackson, MS 39216 USA.; Hobbs, CV (corresponding author), Univ Mississippi, Med Ctr, Dept Microbiol, Jackson, MS 39216 USA.	chobbs@umc.edu	Mofenson, Lynne/P-9631-2019	Mofenson, Lynne/0000-0002-2818-9808; Gabriel, Erin/0000-0002-0504-8404; Elbireer, Ali/0000-0002-2513-3497; Tegha, Gerald/0000-0002-7744-5564; Hobbs, Charlotte/0000-0003-4829-0791; Barlow-Mosha, Linda/0000-0003-3241-2141	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [UM1AI068632, UM1AI068616, UM1AI106716]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Mental Health (NIMH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410, UM1AI069423, UM1AI069530, UM1AI068616, UM1AI068632] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Overall support for the International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT) was provided by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [Award Numbers UM1AI068632 (IMPAACT LOC), UM1AI068616 (IMPAACT SDMC) and UM1AI106716 (IMPAACT LC)], with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of Mental Health (NIMH). We thank the children, parents, and guardians who participated in this study, and the clinical study team for their efforts in this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achan J, 2012, NEW ENGL J MED, V367, P2110, DOI 10.1056/NEJMoa1200501; Anderson C, 1982, COXS REGRESSION MODE; Bennett A, 2013, AM J TROP MED HYG, V89, P840, DOI 10.4269/ajtmh.13-0028; Chanda P, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-75; Flateau C, 2011, LANCET INFECT DIS, V11, P541, DOI 10.1016/S1473-3099(11)70031-7; Frontiers MS, 2002, REFUGEE HDB EXCERPT; German P, 2009, JAIDS-J ACQ IMM DEF, V51, P424, DOI 10.1097/QAI.0b013e3181acb4ff; Greenhalgh S, 2015, AIDS, V29, P473, DOI 10.1097/QAD.0000000000000550; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Hobbs CV, 2013, AIDS, V27, P1674, DOI 10.1097/QAD.0b013e3283621dd4; Hobbs CV, 2009, J INFECT DIS, V199, P134, DOI 10.1086/594369; Hobbs CV, 2013, J INFECT DIS; Kraft TE, 2015, ANTIMICROB AGENTS CH, V59, P6203, DOI 10.1128/AAC.00899-15; Murphy SC, 2013, AM J TROP MED HYG, V89, P824, DOI 10.4269/ajtmh.12-0675; Murphy SC, 2012, AM J TROP MED HYG, V86, P383, DOI 10.4269/ajtmh.2012.10-0658; Natureeba P, 2014, J INFECT DIS, V210, P1938, DOI 10.1093/infdis/jiu346; Nsobya SL, 2004, J INFECT DIS, V189, P2220, DOI 10.1086/421281; Palumbo P, 2010, NEW ENGL J MED, V363, P1510, DOI 10.1056/NEJMoa1000931; Parikh S, 2006, ANTIMICROB AGENTS CH, V50, P2207, DOI 10.1128/AAC.00022-06; Parikh S, 2005, ANTIMICROB AGENTS CH, V49, P2983, DOI 10.1128/AAC.49.7.2983-2985.2005; Parikh S, 2016, CLIN INFECT DIS, V63, P414, DOI 10.1093/cid/ciw291; Porter KA, 2012, ANTIMICROB AGENTS CH, V56, P995, DOI 10.1128/AAC.05322-11; Republic of Malawi MoH, 2008, REP MAL MIN HLTH NAT; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Skinner-Adams TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034399; Skinner-Adams TS, 2004, J INFECT DIS, V190, P1998, DOI 10.1086/425584; Violari A, 2012, NEW ENGL J MED, V366, P2380, DOI 10.1056/NEJMoa1113249; WHO, 2006, GUID CO TRIM PROPH H; WHO, 2009, CO TRIM PROPH HIV EX; World Health Organization, INT MAN CHILDH ILLN; World Health Organization, 2010, GUID HIV INF FEED 20; World Health Organization, CONS GUID US ANT DRU; World Health Organization, 2015, GUID TREATM MAL, Vthird; Ziemniak C, 2011, J CLIN MICROBIOL, V49, P4077, DOI 10.1128/JCM.01004-11	34	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0165140	10.1371/journal.pone.0165140	http://dx.doi.org/10.1371/journal.pone.0165140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936233	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100010
J	Holdsworth, WL; LaPlant, KE; Bell, DC; Jahn, MM; Mazourek, M				Holdsworth, William L.; LaPlant, Kyle E.; Bell, Duane C.; Jahn, Molly M.; Mazourek, Michael			Cultivar-Based Introgression Mapping Reveals Wild Species-Derived Pm-0, the Major Powdery Mildew Resistance Locus in Squash	PLOS ONE			English	Article							GENETIC-LINKAGE MAP; CUCURBITA-PEPO; SPHAEROTHECA-FULIGINEA; PODOSPHAERA-XANTHII; DISEASE RESISTANCE; GENOME ASSOCIATION; SUMMER SQUASH; PUMPKIN; POLYMORPHISMS; EVOLUTION	Powdery mildew is a major fungal disease on squash and pumpkin (Cucurbita spp.) in the US and throughout the world. Genetic resistance to the disease is not known to occur naturally within Cucurbita pepo and only infrequently in Cucurbita moschata, but has been achieved in both species through the introgression of a major resistance gene from the wild species Cucurbita okeechobeensis subsp. martinezii. At present, this gene, Pm-0, is used extensively in breeding, and is found in nearly all powdery mildew-resistant C. pepo and C. moschata commercial cultivars. In this study, we mapped C. okeechobeensis subsp. martinezii-derived single nucleotide polymorphism (SNP) alleles in a set of taxonomically and morphologically diverse and resistant C. pepo and C. moschata cultivars bred at Cornell University that, by common possession of Pm-0, form a shared-trait introgression panel. High marker density was achieved using genotyping-by-sequencing, which yielded over 50,000 de novo SNP markers in each of the three Cucurbita species genotyped. A single 516.4 kb wild-derived introgression was present in all of the resistant cultivars and absent in a diverse set of heirlooms that predated the Pm-0 introgression. The contribution of this interval to powdery mildew resistance was confirmed by association mapping in a C. pepo cultivar panel that included the Cornell lines, heirlooms, and 68 additional C. pepo cultivars and with an independent F-2 population derived from C. okeechobeensis subsp. martinezii x C. moschata. The interval was refined to a final candidate interval of 76.4 kb and CAPS markers were developed inside this interval to facilitate marker-assisted selection.	[Holdsworth, William L.; LaPlant, Kyle E.; Mazourek, Michael] Cornell Univ, Sch Integrat Plant Sci, Sect Plant Breeding & Genet, Ithaca, NY 14853 USA; [Holdsworth, William L.; Bell, Duane C.] Rupp Seeds Inc, Wauseon, OH USA; [Jahn, Molly M.] Univ Wisconsin, Dept Agron, 1575 Linden Dr, Madison, WI 53706 USA	Cornell University; University of Wisconsin System; University of Wisconsin Madison	Mazourek, M (corresponding author), Cornell Univ, Sch Integrat Plant Sci, Sect Plant Breeding & Genet, Ithaca, NY 14853 USA.	mm284@cornell.edu		Jahn, Molly/0000-0003-0181-0374	USDA National Institute of Food and Agriculture, Plant Breeding and Education [2010-85117-20551]; USDA National Institute of Food and Agriculture, Agriculture and Food Research Initiative [2013-67013-21232]; Rupp Seeds Inc; Rupp Seeds Inc.; Calvin Noyes Keeney Endowment for Plant Breeding; Cornell University; USDA National Institute of Food and Agriculture Specialty Crop Research Initiative [2015-51181-24285]	USDA National Institute of Food and Agriculture, Plant Breeding and Education; USDA National Institute of Food and Agriculture, Agriculture and Food Research Initiative; Rupp Seeds Inc; Rupp Seeds Inc.; Calvin Noyes Keeney Endowment for Plant Breeding; Cornell University; USDA National Institute of Food and Agriculture Specialty Crop Research Initiative	Support for William Holdsworth was provided by USDA National Institute of Food and Agriculture, Plant Breeding and Education Grant No. 2010-85117-20551 and the USDA National Institute of Food and Agriculture, Agriculture and Food Research Initiative Competitive Grant No. 2013-67013-21232 and was later employed by Rupp Seeds Inc. (a company that develops and distributes powdery mildew-resistant squash and pumpkin cultivars) during the time in which the manuscript was edited and in review. Duane Bell was employed by Rupp Seeds Inc and received salary support during which time he generated and phenotyped the C. okeechobeensis subsp. martinezii PI 532363 x C. moschata 'Burpee's Butterbush' F2 population. Rupp Seeds Inc. contributed resources for the analysis of the F2 population and support in the form of salaries for authors WLH and DB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Support for Kyle LaPlant was provided by the Calvin Noyes Keeney Endowment for Plant Breeding. Funding for the association analysis was provided via new faculty startup funds from Cornell University. Funding for marker development was provided by USDA National Institute of Food and Agriculture Specialty Crop Research Initiative Grant No. 2015-51181-24285. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADENIJI AA, 1983, J AM SOC HORTIC SCI, V108, P360; [Anonymous], SEQ VERS 4 9 SEQ AN; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Coffey MD, 2006, PHYTOPATHOLOGY, V96, pS25; Cohen R, 2003, EUPHYTICA, V130, P433, DOI 10.1023/A:1023082612420; COHEN R, 1993, PLANT PATHOL, V42, P510, DOI 10.1111/j.1365-3059.1993.tb01530.x; COHEN R, 2002, CUCURBITACEAE 2002, P181; Coleman C, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-89; Contin M., 1978, THESIS CORNELL U ITH; Coolong T, 2011, HORTTECHNOLOGY, V21, P533, DOI 10.21273/HORTTECH.21.5.533; Cornell University Experiment Station, 1999, PLANT VAR PROT BUGL; De Mendiburu F, 2009, HERRAMIENTA ANALISIS; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Esteras C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-80; Fernandez-Pozo N, 2014, NUCL ACIDS RES; Ferriol Maria, 2008, V1, P317; Formisano G, 2010, PLANT GENET RESOUR-C, V8, P198, DOI 10.1017/S1479262110000183; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Gong L, 2008, GENOME, V51, P878, DOI 10.1139/G08-072; Gong L, 2008, THEOR APPL GENET, V117, P37, DOI 10.1007/s00122-008-0750-2; Gong L, 2013, GENET RESOUR CROP EV, V60, P1531, DOI 10.1007/s10722-012-9940-5; Gong L, 2012, THEOR APPL GENET, V124, P875, DOI 10.1007/s00122-011-1752-z; Gonzalez AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010495; Hoberman R, 2009, GENOME RES, V19, P1542, DOI 10.1101/gr.092072.109; Hultengren R., 2016, BREEDING RES ED NEED; Jahn M, 2002, POWDERY MILDEWS: A COMPREHENSIVE TREATISE, P239; Kim KH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145665; Knstkova E, 2005, ACTA HORTIC, P510; Kyle M, 1995, INT S CUC 94 EV ENH; Lawson V, 2005, EVALUATION OF WINTER; Lebeda A, 1996, GENET RESOUR CROP EV, V43, P79, DOI 10.1007/BF00126944; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; McCreight J. D., 2004, Cucurbit Genetics Cooperative, P8; Mcgrath MT, 2007, PHYTOPATHOLOGY, V97, pS73; Mcgrath MT, 2009, PHYTOPATHOLOGY, V99, pS194; MCGRATH MT, 1994, MYCOLOGIA, V86, P517, DOI 10.2307/3760745; McGrath MT, 1996, PLANT DIS, V80, P1044, DOI 10.1094/PD-80-1044; McGrath MT, 2008, POWDERY MILDEW RESIS; McGrath MT, 2010, POWDERY MILDEW RESIS; McGrath MT, 2005, GUIDELINES MANAGING; Menda N, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0287-2; Moncada P, 2001, THEOR APPL GENET, V102, P41, DOI 10.1007/s001220051616; Navazio J., 2012, CUCURBITACEAE ORGANI, P207; NEE M, 1990, ECON BOT, V44, P56, DOI 10.1007/BF02860475; Nimmakayala P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-767; OBRIEN RG, 1988, AUST J EXP AGR, V28, P417, DOI 10.1071/EA9880417; PARIS H. S., 2005, HORTSCIENCE ALEXANDR, V40, P1630; Paris Harry S., 2008, V1, P351; Paris HS, 2003, THEOR APPL GENET, V106, P971, DOI 10.1007/S00122-002-1157-0; Paris HS, 2002, EUPHYTICA, V124, P121, DOI 10.1023/A:1015623013740; Perez-Garcia A, 2009, MOL PLANT PATHOL, V10, P153, DOI 10.1111/j.1364-3703.2008.00527.x; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; R Core Team, 2013, R LANG ENV STAT COMP; Reuscher S, 2015, 1 ANN TASSEL HACKATH; RHODES A. M., 1964, PLANT DIS REPTR, V48, P54; RHODES A. M., 1959, PROC AMER SOC HORT SCI, V74, P546; Robinson RW., 1997, CUCURBITS; SITTERLY WR, 1972, ANNU REV PHYTOPATHOL, V10, P471, DOI 10.1146/annurev.py.10.090172.002351; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; SOWELL G JR, 1973, Hortscience, V8, P492; Srichumpa P, 2005, PLANT PHYSIOL, V139, P885, DOI 10.1104/pp.105.062406; Staub JE., 1996, COMPENDIUM CUCURBIT, P66; Swarts K, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2014.05.0023; Turner S. D., 2014, BIORXIV, DOI DOI 10.1101/005165; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; VANDERBEEK JG, 1992, THEOR APPL GENET, V84, P106, DOI 10.1007/BF00223988; Vlot AC, 2008, PLANT J, V56, P445, DOI 10.1111/j.1365-313X.2008.03618.x; Wang QM, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100949, 10.1371/journal.pone.0110209]; WHITAKER TW, 1956, AM NAT, V90, P171, DOI 10.1086/281923; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Xiao SY, 2001, SCIENCE, V291, P118, DOI 10.1126/science.291.5501.118; Yanagisawa S, 2002, TRENDS PLANT SCI, V7, P555, DOI 10.1016/S1360-1385(02)02362-2; Yang SH, 2013, P NATL ACAD SCI USA, V110, P18572, DOI 10.1073/pnas.1318211110; Zhang B, 1995, PLANT CELL, V7, P2241, DOI 10.1105/tpc.7.12.2241; Zhang Q, 2013, patent, Patent No. [US 20130283463 A1, 20130283463]; Zhou J, 2010, ACTA HORTIC	79	22	24	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167715	10.1371/journal.pone.0167715	http://dx.doi.org/10.1371/journal.pone.0167715			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936008	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100161
J	Jalan-Sakrikar, N; De Assuncao, TM; Lu, J; Almada, LL; Lomberk, G; Fernandez-Zapico, ME; Urrutia, R; Huebert, RC				Jalan-Sakrikar, Nidhi; De Assuncao, Thiago M.; Lu, Jie; Almada, Luciana L.; Lomberk, Gwen; Fernandez-Zapico, Martin E.; Urrutia, Raul; Huebert, Robert C.			Hedgehog Signaling Overcomes an EZH2-Dependent Epigenetic Barrier to Promote Cholangiocyte Expansion	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; SONIC HEDGEHOG; LIVER; DIFFERENTIATION; EZH2; PROLIFERATION; HEPATOCYTES; ACTIVATION; EXPRESSION; BIOLOGY	Background & Aims Developmental morphogens play an important role in coordinating the ductular reaction and portal fibrosis occurring in the setting of cholangiopathies. However, little is known about how membrane signaling events in ductular reactive cells (DRCs) are transduced into nuclear transcriptional changes to drive cholangiocyte maturation and matrix deposition. Therefore, the aim of this study was to investigate potential mechanistic links between cell signaling events and epigenetic regulators in DRCs. Methods Using directed differentiation of induced pluripotent stem cells (iPSC), isolated DRCs, and in vivo models, we examine the mechanisms whereby sonic hedgehog (Shh) overcomes an epigenetic barrier in biliary precursors and promotes both cholangiocyte maturation and deposition of fibronectin (FN). Results We demonstrate, for the first time, that Gli1 influences the differentiation state and fibrogenic capacity of iPSC-derived hepatic progenitors and isolated DRCs. We outline a novel pathway wherein Shh-mediated Gli1 binding in key cholangiocyte gene promoters overcomes an epigenetic barrier conferred by the polycomb protein, enhancer of zeste homolog 2 (EZH2) and initiates the transcriptional program of cholangiocyte maturation. We also define previously unknown functional Gli1 binding sites in the promoters of cytokeratin (CK)7, CK19, and FN. Our in vivo results show that EZH2 KO mice fed the choline-deficient, ethanolamine supplemented (CDE) diet have an exaggerated cholangiocyte expansion associated with more robust ductular reaction and increased peri-portal fibrosis. Conclusion We conclude that Shh/Gli1 signaling plays an integral role in cholangiocyte maturation in vitro by overcoming an EZH2-dependent epigenetic barrier and this mechanism also promotes biliary expansion in vivo.	[Jalan-Sakrikar, Nidhi; De Assuncao, Thiago M.; Lu, Jie; Lomberk, Gwen; Urrutia, Raul; Huebert, Robert C.] Mayo Clin & Mayo Fdn, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Jalan-Sakrikar, Nidhi; De Assuncao, Thiago M.; Lu, Jie; Lomberk, Gwen; Urrutia, Raul; Huebert, Robert C.] Mayo Clin & Mayo Fdn, Gastroenterol Res Unit, Rochester, MN 55905 USA; [Almada, Luciana L.; Fernandez-Zapico, Martin E.] Mayo Clin & Mayo Fdn, Schultze Ctr Novel Therapeut, Rochester, MN USA; [Lomberk, Gwen; Fernandez-Zapico, Martin E.; Urrutia, Raul; Huebert, Robert C.] Mayo Clin & Mayo Fdn, Ctr Cell Signaling Gastroenterol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Huebert, RC (corresponding author), Mayo Clin & Mayo Fdn, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA.; Huebert, RC (corresponding author), Mayo Clin & Mayo Fdn, Gastroenterol Res Unit, Rochester, MN 55905 USA.; Huebert, RC (corresponding author), Mayo Clin & Mayo Fdn, Ctr Cell Signaling Gastroenterol, Rochester, MN 55905 USA.	huebert.robert@mayo.edu	Lomberk, Gwen/AAL-8490-2020; Jalan-Sakrikar, Nidhi/S-8653-2019	Lomberk, Gwen/0000-0001-5463-789X; Jalan-Sakrikar, Nidhi/0000-0001-6795-0121	Loan Repayment Program from the National Institutes of Health; Regenerative Medicine Minnesota; Department of Gastroenterology, Shanghai 10th People's Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China; Gilead Sciences; Mayo Clinic Center for Regenerative Medicine;  [DK100575];  [DK084567]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913, K08DK100575, P30DK084567] Funding Source: NIH RePORTER	Loan Repayment Program from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Regenerative Medicine Minnesota; Department of Gastroenterology, Shanghai 10th People's Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China; Gilead Sciences(Gilead Sciences); Mayo Clinic Center for Regenerative Medicine; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants DK100575, DK084567, and the Loan Repayment Program from the National Institutes of Health; by Regenerative Medicine Minnesota; by the Department of Gastroenterology, Shanghai 10th People's Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China; by Gilead Sciences; and by the Mayo Clinic Center for Regenerative Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altrock E, 2015, J HEPATOL, V62, P625, DOI 10.1016/j.jhep.2014.06.010; Alvaro D, 2008, MOL ASPECTS MED, V29, P50, DOI 10.1016/j.mam.2007.09.007; Cayo MA, 2012, HEPATOLOGY, V56, P2163, DOI 10.1002/hep.25871; Choi SM, 2013, HEPATOLOGY, V57, P2458, DOI 10.1002/hep.26237; De Assuncao TM, 2015, LAB INVEST, V95, P684, DOI 10.1038/labinvest.2015.51; Dianat N, 2014, HEPATOLOGY, V60, P700, DOI 10.1002/hep.27165; Ding H, 2012, J AM SOC NEPHROL, V23, P801, DOI 10.1681/ASN.2011060614; Ding XL, 2014, STEM CELLS DEV, V23, P931, DOI 10.1089/scd.2013.0267; Dolle L, 2015, AM J PHYSIOL-GASTR L, V308, pG233, DOI 10.1152/ajpgi.00069.2014; Fausther Michel, 2013, Curr Pathobiol Rep, V1, P225; Greenbaum LE, 2008, J CLIN INVEST, V118, P3263, DOI 10.1172/JCI37189; Greenbaum LE, 2011, INT J BIOCHEM CELL B, V43, P222, DOI 10.1016/j.biocel.2009.11.006; Grzenda A, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-3; Halilbasic E, 2015, DIGEST DIS, V33, P149, DOI 10.1159/000440827; Hanaoka J, 2013, SURG TODAY, V43, P300, DOI 10.1007/s00595-012-0248-z; Hirose Y, 2009, EXP CELL RES, V315, P2648, DOI 10.1016/j.yexcr.2009.06.018; Kang NL, 2015, MOL CANCER RES, V13, P604, DOI 10.1158/1541-7786.MCR-14-0542; Karantanos T, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00172; Koike H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104776; Lazaridis KN, 2015, MAYO CLIN PROC, V90, P791, DOI 10.1016/j.mayocp.2015.03.017; Bolanos AL, 2012, AM J PHYSIOL-LUNG C, V303, pL978, DOI 10.1152/ajplung.00184.2012; Mann DA, 2014, HEPATOLOGY, V60, P1418, DOI 10.1002/hep.27131; McCabe MT, 2014, EPIGENOMICS-UK, V6, P341, DOI [10.2217/EPI.14.23, 10.2217/epi.14.23]; Michelotti GA, 2013, J CLIN INVEST, V123, P2380, DOI 10.1172/JCI66904; Nakamura N, 2012, CELL REPROGRAM, V14, P171, DOI 10.1089/cell.2011.0064; Nye MD, 2014, J BIOL CHEM, V289, P15495, DOI 10.1074/jbc.M113.545194; Ogawa M, 2015, NAT BIOTECHNOL, V33, P853, DOI 10.1038/nbt.3294; Omenetti A, 2008, GUT, V57, P1275, DOI 10.1136/gut.2008.148619; Omenetti A, 2008, J CLIN INVEST, V118, P3331, DOI 10.1172/JCI35875; Omenetti A, 2007, LAB INVEST, V87, P499, DOI 10.1038/labinvest.3700537; Omenetti A, 2009, HEPATOLOGY, V50, P518, DOI 10.1002/hep.23019; Razumilava N, 2014, J HEPATOL, V60, P599, DOI 10.1016/j.jhep.2013.11.005; Sahin MB, 2008, LIVER TRANSPLANT, V14, P333, DOI 10.1002/lt.21380; Sampaziotis F, 2015, NAT BIOTECHNOL, V33, P845, DOI 10.1038/nbt.3275; Sasaki M, 2015, HISTOL HISTOPATHOL, V30, P267, DOI 10.14670/HH-30.267; Shin DH, 2013, COMPR PHYSIOL, V3, P799, DOI 10.1002/cphy.c120022; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka M, 2012, METHODS MOL BIOL, V826, P25, DOI 10.1007/978-1-61779-468-1_3; Tanimizu N, 2014, DEVELOPMENT, V141, P4448, DOI 10.1242/dev.113654; Tanimizu N, 2014, ORGANOGENESIS, V10, P208, DOI 10.4161/org.27591; Tian AG, 2015, J CELL BIOL, V208, P807, DOI 10.1083/jcb.201409025; Wong TY, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2809192; Xu D, 2009, P NATL ACAD SCI USA, V106, P808, DOI 10.1073/pnas.0812090106; Yin J, 2015, MEDIAT INFLAMM, V2015, DOI DOI 10.1155/2015/272313; Yovchev Mladen I, 2013, Methods Mol Biol, V976, P37, DOI 10.1007/978-1-62703-317-6_4; Yu Y, 2012, LIVER TRANSPLANT, V18, P9, DOI 10.1002/lt.22467; Zeybel M, 2013, J HEPATOL, V59, P1349, DOI 10.1016/j.jhep.2013.05.039	47	11	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168266	10.1371/journal.pone.0168266	http://dx.doi.org/10.1371/journal.pone.0168266			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936185	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100286
J	Muller, A; Berkmann, JC; Scheerer, P; Biebermann, H; Kleinau, G				Mueller, Anne; Berkmann, Julia Catherine; Scheerer, Patrick; Biebermann, Heike; Kleinau, Gunnar			Insights into Basal Signaling Regulation, Oligomerization, and Structural Organization of the Human G-Protein Coupled Receptor 83	PLOS ONE			English	Article							GLUCOCORTICOID-INDUCED RECEPTOR; HUMAN THYROTROPIN RECEPTOR; CRYSTAL-STRUCTURE; OPIOID RECEPTOR; NEUROTENSIN RECEPTOR; ACTIVATION; DOMAIN; GPR83; GPCR; IDENTIFICATION	The murine G-protein coupled receptor 83 (mGPR83) is expressed in the hypothalamus and was previously suggested to be involved in the regulation of metabolism. The neuropeptide PEN has been recently identified as a potent GPR83 ligand. Moreover, GPR83 constitutes functionally relevant hetero-oligomers with other G-protein coupled receptors (GPCR) such as the ghrelin receptor (GHSR) or GPR171. Previous deletion studies also revealed that the long N-terminal extracellular receptor domain (eNDo) of mGPR83 may act as an intra-molecular ligand, which participates in the regulation of basal signaling activity, which is a key feature of GPCR function. Here, we investigated particular amino acids at the eNDo of human GPR83 (hGPR83) by side-directed mutagenesis to identify determinants of the internal ligand. These studies were accompanied by structure homology modeling to combine functional insights with structural information. The capacity for hetero-oligomer formation of hGPR83 with diverse family A GPCRs such as the melanocortin-4 receptor (MC4R) was also investigated, with a specific emphasis on the impact of the eNDo on oligomerization and basal signaling properties. Finally, we demonstrate that hGPR83 exhibits an unusual basal signaling for different effectors, which also supports signaling promiscuity. hGPR83 interacts with a variety of hypothalamic GPCRs such as the MC4R or GHSR. These interactions are not dependent on the ectodomain and most likely occur at interfaces constituted in the transmembrane regions. Moreover, several amino acids at the transition between the eNDo and transmembrane helix 1 were identified, where mutations lead also to biased basal signaling modulation.	[Mueller, Anne; Berkmann, Julia Catherine; Biebermann, Heike; Kleinau, Gunnar] Charite Univ Med Berlin, Inst Expt Pediat Endocrinol, D-13353 Berlin, Germany; [Scheerer, Patrick] Charite Univ Med Berlin, Grp Prot Xray Crystallog & Signal Transduct, Inst Med Phys & Biophys, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kleinau, G (corresponding author), Charite Univ Med Berlin, Inst Expt Pediat Endocrinol, D-13353 Berlin, Germany.	gunnar.kleinau@charite.de	Kleinau, Gunnar/GPX-6330-2022	Muller, Anne/0000-0002-6256-8860; Berkmann, Julia Catherine/0000-0002-5869-504X; Biebermann, Heike/0000-0002-2024-7778; Scheerer, Patrick/0000-0001-5028-2075	Else Kroner-Fresenius-Stiftung (EKFS) [2014_A114]; Deutsche Forschungsgemeinschaft DFG [BI 893/2-2, SFB740-B6, SFB1078-B6, D3/E3-1]; Helmholtz Alliance, "Imaging and Curing Environmental Metabolic Diseases" (ICEMED) [WP19]	Else Kroner-Fresenius-Stiftung (EKFS); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Helmholtz Alliance, "Imaging and Curing Environmental Metabolic Diseases" (ICEMED)	This work is supported by the Else Kroner-Fresenius-Stiftung (EKFS) project 2014_A114 to GK and HB, by the Deutsche Forschungsgemeinschaft DFG (BI 893/2-2 to HB; SFB740-B6 and SFB1078-B6 to PS; DFG - Cluster of Excellence UniCat 'Unifying Concepts in Catalysis' Research Field D3/E3-1 to PS) and by the Helmholtz Alliance, "Imaging and Curing Environmental Metabolic Diseases" (ICEMED), WP19 to HB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgeier A, 1997, MOL CELL ENDOCRINOL, V127, P81, DOI 10.1016/S0303-7207(96)03996-2; ALLGEIER A, 1994, J BIOL CHEM, V269, P13733; Audet M, 2012, CELL, V151, P14, DOI 10.1016/j.cell.2012.09.003; Bakker RA, 2004, J PHARMACOL EXP THER, V311, P131, DOI 10.1124/jpet.104.067041; Biebermann H, 2003, DIABETES, V52, P2984, DOI 10.2337/diabetes.52.12.2984; Biebermann Heike, 2012, Handb Exp Pharmacol, P47, DOI 10.1007/978-3-642-24716-3_3; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Brezillon S, 2001, BRAIN RES, V921, P21, DOI 10.1016/S0006-8993(01)03068-2; Buech TRH, 2008, J BIOL CHEM, V283, P20330, DOI 10.1074/jbc.M800211200; Costanzi Stefano, 2012, Methods Mol Biol, V857, P259, DOI 10.1007/978-1-61779-588-6_11; De Moerlooze L, 2000, CYTOGENET CELL GENET, V90, P146, DOI 10.1159/000015650; DeVree BT, 2016, NATURE, V535, P182, DOI 10.1038/nature18324; Dubins JS, 2012, METABOLISM, V61, P1486, DOI 10.1016/j.metabol.2012.03.015; Elsner A, 2006, PEPTIDES, V27, P372, DOI 10.1016/j.peptides.2005.02.027; Garland SL, 2013, J BIOMOL SCREEN; George SR, 1998, J BIOL CHEM, V273, P30244, DOI 10.1074/jbc.273.46.30244; George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913; Gomes I, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad0694; Gomes I, 2016, ANNU REV PHARMACOL, V56, P403, DOI 10.1146/annurev-pharmtox-011613-135952; Gorinski N, 2012, MOL PHARMACOL, V82, P448, DOI 10.1124/mol.112.079137; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; HARRIGAN MT, 1991, MOL ENDOCRINOL, V5, P1331, DOI 10.1210/mend-5-9-1331; Hu JX, 2013, J BIOL CHEM, V288, P34777, DOI 10.1074/jbc.M113.503714; Huang J., 2013, ADV MECH ENG, V2013, P1, DOI DOI 10.1038/NSMB; Kenakin T, 2005, TRENDS PHARMACOL SCI, V26, P603, DOI 10.1016/j.tips.2005.10.007; Kleinau G, 2016, J MOL ENDOCRINOL; Kleinau Gunnar, 2014, Adv Pharmacol, V70, P81, DOI 10.1016/B978-0-12-417197-8.00003-1; Krumm BE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8895; Lambert NA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115pe12; Laugwitz KL, 1996, P NATL ACAD SCI USA, V93, P116, DOI 10.1073/pnas.93.1.116; LAURENT E, 1987, MOL CELL ENDOCRINOL, V52, P273, DOI 10.1016/0303-7207(87)90055-4; Mancia F, 2008, EMBO REP, V9, P363, DOI 10.1038/embor.2008.27; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Martin AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138463; Muller A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053347; Muller TD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2968; Muller Anne, 2014, BMC Res Notes, V7, P913, DOI 10.1186/1756-0500-7-913; Nyfeler B, 2008, J CELL BIOL, V180, P705, DOI 10.1083/jcb.200709100; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Piechowski CL, 2013, J MOL ENDOCRINOL, V51, P109, DOI 10.1530/JME-13-0061; Piscitelli CL, 2015, MOL PHARMACOL, V88, P536, DOI 10.1124/mol.115.099663; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rediger A, 2009, OBESITY FACTS, V2, P80, DOI 10.1159/000209862; Rozenfeld R, 2011, BIOCHEM J, V433, P11, DOI 10.1042/BJ20100458; Rozenfeld R, 2010, TRENDS PHARMACOL SCI, V31, P124, DOI 10.1016/j.tips.2009.11.008; Sah R, 2007, PEPTIDES, V28, P302, DOI 10.1016/j.peptides.2006.11.013; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schoneberg T, 2016, PHARMACOL RES, V108, P9, DOI 10.1016/j.phrs.2016.03.027; Schulz A, 2000, J BIOL CHEM, V275, P2381, DOI 10.1074/jbc.275.4.2381; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Smit MJ, 2007, ANNU REV PHARMACOL, V47, P53, DOI 10.1146/annurev.pharmtox.47.120505.105126; Szczepek M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5801; Tao YX, 2014, PROG MOL BIOL TRANSL, V121, P1, DOI 10.1016/B978-0-12-800101-1.00001-6; Tao YX, 2014, PREFACE ADV PHARM, V70, pix, DOI [DOI 10.1016/B978-0-12-417197-8.10000-8, 10.1016/B978-0-12-417197-8.10000-8]; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Van Sande J, 2006, J CLIN ENDOCR METAB, V91, P1099, DOI 10.1210/jc.2005-1324; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Yanagawa M, 2011, J BIOL CHEM, V286, P22971, DOI 10.1074/jbc.M110.206870; Zhang HT, 2015, J BIOL CHEM, V290, P29127, DOI 10.1074/jbc.M115.689000; Zhou XE, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.21	64	11	11	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168260	10.1371/journal.pone.0168260	http://dx.doi.org/10.1371/journal.pone.0168260			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936173	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100285
J	Ota, S; Nishimura, M; Murakami, Y; Birukawa, NK; Yoneda, A; Nishita, H; Fujita, R; Sato, Y; Minomi, K; Kajiwara, K; Miyazaki, M; Uchiumi, M; Mikuni, S; Tamura, Y; Mizuguchi, T; Imamura, M; Meguro, M; Kimura, Y; Hirata, K; Niitsu, Y				Ota, Shigenori; Nishimura, Miyuki; Murakami, Yuya; Birukawa, Naoko Kubo; Yoneda, Akihiro; Nishita, Hiroki; Fujita, Ryosuke; Sato, Yasushi; Minomi, Kenjiro; Kajiwara, Keiko; Miyazaki, Miyono; Uchiumi, Maki; Mikuni, Shintaro; Tamura, Yasuaki; Mizuguchi, Toru; Imamura, Masafumi; Meguro, Makoto; Kimura, Yasutoshi; Hirata, Koichi; Niitsu, Yoshiro			Involvement of Pancreatic Stellate Cells in Regeneration of Remnant Pancreas after Partial Pancreatectomy	PLOS ONE			English	Article							COLLAGEN-SPECIFIC CHAPERONE; A-COUPLED LIPOSOMES; BETA-CELLS; ADULT-MOUSE; ACINAR-CELL; ENDOCRINE; EXOCRINE; RATS; PROGENITORS; FIBROSIS	Background and objectives Mechanism of regeneration of remnant pancreas after partial pancreatectomy (PX) is still unknown. In this study, effect of siRNA against the collagen specific chaperone, HSP47, which inhibits collagen secretion from activated pancreas stellate cells (aPSCs), and induces their apoptosis, on regeneration of remnant pancreas was determined. Methods Pancreatectomy was performed according to established methods. Proliferation of cells was assessed by BrdU incorporation. Immunostaining of HSP47 was employed to identify PSCs. Progenitor cells were identified by SOX9 staining. Acinar cells were immunostained for amylase. Co-culture of acinar cells with aPSCs were carried out in a double chamber with a cell culture insert. siRNA HSP47 encapsulated in vitamin A-coupled liposome (VA-lip siRNA HSP47) was delivered to aPSCs by iv injection. Results In remnant pancreas of 90% PX rat, new areas of foci were located separately from duodenal areas with normal pancreatic features. After PX, BrdU uptake of acinar cells and islet cells significantly increased, but was suppressed by treatment with VA-lip siRNA HSP47. BrdU uptake by acinar cells was augmented by co-culturing with aPSCs and the augmentation was nullified by siRNA HSP47. BrdU uptake by progenitor cells in foci area was slightly enhanced by the same treatment. New area which exhibited intermediate features between those of duodenal and area of foci, emerged after the treatment. Conclusion aPSCs play a crucial role in regeneration of remnant pancreas, proliferation of acinar and islet cells after PX through the activity of secreted collagen. Characterization of new area emerged by siRNA HSP47 treatment as to its origin is a future task.	[Ota, Shigenori; Nishimura, Miyuki; Murakami, Yuya; Birukawa, Naoko Kubo; Yoneda, Akihiro; Nishita, Hiroki; Fujita, Ryosuke; Minomi, Kenjiro; Kajiwara, Keiko; Miyazaki, Miyono; Niitsu, Yoshiro] Sapporo Med Univ, Dept Mol Target Explorat, Sapporo, Hokkaido, Japan; [Ota, Shigenori; Mizuguchi, Toru; Imamura, Masafumi; Meguro, Makoto; Kimura, Yasutoshi; Hirata, Koichi] Sapporo Med Univ, Dept Surg Surg Oncol & Sci, Sapporo, Hokkaido, Japan; [Yoneda, Akihiro; Uchiumi, Maki; Mikuni, Shintaro; Tamura, Yasuaki] Hokkaido Univ, Ctr Food & Med Innovat, Dept Mol Therapeut, Sapporo, Hokkaido 060, Japan; [Nishita, Hiroki; Minomi, Kenjiro; Kajiwara, Keiko; Miyazaki, Miyono] Hokkaido Univ, Nitto Denko Corp, Corp Business Dev Div, Hokkaido Lab Mol Therapeut, Sapporo, Hokkaido 060, Japan; [Sato, Yasushi] Sapporo Med Univ, Dept Med Oncol & Hematol, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; Hokkaido University; Hokkaido University; Nitto Denko Corporation; Sapporo Medical University	Niitsu, Y (corresponding author), Sapporo Med Univ, Dept Mol Target Explorat, Sapporo, Hokkaido, Japan.	niitsu@sapmed.ac.jp	今村, 将史/AAC-7369-2022	Sato, Yasushi/0000-0002-6776-4609	KAKENHI-PROJECT [25861207]	KAKENHI-PROJECT	The author received support from KAKENHI-PROJECT; Project Number was 25861207, https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-25861207/. Research Category was Grant-in-Aid for Encouragement of Young Scientists (B). The author was principal Investigator. Investigator ID was 90457705. Project Fiscal Year was 2013-04-01 - 2015-03-31 (Estimated).	Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Baeyens L, 2014, NAT BIOTECHNOL, V32, P76, DOI 10.1038/nbt.2747; Birukawa NK, 2014, J BIOL CHEM, V289, P20209, DOI 10.1074/jbc.M113.544494; Bonner-Weir S, 1993, DIABETES; Criscimanna A, 2011, GASTROENTEROLOGY, V141, P1451, DOI 10.1053/j.gastro.2011.07.003; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Erkan M, 2012, GUT, V61, P172, DOI 10.1136/gutjnl-2011-301220; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Ishiwatari H, 2013, GUT, V62, P1328, DOI 10.1136/gutjnl-2011-301746; Kim TH, 1997, HEPATOLOGY, V26, P896, DOI 10.1002/hep.510260415; Ko SBH, 2010, GASTROENTEROLOGY, V138, P1988, DOI 10.1053/j.gastro.2010.01.001; LEHV M, 1968, AM J PATHOL, V53, P513; Li WC, 2010, J CELL SCI, V123, P2792, DOI 10.1242/jcs.065268; Luttenberger T, 2000, LAB INVEST, V80, P47, DOI 10.1038/labinvest.3780007; Menge BA, 2008, DIABETES, V57, P142, DOI 10.2337/db07-1294; Migliorini A, 2014, MOL METAB, V3, P268, DOI 10.1016/j.molmet.2014.01.010; Pan FC, 2013, DEVELOPMENT, V140, P751, DOI 10.1242/dev.090159; PEARSON KW, 1977, GASTROENTEROLOGY, V72, P469; Sato N, 1998, DIGEST DIS SCI, V43, P2616, DOI 10.1023/A:1026686824173; Sato Y, 2008, NAT BIOTECHNOL, V26, P431, DOI 10.1038/nbt1396; Smukler SR, 2011, CELL STEM CELL, V8, P281, DOI 10.1016/j.stem.2011.01.015; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Xiao XW, 2013, J CLIN INVEST, V123, P2207, DOI 10.1172/JCI66323; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yoneda S, 2013, J CLIN ENDOCR METAB, V98, P2053, DOI 10.1210/jc.2012-3832; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Ziv O, 2013, DEV CELL, V26, P3, DOI 10.1016/j.devcel.2013.06.013	28	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0165747	10.1371/journal.pone.0165747	http://dx.doi.org/10.1371/journal.pone.0165747			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935983	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100015
J	Xu, LF; Zhang, ZY; Xie, TH; Zhang, XY; Dai, T				Xu, Lifang; Zhang, Ziyin; Xie, Tianhua; Zhang, Xiaoyang; Dai, Tu			Inhibition of BDNF-AS Provides Neuroprotection for Retinal Ganglion Cells against Ischemic Injury	PLOS ONE			English	Article							LONG NONCODING RNAS; NEUROTROPHIC FACTOR; GROWTH-FACTOR; RAT RETINA; EXPRESSION; APOPTOSIS	Background: Brain-derived neurotrophic factor (BDNF) protects retinal ganglion cells against ischemia in ocular degenerative diseases. We aimed to determine the effect of BDNF-AS on the ischemic injury of retinal ganglion cells. Methods: The levels of BDNF and BDNF-AS were measured in retinal ganglion cells subjected to oxygen and glucose deprivation. The lentiviral vectors were constructed to either overexpress or knock out BDNF-AS. The luciferase reporter gene assay was used to determine whether BDNF-AS could target its seed sequence on BDNF mRNA. The methyl thiazolyl tetrazolium assay was used to determine cell viability, and TUNEL staining was used for cell apoptosis. Results: The levels of BDNF-AS were negatively correlated with BDNF in ischemic retinal ganglion cells. BDNFAS directly targeted its complementary sequences on BDNF mRNA. BDNF-AS regulated the expression of BDNF and its related genes in retinal ganglion cells. Down-regulation of BDNF-AS increased cell viability and decreased the number of TUNEL-positive retinal ganglion cells under oxygen and glucose deprivation conditions. Conclusion: Inhibition of BDNF-AS protected retinal ganglion cells against ischemia by increasing the levels of BDNF.	[Xu, Lifang; Zhang, Ziyin; Xie, Tianhua; Zhang, Xiaoyang] Wuxi Peoples Hosp, Dept Ophthalmol, Wuxi, Jiangsu, Peoples R China; [Dai, Tu] Wuxi 2 Peoples Hosp, Dept Hepatobiliary, Wuxi, Jiangsu, Peoples R China	Jiangnan University	Dai, T (corresponding author), Wuxi 2 Peoples Hosp, Dept Hepatobiliary, Wuxi, Jiangsu, Peoples R China.	wxdaitut@163.com						Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Dharap A, 2012, STROKE, V43, P2800, DOI 10.1161/STROKEAHA.112.669465; Feng Y, 2012, EXP CLIN ENDOCR DIAB, V120, P199, DOI 10.1055/s-0032-1304571; Guo XJ, 2014, EXP EYE RES, V125, P156, DOI 10.1016/j.exer.2014.06.003; Jiang Y, 2011, NEUROSCIENCE, V172, P398, DOI 10.1016/j.neuroscience.2010.10.054; Khalin I, 2015, INT J NANOMED, V10, P3245, DOI 10.2147/IJN.S77480; Kurokawa T, 1999, INVEST OPHTH VIS SCI, V40, P3006; Lambert WS, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-51; Li JY, 2015, J CRANIOFAC SURG, V26, P548, DOI 10.1097/SCS.0000000000001348; Liu YB, 2015, CELL PHYSIOL BIOCHEM, V35, P1986, DOI 10.1159/000374006; Marler KJ, 2014, J NEUROSCI, V34, P969, DOI 10.1523/JNEUROSCI.1910-13.2014; Mehta SL, 2015, J NEUROSCI, V35, P16443, DOI 10.1523/JNEUROSCI.2943-15.2015; Modarresi F, 2012, NAT BIOTECHNOL, V30, P453, DOI 10.1038/nbt.2158; Qian WF, 2011, BRAZ J MED BIOL RES, V44, P1222, DOI [10.1590/S0100-879X2011007500143, 10.1590/S0100-879X2011001200005]; Roberti G, 2014, J CELL PHYSIOL, V229, P1130, DOI 10.1002/jcp.24573; Steuer H, 2005, INVEST OPHTH VIS SCI, V46, P1047, DOI 10.1167/iovs.04-0925; Strettoi E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00494; UNOKI K, 1994, INVEST OPHTH VIS SCI, V35, P907; Wang RB, 2016, BRAIN RES, V1632, P82, DOI 10.1016/j.brainres.2015.12.015; Weber AJ, 2013, INVEST OPHTH VIS SCI, V54, P6594, DOI 10.1167/iovs.13-12683; Xie B, 2011, J NEUROSCI, V31, P5032, DOI 10.1523/JNEUROSCI.5504-10.2011; Zhang XM, 2010, MOL VIS, V16, P2867	22	25	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0164941	10.1371/journal.pone.0164941	http://dx.doi.org/10.1371/journal.pone.0164941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935942	gold, Green Submitted, Green Published			2022-12-27	WOS:000389587100008
J	Fujio, N; Masuoka, S; Shikano, K; Kusunoki, N; Nanki, T; Kawai, S				Fujio, Natsuki; Masuoka, Shotaro; Shikano, Kotaro; Kusunoki, Natsuko; Nanki, Toshihiro; Kawai, Shinichi			Apparent Hypothalamic-Pituitary-Adrenal Axis Suppression via Reduction of Interleukin-6 by Glucocorticoid Therapy in Systemic Autoimmune Diseases	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; POLYMYALGIA-RHEUMATICA; LUPUS-ERYTHEMATOSUS; SERUM-LEVELS; STEROIDOGENESIS; EXPRESSION; CYTOKINES; NCI-H295R; HORMONES; PROTEIN	Context Suppression of the hypothalamic-pituitary-adrenal (HPA) axis is a serious complication of systemic glucocorticoid therapy. Objective To clarify the influence of proinflammatory cytokines on the HPA axis after onset of glucocorticoid therapy in patients with systemic autoimmune diseases. Patients and Methods Forty-eight glucocorticoid-naive patients with systemic autoimmune diseases (28 women) who were starting prednisolone therapy according to our standard regimens were prospectively observed. Patients were classified into high-dose and low-dose groups depending on the dose of prednisolone administered as indicated for their diseases. Plasma adrenocorticotropic hormone (ACTH) and serum cortisol levels were measured by electrochemiluminescence immunoassay. The corticotropin-releasing hormone (CRH) test was performed at baseline and second and forth weeks after starting glucocorticoid therapy. The increased levels of ACTH (Delta ACTH) and cortisol (Delta cortisol) were investigated. Serum levels of 10 proinflammatory cytokines were measured simultaneously by a multi-spot assay system. Results In the high-dose group, both basal and stimulated levels of ACTH and cortisol were significantly decreased by glucocorticoid therapy. In the low-dose group, basal ACTH and cortisol levels were also significantly decreased by glucocorticoid therapy, but Delta ACTH and Delta cortisol were unchanged. Among 10 cytokines, only interleukin (IL)-6 was significantly decreased by glucocorticoid therapy in both groups and was more closely correlated with cortisol than ACTH. Basal cortisol level was positively correlated with serum IL-6 level in all patients before glucocorticoid therapy. Conclusion In patients with systemic autoimmune diseases, apparent suppression of cortisol during glucocorticoid therapy may be partly mediated by reduced production of IL-6.	[Fujio, Natsuki; Masuoka, Shotaro; Shikano, Kotaro; Kusunoki, Natsuko; Nanki, Toshihiro; Kawai, Shinichi] Toho Univ, Sch Med, Fac Med, Dept Internal Med,Div Rheumatol,Ota Ku, Tokyo, Japan		Kawai, S (corresponding author), Toho Univ, Sch Med, Fac Med, Dept Internal Med,Div Rheumatol,Ota Ku, Tokyo, Japan.	skawai@med.toho-u.ac.jp			Heisei 26 Strategic Research Foundation Project for Private Schools from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Agency for Medical Research and Development on Regulatory Science of Pharmaceuticals and Medical Devices	Heisei 26 Strategic Research Foundation Project for Private Schools from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Agency for Medical Research and Development on Regulatory Science of Pharmaceuticals and Medical Devices(Japan Agency for Medical Research and Development (AMED))	This study was partly supported by a grant from the Heisei 26 Strategic Research Foundation Project for Private Schools from the Ministry of Education, Culture, Sports, Science and Technology of Japan to Toho University (2014-2016) and a grant from the Japan Agency for Medical Research and Development on Regulatory Science of Pharmaceuticals and Medical Devices (2015-2016) to SK.	BERTOUCH JV, 1983, ANN RHEUM DIS, V42, P655, DOI 10.1136/ard.42.6.655; Bornstein SR, 1999, J CLIN ENDOCR METAB, V84, P1729; Crofford LJ, 1997, J CLIN ENDOCR METAB, V82, P1279, DOI 10.1210/jc.82.4.1279; Cutolo M, 2002, J RHEUMATOL, V29, P748; Demir H, 2006, SCAND J RHEUMATOL, V35, P217, DOI 10.1080/03009740500474586; Franchimont D, 2000, GASTROENTEROLOGY, V119, P1560, DOI 10.1053/gast.2000.20235; GABAY C, 1994, ARTHRITIS RHEUM, V37, P1744, DOI 10.1002/art.1780371206; Grondal G, 2000, CLIN EXP RHEUMATOL, V18, P565; Hahn BH., 2015, HARRISONS PRINCIPLES, P2124; Hassan AB, 2006, J AUTOIMMUN, V27, P62, DOI 10.1016/j.jaut.2006.06.003; Jenks BG, 2009, ANN NY ACAD SCI, V1163, P17, DOI 10.1111/j.1749-6632.2008.03620.x; MASTORAKOS G, 1993, J CLIN ENDOCR METAB, V77, P1690, DOI 10.1210/jc.77.6.1690; Mikhaylova IV, 2007, ENDOCRINOLOGY, V148, P386, DOI 10.1210/en.2006-0726; PERLSTEIN RS, 1993, ENDOCRINOLOGY, V132, P946, DOI 10.1210/en.132.3.946; Qiu F, 2013, LUPUS, V22, P1011, DOI 10.1177/0961203313498799; Salvarani C, 1997, LANCET, V350, P43, DOI 10.1016/S0140-6736(97)05001-0; Schuetz Philipp, 2008, BMC Pulm Med, V8, P1, DOI 10.1186/1471-2466-8-1; Stewart PM, 2016, WILLIAMS TXB ENDOCRI, V13, P490; Straub RH, 2000, RHEUMATOLOGY, V39, P624, DOI 10.1093/rheumatology/39.6.624; Tkachenko IV, 2011, STEROIDS, V76, P1103, DOI 10.1016/j.steroids.2011.04.018; Wolff C, 2015, ANN RHEUM DIS, V74, P1890, DOI 10.1136/annrheumdis-2013-203885	21	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167854	10.1371/journal.pone.0167854	http://dx.doi.org/10.1371/journal.pone.0167854			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930715	gold, Green Published, Green Submitted			2022-12-27	WOS:000389580900052
J	Han, BC; Wei, W; Mi, XC; Ma, KP				Han, Bao-cai; Wei, Wei; Mi, Xiang-cheng; Ma, Ke-ping			De Novo Sequencing and Comparative Analysis of Schima superba Seedlings to Explore the Response to Drought Stress	PLOS ONE			English	Article							RNA-SEQ; GENE ONTOLOGY; EXPRESSION; BIOSYNTHESIS; MECHANISMS; TOLERANCE; FOREST; KEGG; TOOL	Schima superba is an important dominant species in subtropical evergreen broadleaved forests of China, and plays a vital role in community structure and dynamics. However, the survival rate of its seedlings in the field is low, and water shortage could be a factor that limits its regeneration. In order to better understand the response of its seedlings to drought stress on a functional genomics scale, RNA-seq technology was utilized in this study to perform a large-scale transcriptome sequencing of the S. superba seedlings under drought stress. More than 320 million clean reads were generated and 72218 unique transcripts were obtained through de novo assembly. These unigenes were further annotated by blasting with different public databases and a total of 53300 unique transcripts were annotated. A total of 31586 simple sequence repeat (SSR) loci were presented. Through gene expression profiling analysis between drought treatment and control, 11038 genes were found to be significantly enriched in drought-stressed seedlings. Based on these differentially expressed genes (DEGs), Gene Ontology (GO) terms enrichment and Kyoto Encyclopedia of Genes and Genomes pathway (KEGG) enrichment analysis indicated that drought stress caused a number of changes in the types of sugars, enzymes, secondary mechanisms, and light responses, and induced some potential physical protection mechanisms. In addition, the expression patterns of 18 transcripts induced by drought, as determined by quantitative real-time PCR, were consistent with their transcript abundance changes, as identified by RNA-seq. This transcriptome study provides a rapid method for understanding the response of S. superba seedlings to drought stress and provides a number of gene sequences available for further functional genomics studies.	[Han, Bao-cai; Wei, Wei; Mi, Xiang-cheng; Ma, Ke-ping] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Han, Bao-cai; Ma, Ke-ping] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ma, KP (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.; Ma, KP (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	kpma@ibcas.ac.cn	, Weiwei/B-2681-2008	, Weiwei/0000-0002-1815-9314	National Natural Science Foundation of China [31261120579]; Direct For Biological Sciences [1643052] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	KPM was supported by the National Natural Science Foundation of China (No. 31261120579), http://www.nsfc.gov/cn.publish/portal1/.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aranda I., 2012, PLANT RESPONSES DROU, P293, DOI DOI 10.1007/978-3-642-32653-0_12; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashrafi H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-571; Audran C, 1998, PLANT PHYSIOL, V118, P1021, DOI 10.1104/pp.118.3.1021; Bassi R, 1997, PHYSIOL PLANTARUM, V100, P769, DOI 10.1034/j.1399-3054.1997.1000404.x; Burbidge A, 1999, PLANT J, V17, P427, DOI 10.1046/j.1365-313X.1999.00386.x; Cornic G, 2000, TRENDS PLANT SCI, V5, P187, DOI 10.1016/S1360-1385(00)01625-3; Ellegren H, 2008, NATURE, V452, P169, DOI 10.1038/nature06737; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Hu XiSheng, 2007, Guangxi Zhiwu / Guihaia, V27, P469; Huang ZhiWei, 2008, Scientia Silvae Sinicae, V44, P101; Kerstiens G, 1996, J EXP BOT, V47, P1813, DOI 10.1093/jxb/47.12.1813; Kissoudis C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00207; Lai JS, 2013, OIKOS, V122, P1636, DOI 10.1111/j.1600-0706.2013.00436.x; Lee KH, 2000, J ENVIRON QUAL, V29, P1200, DOI 10.2134/jeq2000.2941200x; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li HE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0111054; Li Li, 2010, Chinese Journal of Plant Ecology, V34, P241, DOI 10.3773/j.issn.1005-264x.2010.03.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Marenduzzo D, 2006, J CELL BIOL, V175, P681, DOI 10.1083/jcb.200609066; McDowell NG, 2011, PLANT PHYSIOL, V155, P1051, DOI 10.1104/pp.110.170704; Ming T.L., 2007, FLORA CHINA, V12, P366; Murakami R, 2005, FEBS J, V272, P2165, DOI 10.1111/j.1742-4658.2005.04636.x; Mustroph A, 2010, PLANT PHYSIOL, V152, P1484, DOI 10.1104/pp.109.151845; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ort DR, 2002, CURR OPIN PLANT BIOL, V5, P193, DOI 10.1016/S1369-5266(02)00259-5; Palatnik JF, 1997, PLANT PHYSIOL, V115, P1721, DOI 10.1104/pp.115.4.1721; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Raj S, 2011, P NATL ACAD SCI USA, V108, P12521, DOI 10.1073/pnas.1103341108; Seki M, 2007, CURR OPIN PLANT BIOL, V10, P296, DOI 10.1016/j.pbi.2007.04.014; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Seo PJ, 2011, PLANT CELL, V23, P1138, DOI 10.1105/tpc.111.083485; STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031; Steinitz O, 2011, MOL ECOL, V20, P4152, DOI 10.1111/j.1365-294X.2011.05203.x; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Thompson AJ, 2000, PLANT J, V23, P363, DOI 10.1046/j.1365-313x.2000.00789.x; Treutter D, 2006, ENVIRON CHEM LETT, V4, P147, DOI 10.1007/s10311-006-0068-8; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Wingler A, 2002, PHYTOCHEMISTRY, V60, P437, DOI 10.1016/S0031-9422(02)00137-1; Xie DY, 2003, SCIENCE, V299, P396, DOI 10.1126/science.1078540; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang JY, 2005, PLANT J, V42, P689, DOI 10.1111/j.1365-313X.2005.02405.x; Zhang Shou-Ren, 2007, Zhiwu Shengtai Xuebao, V31, P982	48	3	3	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0166975	10.1371/journal.pone.0166975	http://dx.doi.org/10.1371/journal.pone.0166975			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930677	Green Submitted, Green Published, gold			2022-12-27	WOS:000389580900018
J	Hornok, S; Szoke, K; Kovats, D; Estok, P; Gorfol, T; Boldogh, SA; Takacs, N; Kontschan, J; Foldvari, G; Barti, L; Corduneanu, A; Sandor, AD				Hornok, Sandor; Szoke, Krisztina; Kovats, David; Estok, Peter; Gorfol, Tamas; Boldogh, Sandor A.; Takacs, Nora; Kontschan, Jeno; Foldvari, Gabor; Barti, Levente; Corduneanu, Alexandra; Sandor, Attila D.			DNA of Piroplasms of Ruminants and Dogs in Ixodid Bat Ticks	PLOS ONE			English	Article							PARASITIZING BATS; IXODOIDEA; ARIADNAE; ACARI; VESPERTILIONIS; CHIROPTERA; PHYLOGENY; DIVERSITY; SOUTHERN; WESTERN	In this study 308 ticks (Ixodes ariadnae: 26 larvae, 14 nymphs, five females; I. vespertilionis: 89 larvae, 27 nymphs, eight females; I. simplex: 80 larvae, 50 nymphs, nine females) have been collected from 200 individuals of 17 bat species in two countries, Hungary and Romania. After DNA extraction these ticks were molecularly analysed for the presence of piroplasm DNA. In Hungary I. ariadnae was most frequently identified from bat species in the family Vespertilionidae, whereas I. vespertilionis was associated with Rhinolophidae. Ixodes ariadnae was not found in Romania. Four, four and one new bat host species of I. ariadnae, I. vespertilionis and I. simplex were identified, respectively. DNA sequences of piroplasms were detected in 20 bat ticks (15 larvae, four nymphs and one female). I. simplex carried piroplasm DNA sequences significantly more frequently than I. vespertilionis. In I. ariadnae only Babesia vesperuginis DNA was detected, whereas in I. vespertilionis sequences of both B. vesperuginis and B. crassa. From I. simplex the DNA of B. canis, Theileria capreoli, T. orientalis and Theileria sp. OT3 were amplified, as well as a shorter sequence of the zoonotic B. venatorum. Bat ticks are not known to infest dogs or ruminants, i.e. typical hosts and reservoirs of piroplasms molecularly identified in I. vespertilionis and I. simplex. Therefore, DNA sequences of piroplasms detected in these bat ticks most likely originated from the blood of their respective bat hosts. This may indicate either that bats are susceptible to a broader range of piroplasms than previously thought, or at least the DNA of piroplasms may pass through the gut barrier of bats during digestion of relevant arthropod vectors. In light of these findings, the role of bats in the epidemiology of piroplasmoses deserves further investigation.	[Hornok, Sandor; Szoke, Krisztina; Takacs, Nora; Foldvari, Gabor] Univ Vet Med, Dept Parasitol & Zool, Budapest, Hungary; [Kovats, David] Debrecen Univ, Dept Evolutionary Zool & Human Biol, Debrecen, Hungary; [Estok, Peter] Eszterhazy Karoly Univ, Dept Zool, Eger, Hungary; [Gorfol, Tamas] Hungarian Nat Hist Museum, Dept Zool, Budapest, Hungary; [Boldogh, Sandor A.] Aggtelek Natl Pk Directorate, Nat Conservat Dept, Josvafo, Hungary; [Kontschan, Jeno] Hungarian Acad Sci, Agr Res Ctr, Inst Plant Protect, Budapest, Hungary; [Barti, Levente] Romanian Bat Protect Assoc, Satu Mare, Romania; [Corduneanu, Alexandra; Sandor, Attila D.] Univ Agr Sci & Vet Med, Dept Parasitol & Parasit Dis, Cluj Napoca, Romania	University of Veterinary Medicine Budapest; University of Debrecen; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; University of Agricultural Sciences & Veterinary Medicine Cluj Napoca	Hornok, S (corresponding author), Univ Vet Med, Dept Parasitol & Zool, Budapest, Hungary.	Hornok.Sandor@univet.hu	Földvári, Gábor/A-2612-2011; Sándor, Attila D./A-4782-2009; Kontschan, Jeno/G-6807-2012; Görföl, Tamás/F-7688-2010	Földvári, Gábor/0000-0001-5297-9036; Sándor, Attila D./0000-0001-8852-8341; Görföl, Tamás/0000-0002-1910-4024; Kontschan, Jeno/0000-0001-8274-4238	OTKA [115854, 11475-4/2016/FEKUT, PCE 236/2011]	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This study was supported by OTKA 115854 (http://www.otka.hu/en), 11475-4/2016/FEKUT (http://2010-2014.kormany.hu/en/ministry-of-human-resources), and PCE 236/2011 (http://www.osztondijak.ro/scholarship/Palyazati-felhivas- magyarorszagi-osztondijak-elnyeresere-MTA-Domus-Hungarica). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas M, 2014, VET PARASITOL, V200, P276, DOI 10.1016/j.vetpar.2013.12.008; ARTHUR DR, 1956, J PARASITOL, V42, P180, DOI 10.2307/3274734; Burazerovic J, 2015, EXP APPL ACAROL, V66, P281, DOI 10.1007/s10493-015-9891-6; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Casati S, 2006, ANN AGR ENV MED, V13, P65; Corduneanu A, 2016, P 17 INT BAT RES C 2, P50; Dekker Jasja J. A., 2013, Lutra, V56, P111; Dietz C, 2009, BATS BRITAIN EUROPE; Estrada-Pena A, 1999, EXP APPL ACAROL, V23, P685, DOI 10.1023/A:1006241108739; ESTRADA-PENA A, 1989, Revista Iberica de Parasitologia, V49, P165; Feider Z., 1965, FAUNA POPULAR REPUBL, V5/2; FILIPPOVA N A, 1976, Entomologicheskoe Obozrenie, V55, P467; Frank R, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0707-7; Friedhoff KT, 1988, BABESIOSIS DOMESTIC, P45; FUJISAKI K, 1994, PARASITOL TODAY, V10, P31, DOI 10.1016/0169-4758(94)90355-7; GARDNER RA, 1987, PARASITOLOGY, V95, P461, DOI 10.1017/S0031182000057887; Giangaspero A, 2015, TICKS TICK-BORNE DIS, V6, P75, DOI 10.1016/j.ttbdis.2014.09.007; Hammer JF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1323-x; HASHEMIFESHARKI R, 1981, VET QUART, V3, P1; HOCK RJ, 1951, BIOL BULL-US, V101, P289, DOI 10.2307/1538547; HOOGSTRAAL H, 1964, J PARASITOL, V50, P765, DOI 10.2307/3276200; Hornok S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1365-0; Hornok S, 2012, VET MICROBIOL, V159, P541, DOI 10.1016/j.vetmic.2012.04.003; Hornok S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-202; Hornok S, 2016, ACTA VET HUNG, V64, P467, DOI 10.1556/004.2016.043; Hornok S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1236-0; Hornok S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1056-2; Hornok S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1052-6; Hornok S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0665-0; Hutson AM, 2008, IUCN RED LIST THREAT, V2008, DOI [10.2305/IUCN.UK.2008.RLTS.T13561A4160556.en, DOI 10.2305/IUCN.UK.2008.RLTS.T13561A4160556.EN]; Hutterer R, 2005, NATURSCHUTZ BIOL VIE, V28; Izzo MM, 2010, AUST VET J, V88, P45, DOI 10.1111/j.1751-0813.2009.00540.x; Kamau J, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-22; Korotkov Yu. S., 2004, Parazitologiya (St. Petersburg), V38, P492; Kristofik Jan, 2012, Vespertilio, V16, P167; Kunz TH, 2003, BAT ECOLOGY, P3; Kuttler KL, 1988, BABESIOSIS DOMESTIC, P12; Lack JB, 2012, INT J PARASITOL, V42, P353, DOI 10.1016/j.ijpara.2012.02.005; LEBEDEVA NN, 1981, FOLIA PARASIT, V28, P249; Mihalca AD, 2012, EXP APPL ACAROL, V58, P183, DOI 10.1007/s10493-012-9566-5; Neumann LG, 1911, TIERREICH, V26, P98; Piksa K, 2016, PARASITOL RES, V115, P1727, DOI 10.1007/s00436-016-4936-2; Piksa K, 2013, INT J ACAROL, V39, P1, DOI 10.1080/01647954.2012.737831; Presetnik P, 2013, MAMMALIA, V77, P297, DOI 10.1515/mammalia-2012-0033; Rupp Doris, 2004, Spixiana, V27, P185; Sebek Z., 1975, Mitteilungen der Abteilung fur Zoologie am Landesmuseum Joanneum, V4, P67; Sevcik Martin, 2010, Vespertilio, V13-14, P139; Siuda Krzysztof, 2009, Wiad Parazytol, V55, P39; Spisak S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069805; Szoke K, 2016, MAGY ALLATORVOSOK, V138, P15; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vincent S, 2011, HYSTRIX, V22, P57, DOI 10.4404/Hystrix-22.1-4524	53	34	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167735	10.1371/journal.pone.0167735	http://dx.doi.org/10.1371/journal.pone.0167735			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930692	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000389580900041
J	Ritson-Williams, R; Ross, C; Paul, VJ				Ritson-Williams, Raphael; Ross, Cliff; Paul, Valerie J.			Elevated Temperature and Allelopathy Impact Coral Recruitment	PLOS ONE			English	Article							LIFE-HISTORY STAGES; SCLERACTINIAN CORAL; OXIDATIVE STRESS; CLIMATE-CHANGE; POCILLOPORA-DAMICORNIS; MONTASTRAEA-ANNULARIS; OCEAN ACIDIFICATION; PORITES-ASTREOIDES; CHEMICAL DEFENSES; CARIBBEAN CORALS	As climate change continues to alter seawater temperature and chemistry on a global scale, coral reefs show multiple signs of degradation. One natural process that could facilitate the recovery of reef ecosystems is coral recruitment, which can be influenced by the benthic organisms in a local habitat. We experimentally tested both a global stressor (increased seawater temperature) and a local stressor (exposure to microcolin A, a natural product from a common marine benthic cyanobacterium) to determine how these stressors impacted coral larval sublethal stress, survival and settlement. Larvae of Porites astreoides had the same survival and settlement as the controls after exposure to increased temperature alone, but elevated temperature did cause oxidative stress. When exposed to natural concentrations of microcolin A, larval survival and settlement were significantly reduced. When larvae were exposed to these two stressors sequentially there was no interactive effect; but when exposed to both stressors simultaneously, there was a synergistic reduction in larval survival and an increase in oxidative stress more than in either stressor treatment alone. Increased seawater temperatures made larvae more susceptible to a concurrent local stressor disrupting a key process of coral reef recovery and resilience. These results highlight the importance of understanding how interactive stressors of varying spatial scales can impact coral demographics.	[Ritson-Williams, Raphael; Paul, Valerie J.] Smithsonian Marine Stn Ft Pierce, Ft Pierce, FL 34949 USA; [Ritson-Williams, Raphael] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA; [Ross, Cliff] Univ North Florida, Dept Biol, 1 UNF Dr, Jacksonville, FL USA	Smithsonian Institution; Smithsonian National Museum of Natural History; University of Hawaii System; University of Hawaii Manoa; State University System of Florida; University of North Florida	Ritson-Williams, R (corresponding author), Smithsonian Marine Stn Ft Pierce, Ft Pierce, FL 34949 USA.; Ritson-Williams, R (corresponding author), Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA.	rrw33@hawaii.edu			Mote Protect our Reefs Grants [2006-18, 2007-30]; Hunterdon Oceanographic endowment at the Smithsonian Institution; STAR Fellowship Assistance Agreement - U.S. Environmental Protection Agency (EPA) [FP917660]	Mote Protect our Reefs Grants; Hunterdon Oceanographic endowment at the Smithsonian Institution; STAR Fellowship Assistance Agreement - U.S. Environmental Protection Agency (EPA)	This research was funded by Mote Protect our Reefs Grants 2006-18 and 2007-30 and by the Hunterdon Oceanographic endowment at the Smithsonian Institution (RRW CR VJP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The analysis and writing of this research was funded by a STAR Fellowship Assistance Agreement # FP917660 awarded by the U.S. Environmental Protection Agency (EPA) (RRW). It has not been formally reviewed by EPA. The views expressed in this manuscript are solely those of the authors, and EPA does not endorse any products or commercial services mentioned in this publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird A.H., 2006, P 10 INT COR REEF S, P38; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Ban SS, 2014, GLOBAL CHANGE BIOL, V20, P681, DOI 10.1111/gcb.12453; Barott KL, 2012, P ROY SOC B-BIOL SCI, V279, P1655, DOI 10.1098/rspb.2011.2155; Bassim KM, 2003, MAR BIOL, V142, P241, DOI 10.1007/S00227-002-0953-z; Bender D, 2014, MAR ECOL PROG SER, V517, P271, DOI 10.3354/meps11037; Birrell CL, 2008, MAR ECOL PROG SER, V362, P129, DOI 10.3354/meps07524; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Capper A, 2016, J EXP MAR BIOL ECOL, V474, P100, DOI 10.1016/j.jembe.2015.09.008; Chua CM, 2013, MAR ECOL PROG SER, V475, P85, DOI 10.3354/meps10077; Cumbo VR, 2013, J EXP MAR BIOL ECOL, V439, P100, DOI 10.1016/j.jembe.2012.10.019; Cumbo VR, 2013, MAR BIOL, V160, P2903, DOI 10.1007/s00227-013-2280-y; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Diaz-Pulido G, 2010, CORAL REEFS, V29, P203, DOI 10.1007/s00338-009-0573-x; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Downs CA, 2005, MAR POLLUT BULL, V51, P486, DOI 10.1016/j.marpolbul.2005.06.028; Downs CA, 2000, MAR BIOTECHNOL, V2, P533, DOI 10.1007/s101260000038; Dunne RP, 2010, CORAL REEFS, V29, P145, DOI 10.1007/s00338-009-0569-6; Edmunds PJ, 2001, MAR BIOL, V139, P981; Engene N, 2013, J PHYCOL, V49, P1095, DOI 10.1111/jpy.12115; Foster NL, 2008, MAR ECOL PROG SER, V367, P143, DOI 10.3354/meps07594; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Hadfield MG, 2011, ANNU REV MAR SCI, V3, P453, DOI 10.1146/annurev-marine-120709-142753; Hajare SN, 2013, BIOCHIMIE, V95, P1722, DOI 10.1016/j.biochi.2013.05.015; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Humanes A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161616; JACKSON JBC, 1975, P NATL ACAD SCI USA, V72, P5160, DOI 10.1073/pnas.72.12.5160; Krueger T, 2015, COMP BIOCHEM PHYS A, V190, P15, DOI 10.1016/j.cbpa.2015.08.012; Kuffner IB, 2004, CORAL REEFS, V23, P455, DOI 10.1007/s00338-004-0416-8; Kuffner IB, 2006, MAR ECOL PROG SER, V323, P107, DOI 10.3354/meps323107; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Meickle T, 2009, PLANTA MED, V75, P1427, DOI 10.1055/s-0029-1185675; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Morgan MB, 2001, ENVIRON TOXICOL CHEM, V20, P537, DOI 10.1002/etc.5620200312; Morrow KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044859; Negri AP, 2001, MAR ECOL PROG SER, V223, P121, DOI 10.3354/meps223121; Nelson CE, 2013, ISME J, V7, P962, DOI 10.1038/ismej.2012.161; Olsen K, 2014, MAR ECOL PROG SER, V509, P181, DOI 10.3354/meps10880; Paerl HW, 2012, WATER RES, V46, P1349, DOI 10.1016/j.watres.2011.08.002; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Paul VJ, 2008, ADV EXP MED BIOL, V619, P239, DOI 10.1007/978-0-387-75865-7_11; Paul VJ, 2007, BIOL BULL-US, V213, P226, DOI 10.2307/25066642; Paul VJ, 2011, MAR ECOL PROG SER, V426, P161, DOI 10.3354/meps09032; Paul VJ, 2005, CORAL REEFS, V24, P693, DOI 10.1007/s00338-005-0061-x; Paul VJ, 2001, CRC MAR SCI, P227; Pawlik JR, 2007, LIMNOL OCEANOGR, V52, P907, DOI 10.4319/lo.2007.52.2.0907; Radecker N, 2015, TRENDS MICROBIOL, V23, P490, DOI 10.1016/j.tim.2015.03.008; Rasher DB, 2011, P NATL ACAD SCI USA, V108, P17726, DOI 10.1073/pnas.1108628108; Ritson-Williams Raphael, 2009, Smithsonian Contributions to the Marine Sciences, P437; Ross C, 2013, CORAL REEFS, V32, P71, DOI 10.1007/s00338-012-0956-2; Ross C, 2007, J PHYCOL, V43, P466, DOI 10.1111/j.1529-8817.2007.00346.x; Ross C, 2010, HARMFUL ALGAE, V9, P173, DOI 10.1016/j.hal.2009.09.001; Sharp K, 2009, APPL ENVIRON MICROB, V75, P2879, DOI 10.1128/AEM.02656-08; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Thacker RW, 1998, ECOLOGY, V79, P1740; Thurber RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044246; Titlyanov EA, 2007, J EXP MAR BIOL ECOL, V342, P282, DOI 10.1016/j.jembe.2006.11.007; Underwood AJ, 1997, EXPT ECOLOGY; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Webster NS, 2004, APPL ENVIRON MICROB, V70, P1213, DOI 10.1128/AEM.70.2.1213-1221.2004; WIEDENMANN J, 2012, NATURE CLIMATE CHANG, V3, P160, DOI DOI 10.1038/NCLIMATE1661; Yakovleva IM, 2009, MAR ECOL PROG SER, V378, P105, DOI 10.3354/meps07857; Yin HP, 2013, ANTI-CANCER DRUG, V24, P587, DOI 10.1097/CAD.0b013e3283611395	69	21	22	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2016	11	12							e0166581	10.1371/journal.pone.0166581	http://dx.doi.org/10.1371/journal.pone.0166581			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4NG	27926916	gold, Green Published, Green Submitted			2022-12-27	WOS:000389578800003
J	Jangid, K; Kao, MH; Lahamge, A; Williams, MA; Rathbun, SL; Whitman, WB				Jangid, Kamlesh; Kao, Ming-Hung; Lahamge, Aishwarya; Williams, Mark A.; Rathbun, Stephen L.; Whitman, William B.			K-shuff: A Novel Algorithm for Characterizing Structural and Compositional Diversity in Gene Libraries	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; 2ND-ORDER ANALYSIS	K-shuff is a new algorithm for comparing the similarity of gene sequence libraries, providing measures of the structural and compositional diversity as well as the significance of the differences between these measures. Inspired by Ripley's K-function for spatial point pattern analysis, the Intra K-function or IKF measures the structural diversity, including both the richness and overall similarity of the sequences, within a library. The Cross K-function or CKF measures the compositional diversity between gene libraries, reflecting both the number of OTUs shared as well as the overall similarity in OTUs. A Monte Carlo testing procedure then enables statistical evaluation of both the structural and compositional diversity between gene libraries. For 16S rRNA gene libraries from complex bacterial communities such as those found in seawater, salt marsh sediments, and soils, K-shuff yields reproducible estimates of structural and compositional diversity with libraries greater than 50 sequences. Similarly, for pyrosequencing libraries generated from a glacial retreat chrono-sequence and Illumina (R) libraries generated from US homes, K-shuff required >300 and 100 sequences per sample, respectively. Power analyses demonstrated that K-shuff is sensitive to small differences in Sanger or Illumina (R) libraries. This extra sensitivity of K-shuff enabled examination of compositional differences at much deeper taxonomic levels, such as within abundant OTUs. This is especially useful when comparing communities that are compositionally very similar but functionally different. K-shuff will therefore prove beneficial for conventional microbiome analysis as well as specific hypothesis testing.	[Jangid, Kamlesh; Whitman, William B.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Jangid, Kamlesh] Savitribai Phule Pune Univ, Natl Ctr Cell Sci, Microbial Culture Collect, Pune, Maharashtra, India; [Kao, Ming-Hung] Arizona State Univ, Sch Math & Stat Sci, Tempe, AZ USA; [Lahamge, Aishwarya] Savitribai Phule Pune Univ, Inst Biotechnol & Bioinformat, Pune, Maharashtra, India; [Williams, Mark A.] Virginia Polytech & State Univ, Coll Agr & Life Sci, Blacksburg, VA USA; [Rathbun, Stephen L.] Univ Georgia, Dept Epidemiol & Biostat, Athens, GA 30602 USA	University System of Georgia; University of Georgia; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Savitribai Phule Pune University; Arizona State University; Arizona State University-Tempe; Savitribai Phule Pune University; Virginia Polytechnic Institute & State University; University System of Georgia; University of Georgia	Jangid, K (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.; Jangid, K (corresponding author), Savitribai Phule Pune Univ, Natl Ctr Cell Sci, Microbial Culture Collect, Pune, Maharashtra, India.	jangidk@nccs.res.in	Jangid, Kamlesh/AAE-4071-2021; Whitman, William/AAC-5896-2020	Jangid, Kamlesh/0000-0002-9764-8684; Whitman, William/0000-0003-1229-0423; Williams, Mark A./0000-0002-4766-9399	Franklin College of the University of Georgia; USDA; NSF; Department of Biotechnology, Government of India, under the project entitled "Establishment of Microbial Culture Collection" [BT/PR/0054/NDB/52/94/2007]	Franklin College of the University of Georgia; USDA(United States Department of Agriculture (USDA)); NSF(National Science Foundation (NSF)); Department of Biotechnology, Government of India, under the project entitled "Establishment of Microbial Culture Collection"	This work was supported by the Franklin College of the University of Georgia and grants from the USDA and NSF. We thank Mohit Navandar and Rajesh Jangid for helping with the Perl script. KJ acknowledges the funding support of the Department of Biotechnology, Government of India, under the project entitled "Establishment of Microbial Culture Collection" (Grant no. BT/PR/0054/NDB/52/94/2007).	Bunge J., J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Cuevas A, 2004, COMPUT STAT DATA AN, V47, P111, DOI 10.1016/j.csda.2003.10.021; Diggle P., 2003, STAT ANAL SPATIAL PO; Diggle PJ, 2007, BIOMETRICS, V63, P550, DOI 10.1111/j.1541-0420.2006.00683.x; DIGGLE PJ, 1991, BIOMETRICS, V47, P1155, DOI 10.2307/2532668; Diggle PJ, 2000, ADV APPL PROBAB, V32, P331, DOI 10.1017/S0001867800009952; Dunn RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064133; Faircloth BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042543; Halwachs B, 2012, COMPUTATIONAL MED, P37; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; Jangid K, 2013, MOL ECOL, V22, P3415, DOI 10.1111/mec.12325; Jangid K, 2011, SOIL BIOL BIOCHEM, V43, P2184, DOI 10.1016/j.soilbio.2011.06.022; Jangid K, 2010, SOIL BIOL BIOCHEM, V42, P302, DOI 10.1016/j.soilbio.2009.11.008; Lasher C, 2009, MICROB ECOL, V58, P244, DOI 10.1007/s00248-008-9481-9; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Matsen FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056859; McCune B., 2011, MULTIVARIATE ANAL EC; Quail MA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-110; Schloss PD, 2008, ISME J, V2, P265, DOI 10.1038/ismej.2008.5; Schloss PD, 2006, APPL ENVIRON MICROB, V72, P6773, DOI 10.1128/AEM.00474-06; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2006, APPL ENVIRON MICROB, V72, P2379, DOI 10.1128/AEM.72.4.2379-2384.2006; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schloss PD, 2004, APPL ENVIRON MICROB, V70, P5485, DOI 10.1128/AEM.70.9.5485-5492.2004; Shokralla S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09687; Singleton DR, 2001, APPL ENVIRON MICROB, V67, P4374, DOI 10.1128/AEM.67.9.4374-4376.2001; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Yarza P, 2014, NATURE REV MICROBIOL, V12, P635	32	6	6	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167634	10.1371/journal.pone.0167634	http://dx.doi.org/10.1371/journal.pone.0167634			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911946	Green Published, gold, Green Submitted			2022-12-27	WOS:000389520600049
J	Caniffi, C; Cerniello, FM; Gobetto, MN; Sueiro, ML; Costa, MA; Arranz, C				Caniffi, Carolina; Cerniello, Flavia M.; Gobetto, Maria N.; Sueiro, Maria L.; Costa, Maria A.; Arranz, Cristina			Vascular Tone Regulation Induced by C-Type Natriuretic Peptide: Differences in Endothelium-Dependent and -Independent Mechanisms Involved in Normotensive and Spontaneously Hypertensive Rats	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; NITRIC-OXIDE; POTASSIUM CHANNELS; CYCLIC-GMP; K+-CHANNELS; BRADYKININ; EXPRESSION; AORTA; CONTRACTIONS; RECEPTOR	Given that the role of C-type natriuretic peptide (CNP) in the regulation of vascular tone in hypertensive states is unclear, we hypothesized that impaired response of the nitric oxide system to CNP in spontaneously hypertensive rats (SHR) could affect vascular relaxation induced by the peptide in this model of hypertension, and that other endothelial systems or potassium channels opening could also be involved. We examined the effect of CNP on isolated SHR aortas, and the hindlimb vascular resistance (HVR) in response to CNP administration compared to normotensive rats. Aortas were mounted in an isometric organ bath and contracted with phenylephrine. CNP relaxed arteries in a concentration-dependent manner but was less potent in inducing relaxation in SHR. The action of CNP was diminished by removal of the endothelium, inhibition of nitric oxide synthase by N-omega-nitro-L-arginine methyl ester, and inhibition of soluble guanylyl cyclase by 1H-[1,2,4] oxadiazolo[4,3-alpha]quinoxalin-1-one in both groups. In contrast, blockade of cyclooxygenase or subtype 2 bradykinin receptor increased CNP potency only in SHR. In both Wistar and SHR, CNP relaxation was blunted by tetraethylammonium and partially inhibited by BaCl2 and iberiotoxin, indicating that it was due to opening of the Kir and BKCa channels. However, SHR seem to be more sensitive to Kir channel blockade and less sensitive to BKCa channel blockade than normotensive rats. In addition, CNP decreases HVR in Wistar and SHR, but the effect of CNP increasing blood flow was more marked in SHR. We conclude that CNP induces aorta relaxation by activation of the nitric oxide system and opening of potassium channels, but the response to the peptide is impaired in conductance vessel of hypertensive rats.	[Caniffi, Carolina; Cerniello, Flavia M.; Gobetto, Maria N.; Sueiro, Maria L.; Costa, Maria A.; Arranz, Cristina] Univ Buenos Aires, CONICET, Inst Quim & Metab Farm IQUIMEFA, Fac Farm & Bioquim,Catedra Fisiol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Caniffi, C (corresponding author), Univ Buenos Aires, CONICET, Inst Quim & Metab Farm IQUIMEFA, Fac Farm & Bioquim,Catedra Fisiol, Buenos Aires, DF, Argentina.	ccaniffi@ffyb.uba.ar			UBACYT from Universidad de Buenos Aires, Argentina [20020100100060]; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina [PIP-112-201101-00581]	UBACYT from Universidad de Buenos Aires, Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This study was partially supported by grants UBACYT No 20020100100060 (2011-2014) from Universidad de Buenos Aires, Argentina, MAC; and PIP-112-201101-00581 from Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina, CA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095446; Costa MA, 2007, BIOCHEM BIOPH RES CO, V359, P180, DOI 10.1016/j.bbrc.2007.05.095; ASANO M, 1995, J PHARMACOL EXP THER, V275, P775; Blacher J, 2000, ARCH INTERN MED, V160, P1085, DOI 10.1001/archinte.160.8.1085; Brunner F, 2001, CARDIOVASC RES, V51, P577, DOI 10.1016/S0008-6363(01)00283-8; Bujak-Gizycka B, 2011, ACTA BIOCHIM POL, V58, P199; CAMPBELL DJ, 1995, J HYPERTENS, V13, P739; Caniffi C, 2010, PEPTIDES, V31, P1309, DOI 10.1016/j.peptides.2010.03.030; Chauhan SD, 2003, P NATL ACAD SCI USA, V100, P1426, DOI 10.1073/pnas.0336365100; Chen HH, 1998, J CARDIOVASC PHARM, V32, pS22; Cox RH, 2002, VASC PHARMACOL, V38, P13, DOI 10.1016/S1537-1891(02)00122-2; Eichhorn B, 2007, N-S ARCH PHARMACOL, V376, P145, DOI 10.1007/s00210-007-0193-3; Eichler I, 2003, BRIT J PHARMACOL, V138, P594, DOI 10.1038/sj.bjp.0705075; Feletou M, 2010, PFLUG ARCH EUR J PHY, V459, P941, DOI 10.1007/s00424-010-0812-6; GE T, 1995, CIRC RES, V76, P1003, DOI 10.1161/01.RES.76.6.1003; Gluais P, 2005, BRIT J PHARMACOL, V146, P834, DOI 10.1038/sj.bjp.0706390; Gryglewski RJ, 2002, PEDIATR PATHOL MOL M, V21, P279, DOI 10.1080/02770930290056514; Gutman GA, 2003, PHARMACOL REV, V55, P583, DOI 10.1124/pr.55.4.9; HALL JM, 1992, PHARMACOL THERAPEUT, V56, P131, DOI 10.1016/0163-7258(92)90016-S; Hernanz R, 2004, AM J PHYSIOL-HEART C, V287, pH225, DOI 10.1152/ajpheart.00548.2003; Ihara E, 2001, J PHYSIOL-LONDON, V534, P701, DOI 10.1111/j.1469-7793.2001.t01-1-00701.x; Kichuk MR, 1996, CIRCULATION, V94, P44, DOI 10.1161/01.CIR.94.1.44; Kim MY, 2005, AM J PHYSIOL-HEART C, V289, pH792, DOI 10.1152/ajpheart.00050.2005; Li Y, 2014, HYPERTENSION, V63, P846, DOI 10.1161/HYPERTENSIONAHA.113.01772; Liang CC, 2010, FORMOS J ENDOCRIN ME, V1, P1; LINCOLN TM, 1989, PHARMACOL THERAPEUT, V41, P479, DOI 10.1016/0163-7258(89)90127-7; Madhani M, 2003, BRIT J PHARMACOL, V139, P1289, DOI 10.1038/sj.bjp.0705365; MONCADA S, 1991, PHARMACOL REV, V43, P109; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; Neylon CB, 1999, CIRC RES, V85, pE33, DOI 10.1161/01.RES.85.9.e33; Numaguchi Y, 1999, CARDIOVASC RES, V41, P682, DOI 10.1016/S0008-6363(98)00239-9; OZA NB, 1990, J CLIN INVEST, V85, P597, DOI 10.1172/JCI114479; Pandey KN, 2005, PEPTIDES, V26, P901, DOI 10.1016/j.peptides.2004.09.024; Parkington HC, 2002, J PHYSIOL-LONDON, V542, P929, DOI 10.1113/jphysiol.2002.021030; Piech A, 2003, CARDIOVASC RES, V57, P456, DOI 10.1016/S0008-6363(02)00676-4; Pitt B, 1996, CARDIOVASC DRUG THER, V10, P469, DOI 10.1007/BF00051113; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Quayle JM, 1996, J PHYSIOL-LONDON, V494, P715, DOI 10.1113/jphysiol.1996.sp021527; QUAYLE JM, 1993, AM J PHYSIOL, V265, pC1363, DOI 10.1152/ajpcell.1993.265.5.C1363; Robertson BE, 1996, AM J PHYSIOL-HEART C, V271, pH696, DOI 10.1152/ajpheart.1996.271.2.H696; Rodriguez JA, 2006, AM J PHYSIOL-HEART C, V290, pH30, DOI 10.1152/ajpheart.00349.2005; SCHMAIER AH, 1988, J BIOL CHEM, V263, P16327; Simon A, 2009, AM J PHYSIOL-LUNG C, V296, pL248, DOI 10.1152/ajplung.90303.2008; TADDEI S, 1993, J CARDIOVASC PHARM, V22, pS328, DOI 10.1097/00005344-199322008-00086; Vanhoutte PM, 2010, J PHYSL 22, V586, P5295; Villar IC, 2007, CARDIOVASC RES, V74, P515, DOI 10.1016/j.cardiores.2007.02.032; Woodard GE, 2008, INT REV CEL MOL BIO, V268, P59, DOI 10.1016/S1937-6448(08)00803-4; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29	49	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167817	10.1371/journal.pone.0167817	http://dx.doi.org/10.1371/journal.pone.0167817			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936197	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100205
J	Chung, HR; Vakil, M; Munroe, M; Parikh, A; Meador, BM; Wu, PT; Jeong, JH; Woods, JA; Wilund, KR; Boppart, MD				Chung, Hae R.; Vakil, Mayand; Munroe, Michael; Parikh, Alay; Meador, Benjamin M.; Wu, Pei T.; Jeong, Jin H.; Woods, Jeffrey A.; Wilund, Kenneth R.; Boppart, Marni D.			The Impact of Exercise on Statin-Associated Skeletal Muscle Myopathy	PLOS ONE			English	Article							PROTEIN GERANYLGERANYLATION; ATORVASTATIN TREATMENT; UBIQUITIN-PROTEASOME; OXIDATIVE STRESS; CREATINE-KINASE; INCREASES; APOPTOSIS; THERAPY; MICE; HYPERCHOLESTEROLEMIA	HMG-CoA reductase inhibitors (statins) are the most effective pharmacological means of reducing cardiovascular disease risk. The most common side effect of statin use is skeletal muscle myopathy, which may be exacerbated by exercise. Hypercholesterolemia and training status are factors that are rarely considered in the progression of myopathy. The purpose of this study was to determine the extent to which acute and chronic exercise can influence statin-induced myopathy in hypercholesterolemic (ApoE(-/-)) mice. Mice either received daily injections of saline or simvastatin (20 mg/kg) while: 1) remaining sedentary (Sed), 2) engaging in daily exercise for two weeks (novel, Nov), or 3) engaging in daily exercise for two weeks after a brief period of training (accustomed, Acct) (2x3 design, n = 60). Cholesterol, activity, strength, and indices of myofiber damage and atrophy were assessed. Running wheel activity declined in both exercise groups receiving statins (statin x time interaction, p<0.05). Cholesterol, grip strength, and maximal isometric force were significantly lower in all groups following statin treatment (statin main effect, p<0.05). Mitochondrial content and myofiber size were increased and 4-HNE was decreased by exercise (statin x exercise interaction, p<0.05), and these beneficial effects were abrogated by statin treatment. Exercise (Acct and Nov) increased atrogin-1 mRNA in combination with statin treatment, yet enhanced fiber damage or atrophy was not observed. The results from this study suggest that exercise (Nov, Acct) does not exacerbate statin-induced myopathy in ApoE(-/-) mice, yet statin treatment reduces activity in a manner that prevents muscle from mounting a beneficial adaptive response to training.	[Chung, Hae R.; Vakil, Mayand; Meador, Benjamin M.; Wu, Pei T.; Jeong, Jin H.; Wilund, Kenneth R.] Univ Illinois, Dept Kinesiol & Community Hlth, Renal & Cardiovasc Dis Res Lab, Urbana, IL USA; [Munroe, Michael; Parikh, Alay; Boppart, Marni D.] Univ Illinois, Dept Kinesiol & Community Hlth, Mol Muscle Physiol Lab, Urbana, IL 61801 USA; [Munroe, Michael; Parikh, Alay; Boppart, Marni D.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Woods, Jeffrey A.] Univ Illinois, Dept Kinesiol & Community Hlth, Exercise Immunol Res Lab, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Boppart, MD (corresponding author), Univ Illinois, Dept Kinesiol & Community Hlth, Mol Muscle Physiol Lab, Urbana, IL 61801 USA.; Boppart, MD (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA.	mboppart@illinois.edu		Jeong, Jin hee/0000-0002-8748-8429; Meador, Benjamin/0000-0001-8687-1023	University of Illinois (Center for Health, Aging, and Disability)	University of Illinois (Center for Health, Aging, and Disability)	This work was funded by an internal grant provided by the University of Illinois (Center for Health, Aging, and Disability).	Ballard KD, 2013, ATHEROSCLEROSIS, V230, P121, DOI 10.1016/j.atherosclerosis.2013.07.001; Bouitbir J, 2012, MUSCLE NERVE, V46, P367, DOI 10.1002/mus.23309; Bouitbir J, 2011, J APPL PHYSIOL, V111, P1477, DOI 10.1152/japplphysiol.00107.2011; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Dirks AJ, 2006, AM J PHYSIOL-CELL PH, V291, pC1208, DOI 10.1152/ajpcell.00226.2006; Dodd SL, 2010, MUSCLE NERVE, V41, P110, DOI 10.1002/mus.21526; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; Hanai JI, 2007, J CLIN INVEST, V117, P3940, DOI 10.1172/JCI32741; Hubal MJ, 2011, MUSCLE NERVE, V44, P393, DOI 10.1002/mus.22081; Johnson TE, 2004, TOXICOL APPL PHARM, V200, P237, DOI 10.1016/j.taap.2004.04.010; Kang J, 2008, J VASC SURG, V48, P701, DOI 10.1016/j.jvs.2008.04.006; Kavazis AN, 2014, J APPL PHYSIOL, V117, P223, DOI 10.1152/japplphysiol.00210.2014; Kwak HB, 2012, FREE RADICAL BIO MED, V52, P198, DOI 10.1016/j.freeradbiomed.2011.10.449; Larsen S, 2013, J AM COLL CARDIOL, V61, P44, DOI 10.1016/j.jacc.2012.09.036; Mallinson JE, 2009, J PHYSIOL-LONDON, V587, P219, DOI 10.1113/jphysiol.2008.164699; Matzno S, 2005, J PHARM PHARMACOL, V57, P1475, DOI 10.1211/jpp.57.11.0014; Maxwell AJ, 2009, VASC MED, V14, P249, DOI 10.1177/1358863X08100040; Meador BM, 2011, MUSCLE NERVE, V44, P882, DOI 10.1002/mus.22236; Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534; Mikus CR, 2013, J AM COLL CARDIOL, V62, P709, DOI 10.1016/j.jacc.2013.02.074; Muraki A, 2012, J APPL PHYSIOL, V113, P479, DOI 10.1152/japplphysiol.01362.2011; Mutoh T, 1999, FEBS LETT, V444, P85, DOI 10.1016/S0014-5793(99)00031-9; Omar MA, 2002, ANN PHARMACOTHER, V36, P288, DOI 10.1345/aph.1A289; Parker BA, 2013, CIRCULATION, V127, P96, DOI 10.1161/CIRCULATIONAHA.112.136101; Phillips PS, 2002, ANN INTERN MED, V137, P581, DOI 10.7326/0003-4819-137-7-200210010-00009; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023; Schirris TJJ, 2015, CELL METAB, V22, P399, DOI 10.1016/j.cmet.2015.08.002; Scott D, 2009, QJM-INT J MED, V102, P625, DOI 10.1093/qjmed/hcp093; Seachrist JL, 2005, TOXICOL SCI, V88, P551, DOI 10.1093/toxsci/kfi305; Sinzinger H, 2002, J CARDIOVASC PHARM, V40, P163, DOI 10.1097/00005344-200208000-00001; Sirvent P, 2005, BIOCHEM BIOPH RES CO, V329, P1067, DOI 10.1016/j.bbrc.2005.02.070; Sirvent P, 2012, TOXICOL APPL PHARM, V259, P263, DOI 10.1016/j.taap.2012.01.008; SMIT JWA, 1995, EUR J CLIN INVEST, V25, P79, DOI 10.1111/j.1365-2362.1995.tb01530.x; Thompson PD, 1997, METABOLISM, V46, P1206, DOI 10.1016/S0026-0495(97)90218-3; Tomlinson SS, 2005, PHYS THER, V85, P459, DOI 10.1093/ptj/85.5.459; Ucar M, 2000, DRUG SAFETY, V22, P441, DOI 10.2165/00002018-200022060-00003; Urso ML, 2005, ARTERIOSCL THROM VAS, V25, P2560, DOI 10.1161/01.ATV.0000190608.28704.71; Yan Z, 2012, EXERC SPORT SCI REV, V40, P159, DOI 10.1097/JES.0b013e3182575599; Zhang L, 2011, EUR J VASC ENDOVASC, V42, P393, DOI 10.1016/j.ejvs.2011.05.016; Zhong WB, 2003, ENDOCRINOLOGY, V144, P3852, DOI 10.1210/en.2003-0098	41	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168065	10.1371/journal.pone.0168065	http://dx.doi.org/10.1371/journal.pone.0168065			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936249	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100266
J	Hartman, MHT; Vreeswijk-Baudoin, I; Groot, HE; van de Kolk, KWA; de Boer, RA; Leach, IM; Vliegenthart, R; Sillje, HHW; van der Harst, P				Hartman, Minke H. T.; Vreeswijk-Baudoin, Inge; Groot, Hilde E.; van de Kolk, Kees W. A.; de Boer, Rudolf A.; Leach, Irene Mateo; Vliegenthart, Rozemarijn; Sillje, Herman H. W.; van der Harst, Pim			Inhibition of Interleukin-6 Receptor in a Murine Model of Myocardial Ischemia-Reperfusion	PLOS ONE			English	Article							IL-6 RECEPTOR; ANTIBODY; HEART; MECHANISMS; DISEASE; TOCILIZUMAB; LEVEL	Background Interleukin-6 (IL-6) levels are upregulated in myocardial infarction. Recent data suggest a causal role of the IL-6 receptor (IL-6R) in coronary heart disease. We evaluated if IL-6R blockade by a monoclonal antibody (MR16-1) prevents the heart from adverse left ventricular remodeling in a mouse model of ischemia-reperfusion (I/R). Methods CJ57/BL6 mice underwent I/R injury (left coronary artery ligation for 45 minutes) or sham surgery, and thereafter received MR16-1 (2mg/mouse) 5 minutes before reperfusion and 0.5mg/mouse weekly during four weeks, or control IgG treatment. Cardiac Magnetic Resonance Imaging (CMR) and hemodynamic measurements were performed to determine cardiac function after four weeks. Results I/R caused left ventricular dilatation and a decrease in left ventricular ejection fraction (LVEF). However, LVEF was significantly lower in the MR16-1 treatment group compared to the IgG group (28 +/- 4% vs. 35 +/- 6%, p = 0.02; sham 45 +/- 6% vs. 43 +/- 4%, respectively; p = NS). Cardiac relaxation (assessed by dP/dT) was not significantly different between the MR16-1 and IgG groups. Also, no differences were observed in histological myocardial fibrosis, infarct size and myocyte hypertrophy between the groups. Conclusion Blockade of the IL-6R receptor by the monoclonal MR16-1 antibody for four weeks started directly after I/R injury did not prevent the process of cardiac remodeling in mice, but rather associated with a deterioration in the process of adverse cardiac remodeling.	[Hartman, Minke H. T.; Vreeswijk-Baudoin, Inge; Groot, Hilde E.; de Boer, Rudolf A.; Leach, Irene Mateo; Sillje, Herman H. W.; van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [van de Kolk, Kees W. A.] Univ Groningen, Univ Med Ctr Groningen, Cent Anim Facil, Groningen, Netherlands; [Vliegenthart, Rozemarijn] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Leach, IM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands.	i.v.mateo.leach@umcg.nl	de Boer, Rudolf/ABE-9879-2020	Hartman, Minke H.T./0000-0002-6965-3259	Netherlands organization for health research and development (ZonMw) [90.700.441, 114.024.032]	Netherlands organization for health research and development (ZonMw)(Netherlands Organization for Health Research and Development)	This project was supported by the Netherlands organization for health research and development (ZonMw grant "Clinical fellow", grant number 90.700.441 and ZonMW grant "Meer kennis met minder dieren", grant number 114.024.032).	Anderson DR, 2013, CYTOKINE, V62, P395, DOI 10.1016/j.cyto.2013.03.020; Askevold Erik Tandberg, 2014, Curr Heart Fail Rep, V11, P146, DOI 10.1007/s11897-014-0185-9; Askevold ET, 2013, CIRC-HEART FAIL, V6, P91, DOI 10.1161/CIRCHEARTFAILURE.112.972653; De Gennaro L, 2012, INFLAMMATION, V35, P363, DOI 10.1007/s10753-011-9326-4; Fahmi A, 2013, CELL SIGNAL, V25, P898, DOI 10.1016/j.cellsig.2012.12.008; Gajarsa JJ, 2011, HEART FAIL REV, V16, P13, DOI 10.1007/s10741-010-9181-7; Garbers C, 2015, CURR OPIN IMMUNOL, V34, P75, DOI 10.1016/j.coi.2015.02.008; Gjesdal O, 2011, NAT REV CARDIOL, V8, P673, DOI 10.1038/nrcardio.2011.154; Jones SA, 2001, FASEB J, V15, P43, DOI 10.1096/fj.99-1003rev; Kaminski KA, 2009, ATHEROSCLEROSIS, V206, P581, DOI 10.1016/j.atherosclerosis.2009.03.033; Katsume A, 2002, CYTOKINE, V20, P304, DOI 10.1006/cyto.2002.2012; Kleveland O, 2016, EUR HEART J, V37, P2406, DOI 10.1093/eurheartj/ehw171; Kobara M, 2010, CARDIOVASC RES, V87, P424, DOI 10.1093/cvr/cvq078; Konstam MA, 2011, JACC-CARDIOVASC IMAG, V4, P98, DOI 10.1016/j.jcmg.2010.10.008; Laura PA, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/974694; Malaviya AP, 2014, RHEUMATOLOGY, V53, P1344, DOI 10.1093/rheumatology/keu168; Matsushita K, 2005, LAB INVEST, V85, P1210, DOI 10.1038/labinvest.3700322; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; Meems LMG, 2012, J STEROID BIOCHEM, V132, P282, DOI 10.1016/j.jsbmb.2012.06.004; Mihara M, 2002, IMMUNOL LETT, V84, P223, DOI 10.1016/S0165-2478(02)00201-8; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Nishimoto N, 2008, BLOOD, V112, P3959, DOI 10.1182/blood-2008-05-155846; Okazaki M, 2002, IMMUNOL LETT, V84, P231, DOI 10.1016/S0165-2478(02)00202-X; Papavassiliu T, 2005, RADIOLOGY, V236, P57, DOI 10.1148/radiol.2353040601; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Schuett H, 2012, ARTERIOSCL THROM VAS, V32, P281, DOI 10.1161/ATVBAHA.111.229435; Smart N, 2006, CARDIOVASC RES, V69, P164, DOI 10.1016/j.cardiores.2005.08.017; Sposito AC, 2011, ARTERIOSCL THROM VAS, V31, P1240, DOI 10.1161/ATVBAHA.110.218685; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; Uchiyama Y, 2008, INT IMMUNOPHARMACOL, V8, P1595, DOI 10.1016/j.intimp.2008.07.002; Wolf J, 2014, CYTOKINE, V70, P11, DOI 10.1016/j.cyto.2014.05.024; Yu LL, 2013, CIRC-HEART FAIL, V6, P107, DOI 10.1161/CIRCHEARTFAILURE.112.971168	33	28	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167195	10.1371/journal.pone.0167195	http://dx.doi.org/10.1371/journal.pone.0167195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936014	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100071
J	Huang, YR; Zhong, C; Lin, HX; Huang, J				Huang, Yiran; Zhong, Cheng; Lin, Hai Xiang; Huang, Jing			Aligning Metabolic Pathways Exploiting Binary Relation of Reactions	PLOS ONE			English	Article							PROTEIN-INTERACTION; NETWORK ALIGNMENT; GLOBAL ALIGNMENT; LARGE-SCALE; INFORMATION; TOOL	Metabolic pathway alignment has been widely used to find one-to-one and/or one-to-many reaction mappings to identify the alternative pathways that have similar functions through different sets of reactions, which has important applications in reconstructing phylogeny and understanding metabolic functions. The existing alignment methods exhaustively search reaction sets, which may become infeasible for large pathways. To address this problem, we present an effective alignment method for accurately extracting reaction mappings between two metabolic pathways. We show that connected relation between reactions can be formalized as binary relation of reactions in metabolic pathways, and the multiplications of zero-one matrices for binary relations of reactions can be accomplished in finite steps. By utilizing the multiplications of zero-one matrices for binary relation of reactions, we efficiently obtain reaction sets in a small number of steps without exhaustive search, and accurately uncover biologically relevant reaction mappings. Furthermore, we introduce a measure of topological similarity of nodes (reactions) by comparing the structural similarity of the k-neighborhood subgraphs of the nodes in aligning metabolic pathways. We employ this similarity metric to improve the accuracy of the alignments. The experimental results on the KEGG database show that when compared with other state-of-the-art methods, in most cases, our method obtains better performance in the node correctness and edge correctness, and the number of the edges of the largest common connected subgraph for one-to-one reaction mappings, and the number of correct one-to-many reaction mappings. Our method is scalable in finding more reaction mappings with better biological relevance in large metabolic pathways.	[Huang, Yiran] South China Univ Technol, Sch Comp Sci & Engn, Guangzhou, Guangdong, Peoples R China; [Huang, Yiran; Zhong, Cheng] Guangxi Univ, Sch Comp Elect & Informat, Nanning, Peoples R China; [Lin, Hai Xiang] Delft Univ Technol, Fac Elect Engn Math & Comp Sci, Delft, Netherlands; [Huang, Jing] Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Peoples R China	South China University of Technology; Guangxi University; Delft University of Technology; Guangxi University	Huang, YR (corresponding author), South China Univ Technol, Sch Comp Sci & Engn, Guangzhou, Guangdong, Peoples R China.; Huang, YR; Zhong, C (corresponding author), Guangxi Univ, Sch Comp Elect & Informat, Nanning, Peoples R China.	hyr@gxu.edu.cn; chzhong@gxu.edu.cn		Lin, Hai Xiang/0000-0002-1653-4854	National Natural Science Foundation of China [61462005]; Natural Science Foundation of Guangxi [2014GXNSFAA118396]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangxi(National Natural Science Foundation of Guangxi Province)	This work is supported in part by the National Natural Science Foundation of China under Grant No. 61462005, and Natural Science Foundation of Guangxi under Grant No. 2014GXNSFAA118396. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaka G, 2013, BIOINFORMATICS, V29, P145, DOI 10.1093/bioinformatics/btt235; Alberich R, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-58; Ay F, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S3-S2; Ay F, 2011, J COMPUT BIOL, V18, P219, DOI 10.1089/cmb.2010.0280; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Cheng Q, 2009, BIOINFORMATICS, V25, P1989, DOI 10.1093/bioinformatics/btp287; Fionda V, 2011, J COMPUT BIOL, V18, P595, DOI 10.1089/cmb.2009.0144; Hasan MM, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0756-0; Hattori M, 2003, J AM CHEM SOC, V125, P11853, DOI 10.1021/ja036030u; Heymans M, 2003, BIOINFORMATICS, V19, pi138, DOI 10.1093/bioinformatics/btg1018; Hochuli M, 1999, J BACTERIOL, V181, P3226, DOI 10.1128/JB.181.10.3226-3237.1999; Jiang CR, 2010, INT ASIA CONF INFORM, P88, DOI 10.1109/CAR.2010.5456772; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Li YL, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-111; Malod-Dognin N, 2015, BIOINFORMATICS, V31, P2182, DOI 10.1093/bioinformatics/btv130; Milenkovic T, 2010, CANCER INFORM, V9, P121, DOI 10.4137/CIN.S4744; Neyshabur B, 2013, BIOINFORMATICS, V29, P1654, DOI 10.1093/bioinformatics/btt202; Pinter RY, 2005, BIOINFORMATICS, V21, P3401, DOI 10.1093/bioinformatics/bti554; Rosen KH., 1999, DISCRETE MATH ITS AP; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Singh R, 2008, P NATL ACAD SCI USA, V105, P12763, DOI 10.1073/pnas.0806627105; Song B, 2011, IEEE ACM T COMPUT BI, V8, P732, DOI 10.1109/TCBB.2010.41; Tian YY, 2007, BIOINFORMATICS, V23, P232, DOI 10.1093/bioinformatics/btl571; Tohsato Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P376; Wernicke S, 2007, BIOINFORMATICS, V23, P1978, DOI 10.1093/bioinformatics/btm279; Yang QW, 2007, J COMPUT BIOL, V14, P56, DOI 10.1089/cmb.2006.0076; Zhenping L, 2007, BIOINFORMATICS, V23, P1631, DOI 10.1093/bioinformatics/btm156	28	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168044	10.1371/journal.pone.0168044	http://dx.doi.org/10.1371/journal.pone.0168044			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936108	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100260
J	Kampen, H; Kuhlisch, C; Frohlich, A; Scheuch, DE; Walther, D				Kampen, Helge; Kuhlisch, Cornelius; Froehlich, Andreas; Scheuch, Dorothee E.; Walther, Doreen			Occurrence and Spread of the Invasive Asian Bush Mosquito Aedes japonicus japonicus (Diptera: Culicidae) in West and North Germany since Detection in 2012 and 2013, Respectively	PLOS ONE			English	Article							ESTABLISHMENT; VIRUS; POPULATIONS; CEMETERIES; DISCOVERY; THEOBALD	The invasive Asian bush mosquito Aedes japonicus japonicus was first recognised as established in Germany in 2008. In addition to the first known and quickly expanding population in the southwestern part of the country, three separate populations were discovered in West, North and southeastern Germany in 2012, 2013 and 2015, respectively, by means of the `Mueckenatlas', a German instrument of passive mosquito surveillance. Since the first findings of mosquito specimens in West and North Germany, these regions were checked annually for continuing colonisation and spread of the species. Both affected areas were covered by a virtual 10x10km(2) grid pattern in the cells of which cemeteries were screened for immature stages of the mosquito. The cells were considered populated as soon as larvae or pupae were detected, whereas they were classified as negative when no mosquito stages were found in the cemeteries of at least three different towns or villages. Presence was also recorded when Ae. j. japonicus adults were submitted to the `Mueckenatlas' from the respective cell or when there was evidence of local occurrence in localities other than cemeteries. Based on this approach, a significant expansion of the populated area was documented in West Germany since the first detection of Ae. j. japonicus in 2012 (increase in positive grid cells by more than 400%), while the North German population appears not to be expanding so far (reduction of positive grid cells by ca. 30% since 2013). As Ae. j. japonicus finds suitable climatic and ecological conditions in Germany, the differential expansion of the two populations might be attributed to the West German population being older and thus more firmly established than the closely related but younger North German population that might still be in its founder phase. However, geographic spread of all German populations in the future is anticipated. Continuous surveillance is recommended, as Ae. j. japonicus is a competent vector of several pathogens in the laboratory.	[Kampen, Helge; Froehlich, Andreas] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Greifswald, Germany; [Kuhlisch, Cornelius; Scheuch, Dorothee E.; Walther, Doreen] Leibniz Ctr Agr Landscape Res, Muncheberg, Germany	Friedrich Loeffler Institute; Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF)	Kampen, H (corresponding author), Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Greifswald, Germany.	helge.kampen@fli.bund.de			German Federal Office for Agriculture and Food [2810HS022, 2819104615, 2819104115]; Robert-Koch-Institute [1362/1-982]	German Federal Office for Agriculture and Food; Robert-Koch-Institute	Funded by German Federal Office for Agriculture and Food (www.ble.de): grant numbers 2810HS022, 2819104615, 2819104115, Robert-Koch-Institute (www.rki.de): grant number 1362/1-982. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreadis TG, 2001, J MED ENTOMOL, V38, P774, DOI 10.1603/0022-2585-38.6.774; Andreadis TG, 2010, J MED ENTOMOL, V47, P43, DOI 10.1603/033.047.0106; Becker N., 2011, EUROPEAN MOSQUITO B, V9, P88; Burger JF, 2008, ENTOMOL NEWS, V119, P439, DOI 10.3157/0013-872X-119.5.439; CDC (Centers for Disease Control and Prevention), 2012, MOSQ SPEC WHICH W NI; Chagin K. P., 1943, ME DITSINKAIA PARAZITOLOGIIA I PARAZITARNYE BOLEZNI [MED PARASITOL AND PARASITIC DIS], V12, P34; Fielden MA, 2015, CAN ENTOMOL, V147, P737, DOI 10.4039/tce.2015.5; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Harris MC, 2015, EMERG INFECT DIS, V21, P646, DOI 10.3201/eid2104.140734; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; ISSG (Invasive Species Specialist Group), 2009, GLOB INV SPEC DAT OC; Jackson M, 2016, J MED ENTOMOL, V53, P241, DOI 10.1093/jme/tjv164; KAMIMURA K, 1976, SCI MOSQUITOES, P150; Kampen H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-59; Kampen H, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0604-5; Kampen H, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-284; Kaufman MG, 2014, ANNU REV ENTOMOL, V59, P31, DOI 10.1146/annurev-ento-011613-162012; Krebs T, 2014, J VECTOR ECOL, V39, P437, DOI 10.1111/jvec.12119; Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103; Morris JA, 2007, J AM MOSQUITO CONTR, V23, P243, DOI 10.2987/8756-971X(2007)23[243:FROAJJ]2.0.CO;2; OMEARA GF, 1992, J AM MOSQUITO CONTR, V8, P1; R Core Team, 2021, R LANGUAGE ENV STAT; Rochlin I, 2013, BIOL INVASIONS, V15, P991, DOI 10.1007/s10530-012-0345-3; Sardelis MR, 2001, J AM MOSQUITO CONTR, V17, P137; Savignac R, 2002, JOINT M 68 ANN M AM, P21; Schaffner F, 2009, MED VET ENTOMOL, V23, P448, DOI 10.1111/j.1365-2915.2009.00825.x; Schaffner F, 2001, MOSQUITOES EUROPE CD; Schaffner Francis, 2011, European Mosquito Bulletin, V29, P141; TAKASHIMA I, 1985, T ROY SOC TROP MED H, V79, P546, DOI 10.1016/0035-9203(85)90091-4; TAKASHIMA I, 1989, J MED ENTOMOL, V26, P454, DOI 10.1093/jmedent/26.5.454; Thielman A, 2006, J MED ENTOMOL, V43, P138, DOI 10.1603/0022-2585(2006)043[0138:EOOJDC]2.0.CO;2; Turell MJ, 2013, J AM MOSQUITO CONTR, V29, P133, DOI 10.2987/12-6316r.1; Versteirt V, 2009, J MED ENTOMOL, V46, P1464, DOI 10.1603/033.046.0632; Vezzani D, 2007, TROP MED INT HEALTH, V12, P299, DOI [10.1111/j.1365-3165.2006.01781.x, 10.1111/j.1365-3156.2006.01781.x]; Werner D, 2013, PARASITOL RES, V112, P3665, DOI 10.1007/s00436-013-3564-3; Zielke DE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1447-z; Zielke DE, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0648-1; Zielke DE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099093	38	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167948	10.1371/journal.pone.0167948	http://dx.doi.org/10.1371/journal.pone.0167948			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936209	Green Submitted, gold, Green Published			2022-12-27	WOS:000389587100237
J	Kumar, PG; Kavitha, MS; Ahn, BC				Kumar, Pugalendhi Ganesh; Kavitha, Muthu Subash; Ahn, Byeong-Cheol			Automated Detection of Cancer Associated Genes Using a Combined Fuzzy-Rough-SetBased F-Information and Water Swirl Algorithm of Human Gene Expression Data	PLOS ONE			English	Article							MICROARRAY DATA; DECISION RULES; EXPERT-SYSTEM; CLASSIFICATION; PREDICTION; MACHINE; TUMOR; PROFILES; PATTERNS	This study describes a novel approach to reducing the challenges of highly nonlinear multi-class gene expression values for cancer diagnosis. To build a fruitful system for cancer diagnosis, in this study, we introduced two levels of gene selection such as filtering and embedding for selection of potential genes and the most relevant genes associated with cancer, respectively. The filter procedure was implemented by developing a fuzzy rough set (FR)-based method for redefining the criterion function of f-information (FI) to identify the potential genes without discretizing the continuous gene expression values. The embedded procedure is implemented by means of a water swirl algorithm (WSA), which attempts to optimize the rule set and membership function required to classify samples using a fuzzy-rule-based multiclassification system (FRBMS). Two novel update equations are proposed in WSA, which have better exploration and exploitation abilities while designing a self-learning FRBMS. The efficiency of our new approach was evaluated on 13 multicategory and 9 binary datasets of cancer gene expression. Additionally, the performance of the proposed FRFI-WSA method in designing an FRBMS was compared with existing methods for gene selection and optimization such as genetic algorithm (GA), particle swarm optimization (PSO), and artificial bee colony algorithm (ABC) on all the datasets. In the global cancer map with repeated measurements (GCM_ RM) dataset, the FRFI-WSA showed the smallest number of 16 most relevant genes associated with cancer using a minimal number of 26 compact rules with the highest classification accuracy (96.45%). In addition, the statistical validation used in this study revealed that the biological relevance of the most relevant genes associated with cancer and their linguistics detected by the proposed FRFI-WSA approach are better than those in the other methods. The simple interpretable rules with most relevant genes and effectively classified samples suggest that the proposed FRFI-WSA approach is reliable for classification of an individual's cancer gene expression data with high precision and therefore it could be helpful for clinicians as a clinical decision support system.	[Kumar, Pugalendhi Ganesh] Anna Univ, Dept Informat Technol, Reg Campus, Coimbatore, Tamil Nadu, India; [Kavitha, Muthu Subash] Kyungpook Natl Univ, Sch Elect Engn, Dept Comp Vis & Image Proc, Daegu, South Korea; [Ahn, Byeong-Cheol] Kyungpook Natl Univ, Sch Med & Hosp, Dept Nucl Med, Daegu, South Korea	Anna University; Anna University of Technology Coimbatore; Kyungpook National University; Kyungpook National University	Ahn, BC (corresponding author), Kyungpook Natl Univ, Sch Med & Hosp, Dept Nucl Med, Daegu, South Korea.	abc2000@knu.ac.kr	Kavitha, M.S./AAI-6438-2020; Kumar, Ganesh/D-5585-2019	Kumar, Ganesh/0000-0001-8681-8169; Kavitha, Muthu Subash/0000-0002-1676-561X	grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI15C0001]; grant of the National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [NRF-2015M2A2A7A01045177]	grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; grant of the National Research Foundation of Korea (NRF) grant - Korea government (MSIP)	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI15C0001) and a grant of the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (no. NRF-2015M2A2A7A01045177).; This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI15C0001) and a grant of the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. NRF-2015M2A2A7A01045177).	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Cengel Y. A., 2006, FLUID MECH FUNDAMENT; Chang JC, 2005, J CLIN ONCOL, V23, P1169, DOI 10.1200/JCO.2005.03.156; Chowdary D, 2006, J MOL DIAGN, V8, P31, DOI 10.2353/jmoldx.2006.050056; Cromer A, 2004, ONCOGENE, V23, P2484, DOI 10.1038/sj.onc.1207345; Czajkowski M, 2014, ARTIF INTELL MED, V61, P35, DOI 10.1016/j.artmed.2014.01.005; Dehan E, 2007, LUNG CANCER, V56, P175, DOI 10.1016/j.lungcan.2006.12.010; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Dyrskjot L, 2003, NAT GENET, V33, P90, DOI 10.1038/ng1061; GaneshKumar P, 2014, IEEE ACM T COMPUT BI, V11, P347, DOI 10.1109/TCBB.2014.2307325; Gordon GJ, 2002, CANCER RES, V62, P4963; Haque MN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146116; Hippo Y, 2002, CANCER RES, V62, P233; Ho SY, 2006, BIOSYSTEMS, V85, P165, DOI 10.1016/j.biosystems.2006.01.002; Hu QH, 2012, IEEE T FUZZY SYST, V20, P636, DOI 10.1109/TFUZZ.2011.2181180; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Komori O, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/798189; Kraan TCTMV, 2007, ANN RHEUM DIS, V66, P1008, DOI 10.1136/ard.2006.063412; Kumar PG, 2015, INT J DATA MIN BIOIN, V11, P31, DOI 10.1504/IJDMB.2015.066333; Laiho P, 2007, ONCOGENE, V26, P312, DOI 10.1038/sj.onc.1209778; Lee CS, 2011, IEEE T SYST MAN CY B, V41, P139, DOI 10.1109/TSMCB.2010.2048899; Lee Y, 2003, BIOINFORMATICS, V19, P1132, DOI 10.1093/bioinformatics/btg102; Li J., 2002, KENT RIDGE BIOMEDICA; Liu L, 2015, TRANSL CANCER RES, V4, P212, DOI 10.3978/j.issn.2218-676X.2015.05.04; Menser S, 2006, PROCEEDINGS OF THE IEEE SOUTHEASTCON 2006, P250, DOI 10.1109/second.2006.1629359; Moon H, 2007, ARTIF INTELL MED, V41, P197, DOI 10.1016/j.artmed.2007.07.003; Nguyen T. H., 2015, INT J CORR, V2015, P1, DOI DOI 10.1152/AJPHEART.00499.2014; Nutt CL, 2003, CANCER RES, V63, P1602; Pamukcu E, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/370640; Pancho DP, 2013, IEEE T FUZZY SYST, V21, P1133, DOI 10.1109/TFUZZ.2013.2245130; Peterson LE, 2008, INT J APPROX REASON, V47, P17, DOI 10.1016/j.ijar.2007.03.006; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Risinger JI, 2003, CANCER RES, V63, P6; Saito PT, 2015, PLOS ONE, V10, P1; Schaefer G, 2010, IEEE T INF TECHNOL B, V14, P23, DOI 10.1109/TITB.2009.2033590; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Sundaresh Suman, 2005, Int J Bioinform Res Appl, V1, P31, DOI 10.1504/IJBRA.2005.006901; Tan AC, 2005, BIOINFORMATICS, V21, P3896, DOI 10.1093/bioinformatics/bti631; Trawinski K, 2013, IEEE T FUZZY SYST, V21, P950, DOI 10.1109/TFUZZ.2012.2236844; Trawinski K, 2011, INT J UNCERTAIN FUZZ, V19, P589, DOI 10.1142/S0218488511007155; Tsipouras MG, 2007, IEEE T BIO-MED ENG, V54, P2089, DOI 10.1109/TBME.2007.893500; Whitworth J, 2015, EUR J HUM GENET, V23, P581, DOI 10.1038/ejhg.2014.157; Willenbrock H, 2009, RNA, V15, P2028, DOI 10.1261/rna.1699809; Xu R, 2007, IEEE ACM T COMPUT BI, V4, P65, DOI 10.1109/TCBB.2007.1009; Yeang CH, 2001, BIOINFORMATICS S1, V17; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Yeung KY, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-r34; Yoon Y, 2010, IEEE T SYST MAN CY C, V40, P216, DOI 10.1109/TSMCC.2009.2036594; Zhang RX, 2007, IEEE ACM T COMPUT BI, V4, P485, DOI 10.1109/TCBB.2007.1012	56	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167504	10.1371/journal.pone.0167504	http://dx.doi.org/10.1371/journal.pone.0167504			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936033	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100112
J	Mahmud, M; Piwoni, A; Filiczak, N; Janicka, M; Gubernator, J				Mahmud, Mohamed; Piwoni, Adriana; Filiczak, Nina; Janicka, Martyna; Gubernator, Jerzy			Long-Circulating Curcumin-Loaded Liposome Formulations with High Incorporation Efficiency, Stability and Anticancer Activity towards Pancreatic Adenocarcinoma Cell Lines In Vitro	PLOS ONE			English	Article							CANCER-CELLS; TUMOR-GROWTH; APOPTOSIS; DELIVERY; PROLIFERATION; PHOSPHOLIPIDS; NANOPARTICLES; INHIBITION; PACLITAXEL; PROTEINS	The incorporation of hydrophobic drugs into liposomes improve their bioavailability and leads to increased stability and anticancer activity, along with decreased drug toxicity. Curcumin (Cur) is a natural polyphenol compound with a potent anticancer activity in pancreatic adenocarcinoma (PA). In the present study, different types of Cur-loaded liposomal formulations were prepared and characterized in terms of size, shape, zeta potential, optimal drug-to-lipid ratio and stability at 4 degrees C, 37 degrees C; and in human plasma in vitro. The best formulation in terms of these parameters was PEGylated, cholesterol-free formulation based upon hydrogenated soya PC (HSPC: DSPE-PEG(2000): Cur, termed H5), which had a 0.05/10 molar ratio of drug-to-lipid, was found to be stable and had a 96% Cur incorporation efficiency. All Cur-loaded liposomal formulations had potent anticancer activity on the PA cancer cell lines AsPC-1 and BxPC-3, and were less toxic to a normal cell line (NHDF). Furthermore, apoptosis-induction induced by Cur in PA cells was associated with morphological changes including cell shrinkage, cytoplasmic blebbing, irregularity in shape and the externalization of cell membrane phosphatidylserine, which was preceded by an increase in intracellular reactive oxygen species (ROS) generation and caspase 3/7 activation. Because the liposomal formulations tested here, especially the H5 variant which exhibited slow release of the Cur in the human plasma test, the formulation may be stable enough to facilitate the accumulation of pharmacologically active amounts of Cur in target cancer tissue by EPR. Therefore, our formulations could serve as a promising therapeutic approach for pancreatic cancer and other cancers.	[Mahmud, Mohamed; Piwoni, Adriana; Filiczak, Nina; Janicka, Martyna; Gubernator, Jerzy] Univ Wroclaw, Fac Biotechnol, Dept Lipids & Liposomes, Wroclaw, Poland	University of Wroclaw	Mahmud, M (corresponding author), Univ Wroclaw, Fac Biotechnol, Dept Lipids & Liposomes, Wroclaw, Poland.	mohamed.mahmud2@uwr.edu.pl	Filipczak, Nina/AAL-8886-2020	Filipczak, Nina/0000-0001-9285-8298; Mahmud, Mohamed/0000-0003-3237-7999	University of Wroclaw; Wroclaw Center of Biotechnology program, The Leading National Research Center (KNOW)	University of Wroclaw; Wroclaw Center of Biotechnology program, The Leading National Research Center (KNOW)	The authors would like to gratefully and sincerely thank the University of Wroclaw for supporting this research. This work was supported through the Wroclaw Center of Biotechnology program, The Leading National Research Center (KNOW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2002, BIOSCIENCE REP, V22, P225, DOI 10.1023/A:1020186505848; ALLEN TM, 1988, P NATL ACAD SCI USA, V85, P8067, DOI 10.1073/pnas.85.21.8067; ALLEN TM, 1989, BIOCHIM BIOPHYS ACTA, V981, P27, DOI 10.1016/0005-2736(89)90078-3; Chen J, 2016, DRUG DELIV, V23, P1426, DOI 10.3109/10717544.2015.1088598; Chen Y, 2012, MOLECULES, V17, P5972, DOI 10.3390/molecules17055972; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Dhule SS, 2012, NANOMED-NANOTECHNOL, V8, P440, DOI 10.1016/j.nano.2011.07.011; Dos Santos N, 2002, BBA-BIOMEMBRANES, V1561, P188, DOI 10.1016/S0005-2736(02)00345-0; Drummond DC, 1999, PHARMACOL REV, V51, P691; El Kateb N, 2008, J MICROENCAPSUL, V25, P399, DOI [10.1080/02652040802012453, 10.1080/02652040802012453 ]; Erkan M, 2012, NAT REV GASTRO HEPAT, V9, P454, DOI 10.1038/nrgastro.2012.115; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; FREDERIK P M, 1991, Micron and Microscopica Acta, V22, P41, DOI 10.1016/0739-6260(91)90081-A; Gubernator J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091487; Gubernator J, 2010, J CONTROL RELEASE, V146, P68, DOI 10.1016/j.jconrel.2010.05.021; Hail N, 2008, FREE RADICAL BIO MED, V44, P1382, DOI 10.1016/j.freeradbiomed.2007.12.034; Hazzah HA, 2015, INT J PHARMACEUT, V492, P248, DOI 10.1016/j.ijpharm.2015.06.022; Husain K., 2014, J DRUG METABOLISM TO, V5, P1; Jones DT, 2006, CANCER RES, V66, P2749, DOI 10.1158/0008-5472.CAN-05-3857; Kanai M, 2012, POTENTIAL ROLE CURCU; Kanai M, 2014, WORLD J GASTROENTERO, V20, P9384, DOI 10.3748/wjg.v20.i28.9384; Kesharwani P, 2015, COLLOID SURFACE B, V132, P138, DOI 10.1016/j.colsurfb.2015.05.007; Krasnici S, 2003, INT J CANCER, V105, P561, DOI 10.1002/ijc.11108; KULKARNI SB, 1995, J MICROENCAPSUL, V12, P229, DOI 10.3109/02652049509010292; Lasic DD, 1996, NATURE, V380, P561, DOI 10.1038/380561a0; Lasic DD., 1993, LIPOSOMES PHYS APPL; Li H-J, 2016, P NATL ACAD SCI; Li J, 2015, ASIAN J PHARM SCI, V10, P81, DOI 10.1016/j.ajps.2014.09.004; Li L, 2005, CANCER-AM CANCER SOC, V104, P1322, DOI 10.1002/cncr.21300; Lin YG, 2007, CLIN CANCER RES, V13, P3423, DOI 10.1158/1078-0432.CCR-06-3072; Liu AC, 2006, J PHARMACEUT BIOMED, V40, P720, DOI 10.1016/j.jpba.2005.09.032; Lombardi L, 2012, EXPERT OPIN THER TAR, V16, pS71, DOI 10.1517/14728222.2012.662959; Maeda H, 2011, ADV DRUG DELIVER REV, V63, P129, DOI 10.1016/j.addr.2010.05.001; Mates JM, 2000, INT J BIOCHEM CELL B, V32, P157, DOI 10.1016/S1357-2725(99)00088-6; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Mimeault M, 2005, PANCREAS, V31, P301, DOI 10.1097/01.mpa.0000175893.04660.1b; Narang AS, 2011, ADV DRUG DELIVER REV, V63, P640, DOI 10.1016/j.addr.2011.04.002; Ranjan AP, 2013, ANTICANCER RES, V33, P3603; Ravindran J, 2009, AAPS J, V11, P495, DOI 10.1208/s12248-009-9128-x; Salmazi R, 2015, INT J NANOMED, V10, P4815, DOI 10.2147/IJN.S82385; Sari TP, 2015, FOOD HYDROCOLLOID, V43, P540, DOI 10.1016/j.foodhyd.2014.07.011; Semple SC, 1998, ADV DRUG DELIVER REV, V32, P3, DOI 10.1016/S0169-409X(97)00128-2; Singh RK, 2015, CLIN MED INSIGHTS-TH, V7, P63, DOI 10.4137/CMT.S33407; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Syng-ai C, 2004, MOL CANCER THER, V3, P1101; Thayyullathil F, 2008, FREE RADICAL BIO MED, V45, P1403, DOI 10.1016/j.freeradbiomed.2008.08.014; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Tod J, 2013, PANCREATOLOGY, V13, P1, DOI 10.1016/j.pan.2012.11.311; Ulukaya E, 2008, TOXICOL IN VITRO, V22, P232, DOI 10.1016/j.tiv.2007.08.006; Verrax J, 2011, BIOCHEM PHARMACOL, V82, P1540, DOI 10.1016/j.bcp.2011.07.102; Wang H, 2012, ANTI-CANCER AGENT ME, V12, P1281, DOI 10.2174/187152012803833026; Wang YJ, 1997, J PHARMACEUT BIOMED, V15, P1867, DOI 10.1016/S0731-7085(96)02024-9; WEINBERG ED, 1992, BIOL TRACE ELEM RES, V34, P123, DOI 10.1007/BF02785242; Wong AD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123461; WOODLE MC, 1992, BIOCHIM BIOPHYS ACTA, V1113, P171, DOI 10.1016/0304-4157(92)90038-C; Yamada T, 1997, CELL MOL LIFE SCI, V53, P435, DOI 10.1007/s000180050052; Yang T, 2007, DRUG DELIV, V14, P301, DOI 10.1080/10717540601098799; Yoshizawa Y, 2011, INT J PHARMACEUT, V412, P132, DOI 10.1016/j.ijpharm.2011.04.008	59	47	48	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167787	10.1371/journal.pone.0167787	http://dx.doi.org/10.1371/journal.pone.0167787			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936114	Green Published, gold			2022-12-27	WOS:000389587100188
J	Martiny, AC; Ma, LY; Mouginot, C; Chandler, JW; Zinser, ER				Martiny, Adam C.; Ma, Lanying; Mouginot, Cealine; Chandler, Jeremy W.; Zinser, Erik R.			Interactions between Thermal Acclimation, Growth Rate, and Phylogeny Influence Prochlorococcus Elemental Stoichiometry	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; RESOURCE-ALLOCATION; MARINE PROCHLOROCOCCUS; TEMPERATURE; SYNECHOCOCCUS; RATIOS; NITROGEN; PHOSPHORUS; ECOTYPES; PLANKTON	Variability in plankton elemental requirements can be important for global ocean biogeochemistry but we currently have a limited understanding of how ocean temperature influences the plankton C/N/P ratio. Multiple studies have put forward a 'translation-compensation' hypothesis to describe the positive relationship between temperature and plankton N/P or C/P as cells should have lower demand for P-rich ribosomes and associated depressed QP when growing at higher temperature. However, temperature affects many cellular processes beyond translation with unknown outcomes on cellular elemental composition. In addition, the impact of temperature on growth and elemental composition of phytoplankton is likely modulated by the life history and growth rate of the organism. To test the direct and indirect (via growth rate changes) effect of temperature, we here analyzed the elemental composition and ratios in six strains affiliated with the globally abundant marine Cyanobacteria Prochlorococcus. We found that temperature had a significant positive effect on the carbon and nitrogen cell quota, whereas no clear trend was observed for the phosphorus cell quota. The effect on N/P and C/P were marginally significantly positive across Prochlorococcus. The elemental composition and ratios of individual strains were also affected but we found complex interactions between the strain identity, temperature, and growth rate in controlling the individual elemental ratios in Prochlorococcus and no common trends emerged. Thus, the observations presented here does not support the 'translation-compensation' theory and instead suggest unique cellular elemental effects as a result of rising temperature among closely related phytoplankton lineages. Thus, the biodiversity context should be considered when predicting future elemental ratios and how cycles of carbon, nitrogen, and phosphorus may change in a future ocean.	[Martiny, Adam C.; Mouginot, Cealine] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Martiny, Adam C.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Ma, Lanying; Chandler, Jeremy W.; Zinser, Erik R.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of Tennessee System; University of Tennessee Knoxville	Martiny, AC (corresponding author), Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA.; Martiny, AC (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	amartiny@uci.edu	Martiny, Adam/AAC-4459-2019	Martiny, Adam/0000-0003-2829-4314	National Science Foundation [OCE-1046297, OCE-1559002, OCE-1030518, OCE-1233964]; Division Of Ocean Sciences [1559002] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Financial support for this work was provided by the National Science Foundation Dimensions of Biodiversity (OCE-1046297) and Biological Oceanography (OCE-1559002) programs (to ACM) as well as Biological (OCE-1030518) and Chemical (OCE-1233964) Oceanography programs (to ERZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support for this work was provided by the National Science Foundation Dimensions of Biodiversity (OCE-1046297) and Biological Oceanography (OCE-1559002) programs (to ACM) as well as Biological (OCE-1030518) and Chemical (OCE-1233964) Oceanography programs (to ERZ). We thank the captain and crew of the R/V Thomas G. Thompson for support during the POWOW1 cruise.	Alexander H, 2015, P NATL ACAD SCI USA, V112, pE2182, DOI 10.1073/pnas.1421993112; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; Bonachela JA, 2013, BIOGEOSCIENCES, V10, P4341, DOI 10.5194/bg-10-4341-2013; Boyd PW, 2015, NAT CLIM CHANGE, V5, P71, DOI [10.1038/NCLIMATE2441, 10.1038/nclimate2441]; Bremer H., 2008, ECOSAL PLUS, V3, P765; Chandler JW, 2016, ENV MICROBIOL REP, V8, P272, DOI 10.1111/1758-2229.12378; DROOP MR, 1973, J PHYCOL, V9, P264; FELSENSTEIN J, 2006, PHYLIP PHYLOGENY INF; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Flynn KJ, 2010, J PHYCOL, V46, P1, DOI 10.1111/j.1529-8817.2009.00756.x; Fu FX, 2007, J PHYCOL, V43, P485, DOI 10.1111/j.1529-8817.2007.00355.x; Galbraith ED, 2015, P NATL ACAD SCI USA, V112, P8199, DOI 10.1073/pnas.1423917112; Garcia NS, 2016, ISME J; Grob C, 2013, ENV MICROBIOL; Heldal M, 2003, LIMNOL OCEANOGR, V48, P1732, DOI 10.4319/lo.2003.48.5.1732; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Klausmeier CA, 2004, NATURE, V429, P171, DOI 10.1038/nature02454; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lomas MW, 2010, BIOGEOSCIENCES, V7, P695, DOI 10.5194/bg-7-695-2010; Martiny AC, 2013, GLOBAL BIOGEOCHEM CY, V27, P723, DOI 10.1002/gbc.20061; Martiny AC, 2016, LIMNOL OCEANOGR, V61, P531, DOI 10.1002/lno.10233; Martiny AC, 2013, NAT GEOSCI, V6, P279, DOI [10.1038/NGEO1757, 10.1038/ngeo1757]; Mills MM, 2010, NAT GEOSCI, V3, P412, DOI 10.1038/NGEO856; MOORE LR, 1995, MAR ECOL PROG SER, V116, P259, DOI 10.3354/meps116259; Moore LR, 1999, LIMNOL OCEANOGR, V44, P628, DOI 10.4319/lo.1999.44.3.0628; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Morris JJ, 2008, APPL ENVIRON MICROB, V74, P4530, DOI 10.1128/AEM.02479-07; Morris JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016805; Mouginot C, 2015, LIMNOL OCEANOGR, V60, P1634, DOI 10.1002/lno.10123; Nielsen MV, 1996, MAR ECOL PROG SER, V136, P205, DOI 10.3354/meps136205; NIELSEN MV, 1991, J PLANKTON RES, V13, P389, DOI 10.1093/plankt/13.2.389; Oksanen J., 2016, R PACKAG; REDFIELD AC, 1958, AM SCI, V46, P205; RHEE GY, 1978, LIMNOL OCEANOGR, V23, P10, DOI 10.4319/lo.1978.23.1.0010; RHEE GY, 1981, LIMNOL OCEANOGR, V26, P635, DOI 10.4319/lo.1981.26.4.0635; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; Rusch DB, 2010, P NATL ACAD SCI USA, V107, P16184, DOI 10.1073/pnas.1009513107; SHARP JH, 1974, LIMNOL OCEANOGR, V19, P984, DOI 10.4319/lo.1974.19.6.0984; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Talarmin A, 2016, GLOBAL BIOGEOCHEM CY; Teng YC, 2014, NAT GEOSCI, V7, P895, DOI 10.1038/NGEO2303; Toseland A, 2013, NAT CLIM CHANGE, V3, P979, DOI 10.1038/NCLIMATE1989; Weber T, 2012, NATURE, V489, P419, DOI 10.1038/nature11357; Weber TS, 2010, NATURE, V467, P550, DOI 10.1038/nature09403; Woods HA, 2003, FUNCT ECOL, V17, P237, DOI 10.1046/j.1365-2435.2003.00724.x; Yvon-Durocher G, 2015, GLOBAL ECOL BIOGEOGR, V24, P562, DOI 10.1111/geb.12280; Zimmerman AE, 2014, ENVIRON MICROBIOL, V16, P1398, DOI 10.1111/1462-2920.12329; Zinser ER, 2007, LIMNOL OCEANOGR, V52, P2205, DOI 10.4319/lo.2007.52.5.2205	48	29	30	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168291	10.1371/journal.pone.0168291	http://dx.doi.org/10.1371/journal.pone.0168291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936127	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100287
J	Muller, A; Clarkson, C				Muller, Antoine; Clarkson, Chris			Identifying Major Transitions in the Evolution of Lithic Cutting Edge Production Rates	PLOS ONE			English	Article							MIDDLE STONE-AGE; PREPARED CORE TECHNOLOGIES; SOUTH-AFRICA; MODERN HUMANS; TOOL USE; PALEOLITHIC TRANSITION; KAPTHURIN FORMATION; BLADE PRODUCTION; WEST TURKANA; COGNITION	The notion that the evolution of core reduction strategies involved increasing efficiency in cutting edge production is prevalent in narratives of hominin technological evolution. Yet a number of studies comparing two different knapping technologies have found no significant differences in edge production. Using digital analysis methods we present an investigation of raw material efficiency in eight core technologies broadly representative of the long-term evolution of lithic technology. These are bipolar, multiplatform, discoidal, biface, Levallois, prismatic blade, punch blade and pressure blade production. Raw material efficiency is assessed by the ratio of cutting edge length to original core mass. We also examine which flake attributes contribute to maximising raw material efficiency, as well as compare the difference between expert and intermediate knappers in terms of cutting edge produced per gram of core. We identify a gradual increase in raw material efficiency over the broad sweep of lithic technological evolution. The results indicate that the most significant transition in efficiency likely took place with the introduction of small foliate biface, Levallois and prismatic blade knapping, all introduced in the Middle Stone Age / Middle Palaeolithic among early Homo sapiens and Neanderthals. This suggests that no difference in raw material efficiency existed between these species. With prismatic blade technology securely dated to the Middle Palaeolithic, by including the more recent punch and pressure blade technology our results dispel the notion that the transition to the Upper Palaeolithic was accompanied by an increase in efficiency. However, further increases in cutting edge efficiency are evident, with pressure blades possessing the highest efficiency in this study, indicating that late/epi-Palaeolithic and Neolithic blade technologies further increased efficiency.	[Muller, Antoine; Clarkson, Chris] Univ Queensland, Sch Social Sci, St Lucia, Qld, Australia	University of Queensland	Muller, A (corresponding author), Univ Queensland, Sch Social Sci, St Lucia, Qld, Australia.	antoine.muller@uqconnect.edu.au		Muller, Antoine/0000-0003-1646-796X				Ambrose SH, 2001, SCIENCE, V291, P1748, DOI 10.1126/science.1059487; Archer W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132428; Bar-Yosef O, 1999, AM ANTHROPOL, V101, P322, DOI 10.1525/aa.1999.101.2.322; Beck C, 2015, LITHIC TECHNOLOGICAL SYSTEMS AND EVOLUTIONARY THEORY, P83; Bleed P, 2008, J ARCHAEOL METHOD TH, V15, P154, DOI 10.1007/s10816-007-9046-0; Boeda E., 1993, B SOC PREHIST FR; Bordaz J., 1970, TOOLS OLD NEW STONE; Bordes F., 1969, TEBIWA, V12, P1; Bourguignon L, 1997, MOUSTERIEN TYPE QUIN; Brantingham PG, 2000, J ARCHAEOL SCI, V27, P255, DOI 10.1006/jasc.1999.0456; Brantingham PJ, 2001, J ARCHAEOL SCI, V28, P747, DOI 10.1006/jasc.2000.0594; Brown KS, 2012, NATURE, V491, P590, DOI 10.1038/nature11660; Brown KS, 2009, SCIENCE, V325, P859, DOI 10.1126/science.1175028; Brumm A, 2010, J ARCHAEOL SCI, V37, P451, DOI 10.1016/j.jas.2009.09.012; Chazan M, 1997, J HUM EVOL, V33, P719, DOI 10.1006/jhev.1997.0167; CHAZAN M, 1995, CURR ANTHROPOL, V36, P749, DOI 10.1086/204430; Clark G., 2002, J HUM EVOL, V42, P185, DOI [10.1006/jhev.2001.0517, DOI 10.1006/JHEV.2001.0517]; Clark J. E., 2012, EMERGENCE PRESSURE B, P43; Cole J, 2015, CAMB ARCHAEOL J, V25, P713, DOI 10.1017/S0959774315000141; Collins M. B., 1999, CLOVIS BLADE TECHNOL; Combier J., 1967, MEMOIRE U BORDEAU; Crabtree D. E., 1967, TEBIWA, V10, P60; CRABTREE DE, 1968, AM ANTIQUITY, V33, P446, DOI 10.2307/278596; de la Torre I, 2004, CURR ANTHROPOL, V45, P439, DOI 10.1086/422079; de la Torre I, 2003, J HUM EVOL, V44, P203, DOI 10.1016/S0047-2484(02)00206-3; Delagnes A, 2005, J HUM EVOL, V48, P435, DOI 10.1016/j.jhevol.2004.12.005; Delagnes A., 2000, ACTA ANTHR SINICA, V19, P181; Delagnes A, 2006, INTERD CONTRIB ARCH, P85, DOI 10.1007/0-387-24661-4_5; Derevianko A.P., 1995, DEFINITION INTERPRET, V23, P455; Desrosiers P. M., 2012, EMERGENCE PRESSURE B, P181; Dibble E., 1995, DEFINITION INTERPRET, P41; Diez-Martin F, 2010, QUATERNARY RES, V74, P376, DOI 10.1016/j.yqres.2010.07.019; Eren MI, 2011, J ARCHAEOL SCI, V38, P2731, DOI 10.1016/j.jas.2011.06.011; Eren MI, 2011, AM ANTIQUITY, V76, P229, DOI 10.7183/0002-7316.76.2.229; Eren MI, 2008, J HUM EVOL, V55, P952, DOI 10.1016/j.jhevol.2008.07.009; Finlay N, 2008, J ARCHAEOL METHOD TH, V15, P68, DOI 10.1007/s10816-007-9048-y; Fisher LE, 2006, J ANTHROPOL ARCHAEOL, V25, P226, DOI 10.1016/j.jaa.2005.09.005; Flenniken JJ, 2003, MESOAMERICAN LITHIC TECHNOLOGY: EXPERIMENTATION AND INTERPRETATION, P98; Frey SH, 2008, PHILOS T R SOC B, V363, P1951, DOI 10.1098/rstb.2008.0008; Geribas N, 2010, J ARCHAEOL SCI, V37, P2857, DOI 10.1016/j.jas.2010.06.026; Golani, 2013, PALEORIENT, V39, P95; Goren-Inbar N, 2011, PHILOS T R SOC B, V366, P1038, DOI 10.1098/rstb.2010.0365; Gowlett J.A.J., 2011, PALEOANTHROPOLOGY, V2011, P174, DOI DOI 10.4207/PA.2011.ART51; GOWLETT JAJ, 1988, WORLD ARCHAEOL, V20, P13, DOI 10.1080/00438243.1988.9980053; Gowlett JAJ., 1984, CULTURE ED SOC, V38, P199, DOI 10.1111/j.1468-2273.1984.tb01387.x; GREENFIELD PM, 1991, BEHAV BRAIN SCI, V14, P531, DOI 10.1017/S0140525X00071235; Harmand S, 2015, NATURE, V521, P310, DOI 10.1038/nature14464; Hayden B, 1996, INTERD CONT, P9; Heighway Z, 2011, CUTTING EDGE CORE TE; Higuchi S, 2009, NEUROREPORT, V20, P1376, DOI 10.1097/WNR.0b013e3283315570; Hiscock P, 2011, WORLD ARCHAEOL, V43, P653, DOI 10.1080/00438243.2011.624755; Jaubert J., 1993, B SOCI T PR HISTORIQ, V90, P328; Jaubert J., 1995, DEFINITION INTERPRET, V23, P227; Jennings TA, 2010, J ARCHAEOL SCI, V37, P2155, DOI 10.1016/j.jas.2010.02.020; JESKE RJ, 1992, AM ANTIQUITY, V57, P467, DOI 10.2307/280935; Johnson CR, 2010, J HUM EVOL, V58, P193, DOI 10.1016/j.jhevol.2009.10.001; Klein RG, 1989, HUMAN CAREER HUMAN B; krdla P, 2014, QUARTAR, V61, P87; Kuchikura Y, 1973, PALEORIENT, V1, P87; Leduc C, DANISJ J ARCHAEOLOGY, V1, P62; Leroi-Gourhan A., 1957, PREHISTORIC MAN; Leroi-Gourhan Andre, 1993, GESTURE SPEECH; Lin SC, 2013, AM ANTIQUITY, V78, P724, DOI 10.7183/0002-7316.78.4.724; Ludwig B.V., 1998, EARLY HUMAN BEHAV GL, P84; Machin AJ, 2007, J ARCHAEOL SCI, V34, P883, DOI 10.1016/j.jas.2006.09.008; Mahaney R.A., 2014, PALEOANTHROPOLOGY, V2014, P586, DOI DOI 10.4207/PA.2014.ART90; Marks AE, 2006, INTERD CONTRIB ARCH, P121, DOI 10.1007/0-387-24661-4_7; Martinez K, 2010, P NATL ACAD SCI USA, V107, P5762, DOI 10.1073/pnas.0913856107; Marzke MW, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0414; Marzke MW, 1997, AM J PHYS ANTHROPOL, V102, P91; MASAO FT, 1982, ETHNOS, V47, P262; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; MELLARS P, 1989, HUMAN REVOLUTION, P338; MELLARS P, 1989, CURR ANTHROPOL, V30, P349, DOI 10.1086/203755; Moore MW, 2007, J HUM EVOL, V52, P85, DOI 10.1016/j.jhevol.2006.08.002; Moore MW, 2010, STONE TOOLS AND THE EVOLUTION OF HUMAN COGNITION, P13; Morgan TJH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7029; Nishiaki Y., 1989, PALE ORIENT, V15, P215, DOI DOI 10.3406/paleo.1989.4497; Nonaka T, 2010, J HUM EVOL, V59, P155, DOI 10.1016/j.jhevol.2010.04.006; Pasty J.-F., 2000, BULL SOC PREHIST FR, V97, P165; Pelegrin J., 2003, BLADE MAKING TECHNIQ; Pelegrin J., 2009, COGNITIVE ARCHAEOLOG, P95; Peresani M., PALEO; Piperno M, 2009, VERTEBR PALEOBIOL PA, P111, DOI 10.1007/978-1-4020-9060-8_10; Prasciunas MM, 2007, AM ANTIQUITY, V72, P334, DOI 10.2307/40035817; Price T. D, 2007, PRINCIPLES ARCHAEOLO; Rasic R., 2001, LITHIC DEBITAGE CONT, P61; Renfrew C., 2012, ARCHAEOLOGY THEORIES; Robbins LH, 2000, J ARCHAEOL SCI, V27, P1085, DOI 10.1006/jasc.2000.0597; Rolian C, 2011, J HUM EVOL, V61, P26, DOI 10.1016/j.jhevol.2011.01.008; Rots V., 2009, QUARTAR, V56, P37; Schick K. D., 1993, MAKING SILENT STONES; Schlanger N, 1996, CAMB ARCHAEOL J, V6, P231, DOI DOI 10.1017/S0959774300001724; Semaw S, 2000, J ARCHAEOL SCI, V27, P1197, DOI 10.1006/jasc.1999.0592; Shea JJ, 2008, J HUM EVOL, V55, P448, DOI 10.1016/j.jhevol.2008.05.014; SHEETS PD, 1977, LAT AM RES REV, V12, P139; SHEETS PD, 1972, SCIENCE, V175, P632, DOI 10.1126/science.175.4022.632; SHELLEY PH, 1990, J FIELD ARCHAEOL, V17, P187, DOI 10.1179/009346990791548349; Sherratt A, 1997, ANTIQUITY, V71, P271, DOI 10.1017/S0003598X00084908; Shimelmitz R, 2011, J HUM EVOL, V61, P458, DOI 10.1016/j.jhevol.2011.06.003; Shipton C, 2013, J HUM EVOL, V65, P93, DOI 10.1016/j.jhevol.2013.03.007; Shipton C., 2013, B MUJ; Shipton C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065185; Shott MJ., 1989, N AM ARCHAEOL, V10, P1, DOI DOI 10.2190/AAKD-X5Y1-89H6-NGJW; Sorensen M., 2012, EMERGENCE PRESSURE B, P237, DOI [DOI 10.1007/978-1-4614-2003-3, 10.1007/978-1-4614-2003-3_9, DOI 10.1007/978-1-4614-2003-3_9]; Soriano S, 2007, J ARCHAEOL SCI, V34, P681, DOI 10.1016/j.jas.2006.06.017; Soriano S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131127; Stout D, 2002, CURR ANTHROPOL, V43, P693, DOI 10.1086/342638; Stout D, 2008, PHILOS T R SOC B, V363, P1939, DOI 10.1098/rstb.2008.0001; Stout D, 2007, NEUROPSYCHOLOGIA, V45, P1091, DOI 10.1016/j.neuropsychologia.2006.09.014; Stout D, 2014, J ARCHAEOL SCI, V41, P576, DOI 10.1016/j.jas.2013.10.001; Stout D, 2012, PHILOS T R SOC B, V367, P75, DOI 10.1098/rstb.2011.0099; Stout D, 2011, EUR J NEUROSCI, V33, P1328, DOI 10.1111/j.1460-9568.2011.07619.x; Stout D, 2011, PHILOS T R SOC B, V366, P1050, DOI 10.1098/rstb.2010.0369; Stout D, 2009, CAMB ARCHAEOL J, V19, P85, DOI 10.1017/S0959774309000055; Swinnen C., 1994, PALEO, V6, P89; Szeletian J., 2009, SOURCEBOOK PALEOLITH, P407; Titmus GL, 2003, MESOAMERICAN LITHIC TECHNOLOGY: EXPERIMENTATION AND INTERPRETATION, P72; Tixier J., 1972, B SOC PREHISTORIQUE, V69, P134; Tomka S.A., 2001, LITHIC DEBITAGE CONT, P207; Toth N., 2006, OLDOWAN CASE STUDIES, P155; Tryon C. A., 2005, AFR ARCHAEOL REV, V22, P199, DOI [10.1007/s10437-006-9002-5, DOI 10.1007/S10437-006-9002-5]; Tryon CA, 2006, CURR ANTHROPOL, V47, P367, DOI 10.1086/503066; Uomini NT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072693; Usik VI, 1993, PALEORIENT, V19, P5, DOI DOI 10.3406/PALE0.1993.4593; Van Peer P, 1998, CURR ANTHROPOL, V39, pS115, DOI 10.1086/204692; Van Peer P., 1992, LEVALLOIS REDUCTION, V13; Vaquero M, 2001, J FIELD ARCHAEOL, V28, P93, DOI 10.1179/jfa.2001.28.1-2.93; Villa P., 2006, SOUTH AFR HUMANIT, V18, P89; Villa P, 2009, J ARCHAEOL SCI, V36, P441, DOI 10.1016/j.jas.2008.09.028; Wendorf F., 1974, MIDDLE STONE AGE SEQ; White M, 2003, CURR ANTHROPOL, V44, P598, DOI 10.1086/377653; White M, 2011, DEV QUATER SCI, V14, P53; Whittaker J.C., 1994, FLINT KNAPPING MAKIN; Wilkins J, 2012, J ARCHAEOL SCI, V39, P1883, DOI 10.1016/j.jas.2012.01.031; Wynn T, 2002, BEHAV BRAIN SCI, V25, P389, DOI 10.1017/S0140525X02000079; Zaidner Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066851	137	36	36	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167244	10.1371/journal.pone.0167244	http://dx.doi.org/10.1371/journal.pone.0167244			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936135	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100077
J	Navarro, MO; Kwan, GT; Batalov, O; Choi, CY; Pierce, NT; Levin, LA				Navarro, Michael O.; Kwan, Garfield T.; Batalov, Olga; Choi, Chelsea Y.; Pierce, N. Tessa; Levin, Lisa A.			Development of Embryonic Market Squid, Doryteuthis opalescens, under Chronic Exposure to Low Environmental pH and [O-2]	PLOS ONE			English	Article							CALAMARY SEPIOTEUTHIS-AUSTRALIS; OCEAN ACIDIFICATION; CARBONATE CHEMISTRY; SEPIA-OFFICINALIS; CO2 TOLERANCE; EGG MASSES; OXYGEN; VARIABILITY; STATOLITH; TEMPERATURE	The market squid, Doryteuthis opalescens, is an important forage species for the inshore ecosystems of the California Current System. Due to increased upwelling and expansion of the oxygen minimum zone in the California Current Ecosystem, the inshore environment is expected to experience lower pH and [O-2] conditions in the future, potentially impacting the development of seafloor-attached encapsulated embryos. To understand the consequences of this co-occurring environmental pH and [O-2] stress for D. opalescens encapsulated embryos, we performed two laboratory experiments. In Experiment 1, embryo capsules were chronically exposed to a treatment of higher (normal) pH (7.93) and [O-2] (242 mu M) or a treatment of low pH (7.57) and [O-2] (80 mu M), characteristic of upwelling events and/or La Nina conditions. The low pH and low [O-2] treatment extended embryo development duration by 5-7 days; embryos remained at less developed stages more often and had 54.7% smaller statolith area at a given embryo size. Importantly, the embryos that did develop to mature embryonic stages grew to sizes that were similar (non-distinct) to those exposed to the high pH and high [O-2] treatment. In Experiment 2, we exposed encapsulated embryos to a single stressor, low pH (7.56) or low [O-2] (85 mu M), to understand the importance of environmental pH and [O-2] rising and falling together for squid embryogenesis. Embryos in the low pH only treatment had smaller yolk reserves and bigger statoliths compared to those in low [O-2] only treatment. These results suggest that D. opalescens developmental duration and statolith size are impacted by exposure to environmental [O-2] and pH (pCO(2)) and provide insight into embryo resilience to these effects.	[Navarro, Michael O.; Kwan, Garfield T.; Choi, Chelsea Y.; Levin, Lisa A.] UCSD, Scripps Inst Oceanog, Integrat Oceanog Div, La Jolla, CA 92093 USA; [Navarro, Michael O.; Pierce, N. Tessa; Levin, Lisa A.] UCSD, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; [Kwan, Garfield T.; Pierce, N. Tessa] UCSD, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA USA; [Batalov, Olga] UCSD, Div Biol Sci, La Jolla, CA USA; [Choi, Chelsea Y.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; University of Rochester	Navarro, MO (corresponding author), UCSD, Scripps Inst Oceanog, Integrat Oceanog Div, La Jolla, CA 92093 USA.; Navarro, MO (corresponding author), UCSD, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA.	monavarro@alaska.edu		Kwan, Garfield/0000-0001-9183-2731	National Oceanic and Atmospheric Administration (NOAA) [NA100AR4170060]; California Sea Grant College Program through NOAA's National Sea Grant College Program [R/CC-02, R/CC-04]; U.S. Department of Commerce; National Science Foundation-Division of Ocean Sciences [0903551, 0927445, 1041062]	National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); California Sea Grant College Program through NOAA's National Sea Grant College Program; U.S. Department of Commerce; National Science Foundation-Division of Ocean Sciences(National Science Foundation (NSF))	This work was funded by National Oceanic and Atmospheric Administration (NOAA: http://www.noaa.gov/) Grant No. NA100AR4170060, California Sea Grant College Program (https://caseagrant.ucsd.edu/) Project Nos. R/CC-02 and R/CC-04, through NOAA's National Sea Grant College Program (http://seagrant.noaa.gov/), U.S. Department of Commerce (https://www.commerce.gov/), and by the National Science Foundation-Division of Ocean Sciences (http://www.nsf.gov/div/index.jsp?div=oce) Award Nos. 0903551, 0927445 and 1041062. The statements, findings, conclusions and recommendations are those of the authors and do not necessarily reflect the views of California Sea Grant, state agencies, NOAA, NSF or the U.S. Department of Commerce. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkhipkin AI, 2000, J ZOOL, V250, P31, DOI 10.1111/j.1469-7998.2000.tb00575.x; ARNOLD JM, 1965, BIOL BULL, V128, P24, DOI 10.2307/1539386; BENNINGTON CC, 1994, ECOLOGY, V75, P717, DOI 10.2307/1941729; Bockmon EE, 2013, BIOGEOSCIENCES, V10, P5967, DOI 10.5194/bg-10-5967-2013; Bograd SJ, 2015, DEEP-SEA RES PT II, V112, P42, DOI 10.1016/j.dsr2.2014.04.009; Booth JAT, 2014, LIMNOL OCEANOGR, V59, P1127, DOI 10.4319/lo.2014.59.4.1127; Booth JAT, 2012, CONT SHELF RES, V45, P108, DOI 10.1016/j.csr.2012.06.009; BUDELMANN BU, 1979, BRAIN RES, V160, P261, DOI 10.1016/0006-8993(79)90423-2; Chen DS, 1996, BIOL BULL, V190, P69, DOI 10.2307/1542676; Cohen CS, 1996, BIOL BULL, V190, P8, DOI 10.2307/1542671; Cronin ER, 2000, MAR BIOL, V136, P863, DOI 10.1007/s002270000274; Fields W. G., 1965, Fishery Bulletin California, VNo. 131, P1; Frieder CA, 2012, BIOGEOSCIENCES, V9, P3917, DOI 10.5194/bg-9-3917-2012; Gobler CJ, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0976; Gutowska MA, 2009, MAR BIOL, V156, P515, DOI 10.1007/s00227-008-1096-7; Hamdoun A, 2007, P NATL ACAD SCI USA, V104, P1745, DOI 10.1073/pnas.0610108104; HANLON RT, 1989, J EXP BIOL, V141, P187; Hauri C, 2009, OCEANOGRAPHY, V22, P60, DOI 10.5670/oceanog.2009.97; Hu MY, 2016, VIE MILIEU, V66, P57; Hu MRY, 2015, TISSUE BARRIERS, V3, DOI 10.1080/21688370.2015.1064196; Hu MY, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-51; Hu MY, 2011, AM J PHYSIOL-REG I, V301, pR1700, DOI 10.1152/ajpregu.00107.2011; Hu MY, 2011, AM J PHYSIOL-REG I, V300, pR1100, DOI 10.1152/ajpregu.00653.2010; Hu MY, 2009, COMP BIOCHEM PHYS A, V153, P278, DOI 10.1016/j.cbpa.2009.02.040; Kaplan MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063714; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Lacoue-Labarthe T, 2011, AQUAT TOXICOL, V105, P166, DOI 10.1016/j.aquatox.2011.05.021; McClatchie S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044497; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Nam S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049549; Navarro M. M., 2014, THESIS; Navarro MO, 2014, WATER-SUI, V6, P2233, DOI 10.3390/w6082233; O'Connor CM, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00388.1; Perretti CT, 2016, FISH OCEANOGR, V25, P491, DOI 10.1111/fog.12167; Perretti CT, 2014, THESIS; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner H. O., 2010, GUIDE BEST PRACTICES, P167; Reum JCP, 2016, ICES J MAR SCI, V73, P582, DOI 10.1093/icesjms/fsu231; Roberts MJ, 2005, ICES J MAR SCI, V62, P33, DOI 10.1016/j.icesjms.2004.10.002; Robin JP, 2014, ADV MAR BIOL, V67, P361, DOI 10.1016/B978-0-12-800287-2.00004-4; Rosa R, 2014, J EXP BIOL, V217, P518, DOI 10.1242/jeb.096081; Rosa R, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1695; Rosa R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038282; Send U, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007517; Steer MA, 2003, MAR ECOL PROG SER, V261, P175, DOI 10.3354/meps261175; Steer MA, 2002, MAR ECOL PROG SER, V243, P143, DOI 10.3354/meps243143; STRATHMANN RR, 1984, J EXP MAR BIOL ECOL, V84, P85, DOI 10.1016/0022-0981(84)90232-6; STRATHMANN RR, 1995, J MAR BIOL ASSOC UK, V75, P413, DOI 10.1017/S0025315400018270; Takeshita Y, 2015, BIOGEOSCIENCES, V12, P5853, DOI 10.5194/bg-12-5853-2015; Vidal EAG, 2002, B MAR SCI, V71, P915; Warner RR, 2009, MAR ECOL PROG SER, V379, P109, DOI 10.3354/meps07903; Zeidberg L.D., 2011, MAR ECOL, V33, P326; Zeidberg LD, 2011, MAR ECOL-EVOL PERSP, V32, P468, DOI 10.1111/j.1439-0485.2011.00445.x	53	13	13	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167461	10.1371/journal.pone.0167461	http://dx.doi.org/10.1371/journal.pone.0167461			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936085	gold, Green Submitted, Green Published			2022-12-27	WOS:000389587100102
J	Njoku, OS; Manak, MM; O'Connell, RJ; Shutt, ALW; Malia, JA; Heipertz, RA; Tovanabutra, S; Milazzo, MJ; Akintunde, GA; Alabi, AS; Suleiman, A; Ogundeji, AA; Kene, TS; Nelson, R; Ayemoba, OR; Singer, DE; Robb, ML; Peel, SA; Michael, NL				Njoku, Ogbonnaya S.; Manak, Mark M.; O'Connell, Robert J.; Shutt, Ashley L. W.; Malia, Jennifer A.; Heipertz, Richard A., Jr.; Tovanabutra, Sodsai; Milazzo, Mark J.; Akintunde, Gideon Akindiran; Alabi, Abraham S.; Suleiman, Aminu; Ogundeji, Amos A.; Kene, Terfa S.; Nelson, Robbie; Ayemoba, Ojor R.; Singer, Darrell E.; Robb, Merlin L.; Peel, Sheila A.; Michael, Nelson L.			An Evaluation of Selected Populations for HIV-1 Vaccine Cohort Development in Nigeria	PLOS ONE			English	Article							FEMALE SEX WORKERS; B-VIRUS-INFECTION; DRUG-RESISTANCE; HEPATITIS-B; FISHING COMMUNITIES; PREGNANT-WOMEN; LAKE VICTORIA; YOUNG-WOMEN; OYO-STATE; RISK	Development of a globally effective HIV-1 vaccine will need to encompass Nigeria, one of the hardest hit areas, with an estimated 3.2 million people living with HIV. This cross-sectional Institutional Review Board (IRB) approved study was conducted in 2009-12 at four market sites and two highway settlements sites in Nigeria to identify and characterize populations at high risk for HIV; engage support of local stakeholders; and assess the level of interest in future vaccine studies. Demographic, HIV risk data were collected by structured interviewer-administered questionnaires. Blood samples were tested on site by HIV rapid diagnostic tests, followed by rigorous confirmatory testing, subtype evaluation and testing for HBV and HCV markers in a clinical reference laboratory. Of 3229 study participants, 326 were HIV infected as confirmed by Western Blot or RNA, with a HIV prevalence of 15.4%-23.9% at highway settlements and 3.1%-9.1% at market sites. There was no observable correlation of prevalence of HIV-1 (10.1%) with HBV (10.9%) or HCV (2.9%). Major HIV-1 subtypes included CRF02_AG (37.5%); G (27.5%); G/CRF02_AG (25.9%); and non-typeable (8.9%), with 0.3% HIV-2. Univariate analysis found age, gender, marital status, level of education, and sex under substance influence as significant risk factors for HIV (p<0.001). Educating and winning the trust of local community leadership ensured high level of participation (53.3-77.9%) and willingness to participate in future studies (95%). The high HIV prevalence and high risk of HIV infection at highway settlement and mammy markets make them well suited for targeting future vaccine trials in Nigeria.	[Njoku, Ogbonnaya S.; Akintunde, Gideon Akindiran; Suleiman, Aminu; Ogundeji, Amos A.; Kene, Terfa S.; Nelson, Robbie] Walter Reed Program, Abuja, Nigeria; [Manak, Mark M.; Shutt, Ashley L. W.; Heipertz, Richard A., Jr.; Tovanabutra, Sodsai; Milazzo, Mark J.; Robb, Merlin L.] Henry Jackson Fdn, MHRP HJF, Silver Spring, MD USA; [O'Connell, Robert J.] AFRIMS, Bangkok, Thailand; [Malia, Jennifer A.; Peel, Sheila A.; Michael, Nelson L.] US Mil HIV Res Program, Walter Reed Army Inst Res, MHRP WRAIR, Silver Spring, MD USA; [Alabi, Abraham S.] CERMEL Albert Schweitzer Int Fdn Hosp, Lambarene, Gabon; [Ayemoba, Ojor R.] Nigerian Minist Def Hlth Implementat Programme, Abuja, Nigeria; [Singer, Darrell E.] USUHS, Bethesda, MD USA	Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Manak, MM (corresponding author), Henry Jackson Fdn, MHRP HJF, Silver Spring, MD USA.	mmanak@hivresearch.org	Manak, Mark/Q-6553-2019	Manak, Mark/0000-0002-9217-9129; Ayemoba, Ojor/0000-0003-2443-0323	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-11-2-0174]; U.S. Department of Defense (DoD) [W81XWH-11-2-0174]	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DoD)(United States Department of Defense)	This work was supported by a cooperative agreement (W81XWH-11-2-0174) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DoD).	Ajoge HO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017865; Aliyu G, 2010, AIDS CARE, V22, P1277, DOI 10.1080/09540121003692219; Aniebue P N, 2011, Niger Med J, V52, P49; [Anonymous], 2010, NATL GUIDELINES HIV, DOI [10.1128/JVI.03070-12, DOI 10.1128/JVI.03070-12]; Araoye M O, 1996, West Afr J Med, V15, P6; Asiki G, 2013, VACCINE, V31, P5055, DOI 10.1016/j.vaccine.2013.08.080; Atilola Glory O, 2010, J Infect Public Health, V3, P166, DOI 10.1016/j.jiph.2010.08.002; Azuonwu O, 2011, J COMMUN HEALTH, V36, P583, DOI 10.1007/s10900-010-9344-4; Bakari M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1149; Campbell-Yesufu OT, 2011, CLIN INFECT DIS, V52, P780, DOI 10.1093/cid/ciq248; Chakrapani V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051080; Chaplin B, 2011, AIDS RES HUM RETROV, V27, P71, DOI 10.1089/aid.2010.0050; Charurat M, 2012, J INFECT DIS, V205, P1239, DOI 10.1093/infdis/jis103; Delatorre E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098908; Dellar R, 2015, SAMJ S AFR MED J, V105, P952, DOI [10.7196/SAMJ.2015.v105i11.10099, 10.7196/SAMJ.2015.V105I11.10099]; Dhalla S, 2014, AIDS BEHAV, V18, P263, DOI 10.1007/s10461-013-0519-8; Djomand G, 2014, CURR OPIN HIV AIDS, V9, P506, DOI 10.1097/COH.0000000000000090; Ejele O A, 2004, Niger J Med, V13, P336; Ejele O A, 2006, Niger Postgrad Med J, V13, P103; Eluwa GI, 2012, JAIDS-J ACQ IMM DEF, V61, P507, DOI 10.1097/QAI.0b013e31826dfb41; EsuWilliams E, 1997, J ACQ IMMUN DEF SYND, V16, P204, DOI 10.1097/00042560-199711010-00010; Ezeome ER, 2010, DEV WORLD BIOETH, V10, P1, DOI 10.1111/j.1471-8847.2008.00239.x; FMoH, 2012, GLOB AIDS RESP COUNT; FMOH, 2008, NAT HIV AIDS REPR HL; Forbi JC, 2012, J INFECT DEV COUNTR, V6, P854, DOI 10.3855/jidc.2298; HARRY TO, 1994, E AFR MED J, V71, P596; Hegdahl HK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148502; Heipertz RA, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004346; Hladik W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038143; Hoffmann O, 2004, SEX TRANSM INFECT, V80, P69, DOI 10.1136/sti.2004.011908; Imade GE, 2014, AIDS RES HUM RETROV, V30, P127, DOI [10.1089/aid.2013.0074, 10.1089/AID.2013.0074]; Jombo G T A, 2005, Niger J Med, V14, P425; Kijak GH, 2013, J VIROL, V87, P13084, DOI 10.1128/JVI.02624-13; Kiwanuka N, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-986; Manak MM, 2015, J CLIN MICROBIOL, V53, P3501, DOI 10.1128/JCM.01432-15; Mills E, 2004, AIDS, V18, P2235, DOI 10.1097/00002030-200411190-00003; Musa BM, 2015, NIGER J CLIN PRACT, V18, P163, DOI 10.4103/1119-3077.151035; Muula AS, 2008, CROAT MED J, V49, P423, DOI 10.3325/cmj.2008.3.423; National Agency for the Control of AIDS (NACA), 2014, GLOB AIDS RESP COUNT; National Agency for the Control of AIDS (NACA), 2010, UN GEN ASS SPEC SESS; Ojesina AI, 2006, AIDS RES HUM RETROV, V22, P770, DOI 10.1089/aid.2006.22.770; Okpokoro E, 2013, J AIDS CLIN RES, V4, P12; Onwuliri Viola Adaku, 2006, S AIDS NIGERIA NATIO, P309; Papworth E, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18751; Peeters M, 2000, AIDS RES HUM RETROV, V16, P315, DOI 10.1089/088922200309197; Ranganathan M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20749; Sankale JL, 2007, AIDS RES HUM RETROV, V23, P1020, DOI 10.1089/aid.2006.0304; Singh L, 2013, J MED VIROL, V85, P2065, DOI 10.1002/jmv.23716; Smit Joalida, 2005, Afr Health Sci, V5, P198; Stephens Joe, 2006, Washington Post, pA21; Sunmola AM, 2005, AIDS CARE, V17, P208, DOI 10.1080/09540120512331325699; Teitelman AM, 2016, HEALTH PSYCHOL, V35, P751, DOI 10.1037/hea0000351; Ugbebor O, 2011, N AM J MED SCI, V3, P238, DOI 10.4297/najms.2011.3238; UNAIDS, 2014, GLOB REP 2014; UNAIDS, 2011, GOOD PART PRACT GUID	55	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166711	10.1371/journal.pone.0166711	http://dx.doi.org/10.1371/journal.pone.0166711			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936236	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100042
J	Scholtens, RM; de Rooij, SEJA; Vellekoop, AE; Vrouenraets, BC; van Munster, BC				Scholtens, Rikie M.; de Rooij, Sophia E. J. A.; Vellekoop, Annelies E.; Vrouenraets, Bart C.; van Munster, Barbara C.			Preoperative CSF Melatonin Concentrations and the Occurrence of Delirium in Older Hip Fracture Patients: A Preliminary Study	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; ENDOGENOUS MELATONIN; CIRCADIAN-RHYTHM; ELDERLY-PATIENTS; VALIDATION; SECRETION; DEMENTIA; RISK; CARE	Background Delirium is characterized by disturbances in circadian rhythm. Melatonin regulates our circadian rhythm. Our aim was to compare preoperative cerebrospinal fluid (CSF) melatonin levels in patients with and without postoperative delirium. Methods Prospective cohort study with hip fracture patients >= 65 years who were acutely admitted to the hospital for surgical treatment and received spinal anaesthesia. CSF was collected after cannulation, before administering anaesthetics. Melatonin was measured by radioimmunoassay (RIA). Data on delirium was obtained from medical and nursing records. Nurses screened every shift for delirium using the Delirium Observation Screening Scale (DOSS). If the DOSS was >= 3, a psychiatrist was consulted to diagnose possible delirium using the DSM-IV criteria. At admission, demographic data, medical history, and information on functional and cognitive status was obtained. Results Seventy-six patients met the inclusion criteria. Sixty patients were included in the analysis. Main reasons for exclusion were technical difficulties, insufficient CSF or exogenous melatonin use. Thirteen patients (21.7%) experienced delirium during hospitalisation. Baseline characteristics did not differ between patients with and without postoperative delirium. In patients with and without postoperative delirium melatonin levels were 12.88 pg/ml (SD 6.3) and 11.72 pg/ml (SD 4.5) respectively, p-value 0.47. No differences between patients with and without delirium were found in mean melatonin levels in analyses stratified for cognitive impairment or age. Conclusion Preoperative CSF melatonin levels did not differ between patients with and without postoperative delirium. This suggests that, if disturbances in melatonin secretion occur, these might occur after surgery due to postoperative inflammation.	[Scholtens, Rikie M.; de Rooij, Sophia E. J. A.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Geriatr Sect, Amsterdam, Netherlands; [de Rooij, Sophia E. J. A.; van Munster, Barbara C.] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Geriatr Med, Groningen, Netherlands; [Vellekoop, Annelies E.] Erasmus MC, Dept Urol, Rotterdam, Netherlands; [Vrouenraets, Bart C.] Sint Lucas Andreas Hosp, Dept Surg, Amsterdam, Netherlands; [van Munster, Barbara C.] Gelre Hosp, Dept Geriatr, Apeldoorn, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; Erasmus University Rotterdam; Erasmus MC; Sint Lucas Andreas Hospital; Gelre Hospitals	Scholtens, RM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Geriatr Sect, Amsterdam, Netherlands.	r.m.scholtens@amc.uva.nl						American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Brzezinski Amnon, 1997, New England Journal of Medicine, V336, P186; Bumb JM, 2014, SLEEP BIOL RHYTHMS, V12, P69, DOI 10.1111/sbr.12039; Cronin AJ, 2000, LANCET, V356, P1244, DOI 10.1016/S0140-6736(00)02795-1; de Jonghe A, 2014, CAN MED ASSOC J, V186, pE547, DOI 10.1503/cmaj.140495; Fitzgerald JM, 2013, MED HYPOTHESES, V81, P568, DOI 10.1016/j.mehy.2013.06.032; Frenkel WJ, 2014, J AM GERIATR SOC, V62, P342, DOI 10.1111/jgs.12635; Gavinski K, 2016, J HOSP MED, V11, P494, DOI 10.1002/jhm.2580; IBM SPSS Statistics for Windows, 2013, IBM SPSS STAT WINDOW; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; Inouye SK, 1999, DEMENT GERIATR COGN, V10, P393, DOI 10.1159/000017177; Jorm AF, 2004, INT PSYCHOGERIATR, V16, P275, DOI 10.1017/S1041610204000390; KATZ S, 1983, J AM GERIATR SOC, V31, P721, DOI 10.1111/j.1532-5415.1983.tb03391.x; Leentjens AFG, 2014, J PSYCHOSOM RES, V77, P240, DOI 10.1016/j.jpsychores.2014.07.014; Legros C, 2014, J NEUROENDOCRINOL, V26, P151, DOI 10.1111/jne.12134; Leston J, 2010, NEUROSCI LETT, V469, P294, DOI 10.1016/j.neulet.2009.12.008; Lin L, 2013, INT J MOL SCI, V14, P14575, DOI 10.3390/ijms140714575; Liu RY, 1999, J CLIN ENDOCR METAB, V84, P323, DOI 10.1210/jc.84.1.323; Longatti P, 2004, MINIM INVAS NEUROSUR, V47, P350, DOI 10.1055/s-2004-830130; Longatti P, 2007, J PINEAL RES, V42, P113, DOI 10.1111/j.1600-079X.2006.00391.x; Maldonado JR, 2013, AM J GERIAT PSYCHIAT, V21, P1190, DOI 10.1016/j.jagp.2013.09.005; Mishima K, 1999, BIOL PSYCHIAT, V45, P417, DOI 10.1016/S0006-3223(97)00510-6; Pandharipande P, 2008, J TRAUMA, V65, P34, DOI 10.1097/TA.0b013e31814b2c4d; Piotrowicz K, 2015, EXP GERONTOL, V72, P45, DOI 10.1016/j.exger.2015.09.007; Rizzo V, 2002, J CHROMATOGR B, V774, P17, DOI 10.1016/S1570-0232(02)00168-X; Rousseau A, 1999, J NEURAL TRANSM, V106, P883, DOI 10.1007/s007020050208; Scheffer AC, 2011, INT J GERIATR PSYCH, V26, P284, DOI 10.1002/gps.2526; Scholtens RM, 2016, J PSYCHOSOM RES, V86, P20, DOI 10.1016/j.jpsychores.2016.05.005; Schuurmans Marieke J, 2003, Res Theory Nurs Pract, V17, P31, DOI 10.1891/088971803780956425; Seifman MA, 2008, J CEREBR BLOOD F MET, V28, P684, DOI 10.1038/sj.jcbfm.9600603; Shigeta H, 2001, AM J SURG, V182, P449, DOI 10.1016/S0002-9610(01)00761-9; Siddiqi N, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005563.pub3; Tan DX, 2016, MED HYPOTHESES, V86, P3, DOI 10.1016/j.mehy.2015.11.018; Tan DX, 2010, CURR NEUROPHARMACOL, V8, P162, DOI 10.2174/157015910792246263; Tricoire H, 2002, ENDOCRINOLOGY, V143, P84, DOI 10.1210/en.143.1.84; van Velthuijsen EL, 2016, INT J GERIATR PSYCH, V31, P974, DOI 10.1002/gps.4441; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013; Zhao ZY, 2002, CHRONOBIOL INT, V19, P1171, DOI 10.1081/CBI-120015958; Zhou JN, 2003, J PINEAL RES, V35, P125, DOI 10.1034/j.1600-079X.2003.00065.x	39	13	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167621	10.1371/journal.pone.0167621	http://dx.doi.org/10.1371/journal.pone.0167621			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936113	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100133
J	Sullivan, MJ; Carey, AJ; Leclercq, SY; Tan, CK; Ulett, GC				Sullivan, Matthew J.; Carey, Alison J.; Leclercq, Sophie Y.; Tan, Chee K.; Ulett, Glen C.			Increased Age, but Not Parity Predisposes to Higher Bacteriuria Burdens Due to Streptococcus Urinary Tract Infection and Influences Bladder Cytokine Responses, Which Develop Independent of Tissue Bacterial Loads	PLOS ONE			English	Article							GROUP-B STREPTOCOCCUS; ESCHERICHIA-COLI 83972; ASYMPTOMATIC BACTERIURIA; DENDRITIC CELLS; INNATE; EPIDEMIOLOGY; ACTIVATION; VIRULENCE; PATHWAYS; INFANTS	Streptococcus agalactiae causes urinary tract infection (UTI) in pregnant adults, non-pregnant adults, immune-compromised individuals and the elderly. The pathogenesis of S. agalactiae UTI in distinct patient populations is poorly understood. In this study, we used murine models of UTI incorporating young mice, aged and dam mice to show that uropathogenic S. agalactiae causes bacteriuria at significantly higher levels in aged mice compared to young mice and this occurs coincident with equivalent levels of bladder tissue colonisation at 24 h post-infection (p.i.). In addition, aged mice exhibited significantly higher bacteriuria burdens at 48 h compared to young mice, confirming a divergent pattern of bacterial colonization in the urinary tract of aged and young mice. Multiparous mice, in contrast, exhibited significantly lower urinary titres of S. agalactiae compared to age-matched nulliparous mice suggesting that parity enhances the ability of the host to control S. agalactiae bacteriuria. Additionally, we show that both age and parity alter the expression levels of several key regulatory and pro-inflammatory cytokines, which are known to be important the immune response to UTI, including Interleukin (IL)-1 beta, IL-12(p40), and Monocyte Chemoattractant Protein-1 (MCP-1). Finally, we demonstrate that other cytokines, including IL-17 are induced significantly in the S. agalactiae-infected bladder regardless of age and parity status. Collectively, these findings show that the host environment plays an important role in influencing the severity of S. agalactiae UTI; infection dynamics, particularly in the context of bacteriuria, depend on age and parity, which also affect the nature of innate immune responses to infection.	[Sullivan, Matthew J.; Carey, Alison J.; Leclercq, Sophie Y.; Tan, Chee K.; Ulett, Glen C.] Griffith Univ, Sch Med Sci, Gold Coast, Qld, Australia; [Sullivan, Matthew J.; Carey, Alison J.; Leclercq, Sophie Y.; Tan, Chee K.; Ulett, Glen C.] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia; [Leclercq, Sophie Y.] Ezequiel Dias Fdn Funed, Ctr Res & Dev, Belo Horizonte, MG, Brazil; [Carey, Alison J.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia	Griffith University; Griffith University; Menzies Health Institute Queensland; Queensland University of Technology (QUT)	Ulett, GC (corresponding author), Griffith Univ, Sch Med Sci, Gold Coast, Qld, Australia.; Ulett, GC (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia.	g.ulett@griffith.edu.au	Sullivan, Matthew J/C-3857-2009	Sullivan, Matthew J/0000-0003-2276-3132; Ulett, Glen/0000-0002-9638-8091	National Health and Medical Research Council (NHMRC) [APP1005315]; Griffith Health Institute; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)-Brazil [248427/2013-0]; NHMRC [APP1052464]; Australian Research Council [FT110101048]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Griffith Health Institute; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by National Health and Medical Research Council (NHMRC) Project Grants (APP1005315) and funding from the Griffith Health Institute, and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)-Brazil (248427/2013-0 to SYL). AJC is supported by a NHMRC Early Career Peter Doherty Fellowship (APP1052464). GCU is supported by a Australian Research Council Future Fellowship (FT110101048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2010, ANN ALLERG ASTHMA IM, V104, P183, DOI 10.1016/j.anai.2009.11.009; Alvarez JR, 2010, AM J PERINAT, V27, P231, DOI 10.1055/s-0029-1239485; Carey AJ, 2016, CRIT REV MICROBIOL, V42, P780, DOI 10.3109/1040841X.2015.1028885; Cohen HJ, 2003, AM J MED, V114, P180, DOI 10.1016/S0002-9343(02)01484-5; Dobrindt U, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5010021; Duell BL, 2012, J IMMUNOL, V188, P781, DOI 10.4049/jimmunol.1101231; Edwards MS, 2005, CLIN INFECT DIS, V41, P839, DOI 10.1086/432804; Ferrucci L, 1999, J AM GERIATR SOC, V47, P639, DOI 10.1111/j.1532-5415.1999.tb01583.x; FOXMAN B, 1990, AM J PUBLIC HEALTH, V80, P331, DOI 10.2105/AJPH.80.3.331; Foxman B, 2003, INFECT DIS CLIN N AM, V17, P227, DOI 10.1016/S0891-5520(03)00005-9; Foxman B, 2002, AM J MED, V113, p5S; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Freitas CH, 2012, CLINICS, V67, P457, DOI 10.6061/clinics/2012(05)09; Friedlander JI, 2014, J ENDOUROL, V28, P871, DOI 10.1089/end.2014.0002; Gerli R, 2000, MECH AGEING DEV, V121, P37; Goldfarb DS, 1998, CLIN GERIATR MED, V14, P367; Gupta S, 2014, EXP GERONTOL, V54, P47, DOI 10.1016/j.exger.2013.12.009; Hannan TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001042; High KP, 2012, SEMIN IMMUNOL, V24, P373, DOI 10.1016/j.smim.2012.04.007; Hopkins WJ, 1998, INFECT IMMUN, V66, P2798, DOI 10.1128/IAI.66.6.2798-2802.1998; Hull R, 2000, J UROLOGY, V163, P872, DOI 10.1016/S0022-5347(05)67823-8; Inadera H, 1999, J INTERF CYTOK RES, V19, P1179, DOI 10.1089/107999099313127; Ipe DS, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00014; Ipe DS, 2016, INFECT IMMUN, V84, P307, DOI 10.1128/IAI.00938-15; Ipe DS, 2013, FEMS MICROBIOL LETT, V346, P1, DOI 10.1111/1574-6968.12204; Kline KA, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.UTI-0012-2012; Kline KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097798; Kline KA, 2012, INFECT IMMUN, V80, P4186, DOI 10.1128/IAI.00684-12; Kline KA, 2011, INFECT IMMUN, V79, P3588, DOI 10.1128/IAI.00122-11; Koves B, 2014, J UROLOGY, V191, P519, DOI 10.1016/j.juro.2013.07.060; Krambeck AE, 2013, J UROLOGY, V189, P158, DOI 10.1016/j.juro.2012.09.023; Kulkarni R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059091; Leclercq SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep29000; Lung TL, 2000, VACCINE, V18, P1606, DOI 10.1016/S0264-410X(99)00494-6; Matsumoto T, 2001, Curr Urol Rep, V2, P330, DOI 10.1007/s11934-001-0073-1; MCCUE JD, 1993, PHARMACOTHERAPY, V13, pS51; Muller AE, 2006, ACTA OBSTET GYN SCAN, V85, P1027, DOI 10.1080/00016340600780508; Nikolich-Zugich J, 2014, J IMMUNOL, V193, P2622, DOI 10.4049/jimmunol.1401174; Roos V, 2006, INFECT IMMUN, V74, P615, DOI 10.1128/IAI.74.1.615-624.2006; Rowe Theresa A, 2013, Aging health, V9, DOI 10.2217/ahe.13.38; Rudick CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109321; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Shaw AC, 2010, CURR OPIN IMMUNOL, V22, P507, DOI 10.1016/j.coi.2010.05.003; Simhan HN, 2007, AM J OBSTET GYNECOL, V196, P59, DOI 10.1016/j.ajog.2006.08.035; Stamm WE, 2001, J INFECT DIS, V183, pS1, DOI 10.1086/318850; Tan CK, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-273; Tan CK, 2012, INFECT IMMUN, V80, P3145, DOI 10.1128/IAI.00023-12; Trivalle C, 1998, J MED MICROBIOL, V47, P649, DOI 10.1099/00222615-47-7-649; Ulett GC, 2013, CURR OPIN MICROBIOL, V16, P100, DOI 10.1016/j.mib.2013.01.005; Ulett GC, 2010, J INFECT DIS, V201, P866, DOI 10.1086/650696; Ulett KB, 2009, J CLIN MICROBIOL, V47, P2055, DOI 10.1128/JCM.00154-09; Valiathan R, 2016, SCAND J IMMUNOL, V83, P255, DOI 10.1111/sji.12413; Valle J, 2008, J BACTERIOL, V190, P4147, DOI 10.1128/JB.00122-08; Verani JR, 2010, CLIN PERINATOL, V37, P375, DOI 10.1016/j.clp.2010.02.002; [王春生 Wang Chunsheng], 2012, [中国公路学报, China Journal of Highway and Transport], V25, P81; Watts RE, 2012, J INFECT DIS, V206, P1242, DOI 10.1093/infdis/jis493	56	4	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167732	10.1371/journal.pone.0167732	http://dx.doi.org/10.1371/journal.pone.0167732			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936166	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000389587100167
J	Sung, YY; Yoon, T; Jang, S; Kim, HK				Sung, Yoon-Young; Yoon, Taesook; Jang, Seol; Kim, Ho Kyoung			Forsythia suspensa Suppresses House Dust Mite Extract-Induced Atopic Dermatitis in NC/Nga Mice	PLOS ONE			English	Article							NF-KAPPA-B; INFLAMMATORY RESPONSES; TACROLIMUS OINTMENT; ACTIVATION; CHEMOKINE; BLOCKADE; FRUCTUS; KERATINOCYTES; PATHOGENESIS; SEVERITY	Forsythia suspensa (F. suspensa) is a traditional medicine for treatment of inflammation. In this study, we evaluated the therapeutic effects of an ethanol extract from F. suspensa fruits on atopic dermatitis both in vivo and in vitro. We investigated the inhibitory effects of F. suspensa extract on the development of atopic dermatitis-like skin lesions in an NC/Nga mouse model exposed to Dermatophagoides farinae crude extract. Topical application of F. suspensa extract to the mice attenuated the atopic dermatitis symptoms, including increased dermatitis severity score, ear thickness, infiltration of inflammatory cells in the skin lesions, serum levels of IgE, TNF-alpha, and histamine, and expression of chemokines, cytokines, and adhesion molecules in ear tissue. In addition, F. suspensa extract inhibited the production of chemokines in TNF-alpha/IFN-gamma-activated human keratinocytes. High-performance liquid chromatography analysis of FSE revealed the presence of four chemical constituents (forsythiaside, phillyrin, pinoresinol, and phylligenin). These compounds inhibited the production of chemokines in TNF-alpha/IFN-gamma-activated human keratinocytes. These results suggest that the F. suspensa might be a useful candidate for treating allergic skin inflammatory disorders.	[Sung, Yoon-Young; Jang, Seol; Kim, Ho Kyoung] Korea Inst Oriental Med, Mibyeong Res Ctr, Daejeon, South Korea; [Yoon, Taesook] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Coll Pharm, Seoul, South Korea	Korea Institute of Oriental Medicine (KIOM); Ewha Womans University	Kim, HK (corresponding author), Korea Inst Oriental Med, Mibyeong Res Ctr, Daejeon, South Korea.	hkkim@kiom.re.kr			Korea Research Council of Fundamental Science and Technology [G10102]; Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government, MSIP [NRF-2015M3A9E3052336]	Korea Research Council of Fundamental Science and Technology; Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government, MSIP(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This research was supported by project (G10102) "Development of herbal materials for treatment and prevention of allergic disease," which was funded by the Korea Research Council of Fundamental Science and Technology. This research was also supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government, MSIP (NRF-2015M3A9E3052336).	Albanesi Cristina, 2005, Current Drug Targets - Inflammation and Allergy, V4, P329, DOI 10.2174/1568010054022033; Bardana EJ, 2004, ALLERGY, V59, P25, DOI 10.1111/j.1398-9995.2004.00565.x; Bulfone-Paus S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00394; Carroll CL, 2006, DRUG TODAY, V42, P431, DOI 10.1358/dot.2006.42.7.1003316; Chen L, 2010, IMMUNOL CELL BIOL, V88, P334, DOI 10.1038/icb.2009.107; Cheng GD, 2014, EXP THER MED, V7, P179, DOI 10.3892/etm.2013.1378; Choi JK, 2014, AM J CHINESE MED, V42, P967, DOI 10.1142/S0192415X1450061X; Dilshara MG, 2015, BMB REP, V48, P559, DOI 10.5483/BMBRep.2015.48.10.003; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Hanifin JM, 2005, J AM ACAD DERMATOL, V53, pS186, DOI 10.1016/j.jaad.2005.04.062; Horikawa T, 2002, INT IMMUNOL, V14, P767, DOI 10.1093/intimm/dxf044; Inagaki N, 2006, EUR J PHARMACOL, V546, P189, DOI 10.1016/j.ejphar.2006.07.019; Jahnz-Rozyk K, 2005, ALLERGY, V60, P685, DOI 10.1111/j.1398-9995.2005.00774.x; Je IG, 2015, TOXICOL APPL PHARM, V287, P119, DOI 10.1016/j.taap.2015.05.006; Jeong YI, 2015, ALLERGY ASTHMA IMMUN, V7, P557, DOI 10.4168/aair.2015.7.6.557; Jung HW, 2010, NEUROSCI LETT, V480, P215, DOI 10.1016/j.neulet.2010.06.043; Kanda N, 2006, BIOCHEM PHARMACOL, V72, P463, DOI 10.1016/j.bcp.2006.05.001; Kim MS, 2003, INFLAMMATION, V27, P129, DOI 10.1023/A:1023865727780; KRUTMANN J, 1990, J INVEST DERMATOL, V95, P127, DOI 10.1111/1523-1747.ep12477839; Kwon DJ, 2012, BIOCHEM BIOPH RES CO, V417, P1254, DOI 10.1016/j.bbrc.2011.12.119; Kwon TR, 2014, PHOTOCHEM PHOTOBIOL, V90, P1160, DOI 10.1111/php.12284; Lee H, 2014, BIOMOL THER, V22, P438, DOI 10.4062/biomolther.2014.023; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; Lim H, 2008, J ETHNOPHARMACOL, V118, P113, DOI 10.1016/j.jep.2008.03.016; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Nedoszytko B, 2014, POSTEP DERM ALERGOL, V31, P84, DOI 10.5114/pdia.2014.40920; NISHIBE S, 1982, CHEM PHARM BULL, V30, P4548; Otsuka A, 2015, ALLERGY, V70, P131, DOI 10.1111/all.12526; Ozaki Y, 1997, BIOL PHARM BULL, V20, P861, DOI 10.1248/bpb.20.861; Park JH, 2015, J ETHNOPHARMACOL, V171, P85, DOI 10.1016/j.jep.2015.05.039; Pastore Saveria, 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P497; Pivarcsi A, 2005, CURR ALLERGY ASTHM R, V5, P284, DOI 10.1007/s11882-005-0068-y; Prieto JM, 2003, J PHARM PHARMACOL, V55, P1275, DOI 10.1211/0022357021620; Qu HH, 2012, BIOORG CHEM, V40, P87, DOI 10.1016/j.bioorg.2011.09.005; Sasakawa T, 2004, INT ARCH ALLERGY IMM, V133, P55, DOI 10.1159/000076128; Seo WY, 2015, BMB REP, V48, P495, DOI 10.5483/BMBRep.2015.48.9.259; Simpson D, 2005, DRUGS, V65, P827, DOI 10.2165/00003495-200565060-00011; Suto H, 1999, INT ARCH ALLERGY IMM, V120, P70, DOI 10.1159/000053599; Sykes L, 2012, MEDIAT INFLAMM, V2012, DOI [10.1155/2012/416739, DOI 10.1155/2012/416739]; Vestergaard C, 2000, J INVEST DERMATOL, V115, P640, DOI 10.1046/j.1523-1747.2000.00115.x; Yamamoto Mina, 2007, Allergol Int, V56, P139, DOI 10.2332/allergolint.O-06-458; Zhong WT, 2013, FITOTERAPIA, V90, P132, DOI 10.1016/j.fitote.2013.06.003	43	20	22	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167687	10.1371/journal.pone.0167687	http://dx.doi.org/10.1371/journal.pone.0167687			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936051	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100151
J	Ho, V; Chung, LP; Revoltar, M; Lim, SH; Tut, TG; Abubakar, A; Henderson, CJ; Chua, W; Ng, W; Lee, M; De Souza, P; Morgan, M; Lee, CS; Shin, JS				Ho, Vincent; Chung, Liping; Revoltar, Maxine; Lim, Stephanie H.; Tut, Thein-Ga; Abubakar, Askar; Henderson, Chris J.; Chua, Wei; Ng, Weng; Lee, Mark; De Souza, Paul; Morgan, Matthew; Lee, C. Soon; Shin, Joo-Shik			MRE11 and ATM Expression Levels Predict Rectal Cancer Survival and Their Association with Radiotherapy Response	PLOS ONE			English	Article							PREOPERATIVE CHEMORADIATION; LOCAL RECURRENCE; COMPLEX; REPAIR	Background Aberrant expression of DNA repair proteins is associated with poor survival in cancer patients. We investigated the combined expression of MRE11 and ATM as a predictive marker of response to radiotherapy in rectal cancer. Methods MRE11 and ATM expression were examined in tumor samples from 262 rectal cancer patients who underwent surgery for rectal cancer, including a sub-cohort of 54 patients who were treated with neoadjuvant radiotherapy. The relationship between expression of the two-protein panel and tumor regression grade (TRG) was assessed by Mann-Whitney U test and receiver operating characteristics area under curve (ROC-AUC) analysis. The association between expression of the two-protein panel and clinicopathologic variables and survival was examined by Kaplan-Meier methods and Cox regression analysis. Results A high score for two-protein combined expression in the tumor center (TC) was significantly associated with worse disease-free survival (DFS) (P = 0.035) and overall survival (OS) (P = 0.003) in the whole cohort, and with DFS (P = 0.028) and OS (P = 0.024) in the neoadjuvant subgroup (n = 54). In multivariate analysis, the two-protein combination panel (HR = 2.178, 95% CI 1.115-4.256, P = 0.023) and perineural invasion (HR = 2.183, 95% CI 1.222-3.899, P = 0.008) were significantly associated with DFS. Using ROC-AUC analysis of good versus poor histological tumor response among patients treated preoperatively with radiotherapy, the average ROC-AUC was 0.745 for the combined panel, 0.618 for ATM alone, and 0.711 for MRE11 alone. Conclusions The MRE11/ATM two-protein panel developed in this study may have clinical value as a predictive marker of tumor response to neoadjuvant radiotherapy, and a prognostic marker for disease-free and overall survival.	[Ho, Vincent; Chung, Liping; Revoltar, Maxine; Abubakar, Askar; Henderson, Chris J.; De Souza, Paul; Lee, C. Soon; Shin, Joo-Shik] Univ Western Sydney, Sch Med, Penrith, NSW, Australia; [Chung, Liping; Tut, Thein-Ga; Abubakar, Askar; Lee, C. Soon; Shin, Joo-Shik] Ingham Inst Appl Med Res, Liverpool, NSW, Australia; [Lim, Stephanie H.; Chua, Wei; Ng, Weng; De Souza, Paul] Liverpool Hosp, Dept Med Oncol, Liverpool, NSW, Australia; [Lim, Stephanie H.] Univ New South Wales, South Western Sydney Clin Sch, Liverpool, NSW, Australia; [Tut, Thein-Ga; Henderson, Chris J.; Lee, C. Soon; Shin, Joo-Shik] Liverpool Hosp, Dept Anat Pathol, Liverpool, NSW, Australia; [Lee, Mark] Liverpool Hosp, Dept Radiat Oncol, Liverpool, NSW, Australia; [De Souza, Paul] Univ Western Sydney, Sch Med, Discipline Med Oncol, Liverpool, NSW, Australia; [Morgan, Matthew] Bankstown Hosp, Dept Surg, Bankstown, NSW, Australia; [Lee, C. Soon; Shin, Joo-Shik] Univ Western Sydney, Sch Med, Discipline Pathol, Campbelltown, NSW, Australia	Western Sydney University; Ingham Institute for Applied Medical Research; Liverpool Hospital; University of New South Wales Sydney; Liverpool Hospital; Liverpool Hospital; Western Sydney University; Western Sydney University	Ho, V (corresponding author), Univ Western Sydney, Sch Med, Penrith, NSW, Australia.	v.ho@westernsydney.edu.au	de Souza, Paul/P-5069-2019	Tut, Thein Ga/0000-0002-1608-9092; Ng, Weng/0000-0003-2354-1857; Lim, Stephanie Hui-Su/0000-0001-5940-7137; Ho, Vincent/0000-0003-3127-2933	Cancer Institute of NSW [13/TRC/1-01]	Cancer Institute of NSW	We would like to declare that funding support for this research was in part contributed through the Cancer Institute of NSW grant awarded to Professor Paul DeSouza and Professor C Soon Lee (Center for Oncology Education and Research Translation) Award number: 13/TRC/1-01.	Ahmed KA, 2015, ONCOTARGET, V6, P34414, DOI 10.18632/oncotarget.5437; Angele S, 2004, AM J CLIN PATHOL, V121, P231, DOI 10.1309/JTKGGGKURFX3XMGT; Birgisson H, 2005, J CLIN ONCOL, V23, P8697, DOI 10.1200/JCO.2005.02.9017; Camma C, 2000, JAMA-J AM MED ASSOC, V284, P1008, DOI 10.1001/jama.284.8.1008; Chung LP, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3676; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Das P, 2007, CANCER-AM CANCER SOC, V109, P1750, DOI 10.1002/cncr.22625; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Folkesson J, 2005, J CLIN ONCOL, V23, P5644, DOI 10.1200/JCO.2005.08.144; Forker LJ, 2015, CLIN ONCOL R COLL RA; Garcia-Aguilar J, 2003, DIS COLON RECTUM, V46, P298, DOI 10.1007/s10350-004-6545-x; Gray R, 2001, LANCET, V358, P1291; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580; Kuroda S, 2012, ACTA MED OKAYAMA, V66, P83; Lee YC, 2013, DIS COLON RECTUM, V56, P1093, DOI 10.1097/DCR.0b013e318298e36b; Lee YA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063255, 10.1371/journal.pone.0054889]; Pavelitz T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108483; Permuth-Wey J, 2009, CANCER EPIDEM BIOMAR, V18, P28, DOI 10.1158/1055-9965.EPI-08-0713; Rahbari NN, 2013, ANN SURG ONCOL, V20, P4169, DOI 10.1245/s10434-013-3198-9; Sheridan Juliette, 2013, J Gastrointest Cancer, V44, P41, DOI 10.1007/s12029-012-9442-x; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Trakarnsanga A, 2012, WORLD J GASTROENTERO, V18, P5521, DOI 10.3748/wjg.v18.i39.5521; Tut TG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129313	25	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167675	10.1371/journal.pone.0167675	http://dx.doi.org/10.1371/journal.pone.0167675			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930716	Green Published, gold, Green Submitted			2022-12-27	WOS:000389580900037
J	Laguna, TA; Wagner, BD; Williams, CB; Stevens, MJ; Robertson, CE; Welchlin, CW; Moen, CE; Zemanick, ET; Harris, JK				Laguna, Theresa A.; Wagner, Brandie D.; Williams, Cynthia B.; Stevens, Mark J.; Robertson, Charles E.; Welchlin, Cole W.; Moen, Catherine E.; Zemanick, Edith T.; Harris, Jonathan K.			Airway Microbiota in Bronchoalveolar Lavage Fluid from Clinically Well Infants with Cystic Fibrosis	PLOS ONE			English	Article							YOUNG-CHILDREN; PSEUDOMONAS-AERUGINOSA; BACTERIAL COMMUNITIES; PULMONARY-FUNCTION; DIRECTED THERAPY; LUNG-DISEASE; INFLAMMATION; INFECTION; LIFE; DIVERSITY	Background Upper airway cultures guide the identification and treatment of lung pathogens in infants with cystic fibrosis (CF); however, this may not fully reflect the spectrum of bacteria present in the lower airway. Our objectives were to characterize the airway microbiota using bronch-oalveolar lavage fluid (BALF) from asymptomatic CF infants during the first year of life and to investigate the relationship between BALF microbiota, standard culture and clinical characteristics. Methods BALF, nasopharyngeal (NP) culture and infant pulmonary function testing data were collected at 6 months and one year of age during periods of clinical stability from infants diagnosed with CF by newborn screening. BALF was analyzed for total bacterial load by qPCR and for bacterial community composition by 16S ribosomal RNA sequencing. Clinical characteristics and standard BALF and NP culture results were recorded over five years of longitudinal follow-up. Results 12 BALF samples were collected from 8 infants with CF. Streptococcus, Burkholderia, Prevotella, Haemophilus, Porphyromonas, and Veillonella had the highest median relative abundance in infant CF BALF. Two of the 3 infants with repeat BALF had changes in their microbial communities over six months (Morisita-Horn diversity index 0.36, 0.38). Although there was excellent percent agreement between standard NP and BALF cultures, these techniques did not routinely detect all bacteria identified by sequencing. Conclusions BALF in asymptomatic CF infants contains complex microbiota, often missed by traditional culture of airway secretions. Anaerobic bacteria are commonly found in the lower airways of CF infants.	[Laguna, Theresa A.; Williams, Cynthia B.; Welchlin, Cole W.; Moen, Catherine E.] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; [Laguna, Theresa A.; Williams, Cynthia B.; Welchlin, Cole W.; Moen, Catherine E.] Mason Childrens Hosp, Minneapolis, MN 55455 USA; [Wagner, Brandie D.] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Stevens, Mark J.; Zemanick, Edith T.; Harris, Jonathan K.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Robertson, Charles E.] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA	University of Minnesota System; University of Minnesota Twin Cities; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Laguna, TA (corresponding author), Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA.; Laguna, TA (corresponding author), Mason Childrens Hosp, Minneapolis, MN 55455 USA.	lagun005@umn.edu	Zemanick, Edith/D-5260-2017; Zemanick, Edith T/ABF-9455-2020	Zemanick, Edith/0000-0002-7507-9337; Zemanick, Edith T/0000-0002-7507-9337; Wagner, brandie/0000-0002-2745-0103; ROBERTSON, CHARLES/0000-0002-4136-4121; Harris, Jonathan/0000-0002-2378-4202; Laguna, Theresa/0000-0003-4255-0310	American Thoracic Society/Cystic Fibrosis Foundation [ATS/CFF CF-08-001]; National Institutes of Health [K12HD068322]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER	American Thoracic Society/Cystic Fibrosis Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by: 1. American Thoracic Society/Cystic Fibrosis Foundation [ATS/CFF CF-08-001]- T.A.L.; 2. National Institutes of Health [K12HD068322] - T.A.L.	American Thoracic Society, 2005, Am J Respir Crit Care Med, V172, P1463; Armstrong DS, 2005, PEDIATR PULM, V40, P500, DOI 10.1002/ppul.20294; Brennan S, 2005, THORAX, V60, P159, DOI 10.1136/thx.2004.026419; Burns JL, 2014, J CYST FIBROS, V13, P1, DOI 10.1016/j.jcf.2013.09.004; Castile R, 2000, PEDIATR PULM, V30, P215, DOI 10.1002/1099-0496(200009)30:3<215::AID-PPUL6>3.0.CO;2-V; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Coburn B, 2015, SCI REP-UK, V5, DOI 10.1038/srep10241; Dakin CJ, 2002, AM J RESP CRIT CARE, V165, P904, DOI 10.1164/ajrccm.165.7.2010139; Davis SD, 2007, AM J RESP CRIT CARE, V175, P943, DOI 10.1164/rccm.200603-343OC; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Farrell PM, 2003, PEDIATR PULM, V36, P230, DOI 10.1002/ppul.10336; Gilchrist FJ, 2011, ARCH DIS CHILD, V96, P215, DOI 10.1136/adc.2009.177618; Guss AM, 2011, ISME J, V5, P20, DOI 10.1038/ismej.2010.88; Gutierrez JP, 2001, EUR RESPIR J, V17, P281, DOI 10.1183/09031936.01.17202810; Hara N, 2012, J IMMUNOL, V189, P3805, DOI 10.4049/jimmunol.1201257; Hilliard TN, 2007, ARCH DIS CHILD, V92, P898, DOI 10.1136/adc.2006.105825; Hoen AG, 2015, J PEDIATR-US, V167, P138, DOI 10.1016/j.jpeds.2015.02.049; Kahn SE, 2008, DIABETES OBES METAB, V10, P63, DOI 10.1111/j.1463-1326.2008.00945.x; Keiser NW, 2015, AM J RESP CELL MOL, V52, P683, DOI 10.1165/rcmb.2014-0250OC; Klepac-Ceraj V, 2010, ENVIRON MICROBIOL, V12, P1293, DOI 10.1111/j.1462-2920.2010.02173.x; Laguna TA, 2015, AM J RESP CRIT CARE, V191; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LiPuma JJ, 2015, J CLIN MICROBIOL, V53, P2006, DOI 10.1128/JCM.01218-15; Long FR, 2004, J PEDIATR-US, V144, P154, DOI 10.1016/j.jpeds.2003.09.026; Madan JC, 2012, MBIO, V3, DOI 10.1128/mBio.00251-12; Magurran A.E., 2004, MEASURING BIOL DIVER; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Mirkovic B, 2015, AM J RESP CRIT CARE, V192, P1314, DOI 10.1164/rccm.201505-0943OC; Moodie M, 2014, J PEDIATR-US, V165, P564, DOI 10.1016/j.jpeds.2014.05.031; Mott LS, 2012, THORAX, V67, P509, DOI 10.1136/thoraxjnl-2011-200912; Mott LS, 2013, J PEDIAT, P516, DOI [10.1136/thoraxjnl-2011-200912, DOI 10.1136/THORAXJNL2011200912]; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Paganin P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124348; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; Pillarisetti N, 2011, AM J RESP CRIT CARE, V184, P75, DOI 10.1164/rccm.201011-1892OC; Prevaes SMPJ, 2016, AM J RESP CRIT CARE, V193, P504, DOI 10.1164/rccm.201509-1759OC; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ranganathan SC, 2002, AM J RESP CRIT CARE, V166, P1350, DOI 10.1164/rccm.2202041; Ranganathan SC, 2001, LANCET, V358, P1964, DOI 10.1016/S0140-6736(01)06970-7; Renwick J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109798; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; Saiman L, 2003, INFECT CONT HOSP EP, V24, pS6, DOI 10.1086/503485; Saiman L, 2014, INFECT CONT HOSP EP, V35, pS1, DOI 10.1086/676882; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Sly PD, 2009, AM J RESP CRIT CARE, V180, P146, DOI 10.1164/rccm.200901-0069OC; Stafler P, 2011, PEDIATR PULM, V46, P696, DOI 10.1002/ppul.21434; Stick SM, 2009, J PEDIATR-US, V155, P623, DOI 10.1016/j.jpeds.2009.05.005; Stocks J, 2001, EUR RESPIR J, V17, P302, DOI 10.1183/09031936.01.17203020; Stressmann FA, 2012, THORAX, V67, P867, DOI 10.1136/thoraxjnl-2011-200932; Wainwright CE, 2011, JAMA-J AM MED ASSOC, V306, P163, DOI 10.1001/jama.2011.954; Zemanick ET, 2015, ANN AM THORAC SOC, V12, P221, DOI 10.1513/AnnalsATS.201407-310OC; Zemanick ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062917; Zemanick ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015101; Zemanick ET, 2010, PEDIATR PULM, V45, P569, DOI 10.1002/ppul.21221; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	58	40	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167649	10.1371/journal.pone.0167649	http://dx.doi.org/10.1371/journal.pone.0167649			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930727	Green Published, gold, Green Submitted			2022-12-27	WOS:000389580900034
J	Park, SY; Choi, CH; Park, JM; Chun, M; Han, JH; Kim, JI				Park, So-Yeon; Choi, Chang Heon; Park, Jong Min; Chun, MinSoo; Han, Ji Hye; Kim, Jung-in			A Patient-Specific Polylactic Acid Bolus Made by a 3D Printer for Breast Cancer Radiation Therapy	PLOS ONE			English	Article							ELECTRON BOLUS; RADIOTHERAPY; PHOTON; BEAMS; CT	Purpose The aim of this study was to assess the feasibility and advantages of a patient-specific breast bolus made using a 3D printer technique. Methods We used the anthropomorphic female phantom with breast attachments, which volumes are 200, 300, 400, 500 and 650 cc. We simulated the treatment for a right breast patient using parallel opposed tangential fields. Treatment plans were used to investigate the effect of unwanted air gaps under bolus on the dose distribution of the whole breast. The commercial Super-Flex bolus and 3D-printed polylactic acid (PLA) bolus were applied to investigate the skin dose of the breast with the MOSFET measurement. Two boluses of 3 and 5 mm thicknesses were selected. Results There was a good agreement between the dose distribution for a virtual bolus generated by the TPS and PLA bolus. The difference in dose distribution between the virtual bolus and Super-Flex bolus was significant within the bolus and breast due to unwanted air gaps. The average differences between calculated and measured doses in a 200 and 300 cc with PLA bolus were not significant, which were -0.7% and -0.6% for 3mm, and -1.1% and -1.1% for 5 mm, respectively. With the Super-Flex bolus, however, significant dose differences were observed (-5.1% and -3.2% for 3mm, and -6.3% and -4.2% for 5 mm). Conclusion The 3D-printed solid bolus can reduce the uncertainty of the daily setup and help to overcome the dose discrepancy by unwanted air gaps in the breast cancer radiation therapy.	[Park, So-Yeon; Choi, Chang Heon; Park, Jong Min; Chun, MinSoo; Han, Ji Hye; Kim, Jung-in] Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea; [Park, So-Yeon; Choi, Chang Heon; Park, Jong Min; Chun, MinSoo; Kim, Jung-in] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea; [Park, So-Yeon; Choi, Chang Heon; Park, Jong Min; Chun, MinSoo; Han, Ji Hye; Kim, Jung-in] Seoul Natl Univ, Coll Med, Biomed Res Inst, Seoul, South Korea; [Park, Jong Min] Adv Inst Convergence Technol, Ctr Convergence Res Robot, Suwon, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kim, JI (corresponding author), Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea.; Kim, JI (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea.; Kim, JI (corresponding author), Seoul Natl Univ, Coll Med, Biomed Res Inst, Seoul, South Korea.	madangin@gmail.com	Chun, Minsoo/C-4493-2014	Chun, Minsoo/0000-0001-8578-9976	SNUH Research Fund [04-2015-0890]; Seoul National University Hospital Research Fund [04-2015-0890]	SNUH Research Fund; Seoul National University Hospital Research Fund	This research was supported by a grant of the SNUH Research Fund (grant number: 04-2015-0890). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by grant no. 04-2015-0890 from the Seoul National University Hospital Research Fund.	Andic F, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-41; Arac M, 2003, RADIOLOGY, V229, P195, DOI 10.1148/radiol.2291020642; Blitzblau RC, 2013, PRACT RADIAT ONCOL, V3, P241, DOI 10.1016/j.prro.2012.09.004; Burleson S, 2015, J APPL CLIN MED PHYS, V16, P166, DOI 10.1120/jacmp.v16i3.5247; Butson MJ, 2000, RADIAT MEAS, V32, P201, DOI 10.1016/S1350-4487(99)00276-0; Cho JH, 2003, J KOREAN SOC THER RA, V21, P82; Gupta T, 2011, CLIN ONCOL-UK, V23, P86, DOI 10.1016/j.clon.2010.08.029; Hsu SH, 2008, PHYS MED BIOL, V53, P2593, DOI 10.1088/0031-9155/53/10/010; Khan Y., 2013, J CANC THER, V04, P1251, DOI [10.4236/jct.2013.47147, DOI 10.4236/JCT.2013.47147]; Klein Eric E, 2003, J Appl Clin Med Phys, V4, P1, DOI 10.1120/1.1520113; Kudchadker R, 2002, MED PHYS, V29, P1337; Kudchadker R J, 2003, J Appl Clin Med Phys, V4, P321, DOI 10.1120/1.1621494; Lamb A, 1998, PHYS MED BIOL, V43, P1133, DOI 10.1088/0031-9155/43/5/006; LOEVINGER R, 1981, MED PHYS, V8, P1, DOI 10.1118/1.594901; Low DA, 1995, INT J RADIAT ONCOL, V33, P1127, DOI 10.1016/0360-3016(95)00257-X; Mihaylov IB, 2009, RADIOTHER ONCOL, V93, P147, DOI 10.1016/j.radonc.2009.05.008; Park JM, 2014, BR J RADIOL, V87; Park K, 2016, ONCOTARGET, P1; Perkins GH, 2001, INT J RADIAT ONCOL, V51, P1142, DOI 10.1016/S0360-3016(01)01744-8; Su S., 2014, J APPL CLIN MED PHYS, V15, P4831, DOI [DOI 10.1120/JACMP.V15I4.4831, 10.1120/jacmp.v15i4.4831]; Sung W, 2012, RADIAT ONCOL J, V30, P27, DOI 10.3857/roj.2012.30.1.27; TARVER RD, 1988, AM J ROENTGENOL, V151, P1117, DOI 10.2214/ajr.151.6.1117; Turner JY, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20160060; Vyas V, 2013, MED DOSIM, V38, P268, DOI 10.1016/j.meddos.2013.02.007; Yoon Mee Sun, 2012, [PROGRESS in MEDICAL PHYSICS, 의학물리], V23, P219; Zou W, 2015, J APPL CLIN MED PHYS, V16, P90, DOI 10.1120/jacmp.v16i1.5090	26	34	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0168063	10.1371/journal.pone.0168063	http://dx.doi.org/10.1371/journal.pone.0168063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930717	Green Published, Green Submitted, gold			2022-12-27	WOS:000389580900077
J	Wang, L; Wu, ZW; Li, Y; Dong, JG; Zhang, LY; Liang, PS; Liu, YL; Zhao, YH; Song, CX				Wang, Lei; Wu, Zhi-wei; Li, Yan; Dong, Jian-guo; Zhang, Le-yi; Liang, Peng-shuai; Liu, Yan-ling; Zhao, Ya-hua; Song, Chang-xu			Profiling and Identification of Novel Immunogenic Proteins of Staphylococcus hyicus ZC-4 by Immunoproteomic Assay	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; EXUDATIVE EPIDERMITIS; VIRULENCE GENES; CELL-DEATH; AUREUS; PATHOGENESIS; PURIFICATION; RESISTANCE; EXPRESSION; PREDICTION	Staphylococcus hyicus has caused great losses in the swine industry by inducing piglet exudative epidermitis (EE), sow mastitis, metritis, and other diseases and is a threat to human health. The pathogenesis of EE, sow mastitis, and metritis involves the interaction between the host and virulent protein factors of S. hyicus, however, the proteins that interact with the host, especially the host immune system, are unclear. In the present study, immunoproteomics was used to screen the immunogenic proteins of S. hyicus strain ZC-4. The cellular and secreted proteins of S. hyicus strain ZC-4 were obtained, separated by 2D gel electrophoresis, and further analyzed by western blot with S. hyicus strain ZC-4-infected swine serum. Finally, 28 specific immunogenic proteins including 15 cellular proteins and 13 secreted proteins, 26 of which were novel immunogenic proteins from S. hyicus, were identified by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. To further verify their immunogenicity, two representative proteins (acetate kinase [cellular] and enolase [secreted]) were chosen for expression, and the resultant recombinant proteins could react with S. hyicus ZC-4-infected swine serum. In mice, both acetate kinase and enolase activated the immune response by increasing G-CSF and MCP-5 expression, and acetate kinase further activated the immune response by increasing IL-12 expression. Enolase can confer better protection against S. hycius than acetate kinase in mice. For the first time to our knowledge, our results provide detailed descriptions of the cellular and secreted proteins of S. hyicus strain ZC-4. These immunogenic proteins may contribute to investigation and elucidation of the pathogenesis of S. hyicus and provide new candidates for subunit vaccines in the future.	[Wang, Lei; Wu, Zhi-wei; Dong, Jian-guo; Zhang, Le-yi; Liang, Peng-shuai; Liu, Yan-ling; Zhao, Ya-hua; Song, Chang-xu] South China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China; [Wang, Lei; Wu, Zhi-wei; Dong, Jian-guo; Zhang, Le-yi; Liang, Peng-shuai; Liu, Yan-ling; Zhao, Ya-hua; Song, Chang-xu] South China Agr Univ, Natl Engn Ctr Swine Breeding Ind, Guangzhou, Guangdong, Peoples R China; [Li, Yan; Song, Chang-xu] Guangdong Acad Agr Sci, Inst Anim Hlth, Guangzhou, Guangdong, Peoples R China; [Dong, Jian-guo] Xinyang Coll Agr & Forestry, Xinyang Anim Dis Prevent & Control Engn Res Ctr, Xinyang, Peoples R China	South China Agricultural University; South China Agricultural University; Guangdong Academy of Agricultural Sciences	Zhao, YH; Song, CX (corresponding author), South China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China.; Zhao, YH; Song, CX (corresponding author), South China Agr Univ, Natl Engn Ctr Swine Breeding Ind, Guangzhou, Guangdong, Peoples R China.	Yahuazhao@yeah.net; cxsong2004@163.com	liu, yan/HCI-5542-2022; liu, yan/HGV-1365-2022	Song, Chang-xu/0000-0001-5311-0439	Guangdong Provincial Projects [2012A020200014, 2013B020202002]; Guangzou City Project [201508020062]	Guangdong Provincial Projects; Guangzou City Project	This work was supported by the Guangdong Provincial Projects (2012A020200014, and 2013B020202002) and Guangzou City Project (201508020062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alverdy J, 2000, ANN SURG, V232, P480, DOI 10.1097/00000658-200010000-00003; Andresen LO, 1997, MICROB PATHOGENESIS, V22, P113, DOI 10.1006/mpat.1996.0097; Avilan L., 2011, ENZYME RES, V2011, DOI DOI 10.4061/2011/932549; Basavanna S, 2009, INFECT IMMUN, V77, P3412, DOI 10.1128/IAI.01543-08; Cadieux B, 2014, J BACTERIOL, V196, P4044, DOI 10.1128/JB.02044-14; Casas-Godoy L, 2012, METHODS MOL BIOL, V861, P3, DOI 10.1007/978-1-61779-600-5_1; Claro T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018748; De Leon G, 2008, CANCER BIOL THER, V7, P833, DOI 10.4161/cbt.7.6.5839; DEMLEITNER G, 1994, FEMS MICROBIOL LETT, V121, P189, DOI 10.1016/0378-1097(94)90126-0; DEVRIESE LA, 1978, INT J SYST BACTERIOL, V28, P482, DOI 10.1099/00207713-28-4-482; Dutta S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0914-x; FARRIAUX JP, 1974, Z KINDERHEILKD, V118, P231, DOI 10.1007/BF00464614; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Fudaba Y, 2005, MICROB PATHOGENESIS, V39, P171, DOI 10.1016/j.micpath.2005.08.003; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Gupta MK, 2009, J PROTEOME RES, V8, P2319, DOI 10.1021/pr8009462; Hu CY, 2012, BIOCHEM BIOPH RES CO, V419, P617, DOI 10.1016/j.bbrc.2012.02.057; Hughes MJG, 2002, INFECT IMMUN, V70, P1254, DOI 10.1128/IAI.70.3.1254-1259.2002; JONES LD, 1961, VET MED, V14, P1028; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Kofoed CB, 2002, ANTIMICROB AGENTS CH, V46, P3339, DOI 10.1128/AAC.46.11.3339-3342.2002; Krucher NA, 2006, EXP CELL RES, V312, P2757, DOI 10.1016/j.yexcr.2006.05.002; Kurien BT, 2011, METHODS MOL BIOL, V717, P55, DOI 10.1007/978-1-61779-024-9_3; Langan KJ, 1997, PROTOPLASMA, V196, P87, DOI 10.1007/BF01281062; Lee VT, 2001, GENE DEV, V15, P1725, DOI 10.1101/gad.896801; LINDMARK R, 1983, J IMMUNOL METHODS, V62, P1, DOI 10.1016/0022-1759(83)90104-7; Liu KY, 2006, MOL CELL BIOCHEM, V288, P65, DOI 10.1007/s11010-006-9119-5; Liu XK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057959; Mei JM, 1997, MOL MICROBIOL, V26, P399, DOI 10.1046/j.1365-2958.1997.5911966.x; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Rosander A, 2011, VET MICROBIOL, V149, P273, DOI 10.1016/j.vetmic.2010.10.011; Sadykov MR, 2013, J BACTERIOL, V195, P3035, DOI 10.1128/JB.00042-13; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Sato H, 1990, Kitasato Arch Exp Med, V63, P119; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; SCHULZ W, 1969, Archiv fuer Experimentelle Veterinaermedizin, V23, P415; Shao Changli, 2012, Am J Biomed Sci, V4, P85; Shen HB, 2009, PROTEIN PEPTIDE LETT, V16, P1478, DOI 10.2174/092986609789839322; Takeuchi S, 2000, VET MICROBIOL, V71, P169, DOI 10.1016/S0378-1135(99)00158-3; Trinchieri Giorgio, 1992, Progress in Growth Factor Research, V4, P355, DOI 10.1016/0955-2235(92)90016-B; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Veiga-Malta I, 2004, CELL MICROBIOL, V6, P79, DOI 10.1046/j.1462-5822.2003.00344.x; Wang J, 2015, INT J MOL SCI, V16, P14490, DOI 10.3390/ijms160714490; WEGENER HC, 1993, CAN J VET RES, V57, P119; WEGENER HC, 1993, VET MICROBIOL, V34, P363, DOI 10.1016/0378-1135(93)90061-B; Winterhoff N, 2002, J BACTERIOL, V184, P6768, DOI 10.1128/JB.184.24.6768-6776.2002; Yang L, 2003, BIOPHYS J, V84, P509, DOI 10.1016/S0006-3495(03)74870-X; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	48	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167686	10.1371/journal.pone.0167686	http://dx.doi.org/10.1371/journal.pone.0167686			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930728	Green Published, Green Submitted, gold			2022-12-27	WOS:000389580900038
J	Santostasi, NL; Bonizzoni, S; Bearzi, G; Eddy, L; Gimenez, O				Santostasi, Nina Luisa; Bonizzoni, Silvia; Bearzi, Giovanni; Eddy, Lavinia; Gimenez, Olivier			A Robust Design Capture-Recapture Analysis of Abundance, Survival and Temporary Emigration of Three Odontocete Species in the Gulf of Corinth, Greece	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; BEAKED COMMON DOLPHINS; TURSIOPS-TRUNCATUS; DELPHINUS-DELPHIS; CONSERVATION; PATTERNS; CALIFORNIA; VAQUITA; WHALES; MODELS	While the Mediterranean Sea has been designated as a Global Biodiversity Hotspot, assessments of cetacean population abundance are lacking for large portions of the region, particularly in the southern and eastern basins. The challenges and costs of obtaining the necessary data often result in absent or poor abundance information. We applied capturere-capture models to estimate abundance, survival and temporary emigration of odontocete populations within a 2,400 km(2) semi-enclosed Mediterranean bay, the Gulf of Corinth. Boat surveys were conducted in 2011-2015 to collect photo-identification data on striped dolphins Stenella coeruleoalba, short-beaked common dolphins Delphinus delphis (always found together with striped dolphins in mixed groups) and common bottlenose dolphins Tursiops truncatus, totaling 1,873 h of tracking. After grading images for quality and marking distinctiveness, 23,995 high-quality photos were included in a striped and common dolphin catalog, and 2,472 in a bottlenose dolphin catalog. The proportions of striped and common dolphins were calculated from the photographic sample and used to scale capture-recapture estimates. Best-fitting robust design capture-recapture models denoted no temporary emigration between years for striped and common dolphins, and random temporary emigration for bottlenose dolphins, suggesting different residency patterns in agreement with previous studies. Average estimated abundance over the five years was 1,331 (95% CI 1,122-1,578) striped dolphins, 22 (16-32) common dolphins, 55 (36-84) "intermediate" animals (potential striped x common dolphin hybrids) and 38 (32-46) bottlenose dolphins. Apparent survival was constant for striped, common and intermediate dolphins (0.94, 95% CI 0.92-0.96) and year-dependent for bottlenose dolphins (an average of 0.85, 95% CI 0.76-0.95). Our work underlines the importance of long-term monitoring to contribute reliable baseline information that can help assess the conservation status of wildlife populations.	[Santostasi, Nina Luisa; Bonizzoni, Silvia; Bearzi, Giovanni; Eddy, Lavinia] Dolphin Biol & Conservat, Oria, Italy; [Santostasi, Nina Luisa; Gimenez, Olivier] Ctr Ecol Fonct & Evolut, Montpellier, France; [Santostasi, Nina Luisa; Bonizzoni, Silvia; Bearzi, Giovanni; Eddy, Lavinia] OceanCare, Wadenswil, Switzerland; [Santostasi, Nina Luisa] Sapienza Univ Roma, Rome, Italy	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Sapienza University Rome	Santostasi, NL (corresponding author), Dolphin Biol & Conservat, Oria, Italy.; Santostasi, NL (corresponding author), Ctr Ecol Fonct & Evolut, Montpellier, France.; Santostasi, NL (corresponding author), OceanCare, Wadenswil, Switzerland.; Santostasi, NL (corresponding author), Sapienza Univ Roma, Rome, Italy.	n.santostasi@gmail.com	Gimenez, Olivier/G-4281-2010; Bonizzoni, Silvia/AAC-4612-2021; Bearzi, Giovanni/L-6115-2016	Bonizzoni, Silvia/0000-0001-7331-4439; Bearzi, Giovanni/0000-0001-6633-3324; Eddy, Lavinia/0000-0002-2934-7441; Gimenez, Olivier/0000-0001-7001-5142	OceanCare; Sapienza University of Rome	OceanCare; Sapienza University of Rome	The collection of field data was largely funded by OceanCare, a non-profit non-governmental organization committed to ocean conservation (https://www.oceancare org/en/). No grant number is available. OceanCare provided support in the form of salaries for co-authors GB and SB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Nina Luisa Santostasi was supported by a research grant by Sapienza University of Rome (http://www.uniroma1.it/didattica/borse-di-studio/borse-di-perfezionamento-allestero). No grant number is available	Aguilar A., 2012, IUCN RED LIST THREAT, V2012, DOI [10.2305/IUCN.UK.2012-1.RLTS.T16674437A16674052.en, DOI 10.2305/IUCN.UK.2012-1.RLTS.T16674437A16674052.EN]; Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Amstrup S, 2005, HANDBOOK OF CAPTURE-RECAPTURE ANALYSIS, P36; [Anonymous], 1982, ESTIMATION ANIMAL AB; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2007, 3 M CONTR PART ACCOB; [Anonymous], 1951, U CALIFORNIA PUBLICA; BALLANCE LT, 1992, MAR MAMMAL SCI, V8, P262, DOI 10.1111/j.1748-7692.1992.tb00408.x; Bearzi G, 2003, MAMMAL REV, V33, P224, DOI 10.1046/j.1365-2907.2003.00032.x; Bearzi G., 2003, IUCN RED LIST THREAT; Bearzi G, 2012, IUCN RED LIST THREAT, V2012; Bearzi Giovanni, 2008, Endangered Species Research, V5, P1, DOI 10.3354/esr00103; Bearzi G, 2008, AQUAT CONSERV, V18, P130, DOI 10.1002/aqc.843; Bearzi G, 2011, MAR MAMMAL SCI, V27, pE165, DOI 10.1111/j.1748-7692.2010.00448.x; Bearzi G, 2011, J ETHOL, V29, P369, DOI 10.1007/s10164-010-0245-x; Bejder Lars, 2012, Pacific Conservation Biology, V18, P22; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Berrow S, 2012, AQUAT MAMM, V38, P136, DOI 10.1578/AM.38.2.2012.136; Birkun  Jr A, 2010, CONSERVING WHALES DO; Brown AM, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00004; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 1987, AM FISHERIES SOC MON; Calambokidis J, 2004, MAR MAMMAL SCI, V20, P63, DOI 10.1111/j.1748-7692.2004.tb01141.x; Cantor M, 2012, MAR MAMMAL SCI, V28, P63, DOI 10.1111/j.1748-7692.2010.00456.x; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Crossman CA, 2016, ECOL EVOL, V6, P1293, DOI 10.1002/ece3.1913; Currey RJC, 2009, BIOL CONSERV, V142, P1570, DOI 10.1016/j.biocon.2009.02.036; Currey RJC, 2009, AQUAT CONSERV, V19, P658, DOI 10.1002/aqc.1015; de Silva S, 2011, BIOL CONSERV, V144, P1742, DOI 10.1016/j.biocon.2011.03.011; Defran RH, 1999, MAR MAMMAL SCI, V15, P381, DOI 10.1111/j.1748-7692.1999.tb00808.x; Fortuna CM., 2006, THESIS; Frantzis A., 2003, Journal of Cetacean Research and Management, V5, P219; Frantzis Alexandros, 2002, Aquatic Mammals, V28, P188; Gary AN., 2015, FISHMETHODS FISHERY; Gaspari S, 2015, AQUAT CONSERV, V25, P212, DOI 10.1002/aqc.2415; GERRODETTE T, 1993, WILDLIFE SOC B, V21, P515; GERRODETTE T, 1987, ECOLOGY, V68, P1364, DOI 10.2307/1939220; Gkafas A, 2007, P 10 INT C ENV SCI T; Gkafas GA, 2011, THESIS; Gormley AM, 2005, MAR MAMMAL SCI, V21, P204, DOI 10.1111/j.1748-7692.2005.tb01224.x; Hammond P.S., 1990, Reports of the International Whaling Commission Special Issue, P135; Hammond P. S., 2008, IUCN RED LIST THREAT; Hammond PS, 2012, IUCN RED LIST THREAT, DOI 10. 2305/IUCN. UK. 2012. RLTS. T41714A17600466. en; Hammond PS, 1990, IWC, V12; Hansen L.J., 1990, Reports of the International Whaling Commission Special Issue, P101; Iatrou M, 2010, RAPP COMM INT MER ME, V39, P260; Iatrou M., 2010, B GEOLOGICAL SOC GRE, P1018; Iatrou M, 2013, THESIS; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; IUCN, 2012, MAR MAMM SEA TURTL M; IUCN, 2003, GUID APPL IUCN RED L; Karanth KU, 2006, ECOLOGY, V87, P2925, DOI 10.1890/0012-9658(2006)87[2925:ATPDUP]2.0.CO;2; Kendall W. L., 2004, Animal Biodiversity and Conservation, V27, P97; Kendall WL, 1997, ECOLOGY, V78, P563; KENDALL WL, 1995, BIOMETRICS, V51, P293, DOI 10.2307/2533335; Laake JL., 2013, RMARK R INTERFACE AN; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lukoschek V, 2008, WILDLIFE RES, V35, P593, DOI 10.1071/WR07021; Manlik O, 2016, ECOL EVOL, V6, P3496, DOI 10.1002/ece3.2130; Mansur RM, 2012, MAR MAMMAL SCI, V28, P561, DOI 10.1111/j.1748-7692.2011.00520.x; Micheli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079889; MOURA A, 2010, THESIS; Moura AE, 2013, J EVOLUTION BIOL, V26, P63, DOI 10.1111/jeb.12032; Nicholson K, 2012, MAR FRESHWATER RES, V63, P1059, DOI 10.1071/MF12210; OTIS DL, 1978, WILDLIFE MONOGR, P1; Parra GJ, 2006, BIOL CONSERV, V129, P167, DOI 10.1016/j.biocon.2005.10.031; Phillips N. M, 2014, NMFSSEFSC665 NOAA; Pledger S, 2003, BIOMETRICS, V59, P786, DOI 10.1111/j.0006-341X.2003.00092.x; Pleslic G, 2015, AQUAT CONSERV, V25, P125, DOI 10.1002/aqc.2416; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Pradel R., 2005, Animal Biodiversity and Conservation, V28, P189; Pradel R, 1997, BIOMETRICS, V53, P60, DOI 10.2307/2533097; Read AJ, 2003, MAR MAMMAL SCI, V19, P59, DOI 10.1111/j.1748-7692.2003.tb01092.x; Santostasi N. L., 2016, P 30 ANN C EUR CET S; Schaub M, 2004, ECOLOGY, V85, P2107, DOI 10.1890/03-3110; Schwarz CJ, 1996, BIOMETRICS, V52, P860, DOI 10.2307/2533048; Schwarz CJ, 1999, STAT SCI, V14, P427; Silva MA, 2009, MAR ECOL PROG SER, V392, P263, DOI 10.3354/meps08233; Silva MA, 2008, MAR BIOL, V156, P179, DOI 10.1007/s00227-008-1075-z; Slooten Elisabeth, 2007, Endangered Species Research, V3, P169, DOI 10.3354/esr003169; Smith HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076574; Stolen MK, 2003, MAR MAMMAL SCI, V19, P630, DOI 10.1111/j.1748-7692.2003.tb01121.x; Taylor BL, 2007, MAR MAMMAL SCI, V23, P157, DOI 10.1111/j.1748-7692.2006.00092.x; Taylor BL, 1999, MAR MAMMAL SCI, V15, P1004, DOI 10.1111/j.1748-7692.1999.tb00875.x; TAYLOR BL, 1993, CONSERV BIOL, V7, P489, DOI 10.1046/j.1523-1739.1993.07030489.x; Tezanos-Pinto G, 2013, MAR MAMMAL SCI, V29, pE390, DOI 10.1111/mms.12008; Thompson PM, 2000, CONSERV BIOL, V14, P1253, DOI 10.1046/j.1523-1739.2000.00099-410.x; Tyne JA, 2016, BIOL CONSERV, V201, P252, DOI 10.1016/j.biocon.2016.07.024; Tyne JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086132; Urian K, 2015, MAR MAMMAL SCI, V31, P298, DOI 10.1111/mms.12141; Urian KW., 1999, NMFSSEFSC425 NOAA; Vermeulen E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119182; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WILLIAMS JA, 1993, CAN J ZOOL, V71, P2080, DOI 10.1139/z93-293; Wilson B, 1999, ECOL APPL, V9, P288, DOI 10.1890/1051-0761(1999)009[0288:ESAATI]2.0.CO;2; Wolf DE, 2001, CONSERV BIOL, V15, P1039, DOI 10.1046/j.1523-1739.2001.0150041039.x; WURSIG B, 1977, SCIENCE, V198, P755, DOI 10.1126/science.198.4318.755; Wursig B., 1990, Reports of the International Whaling Commission Special Issue, P43; Zeh J, 2002, BIOMETRICS, V58, P832, DOI 10.1111/j.0006-341X.2002.00832.x	100	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2016	11	12							e0166650	10.1371/journal.pone.0166650	http://dx.doi.org/10.1371/journal.pone.0166650			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4NG	27926926	Green Published, gold, Green Submitted			2022-12-27	WOS:000389578800004
J	Xu, CS; Kozlov, G; Wong, K; Gehring, K; Cygler, M				Xu, Caishuang; Kozlov, Guennadi; Wong, Kathy; Gehring, Kalle; Cygler, Miroslaw			Crystal Structure of the Salmonella Typhimurium Effector GtgE	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; CONTAINING VACUOLE; HOST-CELLS; COMPARTMENTS; INHIBITION; MATURATION; VIRULENCE; DELIVERY; NETWORK; PATHWAY	Salmonella Typhimurium GtgE is an effector protein contributing to the virulence of this pathogen. It was shown to possess highly selective proteolytic activity against a subset of Rab proteins that helps in evasion of Salmonella-containing vacuole (SCV) fusion with lysosomes. Cys45, His151 and Asp169 are essential for proteolytic activity. The structure of a C-terminal fragment GtgE(79-214) indicated the presence of a papain-like fold. Here, we present the structure of GtgE(17-214) containing the fully assembled active site. The design of a proteolytically active and crystallizable GtgE construct was aided by NMR spectroscopy. The protein indeed displays papain-like fold with an assembled Cys-His-Asp catalytic triad. Like the full-length GtgE, the crystallizable construct showed low activity in vitro for its known substrates, Rab32 and Rab29. NMR titration experiments showed at most very weak binding of GtgE to the peptide encompassing the Rab29 cleavage site. In view of the low in vitro activity and poor substrate binding, we postulate that the function of GtgE in vivo as a proteolytic enzyme is dependent on other factor(s), such as a protein partner or interactions with the SCV membrane, which stimulate(s) GtgE activity in vivo.	[Xu, Caishuang; Cygler, Miroslaw] Univ Saskatchewan, Dept Biochem, Saskatoon, SK, Canada; [Kozlov, Guennadi; Wong, Kathy; Gehring, Kalle; Cygler, Miroslaw] McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, Montreal, PQ, Canada	University of Saskatchewan; McGill University	Cygler, M (corresponding author), Univ Saskatchewan, Dept Biochem, Saskatoon, SK, Canada.; Cygler, M (corresponding author), McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, Montreal, PQ, Canada.	miroslaw.cygler@usask.ca	Gehring, Kalle/N-2945-2019; Gehring, Kalle/I-4403-2013	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184	CIHR [GSP-48370]; CIHR Genomics grant [GSP-48370]; NSF & NIH/NIGMS via NSF award [DMR-0225180]; NIH/NCRR [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); CIHR Genomics grant; NSF & NIH/NIGMS via NSF award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)National Science Foundation (NSF)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Support was provided by CIHR, GSP-48370 [http://www.cihr-irsc.gc.ca/e/]; The authors declare no conflict of interests. We would like to thank Dr. Tara Sprules at the Quebec/Eastern Canada High Field NMR Facility for assistance with NMR data collection and analysis. This work was funded by a CIHR Genomics grant GSP-48370 to MC and KG. Data were acquired at the Macromolecular Diffraction (MacCHESS) facility at the Cornell High Energy Synchrotron Source (CHESS). CHESS is supported by the NSF & NIH/NIGMS via NSF award DMR-0225180, and the MacCHESS resource is supported by NIH/NCRR award RR-01646.	Bakowski MA, 2008, TRAFFIC, V9, P2022, DOI 10.1111/j.1600-0854.2008.00827.x; Brumell JH, 2003, TRAFFIC, V4, P36, DOI 10.1034/j.1600-0854.2003.40106.x; Brumell JH, 2004, CURR OPIN MICROBIOL, V7, P78, DOI 10.1016/j.mib.2003.12.005; Bujny MV, 2008, J CELL SCI, V121, P2027, DOI 10.1242/jcs.018432; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Figueroa-Bossi N, 1999, MOL MICROBIOL, V33, P167, DOI 10.1046/j.1365-2958.1999.01461.x; Grishin AM, 2014, STRUCTURE, V22, P878, DOI 10.1016/j.str.2014.04.010; Haghjoo E, 2004, P NATL ACAD SCI USA, V101, P4614, DOI 10.1073/pnas.0400932101; Ho TD, 2002, J BACTERIOL, V184, P5234, DOI 10.1128/JB.184.19.5234-5239.2002; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Knodler LA, 2003, TRAFFIC, V4, P587, DOI 10.1034/j.1600-0854.2003.00118.x; Kohler AC, 2014, ACTA CRYSTALLOGR D, V70, P384, DOI 10.1107/S1399004713028393; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mallo GV, 2008, J CELL BIOL, V182, P741, DOI 10.1083/jcb.200804131; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; Ramsden AE, 2007, TRENDS MICROBIOL, V15, P516, DOI 10.1016/j.tim.2007.10.002; Smith AC, 2007, J CELL BIOL, V176, P263, DOI 10.1083/jcb.200611056; Spano S, 2008, CELL HOST MICROBE, V3, P30, DOI 10.1016/j.chom.2007.11.001; Spano S, 2012, SCIENCE, V338, P960, DOI 10.1126/science.1229224; Spano S, 2011, P NATL ACAD SCI USA, V108, P18418, DOI 10.1073/pnas.1111959108; Steele-Mortimer O, 2008, CURR OPIN MICROBIOL, V11, P38, DOI 10.1016/j.mib.2008.01.002; Stenmark H, 2001, GENOME BIOL, V2; TOUCHOT N, 1987, P NATL ACAD SCI USA, V84, P8210, DOI 10.1073/pnas.84.23.8210; Tsuge H, 1999, BIOCHEM BIOPH RES CO, V266, P411, DOI 10.1006/bbrc.1999.1830; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	35	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2016	11	12							e0166643	10.1371/journal.pone.0166643	http://dx.doi.org/10.1371/journal.pone.0166643			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MY	27923041	Green Published, Green Submitted, gold			2022-12-27	WOS:000389577900001
J	Xu, HY; Wang, P				Xu, Haiyang; Wang, Ping			Real-Time Reliability Verification for UAV Flight Control System Supporting Airworthiness Certification	PLOS ONE			English	Article								In order to verify the real-time reliability of unmanned aerial vehicle (UAV) flight control system and comply with the airworthiness certification standard, we proposed a model-based integration framework for modeling and verification of time property. Combining with the advantages of MARTE, this framework uses class diagram to create the static model of software system, and utilizes state chart to create the dynamic model. In term of the defined transformation rules, the MARTE model could be transformed to formal integrated model, and the different part of the model could also be verified by using existing formal tools. For the real-time specifications of software system, we also proposed a generating algorithm for temporal logic formula, which could automatically extract real-time property from time-sensitive live sequence chart (TLSC). Finally, we modeled the simplified flight control system of UAV to check its real-time property. The results showed that the framework could be used to create the system model, as well as precisely analyze and verify the real-time reliability of UAV flight control system.	[Xu, Haiyang; Wang, Ping] Qingdao Agr Univ, Sch Sci & Informat, Qingdao, Shandong, Peoples R China; [Xu, Haiyang] Nanjing Univ Aeronaut & Astronaut, Sch Comp Sci & Technol, Nanjing, Jiangsu, Peoples R China	Qingdao Agricultural University; Nanjing University of Aeronautics & Astronautics	Wang, P (corresponding author), Qingdao Agr Univ, Sch Sci & Informat, Qingdao, Shandong, Peoples R China.	gege3175@163.com			National Natural Science Foundation of China [61572253]; China Postdoctoral Science Foundation [2011M500124]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work is supported by the National Natural Science Foundation of China (General Program) under Grant No. 61572253, China Postdoctoral Science Foundation under Grant No.2011M500124.	[Anonymous], 2016, IND INTERNET THINGS; Bingfeng X, 2012, ACTA AERONAUTICA AST, V33, P796; Bontemps Y., 2003, P 2 INT WORKSH SCEN, P1; Cofer D, 2008, P 27 DIG AV SYST C, p5D; Cofer D, 2010, LECT NOTES COMPUT SC, V6349, P76; Damm W, 2001, FORM METHOD SYST DES, V19, P45, DOI 10.1023/A:1011227529550; Gigante Gabriella, 2012, Leveraging Applications of Formal Methods, Verification and Validation. Applications and Case Studies. Proceedings of the 5th International Symposium, ISoLA 2012, P205, DOI 10.1007/978-3-642-34032-1_21; Guan T, 2015, ACM T INTEL SYST TEC, V7, DOI 10.1145/2795234; Haiyang Xu, 2014, Journal of Software, V9, P807, DOI 10.4304/jsw.9.4.807-813; Houbing Song CB., 2016, CYBER PHYS SYSTEMS F; Huafeng Yu, 2011, 2011 9th IEEE/ACM International Conference on Formal Methods and Models for Codesign (MEMOCODE 2011), P21, DOI 10.1109/MEMCOD.2011.5970507; Jacklin S., 2004, AIAA GUIDANCE NAVIGA; Jiang Y, 2017, IEEE T IND INFORM, V13, P1900, DOI 10.1109/TII.2016.2573762; Kim SK, 2005, LECT NOTES COMPUT SC, V3582, P448; Kim SK, 2002, LECT NOTES COMPUT SC, V2495, P548; Li D, 2010, ROBOT CIM-INT MANUF, V26, P333, DOI 10.1016/j.rcim.2009.11.011; Li WJ, 2016, IEEE T INTELL TRANSP, V17, P960, DOI 10.1109/TITS.2015.2494017; Marelly R, 2002, ACM SIGPLAN NOTICES, V37, P83, DOI 10.1145/583854.582429; Mazzolini M, 2011, IEEE INTL CONF IND I; Moy Y, 2013, IEEE SOFTWARE, V30, P50, DOI 10.1109/MS.2013.43; Ogawa H, 2008, ASIA PAC SOFWR ENG, P377, DOI 10.1109/APSEC.2008.71; Paw YC, 2011, MECHATRONICS, V21, P789, DOI 10.1016/j.mechatronics.2010.09.009; Pingree PJ, 2002, P DIG AV SYST C, p6A4; Posadas H., 2013, EL SYST LEV SYNTH C, P1; Pouryazdan M, 2016, IEEE ACCESS, V4, P529, DOI 10.1109/ACCESS.2016.2519820; Rozier KY, 2011, COMPUT SCI REV, V5, P163, DOI 10.1016/j.cosrev.2010.06.002; Segev E, 2004, ICECS 2004: 11th IEEE International Conference on Electronics, Circuits and Systems, P515; Souyris J, 2009, LECT NOTES COMPUT SC, V5850, P532, DOI 10.1007/978-3-642-05089-3_34; Sreemani T, 1996, COMPASS '96 - PROCEEDINGS OF THE ELEVENTH ANNUAL CONFERENCE ON COMPUTER ASSURANCE, P77, DOI 10.1109/CMPASS.1996.507877; Tafazoli M, 2009, ACTA ASTRONAUT, V64, P195, DOI 10.1016/j.actaastro.2008.07.019; Wang ZK, 2014, MULTIMED TOOLS APPL, V73, P519, DOI 10.1007/s11042-013-1619-1; Wei BC, 2015, MULTIMEDIA SYST, V21, P381, DOI 10.1007/s00530-014-0364-2; Wei BC, 2014, IEEE MULTIMEDIA, V21, P41, DOI 10.1109/MMUL.2013.65; WHALEN M, 2007, P FMICS 2007, V2007, P68, DOI DOI 10.1007/978-3-540-79707-4_; Xu HY, 2015, J SYST ENG ELECTRON, V26, P857, DOI 10.1109/JSEE.2015.00093; [许海洋 Xu Haiyang], 2014, [电子学报, Acta Electronica Sinica], V42, P1515; Zhang Y, 2015, SIGNAL PROCESS, V112, P17, DOI 10.1016/j.sigpro.2014.08.029	37	2	2	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2016	11	12							e0167168	10.1371/journal.pone.0167168	http://dx.doi.org/10.1371/journal.pone.0167168			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MR	27918594	gold, Green Published, Green Submitted			2022-12-27	WOS:000389577100008
J	Varthaman, A; Moreau, HD; Maurin, M; Benaroch, P				Varthaman, Aditi; Moreau, Helene D.; Maurin, Mathieu; Benaroch, Philippe			TLR3-Induced Maturation of Murine Dendritic Cells Regulates CTL Responses by Modulating PD-L1 Trafficking	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; ENDOGENOUS IFN-BETA; DOUBLE-STRANDED-RNA; EFFECTOR DIFFERENTIATION; ANTITUMOR IMMUNITY; LIGAND; TLR3; ANTIGEN; ACTIVATION; CANCER	Targeting TLR3 through formulations of polyl:C is widely studied as an adjuvant in cancer immunotherapy. The efficacy of such targeting has been shown to increase in combination with anti-PD-L1 treatment. Nevertheless, the mechanistic details of the effect of polyl:C on DC maturation and the impact on T-DC interactions upon PD-L1 blockade is largely unknown. Here we found that although DC treatment with polyl:C induced a potent inflammatory response including the production of type I interferon, polyl:C treatment of DCs impaired activation of peptide specific CD8(+) T cells mainly due to PD-L1. Interestingly, we found that PD-L1 trafficking to the cell surface is regulated in two waves in polyl:C-treated DCs. One induced upon overnight treatment and a second more rapid one, specific to polyl: C treatment, was induced upon CD40 signaling leading to a further increase in surface PD-L1 in DCs. The polyl:C-induced cell surface PD-L1 reduced the times of contact between DCs and T cells, potentially accounting for limited T cell activation. Our results reveal a novel CD40-dependent regulation of PD-L1 trafficking induced upon TLR3 signaling that dictates its inhibitory activity. These results provide a mechanistic framework to understand the efficacy of anti-PD-L1 cancer immunotherapy combined with TLR agonists.	[Varthaman, Aditi; Moreau, Helene D.; Maurin, Mathieu; Benaroch, Philippe] PSL Res Univ, Inst Curie, INSERM, U 932, Paris, France; [Varthaman, Aditi] Univ Oxford, Weatherall Inst Mol Med, Radcliffe Dept Med, MRC Human Immunol Unit, Oxford, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite; University of Oxford	Benaroch, P (corresponding author), PSL Res Univ, Inst Curie, INSERM, U 932, Paris, France.	benaroch@curie.fr		Varthaman, Aditi/0000-0002-8703-5534; Moreau, Helene/0000-0001-5715-6864; Benaroch, Philippe/0000-0002-2655-0129	Fondation ARC pour la recherche sur le Cancer; program "Investissements d'Avenir" [ANR-10-IDEX-0001-02 PSL*, ANR-11-LABX-0043, ANR-09-MIEN-021-01, ANR 15 CE13 0009 01]; Insitut National du Cancer [INCA_9301]	Fondation ARC pour la recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); program "Investissements d'Avenir"(French National Research Agency (ANR)); Insitut National du Cancer	HDM was supported by a fellowship from the Fondation ARC pour la recherche sur le Cancer. This work has received support under the program "Investissements d'Avenir" launched by the French Government and implemented by the Agence Nationale de la Recherche with the reference (ANR-10-IDEX-0001-02 PSL* and ANR-11-LABX-0043), ANR-09-MIEN-021-01, ANR 15 CE13 0009 01. The work was also supported by Insitut National du Cancer (INCA_9301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aumeunier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011484; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Boes M, 2015, CANCER LETT, V361, P49, DOI 10.1016/j.canlet.2015.02.027; Caskey M, 2011, J EXP MED, V208, P2357, DOI 10.1084/jem.20111171; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08; Deng LF, 2014, J CLIN INVEST, V124, P687, DOI 10.1172/JCI67313; Estornes Y, 2012, CELL DEATH DIFFER, V19, P1482, DOI 10.1038/cdd.2012.22; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Gatti G, 2013, EUR J IMMUNOL, V43, P1849, DOI 10.1002/eji.201242902; Gibbons RM, 2014, CANCER IMMUNOL IMMUN, V63, P859, DOI 10.1007/s00262-014-1563-6; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Honda T, 2014, IMMUNITY, V40, P235, DOI 10.1016/j.immuni.2013.11.017; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Lafaille FG, 2012, NATURE, V491, P769, DOI 10.1038/nature11583; Nagato T, 2014, CLIN CANCER RES, V20, P1223, DOI 10.1158/1078-0432.CCR-13-2781; Ngoi SM, 2012, P NATL ACAD SCI USA, V109, P10486, DOI 10.1073/pnas.1202607109; Nocera DA, 2016, J IMMUNOL, DOI [10.1084/jem.20081370, 10.1172/JCI67313, DOI 10.1084/JEM.20081370]; Pentcheva-Hoang T, 2007, P NATL ACAD SCI USA, V104, P17765, DOI 10.1073/pnas.0708767104; Pradere JP, 2014, ONCOGENE, V33, P3485, DOI 10.1038/onc.2013.302; Pulko V, 2009, J IMMUNOL, V183, P3634, DOI 10.4049/jimmunol.0900974; Salem ML, 2005, J IMMUNOTHER, V28, P220, DOI 10.1097/01.cji.0000156828.75196.0d; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Sato Y, 2009, CANCER MICROENVIRON, V2, pS205, DOI 10.1007/s12307-009-0022-y; Savina A, 2010, METHODS MOL BIOL, V595, P383, DOI 10.1007/978-1-60761-421-0_25; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; SERREZE DV, 1989, J AUTOIMMUN, V2, P759, DOI 10.1016/0896-8411(89)90003-6; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; Touil T, 2006, J IMMUNOL, V177, P7505, DOI 10.4049/jimmunol.177.11.7505; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	35	14	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167057	10.1371/journal.pone.0167057	http://dx.doi.org/10.1371/journal.pone.0167057			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911948	Green Published, gold, Green Submitted			2022-12-27	WOS:000389520600021
J	Wang, MK; White, C; Akbari, A; Brown, P; Hussain, N; Hiremath, S; Knoll, G				Wang, Michael Ke; White, Christine; Akbari, Ayub; Brown, Pierre; Hussain, Naser; Hiremath, Swapnil; Knoll, Greg			Utilizing Estimated Creatinine Excretion to Improve the Performance of Spot Urine Samples for the Determination of Proteinuria in Kidney Transplant Recipients	PLOS ONE			English	Article							GLOMERULAR-FILTRATION RATE; ALBUMIN EXCRETION; MUSCLE MASS; GRAFT LOSS; CLEARANCE; RISK; PREDICTION; DISEASE; DEATH; RATIO	Background Agreement between spot and 24-hour urine protein measurements is poor in kidney transplant recipients. We investigated whether using formulae to estimate creatinine excretion rate (eCER), rather than assuming a standard creatinine excretion rate, would improve the estimation of proteinuria from spot urine samples in kidney transplant recipients. Methods We measured 24 hour urine protein and albumin and spot albumin: creatinine (ACR) and spot protein: creatinine (PCR) in 181 Kidney transplant recipients. "We utilized 6 different published formulae (Fotheringham, CKD-EPI, Cockcroft-Gault, Walser, Goldwasser and Rule) to estimate eCER and from it calculated estimated albumin and protein excretion rate (eAER and ePER). Bias, precision and accuracy (within 15%, 30% and 50%) of ACR, PCR, eAER, ePER were compared to 24-hour urine protein and albumin. Results ACR and PCR significantly underestimated 24-hour albumin and protein excretion (ACR Bias (IQR), -5.9 mg/day; p < 0.01; PCR Bias, (IQR), -35.2 mg/day; p < 0.01). None of the formulae used to calculate eAER or ePER had a bias that was significantly different from the 24-hour collection (eAER and ePER bias: Fotheringham -0.3 and 7.2, CKD-EPI 0.3 and 13.5, Cockcroft-Gault -3.2 and -13.9, Walser -1.7 and 3.1, Goldwasser -1.3 and -0.5, Rule -0.6 and 4.2 mg/day respectively. The accuracy for ACR and PCR were lower (within 30% being 38% and 43% respectively) than the corresponding values estimated by utilizing eCER (for eAER 46% to 49% and ePER 46-54%). Conclusion Utilizing estimated creatinine excretion to calculate eAER and ePER improves the estimation of 24-hour albuminuria/proteinuria with spot urine samples in kidney transplant recipients.	[Wang, Michael Ke] McMaster Univ, Dept Med, Hamilton, ON, Canada; [White, Christine] Queens Univ, Dept Med, Div Nephrol, Kingston, ON, Canada; [Akbari, Ayub; Brown, Pierre; Hiremath, Swapnil; Knoll, Greg] Univ Ottawa, Dept Med, Div Nephrol, Ottawa, ON, Canada; [Akbari, Ayub; Brown, Pierre; Hiremath, Swapnil; Knoll, Greg] Univ Ottawa, Kidney Res Ctr, Ottawa, ON, Canada; [Akbari, Ayub; Hiremath, Swapnil; Knoll, Greg] Univ Ottawa, Clin Epidemiol Program, Ottawa, ON, Canada; [Hussain, Naser] Mubarak AlKabeer Hosp, Dept Med, Div Nephrol, Kuwait, Kuwait	McMaster University; Queens University - Canada; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; Mubarak Al-Kabeer Hospital	Akbari, A (corresponding author), Univ Ottawa, Dept Med, Div Nephrol, Ottawa, ON, Canada.; Akbari, A (corresponding author), Univ Ottawa, Kidney Res Ctr, Ottawa, ON, Canada.; Akbari, A (corresponding author), Univ Ottawa, Clin Epidemiol Program, Ottawa, ON, Canada.	aakbari@ottawahospital.on.ca	Brown, Pierre Antoine/L-2175-2019; Hiremath, Swapnil/H-3492-2019; Wang, Michael/U-1771-2019	Brown, Pierre Antoine/0000-0002-0283-4530; Hiremath, Swapnil/0000-0003-0010-3416; Wang, Michael/0000-0002-4949-3235; Knoll, Greg/0000-0001-5442-9310; White, Christine/0000-0001-7546-393X	Physicians services incorporated foundation [R03-59]	Physicians services incorporated foundation	This study was supported by Physicians services incorporated foundation grant number R03-59, http://www.psitoundation.org/ (CW, GK). The funders did not have any role in data collection or data analysis or preparation of manuscript or decision to publish.	Abdelmalek JA, 2014, AM J KIDNEY DIS, V63, P415, DOI 10.1053/j.ajkd.2013.10.061; Akbari A, 2012, TRANSPLANTATION, V94, P389, DOI 10.1097/TP.0b013e31825b413e; Andersen S, 2015, SCAND J CLIN LAB INV, V75, P44, DOI 10.3109/00365513.2014.965737; Bauer L, 2016, AM J NEPHROL, V43, P383, DOI 10.1159/000446483; CAMERON JS, 1982, TRANSPLANTATION, V34, P237; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Eckardt KU, 2009, AM J TRANSPLANT, V9, pS1, DOI 10.1111/j.1600-6143.2009.02834.x; Fernandez-Fresnedo G, 2002, TRANSPLANT P, V34, P367, DOI 10.1016/S0041-1345(01)02805-6; Fotheringham J, 2014, AM J KIDNEY DIS, V63, P405, DOI 10.1053/j.ajkd.2013.08.009; GINSBERG JM, 1983, NEW ENGL J MED, V309, P1543, DOI 10.1056/NEJM198312223092503; Goldwasser P, 1997, AM J KIDNEY DIS, V30, P16, DOI 10.1016/S0272-6386(97)90559-X; Halimi JM, 2007, AM J TRANSPLANT, V7, P618, DOI 10.1111/j.1600-6143.2007.01665.x; Hong DSC, 2016, KIDNEY BLOOD PRESS R, V41, P258, DOI 10.1159/000443429; Ix JH, 2011, CLIN J AM SOC NEPHRO, V6, P184, DOI 10.2215/CJN.05030610; KASISKE BL, 1989, TRANSPLANTATION, V48, P424, DOI 10.1097/00007890-198909000-00014; NANKIVELL BJ, 1995, TRANSPLANTATION, V59, P1683, DOI 10.1097/00007890-199506270-00007; Oterdoom LH, 2008, TRANSPLANTATION, V86, P391, DOI 10.1097/TP.0b013e3181788aea; REHLING M, 1984, CLIN SCI, V66, P613, DOI 10.1042/cs0660613; Roodnat JI, 2001, TRANSPLANT P, V33, P1170, DOI 10.1016/S0041-1345(00)02447-7; Rule AD, 2009, KIDNEY INT, V75, P1071, DOI 10.1038/ki.2008.698; SHAW AB, 1983, BRIT MED J, V287, P929, DOI 10.1136/bmj.287.6397.929; VATHSALA A, 1990, TRANSPLANTATION, V49, P35, DOI 10.1097/00007890-199001000-00008; WALSER M, 1993, KIDNEY INT, V44, P1145, DOI 10.1038/ki.1993.361	23	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0166547	10.1371/journal.pone.0166547	http://dx.doi.org/10.1371/journal.pone.0166547			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911917	Green Submitted, Green Published, gold			2022-12-27	WOS:000389520600009
J	Scarpelini, B; Zanoni, M; Sucupira, MCA; Truong, HHM; Janini, LMR; Segurado, IDC; Diaz, RS				Scarpelini, Bruno; Zanoni, Michelle; Araripe Sucupira, Maria Cecilia; Truong, Hong-Ha M.; Ramos Janini, Luiz Mario; Cotrin Segurado, Ismael Dale; Sobhie Diaz, Ricardo			Plasma Metabolomics Biosignature According to HIV Stage of Infection, Pace of Disease Progression, Viremia Level and Immunological Response to Treatment	PLoS One			English	Article							LYMPHOCYTE EGRESS; CANCER; DOPAMINE; BLOOD	Background We evaluated plasma samples HIV-infected individuals with different phenotypic profile among five HIV-infected elite controllers and five rapid progressors after recent HIV infection and one year later and from 10 individuals subjected to antiretroviral therapy, five of whom were immunological non-responders (INR), before and after one year of antiretroviral treatment compared to 175 samples from HIV-negative patients. A targeted quantitative tandem mass spectrometry metabolomics approach was used in order to determine plasma metabolomics biosignature that may relate to HIV infection, pace of HIV disease progression, and immunological response to treatment. Results Twenty-five unique metabolites were identified, including five metabolites that could distinguish rapid progressors and INRs at baseline. Severe deregulation in acylcarnitine and sphingomyelin metabolism compatible with mitochondrial deficiencies was observed. beta-oxidation and sphingosine-1-phosphate-phosphatase-1 activity were down-regulated, whereas acyl-alkyl-containing phosphatidylcholines and alkylglyceronephosphate synthase levels were elevated in INRs. Evidence that elite controllers harbor an inborn error of metabolism (late-onset multiple acyl-coenzyme A dehydrogenase deficiency [MADD]) was detected. Conclusions Blood-based markers from metabolomics show a very high accuracy of discriminating HIV infection between varieties of controls and have the ability to predict rapid disease progression or poor antiretroviral immunological response. These metabolites can be used as biomarkers of HIV natural evolution or treatment response and provide insight into the mechanisms of the disease.	[Scarpelini, Bruno; Zanoni, Michelle; Araripe Sucupira, Maria Cecilia; Ramos Janini, Luiz Mario; Cotrin Segurado, Ismael Dale; Sobhie Diaz, Ricardo] Univ Fed Sao Paulo, Dept Med, Sao Paulo, SP, Brazil; [Truong, Hong-Ha M.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Ramos Janini, Luiz Mario] Univ Fed Sao Paulo, Dept Microbiol, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); University of California System; University of California San Francisco; Universidade Federal de Sao Paulo (UNIFESP)	Diaz, RS (corresponding author), Univ Fed Sao Paulo, Dept Med, Sao Paulo, SP, Brazil.	rsdiaz@catg.com.br	; Araripe Sucupira, Maria Cecilia/K-1931-2012	Janini, Luiz Mario/0000-0002-6186-6284; Araripe Sucupira, Maria Cecilia/0000-0002-1114-5382	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Sao Paulo Research Foundation [04/15856-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported with funding from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Sao Paulo Research Foundation - (04/15856-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende ML, 2010, J EXP MED, V207, P1113, DOI 10.1084/jem.20092210; Sucupira MCA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030292; Bogdanov M, 2008, BRAIN, V131, P389, DOI 10.1093/brain/awm304; Brisch R, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00047; BROWN AS, 1993, J NEURAL TRANSM-GEN, V91, P75, DOI 10.1007/BF01245227; Brumme ZL, 2005, J INFECT DIS, V192, P466, DOI 10.1086/431519; Cassol E, 2014, AIDS, V28, P1579, DOI 10.1097/QAD.0000000000000303; Cassol E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-203; de Mendoza C, 2007, J ANTIMICROB CHEMOTH, V59, P698, DOI 10.1093/jac/dkm012; Garcia-Lorda P, 2000, JPEN-PARENTER ENTER, V24, P317, DOI 10.1177/0148607100024006317; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Goetz MB, 2009, JAIDS-J ACQ IMM DEF, V50, P259, DOI 10.1097/QAI.0b013e3181989a8b; Griffiths WJ, 2011, J INHERIT METAB DIS, V34, P583, DOI 10.1007/s10545-010-9274-4; Grunert SC, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0117-5; GRUNFELD C, 1992, AM J CLIN NUTR, V55, P455, DOI 10.1093/ajcn/55.2.455; Hersperger AR, 2011, BLOOD, V117, P3799, DOI 10.1182/blood-2010-12-322727; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Kilbey A, 2010, CANCER RES, V70, P5860, DOI 10.1158/0008-5472.CAN-10-0726; Koberlin MS, 2015, CELL, V162, P170, DOI 10.1016/j.cell.2015.05.051; Le Stunff H, 2007, J BIOL CHEM, V282, P34372, DOI 10.1074/jbc.M703329200; Mody A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102233; Munshi SU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064298; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609; Olson AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086719; Palsson-McDermott EM, 2013, BIOESSAYS, V35, P965, DOI 10.1002/bies.201300084; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pereira JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009277; Salas-Salvado J, 2001, CLIN NUTR, V20, P379, DOI 10.1054/clnu.2001.0429; Santiago RM, 2014, BEHAV BRAIN RES, V259, P70, DOI 10.1016/j.bbr.2013.10.035; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Sharpstone DR, 1996, AIDS, V10, P1377, DOI 10.1097/00002030-199610000-00010; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Torres RA, 2014, LAB INVEST, V94, P120, DOI 10.1038/labinvest.2013.142; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Vergis EN, 2000, INFECT DIS CLIN N AM, V14, P809, DOI 10.1016/S0891-5520(05)70135-5; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374	37	27	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0161920	10.1371/journal.pone.0161920	http://dx.doi.org/10.1371/journal.pone.0161920			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941971	Green Published, gold, Green Submitted			2022-12-27	WOS:000392745600002
J	Boehme, SA; Franz-Bacon, K; Ludka, J; DiTirro, DN; Ly, TW; Bacon, KB				Boehme, Stefen A.; Franz-Bacon, Karin; Ludka, John; DiTirro, Danielle N.; Ly, Tai Wei; Bacon, Kevin B.			MAP3K19 Is Overexpressed in COPD and Is a Central Mediator of Cigarette Smoke-Induced Pulmonary Inflammation and Lower Airway Destruction	PLOS ONE			English	Article							SMALL INTERFERING RNA; OXIDATIVE STRESS; EPITHELIAL-CELLS; DISEASE; NEUTROPHIL; MECHANISMS; EMPHYSEMA; EXACERBATIONS; EXPRESSION; PREVENTION	Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation and lung inflammation resulting in a progressive decline in lung function whose principle cause is cigarette smoke. MAP3K19 is a novel kinase expressed predominantly by alveolar and interstitial macrophages and bronchial epithelial cells in the lung. We found that MAP3K19 mRNA was overexpressed in a limited sampling of lung tissue from COPD patients, and a closer examination found it to be overexpressed in bronchoalveolar macrophages from COPD patients, as well as the bronchial epithelium and inflammatory cells in the lamina propria. We further found MAP3K19 to be induced in various cell lines upon environmental stress, such as cigarette smoke, oxidative and osmotic stress. Exogenous expression of MAP3K19 in cells caused an upregulation of transcriptionally active NF-kappa B, and secretion of the chemokines CXCL-8, CCL-20 and CCL-7. Inhibition of MAP3K19 activity by siRNA or small molecular weight inhibitors caused a decrease in cigarette smoke-induced inflammation in various murine models, which included a decrease in pulmonary neutrophilia and KC levels. In a chronic cigarette smoke model, inhibition of MAP3K19 significantly attenuated emphysematous changes in airway parenchyma. Finally, in a viral exacerbation model, mice exposed to cigarette smoke and influenza A virus showed a decrease in pulmonary neutrophilia, pro-inflammatory cytokines and viral load upon inhibition of MAP3K19. Collectively, these results suggest that inhibition of MAP3K19 may represent a novel strategy to target COPD that promises to have a potential therapeutic benefit for patients.	[Boehme, Stefen A.; Ludka, John; DiTirro, Danielle N.; Ly, Tai Wei; Bacon, Kevin B.] Axikin Pharmaceut Inc, San Diego, CA 92121 USA; [Franz-Bacon, Karin] DNA Consulting Inc, San Diego, CA USA; [Ludka, John] Calif Inst Biomed Res, La Jolla, CA USA; [DiTirro, Danielle N.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA	Brandeis University	Boehme, SA (corresponding author), Axikin Pharmaceut Inc, San Diego, CA 92121 USA.	sboehme@axikin.com			DNA Consulting, Inc.; Axikin Pharmaceuticals, Inc.; Genomics and Sequencing Core at the UC San Diego Center for AIDS Research [P30 AI036214]; VA San Diego Healthcare System; Veterans Medical Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214] Funding Source: NIH RePORTER	DNA Consulting, Inc.; Axikin Pharmaceuticals, Inc.; Genomics and Sequencing Core at the UC San Diego Center for AIDS Research; VA San Diego Healthcare System(US Department of Veterans Affairs); Veterans Medical Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors Stefen A. Boehme, John Ludka, Danielle DiTirro, Tai Wei Ly and Kevin B. Bacon are currently or previously employees of Axikin Pharmaceuticals, Inc. Karin Franz-Bacon is an employee of DNA Consulting, Inc. Axikin Pharmaceuticals, Inc., provided support in the form of salaries for all of the authors (SAB, KFB, JL, DDT, TWL, KBB), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.; We would like to acknowledge the original contributions to the cloning of MAP3K19 by Drs. S. Watanabe, S. Kondo and J. Encinas (WO 2005/001083 A1). We also thank Dr. Gerrard Manning at the Salk Institute (presently at Genentech Inc.), Jon Athanacio for technical expertise, Drs. Gary Anderson and Andrew Lilja at University of Melbourne, Karen Stebbins and Dr. Dan Lorrain for help with the smoking model, and Pinyi Du at the Genomics and Sequencing Core, UCSD for their outstanding contributions. We would also like to thank Drs. Ruth McLaughlin, Emma Moss and Karen Bingham at Biopta for access to COPD lung tissue, Dr. Claire Weston, Casey Laris and Jeff Hodson at Reveal Biosciences for their histology and imaging work and Dr. Clifton Drew for interpreting the clinical pathology. We would also like to thank Dr. Cesare Saltini (University of Rome and University of Florida) for his help in obtaining patient samples and many insightful discussions. This work was performed with the support of the Genomics and Sequencing Core at the UC San Diego Center for AIDS Research (P30 AI036214), the VA San Diego Healthcare System, and the Veterans Medical Research Foundation.	Angelis N, 2014, J THORAC DIS, V6, pS167, DOI 10.3978/j.issn.2072-1439.2014.03.07; Austin V, 2016, CLIN SCI, V130, P1039, DOI 10.1042/CS20160043; Awji EG, 2015, TOXICOL SCI, V147, P75, DOI 10.1093/toxsci/kfv108; Barnes PJ, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.76; Barnes PJ, 2014, CLIN CHEST MED, V35, P71, DOI 10.1016/j.ccm.2013.10.004; Barnes PJ, 2010, SCIENCE, V330, P40, DOI 10.1126/science.1196017; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Bernardo I, 2015, PHARMACOL THERAPEUT, V155, P60, DOI 10.1016/j.pharmthera.2015.08.005; Boehme SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154874; Brusselle GG, 2009, EUR RESPIR J, V34, P219, DOI 10.1183/09031936.00150208; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Darcan-Nicolaisen Y, 2009, J IMMUNOL, V182, P7501, DOI 10.4049/jimmunol.0713433; Delzell John E Jr, 2013, FP Essent, V409, P23; Demedts IK, 2007, AM J RESP CRIT CARE, V175, P998, DOI 10.1164/rccm.200608-1113OC; Denney L, 2015, IMMUNITY, V43, P945, DOI 10.1016/j.immuni.2015.10.012; Ellisen LW, 2010, NAT MED, V16, P754, DOI 10.1038/nm0710-754; Eurlings IMJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107757; Gao W, 2015, RESPIROLOGY, V20, P722, DOI 10.1111/resp.12542; Grootendorst DC, 2007, THORAX, V62, P1081, DOI 10.1136/thx.2006.075937; Gutbier B, 2010, PULM PHARMACOL THER, V23, P334, DOI 10.1016/j.pupt.2010.03.007; Heijink IH, 2015, AM J RESP CELL MOL, V52, P554, DOI 10.1165/rcmb.2013-0505OC; Hurst JR, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-40; Kirkham PA, 2013, CHEST, V144, P266, DOI 10.1378/chest.12-2664; Knudsen L, 2010, J APPL PHYSIOL, V108, P412, DOI 10.1152/japplphysiol.01100.2009; Konigshoff M, 2009, SWISS MED WKLY, V139, P554, DOI smw-12528; KUNKEL SL, 1991, EXP LUNG RES, V17, P17, DOI 10.3109/01902149109063278; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mackay AJ, 2013, IMMUNOL ALLERGY CLIN, V33, P95, DOI 10.1016/j.iac.2012.10.006; Masubuchi T, 1998, AM J PATHOL, V153, P1903, DOI 10.1016/S0002-9440(10)65704-5; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; MUKAIDA N, 1994, J LEUKOCYTE BIOL, V56, P554, DOI 10.1002/jlb.56.5.554; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Patel RR, 2008, DRUGS, V68, P1511, DOI 10.2165/00003495-200868110-00004; Podowski M, 2012, J CLIN INVEST, V122, P229, DOI 10.1172/JCI46215; Polverino F, 2016, AM J PHYSIOL-LUNG C, V311, pL687, DOI 10.1152/ajplung.00304.2016; Schmidt R, 2013, PLANT CELL, V25, P2115, DOI 10.1105/tpc.113.113068; Sethi S, 2012, AM J MED, V125, P1162, DOI 10.1016/j.amjmed.2012.06.024; Shaykhiev Renat, 2014, Ann Am Thorac Soc, V11 Suppl 5, pS252, DOI 10.1513/AnnalsATS.201402-049AW; Sohal SS, 2013, EXPERT REV RESP MED, V7, P275, DOI [10.1586/ERS.13.26, 10.1586/ers.13.26]; Stebbins KJ, 2010, J PHARMACOL EXP THER, V332, P764, DOI 10.1124/jpet.109.161919; Sundar IK, 2013, ANTIOXID REDOX SIGN, V18, P1956, DOI 10.1089/ars.2012.4863; Takizawa H, 2001, AM J RESP CRIT CARE, V163, P1476, DOI 10.1164/ajrccm.163.6.9908135; Tang K, 2004, J APPL PHYSIOL, V97, P15559; Tashkin DP, 2009, RESP MED, V103, P963, DOI 10.1016/j.rmed.2009.02.013; van der Vaart H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-22; Vareille M, 2011, CLIN MICROBIOL REV, V24, P210, DOI 10.1128/CMR.00014-10	48	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167169	10.1371/journal.pone.0167169	http://dx.doi.org/10.1371/journal.pone.0167169			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935962	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100068
J	Kim, CS; Bae, EH; Ma, SK; Kweon, SS; Kim, SW				Kim, Chang Seong; Bae, Eun Hui; Ma, Seong Kwon; Kweon, Sun-Seog; Kim, Soo Wan			Impact of Transient and Persistent Acute Kidney Injury on Chronic Kidney Disease Progression and Mortality after Gastric Surgery for Gastric Cancer	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; LONG-TERM OUTCOMES; RISK; RECOVERY; DEATH; ASSOCIATION; DYSFUNCTION	Acute kidney injury (AKI) is common after gastric surgery for gastric cancer and associated with adverse outcomes. However, the impact of transient or persistent AKI on clinical outcomes after gastric surgery for gastric cancer has not been described. We performed a retrospective study of 4,886 patients with normal renal function who underwent partial or total gastrectomy for gastric cancer between June 2002 and December 2012. AKI patients were classified as transient and persistent AKI based on the return of serum creatinine to the level indicating no AKI within 7 days. Our outcomes included occurrence of new-onset chronic kidney disease (CKD) and mortality 1 year after gastric surgery. AKI occurred in 638 (13.1%) after gastric surgery. Transient AKI was documented in 574 (90%). Use of diuretics and contrast agents was a common risk factor for persistent and transient AKI. Length of intensive care unit (ICU) and hospital stay, and ICU admission rate were higher in patients with transient AKI than in those without AKI. Although patients with persistent AKI had a higher new-onset CKD 1 year after gastric surgery after adjusting for multiple covariates, transient AKI was not associated with new-onset CKD. The 1-year mortality rates were significantly higher in patients with transient and persistent AKI. Not only persistent AKI but transient AKI is associated with increased risk of hospital complications and a significantly higher risk of long-term mortality than patients without AKI after gastric surgery. Moreover, persistent AKI, but not transient AKI, is associated with CKD progression at 1 year.	[Kim, Chang Seong; Bae, Eun Hui; Ma, Seong Kwon; Kim, Soo Wan] Chonnam Natl Univ, Sch Med, Dept Internal Med, Gwangju, South Korea; [Kweon, Sun-Seog] Chonnam Natl Univ, Sch Med, Dept Prevent Med, Gwangju, South Korea; [Kweon, Sun-Seog] Chonnam Natl Univ, Hwasun Hosp, Jeonnam Reg Canc Ctr, Hwasun Gun, South Korea	Chonnam National University; Chonnam National University; Chonnam National University	Kim, SW (corresponding author), Chonnam Natl Univ, Sch Med, Dept Internal Med, Gwangju, South Korea.	skimw@chonnam.ac.kr	Kweon, Sun-Seog/AAZ-4732-2021	Kweon, Sun-Seog/0000-0003-2378-8550	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2015R1C1A1A01051769]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [2016R1A2B4007870]; Pioneer Research Center Program through the National Research Foundation of Korea - Ministry of Science, ICT Future Planning [2014M3C1A3053036]; grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C2084]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning; Pioneer Research Center Program through the National Research Foundation of Korea - Ministry of Science, ICT Future Planning; grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2015R1C1A1A01051769), by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (2016R1A2B4007870), by the Pioneer Research Center Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT &Future Planning (2014M3C1A3053036), and by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C2084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bihorac A, 2013, CRIT CARE MED, V41, P2570, DOI 10.1097/CCM.0b013e31829860fc; Bihorac A, 2009, ANN SURG, V249, P851, DOI 10.1097/SLA.0b013e3181a40a0b; Bucaloiu ID, 2012, KIDNEY INT, V81, P477, DOI 10.1038/ki.2011.405; Chalikias G, 2016, CARDIOVASC DRUG THER, V30, P515, DOI 10.1007/s10557-016-6683-0; Choi JS, 2013, AM J CARDIOL, V112, P41, DOI 10.1016/j.amjcard.2013.02.051; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Fidalgo P, 2014, J CRIT CARE, V29, P1028, DOI 10.1016/j.jcrc.2014.07.024; Field A, 2009, DISCOVERING STAT USI, P372; Heung M, 2015, AM J KIDNEY DIS; Heung M, 2012, CURR OPIN NEPHROL HY, V21, P628, DOI 10.1097/MNH.0b013e3283588f24; Jones J, 2012, AM J KIDNEY DIS, V60, P402, DOI 10.1053/j.ajkd.2012.03.014; Kellum JA, 2013, CRIT CARE, V17, DOI 10.1186/cc11454; Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group, 2012, KIDNEY INT S, V2, P19, DOI DOI 10.1038/KISUP.2011.32; Kim CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082289; Lee EH, 2012, INTENS CARE MED, V38, P1478, DOI 10.1007/s00134-012-2599-8; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Loef BG, 2005, J AM SOC NEPHROL, V16, P195, DOI 10.1681/ASN.2003100875; Mosier MJ, 2010, J BURN CARE RES, V31, P83, DOI 10.1097/BCR.0b013e3181cb8c87; Spurgeon-Pechman KR, 2007, AM J PHYSIOL-RENAL, V293, pF269, DOI 10.1152/ajprenal.00279.2006; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Uchino S, 2010, NEPHROL DIAL TRANSPL, V25, P1833, DOI 10.1093/ndt/gfp624; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; Wehbe E, 2013, CLIN J AM SOC NEPHRO, V8, P19, DOI 10.2215/CJN.04800512; Wi J, 2011, HEART, V97, P1753, DOI 10.1136/hrt.2010.218677; Zager RA, 2011, AM J PHYSIOL-RENAL, V301, pF1334, DOI 10.1152/ajprenal.00431.2011	25	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168119	10.1371/journal.pone.0168119	http://dx.doi.org/10.1371/journal.pone.0168119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936153	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100273
J	Kingsley, J; Karanth, S; Revere, FL; Agrawal, D				Kingsley, James; Karanth, Siddharth; Revere, Frances Lee; Agrawal, Deepak			Cost Effectiveness of Screening Colonoscopy Depends on Adequate Bowel Preparation Rates - A Modeling Study	PLOS ONE			English	Article							SOCIETY TASK-FORCE; COLORECTAL-CANCER; DECISION-ANALYSIS; PATIENT FACTORS; IMPACT; SURVEILLANCE; QUALITY; RECOMMENDATIONS; POLYPECTOMY; POPULATION	Background Inadequate bowel preparation during screening colonoscopy necessitates repeating colonoscopy. Studies suggest inadequate bowel preparation rates of 20-60%. This increases the cost of colonoscopy for our society. Aim The aim of this study is to determine the impact of inadequate bowel preparation rate on the cost effectiveness of colonoscopy compared to other screening strategies for colorectal cancer (CRC). Methods A microsimulation model of CRC screening strategies for the general population at average risk for CRC. The strategies include fecal immunochemistry test (FIT) every year, colonoscopy every ten years, sigmoidoscopy every five years, or stool DNA test every 3 years. The screening could be performed at private practice offices, outpatient hospitals, and ambulatory surgical centers. Results At the current assumed inadequate bowel preparation rate of 25%, the cost of colonoscopy as a screening strategy is above society's willingness to pay (<$50,000/QALY). Threshold analysis demonstrated that an inadequate bowel preparation rate of 13% or less is necessary before colonoscopy is considered more cost effective than FIT. At inadequate bowel preparation rates of 25%, colonoscopy is still more cost effective compared to sigmoidoscopy and stool DNA test. Sensitivity analysis of all inputs adjusted by +/- 10% showed incremental cost effectiveness ratio values were influenced most by the specificity, adherence, and sensitivity of FIT and colonoscopy. Conclusions Screening colonoscopy is not a cost effective strategy when compared with fecal immunochemical test, as long as the inadequate bowel preparation rate is greater than 13%.	[Kingsley, James] Texas Hlth Presbyterian Hosp, Dept Internal Med, Dallas, TX USA; [Karanth, Siddharth; Revere, Frances Lee] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX 77030 USA; [Agrawal, Deepak] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Southwestern Medical Center Dallas	Agrawal, D (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	Deepak.Agrawal@UTSouthwestern.edu	Karanth, Siddharth/K-6758-2019; Revere, Frances/AAE-8132-2022; Agrawal, Deepak/L-6592-2019	Karanth, Siddharth/0000-0002-4923-2692; Agrawal, Deepak/0000-0001-7224-6921				American Cancer Society, 2011, COL CANC FACTS FIG 2; Tran AH, 2014, JAMA INTERN MED, V174, P1675, DOI 10.1001/jamainternmed.2014.3746; [Anonymous], 2014, MED LETT DRUGS THER, V56, P100; Ben-Horin S, 2007, AM J GASTROENTEROL, V102, P2680, DOI 10.1111/j.1572-0241.2007.01486.x; Borg BB, 2009, CLIN GASTROENTEROL H, V7, P670, DOI 10.1016/j.cgh.2009.02.014; Bourikas LA, 2013, WORLD J GASTRO ENDOS, V5, P468, DOI 10.4253/wjge.v5.i10.468; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Chan WK, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-86; Chiu HM, 2006, AM J GASTROENTEROL, V101, P2719, DOI 10.1111/j.1572-0241.2006.00868.x; Chung YW, 2009, J CLIN GASTROENTEROL, V43, P448, DOI 10.1097/MCG.0b013e3181662442; de Leone A, 2013, WORLD J GASTRO ENDOS, V5, P433, DOI 10.4253/wjge.v5.i9.433; Djalalov S, 2014, MED DECIS MAKING, V34, P809, DOI 10.1177/0272989X14536779; Edejer T, 2003, MAKING CHOICES HLTH; Fatima H, 2010, GASTROINTEST ENDOSC, V71, P1244, DOI 10.1016/j.gie.2009.11.053; Frazier AL, 2000, JAMA-J AM MED ASSOC, V284, P1954, DOI 10.1001/jama.284.15.1954; Froehlich F, 2005, GASTROINTEST ENDOSC, V61, P378, DOI 10.1016/S0016-5107(04)02776-2; Ginsberg Gary M, 2010, Cost Eff Resour Alloc, V8, P2, DOI 10.1186/1478-7547-8-2; Goodwin JS, 2011, ARCH INTERN MED, V171, P1335, DOI 10.1001/archinternmed.2011.212; Harewood GC, 2003, GASTROINTEST ENDOSC, V58, P76, DOI 10.1067/mge.2003.294; Hassan C, 2012, CLIN GASTROENTEROL H, V10, P501, DOI 10.1016/j.cgh.2011.12.037; Hendry PO, 2007, COLORECTAL DIS, V9, P745, DOI 10.1111/j.1463-1318.2007.01220.x; Henry SG, 2007, J GEN INTERN MED, V22, P1415, DOI 10.1007/s11606-007-0281-6; Howard K, 2005, J MED SCREEN, V12, P96, DOI 10.1258/0969141053908276; Johnson DA, 2014, AM J GASTROENTEROL; Khandker RK, 2000, INT J TECHNOL ASSESS, V16, P799, DOI 10.1017/S0266462300102077; Klabunde CN, 2013, MMWR-MORBID MORTAL W, V62, P881; Kruse GR, 2015, J GEN INTERN MED, V30, P277, DOI 10.1007/s11606-014-3015-6; Ladabaum U, 2006, AM J PREV MED, V30, P378, DOI 10.1016/j.amepre.2005.12.010; Ladabaum U, 2014, AM J GASTROENTEROL; Ladabaum U, 2004, ANN M AM GASTR ASS; Larsen Michael, 2011, Am J Gastroenterol, V106, P2058, DOI 10.1038/ajg.2011.238; Lebwohl B, 2011, GASTROINTEST ENDOSC, V73, P1207, DOI 10.1016/j.gie.2011.01.051; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Liang PS, 2014, AM J GASTROENTEROL, V109, P1725, DOI 10.1038/ajg.2014.328; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Loeve F, 2000, J NATL CANCER I, V92, P557, DOI 10.1093/jnci/92.7.557; Maciosek MV, 2006, AM J PREV MED, V31, P80, DOI 10.1016/j.amepre.2006.03.009; Manno M, 2012, DIGEST LIVER DIS, V44, P576, DOI 10.1016/j.dld.2012.02.012; Matro R, 2010, AM J GASTROENTEROL, V105, P1954, DOI 10.1038/ajg.2010.160; Menees SB, 2014, AM J GASTROENTEROL, V109, P148, DOI 10.1038/ajg.2013.243; Ness RM, 2001, AM J GASTROENTEROL, V96, P1797, DOI 10.1016/S0002-9270(01)02437-6; Ness RM, 2000, AM J GASTROENTEROL, V95, P1800; Pignone M, 2005, EC MODELS COLORECTAL; Pyenson B, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-92; Rabeneck L, 2008, GASTROENTEROLOGY, V135, P1899, DOI 10.1053/j.gastro.2008.08.058; Rex DK, 2002, AM J GASTROENTEROL, V97, P1696; Rex DK, 2014, CLIN GASTROENTEROL H, V12, P458, DOI 10.1016/j.cgh.2013.11.003; Ries L, 1997, NIH PUBL, V278; Serper M, 2014, CLIN GASTROENTEROL H, V12, P451, DOI 10.1016/j.cgh.2013.07.036; Sharaf RN, 2013, AM J GASTROENTEROL, V108, P120, DOI 10.1038/ajg.2012.380; Sheffield KM, 2013, JAMA INTERN MED, V173, P542, DOI 10.1001/jamainternmed.2013.2912; Siebert U, 2012, VALUE HEALTH, V15, P812, DOI 10.1016/j.jval.2012.06.014; Simon S., ORG COMMIT GOAL 80 C; Song K, 2004, GASTROENTEROLOGY, V126, P1270, DOI 10.1053/j.gastro.2004.02.016; Surveillance Epidemiology and End Results (SEER) Program, SEER STAT DAT INC SE; Vijan S, 2001, AM J MED, V111, P593, DOI 10.1016/S0002-9343(01)00977-9; Wang HS, 2013, GASTROINTEST ENDOSC, V77, P71, DOI 10.1016/j.gie.2012.08.038; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Wong MCS, 2014, AM J GASTROENTEROL, V109, P1072, DOI 10.1038/ajg.2014.136; Zauber AG, 2007, COST EFFECTIVENESS D; ZAUBER AG, COST EFFECTIVENESS D; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244	62	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167452	10.1371/journal.pone.0167452	http://dx.doi.org/10.1371/journal.pone.0167452			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936028	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100099
J	Lindberg, MR; Schmedes, SE; Hewitt, FC; Haas, JL; Ternus, KL; Kadavy, DR; Budowle, B				Lindberg, Michael R.; Schmedes, Sarah E.; Hewitt, F. Curtis; Haas, Jamie L.; Ternus, Krista L.; Kadavy, Dana R.; Budowle, Bruce			A Comparison and Integration of MiSeq and MinION Platforms for Sequencing Single Source and Mixed Mitochondrial Genomes	PLOS ONE			English	Article							SPECIES IDENTIFICATION; ION TORRENT; BACTERIAL; AMPLIFICATION; MIXTURES; QUALITY; GENE	Single source and multiple donor (mixed) samples of human mitochondrial DNA were analyzed and compared using the MinION and the MiSeq platforms. A generalized variant detection strategy was employed to provide a cursory framework for evaluating the reliability and accuracy of mitochondrial sequences produced by the MinION. The feasibility of long-read phasing was investigated to establish its efficacy in quantitatively distinguishing and deconvolving individuals in a mixture. Finally, a proof-of-concept was demonstrated by integrating both platforms in a hybrid assembly that leverages solely mixture data to accurately reconstruct full mitochondrial genomes.	[Lindberg, Michael R.; Hewitt, F. Curtis; Haas, Jamie L.; Ternus, Krista L.; Kadavy, Dana R.] Signature Sci LLC, Austin, TX USA; [Schmedes, Sarah E.; Budowle, Bruce] Univ North Texas, Hlth Sci Ctr, Dept Mol & Med Genet, Inst Appl Genet, Ft Worth, TX USA; [Budowle, Bruce] King Abdulaziz Univ, CEGMR, Jeddah, Saudi Arabia	University of North Texas System; University of North Texas Denton; King Abdulaziz University	Budowle, B (corresponding author), Univ North Texas, Hlth Sci Ctr, Dept Mol & Med Genet, Inst Appl Genet, Ft Worth, TX USA.; Budowle, B (corresponding author), King Abdulaziz Univ, CEGMR, Jeddah, Saudi Arabia.	Bruce.Budowle@unthsc.edu	Ternus, Krista/AAY-1058-2020	Ternus, Krista/0000-0003-1138-5308; Budowle, Bruce/0000-0003-4116-2930; Lindberg, Michael/0000-0002-7393-8214	Signature Science	Signature Science	We note that the funder (Signature Science) provided support in the form of salaries for authors [ML, JH, CH, KT, and DK)], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adcock GJ, 2001, P NATL ACAD SCI USA, V98, P537, DOI 10.1073/pnas.98.2.537; Ali ME, 2012, MEAT SCI, V91, P454, DOI 10.1016/j.meatsci.2012.02.031; An J, 2007, FORENSIC SCI INT, V167, P59, DOI 10.1016/j.forsciint.2005.12.031; Andreasson H, 2006, INT J LEGAL MED, V120, P383, DOI 10.1007/s00414-005-0072-8; Ashton PM, 2015, NAT BIOTECHNOL, V33, P296, DOI 10.1038/nbt.3103; Bandelt HJ, 2001, INT J LEGAL MED, V115, P64, DOI 10.1007/s004140100228; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604; BOLES TC, 1995, J FORENSIC SCI, V40, P349; Bright JA, 2011, FORENSIC SCI INT-GEN, V5, P381, DOI 10.1016/j.fsigen.2010.08.006; Budowle B, 2009, J FORENSIC SCI, V54, P810, DOI 10.1111/j.1556-4029.2009.01046.x; Castro-Wallace SL, NANOPORE DNA SEQUENC, DOI [10.1101/077651, DOI 10.1101/077651]; Cho AR, 2014, KOREAN J FOOD SCI AN, V34, P799, DOI 10.5851/kosfa.2014.34.6.799; Dalton DL, 2011, FORENSIC SCI INT, V207, pE51, DOI 10.1016/j.forsciint.2010.12.017; Garrison E., 2012, ARXIV PREP ARXIV, V1207, P3907, DOI [10.48550/arXiv.1207.3907, DOI 10.48550/ARXIV.1207.3907]; Gill P, 2012, FORENSIC SCI INT-GEN, V6, P679, DOI 10.1016/j.fsigen.2012.06.002; GILL P, 1994, NAT GENET, V6, P130, DOI 10.1038/ng0294-130; Goodwin S, 2015, GENOME RES, V25, P1750, DOI 10.1101/gr.191395.115; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Gunnarsdottir ED, 2011, GENOME RES, V21, P1, DOI 10.1101/gr.107615.110; Holland M M, 1999, Forensic Sci Rev, V11, P21; Holland MM, 2003, CROAT MED J, V44, P264; Istace B, 2016, BIORXIV, DOI [10.1101/066613, DOI 10.1101/066613]; Jain M, 2015, NAT METHODS, V12, P351, DOI [10.1038/NMETH.3290, 10.1038/nmeth.3290]; Kesmen Z, 2009, MEAT SCI, V82, P444, DOI 10.1016/j.meatsci.2009.02.019; Kilianski A, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0051-z; King JL, 2014, FORENSIC SCI INT-GEN, V12, P128, DOI 10.1016/j.fsigen.2014.06.001; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Laver T, 2015, Biomol Detect Quantif, V3, P1; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lindenbaum P., 2015, PREPRINT; Loman NJ, 2014, BIOINFORMATICS, V30, P3399, DOI 10.1093/bioinformatics/btu555; Mikkelsen M, 2014, FORENSIC SCI INT-GEN, V12, P30, DOI 10.1016/j.fsigen.2014.03.014; Montesino M, 2007, FORENSIC SCI INT, V168, P42, DOI 10.1016/j.forsciint.2006.06.066; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Palo JU, 2007, CROAT MED J, V48, P528; Parson W, 2013, FORENSIC SCI INT-GEN, V7, P543, DOI 10.1016/j.fsigen.2013.06.003; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Quick J, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-22; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Roberts RJ, 2013, GENOME BIOL, V14, DOI [10.1186/gb-2013-14-7-405, 10.1186/gb-2013-14-6-405]; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Seneca S, 2015, EUR J HUM GENET, V23, P41, DOI 10.1038/ejhg.2014.49; Seo SB, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S1-S4; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; STONEKING M, 1991, AM J HUM GENET, V48, P370; Tan A, 2015, BIOINFORMATICS, V31, P2202, DOI 10.1093/bioinformatics/btv112; Tan AS, 2015, CELL METAB, V21, P81, DOI 10.1016/j.cmet.2014.12.003; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220; WILSON MR, 1995, INT J LEGAL MED, V108, P68, DOI 10.1007/BF01369907; Wong LJC, 2013, MITOCHONDRION, V13, P379, DOI 10.1016/j.mito.2013.02.001; Zimmermann B, 2014, CROAT MED J, V55, P115, DOI 10.3325/cmj.2014.55.115	57	21	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167600	10.1371/journal.pone.0167600	http://dx.doi.org/10.1371/journal.pone.0167600			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936026	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100128
J	Tan, GL; Huang, Y; Sheng, HH				Tan, Guolong; Huang, Yao; Sheng, Haohao			Magnetoelectric Response in Multiferroic SrFe12O19 Ceramics	PLOS ONE			English	Article							NEGATIVE CAPACITANCE; OXIDE	We report here realization of ferroelectricity, ferromagnetism and magnetocapacitance effect in singleSrFe(12)O(19)ceramic at room temperature. The ceramics demonstrate a saturated polarization hysteresis loop, two nonlinear I-V peaks and large anomaly of dielectric constant near Curie temperature, which confirm the intrinsic ferroelectricity of SrFe12O19 ceramicswith subsequent heat-treatment in O(2)atmosphere. The remnant polarization of the SrFe12O19 ceramic is estimated to be 103 mu C/cm(2). The ceramic also exhibits strong ferromagnetic characterization, the coercive field and remnant magnetic moment are 6192Oe and 35.8emu/g, respectively. Subsequent annealing SrFe12O19 ceramics in O-2 plays a key role on revealing its intrinsic ferroelectricity and improving the ferromagnetism through transforming Fe2+ into Fe3+. By applying a magnetic field, the capacitance demonstrates remarkable change along with B field, the maximum rate of change in epsilon(Delta epsilon(B)/epsilon(0)) is 1174%, which reflects a giant magnetocapacitance effect in SrFe12O19. XPS and molecular magnetic moment measurements confirmed the transformation of Fe2+ into Fe3+ and removal of oxygen vacancies upon O-2 heat treatment. These combined functional responses in SrFe12O19 ceramics opens substantial possibilities for applications in novel electric devices.	[Tan, Guolong; Huang, Yao; Sheng, Haohao] Wuhan Univ Technol, State Key Lab Adv Technol Mat Synth & Proc, Wuhan, Peoples R China	Wuhan University of Technology	Tan, GL (corresponding author), Wuhan Univ Technol, State Key Lab Adv Technol Mat Synth & Proc, Wuhan, Peoples R China.	gltan@whut.edu.cn	Tan, Guolong/A-1098-2013	Tan, Guolong/0000-0003-0961-5506	Hubei Natural Science Foundation [2014CFB166]; Open fund of State Key Laboratory of Advanced Technology for Materials Synthesis and Processing (Wuhan University of Technology) [2016-KF-15]	Hubei Natural Science Foundation(Natural Science Foundation of Hubei Province); Open fund of State Key Laboratory of Advanced Technology for Materials Synthesis and Processing (Wuhan University of Technology)	This work was supported by the Hubei Natural Science Foundation (under the contract no. 2014CFB166) and the Open fund of State Key Laboratory of Advanced Technology for Materials Synthesis and Processing (Wuhan University of Technology) under the contract no. 2016-KF-15. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bratkovsky AM, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.132103; CARVER JC, 1972, J CHEM PHYS, V57, P973, DOI 10.1063/1.1678348; Catalan G, 2015, NAT MATER, V14, P137, DOI 10.1038/nmat4195; Cheong SW, 2007, NAT MATER, V6, P13, DOI 10.1038/nmat1804; Chun S. H., 2010, PHY REV LETT, V304; Eerenstein W, 2007, NAT MATER, V6, P348, DOI 10.1038/nmat1886; Eerenstein W, 2006, NATURE, V442, P759, DOI 10.1038/nature05023; Ershov M, 1998, IEEE T ELECTRON DEV, V45, P2196, DOI 10.1109/16.725254; Goto T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.257201; Grechnev G.E., 2015, 151000513V1 ARXIV CO; Hill NA, 2002, ANNU REV MATER RES, V32, P1, DOI 10.1146/annurev.matsci.32.101901.152309; Hur N, 2004, NATURE, V429, P392, DOI 10.1038/nature02572; Ishiwata S, 2008, SCIENCE, V319, P1643, DOI 10.1126/science.1154507; Katsura H, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.057205; Kenzelmann M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.087206; Khan AI, 2015, NAT MATER, V14, P182, DOI [10.1038/nmat4148, 10.1038/NMAT4148]; Khomskii D, 2009, PHYSICS, V2, P20, DOI 10.1103/Physics.2.20; Kimura T, 2008, NAT MATER, V7, P291, DOI 10.1038/nmat2125; Kimura T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.137201; Kimura T, 2003, NATURE, V426, P55, DOI 10.1038/nature02018; Kimura T, 2012, ANNU REV CONDEN MA P, V3, P93, DOI 10.1146/annurev-conmatphys-020911-125101; Lee JH, 2010, NATURE, V466, P954, DOI 10.1038/nature09331; Levin I, 2006, ADV MATER, V18, P2044, DOI 10.1002/adma.200600288; Lobo RPSM, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.172105; Lottermoser T, 2004, NATURE, V430, P541, DOI 10.1038/nature02728; Mazumdar D, 2016, J ELECTRON SPECTROSC, V208, P63, DOI 10.1016/j.elspec.2015.10.002; MOMOZAWA N, 1993, J PHYS SOC JPN, V62, P1292, DOI 10.1143/JPSJ.62.1292; Pokharel BP, 2000, J APPL PHYS, V88, P5364, DOI 10.1063/1.1317241; RADO GT, 1964, PHYS REV LETT, V13, P335, DOI 10.1103/PhysRevLett.13.335; Reiner JW, 2009, SCIENCE, V323, P1018, DOI 10.1126/science.1169058; Rowley S. E., SCI REP; Scott JF, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/02/021001; Shen S. P., NATURE COMM; Shen SP, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.180404; Singh A. K., 2009, APPL PHYS, V106; Stucki N., 2008, THESIS U GEN SWITZ, P48; Sugimoto M, 1999, J AM CERAM SOC, V82, P269, DOI 10.1111/j.1551-2916.1999.tb20058.x; Tan GL, 2016, ACTA MATER, V121, P144, DOI 10.1016/j.actamat.2016.08.083; Tan GL, 2015, J AM CERAM SOC, V98, P1812, DOI 10.1111/jace.13530; Tan GL, 2011, J ELECTROCERAM, V26, P170, DOI 10.1007/s10832-011-9641-z; Tan GL, 2013, J ELECTRON MATER, V42, P906, DOI 10.1007/s11664-012-2426-6; Tan GL, 2013, J MAGN MAGN MATER, V327, P87, DOI 10.1016/j.jmmm.2012.09.047; Tokunaga Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.257201; Tokura Y, 2006, SCIENCE, V312, P1481, DOI 10.1126/science.1125227; Vaz CAF, 2010, ADV MATER, V22, P2900, DOI 10.1002/adma.200904326; Wang J, 2003, SCIENCE, V299, P1719, DOI 10.1126/science.1080615; Wang JH, 2007, PROCEEDINGS OF THE 3RD INTERNATIONAL YELLOW RIVER FORUM ON SUSTAINABLE WATER RESOURCES MANAGEMENT AND DELTA ECOSYSTEM MAINTENANCE, VOL I, P259; Yamasaki Y, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.207204; Yang N, 2007, J ALLOY COMPD, V438, P263, DOI 10.1016/j.jallcom.2006.08.037; Zheng RY, 2008, J APPL PHYS, V104, DOI 10.1063/1.2966696	50	14	14	7	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167084	10.1371/journal.pone.0167084	http://dx.doi.org/10.1371/journal.pone.0167084			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935996	Green Submitted, gold, Green Published			2022-12-27	WOS:000389587100059
J	Wang, X; Wei, YZ; Xue, YW; Lu, PO; Yu, LJ; Shen, BZ				Wang, Xin; Wei, Yuzhe; Xue, Yingwei; Lu, Peiou; Yu, Lijuan; Shen, Baozhong			Predictive Role of the Number of F-18-FDG-Positive Lymph Nodes Detected by PET/CT for Pre-Treatment Evaluation of Locally Advanced Gastric Cancer	PLOS ONE			English	Article							METABOLIC TUMOR VOLUME; POSITRON-EMISSION-TOMOGRAPHY; TOTAL LESION GLYCOLYSIS; PROGNOSTIC VALUE; F-18-FDG PET/CT; FOLLOW-UP; CARCINOMA; CT; SURVIVAL; GLUCOSE-TRANSPORTER-1	Objectives The aim of this study was to investigate the predictive value of the numbers of metabolically positive lymph nodes (MPLN) detected by F-18-fluorodeoxyglucose (F-18-FDG) positron emission tomography (PET)/computed tomography (CT) in patients with locally advanced gastric cancer (LAGC). Methods We retrospectively analyzed the records of 50 patients with LAGC (stage T2-T4) who had undergone pre-operative PET/CT examination and laparotomy (total gastrectomy, n = 11; subtotal gastrectomy, n = 13; distal gastrectomy, n = 22; and bypass with gastrojejunstomy, n = 4). The numbers of MPLN were determined by combining visual observations with semiquantitative measurements of the maximized standardized uptake value (SUVmax). Performance was investigated in terms of predicting post-surgical overall survival (OS). Results The median post-surgical OS was 32.57 months (range 3.0-94 months). The numbers of MPLN were moderately correlated with the numbers of histological positive LN (r = 0.694, p = 0.001). In univariate analyses, the numbers of MPLN (<= 2 vs. >= 3), PET/CT LN (positivity vs. negativity), SUVmax of LN (< 2.8 vs. >= 2.8), TNM stage (I, II vs. III, IV), and surgery type (R0 vs. non-R0) were significantly associated with OS. In multivariate analysis, surgery type (R0 vs. non-R0) and numbers of MPLN (<= 2 vs. >= 3) were both independent factors for poor OS. Conclusions This explored study indicates that the number of MPLN could provide additional information for LAGC prognosis. Patients with MPLNs >= 3 may be at the risk of the more bad outcomes, and the further clinical trials are needed.	[Wang, Xin; Lu, Peiou; Yu, Lijuan] Harbin Med Univ, Canc Hosp, PET CT MRI Ctr, Harbin, Heilongjiang Pr, Peoples R China; [Wei, Yuzhe; Xue, Yingwei] Harbin Med Univ, Canc Hosp, Dept Surg Gastroenterol, Harbin, Heilongjiang Pr, Peoples R China; [Shen, Baozhong] Harbin Med Univ, Hosp 4, Dept Radiol, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Wang, X (corresponding author), Harbin Med Univ, Canc Hosp, PET CT MRI Ctr, Harbin, Heilongjiang Pr, Peoples R China.	xinwang826@vip.163.com		Wang, Xin/0000-0002-3499-8871	Heilongjiang Province Natural Science Foundation of China [H201448]	Heilongjiang Province Natural Science Foundation of China(Natural Science Foundation of Heilongjiang Province)	This work was supported by the Heilongjiang Province Natural Science Foundation of China (No. H201448).	Ajani JA, 2013, J NATL COMPR CANC NE, V11, P531, DOI 10.6004/jnccn.2013.0070; Alakus H, 2010, NUCL MED COMMUN, V31, P532, DOI 10.1097/MNM.0b013e32833823ac; Chen WQ, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0042-6; Chung HW, 2010, J CANCER RES CLIN, V136, P1929, DOI 10.1007/s00432-010-0852-5; Coupe NA, 2014, ANN NUCL MED, V28, P128, DOI 10.1007/s12149-013-0791-8; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Ha TK, 2011, J KOREAN SURG SOC, V81, P104, DOI 10.4174/jkss.2011.81.2.104; Huang W, 2014, J NUCL MED, V55, P1584, DOI 10.2967/jnumed.114.142919; Hur H, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-86; Jensen EH, 2007, SURG ONCOL CLIN N AM, V16, P329, DOI 10.1016/j.soc.2007.03.003; Karpeh MS, 2000, ANN SURG, V232, P362, DOI 10.1097/00000658-200009000-00008; Kawamura T, 2001, CANCER-AM CANCER SOC, V92, P634, DOI 10.1002/1097-0142(20010801)92:3<634::AID-CNCR1364>3.0.CO;2-X; Kim EY, 2011, EUR J RADIOL, V79, P183, DOI 10.1016/j.ejrad.2010.02.005; Kim J, 2014, NUCL MED MOLEC IMAG, V48, P33, DOI 10.1007/s13139-013-0243-3; Kim SK, 2006, EUR J NUCL MED MOL I, V33, P148, DOI 10.1007/s00259-005-1887-8; Kwee RM, 2009, GASTRIC CANCER, V12, P6, DOI 10.1007/s10120-008-0492-5; Lee JW, 2014, J NUCL MED, V55, P898, DOI 10.2967/jnumed.113.131847; Lowy AM, 1999, ANN SURG, V229, P303, DOI 10.1097/00000658-199903000-00001; Ott Katja, 2003, Gastric Cancer, V6, P159, DOI 10.1007/s10120-003-0245-4; Ozkan E, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-75; Pak K, 2014, J NUCL MED, V55, P884, DOI 10.2967/jnumed.113.133801; Park JC, 2012, EUR J NUCL MED MOL I, V39, P1107, DOI 10.1007/s00259-012-2116-x; Roder JD, 1998, CANCER-AM CANCER SOC, V82, P621, DOI 10.1002/(SICI)1097-0142(19980215)82:4<621::AID-CNCR2>3.3.CO;2-2; Rosenbaum SJ, 2006, ABDOM IMAGING, V31, P25, DOI 10.1007/s00261-005-0031-3; Sarela AI, 2006, ANN SURG, V243, P189, DOI 10.1097/01.sla.0000197382.43208.a5; Smyth E, 2012, CANCER-AM CANCER SOC, V118, P5481, DOI 10.1002/cncr.27550; Song BI, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001037; Stahl A, 2003, EUR J NUCL MED MOL I, V30, P288, DOI 10.1007/s00259-002-1029-5; von Schulthess GK, 2006, RADIOLOGY, V238, P405, DOI 10.1148/radiol.2382041977; Yamada A, 2006, ANN NUCL MED, V20, P597, DOI 10.1007/BF02984657; Yang QM, 2008, HEPATO-GASTROENTEROL, V55, P782; Youn SH, 2012, J GASTRIC CANCER, V12, P179, DOI 10.5230/jgc.2012.12.3.179; Yun MJ, 2005, J NUCL MED, V46, P1582; Zhang XF, 2004, WORLD J GASTROENTERO, V10, P3405	34	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166836	10.1371/journal.pone.0166836	http://dx.doi.org/10.1371/journal.pone.0166836			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936109	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100045
J	Wilms, E; Gerritsen, J; Smidt, H; Besseling-van der Vaart, I; Rijkers, GT; Fuentes, ARG; Masclee, AAM; Troost, FJ				Wilms, E.; Gerritsen, J.; Smidt, H.; Besseling-van der Vaart, I.; Rijkers, G. T.; Fuentes, A. R. Garcia; Masclee, A. A. M.; Troost, F. J.			Effects of Supplementation of the Synbiotic Ecologic (R) 825/FOS P6 on Intestinal Barrier Function in Healthy Humans: A Randomized Controlled Trial	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CONTROLLED CROSSOVER TRIAL; PLACEBO-CONTROLLED TRIAL; BLOOD MONONUCLEAR-CELLS; TIGHT JUNCTION PROTEINS; GUT PERMEABILITY; EPITHELIAL-CELLS; CELIAC-DISEASE; IN-VIVO; GASTROINTESTINAL PERMEABILITY	Background and Aims Probiotics, prebiotics and synbiotics have been suggested as dietary strategies to improve intestinal barrier function. This study aimed to assess the effect of two weeks synbiotic supplementation on intestinal permeability under basal and stressed conditions. Secondary aims were the assessment of two weeks synbiotic supplementation on systemic immune function and gastrointestinal symptoms including defecation pattern. Design Twenty healthy adults completed a double-blind, controlled, randomized, parallel design study. Intervention Groups either received synbiotic (1.5 x 10(10) CFU Ecologic (R) 825 + 10 g fructo-oligosaccharides (FOSP6) per day) or control supplements for two weeks. Outcomes Intestinal segment specific permeability was assessed non-invasively by oral administration of multiple sugar probes and, subsequently, assessing the excretion of these probes in urine. This test was conducted at baseline and at the end of intervention, in the absence and in the presence of an indomethacin challenge. Indomethacin was applied to induce a compromised gut state. Plasma zonulin, cytokines and chemokines were measured at baseline and at the end of intervention. Gastrointestinal symptoms and stool frequency were recorded at baseline and daily during intervention. Results Significantly more male subjects were in the synbiotic group compared to the control group (P = 0.025). Indomethacin significantly increased urinary lactulose/rhamnose ratio versus without indomethacin, both in the control group (P = 0.005) and in the synbiotic group (P = 0.017). Urinary sugar recoveries and ratios, plasma levels of zonulin, cytokines and chemokines, and gastrointestinal symptom scores were not significantly different after control or synbiotic intervention. Stool frequency within the synbiotic group was significantly increased during synbiotic intervention compared to baseline (P = 0.039) and higher compared to control intervention (P = 0.045). Conclusion Two weeks Ecologic (R) 825/FOS P6 supplementation increased stool frequency, but did not affect intestinal permeability neither under basal nor under indomethacin-induced stressed conditions, immune function or gastrointestinal symptoms in healthy adults.	[Wilms, E.; Fuentes, A. R. Garcia; Masclee, A. A. M.; Troost, F. J.] Maastricht Univ, Med Ctr, NUTRIM Sch Nutr & Translat Res Metab, Div Gastroenterol Hepatol,Dept Internal Med, Maastricht, Netherlands; [Gerritsen, J.; Smidt, H.] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands; [Gerritsen, J.; Besseling-van der Vaart, I.] Winclove Probiot BV, Amsterdam, Netherlands; [Rijkers, G. T.] Univ Coll Roosevelt, Dept Sci, Middelburg, Netherlands; [Rijkers, G. T.] St Antonius Hosp, Dept Med Microbiol & Immunol, Nieuwegein, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Wageningen University & Research; St. Antonius Hospital Utrecht	Wilms, E (corresponding author), Maastricht Univ, Med Ctr, NUTRIM Sch Nutr & Translat Res Metab, Div Gastroenterol Hepatol,Dept Internal Med, Maastricht, Netherlands.	e.wilms@maastrichtuniversity.nl	Rijkers, Ger/AAW-6143-2020; Rijkers, Ger/R-7236-2019; Wilms, Ellen/R-9502-2019; Smidt, Hauke/D-7054-2014	Rijkers, Ger/0000-0001-6948-6123; Wilms, Ellen/0000-0001-7146-8581; Smidt, Hauke/0000-0002-6138-5026; Garcia Fuentes, Alvaro R/0000-0001-7789-0214	Rijksdenstvoor Ondernemend Nederland, an agency of the Dutch Ministry of Economic Affairs [FND-07013]; Winclove Probiotics	Rijksdenstvoor Ondernemend Nederland, an agency of the Dutch Ministry of Economic Affairs; Winclove Probiotics	This work was supported by a grant of Rijksdenstvoor Ondernemend Nederland, an agency of the Dutch Ministry of Economic Affairs (FND-07013). Employees of this agency did not play any role in the conceptualization, performance or publication of this study. Maastricht University Medical Center+, Wageningen University and Winclove Probiotics signed a consortium agreement. JG and IBV are employees of Winclove Probiotics. Winclove Probiotics offers evidence based probiotic solutions for consumers, health professionals and business partners. Winclove Probiotics provided support in the form of salaries for two authors (JG and IBV) and did play a supportive role in the conceptualization and methodology of the study, and the review of the manuscript. JG and IBV had no role in data collection, data analysis and decision to publish.	Blair SA, 2006, LAB INVEST, V86, P191, DOI 10.1038/labinvest.3700373; Damen B, 2012, J NUTR, V142, P470, DOI 10.3945/jn.111.146464; Del Piano M, 2014, J CLIN GASTROENTEROL, V48, pS56, DOI 10.1097/MCG.0000000000000254; Eun CS, 2011, APMIS, V119, P49, DOI 10.1111/j.1600-0463.2010.02691.x; Gotteland M, 2001, ALIMENT PHARM THER, V15, P11, DOI 10.1046/j.1365-2036.2001.00898.x; Hedin CR, 2012, GUT, V61, P311, DOI 10.1136/gut.2011.238568; Hemert S, 2013, ADV MICROBIOL, V3, P212, DOI [DOI 10.4236/AIM.2013.32032, 10.4236/aim.2013.32032]; Hepburn NJ, 2013, BENEF MICROBES, V4, P313, DOI 10.3920/BM2013.0012; Hsieh CY, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12327; Karczewski J, 2010, AM J PHYSIOL-GASTR L, V298, pG851, DOI 10.1152/ajpgi.00327.2009; Korhonen R, 2004, LETT APPL MICROBIOL, V39, P19, DOI 10.1111/j.1472-765X.2004.01531.x; Kuitunen M, 1996, J PEDIATR GASTR NUTR, V22, P197, DOI 10.1097/00005176-199602000-00012; Lamprecht M, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-45; Lee SH, 2015, INTEST RES, V13, P11, DOI 10.5217/ir.2015.13.1.11; Lomax AR, 2012, BRIT J NUTR, V108, P1818, DOI 10.1017/S0007114511007276; Lutgendorff F, 2009, THESIS; Mangalat N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043910; Mankertz J, 2007, CURR OPIN GASTROEN, V23, P379, DOI 10.1097/MOG.0b013e32816aa392; Moreno-Navarrete JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037160; Matsumoto K, 2010, J BIOSCI BIOENG, V110, P547, DOI 10.1016/j.jbiosc.2010.05.016; Olivares M, 2006, INT J FOOD MICROBIOL, V107, P104, DOI 10.1016/j.ijfoodmicro.2005.08.019; Ouwehand AC, 2009, BRIT J NUTR, V101, P367, DOI 10.1017/S0007114508003097; Parassol N, 2005, RES MICROBIOL, V156, P256, DOI 10.1016/j.resmic.2004.09.013; Persborn M, 2013, ALIMENT PHARM THER, V38, P772, DOI 10.1111/apt.12451; Plaza-Diaz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078111; Qin HL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-63; Russo F, 2012, NUTR RES, V32, P940, DOI 10.1016/j.nutres.2012.09.010; Salden BN, 2015, ALIMENT PHARM THER, V42, P273, DOI 10.1111/apt.13266; Sapone A, 2006, DIABETES, V55, P1443, DOI 10.2337/db05-1593; Sapone A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-23; Scholtens PAMJ, 2006, BRIT J NUTR, V95, P1143, DOI 10.1079/BJN20061765; Sierra S, 2010, ANAEROBE, V16, P195, DOI 10.1016/j.anaerobe.2010.02.001; Smecuol E, 1997, GASTROENTEROLOGY, V112, P1129, DOI 10.1016/S0016-5085(97)70123-9; Somasundaram S, 1997, GUT, V41, P344, DOI 10.1136/gut.41.3.344; Sullivan KE, 2000, CLIN DIAGN LAB IMMUN, V7, P920, DOI 10.1128/CDLI.7.6.920-924.2000; Ten Bruggencate SJM, 2006, J NUTR, V136, P70, DOI 10.1093/jn/136.1.70; Troost FJ, 2003, EUR J CLIN NUTR, V57, P1579, DOI 10.1038/sj.ejcn.1601727; Ulsemer P, 2012, BENEF MICROBES, V3, P99, DOI 10.3920/BM2011.0051; van Nieuwenhoven MA, 1999, EUR J CLIN INVEST, V29, P160, DOI 10.1046/j.1365-2362.1999.00421.x; van Wijck K, 2013, CLIN NUTR, V32, P245, DOI 10.1016/j.clnu.2012.06.014; van Wijck K, 2011, J CHROMATOGR B, V879, P2794, DOI 10.1016/j.jchromb.2011.08.002; Verdenelli MC, 2011, LETT APPL MICROBIOL, V52, P596, DOI 10.1111/j.1472-765X.2011.03042.x; Wind RD, 2010, BRIT J NUTR, V104, P1806, DOI 10.1017/S0007114510002746	43	29	30	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167775	10.1371/journal.pone.0167775	http://dx.doi.org/10.1371/journal.pone.0167775			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936169	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100184
J	Yong, MK; Cameron, PU; Spelman, T; Elliott, JH; Fairley, CK; Boyle, J; Miyamasu, M; Lewin, SR				Yong, Michelle K.; Cameron, Paul U.; Spelman, Tim; Elliott, Julian H.; Fairley, Christopher K.; Boyle, Jeffrey; Miyamasu, Misato; Lewin, Sharon R.			Quantifying Adaptive and Innate Immune Responses in HIV-Infected Participants Using a Novel High Throughput Assay	PLOS ONE			English	Article							T-CELL-ACTIVATION; IFN-GAMMA PRODUCTION; ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; VIRAL REPLICATION; INTERFERON-GAMMA; DENDRITIC CELLS; SUPPRESSION; SENESCENCE; CYTOKINES	Objectives HIV infection is characterised by persistent immune dysfunction of both the adaptive and innate immune responses. The aim of this study was to evaluate these responses using a novel high throughput assay in healthy controls and HIV-infected individuals prior to and following anti-retroviral treatment (ART). Design Cross-sectional study. Methods Whole blood was assessed using the QuantiFERON Monitor (R) (QFM) assay containing adaptive and innate immunostimulants. Interferon (IFN)-gamma levels (IU/mL) were measured by enzyme-linked immunosorbent assay (ELISA). Results We recruited HIV-infected participants (n = 20 off ART and viremic; n = 59 on suppressive ART) and HIV-uninfected controls (n = 229). Median IFN-gamma production was significantly higher in HIV-infected participants compared to controls (IFN-gamma 512 vs 223 IU/ml, p<0.0001), but within the HIV-infected participants there was no difference between those on or off ART (median IFN-gamma 512 vs 593 IU/ml p = 0.94). Amongst the HIV-infected participants, IFN-gamma production was higher in individuals with CD4 count>350 compared to <350 cells/mu L (IFN-gamma IU/ml 561 vs 259 p = 0.02) and in males compared to females (IFN-gamma 542 vs 77 IU/ml p = 0.04). There were no associations between IFN-gamma production and age, plasma HIV RNA, nadir CD4 count or duration of HIV infection. Using a multivariable analysis, neither CD4 nor sex were independently predictive of IFN-gamma production. Conclusion Using a high throughput assay which assesses both adaptive and innate immune function, we showed elevated IFN-gamma production in HIV-infected patients both on and off ART. Further research is warranted to determine if changes in QuantiFERON Monitor (R) are associated with clinical outcomes.	[Yong, Michelle K.; Cameron, Paul U.; Lewin, Sharon R.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Yong, Michelle K.; Cameron, Paul U.; Elliott, Julian H.; Lewin, Sharon R.] Monash Univ, Dept Infect Dis, Melbourne, Vic, Australia; [Yong, Michelle K.; Cameron, Paul U.; Elliott, Julian H.; Lewin, Sharon R.] Alfred Hosp, Melbourne, Vic, Australia; [Spelman, Tim] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [Fairley, Christopher K.] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia; [Fairley, Christopher K.] Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Boyle, Jeffrey; Miyamasu, Misato] QIAGEN, Germantown, MD USA	University of Melbourne; Monash University; Florey Institute of Neuroscience & Mental Health; Burnet Institute; Monash University	Yong, MK (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia.; Yong, MK (corresponding author), Monash Univ, Dept Infect Dis, Melbourne, Vic, Australia.; Yong, MK (corresponding author), Alfred Hosp, Melbourne, Vic, Australia.	Michelle.Yong@unimelb.edu.au	Lewin, Sharon/Z-3297-2019; Yong, Michelle/AAC-2549-2020	Yong, Michelle/0000-0002-8692-4145; Lewin, Sharon Ruth/0000-0002-0330-8241; Cameron, Paul Urquhart/0000-0002-1906-6945; Christopher, Fairley/0000-0001-9081-1664	QIAGEN; National Health and Medical Research Council (NHMRC) [0607212]; National Institutes for Health [U19 AI096109]	QIAGEN; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This investigator initiated industry funded study was supported in part by QIAGEN. The study design, statistical analysis and preparation of the manuscript were done independent of the sponsor. MKY was awarded a PhD Scholarship by the National Health and Medical Research Council (NHMRC 0607212). SRL is an NHMRC Practitioner Fellow. SRL and PUC are supported by the National Institutes for Health U19 AI096109. JB and MM are employees of the sponsor but did not have any additional role in the study design, analysis, decision to publish or preparation of the original manuscript.	Chang JJ, 2013, J INFECT DIS, V208, P830, DOI 10.1093/infdis/jit262; Fernandez S, 2006, CLIN IMMUNOL, V120, P163, DOI 10.1016/j.clim.2006.04.570; French MA, 2009, J INFECT DIS, V200, P1212, DOI 10.1086/605890; Gazzola L, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-51; Hart OM, 2005, J IMMUNOL, V175, P1636, DOI 10.4049/jimmunol.175.3.1636; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Jain V, 2013, J INFECT DIS, V208, P1202, DOI 10.1093/infdis/jit311; Jiang YJ, 2013, J CLIN IMMUNOL, V33, P1376, DOI 10.1007/s10875-013-9930-1; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lichtfuss GF, 2011, BIOMARK MED, V5, P171, DOI [10.2217/bmm.11.15, 10.2217/BMM.11.15]; Martinson JA, 2007, CELL IMMUNOL, V250, P75, DOI 10.1016/j.cellimm.2008.01.007; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Mihret A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-125; Rajasuriar R, 2013, AIDS, V27, P1199, DOI 10.1097/QAD.0b013e32835ecb8b; Roberts L, 2010, AIDS, V24, P819, DOI 10.1097/QAD.0b013e3283367836; Roff SR, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00498; Snyder-Cappione JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015412; Sood S, 2014, TRANSPLANTATION, V97, pE50, DOI 10.1097/TP.0000000000000078; Soumelis V, 2001, BLOOD, V98, P906, DOI 10.1182/blood.V98.4.906; Tincati C, 2009, JAIDS-J ACQ IMM DEF, V51, P642, DOI 10.1097/QAI.0b013e3181add695; Voo KS, 2014, J IMMUNOL, V193, P627, DOI 10.4049/jimmunol.1203334; Watanabe D, 2010, VIRAL IMMUNOL, V23, P619, DOI 10.1089/vim.2010.0065	23	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166549	10.1371/journal.pone.0166549	http://dx.doi.org/10.1371/journal.pone.0166549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935986	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100034
J	Li, XC; Cui, JL; Maharjan, S; Lu, LJ; Gong, X				Li, Xiucun; Cui, Jianli; Maharjan, Suraj; Lu, Laijin; Gong, Xu			Reconstruction of the Foot and Ankle Using Pedicled or Free Flaps: Perioperative Flap Survival Analysis	PLOS ONE			English	Article							ARTERY PERFORATOR FLAP; LOWER-EXTREMITY RECONSTRUCTION; ANTEROLATERAL THIGH FLAP; MEDIAL PLANTAR FLAP; RISK-FACTORS; CLINICAL-APPLICATION; PROPELLER FLAPS; LOWER LEG; DEFECTS; EXPERIENCE	Objective The purpose of this study is to determine the correlation between non-technical risk factors and the perioperative flap survival rate and to evaluate the choice of skin flap for the reconstruction of foot and ankle. Methods This was a clinical retrospective study. Nine variables were identified. The Kaplan-Meier method coupled with a log-rank test and a Cox regression model was used to predict the risk factors that influence the perioperative flap survival rate. The relationship between postoperative wound infection and risk factors was also analyzed using a logistic regression model. Results The overall flap survival rate was 85.42%. The necrosis rates of free flaps and pedicled flaps were 5.26% and 20.69%, respectively. According to the Cox regression model, flap type (hazard ratio [HR] = 2.592; 95% confidence interval [CI] (1.606, 4.184); P < 0.001) and postoperative wound infection (HR = 0.266; 95% CI (0.134, 0.529); P < 0.001) were found to be statistically significant risk factors associated with flap necrosis. Based on the logistic regression model, preoperative wound bed inflammation (odds ratio [OR] = 11.371,95% CI (3.117, 41.478), P < 0.001) was a statistically significant risk factor for postoperative wound infection. Conclusion Flap type and postoperative wound infection were both independent risk factors influencing the flap survival rate in the foot and ankle. However, postoperative wound infection was a risk factor for the pedicled flap but not for the free flap. Microvascular anastomosis is a major cause of free flap necrosis. To reconstruct complex or wide soft tissue defects of the foot or ankle, free flaps are safer and more reliable than pedicled flaps and should thus be the primary choice.	[Li, Xiucun; Cui, Jianli; Maharjan, Suraj; Lu, Laijin; Gong, Xu] Jilin Univ, Hosp 1, Dept Hand & Foot Surg, Changchun, Jilin Province, Peoples R China	Jilin University	Gong, X (corresponding author), Jilin Univ, Hosp 1, Dept Hand & Foot Surg, Changchun, Jilin Province, Peoples R China.	triumphlixc@163.com	Li, Xiucun/AAI-9002-2020	Li, Xiucun/0000-0002-3260-6299				Acar MA, 2015, J RECONSTR MICROSURG, V31, P225, DOI 10.1055/s-0034-1395888; Acikel C, 2003, ANN PLAS SURG, V50, P498, DOI 10.1097/01.SAP.0000044141.35292.A7; Balakrishnan Chenicheri, 2009, Can J Plast Surg, V17, pe11; Battiston B, 2011, MICROSURG, V31, P212, DOI 10.1002/micr.20863; Bekara F, 2016, MICROSURG; Bekara F, 2016, PLAST RECONSTR SURG, V137, P314, DOI 10.1097/PRS.0000000000001891; Chai YM, 2007, ANN PLAS SURG, V59, P526, DOI 10.1097/01.sap.0000258969.13723.68; Gir P, 2012, J RECONSTR MICROSURG, V28, P595, DOI 10.1055/s-0032-1315786; GODINA M, 1986, PLAST RECONSTR SURG, V78, P285, DOI 10.1097/00006534-198609000-00001; Gupta A, 2015, J PLAST RECONSTR AES, V68, P1184, DOI 10.1016/j.bjps.2015.05.009; Hollenbeck ST, 2010, PLAST RECONSTR SURG, V125, P924, DOI 10.1097/PRS.0b013e3181cc9630; Hong JP, 2013, ANN PLAS SURG, V71, P380, DOI 10.1097/SAP.0b013e3182503ac5; Hsu WM, 2007, PLAST RECONSTR SURG, V119, P1491, DOI 10.1097/01.prs.0000256057.42415.73; Inui T, 2015, SEMIN VASC SURG, V28, P201, DOI 10.1053/j.semvascsurg.2016.02.002; Kang MJ, 2013, ARCH PLAST SURG-APS, V40, P575, DOI 10.5999/aps.2013.40.5.575; Li Y, 2013, BURNS, V39, P808, DOI 10.1016/j.burns.2012.08.014; Lin YT, 2015, PLAST RECONSTR SURG, V135, P501, DOI 10.1097/PRS.0000000000000884; Liu LF, 2014, ANN PLAS SURG, V72, P689, DOI 10.1097/SAP.0b013e31826c4284; Liu LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083696; Lu TC, 2011, J PLAST RECONSTR AES, V64, P386, DOI 10.1016/j.bjps.2010.05.004; Pinsolle V, 2006, J PLAST RECONSTR AES, V59, P912, DOI 10.1016/j.bjps.2005.11.037; Ruan HJ, 2010, ANN PLAS SURG, V64, P451, DOI 10.1097/SAP.0b013e3181b0c4f6; Schaverien MV, 2010, PLAST RECONSTR SURG, V125, P1735, DOI 10.1097/PRS.0b013e3181ccdc08; Schoeller T, 2004, MICROSURG, V24, P43, DOI 10.1002/micr.10194; Sekido M, 2004, MICROSURG, V24, P289, DOI 10.1002/micr.20022; Voche P, 2005, ANN PLAS SURG, V54, P49, DOI 10.1097/01.sap.0000139565.36738.b3; Wei JW, 2016, PLAST RECONSTR SURG; Wong AK, 2015, MICROSURG, V35, P6, DOI 10.1002/micr.22223; Xiong L, 2016, MICROSURGERY; Yoon ES, 2007, ANN PLAS SURG, V58, P517, DOI 10.1097/01.sap.0000244929.93375.34; Zelken JA, 2016, ANN PLAS SURG, V76, P221, DOI 10.1097/SAP.0000000000000564; Zhao P, 2015, INT J CLIN EXP MED, V8, P9519; Zhu YL, 2013, MICROSURG, V33, P600, DOI 10.1002/micr.22177	33	17	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167827	10.1371/journal.pone.0167827	http://dx.doi.org/10.1371/journal.pone.0167827			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930679	gold, Green Submitted, Green Published			2022-12-27	WOS:000389580900047
J	Oberste, M; Bloch, W; Hubner, ST; Zimmer, P				Oberste, Max; Bloch, Wilhelm; Huebner, Sven T.; Zimmer, Philipp			Do Reported Effects of Acute Aerobic Exercise on Subsequent Higher Cognitive Performances Remain if Tested against an Instructed Self-Myofascial Release Training Control Group? A Randomized Controlled Trial	PLOS ONE			English	Article							RESISTANCE EXERCISE; LACTATE; METABOLISM; ABILITIES; NEURONS; LONDON; STROOP; BRAIN; TOWER; TERM	A substantial body of evidence suggests positive effects of acute aerobic exercise (AAE) on subsequent higher cognitive functions in healthy young adults. These effects are widely understood as a result of the ongoing physiological adaptation processes induced by the preceding AAE. However, designs of published studies do not control for placebo, Hawthorne and subject expectancy effects. Therefore, these studies do not, at a high degree of validity, allow attributing effects of AEE on subsequent cognitive performance to exercise induced physical arousal. In the present study, we applied a randomized controlled blinded experiment to provide robust evidence for a physiological basis of exercise induced cognitive facilitation. Beyond that, the dose response relationship between AAE's intensity and subsequent cognitive performances as well as a potentially mediating role of peripheral lactate in AAE induced cognitive facilitation was investigated. The 121 healthy young subjects who participated in this study were assigned randomly into 3 exercise groups and a self-myofascial release training control group. Exercise groups comprised a low, moderate and high intensity condition in which participants cycled on an ergometer at a heart rate corresponding to 45-50%, 65-70% and 85-90% of their individual maximum heart rate, respectively, for 35 minutes. Participants assigned to the control group completed a 35 minute instructed self-massage intervention using a foam roll. Before and after treatment, participants completed computer based versions of the Stroop task and the Trail Making Test as well as a free recall task. None of the applied exercise regimes exerted a significant effect on participants'performance at any of the applied cognitive testing procedure if compared to self-myofascial release training control group. Post hoc power analyses revealed no effect in the population of f = .2 or larger at a risk of type II error (beta) <= .183 for all measured variables. Our results, therefore, indicate that AAE induced cognitive facilitation is not (exclusively) based on physiological effects. Even if there is a substantial contribution of physiological adaptations to AAE in reported AAE induced cognitive facilitation, in this study, peripheral lactate could not be confirmed as such a factor. Peripheral lactate concentrations and cognitive testing performances after exercise showed rather small empirical and no significant associations. Our results suggest that other psychosocial aspects like expectations and social attention play an important role in AAE induced cognitive facilitation.	[Oberste, Max; Bloch, Wilhelm; Huebner, Sven T.; Zimmer, Philipp] German Sports Univ Cologne, Dept Mol & Cellular Sports Med, Sportpk Mungersdorf 6, Cologne, Germany; [Zimmer, Philipp] Natl Ctr Tumor Dis NCT, Neuenheimer Feld 280, Heidelberg, Germany; [Zimmer, Philipp] German Canc Res Ctr, Neuenheimer Feld 280, Heidelberg, Germany	German Sport University Cologne; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Zimmer, P (corresponding author), German Sports Univ Cologne, Dept Mol & Cellular Sports Med, Sportpk Mungersdorf 6, Cologne, Germany.; Zimmer, P (corresponding author), Natl Ctr Tumor Dis NCT, Neuenheimer Feld 280, Heidelberg, Germany.; Zimmer, P (corresponding author), German Canc Res Ctr, Neuenheimer Feld 280, Heidelberg, Germany.	p.zimmer@dshs-koeln.de						Alexander JRM, 1997, PERS INDIV DIFFER, V23, P815, DOI 10.1016/S0191-8869(97)00054-8; Audiffren M, 2009, ACTA PSYCHOL, V132, P85, DOI 10.1016/j.actpsy.2009.06.008; Behrendt J., 2002, THESIS; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergersen LH, 2007, NEUROSCIENCE, V145, P11, DOI 10.1016/j.neuroscience.2006.11.062; Bouzier-Sore AK, 2003, J CEREBR BLOOD F MET, V23, P1298, DOI 10.1097/01.WCB.0000091761.61714.25; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Chang YK, 2015, MED SCI SPORT EXER, V47, P159, DOI 10.1249/MSS.0000000000000383; Chang YK, 2011, J SPORT EXERCISE PSY, V33, P866, DOI 10.1123/jsep.33.6.866; Chang YK, 2011, J SPORT EXERCISE PSY, V33, P847, DOI 10.1123/jsep.33.6.847; Chang YK, 2009, J SPORT EXERCISE PSY, V31, P640, DOI 10.1123/jsep.31.5.640; Chaya MS, 2012, J ALTERN COMPLEM MED, V18, P1161, DOI 10.1089/acm.2011.0579; Cohen J.E., 1988, STAT POWER ANAL BEHA; Coles K, 2008, J SPORT SCI, V26, P333, DOI 10.1080/02640410701591417; Daamen M, 2012, FUNCTIONAL NEUROIMAG, P109; Dalsgaard MK, 2004, J PHYSIOL-LONDON, V554, P571, DOI 10.1113/jphysiol.2003.055053; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Field A.P., 2020, DISCOVERING STAT USI, V4th; Griffin EW, 2011, PHYSIOL BEHAV, V104, P934, DOI 10.1016/j.physbeh.2011.06.005; Hollmann W, 2009, SPORTIMEDIZIN GRUNDL; Hung TM, 2013, PSYCHOL SPORT EXERC, V14, P728, DOI 10.1016/j.psychsport.2013.05.004; Ivnik RJ, 1996, CLIN NEUROPSYCHOL, V10, P262, DOI 10.1080/13854049608406689; Joyce J, 2009, BRAIN COGNITION, V71, P14, DOI 10.1016/j.bandc.2009.03.004; Junker DH, 2015, J STRENGTH COND RES, V29, P3480, DOI 10.1519/JSC.0000000000001007; LEHRL S, 1995, ACTA NEUROL SCAND, V91, P335, DOI 10.1111/j.1600-0404.1995.tb07018.x; Lowe CJ, 2014, FROTIERS HUMAN NEURO; McCarney R, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-30; Murray NP, 2012, APPL PSYCHOPHYS BIOF, V37, P219, DOI 10.1007/s10484-012-9196-z; Nowak S., 2015, THESIS; Querido JS, 2007, SPORTS MED, V37, P765, DOI 10.2165/00007256-200737090-00002; Reitan RM, 1992, TRAIL MAKING TEST MA; Rodewald K, 2014, TRAIL MAKING TEST LA; Salthouse TA, 2011, INTELLIGENCE, V39, P222, DOI 10.1016/j.intell.2011.03.001; Schuhfried, 2014, INF NACH STROOP MAN; Skriver K, 2014, NEUROBIOLOGY LEARNIN; Smith D, 2003, J CEREBR BLOOD F MET, V23, P658, DOI 10.1097/01.WCB.0000063991.19746.11; Stothart CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109557; Tomporowski PD, 2003, ACTA PSYCHOL, V112, P297, DOI 10.1016/S0001-6918(02)00134-8; van Hall G, 2010, ACTA PHYSIOL, V199, P499, DOI 10.1111/j.1748-1716.2010.02122.x; Van Rensburg KJ, 2008, HUM PSYCHOPHARM CLIN, V23, P193, DOI 10.1002/hup.925; Wechsler ME, 2011, NEW ENGL J MED, V365, P119, DOI 10.1056/NEJMoa1103319; WEI LJ, 1978, ANN STAT, V6, P92, DOI 10.1214/aos/1176344068; Winter B, 2007, NEUROBIOL LEARN MEM, V87, P597, DOI 10.1016/j.nlm.2006.11.003; Wyss MT, 2011, J NEUROSCI, V31, P7477, DOI 10.1523/JNEUROSCI.0415-11.2011; Yanagisawa H, 2010, NEUROIMAGE, V50, P1702, DOI 10.1016/j.neuroimage.2009.12.023	45	8	8	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167818	10.1371/journal.pone.0167818	http://dx.doi.org/10.1371/journal.pone.0167818			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4OA	27930706	Green Submitted, gold, Green Published			2022-12-27	WOS:000389580900046
J	Bolton, PE; West, AJ; Cardilini, APA; Clark, JA; Maute, KL; Legge, S; Brazill-Boast, J; Griffith, SC; Rollins, LA				Bolton, Peri E.; West, Andrea J.; Cardilini, Adam P. A.; Clark, Jennalee A.; Maute, Kimberley L.; Legge, Sarah; Brazill-Boast, James; Griffith, Simon C.; Rollins, Lee A.			Three Molecular Markers Show No Evidence of Population Genetic Structure in the Gouldian Finch (Erythrura gouldiae)	PLOS ONE			English	Article							PER-GENERATION RULE; SPATIAL AUTOCORRELATION; NORTHERN AUSTRALIA; CONSERVATION; DIVERSITY; SOFTWARE; SIZE; INFERENCE; DIFFERENTIATION; POLYMORPHISM	Assessment of genetic diversity and connectivity between regions can inform conservation managers about risk of inbreeding, potential for adaptation and where population boundaries lie. The Gouldian finch (Erythrura gouldiae) is a threatened species in northern Australia, occupying the savannah woodlands of the biogeographically complex monsoon tropics. We present the most comprehensive population genetic analysis of diversity and structure the Gouldian finch using 16 microsatellite markers, mitochondrial control region and 3,389 SNPs from genotyping-by-sequencing. Mitochondrial diversity is compared across three related, co-distributed finches with different conservation threat-statuses. There was no evidence of genetic differentiation across the western part of the range in any of the molecular markers, and haplotype diversity but not richness was lower than a common co-distributed species. Individuals within the panmictic population in the west may be highly dispersive within this wide area, and we urge caution when interpreting anecdotal observations of changes to the distribution and/or flock sizes of Gouldian finch populations as evidence of overall changes to the population size of this species.	[Bolton, Peri E.; Clark, Jennalee A.; Brazill-Boast, James; Griffith, Simon C.; Rollins, Lee A.] Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia; [West, Andrea J.; Cardilini, Adam P. A.; Rollins, Lee A.] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Geelong, Vic, Australia; [Maute, Kimberley L.] Univ Wollongong, Inst Conservat Biol & Environm Management, Wollongong, NSW, Australia; [Legge, Sarah] Australian Wildlife Conservancy, Perth, WA, Australia; [Legge, Sarah] Charles Darwin Univ, Natl Environm Sci Programme Threatened Species Re, Darwin, NT, Australia; [Brazill-Boast, James] NSW Off Environm & Heritage, Reg Operat Div, Ecosyst & Threatened Species Unit, Sydney, NSW, Australia	Macquarie University; Deakin University; University of Wollongong; Charles Darwin University; Office of Environment & Heritage - New South Wales	Bolton, PE (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia.	peri.bolton@mq.edu.au	Griffith, Simon/AAH-3706-2021; Legge, Sarah/AAB-7229-2019; Maute, Kimberly L/D-4642-2017; Griffith, Simon/A-1996-2010; Rollins, Lee/G-3688-2011; Legge, Sarah/GYE-1554-2022; Brazill-Boast, James/R-6195-2019	Griffith, Simon/0000-0001-7612-4999; Legge, Sarah/0000-0001-6968-2781; Maute, Kimberly L/0000-0003-4791-8743; Griffith, Simon/0000-0001-7612-4999; Rollins, Lee/0000-0002-3279-7005; Cardilini, Adam/0000-0002-1032-3466	Australian Research Council [DP0881019, LP0668122, DP130100418]; Save the Gouldian Fund; Macquarie University; Australian Postgraduate Award	Australian Research Council(Australian Research Council); Save the Gouldian Fund; Macquarie University; Australian Postgraduate Award(Australian Government)	Financial support for fieldwork at Wyndham was from an Australian Research Council Grant to Sarah Pryke and SCG (DP0881019), Save the Gouldian Fund, and a Macquarie University Research Excellence Scholarship to JB-B. Funding for fieldwork at Northern Territory and Australian Wildlife Conservancy's Mornington sanctuary was from Australian Research Council Linkage Grant to Stephen Garnett (LP0668122), supporters of the Australian Wildlife Conservancy, the University of Wollongong, Northern Territory Department of Infrastructure, Planning and Environment, Charles Darwin University, Stuart Leslie Bird Research Fund, and the Professor Allen Keast Award (Birdlife Australia). The Australian Agricultural Company, Australian Department of Defence, Australian Wildlife Conservancy and Jawoyn association allowed KLM access to their land. The genetics work was supported by Australian Research Council grants to SCG and LAR (DP130100418), and an Australian Postgraduate Award to PEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDORF FW, 1986, ZOO BIOL, V5, P181, DOI 10.1002/zoo.1430050212; Australian Bureau of Statistics, 2011, AUSTR STAND GEOGR CL; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Balakrishnan CN, 2009, GENETICS, V181, P645, DOI 10.1534/genetics.108.094250; Balloux F, 2004, MOL ECOL, V13, P3021, DOI 10.1111/j.1365-294X.2004.02318.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Banks SC, 2012, MOL ECOL, V21, P2092, DOI 10.1111/j.1365-294X.2012.05485.x; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Berney FL., 1902, EMU; Bowman DMJS, 2010, J BIOGEOGR, V37, P201, DOI 10.1111/j.1365-2699.2009.02210.x; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brazill-Boast J, 2013, EVOL ECOL, V27, P1189, DOI 10.1007/s10682-013-9651-1; Brazill-Boast J, 2011, J ANIM ECOL, V80, P39, DOI 10.1111/j.1365-2656.2010.01756.x; Brazill-Boast J, 2010, EMU, V110, P170, DOI 10.1071/MU09045; Catullo RA, 2014, J BIOGEOGR, V41, P659, DOI 10.1111/jbi.12230; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ellegren H, 2016, NAT REV GENET, V17, P422, DOI 10.1038/nrg.2016.58; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Epps CW, 2015, MOL ECOL; Esparza-Salas R, 2007, THESIS; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Forstmeier W, 2012, MOL ECOL, V21, P3237, DOI 10.1111/j.1365-294X.2012.05593.x; Franklin DC, 1999, BIOL CONSERV, V90, P53, DOI 10.1016/S0006-3207(99)00010-5; Fung T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085925; Garnett S. T., 2011, ACTION PLAN AUSTR BI; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; Hague MTJ, 2016, HEREDITY, V116, P92, DOI 10.1038/hdy.2015.76; HASTINGS A, 1993, ECOLOGY, V74, P1362, DOI 10.2307/1940066; Heslewood MM, 1998, ELECTROPHORESIS, V19, P142, DOI 10.1002/elps.1150190203; Holland SM, 2012, ANAL RAREFACTION; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jackson H, 2013, CONSERV GENET, V14, P1291, DOI 10.1007/s10592-013-0514-7; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; Kearns AM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4994; Kool JT, 2013, LANDSCAPE ECOL, V28, P165, DOI 10.1007/s10980-012-9819-z; Kruck NC, 2013, MOL ECOL RESOUR, V13, P715, DOI 10.1111/1755-0998.12112; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Legge S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137997; Lepais O, 2014, MOL ECOL RESOUR, V14, P1314, DOI 10.1111/1755-0998.12273; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lloyd MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063981; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; Luikart G, 2010, CONSERV GENET, V11, P355, DOI 10.1007/s10592-010-0050-7; Maute KL, 2013, J COMP PHYSIOL B, V183, P1023, DOI 10.1007/s00360-013-0775-y; Meirmans PG, 2015, MOL ECOL, V24, P3223, DOI 10.1111/mec.13243; Mills LS, 1996, CONSERV BIOL, V10, P1509, DOI 10.1046/j.1523-1739.1996.10061509.x; Morin PA, 2009, MOL ECOL RESOUR, V9, P66, DOI 10.1111/j.1755-0998.2008.02392.x; Nabholz B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-54; Nei M., 1987, MOL EVOLUTIONARY GEN; Newhouse DJ, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0546-3; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Potter S, 2012, MOL ECOL, V21, P2254, DOI 10.1111/j.1365-294X.2012.05523.x; Pritchard JK, 2000, GENETICS, V155, P945; Puechmaille SJ, 2016, MOL ECOL RESOUR, V16, P608, DOI 10.1111/1755-0998.12512; Raj A, 2014, GENETICS, V197, P573, DOI 10.1534/genetics.114.164350; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rivers MC, 2014, GLOB ECOL CONSERV, V2, P81, DOI 10.1016/j.gecco.2014.08.005; Rollins LA, 2012, ECOL EVOL, V2, P1208, DOI 10.1002/ece3.259; Runge CA, 2014, FRONT ECOL ENVIRON, V12, P395, DOI 10.1890/130237; Russell-Smith J, 2003, INT J WILDLAND FIRE, V12, P283, DOI 10.1071/WF03015; Ryman N, 2009, MOL ECOL, V18, P2084, DOI 10.1111/j.1365-294X.2009.04187.x; Santure AW, 2010, MOL ECOL, V19, P1439, DOI 10.1111/j.1365-294X.2010.04554.x; Slatkin M, 2005, MOL ECOL, V14, P67, DOI 10.1111/j.1365-294X.2004.02393.x; Smedley J. H., 1904, Emu, Viv, P69; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Stucky Brian J, 2012, J Biomol Tech, V23, P90, DOI 10.7171/jbt.12-2303-004; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Tidemann SC., 1996, BIRD CONSERV INT; van Rooij EP, 2011, EMU, V111, P297, DOI 10.1071/MU10092; Verity R, 2014, MOL ECOL, V23, P4216, DOI 10.1111/mec.12856; Wang JL, 2004, CONSERV BIOL, V18, P332, DOI 10.1111/j.1523-1739.2004.00440.x; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; White TA, 2013, MOL ECOL, V22, P2971, DOI 10.1111/mec.12343; Willing EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042649; Willoughby JR, 2015, BIOL CONSERV, V191, P495, DOI 10.1016/j.biocon.2015.07.025; Wilson GA, 2003, GENETICS, V163, P1177; WOINARSKI JCZ, 1992, EMU, V92, P33, DOI 10.1071/MU9920033; Wright S, 1931, GENETICS, V16, P0097; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	89	7	8	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167723	10.1371/journal.pone.0167723	http://dx.doi.org/10.1371/journal.pone.0167723			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936082	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100163
J	Ford, BM; Franks, LN; Radominska-Pandya, A; Prather, PL				Ford, Benjamin M.; Franks, Lirit N.; Radominska-Pandya, Anna; Prather, Paul L.			Tamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug Development	PLOS ONE			English	Article							HUMAN-BREAST-CANCER; ESTROGEN-RECEPTOR; CB2 RECEPTOR; ALLOSTERIC MODULATORS; SIGNAL-TRANSDUCTION; ADENYLATE-CYCLASE; INVERSE AGONISM; RAT-BRAIN; IN-VITRO; ANTAGONIST	Tamoxifen (Tam) is a selective estrogen receptor (ER) modulator (SERM) that is an essential drug to treat ER-positive breast cancer. Aside from known actions at ERs, recent studies have suggested that some SERMs like Tam also exhibit novel activity at cannabinoid subtype 1 and 2 receptors (CB1R and CB2Rs). Interestingly, cis-(E-Tam) and trans-(Z-Tam) isomers of Tam exhibit over a 100-fold difference in affinity for ERs. Therefore, the current study assessed individual isomers of Tam and subsequent cytochrome P450 metabolic products, 4-hydroxytamoxifen (4OHT) and 4-hydroxy-N-desmethyl tamoxifen (End) for affinity and activity at CBRs. Results showed that Z-4OHT, but not Z-Tam or Z-End, exhibits higher affinity for both CB1 and CB2Rs relative to the E-isomer. Furthermore, Z- and E-isomers of Tam and 4OHT show slightly higher affinity for CB2Rs, while both End isomers are relatively CB1R-selective. When functional activity was assessed by G-protein activation and regulation of the downstream effector adenylyl cyclase, all isomers examined act as full CB1 and CB2R inverse agonists. Interestingly, Z-Tam appears to be more efficacious than the full inverse agonist AM630 at CB2Rs, while both Z-Tam and Z-End exhibit characteristics of insurmountable antagonism at CB1 and CB2Rs, respectively. Collectively, these results suggest that the SERMs Tam, 4OHT and End elicit ER-independent actions via CBRs in an isomer-specific manner. As such, this novel structural scaffold might be used to develop therapeutically useful drugs for treatment of a variety of diseases mediated via CBRs.	[Ford, Benjamin M.; Franks, Lirit N.; Prather, Paul L.] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Coll Med, Little Rock, AR 72205 USA; [Radominska-Pandya, Anna] Univ Arkansas Med Sci, Coll Med, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Prather, PL (corresponding author), Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Coll Med, Little Rock, AR 72205 USA.	PratherPaulL@uams.edu			UAMS Department of Pharmacology and Toxicology	UAMS Department of Pharmacology and Toxicology	These studies were supported by bridging funds provided by the UAMS Department of Pharmacology and Toxicology Dr. Paul L. Prather.	Azizi-Malekabadi H, 2015, ARQ NEURO-PSIQUIAT, V73, P132, DOI 10.1590/0004-282X20140221; Bonhaus DW, 1998, J PHARMACOL EXP THER, V287, P884; Breivogel CS, 2000, J PHARMACOL EXP THER, V295, P328; Brents LK, 2012, BIOCHEM PHARMACOL, V83, P952, DOI 10.1016/j.bcp.2012.01.004; Buggy Y, 2011, DRUG SAFETY, V34, P501, DOI 10.2165/11588510-000000000-00000; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Ciaglia E, 2015, ONCOTARGET, V6, P15464, DOI 10.18632/oncotarget.3895; Clarke M, 1998, LANCET, V351, P1451; Cluny NL, 2010, BRIT J PHARMACOL, V161, P629, DOI 10.1111/j.1476-5381.2010.00908.x; Dalton GD, 2009, CNS NEUROL DISORD-DR, V8, P422, DOI 10.2174/187152709789824615; Detsi A, 2002, J ORG CHEM, V67, P4608, DOI 10.1021/jo0255328; Elkins P, 2014, J PHARMACEUT BIOMED, V88, P174, DOI 10.1016/j.jpba.2013.07.010; Fantegrossi WE, 2014, LIFE SCI, V97, P45, DOI 10.1016/j.lfs.2013.09.017; Fong Tung M, 2014, Adv Pharmacol, V70, P121, DOI 10.1016/B978-0-12-417197-8.00004-3; Franks LN, 2014, EUR J PHARMACOL, V737, P140, DOI 10.1016/j.ejphar.2014.05.007; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Gennari L, 2010, CLIN INTERV AGING, V5, P19; GUO Y, 1994, J MED CHEM, V37, P3867, DOI 10.1021/jm00049a002; Horswill JG, 2007, BRIT J PHARMACOL, V152, P805, DOI 10.1038/sj.bjp.0707347; HOWLETT AC, 1984, MOL PHARMACOL, V26, P532; Idris AI, 2010, CURR NEUROPHARMACOL, V8, P243, DOI 10.2174/157015910792246173; Iusuf D, 2011, J PHARMACOL EXP THER, V337, P710, DOI 10.1124/jpet.110.178301; Jager NGL, 2014, BREAST CANCER RES TR, V143, P477, DOI 10.1007/s10549-013-2826-1; Jankowitz RC, 2013, BREAST, V22, pS165, DOI 10.1016/j.breast.2013.07.032; Jordan VC, 2014, ENDOCR-RELAT CANCER, V21, pR235, DOI 10.1530/ERC-14-0092; JORDAN VC, 1988, ENDOCRINOLOGY, V122, P1449, DOI 10.1210/endo-122-4-1449; KATZENELLENBOGEN BS, 1984, CANCER RES, V44, P112; KATZENELLENBOGEN JA, 1985, J STEROID BIOCHEM, V22, P589, DOI 10.1016/0022-4731(85)90210-9; Kim DK, 2013, GUT, V62, P1044, DOI 10.1136/gutjnl-2012-303347; Kumar P, 2014, BIOCHEM BIOPH RES CO, V443, P144, DOI 10.1016/j.bbrc.2013.11.071; Kumar P, 2013, BIOCHEM BIOPH RES CO, V435, P76, DOI 10.1016/j.bbrc.2013.04.040; Lan R, 1999, AAPS PharmSci, V1, pE4; Landsman RS, 1998, LIFE SCI, V62, pPL109, DOI 10.1016/S0024-3205(97)01187-9; Lee HO, 1997, ARCH PHARM RES, V20, P572, DOI 10.1007/BF02975214; LIEN EA, 1991, CANCER RES, V51, P4837; Lunn CA, 2008, BRIT J PHARMACOL, V153, P226, DOI 10.1038/sj.bjp.0707480; Lunn CA, 2006, EXPERT OPIN THER TAR, V10, P653, DOI 10.1517/14728222.10.5.653; MACKIE K, 1995, J NEUROSCI, V15, P6552; Madadi NR, 2013, BIOORG MED CHEM LETT, V23, P2019, DOI 10.1016/j.bmcl.2013.02.025; Mancino S, 2015, NEUROPSYCHOPHARMACOL; Maximov PY, 2014, BRIT J PHARMACOL, V171, P5624, DOI 10.1111/bph.12864; May LT, 2010, MOL PHARMACOL, V78, P511, DOI 10.1124/mol.110.064493; May LT, 2003, CURR OPIN PHARMACOL, V3, P551, DOI 10.1016/S1471-4892(03)00107-3; Mc Ilroy M, 2006, ENDOCR-RELAT CANCER, V13, P1135, DOI 10.1677/erc.1.01222; Mella-Raipan JA, 2013, MOLECULES, V18, P3972, DOI 10.3390/molecules18043972; Mukhopadhyay P, 2007, J AM COLL CARDIOL, V50, P528, DOI 10.1016/j.jacc.2007.03.057; Nazarali SA, 2014, BREAST CANCER-TARGET, V6, P29, DOI 10.2147/BCTT.S43763; OSBORNE CK, 1992, J CLIN ONCOL, V10, P304, DOI 10.1200/JCO.1992.10.2.304; PERTWEE R, 1995, LIFE SCI, V56, P1949, DOI 10.1016/0024-3205(95)00175-6; Pertwee RG, 2005, LIFE SCI, V76, P1307, DOI 10.1016/j.lfs.2004.10.025; Pertwee RG, 2005, HANDB EXP PHARMACOL, V168, P1; Pliska V, 2014, BIOCHEM PHARMACOL, V91, P119, DOI 10.1016/j.bcp.2014.06.025; Prather PL, 2013, BIOCHEM BIOPH RES CO, V441, P339, DOI 10.1016/j.bbrc.2013.10.057; Price MR, 2005, MOL PHARMACOL, V68, P1484, DOI 10.1124/mol.105.016162; Ramos JA, 2012, INDIAN J UROL, V28, P9, DOI 10.4103/0970-1591.94942; ROBERTSON DW, 1982, J STEROID BIOCHEM, V16, P1, DOI 10.1016/0022-4731(82)90137-6; Ross RA, 1999, BRIT J PHARMACOL, V126, P665, DOI 10.1038/sj.bjp.0702351; Saidak Z, 2006, BRIT J PHARMACOL, V147, P671, DOI 10.1038/sj.bjp.0706661; Santoro A, 2009, INT J CANCER, V125, P996, DOI 10.1002/ijc.24483; Sarnataro D, 2006, MOL PHARMACOL, V70, P1298, DOI 10.1124/mol.106.025601; Schatz AR, 1997, TOXICOL APPL PHARM, V142, P278, DOI 10.1006/taap.1996.8034; Seely KA, 2012, NEUROPHARMACOLOGY, V63, P905, DOI 10.1016/j.neuropharm.2012.06.046; Shi DM, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-173; Shim JY, 2003, BIOPOLYMERS, V71, P169, DOI 10.1002/bip.10424; Shoemaker JL, 2005, J PHARMACOL EXP THER, V314, P868, DOI 10.1124/jpet.105.085282; ter Heine R, 2014, BRIT J CLIN PHARMACO, V78, P572, DOI 10.1111/bcp.12388; Thomas A, 2007, BRIT J PHARMACOL, V150, P613, DOI 10.1038/sj.bjp.0707133; Vasiljevik T, 2013, J MED CHEM, V56, P4537, DOI 10.1021/jm400268b; Velasco G, 2007, MOL NEUROBIOL, V36, P60, DOI 10.1007/s12035-007-0002-5; Velasco G, 2016, PROG NEURO-PSYCHOPH, V64, P259, DOI 10.1016/j.pnpbp.2015.05.010; WEST RE, 1985, J BIOL CHEM, V260, P4428; Whiting PF, 2015, JAMA-J AM MED ASSOC, V313, P2456, DOI 10.1001/jama.2015.6358; Wyllie DJA, 2007, BRIT J PHARMACOL, V150, P541, DOI 10.1038/sj.bjp.0706997; Xie S, 2007, J CLIN PHARM THER, V32, P209, DOI 10.1111/j.1365-2710.2007.00817.x; Yang G, 2013, PHARMACOL THERAPEUT, V139, P392, DOI 10.1016/j.pharmthera.2013.05.005	76	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167240	10.1371/journal.pone.0167240	http://dx.doi.org/10.1371/journal.pone.0167240			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936172	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100076
J	Kawabata, N; Matsuda, M				Kawabata, Noriyuki; Matsuda, Michiyuki			Cell Density-Dependent Increase in Tyrosine-Monophosphorylated ERK2 in MDCK Cells Expressing Active Ras or Raf	PLOS ONE			English	Article							PROTEIN PHOSPHATASE-1; CONTACT INHIBITION; KINASE CASCADE; MAP KINASE; PHOSPHORYLATION; ACTIVATION; VISUALIZATION; BIOSENSORS; NRAS	The extracellular signal-regulated kinase (ERK) is one of the principal hub proteins that transmit growth signals from upstream oncogene products including Ras and BRaf to downstream effector proteins. However, there are both reports supporting and refuting the increase in ERK activity in cancer tissues expressing the active Ras and BRaf proteins. We considered that the cell density might account for this discrepancy. To examine this possibility, we prepared Madin-Darby canine kidney (MDCK) cells that expressed an active HRas, NRas, KRas, or BRaf and an ERK biosensor based on the principle of Forster resonance energy transfer (FRET). As we anticipated, expression of the active Ras or BRaf increased ERK activity at low cell densities. However, the ERK activity was markedly suppressed at high cell densities irrespective of the expression of the active Ras or BRaf. Western blotting analysis with Phos-tag gel revealed the decrease of tyrosine and threonine-diphosphorylated active ERK and the increase of tyrosine-monophosphorylated inactive ERK at high cell density. In addition, we found that calyculin A, an inhibitor for PPP-subfamily protein serine/threonine phosphatases, decreased the tyrosine-monophosphorylated ERK. Our study suggests that PPP-subfamily phosphatases may be responsible for cell density-dependent ERK dephosphorylation in cancer cells expressing active Ras or BRaf protein.	[Kawabata, Noriyuki; Matsuda, Michiyuki] Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Kyoto, Japan	Kyoto University	Matsuda, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Kyoto, Japan.	matsuda.michiyuki.2c@kyoto-u.ac.jp	Kawabata, Noriyuki/CAF-6693-2022	Kawabata, Noriyuki/0000-0001-7235-763X; Matsuda, Michiyuki/0000-0002-5876-9969	Ministry of Education, Culture, Sports, Science, and Technology [15H02397]; Japan Agency for Medical Research and Development [15H0594]; Naito Foundation; Grants-in-Aid for Scientific Research [15H05949] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by 15H02397: Ministry of Education, Culture, Sports, Science, and Technology; http://www.mext.go.jp/en/ 15H0594: Japan Agency for Medical Research and Development; http://www.amed.go.jp/en/ No grant number: Naito Foundation; https://www.naito-f.or.jp/jp/index.php The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1979, NATURE, V281, P259, DOI 10.1038/281259a0; Ahmed S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134708; Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Aoki K, 2013, MOL CELL, V52, P529, DOI 10.1016/j.molcel.2013.09.015; Aoki K, 2009, NAT PROTOC, V4, P1623, DOI 10.1038/nprot.2009.175; Aokia K, 2011, P NATL ACAD SCI USA, V108, P12675, DOI 10.1073/pnas.1104030108; BOS JL, 1989, CANCER RES, V49, P4682; Brautigan DL, 2013, FEBS J, V280, P324, DOI 10.1111/j.1742-4658.2012.08609.x; Burd CE, 2014, CANCER DISCOV, V4, P1418, DOI 10.1158/2159-8290.CD-14-0729; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chuang MJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073401, 10.1371/journal.pone.0083116]; COHEN P, 1989, FEBS LETT, V250, P596, DOI 10.1016/0014-5793(89)80803-8; COOPER GM, 1982, SCIENCE, V217, P801, DOI 10.1126/science.6285471; EAGLE H, 1967, NATURE, V213, P1102, DOI 10.1038/2131102a0; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harvey CD, 2008, P NATL ACAD SCI USA, V105, P19264, DOI 10.1073/pnas.0804598105; Hiratsuka T, 2015, ELIFE, V4, DOI 10.7554/eLife.05178; Houben R, 2008, J INVEST DERMATOL, V128, P2003, DOI 10.1038/jid.2008.30; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Iwamoto N, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aab1967; Jaumot M, 2001, ONCOGENE, V20, P3949, DOI 10.1038/sj.onc.1204526; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Li SJ, 2004, ASIAN J WATER ENV PO, V1, P1, DOI DOI 10.1152/AJPCELL.00020.2004; Mandell JW, 2008, HISTOCHEM CELL BIOL, V130, P465, DOI 10.1007/s00418-008-0474-z; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; MCCOY MS, 1983, NATURE, V302, P79, DOI 10.1038/302079a0; Miyawaki A, 2015, MOL CELL, V58, P632, DOI 10.1016/j.molcel.2015.03.002; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; Oldach L, 2014, CHEM BIOL, V21, P186, DOI 10.1016/j.chembiol.2013.12.012; PASTAN I, 1978, NATURE, V274, P645, DOI 10.1038/274645a0; Perrotti D, 2013, LANCET ONCOL, V14, pE229, DOI 10.1016/S1470-2045(12)70558-2; Sakurai A, 2012, J BIOL CHEM, V287, P31703, DOI 10.1074/jbc.M112.377804; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Smalley KM, 2007, BRIT J CANCER, V96, P445, DOI 10.1038/sj.bjc.6603596; Swingle Mark, 2007, V365, P23; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Vinals F, 1999, MOL CELL BIOL, V19, P2763; Wayne J, 2006, MOL CELL BIOCHEM, V286, P181, DOI 10.1007/s11010-005-9089-z; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]	49	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167940	10.1371/journal.pone.0167940	http://dx.doi.org/10.1371/journal.pone.0167940			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936234	gold, Green Submitted, Green Published			2022-12-27	WOS:000389587100236
J	Muhammad, YS; Hussain, I; Shoukry, AM				Muhammad, Yousaf Shad; Hussain, Ijaz; Shoukry, Alaa Mohamd			Multivariate Multi-Objective Allocation in Stratified Random Sampling: A Game Theoretic Approach	PLOS ONE			English	Article							PUBLIC-GOODS GAME; COOPERATION; EVOLUTION	We consider the problem of multivariate multi-objective allocation where no or limited information is available within the stratum variance. Results show that a game theoretic approach (based on weighted goal programming) can be applied to sample size allocation problems. We use simulation technique to determine payoff matrix and to solve a minimax game.	[Muhammad, Yousaf Shad; Hussain, Ijaz] Quaid I Azam Univ, Dept Stat, Islamabad, Pakistan; [Shoukry, Alaa Mohamd] King Saud Univ, Arriyadh Community Coll, Riyadh, Saudi Arabia; [Shoukry, Alaa Mohamd] KSA Workers Univ, King Saud Univ, Cairo, Egypt	Quaid I Azam University; King Saud University; Egyptian Knowledge Bank (EKB); Cairo University	Muhammad, YS (corresponding author), Quaid I Azam Univ, Dept Stat, Islamabad, Pakistan.	yousuf@qau.edu.pk	Hussain, Ijaz/AAN-5885-2020; Muhammad, Yousaf Shad/ABH-1579-2021; Muhammad, Yousaf Shad/ABH-1068-2021	Hussain, Ijaz/0000-0002-1586-1503; Muhammad, Yousaf Shad/0000-0002-3541-6220; Muhammad, Yousaf Shad/0000-0002-3541-6220	Deanship of Scientific Research at King Saud University [RG-1437-027]	Deanship of Scientific Research at King Saud University(King Saud University)	The authors extend their appreciation to the Deanship of Scientific Research at King Saud University for funding this work through research group no RG-1437-027.	AGGARWAL OP, 1959, ANN MATH STAT, V30, P206, DOI 10.1214/aoms/1177706376; Andersen R., 1979, TOTAL SURVEY ERROR; Ansari A. H., 2009, INT J STAT SCI KOLKA, V1, P45; Bethel J. W., 1986, OPTIMUM ALLOCATION A; Blackwell D, 1979, THEORY GAMES STAT DE; CHATTERJEE S, 1968, J AM STAT ASSOC, V63, P530, DOI 10.2307/2284023; Chen MH, 2016, PHYS LETT A, V380, P40, DOI 10.1016/j.physleta.2015.09.047; Chromy JR., 1987, P SECTION; Cochran WG., 1963, SAMPLING TECHNIQUES; Dalenius T, 1951, SKAND AKTUARIETIDSKR, V34, P133; Dalenius T., 1957, SAMPLING SWEDEN CONT; ERICSON WA, 1965, J AM STAT ASSOC, V60, P750, DOI 10.2307/2283243; FOLKS JL, 1965, J AM STAT ASSOC, V60, P225, DOI 10.2307/2283148; Ghosh JK, 1963, CALCUTTA STATISTICAL, V12, P4, DOI [10.1177/0008068319630102, DOI 10.1177/0008068319630102]; Ghosh SP., 1958, CALCUTTA STAT ASSOC, V8, P81, DOI [10.1177/0008068319580204, DOI 10.1177/0008068319580204]; Groves R.M., 2004, SURVEY ERRORS SURVEY, V536; Jahan N., 2001, DHAKA U J SCI, V49, P197; Jahan N., 1994, J INDIAN STAT ASSOC, V32, P95; Khan A., 2002, CALCUTTA STAT ASS B, V52, P323, DOI DOI 10.1177/0008068320020518; Khan MGM, 2010, J OFF STAT, V26, P695; Khan Mohammad GM, 2008, J INDIAN SOC AGR STA, V62, P42; KISH L, 1976, J ROY STAT SOC A STA, V139, P80, DOI 10.2307/2344384; Kish L, 1965, SURVEY SAMPLING; KOKAN AR, 1967, J ROY STAT SOC B, V29, P115; Kozak M, 2006, COMMUN STAT-SIMUL C, V35, P901, DOI 10.1080/03610910600880286; Linacre SJ, 1993, J OFF STAT, V9, P611; Romero C, 2001, OMEGA-INT J MANAGE S, V29, P63, DOI 10.1016/S0305-0483(00)00026-8; SWINDEL BF, 1972, J AM STAT ASSOC, V67, P684, DOI 10.2307/2284468; Tamiz M, 1998, EUR J OPER RES, V111, P569, DOI 10.1016/S0377-2217(97)00317-2; Varshney R., 2011, J MATH MODEL ALGORIT, V10, P393, DOI DOI 10.1007/S10852-011-9164-2; Varshney R, 2012, MATH METHOD OPER RES, V75, P185, DOI 10.1007/s00186-012-0380-y; Xia CY, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/58002; Xia CY, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525912500567; Xia CY, 2014, APPL MATH COMPUT, V246, P389, DOI 10.1016/j.amc.2014.08.006; Yates F, 1960, SAMPLING METHODS CEN, V54; Zhu CJ, 2014, PHYSICA A, V406, P145, DOI 10.1016/j.physa.2014.03.035	36	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167705	10.1371/journal.pone.0167705	http://dx.doi.org/10.1371/journal.pone.0167705			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936039	Green Submitted, gold, Green Published			2022-12-27	WOS:000389587100160
J	Paldino, S; Kondor, D; Bojic, I; Sobolevsky, S; Gonzalez, MC; Ratti, C				Paldino, Silvia; Kondor, Daniel; Bojic, Iva; Sobolevsky, Stanislav; Gonzalez, Marta C.; Ratti, Carlo			Uncovering Urban Temporal Patterns from Geo-Tagged Photography	PLOS ONE			English	Article							MOBILE; ATTRACTIVENESS	We live in a world where digital trails of different forms of human activities compose big urban data, allowing us to detect many aspects of how people experience the city in which they live or come to visit. In this study we propose to enhance urban planning by taking into a consideration individual preferences using information from an unconventional big data source: dataset of geo-tagged photographs that people take in cities which we then use as a measure of urban attractiveness. We discover and compare a temporal behavior of residents and visitors in ten most photographed cities in the world. Looking at the periodicity in urban attractiveness, the results show that the strongest periodic patterns for visitors are usually weekly or monthly. Moreover, by dividing cities into two groups based on which continent they belong to (i.e., North America or Europe), it can be concluded that unlike European cities, behavior of visitors in the US cities in general is similar to the behavior of their residents. Finally, we apply two indices, called "dilatation attractiveness index" and "dilatation index", to our dataset which tell us the spatial and temporal attractiveness pulsations in the city. The proposed methodology is not only important for urban planning, but also does support various business and public stakeholder decision processes, concentrated for example around the question how to attract more visitors to the city or estimate the impact of special events organized there.	[Paldino, Silvia] Univ Calabria, Dept Phys, Arcavacata Di Rende, CS, Italy; [Paldino, Silvia; Kondor, Daniel; Bojic, Iva; Sobolevsky, Stanislav; Ratti, Carlo] MIT, SENSEable City Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Bojic, Iva] SMART Ctr, SENSEable City Lab, Singapore, Singapore; [Sobolevsky, Stanislav] NYU, Ctr Urban Sci Progress, Brooklyn, NY USA; [Gonzalez, Marta C.] MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA	University of Calabria; Massachusetts Institute of Technology (MIT); New York University; Massachusetts Institute of Technology (MIT)	Bojic, I (corresponding author), MIT, SENSEable City Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Bojic, I (corresponding author), SMART Ctr, SENSEable City Lab, Singapore, Singapore.	ivabojic@mit.edu	Gonzalez, Marta C./E-9456-2011; Kondor, Daniel/AAD-9871-2019; Sobolevsky, Stanislav/ABH-7108-2020	Gonzalez, Marta C./0000-0002-8482-0318; Kondor, Daniel/0000-0003-3720-7462; Sobolevsky, Stanislav/0000-0001-6281-0656; Bojic, Iva/0000-0002-4664-3349	BBVA; MIT SMART Program; Center for Complex Engineering Systems (CCES) at KACST; Center for Complex Engineering Systems (CCES) at MIT; Accenture; Air Liquide; Coca Cola Company; Emirates Integrated Telecommunications Company; ENELfoundation; Ericsson; Expo; Ferrovial; Liberty Mutual; Regional Municipality of Wood Buffalo; Volkswagen Electronics Research Lab; UBER; National Research Foundation; Prime Minister's Office, Singapore; Singapore-MIT Alliance for Research and Technology (SMART) Future Urban Mobility (FM) IRG; research project "Managing Trust and Coordinating Interactions in Smart Networks of People, Machines and Organizations" - Croatian Science Foundation [UIP-11-2013-8813]; Department of Transportation's grant of the New England [UTC Y25]; MIT Portugal Program; Center for Complex Engineering Systems at KACST-MIT; SENSEable city lab consortium; SENSEable city lab	BBVA(BBVA Foundation); MIT SMART Program; Center for Complex Engineering Systems (CCES) at KACST; Center for Complex Engineering Systems (CCES) at MIT; Accenture; Air Liquide; Coca Cola Company; Emirates Integrated Telecommunications Company; ENELfoundation; Ericsson(Ericsson); Expo; Ferrovial; Liberty Mutual; Regional Municipality of Wood Buffalo; Volkswagen Electronics Research Lab; UBER; National Research Foundation; Prime Minister's Office, Singapore; Singapore-MIT Alliance for Research and Technology (SMART) Future Urban Mobility (FM) IRG(Singapore-MIT Alliance for Research & Technology Centre (SMART)); research project "Managing Trust and Coordinating Interactions in Smart Networks of People, Machines and Organizations" - Croatian Science Foundation; Department of Transportation's grant of the New England; MIT Portugal Program; Center for Complex Engineering Systems at KACST-MIT; SENSEable city lab consortium; SENSEable city lab	The authors want to recognize the support of BBVA, MIT SMART Program, Center for Complex Engineering Systems (CCES) at KACST and MIT, Accenture, Air Liquide, The Coca Cola Company, Emirates Integrated Telecommunications Company, The ENELfoundation, Ericsson, Expo 2015, Ferrovial, Liberty Mutual, The Regional Municipality of Wood Buffalo, Volkswagen Electronics Research Lab, UBER, and all the members of the MIT Senseable City Lab Consortium for supporting the research. The research was also supported by the National Research Foundation, Prime Minister's Office, Singapore, under its CREATE programme, Singapore-MIT Alliance for Research and Technology (SMART) Future Urban Mobility (FM) IRG and by research project "Managing Trust and Coordinating Interactions in Smart Networks of People, Machines and Organizations," funded by the Croatian Science Foundation under the project UIP-11-2013-8813. M.C.G. and S.P. were partially funded by the Department of Transportation's grant of the New England UTC Y25, the MIT Portugal Program, and the Center for Complex Engineering Systems at KACST-MIT. This research has been partially funded through the SENSEable city lab consortium. The consortium provided support in the form of salaries for some of the authors (IB, DK, CR) employed by the SENSEable city lab, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini A, 2014, EPJ DATA SCI, V3, DOI 10.1140/epjds31; Belyi A, 2016, ARXIV160105532; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bojic I, 2016, APPL GEOGR, V73, P47, DOI 10.1016/j.apgeog.2016.06.006; Bojic I, 2015, 2015 IEEE International WIE Conference on Electrical and Computer Engineering (WIECON-ECE), P305, DOI 10.1109/WIECON-ECE.2015.7443924; Bojic I, 2015, LECT NOTES COMPUT SC, V9471, P194, DOI 10.1007/978-3-319-27433-1_14; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Brockwell P. J., 2013, TIME SERIES THEORY M; Crandall David J, 2009, P INT C WORLD WID WE, DOI DOI 10.1145/1526709.1526812; Dkondor, 2016, FLICKRTEMPORAL; Fisher D, 2007, IEEE T VIS COMPUT GR, V13, P1184, DOI 10.1109/TVCG.2007.70561; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Grauwin S, 2015, GEOTECH ENVIRON, V13, P363, DOI 10.1007/978-3-319-11469-9_15; Hawelka B, 2014, CARTOGR GEOGR INF SC, V41, P260, DOI 10.1080/15230406.2014.890072; Hoteit S, 2014, COMPUT NETW, V64, P296, DOI 10.1016/j.comnet.2014.02.011; Kung KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096180; Louail T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05276; Pereira RHM, 2013, GEOGR ANAL, V45, P77, DOI 10.1111/gean.12002; Paldino S, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0043-3; Pei T, 2014, INT J GEOGR INF SCI, V28, P1988, DOI 10.1080/13658816.2014.913794; Ratti C., 2014, ARXIV14054301, P10; Ratti C, 2006, ENVIRON PLANN B, V33, P727, DOI 10.1068/b32047; Ratti C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014248; Reades J, 2007, IEEE PERVAS COMPUT, V6, P30, DOI 10.1109/MPRV.2007.53; Sobolevsky S, 2015, ARXIV150600036; Sobolevsky S, 2015, IEEE INT CONGR BIG, P600, DOI 10.1109/BigDataCongress.2015.92; Sobolevsky S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081707; Spirn Anne W., 1998, LANGUAGE LANDSCAPE; Toole Jameson L., 2012, P ACM SIGKDD INT WOR, P1, DOI [10.1145/2346496.2346498, DOI 10.1145/2346496.2346498]; Wang H, 2013, PROCEEDINGS OF THE 5TH (2013) INTERNATIONAL CONFERENCE ON FINANCIAL RISK AND CORPORATE FINANCE MANAGEMENT, VOLS I AND II, P1, DOI 10.1109/ijcnn.2013.6706812	30	6	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0165753	10.1371/journal.pone.0165753	http://dx.doi.org/10.1371/journal.pone.0165753			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27935979	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100016
J	Shanaki, M; Fadaei, R; Moradi, N; Emamgholipour, S; Poustchi, H				Shanaki, Mehrnoosh; Fadaei, Reza; Moradi, Nariman; Emamgholipour, Solaleh; Poustchi, Hossein			The Circulating CTRP13 in Type 2 Diabetes and Non-Alcoholic Fatty Liver Patients	PLOS ONE			English	Article							DISEASE; FAMILY	Numerous studies have shown that C1q/TNF-related proteins (CTRPs) are involved in the pathophysiology of metabolic disorders, such as Non-alcoholic fatty liver disease (NAFLD) and Type 2 Diabetes (T2DM). There is a little information concerning CTRP13 in the context of NAFLD and T2DM. We evaluated the plasma levels of CTRP13 in healthy control and patients with NAFLD, T2DM and NAFLD+T2DM, and also correlations between CTRP13 plasma levels and clinical and subclinical features. Circulating CTRP13 was examined in 88 male (20 healthy control, 22 T2DM patients, 22 NAFLD patients and 22 NAFLD+T2DM patients). CTRP13 and adiponectin plasma levels were measured by ELISA method. CTRP13 serum levels were higher in the control group than the other groups (all p <0.001). CTRP13 had significant negative correlation with unfavorable anthropometric and metabolic factors including BMI, visceral fat, Insulin, HOMA-IR, TG, AST, ALT and gamma-GT and have a positive correlation with plasma concentration of adiponectin. CTRP13 had a significant inverse correlation with cIMT (r = -0.345) and liver stiffness (LS) (r = -0.372) (both, p <0.001). Also, the multiple stepwise linear regression has shown that visceral fat is a significant predictor of CTRP13 serum levels (p <0.001). Multiple stepwise linear regression with LS as the dependent variable showed that ALT (p < 0.001) and SBP (p = 0.010) were two predictor factors for LS. Strikingly, multiple stepwise linear regression showed that CTRP13 (p = 0.006) and SBP (p = 0.007) were two independent predictors for cIMT. Lower CTRP13 in patients with T2DM, NAFLD and NAFLD + T2DM was associated with increased risk of the diseases. CTRP13 have negative associations with unfavorable metabolic factors and also is a negative predictor of cIMT. Our results suggested that CTRP13 could be an associated factor with NAFLD in patients with and without T2DM.	[Shanaki, Mehrnoosh] Shahid Beheshti Univ Med Sci, Sch Allied Med Sci, Dept Lab Sci, Tehran, Iran; [Fadaei, Reza; Emamgholipour, Solaleh] Univ Tehran Med Sci, Dept Biochem, Fac Med, Tehran, Iran; [Moradi, Nariman] Iran Univ Med Sci, Dept Biochem, Fac Med, Tehran, Iran; [Poustchi, Hossein] Univ Tehran Med Sci, Digest Dis Res Inst, Liver & Pancreatobiliary Dis Res Ctr, Tehran, Iran	Shahid Beheshti University Medical Sciences; Tehran University of Medical Sciences; Iran University of Medical Sciences; Tehran University of Medical Sciences	Poustchi, H (corresponding author), Univ Tehran Med Sci, Digest Dis Res Inst, Liver & Pancreatobiliary Dis Res Ctr, Tehran, Iran.	h.poustchi@gmail.com	Emamgholipour, Solaleh/T-6035-2017; Fadaei, Reza/M-9456-2016	Fadaei, Reza/0000-0002-4989-1137; Emamgholipour, Solaleh/0000-0002-9949-5773; Moradi, Nariman/0000-0001-7760-4804; Shanaki, Mehrnoosh/0000-0002-2684-1014				Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Angulo P, 2007, ALIMENT PHARM THER, V25, P883, DOI 10.1111/j.1365-2036.2007.03246.x; Ban B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112931; Byerly MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062862; Coco B, 2007, J VIRAL HEPATITIS, V14, P360, DOI 10.1111/j.1365-2893.2006.00811.x; Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484; Dowman JK, 2010, QJM-INT J MED, V103, P71, DOI 10.1093/qjmed/hcp158; Emamgholipour S, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0099-z; Germano G, 2012, EUR HEART J, V33, P137; Jung CH, 2014, J CLIN ENDOCR METAB, V99, pE2477, DOI 10.1210/jc.2014-2524; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Medina-Bravo P, 2011, ARCH MED RES, V42, P115, DOI 10.1016/j.arcmed.2011.03.002; Merat S, 2015, ARCH IRAN MED, V18, P515, DOI 015188/AIM.009; Mirza MS, 2011, OBESITY VISCERAL FAT; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pan XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094478; Qu H, 2015, J CLIN LIPIDOL, V9, P289, DOI 10.1016/j.jacl.2015.03.006; Schaffler A, 2012, TRENDS ENDOCRIN MET, V23, P194, DOI 10.1016/j.tem.2011.12.003; Seldin MM, 2014, REV ENDOCR METAB DIS, V15, P111, DOI 10.1007/s11154-013-9255-7; Shabani P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118650; WANG HF, 2016, POWER ELECTRON POWER, P1, DOI DOI 10.1186/S12872-016-0266-7; Wang J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/971683; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Wolf RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133955; Yoon JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075535; Yu DX, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016818, 10.1371/journal.pone.0016079]; Yuasa D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099846	27	27	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168082	10.1371/journal.pone.0168082	http://dx.doi.org/10.1371/journal.pone.0168082			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936230	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100270
J	Tanino, H; Kosaka, Y; Nishimiya, H; Tanaka, Y; Minatani, N; Kikuchi, M; Shida, A; Waraya, M; Katoh, H; Enomoto, T; Sengoku, N; Kajita, S; Hoffman, RM; Watanabe, M				Tanino, Hirokazu; Kosaka, Yoshimasa; Nishimiya, Hiroshi; Tanaka, Youko; Minatani, Naoko; Kikuchi, Mariko; Shida, Akiko; Waraya, Mina; Katoh, Hiroshi; Enomoto, Takumo; Sengoku, Norihiko; Kajita, Sabine; Hoffman, Robert M.; Watanabe, Masahiko			BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy	PLOS ONE			English	Article							SUBTYPES	BRCAness is defined as the set of traits in which BRCA1 dysfunction, arising from gene mutation, methylation or deletion, results in DNA repair deficiency. In the present study, we addressed BRCAness, therapeutic efficacy, recurrence, and survival in patients with triple negative breast cancer (TNBC) who were treated with neoadjuvant chemotherapy at Kitasato University Hospital, Japan, between April 2006 and October 2012. BRCAness was determined by preoperative core needle biopsy (CNB) specimens and surgical specimens. Assay was performed using Multiplex Ligation-dependent Probe Amplification (MLPA) with P376-B2 BRCA1ness probemix (MRC-Holland, Amsterdam, The Netherlands). The relative copy number ratio of each sample was compared to Human Genomic DNA (Promega, Madison, WI, USA) as reference samples was calculated with Coffalyser. NET default settings. The BRCAness score was calculated with the relative copy number ratio of various DNA sequences. Values of 0.5 or more were determined as the BRCA1-like Type (BRCAness) and those of less than 0.5 as the Sporadic Type to analyze pathological complete response (pCR) rate, recurrence, and survival. pCR (ypT0/Tis/N0) was observed in 15 patients (pCR rate: 37.5%). These patients had no recurrence. Twelve patients recurred, 8 died from breast cancer. The BRCA1-like Type were 22 and Sporadic Type were 18 in CNB specimens. No major differences were observed between the BRCA1-like Type and Sporadic Type with pCR rate, recurrence rate and survival. Twenty four surgical specimens of non-pCR patients were available and 9 were BRCA1-like Type, who had more recurrences (7/9 vs. 5/15), and their relapse-free survival was also lower (p<0.05) than that of Sporadic Type. Seven BRCA1-like Type patients remained BRCA1-like Type in surgical specimens, were worse in recurrence (p<0.01) and survival (p<0.05) compared with 6 patients whose BRCA status in surgical specimens turned to Sporadic Type. New clinical trials assessing the true recurrence (TR) rate of BRCA-type patients are expected since neither platinum-containing drugs nor poly (ADP-ribose) polymerase (PARP) inhibitors are effective against tumors with nonfunctional BRCA genes.	[Tanino, Hirokazu; Kosaka, Yoshimasa; Nishimiya, Hiroshi; Tanaka, Youko; Minatani, Naoko; Kikuchi, Mariko; Shida, Akiko; Waraya, Mina; Katoh, Hiroshi; Enomoto, Takumo; Sengoku, Norihiko; Watanabe, Masahiko] Kitasato Univ, Sch Med, Dept Surg, Sagamihara, Kanagawa, Japan; [Kajita, Sabine] Kitasato Univ, Sch Med, Dept Pathol, Sagamihara, Kanagawa, Japan; [Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA; [Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA	Kitasato University; Kitasato University; Anti Cancer Inc; University of California System; University of California San Diego	Tanino, H (corresponding author), Kitasato Univ, Sch Med, Dept Surg, Sagamihara, Kanagawa, Japan.	htanino@med.kitasato-u.ac.jp	Tanino, Hirokazu/AAN-4455-2021					Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Joosse SA, 2009, BREAST CANCER RES TR, V116, P479, DOI 10.1007/s10549-008-0117-z; Lips EH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3049; Metzger O, 2012, J CLIN ONCOL, V30, P1879, DOI 10.1200/JCO.2011.38.2010; Nishimiya H, 2014, ANTICANCER RES, V34, P259; Oonk AMM, 2012, ANN ONCOL, V23, P2301, DOI 10.1093/annonc/mdr621; Telli Melinda, 2014, Am Soc Clin Oncol Educ Book, pe37, DOI 10.14694/EdBook_AM.2014.34.e37; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Von Minckwitz G, 2014, ASCO MEETING ABSTRAC, V32, P1005, DOI [10.1200/jco.2014.32.15_suppl, DOI 10.1200/jco.2014.32.15_suppl.1005]; Wessels LFA, 2002, CANCER RES, V62, P7110	12	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0165721	10.1371/journal.pone.0165721	http://dx.doi.org/10.1371/journal.pone.0165721			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935989	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100014
J	Thi, VHD; Coriton, O; Le Clainche, I; Arnaud, D; Gordon, SP; Linc, G; Catalan, P; Hasterok, R; Vogel, JP; Jahier, J; Chalhoub, B				Vinh Ha Dinh Thi; Coriton, Olivier; Le Clainche, Isabelle; Arnaud, Dominique; Gordon, Sean P.; Linc, Gabriella; Catalan, Pilar; Hasterok, Robert; Vogel, John P.; Jahier, Joseph; Chalhoub, Boulos			Recreating Stable Brachypodium hybridum Allotetraploids by Uniting the Divergent Genomes of B. distachyon and B. stacei	PLOS ONE			English	Article							MODEL GRASS; INTERSPECIFIC HYBRIDIZATION; GENE-EXPRESSION; REPRODUCTIVE ISOLATION; SYNTHETIC POLYPLOIDS; BRASSICA-RAPA; EVOLUTION; WHEAT; MECHANISMS; BARRIERS	Brachypodium hybridum (2n = 30) is a natural allopolyploid with highly divergent subgenomes derived from two extant diploid species, B. distachyon (2n = 10) and B. stacei (2n = 20) that differ in chromosome evolution and number. We created synthetic B. hybridum allotetraploids by hybridizing various lines of B. distachyon and B. stacei. The initial amphihaploid F1 interspecific hybrids were obtained at low frequencies when B. distachyon was used as the maternal parent (0.15% or 0.245% depending on the line used) and were sterile. No hybrids were obtained from reciprocal crosses or when autotetraploids of the parental species were crossed. Colchicine treatment was used to double the genome of the F1 amphihaploid lines leading to allotetraploids. The genome-doubled F1 plants produced a few S1 (first selfed generation) seeds after self-pollination. S1 plants from one parental combination (Bd3-1xBsta5) were fertile and gave rise to further generations whereas those of another parental combination (Bd21xABR114) were sterile, illustrating the importance of the parental lineages crossed. The synthetic allotetraploids were stable and resembled the natural B. hybridum at the phenotypic, cytogenetic and genomic levels. The successful creation of synthetic B. hybridum offers the possibility to study changes in genome structure and regulation at the earliest stages of allopolyploid formation in comparison with the parental species and natural B. hybridum.	[Vinh Ha Dinh Thi; Le Clainche, Isabelle; Arnaud, Dominique; Chalhoub, Boulos] Univ Evry Val dEssonne, Org & Evolut Complex Genomes, Inst Natl Rech Agron, Evry, France; [Coriton, Olivier; Jahier, Joseph] Univ Rennes 1, Unite Mixte Rech INRA, Agrocampus Rennes, Inst Genet Environm & Protect Plantes, Le Rheu, France; [Gordon, Sean P.; Vogel, John P.] DOE Joint Genome Inst, Walnut Creek, CA USA; [Linc, Gabriella] Hungarian Acad Sci, Inst Agr, Agr Res Ctr, Brunszv U 2, Martonvasar, Hungary; [Catalan, Pilar] Univ Zaragoza, Dept Agr & Environm Sci, High Polytech Sch Huesca, Huesca, Spain; [Catalan, Pilar] Tomsk State Univ, Inst Biol, Dept Bot, Tomsk, Russia; [Hasterok, Robert] Univ Silesia, Fac Biol & Environm Protect, Dept Plant Anat & Cytol, Katowice, Poland; [Vogel, John P.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Chalhoub, Boulos] Univ Paris Saclay, Univ Evry Val dEssonne, Inst Syst & Synthet Biol, Genopole,Ctr Natl Rech Sci, Evry, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Institut Agro; Agrocampus Ouest; Universite de Rennes; United States Department of Energy (DOE); Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; University of Zaragoza; Tomsk State University; University of Silesia in Katowice; University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); Genopole; UDICE-French Research Universities; Universite Paris Saclay	Chalhoub, B (corresponding author), Univ Evry Val dEssonne, Org & Evolut Complex Genomes, Inst Natl Rech Agron, Evry, France.; Chalhoub, B (corresponding author), Univ Paris Saclay, Univ Evry Val dEssonne, Inst Syst & Synthet Biol, Genopole,Ctr Natl Rech Sci, Evry, France.	chalhoub@evry.inra.fr	Catalan, Pilar/N-7641-2014; Catalan, Pilar/AAL-8833-2020; Hasterok, Robert/A-1629-2008	DINH, Thi Vinh Ha/0000-0002-5420-7352; Vogel, John/0000-0003-1786-2689; Hasterok, Robert/0000-0001-6667-2721	French ANR (Agence Nationale de la Recherche) [ANR-11-BSV5-0015]; Vietnamese International Education Development (VIED); Ministry of Education and Training Vietnam (MOET)	French ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); Vietnamese International Education Development (VIED); Ministry of Education and Training Vietnam (MOET)	This project was funded by the French ANR (Agence Nationale de la Recherche, www.agence-nationale-recherche.fr) 2011 (Ploid-ploid-Wheat, ANR-11-BSV5-0015). Vinh Ha Dinh Thi was support by a PhD fellowship from the Vietnamese International Education Development (VIED) and Ministry of Education and Training Vietnam (MOET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Akama S, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1376; BARKER M. S., 2012, PLANT GENOME DIVERSI, V1, P155, DOI [10.1007/978-3-7091-1130-7_11, DOI 10.1007/978-3-7091-1130-7_11]; Barker MS, 2016, NEW PHYTOL, V210, P391, DOI 10.1111/nph.13698; Beaulieu J, 2009, MOL GENET GENOMICS, V281, P421, DOI 10.1007/s00438-008-0421-7; Besnard G, 2008, ANN BOT-LONDON, V101, P25, DOI 10.1093/aob/mcm275; Betekhtin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115108; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Bouchenak-Khelladi Y, 2014, AM J BOT, V101, P300, DOI 10.3732/ajb.1300439; Brkljacic J, 2011, PLANT PHYSIOL, V157, P3, DOI 10.1104/pp.111.179531; Buggs RJA, 2012, AM J BOT, V99, P372, DOI 10.3732/ajb.1100395; Catalan P, 1997, MOL PHYLOGENET EVOL, V8, P150, DOI 10.1006/mpev.1997.0416; Catalan P, 2014, TRENDS PLANT SCI, V19, P414, DOI 10.1016/j.tplants.2014.05.002; Catalan P, 2012, ANN BOT-LONDON, V109, P385, DOI 10.1093/aob/mcr294; CataluYn P., 2016, GENETICS GENOMICS BR, P9, DOI DOI 10.1007/7397_2015_17; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chalupska D, 2008, P NATL ACAD SCI USA, V105, P9691, DOI 10.1073/pnas.0803981105; Charles M, 2008, GENETICS, V180, P1071, DOI 10.1534/genetics.108.092304; Chen ZJ, 2006, BIOESSAYS, V28, P240, DOI 10.1002/bies.20374; Choudhary BR, 2000, PLANT BREEDING, V119, P417, DOI 10.1046/j.1439-0523.2000.00503.x; Comai L, 2000, PLANT MOL BIOL, V43, P387, DOI 10.1023/A:1006480722854; Cousin A, 2009, CYTOM PART A, V75A, P1015, DOI 10.1002/cyto.a.20816; Dart S, 2004, CAN J BOT, V82, P185, DOI [10.1139/B03-134, 10.1139/b03-134]; Draper J, 2001, PLANT PHYSIOL, V127, P1539, DOI 10.1104/pp.010196; Estep MC, 2014, P NATL ACAD SCI USA, V111, P15149, DOI 10.1073/pnas.1404177111; Fujimoto R, 2011, PLANT MOL BIOL, V77, P419, DOI 10.1007/s11103-011-9820-y; GANGADEVI T, 1985, THEOR APPL GENET, V70, P330, DOI 10.1007/BF00304921; Garvin DF, 2010, GENOME, V53, P1, DOI [10.1139/G09-079, 10.1139/g09-079]; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; Ghani MA, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0272-9; Giraldo P, 2012, GENOME, V55, P523, DOI [10.1139/g2012-039, 10.1139/G2012-039]; Gordon S. P, 2016, GENETICS GENOMICS BR, P313, DOI DOI 10.1007/7397_2015_19; Hammami R, 2014, PLANT SYST EVOL, V300, P2029, DOI 10.1007/s00606-014-1021-0; Hasterok R, 2002, CHROMOSOME RES, V10, P83, DOI 10.1023/A:1014278429178; Hasterok R, 2004, CHROMOSOME RES, V12, P397, DOI 10.1023/B:CHRO.0000034130.35983.99; Hasterok R, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-20; Hong SY, 2011, WEED RES, V51, P612, DOI 10.1111/j.1365-3180.2011.00877.x; Idziak D, 2008, GENOME, V51, P387, DOI 10.1139/G08-017; Idziak D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093503; Jahier J., 1992, TECHNIQUES PLANT CYT; Kashkush K, 2003, NAT GENET, V33, P102, DOI 10.1038/ng1063; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Khan MA, 1999, NORD J BOT, V19, P257, DOI 10.1111/j.1756-1051.1999.tb01108.x; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lee CB, 2008, SEX PLANT REPROD, V21, P183, DOI 10.1007/s00497-008-0077-9; Leflon M, 2006, THEOR APPL GENET, V113, P1467, DOI 10.1007/s00122-006-0393-0; Lim KY, 2006, AM J BOT, V93, P875, DOI 10.3732/ajb.93.6.875; Lopez-Alvarez D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051058; Ludwig-Muller J, 2005, J EXP BOT, V56, P2095, DOI 10.1093/jxb/eri208; Madlung A, 2002, PLANT PHYSIOL, V129, P733, DOI 10.1104/pp.003095; Madlung A, 2013, Cytogenet Genome Res, V140, P270, DOI 10.1159/000351430; Mariam AL, 1996, THEOR APPL GENET, V93, P664, DOI 10.1007/BF00224060; Mason AS, 2015, TRENDS GENET, V31, P5, DOI 10.1016/j.tig.2014.09.011; MEJIAJIMENEZ A, 1994, THEOR APPL GENET, V88, P324, DOI 10.1007/BF00223640; Mestiri I, 2010, NEW PHYTOL, V186, P86, DOI 10.1111/j.1469-8137.2010.03186.x; Nasrallah ME, 2000, PLANT PHYSIOL, V124, P1605, DOI 10.1104/pp.124.4.1605; Natalis LC, 2012, AM J BOT, V99, P1847, DOI 10.3732/ajb.1200085; Ng DWK, 2012, HEREDITY, V108, P419, DOI 10.1038/hdy.2011.92; Osabe K, 2012, INT J MOL SCI, V13, P8696, DOI 10.3390/ijms13078696; Ouyang YD, 2013, ANNU REV PLANT BIOL, V64, P111, DOI 10.1146/annurev-arplant-050312-120205; Paun O, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-113; POYSA V, 1990, THEOR APPL GENET, V79, P187, DOI 10.1007/BF00225950; Presgraves DC, 2010, CURR BIOL, V20, pR440, DOI 10.1016/j.cub.2010.03.032; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; Rapp RA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-18; Rieseberg LH, 1996, SCIENCE, V272, P741, DOI 10.1126/science.272.5262.741; ROBERTSON IH, 1981, GENETICA, V56, P55, DOI 10.1007/BF00126930; Scopece G, 2008, AM NAT, V171, P315, DOI 10.1086/527501; SITCH LA, 1987, EUPHYTICA, V36, P497, DOI 10.1007/BF00041493; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; Soreng RJ, 2015, J SYST EVOL, V53, P117, DOI 10.1111/jse.12150; STEBBINS GL, 1985, ANN MO BOT GARD, V72, P824, DOI 10.2307/2399224; Suay L, 2014, NEW PHYTOL, V201, P645, DOI 10.1111/nph.12534; Szadkowski E, 2011, NEW PHYTOL, V191, P884, DOI 10.1111/j.1469-8137.2011.03729.x; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tate JA, 2009, AM J BOT, V96, P979, DOI 10.3732/ajb.0800299; TAYLOR NL, 1980, EUPHYTICA, V29, P441, DOI 10.1007/BF00025144; te Beest M, 2012, ANN BOT-LONDON, V109, P19, DOI 10.1093/aob/mcr277; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vogel JP, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-88; Vogel JP, 2006, PLANT CELL TISS ORG, V84, P199, DOI 10.1007/s11240-005-9023-9; Wendel JF, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0908-1; Wolny E, 2009, ANN BOT-LONDON, V104, P873, DOI 10.1093/aob/mcp179; Yao XC, 2012, PLANT CELL REP, V31, P781, DOI 10.1007/s00299-011-1200-1	85	13	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167171	10.1371/journal.pone.0167171	http://dx.doi.org/10.1371/journal.pone.0167171			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936041	gold, Green Published			2022-12-27	WOS:000389587100070
J	Elmugabil, A; Hamdan, HZ; Elsheikh, AE; Rayis, DA; Adam, I; Gasim, GI				Elmugabil, Abdelmageed; Hamdan, Hamdan Z.; Elsheikh, Anas E.; Rayis, Duria A.; Adam, Ishag; Gasim, Gasim I.			Serum Calcium, Magnesium, Zinc and Copper Levels in Sudanese Women with Preeclampsia	PLOS ONE			English	Article							PREGNANT-WOMEN; TRACE-ELEMENTS; ANTIOXIDANT ENZYMES; OXIDATIVE STRESS; HEALTH; MANGANESE; ANEMIA; RISK; IRON	Background Although the exact pathophysiology of preeclampsia is not fully understood, several elemental micronutrient abnormalities have been suggested to play a contributory role in preeclampsia. Aims To investigate the levels of calcium, magnesium, zinc and copper in women with preeclampsia. Subjects and Methods A case-control study was conducted in Omdurman Maternity Hospital, Sudan, during the period of September through December 2014. The cases were women with preeclampsia while healthy pregnant women were the controls. The medical and obstetrics history was gathered using questionnaires. The serum levels of calcium, magnesium, zinc and copper were measured using atomic absorption spectrophotometer. Results There was no significant difference between the two groups in their age, gestational age, parity and body mass index. Zinc and copper levels were not significantly different between the two groups. In comparison with the controls, women with preeclampsia had a significantly lower median (inter-quartile) serum calcium [7.6 (4.0-9.6) vs. 8.1 (10.6-14.2), mg/dl, P = 0.032] and higher levels of magnesium [1.9 (1.4-2.5) vs. 1.4 (1.0-1.9) mg/dl; P = 0.003]. In binary logistic regression, lower calcium (OR = 0.73, 95% CI = 0.56-0.95, P = 0.021) and higher magnesium (OR = 5.724, 95% CI = 1.23-26.50, P = 0.026) levels were associated with preeclampsia. There were no significant correlations between levels of hemoglobin and these trace elements. Conclusion The current study showed significant associations between preeclampsia and serum levels of calcium and magnesium.	[Elmugabil, Abdelmageed] El Imam El Mandi Univ, Fac Med, Kosti, Sudan; [Hamdan, Hamdan Z.; Gasim, Gasim I.] Alneelain Univ, Fac Med, Khartoum, Sudan; [Elsheikh, Anas E.] Omdurman Univ, Fac Med, Omdurman, Sudan; [Rayis, Duria A.; Adam, Ishag] Univ Khartoum, Fac Med, Khartoum, Sudan	University of Khartoum	Adam, I (corresponding author), Univ Khartoum, Fac Med, Khartoum, Sudan.	Ishagadam@hotmail.com	Hamdan, Hamdan Zaki/P-1290-2015; Gasim, Gasim Ibrahim Mohamed/AAF-5200-2020	Hamdan, Hamdan Zaki/0000-0001-9269-8239; gasim, gasim/0000-0002-0580-9090; Adam, Ishag/0000-0001-5031-7741				ACOG technical bulletin, 1996, INT J GYNECOL OBSTET, V53, P175; Adam I, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00032; Ali AA, 2012, J OBSTET GYNAECOL, V32, P148, DOI 10.3109/01443615.2011.637140; Ali AAA, 2011, J MATERN-FETAL NEO M, V24, P1077, DOI 10.3109/14767058.2010.545908; Amitava P, 2012, J OBSTET GYN INDIA, V62, P312, DOI 10.1007/s13224-012-0223-z; Bakheit KH, 2010, J OBSTET GYNAECOL, V30, P151, DOI 10.3109/01443610903391005; BELIZAN JM, 1988, AM J OBSTET GYNECOL, V158, P898, DOI 10.1016/0002-9378(88)90091-9; Bueno AA, 2012, J OBSTET GYNAECOL, V32, P241, DOI 10.3109/01443615.2011.641622; Bushra M, 2010, BIOL TRACE ELEM RES, V137, P255, DOI 10.1007/s12011-009-8586-4; Carlson VM, 2011, BJOG-INT J OBSTET GY, V118, P1608, DOI 10.1111/j.1471-0528.2011.03092.x; CARR CW, 1955, P SOC EXP BIOL MED, V89, P546, DOI 10.3181/00379727-89-21870; Collins JF, 2010, NUTR REV, V68, P133, DOI 10.1111/j.1753-4887.2010.00271.x; Duvekot EJ, 2002, EUR J OBSTET GYN R B, V105, P11, DOI 10.1016/S0301-2115(02)00111-2; Elhaj ET, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00087; Farzin L, 2012, J RES MED SCI, V17, P938; Hovdenak N, 2012, EUR J OBSTET GYN R B, V164, P127, DOI 10.1016/j.ejogrb.2012.06.020; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S18; Jahnen-Dechent W, 2012, CLIN KIDNEY J, V5, P3, DOI 10.1093/ndtplus/sfr163; Jain S, 2010, BIOL TRACE ELEM RES, V133, P162, DOI 10.1007/s12011-009-8423-9; Jaiser SR, 2010, J NEUROL, V257, P869, DOI 10.1007/s00415-010-5511-x; Katz O, 2012, J MATERN-FETAL NEO M, V25, P1127, DOI 10.3109/14767058.2011.624221; Levine RJ, 1997, NEW ENGL J MED, V337, P69, DOI 10.1056/NEJM199707103370201; Mistry Hiten, 2013, Pregnancy Hypertens, V3, P76, DOI 10.1016/j.preghy.2013.04.054; Mistry HD, 2015, FREE RADICAL BIO MED, V78, P147, DOI 10.1016/j.freeradbiomed.2014.10.580; Mohamed AA, 2011, BIOL TRACE ELEM RES, V140, P284, DOI 10.1007/s12011-010-8704-3; Negi R, 2012, CLIN NUTR, V31, P946, DOI 10.1016/j.clnu.2012.04.005; Pathak Priyali, 2004, Indian Journal of Pediatrics, V71, P1003, DOI 10.1007/BF02828116; Peacock M, 2010, CLIN J AM SOC NEPHRO, V5, pS23, DOI 10.2215/CJN.05910809; Poston L, 2011, AM J CLIN NUTR, V94, p1980S, DOI 10.3945/ajcn.110.001156; Power ML, 1999, AM J OBSTET GYNECOL, V181, P1560, DOI 10.1016/S0002-9378(99)70404-7; Roohani N, 2013, J RES MED SCI, V18, P144; Sarwar MS, 2013, BIOL TRACE ELEM RES, V154, P14, DOI 10.1007/s12011-013-9721-9; Sheela CN, 2011, J OBSTET GYN INDIA, V61, P72, DOI 10.1007/s13224-011-0005-z; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Sissi C, 2009, NUCLEIC ACIDS RES, V37, P702, DOI 10.1093/nar/gkp024; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Sukonpan Kanchapan, 2005, Archives of Gynecology and Obstetrics, V273, P12, DOI 10.1007/s00404-004-0672-4; Touyz R. M., 2003, Molecular Aspects of Medicine, V24, P107, DOI 10.1016/S0098-2997(02)00094-8; Vafaei H, 2015, INT J REPROD BIOMED, V13, P23; Walsh SB, 2015, MAYO CLIN PROC, V90, P993, DOI 10.1016/j.mayocp.2015.06.011; Wang S, 2002, ARCH PATHOL LAB MED, V126, P947	42	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167495	10.1371/journal.pone.0167495	http://dx.doi.org/10.1371/journal.pone.0167495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911936	Green Published, Green Submitted, gold			2022-12-27	WOS:000389520600039
J	Braga, LM; Prado, GF; Umeda, IIK; Kawauchi, TS; Taboada, AMF; Azevedo, RS; Pereira, HG; Grupi, CJ; Souza, HCC; Moreira, DAR; Nakagawa, NK				Braga, Lays Magalhaes; Prado, Gustavo Faibischew; Kikuchi Umeda, Iracema Ioco; Kawauchi, Tatiana Satie; Froes Taboada, Adriana Marques; Azevedo, Raymundo Soares; Pereira Filho, Horacio Gomes; Grupi, Cesar Jose; Cavenague Souza, Hayala Cristina; Ribeiro Moreira, Dalmo Antonio; Nakagawa, Naomi Kondo			Reproducibility for Heart Rate Variability Analysis during 6-Min Walk Test in Patients with Heart Failure and Agreement between Devices	PLOS ONE			English	Article							RATE MONITOR; POLAR S810; RELIABILITY; SECONDARY; INTERVALS; THERAPY; DEATH; TRIAL; TIME; ECG	Heart rate variability (HRV) analysis is a useful method to assess abnormal functioning in the autonomic nervous system and to predict cardiac events in patients with heart failure (HF). HRV measurements with heart rate monitors have been validated with an electrocardiograph in healthy subjects but not in patients with HF. We explored the reproducibility of HRV in two consecutive six-minute walk tests (6MW), 60-minute apart, using a heart rate monitor (PolarS810i) and a portable electrocardiograph (called Holter) in 50 HF patients (mean age 59 years, NYHA II, left ventricular ejection fraction similar to 35%). The reproducibility for each device was analysed using a paired t-test or the Wilcoxon signed-rank test. Additionally, we assessed the agreement between the two devices based on the HRV indices at rest, during the 6MW and during recovery using concordance correlation coefficients (CCC), 95% confidence intervals and Bland-Altman plots. The test-retest for the HRV analyses was reproducible using Holter and PolarS810i at rest but not during recovery. In the second 6MW, patients showed significant increases in rMSSD and walking distance. The PolarS810i measurements had remarkably high concordance correlation [0.86<CCC<0.99] based on Holter at rest, during 6MW and recovery. At higher rates, a small effect in increasing differences between Holter and Polar in R-R intervals was observed. In conclusion, our study showed good reproducibility of HRV at rest in two consecutive 6MW using Holter and PolarS810i. Additionally, PolarS810i produced good agreements in short-term HRV indices based on Holter simultaneous recordings at rest, during the 6MW and recovery in HF patients.	[Braga, Lays Magalhaes; Kawauchi, Tatiana Satie; Nakagawa, Naomi Kondo] Univ Sao Paulo, Dept Physiotherapy, Fac Med, Sao Paulo, Brazil; [Prado, Gustavo Faibischew] Univ Sao Paulo, Fac Med, Hosp Clin, Pulm Div,Heart Inst InCor, Sao Paulo, Brazil; [Kikuchi Umeda, Iracema Ioco; Froes Taboada, Adriana Marques; Cavenague Souza, Hayala Cristina; Ribeiro Moreira, Dalmo Antonio] Dante Pazzanese Inst Cardiol Sao Paulo State, Sao Paulo, Brazil; [Azevedo, Raymundo Soares] Univ Sao Paulo, Dept Pathol, Sch Med, Sao Paulo, Brazil; [Pereira Filho, Horacio Gomes; Grupi, Cesar Jose] Univ Sao Paulo, Fac Med, Hosp Clin, Cardiol Div,Heart Inst InCor, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Nakagawa, NK (corresponding author), Univ Sao Paulo, Dept Physiotherapy, Fac Med, Sao Paulo, Brazil.	naomi.kondo@usp.br	Souza, Hayala/ABB-4473-2020; Nakagawa, Naomi Kondo/AAM-5681-2020; Azevedo, Raymundo S/B-7593-2008; Nakagawa, Naomi Kondo/B-4602-2009; PEREIRA FILHO, HORACIO/R-1497-2016	Souza, Hayala/0000-0002-7970-5403; Nakagawa, Naomi Kondo/0000-0001-7826-6798; Azevedo, Raymundo S/0000-0003-0660-2371; Nakagawa, Naomi Kondo/0000-0001-7826-6798; Prado, Gustavo/0000-0001-8023-4904	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP 2013/13598-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2013/13598-1). The funder had no role in study design, data collection, data analysis, data interpretation, decision to publish or preparation of the manuscript.	[Anonymous], 2015, DIABETES CARE, V38, pS33, DOI 10.2337/dc15-S009; Barbosa MPCR, 2014, CLIN PHYSIOL FUNCT I; Bilchick KC, 2002, AM J CARDIOL, V90, P24, DOI 10.1016/S0002-9149(02)02380-9; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; COOK JR, 1991, J AM COLL CARDIOL, V17, P480, DOI 10.1016/S0735-1097(10)80119-6; Correa FR, 2013, INT J SPORTS MED, V34, P111, DOI 10.1055/s-0032-1321888; Correa FR, 2012, J RESP CARDIOV PHY T, V1, P37; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Gamelin FX, 2006, MED SCI SPORT EXER, V38, P887, DOI 10.1249/01.mss.0000218135.79476.9c; Porto LGG, 2009, PACE, V32, P43, DOI 10.1111/j.1540-8159.2009.02175.x; Hamilton D M, 2000, J Cardiopulm Rehabil, V20, P156, DOI 10.1097/00008483-200005000-00003; Heart rate variability: standards of measurement physiological interpretation and clinical use, 1996, AQUACULTURE, V93, P1043, DOI [10.1111/j.1542-474X.1996.tb00275.x, DOI 10.1161/STR.0b013e3182587839]; Hernandes NA, 2011, EUR RESPIR J, V38, P261, DOI 10.1183/09031936.00142010; Jiang W, 1997, AM J CARDIOL, V80, P808, DOI 10.1016/S0002-9149(97)00526-2; Kervio G, 2003, MED SCI SPORT EXER, V35, P169, DOI 10.1097/00005768-200301000-00025; Kingsley M, 2005, INT J SPORTS MED, V26, P39, DOI 10.1055/s-2004-817878; La Rovere MT, 2003, CIRCULATION, V107, P565, DOI 10.1161/01.CIR.0000047275.25795.17; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lucreziotti S, 2000, AM HEART J, V139, P1088, DOI 10.1067/mhj.2000.106168; Malfatto G, 1998, AM J CARDIOL, V81, P834, DOI 10.1016/S0002-9149(98)00021-6; NIEMELA MJ, 1994, J AM COLL CARDIOL, V23, P1370, DOI 10.1016/0735-1097(94)90379-4; Nolan J, 1998, CIRCULATION, V98, P1510, DOI 10.1161/01.CIR.98.15.1510; Nunan D, 2008, EUR J APPL PHYSIOL, V103, P529, DOI 10.1007/s00421-008-0742-6; Ponikowski P, 1997, AM J CARDIOL, V79, P1645, DOI 10.1016/S0002-9149(97)00215-4; Ponikowski P, 1996, CLIN SCI, V91, P391, DOI 10.1042/cs0910391; Radespiel-Troger M, 2003, CLIN AUTON RES, V13, P99, DOI 10.1007/s10286-003-0085-7; Caruso FCR, 2011, DISABIL REHABIL, V33, P751, DOI 10.3109/09638288.2010.511420; Sandercock GRH, 2004, PHYSIOL MEAS, V25, P1115, DOI 10.1088/0967-3334/25/5/003; Sandercock GRH, 2005, INT J CARDIOL, V103, P238, DOI 10.1016/j.ijcard.2004.09.013; Shah SA, 2013, AM J CARDIOL, V112, P533, DOI 10.1016/j.amjcard.2013.04.018; STEIN PK, 1995, AM HEART J, V129, P975, DOI 10.1016/0002-8703(95)90119-1; Vanderlei LCM, 2008, BRAZ J MED BIOL RES, V41, P854, DOI 10.1590/S0100-879X2008005000039; VANHOOGENHUYZE D, 1991, AM J CARDIOL, V68, P1668, DOI 10.1016/0002-9149(91)90327-H; Wallen MB, 2012, EUR J APPL PHYSIOL, V112, P1153, DOI 10.1007/s00421-011-2079-9; Weippert M, 2010, EUR J APPL PHYSIOL, V109, P779, DOI 10.1007/s00421-010-1415-9; Wu G, 2003, AM HEART J, V146, P129, DOI 10.1016/S0002-8703(03)00119-4	38	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167407	10.1371/journal.pone.0167407	http://dx.doi.org/10.1371/journal.pone.0167407			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936043	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100092
J	Dahl, M; Deyanova, D; Gutschow, S; Asplund, ME; Lyimo, LD; Karamfilov, V; Santos, R; Bjork, M; Gullstrom, M				Dahl, Martin; Deyanova, Diana; Gutschow, Silvia; Asplund, Maria E.; Lyimo, Liberatus D.; Karamfilov, Ventzislav; Santos, Rui; Bjork, Mats; Gullstrom, Martin			Sediment Properties as Important Predictors of Carbon Storage in Zostera marina Meadows: A Comparison of Four European Areas	PLOS ONE			English	Article							SEAGRASS POSIDONIA-OCEANICA; ORGANIC-MATTER; SULFATE REDUCTION; SURFACE-AREA; BLUE CARBON; GRAIN-SIZE; EELGRASS; BEDS; SEQUESTRATION; DECOMPOSITION	Seagrass ecosystems are important natural carbon sinks but their efficiency varies greatly depending on species composition and environmental conditions. What causes this variation is not fully known and could have important implications for management and protection of the seagrass habitat to continue to act as a natural carbon sink. Here, we assessed sedimentary organic carbon in Zostera marina meadows (and adjacent unvegetated sediment) in four distinct areas of Europe (Gullmar Fjord on the Swedish Skagerrak coast, Asko in the Baltic Sea, Sozopol in the Black Sea and Ria Formosa in southern Portugal) down to similar to 35 cm depth. We also tested how sedimentary organic carbon in Z. marina meadows relates to different sediment characteristics, a range of seagrass-associated variables and water depth. The seagrass carbon storage varied greatly among areas, with an average organic carbon content ranging from 2.79 +/- 0.50% in the Gullmar Fjord to 0.17 +/- 0.02% in the area of Sozopol. We found that a high proportion of fine grain size, high porosity and low density of the sediment is strongly related to high carbon content in Z. marina sediment. We suggest that sediment properties should be included as an important factor when evaluating high priority areas in management of Z. marina generated carbon sinks.	[Dahl, Martin; Deyanova, Diana; Gutschow, Silvia; Lyimo, Liberatus D.; Bjork, Mats; Gullstrom, Martin] Stockholm Univ, Seagrass Ecol & Physiol Res Grp, Dept Ecol Environm & Plant Sci, Stockholm, Sweden; [Asplund, Maria E.] Univ Gothenburg, Sven Loven Ctr Marine Sci, Fiskebackskil, Sweden; [Lyimo, Liberatus D.] Univ Dodoma, Sch Biol Sci, Dodoma, Tanzania; [Karamfilov, Ventzislav] Bulgarian Acad Sci, Inst Biodivers & Ecosyst Res, Sofia, Bulgaria; [Santos, Rui] Univ Algarve, ALGAE Marine Ecol Res Grp, CCMar Ctr Marine Sci, Faro, Portugal	Stockholm University; University of Gothenburg; Bulgarian Academy of Sciences; Universidade do Algarve	Dahl, M (corresponding author), Stockholm Univ, Seagrass Ecol & Physiol Res Grp, Dept Ecol Environm & Plant Sci, Stockholm, Sweden.	martin.dahl@su.se	Karamfilov, Ventzislav/AAT-6249-2021; Björk, Mats/B-4299-2010; Santos, Rui O P/B-4168-2008	Björk, Mats/0000-0003-0363-110X; Santos, Rui O P/0000-0002-7861-4366; Karamfilov, Ventzislav/0000-0002-7758-9584	Swedish research council FORMAS; Swedish International Development Cooperation Agency (Sida) through the Bilateral Marine Science Program	Swedish research council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Swedish International Development Cooperation Agency (Sida) through the Bilateral Marine Science Program	This study was funded by the Swedish research council FORMAS and the Swedish International Development Cooperation Agency (Sida) through the Bilateral Marine Science Program between Sweden and Tanzania. There was no additional external funding received for this study.	ALLER RC, 1994, CHEM GEOL, V114, P331, DOI 10.1016/0009-2541(94)90062-0; Arnosti C, 1998, MAR ECOL PROG SER, V165, P59, DOI 10.3354/meps165059; Avnimelech Y, 2001, AQUACULT ENG, V25, P25, DOI 10.1016/S0144-8609(01)00068-1; Baden S, 2003, AMBIO, V32, P374, DOI 10.1639/0044-7447(2003)032[0374:VSZMLI]2.0.CO;2; BADEN SP, 1984, OPHELIA, V23, P65, DOI 10.1080/00785236.1984.10426605; Baden SP, 2001, ECOL STU AN, V151, P213; BENNER R, 1984, APPL ENVIRON MICROB, V47, P998, DOI 10.1128/AEM.47.5.998-1004.1984; Bergamaschi BA, 1997, GEOCHIM COSMOCHIM AC, V61, P1247, DOI 10.1016/S0016-7037(96)00394-8; Bos AR, 2007, ESTUAR COAST SHELF S, V74, P344, DOI 10.1016/j.ecss.2007.04.006; Boschker HTS, 2000, MAR ECOL PROG SER, V203, P181, DOI 10.3354/meps203181; Bostrom C., 2003, WORLD ATLAS SEAGRASS, P27; Bostrom C, 2006, J EXP MAR BIOL ECOL, V335, P52, DOI 10.1016/j.jembe.2006.02.015; Bostrom C, 2014, AQUAT CONSERV, V24, P410, DOI 10.1002/aqc.2424; Burdige DJ, 2007, CHEM REV, V107, P467, DOI 10.1021/cr050347q; Cabaco S, 2010, MAR ECOL-EVOL PERSP, V31, P300, DOI 10.1111/j.1439-0485.2009.00331.x; Christianen MJA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062413; COWIE GL, 1984, GEOCHIM COSMOCHIM AC, V48, P2075, DOI 10.1016/0016-7037(84)90388-0; Cunha AH, 2013, AQUAT BOT, V104, P193, DOI 10.1016/j.aquabot.2011.08.007; Dahl M, 2016, J ECOL, V104, P654, DOI 10.1111/1365-2745.12564; DALE NG, 1974, LIMNOL OCEANOGR, V19, P509, DOI 10.4319/lo.1974.19.3.0509; Deming JW, 1993, ORGANIC GEOCHEMSTRY; den Hartog C, 1970, SEAGRASSES WORLD; Duarte CM, 2013, OCEAN COAST MANAGE, V83, P32, DOI 10.1016/j.ocecoaman.2011.09.001; Duarte CM, 1998, MAR ECOL PROG SER, V171, P97, DOI 10.3354/meps171097; ENRIQUEZ S, 1992, MAR ECOL PROG SER, V86, P201, DOI 10.3354/meps086201; ENRIQUEZ S, 1993, OECOLOGIA, V94, P457, DOI 10.1007/BF00566960; ERTEL JR, 1985, GEOCHIM COSMOCHIM AC, V49, P2097, DOI 10.1016/0016-7037(85)90067-5; FONSECA MS, 1992, ESTUAR COAST SHELF S, V35, P565, DOI 10.1016/S0272-7714(05)80039-3; Fonseca MS, 1984, N AM J FISH, V4, P37; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; Frederiksen MS, 2006, LIMNOL OCEANOGR, V51, P2308, DOI 10.4319/lo.2006.51.5.2308; Fredriksen S, 2010, MAR BIOL RES, V6, P189, DOI 10.1080/17451000903042461; GAUDETTE HE, 1974, J SEDIMENT PETROL, V44, P249; Gee G.W., 1986, METHODS SOIL ANAL PA, P383; Glew Jr, 2002, DEV PALEOENVIRON RES, V1, P73; Green E.P., 2003, WORLD ATLAS SEAGRASS; Gullstrom M, BLUE CARBON ST UNPUB; Gullstrom M, 2012, MAR BIOL, V159, P413, DOI 10.1007/s00227-011-1819-z; Harris D, 2001, SOIL SCI SOC AM J, V65, P1853, DOI 10.2136/sssaj2001.1853; HEDGES JI, 1995, MAR CHEM, V49, P81, DOI 10.1016/0304-4203(95)00008-F; Hendriks IE, 2008, MAR ECOL PROG SER, V356, P163, DOI 10.3354/meps07316; HENRICHS SM, 1992, MAR CHEM, V39, P119, DOI 10.1016/0304-4203(92)90098-U; Holmer M, 2002, J EXP MAR BIOL ECOL, V270, P25, DOI 10.1016/S0022-0981(02)00015-1; Holmer M, 2006, MAR ECOL PROG SER, V320, P141, DOI 10.3354/meps320141; Holmer M, 2016, AQUAT BOT, V133, P1, DOI 10.1016/j.aquabot.2016.05.001; Idestam-Almquist J, 2000, J VEG SCI, V11, P425, DOI 10.2307/3236635; Jarvis JC, 2014, ESTUAR COAST, P964; Jephson T, 2008, MAR ECOL PROG SER, V369, P63, DOI 10.3354/meps07646; Jerling L, 1977, VEGETATIONS ZONERING; KEIL RG, 1994, NATURE, V370, P549, DOI 10.1038/370549a0; Kelleway JJ, 2016, ECOSYSTEMS, V19, P865, DOI 10.1007/s10021-016-9972-3; Kennedy H, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003848; Kenworthy WJ, 2014, MAR POLLUT BULL, V83, P446, DOI 10.1016/j.marpolbul.2013.11.006; KENWORTHY WJ, 1984, B MAR SCI, V35, P364; Klap VA, 2000, MAR ECOL PROG SER, V194, P1, DOI 10.3354/meps194001; Lavery PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073748; Loo L-O, 2015, HAVET 1888, P42; Marba N, 2015, J ECOL, V103, P296, DOI 10.1111/1365-2745.12370; MAYER LM, 1994, GEOCHIM COSMOCHIM AC, V58, P1271, DOI 10.1016/0016-7037(94)90381-6; MAYER LM, 1994, CHEM GEOL, V114, P347, DOI 10.1016/0009-2541(94)90063-9; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Moore KA, 2003, SEAGRASSES BIOL ECOL, P361; Newton A, 2003, ESTUAR COAST SHELF S, V57, P73, DOI 10.1016/S0272-7714(02)00332-3; Nyqvist A, 2009, AMBIO, V38, P85, DOI 10.1579/0044-7447-38.2.85; OLESEN B, 1994, MAR ECOL PROG SER, V109, P283, DOI 10.3354/meps109283; Peralta G, 2008, MAR ECOL PROG SER, V368, P103, DOI 10.3354/meps07574; Petrova-Karadjova V., 1982, P I FISHERIES, V19, P97; Phillips R., 1988, SMITHSONIAN CONTRIBU; POLLARD PC, 1991, MAR ECOL PROG SER, V69, P149, DOI 10.3354/meps069149; Reusch TBH, 1999, MAR ECOL PROG SER, V183, P301, DOI 10.3354/meps183301; Ricart AM, 2015, MAR POLLUT BULL, V100, P476, DOI 10.1016/j.marpolbul.2015.09.032; Rohr ME, 2016, BIOGEOSCIENCES, V13, P6139, DOI 10.5194/bg-13-6139-2016; Rozaimi M., 2013, J ROY SOC W AUST, V96, P81; Rueda JL, 2008, ESTUAR COAST SHELF S, V79, P157, DOI 10.1016/j.ecss.2008.03.018; Sahm K, 1999, ENVIRON MICROBIOL, V1, P65, DOI 10.1046/j.1462-2920.1999.00007.x; Salo T, 2014, J EXP MAR BIOL ECOL, V461, P425, DOI 10.1016/j.jembe.2014.09.010; Samper-Villarreal J, 2016, LIMNOL OCEANOGR, V61, P938, DOI 10.1002/lno.10262; Serrano O, 2012, GEODERMA, V185, P26, DOI 10.1016/j.geoderma.2012.03.020; Serrano O, 2016, BIOGEOSCIENCES, V13, P4915, DOI 10.5194/bg-13-4915-2016; Serrano O, 2016, BIOGEOSCIENCES, V13, P4581, DOI 10.5194/bg-13-4581-2016; Serrano O, 2014, GLOBAL BIOGEOCHEM CY, V28, P950, DOI 10.1002/2014GB004872; Short F, 2007, J EXP MAR BIOL ECOL, V350, P3, DOI 10.1016/j.jembe.2007.06.012; Skov H, 2012, MOPODECO MODELING PO; Sun FF, 2015, APPL ENVIRON MICROB, V81, P6901, DOI 10.1128/AEM.01382-15; Suykerbuyk W, 2015, ECOSYSTEMS; Thormar J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146479; van Katwijk MM, 2010, ESTUAR COAST SHELF S, V89, P175, DOI 10.1016/j.ecss.2010.06.008; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wilson AM, 2008, ESTUAR COAST SHELF S, V80, P193, DOI 10.1016/j.ecss.2008.06.011; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1	90	69	71	7	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167493	10.1371/journal.pone.0167493	http://dx.doi.org/10.1371/journal.pone.0167493			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936111	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100110
J	Huang, YW; Zhang, YT; Li, K; Zhao, J				Huang, Yuanwei; Zhang, Yanting; Li, Ke; Zhao, Jin			Changes in Prevalence of HIV or Syphilis among Male Sex Workers and Non-Commercial Men Who Have Sex with Men in Shenzhen, China: Results of a Second Survey	PLOS ONE			English	Article							RISK-FACTORS; MONEY BOYS; INFECTION; BEHAVIORS	Background A previous time-location sampling survey (TLS) was performed in 2008 to evaluate the HIV or syphilis infection rate among male sex workers (MSWs) and non-commercial men who have sex with men (ncMSM) in Shenzhen, China. This is a second TLS performed in 2014. This article describes the findings and changes in the prevalence of HIV and syphilis. Methods TLS was used to collect information as a second cross-sectional survey to an earlier TLS assessment. Data on behavior (e.g., sexual history and sexual behavior) were analyzed. Blood specimens were drawn for HIV and syphilis testing. To determine the changes in the prevalence of HIV and syphilis, we analyzed these results and compared them to the results of our first survey. Results A total of 965 participants were recruited, including 489 MSWs and 476 ncMSM. Overall, the prevalence of HIV was 9.7%: 2.9% for MSWs and 16.8% for ncMSM (P<0.001). 10.9% of the 965 participants tested positive for syphilis: 4.5% among MSWs and 17.4% among ncMSM (P<0.001). The HIV prevalence in MSWs decreased from 4.5% in 2008 to 2.9% in 2014 (P = 0.143) but increased in ncMSM (7.0% in 2008 vs 16.8% in 2014, P<0.001). Decreased syphilis rates were observed in both MSWs (12.9% in 2008 vs 4.5% in 2014, P<0.001) and ncMSM (20.2% in 2008 vs 17.4% in 2014, P = 0.221). Conclusions Overall, there was a decline in the prevalence of HIV and syphilis in MSWs but not in ncMSM. The study indicated the need for continued efforts to improve public health, particularly to counter the rising rate of HIV in ncMSM.	[Huang, Yuanwei; Zhang, Yanting; Li, Ke] Shantou Univ, Coll Med, Dept Prevent Med, Shantou, Guangdong, Peoples R China; [Zhao, Jin] Shenzhen Ctr Dis Control & Prevent, Shenzhen, Guangdong, Peoples R China	Shantou University; Shenzhen Center for Disease Control & Prevention (SZCDC)	Li, K (corresponding author), Shantou Univ, Coll Med, Dept Prevent Med, Shantou, Guangdong, Peoples R China.; Zhao, J (corresponding author), Shenzhen Ctr Dis Control & Prevent, Shenzhen, Guangdong, Peoples R China.	keli1122@126.com; szhaojin@gmail.com			National Natural Science Foundation of China [81573211, 81270043]; National Natural Science Foundation of Guangdong Province [2014A030313772]; Shenzhen Technology and Research Fund [JCYJ20140410171018515, JCYJ20140416104959068]; Medical Key Laboratory of Shenzhen	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Shenzhen Technology and Research Fund; Medical Key Laboratory of Shenzhen	This work was supported in part by grants from the National Natural Science Foundation of China (81573211 and 81270043), the National Natural Science Foundation of Guangdong Province (2014A030313772), Shenzhen Technology and Research Fund (JCYJ20140410171018515 and JCYJ20140416104959068) and the Medical Key Laboratory of Shenzhen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai X, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18848; Cai WD, 2010, SEX TRANSM INFECT, V86, P15, DOI 10.1136/sti.2009.037440; Chen L, 2016, JAIDS-J ACQ IMM DEF, V71, P316, DOI 10.1097/QAI.0000000000000833; Chow EPF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022768; Cui Y, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20609; Ghanem Khalil G, 2010, Curr Infect Dis Rep, V12, P140, DOI 10.1007/s11908-010-0083-6; He N, 2007, AIDS, V21, pS73, DOI 10.1097/01.aids.0000304700.85379.f3; Huan XP, 2015, ASIA-PAC J PUBLIC HE, V27, pNP854, DOI 10.1177/1010539513480230; Huang Qin, 2015, Zhonghua Liu Xing Bing Xue Za Zhi, V36, P1297; Liu SS, 2012, AIDS BEHAV, V16, P835, DOI 10.1007/s10461-011-9978-y; Meng XD, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-17; Shi Tong-Xin, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P668; Shimelis T, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0919-7; Stevenson J, 2006, DERMATOL CLIN, V24, P497, DOI 10.1016/j.det.2006.06.013; Tang WM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126604; Tun W, 2008, SEX TRANSM INFECT, V84, P455, DOI 10.1136/sti.2008.031336; Wu Z., 2010, 2010 2 INT C FUT COM, V2; Zhang L, 2013, LANCET INFECT DIS, V13, P955, DOI 10.1016/S1473-3099(13)70245-7; Zhang XX, 2007, AIDS, V21, pS53, DOI 10.1097/01.aids.0000304697.39637.4c; Zhao J, 2015, ARCH SEX BEHAV, V44, P2055, DOI 10.1007/s10508-014-0350-y; Zhao J, 2012, SEX TRANSM DIS, V39, P942, DOI 10.1097/OLQ.0b013e31826f356f; Zhao J, 2011, AIDS BEHAV, V15, P635, DOI 10.1007/s10461-010-9786-9	22	3	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167619	10.1371/journal.pone.0167619	http://dx.doi.org/10.1371/journal.pone.0167619			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935980	Green Submitted, gold, Green Published			2022-12-27	WOS:000389587100132
J	Iwanicki, JL; Severtson, SG; McDaniel, H; Rosenblum, A; Fong, C; Cicero, TJ; Ellis, MS; Kurtz, SP; Buttram, ME; Dart, RC				Iwanicki, Janetta L.; Severtson, S. Geoff; McDaniel, Heather; Rosenblum, Andrew; Fong, Chunki; Cicero, Theodore J.; Ellis, Matthew S.; Kurtz, Steven P.; Buttram, Mance E.; Dart, Richard C.			Abuse and Diversion of Immediate Release Opioid Analgesics as Compared to Extended Release Formulations in the United States	PLOS ONE			English	Article							DETERRENT FORMULATIONS; MISUSE; MODEL	Background Therapeutic use and abuse of prescription opioids in the United States increased substantially between 1990 and 2010. The Centers for Disease Control estimated deaths related to pharmaceutical opioids reached nearly 19,000 in 2014. Of prescription opioids sold, 10% are extended release (ER) and 90% immediate release (IR). However, most regulations and interventions have focused on decreasing ER abuse. Our objective was to compare rates of abuse and diversion of ER and IR opioid analgesics over time using multiple surveillance programs. Methods Rates of abuse and diversion of ER and IR opioid formulations were compared using data from four surveillance programs in the Researched Abuse, Diversion and Addiction Related Surveillance (RADARS (R)) System. Data were evaluated from 2009 through 2015, and Poisson regression used to compare IR and ER opioid cases over time. Results From 2009 to 2015, IR opioids were prescribed at a rate 12 to 16 times higher than ER. In the Poison Center Program, population-adjusted rates of Intentional Abuse for IR were 4.6 fold higher than ER opioids (p<0.001). In the Drug Diversion Program, population-adjusted rates of diversion were 6.1 fold higher for IR than ER opioids (p<0.001). In the Opioid Treatment Program, population-adjusted rates of endorsements for abuse were 1.6 fold higher for IR opioids than ER (p = 0.002). In the Survey of Key Informants' Patients Program, population-adjusted rates of endorsements for abuse were 1.5 fold higher for IR opioids than ER (p<0.001). Conclusions Between 2009 and 2015, IR opioids were prescribed at a much higher rate than ER opioids. Results from four surveillance programs show population-adjusted rates of prescription opioid abuse were markedly higher for IR than ER medications. For the greatest public health benefit, future interventions to decrease prescription opioid abuse should focus on both IR and ER formulations.	[Iwanicki, Janetta L.; Severtson, S. Geoff; McDaniel, Heather; Dart, Richard C.] Denver Hlth & Hosp Author, Rocky Mt Poison & Drug Ctr, Denver, CO 80204 USA; [Rosenblum, Andrew; Fong, Chunki] Natl Dev & Res Inst Inc, New York, NY USA; [Cicero, Theodore J.; Ellis, Matthew S.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Kurtz, Steven P.; Buttram, Mance E.] Nova Southeastern Univ, Ctr Appl Res Subst Use & Hlth Dispar, Ft Lauderdale, FL 33314 USA	Denver Health Medical Center; National Development & Research Institutes, Inc; Washington University (WUSTL); Nova Southeastern University	Iwanicki, JL (corresponding author), Denver Hlth & Hosp Author, Rocky Mt Poison & Drug Ctr, Denver, CO 80204 USA.	Janetta.iwanicki@rmpdc.org		Ellis, Matthew/0000-0003-3753-9651; Dart, Richard/0000-0001-5989-9354; Iwanicki, Janetta/0000-0001-9608-391X	pharmaceutical manufacturers for surveillance, research and reporting services	pharmaceutical manufacturers for surveillance, research and reporting services	The RADARS System is supported by subscriptions from pharmaceutical manufacturers for surveillance, research and reporting services. RADARS System is the property of Denver Health and Hospital Authority, a political subdivision of the State of Colorado. Denver Health retains exclusive ownership of all data, databases and systems. Subscribers do not participate in in data collection or analysis, nor do they have access to the raw data. This study was not sponsored or funded by any subscriber. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Budman SH, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-8; Butler SF, 2011, HARM REDUCT J, V8, DOI 10.1186/1477-7517-8-29; Califf RM, 2016, NEJM; Chou R, 2009, J PAIN, V10, P131, DOI 10.1016/j.jpain.2008.10.009; Cicero TJ, 2015, JAMA PSYCHIAT, V72, P424, DOI 10.1001/jamapsychiatry.2014.3043; Cleland CM, 2011, SUBST ABUSE TREAT PR, V6, DOI 10.1186/1747-597X-6-11; Comer SD, 2012, PAIN, V153, P2315, DOI 10.1016/j.pain.2012.07.035; Conrad C, 2015, MMWR-MORBID MORTAL W, V64, P443; Coplan PM, 2013, PHARMACOEPIDEM DR S, V22, P1274, DOI 10.1002/pds.3522; Dart RC, 2015, NEJM S, V372, P1; Dart RC, 2015, NEW ENGL J MED, V372, P241, DOI [10.1056/NEJMsa1406143, 10.1056/NEJMc1501822]; Dasgupta N, 2006, DRUG ALCOHOL DEPEN, V82, P135, DOI 10.1016/j.drugalcdep.2005.08.019; Dasgupta N, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2810; Davis JM, 2014, PHARMACOEPIDEM DR S, V23, P18, DOI 10.1002/pds.3533; FDA Guidance for Industry, AB DET OP EV LAB; Food and Drug Administration, 2015, 3837517 ID FDA; Franklin G, 2015, AM J PUBLIC HEALTH, V105, P463, DOI 10.2105/AJPH.2014.302367; Harney, 2015, 2015Q3 RADARS; Hwang CS, 2015, PHARMACOEPIDEM DR S, V24, P197, DOI 10.1002/pds.3723; IMS Government Solutions Inc, 2012, NAT PRESCR AUD NPA; Johnson H, 2014, MMWR-MORBID MORTAL W, V63, P569; Jones CM, 2013, JAMA-J AM MED ASSOC, V309, P657, DOI 10.1001/jama.2013.272; Lankenau SE, 2012, INT J DRUG POLICY, V23, P37, DOI 10.1016/j.drugpo.2011.05.014; Paone D, 2015, MMWR-MORBID MORTAL W, V64, P491; Severtson SG, 2016, DRUG ALCOHOL DEPEND; Smith MY, 2008, PHARMACOEPIDEM DR S, V17, P1050, DOI 10.1002/pds.1658; Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality, DAWN REP HIGHL 2011; Surratt HL, 2014, PHARMACOEPIDEM DR S, V23, P314, DOI 10.1002/pds.3553; Volkow ND, 2011, JAMA-J AM MED ASSOC, V305, P1299, DOI 10.1001/jama.2011.401; Wakeland W, 2015, AM J DRUG ALCOHOL AB, V41, P508, DOI 10.3109/00952990.2015.1043435	30	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167499	10.1371/journal.pone.0167499	http://dx.doi.org/10.1371/journal.pone.0167499			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936038	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100111
J	Liu, Z; Tian, L; Chang, Q; Sun, BZ; Zhao, YH				Liu, Zhuang; Tian, Lei; Chang, Qing; Sun, Baozhi; Zhao, Yuhong			A Competency Model for Clinical Physicians in China: A Cross-Sectional Survey	PLOS ONE			English	Article							MINIMUM ESSENTIAL REQUIREMENTS; EXPLORATORY FACTOR-ANALYSIS; MEDICAL-EDUCATION; CULTURAL COMPETENCE; HEALTH; CARE	Background Around the world, regulatory bodies have taken the lead in determining the competencies required to become a physician. As a first step in addressing this project, it was decided to develop a set of core competencies that were unique to China and that might serve as a basis for medical education. The purpose of this paper was to construct a competency model for clinical physicians in China. Methods Data was collected using a cross-sectional survey of 6247 clinicians from seven administrative regions (31 provinces, autonomous regions and municipalities directly under the central government) in China. The total sample was randomly divided into two sub-samples, an initial sample (Sample 1) and a replication sample (Sample 2). Independent exploratory factor analysis was conducted in each sample and the results were compared to determine the stability. After that the confirmatory factor analysis was used to ascertain the competency model for physicians. The reliability, convergent and discriminant validity of competency-based instrument were also examined. Results 76 items with 8 dimensions were identified, accounting for 68.41% of the construct's total variance in the initial sample and 67.47% in the replication sample. For the two samples, the overall scale reliability (Cronbach's alpha) was both 0.985 with dimensions from 0.905 to 0.954 for the initial sample and from 0.902 to 0.955 for the replication sample after deleting the items. In confirmatory factor analysis, the result showed that all items had acceptable goodness of fit index. RMSEA and SRMR were less than 0.08 (RMSEA = 0.046, SRMR = 0.040), while GFI, NFI, IFI, and CFI were higher than 0.9 (GFI = 0.905, NFI = 0.903, IFI = 0.909, CFI = 0.909), leading to acceptable construct validity. All construct reliability values of the factors were higher than 0.70, and all average variance extracted values exceeded 0.50. Thus, we considered the reliability and validity of the 8 dimensions were acceptable. Conclusions The instrument was shown to be both valid and reliable for measuring clinical physicians' competency in China. The results of the competency-based instrument can be used by ministry of health and administrators of hospitals to assess physicians' competencies, encourage and guide them to modify their behaviors according to the evaluation criteria, and also cultivate physicians with strong clinical practice, innovation and independent scientific research ability. Through these measurements and understandings, the overall level of clinical physicians will be increased in China.	[Liu, Zhuang] China Med Univ, Sch Publ Hlth, Shenyang, Liaoning, Peoples R China; [Tian, Lei; Sun, Baozhi] China Med Univ, Res Ctr Med Educ, Shenyang, Liaoning, Peoples R China; [Chang, Qing; Zhao, Yuhong] China Med Univ, Shengjing Hosp, Dept Clin Epidemiol, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University	Zhao, YH (corresponding author), China Med Univ, Shengjing Hosp, Dept Clin Epidemiol, Shenyang, Liaoning, Peoples R China.	yuhongzhaocmu@126.com			National Science Foundation of China [71473268]; Foundation of China Medical Board (CMB) [11-077, 11-047]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of China Medical Board (CMB)	This study was financed by the National Science Foundation of China (Grant No. 71473268), Foundation of China Medical Board (CMB#11-077), and Foundation of China Medical Board (CMB#11-047).	Aarons GA, 2010, PSYCHOL ASSESSMENT, V22, P356, DOI 10.1037/a0019188; Anderson WA, 2011, SCIENCE, V334, P760, DOI 10.1126/science.334.6057.760-b; BAGOZZI RP, 1981, MULTIVAR BEHAV RES, V16, P437, DOI 10.1207/s15327906mbr1604_2; Bhutta Z, 2010, LANCET, V376, P1375; Breen P, 2009, PERSPECTIVES ISSUES, V12, P64; Brown T.A., 2006, CONFIRMATORY FACTOR, Vxiii; Carraccio C, 2002, ACAD MED, V77, P361, DOI 10.1097/00001888-200205000-00003; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Dunn G, 1995, J AM STAT ASS, V90; Ellis SJ, 2003, J BONE JOINT SURG BR, V85, P238; Epstein RM, 2002, JAMA-J AM MED ASSOC, V287, P226, DOI 10.1001/jama.287.2.226; Frank JR, 2010, MED TEACH, V32, P638, DOI 10.3109/0142159X.2010.501190; Frank Jason R, 2005, CANMEDS 2005 PHYS CO; Green KT, 2014, ASSESSMENT, V21, P443, DOI 10.1177/1073191114524014; Hagopian A, 2008, PUBLIC HEALTH REP, V123, P408, DOI 10.1177/003335490812300325; Hair JF, 2010, TECHNOMETRICS, V31, P648; Hancock Gregory R., 2010, REV GUIDE QUANTITATI; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hungin P, 2004, DIGEST LIVER DIS, V36, P309, DOI 10.1016/j.dld.2004.01.017; Iobst WF, 2010, MED TEACH, V32, P651, DOI 10.3109/0142159X.2010.500709; Irvine D, 2001, LANCET, V358, P1807, DOI 10.1016/S0140-6736(01)06800-3; Izquierdo I, 2014, PSICOTHEMA, V26, P395, DOI 10.7334/psicothema2013.349; Leung WC, 2002, BRIT MED J, V325, P693, DOI 10.1136/bmj.325.7366.693; Liu P, 2011, CHINESE J HLTH ED, V27, P366; Liu Y, 2010, EDUC PSYCHOL MEAS, V70, P5, DOI 10.1177/0013164409344548; Olaussen SJ, 2016, AUST J PRIM HEALTH, V22, P100, DOI 10.1071/PY14114; Osborne JW, 2012, PRACTICAL ASSESSMENT, V17, P8; Palmer KT, 2002, OCCUP MED-OXFORD, V52, P341, DOI 10.1093/occmed/52.6.341; Renzaho AMN, 2013, INT J QUAL HEALTH C, V25, P261, DOI 10.1093/intqhc/mzt006; Renzaho A, 2008, AUST HEALTH REV, V32, P223, DOI 10.1071/AH080223; Riggs E, 2014, COMMUNITY DENT ORAL, V42, P43, DOI 10.1111/cdoe.12058; Satava Richard M, 2009, J Grad Med Educ, V1, P172, DOI 10.4300/JGME-D-09-00075.1; Schwarz MR, 2002, MED TEACH, V24, P125, DOI 10.1080/01421590220120740; Stern DT, 2003, MED TEACH, V25, P589, DOI 10.1080/0142159032000151295; Swing SR, 2007, MED TEACH, V29, P648, DOI 10.1080/01421590701392903; Thompson B, 2004, EXPLORATORY CONFIRMA; Tuan Yi-Fu, 2008, HIST GEOGRAPHY CHINA	38	11	12	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166252	10.1371/journal.pone.0166252	http://dx.doi.org/10.1371/journal.pone.0166252			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27935991	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100022
J	Miller, R; Jelbert, SA; Taylor, AH; Cheke, LG; Gray, RD; Loissel, E; Clayton, NS				Miller, Rachael; Jelbert, Sarah A.; Taylor, Alex H.; Cheke, Lucy G.; Gray, Russell D.; Loissel, Elsa; Clayton, Nicola S.			Performance in Object-Choice Aesop's Fable Tasks Are Influenced by Object Biases in New Caledonian Crows but not in Human Children	PLOS ONE			English	Article							CONVERGENT EVOLUTION; CORVUS-MONEDULOIDES; COGNITION; CORVIDS	The ability to reason about causality underlies key aspects of human cognition, but the extent to which non-humans understand causality is still largely unknown. The Aesop's Fable paradigm, where objects are inserted into water-filled tubes to obtain out-of-reach rewards, has been used to test casual reasoning in birds and children. However, success on these tasks may be influenced by other factors, specifically, object preferences present prior to testing or arising during pre-test stone-dropping training. Here, we assessed this 'objectbias' hypothesis by giving New Caledonian crows and 5-10 year old children two objectchoice Aesop's Fable experiments: sinking vs. floating objects, and solid vs. hollow objects. Before each test, we assessed subjects' object preferences and/or trained them to prefer the alternative object. Both crows and children showed pre-test object preferences, suggesting that birds in previous Aesop's Fable studies may also have had initial preferences for objects that proved to be functional on test. After training to prefer the non-functional object, crows, but not children, performed more poorly on these two object-choice Aesop's Fable tasks than subjects in previous studies. Crows dropped the non-functional objects into the tube on their first trials, indicating that, unlike many children, they do not appear to have an a priori understanding of water displacement. Alternatively, issues with inhibition could explain their performance. The crows did, however, learn to solve the tasks over time. We tested crows further to determine whether their eventual success was based on learning about the functional properties of the objects, or associating dropping the functional object with reward. Crows inserted significantly more rewarded, non-functional objects than non-rewarded, functional objects. These findings suggest that the ability of New Caledonian crows to produce performances rivaling those of young children on object-choice Aesop's Fable tasks is partly due to pre-existing object preferences.	[Miller, Rachael; Jelbert, Sarah A.; Cheke, Lucy G.; Loissel, Elsa; Clayton, Nicola S.] Univ Cambridge, Dept Psychol, Cambridge, England; [Taylor, Alex H.; Gray, Russell D.] Univ Auckland, Sch Psychol, Auckland, New Zealand; [Gray, Russell D.] Max Planck Gesell, Max Planck Inst Sci Human Hist, Jena, Germany	University of Cambridge; University of Auckland; Max Planck Society	Jelbert, SA (corresponding author), Univ Cambridge, Dept Psychol, Cambridge, England.	saj48@cam.ac.uk	Taylor, Alex H/D-6428-2012	Loissel, Elsa/0000-0002-1272-7448; Jelbert, Sarah/0000-0002-7503-0648; Cheke, Lucy/0000-0001-5588-7575; Clayton, Nicola/0000-0003-1835-423X; Miller (Harrison), Rachael/0000-0003-2996-9571	European Research Council under the European Union's Seventh Framework Programme (FP7) / ERC [3399933]; Rutherford Discovery Fellowship from the Royal Society of New Zealand	European Research Council under the European Union's Seventh Framework Programme (FP7) / ERC(European Research Council (ERC)); Rutherford Discovery Fellowship from the Royal Society of New Zealand(Royal Society of New Zealand)	This research was funded by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013) / ERC Grant Agreement No. 3399933, awarded to NSC (funding RM, SAJ, EL & NSC). AHT was funded by a Rutherford Discovery Fellowship from the Royal Society of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1990, DEV TIME COURSE HUMA; Bird CD, 2009, P NATL ACAD SCI USA, V106, P10370, DOI 10.1073/pnas.0901008106; Bird CD, 2009, CURR BIOL, V19, P1410, DOI 10.1016/j.cub.2009.07.033; Bluff LA, 2010, P ROY SOC B-BIOL SCI, V277, P1377, DOI 10.1098/rspb.2009.1953; Call J, 1999, CHILD DEV, V70, P381, DOI 10.1111/1467-8624.00028; Chappell J, 2004, ANIM COGN, V7, P121, DOI 10.1007/s10071-003-0202-y; Cheke LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040574; Cheke LG, 2011, ANIM COGN, V14, P441, DOI 10.1007/s10071-011-0379-4; Clayton NS, 2015, Q J EXP PSYCHOL, V68, P209, DOI 10.1080/17470218.2014.943673; DENNETT DC, 1983, BEHAV BRAIN SCI, V6, P343, DOI 10.1017/S0140525X00016393; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Heinrich B, 2005, ETHOLOGY, V111, P962, DOI 10.1111/j.1439-0310.2005.01133.x; Herrmann E, 2007, SCIENCE, V317, P1360, DOI 10.1126/science.1146282; Hofmann MM, 2016, ANIM COGN; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; Jacobs IF, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2504; Jelbert Sarah A, 2015, Commun Integr Biol, V8, pe1035846, DOI 10.1080/19420889.2015.1035846; Jelbert SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092895; Kabadayi C, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160104; Kenward B, 2004, IBIS, V146, P652, DOI 10.1111/j.1474-919x.2004.00299.x; Logan CJ, 2015, BIORXIV; Logan CJ, 2016, PEERJ, V4, DOI 10.7717/peerj.1707; Logan CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103049; Moll FW, 2015, CURR BIOL, V25, P2196, DOI 10.1016/j.cub.2015.07.013; Penn DC, 2007, ANNU REV PSYCHOL, V58, P97, DOI 10.1146/annurev.psych.58.110405.085555; Silva FJ, 2005, LEARN BEHAV, V33, P47; Smirnova A, 2015, CURR BIOL, V25, P256, DOI 10.1016/j.cub.2014.11.063; Taylor AH, 2009, P R SOC B, V276, P247, DOI 10.1098/rspb.2008.1107; Taylor AH, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0796; Taylor AH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0837; Taylor AH, 2012, P NATL ACAD SCI USA, V109, P16389, DOI 10.1073/pnas.1208724109; Taylor AH, 2012, BEHAV BRAIN SCI, V35, P241, DOI 10.1017/S0140525X11001956; Taylor AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026887; Taylor AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009345; Veit L, 2015, P NATL ACAD SCI USA, V112, P15208, DOI 10.1073/pnas.1509760112; von Bayern AMP, 2009, CURR BIOL, V19, P1965, DOI 10.1016/j.cub.2009.10.037; Vonk J, 2015, CURR BIOL, V25, pR69, DOI 10.1016/j.cub.2014.12.001	37	3	3	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168056	10.1371/journal.pone.0168056	http://dx.doi.org/10.1371/journal.pone.0168056			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936242	Green Published, gold			2022-12-27	WOS:000389587100265
J	Rane, TD; Armani, AM				Rane, Tushar D.; Armani, Andrea M.			Two-Photon Microscopy Analysis of Gold Nanoparticle Uptake in 3D Cell Spheroids	PLOS ONE			English	Article							NANORODS; CANCER; CYTOTOXICITY; THERAPY; TISSUE	Nanomaterials can be synthesized from a wide range of material systems in numerous morphologies, creating an extremely diverse portfolio. As result of this tunability, these materials are emerging as a new class of nanotherapeutics and imaging agents. One particularly interesting nanomaterial is the gold nanoparticle. Due to its inherent biocompatibility and tunable photothermal behavior, it has made a rapid transition from the lab setting to in vivo testing. In most nanotherapeutic applications, the efficacy of the agent is directly related to the target of interest. However, the optimization of the AuNP size and shape for efficacy in vitro, prior to testing in in vivo models of a disease, has been largely limited to two dimensional monolayers of cells. Two dimensional cell cultures are unable to reproduce conditions experienced by AuNP in the body. In this article, we systematically investigate the effect of different properties of AuNP on the penetration depth into 3D cell spheroids using two- photon microscopy. The 3D spheroids are formed from the HCT116 cell line, a colorectal carcinoma cell line. In addition to studying different sizes and shapes of AuNPs, we also study the effect of an oligo surface chemistry. There is a significant difference between AuNP uptake profiles in the 2D monolayers of cells as compared to the 3D cell spheroids. Additionally, the range of sizes and shapes studied here also exhibit marked differences in uptake penetration depth and efficacy. Finally, our results demonstrate that two- photon microscopy enables quantitative AuNP localization and concentration data to be obtained at the single spheroid level without fluorescent labeling of the AuNP, thus, providing a viable technique for large scale screening of AuNP properties in 3D cell spheroids as compared to tedious and time consuming techniques like electron microscopy.	[Rane, Tushar D.; Armani, Andrea M.] Univ Southern Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90007 USA	University of Southern California	Armani, AM (corresponding author), Univ Southern Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90007 USA.	armani@usc.edu	Armani, Andrea/X-7611-2019	Armani, Andrea/0000-0001-9890-5104	Office of Naval Research [N000141410374, N000141110910]	Office of Naval Research(Office of Naval Research)	This work was supported by the Office of Naval Research [N000141410374, N000141110910], http://www.onr.nayy.mil/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkilany AM, 2010, J NANOPART RES, V12, P2313, DOI 10.1007/s11051-010-9911-8; Alkilany AM, 2009, SMALL, V5, P701, DOI 10.1002/smll.200801546; Bae KH, 2011, MOL CELLS, V31, P295, DOI 10.1007/s10059-011-0051-5; Chithrani BD, 2007, NANO LETT, V7, P1542, DOI 10.1021/nl070363y; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Dykman LA, 2014, CHEM REV, V114, P1258, DOI 10.1021/cr300441a; Gao NY, 2014, J PHYS CHEM C, V118, P13904, DOI 10.1021/jp502038v; Giljohann DA, 2007, NANO LETT, V7, P3818, DOI 10.1021/nl072471q; Giljohann DA, 2010, ANGEW CHEM INT EDIT, V49, P3280, DOI 10.1002/anie.200904359; Hainfeld JF, 2004, PHYS MED BIOL, V49, pN309, DOI 10.1088/0031-9155/49/18/N03; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Huang XH, 2006, J AM CHEM SOC, V128, P2115, DOI 10.1021/ja057254a; Jain S, 2014, BR J RADIOL; Kim D, 2007, J AM CHEM SOC, V129, P7661, DOI 10.1021/ja071471p; Kim D, 2010, ACS NANO, V4, P3689, DOI 10.1021/nn901877h; Niidome T, 2006, J CONTROL RELEASE, V114, P343, DOI 10.1016/j.jconrel.2006.06.017; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Rosi NL, 2006, SCIENCE, V312, P1027, DOI 10.1126/science.1125559; Scheinberg DA, 2010, NAT REV CLIN ONCOL, V7, P266, DOI 10.1038/nrclinonc.2010.38; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006	22	34	35	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167548	10.1371/journal.pone.0167548	http://dx.doi.org/10.1371/journal.pone.0167548			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936027	Green Submitted, gold, Green Published			2022-12-27	WOS:000389587100121
J	Shen, W; Kong, CX; Xue, Y; Liu, YQ; Cai, MH; Zhang, YX; Jiang, TY; Zhou, XS; Zhou, M				Shen, Wei; Kong, Chuixing; Xue, Ying; Liu, Yiqi; Cai, Menghao; Zhang, Yuanxing; Jiang, Tianyi; Zhou, Xiangshan; Zhou, Mian			Kinase Screening in Pichia pastoris Identified Promising Targets Involved in Cell Growth and Alcohol Oxidase 1 Promoter (P-AOX1) Regulation	PLOS ONE			English	Article							METHANOL UTILIZATION PATHWAY; YEAST HANSENULA-POLYMORPHA; SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE-SEQUENCE; PROTEIN EXPRESSION; CLONING; REPRESSION; GENE; GLUCOKINASE; HEXOKINASE	As one of the most commonly used eukaryotic recombinant protein expression systems, P. pastoris relies heavily on the AOX1 promoter (P-AOX1), which is strongly induced by methanol but strictly repressed by glycerol and glucose. However, the complicated signaling pathways involved in P-AOX1 regulation when supplemented with different carbon sources are poorly understood. Here we constructed a kinase deletion library in P. pastoris and identified 27 mutants which showed peculiar phenotypes in cell growth or PAOX1 regulation. We analyzed both annotations and possible functions of these 27 targets, and then focused on the MAP kinase Hog1. In order to locate its potential downstream components, we performed the phosphoproteome analysis on glycerol cultured WT and Delta hog1 strains and identified 157 differentially phosphorylated proteins. Our results identified important kinases involved in P. pastoris cell growth and P-AOX1 regulation, which could serve as valuable targets for further mechanistic studies.	[Shen, Wei; Kong, Chuixing; Xue, Ying; Liu, Yiqi; Cai, Menghao; Zhang, Yuanxing; Zhou, Xiangshan; Zhou, Mian] East China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai, Peoples R China; [Zhang, Yuanxing] SCICB, Shanghai, Peoples R China; [Jiang, Tianyi] Roche R&D Ctr China Ltd, Shanghai, Peoples R China	East China University of Science & Technology; Roche Holding	Zhou, XS; Zhou, M (corresponding author), East China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai, Peoples R China.	xszhou@ecust.edu.cn; mianzhou@ecust.edu.cn			Chinese National High Technology Research and Development Program [2014AA093501]; National Natural Science Foundation of China [31600056]; National Special Fund for State Key Laboratory of Bioreactor [2060204]; Shanghai Pujiang Program [15PJ1401600]; Roche RD (China) Ltd	Chinese National High Technology Research and Development Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Special Fund for State Key Laboratory of Bioreactor; Shanghai Pujiang Program(Shanghai Pujiang Program); Roche RD (China) Ltd	This work was sponsored by Chinese National High Technology Research and Development Program (2014AA093501), National Natural Science Foundation of China (31600056), National Special Fund for State Key Laboratory of Bioreactor (2060204), and Shanghai Pujiang Program (15PJ1401600). Roche R&D (China) Ltd provided support in the form of salary for author [TJ], but did not have additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author are articulated in the "author contributions" section.	Ahuatzi D, 2007, J BIOL CHEM, V282, P4485, DOI 10.1074/jbc.M606854200; BOONCHIRD C, 1991, MOL GEN GENET, V226, P154, DOI 10.1007/BF00273599; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; Corvey C, 2005, J BIOL CHEM, V280, P25323, DOI 10.1074/jbc.M503719200; Cregg JM, 2000, MOL BIOTECHNOL, V16, P23, DOI 10.1385/MB:16:1:23; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; DeVit MJ, 1997, MOL BIOL CELL, V8, P1603, DOI 10.1091/mbc.8.8.1603; Edmunds JW, 2004, J CELL SCI, V117, P3715, DOI 10.1242/jcs.01346; Hartner FS, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-39; Houard S, 2002, BIOCHIMIE, V84, P1089, DOI 10.1016/S0300-9084(02)00011-1; Karp H, 2003, CURR GENET, V44, P268, DOI 10.1007/s00294-003-0448-6; KORCH C, 1991, MOL GEN GENET, V229, P96, DOI 10.1007/BF00264218; Kramarenko T, 2000, FOLIA MICROBIOL, V45, P521, DOI 10.1007/BF02818721; Laht S, 2002, GENE, V296, P195, DOI 10.1016/S0378-1119(02)00859-4; Lin-Cereghino GP, 2006, MOL CELL BIOL, V26, P883, DOI 10.1128/MCB.26.3.883-897.2006; Lu YJ, 2016, INFLAMMATION, V39, P10, DOI 10.1007/s10753-015-0217-y; Mizuno T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005491; Molin M, 2003, J BIOL CHEM, V278, P1415, DOI 10.1074/jbc.M203030200; Okuzaki D, 1997, GENES CELLS, V2, P753, DOI 10.1046/j.1365-2443.1997.1590358.x; Parua PK, 2012, MOL MICROBIOL, V85, P282, DOI 10.1111/j.1365-2958.2012.08112.x; PAVLIK P, 1993, CURR GENET, V24, P21, DOI 10.1007/BF00324660; Piao HL, 2012, TRAFFIC, V13, P1522, DOI 10.1111/j.1600-0854.2012.01406.x; Polupanov AS, 2012, INT J BIOCHEM CELL B, V44, P1906, DOI 10.1016/j.biocel.2012.07.017; Vilella F, 2005, J BIOL CHEM, V280, P9149, DOI 10.1074/jbc.M411062200; Weinhandl K, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-5; Zhang P, 2010, APPL ENVIRON MICROB, V76, P6108, DOI 10.1128/AEM.00607-10	26	19	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167766	10.1371/journal.pone.0167766	http://dx.doi.org/10.1371/journal.pone.0167766			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936065	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100180
J	Singhi, D; Jain, A; Srivastava, P				Singhi, Divya; Jain, Aayushi; Srivastava, Preeti			Localization of Low Copy Number Plasmid pRC4 in Replicating Rod and Non-Replicating Cocci Cells of Rhodococcus erythropolis PR4	PLOS ONE			English	Article							ESCHERICHIA-COLI CHROMOSOME; MULTICOPY PLASMIDS; BACTERIAL PLASMIDS; BACILLUS-SUBTILIS; VIBRIO-CHOLERAE; SEGREGATION; TERMINUS; GENE; MECHANISMS; DIVISION	Rhodococcus are gram-positive bacteria, which can exist in two different shapes rod and cocci. A number of studies have been done in the past on replication and stability of small plasmids in this bacterium; however, there are no reports on spatial localization and segregation of these plasmids. In the present study, a low copy number plasmid pDS3 containing pRC4 replicon was visualized in growing cells of Rhodococcus erythropolis PR4 (NBRC100887) using P1 parS-ParB-GFP system. Cells were initially cocci and then became rod shaped in exponential phase. Cocci cells were found to be non-replicating as evident by the presence of single fluorescence focus corresponding to the plasmid and diffuse fluorescence of DnaB-GFP. Rod shaped cells contained plasmid either present as one fluorescent focus observed at the cell center or two foci localized at quarter positions. The results suggest that the plasmid is replicated at the cell center and then it goes to quarter position. In order to observe the localization of plasmid with respect to nucleoid, plasmid segregation was also studied in filaments where it was found to be replicated at the cell center in a nucleoid free region. To the best of our knowledge, this is the first report on segregation of small plasmids in R. erythropolis.	[Singhi, Divya; Jain, Aayushi; Srivastava, Preeti] Indian Inst Technol, Dept Biochem Engn & Biotechnol, Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Srivastava, P (corresponding author), Indian Inst Technol, Dept Biochem Engn & Biotechnol, Delhi, India.	preetisrivastava@hotmail.com		Jain, Aayushi/0000-0002-9103-1923	Science and Enginering Research Board, Department of Science and Technology, India; Department of Science and Technology, Government of India	Science and Enginering Research Board, Department of Science and Technology, India; Department of Science and Technology, Government of India(Department of Science & Technology (India))	Science and Enginering Research Board, Department of Science and Technology, India.; The authors would like to thank Dr. Dhruba Chattoraj, NCI, NIH for the kind gift of several plasmids and strains used in the present study, Dr. Shilpi Sharma, IIT Delhi for advices and Mr. Siddhant Malviya, IIT Delhi for help in the image analysis. Financial support from Department of Science and Technology, Government of India is gratefully acknowledged.	Becker E, 2006, EMBO J, V25, P5919, DOI 10.1038/sj.emboj.7601443; CHANG S, 1987, J BACTERIOL, V169, P3952, DOI 10.1128/jb.169.9.3952-3962.1987; DABBS ER, 1990, PLASMID, V23, P242, DOI 10.1016/0147-619X(90)90056-I; FINNERTY WR, 1992, ANNU REV MICROBIOL, V46, P193, DOI 10.1146/annurev.mi.46.100192.001205; Gordon GS, 1997, CELL, V90, P1113, DOI 10.1016/S0092-8674(00)80377-3; Guynet Catherine, 2011, Mob Genet Elements, V1, P236; HASHIMOTO Y, 1992, J GEN MICROBIOL, V138, P1003, DOI 10.1099/00221287-138-5-1003; Hayashi H, 2014, BIOSCI BIOTECH BIOCH, V78, P510, DOI 10.1080/09168451.2014.890029; Ho TQ, 2002, EMBO J, V21, P1864, DOI 10.1093/emboj/21.7.1864; Knoppova M, 2007, CURR MICROBIOL, V55, P234, DOI 10.1007/s00284-007-0106-1; Larkin MJ, 1998, ANTON LEEUW INT J G, V74, P133, DOI 10.1023/A:1001776500413; Li YF, 2003, MOL MICROBIOL, V50, P825, DOI 10.1046/j.1365-2958.2003.03746.x; Li YF, 2002, MOL MICROBIOL, V46, P985, DOI 10.1046/j.1365-2958.2002.03234.x; MEACOCK PA, 1980, CELL, V20, P529, DOI 10.1016/0092-8674(80)90639-X; Million-Weaver S, 2014, PLASMID, V75, P27, DOI 10.1016/j.plasmid.2014.07.002; Nielsen HJ, 2006, MOL MICROBIOL, V61, P383, DOI 10.1111/j.1365-2958.2006.05245.x; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Pogliano J, 2001, P NATL ACAD SCI USA, V98, P4486, DOI 10.1073/pnas.081075798; Reyes-Lamothe R, 2014, NUCLEIC ACIDS RES, V42, P1042, DOI 10.1093/nar/gkt918; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shavandi M, 2009, BIORESOURCE TECHNOL, V100, P475, DOI 10.1016/j.biortech.2008.06.011; Simpson AE, 2003, J BACTERIOL, V185, P2143, DOI 10.1128/JB.185.7.2143-2152.2003; Srivastava P, 2006, J BACTERIOL, V188, P1060, DOI 10.1128/JB.188.3.1060-1070.2006; Srivastava P, 2007, MOL MICROBIOL, V66, P1016, DOI 10.1111/j.1365-2958.2007.05973.x; Srivastava P, 2006, PLASMID, V56, P24, DOI 10.1016/j.plasmid.2006.01.003; Wang JD, 2004, J BACTERIOL, V186, P7084, DOI 10.1128/JB.186.21.7084-7090.2004; Wegrzyn K, 2013, MICROBIOL-SGM, V159, P1010, DOI 10.1099/mic.0.065490-0; Yao SY, 2007, J BACTERIOL, V189, P1946, DOI 10.1128/JB.01451-06	28	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166491	10.1371/journal.pone.0166491	http://dx.doi.org/10.1371/journal.pone.0166491			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935968	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100030
J	Somalinga, V; Buhrman, G; Arun, A; Rose, RB; Grunden, AM				Somalinga, Vijayakumar; Buhrman, Greg; Arun, Ashikha; Rose, Robert B.; Grunden, Amy M.			A High-Resolution Crystal Structure of a Psychrohalophilic alpha-Carbonic Anhydrase from Photobacterium profundum Reveals a Unique Dimer Interface	PLOS ONE			English	Article								Bacterial alpha-carbonic anhydrases (alpha-CA) are zinc containing metalloenzymes that catalyze the rapid interconversion of CO2 to bicarbonate and a proton. We report the first crystal structure of a pyschrohalophilic alpha-CA from a deep-sea bacterium, Photobacterium profundum. Size exclusion chromatography of the purified P. profundum alpha-CA (PprCA) reveals that the protein is a heterogeneous mix of monomers and dimers. Furthermore, an "in-gel" carbonic anhydrase activity assay, also known as protonography, revealed two distinct bands corresponding to monomeric and dimeric forms of PprCA that are catalytically active. The crystal structure of PprCA was determined in its native form and reveals a highly conserved "knot-topology" that is characteristic of alpha-CA's. Similar to other bacterial alpha-CA's, PprCA also crystallized as a dimer. Furthermore, dimer interface analysis revealed the presence of a chloride ion (Cl-) in the interface which is unique to PprCA and has not been observed in any other alpha-CA's characterized so far. Molecular dynamics simulation and chloride ion occupancy analysis shows 100% occupancy for the Cl- ion in the dimer interface. Zinc coordinating triple histidine residues, substrate binding hydrophobic patch residues, and the hydrophilic proton wire residues are highly conserved in PprCA and are identical to other well-studied alpha-CA's.	[Somalinga, Vijayakumar; Arun, Ashikha; Grunden, Amy M.] North Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA; [Buhrman, Greg; Rose, Robert B.] North Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Grunden, AM (corresponding author), North Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA.	amgrunde@ncsu.edu		Grunden, Amy/0000-0002-8025-753X	National Science Foundation [1332341]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (US) nsf.gov, Award number 1332341. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alterio V, 2012, CHEM REV, V112, P4421, DOI 10.1021/cr200176r; De Luca V, 2015, J ENZYM INHIB MED CH, V30, P277, DOI 10.3109/14756366.2014.917085; Di Fiore A, 2015, INT J MOL SCI, V16, P15456, DOI 10.3390/ijms160715456; Di Fiore A, 2013, ACTA CRYSTALLOGR D, V69, P1150, DOI 10.1107/S0907444913007208; Dosmic JF, 2010, BIOCHIM BIOPHYS ACTA, V1804, P326; ERIKSSON AE, 1988, PROTEINS, V4, P274, DOI 10.1002/prot.340040406; Fisher Z, 2005, BIOCHEMISTRY-US, V44, P1097, DOI 10.1021/bi0480279; Huang SH, 1998, J MOL BIOL, V283, P301, DOI 10.1006/jmbi.1998.2077; James P, 2014, ACTA CRYSTALLOGR D, V70, P2607, DOI 10.1107/S1399004714016526; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Richard SB, 2000, BIOCHEMISTRY-US, V39, P992, DOI 10.1021/bi991001a; SILVERMAN DN, 1988, ACCOUNTS CHEM RES, V21, P30, DOI 10.1021/ar00145a005; SULTEMEYER D, 1993, PHYSIOL PLANTARUM, V88, P179, DOI 10.1111/j.1399-3054.1993.tb01776.x; Tripp BC, 2001, J BIOL CHEM, V276, P48615, DOI 10.1074/jbc.R100045200; TSUZUKI M, 1989, AQUAT BOT, V34, P85, DOI 10.1016/0304-3770(89)90051-X; TU CK, 1989, BIOCHEMISTRY-US, V28, P7913, DOI 10.1021/bi00445a054	17	10	11	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168022	10.1371/journal.pone.0168022	http://dx.doi.org/10.1371/journal.pone.0168022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936100	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100256
J	Tellevik, MG; Blomberg, B; Kommedal, O; Maselle, SY; Langeland, N; Moyo, SJ				Tellevik, Marit G.; Blomberg, Bjorn; Kommedal, Oyvind; Maselle, Samuel Y.; Langeland, Nina; Moyo, Sabrina J.			High Prevalence of Faecal Carriage of ESBL-Producing Enterobacteriaceae among Children in Dar es Salaam, Tanzania	PLOS ONE			English	Article							LACTAMASE-PRODUCING ENTEROBACTERIACEAE; SPECTRUM BETA-LACTAMASES; BLOOD-STREAM INFECTIONS; ESCHERICHIA-COLI; RISK-FACTORS; SUSCEPTIBILITY; COLONIZATION; SOUTH; BACTERIA; TRENDS	Background Faecal carriage of ESBL-producing bacteria is a potential risk for transmission and infection. Little is known about faecal carriage of antibiotic resistance in Tanzania. This study aimed to investigate the prevalence of faecal carriage of ESBL-producing Enterobacteriaceae and to identify risk factors for carriage among young children in Tanzania. Methodology/Principal Findings From August 2010 to July 2011, children below 2 years of age were recruited in Dar es Salaam, including healthy community children (n = 250) and children hospitalized due to diarrhoea (n = 250) or other diseases (n = 103). ChromID ESBL agar and ChromID CARBA SMART agar were used for screening. Antimicrobial susceptibility testing was performed by the disk diffusion method. ESBL genotypes were identified by Real-Time PCR and sequencing. The overall prevalence of ESBL carriage was 34.3% (207/603). The prevalence of ESBL carriage was significantly higher among hospitalized children (50.4%), compared to community children (11.6%; P < 0.001; OR = 7.75; 95% CI: 4.99-12.03). We found high prevalence of Multidrug-resistance (94%) among Escherichia coli and Klebsiella pneumoniae isolates. No resistance to carbapenems was detected. For the majority of isolates (94.7%) we detected a bla(CTX-M-15)-like gene. In addition, the plasmid mediated AmpC beta-lactamase CMY-2 was detected for the first time in Tanzania. ESBL prevalence was significantly higher among HIV positive (89.7%) than HIV negative (16.9%) children (P = 0.001; OR = 9.99; 95% CI: 2.52-39.57). Use of antibiotics during the past 14 days and age below 1 year was also associated with ESBL carriage. Conclusions/Significance We report a high rate of faecal carriage of ESBL-producing Enterobacteriaceae among children below 2 years of age in Tanzania, particularly those with HIV-infection. Resistance to a majority of the available antimicrobials commonly used for children in Tanzania leaves few treatment options for infections when caused by these bacteria.	[Tellevik, Marit G.; Blomberg, Bjorn; Langeland, Nina] Haukeland Hosp, Dept Med, Natl Ctr Trop Infect Dis, Bergen, Norway; [Blomberg, Bjorn; Langeland, Nina; Moyo, Sabrina J.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Kommedal, Oyvind] Haukeland Hosp, Dept Microbiol, Bergen, Norway; [Maselle, Samuel Y.; Moyo, Sabrina J.] Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; Muhimbili University of Health & Allied Sciences	Moyo, SJ (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.; Moyo, SJ (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania.	Sabrina.Moyo@uib.no	; Blomberg, Bjorn/B-9605-2015	Moyo, sabrina/0000-0003-4735-1513; Blomberg, Bjorn/0000-0001-5647-4297	University of Bergen, Norway; National Centre for Tropical Infectious Diseases, Haukeland University Hospital, Norway	University of Bergen, Norway; National Centre for Tropical Infectious Diseases, Haukeland University Hospital, Norway	This study was supported by the University of Bergen, Norway, and by the National Centre for Tropical Infectious Diseases, Haukeland University Hospital, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriatahina T, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-204; Blanc V, 2014, J ANTIMICROB CHEMOTH, V69, P1231, DOI 10.1093/jac/dkt519; Blomberg B, 2005, J CLIN MICROBIOL, V43, P745, DOI 10.1128/JCM.43.2.745-749.2005; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; Boutet-Dubois A, 2013, EUR J CLIN MICROBIOL, V32, P1063, DOI 10.1007/s10096-013-1851-7; CLSI, C28A3 CLSI, V29th; Cornejo-Juarez P, 2016, SUPPORT CARE CANCER, V24, P253, DOI 10.1007/s00520-015-2772-z; Cotton MF, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-40; Denkel LA, 2014, J ANTIMICROB CHEMOTH, V69, P2230, DOI 10.1093/jac/dku097; Desta K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161685; Dramowski A, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0354-3; Eibach D, 2016, INT J MED MICROBIOL, V306, P249, DOI 10.1016/j.ijmm.2016.05.006; Farra A, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.07.001; Hijazi SM, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0121-9; Isendahl J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051981; Jean SS, 2016, INT J ANTIMICROB AG, V47, P328, DOI 10.1016/j.ijantimicag.2016.01.008; Karanika S, 2016, CLIN INFECT DIS, V63, P310, DOI 10.1093/cid/ciw283; Kommedal O, 2016, APMIS, V124, P603, DOI 10.1111/apm.12549; Manyahi Joel, 2014, BMC Res Notes, V7, P500, DOI 10.1186/1756-0500-7-500; Marbou WJ, 2016, J INFECT PU IN PRESS; Moore LSP, 2014, J ANTIMICROB CHEMOTH, V69, P3409, DOI 10.1093/jac/dku307; Moyo SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097562; Mshana SE, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1527-x; Nelson Edwin, 2014, BMC Res Notes, V7, P279, DOI 10.1186/1756-0500-7-279; Reddy P, 2007, CLIN INFECT DIS, V45, P846, DOI 10.1086/521260; Reuland EA, 2016, J ANTIMICROB CHEMOTH, V71, P1076, DOI 10.1093/jac/dkv441; Schaumburg F, 2013, J ANTIMICROB CHEMOTH, V68, P2140, DOI 10.1093/jac/dkt164; Stoesser N, 2015, J ANTIMICROB CHEMOTH, V70, P1893, DOI 10.1093/jac/dkv021; Tansarli GS, 2014, J ANTIMICROB CHEMOTH, V69, P1177, DOI 10.1093/jac/dkt500; Tischendorf J, 2016, AM J INFECT CONTROL, V44, P539, DOI 10.1016/j.ajic.2015.12.005; WATERLOW JC, 1977, B WORLD HEALTH ORGAN, V55, P489; Woerther PL, 2011, CLIN INFECT DIS, V53, P677, DOI 10.1093/cid/cir522; World Health Organization, 2014, ANT RES GLOB REP SUR	33	52	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168024	10.1371/journal.pone.0168024	http://dx.doi.org/10.1371/journal.pone.0168024			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936054	Green Submitted, gold, Green Published			2022-12-27	WOS:000389587100257
J	Xing, N; Guan, XX; An, B; Cui, BB; Wang, ZG; Wang, XY; Zhang, XJ; Du, Q; Zhao, XM; Huang, Y; Tong, DW				Xing, Na; Guan, Xiaoxiao; An, Bin; Cui, Beibei; Wang, Zengguo; Wang, Xiaoya; Zhang, Xiujuan; Du, Qian; Zhao, Xiaomin; Huang, Yong; Tong, Dewen			Ultrasensitive Detection of Porcine Epidemic Diarrhea Virus from Fecal Samples Using Functionalized Nanoparticles	PLOS ONE			English	Article							SWINE; PCR; ANTIBODIES; ROTAVIRUS; SERUM; PIGS; DNA	Porcine epidemic diarrhea virus (PEDV) is the main causative agent of porcine diarrhea, which has resulted in devastating damage to swine industry and become a perplexed global problem. PEDV infection causes lesions and clinical symptoms, and infected pigs often succumb to severe dehydration. If there is not a timely and effective method to control its infection, PEDV will spread rapidly across the whole swine farm. Therefore, preclinical identification of PEDV is of great significance for preventing the outbreak and spread of this disease. In this study, a functionalized nanoparticles-based PCR method (UNDP-PCR) specific for PEDV was developed through systematic optimization of functionalized magnetic beads and gold nanoparticles which were further used to specifically enrich viral RNA from the lysate of PEDV stool samples, forming a MMPs-RNA-AuNPs complex. Then, oligonucleotides specific for PEDV coated on AuNPs were eluted from the complex and were further amplified and characterized by PCR. The detection limitation of the established UNDP-PCR method for PEDV was 25 copies in per gram PEDV stool samples, which is 400-fold more sensitive than conventional RT-PCR for stool samples. The UNDP-PCR for PEDV exhibited reliable reproducibility and high specificity, no cross-reaction was observed with other porcine viruses. In 153 preclinical fecal samples, the positive detection rate of UNDP-PCR specific for PEDV (30.72%) was much higher than that of conventional RT-PCR (5.88%) and SYBR Green real-time RT-PCR. In a word, this study provided a RNA extraction and transcription free, rapid and economical method for preclinical PEDV infection, which showed higher sensitivity, specificity and reproducibility, and exhibited application potency for evaluating viral loads of preclinical samples.	[Xing, Na; Guan, Xiaoxiao; An, Bin; Cui, Beibei; Wang, Zengguo; Wang, Xiaoya; Zhang, Xiujuan; Du, Qian; Zhao, Xiaomin; Huang, Yong; Tong, Dewen] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Huang, Y; Tong, DW (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.	Yonghuang@nwsuaf.edu.cn; dwtong@nwsuaf.edu.cn	Huang, Yong/G-9365-2011; du, qian/GYJ-7090-2022		scientific and technological project in Shaanxi province [2015NY155]; innovation project of science and technology plan projects in Shaanxi province [2016KTCL02-13]; Key project of Shaanxi province science and technology innovation team [2013KCT-28]	scientific and technological project in Shaanxi province; innovation project of science and technology plan projects in Shaanxi province; Key project of Shaanxi province science and technology innovation team	This study was funded by grants from the scientific and technological project in Shaanxi province (Grant No. 2015NY155), the innovation project of science and technology plan projects in Shaanxi province (2016KTCL02-13), Key project of Shaanxi province science and technology innovation team (2013KCT-28). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beam A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144818; Ben Salem AN, 2010, J VIROL METHODS, V165, P283, DOI 10.1016/j.jviromet.2010.02.010; Bowman AS, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0348-2; Brian DA, 2005, CURR TOP MICROBIOL, V287, P1, DOI 10.1007/3-540-26765-4_1; Chen JF, 2010, ARCH VIROL, V155, P1471, DOI 10.1007/s00705-010-0720-2; Chen YP, 2015, ACS NANO, V9, P3184, DOI 10.1021/acsnano.5b00240; Ding L., 2011, CHIN J VET MED, V47, P9; DUARTE M, 1993, ADV EXP MED BIOL, V342, P55; Ge FF, 2013, ARCH VIROL, V158, P2227, DOI 10.1007/s00705-013-1722-7; Gerber PF, 2015, METHODSX, V2, P368, DOI 10.1016/j.mex.2015.10.001; Gerber PF, 2014, VET J, V202, P33, DOI 10.1016/j.tvjl.2014.07.018; Gou HC, 2015, MOL CELL PROBE, V29, P48, DOI 10.1016/j.mcp.2014.11.004; Huang Y, 2013, AQ SCI TECH, V1, P1, DOI DOI 10.1016/J.VIRUSRES.2013.03.014; Huang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141545; Huang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097869; Jung K, 2015, VET J, V204, P134, DOI 10.1016/j.tvjl.2015.02.017; Kim YK, 2015, J VIROL METHODS, V225, P4, DOI 10.1016/j.jviromet.2015.08.024; Marthaler D, 2014, J VIROL METHODS, V209, P30, DOI 10.1016/j.jviromet.2014.08.018; Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755; Papp H, 2013, VET MICROBIOL, V165, P190, DOI 10.1016/j.vetmic.2013.03.020; Ren XF, 2011, VIRUS GENES, V42, P229, DOI 10.1007/s11262-011-0570-3; SEHGAL D, 1994, ANAL BIOCHEM, V218, P87, DOI 10.1006/abio.1994.1144; Shi L HY, 2012, ACTA AGR BOREALI OCC, V21, P6; Song D, 2015, CLIN EXP VACCINE RES, V4, P166, DOI 10.7774/cevr.2015.4.2.166; Song D, 2012, VIRUS GENES, V44, P167, DOI 10.1007/s11262-012-0713-1; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; Wang LT, 2013, TROP ANIM HEALTH PRO, V45, P1087, DOI 10.1007/s11250-012-0329-4; Wang W, 2014, TALANTA, V128, P263, DOI 10.1016/j.talanta.2014.05.011; Wang Z. S., 2010, ANXIETY STRESS COPIN, V19, P1; Xu XG, 2012, J VIROL METHODS, V183, P69, DOI 10.1016/j.jviromet.2012.03.034; Xu XG, 2013, VET MICROBIOL, V164, P212, DOI 10.1016/j.vetmic.2013.01.034; Xu XR, 2008, ANTIVIR RES, V78, P188, DOI 10.1016/j.antiviral.2007.12.012; Yuan WZ, 2015, J VIROL METHODS, V220, P18, DOI 10.1016/j.jviromet.2015.04.008; Zhang Q, 2013, ARCH VIROL, V158, P1631, DOI 10.1007/s00705-013-1659-x; Zhao PD, 2014, J VIROL METHODS, V206, P150, DOI 10.1016/j.jviromet.2014.06.006; Zhou WG, 2016, VET MICROBIOL, V182, P75, DOI 10.1016/j.vetmic.2015.10.019	36	10	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167325	10.1371/journal.pone.0167325	http://dx.doi.org/10.1371/journal.pone.0167325			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936019	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100085
J	Murtaza, G; Mermer, P; Pfeil, U; Kummer, W				Murtaza, Ghulam; Mermer, Petra; Pfeil, Uwe; Kummer, Wolfgang			Avertin (R), but Not Volatile Anesthetics Addressing the Two-Pore Domain K plus Channel, TASK-1, Slows Down Cilia-Driven Particle Transport in the Mouse Trachea	PLOS ONE			English	Article							AIRWAY EPITHELIAL-CELLS; IN-VIVO; MUCOCILIARY CLEARANCE; ISOFLURANE; NEURONS; NASAL; MICE; RAT; EXPRESSION; CONTRIBUTE	Rationale Volatile anesthetics inhibit mucociliary clearance in the airways. The two-pore domain K+ channel, TASK-1, represents one of their molecular targets in that they increase its open probability. Here, we determine whether particle transport speed (PTS) at the mucosal surface of the mouse trachea, an important factor of the cilia-driven mechanism in mucociliary clearance, is regulated by TASK-1. Methodology/Results RT-PCR analysis revealed expression of TASK-1 mRNA in the manually dissected and laser-assisted microdissected tracheal epithelium of the mouse. Effects of anesthetics (isoflurane and Avertin (R)) and TASK-1 inhibitors (anandamide and A293) on ciliary activity were investigated by assessment of PTS at the mucosal surface of the explanted and opened murine trachea. Neither TASK-1 inhibitors nor isoflurane had any impact on basal and ATP-stimulated PTS. Avertin (R) reduced basal PTS, and ATP-stimulated PTS decreased in its presence in wild-type (WT) mice. Avertin (R)-induced decrease in basal PTS persisted in WT mice in the presence of TASK-1 inhibitors, and in two different strains of TASK-1 knockout mice. Conclusions/Significance Our findings indicate that TASK-1 is expressed by the tracheal epithelium but is not critically involved in the regulation of tracheal PTS in mice. Avertin (R) reduces PTS independent of TASK-1.	[Murtaza, Ghulam] Justus Liebig Univ, Inst Anat & Cell Biol, Giessen, Germany; German Ctr Lung Res DZL, ECCPS, Giessen, Germany; [Murtaza, Ghulam] King Saud Univ, Dept Neurol, Riyadh, Saudi Arabia	Justus Liebig University Giessen; King Saud University	Murtaza, G (corresponding author), Justus Liebig Univ, Inst Anat & Cell Biol, Giessen, Germany.; Murtaza, G (corresponding author), King Saud Univ, Dept Neurol, Riyadh, Saudi Arabia.	gmurtazay@yahoo.com	Murtaza, Ghulam/AAK-6538-2020	Kummer, Wolfgang/0000-0002-3946-0683				Aller MI, 2005, J NEUROSCI, V25, P11455, DOI 10.1523/JNEUROSCI.3153-05.2005; Berg AP, 2004, J NEUROSCI, V24, P6693, DOI 10.1523/JNEUROSCI.1408-04.2004; Bournival V, 2011, EXP LUNG RES, V37, P205, DOI 10.3109/01902148.2010.536610; Brennan SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080294; Cervin A, 1998, BRIT J ANAESTH, V80, P475, DOI 10.1093/bja/80.4.475; Christopher AB, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00111; De Proost I, 2007, HISTOCHEM CELL BIOL, V128, P301, DOI 10.1007/s00418-007-0318-2; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Gurney AM, 2003, CIRC RES, V93, P957, DOI 10.1161/01.RES.0000099883.68414.61; Hua XY, 2010, J APPL PHYSIOL, V108, P189, DOI 10.1152/japplphysiol.00669.2009; Hussong J, 2013, J BIOMECH, V46, P593, DOI 10.1016/j.jbiomech.2012.08.020; Jiao J, 2012, ORL J OTO-RHINO-LARY, V74, P280, DOI 10.1159/000343800; Keller C, 1998, ANESTH ANALG, V86, P1280, DOI 10.1097/00000539-199806000-00028; Kim D, 1998, CIRC RES, V82, P513, DOI 10.1161/01.RES.82.4.513; Klein MK, 2009, EUR RESPIR J, V33, P1113, DOI 10.1183/09031936.00015108; KORNGREEN A, 1994, BIOPHYS J, V67, P377, DOI 10.1016/S0006-3495(94)80492-8; Krasteva G, 2007, INT J BIOCHEM CELL B, V39, P615, DOI 10.1016/j.biocel.2006.10.019; Lazarenko RM, 2010, J NEUROSCI, V30, P7691, DOI 10.1523/JNEUROSCI.1655-10.2010; Leithner K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157453; Linden AM, 2006, J PHARMACOL EXP THER, V317, P615, DOI 10.1124/jpet.105.098525; Ma WY, 2002, J GEN PHYSIOL, V120, P875, DOI 10.1085/jgp.20028695; Maingret F, 2001, EMBO J, V20, P47, DOI 10.1093/emboj/20.1.47; Matsuura S, 2006, ANESTH ANALG, V102, P1703, DOI 10.1213/01.ane.0000216001.36932.a3; Meuth SG, 2006, MOL PHARMACOL, V69, P1468, DOI 10.1124/mol.105.020594; Mulkey DK, 2007, J NEUROSCI, V27, P14049, DOI 10.1523/JNEUROSCI.4254-07.2007; Ohba T, 2013, J PHARMACOL EXP THER, V347, P145, DOI 10.1124/jpet.113.205138; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Petric S, 2012, CELL PHYSIOL BIOCHEM, V30, P523, DOI 10.1159/000341435; Pfeil U, 2006, BIOCHEM BIOPH RES CO, V343, P885, DOI 10.1016/j.bbrc.2006.03.042; Putzke C, 2007, AM J PHYSIOL-CELL PH, V293, pC1319, DOI 10.1152/ajpcell.00100.2007; Raphael JH, 1996, BRIT J ANAESTH, V76, P854, DOI 10.1093/bja/76.6.854; Raphael JH, 1997, BRIT J ANAESTH, V79, P473, DOI 10.1093/bja/79.4.473; Robertson A, 2004, CLIN OTOLARYNGOL, V29, P157, DOI 10.1111/j.0307-7772.2004.00768.x; RUTLAND J, 1982, AM REV RESPIR DIS, V125, P100; Smuszkiewicz P, 2006, PHARMACOL REP, V58, P736; Turner PJ, 2013, J PHYSIOL-LONDON, V591, P5977, DOI 10.1113/jphysiol.2013.262022; VILLALON M, 1989, BIOPHYS J, V56, P1255, DOI 10.1016/S0006-3495(89)82772-9; Wanner A, 1996, AM J RESP CRIT CARE, V154, P1868, DOI 10.1164/ajrccm.154.6.8970383; Zhao KQ, 2012, AM J PHYSIOL-LUNG C, V302, pL4, DOI 10.1152/ajplung.00102.2011	40	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167919	10.1371/journal.pone.0167919	http://dx.doi.org/10.1371/journal.pone.0167919			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930725	Green Published, gold, Green Submitted			2022-12-27	WOS:000389580900059
J	VandeVoort, CA; Gerona, RR; vom Saal, FS; Tarantal, AF; Hunt, PA; Hillenweck, A; Zalko, D				VandeVoort, Catherine A.; Gerona, Roy R.; vom Saal, Frederick S.; Tarantal, Alice F.; Hunt, Patricia A.; Hillenweck, Anne; Zalko, Daniel			Maternal and Fetal Pharmacokinetics of Oral Radiolabeled and Authentic Bisphenol A in the Rhesus Monkey	PLOS ONE			English	Article							HUMAN HEALTH; EXPOSURE; SERUM; BPA; DISPOSITION; MECHANISMS; ALTERS; DECONJUGATION; PROGESTERONE; GLUCURONIDE	The present study was conducted in pregnant rhesus monkeys to determine the rapidity and extent to which BPA reaches the fetal compartment following oral ingestion, and the 24-hr fate of BPA. To assess metabolism changes during the course of pregnancy, we compared BPA biotransformation during the second and third trimesters in the same animals, measuring the levels of sulfated, gluronidated, and free BPA in maternal serum, amniotic fluid, and fetal serum. All animals showed measurable unconjugated and conjugated BPA in the fetal compartment and slow clearance compared to maternal serum. There were higher levels of BPA-G in amniotic fluid at 150 days gestation compared to 100 days gestation, as well as higher levels of BPA-G than BPA-S. We also monitored H-3-BPA (and metabolites) in key tissues and excreta from a mother and fetus and from a non-pregnant female. The elimination of radioactivity was rapid, but residues were still detectable 24 hr after dosing in all tissues analyzed. These data suggest that, in primates, rapid maternal processing of BPA does not alleviate the risk of exposure to the developing fetus. This study elevates concerns about levels of current BPA human exposure from potentially a large number of unknown sources and the risks posed to developing fetuses.	[VandeVoort, Catherine A.] Univ Calif Davis, Dept Obstet & Gynecol, Davis, CA 95616 USA; [VandeVoort, Catherine A.; Tarantal, Alice F.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Gerona, Roy R.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Program Reprod Hlth & Environm, San Francisco, CA USA; [vom Saal, Frederick S.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Tarantal, Alice F.] Univ Calif Davis, Sch Med, Dept Pediat, Davis, CA 95616 USA; [Tarantal, Alice F.] Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, Davis, CA 95616 USA; [Hunt, Patricia A.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Hillenweck, Anne; Zalko, Daniel] Univ Toulouse, INRA, Toxalim, Toulouse, France	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California San Francisco; University of Missouri System; University of Missouri Columbia; University of California System; University of California Davis; University of California System; University of California Davis; Washington State University; INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	VandeVoort, CA (corresponding author), Univ Calif Davis, Dept Obstet & Gynecol, Davis, CA 95616 USA.; VandeVoort, CA (corresponding author), Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.	cavandevoort@ucdavis.edu			National Institute of Environmental Health Sciences (NIEHS) [ES016770]; CNPRC Base Grant (National Institutes of Health) [OD011107 (RR00169)]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016770] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); CNPRC Base Grant (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institute of Environmental Health Sciences (NIEHS) Grants ES016770 and the CNPRC Base Grant (National Institutes of Health) OD011107 (RR00169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSES, 2013, ASS HLTH RISKS BISPH; BARKLEY MS, 1979, BIOL REPROD, V20, P733, DOI 10.1095/biolreprod20.4.733; Calhoun KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085894; Chapalamadugu KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089096; Corbel T, 2015, DRUG METAB DISPOS, V43, P467, DOI 10.1124/dmd.114.061291; Corbel T, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.112.106369; Doerge DR, 2010, TOXICOL APPL PHARM, V247, P158, DOI 10.1016/j.taap.2010.06.008; Elsworth JD, 2013, NEUROTOXICOLOGY, V35, P113, DOI 10.1016/j.neuro.2013.01.001; Gayrard V, 2013, ENVIRON HEALTH PERSP, V121, P951, DOI 10.1289/ehp.1206339; Gerona RR, 2013, ENVIRON SCI TECHNOL, V47, P12477, DOI 10.1021/es402764d; HODGEN GD, 1972, ENDOCRINOLOGY, V91, P896, DOI 10.1210/endo-91-4-896; Hormann AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110509; Hunt PA, 2012, P NATL ACAD SCI USA, V109, P17525, DOI 10.1073/pnas.1207854109; Jaeg JP, 2004, J AGR FOOD CHEM, V52, P4935, DOI 10.1021/jf049762u; Kopen GC, 1999, J HISTOCHEM CYTOCHEM, V47, P965, DOI 10.1177/002215549904700714; Kurebayashi H, 2005, ARCH TOXICOL, V79, P243, DOI 10.1007/s00204-004-0628-2; Miller V., 2003, PRINCIPLES SEX BASED, P15; MONTANO MM, 1995, BIOL REPROD, V53, P1198, DOI 10.1095/biolreprod53.5.1198; MOTSON RW, 1981, GASTROENTEROLOGY, V80, P655; Pasqualini JR, 2005, J STEROID BIOCHEM, V97, P401, DOI 10.1016/j.jsbmb.2005.08.004; Patterson TA, 2013, TOXICOL APPL PHARM, V267, P41, DOI 10.1016/j.taap.2012.12.006; Peretz J, 2014, ENVIRON HEALTH PERSP, V122, P775, DOI 10.1289/ehp.1307728; POMERANTZ SM, 1985, ENDOCRINOLOGY, V116, P83, DOI 10.1210/endo-116-1-83; RESKO JA, 1975, ENDOCRINOLOGY, V97, P425, DOI 10.1210/endo-97-2-425; REUNING RH, 1989, DRUG METAB DISPOS, V17, P583; Rochester JR, 2013, REPROD TOXICOL, V42, P132, DOI 10.1016/j.reprotox.2013.08.008; Sakamoto H, 2002, BBA-GEN SUBJECTS, V1573, P171, DOI 10.1016/S0304-4165(02)00418-X; SCHELINE RR, 1973, PHARMACOL REV, V25, P451; Seachrist DD, 2016, REPROD TOXICOL, V59, P167, DOI 10.1016/j.reprotox.2015.09.006; Stahlhut RW, 2009, ENVIRON HEALTH PERSP, V117, P784, DOI 10.1289/ehp.0800376; Takeyama J, 2001, J CLIN ENDOCR METAB, V86, P2258, DOI 10.1210/jc.86.5.2258; Tarantal Alice F., 2005, P317, DOI 10.1016/B978-012080261-6/50020-9; Taylor JA, 2011, ENVIRON HEALTH PERSP, V119, P422, DOI 10.1289/ehp.1002514; Teeguarden JG, 2015, TOXICOL APPL PHARM, V288, P131, DOI 10.1016/j.taap.2015.01.009; Tharp AP, 2012, P NATL ACAD SCI USA, V109, P8190, DOI 10.1073/pnas.1120488109; Thayer KA, 2015, ENVIRON INT, V83, P107, DOI 10.1016/j.envint.2015.06.008; Van Winkle LS, 2013, ENVIRON HEALTH PERSP, V121, P912, DOI 10.1289/ehp.1206064; Vandenberg LN, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-25; Vandenberg Laura N., 2013, Reviews on Environmental Health, V28, P37, DOI 10.1515/reveh-2012-0034; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Vandenberg LN, 2013, ENDOCRINE DISRUPTION, V1, pE1; Vokel W, 2002, CHEM RES TOXICOL, V15, P1281, DOI 10.1021/tx025548t; vom Saal FS, 2007, REPROD TOXICOL, V24, P131, DOI 10.1016/j.reprotox.2007.07.005; vom Saal FS, 2014, MOL CELL ENDOCRINOL, V398, P101, DOI 10.1016/j.mce.2014.09.028; vom Saal FS, 2014, REPROD TOXICOL, V45, P105, DOI 10.1016/j.reprotox.2014.01.007; Welshons WV, 2006, ENDOCRINOLOGY, V147, pS56, DOI 10.1210/en.2005-1159; Zalko D, 2003, ENVIRON HEALTH PERSP, V111, P309, DOI 10.1289/ehp.5603	47	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0165410	10.1371/journal.pone.0165410	http://dx.doi.org/10.1371/journal.pone.0165410			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930651	Green Published, gold, Green Submitted			2022-12-27	WOS:000389580900004
J	Akiba, R; Yokouchi, H; Mori, M; Oshitari, T; Baba, T; Sawai, S; Kuwabara, S; Yamamoto, S				Akiba, Ryutaro; Yokouchi, Hirotaka; Mori, Masahiro; Oshitari, Toshiyuki; Baba, Takayuki; Sawai, Setsu; Kuwabara, Satoshi; Yamamoto, Shuichi			Retinal Morphology and Sensitivity Are Primarily Impaired in Eyes with Neuromyelitis Optica Spectrum Disorder (NMOSD)	PLOS ONE			English	Article							NERVE-FIBER LAYER; AQUAPORIN-4 WATER CHANNEL; COHERENCE TOMOGRAPHY; MULTIPLE-SCLEROSIS; MULLER CELLS; NEURITIS; DISTINCTION; THICKNESS; MICROPERIMETRY; SEGMENTATION	Background Previous studies of neuromyelitis optica spectrum disorder (NMOSD) using spectral domain optical coherence tomography (SD-OCT) showed that the outer nuclear layer (ONL) in eyes without a history of optic neuritis (ON) was thinner than that of healthy controls. It remains unclear whether the ONL thinning is caused by a direct attack on the retina by an autoantibody or a retrograde degeneration. Objective To determine the mechanisms involved in the retinal damage in eyes with NMOSD without ON. Methods SD-OCT was used to determine the thicknesses of the different retinal layers of 21 eyes of 12 NMOSD patients without prior ON and 19 eyes of 10 healthy controls. Eyes with peripapillary retinal nerve fiber layer (RNFL) thinning were excluded to eliminate the confounding effects of retrograde degeneration. Microperimetry was used to determine the central retinal sensitivity. The data of the two groups were compared using generalized estimated equation models to account for inter-eye dependencies. Results The ganglion cell plus inner plexiform layer and the inner nuclear layer plus outer plexiform layer thicknesses of the NMOSD eyes were not significantly different from that of the control eyes (P = 0.28, P = 0.78). However, the ONL and average macular thickness (AMT) in the NMOSD eyes were significantly thinner than that of the control eyes (P = 0.022, P = 0.036). The retinal sensitivity in the central 10 degrees, 10 degrees to 2 degrees, and 2 degrees sectors were significantly lower in the NMOSD eyes than in the control eyes (P = 0.013, P = 0.022, P = 0.002). Conclusions The ONL thinning, AMT thinning, and reduced retinal sensitivity in eyes with NMOSD without significant peripapillary RNFL thinning are most likely due to direct retinal pathology.	[Akiba, Ryutaro; Yokouchi, Hirotaka; Oshitari, Toshiyuki; Baba, Takayuki; Yamamoto, Shuichi] Chiba Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med, Chiba, Chiba, Japan; [Mori, Masahiro; Sawai, Setsu; Kuwabara, Satoshi] Chiba Univ, Dept Neurol, Grad Sch Med, Chiba, Chiba, Japan	Chiba University; Chiba University	Yokouchi, H (corresponding author), Chiba Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med, Chiba, Chiba, Japan.	yokouchi123@peace.ocn.ne.jp		Oshitari, Toshiyuki/0000-0002-8273-845X; Akiba, Ryutaro/0000-0001-8078-3794; Kuwabara, Satoshi/0000-0002-4716-8578				Alexander P, 2012, EYE, V26, P678, DOI 10.1038/eye.2012.7; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; de Seze J, 2008, ARCH NEUROL-CHICAGO, V65, P920, DOI 10.1001/archneur.65.7.920; Fernandes DB, 2013, OPHTHALMOLOGY, V120, P387, DOI 10.1016/j.ophtha.2012.07.066; Garcia-Martin E, 2014, OPHTHALMOLOGY, V121, P573, DOI 10.1016/j.ophtha.2013.09.035; Gella L, 2011, CURR EYE RES, V36, P943, DOI 10.3109/02713683.2011.599105; Green AJ, 2009, J NEUROL NEUROSUR PS, V80, P1002, DOI 10.1136/jnnp.2008.166207; Hasler PW, 2008, BRIT J OPHTHALMOL, V92, P645, DOI 10.1136/bjo.2007.130971; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jiao YJ, 2013, NEUROLOGY, V81, P1197, DOI 10.1212/WNL.0b013e3182a6cb5c; Kitley J, 2012, NEUROLOGY, V79, P1273, DOI 10.1212/WNL.0b013e31826aac4e; Lange AP, 2013, J NEURO-OPHTHALMOL, V33, P213, DOI 10.1097/WNO.0b013e31829c510e; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lima VC, 2010, BRIT J OPHTHALMOL, V94, P64, DOI 10.1136/bjo.2009.159772; Lujan BJ, 2015, RETINA-J RET VIT DIS, V35, P1511, DOI 10.1097/IAE.0000000000000527; Markowitz SN, 2013, CAN J OPHTHALMOL, V48, P350, DOI 10.1016/j.jcjo.2012.03.004; Matsumoto H, 2009, AM J OPHTHALMOL, V148, P105, DOI 10.1016/j.ajo.2009.01.018; Merle H, 2008, INVEST OPHTH VIS SCI, V49, P4412, DOI 10.1167/iovs.08-1815; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Nagelhus EA, 1998, J NEUROSCI, V18, P2506; Naismith RT, 2009, NEUROLOGY, V72, P1077, DOI 10.1212/01.wnl.0000345042.53843.d5; Narayanan D, 2014, MULT SCLER J, V20, P1331, DOI 10.1177/1352458514523498; Nielsen S, 1997, J NEUROSCI, V17, P171; Noval S, 2006, ACTA OPHTHALMOL SCAN, V84, P790, DOI 10.1111/j.1600-0420.2006.00724.x; Oberwahrenbrock T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137316; Ozturk F, 2008, J GLAUCOMA, V17, P118, DOI 10.1097/IJG.0b013e31814b97fd; Otani T, 2011, RETINA-J RET VIT DIS, V31, P497, DOI 10.1097/IAE.0b013e3181ed8dae; Outteryck O, 2015, MULTIPLE SCLEROSIS; Park KA, 2014, ACTA OPHTHALMOL, V92, pE57, DOI 10.1111/aos.12215; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Ratchford JN, 2009, NEUROLOGY, V73, P302, DOI 10.1212/WNL.0b013e3181af78b8; Ringelstein M, 2014, MULT SCLER J, V20, P617, DOI 10.1177/1352458513503053; Saidha S, 2011, BRAIN, V134, P518, DOI 10.1093/brain/awq346; Sato DK, 2014, NEUROLOGY, V82, P474, DOI 10.1212/WNL.0000000000000101; Schneider E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066151; Sotirchos ES, 2013, NEUROLOGY, V80, P1406, DOI 10.1212/WNL.0b013e31828c2f7a; Syc SB, 2012, BRAIN, V135, P521, DOI 10.1093/brain/awr264; Tomizawa Y, 2012, J INT MED RES, V40, P1483, DOI 10.1177/147323001204000427; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107; Zajda M, 2015, MULTIPLE SCLEROSIS; Zamvil SS, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000062	44	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167473	10.1371/journal.pone.0167473	http://dx.doi.org/10.1371/journal.pone.0167473			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936154	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100105
J	de Almeida, DV; Macieira, KV; Grinsztejn, BGJ; dos Santos, VGV; Guimaraes, ML				de Almeida, Dalziza Victalina; Macieira, Karine Venegas; Jegerhorn Grinsztejn, Beatriz Gilda; Veloso dos Santos, Valdilea Goncalves; Guimaraes, Monick Lindenmeyer			Cross-Neutralizing Antibodies in HIV-1 Individuals Infected by Subtypes B, F1, C or the B/Bbr Variant in Relation to the Genetics and Biochemical Characteristics of the env Gene	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; RIO-DE-JANEIRO; DRUG-USERS; VACCINE; PREVALENCE; EPITOPES; BRAZIL; GP120; REGION; BROAD	Various HIV-1 env genetic and biochemical features impact the elicitation of cross-reactive neutralizing antibodies in natural infections. Thus, we aimed to investigate cross-neutralizing antibodies in individuals infected with HIV-1 env subtypes B, F1, C or the B/Bbr variant as well as env characteristics. Therefore, plasma samples from Brazilian chronically HIV-1 infected individuals were submitted to the TZM-bl neutralization assay. We also analyzed putative N-glycosylation sites (PNGLs) and the size of gp120 variable domains in the context of HIV-1 subtypes prevalent in Brazil. We observed a greater breadth and potency of the anti-Env neutralizing response in individuals infected with the F1 or B HIV-1 subtypes compared with the C subtype and the variant B/Bbr. We observed greater V1 B/Bbr and smaller V4 F1 than those of other subtypes (p<0.005), however neither was there a correlation verified between the variable region length and neutralization potency, nor between PNLG and HIV-1 subtypes. The enrichment of W at top of V3 loop in weak neutralizing response viruses and the P in viruses with higher neutralization susceptibility was statistically significant (p = 0.013). Some other signatures sites were associated to HIV-1 subtype-specific F1 and B/Bbr samples might influence in the distinct neutralizing response. These results indicate that a single amino acid substitution may lead to a distinct conformational exposure or load in the association domain of the trimer of gp120 and interfere with the induction power of the neutralizing response, which affects the sensitivity of the neutralizing antibody and has significant implications for vaccine design.	[de Almeida, Dalziza Victalina; Macieira, Karine Venegas; Guimaraes, Monick Lindenmeyer] Oswaldo Cruz Inst FIOCRUZ, Lab AIDS & Mol Immunol, Rio De Janeiro, Brazil; [Jegerhorn Grinsztejn, Beatriz Gilda; Veloso dos Santos, Valdilea Goncalves] Natl Inst Infectol FIOCRUZ, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz	de Almeida, DV (corresponding author), Oswaldo Cruz Inst FIOCRUZ, Lab AIDS & Mol Immunol, Rio De Janeiro, Brazil.	dalziza@ioc.fiocruz.br			Collaboration for AIDS Vaccine Discovery (CAVD) - Bill & Melinda Gates Foundation [38619]; Global HIV Vaccine Enterprise (GHVE) Central Service Facilities (CSFs), Dr D Montefiori's Vaccine Immune Monitoring Center (VIMC) [383-0920]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ [E26/110.517/2012]; CNPq	Collaboration for AIDS Vaccine Discovery (CAVD) - Bill & Melinda Gates Foundation; Global HIV Vaccine Enterprise (GHVE) Central Service Facilities (CSFs), Dr D Montefiori's Vaccine Immune Monitoring Center (VIMC); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Collaboration for AIDS Vaccine Discovery (CAVD) funded by the Bill & Melinda Gates Foundation (Grant # 38619) Global HIV Vaccine Enterprise (GHVE) Central Service Facilities (CSFs), especially Dr D Montefiori's Vaccine Immune Monitoring Center (VIMC) (Grant # 383-0920). This work was partially supported by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ (grant number E26/110.517/2012). Monick Lindenmeyer Guimaraes is recipient of a CNPq Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida DV, 2013, AIDS RES HUM RETROV, V29, P488, DOI [10.1089/aid.2012.0052, 10.1089/AID.2012.0052]; Asokan M, 2015, J VIROL, V89, P12501, DOI 10.1128/JVI.02097-15; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; BONGERTZ V, 1994, BRAZ J MED BIOL RES, V27, P1225; Bongertz V, 2000, J ACQ IMMUN DEF SYND, V23, P184; BONGERTZ V, 1991, BRAZ J MED BIOL RES, V24, P815; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; BOYD D, 1990, CELL, V62, P1031, DOI 10.1016/0092-8674(90)90378-R; Chuang GY, 2013, J VIROL, V87, P10047, DOI 10.1128/JVI.00984-13; Cortes FH, 2013, VACCINE, V31, P1106, DOI 10.1016/j.vaccine.2012.12.023; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Covas DT, 1998, J ACQ IMMUN DEF SYND, V19, P74, DOI 10.1097/00042560-199809010-00012; Delatorre E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074072; Delgado E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143325; Doria-Rose NA, 2015, CURR OPIN VIROL, V11, P137, DOI 10.1016/j.coviro.2015.04.002; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Edwards TG, 2002, J VIROL, V76, P2683, DOI 10.1128/JVI.76.6.2683-2691.2002; Gao F, 1996, J VIROL, V70, P1651, DOI 10.1128/JVI.70.3.1651-1667.1996; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Gnanakaran S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000955; Gorman J, 2016, NAT STRUCT MOL BIOL, V23, P81, DOI 10.1038/nsmb.3144; Graf T, 2013, VIROLOGY, V435, P170, DOI 10.1016/j.virol.2012.08.048; Guenaga J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002806; Guimaraes ML, 2001, J CLIN VIROL, V21, P143, DOI 10.1016/S1386-6532(01)00158-5; Guimaraes ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141372; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Kong R, 2015, J VIROL, V89, P2659, DOI 10.1128/JVI.03136-14; Korbie DJ, 2008, NAT PROTOC, V3, P1452, DOI 10.1038/nprot.2008.133; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; MORGADO MG, 1994, AIDS RES HUM RETROV, V10, P569, DOI 10.1089/aid.1994.10.569; Morgado MG, 1998, J ACQ IMMUN DEF SYND, V18, P488, DOI 10.1097/00042560-199808150-00011; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Niculescu I, 2015, AIDS RES HUM RETROV, V31, P488, DOI 10.1089/aid.2014.0189; Pimentel VF, 2013, AIDS RES HUM RETROV, V29, P1553, DOI [10.1089/aid.2013.0050, 10.1089/AID.2013.0050]; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Sarzotti-Kelsoe M, 2014, J IMMUNOL METHODS, V409, P131, DOI 10.1016/j.jim.2013.11.022; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang HL, 2011, J VIROL, V85, P9286, DOI 10.1128/JVI.02286-10; van Gils MJ, 2011, J VIROL, V85, P6986, DOI 10.1128/JVI.00268-11; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Ward AB, 2015, TRENDS BIOCHEM SCI, V40, P101, DOI 10.1016/j.tibs.2014.12.006; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Wibmer CK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003738; Yoon H, 2015, NUCLEIC ACIDS RES, V43, pW213, DOI 10.1093/nar/gkv404; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; Zhu ZY, 2011, J VIROL, V85, P11401, DOI 10.1128/JVI.05312-11; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307	61	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167690	10.1371/journal.pone.0167690	http://dx.doi.org/10.1371/journal.pone.0167690			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936047	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100153
J	Gracia-Rubio, I; Valverde, O; Martinez-Laorden, E; Moscoso-Castro, M; Milanes, MV; Laorden, ML				Gracia-Rubio, Irene; Valverde, Olga; Martinez-Laorden, Elena; Moscoso-Castro, Maria; Milanes, M. Victoria; Laorden, M. Luisa			Maternal Separation Impairs Cocaine-Induced Behavioural Sensitization in Adolescent Mice	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; DOPAMINE D2 RECEPTORS; TRANSCRIPTION FACTORS; D-2 RECEPTORS; ADULT RATS; MORPHINE-WITHDRAWAL; MILD STRESS; EXPRESSION; ADDICTION; BRAIN	Adverse early-life conditions induce persistent disturbances that give rise to negative emotional states. Therefore, early life stress confers increased vulnerability to substance use disorders, mainly during adolescence as the brain is still developing. In this study, we investigated the consequences of maternal separation, a model of maternal neglect, on the psychotropic effects of cocaine and the neuroplasticity of the dopaminergic system. Our results show that mice exposed to maternal separation displayed attenuated behavioural sensitization, while no changes were found in the rewarding effects of cocaine in the conditioned place preference paradigm and in the reinforcing effects of cocaine in the self-administration paradigm. The evaluation of neuroplasticity in the striatal dopaminergic pathways revealed that mice exposed to maternal separation exhibited decreased protein expression levels of D2 receptors and increased levels of the transcriptional factor Nurr1. Furthermore, animals exposed to maternal separation and treated with cocaine exhibited increased DA turnover and protein expression levels of DAT and D2R, while decreased Nurr1 and Pitx3 protein expression levels were observed when compared with saline-treated mice. Taken together, our data demonstrate that maternal separation caused an impairment of cocaine-induced behavioural sensitization possibly due to a dysfunction of the dopaminergic system, a dysfunction that has been proposed as a factor of vulnerability for developing substance use disorders.	[Gracia-Rubio, Irene; Valverde, Olga; Moscoso-Castro, Maria] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Neurobiol Behav Res Grp GReNeC, Barcelona, Spain; [Valverde, Olga] IMIM Hosp Mar Res Inst, Neurosci Res Program, Barcelona, Spain; [Martinez-Laorden, Elena; Milanes, M. Victoria; Laorden, M. Luisa] Univ Murcia, Grp Cellular & Mol Pharmacol, Fac Med, Murcia, Spain; [Martinez-Laorden, Elena; Milanes, M. Victoria; Laorden, M. Luisa] IMIB, Murcia, Spain	Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); University of Murcia	Valverde, O (corresponding author), Univ Pompeu Fabra, Dept Expt & Hlth Sci, Neurobiol Behav Res Grp GReNeC, Barcelona, Spain.; Valverde, O (corresponding author), IMIM Hosp Mar Res Inst, Neurosci Res Program, Barcelona, Spain.	olga.valverde@upf.edu	Milanés, M Victoria/K-6591-2017; Milanés, M. Victoria/AGB-4075-2022; Gracia-Rubio, Irene/E-5545-2014; Valverde, Olga/D-8654-2012	Milanés, M Victoria/0000-0002-0984-2218; Milanés, M. Victoria/0000-0002-0984-2218; Gracia-Rubio, Irene/0000-0003-1028-8581; Valverde, Olga/0000-0003-2264-7852	UE MedBioinformatics project [634143]; MINECO [SAF2013-41761-R-FEDER, SAF2013-49076-P-FEDER]; Spanish Ministry of Health [Retic-ISCIII-RD/12/0028/0024-FEDER, RETICS-ISCIII-RD 12/0028/003-FEDER, 2014/020]; Generalitat de Catalunya [2014SGR34]; Fundacion Seneca [15405/PI/10]; Region de Murcia; FPI [BES-2011-046655, SAF2010-15793]	UE MedBioinformatics project; MINECO(Spanish Government); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Fundacion Seneca(Fundacion Seneca); Region de Murcia; FPI(Spanish Government)	This study was supported by UE MedBioinformatics project (Grant Agreement Number: 634143), MINECO (SAF2013-41761-R-FEDER and SAF2013-49076-P-FEDER), Spanish Ministry of Health (Retic-ISCIII-RD/12/0028/0024-FEDER and RETICS-ISCIII-RD 12/0028/003-FEDER and Plan Nacional sobre Drogas 2014/020), Generalitat de Catalunya (2014SGR34) and Fundacion Seneca (15405/PI/10), Region de Murcia. IG-R was funded by FPI fellowship BES-2011-046655 associated to SAF2010-15793.	Adriani W, 2003, BEHAV NEUROSCI, V117, P695, DOI 10.1037/0735-7044.117.4.695; Anzalone A, 2012, J NEUROSCI, V32, P9023, DOI 10.1523/JNEUROSCI.0918-12.2012; Benoit-Marand M, 2001, J NEUROSCI, V21, P9134, DOI 10.1523/JNEUROSCI.21-23-09134.2001; Bissonette GB, 2016, GENES BRAIN BEHAV, V15, P62, DOI 10.1111/gbb.12257; Blanco E, 2012, PSYCHOPHARMACOLOGY, V220, P27, DOI 10.1007/s00213-011-2446-6; Burke AR, 2014, PSYCHOPHARMACOLOGY, V231, P1557, DOI 10.1007/s00213-013-3369-1; Caine SB, 2002, J NEUROSCI, V22, P2977, DOI 10.1523/JNEUROSCI.22-07-02977.2002; Campos-Melo D, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00044; Cheetham A, 2010, CLIN PSYCHOL REV, V30, P621, DOI 10.1016/j.cpr.2010.04.005; Crews F, 2007, PHARMACOL BIOCHEM BE, V86, P189, DOI 10.1016/j.pbb.2006.12.001; Doremus-Fitzwater TL, 2010, PHARMACOL BIOCHEM BE, V96, P198, DOI 10.1016/j.pbb.2010.05.005; Enman NM, 2015, BIOL PSYCHIAT, V78, P871, DOI 10.1016/j.biopsych.2015.04.024; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Garcia-Perez D, 2016, ADDICT BIOL, V21, P374, DOI 10.1111/adb.12209; Garcia-Perez D, 2015, BRAIN STRUCT FUNCT, V220, P1901, DOI 10.1007/s00429-014-0761-5; Garcia-Perez D, 2015, ADDICT BIOL, V20, P104, DOI 10.1111/adb.12083; George ED, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-123; Gerra G, 2009, NEUROSCI BIOBEHAV R, V33, P601, DOI 10.1016/j.neubiorev.2007.08.002; Gracia-Rubio I, 2016, PROG NEURO-PSYCHOPH, V65, P104, DOI 10.1016/j.pnpbp.2015.09.003; Han X, 2015, PSYCHOPHARMACOLOGY, V232, P1003, DOI 10.1007/s00213-014-3734-8; Hays SL, 2012, BEHAV BRAIN RES, V227, P7, DOI 10.1016/j.bbr.2011.10.033; Jankovic J, 2005, PROG NEUROBIOL, V77, P128, DOI 10.1016/j.pneurobio.2005.09.001; Katunar MR, 2009, J NEUROSCI RES, V87, P1014, DOI 10.1002/jnr.21911; Kaufman J, 2000, BIOL PSYCHIAT, V48, P778, DOI 10.1016/S0006-3223(00)00998-7; Kikusui T, 2005, PSYCHOPHARMACOLOGY, V178, P202, DOI 10.1007/s00213-004-1989-1; Koob GF, 2008, PHILOS T R SOC B, V363, P3113, DOI 10.1098/rstb.2008.0094; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kosten TA, 2003, DEV BRAIN RES, V141, P109, DOI 10.1016/S0165-3806(03)00003-8; Leo D, 2007, EXP NEUROL, V203, P472, DOI 10.1016/j.expneurol.2006.08.024; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Martin M, 2000, EUR J NEUROSCI, V12, P4038, DOI 10.1046/j.1460-9568.2000.00287.x; Martini M, 2012, PSYCHOPHARMACOLOGY, V219, P149, DOI 10.1007/s00213-011-2385-2; Matsuzawa S, 1999, BRAIN RES, V835, P298, DOI 10.1016/S0006-8993(99)01606-6; Matthews K, 1999, PSYCHOPHARMACOLOGY, V141, P123, DOI 10.1007/s002130050816; MATTINGLY BA, 1994, PSYCHOPHARMACOLOGY, V114, P239, DOI 10.1007/BF02244843; Morgan D, 2002, NAT NEUROSCI, V5, P169, DOI 10.1038/nn798; Nazarian A, 2004, BRAIN RES BULL, V63, P295, DOI 10.1016/j.brainresbull.2004.03.004; O'Connor RM, 2015, NEUROPHARMACOLOGY, V99, P168, DOI 10.1016/j.neuropharm.2015.07.012; PAPP M, 1991, PSYCHOPHARMACOLOGY, V104, P255, DOI 10.1007/BF02244188; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Planeta CS, 2002, BRAZ J MED BIOL RES, V35, P1367, DOI 10.1590/S0100-879X2002001100015; PUGLISIALLEGRA S, 1991, LIFE SCI, V48, P1263, DOI 10.1016/0024-3205(91)90521-C; Reddy SDN, 2011, P NATL ACAD SCI USA, V108, P4200, DOI 10.1073/pnas.1101193108; Rezayof A, 2002, PHARMACOL BIOCHEM BE, V74, P187, DOI 10.1016/S0091-3057(02)00989-9; Rodriguez-Arias M., 2015, ADDICT BIOL; Rojas P, 2010, J NEUROSCI RES, V88, P2284, DOI 10.1002/jnr.22377; Sinha R, 2008, ANN NY ACAD SCI, V1141, P105, DOI 10.1196/annals.1441.030; Soria G, 2005, NEUROPSYCHOPHARMACOL, V30, P1670, DOI 10.1038/sj.npp.1300707; SPEAR LP, 1979, BEHAV NEURAL BIOL, V26, P401, DOI 10.1016/S0163-1047(79)91410-9; Tourino C, 2012, BRIT J PHARMACOL, V167, P892, DOI 10.1111/j.1476-5381.2012.02043.x; Tseng KY, 2000, MOL BRAIN RES, V80, P1, DOI 10.1016/S0169-328X(00)00107-8; Valverde O, 1997, PSYCHOPHARMACOLOGY, V131, P79, DOI 10.1007/s002130050268; Vazquez V, 2007, PSYCHOPHARMACOLOGY, V193, P475, DOI 10.1007/s00213-007-0789-9; Volkow ND, 2002, SYNAPSE, V46, P79, DOI 10.1002/syn.10137; WEISS RD, 1992, AM J DRUG ALCOHOL AB, V18, P121, DOI 10.3109/00952999208992825; Widom CS, 2007, ARCH GEN PSYCHIAT, V64, P49	56	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167483	10.1371/journal.pone.0167483	http://dx.doi.org/10.1371/journal.pone.0167483			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936186	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100108
J	Kaul, SC; Ishida, Y; Tamura, K; Wada, T; Iitsuka, T; Garg, S; Kim, M; Gao, R; Nakai, S; Okamoto, Y; Terao, K; Wadhwa, R				Kaul, Sunil C.; Ishida, Yoshiyuki; Tamura, Kazuya; Wada, Teruo; Iitsuka, Tomoko; Garg, Sukant; Kim, Mijung; Gao, Ran; Nakai, Shoichi; Okamoto, Youji; Terao, Keiji; Wadhwa, Renu			Novel Methods to Generate Active Ingredients-Enriched Ashwagandha Leaves and Extracts	PLOS ONE			English	Article							STUDYING CHEMOTYPE VARIATIONS; NF-KAPPA-B; WITHANIA-SOMNIFERA; NMR-SPECTROSCOPY; CANCER-CELLS; GAMMA-CYCLODEXTRIN; ALCOHOLIC EXTRACT; LEAF EXTRACT; WITHAFERIN; APOPTOSIS	Ashwagandha (Withania somnifera) is an Ayurvedic herb commonly used in world-renowned traditional Indian home medicine system. Roots of Ashwagandha have been traditionally known to possess a variety of therapeutic and health promoting potentials that have not been sufficiently supported by laboratory studies. Nevertheless, most, if not all, of the preventive and therapeutic potentials have been assigned to its bioactive components, steroidal alkaloids and lactones. In contrast to the traditional use of roots, we have been exploring bioactivities in leaves of Ashwagandha. Here, we report that the leaves possess higher content of active Withanolides, Withaferin-A (Wi-A) and Withanone (Wi-N), as compared to the roots. We also established, for the first time, hydroponic cultivation of Ashwagandha and investigated the effect of various cultivation conditions on the content of Wi-A and Wi-N by chemical analysis and bioassays. We report that the Withanone/Withaferin Arich leaves could be obtained by manipulating light condition during hydroponic cultivation. Furthermore, we recruited cyclodextrins to prepare extracts with desired ratio of Wi-N and Wi-A. Hydroponically grown Ashwagandha and its extracts with high ratio of withanolides are valuable for cancer treatment.	[Kaul, Sunil C.; Iitsuka, Tomoko; Garg, Sukant; Kim, Mijung; Gao, Ran; Wadhwa, Renu] Natl Inst Adv Ind Sci & Technol, Drug Discovery & Assets Innovat Lab, DBT AIST Int Lab Adv Biomed DAILAB, Tsukuba, Ibaraki, Japan; [Ishida, Yoshiyuki; Terao, Keiji] CycloChem Co Ltd, Chuo Ku, 7-4-5 Minatojima Minamimachi, Kobe, Hyogo, Japan; [Tamura, Kazuya; Nakai, Shoichi] DAI DAN Co Ltd, 390 Kitanagai, Miyoshi, Saitama, Japan; [Wada, Teruo] Osaka Prefecture Univ, 1-1 Nakakugakuencho, Sakai, Osaka, Japan; [Garg, Sukant; Wadhwa, Renu] Univ Tsukuba, Sch Integrat & Global Majors, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan; [Okamoto, Youji] Zuiron Private Ltd, 2-3-1 Nakajyosanjimacho, Tokushima, Tokushima, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Osaka Metropolitan University; University of Tsukuba	Wadhwa, R (corresponding author), Natl Inst Adv Ind Sci & Technol, Drug Discovery & Assets Innovat Lab, DBT AIST Int Lab Adv Biomed DAILAB, Tsukuba, Ibaraki, Japan.; Wadhwa, R (corresponding author), Univ Tsukuba, Sch Integrat & Global Majors, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan.	renu-wadhwa@aist.go.jp	Kaul, Sunil C/L-8671-2018; Wadhwa, Renu/L-8898-2018	Kaul, Sunil C/0000-0002-0046-3916; Wadhwa, Renu/0000-0001-8248-5192	AIST-Industrial Collaboration Funds	AIST-Industrial Collaboration Funds	The study was partly supported by AIST-Industrial Collaboration Funds. Dr. Yoshiyuki Ishida and Dr. Keiji Terao are research employees of CycloChem Co., Ltd. Mr. Kazuya Tamura and Mr. Shoichi Nakai are employees of DAI-DAN Co., Ltd. Dr. Youji Okamoto is an employee of Zuiron Private Ltd. These three commercial companies significantly contributed in the present study starting from conceptualization, investigation, analyses of the data to supervision. The specific roles of these authors are articulated in the 'author contributions' section.	Akihisa T, 2009, REGULATION OF PLANT, V44, P177; Bharti SK, 2011, MAGN RESON CHEM, V49, P659, DOI 10.1002/mrc.2817; Bhatia A, 2013, PHYTOCHEMISTRY, V93, P105, DOI 10.1016/j.phytochem.2013.03.013; Bhattacharya S K, 1997, Indian J Exp Biol, V35, P236; Dar PA, 2016, CURR PHARM DESIGN, V22, P535, DOI 10.2174/1381612822666151125001751; Das T, 2014, BIOCHEM PHARMACOL, V91, P31, DOI 10.1016/j.bcp.2014.06.022; Deocaris CC, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-14; Devi P. Uma, 1996, Indian Journal of Experimental Biology, V34, P927; Devi PU, 1996, INT J RADIAT BIOL, V69, P193, DOI 10.1080/095530096146020; Gao R, 2014, MOL CANCER THER, V13, P2930, DOI 10.1158/1535-7163.MCT-14-0324; Gautam A, 2016, MOL NEUROBIOL, V53, P1760, DOI 10.1007/s12035-015-9117-2; Gautam A, 2013, NEUROBIOL LEARN MEM, V106, P177, DOI 10.1016/j.nlm.2013.08.009; Grin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039065; Ichikawa H, 2006, MOL CANCER THER, V5, P1434, DOI 10.1158/1535-7163.MCT-06-0096; Kalani A, 2012, BMJ CASE REP, V2012; Kamigauchi M, 2007, CHEM PHARM BULL, V55, P729, DOI 10.1248/cpb.55.729; Kataria H, 2016, MOL NEUROBIOL, V53, P4143, DOI 10.1007/s12035-015-9320-1; Kataria H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055316; Kataria H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037080; Kataria H, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/nep188; Khanna D, 2007, CURR OPIN PHARMACOL, V7, P344, DOI 10.1016/j.coph.2007.03.002; Khedgikar V, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.294; Konar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027265; Kuboyama T, 2014, BIOL PHARM BULL, V37, P892, DOI 10.1248/bpb.b14-00022; Lee J, 2015, MOL CARCINOGEN, V54, P417, DOI 10.1002/mc.22110; Lopez-Miranda S, 2016, FOOD CHEM, V203, P379, DOI 10.1016/j.foodchem.2016.02.100; Mandal C, 2008, APOPTOSIS, V13, P1450, DOI 10.1007/s10495-008-0271-0; Mantegna S, 2012, FOOD CHEM, V130, P746, DOI 10.1016/j.foodchem.2011.07.038; Miyoshi N, 2011, J NUTR BIOCHEM, V22, P1121, DOI 10.1016/j.jnutbio.2010.09.011; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Murthy M. R. Ven, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P238; Namdeo AG, 2011, PLANTA MED, V77, P1958, DOI 10.1055/s-0031-1279997; Raghavan A, 2015, MOL NEUROBIOL, V52, P1093, DOI 10.1007/s12035-014-8907-2; Sangwan Neelam S, 2014, Recent Pat Biotechnol, V8, P25, DOI 10.2174/1872208307666131218125300; Shah N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120554; Shah N, 2009, CANCER SCI, V100, P1740, DOI 10.1111/j.1349-7006.2009.01236.x; Sidhu OP, 2011, PHYTOCHEM ANALYSIS, V22, P492, DOI 10.1002/pca.1307; Singh D, 2007, PHYTOTHER RES, V21, P905, DOI 10.1002/ptr.2180; Singh N, 2011, AFR J TRADIT COMPLEM, V8, P208, DOI 10.4314/ajtcam.v8i5S.9; Singh P, 2015, MOL BIOL INT, V2015, P1, DOI DOI 10.1080/02648725.2015.1020467; Sinha P, 2013, CANCER IMMUNOL IMMUN, V62, P1663, DOI 10.1007/s00262-013-1470-2; Stan SD, 2008, NUTR CANCER, V60, P51, DOI 10.1080/01635580802381477; Terao K, 2006, NUTR RES, V26, P503, DOI 10.1016/j.nutres.2006.08.004; Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938; Tohda C, 2000, NEUROREPORT, V11, P1981, DOI 10.1097/00001756-200006260-00035; Uchida R, 2015, INT J MOL SCI, V16, P10105, DOI 10.3390/ijms160510105; Vaishnavi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044419; Vyas AR, 2014, AAPS J, V16, P1, DOI 10.1208/s12248-013-9531-1; Wadhwa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077189; Widodo N, 2008, CANCER LETT, V262, P37, DOI 10.1016/j.canlet.2007.11.037; Widodo N, 2007, CLIN CANCER RES, V13, P2298, DOI 10.1158/1078-0432.CCR-06-0948; Widodo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013536; Widodo N, 2009, J GERONTOL A-BIOL, V64, P1031, DOI 10.1093/gerona/glp088; Zhao J, 2002, CHEM PHARM BULL, V50, P760, DOI 10.1248/cpb.50.760	54	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166945	10.1371/journal.pone.0166945	http://dx.doi.org/10.1371/journal.pone.0166945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936030	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100050
J	Seemanova, E; Varon, R; Vejvalka, J; Jarolim, P; Seeman, P; Chrzanowska, KH; Digweed, M; Resnick, I; Kremensky, I; Saar, K; Hoffmann, K; Dutrannoy, V; Karbasiyan, M; Ghani, M; Baric, I; Tekin, M; Kovacs, P; Krawczak, M; Reis, A; Sperling, K; Nothnagel, M				Seemanova, Eva; Varon, Raymonda; Vejvalka, Jan; Jarolim, Petr; Seeman, Pavel; Chrzanowska, Krystyna H.; Digweed, Martin; Resnick, Igor; Kremensky, Ivo; Saar, Kathrin; Hoffmann, Katrin; Dutrannoy, Veronique; Karbasiyan, Mohsen; Ghani, Mehdi; Baric, Ivo; Tekin, Mustafa; Kovacs, Peter; Krawczak, Michael; Reis, Andre; Sperling, Karl; Nothnagel, Michael			The Slavic NBN Founder Mutation: A Role for Reproductive Fitness?	PLOS ONE			English	Article							NIJMEGEN BREAKAGE SYNDROME; DOUBLE-STRAND BREAKS; MAP-O-MAT; 657DEL5 MUTATION; CANCER-RISK; NBS1 GENE; HUMAN GENOME; CLINICAL-MANIFESTATION; DEFECTIVE RESPONSE; FEMALE FERTILITY	The vast majority of patients with Nijmegen Breakage Syndrome (NBS) are of Slavic origin and carry a deleterious deletion (c.657de15; rs587776650) in the NBN gene on chromosome 8q21. This mutation is essentially confined to Slavic populations and may thus be considered a Slavic founder mutation. Notably, not a single parenthood of a homozygous c.657de15 carrier has been reported to date, while heterozygous carriers do reproduce but have an increased cancer risk. These observations seem to conflict with the considerable carrier frequency of c.657de15 of 0.5% to 1% as observed in different Slavic populations because deleterious mutations would be eliminated quite rapidly by purifying selection. Therefore, we propose that heterozygous c.657de15 carriers have increased reproductive success, i.e., that the mutation confers heterozygote advantage. In fact, in our cohort study of the reproductive history of 24 NBS pedigrees from the Czech Republic, we observed that female carriers gave birth to more children on average than female non-carriers, while no such reproductive differences were observed for males. We also estimate that c.657de15 likely occurred less than 300 generations ago, thus supporting the view that the original mutation predated the historic split and subsequent spread of the 'Slavic people'. We surmise that the higher fertility of female c.657de15 carriers reflects a lower miscarriage rate in these women, thereby reflecting the role of the NBN gene product, nibrin, in the repair of DNA double strand breaks and their processing in immune gene rearrangements, telomere maintenance, and meiotic recombination, akin to the previously described role of the DNA repair genes BRCA1 and BRCA2.	[Seemanova, Eva] Charles Univ Prague, Med Sch 2, Dept Clin Genet, Inst Biol & Med Genet, Prague, Czech Republic; [Varon, Raymonda; Digweed, Martin; Dutrannoy, Veronique; Karbasiyan, Mohsen; Sperling, Karl] Charite Univ Med Berlin, Inst Med & Human Genet, Berlin, Germany; [Vejvalka, Jan] Charles Univ Prague, Med Sch 2, Dept Informat, Prague, Czech Republic; [Jarolim, Petr] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA USA; [Seeman, Pavel] Charles Univ Prague, Med Sch 2, Dept Pediat Neurol, DNA Lab, Prague, Czech Republic; [Seeman, Pavel] Univ Hosp Motol, Prague, Czech Republic; [Chrzanowska, Krystyna H.] Childrens Mem Hlth Inst, Dept Med Genet, Warsaw, Poland; [Resnick, Igor] Hadassah Hebrew Univ, Med Ctr, Dept Bone Marrow Transplantat & Canc Immunotherap, Jerusalem, Israel; [Kremensky, Ivo] Med Univ, Univ Hosp Obstet & Gynecol, Natl Genet Lab, Sofia, Bulgaria; [Saar, Kathrin] Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Hoffmann, Katrin] Martin Luther Univ Halle Wittenberg, Inst Human Genet, Halle, Germany; [Ghani, Mehdi] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Baric, Ivo] Univ Hosp Ctr Zagreb, Dept Paediat, Zagreb, Croatia; [Baric, Ivo] Univ Zagreb, Sch Med, Zagreb, Croatia; [Tekin, Mustafa] Ankara Univ, Sch Med, Div Pediat Mol Genet, Ankara, Turkey; [Kovacs, Peter] Univ Leipzig, Med Ctr, IFB AdiposityDiseases, Leipzig, Germany; [Krawczak, Michael] Univ Kiel, Inst Med Informat & Stat, Kiel, Germany; [Reis, Andre] Friedrich Alexander Univ Erlangen Nurnberg FAU, Inst Human Genet, Erlangen, Germany; [Nothnagel, Michael] Univ Cologne, Cologne Ctr Genom, Cologne, Germany	Charles University Prague; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Charles University Prague; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Charles University Prague; Motol University Hospital; Children's Memorial Health Institute; Hebrew University of Jerusalem; Hadassah University Medical Center; Medical University Sofia; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Martin Luther University Halle Wittenberg; University of Toronto; University of Zagreb; University of Zagreb; Ankara University; Leipzig University; University of Kiel; University of Erlangen Nuremberg; University of Cologne	Seemanova, E (corresponding author), Charles Univ Prague, Med Sch 2, Dept Clin Genet, Inst Biol & Med Genet, Prague, Czech Republic.; Nothnagel, M (corresponding author), Univ Cologne, Cologne Ctr Genom, Cologne, Germany.	eva.seemanova@lfmotol.cuni.cz; michael.nothnagel@uni-koeln.de	Krawczak, Michael/A-8964-2010; Reis, André/D-2309-2009; Tekin, Mustafa/ABG-7627-2020; Nothnagel, Michael/L-7187-2019; Nothnagel, Michael/G-6545-2014	Krawczak, Michael/0000-0003-2603-1502; Reis, André/0000-0002-6301-6363; Nothnagel, Michael/0000-0001-8305-7114; Kovacs, Peter/0000-0002-0290-5423; Jarolim, Petr/0000-0002-9612-8652; Chrzanowska, Krystyna/0000-0003-3888-0624; Tekin, Mustafa/0000-0002-3525-7960; Reis, AlessanRSS/0000-0001-8486-7469; Ghani, Mahdi/0000-0001-6455-7199; Saar, Kathrin/0000-0002-4483-1557	Sander Stiftung; DFG; German Ministry of Education and Research (BMBF) through National Genome Research Network (NGFN); Ministry of Science, Education and Sport of the Republic of Croatia [108-1081870-1885]; Czech Ministry of Health [AZV 12-31899 A, DRO 00064203]; Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01E01501]; Collaborative Research Center - German Research Foundation [CRC 1052, C01, B03]	Sander Stiftung; DFG(German Research Foundation (DFG)); German Ministry of Education and Research (BMBF) through National Genome Research Network (NGFN)(Federal Ministry of Education & Research (BMBF)); Ministry of Science, Education and Sport of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Czech Ministry of Health(Ministry of Health, Czech Republic); Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); Collaborative Research Center - German Research Foundation	This work was supported by grants from the Sander Stiftung to KS and ES, by grants from the DFG to AR, KS and MD, by the German Ministry of Education and Research (BMBF) through National Genome Research Network (NGFN) grants to MK and MN, by grant 108-1081870-1885 of the Ministry of Science, Education and Sport of the Republic of Croatia to IB, and by grants AZV 12-31899 A and DRO 00064203 from the Czech Ministry of Health to PS. The Sorb study was supported by Federal Ministry of Education and Research (BMBF), Germany, (FKZ: 01E01501) and by grants from the Collaborative Research Center funded by the German Research Foundation (CRC 1052; C01, B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auguie B, 2017, GRIDEXTRA MISCELLANE; Bogdanova N, 2008, BREAST CANCER RES TR, V112, P75, DOI 10.1007/s10549-007-9820-4; Borde V, 2007, CHROMOSOME RES, V15, P551, DOI 10.1007/s10577-007-1147-9; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Buslov KG, 2005, INT J CANCER, V114, P585, DOI 10.1002/ijc.20765; Carlomagno F, 1999, GENE CHROMOSOME CANC, V25, P393, DOI 10.1002/(SICI)1098-2264(199908)25:4<393::AID-GCC12>3.0.CO;2-8; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Cheung VG, 2006, GENOME RES, V16, P973, DOI 10.1101/gr.5320706; Chrzanowska KH, 2006, INT J CANCER, V118, P1269, DOI 10.1002/ijc.21439; Chrzanowska KH, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-13; Cilli D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114651; Cybulski C, 2004, CANCER RES, V64, P1215, DOI 10.1158/0008-5472.CAN-03-2502; Delhanty JDA, 2005, CYTOGENET GENOME RES, V111, P237, DOI 10.1159/000086894; Demuth I, 2007, ONCOGENE, V26, P7792, DOI 10.1038/sj.onc.1210876; Difilippantonio S, 2007, J EXP MED, V204, P1003, DOI 10.1084/jem.20070319; Digweed M, 2004, DNA REPAIR, V3, P1207, DOI 10.1016/j.dnarep.2004.03.004; Digweed M, 1999, BIOESSAYS, V21, P649, DOI 10.1002/(SICI)1521-1878(199908)21:8<649::AID-BIES4>3.0.CO;2-O; Drabek J, 2002, CANCER GENET CYTOGEN, V138, P157, DOI 10.1016/S0165-4608(02)00594-0; Gao P, 2013, MUTAGENESIS, V28, P683, DOI 10.1093/mutage/get048; Gemmell NJ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000125; Gillespie J. H., 2004, POPULATION GENETICS; Gorbsky GJ., 2014, FEBS J, V282, P2471; Gorski B, 2003, INT J CANCER, V106, P379, DOI 10.1002/ijc.11231; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; He M, 2012, BREAST CANCER RES TR, V133, P111, DOI 10.1007/s10549-011-1700-2; Huang LO, 2013, HUM GENET, V132, P245, DOI 10.1007/s00439-012-1257-0; Kanka C, 2007, ANTICANCER RES, V27, P3015; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong X, 2005, BIOINFORMATICS, V21, P557, DOI 10.1093/bioinformatics/bti024; Kushniarevich A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135820; Kwiatkowski F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127363; Lamarche BJ, 2010, FEBS LETT, V584, P3682, DOI 10.1016/j.febslet.2010.07.029; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Lombard DB, 2000, CANCER RES, V60, P2331; Macklon NS, 2002, HUM REPROD UPDATE, V8, P333, DOI 10.1093/humupd/8.4.333; Maser RS, 2001, NAT GENET, V27, P417, DOI 10.1038/86920; Mateju M, 2012, BREAST CANCER RES TR, V133, P809, DOI 10.1007/s10549-012-2049-x; Matise TC, 2007, GENOME RES, V17, P1783, DOI 10.1101/gr.7156307; Matise TC, 1999, AM J HUM GENET, V65, pA435; Matsuura S, 1998, NAT GENET, V19, P179, DOI 10.1038/549; Maurer M, 2010, J APPL GENET, V51, P211, DOI 10.1007/BF03195730; Mielnik-Sikorska M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054360; Nagaoka SI, 2012, NAT REV GENET, V13, P493, DOI 10.1038/nrg3245; Oliver TR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000033; Pardini B, 2009, MUTAT RES-FUND MOL M, V666, P64, DOI 10.1016/j.mrfmmm.2009.04.004; Petersen MB, 2000, CYTOGENET CELL GENET, V91, P199, DOI 10.1159/000056844; Rannala B, 2001, AM J HUM GENET, V69, P159, DOI 10.1086/321279; Rebala K, 2007, J HUM GENET, V52, P406, DOI 10.1007/s10038-007-0125-6; Reeve JP, 2002, BIOINFORMATICS, V18, P894, DOI 10.1093/bioinformatics/18.6.894; Resnick IB, 2003, AM J MED GENET A, V120A, P174, DOI 10.1002/ajmg.a.20188; ROTTER JI, 1987, NATURE, V329, P289, DOI 10.1038/329289a0; Rozhanskii I. L. K AA, 2012, ADV ANTHR, V2, P139, DOI DOI 10.4236/aa.2012.23017; Santos MA, 2010, REPRODUCTION, V139, P23, DOI 10.1530/REP-09-0187; Seeman P, 2004, PEDIATR NEUROL, V30, P195, DOI 10.1016/j.pediatrneurol.2003.07.003; Seemanov E, 2007, JNCI-J NATL CANCER I, V99, P1875, DOI 10.1093/jnci/djm251; Seemanova E, 2004, Cas Lek Cesk, V143, P538; Seemanova E, 2004, CAS LEK CESK, V143, P542; Shimada M, 2009, CANCER RES, V69, P1768, DOI 10.1158/0008-5472.CAN-08-3016; Smith KR, 2013, CURR OPIN OBSTET GYN, V25, P207, DOI 10.1097/GCO.0b013e32835f1731; Smith KR, 2012, P ROY SOC B-BIOL SCI, V279, P1389, DOI 10.1098/rspb.2011.1697; Steffen J, 2004, INT J CANCER, V111, P67, DOI 10.1002/ijc.20239; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Varon R, 2000, EUR J HUM GENET, V8, P900, DOI 10.1038/sj.ejhg.5200554; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Veeramah KR, 2011, EUR J HUM GENET, V19, P995, DOI 10.1038/ejhg.2011.65; Voskarides K, 2014, GENET TEST MOL BIOMA, V18, P533, DOI 10.1089/gtmb.2014.0053; Yuan JS, 2010, J BIOL CHEM, V285, P1097, DOI 10.1074/jbc.M109.078436; Ziolkowska I, 2006, J APPL GENET, V47, P269, DOI 10.1007/BF03194635	69	12	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167984	10.1371/journal.pone.0167984	http://dx.doi.org/10.1371/journal.pone.0167984			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936167	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000389587100245
J	Vuong, TD; Walker, DR; Nguyen, BT; Nguyen, TT; Dinh, HX; Hyten, DL; Cregan, PB; Sleper, DA; Lee, JD; Shannon, JG; Nguyen, HT				Vuong, Tri D.; Walker, David R.; Nguyen, Binh T.; Nguyen, Tuyet T.; Dinh, Hoan X.; Hyten, David L.; Cregan, Perry B.; Sleper, David A.; Lee, Jeong D.; Shannon, James G.; Nguyen, Henry T.			Molecular Characterization of Resistance to Soybean Rust (Phakopsora pachyrhizi Syd. & Syd.) in Soybean Cultivar DT 2000 (PI 635999)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; HETERODERA-GLYCINES ICHINOHE; BULKED SEGREGANT ANALYSIS; UNITED-STATES; 1ST REPORT; GENES; IDENTIFICATION; GERMPLASM; CONFIRMATION; POPULATIONS	Resistance to soybean rust (SBR), caused by Phakopsora pachyrhizi Syd. & Syd., has been identified in many soybean germplasm accessions and is conferred by either dominant or recessive genes that have been mapped to six independent loci (Rpp1 -Rpp6), but No U. S. cultivars are resistant to SBR. The cultivar DT 2000 (PI 635999) has resistance to P. pachyrhizi isolates and field populations from the United States as well as Vietnam. A F-6:7 recombinant inbred line (RIL) population derived from Williams 82 x DT 2000 was used to identify genomic regions associated with resistance to SBR in the field in Ha Noi, Vietnam, and in Quincy, Florida, in 2008. Bulked segregant analysis (BSA) was conducted using the soybean single nucleotide polymorphism (SNP) USLP 1.0 panel along with simple sequence repeat (SSR) markers to detect regions of the genome associated with resistance. BSA identified four BARC_SNP markers near the Rpp3 locus on chromosome (Chr.) 6. Genetic analysis identified an additional genomic region around the Rpp4 locus on Chr. 18 that was significantly associated with variation in the area under disease progress curve (AUDPC) values and sporulation in Vietnam. Molecular markers tightly linked to the DT 2000 resistance alleles on Chrs. 6 and 18 will be useful for marker-assisted selection and backcrossing in order to pyramid these genes with other available SBR resistance genes to develop new varieties with enhanced and durable resistance to SBR.	[Vuong, Tri D.; Sleper, David A.; Shannon, James G.; Nguyen, Henry T.] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA; [Walker, David R.] Univ Illinois, USDA ARS, Soybean Maize Germplasm Pathol & Genet Res Unit, Urbana, IL USA; [Walker, David R.] Univ Illinois, Dept Crop Sci, Urbana, IL USA; [Nguyen, Binh T.; Nguyen, Tuyet T.; Dinh, Hoan X.] PPRI, Hanoi, Vietnam; [Hyten, David L.; Cregan, Perry B.] USDA ARS, Soybean Genom & Improvement Lab, Beltsville, MD USA; [Lee, Jeong D.] Univ Missouri, Div Plant Sci, Portageville, MO USA; [Hyten, David L.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA; [Lee, Jeong D.] Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea	University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia; University of Nebraska System; University of Nebraska Lincoln; Kyungpook National University	Vuong, TD; Nguyen, HT (corresponding author), Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA.	vuongt@missouri.edu; nguyenhenry@missouri.edu	Dinh, Hoan/AGX-7514-2022	Dinh, Hoan/0000-0001-6442-0416	United Soybean Board as a part of the project "Identification and utilization of resistance to soybean rust" (USB) [1235]; National Center for Soybean Biotechnology (USDA-CSREES Award) [2008-34555-19305]; ARS [ARS-0422909] Funding Source: Federal RePORTER	United Soybean Board as a part of the project "Identification and utilization of resistance to soybean rust" (USB); National Center for Soybean Biotechnology (USDA-CSREES Award); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was partially funded by the United Soybean Board [http://unitedsoybean.org/] as a part of the project "Identification and utilization of resistance to soybean rust" (USB # 1235) and by the National Center for Soybean Biotechnology (USDA-CSREES Award No. 2008-34555-19305). The United Soybean Board had read the manuscript and has indicted their approval of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu H, 2013, J GEN PLANT PATHOL, V79, P28, DOI 10.1007/s10327-012-0421-7; BERNARD RL, 1988, CROP SCI, V28, P1027; Bonde MR, 2006, PLANT DIS, V90, P708, DOI 10.1094/PD-90-0708; BROMFIELD KR, 1980, CROP SCI, V20, P254, DOI 10.2135/cropsci1980.0011183X002000020026x; Calvo ES, 2008, CROP SCI, V48, P1350, DOI 10.2135/cropsci2007.10.0589; Chakraborty N, 2009, CROP SCI, V49, P783, DOI 10.2135/cropsci2008.06.0335; Elliott RJ, 1999, LEARNING SAS COMPUTE, P39; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Frederick R. D., 2006, PLANT HLTH PROGR, DOI 10.1094.PHP-2006=0104-01-RS; Garcia A, 2008, THEOR APPL GENET, V117, P545, DOI 10.1007/s00122-008-0798-z; Garcia A, 2011, CROP SCI, V51, P32, DOI 10.2135/cropsci2010.01.0037; Harris DK, 2015, CROP SCI, V55, P2161, DOI 10.2135/cropsci2014.09.0671; Hartman G. L., 2011, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V6, P1, DOI 10.1079/PAVSNNR20116025; HARTMAN GL, 1992, PLANT DIS, V76, P396, DOI 10.1094/PD-76-0396; Hartman GL, 2005, PLANT DIS, V89, P664, DOI 10.1094/PD-89-0664; HARTMAN GL, 1991, PLANT DIS, V75, P596, DOI 10.1094/PD-75-0596; HARTWIG EE, 1986, CROP SCI, V26, P1135, DOI 10.2135/cropsci1986.0011183X002600010072x; HARTWIG EE, 1983, CROP SCI, V23, P237, DOI 10.2135/cropsci1983.0011183X002300020012x; Hossain MM, 2015, PLANT PATHOL, V64, P147, DOI 10.1111/ppa.12226; Hyten DL, 2010, CROP SCI, V50, P960, DOI 10.2135/cropsci2009.06.0360; Hyten DL, 2009, CROP SCI, V49, P265, DOI 10.2135/cropsci2008.08.0511; Kendrick MD, 2011, PHYTOPATHOLOGY, V101, P535, DOI 10.1094/PHYTO-09-10-0257; KILLGORE E, 1994, PLANT DIS, V78, P1216, DOI 10.1094/PD-78-1216B; Li SX, 2012, THEOR APPL GENET, V125, P133, DOI 10.1007/s00122-012-1821-y; MCLEAN RJ, 1980, AUST J AGR RES, V31, P951, DOI 10.1071/AR9800951; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Miles MR, 2008, PLANT DIS, V92, P96, DOI 10.1094/PDIS-92-1-0096; MILES MR, 2003, SOYBEAN RUST IS US C; Monteros MJ, 2007, CROP SCI, V47, P829, DOI 10.2135/cropsci06.07.0462; Paul C, 2013, PLANT DIS, V97, P1379, DOI 10.1094/PDIS-02-13-0182-PDN; Paul C, 2009, CROP SCI, V49, P1781, DOI 10.2135/cropsci2008.12.0710; Pham TA, 2010, FIELD CROP RES, V117, P131, DOI 10.1016/j.fcr.2010.02.011; Pham TA, 2009, PLANT DIS, V93, P224, DOI 10.1094/PDIS-93-3-0224; Ray JD, 2009, THEOR APPL GENET, V119, P271, DOI 10.1007/s00122-009-1036-z; Ronin YI, 1998, THEOR APPL GENET, V97, P1169, DOI 10.1007/s001220051006; Schneider RW, 2005, PLANT DIS, V89, P774, DOI 10.1094/PD-89-0774A; SHANER G, 1977, PHYTOPATHOLOGY, V67, P1051, DOI 10.1094/Phyto-67-1051; Shanmugasundaram S, 2004, P 7 WORLD SOYB RES C, P456; Silva DCG, 2008, THEOR APPL GENET, V117, P57, DOI 10.1007/s00122-008-0752-0; Sinclair J.B., 1999, COMPENDIUM SOYBEAN D, Vfourth, P25; Singh RJ, 2015, THEOR APPL GENET; Twizeyimana M, 2008, PLANT DIS, V92, P947, DOI 10.1094/PDIS-92-6-0947; Twizeyimana M, 2011, PLANT DIS, V95, P43, DOI 10.1094/PDIS-06-10-0436; Twizeyimana M, 2012, PLANT DIS, V96, P75; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Vuong TD, 2011, EUPHYTICA, V181, P101, DOI 10.1007/s10681-011-0430-1; Vuong TD, 2010, THEOR APPL GENET, V121, P1253, DOI 10.1007/s00122-010-1385-7; Walker DR, 2011, CROP SCI, V51, P678, DOI 10.2135/cropsci2010.06.0340; Walker DR, 2014, CROP SCI, V54, P1433, DOI 10.2135/cropsci2013.09.0654; Yang J, 2007, BIOINFORMATICS, V23, P1527, DOI 10.1093/bioinformatics/btm143; Yorinori JT, 2005, PLANT DIS, V89, P675, DOI 10.1094/PD-89-0675	53	16	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0164493	10.1371/journal.pone.0164493	http://dx.doi.org/10.1371/journal.pone.0164493			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935940	Green Published, gold			2022-12-27	WOS:000389587100006
J	Woods, DL; Wyma, JM; Herron, TJ; Yund, EW				Woods, David L.; Wyma, John M.; Herron, Timothy J.; Yund, E. William			Computerized Analysis of Verbal Fluency: Normative Data and the Effects of Repeated Testing, Simulated Malingering, and Traumatic Brain Injury	PLOS ONE			English	Article							LATENT SEMANTIC ANALYSIS; WORD-ASSOCIATION TEST; COMPONENT ANALYSIS; NEUROPSYCHOLOGICAL OUTCOMES; ALZHEIMERS-DISEASE; EXECUTIVE FUNCTION; CATEGORY FLUENCY; DESIGN FLUENCY; LOBE LESIONS; FREE-RECALL	In verbal fluency (VF) tests, subjects articulate words in a specified category during a short test period (typically 60 s). Verbal fluency tests are widely used to study language development and to evaluate memory retrieval in neuropsychiatric disorders. Performance is usually measured as the total number of correct words retrieved. Here, we describe the properties of a computerized VF (C-VF) test that tallies correct words and repetitions while providing additional lexical measures of word frequency, syllable count, and typicality. In addition, the C-VF permits (1) the analysis of the rate of responding over time, and (2) the analysis of the semantic relationships between words using a new method, Explicit Semantic Analysis (ESA), as well as the established semantic clustering and switching measures developed by Troyer et al. (1997). In Experiment 1, we gathered normative data from 180 subjects ranging in age from 18 to 82 years in semantic ("animals) and phonemic (letter "F") conditions. The number of words retrieved in 90 s correlated with education and daily hours of computeruse. The rate of word production declined sharply over time during both tests. In semantic conditions, correct-word scores correlated strongly with the number of ESA and Troyer-defined semantic switches as well as with an ESA-defined semantic organization index (SOI). In phonemic conditions, ESA revealed significant semantic influences in the sequence of words retrieved. In Experiment 2, we examined the test-retest reliability of different measures across three weekly tests in 40 young subjects. Different categories were used for each semantic ("animals", "parts of the body", and "foods") and phonemic (letters "F", "A", and "S") condition. After regressing out the influences of education and computeruse, we found that correct-word z-scores in the first session did not differ from those of the subjects in Experiment 1. Word production was uniformly greater in semantic than phonemic conditions. Intraclass correlation coefficients (ICCs) of correct-word z-scores were higher for phonemic (0.91) than semantic (0.77) tests. In semantic conditions, good reliability was also seen for the SOI (ICC = 0.68) and ESA-defined switches in semantic categories (ICC = 0.62). In Experiment 3, we examined the performance of subjects from Experiment 2 when instructed to malinger: 38% showed abnormal (p<0.05) performance in semantic conditions. Simulated malingerers with abnormal scores could be distinguished with 80% sensitivity and 89% specificity from subjects with abnormal scores in Experiment 1 using lexical, temporal, and semantic measures. In Experiment 4, we tested patients with mild and severe traumatic brain injury (mTBI and sTBI). Patients with mTBI performed within the normal range, while patients with sTBI showed significant impairments in correct-word z-scores and category shifts. The lexical, temporal, and semantic measures of the C-VF provide an automated and comprehensive description of verbal fluency performance.	[Woods, David L.; Wyma, John M.; Herron, Timothy J.; Yund, E. William] VANCHCS, Human Cognit Neurophysiol Lab, Martinez, CA 94553 USA; [Woods, David L.] UC Davis Dept Neurol, Sacramento, CA 95820 USA; [Woods, David L.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Woods, David L.] UC Davis Ctr Mind & Brain, Davis, CA 95616 USA; [Woods, David L.; Wyma, John M.] NeuroBehav Syst Inc, Berkeley, CA 94706 USA	University of California System; University of California Davis; University of California System; University of California Davis	Woods, DL (corresponding author), VANCHCS, Human Cognit Neurophysiol Lab, Martinez, CA 94553 USA.; Woods, DL (corresponding author), UC Davis Dept Neurol, Sacramento, CA 95820 USA.; Woods, DL (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.; Woods, DL (corresponding author), UC Davis Ctr Mind & Brain, Davis, CA 95616 USA.; Woods, DL (corresponding author), NeuroBehav Syst Inc, Berkeley, CA 94706 USA.	dlwoods@ucdavis.edu		Yund, E./0000-0002-6833-0052; Woods, David/0000-0002-8804-3587; Herron, Timothy/0000-0002-4297-014X	"VA Rehabilitation Research and Development Grants'' [CX000583, CX001000]; "VA Research and Development Grants'' [CX000583, CX001000]; Veterans Affairs [I01CX001000] Funding Source: NIH RePORTER	"VA Rehabilitation Research and Development Grants''; "VA Research and Development Grants''; Veterans Affairs(US Department of Veterans Affairs)	The funding source should be changed from "VA Rehabilitation Research and Development Grants grant CX000583 and CX001000 to DLW" to "VA Research and Development Grants grant CX000583 and CX001000 to DLW".	Andreou G, 2013, ADHD-ATTEND DEFICIT, V5, P343, DOI 10.1007/s12402-013-0112-z; Baldo JV, 2001, J INT NEUROPSYCH SOC, V7, P586, DOI 10.1017/S1355617701755063; Basso MR, 1999, CLIN NEUROPSYCHOL, V13, P283, DOI 10.1076/clin.13.3.283.1743; Benito-Cuadrado MM, 2002, J CLIN EXP NEUROPSYC, V24, P1117, DOI 10.1076/jcen.24.8.1117.8376; Benton A.L., 1983, MULTILINGUAL APLASIA, V2nd; Bittner RM, 2006, BRAIN INJURY, V20, P971, DOI 10.1080/02699050600909763; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Bousfield WA, 1944, J GEN PSYCHOL, V30, P149, DOI 10.1080/00221309.1944.10544467; BUTTERS N, 1978, ARCH NEUROL-CHICAGO, V35, P585, DOI 10.1001/archneur.1978.00500330033006; Capitani E, 1999, CORTEX, V35, P273, DOI 10.1016/S0010-9452(08)70800-1; Cavaco S, 2013, ARCH CLIN NEUROPSYCH, V28, P262, DOI 10.1093/arclin/act001; Cohen MJ, 1999, ARCH CLIN NEUROPSYCH, V14, P433, DOI 10.1016/S0887-6177(98)00038-9; Connelly V., 2005, EDUC PSYCHOL-UK, V25, P99, DOI [10.1080/0144341042000294912, DOI 10.1080/0144341042000294912]; Cralidis A, 2014, BRAIN INJURY, V28, P456, DOI 10.3109/02699052.2014.896945; Crowe SF, 1998, J CLIN EXP NEUROPSYC, V20, P391, DOI 10.1076/jcen.20.3.391.810; Curtis KL, 2008, CLIN NEUROPSYCHOL, V22, P930, DOI 10.1080/13854040701563591; Passos VMD, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0454-6; Delis DC, 2001, DELIS KAPLAN EXECUTI; Demakis GJ, 1999, ARCH CLIN NEUROPSYCH, V14, P401, DOI 10.1016/S0887-6177(98)00039-0; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Dykiert D, 2013, PSYCHOL ASSESSMENT, V25, P1361, DOI 10.1037/a0033623; Ehlen F, 2015, PSYCHON B REV; Federmeier KD, 2010, BRAIN LANG, V115, P149, DOI 10.1016/j.bandl.2010.07.006; Fernaeus SE, 1998, J CLIN EXP NEUROPSYC, V20, P137, DOI 10.1076/jcen.20.2.137.1170; Fernaeus SE, 2001, DEMENT GERIATR COGN, V12, P52, DOI 10.1159/000051235; Fernaeus SE, 2008, CORTEX, V44, P161, DOI 10.1016/j.cortex.2006.04.002; Fitzpatrick S, 2013, NEUROPSYCHOL REV, V23, P138, DOI 10.1007/s11065-013-9224-7; Gabrilovich E., 2011, ACM T INFORM SYSTEMS, V29, P1, DOI DOI 10.1145/1961209.1961211; Gabrilovich E, 2009, J ARTIF INTELL RES, V34, P443, DOI 10.1613/jair.2669; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; GRUENEWALD PJ, 1980, J EXP PSYCHOL-HUM L, V6, P225, DOI 10.1037/0278-7393.6.3.225; Hall JR, 2011, AGING NEUROPSYCHOL C, V18, P353, DOI [10.1080/13825585.2011.557495, 10.3109/17482941.2010.538698]; Hankee LD, 2013, EXP AGING RES, V39, P515, DOI 10.1080/0361073X.2013.839029; Haugrud N, 2011, J INT NEUROPSYCH SOC, V17, P1153, DOI 10.1017/S1355617711001196; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Henry JD, 2004, NEUROPSYCHOLOGIA, V42, P1212, DOI 10.1016/j.neuropsychologia.2004.02.001; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Henry JD, 2004, J INT NEUROPSYCH SOC, V10, P608, DOI 10.1017/S1355617704104141; Henry Julie D, 2005, Cogn Neuropsychiatry, V10, P1, DOI 10.1080/13546800344000309; Hills TT, 2012, PSYCHOL REV, V119, P431, DOI 10.1037/a0027373; Hoogendam YY, 2014, EUR J EPIDEMIOL, V29, P133, DOI 10.1007/s10654-014-9885-4; Hubel KA, 2013, PERCEPT MOTOR SKILL, V116, P929, DOI 10.2466/25.29.PMS.116.3.929-952; Hubel KA, 2013, J CLIN EXP NEUROPSYC, V35, P745, DOI 10.1080/13803395.2013.824070; Ide N, 2001, PROCEEDINGS OF CORPU; John D, 2009, J PHYS ACT HEALTH, V6, P617, DOI 10.1123/jpah.6.5.617; Jones MN, 2007, PSYCHOL REV, V114, P1, DOI 10.1037/0033-295X.114.1.1; Juhasz BJ, 2012, PSYCHIAT RES, V200, P177, DOI 10.1016/j.psychres.2012.06.035; Kaplan E., 1983, THE ASSESSMENT OF AP; Kave G, 2011, J CLIN EXP NEUROPSYC, V33, P358, DOI 10.1080/13803395.2010.518703; Kertesz A., 1982, WESTERN APHASIA BATT; Khalil MS, 2010, J CLIN EXP NEUROPSYC, V32, P1028, DOI 10.1080/13803391003672305; Koren R, 2005, ARCH CLIN NEUROPSYCH, V20, P1087, DOI 10.1016/j.acn.2005.06.012; Landauer TK, 1998, DISCOURSE PROCESS, V25, P259, DOI 10.1080/01638539809545028; Lanting S, 2009, J INT NEUROPSYCH SOC, V15, P196, DOI 10.1017/S1355617709090237; Ledoux K, 2014, J CLIN EXP NEUROPSYC, V36, P205, DOI 10.1080/13803395.2013.878689; Llewellyn DJ, 2009, AGING NEUROPSYCHOL C, V16, P433, DOI 10.1080/13825580902773867; Loonstra A S, 2001, Appl Neuropsychol, V8, P161, DOI 10.1207/S15324826AN0803_5; Mac Donald CL, 2015, BRAIN, V138, P1314, DOI 10.1093/brain/awv038; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; Nicodemus KK, 2014, CORTEX, V55, P182, DOI 10.1016/j.cortex.2013.12.004; OBER BA, 1986, J CLIN EXP NEUROPSYC, V8, P75, DOI 10.1080/01688638608401298; Ostrosky-Solis F, 2007, ARCH CLIN NEUROPSYCH, V22, P367, DOI 10.1016/j.acn.2007.01.011; Pakhomov SVS, 2016, NEUROPSYCHOLOGIA, V89, P42, DOI 10.1016/j.neuropsychologia.2016.05.031; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Robert PH, 1997, EUR PSYCHIAT, V12, P124, DOI 10.1016/S0924-9338(97)80200-3; Roberts PM, 1997, BRAIN LANG, V59, P412, DOI 10.1006/brln.1997.1753; Rodriguez-Aranda C, 2006, DEV NEUROPSYCHOL, V30, P697, DOI 10.1207/s15326942dn3002_3; ROHRER D, 1995, J EXP PSYCHOL LEARN, V21, P1127, DOI 10.1037/0278-7393.21.5.1127; Roldan-Tapia L, 2012, APPL NEUROPSYCH-ADUL, V19, P2, DOI 10.1080/09084282.2011.595458; Ross TP, 2007, ARCH CLIN NEUROPSYCH, V22, P475, DOI 10.1016/j.acn.2007.01.026; Ross TP, 2003, ARCH CLIN NEUROPSYCH, V18, P153, DOI 10.1016/S0887-6177(01)00192-5; Rosselli M, 2009, AGING NEUROPSYCHOL C, V16, P721, DOI 10.1080/13825580902912739; Shandera-Ochsner AL, 2013, CLIN NEUROPSYCHOL, V27, P881, DOI 10.1080/13854046.2013.802017; Shao Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00772; Stolwyk R, 2015, J CLIN EXP NEUROPSYC, P1; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Takacs A, 2014, CHILD NEUROPSYCHOL, V20, P415, DOI 10.1080/09297049.2013.799645; Tallberg IM, 2008, SCAND J PSYCHOL, V49, P479, DOI 10.1111/j.1467-9450.2008.00653.x; Then FS, 2014, J OCCUP MED TOXICOL, V9, DOI 10.1186/1745-6673-9-23; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Troyer AK, 1998, NEUROPSYCHOLOGIA, V36, P499, DOI 10.1016/S0028-3932(97)00152-8; Troyer AK, 2000, J CLIN EXP NEUROPSYC, V22, P370, DOI 10.1076/1380-3395(200006)22:3;1-V;FT370; Tsirka V, 2010, INT J NEUROSCI, V120, P184, DOI 10.3109/00207450903585308; Turken And U, 2009, BMC Med Imaging, V9, P20, DOI 10.1186/1471-2342-9-20; Van der Elst W, 2006, J INT NEUROPSYCH SOC, V12, P80, DOI 10.1017/S1355617706060115; van Hooren SAH, 2007, AGING NEUROPSYCHOL C, V14, P40, DOI 10.1080/138255890969483; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Vita MG, 2014, J ALZHEIMERS DIS, V42, P1171, DOI 10.3233/JAD-140570; Vonberg I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115846; Wecker NS, 2005, NEUROPSYCHOLOGY, V19, P345, DOI 10.1037/0894-4105.19.3.345; WIXTED JT, 1994, PSYCHON B REV, V1, P89, DOI 10.3758/BF03200763; Woods DL, 2016, MEMORY, V24, P1142, DOI 10.1080/09658211.2015.1076849; Woods DL, 2016, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00690; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00595; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00540; Woods DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124345; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00288; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00193; Woods DL, 2011, J CLIN EXP NEUROPSYC, V33, P721, DOI 10.1080/13803395.2010.550602; Woods DL, 2011, J CLIN EXP NEUROPSYC, V33, P101, DOI 10.1080/13803395.2010.493149; Woods DL, 2015, FRONT HUM NEUROSCI; Woods DL, 2016, PLOS ONE; Woods DL, 2016, FRONTIERS IN HUMAN N; Woods SP, 2005, J INT NEUROPSYCH SOC, V11, P408, DOI 10.1017/S1355617705050460; Zahodne LB, 2011, J INT NEUROPSYCH SOC, V17, P1039, DOI 10.1017/S1355617711001044; Zakzanis KK, 2013, BRAIN INJURY, V27, P903, DOI 10.3109/02699052.2013.775505; Zakzanis KK, 2011, J CLIN EXP NEUROPSYC, V33, P785, DOI 10.1080/13803395.2011.558496; Zarino B, 2014, NEUROL SCI, V35, P1405, DOI 10.1007/s10072-014-1729-1	113	22	22	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166439	10.1371/journal.pone.0166439	http://dx.doi.org/10.1371/journal.pone.0166439			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936001	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100026
J	Akhter, S; Anwar, I; Akter, R; Kumkum, FA; Nisha, MK; Ashraf, F; Islam, F; Begum, N; Chowdhury, ME; Austin, A; Islam, SS; Rahman, A				Akhter, Sadika; Anwar, Iqbal; Akter, Rashida; Kumkum, Feroza Akhter; Nisha, Monjura Khatun; Ashraf, Fatema; Islam, Ferdousi; Begum, Nazneen; Chowdhury, Mahbub Elahi; Austin, Anne; Islam, Syed Shariful; Rahman, Aminur			Barriers to Timely and Safe Blood Transfusion for PPH Patients: Evidence from a Qualitative Study in Dhaka, Bangladesh	PLOS ONE			English	Article								Background and Objectives In Bangladesh, postpartum hemorrhage (PPH) is the leading cause of maternal mortality accounting for 31% of all blood transfusions in the country. Although safe blood transfusion is one of the 8 signal functions of Comprehensive Emergency Obstetric Care (CEmOC) strategy, most of the designated public sector CEmOC facilities do not have on-site blood storage system. Emergent blood is mainly available from external blood banks. As a result, emergent patients are to rely on an unregulated network of brokers for blood which may raise question about blood safety. This study explored lived experiences of patients' attendants, managers, providers, and blood brokers before and after the implementation of an on-line Blood Information and Management Application (BIMA) in regards to barriers and facilitators of blood transfusion for emergent patients. Methods Data were collected at Dhaka Medical College Hospital (DMCH), a tertiary-level teaching hospital before (January 2014) and after (March 2015) the introduction of an online BIMA system. Data collection methods included 24 key informant interviews (KIIs) and 40 in-depth interviews (IDIs). KIIs were conducted with formal health service providers, health managers and unlicensed blood brokers. IDIs were conducted with the relatives and husbands of women who suffered PPH, and needed emergency blood. Results Patients' attendants were unaware of patients' blood type and availability of blood in emergency situation. Newly introduced online BIMA system could facilitate blood transfusion process for poor patients at lower cost and during any time of day and night. However, service providers and service recipients were heavily dependent on a network of unlicensed blood brokers for required blood for emergent PPH patients. Blood collected through unlicensed blood brokers is un-screened, unregulated and probably unsafe. Blood brokers feel that they are providing a needed service, acknowledged a financial incentive and unaware about safety of blood that they supply. Conclusions Ensuring safe and timely blood transfusion is necessary to end preventable maternal mortality. In a context where facilities have no on-site blood, and both providers and patient attendants are heavily dependent on an unregulated cadre of unlicensed blood brokers, access to timely safe blood transfusion is seriously threatened. BIMA is a promising intervention to reduce inefficiencies in obtaining blood, but steps must be taken to ensure buy-in from current purveyors of blood, and to increase the acceptance of the intervention.	[Akhter, Sadika; Anwar, Iqbal; Akter, Rashida; Kumkum, Feroza Akhter; Chowdhury, Mahbub Elahi; Rahman, Aminur] Int Ctr Diarrhoeal & Dis Res Bangladesh Icddr B, Dhaka, Bangladesh; [Akhter, Sadika] Griffith Univ, Ctr Environm & Populat Hlth, Griffith, NSW, Australia; [Nisha, Monjura Khatun] Sydney Med Sch, Sch Publ Hlth, Sydney, NSW, Australia; [Ashraf, Fatema] Shaheed Suhrawardi Med Coll & Hosp, Dhaka, Bangladesh; [Islam, Ferdousi; Begum, Nazneen] Dhaka Med Coll & Hosp, Dhaka, Bangladesh; [Austin, Anne] JSI Res & Training Inst Inc, Boston, MA USA; [Islam, Syed Shariful] Bangabandhu Sheikh Mujib Med Univ, Dept Publ Hlth & Informat, Dhaka, Bangladesh; [Rahman, Aminur] Chulalongkorn Univ, Coll Publ Hlth Sci, Bangkok, Thailand	International Centre for Diarrhoeal Disease Research (ICDDR); Griffith University; University of Sydney; Dhaka Medical College; Bangabandhu Sheikh Mujib Medical University (BSMMU); Chulalongkorn University	Akhter, S (corresponding author), Int Ctr Diarrhoeal & Dis Res Bangladesh Icddr B, Dhaka, Bangladesh.; Akhter, S (corresponding author), Griffith Univ, Ctr Environm & Populat Hlth, Griffith, NSW, Australia.	sadika@icddrb.org	Rahman, Aminur/AAG-5391-2020	Rahman, Aminur/0000-0003-1434-3883	Maternal Health Task Force at the Harvard T. H. Chan School of Public Health from the Bill & Melinda Gates Foundation [01065000621]	Maternal Health Task Force at the Harvard T. H. Chan School of Public Health from the Bill & Melinda Gates Foundation	This project was made possible with support from the Maternal Health Task Force at the Harvard T. H. Chan School of Public Health through Grant# 01065000621 from the Bill & Melinda Gates Foundation.	Alam B, 2015, INT J GYNECOL OBSTET, V131, P63, DOI 10.1016/j.ijgo.2015.04.041; Alkema L, 2015, LANCET; Balki M, 2008, J OBSTET GYNAECOL CA, V30, P1002, DOI 10.1016/S1701-2163(16)32994-2; Bangladesh. Bangladesh Planning Commission. General Economics Division, 2014, MILL DEV GOALS PROGR; Bhuiya I, 1995, SITUATION BLOOD TEST; Boyatzis R. E., 1998, TRANSFORMING QUALITA, DOI 10.1191/1478088706qp063oa; Hossain M, 1994, SOUV 13 SANDH CENTR; Miles M.B., 1994, ANAL DONNEES QUALITA, V2nd; National Institute of Population Research and Training, 2012, BANGL MAT MORT HLTH; Rahman A, 2016, DIGITAL BLOOD MANAGE; Ryan G.W., 2003, FIELD METHOD, V15, P85, DOI DOI 10.1177/1525822X02239569; United Nations, 2016, 17 GOALS TRANSF WORL; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT	13	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167399	10.1371/journal.pone.0167399	http://dx.doi.org/10.1371/journal.pone.0167399			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911959	Green Submitted, gold, Green Published			2022-12-27	WOS:000389520600033
J	Gradnigo, JS; Majumdar, A; Norgren, RB; Moriyama, EN				Gradnigo, Julien S.; Majumdar, Abhishek; Norgren, Robert B., Jr.; Moriyama, Etsuko N.			Advantages of an Improved Rhesus Macaque Genome for Evolutionary Analyses	PLOS ONE			English	Article							TRANSCRIPTOME; ALIGNMENT	The rhesus macaque (Macaca mulatta) is widely used in molecular evolutionary analyses, particularly to identify genes under adaptive or unique evolution in the human lineage. For such studies, it is necessary to align nucleotide sequences of homologous protein-coding genes among multiple species. The validity of these analyses is dependent on high quality genomic data. However, for most mammalian species (other than humans and mice), only draft genomes are available. There has been concern that some results obtained from evolutionary analyses using draft genomes may not be correct. The rhesus macaque provides a unique opportunity to determine whether an improved genome (MacaM) yields better results than a draft genome (rheMac2) for evolutionary studies. We compared protein-coding genes annotated in the rheMac2 and MacaM genomes with their human orthologs. We found many genes annotated in rheMac2 had apparently spurious sequences not present in genes derived from MacaM. The rheMac2 annotations also appeared to inflate a frequently used evolutionary index,. (the ratio of nonsynonymous to synonymous substitution rates). Genes with these spurious sequences must be filtered out from evolutionary analyses to obtain correct results. With the MacaM genome, improved sequence information means many more genes can be examined for indications of selection. These results indicate how upgrading genomes from draft status to a higher level of quality can improve interpretation of evolutionary patterns.	[Gradnigo, Julien S.; Moriyama, Etsuko N.] Univ Nebraska Lincoln, Sch Biol Sci, Lincoln, NE 68588 USA; [Majumdar, Abhishek; Norgren, Robert B., Jr.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA; [Moriyama, Etsuko N.] Univ Nebraska Lincoln, Ctr Plant Sci Innovat, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Lincoln	Moriyama, EN (corresponding author), Univ Nebraska Lincoln, Sch Biol Sci, Lincoln, NE 68588 USA.; Moriyama, EN (corresponding author), Univ Nebraska Lincoln, Ctr Plant Sci Innovat, Lincoln, NE 68588 USA.	emoriyama2@unl.edu		Norgren, Robert/0000-0002-0021-5875	National Institute of Health grant [R24RR017444]; Nebraska Research Initiative	National Institute of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Research Initiative	This work was supported by National Institute of Health grant R24RR017444 (RBN), and also in part by funds from the Nebraska Research Initiative (RBN and ENM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Karere GM, 2008, GENOMICS, V92, P210, DOI 10.1016/j.ygeno.2008.05.013; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Mallick S, 2009, GENOME RES, V19, P922, DOI 10.1101/gr.086512.108; Maudhoo MD, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0061-x; Maudhoo MD, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-14; Nagy A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-353; National Center for Biotechnology Information, ANN RHEMAC2 GFF FORM; New Rhesus Genome (MacaM), FAST CHROM GTF ANN F, DOI [10.1093/molbev/msm088, DOI 10.1093/MOLBEV/MSM088]; Norgren RB, 2013, ILAR J, V54, P144, DOI 10.1093/ilar/ilt037; Prosdocimi F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-5; Roberto R, 2008, CHROMOSOME RES, V16, P977, DOI 10.1007/s10577-008-1255-1; Schneider A, 2009, GENOME BIOL EVOL, V1, P114, DOI 10.1093/gbe/evp012; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Thibaud-Nissen F., 2013, NCBI HDB; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vallender EJ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r87; Yan GM, 2011, NAT BIOTECHNOL, V29, P1019, DOI 10.1038/nbt.1992; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang XF, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-206; Zimin AV, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-20	23	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167376	10.1371/journal.pone.0167376	http://dx.doi.org/10.1371/journal.pone.0167376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911958	Green Submitted, Green Published, gold			2022-12-27	WOS:000389520600032
J	Kawaguchi, T; Cho, D; Hayashi, M; Tsukiyama, T; Kimura, K; Matsuyama, S; Minami, N; Yamada, M; Imai, H				Kawaguchi, Takamasa; Cho, Dooseon; Hayashi, Masafumi; Tsukiyama, Tomoyuki; Kimura, Koji; Matsuyama, Shuichi; Minami, Naojiro; Yamada, Masayasu; Imai, Hiroshi			Derivation of Induced Trophoblast Cell Lines in Cattle by Doxycycline-Inducible piggyBac Vectors	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; BOVINE CONCEPTUS DEVELOPMENT; INTERFERON-TAU; TRANSCRIPTION FACTOR; PLACENTAL-LACTOGEN; GROWTH-FACTORS; MESSENGER-RNA; IN-VITRO; TROPHECTODERM; EXPRESSION	Trophectoderm lineage specification is one of the earliest differentiation events in mammalian development. The trophoblast lineage, which is derived from the trophectoderm, mediates implantation and placental formation. However, the processes involved in trophoblastic differentiation and placental formation in cattle remain unclear due to interspecies differences when compared with other model systems and the small repertoire of available trophoblast cell lines. Here, we describe the generation of trophoblast cell lines (biTBCs) from bovine amnion-derived cells (bADCs) using an induced pluripotent stem cell technique. bADCs were introduced with piggyBac vectors containing doxycycline (Dox)-inducible transcription factors (Oct3/4(POU5F1), Sox2, Klf4, and c-Myc). Colonies that appeared showed a flattened epithelial-like morphology similar to cobblestones, had a more definite cell boundary between cells, and frequently formed balloon-like spheroids similar to trophoblastic vesicles (TVs). biTBCs were propagated for over 60 passages and expressed trophoblast-related (CDX2, ELF5, ERR/3, and /IFN-tau) and pluripotency-related genes (endogenous OCT3/4, SOX2, KLF4, and c-MYC). Furthermore, when biTBCs were induced to differentiate by removing Dox from culture, they formed binucleate cells and began to express pregnancy -related genes (PL, PRP1, and PAG1). This is the first report demonstrating that the induction of pluripotency in bovine amniotic cells allows the generation of trophoblastic cell lines that possess trophoblast stem cell-like characteristics and have the potential to differentiate into the extra-embryonic cell lineage. These cell lines can be a new cell source as a model for studying trophoblast cell lineages and implantation processes in cattle.	[Kawaguchi, Takamasa; Cho, Dooseon; Hayashi, Masafumi; Minami, Naojiro; Yamada, Masayasu; Imai, Hiroshi] Kyoto Univ, Grad Sch Agr, Reprod Biol Lab, Kyoto, Japan; [Tsukiyama, Tomoyuki] Shiga Univ Med Sci, Res Ctr Anim Life Sci, Shiga, Japan; [Kimura, Koji; Matsuyama, Shuichi] NARO Inst Livestock & Grassland Sci, Anim Feeding & Management Res Div, Nasushiobara, Tochigi, Japan; [Kawaguchi, Takamasa] Ono Pharmaceut Co Ltd, Fukui Res Inst, Fukui, Japan; [Kimura, Koji] Okayama Univ, Grad Sch Environm & Life Sci, Reprod Physiol Lab, Okayama, Japan	Kyoto University; Shiga University of Medical Science; Ono Pharmaceutical Co Ltd; Okayama University	Imai, H (corresponding author), Kyoto Univ, Grad Sch Agr, Reprod Biol Lab, Kyoto, Japan.	imai@kais.kyoto-u.ac.jp	TSUKIYAMA, Tomoyuki/AAI-3082-2020	TSUKIYAMA, Tomoyuki/0000-0002-2657-7719	Ministry of Education, Science and Culture [26292168]	Ministry of Education, Science and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant from the Ministry of Education, Science and Culture to KK and HI (grant 26292168). No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amita M, 2013, P NATL ACAD SCI USA, V110, pE1212, DOI 10.1073/pnas.1303094110; Bai H, 2011, J REPROD DEVELOP, V57, P518, DOI 10.1262/jrd.10-186K; Bai H, 2009, MOL REPROD DEV, V76, P1143, DOI 10.1002/mrd.21082; Berg DK, 2011, DEV CELL, V20, P244, DOI 10.1016/j.devcel.2011.01.003; Cauffman G, 2005, MOL HUM REPROD, V11, P173, DOI 10.1093/molehr/gah155; Chen LY, 2009, CELL RES, V19, P1052, DOI 10.1038/cr.2009.79; Chen Y, 2013, BIOCHEM BIOPH RES CO, V431, P197, DOI 10.1016/j.bbrc.2012.12.135; Cooke FNT, 2009, REPRODUCTION, V137, P259, DOI 10.1530/REP-08-0396; Degrelle SA, 2005, DEV BIOL, V288, P448, DOI 10.1016/j.ydbio.2005.09.043; Dunne LD, 2000, ANIM REPROD SCI, V58, P39, DOI 10.1016/S0378-4320(99)00088-3; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Ezashi T, 2011, BIOL REPROD, V85, P779, DOI 10.1095/biolreprod.111.092809; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Fields SD, 2011, THERIOGENOLOGY, V75, P1466, DOI 10.1016/j.theriogenology.2010.12.007; FLECHON JE, 1995, PLACENTA, V16, P643, DOI 10.1016/0143-4004(95)90033-0; Fujishiro S, 2013, STEM CELLS DEV, V22, P473, DOI 10.1089/scd.2012.0173; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; GUILLOMOT M, 1990, BIOL CELL, V68, P205, DOI 10.1016/0248-4900(90)90309-Q; Hashizume K, 2006, METH MOLEC MED, V121, P179; HOFFMAN LH, 1993, J EXP ZOOL, V266, P559, DOI 10.1002/jez.1402660607; Honda A, 2010, J BIOL CHEM, V285, P31362, DOI 10.1074/jbc.M110.150540; Imakawa K, 2006, MOL REPROD DEV, V73, P559, DOI 10.1002/mrd.20457; IMAKAWA K, 1987, NATURE, V330, P377, DOI 10.1038/330377a0; Ka H, 2001, ENDOCRINOLOGY, V142, P2303, DOI 10.1210/en.142.6.2303; Kawaguchi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135403; Kimura K, 2004, MOL REPROD DEV, V67, P193, DOI 10.1002/mrd.10389; Kinoshita M, 2014, REPROD MED BIOL; Kobolak J, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-88; Kubaczka C, 2014, STEM CELL REP, V2, P232, DOI 10.1016/j.stemcr.2013.12.013; Kuijk EW, 2008, DEV DYNAM, V237, P918, DOI 10.1002/dvdy.21480; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Miyazaki H, 2002, PLACENTA, V23, P613, DOI 10.1053/plac.2002.0846; Nakano H, 2002, CELL TISSUE RES, V307, P225, DOI 10.1007/s00441-001-0491-x; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohinata Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107308; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Ozawa M, 2013, REPRODUCTION, V145, P191, DOI 10.1530/REP-12-0220; Pfeffer PL, 2012, REPRODUCTION, V143, P231, DOI 10.1530/REP-11-0374; RAMSOONDAR J, 1993, BIOL REPROD, V49, P681, DOI 10.1095/biolreprod49.4.681; Roberts RM, 2011, BIOL REPROD, V84, P412, DOI 10.1095/biolreprod.110.088724; ROBERTS RM, 1992, ENDOCR REV, V13, P432, DOI 10.1210/er.13.3.432; Sahgal N, 2006, METH MOLEC MED, V121, P159; Sakurai T, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100180; Shimada A, 2001, PLACENTA, V22, P652, DOI 10.1053/plac.2001.0702; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Sumer H, 2011, J ANIM SCI, V89, P2708, DOI 10.2527/jas.2010-3666; Suzuki Y, 2011, REPRODUCTION, V142, P733, DOI 10.1530/REP-11-0275; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Talbot NC, 2000, BIOL REPROD, V62, P235, DOI 10.1095/biolreprod62.2.235; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tsukiyama T, 2011, GENES CELLS, V16, P815, DOI 10.1111/j.1365-2443.2011.01528.x; Ushizawa K, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-17; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108	56	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167550	10.1371/journal.pone.0167550	http://dx.doi.org/10.1371/journal.pone.0167550			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907214	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700190
J	Bruckner, S; Kammer, T				Brueckner, Sabrina; Kammer, Thomas			No Modulation of Visual Cortex Excitability by Transcranial Direct Current Stimulation	PLOS ONE			English	Article							THETA-BURST STIMULATION; HUMAN MOTOR CORTEX; MAGNETIC STIMULATION; CORTICAL EXCITABILITY; PHOSPHENE THRESHOLDS; LOW-FREQUENCY; LIGHT DEPRIVATION; MOVING PHOSPHENE; TDCS; PERCEPTION	Measuring phosphene thresholds (PTs) is often used to investigate changes in the excitability of the human visual cortex through different brain stimulation methods like repetitive transcranial magnetic stimulation (rTMS) or transcranial direct current stimulation (tDCS). In several studies, PT increase or decrease has been shown after rTMS or tDCS application. Recently, using PT measurements we showed that the state of the neurons in the visual cortex after rTMS might have an influence on the modulatory effects of stimulation. In the present study we aimed to investigate whether visual cortex activity following stimulation influences the modulatory effects of tDCS as well. In a between-group design, anodal or cathodal tDCS was applied to the visual cortex twice per subject, with either high or low visual demand following stimulation. We observed no modulation of PT neither directly following both anodal and cathodal tDCS nor following the visual demand periods. We rather found high inter-individual variability in the response to tDCS, and intra-individual reliability in the direction of modulation was observed for cathodal tDCS only. Thus, our results do not confirm the modulatory effects of tDCS on visual cortex excitability published previously. Moreover, they support the confirmation that tDCS effects have little reliability on varied TMS outcome measurements.	[Brueckner, Sabrina; Kammer, Thomas] Univ Ulm, Sect Neurostimulat, Dept Psychiat, Ulm, Germany	Ulm University	Bruckner, S (corresponding author), Univ Ulm, Sect Neurostimulat, Dept Psychiat, Ulm, Germany.	sabrina.brueckner@uni-ulm.de	Kammer, Thomas/K-2168-2012	Kammer, Thomas/0000-0002-2769-5645; Lorenz, Sabrina/0000-0001-5798-4838				Antal A, 2003, EXP BRAIN RES, V150, P375, DOI 10.1007/s00221-003-1459-8; Antal A, 2004, NEUROREPORT, V15, P297, DOI 10.1097/00001756-200402090-00017; Antal A, 2004, NEUROREPORT, V15, P1307, DOI 10.1097/01.wnr.0000127460.08361.84; Antal A, 2004, INVEST OPHTH VIS SCI, V45, P702, DOI 10.1167/iovs.03-0688; Antal A, 2003, NEUROPSYCHOLOGIA, V41, P1802, DOI 10.1016/S0028-3932(03)00181-7; Antal A, 2001, NEUROREPORT, V12, P3553, DOI 10.1097/00001756-200111160-00036; Antal A, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00642; Bach M, 1996, OPTOMETRY VISION SCI, V73, P49, DOI 10.1097/00006324-199601000-00008; BARKER AT, 1985, J PHYSIOL-LONDON, V369, pP3; Bocci T, 2014, J NEURAL TRANSM, V121, P221, DOI 10.1007/s00702-013-1104-z; Boroojerdi B, 2000, CEREB CORTEX, V10, P529, DOI 10.1093/cercor/10.5.529; Boroojerdi B, 2000, NEUROLOGY, V54, P1529, DOI 10.1212/WNL.54.7.1529; Brighina F, 2002, EXP BRAIN RES, V145, P177, DOI 10.1007/s00221-002-1096-7; Bruckner S, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00591; Bruckner S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159743; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Dundas JE, 2007, CLIN NEUROPHYSIOL, V118, P1166, DOI 10.1016/j.clinph.2007.01.010; Fierro B, 2005, J PHYSIOL-LONDON, V565, P659, DOI 10.1113/jphysiol.2004.080184; Franca M, 2006, CLIN NEUROPHYSIOL, V117, P1808, DOI 10.1016/j.clinph.2006.03.019; Furubayashi T, 2008, EXP BRAIN RES, V185, P279, DOI 10.1007/s00221-007-1149-z; Gangitano M, 2002, CLIN NEUROPHYSIOL, V113, P1249, DOI 10.1016/S1388-2457(02)00109-8; Gratton C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101430; Hamada M, 2013, CEREB CORTEX, V23, P1593, DOI 10.1093/cercor/bhs147; Horvath JC, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00002; Horvath JC, 2015, NEUROPSYCHOLOGIA, V66, P213, DOI 10.1016/j.neuropsychologia.2014.11.021; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; Kammer T, 2007, NEUROIMAGE, V36, P313, DOI 10.1016/j.neuroimage.2007.03.001; Lang N, 2004, EXP BRAIN RES, V156, P439, DOI 10.1007/s00221-003-1800-2; Lang N, 2007, INVEST OPHTH VIS SCI, V48, P5782, DOI 10.1167/iovs.07-0706; Maeda F, 2000, EXP BRAIN RES, V133, P425, DOI 10.1007/s002210000432; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P1002, DOI 10.1016/S1388-2457(00)00284-4; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nozari N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084338; Pascual-Leone A, 1998, J CLIN NEUROPHYSIOL, V15, P333, DOI 10.1097/00004691-199807000-00005; Pirulli C, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00226; Pirulli C, 2013, BRAIN STIMUL, V6, P683, DOI 10.1016/j.brs.2012.12.005; Rauschecker AM, 2004, EXP BRAIN RES, V157, P124, DOI 10.1007/s00221-004-1910-5; Simis M, 2013, NEUROREPORT, V24, P973, DOI 10.1097/WNR.0000000000000021; Siniatchkin M, 2011, CLIN NEUROPHYSIOL, V122, P2475, DOI 10.1016/j.clinph.2011.05.003; Stagg CJ, 2009, EUR J NEUROSCI, V30, P1412, DOI 10.1111/j.1460-9568.2009.06937.x; Stewart LM, 2001, NEUROPSYCHOLOGIA, V39, P415, DOI 10.1016/S0028-3932(00)00130-5; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wiethoff S, 2014, BRAIN STIMUL, V7, P468, DOI 10.1016/j.brs.2014.02.003	44	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167697	10.1371/journal.pone.0167697	http://dx.doi.org/10.1371/journal.pone.0167697			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936117	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100155
J	de Haan, GA; Melis-Dankers, BJM; Brouwer, WH; Tucha, O; Heutink, J				de Haan, Gera A.; Melis-Dankers, Bart J. M.; Brouwer, Wiebo H.; Tucha, Oliver; Heutink, Joost			The Effects of Compensatory Scanning Training on Mobility in Patients with Homonymous Visual Field Defects: Further Support, Predictive Variables and Follow-Up	PLOS ONE			English	Article							RECOVERY; ACUITY; STATE; CHART	Introduction People with homonymous visual field defects (HVFD) often report difficulty detecting obstacles in the periphery on their blind side in time when moving around. Recently, a randomized controlled trial showed that the InSight-Hemianopia Compensatory Scanning Training (IH-CST) specifically improved detection of peripheral stimuli and avoiding obstacles when moving around, especially in dual task situations. Method The within-group training effects of the previously reported IH-CST are examined in an extended patient group. Performance of patients with HVFD on a pre-assessment, postassessment and follow-up assessment and performance of a healthy control group are compared. Furthermore, it is examined whether training effects can be predicted by demographic characteristics, variables related to the visual disorder, and neuropsychological test results. Results Performance on both subjective and objective measures of mobility-related scanning was improved after training, while no evidence was found for improvement in visual functions (including visual fields), reading, visual search and dot counting. Self-reported improvement did not correlate with improvement in objective mobility performance. According to the participants, the positive effects were still present six to ten months after training. No demographic characteristics, variables related to the visual disorder, and neuropsychological test results were found to predict the size of training effect, although some inconclusive evidence was found for more improvement in patients with left-sided HVFD than in patients with right-sided HFVD. Conclusion Further support was found for a positive effect of IH-CST on detection of visual stimuli during mobility-related activities specifically. Based on the reports given by patients, these effects appear to be long-term effects. However, no conclusions can be drawn on the objective long-term training effects.	[de Haan, Gera A.; Brouwer, Wiebo H.; Tucha, Oliver; Heutink, Joost] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands; [de Haan, Gera A.; Melis-Dankers, Bart J. M.; Heutink, Joost] Royal Dutch Visio Ctr Expertise Blind & Partially, Haren, Netherlands; [Brouwer, Wiebo H.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands	University of Groningen; University of Groningen	de Haan, GA (corresponding author), Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands.; de Haan, GA (corresponding author), Royal Dutch Visio Ctr Expertise Blind & Partially, Haren, Netherlands.	G.A.de.Haan@rug.nl	Tucha, Oliver/AAD-1403-2019; Heutink, Joost/A-9694-2013	de Haan, Gera/0000-0002-3055-3920; Heutink, Joost/0000-0002-4811-968X	Royal Dutch Visio [0I0204]; University of Groningen; ZonMw-InZicht [94307005]	Royal Dutch Visio; University of Groningen; ZonMw-InZicht	The study was funded by Royal Dutch Visio (0I0204; www.visio.org/en-gb/kennis-expertise/onderzoeken; JH), The University of Groningen (http://www.rug.nl/research; JH) and ZonMw-InZicht (94307005; www.zonmw.nl/en/programmes/insight; JH). The funders had no role in study design, data collection and analysis,	Ali M, 2013, NEUROREHAB NEURAL RE, V27, P133, DOI 10.1177/1545968312454683; American Medical Association, 2008, GUIDES EVALUATION PE, P281; Baraldi AN, 2010, J SCHOOL PSYCHOL, V48, P5, DOI 10.1016/j.jsp.2009.10.001; Bowen A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003586.pub3; Brouwer WH, 2002, J HEAD TRAUMA REHAB, V17, P1, DOI 10.1097/00001199-200202000-00003; Cohen J.E., 1988, STAT POWER ANAL BEHA; de Haan GA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134459; de Haan GA, 2015, J NEURO-OPHTHALMOL, V35, P259, DOI 10.1097/WNO.0000000000000244; de Haan GA, 2014, SURV OPHTHALMOL, V59, P77, DOI 10.1016/j.survophthal.2013.02.006; Duits A., 2006, NEUROPSYCHOLOGISCHE, P119; FERRIS FL, 1982, AM J OPHTHALMOL, V94, P91, DOI 10.1016/0002-9394(82)90197-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; KERKHOFF G, 1990, NERVENARZT, V61, P711; KOOIJMAN AC, 1994, INVEST OPHTH VIS SCI, V35, P1371; Langelaan M, 2005, OPHTHAL PHYSL OPT, V25, P136, DOI 10.1111/j.1475-1313.2004.00266.x; Maaijwee K J M, 2007, Ned Tijdschr Geneeskd, V151, P2494; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Meyers JE, 1995, KEY COMPLEX FIGURE T; Pambakian ALM, 1997, BRIT J OPHTHALMOL, V81, P324, DOI 10.1136/bjo.81.4.324; Radner T, 1998, KLIN MONATSBL AUGENH, V213, P174, DOI 10.1055/s-2008-1034969; Reitan RM, 1958, VALIDITY TRAIL MAKIN, V8, P271; Saan RJ, 1986, 15 WOORDEN TESTS VOO; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schmand B., 1992, NEDERLANDSE LEESTEST; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Tant MLM, 2002, VISUAL PERFORMANCE H; Turano KA, 1999, INVEST OPHTH VIS SCI, V40, P865; Van der Elst W, 2005, J INT NEUROPSYCH SOC, V11, P290, DOI 10.1017/S1355617705050344; Van der Sterre GW, 2001, NATL EYE I VISUAL FU; Vlakveld W, 2011, HAZARD ANTICIPATION, P115; Wechsler D., 2010, WAIS 4 WECHSLER ADUL; Zhang X, 2006, NEUROLOGY, V66, P901, DOI 10.1212/01.wnl.0000203338.54323.22	32	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166310	10.1371/journal.pone.0166310	http://dx.doi.org/10.1371/journal.pone.0166310			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27935973	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100024
J	Kaplan, DA; Olabarrieta, M; Frederick, P; Valle-Levinson, A				Kaplan, David A.; Olabarrieta, Maitane; Frederick, Peter; Valle-Levinson, Arnoldo			Freshwater Detention by Oyster Reefs: Quantifying a Keystone Ecosystem Service	PLOS ONE			English	Article							SEA-LEVEL; RESTORATION; POPULATION; FLORIDA; BAY; USA	Oyster reefs provide myriad ecosystem services, including water quality improvement, fisheries and other faunal support, shoreline protection from erosion and storm surge, and economic productivity. However, their role in directing flow during non-storm conditions has been largely neglected. In regions where oyster reefs form near the mouth of estuarine rivers, they likely alter ocean-estuary exchange by acting as fresh water "dams". We hypothesize that these reefs have the potential to detain fresh water and influence salinity over extensive areas, thus providing a "keystone" ecosystem service by supporting estuarine functions that rely on the maintenance of estuarine (i.e., brackish) conditions in the near-shore environment. In this work, we investigated the effects of shore-parallel reefs on estuarine salinity using field data and hydrodynamic modeling in a degraded reef complex in the northeastern Gulf of Mexico. Results suggested that freshwater detention by long linear chains of oyster reefs plays an important role in modulating salinities, not only in the oysters' local environment, but over extensive estuarine areas (tens of square kilometers). Field data confirmed the presence of salinity differences between landward and seaward sides of the reef, with long-term mean salinity differences of >30% between sides. Modeled results expanded experimental findings by illustrating how oyster reefs affect the lateral and offshore extent of freshwater influence. In general, the effects of simulated reefs were most pronounced when they were highest in elevation, without gaps, and when riverine discharge was low. Taken together, these results describe a poorly documented ecosystem service provided by oyster reefs; provide an estimate of the magnitude and spatial extent of this service; and offer quantitative information to help guide future oyster reef restoration.	[Kaplan, David A.; Olabarrieta, Maitane; Valle-Levinson, Arnoldo] Univ Florida, Engn Sch Sustainable Infrastruct & Environm, Gainesville, FL 32611 USA; [Frederick, Peter] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Kaplan, DA (corresponding author), Univ Florida, Engn Sch Sustainable Infrastruct & Environm, Gainesville, FL 32611 USA.	dkaplan@ufl.edu		Valle, Arnoldo/0000-0002-3852-0971; Kaplan, David/0000-0002-0103-0928; Frederick, Peter/0000-0002-8098-9490	Florida SeaGrant [GM02389]	Florida SeaGrant	This work was partially supported by Florida SeaGrant under contract number GM02389. There was no additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; Bilkovic DM, 2008, MAR ECOL PROG SER, V358, P27, DOI 10.3354/meps07279; Blair S, 2015, ECOSYSTEM SERVICES V; Bureau UC, GENERATED D KAPLAN U; Camp E. V., 2015, ECOLOGY SOC, V20; Chassignet EP, 2000, DYNAM ATMOS OCEANS, V32, P155, DOI 10.1016/S0377-0265(00)00046-4; Coen LD, 2007, MAR ECOL PROG SER, V341, P303, DOI 10.3354/meps341303; Dekshenieks MM, 2000, ESTUARIES, V23, P593, DOI 10.2307/1352887; Ermgassen PSEZ, 2012, P ROY SOC B-BIOL SCI, V279, P3393, DOI 10.1098/rspb.2012.0313; Frederick P, 2016, J SHELLFISH RES, V35, P359, DOI 10.2983/035.035.0210; Grabowski JH, 2012, BIOSCIENCE, V62, P900, DOI 10.1525/bio.2012.62.10.10; Grinnell RS, 1972, STRUCTURE DEV OYSTER; Haidvogel DB, 2008, J COMPUT PHYS, V227, P3595, DOI 10.1016/j.jcp.2007.06.016; Haidvogel DB, 2000, DYNAM ATMOS OCEANS, V32, P239, DOI 10.1016/S0377-0265(00)00049-X; Kellogg ML, 2013, MAR ECOL PROG SER, V480, P1, DOI 10.3354/meps10331; Kirby MX, 2004, P NATL ACAD SCI USA, V101, P13096, DOI 10.1073/pnas.0405150101; Livingston RJ, 2000, ESTUAR COAST SHELF S, V50, P655, DOI 10.1006/ecss.1999.0597; Madsen PA, 1988, COASTAL ENG P, V1; McCay DPF, 2003, MAR ECOL PROG SER, V264, P197; MOAC, 2007, MAR OYST ADV COMM 20; Rodriguez AB, 2014, NAT CLIM CHANGE, V4, P493, DOI [10.1038/nclimate2216, 10.1038/NCLIMATE2216]; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scyphers SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022396; Seavey JR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00205.1; Shchepetkin A, 2005, REGIONAL OCEAN MODEL; Styles R, 2015, J COASTAL RES, V31, P978, DOI 10.2112/JCOASTRES-D-14-00115.1; Talmage SC, 2009, LIMNOL OCEANOGR, V54, P2072, DOI 10.4319/lo.2009.54.6.2072; Tolley SG, 2005, J SHELLFISH RES, V24, P1007; van de Koppel J, 2015, ANNU REV MAR SCI, V7, P139, DOI 10.1146/annurev-marine-010814-015805; Wang H, 2008, ECOL MODEL, V211, P77, DOI 10.1016/j.ecolmodel.2007.08.018; Wright EE, 2005, J SEDIMENT RES, V75, P621, DOI 10.2110/jsr.2005.051	31	19	19	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167694	10.1371/journal.pone.0167694	http://dx.doi.org/10.1371/journal.pone.0167694			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936184	Green Published, gold			2022-12-27	WOS:000389587100154
J	Little, HA; Gilbert, TC; Athorn, ML; Marshall, AR				Little, Holly A.; Gilbert, Tania C.; Athorn, Marie L.; Marshall, Andrew R.			Evaluating Conservation Breeding Success for an Extinct-in-the-Wild Antelope	PLOS ONE			English	Article							RHINOCEROS DICEROS-BICORNIS; REPRODUCTIVE SUCCESS; ANIMAL-WELFARE; GROUP-SIZE; US ZOOS; BEHAVIOR; SURVIVAL; AGE; POPULATION; MANAGEMENT	With the number of threatened species increasing globally, conservation breeding is vitally important now more than ever. However, no previous peer-reviewed study has attempted to determine how the varying conditions across zoos have influenced breeding by an extinct-in- the-wild species. We therefore use questionnaires and studbook data to evaluate the influence of husbandry practices and enclosure design on scimitar-horned oryx (Oryx dammah) breeding success, at the herd level. Regression models were used to identify the variables that best predicted breeding success among 29 zoos across a five-year period. Calf survival decreased with herd age and the use of soft substrates in hardstand areas (yard area usually adjacent to the indoor housing), explaining 30.7% of overall variation. Calf survival also decreased where herds were small and where food provisions were not raised (and hence likely incited competition), although these were less influential. Likewise, birth rate decreased with soft substrates in hardstand areas and unraised food provisions, although these were less influential than for calf survival. Birth rate increased with year-round male presence, yet this decreased calf survival. Compared to previous studies, the number of enclosure/husbandry influences on breeding were relatively few. Nevertheless, these few enclosure/husbandry influences explained over one third of the variation in calf survival. Our data therefore suggest some potential improvements and hence that extinct-in- the-wild species stand a greater chance of survival with empirical design of zoo enclosures and husbandry methods.	[Little, Holly A.; Athorn, Marie L.; Marshall, Andrew R.] Univ York, Dept Environm, CIRCLE, York, N Yorkshire, England; [Little, Holly A.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield, S Yorkshire, England; [Gilbert, Tania C.] Marwell Wildlife, Winchester, Hants, England; [Athorn, Marie L.] Univ York, Dept Biol, York, N Yorkshire, England; [Marshall, Andrew R.] Flamingo Land Ltd, Kirby Misperton, N Yorkshire, England	University of York - UK; University of Sheffield; University of York - UK	Little, HA (corresponding author), Univ York, Dept Environm, CIRCLE, York, N Yorkshire, England.; Little, HA (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield, S Yorkshire, England.	hlittle1@sheffield.ac.uk		Little, Holly/0000-0001-5220-6906	Flamingo Land; University of York	Flamingo Land; University of York(European Commission)	Both Flamingo Land and the University of York provided support in the form of salaries for one author (AM), but these funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abello M. T., 2006, International Zoo Yearbook, V40, P323, DOI 10.1111/j.1748-1090.2006.00323.x; [Anonymous], 2015, IUCN RED LIST THREAT; Aschwanden J, 2009, APPL ANIM BEHAV SCI, V119, P180, DOI 10.1016/j.applanim.2009.04.004; Barbosa A, 1997, POLAR BIOL, V18, P410, DOI 10.1007/s003000050207; Barongi R., 2015, COMMITTING CONSERVAT, V69; Blay N, 2001, ZOO BIOL, V20, P545, DOI 10.1002/zoo.10002; Carlstead K, 1999, ZOO BIOL, V18, P17, DOI 10.1002/(SICI)1098-2361(1999)18:1&lt;17::AID-ZOO4&gt;3.0.CO;2-K; Carlstead K, 1999, ZOO BIOL, V18, P35, DOI 10.1002/(SICI)1098-2361(1999)18:1&lt;35::AID-ZOO5&gt;3.0.CO;2-L; Carlstead K, 2005, ZOO BIOL, V24, P215, DOI 10.1002/zoo.20050; Clark FE, 2012, ZOO BIOL, V31, P397, DOI 10.1002/zoo.20380; Clubb R, 2003, NATURE, V425, P473, DOI 10.1038/425473a; Clubb R, 2008, SCIENCE, V322, P1649, DOI 10.1126/science.1164298; Coelho CM, 2012, ZOO BIOL, V31, P453, DOI 10.1002/zoo.20410; Conde D. A., 2013, PLOS ONE, V8, P1; Creel S, 2015, BEHAV ECOL, V26, P1414, DOI 10.1093/beheco/arv100; Dalgaard P, 2008, STAT COMPUT SER, P1, DOI 10.1007/978-0-387-79054-1_1; Descovich KA, 2012, APPL ANIM BEHAV SCI, V140, P92, DOI 10.1016/j.applanim.2012.05.009; Dodeen H.M., 2003, ASSESS EVAL HIGH EDU, V28, P505, DOI [10.1080/02602930301674, DOI 10.1080/02602930301674]; Ellenberg U, 2006, BIOL CONSERV, V133, P95, DOI 10.1016/j.biocon.2006.05.019; Gilbert T, 2004, BIOL HUSBANDRY CONSE; Gilbert T, 2008, REINTRODUCTION SCIMI; Hoffmann M, 2015, CONSERV BIOL, V29, P1303, DOI 10.1111/cobi.12519; Holdgate MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153301; IUCN SSC ANTELOPE SPECIALIST GROUP, 2008, IUCN RED LIST THREAT; Jamieson IG, 2011, CONSERV BIOL, V25, P115, DOI 10.1111/j.1523-1739.2010.01574.x; King C. E., 2014, International Zoo Yearbook, V48, P184, DOI 10.1111/izy.12041; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Lariviere S, 2005, ZOO BIOL, V24, P83, DOI 10.1002/zoo.20035; Li C, 2007, ZOO BIOL, V26, P461, DOI 10.1002/zoo.20132; Lockyear KM, 2009, ZOO BIOL, V28, P214, DOI 10.1002/zoo.20224; Luz MPP, 2015, J EQUINE VET SCI, V35, P843, DOI 10.1016/j.jevs.2015.08.004; Maisch H., 2010, International Zoo Yearbook, V44, P149, DOI 10.1111/j.1748-1090.2009.00090.x; Marshall AR, 2016, ZOO BIOL; Marshall AR, ZOO BIOL IN PRESS; Mason GJ, 2010, ZOO BIOL, V29, P256, DOI [10.1002/zoo.20303, 10.1002/zoo.20256]; Melfi VA, 2009, ZOO BIOL, V28, P574, DOI 10.1002/zoo.20288; Meredith A, 2011, WILDLIFE MED REHABIL; Miller RE, 2014, FOWLERS ZOO WILD ANI; Newby J, 2016, CONSERV SCI PRACT, P253; Ogden R, 2012, CONSERV GENET RESOUR, V4, P471, DOI 10.1007/s12686-011-9577-2; Peng JJ, 2007, APPL ANIM BEHAV SCI, V104, P151, DOI 10.1016/j.applanim.2006.04.029; Peters M, 2001, VET PARASITOL, V97, P153, DOI 10.1016/S0304-4017(01)00401-0; Reid JM, 2010, J ANIM ECOL, V79, P851, DOI 10.1111/j.1365-2656.2010.01669.x; Robinson SE, 2010, SOUTHWEST NAT, V55, P510, DOI 10.1894/SGM-08.1; Saragusty J, 2009, ANIM REPROD SCI, V115, P247, DOI 10.1016/j.anireprosci.2008.10.019; Saunders SP, 2014, ANIM REPROD SCI, V144, P38, DOI 10.1016/j.anireprosci.2013.11.006; SELVIN HC, 1966, AM STAT, V20, P20, DOI 10.2307/2681493; Slate J, 2000, P ROY SOC B-BIOL SCI, V267, P1657, DOI 10.1098/rspb.2000.1192; Swaisgood RR, 2007, APPL ANIM BEHAV SCI, V102, P139, DOI 10.1016/j.applanim.2006.05.027; Vanpe C, 2009, J MAMMAL, V90, P661, DOI 10.1644/08-MAMM-A-137R.1; Vermeer J, 2015, J ZOO AQUAR RES, V3, P6; Wei FW, 2005, ZOO BIOL, V24, P169, DOI 10.1002/zoo.20034; Weladji RB, 2010, OECOLOGIA, V162, P261, DOI 10.1007/s00442-009-1443-5; Young RJ., 2005, ENV ENRICHMENT CAPTI; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	55	7	7	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166912	10.1371/journal.pone.0166912	http://dx.doi.org/10.1371/journal.pone.0166912			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935999	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000389587100048
J	Muller, A; Seinige, D; Jansen, W; Klein, G; Ehricht, R; Monecke, S; Kehrenberg, C				Mueller, Anja; Seinige, Diana; Jansen, Wiebke; Klein, Guenter; Ehricht, Ralf; Monecke, Stefan; Kehrenberg, Corinna			Variety of Antimicrobial Resistances and Virulence Factors in Staphylococcus aureus Isolates from Meat Products Legally and Illegally Introduced to Germany	PLOS ONE			English	Article							METHICILLIN-RESISTANT; CLONAL COMPLEXES; IDENTIFICATION; POULTRY; SUSCEPTIBILITY; OXACILLIN; SPREAD; GENES; GRLA; FOOD	Food products of animal origin can serve as a vehicle for Staphylococcus (S.) aureus, a facultative pathogen involved in a variety of diseases. As a result, international trade and illegal transportation of foodstuffs can facilitate the distribution of S. aureus over long distances. In this study, we investigated S. aureus isolates recovered from meat products confiscated from passengers returning from non-EU countries at two German airports and from samples of legally imported meats from non-EU countries. The aim was to characterize isolates in regard to their genetic relatedness as well as their antimicrobial resistance profiles and major virulence factors in order to assess potential risks associated with these products. The isolates were characterized by spa typing, MLST, macrorestriction analysis, microarray analysis and antimicrobial susceptibility testing. MRSA isolates were further characterized by dru typing. The characteristics of the majority of the isolates indicated a human origin, rather than an association with livestock. The results further revealed a considerable heterogeneity among the MRSA isolates, despite their common origin. Overall, a plenitude of major virulence factors and antimicrobial resistances was detected among the isolates, highlighting the potential risks associated with contaminated meat products and the transportation of such products among different countries.	[Mueller, Anja; Seinige, Diana; Jansen, Wiebke; Klein, Guenter; Kehrenberg, Corinna] Univ Vet Med Hannover, Inst Food Qual & Food Safety, Fdn, Hannover, Germany; [Jansen, Wiebke] Univ Namur, Integrated Vet Res Unit, Namur, Belgium; [Ehricht, Ralf; Monecke, Stefan] Alere Technol GmbH, Jena, Germany; [Ehricht, Ralf; Monecke, Stefan] InfectoGnost Res Campus, Jena, Germany; [Monecke, Stefan] Tech Univ Dresden, Inst Med Microbiol & Hyg, Dresden, Germany	University of Veterinary Medicine Hannover, Foundation; University of Namur; Alere; Technische Universitat Dresden	Kehrenberg, C (corresponding author), Univ Vet Med Hannover, Inst Food Qual & Food Safety, Fdn, Hannover, Germany.	corinna.kehrenberg@tiho-hannover.de	Kehrenberg, Corinna/GSI-9835-2022	Muller, Anja/0000-0002-3179-6684	German Federal Ministry of Education and Research [13N12697]; Alere Technologies GmbH	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Alere Technologies GmbH	This work was in part supported by the German Federal Ministry of Education and Research within the research program for civil safety and security, project ZooGloW [grant number 13N12697]. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. Alere Technologies GmbH provided support in the form of salaries for authors (RE SM), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aarestrup FM, 2000, VET MICROBIOL, V74, P353, DOI 10.1016/S0378-1135(00)00197-8; Beutlich J, 2015, INT J FOOD MICROBIOL, V209, P13, DOI 10.1016/j.ijfoodmicro.2014.10.017; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Clinical and Laboratory Standards Institute, 2012, METHODS DILUTION ANT, V32; Clinical and Laboratory Standards Institute (CLSI), 2020, PERFORMANCE STANDARD, V5th; Clinical Laboratory Standards Institute (CLSI), 2014, PERF STAND ANT SUSC; CLSI, 2021, PERFORMANCE STANDARD, V5th; Croes S, 2010, CLIN MICROBIOL INFEC, V16, P979, DOI [10.1111/j.1469-0691.2010.02956.x, 10.1111/j.1469-0691.2009.02956.x]; Cuny C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024360; de Boer E, 2009, INT J FOOD MICROBIOL, V134, P52, DOI 10.1016/j.ijfoodmicro.2008.12.007; EC, 2016, EU MARK SIT POULTR; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fessler A, 2010, J ANTIMICROB CHEMOTH, V65, P619, DOI 10.1093/jac/dkq021; Gales AC, 2009, BRAZ J INFECT DIS, V13, P90, DOI 10.1590/S1413-86702009000200004; Goering RV, 2008, CLIN MICROBIOL INFEC, V14, P964, DOI 10.1111/j.1469-0691.2008.02073.x; Gomez-Sanz E, 2013, ANTIMICROB AGENTS CH, V57, P5763, DOI 10.1128/AAC.00948-13; Harastani HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103715; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Jansen W, 2016, ZOONOSES PUBLIC HLTH, V63, P53, DOI 10.1111/zph.12204; Jansen W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150023; Kadariya J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/827965; Kehrenberg C, 2005, ANTIMICROB AGENTS CH, V49, P813, DOI 10.1128/AAC.49.2.813-815.2005; LECLERCQ R, 1991, ANTIMICROB AGENTS CH, V35, P1267, DOI 10.1128/AAC.35.7.1267; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; MCDOUGAL LK, 1986, J CLIN MICROBIOL, V23, P832, DOI 10.1128/JCM.23.5.832-839.1986; Meemken D, 2013, APPL ENVIRON MICROB, V79, P1739, DOI 10.1128/AEM.03189-12; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2013, VET MICROBIOL, V162, P806, DOI 10.1016/j.vetmic.2012.10.018; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Murchan S, 2003, J CLIN MICROBIOL, V41, P1574, DOI 10.1128/JCM.41.4.1574-1585.2003; Nadarajah J, 2006, J MED MICROBIOL, V55, P1675, DOI 10.1099/jmm.0.46700-0; Ogata K, 2012, APPL ENVIRON MICROB, V78, P2797, DOI 10.1128/AEM.07470-11; Rodriguez-Lazaro D, 2015, INT J FOOD MICROBIOL, V209, P29, DOI 10.1016/j.ijfoodmicro.2014.08.016; Sallam KI, 2015, J FOOD PROTECT, V78, P1879, DOI 10.4315/0362-028X.JFP-15-150; Sasaki T, 2010, J CLIN MICROBIOL, V48, P765, DOI 10.1128/JCM.01232-09; Schmitz FJ, 1998, J ANTIMICROB CHEMOTH, V41, P481, DOI 10.1093/jac/41.4.481; Schwarz S, 2010, VET MICROBIOL, V141, P1, DOI 10.1016/j.vetmic.2009.12.013; Strommenger B, 2003, J CLIN MICROBIOL, V41, P4089, DOI 10.1128/JCM.41.9.4089-4094.2003; Tilahun AY, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/468285; Yamagishi JI, 1996, ANTIMICROB AGENTS CH, V40, P1157, DOI 10.1128/AAC.40.5.1157	40	11	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167864	10.1371/journal.pone.0167864	http://dx.doi.org/10.1371/journal.pone.0167864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936152	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100220
J	Brigida, ABS; Rojas, CA; Grativol, C; de Armas, EM; Entenza, JOP; Thiebaut, F; Lima, MD; Farrinelli, L; Hemerly, AS; Lifschitz, S; Ferreira, PCG				Santa Brigida, Ailton B.; Rojas, Cristian A.; Grativol, Clicia; de Armas, Elvismary M.; Entenza, Julio O. P.; Thiebaut, Flavia; Lima, Marcelo de F.; Farrinelli, Laurent; Hemerly, Adriana S.; Lifschitz, Sergio; Ferreira, Paulo C. G.			Sugarcane transcriptome analysis in response to infection caused by Acidovorax avenae subsp avenae	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; RECEPTOR-LIKE KINASES; ALDEHYDE-DEHYDROGENASE GENE; SPECTRUM DISEASE RESISTANCE; GENOME-WIDE ANALYSIS; RNA-SEQ DATA; ARABIDOPSIS-THALIANA; PLANT DEFENSE; ENHANCED RESISTANCE; PRIMARY METABOLISM	Sugarcane is an important tropical crop mainly cultivated to produce ethanol and sugar. Crop productivity is negatively affected by Acidovorax avenae subsp avenae (Aaa), which causes the red stripe disease. Little is known about the molecular mechanisms triggered in response to the infection. We have investigated the molecular mechanism activated in sugarcane using a RNA-seq approach. We have produced a de novo transcriptome assembly (TR7) from sugarcane RNA-seq libraries submitted to drought and infection with Aaa. Together, these libraries present 247 million of raw reads and resulted in 168,767 reference transcripts. Mapping in TR7 of reads obtained from infected libraries, revealed 798 differentially expressed transcripts, of which 723 were annotated, corresponding to 467 genes. GO and KEGG enrichment analysis showed that several metabolic pathways, such as code for proteins response to stress, metabolism of carbohydrates, processes of transcription and translation of proteins, amino acid metabolism and biosynthesis of secondary metabolites were significantly regulated in sugarcane. Differential analysis revealed that genes in the biosynthetic pathways of ET and JA PRRs, oxidative burst genes, NBS-LRR genes, cell wall fortification genes, SAR induced genes and pathogenesis-related genes (PR) were upregulated. In addition, 20 genes were validated by RT-qPCR. Together, these data contribute to a better understanding of the molecular mechanisms triggered by the Aaa in sugarcane and opens the opportunity for the development of molecular markers associated with disease tolerance in breeding programs.	[Santa Brigida, Ailton B.; Thiebaut, Flavia; Hemerly, Adriana S.; Ferreira, Paulo C. G.] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Bioquim Med Leopoldo Meis, Lab Biol Mol Plantas, Rio De Janeiro, RJ, Brazil; [Rojas, Cristian A.] Univ Fed Integracao Latino Amer, Inst Latino Amer Ciencias Vida & Nat, Foz Do Iguacu, Parana, Brazil; [Grativol, Clicia] Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Quim & Funcao Prot & Peptideos, Campos Goytacazes, Rio De Janeiro, Brazil; [de Armas, Elvismary M.; Entenza, Julio O. P.; Lifschitz, Sergio] Pontificia Univ Catolica Rio de Janeiro, Dept Informat, Rio De Janeiro, RJ, Brazil; [Lima, Marcelo de F.] Univ Fed Rural Rio de Janeiro, Inst Ciencias Exatas, Dept Quim, Seropedica, RJ, Brazil; [Farrinelli, Laurent] Fasteris SA, 1228 Plan Les Ouates, Geneva, Switzerland	Universidade Federal do Rio de Janeiro; Universidade Federal da Integracao Latino-Americana; Universidade Estadual do Norte Fluminense; Pontificia Universidade Catolica do Rio de Janeiro; Universidade Federal Rural do Rio de Janeiro (UFRRJ)	Ferreira, PCG (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Bioquim Med Leopoldo Meis, Lab Biol Mol Plantas, Rio De Janeiro, RJ, Brazil.	paulof@bioqmed.ufrj.br	Lifschitz, Sérgio/F-2816-2014; Thiebaut, Flavia/B-3867-2018; Thiebaut, Flavia/AAU-5318-2021	Lifschitz, Sérgio/0000-0003-3073-3734; Thiebaut, Flavia/0000-0002-8833-1722; Grativol, Clicia/0000-0002-8873-701X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Institute Nacional de Ciencia e Tecnologia em Fixacao Biologica de Nitrogenio; Fundacao de Amparo a Pesquisa do Rio de Janeiro; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; FASTERIS SA	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Institute Nacional de Ciencia e Tecnologia em Fixacao Biologica de Nitrogenio; Fundacao de Amparo a Pesquisa do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FASTERIS SA	The work was supported by the following: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - ABSB and PCGF; Institute Nacional de Ciencia e Tecnologia em Fixacao Biologica de Nitrogenio - PCGF; Fundacao de Amparo a Pesquisa do Rio de Janeiro - PCGF; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - PCGF. FASTERIS SA provided support in the form of salaries for authors [L.F.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of L.F. are articulated in the "author contributions" section.	Acharya BR, 2007, PLANT J, V50, P488, DOI 10.1111/j.1365-313X.2007.03064.x; Agrawal GK, 2001, J PLANT PHYSIOL, V158, P133, DOI 10.1078/0176-1617-00186; Albrecht C, 2008, PLANT PHYSIOL, V148, P611, DOI 10.1104/pp.108.123216; Alvarez ME, 2010, MOL PLANT PATHOL, V11, P563, DOI [10.1111/J.1364-3703.2010.00621.X, 10.1111/j.1364-3703.2010.00621.x]; [Anonymous], J NATURAL RESOURCES; Pascual MB, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0640-0; Berger S, 2004, PHYSIOL PLANTARUM, V122, P419, DOI 10.1111/j.1399-3054.2004.00433.x; Berger S, 2007, J EXP BOT, V58, P4019, DOI 10.1093/jxb/erm298; Boerner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043047; Bohman S, 2002, THEOR APPL GENET, V105, P498, DOI 10.1007/s00122-002-0885-5; Bolouri Moghaddam MR, 2012, J EXP BOT, V63, P3989, DOI 10.1093/jxb/ers129; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Bonfig KB, 2006, PLANTA, V225, P1, DOI 10.1007/s00425-006-0303-3; Broekaert WF, 2006, ANNU REV PHYTOPATHOL, V44, P393, DOI 10.1146/annurev.phyto.44.070505.143440; Camejo D, 2016, PLANT PHYSIOL BIOCH, V103, P10, DOI 10.1016/j.plaphy.2016.02.035; Champigny MJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00230; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Cheavegatti-Gianotto Adriana, 2011, Trop Plant Biol, V4, P62, DOI 10.1007/s12042-011-9068-3; Chern M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006049; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Cosio C, 2009, J EXP BOT, V60, P391, DOI 10.1093/jxb/ern318; Czernic P, 1999, PLANT J, V18, P321, DOI 10.1046/j.1365-313X.1999.00447.x; D'Hont A, 2005, CYTOGENET GENOME RES, V109, P27, DOI 10.1159/000082378; Daudi A, 2012, PLANT CELL, V24, P275, DOI 10.1105/tpc.111.093039; Denance N, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00155; Dillon SL, 2007, ANN BOT-LONDON, V100, P975, DOI 10.1093/aob/mcm192; Ding B, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00675; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Ederli L, 2011, J PLANT PHYSIOL, V168, P1784, DOI 10.1016/j.jplph.2011.05.018; Essmann J, 2008, PLANT PHYSIOL, V147, P1288, DOI 10.1104/pp.108.121418; Fontana PD, 2013, EUR J PLANT PATHOL, V137, P525, DOI 10.1007/s10658-013-0263-y; Fontana PD, 2016, GENOME ANNOUNC, V4, P15; Fradin EF, 2011, PLANT PHYSIOL, V156, P2255, DOI 10.1104/pp.111.180067; Franco SD, 2015, BIOCHEM BIOPH RES CO, V466, P629, DOI 10.1016/j.bbrc.2015.09.054; Fu ZQ, 2013, ANNU REV PLANT BIOL, V64, P839, DOI 10.1146/annurev-arplant-042811-105606; Gechev TS, 2005, J CELL BIOL, V168, P17, DOI 10.1083/jcb.200409170; Giglioti E. A., 2000, FALSE RED STRIPE GUI; Gomez-Ariza J, 2007, MOL PLANT MICROBE IN, V20, P832, DOI 10.1094/MPMI-20-7-0832; Gou XP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002452; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo J, 2016, POSTHARVEST BIOL TEC, V111, P337, DOI 10.1016/j.postharvbio.2015.09.002; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Helliwell EE, 2013, PLANT BIOTECHNOL J, V11, P33, DOI 10.1111/pbi.12004; Herbers K, 1996, PLANT CELL, V8, P793, DOI 10.1105/tpc.8.5.793; Hiruma K, 2013, P NATL ACAD SCI USA, V110, P9589, DOI 10.1073/pnas.1305745110; Hotta C. T., 2010, Tropical Plant Biology, V3, P75, DOI 10.1007/s12042-010-9050-5; Huang WZ, 2008, PLANT MOL BIOL, V68, P451, DOI 10.1007/s11103-008-9382-9; Huot B, 2014, MOL PLANT, V7, P1267, DOI 10.1093/mp/ssu049; Idanheimo N, 2014, BIOCHEM BIOPH RES CO, V445, P457, DOI 10.1016/j.bbrc.2014.02.013; Isaacs M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00566; Jensen MK, 2008, PLANT J, V56, P867, DOI 10.1111/j.1365-313X.2008.03646.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jorda L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00897; Kangasjarvi S, 2012, J EXP BOT, V63, P1619, DOI 10.1093/jxb/err402; Karkonen A, 2015, PHYTOCHEMISTRY, V112, P22, DOI 10.1016/j.phytochem.2014.09.016; Kim NH, 2015, J EXP BOT, V66, P3367, DOI 10.1093/jxb/erv147; Kocal N, 2008, PLANT PHYSIOL, V148, P1523, DOI 10.1104/pp.108.127977; Kotchoni SO, 2006, PLANT CELL ENVIRON, V29, P1033, DOI 10.1111/j.1365-3040.2005.01458.x; Kwon Y, 2011, J PLANT RES, V124, P193, DOI 10.1007/s10265-010-0354-1; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larsson E, 2012, ANN BOT-LONDON, V110, P923, DOI 10.1093/aob/mcs151; Levitz SA, 2004, MICROBES INFECT, V6, P1351, DOI 10.1016/j.micinf.2004.08.014; Lewis MW, 2010, PLANT J, V62, P817, DOI 10.1111/j.1365-313X.2010.04194.x; Li B, 2014, SCI REP-UK, V4, DOI 10.1038/srep05698; Li B, 2011, J GEN PLANT PATHOL, V77, P64, DOI 10.1007/s10327-010-0280-z; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li L, 2016, SCI CHINA LIFE SCI; Liu B, 2014, INT J AEROSPACE ENG, V2014, DOI 10.1155/2014/540235; Liu H., 2012, OPTIM METHOD SOFTW, V1, P1, DOI DOI 10.1128/GEN0MEA.00936-13; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Liu JJ, 2010, PLANT CELL REP, V29, P419, DOI 10.1007/s00299-010-0826-8; Liu PP, 2011, PLANT PHYSIOL, V155, P1762, DOI 10.1104/pp.110.171694; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu K, 2016, J EXPT BOT; Maccheroni W., 2006, ATUALIZACAO PRODUCAO, P239; Macho AP, 2014, MOL CELL, V54, P263, DOI 10.1016/j.molcel.2014.03.028; Mackintosh CA, 2007, PLANT CELL REP, V26, P479, DOI 10.1007/s00299-006-0265-8; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Maldonado AM, 2002, NATURE, V419, P399, DOI 10.1038/nature00962; Martinelli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038039; Meier K, 2014, EPIGENETICS-US, V9, P1485, DOI 10.4161/15592294.2014.971580; Morkunas I, 2005, PLANT PHYSIOL BIOCH, V43, P363, DOI 10.1016/j.plaphy.2005.02.011; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muchembled J, 2006, PHYTOCHEMISTRY, V67, P1104, DOI 10.1016/j.phytochem.2006.02.025; Nakabayashi R, 2014, PLANT J, V77, P367, DOI 10.1111/tpj.12388; Naoumkina MA, 2010, MOL PLANT PATHOL, V11, P829, DOI 10.1111/j.1364-3703.2010.00648.x; Nery FC, 2006, BIOCHEM BIOPH RES CO, V341, P847, DOI 10.1016/j.bbrc.2006.01.036; Nery FC, 2004, J BIOL CHEM, V279, P11444, DOI 10.1074/jbc.M306672200; Ohme-Takagi Masaru S H, 1995, PLANT CELL, V7, P173; Osakabe Y, 2013, J EXP BOT, V64, P445, DOI 10.1093/jxb/ers354; Park CJ, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00177; Patra B, 2013, BBA-GENE REGUL MECH, V1829, P1236, DOI 10.1016/j.bbagrm.2013.09.006; Patrick JW, 2013, PLANT BIOTECHNOL J, V11, P142, DOI 10.1111/pbi.12002; Petrussa E, 2013, INT J MOL SCI, V14, P14950, DOI 10.3390/ijms140714950; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Postma J, 2013, J CHEM INF MODEL, V53, P627; Pratelli R, 2014, J EXP BOT, V65, P5535, DOI 10.1093/jxb/eru320; Renard-Merlier D, 2007, PHYTOCHEMISTRY, V68, P1156, DOI 10.1016/j.phytochem.2007.02.011; Rico A, 2008, MOL PLANT MICROBE IN, V21, P269, DOI 10.1094/MPMI-21-2-0269; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Rojas CM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00017; Rojas CM, 2012, PLANT CELL, V24, P336, DOI 10.1105/tpc.111.093245; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Rout E, 2016, EUR J PLANT PATHOL, V144, P345, DOI 10.1007/s10658-015-0772-y; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Sablowski RWM, 1998, CELL, V92, P93, DOI 10.1016/S0092-8674(00)80902-2; Schaad NW, 2008, SYST APPL MICROBIOL, V31, P434, DOI 10.1016/j.syapm.2008.09.003; Schaarschmidt S, 2006, J EXP BOT, V57, P4015, DOI 10.1093/jxb/erl172; Schafer P, 2004, MOL PLANT MICROBE IN, V17, P366, DOI 10.1094/MPMI.2004.17.4.366; Scharte J, 2005, PLANT CELL ENVIRON, V28, P1421, DOI 10.1111/j.1365-3040.2005.01380.x; Schestibratov KA, 2005, SCI HORTIC-AMSTERDAM, V106, P177, DOI 10.1016/j.scienta.2005.03.016; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; Shao HB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00902; Shen XL, 2011, PLANT CELL ENVIRON, V34, P179, DOI 10.1111/j.1365-3040.2010.02219.x; Singh NK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0083963, 10.1371/journal.pone.0073005]; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Sun L., 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1111/MPP.12078; Sunkar R, 2003, PLANT J, V35, P452, DOI 10.1046/j.1365-313X.2003.01819.x; Tegeder M, 2012, CURR OPIN PLANT BIOL, V15, P315, DOI 10.1016/j.pbi.2012.02.001; Tor M, 2009, J EXP BOT, V60, P3645, DOI 10.1093/jxb/erp233; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Truman W, 2006, PLANT J, V46, P14, DOI 10.1111/j.1365-313X.2006.02672.x; UK CI, 1995, AC AV SUBSP AV DISTR; Valdivia ER, 2013, J EXP BOT, V64, P1333, DOI 10.1093/jxb/ers394; Van Bel M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r134; Van Bel M, 2012, PLANT PHYSIOL, V158, P590, DOI 10.1104/pp.111.189514; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; VANDERWEL H, 1972, EUR J BIOCHEM, V31, P221; Vargas L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114744; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Wang G., 2012, J APPL MATH, V2012, P1, DOI DOI 10.1155/2012/265760; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Wen JQ, 2004, PLANT J, V37, P668, DOI 10.1111/j.1365-313X.2003.01994.x; Wrzaczek M, 2010, TRANSCRIPTIONAL REGU, V1, P1; Wu Y, 2013, J INTEGR PLANT BIOL, V55, P1271, DOI 10.1111/jipb.12123; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xie Q, 2002, NATURE, V419, P167, DOI 10.1038/nature00998; Yang DL, 2013, MOL PLANT, V6, P675, DOI 10.1093/mp/sst056; Yeh Y-H, 2016, PLANT CELL; Yoon J, 2015, J INTEGR PLANT BIOL, V57, P902, DOI 10.1111/jipb.12422; Zaragoza O, 2009, ADV APPL MICROBIOL, V68, P133, DOI 10.1016/S0065-2164(09)01204-0; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang W., 2013, CLIN TRANSL ONCOL, P1, DOI DOI 10.1007/S00417-013-2267-X; ZHANG W, 2014, PLOS ONE, V9; Zhang XJ, 2013, PLANT PHYSIOL BIOCH, V67, P189, DOI 10.1016/j.plaphy.2013.03.013; Zvereva AS, 2012, VIRUSES-BASEL, V4, P2578, DOI 10.3390/v4112578	151	29	30	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166473	10.1371/journal.pone.0166473	http://dx.doi.org/10.1371/journal.pone.0166473			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936012	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100028
J	Valenti, G; Bonomi, AG; Westerterp, KR				Valenti, Giulio; Bonomi, Alberto G.; Westerterp, Klaas R.			Diurnal Patterns of Physical Activity in Relation to Activity Induced Energy Expenditure in 52 to 83 Years-Old Adults	PLOS ONE			English	Article							DOUBLY LABELED WATER; SEDENTARY BEHAVIOR; ACTIVITY LEVEL; SLEEP; MEN; AGE	Background Ageing is associated with a declining physical activity level (PAL) and changes in the diurnal activity pattern. Changes in the activity pattern might help explaining the age-associated reduction of physical activity. Objective The aims were to investigate diurnal activity patterns within groups of older adults classified by PAL, to investigate diurnal activity patterns within age-groups and to investigate the association between the drop in activity and aerobic fitness. Methods Thirty-one healthy subjects aged between 52 and 83y were recruited for the study. Subjects were divided in sedentary (PAL< 1.75), moderately active (1.75< PAL< 1.90), and active (1.90< PAL) older adults with energy expenditure measurements obtained with the doubly labelled water technique. Diurnal activity patterns were based on activity counts from an accelerometer during wake time and then divided in four quarters of equal time length. Additionally, aerobic fitness was measured as maximal oxygen uptake. Results Subjects had a PAL between 1.43 and 2.34 and an aerobic fitness between 18 and 49 ml/kg/min. Overall, activity patterns showed a peak in the first quarter of wake time (around 10AM) followed by a gradual decline of, on average, 5% per hour. Active subjects reached their peak in the first quarter and remained active until after the third quarter (11% drop each quarter on average). Moderately active and sedentary subjects reached their peak during the second quarter with a decrease during the third quarter (respectively 29% and 17% drop each quarter on average). The drop in physical activity between the first and the second half of the wake time was negatively associated with aerobic fitness (r = -0.39, p< 0.05). Conclusion Active older adults maintained a larger amount of body movement for longer during their wake time. Diurnal physical activity declined more in adults >= 66 years old with lower aerobic fitness.	[Valenti, Giulio; Westerterp, Klaas R.] Maastricht Univ, Dept Human Biol, Maastricht, Netherlands; [Bonomi, Alberto G.] Philips Res Labs, Personal Hlth Solut, Eindhoven, Netherlands	Maastricht University; Philips; Philips Research	Valenti, G (corresponding author), Maastricht Univ, Dept Human Biol, Maastricht, Netherlands.	g.valenti@maastrichtuniversity.nl		Valenti, Giulio/0000-0002-8002-6133	Maastricht University; Philips Research Laboratories	Maastricht University; Philips Research Laboratories	Maastricht University provided support in the form of materials and salaries for GV and KRW but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Philips Research Laboratories provided support in the form of salaries for AGB but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the "author contributions" section. The clinical trial was not sponsored by Philips Research Laboratories.	Aadland E, 2012, J OBES, V2012, DOI 10.1155/2012/810594; Arnardottir NY, 2013, AGE AGEING, V42, P222, DOI 10.1093/ageing/afs160; Barbosa JF, 2015, PHYSIOTHERAPY; Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; Blair SN, 2001, MED SCI SPORT EXER, V33, pS379, DOI 10.1097/00005768-200106001-00007; Bonnefoy M, 2001, J AM GERIATR SOC, V49, P28, DOI 10.1046/j.1532-5415.2001.49006.x; Bonomi AG, 2010, OBESITY, V18, P1845, DOI 10.1038/oby.2010.34; BROUWER E, 1957, ACTA PHYSIOL PHARM N, V6, P795; Brzezinski Amnon, 1997, New England Journal of Medicine, V336, P186; Cai ZY, 2014, J STRENGTH COND RES, V28, P2597, DOI 10.1519/JSC.0000000000000428; Chen T, 2015, J PHYS ACT HLTH; COSTILL DL, 1970, J APPL PHYSIOL, V28, P251, DOI 10.1152/jappl.1970.28.3.251; Egerton T, 2015, J GERONTOL A; Erickson KI, 2009, HIPPOCAMPUS, V19, P1030, DOI 10.1002/hipo.20547; Gabriel KP, 2012, MED SCI SPORT EXER, V44, P104, DOI 10.1249/MSS.0b013e318229056e; Hoos MB, 2003, EUR J APPL PHYSIOL, V89, P624, DOI 10.1007/s00421-003-0891-6; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Huang G, 2015, EUR J PREV CARDIOL; Karstoft K, 2015, IMMUNOL CELL BIOL; Kokkinos Peter, 2012, ISRN Cardiol, V2012, P718789, DOI 10.5402/2012/718789; KUIPERS H, 1985, INT J SPORTS MED, V6, P197, DOI 10.1055/s-2008-1025839; Lucertini F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141970; Luik AL, 2015, PSYCHONEUROENDOCRINO, V53, P207, DOI 10.1016/j.psyneuen.2015.01.011; Lupien S, 1996, NEUROBIOL AGING, V17, P95, DOI 10.1016/0197-4580(95)02005-5; Meijer EP, 2002, J AM GERIATR SOC, V50, P349, DOI 10.1046/j.1532-5415.2002.50069.x; Meijer EP, 2001, INT J OBESITY, V25, P935, DOI 10.1038/sj.ijo.0801644; Melton L J 3rd, 2000, Mayo Clin Proc, V75 Suppl, pS10; Milanovic Z, 2013, CLIN INTERV AGING, V8, DOI 10.2147/CIA.S44112; Myers J, 2003, CIRCULATION, V107, pE2, DOI 10.1161/01.CIR.0000048890.59383.8D; Plasqui G, 2013, OBES REV, V14, P451, DOI 10.1111/obr.12021; Pollock ML, 1998, MED SCI SPORT EXER, V30, P975, DOI 10.1097/00005768-199806000-00032; Rothenberg E M, 2002, J Nutr Health Aging, V6, P177; Sartini C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1976-y; Schrack JA, 2014, J GERONTOL A-BIOL, V69, P973, DOI 10.1093/gerona/glt199; Thompson PD, 2013, CURR SPORT MED REP, V12, P215, DOI 10.1249/JSR.0b013e31829a68cf; Westerterp K R, 2000, Curr Opin Clin Nutr Metab Care, V3, P485, DOI 10.1097/00075197-200011000-00011; WESTERTERP KR, 1988, J APPL PHYSIOL, V65, P53, DOI 10.1152/jappl.1988.65.1.53; Westerterp KR, 1995, RES S1, P49; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Wouters-Adriaens MPE, 2006, BRIT J NUTR, V95, P1166, DOI 10.1079/BJN20061784; Xiao L, 2015, BIOSTATISTICS, V16, P352, DOI 10.1093/biostatistics/kxu045	41	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167824	10.1371/journal.pone.0167824	http://dx.doi.org/10.1371/journal.pone.0167824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936145	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100207
J	Smits, LP; van Wijk, DF; Duivenvoorden, R; Xu, DX; Yuan, C; Stroes, ES; Nederveen, AJ				Smits, Loek P.; van Wijk, Diederik F.; Duivenvoorden, Raphael; Xu, Dongxiang; Yuan, Chun; Stroes, Erik S.; Nederveen, Aart J.			Manual versus Automated Carotid Artery Plaque Component Segmentation in High and Lower Quality 3.0 Tesla MRI Scans	PLOS ONE			English	Article							IN-VIVO QUANTIFICATION; ATHEROSCLEROTIC PLAQUE; CEREBROVASCULAR EVENTS; REPRODUCIBILITY; CLASSIFICATION; MORPHOLOGY; RESOLUTION; 3.0-TESLA; DIAGNOSIS; STENOSIS	Purpose To study the interscan reproducibility of manual versus automated segmentation of carotid artery plaque components, and the agreement between both methods, in high and lower quality MRI scans. Methods 24 patients with 30-70% carotid artery stenosis were planned for 3T carotid MRI, followed by a rescan within 1 month. A multicontrast protocol (T1w, T2w, PDw and TOF sequences) was used. After co-registration and delineation of the lumen and outer wall, segmentation of plaque components (lipid-rich necrotic cores (LRNC) and calcifications) was performed both manually and automated. Scan quality was assessed using a visual quality scale. Results Agreement for the detection of LRNC (Cohen's kappa (k) is 0.04) and calcification (k = 0.41) between both manual and automated segmentation methods was poor. In the high-quality scans (visual quality score >= 3), the agreement between manual and automated segmentation increased to k = 0.55 and k = 0.58 for, respectively, the detection of LRNC and calcification larger than 1 mm(2). Both manual and automated analysis showed good interscan reproducibility for the quantification of LRNC (intraclass correlation coefficient (ICC) of 0.94 and 0.80 respectively) and calcified plaque area (ICC of 0.95 and 0.77, respectively). Conclusion Agreement between manual and automated segmentation of LRNC and calcifications was poor, despite a good interscan reproducibility of both methods. The agreement between both methods increased to moderate in high quality scans. These findings indicate that image quality is a critical determinant of the performance of both manual and automated segmentation of carotid artery plaque components.	[Smits, Loek P.; van Wijk, Diederik F.; Duivenvoorden, Raphael; Stroes, Erik S.] Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands; [Xu, Dongxiang; Yuan, Chun] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Nederveen, Aart J.] Acad Med Ctr, Dept Radiol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Washington; University of Washington Seattle; University of Amsterdam; Academic Medical Center Amsterdam	Smits, LP (corresponding author), Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands.	L.P.Smits@amc.uva.nl	Duivenvoorden, Raphaël/B-5154-2019	Duivenvoorden, Raphaël/0000-0003-1446-8336; Nederveen, Aart/0000-0002-5477-973X				Altaf N, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000173; Balu Niranjan, 2009, Top Magn Reson Imaging, V20, P203, DOI 10.1097/RMR.0b013e3181ea287d; Biasiolli L, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-69; Brott TG, 2011, STROKE, V81, pE76; Coolen B. F., 2015, MAGN RESON MED, V75, P1; Duivenvoorden R, 2009, CIRC-CARDIOVASC IMAG, V2, P235, DOI 10.1161/CIRCIMAGING.108.788059; Esposito-Bauer L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067927; Gao S, 2015, MAGN RESON MATER PHY, V28, P535, DOI 10.1007/s10334-015-0495-2; Kerwin William, 2007, Top Magn Reson Imaging, V18, P371; Kerwin WS, 2008, J MAGN RESON IMAGING, V28, P987, DOI 10.1002/jmri.21529; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Li FY, 2010, J MAGN RESON IMAGING, V31, P168, DOI 10.1002/jmri.22014; Liu F, 2006, MAGN RESON MED, V55, P659, DOI 10.1002/mrm.20814; Mono ML, 2012, CEREBROVASC DIS, V34, P343, DOI 10.1159/000343227; Rerkasem K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001081.pub2; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Saam T, 2005, ARTERIOSCL THROM VAS, V25, P234, DOI 10.1161/01.ATV.0000149867.61851.31; Saam T, 2013, J AM COLL CARDIOL, V62, P1081, DOI 10.1016/j.jacc.2013.06.015; Swain S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a786; Takaya N, 2006, STROKE, V37, P818, DOI 10.1161/01.STR.0000204638.91099.91; Takaya N, 2006, J MAGN RESON IMAGING, V24, P203, DOI 10.1002/jmri.20599; Truijman MTB, 2014, INT J STROKE, V9, P747, DOI 10.1111/ijs.12167; van Wijk DF, 2013, MAGMA; van Wijk DF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130878; van Wijk DF, 2014, MAGN RESON MATER PHY, V27, P219, DOI 10.1007/s10334-013-0407-2; van 't Klooster R, 2012, AM J NEURORADIOL, V33, P1621, DOI 10.3174/ajnr.A3028; Yuan C, 2002, J MAGN RESON IMAGING, V15, P62, DOI 10.1002/jmri.10030	27	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0164267	10.1371/journal.pone.0164267	http://dx.doi.org/10.1371/journal.pone.0164267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930665	Green Published, Green Submitted, gold			2022-12-27	WOS:000389580900001
J	Viktorova, J; Jandova, Z; Madlenakova, M; Prouzova, P; Bartunek, V; Vrchotova, B; Lovecka, P; Musilova, L; Macek, T				Viktorova, Jitka; Jandova, Zuzana; Madlenakova, Michaela; Prouzova, Petra; Bartunek, Vilem; Vrchotova, Blanka; Lovecka, Petra; Musilova, Lucie; Macek, Tomas			Native Phytoremediation Potential of Urtica dioica for Removal of PCBs and Heavy Metals Can Be Improved by Genetic Manipulations Using Constitutive CaMV 35S Promoter	PLOS ONE			English	Article							BACTERIAL BPHC GENE; ENDOPHYTIC BACTERIA; TRANSGENIC TOBACCO; CONTAMINATED SOIL; PLANT-GROWTH; ACCUMULATION; CADMIUM; METABOLISM; EXPRESSION; TOLERANCE	Although stinging nettle (Urtica dioica) has been shown to reduce HM (heavy metal) content in soil, its wider phytoremediation potential has been neglected. Urtica dioica was cultivated in soils contaminated with HMs or polychlorinated biphenyls (PCBs). After four months, up to 33% of the less chlorinated biphenyls and 8% of HMs (Zn, Pb, Cd) had been removed. Bacteria were isolated from the plant tissue, with the endophytic bacteria Bacillus shackletonii and Streptomyces badius shown to have the most significant effect. These bacteria demonstrated not only benefits for plant growth, but also extreme tolerance to As, Zn and Pb. Despite these results, the native phytoremediation potential of nettles could be improved by biotechnologies. Transient expression was used to investigate the functionality of the most common constitutive promoter, CaMV 35S in Urtica dioica. This showed the expression of the CUP and bphC transgenes. Collectively, our findings suggest that remediation by stinging nettle could have a much wider range of applications than previously thought.	[Viktorova, Jitka; Jandova, Zuzana; Madlenakova, Michaela; Prouzova, Petra; Vrchotova, Blanka; Lovecka, Petra; Musilova, Lucie; Macek, Tomas] UCT Prague, Fac Food & Biochem Technol, Dept Biochem & Microbiol, Tech 3, Prague, Czech Republic; [Bartunek, Vilem] UCT Prague, Fac Chem Technol, Dept Inorgan Chem, Tech 3, Prague, Czech Republic	University of Chemistry & Technology, Prague; University of Chemistry & Technology, Prague	Macek, T (corresponding author), UCT Prague, Fac Food & Biochem Technol, Dept Biochem & Microbiol, Tech 3, Prague, Czech Republic.	tomas.macek@vscht.cz	Musilová, Lucie/AAL-6331-2020; Viktorova, Jitka/B-5707-2014; Macek, Tomas/K-1843-2012; Madlenakova, Michaela/H-9346-2017	Musilová, Lucie/0000-0002-8244-8006; Viktorova, Jitka/0000-0003-0857-153X; Macek, Tomas/0000-0002-7281-9512; Madlenakova, Michaela/0000-0001-9805-0505	Technology Agency of the Czech Republic [TA03011184]; Grant Agency of the Czech Republic [15-22276S]	Technology Agency of the Czech Republic; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This work was supported by Technology Agency of the Czech Republic of project No. TA03011184 and by Grant Agency of the Czech Republic of project No. 15-22276S.	Amaresan N, 2012, ANN MICROBIOL, V62, P805, DOI 10.1007/s13213-011-0321-7; Barzanti R, 2007, MICROB ECOL, V53, P306, DOI 10.1007/s00248-006-9164-3; Boshoff M, 2014, SCI TOTAL ENVIRON, V493, P862, DOI 10.1016/j.scitotenv.2014.06.076; Chaney RL, 1997, CURR OPIN BIOTECH, V8, P279, DOI 10.1016/S0958-1669(97)80004-3; Chebotar VK, 2015, APPL BIOCHEM MICRO+, V51, P271, DOI 10.1134/S0003683815030059; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; DADARWAL KR, 1981, J BIOSCIENCE, V3, P117, DOI 10.1007/BF02702653; DWORKIN M, 1958, J BACTERIOL, V75, P592, DOI 10.1128/JB.75.5.592-603.1958; Edwards HGM, 1998, SPECTROCHIM ACTA A, V54, P745, DOI 10.1016/S1386-1425(98)00013-4; ERNST WHO, 1987, CHEMOSPHERE, V16, P233, DOI 10.1016/0045-6535(87)90127-5; Fiser J, 2012, 5TH INTERNATIONAL SYMPOSIUM ON BIOSORPTION AND BIOREMEDIATION, P14; Gounden D, 2016, J ENVIRON SCI HEAL B, V51, P1, DOI 10.1080/03601234.2015.1080477; Grubor M, 2008, ARCH BIOL SCI, V60, P239, DOI 10.2298/ABS0802239G; Gulcin I, 2005, J ENZYM INHIB MED CH, V20, P297, DOI 10.1080/1475636032000141890; Hartley L., 2004, CHARACTERIZATION HEA; Hlozkova K, 2013, RES MICROBIOL, V164, P1009, DOI 10.1016/j.resmic.2013.10.002; Ho M-W, 2011, MICROBIAL ECOLOGY IN, V11; Holm FW, 2012, EFFLUENTS ALTERNATIV; Hussain S, 2009, CRIT REV ENV SCI TEC, V39, P843, DOI 10.1080/10643380801910090; Ibanez S, 2016, NEW BIOTECHNOL, V33, P625, DOI 10.1016/j.nbt.2015.11.008; Jasim B, 2013, PLANT GROWTH REGUL, V71, P1, DOI 10.1007/s10725-013-9802-y; Kapila J, 1997, PLANT SCI, V122, P101, DOI 10.1016/S0168-9452(96)04541-4; Khan AL, 2014, J MICROBIOL, V52, P689, DOI 10.1007/s12275-014-4002-7; Koblar A, 2015, J FLUORINE CHEM, V172, P7, DOI 10.1016/j.jfluchem.2015.01.006; Logan NA, 2004, INT J SYST EVOL MICR, V54, P373, DOI 10.1099/ijs.0.02661-0; Macek T, 2002, ACTA BIOTECHNOL, V22, P101, DOI 10.1002/1521-3846(200205)22:1/2&lt;101::AID-ABIO101&gt;3.0.CO;2-N; Macek T, 2008, TRENDS BIOTECHNOL, V26, P146, DOI 10.1016/j.tibtech.2007.11.009; MCINROY JA, 1995, PLANT SOIL, V173, P337, DOI 10.1007/BF00011472; Miliute I., 2011, Biologija, V57, P98; Musilova L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081205; Novakova M, 2009, BIOTECHNOL BIOENG, V102, P29, DOI 10.1002/bit.22038; Obasi N.A., 2013, INT J CURRENT BIOCH, V1, P16; Ohkama N, 1999, SOIL SCI PLANT NUTR, V45, P767, DOI 10.1080/00380768.1999.10415842; Pachura P, 2016, DESALIN WATER TREAT, V57, P1469, DOI 10.1080/19443994.2015.1017330; Panz K, 2012, J ENVIRON MANAGE, V113, P85, DOI 10.1016/j.jenvman.2012.08.016; Pavlikova D, 2004, PLANT SOIL ENVIRON, V50, P513, DOI 10.17221/4067-PSE; Pavlikova D, 2007, INT J PHYTOREMEDIAT, V9, P71, DOI 10.1080/15226510601139433; Radulescu C, 2013, ROM J PHYS, V58, P1337; Rajkumar M, 2009, CHEMOSPHERE, V77, P153, DOI 10.1016/j.chemosphere.2009.06.047; Robinson T, 2001, BIORESOURCE TECHNOL, V77, P247, DOI 10.1016/S0960-8524(00)00080-8; SAFE S, 1993, ENVIRON HEALTH PERSP, V100, P259, DOI 10.2307/3431532; Scherer J, 2009, MOL MICROBIOL, V73, P601, DOI 10.1111/j.1365-2958.2009.06792.x; Shams KM, 2010, PLANT SOIL, V328, P175, DOI 10.1007/s11104-009-0095-x; Sheoran V, 2009, MINER ENG, V22, P1007, DOI 10.1016/j.mineng.2009.04.001; Shin SH, 2001, J MICROBIOL METH, V44, P89, DOI 10.1016/S0167-7012(00)00229-3; Silver S, 2005, J IND MICROBIOL BIOT, V32, P587, DOI 10.1007/s10295-005-0019-6; Silver S, 2005, APPL ENVIRON MICROB, V71, P599, DOI 10.1128/AEM.71.2.599-608.2005; Sinclair SA, 2012, BBA-MOL CELL RES, V1823, P1553, DOI 10.1016/j.bbamcr.2012.05.016; Tanvir R, 2014, NAT PROD RES, V28, P2048, DOI 10.1080/14786419.2014.919579; Tarhan L, 2016, BIOL PLANTARUM, V60, P163, DOI 10.1007/s10535-015-0570-6; Uhlik O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040653; Uhlik O, 2009, APPL ENVIRON MICROB, V75, P6471, DOI 10.1128/AEM.00466-09; Van Aken B, 2010, ENVIRON SCI TECHNOL, V44, P2767, DOI 10.1021/es902514d; Verbruggen N, 2009, NEW PHYTOL, V181, P759, DOI 10.1111/j.1469-8137.2008.02748.x; Viktorova J, 2014, INT J PHYTOREMEDIAT, V16, P937, DOI 10.1080/15226514.2013.810575; WILKEN A, 1995, ENVIRON TOXICOL CHEM, V14, P2017, DOI [10.1897/1552-8618(1995)14[2017:MODPCI]2.0.CO;2, 10.1002/etc.5620141203]	56	13	15	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167927	10.1371/journal.pone.0167927	http://dx.doi.org/10.1371/journal.pone.0167927			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930707	Green Published, gold			2022-12-27	WOS:000389580900061
J	Gonzalez, CV; Jofre, MF; Vila, HF; Stoffel, M; Bottini, R; Giordano, CV				Veronica Gonzalez, Carina; Florencia Jofre, Maria; Vila, Hernan F.; Stoffel, Markus; Bottini, Ruben; Valeria Giordano, Carla			Morphology and Hydraulic Architecture of Vitis vinifera L. cv. Syrah and Torrontes Riojano Plants Are Unaffected by Variations in Red to Far-Red Ratio	PLOS ONE			English	Article							LEAF-AREA DENSITY; GRAPEVINE CANOPIES; LIGHT ENVIRONMENT; SHADE TOLERANCE; PHYTOCHROME; RESPONSES; MICROCLIMATE; PRESSURE; QUALITY; YIELD	Plants have evolved an array of specific photoreceptors to acclimate to the light environment. By sensing light signals, photoreceptors modulate plant morphology, carbon-and water-physiology, crop yield and quality of harvestable organs, among other responses. Many cultural practices and crop management decisions alter light quantity and quality perceived by plants cultivated in the field. Under full sunlight, phytochromes perceive high red to far red ratios (R:FR; 1.1), whereas overhead or lateral low R:FR (below 1.1) are sensed in the presence of plant shade or neighboring plants, respectively. Grapevine is one of the most important fruit crops in the world. To date, studies on grapevine response to light focused on different Photosynthetic Active Radiation (PAR) levels; however, limited data exist about its response to light quality. In this study we aimed to investigate morphological, biochemical, and hydraulic responses of Vitis vinifera to variations in R:FR. Therefore, we irradiated Syrah and Torronte's Riojano plants, grown in a glasshouse, with lateral FR light (low lateral R:FR treatment), while others, that were kept as controls, were not irradiated (ambient lateral R:FR treatment). In response to the low lateral R:FR treatment, grapevine plants did not display any of the SAS morphological markers (i.e. stem length, petiole length and angle, number of lateral shoots) in any of the cultivars assessed, despite an increase in gibberelins and auxin concentrations in leaf tissues. Low lateral R:FR did not affect dry matter partitioning, water-related traits (stomata density and index, wood anatomy), or water-related physiology (plant conductance, transpiration rate, stem hydraulic conductivity, stomatal conductance). None of the Vitis vinifera varieties assessed displayed the classical morphological and hydraulic responses associated to SAS induced by phytochromes. We discuss these results in the context of natural grapevine environment and agronomical relevance.	[Veronica Gonzalez, Carina; Florencia Jofre, Maria; Bottini, Ruben] UNCuyo, CONICET, IBAM, Fac Ciencias Agr, Almirante Brown 500 Chacras Coria, Mendoza, Argentina; [Veronica Gonzalez, Carina; Florencia Jofre, Maria] Univ Nacl Cuyo, Fac Ciencias Exactas & Nat, Mendoza, Argentina; [Vila, Hernan F.] Inst Nacl Tecnol Agr, Lab Viticulture, Estn Expt Agr Mendoza, San Martin 3853, Mendoza, Argentina; [Stoffel, Markus] Univ Bern, Dendrolab Ch, Baltzerstr 1 3, Bern, Switzerland; [Stoffel, Markus] Univ Geneva, Inst Environm Sci, Climat Change & Climate Impacts, Blvd Carl Vogt 66, Geneva, Switzerland; [Valeria Giordano, Carla] Consejo Nacl Invest Cient & Tecn, IADIZA, Av Ruiz Leal S-N,Parque Gen San Martin, Mendoza, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza; Instituto Nacional de Tecnologia Agropecuaria (INTA); University of Bern; University of Geneva; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Giordano, CV (corresponding author), Consejo Nacl Invest Cient & Tecn, IADIZA, Av Ruiz Leal S-N,Parque Gen San Martin, Mendoza, Argentina.	cgiordano@mendoza-conicet.gob.ar	Bottini, Rubén/AAS-9320-2021; Stoffel, Markus/A-1793-2017	Stoffel, Markus/0000-0003-0816-1303; Gonzalez, Carina/0000-0003-3014-7129	Fondo para la Investigacion Cientifica y Tecnologica [PICT 2010-1755]; Secretaria de Ciencia, Tecnica y Posgrado, Universidad Nacional de Cuyo [M008]	Fondo para la Investigacion Cientifica y Tecnologica; Secretaria de Ciencia, Tecnica y Posgrado, Universidad Nacional de Cuyo	This work was funded by PICT 2010-1755 - Fondo para la Investigacion Cientifica y Tecnologica (http://www.agencia.mincyt.gob.ar/) to CVGiordano, and M008 - Secretaria de Ciencia, Tecnica y Posgrado, Universidad Nacional de Cuyo (http://www.uncuyo.edu.ar/ciencia_tecnica_y_posgrado/proyectos-de-investigacion) to CVGonzalez.	Arbellay E, 2012, J EXP BOT, V63, P3271, DOI 10.1093/jxb/ers050; Ballare CL, 2014, ANNU REV PLANT BIOL, V65, P335, DOI 10.1146/annurev-arplant-050213-040145; BALLARE CL, 1987, PLANT CELL ENVIRON, V10, P551, DOI 10.1111/1365-3040.ep11604091; Boccalandro HE, 2003, PLANT PHYSIOL, V133, P1539, DOI 10.1104/pp.103.029579; BUTTROSE M. S., 1969, Vitis, V8, P280; BUTTROSE MS, 1968, ANN BOT-LONDON, V32, P753, DOI 10.1093/oxfordjournals.aob.a084247; CARTECHINI A, 1995, AM J ENOL VITICULT, V46, P227; Casal JJ, 2013, ISRN AGRONOMY, V2013, P16; Casal JJ, 2013, ANNU REV PLANT BIOL, V64, P403, DOI 10.1146/annurev-arplant-050312-120221; Casal Jorge J, 2012, Arabidopsis Book, V10, pe0157, DOI 10.1199/tab.0157; Castellarin SD, 2007, PLANT CELL ENVIRON, V30, P1381, DOI 10.1111/j.1365-3040.2007.01716.x; CHAPPELLE EW, 1992, REMOTE SENS ENVIRON, V39, P239, DOI 10.1016/0034-4257(92)90089-3; Deluc LG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-212; Demotes-Mainard S, 2016, ENVIRON EXP BOT, V121, P4, DOI 10.1016/j.envexpbot.2015.05.010; Di Rienzo JA, 2002, J AGRIC BIOL ENVIR S, V7, P129, DOI 10.1198/10857110260141193; DOKOOZLIAN NK, 1995, AM J ENOL VITICULT, V46, P209; DOKOOZLIAN NK, 1995, AM J ENOL VITICULT, V46, P219; Downey MO, 2006, AM J ENOL VITICULT, V57, P257; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Franklin KA, 2005, ANN BOT-LONDON, V96, P169, DOI 10.1093/aob/mci165; Franklin KA, 2008, NEW PHYTOL, V179, P930, DOI 10.1111/j.1469-8137.2008.02507.x; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Galvao VC, 2015, CURR OPIN NEUROBIOL, V34, P46, DOI 10.1016/j.conb.2015.01.013; Gilbert IR, 2001, NATURE, V411, P792, DOI 10.1038/35081062; Gladstone EA, 2003, VITIS, V42, P123; Gommers CMM, 2013, TRENDS PLANT SCI, V18, P65, DOI 10.1016/j.tplants.2012.09.008; Heindl JC, 1983, PLANT PHYSL, V73; Keller M, 2010, SCIENCE OF GRAPEVINES: ANATOMY AND PHYSIOLOGY, P1; Kuhn N, 2013, J EXPT BOT; Kurepin LV, 2014, PLANT SCI, V229, P280, DOI 10.1016/j.plantsci.2014.10.006; Leicht SA, 2006, AM J BOT, V93, P972, DOI 10.3732/ajb.93.7.972; Libenson S, 2002, CROP SCI, V42, P1180, DOI 10.2135/cropsci2002.1180; Masciarelli O, 2014, MICROBIOL RES, V169, P609, DOI 10.1016/j.micres.2013.10.001; MORGAN DC, 1979, PLANTA, V145, P253, DOI 10.1007/BF00454449; OIV, 2011, VIN WIN OUTL; Palliotti A, 2000, AM J ENOL VITICULT, V51, P122; Pierik R, 2013, J EXPT BOT; Putz F, 2012, ECOLOGY INFO, V24; Robson PRH, 1996, NAT BIOTECHNOL, V14, P995, DOI 10.1038/nbt0896-995; Sanchez LA, 2005, AM J ENOL VITICULT, V56, P319; Schnitzer SA, 2002, TRENDS ECOL EVOL, V17, P223, DOI 10.1016/S0169-5347(02)02491-6; SCHOLANDER PF, 1965, SCIENCE, V148, P339, DOI 10.1126/science.148.3668.339; SCHULTE PJ, 1985, J EXP BOT, V36, P1590, DOI 10.1093/jxb/36.10.1590; SCHULTZ HR, 1993, PLANTA, V190, P393, DOI 10.1007/BF00196969; SMART RE, 1988, AM J ENOL VITICULT, V39, P250; Tambussi E., 2010, TECNICAS MEDICION EC, P129; Terral JF, 2010, ANN BOT-LONDON, V105, P443, DOI 10.1093/aob/mcp298; TYREE MT, 1982, CAN J BOT, V60, P911, DOI 10.1139/b82-117; Ugarte CC, 2010, J EXP BOT; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; Valladares F, 2011, ANN BOT-LONDON, V108, P231, DOI 10.1093/aob/mcr132; Gonzalez CV, 2015, PHYTOCHEMISTRY, V110, P46, DOI 10.1016/j.phytochem.2014.11.018; Gonzalez CV, 2012, PLANT CELL ENVIRON, V35, P1958, DOI 10.1111/j.1365-3040.2012.02529.x; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2	54	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167767	10.1371/journal.pone.0167767	http://dx.doi.org/10.1371/journal.pone.0167767			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911923	Green Published, gold			2022-12-27	WOS:000389520600051
J	Alajez, NM				Alajez, Nehad M.			Large-Scale Analysis of Gene Expression Data Reveals a Novel Gene Expression Signature Associated with Colorectal Cancer Distant Recurrence	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; PROGNOSTIC-SIGNIFICANCE; GENOMICS; INVASION; TUMORS	Colorectal cancer (CRC) is the fourth-ranked cause of cancer-related deaths worldwide. Despite recent advances in CRC management, distant recurrence (DR) remains the major cause of mortality in patients with preoperative chemotherapy and radiotherapy, underscoring a need to precisely identify novel gene signatures for predicting the risk of systemic relapse. Herein, we integrated two independent CRC gene expression datasets: the GSE71222 dataset, including 26 patients who developed DR and 126 patients who did not develop DR, and the GSE21510 dataset, including 23 patients who developed DR and 76 patients who did not develop DR. Our data revealed 37 common upregulated genes (fold change (FC) >= 1.5, P < 0.05) and three common downregulated genes (FC <= 1.5, P < 0.05) between DR and non-recurrent patients from the two datasets. We subsequently validated the upregulated gene panel in the Cancer Genome Atlas CRC datasets (379 patients), which identified a five-gene signature (S100A2, VIP, HOXC6, DACT1, KIF26B) associated with poor overall survival (OS, log-rank test P-value: 1.19 x 10(-4)) and poor disease-free survival (DFS, log-rank test P-value: 0.002). In a Cox proportional hazards multiple regression model, the five-gene signature and tumor stage retained their significance as independent prognostic factors for CRC DFS and OS. Therefore, our data identified a novel DR gene expression signature associated with worse prognosis in CRC.	[Alajez, Nehad M.] King Saud Univ, Dept Anat, Coll Med, Stem Cell Unit, Riyadh, Saudi Arabia	King Saud University	Alajez, NM (corresponding author), King Saud Univ, Dept Anat, Coll Med, Stem Cell Unit, Riyadh, Saudi Arabia.	nalajez@ksu.edu.sa		Alajez, Nehad/0000-0002-1546-1091	Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia	Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia	This work was supported by the Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-toub M, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0123-0; Al-toub M, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt325; Alajez NM, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.64; Alajez NM, 2016, SAUDI J GASTROENTERO, V22, P288, DOI 10.4103/1319-3767.187602; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458; Hamid ARAH, 2015, PROSTATE, V75, P1868, DOI 10.1002/pros.23065; Knijn N, 2016, AM J SURG PATHOL, V40, P103, DOI 10.1097/PAS.0000000000000518; Kumar M, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-014-0369-9; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Masuda T, 2016, INT J ONCOL, V48, P975, DOI 10.3892/ijo.2016.3329; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Schuetz CS, 2006, CANCER RES, V66, P5278, DOI 10.1158/0008-5472.CAN-05-4610; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Takahashi H, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1783-y; Tsai HL, 2008, J SURG ONCOL, V97, P383, DOI 10.1002/jso.20942; Tsukamoto S, 2011, CLIN CANCER RES, V17, P2444, DOI 10.1158/1078-0432.CCR-10-2884; Vishnubalaji R, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.556; Watanabe T, 2001, NEW ENGL J MED, V344, P1196, DOI 10.1056/NEJM200104193441603; Yuan GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034004	25	18	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167455	10.1371/journal.pone.0167455	http://dx.doi.org/10.1371/journal.pone.0167455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935967	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100100
J	Cautain, B; Castillo, F; Musso, L; Ferreira, BI; de Pedro, N; Quesada, LR; Machado, S; Vicente, F; Dallavalle, S; Link, W				Cautain, Bastien; Castillo, Francisco; Musso, Loana; Ferreira, Bibiana I.; de Pedro, Nuria; Quesada, Lorena Rodriguez; Machado, Susana; Vicente, Francisca; Dallavalle, Sabrina; Link, Wolfgang			Discovery of a Novel, Isothiazolonaphthoquinone-Based Small Molecule Activator of FOXO Nuclear-Cytoplasmic Shuttling	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTOR; DUAL-SPECIFICITY PHOSPHATASE; CYCLOADDITION REACTIONS; NITRILE SULFIDES; INHIBITORS; CANCER; TRANSLOCATION; SCREEN; POTENT; CELLS	FOXO factors are tumour suppressor proteins commonly inactivated in human tumours by posttranslational modifications. Furthermore, genetic variation within the FOXO3a gene is consistently associated with human longevity. Therefore, the pharmacological activation of FOXO proteins is considered as an attractive therapeutic approach to treat cancer and age-related diseases. In order to identify agents capable of activating FOXOs, we tested a collection of small chemical compounds using image-based high content screening technology. Here, we report the discovery of LOM612 (compound 1a), a newly synthesized isothiazolonaphthoquinone as a potent FOXO relocator. Compound 1a induces nuclear translocation of a FOXO3a reporter protein as well as endogenous FOXO3a and FOXO1 in U2OS cells in a dose-dependent manner. This activity does not affect the subcellular localization of other cellular proteins including NFkB or inhibit CRM1-mediated nuclear export. Furthermore, compound 1a shows a potent antiproliferative effect in human cancer cell lines.	[Cautain, Bastien; Castillo, Francisco; de Pedro, Nuria; Quesada, Lorena Rodriguez; Vicente, Francisca] Fdn MEDINA, Parque Tecnol Ciencias Salud, Granada, Spain; [Musso, Loana; Dallavalle, Sabrina] Univ Milan, DeFENS Dept Food Environm & Nutr Sci, I-20122 Milan, Italy; [Ferreira, Bibiana I.; Machado, Susana; Link, Wolfgang] Ctr Biomed Res CBMR, Gambelas Campus, Faro, Portugal; [Ferreira, Bibiana I.; Link, Wolfgang] Univ Algarve, Dept Biomed Sci & Med, Regenerat Med Program, Campus Gambelas, Faro, Portugal	University of Milan; Universidade do Algarve	Link, W (corresponding author), Ctr Biomed Res CBMR, Gambelas Campus, Faro, Portugal.; Link, W (corresponding author), Univ Algarve, Dept Biomed Sci & Med, Regenerat Med Program, Campus Gambelas, Faro, Portugal.	walink@ualg.pt	Machado, Susana/K-4033-2012; Link, Wolfgang/F-4435-2012; Dallavalle, Sabrina/AGY-7086-2022; Cautain, Bastien/W-1948-2018	Machado, Susana/0000-0002-3152-1701; Link, Wolfgang/0000-0002-3340-5165; Dallavalle, Sabrina/0000-0002-8813-8922; Cautain, Bastien/0000-0002-1324-3576; ferreira, Bibiana/0000-0003-4772-9395; Castillo Correa, Francisco Jose/0000-0001-5587-9612	Fundacao para a Ciencia e a Tecnologia (FCT) Research Center [UID/BIM/04773/2013 CBMR1334]; FCT [SFRH/BPD/100434/2014R]; ProRegem grant [PD/BD/114258/2016]	Fundacao para a Ciencia e a Tecnologia (FCT) Research Center; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); ProRegem grant	This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT) Research Center Grant UID/BIM/04773/2013 CBMR1334. B. I. Ferreira is the recipient of a FCT 2014 research grant SFRH/BPD/100434/2014R. S. Machado is the recipient of a ProRegem grant PD/BD/114258/2016.; This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT) Research Center Grant UID/BIM/04773/2013 CBMR1334. B. I. Ferreira is the recipient of a FCT 2014 research grant SFRH/BPD/100434/2014R. S. Machado is the recipient of a ProRegem grant PD/BD/114258/2016. We acknowledge COST Actions CM1106 (Chemical Approaches to Targeting Drug Resistance in Cancer Stem Cells) for facilitating the collaboration between chemists and biologists. We thank D. Pasarella for coordinating the COST Action CM1106. We are indebted to N. Martinet for organizing and handling the COST Action CM1106 compound collection.	Blagosklonny MV, 2012, ONCOTARGET, V3, P1711, DOI 10.18632/oncotarget.890; Blunt CE, 2015, ANGEW CHEM INT EDIT, V54, P8740, DOI 10.1002/anie.201503323; Brisson M, 2004, MOL PHARMACOL, V66, P824, DOI 10.1124/mol.104.001784; Brisson M, 2007, MOL PHARMACOL, V71, P184, DOI 10.1124/mol.106.028589; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Pham CD, 2013, ORG LETT, V15, P2230, DOI 10.1021/ol400791n; Cortes R, 2014, METALLOMICS, V6, P622, DOI 10.1039/c3mt00194f; Dansen TB, 2008, TRENDS CELL BIOL, V18, P421, DOI 10.1016/j.tcb.2008.07.004; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Feng X, 2011, AM SOC MICROBIOLOGY, V31, P3457, DOI 1042/BJ20040167; Ferreira BI, 2015, CANCER J, V21, P441, DOI 10.1097/PPO.0000000000000161; Granda TG, 2013, INVEST NEW DRUG, V31, P66, DOI 10.1007/s10637-012-9835-5; Hill R, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0482-y; HOFFMANN I, 1994, J CELL SCI, P75; Hogan IT, TETRAHEDRON PERGAMON; HOWE RK, 1978, J ORG CHEM, V43, P3736, DOI 10.1021/jo00413a024; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; John F C Ross, 2013, ARKIVOC, V2013, P372; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Kau TR, 2004, NAT REV CANCER, V4, P106, DOI 10.1038/nrc1274; Lazo JS, 2002, MOL PHARMACOL, V61, P720, DOI 10.1124/mol.61.4.720; Lazo JS, 2001, J MED CHEM, V44, P4042, DOI 10.1021/jm0102046; Link W, 2009, J BIOL CHEM, V284, P28392, DOI 10.1074/jbc.M109.038984; Martins R., 2015, AGING CELL; Martins RK, 2015, MOLECULAR INHIBITORS, V43; Mori M, 2014, CHEMMEDCHEM, V9, P973, DOI 10.1002/cmdc.201400044; Nakae K, 1999, J BIOMOL SCREEN, V4, P67; Nakae K, 2013, J NAT PROD, V76, P510, DOI 10.1021/np300643f; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Patel MN, 2013, NAT REV DRUG DISCOV, V12, P35, DOI 10.1038/nrd3913; PATON RM, 1980, J CHEM SOC CHEM COMM, P1194, DOI 10.1039/c39800001194; Peyregne VP, 2005, MOL CANCER THER, V4, P595; Reese CB, 2003, ORG BIOMOL CHEM, V1, P3160, DOI 10.1039/b306341k; SANDERS MJ, 1980, J ORG CHEM, V45, P3753, DOI 10.1021/jo01307a007; Shi F, 2006, ORG LETT, V8, P1411, DOI 10.1021/ol060207i; STRATMANN K, 1994, J ORG CHEM, V59, P6279, DOI 10.1021/jo00100a032; Tarrado-Castellarnau M, 2015, PHARM RES; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Webb AE, 2014, TRENDS BIOCHEM SCI, V39, P159, DOI 10.1016/j.tibs.2014.02.003; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Zanella F, 2010, CURR CANCER DRUG TAR, V10, P135, DOI 10.2174/156800910791054158; Zanella F, 2008, CHEMBIOCHEM, V9, P2229, DOI 10.1002/cbic.200800255; Zanella F, 2007, ASSAY DRUG DEV TECHN, V5, P333, DOI 10.1089/adt.2007.058; Zanella F, 2013, TRAFFIC, V14, P247, DOI 10.1111/tra.12034; Zanella F, 2010, TRENDS BIOTECHNOL, V28, P237, DOI 10.1016/j.tibtech.2010.02.005; Zanella F, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-14	48	19	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167491	10.1371/journal.pone.0167491	http://dx.doi.org/10.1371/journal.pone.0167491			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936162	Green Published, gold, Green Submitted			2022-12-27	WOS:000389587100109
J	Dunstan, RH; Sparkes, DL; Dascombe, BJ; Macdonald, MM; Evans, CA; Stevens, CJ; Crompton, MJ; Gottfries, J; Franks, J; Murphy, G; Wood, R; Roberts, TK				Dunstan, R. Hugh; Sparkes, Diane L.; Dascombe, Benjamin J.; Macdonald, Margaret M.; Evans, Craig A.; Stevens, Christopher J.; Crompton, Marcus J.; Gottfries, Johan; Franks, Jesse; Murphy, Grace; Wood, Ryan; Roberts, Timothy K.			Sweat Facilitated Amino Acid Losses in Male Athletes during Exercise at 32-34 degrees C	PLOS ONE			English	Article							HUMAN ECCRINE SWEAT; STRATUM-CORNEUM; PROTEIN; CHILDREN	Sweat contains amino acids and electrolytes derived from plasma and athletes can lose 1-2L of sweat per hour during exercise. Sweat may also contain contributions of amino acids as well as urea, sodium and potassium from the natural moisturizing factors (NMF) produced in the stratum corneum. In preliminary experiments, one participant was tested on three separate occasions to compare sweat composition with surface water washings from the same area of skin to assess contributions from NMF. Two participants performed a 40 minute self-paced cycle session with sweat collected from cleansed skin at regular intervals to assess the contributions to the sweat load from NMF over the period of exercise. The main study investigated sweat amino acid composition collected from nineteen male athletes following standardised endurance exercise regimes at 32-34 degrees C and 20-30% RH. Plasma was also collected from ten of the athletes to compare sweat and plasma composition of amino acids. The amino acid profiles of the skin washings were similar to the sweat, suggesting that the NMF could contribute certain amino acids into sweat. Since the sweat collected from athletes contained some amino acid contributions from the skin, this fluid was subsequently referred to as "faux" sweat. Samples taken over 40 minutes of exercise showed that these contributions diminished over time and were minimal at 35 minutes. In the main study, the faux sweat samples collected from the athletes with minimal NMF contributions, were characterised by relatively high levels of serine, histidine, ornithine, glycine and alanine compared with the corresponding levels measured in the plasma. Aspartic acid was detected in faux sweat but not in the plasma. Glutamine and proline were lower in the faux sweat than plasma in all the athletes. Three phenotypic groups of athletes were defined based on faux sweat volumes and composition profiles of amino acids with varying relative abundances of histidine, serine, glycine and ornithine. It was concluded that for some individuals, faux sweat resulting from exercise at 32-34 degrees C and 20-30% RH posed a potentially significant source of amino acid loss.	[Dunstan, R. Hugh; Sparkes, Diane L.; Macdonald, Margaret M.; Evans, Craig A.; Crompton, Marcus J.; Franks, Jesse; Murphy, Grace; Wood, Ryan; Roberts, Timothy K.] Univ Newcastle, Callaghan, NSW, Australia; [Dascombe, Benjamin J.] La Trobe Univ, Melbourne, Vic, Australia; [Stevens, Christopher J.] Southern Cross Univ, Sch Hlth & Human Sci, Coffs Harbour, NSW, Australia; [Gottfries, Johan] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	University of Newcastle; La Trobe University; Southern Cross University; University of Gothenburg	Dunstan, RH (corresponding author), Univ Newcastle, Callaghan, NSW, Australia.	hugh.dunstan@newcastle.edu.au	Roberts, Tim K/A-4286-2009; Stevens, Christopher/R-6258-2017	Stevens, Christopher/0000-0002-4641-0342; Dascombe, Ben/0000-0003-3374-3575	Harold Stannet Williams and Judith Mason Research Foundation; Gideon Lang Research Foundation	Harold Stannet Williams and Judith Mason Research Foundation; Gideon Lang Research Foundation	This work was funded by the Harold Stannet Williams and Judith Mason Research Foundation [http//www.anz.com/resources/2/f/2fce2b804a47773887c8cfac93b0266b/20140109_MasonNatMedGuidelines.pdf?MOD-AJPERES] and the Gideon Lang Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG MD, 1973, METABOLISM, V22, P561, DOI 10.1016/0026-0495(73)90069-3; BOOTH FW, 1985, FED PROC, V44, P2293; BURKE RC, 1966, YALE J BIOL MED, V38, P355; Dunstan R. H., 2014, Food and Nutrition Sciences, V5, P231, DOI 10.4236/fns.2014.52028; Dunstan RH, 2015, COMP EXERC PHYSIOL, V11, P201, DOI 10.3920/CEP150027; Embden G, 1910, BIOCHEM Z, V28, P230; Evans C, 2008, NUTR NEUROSCI, V11, P9, DOI 10.1179/147683008X301360; GITLITZ PH, 1974, CLIN CHEM, V20, P1305; HIER SW, 1946, J BIOL CHEM, V166, P327; Kutyshenko VP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028824; LACEY JM, 1990, NUTR REV, V48, P297, DOI 10.1111/j.1753-4887.1990.tb02967.x; LIAPPIS N, 1979, EUR J APPL PHYSIOL, V42, P227, DOI 10.1007/BF00423292; LIAPPIS N, 1972, AM J CLIN NUTR, V25, P661; MacIntosh BR, 2002, CAN J APPL PHYSIOL, V27, P42, DOI 10.1139/h02-003; Mark H, 2013, INT J COSMETIC SCI, V35, P163, DOI 10.1111/ics.12019; Maughan RJ, 2007, INT J SPORT NUTR EXE, V17, P583, DOI 10.1123/ijsnem.17.6.583; McSWINEY B. A., 1934, PROC ROY SOC MED, V27, P839; MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543; Phillips SM, 2004, NUTRITION, V20, P689, DOI 10.1016/j.nut.2004.04.009; Phillips SM, 1999, AM J PHYSIOL-ENDOC M, V276, pE118; RAWLINGS AV, 1994, J INVEST DERMATOL, V103, P731, DOI 10.1111/1523-1747.ep12398620; Rawlings AV, 2004, DERMATOLOGIC THERAPY; ROBINSON S, 1954, PHYSIOL REV, V34, P202, DOI 10.1152/physrev.1954.34.2.202; SATO K, 1983, AM J PHYSIOL, V245, pR203, DOI 10.1152/ajpregu.1983.245.2.R203; SCOTT IR, 1982, BIOCHIM BIOPHYS ACTA, V719, P110, DOI 10.1016/0304-4165(82)90314-2; Stevens CJ, 2013, J SPORT SCI, V31, P1271, DOI 10.1080/02640414.2013.779740; Tipton KD, 2001, INT J SPORT NUTR EXE, V11, P109, DOI 10.1123/ijsnem.11.1.109; Weschler LB, 2008, J APPL PHYSIOL, V105, P1376, DOI 10.1152/japplphysiol.00924.2007; WHO, 2007, WHO TECH REP SER, V935, P1	29	21	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167844	10.1371/journal.pone.0167844	http://dx.doi.org/10.1371/journal.pone.0167844			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936120	gold, Green Published, Green Submitted			2022-12-27	WOS:000389587100213
J	Grasso, R; Abe, T; Cirrone, GAP; Cuttone, G; Gulino, M; Musumeci, F; Romano, F; Ryuto, H; Scordino, A				Grasso, Rosaria; Abe, Tomoko; Cirrone, Giuseppe A. P.; Cuttone, Giacomo; Gulino, Marisa; Musumeci, Francesco; Romano, Francesco; Ryuto, Hiromichi; Scordino, Agata			Effects of Ion Irradiation on Seedlings Growth Monitored by Ultraweak Delayed Luminescence	PLOS ONE			English	Article							HADRON THERAPY; CANCER; QUALITY; MUTANTS; HARVEST; DAMAGE	The optical technique based on the measurement of delayed luminescence emitted from the biological samples has demonstrated its ability to provide valid and predictive information on the functional status of various biological systems. We want to extend this technique to study the effect of ionizing radiation on biological systems. In particular we are interested in the action of ion beams, used for therapeutic purposes or to increase the biological diversity. In general, the assessment of the damage that radiation produces both in the target objects and in the surrounding tissues, requires considerable time because is based on biochemical analysis or on the examination of the evolution of the irradiated systems. The delayed luminescence technique could help to simplify this investigation. We have so started our studies performing irradiations of some relatively simple vegetable models. In this paper we report results obtained from mung bean (Vigna radiata) seeds submitted to a C-12 ion beam at the energy of 62 MeV/nucleon. The dry seeds were irradiated at doses from 50 to 7000 Gy. The photoinduced delayed luminescence of each seed before and after ion irradiation was measured. The growth of seedlings after irradiation was compared with that of untreated seeds. A growth reduction on increasing the dose was registered. The results show strong correlations between the ion irradiation dose, seeds growth and delayed luminescence intensity. In particular, the delayed luminescence intensity is correlated by a logistic function to the seedlings elongation and, after performing a suitable measurement campaign based on blind tests, it could become a tool able to predict the growth of seeds after ion irradiation. Moreover these results demonstrate that measurements of delayed luminescence could be used as a fast and non-invasive technique to check the effects of ion beams on relatively simple biological systems.	[Grasso, Rosaria; Musumeci, Francesco; Scordino, Agata] Catania Univ, Dept Phys & Astron, Catania, Italy; [Grasso, Rosaria; Cirrone, Giuseppe A. P.; Cuttone, Giacomo; Gulino, Marisa; Musumeci, Francesco; Romano, Francesco; Scordino, Agata] Ist Nazl Fis Nucl Catania, Lab Nazl Sud, Catania, Italy; [Abe, Tomoko] RIKEN Nishina Ctr, Wako, Saitama, Japan; [Gulino, Marisa] Univ Enna Kore, Fac Ingn & Architettura, Enna, Italy; [Ryuto, Hiromichi] Kyoto Univ, Photon & Elect Sci & Engn Ctr, Kyoto, Japan	University of Catania; Istituto Nazionale di Fisica Nucleare (INFN); RIKEN; Universita Kore di ENNA; Kyoto University	Grasso, R (corresponding author), Catania Univ, Dept Phys & Astron, Catania, Italy.; Grasso, R (corresponding author), Ist Nazl Fis Nucl Catania, Lab Nazl Sud, Catania, Italy.	grasso@lns.infn.it	Grasso, Rosaria/A-9143-2012; Grasso, Rosaria/AAH-1726-2019; Gulino, Marisa/AAC-4620-2021; Cirrone, Giuseppe/AAF-7101-2021; Romano, Francesco Paolo/F-9896-2014	Grasso, Rosaria/0000-0003-4864-9880; Cirrone, Giuseppe/0000-0001-5733-9281; Romano, Francesco Paolo/0000-0003-4932-4455; Cuttone, Giacomo/0000-0002-9534-4855				Abe T, 2002, J RADIAT RES, V43, pS157; Baran I, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.127006; Baskar R, 2012, INT J MED SCI, V9, P193, DOI 10.7150/ijms.3635; Blakely EA, 2004, RADIOTHER ONCOL, V73, pS134, DOI 10.1016/S0167-8140(04)80035-5; Brizhik L, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.021902; Brizhik L, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.031902; Choi J, 2012, RADIAT ONCOL J, V30, P1, DOI 10.3857/roj.2012.30.1.1; Costanzo E, 2008, EUR BIOPHYS J BIOPHY, V37, P235, DOI 10.1007/s00249-007-0221-8; Habermehl D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113591; Ho M.-W., 1995, NEURONETWORK WORLD, V5, P733; Honda I, 2006, EUPHYTICA, V152, P61, DOI 10.1007/s10681-006-9177-5; Hsu BD, 2007, PLANT SCI, V172, P604, DOI 10.1016/j.plantsci.2006.11.006; Lanzano L, 2009, LUMINESCENCE, V24, P409, DOI 10.1002/bio.1127; LI KH, 1983, PHYS LETT A, V93, P262; Liu YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085323; Lodge M, 2007, RADIOTHER ONCOL, V83, P110, DOI 10.1016/j.radonc.2007.04.007; Morishita T, 2003, NUCL INSTRUM METH B, V206, P565, DOI 10.1016/S0168-583X(03)00826-7; Niggli HJ, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1899185; Niggli HJ, 2014, J ELECT ELECT SYST, V3, P126, DOI DOI 10.4172/2332-0796.1000126; Pelaz L, 2004, J APPL PHYS, V96, P5947, DOI 10.1063/1.1808484; Saeys W, 2008, APPL OPTICS, V47, P908, DOI 10.1364/AO.47.000908; Schulz-Ertner D, 2007, J CLIN ONCOL, V25, P953, DOI 10.1200/JCO.2006.09.7816; Scordino A, 2000, J PHOTOCH PHOTOBIO B, V56, P181, DOI 10.1016/S1011-1344(00)00078-6; Scordino A, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.11.117005; Scordino A, 2014, J PHOTOCH PHOTOBIO B, V139, P76, DOI 10.1016/j.jphotobiol.2014.03.027; Southworth-Davies RJ, 2007, STRUCTURE, V15, P1531, DOI 10.1016/j.str.2007.10.013; Subedi PP, 2007, POSTHARVEST BIOL TEC, V43, P326, DOI 10.1016/j.postharvbio.2006.09.012; Wang TJC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136307; Yu ZL, 2000, IEEE T PLASMA SCI, V28, P128, DOI 10.1109/27.842882; Zhang BP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112624; Zude M, 2007, POSTHARVEST BIOL TEC, V45, P30, DOI 10.1016/j.postharvbio.2007.01.010	31	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167998	10.1371/journal.pone.0167998	http://dx.doi.org/10.1371/journal.pone.0167998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936220	Green Published, Green Submitted, gold			2022-12-27	WOS:000389587100246
J	Hong, S; Rovira, A; Davies, P; Ahlstrom, C; Muellner, P; Rendahl, A; Olsen, K; Bender, JB; Wells, S; Perez, A; Alvarez, J				Hong, Samuel; Rovira, Albert; Davies, Peter; Ahlstrom, Christina; Muellner, Petra; Rendahl, Aaron; Olsen, Karen; Bender, Jeff B.; Wells, Scott; Perez, Andres; Alvarez, Julio			Serotypes and Antimicrobial Resistance in Salmonella enterica Recovered from Clinical Samples from Cattle and Swine in Minnesota, 2006 to 2015	PLOS ONE			English	Article							FOOD ANIMALS; CAMPYLOBACTER-JEJUNI; MONITORING-SYSTEM; UNITED-STATES; NONTYPHOIDAL SALMONELLA; HUMAN HEALTH; TYPHIMURIUM; PATHOGENS; CONSEQUENCES; EPIDEMIOLOGY	Salmonellosis remains one of the leading causes of foodborne disease worldwide despite preventive efforts at various stages of the food production chain. The emergence of multi drug resistant (MDR) non-typhoidal Salmonella enterica represents an additional challenge for public health authorities. Food animals are considered a major reservoir and potential source of foodborne salmonellosis; thus, monitoring of Salmonella strains in livestock may help to detect emergence of new serotypes/MDR phenotypes and to gain a better understanding of Salmonella epidemiology. For this reason, we analyzed trends over a nine-year period in serotypes, and antimicrobial resistance, of Salmonella isolates recovered at the Minnesota Veterinary Diagnostic Laboratory (MVDL) from swine (n = 2,537) and cattle (n = 1,028) samples. Prevalence of predominant serotypes changed over time; in swine, S. Typhimurium and S. Derby decreased and S. Agona and S. 4,5,12:i:-increased throughout the study period. In cattle, S. Dublin, S. Montevideo and S. Cerro increased and S. Muenster became less frequent. Median minimum inhibitory concentration (MIC) values and proportion of antibiotic resistant isolates were higher for those recovered from swine compared with cattle, and were particularly high for certain antibiotic-serotype combinations. The proportion of resistant swine isolates was also higher than observed in the NARMS data, probably due to the different cohort of animals represented in each dataset. Results provide insight into the dynamics of antimicrobial resistant Salmonella in livestock in Minnesota, and can help to monitor emerging trends in antimicrobial resistance.	[Hong, Samuel; Davies, Peter; Bender, Jeff B.; Wells, Scott; Perez, Andres; Alvarez, Julio] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Rovira, Albert; Olsen, Karen] Univ Minnesota, Coll Vet Med, Vet Diagnost Lab, St Paul, MN 55108 USA; [Ahlstrom, Christina; Muellner, Petra] Epiinteract, Wellington, New Zealand; [Rendahl, Aaron] Univ Minnesota, Sch Stat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Alvarez, J (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA.	jalvarez@umn.edu	Hong, Samuel Leandro/ABC-7942-2020; Alvarez, Julio/H-8292-2013; Perez, Andres/HGD-8377-2022	Hong, Samuel Leandro/0000-0001-6354-4943; Alvarez, Julio/0000-0002-8999-9417; Bender, Jeffrey/0000-0003-4645-9936; Rendahl, Aaron/0000-0001-5434-3592	Global Food Venture MNDrive initiative; Alberta Innovates [201401123] Funding Source: researchfish	Global Food Venture MNDrive initiative; Alberta Innovates	This work was supported by Global Food Venture MNDrive initiative (https.//mndrive.umn.edu/food/projects) JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson Joseph H, 2004, Epidemiol Perspect Innov, V1, P6, DOI 10.1186/1742-5573-1-6; Aerts M, 2011, SCI REPORT SUBMITTED; Altman D.G., 1991, PRACTICAL STATISTIC; Angulo FJ, 2004, REV SCI TECH OIE, V23, P485; Angulo FJ, 2004, J VET MED B, V51, P374, DOI 10.1111/j.1439-0450.2004.00789.x; Angulo FJ, 2000, MICROB DRUG RESIST, V6, P77, DOI 10.1089/mdr.2000.6.77; Batz M, 2014, FOODBORNE PATHOG DIS, V11, P395, DOI 10.1089/fpd.2013.1658; Bjork KE, 2015, PREV VET MED, V122, P265, DOI 10.1016/j.prevetmed.2015.10.010; CDC, 2012, NAT ANT RES MON SYST; CDC, 2013, NAT ANT RES MON SYST; CDC, 2012, SALM ANN REP; CDC, 2019, NAT ANT RES MON SYST; CDC, 2013, ANTIBIOTIC RESISTANC; CDC, OUTBR MULT RES SALM; Chen S, 2004, APPL ENVIRON MICROB, V70, P1, DOI 10.1128/AEM.70.1.1-7.2004; Cito F, 2013, OUTBREAK UNUSUAL SAL; CLSI, 2012, M100S22 CLSI, V32; Cochrane D, 1949, J AM STAT ASS, V44; Davis MA, 1999, EMERG INFECT DIS, V5, P802, DOI 10.3201/eid0506.990610; DOHOO I, 2003, VET EPIDEMIOLOGIC RE, P391; Douris A, 2008, MICROB DRUG RESIST, V14, P55, DOI 10.1089/mdr.2008.0787; FDA, 2015, NARMS NOW INT DAT HA; FDA, 2008, FED REG, V73, P1; FDA, NARMS INT RERP 2012; FEINSINGER P, 1981, ECOLOGY, V62, P27, DOI 10.2307/1936664; Foley S L, 2008, J Anim Sci, V86, pE149; Frye JG, 2007, INT J ANTIMICROB AG, V30, P134, DOI 10.1016/j.ijantimicag.2007.03.013; Frye JG, 2008, MICROB DRUG RESIST, V14, P251, DOI 10.1089/mdr.2008.0844; Garcia L. S., 2010, CLIN MICROBIOLOGY PR; Garrett N, 2007, J APPL MICROBIOL, V103, P2113, DOI 10.1111/j.1365-2672.2007.03437.x; Gilbert JM, 2007, FUTURE MICROBIOL, V2, P493, DOI 10.2217/17460913.2.5.493; Gilliss D, 2013, MMWR-MORBID MORTAL W, V62, P283; Gossner CM, 2012, EURO SURVEILL, V17; Gray JT, 2004, ANTIMICROB AGENTS CH, V48, P3179, DOI 10.1128/AAC.48.8.3179-3181.2004; Guerrant RL, 2001, CLIN INFECT DIS, V32, P331, DOI 10.1086/318514; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457; Hopkins K L, 2010, Euro Surveill, V15, P19580; Landers TF, 2012, PUBLIC HEALTH REP, V127, P4, DOI 10.1177/003335491212700103; Muellner P, 2011, PREV VET MED, V102, P242, DOI 10.1016/j.prevetmed.2011.07.011; Mullner P, 2010, APPL ENVIRON MICROB, V76, P2145, DOI 10.1128/AEM.00862-09; Mullner P, 2009, INFECT GENET EVOL, V9, P1311, DOI 10.1016/j.meegid.2009.09.003; Nielsen LR, 2013, VET MICROBIOL, V162, P1, DOI 10.1016/j.vetmic.2012.08.003; Oksanen J., 2007, COMMUNITY ECOL PACKA, V10; Perron GG, 2007, INFECT GENET EVOL, V7, P223, DOI 10.1016/j.meegid.2006.09.003; Phillips I, 2004, J ANTIMICROB CHEMOTH, V53, P28, DOI 10.1093/jac/dkg483; Rigney CP, 2004, JAVMA-J AM VET MED A, V224, P524, DOI 10.2460/javma.2004.224.524; ROSEF O, 1985, APPL ENVIRON MICROB, V49, P1507, DOI 10.1128/AEM.49.6.1507-1510.1985; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Switt AIM, 2009, FOODBORNE PATHOG DIS, V6, P407, DOI 10.1089/fpd.2008.0213; Team RC, 2014, R LANG ENV STAT COMP; Travers K, 2002, CLIN INFECT DIS, V34, pS131, DOI 10.1086/340251; USDA, 2011, NAT ANT RES MON SYST; Varma JK, 2005, J INFECT DIS, V191, P554, DOI 10.1086/427263; Velge P, 2005, VET RES, V36, P267, DOI 10.1051/vetres:2005005; World Health Organization [WHO], 2015, ESTIMATES GLOBAL BUR; Zhao S, 2007, VET MICROBIOL, V123, P122, DOI 10.1016/j.vetmic.2007.03.001; Zhao S, 2005, FOODBORNE PATHOG DIS, V2, P169, DOI 10.1089/fpd.2005.2.169	58	41	44	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168016	10.1371/journal.pone.0168016	http://dx.doi.org/10.1371/journal.pone.0168016			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936204	gold, Green Submitted, Green Published			2022-12-27	WOS:000389587100252
J	Irum, B; Khan, SY; Ali, M; Daud, M; Kabir, F; Rauf, B; Fatima, F; Iqbal, H; Khan, AO; Al Obaisi, S; Naeem, MA; Nasir, IA; Khan, SN; Husnain, T; Riazuddin, S; Akram, J; Eghrari, AO; Riazuddin, SA				Irum, Bushra; Khan, Shahid Y.; Ali, Muhammad; Daud, Muhammad; Kabir, Firoz; Rauf, Bushra; Fatima, Fareeha; Iqbal, Hira; Khan, Arif O.; Al Obaisi, Saif; Naeem, Muhammad Asif; Nasir, Idrees A.; Khan, Shaheen N.; Husnain, Tayyab; Riazuddin, Sheikh; Akram, Javed; Eghrari, Allen O.; Riazuddin, S. Amer			Deletion at the GCNT2 Locus Causes Autosomal Recessive Congenital Cataracts	PLOS ONE			English	Article							ADULT-I-PHENOTYPE; CONSANGUINEOUS PAKISTANI FAMILIES; ANTIGEN-EXPRESSION; MOLECULAR-GENETICS; NONSENSE MUTATION; ASSOCIATION; LINKAGE; CELLS; MAPS; LENS	Purpose The aim of this study is to identify the molecular basis of autosomal recessive congenital cataracts (arCC) in a large consanguineous pedigree. Methods All participating individuals underwent a detailed ophthalmic examination. Each patient's medical history, particularly of cataracts and other ocular abnormalities, was compiled from available medical records and interviews with family elders. Blood samples were donated by all participating family members and used to extract genomic DNA. Genetic analysis was performed to rule out linkage to known arCC loci and genes. Whole-exome sequencing libraries were prepared and paired-end sequenced. A large deletion was found that segregated with arCC in the family, and chromosome walking was conducted to estimate the proximal and distal boundaries of the deletion mutation. Results Exclusion and linkage analysis suggested linkage to a region of chromosome 6p24 harboring GCNT2 (glucosaminyl (N-acetyl) transferase 2) with a two-point logarithm of odds score of 5.78. PCR amplifications of the coding exons of GCNT2 failed in individuals with arCC, and whole-exome data analysis revealed a large deletion on chromosome 6p in the region harboring GCNT2. Chromosomal walking using multiple primer pairs delineated the extent of the deletion to approximately 190 kb. Interestingly, a failure to amplify a junctional fragment of the deletion break strongly suggests an insertion in addition to the large deletion. Conclusion Here, we report a novel insertion/deletion mutation at the GCNT2 locus that is responsible for congenital cataracts in a large consanguineous family.	[Irum, Bushra; Khan, Shahid Y.; Ali, Muhammad; Daud, Muhammad; Kabir, Firoz; Rauf, Bushra; Eghrari, Allen O.; Riazuddin, S. Amer] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD USA; [Irum, Bushra; Rauf, Bushra; Fatima, Fareeha; Iqbal, Hira; Naeem, Muhammad Asif; Nasir, Idrees A.; Khan, Shaheen N.; Husnain, Tayyab; Riazuddin, Sheikh] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore, Pakistan; [Khan, Arif O.; Al Obaisi, Saif] King Khalid Eye Specialist Hosp, Riyadh, Saudi Arabia; [Riazuddin, Sheikh; Akram, Javed] Univ Hlth Sci, Allama Iqbal Med Coll, Lahore, Pakistan; [Riazuddin, Sheikh; Akram, Javed] Shaheed Zulfiqar Ali Bhutto Med Univ, Natl Ctr Genet Dis, Islamabad, Pakistan; [Riazuddin, S. Amer] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; King Khaled Eye Specialist Hospital; University of Health Science - Pakistan; Johns Hopkins University	Riazuddin, SA (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD USA.; Riazuddin, SA (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA.	riazuddin@jhmi.edu	Husnain, Tayyab/AAE-9033-2019; Iqbal, Hira/B-1283-2012; Eghrari, Allen/AAI-9282-2021; Nasir, Idrees Ahmad/T-7695-2019; Eghrari, Allen/ABH-4964-2020	Iqbal, Hira/0000-0002-1286-4880; Eghrari, Allen/0000-0003-2798-038X; Naeem, Muhammad Asif/0000-0001-8547-6419	National Eye Institute [R01EY022714]; Knights Templar Eye Foundation; King Khaled Eye Specialist Hospital-Johns Hopkins University; National Academy of Sciences, Washington DC USA; Higher Education Commission, Islamabad Pakistan; NATIONAL EYE INSTITUTE [R01EY022714] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Knights Templar Eye Foundation; King Khaled Eye Specialist Hospital-Johns Hopkins University; National Academy of Sciences, Washington DC USA; Higher Education Commission, Islamabad Pakistan(Higher Education Commission of Pakistan); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported in part by the National Eye Institute, grant R01EY022714 (SAR), the Knights Templar Eye Foundation grant (SAR), King Khaled Eye Specialist Hospital-Johns Hopkins University collaboration grant (SAR), the National Academy of Sciences, Washington DC USA, and the Higher Education Commission, Islamabad Pakistan. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Safieh L, 2009, MOL VIS, V15, P980; Aldahmesh MA, 2012, GENET MED, V14, P955, DOI 10.1038/gim.2012.86; Aldahmesh MA, 2012, HUM MUTAT, V33, P960, DOI 10.1002/humu.22071; Apple DJ, 2000, SURV OPHTHALMOL, V45, pS5; Bermejo E, 1998, AM J MED GENET, V75, P497, DOI 10.1002/(SICI)1096-8628(19980217)75:5<497::AID-AJMG8>3.0.CO;2-K; Borck G, 2012, HUM GENET, V131, P209, DOI 10.1007/s00439-011-1062-1; Butt T, 2007, MOL VIS, V13, P1635; Chen GY, 2005, MOL CELL BIOL, V25, P7828, DOI 10.1128/MCB.25.17.7828-7838.2005; Chen JJ, 2011, AM J HUM GENET, V88, P827, DOI 10.1016/j.ajhg.2011.05.008; Cohen D, 2007, INVEST OPHTH VIS SCI, V48, P2208, DOI 10.1167/iovs.06-1019; FUKUDA M, 1986, J BIOL CHEM, V261, P2796; FUKUDA M, 1979, J BIOL CHEM, V254, P3700; Gilbert C, 2001, B WORLD HEALTH ORGAN, V79, P227; Gill D, 2000, INVEST OPHTH VIS SCI, V41, P159; Heon E, 2001, AM J HUM GENET, V68, P772, DOI 10.1086/318798; Inaba N, 2003, BLOOD, V101, P2870, DOI 10.1182/blood-2002-09-2838; Jiao XD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157005; Jiaox X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137973; Kaul H, 2010, MOL VIS, V16, P511; Kaul H, 2010, MOL VIS, V16, P240; Khan SY, 2015, INVEST OPHTH VIS SCI, V56, P4919, DOI 10.1167/iovs.14-16253; Khan SY, 2016, EXP EYE RES; Lachke SA, 2011, SCIENCE, V331, P1571, DOI 10.1126/science.1195970; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lin M, 2006, TRANSFUSION, V46, P1982, DOI 10.1111/j.1537-2995.2006.01006.x; MARSH WL, 1960, NATURE, V188, P753, DOI 10.1038/188753a0; Ponnam SPG, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.050138; Pras E, 2000, INVEST OPHTH VIS SCI, V41, P3511; Pras E, 2004, INVEST OPHTH VIS SCI, V45, P1940, DOI 10.1167/iovs.03-1117; Pras E, 2002, AM J HUM GENET, V70, P1363, DOI 10.1086/340318; Pras E, 2001, ISR MED ASSOC J, V3, P559; Ramachandran RD, 2007, HUM GENET, V121, P475, DOI 10.1007/s00439-006-0319-6; Riazuddin SA, 2005, INVEST OPHTH VIS SCI, V46, P2100, DOI 10.1167/iovs.04-1481; Riazuddin SA, 2005, INVEST OPHTH VIS SCI, V46, P623, DOI 10.1167/iovs.04-0955; Sabir N, 2010, MOL VIS, V16, P2911; Sabir N, 2010, MOL VIS, V16, P2634; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Shiels A, 2013, CLIN GENET, V84, P120, DOI 10.1111/cge.12182; Shiels A, 2010, MOL VIS, V16, P2007; Smaoui N, 2004, INVEST OPHTH VIS SCI, V45, P2716, DOI 10.1167/iovs.03-1370; WATANABE K, 1979, J BIOL CHEM, V254, P3221; WIENER AS, 1956, ANN INTERN MED, V44, P221, DOI 10.7326/0003-4819-44-2-221; Wride MA, 2011, PHILOS T R SOC B, V366, P1219, DOI 10.1098/rstb.2010.0324; Wussuki-Lior O, 2011, MOL VIS, V17, P1011; YAMAGUCH.H, 1972, P JPN ACAD, V48, P625, DOI 10.2183/pjab1945.48.625; Yasmeen A, 2010, MOL VIS, V16, P682; Yu LC, 2003, BLOOD, V101, P2081, DOI 10.1182/blood-2002-09-2693; Yu LC, 2001, BLOOD, V98, P3840, DOI 10.1182/blood.V98.13.3840; Yu LC, 2011, CURR OPIN HEMATOL, V18, P421, DOI 10.1097/MOH.0b013e32834baae9; Zhao L, 2015, NATURE, V523, P607, DOI 10.1038/nature14650	50	7	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167562	10.1371/journal.pone.0167562	http://dx.doi.org/10.1371/journal.pone.0167562			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936067	Green Submitted, gold, Green Published			2022-12-27	WOS:000389587100125
J	Milicevic, NM; Nohroudi, K; Schmidt, F; Schmidt, H; Ringer, C; Sorensen, GL; Milicevic, Z; Westermann, J				Milicevic, Novica M.; Nohroudi, Klaus; Schmidt, Friederike; Schmidt, Hendrik; Ringer, Cornelia; Sorensen, Grith Lykke; Milicevic, Zivana; Westermann, Juergen			Growth of Murine Splenic Tissue Is Suppressed by Lymphotoxin beta-Receptor Signaling (LT beta R) Originating from Splenic and Non-Splenic Tissues	PLOS ONE			English	Article							MICROFIBRIL-ASSOCIATED GLYCOPROTEIN; TUMOR-NECROSIS-FACTOR; T-CELL HOMEOSTASIS; LYMPH-NODE; SECRETORY LYSOSOMES; MESSENGER-RNA; PROTEIN 4; EXPRESSION; SECONDARY; MFAP4	Development and maintenance of secondary lymphoid organs such as lymph nodes and spleen essentially depend on lymphotoxin beta-receptor (LT beta R) signaling. It is unclear, however, by which molecular mechanism their size is limited. Here, we investigate whether the LT beta R pathway is also growth suppressing. By using splenic tissue transplantation it is possible to analyze a potential contribution of LT beta R signaling inside and outside of the implanted tissue. We show that LT beta R signaling within the endogenous spleen and within non-splenic tissues both significantly suppressed the regeneration of implanted splenic tissue. The suppressive activity positively correlated with the total number of LT beta R expressing cells in the animal (regenerate weights of 115 +/- 8 mg in LT beta R deficient recipients and of 12 +/- 9 mg in wild-type recipients), affected also developed splenic tissue, and was induced but not executed via LT beta R signaling. Two-dimensional differential gel electrophoresis and subsequent mass spectrometry of stromal splenic tissue was applied to screen for potential factors mediating the LT beta R dependent suppressive activity. Thus, LT beta R dependent growth suppression is involved in regulating the size of secondary lymphoid organs, and might be therapeutically used to eradicate tertiary lymphoid tissues during autoimmune diseases.	[Milicevic, Novica M.; Milicevic, Zivana] Univ Belgrade, Inst Histol & Embryol, Fac Med, Beograd, Serbia; [Nohroudi, Klaus] Univ Cologne, Dept Anat 1, Cologne, Germany; [Schmidt, Friederike; Schmidt, Hendrik; Ringer, Cornelia; Westermann, Juergen] Univ Lubeck, Ctr Struct & Cell Biol Med, Inst Anat, Lubeck, Germany; [Sorensen, Grith Lykke] Univ Southern Denmark, Inst Mol Med, Dept Canc & Inflammat, Odense, Denmark	University of Belgrade; University of Cologne; University of Lubeck; University of Southern Denmark	Westermann, J (corresponding author), Univ Lubeck, Ctr Struct & Cell Biol Med, Inst Anat, Lubeck, Germany.	westermann@anat.uni-luebeck.de		Sorensen, Grith Lykke/0000-0002-5273-1097	Ministry for Education, Science and Technological Development of Republic of Serbia [175005]; Alexander von Humboldt-Foundation [DEU/1033146]; Deutsche Forschungsgemeinschaft [SFB 654]; Lundbeck Foundation [R67-2010-6409, R108-2012-10802, R164-2013-15355] Funding Source: researchfish; Novo Nordisk Fonden [NNF16OC0021136] Funding Source: researchfish	Ministry for Education, Science and Technological Development of Republic of Serbia; Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	NMM: Ministry for Education, Science and Technological Development of Republic of Serbia; grant number: 175005; http://www.mpn.gov.rs and Alexander von Humboldt-Foundation; grant number: DEU/1033146; https://www.humboldt-foundation.de. JW: Deutsche Forschungsgemeinschaft; grant number: SFB 654, C4; http://www.dfg.de/.	Almeida ARM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00125; Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Aoki K, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-99; Banczyk D, 2014, EUR J IMMUNOL, V44, P93, DOI 10.1002/eji.201343811; Bell EB, 2008, TRENDS IMMUNOL, V29, P405, DOI 10.1016/j.it.2008.06.002; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Boehm T, 2014, ANNU REV ANIM BIOSCI, V2, P259, DOI 10.1146/annurev-animal-022513-114201; Boulianne B, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00243; Browning JL, 2005, IMMUNITY, V23, P539, DOI 10.1016/j.immuni.2005.10.002; Browning JL, 2002, J IMMUNOL, V168, P5079, DOI 10.4049/jimmunol.168.10.5079; Carragher DM, 2008, SEMIN IMMUNOL, V20, P26, DOI 10.1016/j.smim.2007.12.004; Chyou S, 2011, J IMMUNOL, V187, P5558, DOI 10.4049/jimmunol.1101724; Cupedo T, 2004, IMMUNITY, V21, P655, DOI 10.1016/j.immuni.2004.09.006; Cyster JG, 2014, J IMMUNOL, V192, P2007, DOI 10.4049/jimmunol.1400059; De Trez C, 2008, J IMMUNOL, V180, P238, DOI 10.4049/jimmunol.180.1.238; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Dummer W, 2001, J IMMUNOL, V166, P2460, DOI 10.4049/jimmunol.166.4.2460; Endres R, 1999, J EXP MED, V189, P159, DOI 10.1084/jem.189.1.159; Ettinger R, 1996, P NATL ACAD SCI USA, V93, P13102, DOI 10.1073/pnas.93.23.13102; FORCE WR, 1995, J IMMUNOL, V155, P5280; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Gommerman JL, 2003, NAT REV IMMUNOL, V3, P642, DOI 10.1038/nri1151; Grabner R, 2009, J EXP MED, V206, P233, DOI 10.1084/jem.20080752; Hrebicek T, 2007, ELECTROPHORESIS, V28, P1161, DOI 10.1002/elps.200600639; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Kalies K, 2008, J IMMUNOL, V180, P5457, DOI 10.4049/jimmunol.180.8.5457; KOBAYASHI R, 1994, BIOCHEM BIOPH RES CO, V198, P1262, DOI 10.1006/bbrc.1994.1178; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Koroleva EP, 2016, CYTOKINE IN PRESS; Kumar V, 2015, IMMUNITY, V42, P719, DOI 10.1016/j.immuni.2015.03.015; Kumar V, 2010, BLOOD, V115, P4725, DOI 10.1182/blood-2009-10-250118; Lausen M, 1999, J BIOL CHEM, V274, P32234, DOI 10.1074/jbc.274.45.32234; Lee Y, 2006, IMMUNITY, V25, P499, DOI 10.1016/j.immuni.2006.06.016; Lu TT, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00047; Ludewig B, 1998, J EXP MED, V188, P1493, DOI 10.1084/jem.188.8.1493; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; METCALF D, 1963, AUST J EXP BIOL MED, V41, P437, DOI 10.1038/icb.1963.64; METCALF D, 1964, TRANSPLANTATION, V2, P387, DOI 10.1097/00007890-196405000-00008; Milicevic NM, 2005, IMMUNOLOGY, V116, P308, DOI 10.1111/j.1365-2567.2005.02226.x; Milicevic NM, 2016, CELL TISSUE RES, V365, P135, DOI 10.1007/s00441-016-2374-1; Milicevic NM, 2011, J IMMUNOL, V186, P1486, DOI 10.4049/jimmunol.1000740; Molleken C, 2009, HEPATOLOGY, V49, P1257, DOI 10.1002/hep.22764; Montaudouin C, 2013, J IMMUNOL, V190, P106, DOI 10.4049/jimmunol.1200907; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Onder L, 2013, J EXP MED, V210, P465, DOI 10.1084/jem.20121462; PABST R, 1991, INT REV CYTOL, V128, P215; Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011; Randall TD, 2008, ANNU REV IMMUNOL, V26, P627, DOI 10.1146/annurev.immunol.26.021607.090257; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Schlosser A, 2006, SCAND J IMMUNOL, V64, P104, DOI 10.1111/j.1365-3083.2006.01778.x; Schlosser A, 2016, ARTERIOSCL THROM VAS, V36, P122, DOI 10.1161/ATVBAHA.115.306672; Schmidt H, 2008, PROTEOMICS, V8, P2911, DOI 10.1002/pmic.200800170; Schmidt H, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-41; Schulz O, 2016, ANNU REV IMMUNOL, V34, P203, DOI 10.1146/annurev-immunol-041015-055649; Summers-DeLuca LE, 2007, J EXP MED, V204, P1071, DOI 10.1084/jem.20061968; Textor J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003752; Toyoshima T, 2005, EXP CELL RES, V307, P224, DOI 10.1016/j.yexcr.2005.03.005; Tumanov AV, 2003, IMMUNOL REV, V195, P106, DOI 10.1034/j.1600-065X.2003.00071.x; Ware CF, 2008, IMMUNOL REV, V223, P186, DOI 10.1111/j.1600-065X.2008.00629.x; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Westermann J, 2005, J IMMUNOL, V174, P2517, DOI 10.4049/jimmunol.174.5.2517; WESTERMANN J, 1992, CLIN INVESTIGATOR, V70, P539; Withers DR, 2016, NAT MED, V22, P319, DOI 10.1038/nm.4046; Withers DR, 2011, CURR BIOL, V21, pR381, DOI 10.1016/j.cub.2011.03.022	68	4	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166901	10.1371/journal.pone.0166901	http://dx.doi.org/10.1371/journal.pone.0166901			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936003	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100047
J	Wang, KW; Wang, MH; Gannon, M; Holterman, A				Wang, Kewei; Wang, Minhua; Gannon, Maureen; Holterman, AiXuan			Growth Hormone Mediates Its Protective Effect in Hepatic Apoptosis through Hnf6	PLOS ONE			English	Article							NUCLEAR FACTOR 6; ONECUT TRANSCRIPTION FACTORS; FACTOR-I; CELLULAR INHIBITOR; GENE-EXPRESSION; SIGNAL TRANSDUCER; RAT HEPATOCYTES; LIVER FIBROSIS; MURINE LIVER; CANCER CELLS	Background and Aims Growth hormone (GH) not only supports hepatic metabolism but also protects against hepatocyte cell death. Hnf6 (or Oc1) belonging to the Onecut family of hepatocyte transcription factors known to regulate differentiated hepatic function, is a GH-responsive gene. We evaluate if GH mediates Hnf6 activity to attenuate hepatic apoptotic injury. Methods We used an animal model of hepatic apoptosis by bile duct ligation (BDL) with Hnf6 -/-(KO) mice in which hepatic Hnf6 was conditionally inactivated. GH was administered to adult wild type WT and KO mice for the 7 days of BDL to enhance Hnf6 expression. In vitro, primary hepatocytes derived from KO and WT liver were treated with LPS and hepatocyte apoptosis was assessed with and without GH treatment. Results In WT mice, GH treatment enhanced Hnf6 expression during BDL, inhibited Caspase -3, -8 and -9 responses and diminished hepatic apoptotic and fibrotic injury. GH-mediated upregulation of Hnf6 expression and parallel suppression of apoptosis and fibrosis in WT BDL liver were abrogated in KO mice. LPS activated apoptosis and suppressed Hnf6 expression in primary hepatocytes. GH/LPS co-treatment enhanced Hnf6 expression with corresponding attenuation of apoptosis in WT-derived hepatocytes, but not in KO hepatocytes. ChiP-on-ChiP and electromobility shift assays of KO and WT liver nuclear extracts identified Ciap1 (or Birc2) as an Hnf6-bound target gene. Ciap1 expression patterns closely follow Hnf6 expression in the liver and in hepatocytes. Conclusion GH broad protective actions on hepatocytes during liver injury are effected through Hnf6, with Hnf6 transcriptional activation of Ciap1 as an underlying molecular mediator.	[Wang, Kewei; Wang, Minhua; Holterman, AiXuan] Univ Illinois, Coll Med, Dept Surg Pediat Surg, Peoria, IL 61605 USA; [Gannon, Maureen] Vanderbilt Univ, Med Ctr, Dept Med, 221 Kirkland Hall, Nashville, TN 37235 USA; [Gannon, Maureen] Vanderbilt Univ, Med Ctr, Dept Mol Physiol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Gannon, Maureen] Vanderbilt Univ, Med Ctr, Dept Biophys, 221 Kirkland Hall, Nashville, TN 37235 USA	University of Illinois System; University of Illinois Peoria; Vanderbilt University; Vanderbilt University; Vanderbilt University	Holterman, A (corresponding author), Univ Illinois, Coll Med, Dept Surg Pediat Surg, Peoria, IL 61605 USA.	aixuan.l.holterman@osfhealthcare.org		Holterman, Aixuan/0000-0003-2819-7434	NIH [R21 DK070784-02, U01DK089540, R01DK105689]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Grant support was provided by NIH R21 DK070784-02 to AH, and U01DK089540 and R01DK105689 to MG.	Akazawa Y, 2013, AM J PHYSIOL-GASTR L, V305, pG611, DOI 10.1152/ajpgi.00111.2013; Arnt CR, 2002, J BIOL CHEM, V277, P44236, DOI 10.1074/jbc.M207578200; Baserga R, 1997, BBA-REV CANCER, V1332, pF105, DOI 10.1016/S0304-419X(97)00007-3; Blaas L, 2010, HEPATOLOGY, V51, P1319, DOI 10.1002/hep.23469; Bockbrader KM, 2005, ONCOGENE, V24, P7381, DOI 10.1038/sj.onc.1208888; Bonefeld K, 2011, LIVER INT, V31, P911, DOI 10.1111/j.1478-3231.2010.02428.x; Budhidarmo R, 2015, SEMIN CELL DEV BIOL, V39, P80, DOI 10.1016/j.semcdb.2014.12.002; CastillaCortazar I, 1997, GASTROENTEROLOGY, V113, P1682, DOI 10.1053/gast.1997.v113.pm9352873; Clotman F, 2005, GENE DEV, V19, P1849, DOI 10.1101/gad.340305; Clotman F, 2002, DEVELOPMENT, V129, P1819; Costa RH, 2003, HEPATOLOGY, V38, P1331, DOI 10.1016/j.hep.2003.09.034; De Vas MG, 2015, DEVELOPMENT, V142, P871, DOI 10.1242/dev.110759; Delesque-Touchard N, 2000, J BIOL CHEM, V275, P34173, DOI 10.1074/jbc.M004027200; Ebert G, 2015, P NATL ACAD SCI USA, V112, P5797, DOI 10.1073/pnas.1502390112; Fickert P, 2004, GASTROENTEROLOGY, V127, P261, DOI 10.1053/j.gastro.2004.04.009; Gatto M, 2008, LAB INVEST, V88, P986, DOI 10.1038/labinvest.2008.63; Glaser S, 2010, AM J PHYSIOL-GASTR L, V299, pG769, DOI 10.1152/ajpgi.00237.2010; Guicciardi ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092124; Held MA, 2005, AM J PHYSIOL-GASTR L, V288, pG986, DOI 10.1152/ajpgi.00287.2004; Holterman AXL, 2002, HEPATOLOGY, V35, P1392, DOI 10.1053/jhep.2002.33680; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Jacquemin P, 1999, J BIOL CHEM, V274, P2665, DOI 10.1074/jbc.274.5.2665; Jung SA, 2015, J BIOL CHEM, V290, P9974, DOI 10.1074/jbc.M114.600874; Koyama Y, 2015, CLIN RES HEPATOL GAS, V39, pS75, DOI 10.1016/j.clinre.2015.06.011; Lahuna O, 1997, P NATL ACAD SCI USA, V94, P12309, DOI 10.1073/pnas.94.23.12309; Lahuna O, 2000, MOL ENDOCRINOL, V14, P285, DOI 10.1210/me.14.2.285; Lannoy VJ, 2002, DIABETOLOGIA, V45, P1136, DOI 10.1007/s00125-002-0856-z; Lemke J, 2014, CELL DEATH DIFFER, V21, P1350, DOI 10.1038/cdd.2014.81; Lucifora J, 2015, NAT REV GASTRO HEPAT, V12, P377, DOI 10.1038/nrgastro.2015.103; Mair M, 2010, GASTROENTEROLOGY, V138, P2499, DOI 10.1053/j.gastro.2010.02.049; Margagliotti S, 2007, DEV BIOL, V311, P579, DOI 10.1016/j.ydbio.2007.09.013; Metalli VD, 2007, DIGEST LIVER DIS, V39, P654, DOI 10.1016/j.dld.2007.03.008; Mirpuri E, 2002, INT J BIOCHEM CELL B, V34, P242, DOI 10.1016/S1357-2725(01)00123-6; Onori P, 2007, J HISTOCHEM CYTOCHEM, V55, P327, DOI 10.1369/jhc.6R7125.2006; Qi YF, 2012, J BIOL CHEM, V287, P32236, DOI 10.1074/jbc.M112.362160; Rausa F, 1997, DEV BIOL, V192, P228, DOI 10.1006/dbio.1997.8744; Saleem M, 2013, CHEM BIOL DRUG DES, V82, P243, DOI 10.1111/cbdd.12176; Schoemaker MH, 2002, J HEPATOL, V36, P742, DOI 10.1016/S0168-8278(02)00063-6; Silke J, 2014, METHOD ENZYMOL, V545, P35, DOI 10.1016/B978-0-12-801430-1.00002-0; Stiedl P, 2015, HEPATOLOGY, V61, P613, DOI 10.1002/hep.27408; Tan YJ, 2006, GASTROENTEROLOGY, V130, P1283, DOI 10.1053/j.gastro.2006.01.010; Tan YJ, 2002, HEPATOLOGY, V35, P790, DOI 10.1053/jhep.2002.32482; Vanderpool C, 2012, HEPATOLOGY, V55, P232, DOI 10.1002/hep.24631; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang KPC, 2011, J SURG RES, V167, P237, DOI 10.1016/j.jss.2009.07.051; Wang KW, 2013, CELL SIGNAL, V25, P867, DOI 10.1016/j.cellsig.2012.12.012; Wang MH, 2004, HEPATOLOGY, V40, P600, DOI 10.1002/hep.20349; Wang MH, 2008, AM J PHYSIOL-GASTR L, V295, pG357, DOI 10.1152/ajpgi.00581.2007; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; Woelfle J, 2003, J BIOL CHEM, V278, P51261, DOI 10.1074/jbc.M309486200; Zhang H, 2009, MECH DEV; Zhang HJ, 2009, MECH DEVELOP, V126, P958, DOI 10.1016/j.mod.2009.09.006; Zhang YJ, 2012, MOL CELL BIOL, V32, P880, DOI 10.1128/MCB.06312-11; Zhao DJ, 2015, LIFE SCI, V137, P81, DOI 10.1016/j.lfs.2015.07.011	54	6	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167085	10.1371/journal.pone.0167085	http://dx.doi.org/10.1371/journal.pone.0167085			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936029	Green Submitted, Green Published, gold			2022-12-27	WOS:000389587100060
J	Chen, L; Li, T; Liu, JF; Shi, YT; Wang, H				Chen, Lin; Li, Tao; Liu, Jinfeng; Shi, Yongtang; Wang, Hua			On the Wiener Polarity Index of Lattice Networks	PLOS ONE			English	Article							ENERGY-LIKE INVARIANT; TOPOLOGICAL INDEXES; RANDIC ENERGY; KIRCHHOFF INDEX; MATCHING ENERGY; ESTRADA INDEX; MOLECULAR-ORBITALS; HEXAGONAL SYSTEMS; UNICYCLIC GRAPHS; COMPLEX NETWORKS	Network structures are everywhere, including but not limited to applications in biological, physical and social sciences, information technology, and optimization. Network robustness is of crucial importance in all such applications. Research on this topic relies on finding a suitable measure and use this measure to quantify network robustness. A number of distance-based graph invariants, also known as topological indices, have recently been incorporated as descriptors of complex networks. Among them the Wiener type indices are the most well known and commonly used such descriptors. As one of the fundamental variants of the original Wiener index, the Wiener polarity index has been introduced for a long time and known to be related to the cluster coefficient of networks. In this paper, we consider the value of the Wiener polarity index of lattice networks, a common network structure known for its simplicity and symmetric structure. We first present a simple general formula for computing the Wiener polarity index of any graph. Using this formula, together with the symmetric and recursive topology of lattice networks, we provide explicit formulas of the Wiener polarity index of the square lattices, the hexagonal lattices, the triangular lattices, and the 3(3)center dot 4(2) lattices. We also comment on potential future research topics.	[Chen, Lin; Liu, Jinfeng; Shi, Yongtang] Nankai Univ, Ctr Combinator, Tianjin, Peoples R China; [Chen, Lin; Liu, Jinfeng; Shi, Yongtang] Nankai Univ, LPMC TJKLC, Tianjin, Peoples R China; [Li, Tao] Nankai Univ, Coll Comp & Control Engn, Tianjin 300071, Peoples R China; [Wang, Hua] Georgia Southern Univ, Dept Math Sci, Statesboro, GA 30460 USA	Nankai University; Nankai University; Nankai University; University System of Georgia; Georgia Southern University	Li, T (corresponding author), Nankai Univ, Coll Comp & Control Engn, Tianjin 300071, Peoples R China.	litao@nankai.edu.cn			National Science Foundation of China [11371021]; Natural Science Foundation of Tianjin [16JCYBJC15200]; Simons Foundation [245307]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); Simons Foundation	This work was supported by The National Science Foundation of China (No. 11371021), Recipient: Yongtang Shi; The Natural Science Foundation of Tianjin (No. 16JCYBJC15200), Recipient: Tao Li; and The Simons Foundation (No. 245307), Recipient: Hua Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALABAN AT, 1982, CHEM PHYS LETT, V89, P399, DOI 10.1016/0009-2614(82)80009-2; BALABAN AT, 1983, PURE APPL CHEM, V55, P199, DOI 10.1351/pac198855020199; Behmaram A, 2012, APPL MATH LETT, V25, P1510, DOI 10.1016/j.aml.2012.01.006; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bollobas B, 1998, ARS COMBINATORIA, V50, P225; Bondy J.A., 2008, GRAPH THEORY; Bozkurt SB, 2010, MATCH-COMMUN MATH CO, V64, P239; Cao SJ, 2014, INFORM SCIENCES, V278, P22, DOI 10.1016/j.ins.2014.03.133; Chen L, 2016, MATCH-COMMUN MATH CO, V75, P315; Chen L, 2016, APPL MATH COMPUT, V273, P976, DOI 10.1016/j.amc.2015.10.025; Chen L, 2015, COMPLEXITY, V21, P224, DOI 10.1002/cplx.21599; Chen L, 2015, MATCH-COMMUN MATH CO, V73, P105; Chen MH, 2016, PHYS LETT A, V380, P40, DOI 10.1016/j.physleta.2015.09.047; Chen XD, 2015, MATCH-COMMUN MATH CO, V73, P149; Chen XD, 2015, MATCH-COMMUN MATH CO, V73, P163; Chen ZQ, 2014, ENTROPY-SWITZ, V16, P5416, DOI 10.3390/e16105416; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Das KC, 2015, MATCH-COMMUN MATH CO, V73, P81; Das KC, 2014, MATCH-COMMUN MATH CO, V72, P227; Deng HY, 2010, J SERB CHEM SOC, V75, P1405, DOI 10.2298/JSC100320114D; Deng HY, 2010, MATCH-COMMUN MATH CO, V63, P257; Dobrynin AA, 2002, ACTA APPL MATH, V72, P247, DOI 10.1023/A:1016290123303; Dobrynin AA, 2001, ACTA APPL MATH, V66, P211, DOI 10.1023/A:1010767517079; Dorogovtsev SN, 2002, ADV PHYS, V51, P1079, DOI 10.1080/00018730110112519; Du WX, 2009, MATCH-COMMUN MATH CO, V62, P235; Ellens W, 2013, ARXIV 1311 5064V1 CS; Feng LH, 2014, ARS COMBINATORIA, V114, P33; Feng LH, 2013, GRAPH COMBINATOR, V29, P449, DOI 10.1007/s00373-012-1143-5; Gao N, 2015, MATCH-COMMUN MATH CO, V73, P133; Ghebleh M, 2016, MATCH-COMMUN MATH CO, V76, P731; Gu R, 2015, MATCH-COMMUN MATH CO, V73, P61; Gupta S, 2000, J MOL GRAPH MODEL, V18, P18, DOI 10.1016/S1093-3263(00)00027-9; GUTMAN I, 1972, CHEM PHYS LETT, V17, P535, DOI 10.1016/0009-2614(72)85099-1; GUTMAN I, 1975, J CHEM PHYS, V62, P3399, DOI 10.1063/1.430994; Gutman I., 1978, BER MATH STATIST STA, V103, P1, DOI 10.1002/9783527627981; Gutman I, 2012, DISCRETE APPL MATH, V160, P2177, DOI 10.1016/j.dam.2012.06.001; HOSOYA H, 1971, B CHEM SOC JPN, V44, P2332, DOI 10.1246/bcsj.44.2332; Hosoya H, 2002, TOPOLOGY IN CHEMISTR, DOI [10.1533/9780857099617.38, DOI 10.1533/9780857099617.38]; Hou HQ, 2012, APPL MATH COMPUT, V218, P10149, DOI 10.1016/j.amc.2012.03.090; Hua HB, 2016, APPL MATH COMPUT, V280, P162, DOI 10.1016/j.amc.2016.01.043; Jaklic G, 2012, ARS MATH CONTEMP, V5, P99; Jooyandeh M, 2009, MATCH-COMMUN MATH CO, V62, P561; Khalifeh MH, 2009, EUR J COMBIN, V30, P1149, DOI 10.1016/j.ejc.2008.09.019; KIER LB, 1977, EUR J MED CHEM, V12, P307; KLEIN DJ, 1993, J MATH CHEM, V12, P81, DOI 10.1007/BF01164627; Kraus V, 2014, INFORM SCIENCES, V288, P220, DOI 10.1016/j.ins.2014.07.018; Li SL, 2016, J STAT PHYS, V164, P449, DOI 10.1007/s10955-016-1552-6; Li X., 2012, GRAPH ENERGY, DOI [10.1007/978-1-4614-4220-2, DOI 10.1007/978-1-4614-4220-2]; Li XL, 2005, MATCH-COMMUN MATH CO, V54, P195; Li XL, 2008, MATCH-COMMUN MATH CO, V59, P127; Li XL, 2013, MATCH-COMMUN MATH CO, V70, P85; Liu JB, 2015, APPL MATH COMPUT, V270, P62, DOI 10.1016/j.amc.2015.08.008; Liu JB, 2015, PHYSICA A, V422, P193, DOI 10.1016/j.physa.2014.12.006; Liu JB, 2015, APPL MATH COMPUT, V253, P205, DOI 10.1016/j.amc.2014.12.035; Liu MH, 2013, MATCH-COMMUN MATH CO, V69, P491; Liu MH, 2011, MATCH-COMMUN MATH CO, V66, P293; Lukovits I, 1998, J CHEM INF COMP SCI, V38, P715, DOI 10.1021/ci970122j; Ma J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19066; Ma J, 2014, ARS COMBINATORIA, V116, P235; Nosal E, 1970, THESIS; Pirzada S, 2015, MATCH-COMMUN MATH CO, V73, P41; Rada J, 2014, MATCH-COMMUN MATH CO, V72, P125; Shrock R, 2000, J PHYS A-MATH GEN, V33, P3881, DOI 10.1088/0305-4470/33/21/303; Sydney A, 2008, IEEE ACM BIONETICS, DOI [10.4108/ICST.BIONETICS2008.4713, DOI 10.4108/ICST.BIONETICS2008.4713]; WIENER H, 1947, J AM CHEM SOC, V69, P17, DOI 10.1021/ja01193a005; Wu XY, 2010, ACTA APPL MATH, V110, P535, DOI 10.1007/s10440-009-9460-2; Xia CY, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525912500567; Xia CY, 2014, APPL MATH COMPUT, V246, P389, DOI 10.1016/j.amc.2014.08.006; Xu KX, 2014, MATCH-COMMUN MATH CO, V71, P461; Yan WG, 2009, PHYSICA A, V388, P1463, DOI 10.1016/j.physa.2008.12.058; Ye LZ, 2011, LINEAR MULTILINEAR A, V59, P645, DOI 10.1080/03081081003794233; Yu GH, 2017, APPL MATH COMPUT, V293, P287, DOI 10.1016/j.amc.2016.08.032; Yu GH, 2013, LINEAR ALGEBRA APPL, V438, P2036, DOI 10.1016/j.laa.2012.09.031; Yu GH, 2011, J MATH ANAL APPL, V375, P99, DOI 10.1016/j.jmaa.2010.08.054; Zhang YH, 2016, APPL MATH COMPUT, V273, P880, DOI 10.1016/j.amc.2015.10.045	76	16	16	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167075	10.1371/journal.pone.0167075	http://dx.doi.org/10.1371/journal.pone.0167075			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930705	gold, Green Published, Green Submitted			2022-12-27	WOS:000389580900019
J	Richter, SH; Kastner, N; Loddenkemper, DH; Kaiser, S; Sachser, N				Richter, S. Helene; Kaestner, Niklas; Loddenkemper, Dirk-Heinz; Kaiser, Sylvia; Sachser, Norbert			A Time to Wean? Impact of Weaning Age on Anxiety-Like Behaviour and Stability of Behavioural Traits in Full Adulthood	PLOS ONE			English	Article							MATERNAL-CARE; HOUSE MICE; ANIMAL PERSONALITY; MUS-MUSCULUS; STRESS; DECREASES; MOUSE; RATS; MECHANISMS; EXPRESSION	In mammals, weaning constitutes an important phase in the progression to adulthood. It comprises the termination of suckling and is characterized by several changes in the behaviour of both mother and offspring. Furthermore, numerous studies in rodents have shown that the time point of weaning shapes the behavioural profile of the young. Most of these studies, however, have focused on 'early weaning', while relatively little work has been done to study 'late weaning' effects. The aim of the present study was therefore to explore behavioural effects of 'late weaning', and furthermore to gain insights into modulating effects of weaning age on the consistency of behavioural expressions over time. In total, 25 male and 20 female C57BL/6J mice, weaned after three (W3) or four (W4) weeks of age, were subjected to a series of behavioural paradigms widely used to assess anxiety-like behaviour, exploratory locomotion, and nest building performance. Behavioural testing took place with the mice reaching an age of 20 weeks and was repeated eight weeks later to investigate the stability of behavioural expressions over time. At the group level, W4 mice behaved less anxious and more explorative than W3 animals in the Open Field and Novel Cage, while anxiety-like behaviour on the Elevated Plus Maze was modulated by a weaning-age-by-sex interaction. Furthermore, weaning age shaped the degree of behavioural stability over time in a sex-specific way. While W3 females and W4 males displayed a remarkable degree of behavioural stability over time, no such patterns were observed in W3 males and W4 females. Adding to the existing literature, we could thus confirm that effects of weaning age do indeed exist when prolonging this phase, and were furthermore able to provide first evidence for the impact of weaning age and sex on the consistency of behavioural expressions over time.	[Richter, S. Helene; Kaestner, Niklas; Loddenkemper, Dirk-Heinz; Kaiser, Sylvia; Sachser, Norbert] Univ Munster, Dept Behav Biol, Munster, Germany	University of Munster	Richter, SH (corresponding author), Univ Munster, Dept Behav Biol, Munster, Germany.	richterh@uni-muenster.de		Kaiser, Sylvia/0000-0003-2770-7367	German Research Foundation [SFB/TRR58]	German Research Foundation(German Research Foundation (DFG))	This study was supplied by a grant from the German Research Foundation to NS (SFB/TRR58, Project A01, http://sfbtrr58.uni-muenster.de/a01.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolomucci A, 2004, PSYCHONEUROENDOCRINO, V29, P899, DOI 10.1016/j.psyneuen.2003.08.003; Bodden C, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00047; Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; Champagne FA, 2007, PHYSIOL BEHAV, V91, P325, DOI 10.1016/j.physbeh.2007.03.014; COUNSILMAN JJ, 1985, ANIM BEHAV, V33, P1023, DOI 10.1016/S0003-3472(85)80037-3; Curley JP, 2009, DEV NEUROSCI-BASEL, V31, P318, DOI 10.1159/000216543; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Dingemanse NJ, 2002, ANIM BEHAV, V64, P929, DOI 10.1006/anbe.2002.2006; Farshim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep21958; Ferdman N, 2007, BEHAV BRAIN RES, V180, P174, DOI 10.1016/j.bbr.2007.03.011; Freund J, 2013, SCIENCE, V340, P756, DOI 10.1126/science.1235294; Fuss J, 2013, BEHAV BRAIN RES, V243, P191, DOI 10.1016/j.bbr.2013.01.015; GERLACH G, 1990, BIOL J LINN SOC, V41, P271, DOI 10.1111/j.1095-8312.1990.tb00835.x; Gerlach G, 1996, BEHAV ECOL SOCIOBIOL, V39, P159, DOI 10.1007/s002650050277; Groothuis TGG, 2011, DEV PSYCHOBIOL, V53, P641, DOI 10.1002/dev.20574; Heiming RS, 2011, HORM BEHAV, V60, P397, DOI 10.1016/j.yhbeh.2011.07.006; HOLDER JL, 1991, ETHOLOGY, V88, P297; HOLSON RR, 1992, NEUROTOXICOL TERATOL, V14, P221, DOI 10.1016/0892-0362(92)90020-B; Hoyer C, 2012, REPROD TOXICOL, V34, P86, DOI 10.1016/j.reprotox.2012.03.006; Iwata E, 2007, PHYSIOL BEHAV, V91, P318, DOI 10.1016/j.physbeh.2007.03.013; JOHNSTON AL, 1991, PHYSIOL BEHAV, V49, P245, DOI 10.1016/0031-9384(91)90039-Q; Kanari K, 2005, BEHAV BRAIN RES, V156, P45, DOI 10.1016/j.bbr.2004.05.008; Kikusui T, 2005, BEHAV BRAIN RES, V162, P200, DOI 10.1016/j.bbr.2005.03.013; Kikusui T, 2004, PHYSIOL BEHAV, V81, P37, DOI 10.1016/j.physbeh.2003.12.016; Kikusui T, 2007, BRAIN RES, V1133, P115, DOI 10.1016/j.brainres.2006.11.031; Kikusui T, 2006, BEHAV BRAIN RES, V175, P96, DOI 10.1016/j.bbr.2006.08.007; Kikusui T, 2009, PSYCHONEUROENDOCRINO, V34, P762, DOI 10.1016/j.psyneuen.2008.12.009; KONIG B, 1987, BEHAV ECOL SOCIOBIOL, V20, P1, DOI 10.1007/BF00292161; KONIG B, 1994, BEHAV ECOL SOCIOBIOL, V34, P275, DOI 10.1007/s002650050043; KRACKOW S, 1989, ANIM BEHAV, V37, P177, DOI 10.1016/0003-3472(89)90108-5; Latham N, 2004, APPL ANIM BEHAV SCI, V86, P261, DOI 10.1016/j.applanim.2004.02.006; Laviola G, 1997, PSYCHOBIOLOGY, V25, P163; Lazic SE, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-37; Lee P. C., 1996, Evolutionary Anthropology, V5, P87, DOI 10.1002/(SICI)1520-6505(1996)5:3<87::AID-EVAN4>3.0.CO;2-T; LEE PC, 1991, J ZOOL, V225, P99, DOI 10.1111/j.1469-7998.1991.tb03804.x; Lehmann J, 2000, REV NEUROSCIENCE, V11, P383; Lerch S, 2015, BEHAV BRAIN RES, V279, P155, DOI 10.1016/j.bbr.2014.11.007; Lewejohann L, 2011, DEV PSYCHOBIOL, V53, P624, DOI 10.1002/dev.20553; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Maestripieri D., 2013, ANIMAL PERSONALITIES, P279; MARTIN P, 1985, ANIM BEHAV, V33, P1024, DOI 10.1016/S0003-3472(85)80038-5; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; MENDL M, 1991, BEHAVIOUR, V116, P11, DOI 10.1163/156853990X00347; Pocock MJO, 2005, BIOL J LINN SOC, V84, P565, DOI 10.1111/j.1095-8312.2005.00455.x; Pryce CR, 2003, NEUROSCI BIOBEHAV R, V27, P57, DOI 10.1016/S0149-7634(03)00009-5; Reale D, 2010, PHILOS T R SOC B, V365, P3937, DOI 10.1098/rstb.2010.0222; Remmes J, FRONT BEHAV IN PRESS; Richter SH, 2016, ANIM BEHAV, V114, P261, DOI 10.1016/j.anbehav.2016.02.003; Richter SH, 2014, BEHAV BRAIN RES, V270, P300, DOI 10.1016/j.bbr.2014.05.002; Ridder S, 2005, J NEUROSCI, V25, P6243, DOI 10.1523/JNEUROSCI.0736-05.2005; Sachser N, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0344; Sachser N, 2011, NEUROSCI BIOBEHAV R, V35, P1518, DOI 10.1016/j.neubiorev.2010.09.002; Schuett W, 2010, BIOL REV, V85, P217, DOI 10.1111/j.1469-185X.2009.00101.x; Shimozuru M, 2007, DEV PSYCHOBIOL, V49, P343, DOI 10.1002/dev.20202; Solomon NG, 2003, J MAMMAL, V84, P1182, DOI 10.1644/BLe-013; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; Tarantino LM, 2000, MAMM GENOME, V11, P555, DOI 10.1007/s003350010107; TRIVERS RL, 1974, AM ZOOL, V14, P249; Voikar V, 2001, PHYSIOL BEHAV, V72, P271, DOI 10.1016/S0031-9384(00)00405-4; Weber EM, 2008, APPL ANIM BEHAV SCI, V114, P1, DOI 10.1016/j.applanim.2008.06.006; WILLIAMS E, 1953, BEHAVIOUR, V6, P35, DOI 10.1163/156853954X00031; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001; Zorrilla EP, 1997, DEV PSYCHOBIOL, V30, P141, DOI 10.1002/(SICI)1098-2302(199703)30:2<141::AID-DEV5>3.0.CO;2-Q	65	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167652	10.1371/journal.pone.0167652	http://dx.doi.org/10.1371/journal.pone.0167652			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930688	Green Published, gold, Green Submitted			2022-12-27	WOS:000389580900036
J	White, SL; Lawlor, DA; Briley, AL; Godfrey, KM; Nelson, SM; Oteng-Ntim, E; Robson, SC; Sattar, N; Seed, PT; Vieira, MC; Welsh, P; Whitworth, M; Poston, L; Pasupathy, D				White, Sara L.; Lawlor, Debbie A.; Briley, Annette L.; Godfrey, Keith M.; Nelson, Scott M.; Oteng-Ntim, Eugene; Robson, Stephen C.; Sattar, Naveed; Seed, Paul T.; Vieira, Matias C.; Welsh, Paul; Whitworth, Melissa; Poston, Lucilla; Pasupathy, Dharmintra		UPBEAT Consortium	Early Antenatal Prediction of Gestational Diabetes in Obese Women: Development of Prediction Tools for Targeted Intervention	PLOS ONE			English	Article							PREGNANT-WOMEN; INSULIN-RESISTANCE; RISK; MELLITUS; UPBEAT; METABOLOMICS; METFORMIN; GLUCOSE; PLACEBO; COHORT	All obese women are categorised as being of equally high risk of gestational diabetes (GDM) whereas the majority do not develop the disorder. Lifestyle and pharmacological interventions in unselected obese pregnant women have been unsuccessful in preventing GDM. Our aim was to develop a prediction tool for early identification of obese women at high risk of GDM to facilitate targeted interventions in those most likely to benefit. Clinical and anthropometric data and non-fasting blood samples were obtained at 15(+0)-18(+6) weeks' gestation in 1303 obese pregnant women from UPBEAT, a randomised controlled trial of a behavioural intervention. Twenty one candidate biomarkers associated with insulin resistance, and a targeted nuclear magnetic resonance (NMR) metabolome were measured. Prediction models were constructed using stepwise logistic regression. Twenty six percent of women (n = 337) developed GDM (International Association of Diabetes and Pregnancy Study Groups criteria). A model based on clinical and anthropometric variables (age, previous GDM, family history of type 2 diabetes, systolic blood pressure, sum of skinfold thicknesses, waist: height and neck: thigh ratios) provided an area under the curve of 0.71 (95% CI 0.68-0.74). This increased to 0.77 (95% CI 0.73-0.80) with addition of candidate biomarkers (random glucose, haemoglobin A1c (HbA1c), fructosamine, adiponectin, sex hormone binding globulin, triglycerides), but was not improved by addition of NMR metabolites (0.77; 95% CI 0.74-0.81). Clinically translatable models for GDM prediction including readily measurable variables e.g. mid-arm circumference, age, systolic blood pressure, HbA1c and adiponectin are described. Using a >= 35% risk threshold, all models identified a group of high risk obese women of whom approximately 50% (positive predictive value) later developed GDM, with a negative predictive value of 80%. Tools for early pregnancy identification of obese women at risk of GDM are described which could enable targeted interventions for GDM prevention in women who will benefit the most.	[White, Sara L.; Briley, Annette L.; Oteng-Ntim, Eugene; Seed, Paul T.; Vieira, Matias C.; Poston, Lucilla; Pasupathy, Dharmintra] Kings Coll London, Div Womens Hlth, London, England; [Lawlor, Debbie A.] Univ Bristol, MRC, Integrat Epidemiol Unit, Bristol, Avon, England; [Lawlor, Debbie A.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Briley, Annette L.; Oteng-Ntim, Eugene; Pasupathy, Dharmintra] Guys & St Thomas NHS Fdn Trust, London, England; [Godfrey, Keith M.] Univ Southampton, MRC, Lifecourse Epidemiol Unit, Southampton, Hants, England; [Godfrey, Keith M.] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Godfrey, Keith M.] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Nelson, Scott M.] Univ Glasgow, Sch Med, Glasgow, Lanark, Scotland; [Robson, Stephen C.] Newcastle Univ, Uterine Cell Signalling Grp, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Sattar, Naveed; Welsh, Paul] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Whitworth, Melissa] Cent Manchester Univ Hosp NHS Fdn Trust, Matern Serv, Manchester, Lancs, England; [Whitworth, Melissa] Univ Manchester, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England	University of London; King's College London; University of Bristol; University of Bristol; Guy's & St Thomas' NHS Foundation Trust; University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Glasgow; Newcastle University - UK; University of Glasgow; University of Manchester; University of Manchester	Pasupathy, D (corresponding author), Kings Coll London, Div Womens Hlth, London, England.; Pasupathy, D (corresponding author), Guys & St Thomas NHS Fdn Trust, London, England.	Dharmintra.Pasupathy@kcl.ac.uk	Briley, Annette/AAZ-5305-2020; Pasupathy, Dharmintra/N-9586-2019; Briley, Annette/N-1704-2019; Seed, Paul T/C-4435-2008	Briley, Annette/0000-0002-4266-920X; Pasupathy, Dharmintra/0000-0002-6722-1006; Seed, Paul T/0000-0001-7904-7933; /0000-0002-8076-4275; Robson, Stephen/0000-0001-7897-7987; Poston, Lucilla/0000-0003-1100-2821; Nelson, Scott/0000-0002-9099-3047; White, Sara Louise/0000-0001-7979-0508; Goff, Louise/0000-0001-9633-8759; Lawlor, Debbie A/0000-0002-6793-2262; Singh, Claire/0000-0003-1681-8467; Godfrey, Keith/0000-0002-4643-0618; Robinson, Sian/0000-0003-1766-7269	UK's National Institute for Health Research [RP-PG-0407-10452]; Chief Scientist Office Scottish Government Health Directorates (Edinburgh) [CZB/A/680]; Guys and St Thomas' Charity [1060508]; Tommy's Charity [SC039280]; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London; Medical Research Council UK [MR/L002477/1]; Diabetes UK Sir George Alberti Research Training Fellowship; MRC [MC_UP_A620_1017, MR/L002477/1, MC_UU_12011/4] Funding Source: UKRI; Medical Research Council [MC_UU_12011/4, MR/L002477/1, MC_UP_A620_1017] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10104, NF-SI-0515-10042, CL-2010-17-007, RP-PG-0407-10452] Funding Source: researchfish; Chief Scientist Office [CZB/4/680] Funding Source: researchfish	UK's National Institute for Health Research; Chief Scientist Office Scottish Government Health Directorates (Edinburgh); Guys and St Thomas' Charity; Tommy's Charity; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes UK Sir George Alberti Research Training Fellowship(Diabetes UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	The UPBEAT trial was funded by the UK's National Institute for Health Research (www.nihr.ac.uk) under its grants for applied research programme (RP-PG-0407-10452). Contributions to funding were also provided by the Chief Scientist Office Scottish Government Health Directorates (Edinburgh) (www.cso.scot.nhs.uk) (CZB/A/680), Guys and St Thomas' Charity (www.gsttcharity.org.uk) (1060508), Tommy's Charity (www.tommys.org) (SC039280), and the NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London (www.guysandstthomasbrc.nihr.ac.uk). Medical Research Council UK (www.mrc.ac.uk) provided additional funding for the biomarker study (MR/L002477/1). SLW is supported by the Diabetes UK Sir George Alberti Research Training Fellowship (www.diabetes.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1989, STAT MED, V8, P771, DOI 10.1002/sim.4780080702; [Anonymous], 2016, Obstet Gynecol, V127, P979, DOI 10.1097/AOG.0000000000001439; [Anonymous], 2015, NICE GUIDELINES DIAB; Briley AL, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-74; Chiswick C, 2015, LANCET DIABETES ENDO, V3, P778, DOI 10.1016/S2213-8587(15)00219-3; Corrado F, 2012, DIABETES METAB, V38, P458, DOI 10.1016/j.diabet.2012.03.006; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Dodd JM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1285; Eleftheriades M, 2014, METABOLISM, V63, P1419, DOI 10.1016/j.metabol.2014.07.016; Enquobahrie DA, 2015, J CLIN ENDOCR METAB, V100, P4348, DOI 10.1210/jc.2015-2862; Ferreira AFA, 2011, CLIN CHEM, V57, P609, DOI 10.1373/clinchem.2010.159806; Fischer K, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001606; Graig LA, 2016, BIOMAKER TESTS MOL T; Harreiter J, 2016, DIABETES CARE, V39, pE90, DOI 10.2337/dc16-0200; Harrison CL, 2015, DIABETES RES CLIN PR, V107, P61, DOI 10.1016/j.diabres.2014.09.006; HARRISON GG, 1991, ANTHROPOMETRIC STAND, P55; Huidobro A, 2010, REV MED CHILE, V138, P1373, DOI /S0034-98872010001200005; Iliodromiti S, 2016, DIABETOLOGIA, V59, P692, DOI 10.1007/s00125-015-3855-6; Ivanescu AE, 2016, INT J OBESITY, V40, P887, DOI 10.1038/ijo.2015.214; KautzkyWiller A, 1997, DIABETES CARE, V20, P1717, DOI 10.2337/diacare.20.11.1717; Maitland RA, 2014, DIABETIC MED, V31, P963, DOI 10.1111/dme.12482; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Nanda S, 2011, PRENATAL DIAG, V31, P135, DOI 10.1002/pd.2636; Nelson SM, 2010, HUM REPROD UPDATE, V16, P255, DOI 10.1093/humupd/dmp050; Poston L, 2015, LANCET DIABETES ENDO, V3, P767, DOI 10.1016/S2213-8587(15)00227-2; Sattar N, 2008, DIABETOLOGIA, V51, P926, DOI 10.1007/s00125-008-0954-7; Savvidou M, 2010, DIABETES, V59, P3017, DOI 10.2337/db10-0688; Scholtens DM, 2014, DIABETES CARE, V37, P158, DOI 10.2337/dc13-0989; Soininen P, 2015, CIRC-CARDIOVASC GENE, V8, P192, DOI 10.1161/CIRCGENETICS.114.000216; Sommer C, 2015, EUR J ENDOCRINOL, V172, P649, DOI 10.1530/EJE-15-0060; Sovio U, 2016, DIABETES CARE, V39, P982, DOI 10.2337/dc16-0160; Syngelaki A, 2016, NEW ENGL J MED, V374, P434, DOI 10.1056/NEJMoa1509819; Theriault S, 2016, CLIN CHEM LAB MED, V54, P509, DOI 10.1515/cclm-2015-0537; Tillin T, 2015, DIABETOLOGIA, V58, P968, DOI 10.1007/s00125-015-3517-8; Tomedi LE, 2014, MATERN CHILD HLTH J, V18, P1265, DOI 10.1007/s10995-013-1361-3; Torloni MR, 2009, OBES REV, V10, P194, DOI 10.1111/j.1467-789X.2008.00541.x; WHO Guidelines Approved by the Guidelines Review Committee, 2013, DIAGN CRIT CLASS HYP; Wright E, 1996, STATA TECH B, V34, P24; Wurtz P, 2012, DIABETES, V61, P1372, DOI 10.2337/db11-1355; Zhu WW, 2013, DIABETES CARE, V36, P586, DOI 10.2337/dc12-1157	42	40	40	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167846	10.1371/journal.pone.0167846	http://dx.doi.org/10.1371/journal.pone.0167846			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930697	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000389580900050
J	Liao, CD; Tsauo, JY; Liou, TH; Chen, HC; Rau, CL				Liao, Chun-De; Tsauo, Jau-Yih; Liou, Tsan-Hon; Chen, Hung-Chou; Rau, Chi-Lun			Efficacy of Noninvasive Stellate Ganglion Blockade Performed Using Physical Agent Modalities in Patients with Sympathetic Hyperactivity-Associated Disorders: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							REGIONAL PAIN SYNDROME; ELECTRICAL NERVE-STIMULATION; XENON LIGHT IRRADIATION; LOCKED-IN SYNDROME; BLOOD-FLOW; NEUROPATHIC PAIN; CLINICAL-TRIALS; PEDRO SCALE; ULTRASOUND; QUALITY	Background Stellate ganglion blockade (SGB) is mainly used to relieve symptoms of neuropathic pain in conditions such as complex regional pain syndrome and has several potential complications. Noninvasive SGB performed using physical agent modalities (PAMs), such as light irradiation and electrical stimulation, can be clinically used as an alternative to conventional invasive SGB. However, its application protocols vary and its clinical efficacy remains controversial. This study investigated the use of noninvasive SGB for managing neuropathic pain or other disorders associated with sympathetic hyperactivity. Materials and Methods We performed a comprehensive search of the following online databases: Medline, PubMed, Excerpta Medica Database, Cochrane Library Database, Ovid MEDLINE, Europe PubMed Central, EBSCOhost Research Databases, CINAHL, ProQuest Research Library, Physiotherapy Evidence Database, WorldWideScience, BIOSIS, and Google Scholar. We identified and included quasi-randomized or randomized controlled trials reporting the efficacy of SGB performed using therapeutic ultrasound, transcutaneous electrical nerve stimulation, light irradiation using low-level laser therapy, or xenon light or linearly polarized near-infrared light irradiation near or over the stellate ganglion region in treating complex regional pain syndrome or disorders requiring sympatholytic management. The included articles were subjected to a meta-analysis and risk of bias assessment. Results Nine randomized and four quasi-randomized controlled trials were included. Eleven trials had good methodological quality with a Physiotherapy Evidence Database (PEDro) score of >= 6, whereas the remaining two trials had a PEDro score of <6. The meta-analysis results revealed that the efficacy of noninvasive SGB on 100-mm visual analog pain score is higher than that of a placebo or active control (weighted mean difference, -21.59 mm; 95% CI, -34.25, -8.94; p = 0.0008). Conclusions Noninvasive SGB performed using PAMs effectively relieves pain of various etiologies, making it a valuable addition to the contemporary pain management armamentarium. However, this evidence is limited by the potential risk of bias.	[Liao, Chun-De; Tsauo, Jau-Yih] Natl Taiwan Univ, Coll Med, Sch & Grad Inst Phys Therapy, Taipei, Taiwan; [Liao, Chun-De; Liou, Tsan-Hon; Chen, Hung-Chou; Rau, Chi-Lun] Taipei Med Univ, Shuang Ho Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Chen, Hung-Chou] Taipei Med Univ, Shuang Ho Hosp, Ctr Evidence Based Hlth Care, Taipei, Taiwan; [Liou, Tsan-Hon; Rau, Chi-Lun] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Liou, Tsan-Hon; Chen, Hung-Chou] Taipei Med Univ, Sch Med, Dept Phys Med & Rehabil, Coll Med, Taipei, Taiwan	National Taiwan University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University	Rau, CL (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.; Rau, CL (corresponding author), Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan.	rauchilun@gmail.com	Liou, Tsan-Hon/I-8808-2019; Liao, Chun-De/AAW-5990-2020	Liao, Chun-De/0000-0002-1930-4915; Liou, Tsan-Hon/0000-0002-0959-4023; Tsauo, Jau-Yih/0000-0003-4607-4454; Chen, Hung-Chou/0000-0001-8510-7437				Abrams KR, 2005, STAT MED, V24, P3823, DOI 10.1002/sim.2423; Ackerman WE, 2006, SOUTH MED J, V99, P1084, DOI 10.1097/01.smj.0000233257.76957.b2; Adachi M, 2015, HEART RHYTHM, V12, pS400; Askin A, 2014, INT J CLIN EXP MED, V7, P5603; Aydemir K, 2006, J RHEUMATOLOGY MED R, V17, P193; Barker R, 2007, ANESTH ANALG, V104, P1150, DOI 10.1213/01.ane.0000260564.52592.63; Basford JR, 2003, LASER SURG MED, V32, P417, DOI 10.1002/lsm.10186; Birklein F, 2001, NEUROLOGY, V57, P2179, DOI 10.1212/WNL.57.12.2179; Birklein F, 2008, NEUROSCI LETT, V437, P199, DOI 10.1016/j.neulet.2008.03.081; Bjordal JM, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-51; Bjordal JM, 2011, SUPPORT CARE CANCER, V19, P1069, DOI 10.1007/s00520-011-1202-0; Blake E, 2008, NATUROPATHIC PHYS ME, P539; Bolel K, 2006, RHEUMATOL INT, V26, P788, DOI 10.1007/s00296-005-0081-4; Bowden J, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-41; Bruehl S, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h2730; Brunner F, 2011, J MUSCULOSKELET PAIN, V19, P207, DOI 10.3109/10582452.2011.609638; Cacciatore F, 2012, EUR J PREV CARDIOL, V19, P1401, DOI 10.1177/1741826711422991; Chaturvedi A, 2010, INDIAN J ANAESTH, V54, P324, DOI 10.4103/0019-5049.68376; Chow RT, 2009, LANCET, V374, P1897, DOI 10.1016/S0140-6736(09)61522-1; Cipriano G, 2014, J APPL PHYSIOL, V117, P633, DOI 10.1152/japplphysiol.00993.2013; COHEN SP, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.F7656; Costantini A, 2005, Minerva Anestesiol, V71, P471; Day Miles, 2008, Pain Pract, V8, P98, DOI 10.1111/j.1533-2500.2008.00177.x; de Morton NA, 2009, AUST J PHYSIOTHER, V55, P129, DOI 10.1016/S0004-9514(09)70043-1; de Mos M, 2007, PAIN, V129, P12, DOI 10.1016/j.pain.2006.09.008; Deeks J J, 2003, Health Technol Assess, V7, piii; dos Santos LDC, 2015, PHOTOCHEM PHOTOBIOL, V91, P1231, DOI 10.1111/php.12490; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Falaki Farnaz, 2014, J Dent Res Dent Clin Dent Prospects, V8, P1, DOI 10.5681/joddd.2014.001; Fassoulaki A, 1994, Anaesthesiol Reanim, V19, P49; Fattal C., 2009, Annals of Physical and Rehabilitation Medicine, V52, P149, DOI 10.1016/j.rehab.2008.12.006; Foley NC, 2006, PHYS THER, V86, P817, DOI 10.1093/ptj/86.6.817; FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q; Fulop AM, 2010, CLIN J PAIN, V26, P729, DOI 10.1097/AJP.0b013e3181f09713; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; Han SM, 2001, J KOREAN PAIN SOC, V14, P37; Hashimoto Toshikazu, 1997, Laser Therapy, V9, P7; Hazneci B, 2005, TURK J PHYS MED REHA, V51, P83; Higa K, 2006, ANESTHESIOLOGY, V105, P1238, DOI 10.1097/00000542-200612000-00024; Huang D, 2012, SCI WORLD J, DOI 10.1100/2012/567496; Iakimova M E, 2004, Adv Gerontol, V14, P101; Ikeda T, 2000, SHOWA U J MED SCI, V12, P241; Kasamaki Y, 2009, CIRC J, V73, P582; Kimura T, 2005, BRIT J ANAESTH, V94, P840, DOI 10.1093/bja/aei134; Kudoh Akira, 1998, Laser Therapy, V10, P65; Kukull WA, 2012, NEUROLOGY, V78, P1886, DOI 10.1212/WNL.0b013e318258f812; Larsen B, 1995, Anasthesiol Intensivmed Notfallmed Schmerzther, V30, P155, DOI 10.1055/s-2007-996465; Lee CH, 2006, PHOTOMED LASER SURG, V24, P17, DOI 10.1089/pho.2006.24.17; Leonard G, 2015, CAN J NEUROL SCI, V42, P125, DOI 10.1017/cjn.2015.10; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lotze M, 2015, PHYS THER, V95, P1316, DOI 10.2522/ptj.20140581; Maher CG, 2003, PHYS THER, V83, P713, DOI 10.1093/ptj/83.8.713; Mahli A, 2002, EUR J ANAESTH, V19, P376, DOI 10.1017/S0265021502000613; Makharita MY, 2012, PAIN PHYSICIAN, V15, P467; Martinez-Lavin M, 2002, BMC MUSCULOSKEL DIS, V3, DOI 10.1186/1471-2474-3-2; Martinez-Lavin Manuel, 2004, Curr Pain Headache Rep, V8, P385, DOI 10.1007/s11916-996-0012-4; Masaaki S, 1986, J JPN SOC ACUPUNCT M, V36, P281; Matsuda T, 1999, J JPN SOC PAIN CLIN, V6, P17; Mii Seiji, 2007, Journal of Nippon Medical School, V74, P23, DOI 10.1272/jnms.74.23; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Momota Y, 2014, CASE REP DENT, V2014, DOI 10.1155/2014/171657; Mori S, 2002, NIHON GANKA KIYO, V53, P699; Murakami F., 1993, Laser Therapy, V5, P131; Myojo Y, 1998, HOKURIKU J ANESTH, V32, P29; Nacitarhan V, 2005, ULTRASOUND MED BIOL, V31, P643, DOI 10.1016/j.ultrasmedbio.2005.01.010; Nakajima F, 2015, J PHYS THER SCI, V27, P209, DOI 10.1589/jpts.27.209; Nakase M, 2004, ORAL DIS, V10, P217, DOI 10.1111/j.1601-0825.2004.01001.x; Nickel FT, 2012, EUR NEUROPSYCHOPHARM, V22, P81, DOI 10.1016/j.euroneuro.2011.05.005; Nitta K, 1995, HOKURIKU J ANESTH, V29, P55; Nogami K, 2015, J ORAL MAXIL SURG, V73, P1267, DOI 10.1016/j.joms.2015.01.012; Noro Hiroshi, 1997, Journal of Japanese Association of Physical Medicine Balneology and Climatology, V60, P193; Oaklander AL, 2009, ANN NEUROL, V65, P629, DOI 10.1002/ana.21692; Okita M, 2007, MASUI TO SOSEI, V43, P1; Otsuka H, 1992, Masui, V41, P1814; Otsuka H., 1992, Laser Therapy, V4, P117; PORTWOOD MM, 1987, ARCH PHYS MED REHAB, V68, P116; RICCI NA, 2010, REV BRAS FISIOTER, V14, P1, DOI DOI 10.1590/S1413-35552010000100002; Saeki Shigeru, 2006, Masui, V55, P1104; Saeki T, 2001, J JUZEN MED SOC, V110, P252; Sari S, 2014, AGRI, V26, P97, DOI 10.5505/agri.2014.41961; Saxena Ashok K, 2004, Pain Pract, V4, P245, DOI 10.1111/j.1533-2500.2004.04309.x; Schlereth T, 2014, AUTON NEUROSCI-BASIC, V182, P102, DOI 10.1016/j.autneu.2013.12.011; Schwartz RG, 1998, J BACK MUSCULOSKELET, V10, P31, DOI 10.3233/BMR-1998-10105; Sedgwick P, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4718; Siegenthaler A, 2012, REGION ANESTH PAIN M, V37, P224, DOI 10.1097/AAP.0b013e31823d40fe; Stanton TR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004598.pub3; Sugiyama T, 2006, JAP J CLIN OPHTHAL, V60, P2041; Takanami I, 2009, THORAC CARDIOV SURG, V57, P311, DOI 10.1055/s-2008-1038845; Takeyoshi Satoru, 1996, Laser Therapy, V8, P159; Tamagawa Shingo, 1996, Laser Therapy, V8, P155; Tomasi FP, 2015, INT J SPORTS MED, V36, P661, DOI 10.1055/s-0034-1387763; Tran KM, 2000, ANESTH ANALG, V90, P1396, DOI 10.1097/00000539-200006000-00025; Tuz M, 2003, ACTA ANAESTH SCAND, V47, P485, DOI 10.1034/j.1399-6576.2003.00076.x; Uchida T, 2015, J ANESTH, V29, P321, DOI 10.1007/s00540-014-1914-7; Velasco F, 2009, PAIN, V147, P91, DOI 10.1016/j.pain.2009.08.024; Wajima Z, 1996, Masui, V45, P433; Wan X, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-135; Wee JS, 2001, CHONNAM MED J, V37, P49; WULF H, 1992, ANAESTHESIST, V41, P146; Yamada Hiromichi, 1995, Laser Therapy, V7, P157; YANAGIHARA N, 1988, ANN OTO RHINOL LARYN, V97, P3, DOI 10.1177/00034894880976S301; Yoo Changheon, 1993, Laser Therapy, V5, P153; Yoshida H, 2009, J PHYS THER SCI, V21, P355, DOI 10.1589/jpts.21.355; Yoshida H, 2009, J PHYS THER SCI, V21, P1, DOI 10.1589/jpts.21.1; Yoshizawa A, 2005, LASER THER, V14, P135; Zamuner AR, 2015, CLIN EXP RHEUMATOL, V33, pS53; Zoller B, 1994, AKUPUNKTUR, V22, P268	107	5	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167476	10.1371/journal.pone.0167476	http://dx.doi.org/10.1371/journal.pone.0167476			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911934	gold, Green Published, Green Submitted			2022-12-27	WOS:000389520600037
J	Russell, KA; Chow, NHC; Dukoff, D; Gibson, TWG; LaMarre, J; Bette, DH; Koch, TG				Russell, Keith A.; Chow, Natalie H. C.; Dukoff, David; Gibson, Thomas W. G.; LaMarre, Jonathan; Bette, Dean H.; Koch, Thomas G.			Characterization and Immunomodulatory Effects of Canine Adipose Tissue- and Bone Marrow-Derived Mesenchymal Stromal Cells	PLOS ONE			English	Article							PROLIFERATION IN-VITRO; STEM-CELLS; CORD BLOOD; CHONDROGENIC DIFFERENTIATION; INTERFERON-GAMMA; MECHANISMS; EXPRESSION; CULTURE; BMP2	Background Mesenchymal stromal cells (MSC) hold promise for both cell replacement and immune modulation strategies owing to their progenitor and non-progenitor functions, respectively. Characterization of MSC from different sources is an important and necessary step before clinical use of these cells is widely adopted. Little is known about the biology and function of canine MSC compared to their mouse or human counterparts. This knowledge-gap impedes development of canine evidence-based MSC technologies. Hypothesis and Objectives We hypothesized that canine adipose tissue (AT) and bone marrow (BM) MSC (derived from the same dogs) will have similar differentiation and immune modulatory profiles. Our objectives were to evaluate progenitor and non-progenitor functions as well as other characteristics of AT-and BM-MSC including 1) proliferation rate, 2) cell surface marker expression, 3) DNA methylation levels, 4) potential for trilineage differentiation towards osteogenic, adipogenic, and chondrogenic cell fates, and 5) immunomodulatory potency in vitro. Results 1) AT-MSC proliferated at more than double the rate of BM-MSC (population doubling times in days) for passage (P) 2, AT: 1.69, BM: 3.81; P3, AT: 1.80, BM: 4.06; P4, AT: 2.37, BM: 5.34; P5, AT: 3.20, BM: 7.21). 2) Canine MSC, regardless of source, strongly expressed cell surface markers MHC I, CD29, CD44, and CD90, and were negative for MHC II and CD45. They also showed moderate expression of CD8 and CD73 and mild expression of CD14. Minor differences were found in expression of CD4 and CD34. 3) Global DNA methylation levels were significantly lower in BM-MSC compared to AT-MSC. 4) Little difference was found between AT-and BM-MSC in their potential for adipogenesis and osteogenesis. Chondrogenesis was poor to absent for both sources in spite of adding varying levels of bone-morphogenic protein to our standard transforming growth factor (TGF-beta 3)-based induction medium. 5) Immunomodulatory capacity was equal regardless of cell source when tested in mitogen-stimulated lymphocyte reactions. Priming of MSC with pro-inflammatory factors interferon-gamma and/or tumour necrosis factor did not increase the lymphocyte suppressive properties of the MSC compared to untreated MSC. Conclusions/Significance No significant differences were found between AT-and BM-MSC with regard to their immunophenotype, progenitor, and non-progenitor functions. Both MSC populations showed strong adipogenic and osteogenic potential and poor chondrogenic potential. Both significantly suppressed stimulated peripheral blood mononuclear cells. The most significant differences found were the higher isolation success and proliferation rate of AT-MSC, which could be realized as notable benefits of their use over BM-MSC.	[Russell, Keith A.; Chow, Natalie H. C.; Dukoff, David; LaMarre, Jonathan; Koch, Thomas G.] Univ Guelph, Dept Biomed Sci, Ontario Vet Coll, Guelph, ON, Canada; [Gibson, Thomas W. G.] Univ Guelph, Ontario Vet Coll, Clin Studies, Guelph, ON, Canada; [Bette, Dean H.] Univ Western Ontario, Physiol & Pharmacol, London, ON, Canada; [Koch, Thomas G.] Aarhus Univ, Orthopaed Res Lab, Aarhus, Denmark	University of Guelph; University of Guelph; Western University (University of Western Ontario); Aarhus University	Russell, KA (corresponding author), Univ Guelph, Dept Biomed Sci, Ontario Vet Coll, Guelph, ON, Canada.	karussell.edu@gmail.com	Russell, Keith/HHS-2364-2022	Russell, Keith/0000-0002-1704-2966	Morris Animal Foundation [D12CA-313]; Pet Trust Research Foundation, Ontario Veterinary College; Dean's Office, Ontario Veterinary College; Department of Biomedical Sciences at the University of Guelph	Morris Animal Foundation; Pet Trust Research Foundation, Ontario Veterinary College; Dean's Office, Ontario Veterinary College; Department of Biomedical Sciences at the University of Guelph	This project was supported by the Morris Animal Foundation, grant ID# D12CA-313; Pet Trust Research Foundation, Ontario Veterinary College; The Dean's Office, Ontario Veterinary College and the Department of Biomedical Sciences at the University of Guelph. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An CH, 2010, ANN BIOMED ENG, V38, P1647, DOI 10.1007/s10439-009-9892-x; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Berdasco M, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt83; Berg LC, 2009, VET COMP ORTHOPAED, V22, P363, DOI 10.3415/VCOT-08-10-0107; Bertolo A, 2015, CELL TRANSPLANT, V24, P1969, DOI 10.3727/096368914X685294; Brinkhof B, 2006, ANAL BIOCHEM, V356, P36, DOI 10.1016/j.ab.2006.06.001; Choi SA, 2013, IN VITRO CELL DEV-AN, V49, P42, DOI 10.1007/s11626-012-9569-x; Co C, 2014, OSTEOARTHR CARTILAGE, V22, P472, DOI 10.1016/j.joca.2013.12.021; Collas P, 2008, TRANSFUS MED HEMOTH, V35, P205, DOI 10.1159/000127449; Csaki C, 2007, HISTOCHEM CELL BIOL, V128, P507, DOI 10.1007/s00418-007-0337-z; de Bakker E, 2014, VET Q, V2176, P1; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; English K, 2007, IMMUNOL LETT, V110, P91, DOI 10.1016/j.imlet.2007.04.001; Eslaminejad MB, 2010, ANAT HISTOL EMBRYOL, V39, P446, DOI 10.1111/j.1439-0264.2010.01013.x; Figueroa RJ, 2011, VET COMP ORTHOPAED, V24, P354, DOI 10.3415/VCOT-10-10-0142; Griffin MD, 2010, HUM GENE THER, V21, P1641, DOI 10.1089/hum.2010.156; Guercio A, 2013, CELL BIOL INT, V37, P789, DOI 10.1002/cbin.10090; Guilak F, 2004, BIORHEOLOGY, V41, P389; Hodgkiss-Geere HM, 2012, VET J, V194, P361, DOI 10.1016/j.tvjl.2012.05.011; Kamishina H, 2006, AM J VET RES, V67, P1921, DOI 10.2460/ajvr.67.11.1921; Kang BJ, 2012, J VET SCI, V13, P299, DOI 10.4142/jvs.2012.13.3.299; Kang JW, 2008, STEM CELLS DEV, V17, P681, DOI 10.1089/scd.2007.0153; Kisiel AH, 2012, AM J VET RES, V73, P1305, DOI 10.2460/ajvr.73.8.1305; Kol A, 2014, STEM CELLS DEV, V23, P1831, DOI 10.1089/scd.2014.0128; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209; Lee J, 2015, EURASIP J WIREL COMM, P1, DOI 10.1186/s13638-015-0359-5; Lee WS, 2011, BIOL BLOOD MARROW TR, V17, P465, DOI 10.1016/j.bbmt.2010.04.016; Martinello T, 2011, RES VET SCI, V91, P18, DOI 10.1016/j.rvsc.2010.07.024; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; NEUPANE M, 2008, TISSUE ENG PART A, V14, P1007, DOI DOI 10.1089/TEA.2007.0207; Park SA, 2013, CYTOTHERAPY, V15, P1498, DOI 10.1016/j.jcyt.2013.06.009; Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x; Reich CM, 2012, VET RES COMMUN, V36, P139, DOI 10.1007/s11259-012-9523-0; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Russell KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136621; Ryan JM, 2007, CLIN EXP IMMUNOL, V149, P353, DOI 10.1111/j.1365-2249.2007.03422.x; Schmitt B, 2003, DIFFERENTIATION, V71, P567, DOI 10.1111/j.1432-0436.2003.07109003.x; Screven R, 2014, VET IMMUNOL IMMUNOP, V161, P21, DOI 10.1016/j.vetimm.2014.06.002; Shirasawa S, 2006, J CELL BIOCHEM, V97, P84, DOI 10.1002/jcb.20546; Sullivan MO, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2015.00082; Takemitsu H, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-150; Toh WS, 2005, GROWTH FACTORS, V23, P313, DOI 10.1080/08977190500252763; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Vieira NM, 2010, CELL TRANSPLANT, V19, P279, DOI 10.3727/096368909X481764; Volk SW, 2012, CELL TRANSPLANT, V21, P2189, DOI 10.3727/096368912X636821; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762; Zucconi E, 2010, STEM CELLS DEV, V19, P395, DOI 10.1089/scd.2008.0314	51	74	76	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167442	10.1371/journal.pone.0167442	http://dx.doi.org/10.1371/journal.pone.0167442			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907211	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700158
